PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Coquille, S; Roux, C; Fitzpatrick, TB; Thore, S				Coquille, Sandrine; Roux, Celine; Fitzpatrick, Teresa B.; Thore, Stephane			The Last Piece in the Vitamin B-1 Biosynthesis Puzzle STRUCTURAL AND FUNCTIONAL INSIGHT INTO YEAST 4-AMINO-5-HYDROXYMETHYL-2-METHYLPYRIMIDINE PHOSPHATE (HMP-P) SYNTHASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; BINDING-PROTEIN; THIAMIN; ENZYMES; PYRIDOXINE; HISTIDINE; THIAZOLE; PROMOTER; IRON	Vitamin B-1 is essential for all organisms being well recognized as a necessary cofactor for key metabolic pathways such as glycolysis, and was more recently implicated in DNA damage responses. Little is known about the enzyme responsible for the formation of the pyrimidine moiety (4-amino-5-hydroxymethyl-2-methylpyrimidine phosphate (HMP-P) synthase). We report a structure-function study of the HMP-P synthase from yeast, THI5p. Our crystallographic structure shows that THI5p is a mix between periplasmic binding proteins and pyridoxal 5'-phosphate-dependent enzymes. Mutational and yeast complementation studies identify the key residues for HMP-P biosynthesis as well as the use of pyridoxal 5'-phosphate as a substrate rather thanasacofactor. Furthermore, we could show that iron binding to HMP-P synthase is essential for the reaction.	[Roux, Celine; Fitzpatrick, Teresa B.] Univ Geneva, Dept Bot & Plant Biol, CH-1211 Geneva, Switzerland; [Coquille, Sandrine; Thore, Stephane] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Fitzpatrick, TB (corresponding author), Univ Geneva, Dept Bot & Plant Biol, CH-1211 Geneva, Switzerland.	Theresa.fitzpatrick@unige.ch; Stephane.thore@unige.ch	Thore, stéphane/M-7759-2014; Thore, Stephane/AAW-6482-2020	Thore, stéphane/0000-0001-7058-3887; Thore, Stephane/0000-0001-7058-3887; Coquille, Sandrine/0000-0001-6168-3659	Swiss National Science Foundation Research [PP00A-119186, 31003A-124909, 31003A-140924]; University of Geneva; E. Boninchi Foundation; E. & L. Schmidheiny Foundation; Swiss National Science Foundation R'equip Grant [316030-128787]	Swiss National Science Foundation Research(Swiss National Science Foundation (SNSF)); University of Geneva; E. Boninchi Foundation; E. & L. Schmidheiny Foundation; Swiss National Science Foundation R'equip Grant(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Science Foundation Research Grants PP00A-119186 (to T. B. F.), 31003A-124909 and 31003A-140924 (to S. T.), and the University of Geneva.; We are indebted to Dr. Peter A. Meacock (University of Leicester) for kindly providing yeast strain RWY16. We thank the Functional Genomics Center Zurich for the mass spectrometry analysis. We are also grateful to Dr. Nicolas Szydlowski and Dr. Michael Moulin (University of Geneva) for assistance and for developing the vitamin B<INF>6</INF> HPLC method (to be published elsewhere) and to Dr. Markus Kaufmann (University of Geneva) for performing the static light scattering analysis. We thank all the members of the Thore laboratory for providing excellent feedback. We are grateful to Vincent Olieric and Wang Meitian at the Swiss Light Source and to Andrew McCarthy at the European Synchrotron Radiation Facility, whose outstanding efforts have made these experiments possible. We further acknowledge the financial contributions from the E. Boninchi Foundation, the E. & L. Schmidheiny Foundation, and the Swiss National Science Foundation R'equip Grant 316030-128787 used to set up the crystallography platform.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bale S, 2010, BIOCHEMISTRY-US, V49, P8929, DOI 10.1021/bi101209t; Beinert H, 1978, Methods Enzymol, V54, P435; Bisht S, 2012, J BIOL CHEM, V287, P20369, DOI 10.1074/jbc.M112.351809; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Chatterjee A, 2007, J AM CHEM SOC, V129, P2914, DOI 10.1021/ja067606t; Chatterjee A, 2011, NATURE, V478, P542, DOI 10.1038/nature10503; Christen P, 2001, CHEM REC, V1, P436, DOI 10.1002/tcr.10005; Denesyuk AI, 2003, BBA-PROTEINS PROTEOM, V1647, P234, DOI 10.1016/S1570-9639(03)00057-8; DUNATHAN HC, 1966, P NATL ACAD SCI USA, V55, P712, DOI 10.1073/pnas.55.4.712; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Fitzpatrick TB, 2012, PLANT CELL, V24, P395, DOI 10.1105/tpc.111.093120; Fukami-Kobayashi K, 1999, J MOL BIOL, V286, P279, DOI 10.1006/jmbi.1998.2454; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Jurgenson CT, 2009, ANNU REV BIOCHEM, V78, P569, DOI 10.1146/annurev.biochem.78.072407.102340; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lai RY, 2012, J AM CHEM SOC, V134, P9157, DOI 10.1021/ja302474a; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; MAO B, 1982, J BIOL CHEM, V257, P1131; Matsuda N, 2004, J BIOCHEM, V135, P33, DOI 10.1093/jb/mvh004; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moore PS, 1995, BIOCHIMIE, V77, P724, DOI 10.1016/0300-9084(96)88189-2; Mozzarelli A, 2006, CHEM REC, V6, P275, DOI 10.1002/tcr.20094; Raschke M, 2007, P NATL ACAD SCI USA, V104, P19637, DOI 10.1073/pnas.0709597104; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; STOOKEY L, 1970, TALANTA, V17, P644, DOI 10.1016/0039-9140(70)80016-9; TANG CSL, 1994, J BIOL CHEM, V269, P11921; Tazuya K, 1995, BIOCHEM MOL BIOL INT, V36, P883; Uenishi K, 2008, J NUTR SCI VITAMINOL, V54, P25, DOI 10.3177/jnsv.54.7; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wightman R, 2003, MICROBIOL-SGM, V149, P1447, DOI 10.1099/mic.0.26194-0; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Zeidler J, 2003, J AM CHEM SOC, V125, P13094, DOI 10.1021/ja030261j; Zurlinden A, 1997, J BACTERIOL, V179, P5956, DOI 10.1128/jb.179.18.5956-5958.1997	39	19	20	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42333	42343		10.1074/jbc.M112.397240	http://dx.doi.org/10.1074/jbc.M112.397240			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23048037	Green Published, hybrid			2022-12-28	WOS:000312103000068
J	Das, S; Sudarsan, R; Sivakami, S; Sharma, S				Das, Sudipta; Sudarsan, Rajagopal; Sivakami, Subramanian; Sharma, Shobhona			Erythrocytic Stage-dependent Regulation of Oligomerization of Plasmodium Ribosomal Protein P2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; IN-VITRO; BETA PEPTIDES; PRION PROTEIN; P0; FALCIPARUM; BINDING; DOMAIN; STALK; EXPRESSION	The eukaryotic 60 S-ribosomal stalk consists of P0, P1, and P2 proteins, which associate in a pentameric structure (P1(2)-P0-P2(2)). The Plasmodium falciparum protein P2 (PfP2) appears to play nonribosomal roles. It gets exported to the infected erythrocyte (IE) surface at 30 h post-merozoite invasion (PMI), concomitant with extensive oligomerization. Here we present certain biophysical properties of PfP2. Recombinant P2 (rPfP2) protein showed SDS-resistant oligomerization, which could be significantly abolished under reducing conditions. However, the protein continued to oligomerize even when both cysteine residues were mutated, and with up to 40 amino acids (aa) deleted from the C-terminal end. CD analysis of P2 showed largely alpha-helical and random coil domains. The SDS- and DTT-resistant oligomerization was studied further as it occurred in a development-specific manner in Plasmodium. In a synchronized erythrocytic culture of P. falciparum, the PfP2 protein was detected as part of the ribosomal complex (similar to 96 kDa) at 18 and 30 h PMI, and was SDS sensitive. However, at 30 h, large amounts of SDS-sensitive aggregates of >600 kDa were also seen. At 30 h PMI, each of the parasites, IE cytosol and IE ghost contained 60-80-kDa PfP2 complexes, which resolved to a single 65-kDa species on SDS-PAGE. Tetramethylrhodamine-labeled rPfP2 protein exhibited DTT- and SDS-resistant oligomerization when treated with P. falciparum parasite extracts only from 24 to 36 h PMI, and multiple proteins appeared to be required for this oligomerization. Understanding the regulation of oligomerization of PfP2 may help in the elucidation of the novel structure-function relationship in the export of PfP2 to the red cell surface.	[Das, Sudipta; Sudarsan, Rajagopal; Sharma, Shobhona] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India; [Sivakami, Subramanian] Univ Mumbai, Dept Life Sci, Bombay 400098, Maharashtra, India	Tata Institute of Fundamental Research (TIFR); University of Mumbai	Sharma, S (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	sharma@tifr.res.in		Rajagopal, Sudarsan/0000-0002-4170-3875; DAS, SUDIPTA/0000-0002-8644-7342	Tata Institute of Fundamental Research, DAE, India	Tata Institute of Fundamental Research, DAE, India	This work was supported by an intramural grant from Tata Institute of Fundamental Research, DAE, India. Part of this work was presented at the Gordon Research Conference on Malaria, 31st July-5th August, 2011, Pisa, Italy, as a poster (by S. Das).	Anthony V, 2002, CURR PROTEIN PEPT SC, V3, P485, DOI 10.2174/1389203023380503; Arnesano F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007052; Aruna K, 2005, GENE, V357, P9, DOI 10.1016/j.gene.2005.04.007; Bagriantsev SN, 2006, METHOD ENZYMOL, V412, P33, DOI 10.1016/S0076-6879(06)12003-0; Bernard K, 2009, J BIOL CHEM, V284, P30754, DOI 10.1074/jbc.M109.056010; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005; Bowerman CJ, 2011, BIOMACROMOLECULES, V12, P2735, DOI 10.1021/bm200510k; Chatterjee S, 2000, MOL BIOCHEM PARASIT, V107, P143, DOI 10.1016/S0166-6851(99)00226-1; Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Das S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002858; Dos Reis S, 2002, J BIOL CHEM, V277, P5703, DOI 10.1074/jbc.M110183200; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDFARB LG, 1991, P NATL ACAD SCI USA, V88, P10926, DOI 10.1073/pnas.88.23.10926; Gonzalo P, 2003, BIOL CELL, V95, P179, DOI 10.1016/S0248-4900(03)00034-0; Hagiya A, 2005, J BIOL CHEM, V280, P39193, DOI 10.1074/jbc.M506050200; Hanson CL, 2004, J BIOL CHEM, V279, P42750, DOI 10.1074/jbc.M405718200; Hashimoto K, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035007; HASLER P, 1991, J BIOL CHEM, V266, P13815; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Hundt C, 2003, BIOL CHEM, V384, P791, DOI 10.1515/BC.2003.088; Iconomidou VA, 2008, CURR PROTEIN PEPT SC, V9, P291, DOI 10.2174/138920308784534041; Ilag LL, 2005, P NATL ACAD SCI USA, V102, P8192, DOI 10.1073/pnas.0502193102; Ispolatov I, 2005, NUCLEIC ACIDS RES, V33, P3629, DOI 10.1093/nar/gki678; Kasai H, 2003, J HISTOCHEM CYTOCHEM, V51, P567, DOI 10.1177/002215540305100502; KASLOW DC, 1994, MOL BIOCHEM PARASIT, V63, P283, DOI 10.1016/0166-6851(94)90064-7; Kostka M, 2008, J BIOL CHEM, V283, P10992, DOI 10.1074/jbc.M709634200; Lazo ND, 2005, AMYLOID PROTEINS: THE BETA SHEET CONFORMATION AND DISEASE, VOLS 1 AND 2, P385; Lee HJ, 2011, EXP MOL MED, V43, P216, DOI 10.3858/emm.2011.43.4.026; Lee KM, 2010, NUCLEIC ACIDS RES, V38, P5206, DOI 10.1093/nar/gkq231; Lee KK, 2002, J BIOL CHEM, V277, P12351, DOI 10.1074/jbc.M108138200; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; LOBO CA, 1994, INFECT IMMUN, V62, P651, DOI 10.1128/IAI.62.2.651-656.1994; LYNCH BA, 1991, P NATL ACAD SCI USA, V88, P10402, DOI 10.1073/pnas.88.23.10402; Mishra P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036279; Nag S, 2011, J BIOL CHEM, V286, P13827, DOI 10.1074/jbc.M110.199885; Neumeyer T, 2008, J BIOL CHEM, V283, P3904, DOI 10.1074/jbc.M709807200; Norrgard MA, 2011, J BIOL CHEM, V286, P16871, DOI 10.1074/jbc.M111.230078; Pietila R, 2012, J CELL SCI, V125, P2212, DOI 10.1242/jcs.098020; Prugnolle F, 2011, VIRULENCE, V2, P71, DOI 10.4161/viru.2.1.14608; Rajeshwari K, 2004, INFECT IMMUN, V72, P5515, DOI 10.1128/IAI.72.9.5515-5521.2004; REMACHA M, 1992, J BIOL CHEM, V267, P12061; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; SAENZROBLES MT, 1990, BIOCHIM BIOPHYS ACTA, V1050, P51, DOI 10.1016/0167-4781(90)90140-W; Santos C, 2005, MOL MICROBIOL, V58, P217, DOI 10.1111/j.1365-2958.2005.04816.x; Schomburg I, 2004, NUCLEIC ACIDS RES, V32, pD431, DOI 10.1093/nar/gkh081; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shimizu T, 2002, NUCLEIC ACIDS RES, V30, P2620, DOI 10.1093/nar/gkf379; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Singh S, 2002, MOL BIOCHEM PARASIT, V119, P121, DOI 10.1016/S0166-6851(01)00394-2; SKEIKY YAW, 1993, J IMMUNOL, V151, P5504; SOREGHAN B, 1994, J BIOL CHEM, V269, P28551; Spence JM, 2000, INFECT IMMUN, V68, P5002, DOI 10.1128/IAI.68.9.5002-5010.2000; Szick K, 1998, P NATL ACAD SCI USA, V95, P2378, DOI 10.1073/pnas.95.5.2378; Tchorzewski M, 2002, INT J BIOCHEM CELL B, V34, P911, DOI 10.1016/S1357-2725(02)00012-2; Tchorzewski M, 2000, BBA-MOL CELL RES, V1499, P63, DOI 10.1016/S0167-4889(00)00108-7; Tycko R, 2010, BIOCHEMISTRY-US, V49, P9488, DOI 10.1021/bi1013134; Uchiumi T, 1999, J BIOL CHEM, V274, P27578, DOI 10.1074/jbc.274.39.27578; Uchiumi T, 2002, J BIOL CHEM, V277, P41401, DOI 10.1074/jbc.M207424200; Uchiumi T, 2002, J BIOL CHEM, V277, P3857, DOI 10.1074/jbc.M107730200; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; Urakov VN, 2010, PRION, V4, P45, DOI 10.4161/pri.4.1.11074; Wang X, 2007, J BIOL CHEM, V282, P3713, DOI 10.1074/jbc.M609228200; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; WOOL IG, 1991, BIOCHIMIE, V73, P861, DOI 10.1016/0300-9084(91)90127-M	70	6	6	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41499	41513		10.1074/jbc.M112.384388	http://dx.doi.org/10.1074/jbc.M112.384388			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23060439	hybrid, Green Published			2022-12-28	WOS:000311887600060
J	Hudson, BD; Tikhonova, IG; Pandey, SK; Ulven, T; Milligan, G				Hudson, Brian D.; Tikhonova, Irina G.; Pandey, Sunil K.; Ulven, Trond; Milligan, Graeme			Extracellular Ionic Locks Determine Variation in Constitutive Activity and Ligand Potency between Species Orthologs of the Free Fatty Acid Receptors FFA2 and FFA3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; AGONISM; GPCRS; DRUG; IDENTIFICATION; PHARMACOLOGY; ALLOSTERISM; INVERSE; PATHWAY	Free fatty acid receptors 2 and 3 (FFA2 and FFA3) are G protein-coupled receptors for short chain free fatty acids (SCFAs). They respond to the same set of endogenous ligands but with distinct rank-order of potency such that acetate (C2) has been described as FFA2-selective, whereas propionate (C3) is nonselective. Although C2 was confirmed to be selective for human FFA2 over FFA3, this ligand was not selective between the mouse orthologs. Moreover, although C3 was indeed not selective between the human orthologs, it displayed clear selectivity for mouse FFA3 over mouse FFA2. This altered selectivity to C2 and C3 resulted from broad differences in SCFAs potency at the mouse orthologs. In studies to define the molecular basis for these observations, marked variation in ligand-independent constitutive activity was identified using a [S-35]GTP gamma S assay. The orthologs with higher potency for the SCFAs, human FFA2 and mouse FFA3, displayed high constitutive activity in this assay, whereas the orthologs with lower potency for the agonist ligands, mouse FFA2 and human FFA3, did not. Sequence alignments of the second extracellular loop identified single negatively charged residues in FFA2 and FFA3 not conserved between species and predicted to form ionic lock interactions with arginine residues within the FFA2 or FFA3 agonist binding pocket to regulate constitutive activity and SCFA potency. Reciprocal mutation of these residues between species orthologs resulted in the induction (or repression) of constitutive activity and in most cases also yielded corresponding changes in SCFA potency.	[Hudson, Brian D.; Milligan, Graeme] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland; [Tikhonova, Irina G.] Queens Univ Belfast, Ctr Med Biol, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland; [Pandey, Sunil K.; Ulven, Trond] Univ So Denmark, Dept Chem & Phys, DK-5230 Odense M, Denmark	University of Glasgow; Queens University Belfast; University of Southern Denmark	Milligan, G (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Mol Pharmacol Grp, Wolfson Link Bldg 253, Glasgow G12 8QQ, Lanark, Scotland.	Graeme.Milligan@glasgow.ac.uk	Ulven, Trond/H-5500-2015; Pandey, Sunil Kumar/AAP-2234-2021; Hudson, B. D./H-4845-2013; Milligan, Graeme/F-9426-2011	Ulven, Trond/0000-0002-8135-1755; Hudson, B. D./0000-0001-7059-0091; Milligan, Graeme/0000-0002-6946-3519	Wellcome Trust [089600/Z/09/Z]; Danish Council for Strategic Research [11-116196]; Canadian Institutes of Health Research	Wellcome Trust(Wellcome TrustEuropean Commission); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Wellcome Trust 089600/Z/09/Z (to G. M.), the Danish Council for Strategic Research 11-116196 (to T. U. and G. M.), and the Canadian Institutes of Health Research (fellowship to B. D. H.).	Alquier T, 2009, DIABETES, V58, P1035, DOI 10.2337/db09-0215; Brantis C. E., 2011, Int. Appl, Patent No. [WO2011092284, 2011092284]; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Burant CF, 2012, LANCET, V379, P1403, DOI 10.1016/S0140-6736(11)61879-5; Congreve M, 2011, ADV PHARMACOL, V62, P1, DOI 10.1016/B978-0-12-385952-5.00011-7; Cotecchia S, 2007, BIOCHEM PHARMACOL, V73, P1076, DOI 10.1016/j.bcp.2006.10.024; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Ge HF, 2008, ENDOCRINOLOGY, V149, P4519, DOI 10.1210/en.2008-0059; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Hudson BD, 2011, ADV PHARMACOL, V62, P175, DOI 10.1016/B978-0-12-385952-5.00006-3; Hudson BD, 2012, FASEB J, V26, P4951, DOI 10.1096/fj.12-213314; Jenkins L, 2010, BIOCHEM J, V432, P451, DOI 10.1042/BJ20101287; Kenakin T, 2004, TRENDS PHARMACOL SCI, V25, P186, DOI 10.1016/j.tips.2004.02.012; Kenakin T, 2001, FASEB J, V15, P598, DOI 10.1096/fj.00-0438rev; Lee T, 2008, MOL PHARMACOL, V74, P1599, DOI 10.1124/mol.108.049536; Milligan G, 2009, BRIT J PHARMACOL, V158, P146, DOI 10.1111/j.1476-5381.2009.00421.x; Oh DY, 2011, CURR OPIN CLIN NUTR, V14, P322, DOI 10.1097/MCO.0b013e3283479230; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; Rayasam GV, 2007, EXPERT OPIN THER TAR, V11, P661, DOI 10.1517/14728222.11.5.661; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Schlyer S, 2006, DRUG DISCOV TODAY, V11, P481, DOI 10.1016/j.drudis.2006.04.008; Schmidt J, 2011, J BIOL CHEM, V286, P10628, DOI 10.1074/jbc.M110.210872; Smith NJ, 2011, MOL PHARMACOL, V80, P163, DOI 10.1124/mol.110.070789; Stoddart LA, 2008, J BIOL CHEM, V283, P32913, DOI 10.1074/jbc.M805601200; Stoddart LA, 2008, PHARMACOL REV, V60, P405, DOI 10.1124/pr.108.00802; Sum CS, 2009, J BIOL CHEM, V284, P3529, DOI 10.1074/jbc.M806987200; Swanson R, 2010, CURR PHARM BIOTECHNO, V11, P757, DOI 10.2174/138920110792927775; Talukdar S, 2011, TRENDS PHARMACOL SCI, V32, P543, DOI 10.1016/j.tips.2011.04.004; Topiol S, 2009, BIOCHEM PHARMACOL, V78, P11, DOI 10.1016/j.bcp.2009.02.012; Wheatley M, 2012, BRIT J PHARMACOL, V165, P1688, DOI 10.1111/j.1476-5381.2011.01629.x; Williams C, 2009, METHODS MOL BIOL, V552, P39, DOI 10.1007/978-1-60327-317-6_3; Zaibi MS, 2010, FEBS LETT, V584, P2381, DOI 10.1016/j.febslet.2010.04.027	33	89	94	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41195	41209		10.1074/jbc.M112.396259	http://dx.doi.org/10.1074/jbc.M112.396259			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23066016	Green Published, hybrid			2022-12-28	WOS:000311887600035
J	Purushothaman, A; Babitz, SK; Sanderson, RD				Purushothaman, Anurag; Babitz, Stephen K.; Sanderson, Ralph D.			Heparanase Enhances the Insulin Receptor Signaling Pathway to Activate Extracellular Signal-regulated Kinase in Multiple Myeloma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGGRESSIVE TUMOR PHENOTYPE; PROTEIN-KINASE; GROWTH-FACTOR; SULFATE PROTEOGLYCANS; SUBSTRATE 1; IN-VIVO; EXPRESSION; METASTASIS; SYNDECAN-1; CANCER	ERK signaling regulates proliferation, survival, drug resistance, and angiogenesis in cancer. Although the mechanisms regulating ERK activation are not fully understood, we previously demonstrated that ERK phosphorylation is elevated by heparanase, an enzyme associated with aggressive behavior of many cancers. In the present study, myeloma cell lines expressing either high or low levels of heparanase were utilized to determine how heparanase stimulates ERK signaling. We discovered that the insulin receptor was abundant on cells expressing either high or low levels of heparanase, but the receptor was highly phosphorylated in heparanase-high cells compared with heparanase-low cells. In addition, protein kinase C activity was elevated in heparanase-high cells, and this enhanced expression of insulin receptor substrate-1 (IRS-1), the principle intracellular substrate for phosphorylation by the insulin receptor. Blocking insulin receptor function with antibody or a small molecule inhibitor or knockdown of IRS-1 expression using shRNA diminished heparanase-mediated ERK activation in the tumor cells. In addition, up-regulation of the insulin signaling pathway by heparanase and the resulting ERK activation were dependent on heparanase retaining its enzyme activity. These results reveal a novel mechanism whereby heparanase enhances activation of the insulin receptor signaling pathway leading to ERK activation and modulation of myeloma behavior.	[Purushothaman, Anurag; Babitz, Stephen K.; Sanderson, Ralph D.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Purushothaman, Anurag; Sanderson, Ralph D.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sanderson, RD (corresponding author), Univ Alabama Birmingham, Dept Pathol, 1720 2nd Ave S,WTI 602B, Birmingham, AL 35294 USA.	sanderson@uab.edu			National Institutes of Health [CA135075, CA138340, P30 AR48311, P30 AR46031]; NATIONAL CANCER INSTITUTE [R01CA135075, R01CA138340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311, P30AR046031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA135075 and CA138340 (to R. D. S).; We thank Dr. Israel Vlodavsky (Technion, Haifa, Israel) for providing recombinant heparanase. We acknowledge Enid Keyser at the University of Alabama at Birmingham flow cytometry core facility for assistance with flow analysis (supported by National Institutes of Health Grant P30 AR48311). Histology services were performed by the University of Alabama at Birmingham Center for Metabolic Bone Disease's Histomorphometry and Molecular Analysis Core Laboratory (supported by National Institutes of Health Grant P30 AR46031).	Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; Beauvais DM, 2010, J CELL SCI, V123, P3796, DOI 10.1242/jcs.067645; Birmann BM, 2009, CANCER EPIDEM BIOMAR, V18, P282, DOI 10.1158/1055-9965.EPI-08-0778; Boyd D Barry, 2003, Integr Cancer Ther, V2, P315, DOI 10.1177/1534735403259152; Breitkreutz I, 2007, BRIT J HAEMATOL, V139, P55, DOI 10.1111/j.1365-2141.2007.06747.x; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chang Q, 2002, CANCER RES, V62, P6035; Chen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004947; Dalmizrak O, 2007, CANCER RES, V67, P2124, DOI 10.1158/0008-5472.CAN-06-3954; Deangelis T, 2010, J CELL PHYSIOL, V224, P658, DOI 10.1002/jcp.22164; DeVente JE, 1996, J BIOL CHEM, V271, P32276, DOI 10.1074/jbc.271.50.32276; Doweck I, 2006, NEOPLASIA, V8, P1055, DOI 10.1593/neo.06577; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P23536, DOI 10.1074/jbc.M400554200; Hideshima T, 2004, BLOOD, V104, P607, DOI 10.1182/blood-2004-01-0037; Hideshima T, 2006, BLOOD, V107, P4053, DOI 10.1182/blood-2005-08-3434; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Ito T, 1996, MOL CELL BIOL, V16, P943; Kelly T, 2003, CANCER RES, V63, P8749; Kim KH, 2010, BIOMAT PROP PROD DEV, P149; Levy-Adam F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002319; Levy-Adam F, 2010, SEMIN CANCER BIOL, V20, P153, DOI 10.1016/j.semcancer.2010.06.005; MYERS MG, 1994, TRENDS BIOCHEM SCI, V19, P289, DOI 10.1016/0968-0004(94)90007-8; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Purushothaman A, 2011, J BIOL CHEM, V286, P30377, DOI 10.1074/jbc.M111.254789; Purushothaman A, 2010, BLOOD, V115, P2449, DOI 10.1182/blood-2009-07-234757; Ritchie JP, 2011, CLIN CANCER RES, V17, P1382, DOI 10.1158/1078-0432.CCR-10-2476; ROSE DW, 1994, P NATL ACAD SCI USA, V91, P797, DOI 10.1073/pnas.91.2.797; Sanderson RD, 2004, MATRIX BIOL, V23, P341, DOI 10.1016/j.matbio.2004.08.004; Shafat I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017312; Sprynski AC, 2010, LEUKEMIA, V24, P1940, DOI 10.1038/leu.2010.192; Tai YT, 2007, BLOOD, V110, P1656, DOI 10.1182/blood-2007-03-081240; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; Tanaka S, 1997, HEPATOLOGY, V26, P598; Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200; Tsitoura DC, 2004, J CLIN INVEST, V113, P619, DOI 10.1172/JCI200418975; WATERS SB, 1993, J BIOL CHEM, V268, P22231; WHITE MF, 1994, J BIOL CHEM, V269, P1; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Yang Y, 2005, BLOOD, V105, P1303, DOI 10.1182/blood-200406-2141; Yang Y, 2002, BLOOD, V100, P610, DOI 10.1182/blood.V100.2.610; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811	43	39	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41288	41296		10.1074/jbc.M112.391417	http://dx.doi.org/10.1074/jbc.M112.391417			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23048032	Green Published, hybrid			2022-12-28	WOS:000311887600043
J	Ehira, S; Ohmori, M				Ehira, Shigeki; Ohmori, Masayuki			The Redox-sensing Transcriptional Regulator RexT Controls Expression of Thioredoxin A2 in the Cyanobacterium Anabaena sp Strain PCC 7120	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; HETEROCYST DEVELOPMENT; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; SIGMA-FACTOR; SP PCC-7120; NITROGEN; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; REPRESSOR; GROWTH	Thioredoxins are ubiquitous proteins that catalyze thiol-disulfide redox reactions. They have a crucial role in the oxidative stress response as well as the redox regulation of metabolic enzymes. In cyanobacteria, little is known about the regulation of trx gene expression despite the importance of thioredoxins in cellular functions. In the present study, transcriptional regulation of the trx genes under oxidative stress conditions was investigated in the heterocystous cyanobacterium Anabaena sp. strain PCC 7120. When cells were exposed to H2O2, only the trxA2 gene (all1866) of seven trx genes was induced. Disruption of the rexT gene (alr1867), encoding a transcriptional regulator of the ArsR family, resulted in increased expression of trxA2. RexT bound to the region downstream of the transcription initiation site of trxA2. The DNA binding activity of RexT was impaired by H2O2 through the formation of an intramolecular disulfide bond, which induced expression of the trxA2 gene. The inactivated DNA binding activity of RexT was restored by reduced TrxA2. Hence, RexT is considered as a redox-sensing transcriptional repressor of trxA2. These results support the idea that the RexT-TrxA2 regulatory system is important for the oxidative stress response in this cyanobacterium.	[Ehira, Shigeki; Ohmori, Masayuki] Chuo Univ, Fac Sci & Engn, Dept Biol Sci, Bunkyo Ku, Tokyo 1128551, Japan; [Ehira, Shigeki] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Saitama 3320012, Japan	Chuo University; Japan Science & Technology Agency (JST)	Ohmori, M (corresponding author), Chuo Univ, Fac Sci & Engn, Dept Biol Sci, Bunkyo Ku, 1-13-27 Kasuga, Tokyo 1128551, Japan.	ohmori@bio.chuo-u.ac.jp	Ehira, Shigeki/D-6081-2013	Ehira, Shigeki/0000-0002-4121-7367	PRESTO of the Japan Science and Technology Agency; Japan Society for the Promotion of Science [23603005]	PRESTO of the Japan Science and Technology Agency; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by PRESTO of the Japan Science and Technology Agency (to S. E.) and Grant-in-aid for Scientific Research (C) 23603005 from the Japan Society for the Promotion of Science (to S. E.).	BLACK TA, 1993, MOL MICROBIOL, V9, P77, DOI 10.1111/j.1365-2958.1993.tb01670.x; Buchanan BB, 2012, BBA-GEN SUBJECTS, V1820, P1822, DOI 10.1016/j.bbagen.2012.07.006; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7022, DOI 10.1073/pnas.91.15.7022; COSSAR JD, 1984, J GEN MICROBIOL, V130, P991; DAI HP, 1992, J PHOTOCH PHOTOBIO B, V16, P285; Ehira S, 2006, MOL MICROBIOL, V59, P1692, DOI 10.1111/j.1365-2958.2006.05049.x; Ehira S, 2011, J BIOL CHEM, V286, P38109, DOI 10.1074/jbc.M111.289124; Ehira S, 2009, J BACTERIOL, V191, P2964, DOI 10.1128/JB.00112-09; ELHAI J, 1988, METHOD ENZYMOL, V167, P747; ELHAI J, 1988, GENE, V68, P119, DOI 10.1016/0378-1119(88)90605-1; Perez-Perez ME, 2009, MOL PLANT, V2, P270, DOI 10.1093/mp/ssn070; Perez-Perez ME, 2006, PROTEOMICS, V6, pS186, DOI 10.1002/pmic.200500215; Florencio FJ, 2006, PHOTOSYNTH RES, V89, P157, DOI 10.1007/s11120-006-9093-5; Flores E, 2010, NAT REV MICROBIOL, V8, P39, DOI 10.1038/nrmicro2242; Guimaraes BG, 2011, J BIOL CHEM, V286, P26148, DOI 10.1074/jbc.M111.234039; Hisabori T, 2007, PHOTOCHEM PHOTOBIOL, V83, P145, DOI 10.1562/2006-02-27-IR-816; Kaneko T, 2001, DNA RES, V8, P205, DOI 10.1093/dnares/8.5.205; Kobayashi M, 2004, PLANT CELL PHYSIOL, V45, P290, DOI 10.1093/pcp/pch034; Kumar K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000315; Latifi A, 2009, FEMS MICROBIOL REV, V33, P258, DOI 10.1111/j.1574-6976.2008.00134.x; Lechno-Yossef S, 2011, J BACTERIOL, V193, P3482, DOI 10.1128/JB.05010-11; Li H, 2004, J BACTERIOL, V186, P3331, DOI 10.1128/JB.186.11.3331-3345.2004; Lindahl M, 2003, P NATL ACAD SCI USA, V100, P16107, DOI 10.1073/pnas.2534397100; Montrichard F, 2009, J PROTEOMICS, V72, P452, DOI 10.1016/j.jprot.2008.12.002; Nakano S, 2005, MOL MICROBIOL, V55, P498, DOI 10.1111/j.1365-2958.2004.04395.x; Nakano S, 2003, P NATL ACAD SCI USA, V100, P13603, DOI 10.1073/pnas.2235180100; Nakao M, 2010, NUCLEIC ACIDS RES, V38, pD379, DOI 10.1093/nar/gkp915; Paget MSB, 1998, EMBO J, V17, P5776, DOI 10.1093/emboj/17.19.5776; Pascual MB, 2010, J BIOL CHEM, V285, P34485, DOI 10.1074/jbc.M110.160465; Pinto FL, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-79; Ritz D, 2000, J BIOL CHEM, V275, P2505, DOI 10.1074/jbc.275.4.2505; SUMMERS ML, 1995, J BACTERIOL, V177, P6184, DOI 10.1128/jb.177.21.6184-6194.1995; Tichy M, 1999, J BACTERIOL, V181, P1875, DOI 10.1128/JB.181.6.1875-1882.1999; UDVARDY J, 1984, J BACTERIOL, V157, P681, DOI 10.1128/JB.157.2.681-683.1984; Wolk C.P., 1994, MOL BIOL CYANOBACTER, P769, DOI DOI 10.1007/978-94-011-0227-8_27; Ye J, 2005, J BACTERIOL, V187, P4214, DOI 10.1128/JB.187.12.4214-4221.2005; Zhao HY, 2010, MICROBIOL-SGM, V156, P385, DOI 10.1099/mic.0.033548-0; Zhao WX, 2007, MOL MICROBIOL, V66, P1219, DOI 10.1111/j.1365-2958.2007.05994.x; Zhao WX, 2007, PLANT CELL PHYSIOL, V48, P563, DOI 10.1093/pcp/pcm025	39	27	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40433	40440		10.1074/jbc.M112.384206	http://dx.doi.org/10.1074/jbc.M112.384206			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23027868	Green Published, hybrid			2022-12-28	WOS:000311448800034
J	Zivkovic, ML; Zareba-Koziol, M; Zhukova, L; Poznanski, J; Zhukov, I; Wyslouch-Cieszynska, A				Zivkovic, Martina Lenarcic; Zareba-Koziol, Monika; Zhukova, Liliya; Poznanski, Jaroslaw; Zhukov, Igor; Wyslouch-Cieszynska, Aleksandra			Post-translational S-Nitrosylation Is an Endogenous Factor Fine Tuning the Properties of Human S100A1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; 3-DIMENSIONAL SOLUTION STRUCTURE; CALCIUM-BINDING PROPERTIES; NMR CHEMICAL-SHIFTS; EF-HAND TYPE; DIPOLAR COUPLINGS; APO-S100A1 PROTEIN; FUNCTIONAL ROLES; CALBINDIN D-9K; HEART-FAILURE	S100A1 is a member of the Ca2+-binding S100 protein family. It is expressed in brain and heart tissue, where it plays a crucial role as a modulator of Ca2+ homeostasis, energy metabolism, neurotransmitter release, and contractile performance. Biological effects of S100A1 have been attributed to its direct interaction with a variety of target proteins. The (patho) physiological relevance of S100A1 makes it an important molecular target for future therapeutic intervention. S-Nitrosylation is a post-translational modification of proteins, which plays a role in cellular signal transduction under physiological and pathological conditions. In this study, we confirmed that S100A1 protein is endogenously modified by Cys(85) S-nitrosylation in PC12 cells, which are a well established model system for studying S100A1 function. We used isothermal calorimetry to show that S-nitrosylation facilitates the formation of Ca2+-loaded S100A1 at physiological ionic strength conditions. To establish the unique influence of the S-nitroso group, our study describes high resolution three-dimensional structures of human apo-S100A1 protein with the Cys(85) thiol group in reduced and S-nitrosylated states. Solution structures of the proteins are based on NMR data obtained at physiological ionic strength. Comparative analysis shows that S-nitrosylation fine tunes the overall architecture of S100A1 protein. Although the typical S100 protein intersubunit four-helix bundle is conserved upon S-nitrosylation, the conformation of S100A1 protein is reorganized at the sites most important for target recognition (i.e. the C-terminal helix and the linker connecting two EF-hand domains). In summary, this study discloses cysteine S-nitrosylation as a new factor responsible for increasing functional diversity of S100A1 and helps explain the role of S100A1 as a Ca2+ signal transmitter sensitive to NO/redox equilibrium within cells.	[Zivkovic, Martina Lenarcic; Zhukov, Igor] Slovenian NMR Ctr, Natl Inst Chem, Ljubljana 1001, Slovenia; [Zareba-Koziol, Monika; Zhukova, Liliya; Poznanski, Jaroslaw; Zhukov, Igor; Wyslouch-Cieszynska, Aleksandra] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland	National Institute of Chemistry - Slovenia; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Zhukov, I (corresponding author), Slovenian NMR Ctr, Natl Inst Chem, Hajdrihova 19, Ljubljana 1001, Slovenia.	igor@ibb.waw.pl; olawyslouch@ibb.waw.pl	Poznanski, Jaroslaw/F-7705-2014; poznanski, jarek/G-7064-2013; Zareba-Koziol, Monika/E-1276-2015; Zhukov, Igor/J-4069-2015	Poznanski, Jaroslaw/0000-0003-2684-1775; Zareba-Koziol, Monika/0000-0003-3544-6259; Zhukova, Lilia/0000-0001-8607-2918; Wyslouch Cieszynska, Aleksandra/0000-0002-7006-2456; Zhukov, Igor/0000-0002-9912-1018	Polish Ministry of Education [3P04A01424]; Slovenian Research Agency; Ministry of Higher Education, Science, and Technology of Republic of Slovenia [P1-0242]; EN-FIST Center of Excellence; East-NMR FP7 Project [228461]; European Union [POIG.01.01.02-00-048/09]	Polish Ministry of Education; Slovenian Research Agency(Slovenian Research Agency - Slovenia); Ministry of Higher Education, Science, and Technology of Republic of Slovenia; EN-FIST Center of Excellence; East-NMR FP7 Project; European Union(European Commission)	This work was supported by Polish Ministry of Education Grant 3P04A01424 and Slovenian Research Agency and Ministry of Higher Education, Science, and Technology of Republic of Slovenia Program P1-0242 (to M. L. Z.). This work was also supported in part by the EN-FIST Center of Excellence (to I. Z.), East-NMR FP7 Project (Contract 228461), and Transnational Access Program and Innovative Economy Program Grant POIG.01.01.02-00-048/09 co-financed by European Union resources (to A. W.).	Al-Hashimi HM, 2000, J MAGN RESON, V142, P153, DOI 10.1006/jmre.1999.1937; Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; BAUDIER J, 1986, J BIOL CHEM, V261, P8204; BAUDIER J, 1986, BIOCHEMISTRY-US, V25, P6934, DOI 10.1021/bi00370a029; Benfenati F, 2004, J NEUROCHEM, V89, P1260, DOI 10.1111/j.1471-4159.2004.02419.x; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Boerries M, 2007, MOL CELL BIOL, V27, P4365, DOI 10.1128/MCB.02045-06; Bolewska K, 1997, ACTA BIOCHIM POL, V44, P275; Brinks H, 2011, J AM COLL CARDIOL, V58, P966, DOI 10.1016/j.jacc.2011.03.054; Chan NL, 1998, BIOCHEMISTRY-US, V37, P16459, DOI 10.1021/bi9816711; Chen YY, 2008, J BIOL CHEM, V283, P35265, DOI 10.1074/jbc.M805287200; Clore GM, 1998, P NATL ACAD SCI USA, V95, P5891, DOI 10.1073/pnas.95.11.5891; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deloulme Jean Christophe, 2002, Methods Mol Biol, V172, P185; Derakhshan B, 2007, CARDIOVASC RES, V75, P210, DOI 10.1016/j.cardiores.2007.04.023; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Drohat AC, 1998, BIOCHEMISTRY-US, V37, P2729, DOI 10.1021/bi972635p; Drohat AC, 1999, PROTEIN SCI, V8, P800; Drohat AC, 1997, PROTEIN SCI, V6, P1577, DOI 10.1002/pro.5560060721; Garbuglia M, 1999, BIOCHEM BIOPH RES CO, V254, P36, DOI 10.1006/bbrc.1998.9881; Goch G, 2005, FEBS J, V272, P2557, DOI 10.1111/j.1742-4658.2005.04680.x; Goddart T. D., 2008, SPARKY VERSION 3; Groves P, 1997, PROTEIN SCI, V6, P323; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; Hare JM, 2005, J CLIN INVEST, V115, P509, DOI 10.1172/JCI200524459; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Jaffrey S. R., 2001, SCI STKE, pp11; Job P, 1928, ANN CHIM FRANCE, V9, P113; Johnson E, 2006, J MOL BIOL, V357, P1237, DOI 10.1016/j.jmb.2006.01.031; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kraus C, 2009, J MOL CELL CARDIOL, V47, P445, DOI 10.1016/j.yjmcc.2009.06.003; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Landar A, 1998, BIOCHEMISTRY-US, V37, P17429, DOI 10.1021/bi9817921; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lima B, 2010, CIRC RES, V106, P633, DOI 10.1161/CIRCRESAHA.109.207381; Malik S, 2008, PROTEINS, V73, P28, DOI 10.1002/prot.22037; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; Markowitz J, 2005, BIOCHEMISTRY-US, V44, P7305, DOI 10.1021/bi050321t; Marquardt D., 1963, INT J COMPUT VISION, V11, P431, DOI DOI 10.1137/0111030; Most P, 2005, J CELL SCI, V118, P421, DOI 10.1242/jcs.01614; Most P, 2007, AM J PHYSIOL-REG I, V293, pR568, DOI 10.1152/ajpregu.00075.2007; Most P, 2006, CIRCULATION, V114, P1258, DOI 10.1161/CIRCULATIONAHA.106.622415; Nakamura T, 2011, CELL DEATH DIFFER, V18, P1478, DOI 10.1038/cdd.2011.65; Nelson MR, 2002, PROTEIN SCI, V11, P198, DOI 10.1110/ps.33302; Nowakowski M, 2011, J STRUCT BIOL, V174, P391, DOI 10.1016/j.jsb.2011.01.011; Okada M, 2002, BIOCHEM BIOPH RES CO, V292, P1023, DOI 10.1006/bbrc.2002.6761; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Ottiger M, 1998, J BIOMOL NMR, V12, P361, DOI 10.1023/A:1008366116644; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; REID KSC, 1985, FEBS LETT, V190, P209, DOI 10.1016/0014-5793(85)81285-0; Rohde D, 2011, J MOL CELL CARDIOL, V50, P777, DOI 10.1016/j.yjmcc.2010.08.012; Rohde D, 2010, J CARDIOVASC TRANSL, V3, P525, DOI 10.1007/s12265-010-9211-9; Rustandi RR, 2002, BIOCHEMISTRY-US, V41, P788, DOI 10.1021/bi0118308; Salonen LM, 2011, ANGEW CHEM INT EDIT, V50, P4808, DOI 10.1002/anie.201007560; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Schreiter ER, 2007, J BIOL CHEM, V282, P19773, DOI 10.1074/jbc.M701363200; Seth D, 2011, CURR OPIN CHEM BIOL, V15, P129, DOI 10.1016/j.cbpa.2010.10.012; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sun JH, 2010, CIRC RES, V106, P285, DOI 10.1161/CIRCRESAHA.109.209452; Uversky VN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S7; van Dieck J, 2009, J MOL BIOL, V394, P922, DOI 10.1016/j.jmb.2009.10.002; Volkers M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/178614; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang X, 2008, PROTEIN SCI, V17, P899, DOI 10.1110/ps.073395108; Weichsel A, 2007, BIOCHEMISTRY-US, V46, P1219, DOI 10.1021/bi061878r; Williams JG, 2003, P NATL ACAD SCI USA, V100, P6376, DOI 10.1073/pnas.1037299100; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wolfram Research Inc., 2010, MATHEMATICA; Wright NT, 2008, J BIOMOL NMR, V42, P279, DOI 10.1007/s10858-008-9282-y; Wright NT, 2009, J MOL BIOL, V386, P1265, DOI 10.1016/j.jmb.2009.01.022; Wright NT, 2005, J MOL BIOL, V353, P410, DOI 10.1016/j.jmb.2005.08.027; Zhukov I, 2008, BIOCHEMISTRY-US, V47, P640, DOI 10.1021/bi701762v; Zhukova L, 2004, BBA-MOL CELL RES, V1742, P191, DOI 10.1016/j.bbamcr.2004.10.002; Zimmer DB, 2005, CELL MOL BIOL, V51, P201, DOI 10.1170/T620; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297; Zimmer DB, 1998, J BIOL CHEM, V273, P4705, DOI 10.1074/jbc.273.8.4705	78	15	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40457	40470		10.1074/jbc.M112.418392	http://dx.doi.org/10.1074/jbc.M112.418392			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	22989881	Green Published, hybrid			2022-12-28	WOS:000311448800037
J	Veverka, V; Baker, T; Redpath, NT; Carrington, B; Muskett, FW; Taylor, RJ; Lawson, ADG; Henry, AJ; Carr, MD				Veverka, Vaclav; Baker, Terry; Redpath, Nicholas T.; Carrington, Bruce; Muskett, Frederick W.; Taylor, Richard J.; Lawson, Alastair D. G.; Henry, Alistair J.; Carr, Mark D.			Conservation of Functional Sites on Interleukin-6 and Implications for Evolution of Signaling Complex Assembly and Therapeutic Intervention	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE DETERMINATION; CYTOKINE RECEPTOR; NMR ASSIGNMENT; GP130; DYNAMICS; DOMAIN; IL-6; SEQUENCE; MTOR; ACID	A number of secreted cytokines, such as interleukin-6 (IL-6), are attractive targets for the treatment of inflammatory diseases. We have determined the solution structure of mouse IL-6 to assess the functional significance of apparent differences in the receptor interaction sites (IL-6R alpha and gp130) suggested by the fairly low degree of sequence similarity with human IL-6. Structure-based sequence alignment of mouse IL-6 and human IL-6 revealed surprising differences in the conservation of the two distinct gp130 binding sites (IIa and IIIa), which suggests a primacy for site III-mediated interactions in driving initial assembly of the IL-6/IL-6R alpha/gp130 ternary complex. This is further supported by a series of direct binding experiments, which clearly demonstrate a high affinity IL-6/IL-6R alpha-gp130 interaction via site III but only weak binding via site II. Collectively, our findings suggest a pathway for the evolution of the hexameric, IL-6/IL-6R alpha/gp130 signaling complex and strategies for therapeutic targeting. We propose that the signaling complex originally involved specific interactions between IL-6 and IL-6R alpha (site I) and between the D1 domain of gp130 and IL-6/IL-6R alpha (site III), with the later inclusion of interactions between the D2 and D3 domains of gp130 and IL-6/IL-6R alpha (site II) through serendipity. It seems likely that IL-6 signaling benefited from the evolution of a multipurpose, nonspecific protein interaction surface on gp130, now known as the cytokine binding homology region (site II contact surface), which fortuitously contributes to stabilization of the IL-6/IL-6R alpha/gp130 signaling complex.	[Veverka, Vaclav; Muskett, Frederick W.; Carr, Mark D.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Baker, Terry; Redpath, Nicholas T.; Carrington, Bruce; Taylor, Richard J.; Lawson, Alastair D. G.; Henry, Alistair J.] UCB Pharma, Slough SL1 4EN, Berks, England; [Veverka, Vaclav] Acad Sci Czech Republic, Inst Organ Chem & Biochem, CR-16610 Prague 6, Czech Republic	University of Leicester; UCB Pharma SA; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Carr, MD (corresponding author), Univ Leicester, Dept Biochem, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	mdc12@le.ac.uk	Veverka, Vaclav/G-9174-2014; Veverka, Vaclav/P-5251-2019	Veverka, Vaclav/0000-0003-3782-5279; Veverka, Vaclav/0000-0003-3782-5279; Carr, Mark/0000-0002-3939-0996				Barton VA, 2000, J BIOL CHEM, V275, P36197, DOI 10.1074/jbc.M004648200; Boulanger MJ, 2004, ADV PROTEIN CHEM, V68, P107; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Doreleijers J. F., 2012, J BIOMOL NM IN PRESS; Finckh A, 2008, CURR OPIN RHEUMATOL, V20, P269, DOI 10.1097/BOR.0b013e3282fa13b4; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; GUNTERT P, 1991, Journal of Biomolecular NMR, V1, P447, DOI 10.1007/BF02192866; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hoischen SH, 2000, EUR J BIOCHEM, V267, P3604, DOI 10.1046/j.1432-1327.2000.01389.x; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Matadeen R, 2007, STRUCTURE, V15, P441, DOI 10.1016/j.str.2007.02.006; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Moritz RL, 1999, GROWTH FACTORS, V16, P265, DOI 10.3109/08977199909069145; Renshaw PS, 2004, J BIOMOL NMR, V30, P225, DOI 10.1023/B:JNMR.0000048852.40853.5c; Schroers A, 2005, PROTEIN SCI, V14, P783, DOI 10.1110/ps.041117105; SIMPSON RJ, 1988, EUR J BIOCHEM, V176, P187, DOI 10.1111/j.1432-1033.1988.tb14267.x; Skiniotis G, 2005, NAT STRUCT MOL BIOL, V12, P545, DOI 10.1038/nsmb941; Skiniotis G, 2008, MOL CELL, V31, P737, DOI 10.1016/j.molcel.2008.08.011; Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; TANABE O, 1988, J IMMUNOL, V141, P3875; Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693; Veverka V, 2006, J BIOMOL NMR, V36, P3, DOI 10.1007/s10858-005-4324-1; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Waters LC, 2006, J BIOMOL NMR, V36, P18, DOI 10.1007/s10858-005-5887-6; Xu GY, 1997, J MOL BIOL, V268, P468, DOI 10.1006/jmbi.1997.0933	32	15	18	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.405597	http://dx.doi.org/10.1074/jbc.M112.405597			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23027872	Green Published, hybrid			2022-12-28	WOS:000311233800071
J	Autry, JM; Rubin, JE; Svensson, B; Li, J; Thomas, DD				Autry, Joseph M.; Rubin, John E.; Svensson, Bengt; Li, Ji; Thomas, David D.			Nucleotide Activation of the Ca-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; TIME-RESOLVED FLUORESCENCE; RESONANCE ENERGY-TRANSFER; CALCIUM-PUMP; PHOSPHORYL-TRANSFER; SKELETAL-MUSCLE; ADENOSINE-TRIPHOSPHATASE; CATALYTIC CYCLE; BINDING DOMAIN; RECONSTITUTED PROTEOLIPOSOMES	We have used fluorescence spectroscopy, molecular modeling, and limited proteolysis to examine structural dynamics of the sarcoplasmic reticulum Ca-ATPase (SERCA). The Ca-ATPase in sarcoplasmic reticulum vesicles from fast twitch muscle (SERCA1a isoform) was selectively labeled with fluorescein isothiocyanate (FITC), a probe that specifically reacts with Lys-515 in the nucleotide-binding site. Conformation-specific proteolysis demonstrated that FITC labeling does not induce closure of the cytoplasmic headpiece, thereby assigning FITC-SERCA as a nucleotide-free enzyme. We used enzyme reverse mode to synthesize FITC monophosphate (FMP) on SERCA, producing a phosphorylated pseudosubstrate tethered to the nucleotide-binding site of a Ca2+-free enzyme (E2 state to prevent FMP hydrolysis). Conformation-specific proteolysis demonstrated that FMP formation induces SERCA headpiece closure similar to ATP binding, presumably due to the high energy phosphoryl group on the fluorescent probe (ATP.E2 analog). Subnanosecond-resolved detection of fluorescence lifetime, anisotropy, and quenching was used to characterize FMP-SERCA (ATP.E2 state) versus FITC-SERCA in Ca2+-free, Ca2+-bound, and actively cycling phosphoenzyme states (E2, E1, and EP). Time-resolved spectroscopy revealed that FMP-SERCA exhibits increased probe dynamics but decreased probe accessibility compared with FITC-SERCA, indicating that ATP exhibits enhanced dynamics within a closed cytoplasmic headpiece. Molecular modeling was used to calculate the solvent-accessible surface area of FITC and FMP bound to SERCA crystal structures, revealing a positive correlation of solvent-accessible surface area with quenching but not anisotropy. Thus, headpiece closure is coupled to substrate binding but not active site dynamics. We propose that dynamics in the nucleotide-binding site of SERCA is important for Ca2+ binding (distal allostery) and phosphoenzyme formation (direct activation).	[Autry, Joseph M.; Rubin, John E.; Svensson, Bengt; Li, Ji; Thomas, David D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Thomas, DD (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, 6-155 Jackson Hall, Minneapolis, MN 55455 USA.	ddt@umn.edu	Autry, Joseph M./X-6839-2019	Autry, Joseph M./0000-0002-1144-725X; Thomas, David D./0000-0002-8822-2040	National Institutes of Health [R01 GM27906, P30 AR0507220, T32 AR007612]; University of Minnesota; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG042996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota(University of Minnesota System); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM27906, P30 AR0507220, and T32 AR007612 (to D. D. T.).; Supported by a doctoral dissertation fellowship from the University of Minnesota.	Abu-Abed M, 2004, BIOCHEM J, V379, P235, DOI 10.1042/BJ20040168; Abu-Abed M, 2002, BIOCHEMISTRY-US, V41, P1156, DOI 10.1021/bi015703n; ALLEN G, 1976, FEBS LETT, V63, P188, DOI 10.1016/0014-5793(76)80223-2; Autry JM, 2011, J BIOL CHEM, V286, P31697, DOI 10.1074/jbc.M111.246843; BENDERS AAGM, 1992, BIOCHIM BIOPHYS ACTA, V1112, P89, DOI 10.1016/0005-2736(92)90258-N; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; BIGELOW DJ, 1992, BIOCHIM BIOPHYS ACTA, V1113, P323, DOI 10.1016/0304-4157(92)90005-U; BIRMACHU W, 1990, BIOCHEMISTRY-US, V29, P3904, DOI 10.1021/bi00468a017; BIRMACHU W, 1989, BIOCHEMISTRY-US, V28, P3940, DOI 10.1021/bi00435a047; BODLEY AL, 1987, J BIOL CHEM, V262, P13997; Boehr DD, 2010, P NATL ACAD SCI USA, V107, P1373, DOI 10.1073/pnas.0914163107; BRANDT NR, 1980, J BIOL CHEM, V255, P6290; BRIGGS FN, 1986, BIOCHEM BIOPH RES CO, V135, P864; CHAMPEIL P, 1988, J BIOL CHEM, V263, P12288; Champeil P, 2001, J BIOL CHEM, V276, P5795, DOI 10.1074/jbc.M006980200; Chen LTL, 2009, BIOCHEMISTRY-US, V48, P2411, DOI 10.1021/bi8021526; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2001, FEBS LETT, V489, P277, DOI 10.1016/S0014-5793(01)02111-1; Delavoie F, 2003, ANN NY ACAD SCI, V986, P17, DOI 10.1111/j.1749-6632.2003.tb07133.x; Espinoza-Fonseca LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026936; FERNANDEZ JL, 1980, BIOCHIM BIOPHYS ACTA, V599, P552, DOI 10.1016/0005-2736(80)90199-6; FERNANDEZBELDA F, 1988, ARCH BIOCHEM BIOPHYS, V260, P118, DOI 10.1016/0003-9861(88)90431-6; FERREIRA ST, 1989, J BIOL CHEM, V264, P15392; Freire MM, 2002, BBA-BIOENERGETICS, V1553, P238, DOI 10.1016/S0005-2728(01)00245-6; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; HASSELBACH W, 1978, BIOCHIM BIOPHYS ACTA, V515, P23, DOI 10.1016/0304-4157(78)90007-2; Henao F, 2001, J BIOL CHEM, V276, P24284, DOI 10.1074/jbc.M103905200; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; HIGHSMITH S, 1986, BIOCHEMISTRY-US, V25, P1049, DOI 10.1021/bi00353a015; Hou ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040369; Hua SM, 2002, BIOCHEMISTRY-US, V41, P2264, DOI 10.1021/bi015684h; Huang Z, 1999, J BIOMOL SCREEN, V4, P327, DOI 10.1177/108705719900400608; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huntley JJA, 2000, BIOCHEMISTRY-US, V39, P13356, DOI 10.1021/bi001210r; INESI G, 1985, ANNU REV PHYSIOL, V47, P573, DOI 10.1146/annurev.ph.47.030185.003041; INESI G, 1980, J BIOL CHEM, V255, P3025; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; Inesi G, 2006, BIOCHEMISTRY-US, V45, P13769, DOI 10.1021/bi061255d; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; JONES LR, 1977, J BIOL CHEM, V252, P3315; Karon BS, 1999, BIOCHEMISTRY-US, V38, P9301, DOI 10.1021/bi990190u; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; KIRLEY TL, 1985, BIOCHEM BIOPH RES CO, V130, P732, DOI 10.1016/0006-291X(85)90477-2; Korman VL, 2006, J MOL BIOL, V356, P1107, DOI 10.1016/j.jmb.2005.10.024; Lakowicz J. R., 2013, PRINCIPLES FLUORESCE, P1; Lassila JK, 2011, ANNU REV BIOCHEM, V80, P669, DOI 10.1146/annurev-biochem-060409-092741; Laursen M, 2009, J BIOL CHEM, V284, P13513, DOI 10.1074/jbc.C900031200; LEVY D, 1990, J BIOL CHEM, V265, P19524; Li F, 2002, J MOL BIOL, V315, P459, DOI 10.1006/jmbi.2001.5256; Ma HL, 2003, J BIOL CHEM, V278, P28938, DOI 10.1074/jbc.M304120200; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; Masterson LR, 2010, NAT CHEM BIOL, V6, P821, DOI 10.1038/NCHEMBIO.452; McIntosh DB, 2008, BIOCHEMISTRY-US, V47, P6386, DOI 10.1021/bi800290q; McIntosh DB, 1999, J BIOL CHEM, V274, P25227, DOI 10.1074/jbc.274.36.25227; McIntosh DB, 2004, J BIOL CHEM, V279, P32515, DOI 10.1074/jbc.M403242200; MCINTOSH DB, 1994, J BIOL CHEM, V269, P21587; MCINTOSH DB, 1992, J BIOL CHEM, V267, P5301; McIntosh DB, 1996, J BIOL CHEM, V271, P25778, DOI 10.1074/jbc.271.42.25778; MITCHINSON C, 1982, FEBS LETT, V146, P87, DOI 10.1016/0014-5793(82)80710-2; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Moller JV, 2005, CURR OPIN STRUC BIOL, V15, P387, DOI 10.1016/j.sbi.2005.06.005; Moncoq K, 2007, J BIOL CHEM, V282, P9748, DOI 10.1074/jbc.M611653200; Mueller B, 2004, BIOCHEMISTRY-US, V43, P12846, DOI 10.1021/bi0489457; Muretta JM, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3480647; Nesmelov YE, 2011, P NATL ACAD SCI USA, V108, P1891, DOI 10.1073/pnas.1012320108; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; PAPP S, 1987, BIOPHYS J, V51, P205, DOI 10.1016/S0006-3495(87)83326-X; Pei Q, 2007, MATER TRANS, V48, P735, DOI 10.2320/matertrans.48.735; PICK U, 1980, BIOCHIM BIOPHYS ACTA, V626, P255, DOI 10.1016/0005-2795(80)90216-0; PICK U, 1981, FEBS LETT, V123, P131, DOI 10.1016/0014-5793(81)80036-1; PICK U, 1981, FEBS LETT, V123, P127, DOI 10.1016/0014-5793(81)80035-X; PICK U, 1981, EUR J BIOCHEM, V121, P187, DOI 10.1111/j.1432-1033.1981.tb06448.x; PICK U, 1982, J BIOL CHEM, V257, P6120; SASSAROLI M, 1986, BIOPHYS CHEM, V25, P283, DOI 10.1016/0301-4622(86)80020-5; She MD, 1997, BIOPHYS J, V73, P1042, DOI 10.1016/S0006-3495(97)78137-2; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Stokes DL, 2005, J BIOL CHEM, V280, P18063, DOI 10.1074/jbc.M500031200; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2011, P NATL ACAD SCI USA, V108, P1833, DOI 10.1073/pnas.1017659108; Tran K, 2009, BIOPHYS J, V96, P2029, DOI 10.1016/j.bpj.2008.11.045; VOSS JC, 1995, BIOCHEMISTRY-US, V34, P930, DOI 10.1021/bi00003a027; WAWRZYNOW A, 1993, BIOCHIM BIOPHYS ACTA, V1203, P60, DOI 10.1016/0167-4838(93)90036-Q; Winters DL, 2008, BIOCHEMISTRY-US, V47, P4246, DOI 10.1021/bi702089j; Xu C, 2002, J MOL BIOL, V316, P201, DOI 10.1006/jmbi.2001.5330; YAMAMOTO H, 1989, J BIOCHEM-TOKYO, V106, P1121, DOI 10.1093/oxfordjournals.jbchem.a122976; YU X, 1993, BIOPHYS J, V64, P1232, DOI 10.1016/S0006-3495(93)81489-9	93	22	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39070	39082		10.1074/jbc.M112.404434	http://dx.doi.org/10.1074/jbc.M112.404434			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22977248	Green Published, hybrid			2022-12-28	WOS:000310982800063
J	Burrows, AC; Prokop, J; Summers, MK				Burrows, Amy C.; Prokop, John; Summers, Matthew K.			Skp1-Cul1-F-box Ubiquitin Ligase (SCF beta TrCP)-mediated Destruction of the Ubiquitin-specific Protease USP37 during G(2)-phase Promotes Mitotic Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCF-BETA-TRCP; S-PHASE ENTRY; CELL-CYCLE; DNA-DAMAGE; ANAPHASE; DEGRADATION; CHECKPOINT; COMPLEX; PROGRESSION; BOX	Ubiquitin-mediated proteolysis is a key regulatory process in cell cycle progression. The Skp1-Cul1-F-box (SCF) and anaphase-promoting complex (APC) ubiquitin ligases target numerous components of the cell cycle machinery for destruction. Throughout the cell cycle, these ligases cooperate to maintain precise levels of key regulatory proteins, and indirectly, each other. Recently, we have identified the deubiquitinase USP37 as a regulator of the cell cycle. USP37 expression is cell cycle-regulated, being expressed in late G(1) and ubiquitinated by APC(Cdh1) in early G(1). Here we report that in addition to destruction at G(1), a major fraction of USP37 is degraded at the G(2)/M transition, prior to APC substrates and similar to SCF beta TrCP substrates. Consistent with this hypothesis, USP37 interacts with components of the SCF in a beta TrCP-dependent manner. Interaction with beta TrCP and subsequent degradation is phosphorylation-dependent and is mediated by the Polo-like kinase (Plk1). USP37 is stabilized in G(2) by depletion of beta TrCP as well as chemical or genetic manipulation of Plk1. Similarly, mutation of the phospho-sites abolishes beta TrCP binding and renders USP37 resistant to Plk1 activity. Expression of this mutant hinders the G(2)/M transition. Our data demonstrate that tight regulation of USP37 levels is required for proper cell cycle progression.	[Burrows, Amy C.; Prokop, John; Summers, Matthew K.] Cleveland Clin, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Summers, MK (corresponding author), Cleveland Clin, Dept Canc Biol, Lerner Res Inst, 9500 Euclid Ave,NB40, Cleveland, OH 44195 USA.	summerm@ccf.org			Lerner Research Institute; NATIONAL CANCER INSTITUTE [T32CA009151] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER	Lerner Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by seed funds provided by the Lerner Research Institute (to M.K.S.).	Alexander J, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001796; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Bianchi F, 2007, J CLIN INVEST, V117, P3436, DOI 10.1172/JCI32007; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Donzelli M, 2002, EMBO J, V21, P4875, DOI 10.1093/emboj/cdf491; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gao DM, 2009, MOL BIOL CELL, V20, P3305, DOI 10.1091/mbc.E09-01-0092; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598; Huang XD, 2011, MOL CELL, V42, P511, DOI 10.1016/j.molcel.2011.03.027; Inuzuka H, 2010, CANCER CELL, V18, P147, DOI 10.1016/j.ccr.2010.06.015; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Moshe Y, 2004, P NATL ACAD SCI USA, V101, P7937, DOI 10.1073/pnas.0402442101; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Pfleger CM, 2000, GENE DEV, V14, P655; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Prinz S, 1998, CURR BIOL, V8, P750, DOI 10.1016/S0960-9822(98)70298-2; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Seki A, 2008, J CELL BIOL, V181, P65, DOI 10.1083/jcb.200712027; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Summers MK, 2008, MOL CELL, V31, P544, DOI 10.1016/j.molcel.2008.07.014; Summers MK, 2005, ONCOGENE, V24, P2589, DOI 10.1038/sj.onc.1208428; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Tse WKF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-637; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Weinstein J, 1997, J BIOL CHEM, V272, P28501, DOI 10.1074/jbc.272.45.28501; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Ye Y, 2009, MOL BIOSYST, V5, P1797, DOI 10.1039/b907669g	44	31	34	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39021	39029		10.1074/jbc.M112.390328	http://dx.doi.org/10.1074/jbc.M112.390328			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23027877	Green Published, hybrid			2022-12-28	WOS:000310982800058
J	Barreteau, H; Tiouajni, M; Graille, M; Josseaume, N; Bouhss, A; Patin, D; Blanot, D; Fourgeaud, M; Mainardi, JL; Arthur, M; van Tilbeurgh, H; Mengin-Lecreulx, D; Touze, T				Barreteau, Helene; Tiouajni, Mounira; Graille, Marc; Josseaume, Nathalie; Bouhss, Ahmed; Patin, Delphine; Blanot, Didier; Fourgeaud, Martine; Mainardi, Jean-Luc; Arthur, Michel; van Tilbeurgh, Herman; Mengin-Lecreulx, Dominique; Touze, Thierry			Functional and Structural Characterization of PaeM, a Colicin M-like Bacteriocin Produced by Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M IMMUNITY PROTEIN; ESCHERICHIA-COLI; PEPTIDOGLYCAN PRECURSORS; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; BIOSYNTHESIS; EVOLUTION; TOXICITY; OUTS; FKPA	Colicin M (ColM) is the only enzymatic colicin reported to date that inhibits cell wall peptidoglycan biosynthesis. It catalyzes the specific degradation of the lipid intermediates involved in this pathway, thereby provoking lysis of susceptible Escherichia coli cells. A gene encoding a homologue of ColM was detected within the exo U-containing genomic island A carried by certain pathogenic Pseudomonas aeruginosa strains. This bacteriocin (pyocin) that we have named PaeM was crystallized, and its structure with and without an Mg2+ ion bound was solved. In parallel, site-directed mutagenesis of conserved PaeM residues from the C-terminal domain was performed, confirming their essentiality for the protein activity both in vitro (lipid II-degrading activity) and in vivo (cytotoxicity against a susceptible P. aeruginosa strain). Although PaeM is structurally similar to ColM, the conformation of their active sites differs radically; in PaeM, residues essential for enzymatic activity and cytotoxicity converge toward a same pocket, whereas in ColM they are spread along a particularly elongated active site. We have also isolated a minimal domain corresponding to the C-terminal half of the PaeM protein and exhibiting a 70-fold higher enzymatic activity as compared with the full-length protein. This isolated domain of the PaeM bacteriocin was further shown to kill E. coli cells when addressed to the periplasm of these bacteria.	[Mengin-Lecreulx, Dominique] Univ Paris 11, UMR CNRS 8619, IBBMC,Lab Enveloppes Bacteriennes & Antibiot, Inst Biochim & Biophys Mol & Cellulaire,UMR 8619, F-91405 Orsay, France; [Barreteau, Helene; Tiouajni, Mounira; Graille, Marc; Bouhss, Ahmed; Patin, Delphine; Blanot, Didier; van Tilbeurgh, Herman; Mengin-Lecreulx, Dominique; Touze, Thierry] CNRS, UMR 8619, F-91405 Orsay, France; [Josseaume, Nathalie; Fourgeaud, Martine; Mainardi, Jean-Luc; Arthur, Michel] Univ Paris 06, UMR S 872, Lab Rech Mol Antibiot, Ctr Rech Cordeliers, F-75006 Paris 6, France; [Josseaume, Nathalie; Fourgeaud, Martine; Mainardi, Jean-Luc; Arthur, Michel] Univ Paris 05, F-75006 Paris, France; [Josseaume, Nathalie; Fourgeaud, Martine; Mainardi, Jean-Luc; Arthur, Michel] Hop Europeen Georges Pompidou, AP HP, F-75015 Paris, France; [Josseaume, Nathalie; Fourgeaud, Martine; Mainardi, Jean-Luc; Arthur, Michel] INSERM, U872, F-75006 Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Mengin-Lecreulx, D (corresponding author), Univ Paris 11, UMR CNRS 8619, IBBMC,Lab Enveloppes Bacteriennes & Antibiot, Inst Biochim & Biophys Mol & Cellulaire,UMR 8619, Bat 430, F-91405 Orsay, France.	dominique.mengin-lecreulx@u-psud.fr	Arthur, Michel/G-3680-2013; GRAILLE, Marc/D-3242-2014; Touzé, Thierry/GLT-1308-2022; MAINARDI, Jean-Luc/E-2714-2014	Arthur, Michel/0000-0003-1007-636X; GRAILLE, Marc/0000-0002-7853-5852; MAINARDI, Jean-Luc/0000-0002-4159-0129; MENGIN-LECREULX, Dominique/0000-0003-3205-0275; Touze, Thierry/0000-0002-2176-6537	Agence Nationale de la Recherche (PEPGLYCOL project) [ANR-07-MIME-020]; Centre National de la Recherche Scientifique [UMR 8619]	Agence Nationale de la Recherche (PEPGLYCOL project)(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from the Agence Nationale de la Recherche (PEPGLYCOL project, ANR-07-MIME-020) and the Centre National de la Recherche Scientifique (UMR 8619).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AMREIN KE, 1995, P NATL ACAD SCI USA, V92, P1048, DOI 10.1073/pnas.92.4.1048; Barneoud-Arnoulet A, 2010, J BACTERIOL, V192, P5212, DOI 10.1128/JB.00431-10; Barreteau H, 2012, MICROB DRUG RESIST, V18, P222, DOI 10.1089/mdr.2011.0230; Barreteau H, 2010, J BIOL CHEM, V285, P12378, DOI 10.1074/jbc.M109.093583; Barreteau H, 2009, J BACTERIOL, V191, P3657, DOI 10.1128/JB.01824-08; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAUN V, 1973, BIOCHIM BIOPHYS ACTA, V323, P87, DOI 10.1016/0005-2736(73)90433-1; Braun V, 2002, BIOCHIMIE, V84, P365, DOI 10.1016/S0300-9084(02)01427-X; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; DAGERT M, 1979, GENE, V6, P23, DOI 10.1016/0378-1119(79)90082-9; El Ghachi M, 2006, J BIOL CHEM, V281, P22761, DOI 10.1074/jbc.M602834200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gerard F, 2011, J BACTERIOL, V193, P205, DOI 10.1128/JB.01119-10; Grinter R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033033; Helbig S, 2011, J BIOL CHEM, V286, P6280, DOI 10.1074/jbc.M110.165274; Helbig S, 2011, J BACTERIOL, V193, P815, DOI 10.1128/JB.01206-10; Hullmann J, 2008, MOL MICROBIOL, V69, P926, DOI 10.1111/j.1365-2958.2008.06327.x; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kulasekara BR, 2006, J BACTERIOL, V188, P4037, DOI 10.1128/JB.02000-05; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; Miller J. H., 1972, EXPT MOL GENETICS, P431; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Patin D, 2012, BIOCHIMIE, V94, P985, DOI 10.1016/j.biochi.2011.12.019; PILSL H, 1993, MOL GEN GENET, V240, P103, DOI 10.1007/BF00276889; PUGSLEY AP, 1984, MICROBIOL SCI, V1, P203; PUGSLEY AP, 1984, MICROBIOL SCI, V1, P168; Sambrook J., 2002, MOL CLONING LAB MANU; SCHALLER K, 1982, J BACTERIOL, V152, P994; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Uson I, 2012, J STRUCT BIOL, V178, P45, DOI 10.1016/j.jsb.2012.02.004; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Zeth K, 2008, J BIOL CHEM, V283, P25324, DOI 10.1074/jbc.M802591200	34	22	23	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37395	37405		10.1074/jbc.M112.406439	http://dx.doi.org/10.1074/jbc.M112.406439			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22977250	hybrid, Green Published			2022-12-28	WOS:000310588500070
J	Chaikuad, A; Alfano, I; Kerr, G; Sanvitale, CE; Boergermann, JH; Triffitt, JT; von Delft, F; Knapp, S; Knaus, P; Bullock, AN				Chaikuad, Apirat; Alfano, Ivan; Kerr, Georgina; Sanvitale, Caroline E.; Boergermann, Jan H.; Triffitt, James T.; von Delft, Frank; Knapp, Stefan; Knaus, Petra; Bullock, Alex N.			Structure of the Bone Morphogenetic Protein Receptor ALK2 and Implications for Fibrodysplasia Ossificans Progressiva	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA RECEPTOR; CRYSTAL-STRUCTURE; I RECEPTOR; CELL-MEMBRANE; MUTATION; DOMAIN; ACTIVATION; FAMILY; MODEL; DIFFERENTIATION	Bone morphogenetic protein (BMP) receptor kinases are tightly regulated to control development and tissue homeostasis. Mutant receptor kinase domains escape regulation leading to severely degenerative diseases and represent an important therapeutic target. Fibrodysplasia ossificans progressiva (FOP) is a rare but devastating disorder of extraskeletal bone formation. FOP-associated mutations in the BMP receptor ALK2 reduce binding of the inhibitor FKBP12 and promote leaky signaling in the absence of ligand. To establish structural mechanisms of receptor regulation and to address the effects of FOP mutation, we determined the crystal structure of the cytoplasmic domain of ALK2 in complex with the inhibitors FKBP12 and dorsomorphin. FOP mutations break critical interactions that stabilize the inactive state of the kinase, thereby facilitating structural rearrangements that diminish FKBP12 binding and promote the correct positioning of the glycine-serine-rich loop and alpha C helix for kinase activation. The balance of these effects accounts for the comparable activity of R206H and L196P. Kinase activation in the clinically benign mutant L196P is far weaker than R206H but yields equivalent signals due to the stronger interaction of FKBP12 with R206H. The presented ALK2 structure offers a valuable template for the further design of specific inhibitors of BMP signaling.	[Chaikuad, Apirat; Alfano, Ivan; Kerr, Georgina; Sanvitale, Caroline E.; von Delft, Frank; Knapp, Stefan; Bullock, Alex N.] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Boergermann, Jan H.; Knaus, Petra] Free Univ Berlin, Inst Chem Biochem, D-14195 Berlin, Germany; [Triffitt, James T.] Univ Oxford, Botnar Res Ctr, Oxford OX3 7LD, England	University of Oxford; Free University of Berlin; University of Oxford	Bullock, AN (corresponding author), Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England.	alex.bullock@sgc.ox.ac.uk	Knapp, Stefan/AAG-2347-2019	Knapp, Stefan/0000-0001-5995-6494; von Delft, Frank/0000-0003-0378-0017; Chaikuad, Apirat/0000-0003-1120-2209	Roemex postdoctoral fellowship; University of Oxford FOP Research Fund; German Research Foundation Collaborative Research Centre [SFB 760]; Canadian Institutes for Health Research; Genome Canada; GlaxoSmithKline; Lilly Canada; Novartis Research Foundation; Pfizer; Takeda; AbbVie; Canada Foundation for Innovation; Ontario Ministry of Economic Development and Innovation; Wellcome Trust [092809/Z/10/Z]	Roemex postdoctoral fellowship; University of Oxford FOP Research Fund; German Research Foundation Collaborative Research Centre(German Research Foundation (DFG)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Lilly Canada(Eli Lilly); Novartis Research Foundation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); AbbVie(AbbVie); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Ministry of Economic Development and Innovation; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by a Roemex postdoctoral fellowship (to G. K.), the University of Oxford FOP Research Fund (to C. E. S.), and German Research Foundation Collaborative Research Centre Grant SFB 760 (to P. K.).; We thank Kirsten Petrie and Binesh Shrestra for help with ALK2 expression and staff at the Diamond Light Source for help with diffraction data collection. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Lilly Canada, the Novartis Research Foundation, Pfizer, Takeda, AbbVie, the Canada Foundation for Innovation, the Ontario Ministry of Economic Development and Innovation, and the Wellcome Trust Grant 092809/Z/10/Z.	Blake, 2007, SCI STKE, DOI DOI 10.1126/STKE.3992007CM1; Bocciardi R, 2009, EUR J HUM GENET, V17, P311, DOI 10.1038/ejhg.2008.178; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswaran J, 2009, P NATL ACAD SCI USA, V106, P20198, DOI 10.1073/pnas.0901989106; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fukuda T, 2008, BIOCHEM BIOPH RES CO, V377, P905, DOI 10.1016/j.bbrc.2008.10.093; Fukuda T, 2009, J BIOL CHEM, V284, P7149, DOI 10.1074/jbc.M801681200; Furuya H, 2008, AM J MED GENET A, V146A, P459, DOI 10.1002/ajmg.a.32151; Gregson CL, 2011, BONE, V48, P654, DOI 10.1016/j.bone.2010.10.164; Groppe JC, 2011, CELLS TISSUES ORGANS, V194, P291, DOI 10.1159/000324230; Han S, 2007, PROTEIN SCI, V16, P2272, DOI 10.1110/ps.073068407; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; Huse M, 2001, MOL CELL, V8, P671, DOI 10.1016/S1097-2765(01)00332-X; Kan LX, 2004, AM J PATHOL, V165, P1107, DOI 10.1016/S0002-9440(10)63372-X; Kaplan FS, 2006, ANN NY ACAD SCI, V1068, P54, DOI 10.1196/annals.1346.008; Kaplan Frederick S, 2009, Hum Mutat, V30, P379, DOI 10.1002/humu.20868; Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200; Le VQ, 2012, DEV DYNAM, V241, P200, DOI 10.1002/dvdy.22779; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohte S, 2011, BIOCHEM BIOPH RES CO, V407, P213, DOI 10.1016/j.bbrc.2011.03.001; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Petrie KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005005; Qin BY, 2001, MOL CELL, V8, P1303, DOI 10.1016/S1097-2765(01)00417-8; Shen Q, 2009, J CLIN INVEST, V119, P3462, DOI 10.1172/JCI37412; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shore EM, 2010, NAT REV RHEUMATOL, V6, P518, DOI 10.1038/nrrheum.2010.122; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Song GA, 2010, J BIOL CHEM, V285, P22542, DOI 10.1074/jbc.M109.094557; van Dinther M, 2010, J BONE MINER RES, V25, P1208, DOI [10.1002/jbmr.091110, 10.1359/jbmr.091110]; WANG TW, 1994, SCIENCE, V265, P674, DOI 10.1126/science.7518616; Wang TW, 1996, CELL, V86, P435, DOI 10.1016/S0092-8674(00)80116-6; Whyte MP, 2012, J BONE MINER RES, V27, P729, DOI 10.1002/jbmr.1473; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wu JW, 2001, MOL CELL, V8, P1277, DOI 10.1016/S1097-2765(01)00421-X; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	49	134	139	3	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36990	36998		10.1074/jbc.M112.365932	http://dx.doi.org/10.1074/jbc.M112.365932			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22977237	hybrid, Green Published			2022-12-28	WOS:000310588500034
J	Nadeau, OW; Lane, LA; Xu, D; Sage, J; Priddy, TS; Artigues, A; Villar, MT; Yang, Q; Robinson, CV; Zhang, Y; Carlson, GM				Nadeau, Owen W.; Lane, Laura A.; Xu, Dong; Sage, Jessica; Priddy, Timothy S.; Artigues, Antonio; Villar, Maria T.; Yang, Qing; Robinson, Carol V.; Zhang, Yang; Carlson, Gerald M.			Structure and Location of the Regulatory beta Subunits in the (alpha beta gamma delta)(4) Phosphorylase Kinase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; ALPHA-SUBUNIT; CATALYTIC SUBUNIT; GAMMA-SUBUNIT; MACROMOLECULAR ASSEMBLIES; 3-DIMENSIONAL STRUCTURE; STRUCTURE PREDICTION; ANGSTROM RESOLUTION; MASS-SPECTROMETRY; CROSS-LINKING	Phosphorylase kinase (PhK) is a hexadecameric (alpha beta gamma delta)(4) complex that regulates glycogenolysis in skeletal muscle. Activity of the catalytic gamma subunit is regulated by allosteric activators targeting the regulatory alpha, beta, and delta subunits. Three-dimensional EM reconstructions of PhK show it to be two large (alpha beta gamma delta)(2) lobes joined with D-2 symmetry through interconnecting bridges. The subunit composition of these bridges was unknown, although indirect evidence suggested the beta subunits may be involved in their formation. We have used biochemical, biophysical, and computational approaches to not only address the quaternary structure of the beta subunits within the PhK complex, i.e. whether they compose the bridges, but also their secondary and tertiary structures. The secondary structure of beta was determined to be predominantly helical by comparing the CD spectrum of an alpha gamma delta subcomplex with that of the native (alpha beta gamma delta)(4) complex. An atomic model displaying tertiary structure for the entire beta subunit was constructed using chemical cross-linking, MS, threading, and ab initio approaches. Nearly all this model is covered by two templates corresponding to glycosyl hydrolase 15 family members and theAsubunit of protein phosphatase 2A. Regarding the quaternary structure of the beta subunits, they were directly determined to compose the four interconnecting bridges in the (alpha beta gamma delta)(4) kinase core, because a beta(4) subcomplex was observed through both chemical cross-linking and top-down MS of PhK. The predicted model of the beta subunit was docked within the bridges of a cryoelectron microscopic density envelope of PhK utilizing known surface features of the subunit.	[Nadeau, Owen W.; Sage, Jessica; Priddy, Timothy S.; Artigues, Antonio; Villar, Maria T.; Yang, Qing; Carlson, Gerald M.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Lane, Laura A.; Robinson, Carol V.] Univ Oxford, Phys & Theoret Chem Lab, Dept Chem, Oxford OX1 3QZ, England; [Xu, Dong; Zhang, Yang] Univ Michigan, Sch Med, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	University of Kansas; University of Kansas Medical Center; University of Oxford; University of Michigan System; University of Michigan	Carlson, GM (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	gcarlson@kumc.edu	xu, dong/I-7737-2013	xu, dong/0000-0002-6616-1427; robinson, carol/0000-0001-7829-5505	National Institutes of Health [R01 DK32953]; NIGMS [GM083107, GM084222]; National Science Foundation Grant [DBI 1027394]; University of Michigan-Shanghai Jiao Tong University Joint Institute Foundation; Royal Society and the Engineering and Physical Sciences Research Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084222, R01GM083107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation Grant(National Science Foundation (NSF)); University of Michigan-Shanghai Jiao Tong University Joint Institute Foundation; Royal Society and the Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK32953 (to G. M. C.) and Grants GM083107 and GM084222 from NIGMS (to Y. Z.). This work was also supported by National Science Foundation Grant DBI 1027394 and the University of Michigan-Shanghai Jiao Tong University Joint Institute Foundation (to Y. Z.) and the Royal Society and the Engineering and Physical Sciences Research Council (to C. V. M.). Downloaded from www.jbc.org at ISI, Thomson Scientific, on November 3, 2012	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benesch JL, 2006, CURR OPIN STRUC BIOL, V16, P245, DOI 10.1016/j.sbi.2006.03.009; Benesch JLP, 2007, CHEM REV, V107, P3544, DOI 10.1021/cr068289b; Boulatnikov IG, 2009, BIOCHEMISTRY-US, V48, P10183, DOI 10.1021/bi901429y; Brill TB, 1999, J PHYS ORG CHEM, V12, P819, DOI 10.1002/(SICI)1099-1395(199911)12:11<819::AID-POC192>3.0.CO;2-R; Brushia Robert J., 1999, Frontiers in Bioscience, V4, pd618, DOI 10.2741/Brushia; Carriere C, 2008, PROTEINS, V71, P1597, DOI 10.1002/prot.22006; Carriere C, 2008, BBA-MOL BASIS DIS, V1782, P664, DOI 10.1016/j.bbadis.2008.09.011; Chalkley RJ, 2005, METHOD ENZYMOL, V402, P289, DOI 10.1016/S0076-6879(05)02009-4; CHAN KFJ, 1982, J BIOL CHEM, V257, P5939; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; CHENG A, 1985, J BIOL CHEM, V260, P2535; COHEN P, 1975, EUR J BIOCHEM, V51, P79, DOI 10.1111/j.1432-1033.1975.tb03909.x; COHEN P, 1973, EUR J BIOCHEM, V34, P1, DOI 10.1111/j.1432-1033.1973.tb02721.x; DASGUPTA M, 1989, J BIOL CHEM, V264, P17156; FITZGERALD TJ, 1984, J BIOL CHEM, V259, P3266; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Jeyasingham MD, 2008, J MOL BIOL, V377, P623, DOI 10.1016/j.jmb.2007.12.072; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KEE SM, 1986, J BIOL CHEM, V261, P4732; KILIMANN MW, 1988, P NATL ACAD SCI USA, V85, P9381, DOI 10.1073/pnas.85.24.9381; KING MM, 1983, J BIOL CHEM, V258, P9925; KING MM, 1981, J BIOL CHEM, V256, P1058; KNELLER DG, 1990, J MOL BIOL, V214, P171, DOI 10.1016/0022-2836(90)90154-E; KREBS EG, 1964, BIOCHEMISTRY-US, V3, P1022, DOI 10.1021/bi00896a003; Lane L. A., 2012, MOL CELL PR IN PRESS; Li YQ, 2009, PROTEINS, V76, P665, DOI 10.1002/prot.22380; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Lowe ED, 1997, EMBO J, V16, P6646, DOI 10.1093/emboj/16.22.6646; Mizuno M, 2004, J BIOL CHEM, V279, P10575, DOI 10.1074/jbc.M310771200; Nadeau O. W., 2005, PROTEIN PROTEIN INTE, P105; Nadeau OW, 2005, PROTEIN SCI, V14, P914, DOI 10.1110/ps.041123905; Nadeau OW, 2002, STRUCTURE, V10, P23, DOI 10.1016/S0969-2126(01)00678-5; Nadeau OW, 1999, BIOCHEMISTRY-US, V38, P2551, DOI 10.1021/bi982060b; NADEAU OW, 1994, J BIOL CHEM, V269, P29670; Nadeau OW, 2008, MOL CELL PROTEOMICS, V7, P739, DOI 10.1074/mcp.M800020-MCP200; Nadeau OW, 2007, J MOL BIOL, V365, P1429, DOI 10.1016/j.jmb.2006.10.061; Nadeau OW, 2010, BIOCHEMISTRY-US, V49, P6505, DOI 10.1021/bi101006j; Nelson MR, 1998, BIOMETALS, V11, P297, DOI 10.1023/A:1009253808876; NEWSHOLME P, 1992, J BIOL CHEM, V267, P810; NORCUM MT, 1994, J MOL BIOL, V241, P94, DOI 10.1006/jmbi.1994.1476; OWEN DJ, 1995, STRUCTURE, V3, P467, DOI 10.1016/S0969-2126(01)00180-0; Pallen MJ, 2003, PROTEIN SCI, V12, P1804, DOI 10.1110/ps.0371103; PAUDEL HK, 1987, J BIOL CHEM, V262, P11912; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Priddy TS, 2007, PROTEIN SCI, V16, P517, DOI 10.1110/ps.062577507; Priddy TS, 2005, PROTEIN SCI, V14, P1039, DOI 10.1110/ps.041124705; Rice NA, 2002, J BIOL CHEM, V277, P14681, DOI 10.1074/jbc.M201229200; Schilling B, 2003, J AM SOC MASS SPECTR, V14, P834, DOI 10.1016/S1044-0305(03)00327-1; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Sigman ME, 2005, RAPID COMMUN MASS SP, V19, P3731, DOI 10.1002/rcm.2247; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; SREERAMA N, 1994, J MOL BIOL, V242, P497, DOI 10.1006/jmbi.1994.1597; SVENSSON B, 1992, CARBOHYD RES, V227, P29, DOI 10.1016/0008-6215(92)85059-9; Taverner T, 2008, ACCOUNTS CHEM RES, V41, P617, DOI 10.1021/ar700218q; TEO TS, 1973, J BIOL CHEM, V248, P588; Traxler KW, 2001, J STRUCT BIOL, V135, P231, DOI 10.1006/jsbi.2001.4411; TREMPE MR, 1987, J BIOL CHEM, V262, P4333; TREMPE MR, 1986, J BIOL CHEM, V261, P2882; Venien-Bryan C, 2002, STRUCTURE, V10, P33, DOI 10.1016/S0969-2126(01)00691-8; Venien-Bryan C, 2009, STRUCTURE, V17, P117, DOI 10.1016/j.str.2008.10.013; Wilkinson DA, 1997, J MOL BIOL, V265, P319, DOI 10.1006/jmbi.1996.0739; WILKINSON DA, 1994, J MOL BIOL, V235, P974, DOI 10.1006/jmbi.1994.1051; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Xu D, 2011, PROTEINS, V79, P147, DOI 10.1002/prot.23111; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; ZANDER NF, 1988, P NATL ACAD SCI USA, V85, P2929, DOI 10.1073/pnas.85.9.2929; Zhang Y, 2004, J COMPUT CHEM, V25, P865, DOI 10.1002/jcc.20011; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	72	14	14	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36651	36661		10.1074/jbc.M112.412874	http://dx.doi.org/10.1074/jbc.M112.412874			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22969083	hybrid, Green Published			2022-12-28	WOS:000310588500003
J	Grassie, ME; Sutherland, C; Ulke-Lemee, A; Chappellaz, M; Kiss, E; Walsh, MP; MacDonald, JA				Grassie, Michael E.; Sutherland, Cindy; Ulke-Lemee, Annegret; Chappellaz, Mona; Kiss, Enikoe; Walsh, Michael P.; MacDonald, Justin A.			Cross-talk between Rho-associated Kinase and Cyclic Nucleotide-dependent Kinase Signaling Pathways in the Regulation of Smooth Muscle Myosin Light Chain Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ SENSITIZATION; SUBSTRATE-SPECIFICITY; PHOSPHORYLATION SITES; TARGET SUBUNIT; MECHANISM; CONTRACTION; DIPHOSPHORYLATION; IDENTIFICATION; INHIBITION; RELAXATION	Ca2+ sensitization of smooth muscle contraction depends upon the activities of protein kinases, including Rho-associated kinase, that phosphorylate the myosin phosphatase targeting subunit (MYPT1) at Thr(697) and/or Thr(855) (rat sequence numbering) to inhibit phosphatase activity and increase contractile force. Both Thr residues are preceded by the sequence RRS, and it has been suggested that phosphorylation at Ser(696) prevents phosphorylation at Thr(697). However, the effects of Ser(854) and dual Ser(696)-Thr(697) and Ser(854)-Thr(855) phosphorylations on myosin phosphatase activity and contraction are unknown. We characterized a suite of MYPT1 proteins and phosphospecific antibodies for specificity toward monophosphorylation events (Ser(696), Thr(697), Ser(854), and Thr(855)), Ser phosphorylation events (Ser(696)/Ser(854)) and dual Ser/Thr phosphorylation events (Ser(696)-Thr(697) and Ser(854)-Thr(855)). Dual phosphorylation at Ser(696)-Thr(697) and Ser(854)-Thr(855) by cyclic nucleotide-dependent protein kinases had no effect on myosin phosphatase activity, whereas phosphorylation at Thr(697) and Thr(855) by Rho-associated kinase inhibited phosphatase activity and prevented phosphorylation by cAMP-dependent protein kinase at the neighboring Ser residues. Forskolin induced phosphorylation at Ser(696), Thr(697), Ser(854), and Thr(855) in rat caudal artery, whereas U46619 induced Thr(697) and Thr(855) phosphorylation and prevented the Ser phosphorylation induced by forskolin. Furthermore, pretreatment with forskolin prevented U46619-induced Thr phosphorylations. We conclude that cross-talk between cyclic nucleotide and RhoA signaling pathways dictates the phosphorylation status of the Ser(696)-Thr(697) and Ser(854)-Thr(855) inhibitory regions of MYPT1 in situ, thereby regulating the activity of myosin phosphatase and contraction.	Univ Calgary, Smooth Muscle Res Grp, Calgary, AB T2N 4Z6, Canada; Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4Z6, Canada	University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary	MacDonald, JA (corresponding author), 3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	jmacdo@ucalgary.ca		MacDonald, Justin/0000-0002-9238-8473	Canadian Institutes of Health Research [MOP-72720, MOP-111262]; Heart and Stroke Foundation of Canada; Alberta Innovates-Health Solutions (AIHS) Scientist Award; Canada Research Chair in Vascular Smooth Muscle Research; Alberta Innovates-Health Solutions (AIHS) Senior Scholar Award; Canada Research Chair in Smooth Muscle Pathophysiology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Alberta Innovates-Health Solutions (AIHS) Scientist Award; Canada Research Chair in Vascular Smooth Muscle Research; Alberta Innovates-Health Solutions (AIHS) Senior Scholar Award; Canada Research Chair in Smooth Muscle Pathophysiology	This work was supported in part by Canadian Institutes of Health Research Grants MOP-72720 (to J. A. M.) and MOP-111262 (to M. P. W.).; Holds a Heart and Stroke Foundation of Canada fellowship.; Holds an Alberta Innovates-Health Solutions (AIHS) Scientist Award and Canada Research Chair in Vascular Smooth Muscle Research.; Holds an Alberta Innovates-Health Solutions (AIHS) Senior Scholar Award and Canada Research Chair in Smooth Muscle Pathophysiology. To whom correspondence should be addressed: 3280 Hospital Dr. NW, Calgary, Alberta T2N 4Z6, Canada. Tel.: 403-210-8433; Fax: 403-270-2211; E-mail: jmacdo@ucalgary.ca.	Bolz SS, 2003, CIRCULATION, V107, P3081, DOI 10.1161/01.CIR.0000074202.19612.8C; Borman MA, 2002, J BIOL CHEM, V277, P23441, DOI 10.1074/jbc.M201597200; Borman MA, 2009, MOL CELL BIOCHEM, V327, P93, DOI 10.1007/s11010-009-0047-z; Borysova L, 2011, CELL CALCIUM, V50, P393, DOI 10.1016/j.ceca.2011.07.003; Bridges D, 2006, BIOCHEM BIOPH RES CO, V346, P351, DOI 10.1016/j.bbrc.2006.05.138; Carvajal JA, 2000, J CELL PHYSIOL, V184, P409, DOI 10.1002/1097-4652(200009)184:3<409::AID-JCP16>3.3.CO;2-B; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; GONG MC, 1992, J BIOL CHEM, V267, P14662; Grassie ME, 2011, ARCH BIOCHEM BIOPHYS, V510, P147, DOI 10.1016/j.abb.2011.01.018; Ichikawa K, 1996, J BIOL CHEM, V271, P4733; INAGAKI M, 1990, J BIOL CHEM, V265, P4722; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Khromov A, 2009, J BIOL CHEM, V284, P21569, DOI 10.1074/jbc.M109.019729; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; MacDonald JA, 2001, P NATL ACAD SCI USA, V98, P2419, DOI 10.1073/pnas.041331498; MacDonald JA, 2001, FEBS LETT, V493, P91, DOI 10.1016/S0014-5793(01)02277-3; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; Miller JL, 2008, PROTEIN SCI, V17, P251, DOI 10.1110/ps.073185608; Moffat LD, 2011, J BIOL CHEM, V286, P36978, DOI 10.1074/jbc.M111.257949; Morgado M, 2012, CELL MOL LIFE SCI, V69, P247, DOI 10.1007/s00018-011-0815-2; Muranyi A, 2005, FEBS LETT, V579, P6611, DOI 10.1016/j.febslet.2005.10.055; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Nakamura K, 2007, CIRC RES, V101, P712, DOI 10.1161/CIRCRESAHA.107.153981; Patwardhan P, 2007, CELL SIGNAL, V19, P2218, DOI 10.1016/j.cellsig.2007.06.006; Sanders KM, 2001, J APPL PHYSIOL, V91, P1438, DOI 10.1152/jappl.2001.91.3.1438; Shin HM, 2002, CIRC RES, V90, P546, DOI 10.1161/01.RES.0000012822.23273.EC; SHIRAZI A, 1994, J BIOL CHEM, V269, P31598; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Sriwai W, 2008, BIOCHEM J, V411, P543, DOI [10.1042/BJ20071299, 10.1042/bj20071299]; Sutherland C, 2012, J BIOL CHEM, V287, P24064, DOI 10.1074/jbc.M112.371609; Tan I, 2001, J BIOL CHEM, V276, P21209, DOI 10.1074/jbc.M102615200; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; Walsh MP, 2011, IUBMB LIFE, V63, P987, DOI 10.1002/iub.527; Webb RC, 2003, ADV PHYSIOL EDUC, V27, P201, DOI 10.1152/advan.00025.2003; Weber LP, 1999, J PHYSIOL-LONDON, V516, P805, DOI 10.1111/j.1469-7793.1999.0805u.x; Wilson DP, 2005, BIOCHEM J, V392, P641, DOI 10.1042/BJ20051173; Wilson DP, 2005, BIOCHEM J, V389, P763, DOI 10.1042/BJ20050237; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200; Wu XQ, 1996, BIOCHEM BIOPH RES CO, V220, P658, DOI 10.1006/bbrc.1996.0460	40	31	32	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36356	36369		10.1074/jbc.M112.398479	http://dx.doi.org/10.1074/jbc.M112.398479			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22948155	Green Published, hybrid			2022-12-28	WOS:000310364000056
J	Hardison, RC				Hardison, Ross C.			Genome-wide Epigenetic Data Facilitate Understanding of Disease Susceptibility Association Studies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							LOCUS ACTIVATION REGION; MENDELIAN-INHERITANCE; HYPERSENSITIVE SITES; CHROMATIN-STRUCTURE; GLOBIN GENE; EXPRESSION; TRANSCRIPTION; RS6983267; VARIANTS; COMMON	Complex traits such as susceptibility to diseases are determined in part by variants at multiple genetic loci. Genome-wide association studies can identify these loci, but most phenotype-associated variants lie distal to protein-coding regions and are likely involved in regulating gene expression. Understanding how these genetic variants affect complex traits depends on the ability to predict and test the function of the genomic elements harboring them. Community efforts such as the ENCODE Project provide a wealth of data about epigenetic features associated with gene regulation. These data enable the prediction of testable functions for many phenotype-associated variants.	[Hardison, Ross C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16801 USA; [Hardison, Ross C.] Penn State Univ, Ctr Comparat Genom & Bioinformat, Huck Inst Life Sci, University Pk, PA 16801 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hardison, RC (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16801 USA.	rch8@psu.edu	Hardison, Ross C/G-1142-2010	Hardison, Ross C/0000-0003-4084-7516	National Institutes of Health Grants [R01 DK065806, RC HG005573, U01 HG004695]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005573, U01HG004695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017155] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK065806, RC HG005573, and U01 HG004695. This is the sixth article in the Thematic Minireview Series on Results from the ENCODE Project: Integrative Global Analyses of Regulatory Regions in the Human Genome.	Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Boyd KE, 1997, MOL CELL BIOL, V17, P2529, DOI 10.1128/MCB.17.5.2529; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Carvajal-Carmona LG, 2011, HUM MOL GENET, V20, P2879, DOI 10.1093/hmg/ddr190; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elnitski L, 2006, GENOME RES, V16, P1455, DOI 10.1101/gr.4140006; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Farrell JJ, 2011, BLOOD, V117, P4935, DOI 10.1182/blood-2010-11-317081; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; FORRESTER WC, 1987, NUCLEIC ACIDS RES, V15, P10159, DOI 10.1093/nar/15.24.10159; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; GALAU GA, 1976, CELL, V7, P487, DOI 10.1016/0092-8674(76)90200-2; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Giardine B, 2007, HUM MUTAT, V28, P554, DOI 10.1002/humu.20484; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; HIGGS DR, 1990, GENE DEV, V4, P1588, DOI 10.1101/gad.4.9.1588; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/nmeth.1937, 10.1038/NMETH.1937]; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; ORKIN SH, 1992, BLOOD, V80, P575; ORKIN SH, 1983, NUCLEIC ACIDS RES, V11, P4727, DOI 10.1093/nar/11.14.4727; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Schaub M. A., 2012, GENOME RES IN PRESS; Schones DE, 2008, NAT REV GENET, V9, P179, DOI 10.1038/nrg2270; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; The ENCODE Project Consortium, 2012, NATURE IN PRESS; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wokolorczyk D, 2008, CANCER RES, V68, P9982, DOI 10.1158/0008-5472.CAN-08-1838; Wold B, 2008, NAT METHODS, V5, P19, DOI 10.1038/NMETH1157; Wu WS, 2011, GENOME RES, V21, P1659, DOI 10.1101/gr.125088.111; Zhong H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000932	78	31	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					30932	30940		10.1074/jbc.R112.352427	http://dx.doi.org/10.1074/jbc.R112.352427			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22952232	Green Published, hybrid			2022-12-28	WOS:000308791300007
J	Vela, A; Fedorova, O; Ding, SC; Pyle, AM				Vela, Adriana; Fedorova, Olga; Ding, Steve C.; Pyle, Anna Marie			The Thermodynamic Basis for Viral RNA Detection by the RIG-I Innate Immune Sensor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATTERN-RECOGNITION; STRUCTURAL BASIS; TERMINAL DOMAIN; HELICASE; INSIGHTS; ACTIVATION; BINDING; LGP2	RIG-I is a cytoplasmic surveillance protein that contributes to the earliest stages of the vertebrate innate immune response. The protein specifically recognizes 5'-triphosphorylated RNA structures that are released into the cell by viruses, such as influenza and hepatitis C. To understand the energetic basis for viral RNA recognition by RIG-I, we studied the binding of RIG-I domain variants to a family of dsRNA ligands. Thermodynamic analysis revealed that the isolated RIG-I domains each make important contributions to affinity and that they interact using different strategies. Covalent linkage between the domains enhances RNA ligand specificity while reducing overall binding affinity, thereby providing a mechanism for discriminating virus from host RNA.	[Fedorova, Olga; Pyle, Anna Marie] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Vela, Adriana] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Fedorova, Olga; Pyle, Anna Marie] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Ding, Steve C.] Burnham Inst Med Res, La Jolla, CA 92037 USA	Yale University; Yale University; Howard Hughes Medical Institute; Sanford Burnham Prebys Medical Discovery Institute	Pyle, AM (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, 266 Whitney Ave,Box 208114, New Haven, CT 06520 USA.	anna.pyle@yale.edu						Beran RKF, 2007, J BIOL CHEM, V282, P34913, DOI 10.1074/jbc.M707165200; Cantor C.R, 1980, BIOPHYSICAL CHEM 3, P874; Chen CP, 2005, P NATL ACAD SCI USA, V102, P8531, DOI 10.1073/pnas.0503319102; Civril F, 2011, EMBO REP, V12, P1127, DOI 10.1038/embor.2011.190; Coleman TM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh007; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Cutler TA, 2009, J MOL BIOL, V386, P854, DOI 10.1016/j.jmb.2008.10.090; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fersht A., 1985, ENZYME STRUCTURE MEC, P129; Fujita T, 2007, BIOCHIMIE, V89, P754, DOI 10.1016/j.biochi.2007.01.013; Gee P, 2008, J BIOL CHEM, V283, P9488, DOI 10.1074/jbc.M706777200; Hartmann RK, 2005, HANDBOOK OF RNA BIOCHEMISTRY, P1, DOI 10.1002/9783527619504; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Komuro A, 2006, J VIROL, V80, P12332, DOI 10.1128/JVI.01325-06; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Lu C, 2011, NUCLEIC ACIDS RES, V39, P1565, DOI 10.1093/nar/gkq974; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Murali A, 2008, J BIOL CHEM, V283, P15825, DOI 10.1074/jbc.M800542200; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Qin PZ, 1999, J MOL BIOL, V291, P15, DOI 10.1006/jmbi.1999.2922; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Sarkar D, 2008, P NATL ACAD SCI USA, V105, P17040, DOI 10.1073/pnas.0804956105; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; WINCOTT F, 1995, NUCLEIC ACIDS RES, V23, P2677, DOI 10.1093/nar/23.14.2677	28	44	47	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42564	42573		10.1074/jbc.M112.385146	http://dx.doi.org/10.1074/jbc.M112.385146			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23055530	hybrid, Green Published			2022-12-28	WOS:000312501600018
J	Lee, SK; Potempa, M; Swanstrom, R				Lee, Sook-Kyung; Potempa, Marc; Swanstrom, Ronald			The Choreography of HIV-1 Proteolytic Processing and Virion Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							IMMUNODEFICIENCY-VIRUS TYPE-1; PROTEASE CLEAVAGE SITES; SMALL-MOLECULE INHIBITION; HIGH-LEVEL RESISTANCE; RESPONSE CURVE SLOPE; CROSS-RESISTANCE; KINETIC CHARACTERIZATION; VIRAL SUPPRESSION; DRUG-RESISTANCE; TERMINAL DOMAIN	HIV-1 has been the target of intensive research at the molecular and biochemical levels for >25 years. Collectively, this work has led to a detailed understanding of viral replication and the development of 24 approved drugs that have five different targets on various viral proteins and one cellular target (CCR5). Although most drugs target viral enzymatic activities, our detailed knowledge of so much of the viral life cycle is leading us into other types of inhibitors that can block or disrupt protein-protein interactions. Viruses have compact genomes and employ a strategy of using a small number of proteins that can form repeating structures to enclose space (i.e. condensing the viral genome inside of a protein shell), thus minimizing the need for a large protein coding capacity. This creates a relatively small number of critical protein-protein interactions that are essential for viral replication. For HIV-1, the Gag protein has the role of a polyprotein precursor that contains all of the structural proteins of the virion: matrix, capsid, spacer peptide 1, nucleocapsid, spacer peptide 2, and p6 (which contains protein-binding domains that interact with host proteins during budding). Similarly, the Gag-Pro-Pol precursor encodes most of the Gag protein but now includes the viral enzymes: protease, reverse transcriptase (with its associated RNase H activity), and integrase. Gag and Gag-Pro-Pol are the substrates of the viral protease, which is responsible for cleaving these precursors into their mature and fully active forms (see Fig. 1A).	[Lee, Sook-Kyung; Swanstrom, Ronald] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Potempa, Marc; Swanstrom, Ronald] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Lee, Sook-Kyung; Swanstrom, Ronald] Univ N Carolina, UNC Ctr AIDS Res, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Swanstrom, R (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	risunc@med.unc.edu			National Institutes of Health [P01 GM066524, R37 AI44667, R21 NS073052]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI044667, R01AI044667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM066524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS073052] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 GM066524, R37 AI44667, and R21 NS073052. This is the fourth article in the Thematic Minireview Series on Understanding Human Immunodeficiency Virus-Host Interactions at the Biochemical Level.	Agniswamy J, 2012, BIOCHEMISTRY-US, V51, P1041, DOI 10.1021/bi201809s; Ambrose Z, 2006, J VIROL, V80, P2578, DOI 10.1128/JVI.80.5.2578-2581.2006; Anderson Jeffrey, 2009, V189, P85; Arribas JR, 2005, JAIDS-J ACQ IMM DEF, V40, P280, DOI 10.1097/01.qai.0000180077.59159.f4; Bally F, 2000, AIDS RES HUM RETROV, V16, P1209, DOI 10.1089/08892220050116970; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Blair WS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001220; Boyer PL, 2001, J VIROL, V75, P4832, DOI 10.1128/JVI.75.10.4832-4842.2001; Breuer S, 2012, J MED CHEM, V55, P4968, DOI 10.1021/jm201442t; Breuer S, 2011, BIOCHEMISTRY-US, V50, P4371, DOI 10.1021/bi200031m; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Carlson LA, 2008, CELL HOST MICROBE, V4, P592, DOI 10.1016/j.chom.2008.10.013; Chang MW, 2011, J MOL BIOL, V410, P756, DOI 10.1016/j.jmb.2011.03.038; Checkley MA, 2010, VIROLOGY, V400, P137, DOI 10.1016/j.virol.2010.01.028; CHEN ZG, 1995, J BIOL CHEM, V270, P21433, DOI 10.1074/jbc.270.37.21942; Coren LV, 2007, J VIROL, V81, P10047, DOI 10.1128/JVI.02496-06; Croteau G, 1997, J VIROL, V71, P1089, DOI 10.1128/JVI.71.2.1089-1096.1997; de la Carriere LC, 1999, J VIROL, V73, P3455; Deeks SG, 2002, J INFECT DIS, V185, P315, DOI 10.1086/338467; Doyon L, 1996, J VIROL, V70, P3763, DOI 10.1128/JVI.70.6.3763-3769.1996; ERICKSONVIITANEN S, 1989, AIDS RES HUM RETROV, V5, P577, DOI 10.1089/aid.1989.5.577; FU W, 1994, J VIROL, V68, P5013, DOI 10.1128/JVI.68.8.5013-5018.1994; Ganser-Pornillos BK, 2012, ADV EXP MED BIOL, V726, P441, DOI 10.1007/978-1-4614-0980-9_20; GULNIK SV, 1995, BIOCHEMISTRY-US, V34, P9282, DOI 10.1021/bi00029a002; Henderson GJ, 2012, ANTIMICROB AGENTS CH, V56, P623, DOI 10.1128/AAC.05549-11; Hermle J, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-32; HO DD, 1994, J VIROL, V68, P2016, DOI 10.1128/JVI.68.3.2016-2020.1994; Hoffman NG, 2003, VIROLOGY, V314, P536, DOI 10.1016/S0042-6822(03)00484-7; Huang LQ, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-79; Ivanchenko S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000652; JACKS T, 1990, CURR TOP MICROBIOL, V157, P93; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; Jouvenet N, 2009, P NATL ACAD SCI USA, V106, P19114, DOI 10.1073/pnas.0907364106; KAPLAN AH, 1994, J VIROL, V68, P6782, DOI 10.1128/JVI.68.10.6782-6786.1994; KAPLAN AH, 1994, P NATL ACAD SCI USA, V91, P5597, DOI 10.1073/pnas.91.12.5597; Katlama C, 2010, AIDS, V24, P2365, DOI 10.1097/QAD.0b013e32833dec20; Keller PW, 2011, J VIROL, V85, P1420, DOI 10.1128/JVI.01926-10; Kelly BN, 2007, J MOL BIOL, V373, P355, DOI 10.1016/j.jmb.2007.07.070; King NM, 2004, CHEM BIOL, V11, P1333, DOI 10.1016/j.chembiol.2004.08.010; Koch N, 2001, AIDS, V15, P526, DOI 10.1097/00002030-200103090-00013; KRAUSSLICH HG, 1991, P NATL ACAD SCI USA, V88, P3213, DOI 10.1073/pnas.88.8.3213; Kutluay SB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001200; Lee SK, 2009, J VIROL, V83, P8536, DOI 10.1128/JVI.00317-09; Lefebvre E, 2008, AIDS REV, V10, P131; Lemke CT, 2012, J VIROL, V86, P6643, DOI 10.1128/JVI.00493-12; Li F, 2003, P NATL ACAD SCI USA, V100, P13555, DOI 10.1073/pnas.2234683100; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Louis JM, 1999, NAT STRUCT BIOL, V6, P868; Ludwig C, 2008, J VIROL, V82, P4573, DOI 10.1128/JVI.02353-07; Mammano F, 2000, J VIROL, V74, P8524, DOI 10.1128/JVI.74.18.8524-8531.2000; Mammano F, 1998, J VIROL, V72, P7632, DOI 10.1128/JVI.72.9.7632-7637.1998; MARKOWITZ M, 1995, J VIROL, V69, P701, DOI 10.1128/JVI.69.2.701-706.1995; Martinez-Picado J, 1999, J VIROL, V73, P3744, DOI 10.1128/JVI.73.5.3744-3752.1999; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Mortuza GB, 2004, NATURE, V431, P481, DOI 10.1038/nature02915; Muller B, 2009, J BIOL CHEM, V284, P29692, DOI 10.1074/jbc.M109.027144; Nguyen AT, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-101; Nijhuis M, 1999, AIDS, V13, P2349, DOI 10.1097/00002030-199912030-00006; Ozen A, 2011, J MOL BIOL, V410, P726, DOI 10.1016/j.jmb.2011.03.053; Ott DE, 2009, J VIROL, V83, P7718, DOI 10.1128/JVI.00099-09; Parry CM, 2009, J VIROL, V83, P9094, DOI 10.1128/JVI.02356-08; PARTALEDIS JA, 1995, J VIROL, V69, P5228, DOI 10.1128/JVI.69.9.5228-5235.1995; Pazhanisamy S, 1996, J BIOL CHEM, V271, P17979, DOI 10.1074/jbc.271.30.17979; Pettit SC, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-66; PETTIT SC, 1991, J BIOL CHEM, V266, P14539; PETTIT SC, 1994, J VIROL, V68, P8017, DOI 10.1128/JVI.68.12.8017-8027.1994; Pettit SC, 2004, J VIROL, V78, P8477, DOI 10.1128/JVI.78.16.8477-8485.2004; Pettit SC, 2003, J VIROL, V77, P366, DOI 10.1128/JVI.77.1.366-374.2003; Pettit SC, 2002, J VIROL, V76, P10226, DOI 10.1128/JVI.76.20.10226-10233.2002; Prabu-Jeyabalan M, 2004, J VIROL, V78, P12446, DOI 10.1128/JVI.78.22.12446-12454.2004; Prabu-Jeyabalan M, 2002, STRUCTURE, V10, P369, DOI 10.1016/S0969-2126(02)00720-7; Resch W, 2002, J VIROL, V76, P8659, DOI 10.1128/JVI.76.17.8659-8666.2002; Rhee SY, 2010, ANTIMICROB AGENTS CH, V54, P4253, DOI 10.1128/AAC.00574-10; Rulli SJ, 2006, VIROLOGY, V347, P364, DOI 10.1016/j.virol.2005.12.012; Sampah MES, 2011, P NATL ACAD SCI USA, V108, P7613, DOI 10.1073/pnas.1018360108; Schock HB, 1996, J BIOL CHEM, V271, P31957, DOI 10.1074/jbc.271.50.31957; Shehu-Xhilaga M, 2001, J VIROL, V75, P9156, DOI 10.1128/JVI.75.19.9156-9164.2001; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Shen L, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002304; Sheng NJ, 1997, J VIROL, V71, P5723, DOI 10.1128/JVI.71.8.5723-5732.1997; SHENG NJ, 1994, J VIROL, V68, P6207, DOI 10.1128/JVI.68.10.6207-6214.1994; Shi J, 2011, J VIROL, V85, P542, DOI 10.1128/JVI.01406-10; Sticht J, 2005, NAT STRUCT MOL BIOL, V12, P671, DOI 10.1038/nsmb964; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Swanstrom R., 1997, P263; Tang C, 2003, J MOL BIOL, V327, P1013, DOI 10.1016/S0022-2836(03)00289-4; Tang C, 2008, NATURE, V455, P693, DOI 10.1038/nature07342; Ternois F, 2005, NAT STRUCT MOL BIOL, V12, P678, DOI 10.1038/nsmb967; Thomas JA, 2008, VIRUS RES, V134, P39, DOI 10.1016/j.virusres.2007.12.006; Tong WJ, 1997, BIOCHEMISTRY-US, V36, P5749, DOI 10.1021/bi962410z; TRITCH RJ, 1991, J VIROL, V65, P922, DOI 10.1128/JVI.65.2.922-930.1991; Valantin MA, 2012, J ANTIMICROB CHEMOTH, V67, P691, DOI 10.1093/jac/dkr504; VOGT VM, 1973, P NATL ACAD SCI USA, V70, P1734, DOI 10.1073/pnas.70.6.1734; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Watkins T, 2003, ANTIMICROB AGENTS CH, V47, P759, DOI 10.1128/AAC.47.2.759-769.2003; Weiss ER, 2011, J MOL BIOL, V410, P525, DOI 10.1016/j.jmb.2011.04.055; Wiegers K, 1998, J VIROL, V72, P2846, DOI 10.1128/JVI.72.4.2846-2854.1998; Zennou V, 1998, J VIROL, V72, P3300, DOI 10.1128/JVI.72.4.3300-3306.1998; Zhang YM, 1997, J VIROL, V71, P6662, DOI 10.1128/JVI.71.9.6662-6670.1997; Zhou J, 2005, J BIOL CHEM, V280, P42149, DOI 10.1074/jbc.M508951200; Zhou J, 2004, J VIROL, V78, P922, DOI 10.1128/JVI.78.2.922-929.2004	101	84	86	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					40867	40874		10.1074/jbc.R112.399444	http://dx.doi.org/10.1074/jbc.R112.399444			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23043111	Green Published, hybrid			2022-12-28	WOS:000311887600005
J	Mishra, J; Karanki, SS; Kumar, N				Mishra, Jayshree; Karanki, Satya Sridhar; Kumar, Narendra			Identification of Molecular Switch Regulating Interactions of Janus Kinase 3 with Cytoskeletal Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; JAK3; DOMAIN; VILLIN; EXPRESSION; MUTATIONS	Janus kinase 3 (Jak3) is a nonreceptor tyrosine kinase expressed in both hematopoietic and nonhematopoietic cells. Although mutations that abrogate Jak3 functions cause different immunological disorders, its constitutive activation leads to various types of cancer. Previously, we demonstrated that Jak3 interacted with actin-binding protein villin, thereby facilitating cytoskeletal remodeling and wound repair. In this study, we characterize the structural determinants that regulate the interactions between Jak3 and cytoskeletal proteins of the villin/gelsolin family. Functional reconstitution of kinase activity by recombinant full-length (wt) Jak3 using Jak3-wt or villin/gelsolin-wt as substrate showed that Jak3 autophosphorylation was the rate-limiting step during interactions between Jak3 and cytoskeletal proteins. Determination of kinetic parameters showed that phosphorylated (P) Jak3-wt binds to P-villin-wt with a dissociation constant (K-d) of 23 nM and a Hill's coefficient of 3.7. Pairwise binding between Jak3 mutants and P-villin-wt showed that the FERM domain of Jak3 was sufficient for binding to P-villin-wt with a K-d of 40.0 nM. However, the SH2 domain of Jak3 prevented P-villin-wt from binding to the FERM domain of nonphosphorylated protein. We demonstrate that the intramolecular interaction between the FERM and SH2 domains of nonphosphorylated Jak3 prevented Jak3 from binding to villin and that tyrosine autophosphorylation of Jak3 at the SH2 domain decreased these intramolecular interactions and facilitated binding of the FERM domain to villin. Thus we demonstrate the molecular mechanism of interactions between Jak3 and cytoskeletal proteins where tyrosine phosphorylation of the SH2 domain acted as an intramolecular switch for the interactions between Jak3 and cytoskeletal proteins.	[Mishra, Jayshree; Karanki, Satya Sridhar; Kumar, Narendra] Texas A&M Hlth Sci Ctr, Irma Lerma Rangel ILR Coll Pharm, Dept Pharmaceut Sci, Kingsville, TX 78363 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Kumar, N (corresponding author), Texas A&M HSC, ILR Coll Pharm, 1010 West Ave B,MSC 131, Kingsville, TX 78363 USA.	nkumar@tamhsc.edu	MISHRA, JAYSHREE/O-3468-2018	MISHRA, JAYSHREE/0000-0003-0619-0629; Kumar, Narendra/0000-0002-1193-0954	National Institutes of Health [DK081661]; Crohn's & Colitis Foundation of America [1351, 2188]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK081661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's & Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK081661 to N. K.). This work was also supported by grants from the Crohn's & Colitis Foundation of America (CCFA Reference Numbers 1351 and 2188).	Chrencik JE, 2010, J MOL BIOL, V400, P413, DOI 10.1016/j.jmb.2010.05.020; Cornejo MG, 2009, INT J BIOCHEM CELL B, V41, P2376, DOI 10.1016/j.biocel.2009.09.004; Ferrary E, 1999, J CELL BIOL, V146, P819, DOI 10.1083/jcb.146.4.819; FRIEDERICH E, 1990, BIOESSAYS, V12, P403, DOI 10.1002/bies.950120902; Haan C, 2006, BIOCHEM PHARMACOL, V72, P1538, DOI 10.1016/j.bcp.2006.04.013; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Kampa D, 2000, BIOCHEM BIOPH RES CO, V278, P175, DOI 10.1006/bbrc.2000.3757; Kumar N, 2004, J BIOL CHEM, V279, P3096, DOI 10.1074/jbc.M308878200; Kumar N, 2007, J BIOL CHEM, V282, P30341, DOI 10.1074/jbc.C600319200; Lin Q, 2005, AM J PATHOL, V167, P969, DOI 10.1016/S0002-9440(10)61187-X; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Mishra J, 2012, AM J PHYSIOL-CELL PH, V302, pC735, DOI 10.1152/ajpcell.00316.2011; Safford MG, 1997, EXP HEMATOL, V25, P374; TAKAHASHI T, 1994, FEBS LETT, V342, P124, DOI 10.1016/0014-5793(94)80485-0; Zhou YJ, 1997, P NATL ACAD SCI USA, V94, P13850, DOI 10.1073/pnas.94.25.13850; Zhou YJ, 2001, MOL CELL, V8, P959, DOI 10.1016/S1097-2765(01)00398-7	16	15	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41386	41391		10.1074/jbc.C112.363507	http://dx.doi.org/10.1074/jbc.C112.363507			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23012362	Green Published, hybrid			2022-12-28	WOS:000311887600051
J	Burmeister, BT; Taglieri, DM; Wang, L; Carnegie, GK				Burmeister, Brian T.; Taglieri, Domenico M.; Wang, Li; Carnegie, Graeme K.			Src Homology 2 Domain-containing Phosphatase 2 (Shp2) Is a Component of the A-kinase-anchoring Protein (AKAP)-Lbc Complex and Is Inhibited by Protein Kinase A (PKA) under Pathological Hypertrophic Conditions in the Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AKAP SIGNALING COMPLEXES; CARDIAC-HYPERTROPHY; TYROSINE-PHOSPHATASE; DILATED CARDIOMYOPATHY; SCAFFOLDING PROTEINS; LEOPARD-SYNDROME; NOONAN-SYNDROME; NEURAL CREST; LIVING CELLS; PTPN11 SHP2	Pathological cardiac hypertrophy (an increase in cardiac mass resulting from stress-induced cardiac myocyte growth) is a major factor underlying heart failure. Our results identify a novel mechanism of Shp2 inhibition that may promote cardiac hypertrophy. We demonstrate that the tyrosine phosphatase, Shp2, is a component of the A-kinase-anchoring protein (AKAP)-Lbc complex. AKAP-Lbc facilitates PKA phosphorylation of Shp2, which inhibits its protein-tyrosine phosphatase activity. Given the important cardiac roles of both AKAP-Lbc and Shp2, we investigated the AKAP-Lbc-Shp2 interaction in the heart. AKAP-Lbc-tethered PKA is implicated in cardiac hypertrophic signaling; however, mechanism of PKA action is unknown. Mutations resulting in loss of Shp2 catalytic activity are also associated with cardiac hypertrophy and congenital heart defects. Our data indicate that AKAP-Lbc integrates PKA and Shp2 signaling in the heart and that AKAP-Lbc-associated Shp2 activity is reduced in hypertrophic hearts in response to chronic beta-adrenergic stimulation and PKA activation. Thus, while induction of cardiac hypertrophy is a multifaceted process, inhibition of Shp2 activity through AKAP-Lbc-anchored PKA is a previously unrecognized mechanism that may promote compensatory cardiac hypertrophy.	[Burmeister, Brian T.; Taglieri, Domenico M.; Wang, Li; Carnegie, Graeme K.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Carnegie, GK (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, 835 S Wolcott Ave,E403 MSB, Chicago, IL 60612 USA.	carnegie@uic.edu			American Heart Association [11SDG5230003]; National Center for Advancing Translational Science-University of Illinois at Chicago Center for Clinical and Translational Sciences [UL1TR000050]; National Institutes of Health through the University of Illinois at Chicago Department of Cardiology [5T32HL072742-09]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000050] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072742] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Center for Advancing Translational Science-University of Illinois at Chicago Center for Clinical and Translational Sciences; National Institutes of Health through the University of Illinois at Chicago Department of Cardiology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association Grant 11SDG5230003 (to G.K.C.) and National Center for Advancing Translational Science-University of Illinois at Chicago Center for Clinical and Translational Sciences Grant UL1TR000050.; Supported by National Institutes of Health T32 Training Grant 5T32HL072742-09 through the University of Illinois at Chicago Department of Cardiology.	Alto N, 2002, DIABETES, V51, pS385, DOI 10.2337/diabetes.51.2007.S385; Appert-Collin A, 2007, P NATL ACAD SCI USA, V104, P10140, DOI 10.1073/pnas.0701099104; Aye TT, 2012, J MOL CELL CARDIOL, V52, P511, DOI 10.1016/j.yjmcc.2011.06.003; Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; Cardone L, 2004, MOL CELL BIOL, V24, P4613, DOI 10.1128/MCB.24.11.4613-4626.2004; Cariolato L, 2011, J BIOL CHEM, V286, P7925, DOI 10.1074/jbc.M110.185645; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; Carnegie GK, 2011, J CARDIOVASC PHARM, V58, P451, DOI 10.1097/FJC.0b013e31821c0220; Carnegie GK, 2009, IUBMB LIFE, V61, P394, DOI 10.1002/iub.168; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Diviani D, 2001, J CELL SCI, V114, P1431; Diviani D, 2011, AM J PHYSIOL-HEART C, V301, pH1742, DOI 10.1152/ajpheart.00569.2011; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Ishida H, 2011, AM J PHYSIOL-HEART C, V301, pH1531, DOI 10.1152/ajpheart.00216.2011; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kontaridis MI, 2008, CIRCULATION, V117, P1423, DOI 10.1161/CIRCULATIONAHA.107.728865; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Krenz M, 2008, P NATL ACAD SCI USA, V105, P18930, DOI 10.1073/pnas.0806556105; Marin TM, 2008, CIRC RES, V103, P813, DOI 10.1161/CIRCRESAHA.108.179754; Marin TM, 2011, J CLIN INVEST, V121, P1026, DOI 10.1172/JCI44972; Mauban JRH, 2009, PHYSIOLOGY, V24, P78, DOI 10.1152/physiol.00041.2008; Nakamura T, 2007, J CLIN INVEST, V117, P2123, DOI 10.1172/JCI30756; Nakamura T, 2009, P NATL ACAD SCI USA, V106, P11270, DOI 10.1073/pnas.0902230106; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; Pidoux G, 2010, J MOL ENDOCRINOL, V44, P271, DOI 10.1677/JME-10-0010; Princen F, 2009, MOL CELL BIOL, V29, P378, DOI 10.1128/MCB.01661-08; Schillace RV, 1999, CURR BIOL, V9, P321, DOI 10.1016/S0960-9822(99)80141-9; Shi FM, 2011, SCIENCE, V332, P1043, DOI 10.1126/science.1208063; Shyu YJ, 2008, NAT PROTOC, V3, P1693, DOI 10.1038/nprot.2008.157; Smith FD, 2010, NAT CELL BIOL, V12, P1242, DOI 10.1038/ncb2130; Stewart RA, 2010, DEV CELL, V18, P750, DOI [10.1016/j.devcel.2010.03.009, 10.1016/j.devce1.2010.03.009]; Taglieri DM, 2011, J MOL CELL CARDIOL, V51, P988, DOI 10.1016/j.yjmcc.2011.09.016; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527	35	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40535	40546		10.1074/jbc.M112.385641	http://dx.doi.org/10.1074/jbc.M112.385641			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23045525	Green Published, hybrid			2022-12-28	WOS:000311448800044
J	Changeux, JP				Changeux, Jean-Pierre			The Nicotinic Acetylcholine Receptor: The Founding Father of the Pentameric Ligand-gated Ion Channel Superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							AFFINITY BINDING-SITE; MARMORATA ELECTRIC ORGAN; MEMBRANE-FRAGMENTS RICH; IN-VITRO EXCITATION; X-RAY-STRUCTURE; CHOLINERGIC-RECEPTOR; TORPEDO-MARMORATA; ALPHA-SUBUNIT; DELTA-SUBUNIT; ELECTROPHORUS-ELECTRICUS	A critical event in the history of biological chemistry was the chemical identification of the first neurotransmitter receptor, the nicotinic acetylcholine receptor. Disciplines as diverse as electrophysiology, pharmacology, and biochemistry joined together in a unified and rational manner with the common goal of successfully identifying the molecular device that converts a chemical signal into an electrical one in the nervous system. The nicotinic receptor has become the founding father of a broad family of pentameric membrane receptors, paving the way for their identification, including that of the GABA(A) receptors.	[Changeux, Jean-Pierre] Coll France, F-75005 Paris, France; [Changeux, Jean-Pierre] Inst Pasteur, F-75724 Paris 15, France	UDICE-French Research Universities; PSL Research University Paris; College de France; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Changeux, JP (corresponding author), Coll France, F-75005 Paris, France.	changeux@noos.fr						BALLIVET M, 1982, P NATL ACAD SCI-BIOL, V79, P4466, DOI 10.1073/pnas.79.14.4466; BARNARD EA, 1982, PROC R SOC SER B-BIO, V215, P241, DOI 10.1098/rspb.1982.0040; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; BOULTER J, 1986, NATURE, V319, P368, DOI 10.1038/319368a0; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; BRISSON AD, 1975, P NATL ACAD SCI USA, V72, P1087, DOI 10.1073/pnas.72.3.1087; CARTAUD J, 1973, FEBS LETT, V33, P109, DOI 10.1016/0014-5793(73)80171-1; CHANG C. C., 1963, ARCH INTERNATL PHARMACODYN THER, V144, P241; Changeux J. P., 1990, FIDIA RES FDN NEUROS, V4, P17; Changeux J-P, 2005, NICOTINIC ACETYLCHOL; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; CHANGEUX JP, 1969, CR ACAD SCI D NAT, V269, P1788; CHANGEUX JP, 1970, CR ACAD SCI D NAT, V270, P2864; CHANGEUX JP, 1970, P NATL ACAD SCI USA, V67, P1241, DOI 10.1073/pnas.67.3.1241; CHANGEUX JP, 1967, P NATL ACAD SCI USA, V58, P2063, DOI 10.1073/pnas.58.5.2063; CLAUDIO T, 1983, P NATL ACAD SCI-BIOL, V80, P1111, DOI 10.1073/pnas.80.4.1111; COHEN GN, 1957, BACTERIOL REV, V21, P169, DOI 10.1128/MMBR.21.3.169-194.1957; COHEN JB, 1972, FEBS LETT, V26, P43, DOI 10.1016/0014-5793(72)80538-6; COHEN JB, 1973, BIOCHEMISTRY-US, V12, P4855, DOI 10.1021/bi00748a008; COHEN JB, 1974, MOL PHARMACOL, V10, P904; COLQUHOUN D, 1976, MOL PHARMACOL, V12, P519; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; DENNIS M, 1988, BIOCHEMISTRY-US, V27, P2346, DOI 10.1021/bi00407a016; DENNIS M, 1986, FEBS LETT, V207, P243, DOI 10.1016/0014-5793(86)81497-1; DEVILLERSTHIERY A, 1979, FEBS LETT, V104, P99, DOI 10.1016/0014-5793(79)81092-3; DEVILLERSTHIERY A, 1983, P NATL ACAD SCI-BIOL, V80, P2067, DOI 10.1073/pnas.80.7.2067; DUPONT Y, 1974, FEBS LETT, V40, P130, DOI 10.1016/0014-5793(74)80910-5; Duret G, 2011, P NATL ACAD SCI USA, V108, P12143, DOI 10.1073/pnas.1104494108; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; EPSTEIN M, 1978, J BIOL CHEM, V253, P6660; FENTON JW, 1965, BIOCHEM BIOPH RES CO, V20, P315, DOI 10.1016/0006-291X(65)90366-9; GALZI JL, 1990, J BIOL CHEM, V265, P10430; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; Gill JK, 2012, MOL PHARMACOL, V81, P710, DOI 10.1124/mol.111.076026; GIRAUDAT J, 1986, P NATL ACAD SCI USA, V83, P2719, DOI 10.1073/pnas.83.8.2719; GIRAUDAT J, 1987, BIOCHEMISTRY-US, V26, P2410, DOI 10.1021/bi00383a003; GIRAUDAT J, 1982, EMBO J, V1, P713, DOI 10.1002/j.1460-2075.1982.tb01235.x; GRUNHAGEN HH, 1976, J MOL BIOL, V106, P497, DOI 10.1016/0022-2836(76)90249-7; GRUNHAGEN HH, 1977, EUR J BIOCHEM, V80, P225, DOI 10.1111/j.1432-1033.1977.tb11875.x; GRUNHAGEN HH, 1976, J MOL BIOL, V106, P517, DOI 10.1016/0022-2836(76)90250-3; HAZELBAUER GL, 1974, P NATL ACAD SCI USA, V71, P1479, DOI 10.1073/pnas.71.4.1479; HEIDMANN T, 1983, BIOCHEMISTRY-US, V22, P5452, DOI 10.1021/bi00292a029; HEIDMANN T, 1986, BIOCHEMISTRY-US, V25, P6109, DOI 10.1021/bi00368a041; HEIDMANN T, 1979, EUR J BIOCHEM, V94, P281, DOI 10.1111/j.1432-1033.1979.tb12894.x; HEIDMANN T, 1984, P NATL ACAD SCI-BIOL, V81, P1897, DOI 10.1073/pnas.81.6.1897; HEIDMANN T, 1982, CR ACAD SCI III-VIE, V295, P345; HEIDMANN T, 1979, EUR J BIOCHEM, V94, P255, DOI 10.1111/j.1432-1033.1979.tb12893.x; HEIDMANN T, 1980, BIOCHEM BIOPH RES CO, V97, P889, DOI 10.1016/0006-291X(80)91460-6; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; HUCHO F, 1986, FEBS LETT, V205, P137, DOI 10.1016/0014-5793(86)80881-X; HUCHO F, 1973, FEBS LETT, V38, P11, DOI 10.1016/0014-5793(73)80500-9; HUNKAPILLER MW, 1979, BIOCHEM BIOPH RES CO, V91, P164, DOI 10.1016/0006-291X(79)90598-9; IMOTO K, 1986, NATURE, V324, P670, DOI 10.1038/324670a0; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; JACKSON MB, 1984, P NATL ACAD SCI-BIOL, V81, P3901, DOI 10.1073/pnas.81.12.3901; Kabbani N, 2007, P NATL ACAD SCI USA, V104, P20570, DOI 10.1073/pnas.0710314104; KAO PN, 1984, J BIOL CHEM, V259, P1662; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; KARLIN A, 1968, P NATL ACAD SCI USA, V60, P668, DOI 10.1073/pnas.60.2.668; KARLSSON E, 1972, FEBS LETT, V28, P107, DOI 10.1016/0014-5793(72)80688-4; KASAI M, 1970, CR ACAD SCI D NAT, V270, P1400; KASAI M, 1971, J MEMBRANE BIOL, V6, P1, DOI 10.1007/BF01874112; KLETT RP, 1973, J BIOL CHEM, V248, P6841; Krause RM, 1998, MOL PHARMACOL, V53, P283, DOI 10.1124/mol.53.2.283; Le Novere N, 2002, P NATL ACAD SCI USA, V99, P3210, DOI 10.1073/pnas.042699699; LEONARD RJ, 1988, SCIENCE, V242, P1578, DOI 10.1126/science.2462281; LINDSTROM J, 1979, BIOCHEMISTRY-US, V18, P4470, DOI 10.1021/bi00588a004; Lindstrom J., 1974, SYNAPTIC TRANSMISSIO, P191; MEUNIER JC, 1974, EUR J BIOCHEM, V45, P371, DOI 10.1111/j.1432-1033.1974.tb03563.x; MEUNIER JC, 1971, CR ACAD SCI D NAT, V272, P117; MILEDI R, 1971, NATURE, V229, P554, DOI 10.1038/229554a0; MISHINA M, 1984, NATURE, V307, P604, DOI 10.1038/307604a0; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MULLE C, 1992, NEURON, V8, P937, DOI 10.1016/0896-6273(92)90208-U; Nachmansohn D., 1959, CHEM MOL BASIS NERVE; NICKEL E, 1973, BRAIN RES, V57, P508, DOI 10.1016/0006-8993(73)90158-3; NODA M, 1982, NATURE, V299, P793, DOI 10.1038/299793a0; NODA M, 1983, NATURE, V302, P528, DOI 10.1038/302528a0; NODA M, 1983, NATURE, V301, P251, DOI 10.1038/301251a0; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Nury H, 2010, P NATL ACAD SCI USA, V107, P6275, DOI 10.1073/pnas.1001832107; OBERTHUR W, 1986, EMBO J, V5, P1815, DOI 10.1002/j.1460-2075.1986.tb04431.x; OLSEN RW, 1972, FEBS LETT, V28, P96, DOI 10.1016/0014-5793(72)80686-0; OSWALD R, 1981, P NATL ACAD SCI-BIOL, V78, P3925, DOI 10.1073/pnas.78.6.3925; OSWALD RE, 1982, FEBS LETT, V139, P225, DOI 10.1016/0014-5793(82)80857-0; Pan JJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1703; RAFTERY M A, 1974, Journal of Supramolecular Structure, V2, P582, DOI 10.1002/jss.400020506; RAFTERY MA, 1980, SCIENCE, V208, P1454, DOI 10.1126/science.7384786; SAITOH T, 1980, FEBS LETT, V116, P30, DOI 10.1016/0014-5793(80)80522-9; SCHMIDT J, 1972, BIOCHEM BIOPH RES CO, V49, P572, DOI 10.1016/0006-291X(72)90449-4; SOBEL A, 1977, EUR J BIOCHEM, V80, P215, DOI 10.1111/j.1432-1033.1977.tb11874.x; SUMIKAWA K, 1982, NUCLEIC ACIDS RES, V10, P5809, DOI 10.1093/nar/10.19.5809; Taly A, 2005, BIOPHYS J, V88, P3954, DOI 10.1529/biophysj.104.050229; Tasneem A, 2005, GENOME BIOL, V6; TEICHBERG VI, 1977, NATURE, V267, P540, DOI 10.1038/267540a0; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; VERNINO S, 1992, NEURON, V8, P127, DOI 10.1016/0896-6273(92)90114-S; VILLARROEL A, 1991, P ROY SOC B-BIOL SCI, V243, P69, DOI 10.1098/rspb.1991.0012; WEBER M, 1974, MOL PHARMACOL, V10, P35; WEBER M, 1975, P NATL ACAD SCI USA, V72, P3443, DOI 10.1073/pnas.72.9.3443; WEILAND G, 1977, J BIOL CHEM, V252, P7648; WEILL CL, 1974, BIOCHEM BIOPH RES CO, V61, P997, DOI 10.1016/0006-291X(74)90254-X; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101	109	149	154	2	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40207	40215		10.1074/jbc.R112.407668	http://dx.doi.org/10.1074/jbc.R112.407668			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23038257	hybrid, Green Published			2022-12-28	WOS:000311448800012
J	Kitazume, S; Yoshihisa, A; Yamaki, T; Oikawa, M; Tachida, Y; Ogawa, K; Imamaki, R; Hagiwara, Y; Kinoshita, N; Takeishi, Y; Furukawa, K; Tomita, N; Arai, H; Iwata, N; Saido, T; Yamamoto, N; Taniguchi, N				Kitazume, Shinobu; Yoshihisa, Akiomi; Yamaki, Takayoshi; Oikawa, Masayoshi; Tachida, Yuriko; Ogawa, Kazuko; Imamaki, Rie; Hagiwara, Yoshiaki; Kinoshita, Noriaki; Takeishi, Yasuchika; Furukawa, Katsutoshi; Tomita, Naoki; Arai, Hiroyuki; Iwata, Nobuhisa; Saido, Takaomi; Yamamoto, Naomasa; Taniguchi, Naoyuki			Soluble Amyloid Precursor Protein 770 Is Released from Inflamed Endothelial Cells and Activated Platelets A NOVEL BIOMARKER FOR ACUTE CORONARY SYNDROME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; CEREBRAL THROMBOSIS; BETA PRODUCTION; ANGIOPATHY; APP; PATHOGENESIS; PERSPECTIVE; INHIBITION; MECHANISMS	Most Alzheimer disease (AD) patients show deposition of amyloid beta (A beta) peptide in blood vessels as well as the brain parenchyma. We previously found that vascular endothelial cells express amyloid beta precursor protein (APP) 770, a different APP isoform from neuronal APP695, and produce A beta. Since the soluble APP cleavage product, sAPP, is considered to be a possible marker for AD diagnosis, sAPP has been widely measured as a mixture of these variants. We hypothesized that measurement of the endothelial APP770 cleavage product in patients separately from that of neuronal APP695 would enable discrimination between endothelial and neurological dysfunctions. Using our newly developed ELISA system for sAPP770, we observed that inflammatory cytokines significantly enhanced sAPP770 secretion by endothelial cells. Furthermore, we unexpectedly found that sAPP770 was rapidly released from activated platelets. We also found that cerebrospinal fluid mainly contained sAPP695, while serum mostly contained sAPP770. Finally, to test our hypothesis that sAPP770 could be an indicator for endothelial dysfunction, we applied our APP770 ELISA to patients with acute coronary syndrome (ACS), in which endothelial injury and platelet activation lead to fibrous plaque disruption and thrombus formation. Development of a biomarker is essential to facilitate ACS diagnosis in clinical practice. The results revealed that ACS patients had significantly higher plasma sAPP770 levels. Furthermore, in myocardial infarction model rats, an increase in plasma sAPP preceded the release of cardiac enzymes, currently used markers for acute myocardial infarction. These findings raise the possibility that sAPP770 can be a useful biomarker for ACS.	[Kitazume, Shinobu; Imamaki, Rie; Taniguchi, Naoyuki] RIKEN, Adv Sci Inst, Dis Glyc Team, Wako, Saitama 3510198, Japan; [Yoshihisa, Akiomi; Yamaki, Takayoshi; Oikawa, Masayoshi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Adv Cardiac Therapeut Cardiol & Hematol, Fukushima 9601295, Japan; [Hagiwara, Yoshiaki; Kinoshita, Noriaki] Immunobiol Labs Co Ltd, Dept Biol Sci, Fujioka, Gunma 3750005, Japan; [Furukawa, Katsutoshi; Tomita, Naoki; Arai, Hiroyuki] Tohoku Univ, Inst Dev Aging & Canc, Div Brain Sci, Dept Geriatr & Gerontol,Aoba Ku, Sendai, Miyagi 9808575, Japan; [Iwata, Nobuhisa; Saido, Takaomi] RIKEN, Lab Proteolyt Neurosci, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Yamamoto, Naomasa] Ohu Univ, Sch Pharmaceut Sci, Dept Biochem, Koriyama, Fukushima 9638611, Japan	RIKEN; Fukushima Medical University; Immuno-Biological Laboratories Co. Ltd.; Tohoku University; RIKEN	Kitazume, S (corresponding author), RIKEN, Adv Sci Inst, Dis Glyc Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	shinobuk@riken.jp	Sado, Takaomi/AAN-2759-2021; Saido, Takaomi C/N-5472-2015; Taniguchi, Naoyuki/I-4182-2014; Taniguchi, Naoyuki/A-7086-2016	Sado, Takaomi/0000-0003-1970-6903; Saido, Takaomi C/0000-0003-1970-6903; Taniguchi, Naoyuki/0000-0001-5889-5968; 	Systems Glycobiology Research Project; strategic programs for RD of RIKEN; Ministry of Education, Science, Sports and Culture of Japan; Takeda Science Foundation	Systems Glycobiology Research Project; strategic programs for RD of RIKEN; Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by grants from the Systems Glycobiology Research Project and from the strategic programs for R&D of RIKEN (to N. T.), a Grant-in Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan (to N. T. and S. K.), and a grant from the Takeda Science Foundation (to S. K.).	ADAMS JE, 1994, NEW ENGL J MED, V330, P670, DOI 10.1056/NEJM199403103301003; Breteler MMB, 2000, NEUROBIOL AGING, V21, P153, DOI 10.1016/S0197-4580(99)00110-4; BUSH AI, 1990, J BIOL CHEM, V265, P15977; BUXBAUM JD, 1992, P NATL ACAD SCI USA, V89, P10075, DOI 10.1073/pnas.89.21.10075; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Esiri MM, 1999, LANCET, V354, P919, DOI 10.1016/S0140-6736(99)02355-7; FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406; GLENNER GG, 1981, ANN PATHOL, V1, P120; Gnatenko DV, 2010, BLOOD, V115, P7, DOI 10.1182/blood-2009-05-224477; Han BH, 2008, J NEUROSCI, V28, P13542, DOI 10.1523/JNEUROSCI.4686-08.2008; Jagust WJ, 1998, NEUROLOGY, V51, P1009, DOI 10.1212/WNL.51.4.1009; Kim ML, 2008, J NEUROSCI, V28, P12052, DOI 10.1523/JNEUROSCI.2913-08.2008; Kitazume S, 2010, J BIOL CHEM, V285, P40097, DOI 10.1074/jbc.M110.144626; MANDYBUR TI, 1975, NEUROLOGY, V25, P120, DOI 10.1212/WNL.25.2.120; Maruyama M, 2004, ARCH NEUROL-CHICAGO, V61, P716, DOI 10.1001/archneur.61.5.716; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Olsson A, 2003, EXP NEUROL, V183, P74, DOI 10.1016/S0014-4886(03)00027-X; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; PROHOVNIK I, 1988, NEUROLOGY, V38, P931, DOI 10.1212/WNL.38.6.931; SCHMAIER AH, 1993, J CLIN INVEST, V92, P2540, DOI 10.1172/JCI116863; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Tachida Y, 2008, J NEUROCHEM, V104, P1387, DOI 10.1111/j.1471-4159.2007.05127.x; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; VANNOSTRAND WE, 1990, SCIENCE, V248, P745, DOI 10.1126/science.2110384; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; VINTERS HV, 1987, STROKE, V18, P311, DOI 10.1161/01.STR.18.2.311; WERTKIN AM, 1993, P NATL ACAD SCI USA, V90, P9513, DOI 10.1073/pnas.90.20.9513; Wu GX, 2011, J NEUROSCI RES, V89, P822, DOI 10.1002/jnr.22618; Xu F, 2005, P NATL ACAD SCI USA, V102, P18135, DOI 10.1073/pnas.0507798102; Xu F, 2009, J NEUROSCI, V29, P5666, DOI 10.1523/JNEUROSCI.0095-09.2009; Yaoita H, 2002, CIRCULATION, V105, P975, DOI 10.1161/hc0802.104503; Zetterberg H, 2008, ARCH NEUROL-CHICAGO, V65, P1102, DOI 10.1001/archneur.65.8.1102	36	39	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40817	40825		10.1074/jbc.M112.398578	http://dx.doi.org/10.1074/jbc.M112.398578			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23033480	hybrid, Green Published			2022-12-28	WOS:000311448800069
J	Schneider, EH; Weaver, JD; Gaur, SS; Tripathi, BK; Jesaitis, AJ; Zelenka, PS; Gao, JL; Murphy, PM				Schneider, Erich H.; Weaver, Joseph D.; Gaur, Sonia S.; Tripathi, Brajendra K.; Jesaitis, Algirdas J.; Zelenka, Peggy S.; Gao, Ji-Liang; Murphy, Philip M.			The Leukocyte Chemotactic Receptor FPR1 Is Functionally Expressed on Human Lens Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMYL PEPTIDE RECEPTOR; N-FORMYLPEPTIDE RECEPTOR; MESENCHYMAL STEM-CELLS; CHEMOATTRACTANT RECEPTORS; HUMAN NEUTROPHIL; G-PROTEIN; BINDING; LIGAND; ACTIVATION; FAMILY	Formyl peptide receptor 1 (FPR1) is a G protein-coupled chemoattractant receptor expressed mainly on leukocytes. Surprisingly, aging Fpr1(-/-) mice develop spontaneous lens degeneration without inflammation or infection (J.-L. Gao et al., manuscript in preparation). Therefore, we hypothesized that FPR1 is functionally expressed directly on lens epithelial cells, the only cell type in the lens. Consistent with this, the human fetal lens epithelial cell line FHL 124 expressed FPR1 FPR1 mRNA and was strongly FPR1 protein-positive by Western blot and FACS. Competition binding using FPR1 ligands N-formyl-Nle-Leu-Phe-Nle-Tyr-Lys (Nle = Norleucine), formylmethionylleucylphenylalanine, and peptide W revealed the same profile for FHL 124 cells, neutrophils, and FPR1-transfected HEK 293 cells. Saturation binding with fluorescein-labeled N-formyl-Nle-Leu-Phe-Nle-Tyr-Lys revealed similar to 2500 specific binding sites on FHL-124 cells (K-D similar to 0.5 nM) versus similar to 40,000 sites on neutrophils (K-D = 3.2 nM). Moreover, formylmethionylleucylphenylalanine induced pertussis toxin-sensitive Ca2+ flux in FHL 124 cells, consistent with classic G(i)-mediated FPR1 signaling. FHL 124 cell FPR1 was atypical in that it resisted agonist-induced internalization. Expression of FPR1 was additionally supported by detection of the intact full-length open reading frame in sequenced cDNA from FHL 124 cells. Thus, FHL-124 cells express functional FPR1, which is consistent with a direct functional role for FPR1 in the lens, as suggested by the phenotype of Fpr1 knock-out mice.	[Schneider, Erich H.; Weaver, Joseph D.; Gaur, Sonia S.; Gao, Ji-Liang; Murphy, Philip M.] NIAID, Mol Signaling Sect, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Tripathi, Brajendra K.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Jesaitis, Algirdas J.] Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA; [Zelenka, Peggy S.] NEI, Sect Cellular Differentiat, Lab Mol & Dev Biol, NIH, Rockville, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Montana State University System; Montana State University Bozeman; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Murphy, PM (corresponding author), NIAID, Mol Signaling Sect, Lab Mol Immunol, NIH, Bldg 10,Rm 11N113,10 Ctr Dr, Bethesda, MD 20892 USA.	pmm@nih.gov	Schneider, Erich H/B-9051-2016; Gao, Ji-Liang/Y-4397-2019	Schneider, Erich H/0000-0002-7905-4276; Gaur, Sonia/0000-0001-9497-5412; Jesaitis, Algirdas/0000-0001-9001-5617	Division of Intramural Research of the NIAID, National Institutes of Health; German Research Foundation Grant [SCHN 1192/1-1]; Public Health Service Grant [R01 AI22735]; Helmsley Senior Investigator Award from the Crohn and Colitis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022735, ZIAAI000615] Funding Source: NIH RePORTER	Division of Intramural Research of the NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); German Research Foundation Grant; Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); Helmsley Senior Investigator Award from the Crohn and Colitis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the Division of Intramural Research of the NIAID, National Institutes of Health. This work was also supported by German Research Foundation Grant SCHN 1192/1-1 (to E. H. S.).; Supported by Public Health Service Grant R01 AI22735 and a Helmsley Senior Investigator Award from the Crohn and Colitis Foundation.	Augusteyn RC, 2007, MOL VIS, V13, P252; Babbin BA, 2007, J IMMUNOL, V179, P8112, DOI 10.4049/jimmunol.179.12.8112; Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; Becker EL, 1998, CELL TISSUE RES, V292, P129, DOI 10.1007/s004410051042; CROWELL RE, 1989, AM J PHYSIOL, V257, pH107, DOI 10.1152/ajpheart.1989.257.1.H107; de Paulis A, 2009, J IMMUNOL, V183, P3761, DOI 10.4049/jimmunol.0900863; FAY SP, 1991, BIOCHEMISTRY-US, V30, P5066, DOI 10.1021/bi00234a033; Hartt JK, 1999, J EXP MED, V190, P741, DOI 10.1084/jem.190.5.741; Hartt JK, 2000, BIOCHEM BIOPH RES CO, V272, P699, DOI 10.1006/bbrc.2000.2846; Harvath L, 1999, Methods Mol Biol, V115, P299; Huang J, 2010, BRIT J CANCER, V102, P1052, DOI 10.1038/sj.bjc.6605591; Huang J, 2008, CANCER LETT, V267, P254, DOI 10.1016/j.canlet.2008.03.014; Ibaraki N, 1998, EXP EYE RES, V67, P577, DOI 10.1006/exer.1998.0551; JESAITIS AJ, 1993, J IMMUNOL, V151, P5653; Keitoku M, 1997, J MOL CELL CARDIOL, V29, P881, DOI 10.1006/jmcc.1996.0291; Kim MK, 2007, FEBS LETT, V581, P1917, DOI 10.1016/j.febslet.2007.03.078; Kim SD, 2009, J IMMUNOL, V183, P5511, DOI 10.4049/jimmunol.0802986; Liu XW, 2012, NAT IMMUNOL, V13, P457, DOI 10.1038/ni.2258; MALECH HL, 1985, J BIOL CHEM, V260, P2509; MCCOY R, 1995, J EXP MED, V182, P207, DOI 10.1084/jem.182.1.207; McDermott DH, 2010, BLOOD, V116, P2793, DOI 10.1182/blood-2010-01-265942; Miettinen HM, 1997, J IMMUNOL, V159, P4045; NEUBIG RR, 1979, P NATL ACAD SCI USA, V76, P690, DOI 10.1073/pnas.76.2.690; PEREZ HD, 1991, J CLIN INVEST, V87, P971, DOI 10.1172/JCI115105; Rabiet MJ, 2005, EUR J IMMUNOL, V35, P2486, DOI 10.1002/eji.200526338; Rane MJ, 1997, J IMMUNOL, V159, P5070; Reddan JR, 1999, INVEST OPHTH VIS SCI, V40, pS970; REMES JJ, 1991, BIOCHEM J, V277, P67, DOI 10.1042/bj2770067; Rescher U, 2002, J IMMUNOL, V169, P1500, DOI 10.4049/jimmunol.169.3.1500; Riesselman M, 2007, J IMMUNOL, V179, P2520, DOI 10.4049/jimmunol.179.4.2520; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Sahagun-Ruiz A, 2001, GENES IMMUN, V2, P335, DOI 10.1038/sj.gene.6363787; Shao GH, 2011, AM J RESP CELL MOL, V44, P264, DOI 10.1165/rcmb.2010-0246RC; Shin MK, 2011, J BIOL CHEM, V286, P17133, DOI 10.1074/jbc.M110.197772; SKLAR LA, 1984, J BIOL CHEM, V259, P5661; SKLAR LA, 1985, MOL PHARMACOL, V28, P323; VanCompernolle SE, 2003, J IMMUNOL, V171, P2050, DOI 10.4049/jimmunol.171.4.2050; Viswanathan A, 2007, STEM CELLS, V25, P1263, DOI 10.1634/stemcells.2006-0522; Wenzel-Seifert K, 2003, N-S ARCH PHARMACOL, V367, P509, DOI 10.1007/s00210-003-0714-7; Wenzel-Seifert K, 2003, BIOCHEM BIOPH RES CO, V301, P693, DOI 10.1016/S0006-291X(03)00023-8; Yang H, 2010, J GENET GENOMICS, V37, P771, DOI 10.1016/S1673-8527(09)60094-1; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Zhang XG, 2011, INVEST OPHTH VIS SCI, V52, P3160, DOI 10.1167/iovs.10-5156	44	11	13	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40779	40792		10.1074/jbc.M112.411181	http://dx.doi.org/10.1074/jbc.M112.411181			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23012360	hybrid, Green Published			2022-12-28	WOS:000311448800066
J	Maxwell, JT; Natesan, S; Mignery, GA				Maxwell, Joshua T.; Natesan, Sankar; Mignery, Gregory A.			Modulation of Inositol 1,4,5-Trisphosphate Receptor Type 2 Channel Activity by Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII)-mediated Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC MYOCYTES; HISTONE DEACETYLASE-4; ATRIAL MYOCYTES; INSP3 RECEPTOR; CA2+ RELEASE; CALCIUM; BINDING; SIGNALS; CAMKII; LIGAND	InsP(3)-mediated calcium release through the type 2 inositol 1,4,5-trisphosphate receptor (InsP(3)R2) in cardiac myocytes results in the activation of associated CaMKII, thus enabling the kinase to act on downstream targets, such as histone deacetylases 4 and 5 (HDAC4 and HDAC5). The CaMKII activity also feedback modulates InsP(3)R2 function by direct phosphorylation and results in a dramatic decrease in the receptor-channel open probability (P-0). We have identified S150 in the InsP(3)R2 core suppressor domain (amino acids 1-225) as the specific residue that is phosphorylated by CaMKII. Site-directed mutagenesis reveals that S150 is the CaMKII phosphorylation site responsible for modulation of channel activity. Nonphosphorylatable (S150A) and phosphomimetic (S150E) mutations were studied in planar lipid bilayers. The InsP(3)R2 S150A channel showed no decrease in activity when treated with CaMKII. Conversely, the phosphomimetic (S150E) channel displayed a very low P-0 under normal recording conditions in the absence of CaMKII (2 mu M InsP(3) and 250 nM [Ca2+](FREE)) and mimicked a WT channel that has been phosphorylated by CaMKII. Phopho-specific antibodies demonstrate that InsP(3)R2 Ser-150 is phosphorylated in vivo by CaMKII delta. The results of this study show that serine 150 of the InsP(3)R2 is phosphorylated by CaMKII and results in a decrease in the channel open probability.	[Maxwell, Joshua T.; Natesan, Sankar; Mignery, Gregory A.] Loyola Univ Chicago, Stritch Sch Med, Dept Cell & Mol Physiol, Maywood, IL 60153 USA	Loyola University Chicago	Mignery, GA (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Cell & Mol Physiol, 2160 S 1st Ave, Maywood, IL 60153 USA.	gmigner@lumc.edu	Natesan, Sankar/C-9866-2015		National Institutes of Health [P01HL080101]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work supported, in whole or in part, by National Institutes of Health Grant P01HL080101 (to G. A. M.).	Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Bare DJ, 2005, J BIOL CHEM, V280, P15912, DOI 10.1074/jbc.M414212200; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Domeier TL, 2008, AM J PHYSIOL-HEART C, V294, pH596, DOI 10.1152/ajpheart.01155.2007; GO LO, 1995, J CLIN INVEST, V95, P888, DOI 10.1172/JCI117739; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; Kaznacheyeva E, 1998, J GEN PHYSIOL, V111, P847, DOI 10.1085/jgp.111.6.847; Kockskamper J, 2008, J MOL CELL CARDIOL, V45, P128, DOI 10.1016/j.yjmcc.2008.05.014; Li XD, 2005, CIRC RES, V96, P1274, DOI 10.1161/01.RES.0000172556.05576.4c; Little GH, 2007, J BIOL CHEM, V282, P7219, DOI 10.1074/jbc.M604281200; Mackenzie L, 2002, J PHYSIOL-LONDON, V541, P395, DOI 10.1113/jphysiol.2001.013411; Maier LS, 2002, J MOL CELL CARDIOL, V34, P919, DOI 10.1006/jmcc.2002.2038; Matifat F, 2001, PFLUG ARCH EUR J PHY, V441, P796, DOI 10.1007/s004240000479; MIGNERY GA, 1992, J BIOL CHEM, V267, P7450; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; MOSCHELLA MC, 1993, J CELL BIOL, V120, P1137, DOI 10.1083/jcb.120.5.1137; Perez PJ, 1997, J BIOL CHEM, V272, P23961, DOI 10.1074/jbc.272.38.23961; Ramos-Franco J, 2000, BIOPHYS J, V79, P1388, DOI 10.1016/S0006-3495(00)76391-0; Ramos-Franco J, 1998, BIOPHYS J, V75, P2783, DOI 10.1016/S0006-3495(98)77721-5; Seo MD, 2012, NATURE, V483, P108, DOI 10.1038/nature10751; SUDHOF TC, 1991, EMBO J, V10, P3199, DOI 10.1002/j.1460-2075.1991.tb04882.x; Tu HP, 2005, BIOPHYS J, V88, P1046, DOI 10.1529/biophysj.104.049593; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200; Zhu DM, 1996, BIOCHEMISTRY-US, V35, P7214, DOI 10.1021/bi952471h; Zima AV, 2007, J PHYSIOL-LONDON, V584, P601, DOI 10.1113/jphysiol.2007.140731; Zima AV, 2004, J PHYSIOL-LONDON, V555, P607, DOI 10.1113/jphysiol.2003.058529	31	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.374058	http://dx.doi.org/10.1074/jbc.M112.374058			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23019322	Green Published, hybrid			2022-12-28	WOS:000311233800014
J	Grispo, MT; Natarajan, C; Projecto-Garcia, J; Moriyama, H; Weber, RE; Storz, JF				Grispo, Michael T.; Natarajan, Chandrasekhar; Projecto-Garcia, Joana; Moriyama, Hideaki; Weber, Roy E.; Storz, Jay F.			Gene Duplication and the Evolution of Hemoglobin Isoform Differentiation in Birds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-ALTITUDE RESPIRATION; DUCK AYTHYA-FULIGULA; ALPHA-A-CHAINS; GLOBIN GENE; OXYGEN-BINDING; FUNCTIONAL DIVERSIFICATION; VERTEBRATE HEMOGLOBINS; ORGANIC-PHOSPHATES; CHICKEN HEMOGLOBIN; GYPS-RUEPPELLII	The majority of bird species co-express two functionally distinct hemoglobin (Hb) isoforms in definitive erythrocytes as follows: HbA (the major adult Hb isoform, with alpha-chain subunits encoded by the alpha(A)-globin gene) and HbD (the minor adult Hb isoform, with alpha-chain subunits encoded by the alpha(D)-globin gene). The alpha(D)-globin gene originated via tandem duplication of an embryonic alpha-like globin gene in the stem lineage of tetrapod vertebrates, which suggests the possibility that functional differentiation between the HbA and HbD isoforms may be attributable to a retained ancestral character state in HbD that harkens back to a primordial, embryonic function. To investigate this possibility, we conducted a combined analysis of protein biochemistry and sequence evolution to characterize the structural and functional basis of Hb isoform differentiation in birds. Functional experiments involving purified HbA and HbD isoforms from 11 different bird species revealed that HbD is characterized by a consistently higher O-2 affinity in the presence of allosteric effectors such as organic phosphates and Cl- ions. In the case of both HbA and HbD, analyses of oxygenation properties under the two-state Monod-Wyman-Changeux allosteric model revealed that the pH dependence of Hb-O-2 affinity stems primarily from changes in the O-2 association constant of deoxy (T-state)-Hb. Ancestral sequence reconstructions revealed that the amino acid substitutions that distinguish the adult-expressed Hb isoforms are not attributable to the retention of an ancestral (pre-duplication) character state in the alpha(D)-globin gene that is shared with the embryonic alpha-like globin gene.	[Grispo, Michael T.; Natarajan, Chandrasekhar; Projecto-Garcia, Joana; Moriyama, Hideaki; Storz, Jay F.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Weber, Roy E.] Aarhus Univ, Inst Biosci, DK-8000 Aarhus C, Denmark	University of Nebraska System; University of Nebraska Lincoln; Aarhus University	Storz, JF (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.	jstorz2@unl.edu	Natarajan, Chandrasekar/ABG-5195-2020; Natarajan, Chandrasekhar/D-3144-2012	Natarajan, Chandrasekhar/0000-0002-4841-0426	National Institutes of Health from NHLBI [R01 HL087216, HL087216-S1]; National Science Foundation [IOS-0949931]; Science Faculty, Aarhus University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087216] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation(National Science Foundation (NSF)); Science Faculty, Aarhus University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL087216 and HL087216-S1 from NHLBI. This work was also supported by National Science Foundation Grant IOS-0949931 and the Science Faculty, Aarhus University.	Abbasi A, 2002, BIOCHEM BIOPH RES CO, V291, P176, DOI 10.1006/bbrc.2002.6399; Adair GS, 1925, J BIOL CHEM, V63, P529; Alev C, 2009, DEV GENES EVOL, V219, P353, DOI 10.1007/s00427-009-0294-8; AMICONI G, 1985, EUR J BIOCHEM, V150, P387, DOI 10.1111/j.1432-1033.1985.tb09032.x; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; ARNONE A, 1974, NATURE, V249, P34, DOI 10.1038/249034a0; BAUMANN R, 1987, J EXP ZOOL, P227; BINOTTI I, 1971, ARCH BIOCHEM BIOPHYS, V142, P274, DOI 10.1016/0003-9861(71)90284-0; Brittain T, 2002, MOL ASPECTS MED, V23, P293, DOI 10.1016/S0098-2997(02)00004-3; BRYGIER J, 1976, BIOCHIMIE, V58, P755, DOI 10.1016/S0300-9084(76)80403-8; Bunn HF, 1986, HEMOGLOBIN MOL GENET; CAO Y, 1994, J MOL EVOL, V39, P519; CIROTTO C, 1987, DEVELOPMENT, V101, P805; COBB JA, 1992, J BIOL CHEM, V267, P1183; Dickerson R.E., 1983, HEMOGLOBIN STRUCTURE; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferry RM, 1929, J BIOL CHEM, V81, P175; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GILL SJ, 1980, J BIOL CHEM, V255, P7855; GODOVAC-ZIMMERMANN J, 1985, BIOL CHEM H-S, V366, P503, DOI 10.1515/bchm3.1985.366.1.503; GODOVAC-ZIMMERMANN J, 1984, H-S Z PHYSIOL CHEM, V365, P1107, DOI 10.1515/bchm2.1984.365.2.1107; Gribaldo S, 2003, MOL BIOL EVOL, V20, P1754, DOI 10.1093/molbev/msg171; GRIGG GC, 1993, J EXP BIOL, V175, P15; Gu X, 2001, MOL BIOL EVOL, V18, P453, DOI 10.1093/oxfordjournals.molbev.a003824; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; HIEBL I, 1987, BIOL CHEM H-S, V368, P333, DOI 10.1515/bchm3.1987.368.1.333; HIEBL I, 1988, BIOL CHEM H-S, V369, P217, DOI 10.1515/bchm3.1988.369.1.217; HIEBL I, 1989, BIOL CHEM H-S, V370, P699, DOI 10.1515/bchm3.1989.370.2.699; Hoffmann FG, 2008, MOL BIOL EVOL, V25, P591, DOI 10.1093/molbev/msn004; Hoffmann FG, 2007, MOL BIOL EVOL, V24, P1982, DOI 10.1093/molbev/msm127; Hoffmann FG, 2012, MOL BIOL EVOL, V29, P303, DOI 10.1093/molbev/msr207; Hoffmann FG, 2011, GENOME BIOL EVOL, V3, P588, DOI 10.1093/gbe/evr055; Hoffmann FG, 2010, MOL BIOL EVOL, V27, P1126, DOI 10.1093/molbev/msp325; Imai K., 1982, ALLOSTERIC EFFECTS H; Ingermann RL, 1997, HDB PHYSL, VI, P357; ISAACKS RE, 1976, ARCH BIOCHEM BIOPHYS, V173, P114, DOI 10.1016/0003-9861(76)90240-X; Jensen FB, 2004, ACTA PHYSIOL SCAND, V182, P215, DOI 10.1111/j.1365-201X.2004.01361.x; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Knapp JE, 1999, J BIOL CHEM, V274, P6411, DOI 10.1074/jbc.274.10.6411; LEE KS, 1976, BIOCHIM BIOPHYS ACTA, V427, P178, DOI 10.1016/0005-2795(76)90295-6; Lutfullah G, 2005, BIOCHEM BIOPH RES CO, V326, P123, DOI 10.1016/j.bbrc.2004.10.209; LUTZ PL, 1980, AM ZOOL, V20, P187; MILLS FC, 1976, BIOCHEMISTRY-US, V15, P5350, DOI 10.1021/bi00669a023; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nikinmaa M, 2001, RESP PHYSIOL, V128, P317, DOI 10.1016/S0034-5687(01)00309-7; NOTHUM R, 1989, BIOL CHEM H-S, V370, P1197, DOI 10.1515/bchm3.1989.370.2.1197; OBERTHUR W, 1986, BIOL CHEM H-S, V367, P507, DOI 10.1515/bchm3.1986.367.1.507; OBERTHUR W, 1983, H-S Z PHYSIOL CHEM, V364, P119, DOI 10.1515/bchm2.1983.364.1.119; PERUTZ MF, 1983, MOL BIOL EVOL, V1, P1; PERUTZ MF, 1959, J MOL BIOL, V1, P402, DOI 10.1016/S0022-2836(59)80024-3; Rana MS, 2008, PROTEINS, V70, P553, DOI 10.1002/prot.21793; Rana MS, 2011, PROTEINS, V79, P1499, DOI 10.1002/prot.22978; Riccio A, 2001, BIOPHYS J, V81, P1938, DOI 10.1016/S0006-3495(01)75845-6; RIGGS A, 1976, FED PROC, V35, P2115; Riggs A., 1979, COMP BIOCH PHYSL, V62, P257; Riggs AF, 1998, J EXP BIOL, V201, P1073; SAHA A, 1965, COMP BIOCHEM PHYSIOL, V15, P217, DOI 10.1016/0010-406X(65)90348-8; Sanna MT, 2007, BIOL CHEM, V388, P787, DOI 10.1515/BC.2007.102; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Storz JF, 2011, IUBMB LIFE, V63, P313, DOI 10.1002/iub.482; Storz JF, 2011, J EXP BIOL, V214, P575, DOI 10.1242/jeb.050443; SULTANA C, 1989, J PROTEIN CHEM, V8, P629, DOI 10.1007/BF01025603; Tamburrini M, 2000, EUR J BIOCHEM, V267, P6089, DOI 10.1046/j.1432-1327.2000.01699.x; TAMBURRINI M, 1994, J MOL BIOL, V237, P615, DOI 10.1006/jmbi.1994.1259; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; TYUMA I, 1973, BIOCHEMISTRY-US, V12, P1491, DOI 10.1021/bi00732a004; VANDECASSERIE C, 1973, COMP BIOCHEM PHYSIOL, V44, P711, DOI 10.1016/0300-9629(73)90136-9; Weber R. E, 1995, HYPOXIA BRAIN, P31; WEBER RE, 1994, J EXP BIOL, V192, P1; WEBER RE, 1987, J COMP PHYSIOL B, V157, P145, DOI 10.1007/BF00692358; WEBER RE, 1995, J MOL BIOL, V251, P703, DOI 10.1006/jmbi.1995.0466; WEBER RE, 1990, COMP PHYSIOL, V6, P58; WEBER RE, 1988, ANNU REV PHYSIOL, V50, P161, DOI 10.1146/annurev.ph.50.030188.001113; Weber RE, 2000, J BIOL CHEM, V275, P17297, DOI 10.1074/jbc.M001209200; WEBER RE, 1992, J APPL PHYSIOL, V72, P1611, DOI 10.1152/jappl.1992.72.4.1611; Weber RE, 2004, AM J PHYSIOL-REG I, V287, pR454, DOI 10.1152/ajpregu.00060.2004; WEBER RE, 1988, BIOL CHEM H-S, V369, P233, DOI 10.1515/bchm3.1988.369.1.233; Weber RE, 2004, RESP PHYSIOL NEUROBI, V144, P141, DOI 10.1016/j.resp.2004.04.018; Weber RE, 2002, AM J PHYSIOL-REG I, V283, pR1052, DOI 10.1152/ajpregu.00292.2002; Weber RE, 2000, HEMOGLOBIN FUNCTION IN VERTEBRATES, P23; WEBER RE, 1986, AM J PHYSIOL, V251, pR901, DOI 10.1152/ajpregu.1986.251.5.R901; Weber Roy E., 1996, P75; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; WYMAN J, 1964, ADV PROTEIN CHEM, V19, P223, DOI 10.1016/S0065-3233(08)60190-4; YANG ZH, 1995, GENETICS, V141, P1641; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; ZUIDERWEG ERP, 1981, EUR J BIOCHEM, V118, P95, DOI 10.1111/j.1432-1033.1981.tb05490.x	87	49	52	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.375600	http://dx.doi.org/10.1074/jbc.M112.375600			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22962007	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000310642200006
J	Yates, LA; Fuzery, AK; Bonet, R; Campbell, ID; Gilbert, RJC				Yates, Luke A.; Fuezery, Anna K.; Bonet, Roman; Campbell, Iain D.; Gilbert, Robert J. C.			Biophysical Analysis of Kindlin-3 Reveals an Elongated Conformation and Maps Integrin Binding to the Membrane-distal beta-Subunit NPXY Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; TALIN HEAD; CYTOPLASMIC TAILS; KINDLER-SYNDROME; STRUCTURAL BASIS; DISTINCT ROLES; ACTIVATION; DOMAIN; PROTEINS; ADHESION	Kindlin-3, a 75-kDa protein, has been shown to be critical for hemostasis, immunity, and bone metabolism via its role in integrin activation. The Kindlin family is hallmarked by a FERM domain comprised of F1, F2, and F3 subdomains together with an N-terminal F0 domain and a pleckstrin homology domain inserted in the F2 domain. Recombinant Kindlin-3 was cloned, expressed, and purified, and its domain organization was studied by x-ray scattering and other techniques to reveal an extended conformation. This unusual elongated structure is similar to that found in the paralogue Talin head domain. Analytical ultracentrifugation experiments indicated that Kindlin-3 forms a ternary complex with the Talin and beta-integrin cytoplasmic tails. NMR showed that Kindlin-3 specifically recognizes the membrane-distal tail NPXY motif in both the beta(1A) and beta(1D) isoforms, although the interaction is stronger with beta(1A). An upstream Ser/Thr cluster in the tails also plays a critical role. Overall these data support current biological, clinical, and mutational data on Kindlin-3/beta-tail binding and provide novel insights into the overall conformation and interactions of Kindlin-3.	[Yates, Luke A.; Gilbert, Robert J. C.] Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Fuezery, Anna K.; Bonet, Roman; Campbell, Iain D.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Gilbert, RJC (corresponding author), Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	gilbert@strubi.ox.ac.uk		Gilbert, Robert/0000-0001-9336-5604; Yates, Luke/0000-0002-5023-0803	Medical Research Council (MRC); National Institutes of Health [U54 GM06434]; MRC [G0900052 1/1]; Oxford Division of Structural Biology is part of the Wellcome Trust Centre for Human Genetics [090532/Z/09/Z]; MRC [G0900052] Funding Source: UKRI; Medical Research Council [G0900052] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oxford Division of Structural Biology is part of the Wellcome Trust Centre for Human Genetics; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by a Medical Research Council (MRC) graduate studentship.; Supported by Grant U54 GM06434 from the National Institutes of Health-funded Cell Migration Consortium. Present address: Dept. of Pathology, Johns Hopkins University, Baltimore, MD 21287.; Supported by MRC Grant G0900052 1/1.; We thank Dr. Michele Erat for assistance with the SAXS data collection. The Oxford Division of Structural Biology is part of the Wellcome Trust Centre for Human Genetics (Wellcome Trust Core Award Grant 090532/Z/09/Z).	Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Anthis NJ, 2010, STRUCTURE, V18, P1654, DOI 10.1016/j.str.2010.09.018; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bialkowska K, 2010, J BIOL CHEM, V285, P18640, DOI 10.1074/jbc.M109.085746; Bledzka K, 2012, J BIOL CHEM, V287, P24585, DOI 10.1074/jbc.M111.336743; Bledzka K, 2010, J BIOL CHEM, V285, P30370, DOI 10.1074/jbc.C110.134247; Bottcher RT, 2012, NAT CELL BIOL, V14, P584, DOI 10.1038/ncb2501; Boyd RS, 2003, LEUKEMIA, V17, P1605, DOI 10.1038/sj.leu.2402993; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Czuchra A, 2006, J CELL BIOL, V174, P889, DOI 10.1083/jcb.200604060; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Elliott PR, 2010, STRUCTURE, V18, P1289, DOI 10.1016/j.str.2010.07.011; Feng C, 2012, J BIOL CHEM, V287, P10714, DOI 10.1074/jbc.M111.299594; de la Torre JG, 2007, J PHYS CHEM B, V111, P955, DOI 10.1021/jp0647941; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Goddard T.D., 2000, SPARKY; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; Goult BT, 2009, J MOL BIOL, V394, P944, DOI 10.1016/j.jmb.2009.09.061; Grigorieff N, 2000, ACTA CRYSTALLOGR D, V56, P1270, DOI 10.1107/S0907444900009549; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Has C, 2009, AM J PATHOL, V175, P1442, DOI 10.2353/ajpath.2009.090203; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kahner BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034056; Kelley LA, 1997, PROTEIN SCI, V6, P2628; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; KRATKY O, 1951, Z ELEKTROCHEM, V55, P53; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Law DA, 1999, NATURE, V401, P808, DOI 10.1038/44599; Lefort CT, 2012, BLOOD, V119, P4275, DOI 10.1182/blood-2011-08-373118; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Margadant C, 2012, CURR BIOL, V22, P1554, DOI 10.1016/j.cub.2012.06.060; Merrington CL, 1997, MOL BIOTECHNOL, V8, P283, DOI 10.1007/BF02760782; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Mori T, 2008, J BIOL CHEM, V283, P29602, DOI 10.1074/jbc.M803606200; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Oxley CL, 2008, J BIOL CHEM, V283, P5420, DOI 10.1074/jbc.M709435200; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qadota H, 2012, J BIOL CHEM, V287, P28537, DOI 10.1074/jbc.M112.354852; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Schmidt S, 2011, J CELL BIOL, V192, P883, DOI 10.1083/jcb.201007141; Siegel DH, 2003, AM J HUM GENET, V73, P174, DOI 10.1086/376609; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048	58	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.415208	http://dx.doi.org/10.1074/jbc.M112.415208			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22989875	hybrid, Green Published			2022-12-28	WOS:000310642200012
J	Kocieda, VP; Adhikary, S; Emig, F; Yen, JH; Toscano, MG; Ganea, D				Kocieda, Virginia P.; Adhikary, Sabina; Emig, Frances; Yen, Jui-Hung; Toscano, Miguel G.; Ganea, Doina			Prostaglandin E2-induced IL-23p19 Subunit Is Regulated by cAMP-responsive Element-binding Protein and C/AATT Enhancer-binding Protein beta in Bone Marrow-derived Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; T-CELLS; EP4 RECEPTOR; C-REL; INFLAMMATORY DISEASES; TH17 EXPANSION; E-2; P19; EXPRESSION; INTERLEUKIN-23	We reported previously that prostaglandin E2 (PGE2)up-regulates IL- 23 in vitro in bone marrow-derived dendritic cells and in vivo in models of collagen-induced arthritis and inflammatory bowel disease, leading to preferential Th17 development and activity. There is very little information on the molecular mechanisms involved in the PGE2-induced up-regulation of Il23a gene expression. In this study we investigated the signaling pathways and transcription factors involved in the stimulatory effect of PGE2. Although PGE2 does not induce IL-23p19 expression by itself, it synergizes with both extra- and intracellular Toll-like receptor ligands and with inflammatory cytokines such as TNF alpha. We established that the effect of PGE2 in conjunction with either LPS or TNF alpha is mediated through the EP4 receptor and the cAMP-dependent activation of both protein kinase A (PKA) and exchange protein activated by cAMP (EPAC). Using the EP4 agonist PGE(1)OH in conjunction with TNF alpha, we found that PKA-induced phosphorylation of cAMP-response element-binding protein ((CREB)-C-P) and EPAC-induced phosphorylation of C/AATT enhancer-binding protein beta (C-P/EBP beta) mediate the stimulatory effect of PGE2 on IL-23p19 expression. This is the first report of CREB and C/EBP beta involvement in Il23a promoter activation. Mutation within the putative CREB and C/EBP sites combined with in vivo DNA binding (ChIP) assays identified the distal CREB site (-1125) and the two proximal C/EBP sites (-274 and -232) as essential for PKA-activated CREB and EPAC-activated C/EBP beta-induced IL-23p19 expression.	[Kocieda, Virginia P.; Emig, Frances; Yen, Jui-Hung; Toscano, Miguel G.; Ganea, Doina] Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA; [Adhikary, Sabina] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19140 USA; [Toscano, Miguel G.] Univ Granada, Pfizer, Human DNA Variabil Dept, Junta de Andalucia Ctr Genom & Oncol Res GENYO, Granada 18018, Spain	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pfizer; University of Granada	Ganea, D (corresponding author), Temple Univ, Sch Med, Dept Microbiol & Immunol, 3500 N Broad St, Philadelphia, PA 19140 USA.	dganea@temple.edu	Yen, Jui-Hung/AAV-3455-2020; Toscano, Miguel G./I-1053-2015	Toscano, Miguel G./0000-0002-6384-3123; Yen, Jui-Hung Jimmy/0000-0002-7325-9756	National Institutes of Health [2RO1AI052306, 2T32AI007101-30, 3RO1AI084065-03S1]; National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007101, R01AI084065, R01AI052306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants 2RO1AI052306, 2T32AI007101-30, and 3RO1AI084065-03S1 (to D. G.) and by Bridge To Doctorate funding (National Science Foundation; to V. P. K.).	Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Al-Salleeh F, 2008, J IMMUNOL, V181, P4523, DOI 10.4049/jimmunol.181.7.4523; Becher B, 2011, CURR OPIN IMMUNOL, V23, P707, DOI 10.1016/j.coi.2011.08.005; Billington CK, 2012, BRIT J PHARMACOL, V166, P401, DOI 10.1111/j.1476-5381.2011.01719.x; Breckler M, 2011, CELL SIGNAL, V23, P1257, DOI 10.1016/j.cellsig.2011.03.007; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; Chen Q, 2010, BRIT J PHARMACOL, V160, P292, DOI 10.1111/j.1476-5381.2010.00647.x; Chizzolini C, 2008, BLOOD, V112, P3696, DOI 10.1182/blood-2008-05-155408; Duvallet E, 2011, ANN MED, V43, P503, DOI 10.3109/07853890.2011.577093; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Hara S, 2010, BIOCHIMIE, V92, P651, DOI 10.1016/j.biochi.2010.02.007; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Jing H, 2003, J LEUKOCYTE BIOL, V74, P868, DOI 10.1189/jlb.0303116; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Khayrullina T, 2008, J IMMUNOL, V181, P721, DOI 10.4049/jimmunol.181.1.721; Kim HR, 2007, RHEUMATOLOGY, V46, P57, DOI 10.1093/rheumatology/kel159; Li YH, 2008, EXP MOL PATHOL, V84, P1, DOI 10.1016/j.yexmp.2007.09.004; Liang XB, 2011, J CLIN INVEST, V121, P4362, DOI 10.1172/JCI46279; Liu WC, 2009, J BIOL CHEM, V284, P24006, DOI 10.1074/jbc.M109.025528; Matsuoka T, 2007, THESCIENTIFICWORLDJO, V7, P1329, DOI 10.1100/tsw.2007.182; McCoy JM, 2002, J CLIN INVEST, V110, P651, DOI 10.1172/JCI200215528; Migita K, 2010, CLIN EXP IMMUNOL, V162, P244, DOI 10.1111/j.1365-2249.2010.04242.x; Minami M, 2008, J BIOL CHEM, V283, P9692, DOI 10.1074/jbc.M709663200; Mise-Omata S, 2007, J IMMUNOL, V179, P6596, DOI 10.4049/jimmunol.179.10.6596; Myer RG, 2010, EXP GERONTOL, V45, P834, DOI 10.1016/j.exger.2010.06.007; Narumiya S, 2009, J MOL MED, V87, P1015, DOI 10.1007/s00109-009-0500-1; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Roos AB, 2012, J ENDOCRINOL, V212, P291, DOI 10.1530/JOE-11-0369; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Sakata D, 2010, IUBMB LIFE, V62, P591, DOI 10.1002/iub.356; Sands WA, 2012, METHODS MOL BIOL, V809, P201, DOI 10.1007/978-1-61779-376-9_14; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Sheibanie AF, 2004, FASEB J, V18, P1318, DOI 10.1096/fj.03-1367fje; Sheibanie AF, 2007, ARTHRITIS RHEUM-US, V56, P2608, DOI 10.1002/art.22794; Sheibanie AF, 2007, J IMMUNOL, V178, P8138, DOI 10.4049/jimmunol.178.12.8138; Sheikh SZ, 2011, J BIOL CHEM, V286, P1174, DOI 10.1074/jbc.M110.147884; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Stefanelli P, 2012, PROSTAG OTH LIPID M, V99, P24, DOI 10.1016/j.prostaglandins.2012.04.002; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Takayama K, 2002, J BIOL CHEM, V277, P44147, DOI 10.1074/jbc.M204810200; Tang CL, 2012, IMMUNOLOGY, V135, P112, DOI 10.1111/j.1365-2567.2011.03522.x; Tang EHC, 2012, J CARDIOVASC PHARM, V59, P116, DOI 10.1097/FJC.0b013e3182244a12; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Yang L, 2012, MOL IMMUNOL, V51, P51, DOI 10.1016/j.molimm.2012.02.004; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Yarwood SJ, 2008, J BIOL CHEM, V283, P6843, DOI 10.1074/jbc.M710342200; Yen JH, 2008, BLOOD, V111, P260, DOI 10.1182/blood-2007-05-090613; Yen JH, 2011, J BIOL CHEM, V286, P38913, DOI 10.1074/jbc.M111.252932; Zhu LX, 2011, MOL IMMUNOL, V48, P647, DOI 10.1016/j.molimm.2010.11.008; Zhu S, 2012, CLIN SCI, V122, P487, DOI 10.1042/CS20110496	53	35	35	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36922	36935		10.1074/jbc.M112.402958	http://dx.doi.org/10.1074/jbc.M112.402958			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22977257	Green Published, hybrid			2022-12-28	WOS:000310588500029
J	Liu, SP; Mistry, A; Reynolds, JM; Lloyd, DB; Griffor, MC; Perry, DA; Ruggeri, RB; Clark, RW; Qiu, XY				Liu, Shenping; Mistry, Anil; Reynolds, Jennifer M.; Lloyd, David B.; Griffor, Matthew C.; Perry, David A.; Ruggeri, Roger B.; Clark, Ronald W.; Qiu, Xiayang			Crystal Structures of Cholesteryl Ester Transfer Protein in Complex with Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; RAISING HDL; ANTIINFLAMMATORY PROPERTIES; CETP INHIBITORS; BLOOD-PRESSURE; DOUBLE-BLIND; TORCETRAPIB; ATHEROSCLEROSIS; TARGET; RISK	Human plasma cholesteryl ester transfer protein (CETP) transports cholesteryl ester from the antiatherogenic high-density lipoproteins (HDL) to the proatherogenic low-density and very low-density lipoproteins (LDL and VLDL). Inhibition of CETP has been shown to raise human plasma HDL cholesterol (HDL-C) levels and is potentially a novel approach for the prevention of cardiovascular diseases. Here, we report the crystal structures of CETP in complex with torcetrapib, a CETP inhibitor that has been tested in phase 3 clinical trials, and compound 2, an analog from a structurally distinct inhibitor series. In both crystal structures, the inhibitors are buried deeply within the protein, shifting the bound cholesteryl ester in the N-terminal pocket of the long hydrophobic tunnel and displacing the phospholipid from that pocket. The lipids in the C-terminal pocket of the hydrophobic tunnel remain unchanged. The inhibitors are positioned near the narrowing neck of the hydrophobic tunnel of CETP and thus block the connection between the N- and C-terminal pockets. These structures illuminate the unusual inhibition mechanism of these compounds and support the tunnel mechanism for neutral lipid transfer by CETP. These highly lipophilic inhibitors bind mainly through extensive hydrophobic interactions with the protein and the shifted cholesteryl ester molecule. However, polar residues, such as Ser-230 and His-232, are also found in the inhibitor binding site. An enhanced understanding of the inhibitor binding site may provide opportunities to design novel CETP inhibitors possessing more drug-like physical properties, distinct modes of action, or alternative pharmacological profiles.	[Liu, Shenping; Mistry, Anil; Griffor, Matthew C.; Qiu, Xiayang] Pfizer Groton Labs, Dept Struct Biol & Biophys, Groton, CT 06340 USA; [Reynolds, Jennifer M.; Lloyd, David B.] Pfizer Groton Labs, Dept Pharmacokinet Dynam & Metab, Groton, CT 06340 USA; [Perry, David A.; Ruggeri, Roger B.; Clark, Ronald W.] Pfizer Groton Labs, Dept Cardiovasc Metab & Endocrine Dis Med Chem, Groton, CT 06340 USA	Pfizer; Pfizer; Pfizer	Liu, SP (corresponding author), Pfizer Groton Labs, Dept Struct Biol & Biophys, Eastern Point Rd, Groton, CT 06340 USA.	shenping.liu@pfizer.com; xiayang.qiu@pfizer.com						AGELLON LB, 1991, J BIOL CHEM, V266, P10796; Ali A., 2005, U.S. Patent, Patent No. [2006/0040999 A1, 20060040999]; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Barter PJ, 2003, ARTERIOSCL THROM VAS, V23, P160, DOI 10.1161/01.ATV.0000054658.91146.64; Bots ML, 2007, LANCET, V370, P153, DOI 10.1016/S0140-6736(07)61088-5; BROWN ML, 1989, NATURE, V342, P448, DOI 10.1038/342448a0; Bruckert E, 2007, INT J CLIN PRACT, V61, P1905, DOI 10.1111/j.1742-1241.2007.01509.x; Cannon CP, 2011, JAMA-J AM MED ASSOC, V306, P2153, DOI 10.1001/jama.2011.1687; Cao GQ, 2011, J LIPID RES, V52, P2169, DOI 10.1194/jlr.M018069; Chang G., 2007, U.S. Patent, Patent No. 7919506; Clark RW, 2006, J LIPID RES, V47, P537, DOI 10.1194/jlr.M500349-JLR200; Damon D. B., 2003, U.S. Patent, Patent No. 6706881; Dullaart RPF, 2007, EUR J CLIN INVEST, V37, P90, DOI 10.1111/j.1365-2362.2007.01756.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forrest MJ, 2008, BRIT J PHARMACOL, V154, P1465, DOI 10.1038/bjp.2008.229; Gumkowski M. J., 2002, U.S. Patent, Patent No. 6962931; Hamilton JA, 2007, NAT STRUCT MOL BIOL, V14, P95, DOI 10.1038/nsmb0207-95; Hooper AJ, 2012, EXPERT OPIN INV DRUG, V21, P1427, DOI 10.1517/13543784.2012.699040; Howes LG, 2007, EXPERT OPIN INV DRUG, V16, P1509, DOI 10.1517/13543784.16.10.1509; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; Joy T, 2008, NAT REV DRUG DISCOV, V7, P143, DOI 10.1038/nrd2489; Joy T, 2009, CURR OPIN CARDIOL, V24, P364, DOI 10.1097/HCO.0b013e32832ac166; Kastelein JJP, 2007, NEW ENGL J MED, V356, P1620, DOI 10.1056/NEJMoa071359; Krishna R, 2007, LANCET, V370, P1907, DOI 10.1016/S0140-6736(07)61813-3; Linsel-Nitschke P, 2005, NAT REV DRUG DISCOV, V4, P193, DOI 10.1038/nrd1658; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lloyd DB, 2005, BBA-MOL CELL BIOL L, V1737, P69, DOI 10.1016/j.bbalip.2005.09.007; Lloyd DB, 2005, J BIOL CHEM, V280, P14918, DOI 10.1074/jbc.M500523200; Nicholls SJ, 2011, JAMA-J AM MED ASSOC, V306, P2099, DOI 10.1001/jama.2011.1649; Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635; Okamoto H, 2000, NATURE, V406, P203, DOI 10.1038/35018119; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Pecheniuk NM, 2006, J THROMB HAEMOST, V4, P2080, DOI 10.1111/j.1538-7836.2006.02099.x; Qiu XY, 2007, NAT STRUCT MOL BIOL, V14, P106, DOI 10.1038/nsmb1197; Ranalletta M, 2010, J LIPID RES, V51, P2739, DOI 10.1194/jlr.M007468; Ruggeri RB, 2005, CURR TOP MED CHEM, V5, P257, DOI 10.2174/1568026053544506; Stein EA, 2010, EUR HEART J, V31, P480, DOI 10.1093/eurheartj/ehp601; Sugano M, 1998, J BIOL CHEM, V273, P5033, DOI 10.1074/jbc.273.9.5033; Tall AR, 2007, NEW ENGL J MED, V356, P1364, DOI 10.1056/NEJMe078029; Tall AR, 2007, ARTERIOSCL THROM VAS, V27, P257, DOI 10.1161/01.ATV.0000256728.60226.77; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Vergeer M, 2008, NAT CLIN PRACT CARD, V5, P302, DOI 10.1038/ncpcardio1190; WHO, 2008, ATLAS HEART DIS STRO; Yvan-Charvet L, 2007, ARTERIOSCL THROM VAS, V27, P1132, DOI 10.1161/ATVBAHA.106.138347; Zhang L, 2012, NAT CHEM BIOL, V8, P342, DOI [10.1038/NCHEMBIO.796, 10.1038/nchembio.796]	47	54	56	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37321	37329		10.1074/jbc.M112.380063	http://dx.doi.org/10.1074/jbc.M112.380063			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22961980	Green Published, hybrid			2022-12-28	WOS:000310588500063
J	Shan, JX; Fu, LC; Balasubramanian, MN; Anthony, T; Kilberg, MS				Shan, Jixiu; Fu, Lingchen; Balasubramanian, Mukundh N.; Anthony, Tracy; Kilberg, Michael S.			ATF4-dependent Regulation of the JMJD3 Gene during Amino Acid Deprivation Can Be Rescued in Atf4-deficient Cells by Inhibition of Deacetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIETARY-PROTEIN RESTRICTION; ASPARAGINE SYNTHETASE GENE; DEMETHYLASE JMJD3; TRANSCRIPTION FACTORS; HISTONE ACETYLATION; PROMOTER REGION; COMPOSITE SITE; PREGNANT RATS; C-JUN; EXPRESSION	Following amino acid deprivation, the amino acid response (AAR) induces transcription from specific genes through a collection of signaling mechanisms, including the GCN2-eIF2-ATF4 pathway. The present report documents that the histone demethylase JMJD3 is an activating transcription factor 4 (ATF4)-dependent target gene. The JMJD3 gene contains two AAR-induced promoter activities and chromatin immunoprecipitation (ChIP) analysis showed that the AAR leads to enhanced ATF4 recruitment to the C/EBP-ATF response element (CARE) upstream of Promoter-1. AAR-induced histone modifications across the JMJD3 gene locus occur upon ATF4 binding. Jmjd3 transcription is not induced in Atf4-knock-out cells, but the AAR-dependent activation was rescued by inhibition of histone deacetylation with trichostatin A (TSA). The TSA rescue of AAR activation in the absence of Atf4 also occurred for the Atf3 and C/EBP homology protein (Chop) genes, but not for the asparagine synthetase gene. ChIP analysis of the Jmjd3, Atf3, and Chop genes in Atf4 knock-out cells documented that activation of the AAR in the presence of TSA led to specific changes in acetylation of histone H4. The results suggest that a primary function of ATF4 is to recruit histone acetyltransferase activity to a sub-set of AAR target genes. Thus, absolute binding of ATF4 to these particular genes is not required and no ATF4 interaction with the general transcription machinery is necessary. The data are consistent with the hypothesis that ATF4 functions as a pioneer factor to alter chromatin structure and thus, enhance transcription in a gene-specific manner.	[Shan, Jixiu; Fu, Lingchen; Balasubramanian, Mukundh N.; Kilberg, Michael S.] Univ Florida, Dept Biochem & Mol Biol, Genet Inst, Shands Canc Ctr,Coll Med, Gainesville, FL 32610 USA; [Shan, Jixiu; Fu, Lingchen; Balasubramanian, Mukundh N.; Kilberg, Michael S.] Univ Florida, Ctr Nutr Sci, Coll Med, Gainesville, FL 32610 USA; [Anthony, Tracy] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Rutgers State University New Brunswick	Kilberg, MS (corresponding author), Univ Florida, Dept Biochem & Mol Biol, Genet Inst, Shands Canc Ctr,Coll Med, Box 100245, Gainesville, FL 32610 USA.	mkilberg@ufl.edu	Anthony, Tracy/K-7951-2017	Anthony, Tracy/0000-0002-8586-5884	National Institutes of Health [DK092062, DK094729, HD070487]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD070487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094729, R01DK092062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported, in whole or in part, by Grants DK092062 and DK094729 (to M. S. K.) and HD070487 (to T. G. A.) from the National Institutes of Health.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Ameri K, 2004, BLOOD, V103, P1876, DOI 10.1182/blood-2003-06-1859; Barbosa-Tessmann IP, 2000, J BIOL CHEM, V275, P26976; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Barkess G, 2012, BIOCHEM J, V442, P495, DOI 10.1042/BJ20111502; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Bruhat A, 2007, NUCLEIC ACIDS RES, V35, P1312, DOI 10.1093/nar/gkm038; Bunpo P, 2009, J BIOL CHEM, V284, P32742, DOI 10.1074/jbc.M109.047910; Burdge GC, 2007, BRIT J NUTR, V97, P435, DOI 10.1017/S0007114507352392; Burgold T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003034; Carraro V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015716; Chaveroux C, 2009, MOL CELL BIOL, V29, P6515, DOI 10.1128/MCB.00489-09; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Deval C, 2009, FEBS J, V276, P707, DOI 10.1111/j.1742-4658.2008.06818.x; Endo Y, 2002, J NUTR, V132, P3632, DOI 10.1093/jn/132.12.3632; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Fu LC, 2011, J BIOL CHEM, V286, P36724, DOI 10.1074/jbc.M111.277673; Gjymishka A, 2008, J BIOL CHEM, V283, P27736, DOI 10.1074/jbc.M803781200; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; HSU JC, 1992, MOL CELL BIOL, V12, P4654, DOI 10.1128/MCB.12.10.4654; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Jones RS, 2007, NATURE, V450, P357, DOI 10.1038/450357a; Kawasaki H, 2000, NATURE, V405, P195, DOI 10.1038/35012097; Kilberg MS, 2012, ADV NUTR, V3, P295, DOI 10.3945/an.112.001891; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee JI, 2008, PHYSIOL GENOMICS, V33, P218, DOI 10.1152/physiolgenomics.00263.2007; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lopez AB, 2007, BIOCHEM J, V402, P163, DOI 10.1042/BJ20060941; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Palii SS, 2006, BIOCHEM J, V395, P517, DOI 10.1042/BJ20051867; Palii SS, 2004, J BIOL CHEM, V279, P3463, DOI 10.1074/jbc.M310483200; Pan YX, 2007, BIOCHEM J, V401, P299, DOI 10.1042/BJ20061261; Plachetka A, 2008, MOL CELL BIOL, V28, P2102, DOI 10.1128/MCB.01943-07; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Serandour AA, 2011, GENOME RES, V21, P555, DOI 10.1101/gr.111534.110; Shan JX, 2010, PHYSIOL GENOMICS, V41, P315, DOI 10.1152/physiolgenomics.00217.2009; Shaw T, 2009, EMBO REP, V10, P881, DOI 10.1038/embor.2009.102; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Su N, 2009, HEPATOLOGY, V50, P282, DOI 10.1002/hep.22971; Su N, 2008, J BIOL CHEM, V283, P35106, DOI 10.1074/jbc.M806874200; Thiaville MM, 2008, J BIOL CHEM, V283, P10848, DOI 10.1074/jbc.M708320200; Thiaville MM, 2008, BIOCHEM J, V410, P473, DOI 10.1042/BJ20071252; Trojer P, 2006, CELL, V125, P213, DOI 10.1016/j.cell.2006.04.003; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Winkler GS, 2002, P NATL ACAD SCI USA, V99, P3517, DOI 10.1073/pnas.022042899; Wolfgang CD, 1997, MOL CELL BIOL, V17, P6700, DOI 10.1128/MCB.17.11.6700; Zheng SS, 2012, J NUTR BIOCHEM, V23, P1064, DOI 10.1016/j.jnutbio.2011.05.013; Zheng SS, 2011, EPIGENETICS-US, V6, P161, DOI 10.4161/epi.6.2.13472	64	35	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36393	36403		10.1074/jbc.M112.399600	http://dx.doi.org/10.1074/jbc.M112.399600			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22955275	Green Published, hybrid			2022-12-28	WOS:000310364000059
J	Smith, W				Smith, William			Essential Fatty Acids: The Work of George and Mildred Burr	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							DEFICIENCY		Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Smith, W (corresponding author), Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA.							Burr G. O., 1981, PROG LIPID RES, V20, pxxv; Burr GO, 1981, PROG LIPID RES, V20, P27; HANSEN AE, 1958, J NUTR, V66, P565, DOI 10.1093/jn/66.4.565; HOLMAN RT, 1988, J NUTR, V118, P535, DOI 10.1093/jn/118.5.535; HOLMAN RT, 1982, AM J CLIN NUTR, V35, P617, DOI 10.1093/ajcn/35.3.617; Reed LL, 1930, J BIOL CHEM, V81, P147; Zheng YX, 2011, J BIOL CHEM, V286, P24046, DOI 10.1074/jbc.M111.251496	7	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35439	35441		10.1074/jbc.O112.000005	http://dx.doi.org/10.1074/jbc.O112.000005			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	23066112	Green Published, hybrid			2022-12-28	WOS:000309968000051
J	Sindhu, C; Samavarchi-Tehrani, P; Meissner, A				Sindhu, Camille; Samavarchi-Tehrani, Payman; Meissner, Alexander			Transcription Factor-mediated Epigenetic Reprogramming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							EMBRYONIC STEM-CELLS; PROTEIN-INTERACTION NETWORK; DEFINED FACTORS; SOMATIC-CELLS; HUMAN FIBROBLASTS; SELF-RENEWAL; GENE-EXPRESSION; CHROMATIN-STRUCTURE; FUNCTIONAL-NEURONS; DIRECT CONVERSION	Input from various signaling pathways in conjunction with specific transcription factors (TFs), noncoding RNAs, and epigenetic modifiers governs the maintenance of cellular identity. Endogenous or exogenous TFs operate within certain boundaries, which are set, in part, by the cell type-specific epigenetic landscape. Ectopic expression of selected TFs can override the cellular identity and induce reprogramming to alternative fates. In this minireview, we summarize many of the classic examples and a large number of recent studies that have taken advantage of TF-mediated reprogramming to produce cell types of biomedical relevance.	[Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; Harvard Stem Cell Inst, Cambridge, MA 02138 USA; Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Meissner, A (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	alexander_meissner@harvard.edu			National Institutes of Health Grants [P01GM099117, U01ES017155]; Pew Charitable Trusts; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Trusts; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01GM099117 and U01ES017155 (to A. M.). This work was also supported by the Pew Charitable Trusts (to A. M.). This is the fifth article in the Thematic Minireview Series on Results from the ENCODE Project: Integrative Global Analyses of Regulatory Regions in the Human Genome.	Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; BOLUND L, 1969, J CELL SCI, V4, P71; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; BRIGGS R, 1952, P NATL ACAD SCI USA, V38, P455, DOI 10.1073/pnas.38.5.455; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Chen JK, 2011, CELL RES, V21, P205, DOI 10.1038/cr.2010.172; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; CHOI J, 1990, P NATL ACAD SCI USA, V87, P7988, DOI 10.1073/pnas.87.20.7988; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dejosez M, 2010, GENE DEV, V24, P1479, DOI 10.1101/gad.1935210; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Edge ASB, 2008, CURR OPIN NEUROBIOL, V18, P377, DOI 10.1016/j.conb.2008.10.001; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Fisher CL, 2011, CURR OPIN GENET DEV, V21, P140, DOI 10.1016/j.gde.2011.01.015; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Graf T, 2011, CELL STEM CELL, V9, P504, DOI 10.1016/j.stem.2011.11.012; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Gupta P, 2009, J CELL MOL MED, V13, P4349, DOI 10.1111/j.1582-4934.2009.00757.x; GURDON JB, 1962, DEV BIOL, V4, P256, DOI 10.1016/0012-1606(62)90043-X; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Heyworth C, 2002, EMBO J, V21, P3770, DOI 10.1093/emboj/cdf368; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Iwasaki H, 2003, IMMUNITY, V19, P451, DOI 10.1016/S1074-7613(03)00242-5; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim SW, 2011, DEV BIOL, V357, P492, DOI 10.1016/j.ydbio.2011.06.009; Kirjavainen A, 2008, DEV BIOL, V322, P33, DOI 10.1016/j.ydbio.2008.07.004; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Liu XS, 2008, CELL RES, V18, P1177, DOI 10.1038/cr.2008.309; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; Masip M, 2010, MOL HUM REPROD, V16, P856, DOI 10.1093/molehr/gaq059; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Noggle S, 2011, NATURE, V478, P70, DOI 10.1038/nature10397; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Papp B, 2011, CELL RES, V21, P486, DOI 10.1038/cr.2011.28; Pereira CF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000170; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Scott EW, 1997, IMMUNITY, V6, P437, DOI 10.1016/S1074-7613(00)80287-3; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Stopka T, 2005, EMBO J, V24, P3712, DOI 10.1038/sj.emboj.7600834; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Theunissen TW, 2011, CURR BIOL, V21, P65, DOI 10.1016/j.cub.2010.11.074; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xie LQ, 2011, EMBO J, V30, P1473, DOI 10.1038/emboj.2011.91; Yang JC, 2008, P NATL ACAD SCI USA, V105, P19756, DOI 10.1073/pnas.0809321105; Yechoor V, 2009, DEV CELL, V16, P358, DOI 10.1016/j.devcel.2009.01.012; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	111	20	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					30922	30931		10.1074/jbc.R111.319046	http://dx.doi.org/10.1074/jbc.R111.319046			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22952239	Green Published, hybrid			2022-12-28	WOS:000308791300006
J	Graziano, V; Luo, GB; Blainey, PC; Perez-Berna, AJ; Mcgrath, WJ; Flint, SJ; Martin, CS; Xie, XS; Mangel, WF				Graziano, Vito; Luo, Guobin; Blainey, Paul C.; Perez-Berna, Ana J.; Mcgrath, William J.; Flint, S. Jane; San Martin, Carmen; Xie, X. Sunney; Mangel, Walter F.			Regulation of a Viral Proteinase by a Peptide and DNA in One-dimensional Space II. ADENOVIRUS PROTEINASE IS ACTIVATED IN AN UNUSUAL ONE-DIMENSIONAL BIOCHEMICAL REACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING; TRANSPORT; COFACTORS; VIRION; TYPE-2; HEXON	Late in an adenovirus infection, the viral proteinase (AVP) becomes activated to process virion precursor proteins used in virus assembly. AVP is activated by two cofactors, the viral DNA and pVIc, an 11-amino acid peptide originating from the C terminus of the precursor protein pVI. There is a conundrum in the activation of AVP in that AVP and pVI are sequence-independent DNA-binding proteins with nM equilibrium dissociation constants such that in the virus particle, they are predicted to be essentially irreversibly bound to the viral DNA. Here, we resolve that conundrum by showing that activation of AVP takes place on the one-dimensional contour of DNA. In vitro, pVI, a substrate, slides on DNA via one-dimensional diffusion, D-1 = 1.45 x 10(6) bp(2)/s, until it binds to AVP also on the same DNA molecule. AVP, partially activated by being bound to DNA, excises pVIc, which binds to the AVP molecule that cut it out. pVIc then forms a disulfide bond with AVP forming the fully active AVP-pVIc complex bound to DNA. In vivo, in heat-disrupted immature virus, AVP was also activated by pVI in DNA-dependent reactions. This activation mechanism illustrates a new paradigm for virion maturation and a new way, by sliding on DNA, for bimolecular complexes to form among proteins not involved in DNA metabolism.	[Graziano, Vito; Mcgrath, William J.; Mangel, Walter F.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Luo, Guobin; Blainey, Paul C.; Xie, X. Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Perez-Berna, Ana J.; San Martin, Carmen] CSIC, CNB, Dept Macromol Struct, E-28049 Madrid, Spain; [Flint, S. Jane] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; Harvard University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Princeton University	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu; mangel@bnl.gov	San Martín, Carmen/A-4074-2010; Perez-Berna, Ana/G-2789-2016	San Martín, Carmen/0000-0001-9799-175X; Blainey, Paul/0000-0002-4889-8783; Perez-Berna, Ana/0000-0003-4145-532X; McGrath, William/0000-0002-9375-624X	National Institutes of Health [R01AI41599, GM037705]; National Institutes of Health; National Science Foundation; Ministerio de Ciencia e Innovacion of Spain [BFU2010-16382, FIS2010-10552-E]; Juan de la Cierva from the Ministerio de Ciencia e Innovacion of Spain; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041599, R21AI113565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037705] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Juan de la Cierva from the Ministerio de Ciencia e Innovacion of Spain; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI41599 (to W. F. M.) and GM037705 (to S. J. F.) and the National Institutes of Health Director's Pioneer Award and a National Science Foundation grant (to X. S. X.). This work was also supported by Grants BFU2010-16382 and FIS2010-10552-E from the Ministerio de Ciencia e Innovacion of Spain (to C. S. M.); The recipient of a Juan de la Cierva postdoctoral contract from the Ministerio de Ciencia e Innovacion of Spain.	Bagchi B, 2008, J PHYS CHEM B, V112, P6282, DOI 10.1021/jp077568f; Bajpayee NS, 2005, BIOCHEMISTRY-US, V44, P8721, DOI 10.1021/bi0502240; Baniecki ML, 2002, BIOCHEMISTRY-US, V41, P430, DOI 10.1021/bi015150g; Baniecki ML, 2001, BIOCHEMISTRY-US, V40, P12349, DOI 10.1021/bi0109008; Blainey PC, 2013, J BIOL CHEM, V288, P2092, DOI 10.1074/jbc.M112.407460; Blainey PC, 2009, NAT STRUCT MOL BIOL, V16, P1224, DOI 10.1038/nsmb.1716; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Brown MT, 1996, FEBS LETT, V388, P233, DOI 10.1016/0014-5793(96)00569-8; Casjens S., 1997, STRUCTURAL BIOL VIRU, P3; Ding JZ, 1996, EMBO J, V15, P1778, DOI 10.1002/j.1460-2075.1996.tb00526.x; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Flint S.J., 2000, PRINCIPLES VIROLOGY; Flint S.J., 2020, PRINCIPLES VIROLOGY, V2; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Graziano V, 2013, J BIOL CHEM, V288, P2059, DOI 10.1074/jbc.M112.377150; Gupta S, 2004, MOL CELL PROTEOMICS, V3, P950, DOI 10.1074/mcp.M400037-MCP200; Lehmberg E, 1999, J CHROMATOGR B, V732, P411, DOI 10.1016/S0378-4347(99)00316-3; MANGEL WF, 1993, NATURE, V361, P274, DOI 10.1038/361274a0; Mangel WF, 1996, J BIOL CHEM, V271, P536, DOI 10.1074/jbc.271.1.536; Mangenot S, 2003, BIOPHYS J, V85, P1817, DOI 10.1016/S0006-3495(03)74610-4; MATTHEWS DA, 1995, J GEN VIROL, V76, P1959, DOI 10.1099/0022-1317-76-8-1959; MATTHEWS DA, 1994, J GEN VIROL, V75, P3365, DOI 10.1099/0022-1317-75-12-3365; McGrath WJ, 1996, VIROLOGY, V217, P131, DOI 10.1006/viro.1996.0100; McGrath WJ, 2002, VIROLOGY, V296, P234, DOI 10.1006/viro.2002.1394; McGrath WJ, 2001, BIOCHEMISTRY-US, V40, P13237, DOI 10.1021/bi0111653; McGrath WJ, 2001, BIOCHEMISTRY-US, V40, P14468, DOI 10.1021/bi011562d; Perez-Berna AJ, 2009, J MOL BIOL, V392, P547, DOI 10.1016/j.jmb.2009.06.057; Ramakrishnan V, 1997, CRIT REV EUKAR GENE, V7, P215, DOI 10.1615/CritRevEukarGeneExpr.v7.i3.20; RUSSELL WC, 1982, J GEN VIROL, V63, P69, DOI 10.1099/0022-1317-63-1-69; VANOOSTRUM J, 1985, J VIROL, V56, P439, DOI 10.1128/JVI.56.2.439-448.1985; WEBER J, 1976, J VIROL, V17, P462, DOI 10.1128/JVI.17.2.462-471.1976; WEBSTER A, 1993, CELL, V72, P97, DOI 10.1016/0092-8674(93)90053-S; Wodrich H, 2003, EMBO J, V22, P6245, DOI 10.1093/emboj/cdg614	33	26	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					2068	2080		10.1074/jbc.M112.407312	http://dx.doi.org/10.1074/jbc.M112.407312			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23043137	Green Published, hybrid			2022-12-28	WOS:000313751400058
J	King, GJ; Stockli, J; Hu, SH; Winnen, B; Duprez, WGA; Meoli, CC; Junutula, JR; Jarrott, RJ; James, DE; Whitten, AE; Martin, JL				King, Gordon J.; Stoeckli, Jacqueline; Hu, Shu-Hong; Winnen, Brit; Duprez, Wilko G. A.; Meoli, Christopher C.; Junutula, Jagath R.; Jarrott, Russell J.; James, David E.; Whitten, Andrew E.; Martin, Jennifer L.			Membrane Curvature Protein Exhibits Interdomain Flexibility and Binds a Small GTPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; BAR DOMAINS; PH DOMAIN; IDENTIFICATION; APPL1; ENDOPHILIN; COMPLEX; SYSTEM; RAC	The APPL1 and APPL2 proteins (APPL (adaptor protein, phosphotyrosine interaction, pleckstrin homology (PH) domain, and leucine zipper-containing protein)) are localized to their own endosomal subcompartment and interact with a wide range of proteins and small molecules at the cell surface and in the nucleus. They play important roles in signal transduction through their ability to act as Rab effectors. (Rabs are a family of Ras GTPases involved in membrane trafficking.) Both APPL1 and APPL2 comprise an N-terminal membrane-curving BAR (Bin-amphiphysin-Rvs) domain linked to a PH domain and a C-terminal phosphotyrosine-binding domain. The structure and interactions of APPL1 are well characterized, but little is known about APPL2. Here, we report the crystal structure and low resolution solution structure of the BARPH domains of APPL2. We identify a previously undetected hinge site for rotation between the two domains and speculate that this motion may regulate APPL2 functions. We also identified Rab binding partners of APPL2 and show that these differ from those of APPL1, suggesting that APPL-Rab interaction partners have co-evolved over time. Isothermal titration calorimetry data reveal the interaction between APPL2 and Rab31 has a K-d of 140 nM. Together with other biophysical data, we conclude the stoichiometry of the complex is 2:2.	[King, Gordon J.; Hu, Shu-Hong; Winnen, Brit; Duprez, Wilko G. A.; Jarrott, Russell J.; Whitten, Andrew E.; Martin, Jennifer L.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Stoeckli, Jacqueline; Meoli, Christopher C.; James, David E.] Garvan Inst Med Res, Diabet & Obes Res Program, Sydney, NSW 2010, Australia; [Junutula, Jagath R.] Genentech Inc, San Francisco, CA 94080 USA; [James, David E.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	University of Queensland; Garvan Institute of Medical Research; Roche Holding; Genentech; University of New South Wales Sydney	Whitten, AE (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	a.whitten@imb.uq.edu.au; j.martin@imb.uq.edu.au	King, Gordon/J-8718-2014; Stoeckli, Jacqueline/Z-4443-2019; Stoeckli, Jacqueline/D-7053-2016; Junutula, Jagath Reddy/ABD-4753-2020; Martin, Jennifer L./A-6039-2010	Stoeckli, Jacqueline/0000-0002-6446-7350; Stoeckli, Jacqueline/0000-0002-6446-7350; Junutula, Jagath Reddy/0000-0002-5942-4428; Martin, Jennifer L./0000-0002-9225-8863; Jarrott, Russell/0000-0003-4326-1203; Winnen, Brit/0000-0003-1958-335X; Whitten, Andrew/0000-0001-8856-3120; James, David/0000-0001-5946-5257	Australian National Health and Medical Research Council (NHMRC) [535921]; Australian Synchrotron Grant [AS111/SAXSFI/3171]; ARC [FL0992138]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Synchrotron Grant; ARC(Australian Research Council)	This work was supported by the Australian National Health and Medical Research Council (NHMRC) Program Grant 535921. The scattering data were collected with support from Australian Synchrotron Grant AS111/SAXSFI/3171.; An ARC Australian Laureate Fellow (Grant FL0992138) and honorary NHMRC Fellow (ID 455829). To whom correspondence may be addressed: Institute for Molecular Bioscience, University of Queensland, Brisbane Qld 4072, Australia. Tel.: 61-7-3346-2016; Fax: 61-7-3346-2101; E-mail: j.martin@imb.uq.edu.au.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Bunney TD, 2009, MOL CELL, V34, P223, DOI 10.1016/j.molcel.2009.02.023; Ceccarelli DFJ, 2007, J BIOL CHEM, V282, P13864, DOI 10.1074/jbc.M700505200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chial HJ, 2008, TRAFFIC, V9, P215, DOI 10.1111/j.1600-0854.2007.00680.x; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Cookson D. J., 2007, SAXS15ID SOFTWARE AC; DeLano W.L, PYMOL MOL GRAPHICS S; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351; Kutateladze TG, 2010, NAT CHEM BIOL, V6, P507, DOI [10.1038/NCHEMBIO.390, 10.1038/nchembio.390]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li J, 2007, STRUCTURE, V15, P525, DOI 10.1016/j.str.2007.03.011; Lodhi IJ, 2007, CELL METAB, V5, P59, DOI 10.1016/j.cmet.2006.12.006; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Nakano-Kobayashi A, 2009, CURR BIOL, V19, P1133, DOI 10.1016/j.cub.2009.05.022; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Qualmann B, 2011, EMBO J, V30, P3501, DOI 10.1038/emboj.2011.266; Rodriguez-Gabin AG, 2001, J NEUROSCI RES, V66, P1149, DOI 10.1002/jnr.1253.abs; Rowland SL, 2004, MOL CELL, V13, P689, DOI 10.1016/S1097-2765(04)00084-X; Smaczynska-de Rooij II, 2012, TRAFFIC, V13, P317, DOI 10.1111/j.1600-0854.2011.01311.x; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Wang CH, 2009, J BIOL CHEM, V284, P31608, DOI 10.1074/jbc.M109.010355; Wang Q, 2008, STRUCTURE, V16, P1574, DOI 10.1016/j.str.2008.07.016; Westlake CJ, 2007, P NATL ACAD SCI USA, V104, P1236, DOI 10.1073/pnas.0610500104; Whitten AE, 2008, J APPL CRYSTALLOGR, V41, P222, DOI 10.1107/S0021889807055136; Zhu GY, 2007, EMBO J, V26, P3484, DOI 10.1038/sj.emboj.7601771	46	14	14	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					40996	41006		10.1074/jbc.M112.349803	http://dx.doi.org/10.1074/jbc.M112.349803			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23055524	Green Published, hybrid			2022-12-28	WOS:000311887600017
J	Klase, Z; Houzet, L; Jeang, KT				Klase, Zachary; Houzet, Laurent; Jeang, Kuan-Teh			MicroRNAs and HIV-1: Complex Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							INFLUENZA-A VIRUS; SILENCING SUPPRESSOR ACTIVITY; SMALL NONCODING RNAS; CELLULAR MICRORNA; PROTEIN EXPRESSION; VIRAL REPLICATION; BINDING-PROTEIN; MESSENGER-RNAS; INTERFERENCE; INFECTION	RNAi plays important roles in many biological processes, including cellular defense against viral infection. Components of the RNAi machinery are widely conserved in plants and animals. In mammals, microRNAs (miRNAs) represent an abundant class of cell encoded small noncoding RNAs that participate in RNAi-mediated gene silencing. Here, findings that HIV-1 replication in cells can be regulated by miRNAs and that HIV-1 infection of cells can alter cellular miRNA expression are reviewed. Lessons learned from and questions outstanding about the complex interactions between HIV-1 and cellular miRNAs are discussed.	[Klase, Zachary; Houzet, Laurent; Jeang, Kuan-Teh] NIAID, Mol Virol Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Jeang, KT (corresponding author), NIAID, Mol Virol Sect, Mol Microbiol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	kjeang@niaid.nih.gov			NIAID; Office of the Director, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000547] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by NIAID intramural funding and by the Intramural AIDS Targeted Antiviral Program (IATAP) from the Office of the Director, National Institutes of Health. This is the sixth article in the Thematic Minireview Series on Understanding Human Immunodeficiency Virus-Host Interactions at the Biochemical Level.	Abe M, 2010, FEBS LETT, V584, P4313, DOI 10.1016/j.febslet.2010.09.031; Agrawal N, 2003, MICROBIOL MOL BIOL R, V67, P657, DOI 10.1128/MMBR.67.4.657-685.2003; Ahluwalia JK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-117; Althaus CF, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-27; Barbagallo MS, 2012, DNA CELL BIOL, V31, P1303, DOI 10.1089/dna.2011.1585; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Bennasser Y, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-95; Betel D, 2007, PLOS COMPUT BIOL, V3, P2219, DOI 10.1371/journal.pcbi.0030222; Bignami F, 2012, BLOOD, V119, P6259, DOI 10.1182/blood-2011-09-379503; Bivalkar-Mehla S, 2011, VIRUS RES, V155, P1, DOI 10.1016/j.virusres.2010.10.003; Bouttier M, 2012, NUCLEIC ACIDS RES, V40, P775, DOI 10.1093/nar/gkr762; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Buggele WA, 2012, J BIOL CHEM, V287, P31027, DOI 10.1074/jbc.M112.387670; Chable-Bessia C, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-26; Chang JR, 2011, J BIOL CHEM, V286, P41125, DOI 10.1074/jbc.M111.268466; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chi YH, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-9; Chiang K, 2012, J VIROL, V86, P3244, DOI 10.1128/JVI.05065-11; Clerc I, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-74; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; Das SK, 2010, P NATL ACAD SCI USA, V107, P11948, DOI 10.1073/pnas.0914143107; de Vries W, 2009, J GEN VIROL, V90, P1916, DOI 10.1099/vir.0.008284-0; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Fabozzi G, 2011, J VIROL, V85, P2512, DOI 10.1128/JVI.01160-10; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grassmann R, 2008, BBA-GENE REGUL MECH, V1779, P706, DOI 10.1016/j.bbagrm.2008.05.005; Haasnoot J, 2007, PLOS PATHOG, V3, P794, DOI 10.1371/journal.ppat.0030086; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hariharan M, 2005, BIOCHEM BIOPH RES CO, V337, P1214, DOI 10.1016/j.bbrc.2005.09.183; Hayes AM, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-36; Houzet L, 2012, NUCLEIC ACIDS RES, V40, P11684, DOI 10.1093/nar/gks912; Houzet L, 2011, BBA-GENE REGUL MECH, V1809, P686, DOI 10.1016/j.bbagrm.2011.05.009; Houzet L, 2011, EXP BIOL MED, V236, P962, DOI 10.1258/ebm.2010.010272; Houzet L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-118; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Jeang KT, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-58; Jopling CL, 2012, RNA BIOL, V9, DOI 10.4161/rna.18827; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kincaid RP, 2012, P NATL ACAD SCI USA, V109, P3077, DOI 10.1073/pnas.1116107109; Klase Z, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-63; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Kobayashi-Ishihara M, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-38; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Krakauer DC, 1999, P ROY SOC B-BIOL SCI, V266, P1069, DOI 10.1098/rspb.1999.0745; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Li WX, 2001, CURR OPIN BIOTECH, V12, P150, DOI 10.1016/S0958-1669(00)00190-7; Lin J, 2007, J VIROL, V81, P12218, DOI 10.1128/JVI.01390-07; Llave C, 2010, TRENDS PLANT SCI, V15, P701, DOI 10.1016/j.tplants.2010.09.001; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Ma YJ, 2012, J CELL MOL MED, V16, P2539, DOI 10.1111/j.1582-4934.2012.01572.x; Matskevich AA, 2007, J GEN VIROL, V88, P2627, DOI 10.1099/vir.0.83103-0; Matsuda E, 2009, P NATL ACAD SCI USA, V106, P15657, DOI 10.1073/pnas.0908305106; MCMILLAN NAJ, 1995, VIROLOGY, V213, P413, DOI 10.1006/viro.1995.0014; Morris KV, 2008, CURR TOP MICROBIOL, V320, P211; Mukerjee R, 2011, J BIOL CHEM, V286, P34976, DOI 10.1074/jbc.M111.241547; Nathans R, 2009, MOL CELL, V34, P696, DOI 10.1016/j.molcel.2009.06.003; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Pantaleo V, 2011, ADV EXP MED BIOL, V722, P39, DOI 10.1007/978-1-4614-0332-6_3; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Potenza N, 2011, NUCLEIC ACIDS RES, V39, P5157, DOI 10.1093/nar/gkr067; Qian S, 2009, P NATL ACAD SCI USA, V106, P605, DOI 10.1073/pnas.0806822106; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Rigoutsos I, 2009, CANCER RES, V69, P3245, DOI 10.1158/0008-5472.CAN-09-0352; Schnettler E, 2009, EMBO REP, V10, P258, DOI 10.1038/embor.2009.6; Schopman NCT, 2012, NUCLEIC ACIDS RES, V40, P414, DOI 10.1093/nar/gkr719; Shen CJ, 2012, FASEB J, V26, P4755, DOI 10.1096/fj.12-209023; SHIRAZI Y, 1994, J INTERFERON RES, V14, P259, DOI 10.1089/jir.1994.14.259; Song LP, 2010, J VIROL, V84, P8849, DOI 10.1128/JVI.00456-10; Song R, 2011, P NATL ACAD SCI USA, V108, P13159, DOI 10.1073/pnas.1108567108; Suh N, 2011, DEVELOPMENT, V138, P1653, DOI 10.1242/dev.056234; Sun GH, 2012, NUCLEIC ACIDS RES, V40, P2181, DOI 10.1093/nar/gkr961; Sung TL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000263; Suzuki K, 2011, RNA BIOL, V8, P1035, DOI 10.4161/rna.8.6.16264; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Tchurikov NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021882; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Van Stry M, 2012, J VIROL, V86, P4151, DOI 10.1128/JVI.05303-11; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; Watashi K, 2010, J BIOL CHEM, V285, P24707, DOI 10.1074/jbc.M109.062976; Witwer KW, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-5; Yao YX, 2008, J VIROL, V82, P4007, DOI 10.1128/JVI.02659-07; Yeung ML, 2011, PHARM RES-DORDR, V28, P3043, DOI 10.1007/s11095-011-0526-2; Yeung ML, 2009, NUCLEIC ACIDS RES, V37, P6575, DOI 10.1093/nar/gkp707; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033; Yeung ML, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-81; Zamore PD, 2010, EMBO J, V29, P3219, DOI 10.1038/emboj.2010.232; Zhang G, 2010, CURR GENOMICS, V11, P311, DOI 10.2174/138920210791616671; Zhang HS, 2012, BBA-MOL CELL RES, V1823, P1017, DOI 10.1016/j.bbamcr.2012.02.014; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; Zhu Weizhu, 2009, BMC Res Notes, V2, P89, DOI 10.1186/1756-0500-2-89	100	52	55	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					40884	40890		10.1074/jbc.R112.415448	http://dx.doi.org/10.1074/jbc.R112.415448			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23043098	hybrid, Green Published			2022-12-28	WOS:000311887600007
J	Wieschhaus, AJ; Le Breton, GC; Chishti, AH				Wieschhaus, Adam J.; Le Breton, Guy C.; Chishti, Athar H.			Headpiece Domain of Dematin Regulates Calcium Mobilization and Signaling in Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-BLOOD PLATELETS; INOSITOL 1,4,5-TRISPHOSPHATE 3-KINASES; DENSE TUBULAR SYSTEM; ERYTHROCYTE-MEMBRANE; F-ACTIN; INTEGRIN ALPHA(IIB)BETA(3); PLASMA-MEMBRANE; PROTEIN; LOCALIZATION; ACTIVATION	Dematin is a broadly expressed membrane cytoskeletal protein that has been well characterized in erythrocytes and to a lesser extent in non-erythroid cells. However, dematin's function in platelets is not known. Here, we show that dematin is abundantly expressed in both human and mouse platelets. Platelets harvested from the dematin headpiece knock-out (HPKO) mouse model exhibit a striking defect in the mobilization of calcium in response to multiple agonists of platelet activation. The reduced calcium mobilization in HPKO platelets is associated with concomitant inhibition of platelet aggregation and granule secretion. Integrin alpha(IIb)beta(3) activation in response to agonists is attenuated in the HPKO platelets. The mutant platelets show nearly normal spreading on fibrinogen and an unaltered basal cAMP level; however, the clot retraction was compromised in the mutant mice. Immunofluorescence analysis indicated that dematin is present both at the dense tubular system and plasma membrane fractions of platelets. Proteomic analysis of dematin-associated proteins in human platelets identified inositol 1,4,5-trisphosphate 3-kinase isoform B (IP3KB) as a binding partner, which was confirmed by immunoprecipitation analysis. IP3KB, a dense tubular system protein, is a major regulator of calcium homeostasis. Loss of the dematin headpiece resulted in a decrease of IP3KB at the membrane and increased levels of IP3KB in the cytosol. Collectively, these findings unveil dematin as a novel regulator of internal calcium mobilization in platelets affecting multiple signaling and cytoskeletal functions. Implications of a conserved role of dematin in the regulation of calcium homeostasis in other cell types will be discussed.	[Wieschhaus, Adam J.; Chishti, Athar H.] Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Boston, MA 02111 USA; [Wieschhaus, Adam J.] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Program Physiol, Boston, MA 02111 USA; [Wieschhaus, Adam J.] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Program Pharmacol, Boston, MA 02111 USA; [Wieschhaus, Adam J.] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Program Microbiol, Boston, MA 02111 USA; [Wieschhaus, Adam J.; Le Breton, Guy C.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA	Tufts University; Tufts University; Tufts University; Tufts University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Chishti, AH (corresponding author), Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, 150 Harrison Ave,Rm 701A, Boston, MA 02111 USA.	athar.chishti@tufts.edu			National Institutes of Health [HL095050, HL089517, HL051445, HL24530]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089517, R56HL051445, R01HL024530, R01HL051445, R01HL095050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL095050, HL089517, and HL051445 (to A. H. C.) and HL24530 (to G. C. L.).	AZIM AC, 1995, J BIOL CHEM, V270, P17407, DOI 10.1074/jbc.270.29.17407; Barkalow KL, 2003, J CELL BIOL, V161, P557, DOI 10.1083/jcb.200211122; Barrientos T, 2007, J BIOL CHEM, V282, P8393, DOI 10.1074/jbc.M607549200; BENNETT V, 1993, ANNU REV CELL BIOL, V9, P27, DOI 10.1146/annurev.cellbio.9.1.27; Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Chen HQ, 2007, J BIOL CHEM, V282, P4124, DOI 10.1074/jbc.M610231200; Chen JM, 2005, MICROCIRCULATION, V12, P235, DOI 10.1080/10739680590925484; Chen L, 2009, PROTEIN SCI, V18, P629, DOI 10.1002/pro.59; CHEN YP, 1994, J BIOL CHEM, V269, P18307; CUTLER L, 1978, BIOCHIM BIOPHYS ACTA, V542, P357, DOI 10.1016/0304-4165(78)90367-7; DASILVA CP, 1994, J BIOL CHEM, V269, P12521; DEAN WL, 1984, J BIOL CHEM, V259, P7343; DERICK LH, 1992, EUR J CELL BIOL, V57, P317; El Haouari M, 2008, BLOOD CELL MOL DIS, V41, P119, DOI 10.1016/j.bcmd.2008.02.010; El Haouari M, 2009, BLOOD CELL MOL DIS, V42, P38, DOI 10.1016/j.bcmd.2008.07.003; El-Daher SS, 2000, BLOOD, V95, P3412, DOI 10.1182/blood.V95.11.3412.011k03_3412_3422; ENOUF J, 1989, BIOCHEM J, V263, P547, DOI 10.1042/bj2630547; FAQUIN WC, 1988, EUR J CELL BIOL, V46, P168; Ferrary E, 1999, J CELL BIOL, V146, P819, DOI 10.1083/jcb.146.4.819; Flevaris P, 2007, J CELL BIOL, V179, P553, DOI 10.1083/jcb.200703185; Frank BS, 2004, J BIOL CHEM, V279, P7909, DOI 10.1074/jbc.M310524200; Gilligan DM, 2002, BLOOD, V99, P2418, DOI 10.1182/blood.V99.7.2418; GILMAN AG, 1970, P NATL ACAD SCI USA, V67, P305, DOI 10.1073/pnas.67.1.305; Gregg D, 2003, CIRCULATION, V108, pE88, DOI 10.1161/01.CIR.0000086897.15588.4B; HUSAINCHISHTI A, 1989, J BIOL CHEM, V264, P8985; HUSAINCHISHTI A, 1988, NATURE, V334, P718, DOI 10.1038/334718a0; Jantzen HM, 2001, J CLIN INVEST, V108, P477; KASERGLANZMANN R, 1978, BIOCHIM BIOPHYS ACTA, V512, P1, DOI 10.1016/0005-2736(78)90213-4; Khan AA, 2008, J BIOL CHEM, V283, P14600, DOI 10.1074/jbc.M707818200; Khanna R, 2002, P NATL ACAD SCI USA, V99, P6637, DOI 10.1073/pnas.052155999; Kim SH, 2011, TOXICOL SCI, V124, P215, DOI 10.1093/toxsci/kfr222; Kovacs T, 1997, BRIT J HAEMATOL, V97, P192, DOI 10.1046/j.1365-2141.1997.9982639.x; Law DA, 1996, J BIOL CHEM, V271, P10811, DOI 10.1074/jbc.271.18.10811; Leng LJ, 1998, BLOOD, V91, P4206, DOI 10.1182/blood.V91.11.4206.411k30_4206_4215; Lloyd-Burton SM, 2007, J BIOL CHEM, V282, P9526, DOI 10.1074/jbc.M610253200; MENASHI S, 1982, FEBS LETT, V140, P298, DOI 10.1016/0014-5793(82)80918-6; Mohseni M, 2008, MOL CELL BIOL, V28, P4712, DOI 10.1128/MCB.00237-08; Mohseni M, 2009, CELL ADHES MIGR, V3, P191, DOI 10.4161/cam.3.2.7375; Naik UP, 2003, BLOOD, V102, P1355, DOI 10.1182/blood-2003-02-0591; Nalaskowski MM, 2011, J BIOL CHEM, V286, P4500, DOI 10.1074/jbc.M110.173062; Pannerden HEVT, 2009, BLOOD, V114, P4738, DOI 10.1182/blood-2009-03-210450; Reed GL, 2000, BLOOD, V96, P3334; Remijn JA, 2002, ARTERIOSCL THROM VAS, V22, P686, DOI 10.1161/01.ATV.0000012805.49079.23; Roof DJ, 1997, J CELL BIOL, V138, P575, DOI 10.1083/jcb.138.3.575; RYBICKI JP, 1983, BIOCHIM BIOPHYS ACTA, V751, P66, DOI 10.1016/0005-2760(83)90257-6; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; SIEGEL DL, 1985, J CELL BIOL, V100, P775, DOI 10.1083/jcb.100.3.775; Soriano S, 1997, FEBS LETT, V403, P1, DOI 10.1016/S0014-5793(96)01516-5; Srinivasan S, 2009, J BIOL CHEM, V284, P16108, DOI 10.1074/jbc.M809780200; Varga-Szabo D, 2009, J THROMB HAEMOST, V7, P1057, DOI 10.1111/j.1538-7836.2009.03455.x; Xia HJ, 2005, CELL RES, V15, P83, DOI 10.1038/sj.cr.7290270; Yu JCH, 2005, BIOCHEM J, V392, P435, DOI 10.1042/BJ20050829; Zahedi RP, 2008, J PROTEOME RES, V7, P526, DOI 10.1021/pr0704130; Zhang GY, 2011, J BIOL CHEM, V286, P39466, DOI 10.1074/jbc.M111.239608; Zhu DM, 2000, J BIOL CHEM, V275, P6063, DOI 10.1074/jbc.275.9.6063	57	1	4	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41218	41231		10.1074/jbc.M112.364679	http://dx.doi.org/10.1074/jbc.M112.364679			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23060452	Green Published, hybrid			2022-12-28	WOS:000311887600037
J	Chen, L; Chen, DT; Kurtyka, C; Rawal, B; Fulp, WJ; Haura, EB; Cress, WD				Chen, Lu; Chen, Dung-Tsa; Kurtyka, Courtney; Rawal, Bhupendra; Fulp, William J.; Haura, Eric B.; Cress, W. Douglas			Tripartite Motif Containing 28 (Trim28) Can Regulate Cell Proliferation by Bridging HDAC1/E2F Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL COREPRESSOR TIF1-BETA; E2F FAMILY-MEMBERS; SUBCELLULAR-LOCALIZATION; DNA-SYNTHESIS; EXPRESSION; GENE; CYCLE; HETEROCHROMATIN; RECEPTOR; SURVIVAL	Trim28 is a poorly understood transcriptional co-factor with pleiotropic biological activities. Although Trim28 mRNA is found in many studies to be up-regulated in both lung and breast cancer tissues relative to normal adjacent tissue, we found that within a panel of early-stage lung adenocarcinomas high levels of Trim28 protein correlate with better overall survival. This surprising observation suggests that Trim 28 may have anti-proliferative activity within tumors. To test this hypothesis, we used shRNAi to generate Trim28-knockdown breast and lung cancer cell lines and found that Trim28 depletion led to increased cell proliferation. Likewise, overexpression of Trim28 led to decreased cell proliferation. Confocal microscopy indicated co-localization of E2F3 and E2F4 with Trim28 within the cell nucleus, and co-immunoprecipitation assays demonstrated that Trim28 can bind both E2F3 and E2F4. Trim28 overexpression inhibited the transcriptional activity of E2F3 and E2F4, whereas Trim28 deficiency enhanced their activity. Co-immunoprecipitations further indicated that Trim28 bridges an interaction between E2Fs 3 and 4 and HDAC1. Promoter-reporter assays demonstrated that the ability of HDAC1 to repress E2F3 and E2F4-driven transcription is dependent on Trim28. Trim28 depletion increased E2F3 and E2F4 DNA binding activity, as measured by chromatin-immunoprecipitation (ChIP) assays while simultaneously reducing HDAC1 binding. Finally, ChIP-ReChIP experiments demonstrated that Trim/E2F complexes exist on several E2F-regulated promoters. Taken together, these results suggest that Trim28 has anti-proliferative activity in lung cancers via repression of members of the E2F family that are critical for cell proliferation.	[Chen, Lu; Chen, Dung-Tsa; Kurtyka, Courtney; Rawal, Bhupendra; Fulp, William J.; Haura, Eric B.; Cress, W. Douglas] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Cress, WD (corresponding author), 12902 Magnolia Dr, Tampa, FL 33612 USA.	Douglas.cress@moffitt.org	Fulp, William/AAD-2369-2022	Fulp, William/0000-0001-6888-0794	NCI, National Institutes of Health [CA119997, CA129343, CA163068, CA118809]; Moffitt Cancer Center; NATIONAL CANCER INSTITUTE [P50CA119997, R01CA129343, U54CA163068, U56CA118809, P30CA076292] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Moffitt Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grants CA119997, CA129343, CA163068, and CA118809 and the Moffitt Cancer Center (to W. D. C. and L. C.).	Adams MR, 2000, MOL CELL BIOL, V20, P3633, DOI 10.1128/MCB.20.10.3633-3639.2000; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Cammas F, 2000, DEVELOPMENT, V127, P2955; Cammas F, 2004, GENE DEV, V18, P2147, DOI 10.1101/gad.302904; Cammas F, 2002, J CELL SCI, V115, P3439; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Chang CJ, 1998, MOL CELL BIOL, V18, P5880, DOI 10.1128/MCB.18.10.5880; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chong JL, 2009, MOL CELL BIOL, V29, P414, DOI 10.1128/MCB.01161-08; DeGregori J, 2006, CURR MOL MED, V6, P739; Flores AM, 1998, ONCOGENE, V16, P1289, DOI 10.1038/sj.onc.1201633; Freeman SN, 2008, J BIOL CHEM, V283, P2353, DOI 10.1074/jbc.M705986200; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Haura EB, 2005, CLIN CANCER RES, V11, P8288, DOI 10.1158/1078-0432.CCR-05-0827; He YW, 2000, ONCOGENE, V19, P3422, DOI 10.1038/sj.onc.1203682; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Johnson DG, 2006, CURR MOL MED, V6, P731; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; KOWALIK TF, 1995, J VIROL, V69, P2491, DOI 10.1128/JVI.69.4.2491-2500.1995; Lammens T, 2009, TRENDS CELL BIOL, V19, P111, DOI 10.1016/j.tcb.2009.01.002; Leone G, 1998, GENE DEV, V12, P2120, DOI 10.1101/gad.12.14.2120; Leone G, 2001, MOL CELL, V8, P105, DOI 10.1016/S1097-2765(01)00275-1; Leone G, 2000, MOL CELL BIOL, V20, P3626, DOI 10.1128/MCB.20.10.3626-3632.2000; Lindeman GJ, 1997, P NATL ACAD SCI USA, V94, P5095, DOI 10.1073/pnas.94.10.5095; Ma YH, 2003, J BIOL CHEM, V278, P16770, DOI 10.1074/jbc.M212702200; Ma YH, 2010, J BIOL CHEM, V285, P9813, DOI 10.1074/jbc.M109.091496; Marzio G, 2000, J BIOL CHEM, V275, P10887, DOI 10.1074/jbc.275.15.10887; Mascle XH, 2007, J BIOL CHEM, V282, P10190, DOI 10.1074/jbc.M611429200; Nakamura Y, 2006, INT J HEMATOL, V84, P377, DOI 10.1532/IJH97.06151; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Rambaud J, 2009, J BIOL CHEM, V284, P14147, DOI 10.1074/jbc.M809023200; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Su LJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-140; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Wang CG, 2005, J BIOL CHEM, V280, P12339, DOI 10.1074/jbc.C400536200; Wang CG, 2007, J BIOL CHEM, V282, P29902, DOI 10.1074/jbc.M704757200; Weinberg RA, 1996, CELL, V85, P457, DOI 10.1016/S0092-8674(00)81244-1; Yokoe T, 2010, ANN SURG ONCOL, V17, P821, DOI 10.1245/s10434-009-0795-8; Zheng Z, 2005, CHEST, V128, P308, DOI 10.1378/chest.128.1.308; Zheng Z, 2007, NEW ENGL J MED, V356, P800, DOI 10.1056/NEJMoa065411	47	69	74	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40106	40118		10.1074/jbc.M112.380865	http://dx.doi.org/10.1074/jbc.M112.380865			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23060449	hybrid, Green Published			2022-12-28	WOS:000311448800002
J	Hneino, M; Blirando, K; Buard, V; Tarlet, G; Benderitter, M; Hoodless, P; Francois, A; Milliat, F				Hneino, Mohammad; Blirando, Karl; Buard, Valerie; Tarlet, Georges; Benderitter, Marc; Hoodless, Pamela; Francois, Agnes; Milliat, Fabien			The TG-interacting Factor TGIF1 Regulates Stress-induced Proinflammatory Phenotype of Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMAD TRANSCRIPTIONAL COREPRESSOR; RADIATION ENTEROPATHY; IONIZING-RADIATION; KAPPA-B; MICE; INFLAMMATION; ACTIVATION; PATHWAY; INJURY; DAMAGE	The endothelium contributes to the control of the tissue inflammatory response following stress and in particular after exposure to ionizing radiation. We previously showed that the TG-interacting factor 1 (TGIF1) plays a role in radiation-induced normal tissue injury. In this study we hypothesized that this protein could play a role in inflammation. The role of TGIF1 in the stress-induced proinflammatory phenotype was investigated in human endothelial cells. In HUVECs ionizing radiation induces TGIF1 expression as well as a proinflammatory phenotype associated with up-regulation of IL-6, IL-8, CXCL1, MIP-2, and MCP-1. TGIF1 overexpression enhances the radiation-induced proinflammatory phenotype whereas TGIF1 silencing limits both the TNF-alpha- and radiation-induced overexpression of proinflammatory cytokines. Interestingly, in vivo, in radiation-induced intestinal inflammation in mice, TGIF1 genetic deficiency is associated with a reduced radiation-induced overexpression of proinflammatory molecules. In HUVECs, TNF-alpha and radiation-induced NF-kappa B pathway activation is not influenced by TGIF1 expression, whereas TGIF1 knockdown inhibits both TNF-alpha- and radiation-induced p38 MAPK pathway activation. This study demonstrates that TGIF1 plays a role in TNF-alpha- and radiation-induced inflammation and suggests that it could be a target in limiting this event in the vascular compartment.	[Hneino, Mohammad; Blirando, Karl; Buard, Valerie; Tarlet, Georges; Benderitter, Marc; Francois, Agnes; Milliat, Fabien] Inst Radiol Protect & Nucl Safety, Lab Radiopathol & Expt Therapeut, F-92262 Fontenay Aux Roses, France; [Hoodless, Pamela] Univ British Columbia, British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada	British Columbia Cancer Agency; University of British Columbia	Milliat, F (corresponding author), Inst Radiol Protect & Nucl Safety IRSN, Lab Radiopathol & Expt Therapeut, BP17, F-92262 Fontenay Aux Roses, France.	fabien.milliat@irsn.fr		Hoodless, Pamela/0000-0003-1371-0725; Milliat, Fabien/0000-0001-8249-9498; TARLET, Georges/0000-0002-4756-5127	Institute for Radiological Protection and Nuclear Safety	Institute for Radiological Protection and Nuclear Safety	This work was supported by the Institute for Radiological Protection and Nuclear Safety.	Abderrahmani R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035740; Amankulor NM, 2009, J NEUROSCI, V29, P10299, DOI 10.1523/JNEUROSCI.2500-09.2009; Anscher MS, 2010, ONCOLOGIST, V15, P350, DOI 10.1634/theoncologist.2009-S101; Barnett GC, 2009, NAT REV CANCER, V9, P134, DOI 10.1038/nrc2587; Bartholin L, 2006, MOL CELL BIOL, V26, P990, DOI 10.1128/MCB.26.3.990-1001.2006; Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Blirando K, 2011, AM J PATHOL, V178, P640, DOI 10.1016/j.ajpath.2010.10.003; Chou CH, 2009, INT J RADIAT ONCOL, V75, P1553, DOI 10.1016/j.ijrobp.2009.08.034; Demange C, 2009, MOL CELL, V36, P1073, DOI 10.1016/j.molcel.2009.12.009; Flanders KC, 2008, AM J PATHOL, V173, P68, DOI 10.2353/ajpath.2008.070937; Flanders KC, 2002, AM J PATHOL, V160, P1057, DOI 10.1016/S0002-9440(10)64926-7; Gaugler M-H, 2005, BRIT J RADIOL, V78, P100, DOI [10.1259/bjr/24511652, DOI 10.1259/BJR/24511652]; Halle M, 2010, J AM COLL CARDIOL, V55, P1227, DOI 10.1016/j.jacc.2009.10.047; Hneino M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035672; Holler V, 2009, J INVEST DERMATOL, V129, P1280, DOI 10.1038/jid.2008.360; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Kruse JJCM, 2009, RADIAT RES, V171, P188, DOI 10.1667/RR1526.1; Kuldo JM, 2005, AM J PHYSIOL-CELL PH, V289, pC1229, DOI 10.1152/ajpcell.00620.2004; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Mar L, 2006, MOL CELL BIOL, V26, P4302, DOI 10.1128/MCB.02156-05; Martin M, 2000, INT J RADIAT ONCOL, V47, P277, DOI 10.1016/S0360-3016(00)00435-1; Milliat F, 2008, AM J PATHOL, V172, P691, DOI 10.2353/ajpath.2008.070930; Milliat F, 2006, AM J PATHOL, V169, P1484, DOI 10.2353/ajpath.2006.060116; Molla M, 2007, WORLD J GASTROENTERO, V13, P3043, DOI 10.3748/wjg.v13.i22.3043; Nunez V, 2010, P NATL ACAD SCI USA, V107, P10626, DOI 10.1073/pnas.0913545107; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Pessah M, 2001, P NATL ACAD SCI USA, V98, P6198, DOI 10.1073/pnas.101579798; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Scharpfenecker M, 2009, INT J RADIAT ONCOL, V73, P506, DOI 10.1016/j.ijrobp.2008.09.052; Taniguchi K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002524; Wang JR, 2007, WORLD J GASTROENTERO, V13, P3047, DOI 10.3748/wjg.v13.i22.3047; Wotton D, 1999, J BIOL CHEM, V274, P37105, DOI 10.1074/jbc.274.52.37105; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6	33	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38913	38921		10.1074/jbc.M112.388389	http://dx.doi.org/10.1074/jbc.M112.388389			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22995913	Green Published, hybrid			2022-12-28	WOS:000310982800047
J	Meziane-Cherif, D; Saul, FA; Haouz, A; Courvalin, P				Meziane-Cherif, Djalal; Saul, Frederick A.; Haouz, Ahmed; Courvalin, Patrice			Structural and Functional Characterization of VanG D-Ala:D-Ser Ligase Associated with Vancomycin Resistance in Enterococcus faecalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-ALANINE LIGASE; D-LACTATE LIGASE; ALANYL-D-ALANINE; MULTIPLE SEQUENCE ALIGNMENT; LEUCONOSTOC-MESENTEROIDES; PEPTIDOGLYCAN PRECURSORS; GLYCOPEPTIDE RESISTANCE; CRYSTAL-STRUCTURE; GENE-CLUSTER; SUBSITE 2	D-Alanyl: D-lactate (D-Ala: D-Lac) and D-alanyl: D-serine ligases are key enzymes in vancomycin resistance of Gram-positive cocci. They catalyze a critical step in the synthesis of modified peptidoglycan precursors that are low binding affinity targets for vancomycin. The structure of the D-Ala: D-Lac ligase VanA led to the understanding of the molecular basis for its specificity, but that of D-Ala: D-Ser ligases had not been determined. We have investigated the enzymatic kinetics of the D-Ala: D-Ser ligase VanG from Enterococcus faecalis and solved its crystal structure in complex with ADP. The overall structure of VanG is similar to that of VanA but has significant differences mainly in the N-terminal and central domains. Based on reported mutagenesis data and comparison of the VanG and VanA structures, we show that residues Asp-243, Phe-252, and Arg-324 are molecular determinants for D-Ser selectivity. These residues are conserved in both enzymes and explain why VanA also displays D-Ala: D-Ser ligase activity, albeit with low catalytic efficiency in comparison with VanG. These observations suggest that D-Ala: D-Lac and D-Ala: D-Ser enzymes have evolved from a common ancestral D-Ala: D-X ligase. The crystal structure of VanG showed an unusual interaction between two dimers involving residues of the omega loop that are deeply anchored in the active site. We constructed an octapeptide mimicking the omega loop and found that it selectively inhibits VanG and VanA but not Staphylococcus aureus D-Ala: D-Ala ligase. This study provides additional insight into the molecular evolution of D-Ala: D-X ligases and could contribute to the development of new structure-based inhibitors of vancomycin resistance enzymes.	[Meziane-Cherif, Djalal; Courvalin, Patrice] Inst Pasteur, Unite Agents Antibacteriens, F-75724 Paris 15, France; [Saul, Frederick A.; Haouz, Ahmed] Inst Pasteur, CNRS, UMR3528, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Meziane-Cherif, D (corresponding author), Inst Pasteur, Unite Agents Antibacteriens, 25 Rue Dr Roux, F-75724 Paris 15, France.	djalal.meziane-cherif@pasteur.fr		HAOUZ, Ahmed/0000-0003-1196-1635				Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; ARTHUR M, 1992, ANTIMICROB AGENTS CH, V36, P867, DOI 10.1128/AAC.36.4.867; ARTHUR M, 1993, J BACTERIOL, V175, P117, DOI 10.1128/JB.175.1.117-127.1993; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boyd DA, 2008, ANTIMICROB AGENTS CH, V52, P2667, DOI 10.1128/AAC.01516-07; BUGG TDH, 1991, BIOCHEMISTRY-US, V30, P2017, DOI 10.1021/bi00222a002; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Courvalin P, 2006, CLIN INFECT DIS, V42, pS25, DOI 10.1086/491711; DAUB E, 1988, BIOCHEMISTRY-US, V27, P3701, DOI 10.1021/bi00410a027; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAN C, 1994, SCIENCE, V266, P439, DOI 10.1126/science.7939684; GROVES P, 1994, STRUCTURE, V2, P747, DOI 10.1016/S0969-2126(94)00075-1; Healy VL, 1998, CHEM BIOL, V5, P197, DOI 10.1016/S1074-5521(98)90633-0; Healy VL, 2000, CHEM BIOL, V7, pR109, DOI 10.1016/S1074-5521(00)00116-2; Kitamura Y, 2009, ACTA CRYSTALLOGR D, V65, P1098, DOI 10.1107/S0907444909029710; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuzin AP, 2000, STRUCT FOLD DES, V8, P463, DOI 10.1016/S0969-2126(00)00129-5; Lebreton F, 2011, ANTIMICROB AGENTS CH, V55, P4606, DOI 10.1128/AAC.00714-11; Lessard IAD, 1999, BIOCHEMISTRY-US, V38, P14006, DOI 10.1021/bi991384c; Liu SP, 2006, P NATL ACAD SCI USA, V103, P15178, DOI 10.1073/pnas.0604905103; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moubareck C, 2009, ANTIMICROB AGENTS CH, V53, P3657, DOI 10.1128/AAC.00338-09; MULLINS LS, 1990, J BIOL CHEM, V265, P8993; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NEUHAUS FC, 1962, J BIOL CHEM, V237, P3128; Neuhaus FC, 2011, J MOL GRAPH MODEL, V30, P31, DOI 10.1016/j.jmgm.2011.06.002; Neuhaus FC, 2010, J MOL GRAPH MODEL, V28, P728, DOI 10.1016/j.jmgm.2010.01.010; Park IS, 1997, P NATL ACAD SCI USA, V94, P10040, DOI 10.1073/pnas.94.19.10040; Park IS, 1997, J BIOL CHEM, V272, P9210; REYNOLDS PE, 1994, BIOCHEM J, V301, P5, DOI 10.1042/bj3010005; REYNOLDS PE, 1989, EUR J CLIN MICROBIOL, V8, P943, DOI 10.1007/BF01967563; Roper DI, 2000, P NATL ACAD SCI USA, V97, P8921, DOI 10.1073/pnas.150116497; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SHI Y, 1995, BIOCHEMISTRY-US, V34, P2768, DOI 10.1021/bi00009a005; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tytgat I, 2009, CURR MED CHEM, V16, P2566, DOI 10.2174/092986709788682029; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weber P, 2009, ACTA CRYSTALLOGR F, V65, P1024, DOI 10.1107/S1744309109033831; Wu DL, 2008, PROTEINS, V72, P1148, DOI 10.1002/prot.22009; Xu XG, 2010, ANTIMICROB AGENTS CH, V54, P4643, DOI 10.1128/AAC.01710-09	41	16	16	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.405522	http://dx.doi.org/10.1074/jbc.M112.405522			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22969085	Green Published, hybrid			2022-12-28	WOS:000310642200001
J	Wang, K; Yang, ZF; Liu, X; Mao, K; Nair, U; Klionsky, DJ				Wang, Ke; Yang, Zhifen; Liu, Xu; Mao, Kai; Nair, Usha; Klionsky, Daniel J.			Phosphatidylinositol 4-Kinases Are Required for Autophagic Membrane Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; ACTIN CYTOSKELETON; SELECTIVE AUTOPHAGY; BUDDING YEAST; GENE ENCODES; PATHWAYS; PROTEIN; GOLGI; MITOPHAGY; TRANSPORT	Macroautophagy (hereafter autophagy) is a degradative cellular pathway that protects eukaryotic cells from stress, starvation, and microbial infection. This process must be tightly controlled because too little or too much autophagy can be deleterious to cellular physiology. The phosphatidylinositol (PtdIns) 3-kinase Vps34 is a lipid kinase that regulates autophagy, but the role of other PtdIns kinases has not been examined. Here we demonstrate a role for PtdIns 4-kinases and PtdIns4P 5-kinases in selective and nonselective types of autophagy in yeast. The PtdIns 4-kinase Pik1 is involved in Atg9 trafficking through the Golgi and is involved in both nonselective and selective types of autophagy, whereas the PtdIns4P 5-kinase Mss4 is specifically involved in mitophagy but not nonselective autophagy. Our data indicate that phosphoinositide kinases have multiple roles in the regulation of autophagic pathways.	[Klionsky, Daniel J.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mol Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Cellular Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Dev Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Klionsky, DJ (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	klionsky@umich.edu			National Institutes of Health [GM053396]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM053396 (to D. J. K.).	Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5; BANKAITIS VA, 1989, J CELL BIOL, V108, P1271, DOI 10.1083/jcb.108.4.1271; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; Cao Y, 2007, AUTOPHAGY, V3, P17, DOI 10.4161/auto.3371; Desrivieres S, 1998, J BIOL CHEM, V273, P15787, DOI 10.1074/jbc.273.25.15787; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Ferguson CJ, 2009, HUM MOL GENET, V18, P4868, DOI 10.1093/hmg/ddp460; Geng JF, 2010, MOL BIOL CELL, V21, P2257, DOI 10.1091/mbc.E09-11-0969; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; Han GS, 2002, J BIOL CHEM, V277, P47709, DOI 10.1074/jbc.M207996200; He CC, 2007, AUTOPHAGY, V3, P271, DOI 10.4161/auto.3912; He CC, 2008, MOL BIOL CELL, V19, P5506, DOI 10.1091/mbc.E08-05-0544; Hendricks KB, 1999, NAT CELL BIOL, V1, P234, DOI 10.1038/12058; Ho CY, 2012, TRAFFIC, V13, P1, DOI 10.1111/j.1600-0854.2011.01246.x; Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200; Kanki T, 2010, AUTOPHAGY, V6, P278, DOI 10.4161/auto.6.2.10901; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kim J, 2001, J CELL BIOL, V152, P51, DOI 10.1083/jcb.152.1.51; Klionsky DJ, 2011, AUTOPHAGY, V7, P1273, DOI 10.4161/auto.7.11.17661; KLIONSKY DJ, 1989, EMBO J, V8, P2241, DOI 10.1002/j.1460-2075.1989.tb08348.x; Labbe S, 1999, METHOD ENZYMOL, V306, P145; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Manjithaya R, 2010, J CELL BIOL, V189, P303, DOI 10.1083/jcb.200909154; Mao K, 2011, J CELL BIOL, V193, P755, DOI 10.1083/jcb.201102092; Mari M, 2010, J CELL BIOL, V190, P1005, DOI 10.1083/jcb.200912089; Monastyrska I, 2008, MOL BIOL CELL, V19, P1962, DOI 10.1091/mbc.E07-09-0892; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Reggiori F, 2005, MOL BIOL CELL, V16, P5843, DOI 10.1091/mbc.E05-07-0629; Reggiori F, 2004, DEV CELL, V6, P79, DOI 10.1016/S1534-5807(03)00402-7; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; Shahnazari S, 2010, CELL HOST MICROBE, V8, P137, DOI 10.1016/j.chom.2010.07.002; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Strahl T, 2005, J CELL BIOL, V171, P967, DOI 10.1083/jcb.200504104; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Stromhaug PE, 2004, MOL BIOL CELL, V15, P3553, DOI 10.1091/mbc.E04-02-0147; van der Vaart A, 2010, MOL BIOL CELL, V21, P2270, DOI 10.1091/mbc.E09-04-0345; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yamashita SI, 2006, J CELL BIOL, V173, P709, DOI 10.1083/jcb.200512142; YOSHIDA S, 1994, J BIOL CHEM, V269, P1166	45	50	53	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.371591	http://dx.doi.org/10.1074/jbc.M112.371591			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22977244	Green Published, hybrid			2022-12-28	WOS:000310642200031
J	Kim, C; Milheirico, C; Gardete, S; Holmes, MA; Holden, MTG; de Lencastre, H; Tomasz, A				Kim, Choonkeun; Milheirico, Catarina; Gardete, Susana; Holmes, Mark A.; Holden, Matt T. G.; de Lencastre, Herminia; Tomasz, Alexander			Properties of a Novel PBP2A Protein Homolog from Staphylococcus aureus Strain LGA251 and Its Contribution to the beta-Lactam-resistant Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENICILLIN-BINDING PROTEINS; METHICILLIN-RESISTANT; CELL-WALL; STREPTOCOCCUS-PNEUMONIAE; MECA GENE; ANTIBIOTICS; CEFTOBIPROLE; CEFTAROLINE; EXPRESSION; AFFINITY	Methicillin-resistant Staphylococcus aureus (MRSA) strains show strain-to-strain variation in resistance level, in genetic background, and also in the structure of the chromosomal cassette (SCCmec) that carries the resistance gene mecA. In contrast, strain-to-strain variation in the sequence of the mecA determinant was found to be much more limited among MRSA isolates examined so far. The first exception to this came with the recent identification of MRSA strain LGA251, which carries a new homolog of this gene together with regulatory elements mecI/mecR that also have novel, highly divergent structures. After cloning and purification in Escherichia coli, PBP2A(LGA), the protein product of the new mecA homolog, showed aberrant mobility in SDS-PAGE, structural instability and loss of activity at 37 degrees C, and a higher relative affinity for oxacillin as compared with cefoxitin. The mecA homolog free of its regulatory elements was cloned into a plasmid and introduced into the background of the beta-lactam-susceptible S. aureus strain COL-S. In this background, the mecA homolog expressed a high-level resistance to cefoxitin (MIC = 400 mu g/ml) and a somewhat lower resistance to oxacillin (minimal inhibitory concentration = 200 mu g/ml). Similar to PBP2A, the protein homolog PBP2A(LGA) was able to replace the essential function of the S. aureus PBP2 for growth. In contrast to PBP2A, PBP2A(LGA) did not depend on the transglycosylase activity of the native PBP2 for expression of high level resistance to oxacillin, suggesting that the PBP2A homolog may preferentially cooperate with a monofunctional transglycosylase as the alternative source of transglycosylase activity.	[Kim, Choonkeun; Gardete, Susana; de Lencastre, Herminia; Tomasz, Alexander] Rockefeller Univ, Lab Microbiol & Infect Dis, New York, NY 10065 USA; [Milheirico, Catarina; Gardete, Susana; de Lencastre, Herminia] Univ Nova Lisboa, Mol Genet Lab, Inst Tecnol Quim & Biol, P-2780 Oeiras, Portugal; [Holmes, Mark A.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; [Holden, Matt T. G.] Wellcome Trust Sanger Inst, Cambridge CB10 1RQ, England	Rockefeller University; Universidade Nova de Lisboa; University of Cambridge; Wellcome Trust Sanger Institute	Tomasz, A (corresponding author), Rockefeller Univ, Lab Microbiol & Infect Dis, 1230 York Ave, New York, NY 10065 USA.	tomasz@rockefeller.edu	Holden, Matthew TG/K-6449-2014; /AAT-3815-2021	Holden, Matthew TG/0000-0002-4958-2166; Holmes, Mark/0000-0002-5454-1625; /0000-0001-6816-8932; Milheirico, Catarina/0000-0002-2825-8850; Tomasz, Alexander/0000-0003-1520-1983; Kim, Choon/0000-0003-0306-8935	United States Public Health Service Grant [2 RO1 AI457838-13]; Fundacao para a Ciencia e Tecnologia (FCT), Portugal [PEst-OE/EQB/LA0004/2011]; FCT [SFRH/BPD/63992/2009, SFRH/BPD/25403/2005]; Palm Beach Infectious Disease Institute, Florida; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045738] Funding Source: NIH RePORTER; Medical Research Council [G1001787] Funding Source: researchfish; MRC [G1001787] Funding Source: UKRI	United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Palm Beach Infectious Disease Institute, Florida; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Partial support for this work was provided by United States Public Health Service Grant 2 RO1 AI457838-13 (to A. T.). This work was also supported by Fundacao para a Ciencia e Tecnologia (FCT) project PEst-OE/EQB/LA0004/2011, Portugal; by FCT Grants SFRH/BPD/63992/2009 (to C. M.) and SFRH/BPD/25403/2005 (to S. G.); and by a fellowship from the Palm Beach Infectious Disease Institute, Florida.	Antignac A, 2009, ANTIMICROB AGENTS CH, V53, P435, DOI 10.1128/AAC.01099-08; CHAMBERS HF, 1990, J INFECT DIS, V161, P1170, DOI 10.1093/infdis/161.6.1170; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Chung M, 2008, ANTIMICROB AGENTS CH, V52, P2709, DOI 10.1128/AAC.00266-08; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Cuny C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024360; Davies TA, 2007, ANTIMICROB AGENTS CH, V51, P2621, DOI 10.1128/AAC.00029-07; DELENCASTRE H, 1991, ANTIMICROB AGENTS CH, V35, P632, DOI 10.1128/AAC.35.4.632; Figueiredo TA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002508; Fuda C, 2006, J BIOL CHEM, V281, P10035, DOI 10.1074/jbc.M508846200; Fuda C, 2004, J BIOL CHEM, V279, P40802, DOI 10.1074/jbc.M403589200; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Gardete S, 2006, MICROBIOL-SGM, V152, P2549, DOI 10.1099/mic.0.29078-0; Gardete S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002505; HARTMAN BJ, 1984, J BACTERIOL, V158, P513, DOI 10.1128/JB.158.2.513-516.1984; HARTMAN BJ, 1986, ANTIMICROB AGENTS CH, V29, P85, DOI 10.1128/AAC.29.1.85; Ito T, 1999, ANTIMICROB AGENTS CH, V43, P1449, DOI 10.1128/AAC.43.6.1449; JEVONS MP, 1961, BRIT MED J, V1, P124, DOI 10.1136/bmj.1.5219.124-a; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kosowska-Shick K, 2010, ANTIMICROB AGENTS CH, V54, P1670, DOI 10.1128/AAC.00019-10; KRAEMER GR, 1990, CURR MICROBIOL, V21, P373, DOI 10.1007/BF02199440; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lovering AL, 2007, SCIENCE, V315, P1402, DOI 10.1126/science.1136611; Moisan H, 2010, J ANTIMICROB CHEMOTH, V65, P713, DOI 10.1093/jac/dkp503; Monk IR, 2012, MBIO, V3, DOI 10.1128/mBio.00277-11; OSHIDA T, 1992, J BACTERIOL, V174, P4952, DOI 10.1128/JB.174.15.4952-4959.1992; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Pereira SFF, 2007, J BACTERIOL, V189, P3525, DOI 10.1128/JB.00044-07; Pinho MG, 2001, P NATL ACAD SCI USA, V98, P10886, DOI 10.1073/pnas.191260798; Pinho MG, 2001, J BACTERIOL, V183, P6525, DOI 10.1128/JB.183.22.6525-6531.2001; Reed P, 2011, J BACTERIOL, V193, P2549, DOI 10.1128/JB.01474-10; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P3765, DOI 10.1128/AAC.00187-11; Steinle A, 2001, IMMUNOGENETICS, V53, P279, DOI 10.1007/s002510100325; Wu SW, 2001, J BACTERIOL, V183, P2417, DOI 10.1128/JB.183.8.2417-2424.2001; Zhao GS, 1999, ANTIMICROB AGENTS CH, V43, P1124, DOI 10.1128/AAC.43.5.1124; Zhou YJ, 2008, J BACTERIOL, V190, P508, DOI 10.1128/JB.01549-07	36	91	97	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36854	36863		10.1074/jbc.M112.395962	http://dx.doi.org/10.1074/jbc.M112.395962			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22977239	Green Published, hybrid			2022-12-28	WOS:000310588500022
J	Rogers, H; Wang, L; Yu, XB; Alnaeeli, M; Cui, KR; Zhao, KJ; Bieker, JJ; Prchal, J; Huang, SM; Weksler, B; Noguchi, CT				Rogers, Heather; Wang, Li; Yu, Xiaobing; Alnaeeli, Mawadda; Cui, Kairong; Zhao, Keji; Bieker, James J.; Prchal, Josef; Huang, Suming; Weksler, Babette; Noguchi, Constance Tom			T-cell Acute Leukemia 1 (TAL1) Regulation of Erythropoietin Receptor and Association with Excessive Erythrocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; TRANSCRIPTION FACTOR GATA-1; ERYTHROID-CELLS; HEMATOPOIETIC DEVELOPMENT; FAMILIAL ERYTHROCYTOSIS; CHROMATIN OCCUPANCY; OXYGEN HOMEOSTASIS; POLYCYTHEMIA-VERA; GENE-EXPRESSION; POSITIVE ROLE	During erythropoiesis, erythropoietin stimulates induction of erythroid transcription factors that activate expression of erythroid genes including the erythropoietin receptor (EPO-R) that results in increased sensitivity to erythropoietin. DNA binding of the basic helix-loop-helix transcription factor, TAL1/SCL, is required for normal erythropoiesis. A link between elevated TAL1 and excessive erythrocytosis is suggested by erythroid progenitor cells from a patient that exhibits unusually high sensitivity to erythropoietin with concomitantly elevated TAL1 and EPO-R expression. We found that TAL1 regulates EPO-R expression mediated via three conserved E-box binding motifs (CAGCTG) in the EPO-R 5' untranslated transcribed region. TAL1 increases association of the GATA-1.TAL1.LMO2.LDB1 transcription activation complex to the region that includes the transcription start site and the 5' GATA and 3' E-box motifs flanking the EPO-R transcription start site suggesting that TAL1 promotes accessibility of this region. Nucleosome shifting has been demonstrated to facilitate TAL1 but not GATA-1 binding to regulate target gene expression. Accordingly, we observed that with induced expression of EPO-R in hemotopoietic progenitor cells, nucleosome phasing shifts to increase the linker region containing the EPO-R transcription start site and TAL1 binds to the flanking 5' GATA and 3' E-box regions of the promoter. These data suggest that TAL1 binds to the EPO-R promoter to activate EPO-R expression and provides a potential link to elevated EPO-R expression leading to hypersensitivity to erythropoietin and the resultant excessive erythrocytosis.	[Rogers, Heather; Wang, Li; Yu, Xiaobing; Alnaeeli, Mawadda; Noguchi, Constance Tom] NIDDK, Mol Med Branch, Bethesda, MD 20892 USA; [Cui, Kairong; Zhao, Keji] NHLBI, NIH, Lab Mol Immunol, Bethesda, MD 20892 USA; [Bieker, James J.] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Prchal, Josef] Univ Utah, Div Hematol, Salt Lake City, UT 84132 USA; [Prchal, Josef] VAH, Salt Lake City, UT 84132 USA; [Huang, Suming] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL USA; [Huang, Suming] Univ Florida, Coll Med, Shands Canc Ctr, Gainesville, FL USA; [Weksler, Babette] Cornell Univ, Weill Med Coll, Div Hematol Oncol, New York, NY 10065 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Icahn School of Medicine at Mount Sinai; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Cornell University	Noguchi, CT (corresponding author), Bldg 10,Rm 9N319,10 Ctr Dr,MSC 1822, Bethesda, MD 20892 USA.	connien@helix.nih.gov	cheng, yong/I-4270-2012		National Institutes of Health Intramural Research Program of the NIDDK; NATIONAL CANCER INSTITUTE [P01CA108671] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006030, ZIAHL006031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025061, R01DK046865] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the NIDDK; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NIDDK.	Agarwal N, 2007, ADV EXP MED BIOL, V618, P195; Anderson KP, 2000, BLOOD, V95, P1652, DOI 10.1182/blood.V95.5.1652.005k23_1652_1655; Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; [Anonymous], SCI; Aplan PD, 2006, TRENDS GENET, V22, P46, DOI 10.1016/j.tig.2005.10.002; APLAN PD, 1992, BLOOD, V79, P1327; Arcasoy MO, 1999, EXP HEMATOL, V27, P63, DOI 10.1016/S0301-472X(98)00003-4; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bockamp EO, 1997, J BIOL CHEM, V272, P8781, DOI 10.1074/jbc.272.13.8781; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507; CHIN K, 1995, NUCLEIC ACIDS RES, V23, P3041, DOI 10.1093/nar/23.15.3041; Delabesse E, 2005, MOL CELL BIOL, V25, P5215, DOI 10.1128/MCB.25.12.5215-5225.2005; Elefanty AG, 1997, BLOOD, V90, P1435, DOI 10.1182/blood.V90.4.1435.1435_1435_1447; Fernandez LA, 2001, MOL CELL BIOL, V21, P196, DOI 10.1128/MCB.21.1.196-208.2001; Fibach E, 1998, HEMOGLOBIN, V22, P445, DOI 10.3109/03630269809071542; Fine BM, 2004, BLOOD, V103, P1043, DOI 10.1182/blood-2003-05-1518; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Gottgens B, 2002, EMBO J, V21, P3039, DOI 10.1093/emboj/cdf286; Hall MA, 2005, MOL CELL BIOL, V25, P6355, DOI 10.1128/MCB.25.15.6355-6362.2005; Hu GQ, 2011, GENOME RES, V21, P1650, DOI 10.1101/gr.121145.111; Hu X, 2009, EPIGENETICS-US, V4, P257, DOI 10.4161/epi.4.6.9711; Hu X, 2009, P NATL ACAD SCI USA, V106, P10141, DOI 10.1073/pnas.0900437106; Huang S, 2000, MOL CELL BIOL, V20, P2248, DOI 10.1128/MCB.20.6.2248-2259.2000; Huang SM, 2000, EMBO J, V19, P6792, DOI 10.1093/emboj/19.24.6792; Ismailoglu I, 2008, EXP HEMATOL, V36, P1593, DOI 10.1016/j.exphem.2008.07.005; Kassouf MT, 2008, BLOOD, V112, P1056, DOI 10.1182/blood-2007-12-128900; Kassouf MT, 2010, GENOME RES, V20, P1064, DOI 10.1101/gr.104935.110; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Meier N, 2006, DEVELOPMENT, V133, P4913, DOI 10.1242/dev.02656; Meyer L, 2007, BLOOD, V109, P5215, DOI 10.1182/blood-2006-10-055350; NOGUCHI CT, 1991, BLOOD, V78, P2548; Nussenzveig RH, 2007, EXP HEMATOL, V35, P32, DOI 10.1016/j.exphem.2006.11.012; Percy MJ, 2008, NEW ENGL J MED, V358, P162, DOI 10.1056/NEJMoa073123; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; Pope NJ, 2010, NUCLEIC ACIDS RES, V38, P2190, DOI 10.1093/nar/gkp1159; Ravet E, 2004, BLOOD, V103, P3326, DOI 10.1182/blood-2003-05-1689; Rogers HM, 2008, EXP HEMATOL, V36, P17, DOI 10.1016/j.exphem.2007.08.014; Russell LJ, 2009, LEUKEMIA, V23, P614, DOI 10.1038/leu.2008.250; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schuh AH, 2005, MOL CELL BIOL, V25, P10235, DOI 10.1128/MCB.25.23.10235-10250.2005; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Sengupta T, 2009, P NATL ACAD SCI USA, V106, P4213, DOI 10.1073/pnas.0808347106; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; Vyas P, 1999, DEVELOPMENT, V126, P2799; Wang L, 2012, J BIOL CHEM, V287, P30157, DOI 10.1074/jbc.M112.376640; Wilson NK, 2009, BLOOD, V113, P5456, DOI 10.1182/blood-2009-01-200048; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Xu ZX, 2003, MOL CELL BIOL, V23, P7585, DOI 10.1128/MCB.23.21.7585-7599.2003; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; ZON LI, 1991, P NATL ACAD SCI USA, V88, P10638, DOI 10.1073/pnas.88.23.10638	53	10	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36720	36731		10.1074/jbc.M112.378398	http://dx.doi.org/10.1074/jbc.M112.378398			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22982397	Green Published, hybrid			2022-12-28	WOS:000310588500010
J	Thakur, P; Dadsetan, S; Fomina, AF				Thakur, Pratima; Dadsetan, Sepehr; Fomina, Alla F.			Bidirectional Coupling between Ryanodine Receptors and Ca2+ Release-activated Ca2+ (CRAC) Channel Machinery Sustains Store-operated Ca2+ Entry in Human T Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN DENDRITIC CELLS; HUMAN B-LYMPHOCYTES; CYCLIC ADP-RIBOSE; PLASMA-MEMBRANE; SKELETAL-MUSCLE; MONOCLONAL-ANTIBODIES; INTRACELLULAR CALCIUM; MOLECULAR-BASIS; FEEDER CELLS; EXPRESSION	The expression and functional significance of ryanodine receptors (RyR) were investigated in resting and activated primary human T cells. RyR1, RyR2, and RyR3 transcripts were detected in human T cells. RyR1/2 transcript levels increased, whereas those of RyR3 decreased after T cell activation. RyR1/2 protein immunoreactivity was detected in activated but not in resting T cells. The RyR agonist caffeine evoked Ca2+ release from the intracellular store in activated T cells but not in resting T cells, indicating that RyR are functionally up-regulated in activated T cells compared with resting T cells. In the presence of store-operated Ca2+ entry (SOCE) via plasmalemmal Ca2+ release-activated Ca2+ (CRAC) channels, RyR blockers reduced the Ca2+ leak from the endoplasmic reticulum (ER) and the magnitude of SOCE, suggesting that a positive feedback relationship exists between RyR and CRAC channels. Overexpression of fluorescently tagged RyR2 and stromal interaction molecule 1 (STIM1), an ER Ca2+ sensor gating CRAC channels, in HEK293 cells revealed that RyR are co-localized with STIM1 in the puncta formed after store depletion. These data indicate that in primary human T cells, the RyR are coupled to CRAC channel machinery such that SOCE activates RyR via a Ca2+ induced Ca2+ release mechanism, which in turn reduces the Ca2+ concentration within the ER lumen in the vicinity of STIM1, thus facilitating SOCE by reducing store-dependent CRAC channel inactivation. Treatment with RyR blockers suppressed activated T cell expansion, demonstrating the functional importance of RyR in T cells.	[Thakur, Pratima; Dadsetan, Sepehr; Fomina, Alla F.] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Fomina, AF (corresponding author), Univ Calif Davis, Dept Physiol & Membrane Biol, 1 Shields Ave, Davis, CA 95616 USA.	affomina@ucdavis.edu						AIREY JA, 1993, BIOCHEMISTRY-US, V32, P5739, DOI 10.1021/bi00073a003; AIREY JA, 1990, J BIOL CHEM, V265, P14187; Berg I, 2000, J CELL BIOL, V150, P581, DOI 10.1083/jcb.150.3.581; Bergling S, 1998, CELL CALCIUM, V23, P251, DOI 10.1016/S0143-4160(98)90123-3; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bracci L, 2007, J CELL SCI, V120, P2232, DOI 10.1242/jcs.007203; Burdakov D, 2005, CELL CALCIUM, V38, P303, DOI 10.1016/j.ceca.2005.06.010; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; Clark JH, 2010, J BIOL CHEM, V285, P13542, DOI 10.1074/jbc.M110.101485; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.bi.63.070194.005145; Dadsetan S, 2008, J BIOL CHEM, V283, P12512, DOI 10.1074/jbc.M709330200; Dammermann W, 2005, J BIOL CHEM, V280, P21394, DOI 10.1074/jbc.M413085200; Dammermann W, 2009, P NATL ACAD SCI USA, V106, P10678, DOI 10.1073/pnas.0809997106; Datta S, 2009, TRENDS IMMUNOL, V30, P430, DOI 10.1016/j.it.2009.06.002; Dolganov GM, 2001, GENOME RES, V11, P1473, DOI 10.1101/gr.191301; Du GG, 1998, J BIOL CHEM, V273, P33259, DOI 10.1074/jbc.273.50.33259; Dustin ML, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002311; Fanger CM, 2000, J IMMUNOL, V164, P1153, DOI 10.4049/jimmunol.164.3.1153; Feske S, 2011, ANN NY ACAD SCI, V1238, P74, DOI 10.1111/j.1749-6632.2011.06240.x; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Fomina AF, 2000, J CELL BIOL, V150, P1435, DOI 10.1083/jcb.150.6.1435; Gasser A, 2006, J BIOL CHEM, V281, P2489, DOI 10.1074/jbc.M506525200; GEPPERT TD, 1988, J CLIN INVEST, V81, P1497, DOI 10.1172/JCI113481; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Guse AH, 1999, NATURE, V398, P70, DOI 10.1038/18024; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hosoi E, 2001, J IMMUNOL, V167, P4887, DOI 10.4049/jimmunol.167.9.4887; JENKINS MK, 1990, J IMMUNOL, V144, P16; Kalamasz D, 2004, J IMMUNOTHER, V27, P405, DOI 10.1097/00002371-200409000-00010; Karamitros D, 2011, CRIT REV IMMUNOL, V31, P209, DOI 10.1615/CritRevImmunol.v31.i3.30; Kruisbeek A. M., 2004, CURR PROTOC IMMUNOL; Krummel MF, 2010, J CLIN IMMUNOL, V30, P364, DOI 10.1007/s10875-010-9393-6; Kunerth S, 2004, J CELL SCI, V117, P2141, DOI 10.1242/jcs.01063; Langhorst MF, 2004, CELL SIGNAL, V16, P1283, DOI 10.1016/j.cellsig.2004.03.013; Levine BL, 1997, J IMMUNOL, V159, P5921; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Li P, 2001, J GEN PHYSIOL, V118, P33, DOI 10.1085/jgp.118.1.33; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Lioudyno MI, 2008, P NATL ACAD SCI USA, V105, P2011, DOI 10.1073/pnas.0706122105; Liu Z, 2010, J CELL SCI, V123, P1775, DOI 10.1242/jcs.064071; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Manjarres IM, 2010, CELL CALCIUM, V47, P412, DOI 10.1016/j.ceca.2010.03.001; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; Metcalfe J C, 1980, Biochem Soc Symp, V45, P1; Nagaleekar VK, 2008, J IMMUNOL, V181, P8315, DOI 10.4049/jimmunol.181.12.8315; NEGULESCU PA, 1994, P NATL ACAD SCI USA, V91, P2873, DOI 10.1073/pnas.91.7.2873; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Nori A, 1996, CELL CALCIUM, V19, P375, DOI 10.1016/S0143-4160(96)90110-4; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Petersen OH, 2007, CELL CALCIUM, V42, P373, DOI 10.1016/j.ceca.2007.05.012; RAO A, 1994, IMMUNOL TODAY, V15, P274, DOI 10.1016/0167-5699(94)90007-8; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwarzmann N, 2002, J BIOL CHEM, V277, P50636, DOI 10.1074/jbc.M209061200; Sei Y, 1999, J BIOL CHEM, V274, P5995, DOI 10.1074/jbc.274.9.5995; Sei Y, 2001, CELL CALCIUM, V29, P149, DOI 10.1054/ceca.2000.0175; Smyth JT, 2008, J CELL SCI, V121, P762, DOI 10.1242/jcs.023903; SunderPlassmann R, 1996, BLOOD, V87, P5179, DOI 10.1182/blood.V87.12.5179.bloodjournal87125179; Swain SL, 1999, CURR OPIN IMMUNOL, V11, P180, DOI 10.1016/S0952-7915(99)80030-2; Sweeney ZK, 2009, CHEMMEDCHEM, V4, P707, DOI 10.1002/cmdc.200800452; Alonso MT, 2012, MOL CELL ENDOCRINOL, V353, P37, DOI 10.1016/j.mce.2011.08.021; Uemura Y, 2007, BIOCHEM BIOPH RES CO, V362, P510, DOI 10.1016/j.bbrc.2007.08.024; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Vukcevic M, 2008, J BIOL CHEM, V283, P34913, DOI 10.1074/jbc.M804472200; Wang RW, 2007, J BIOL CHEM, V282, P17785, DOI 10.1074/jbc.M700660200; Wenning AS, 2011, BBA-MOL CELL RES, V1813, P412, DOI 10.1016/j.bbamcr.2010.12.022; Wu MM, 2007, CELL CALCIUM, V42, P163, DOI 10.1016/j.ceca.2007.03.003; Wulff H, 2003, CURR OPIN DRUG DI DE, V6, P640; Zalk R, 2007, ANNU REV BIOCHEM, V76, P367, DOI 10.1146/annurev.biochem.76.053105.094237; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813; Zucchi R, 1997, PHARMACOL REV, V49, P1; ZWEIFACH A, 1995, J BIOL CHEM, V270, P14445, DOI 10.1074/jbc.270.24.14445	77	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37233	37244		10.1074/jbc.M112.398974	http://dx.doi.org/10.1074/jbc.M112.398974			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22948152	Green Published, hybrid			2022-12-28	WOS:000310588500056
J	Hong, M; Bao, L; Kefaloyianni, E; Agullo-Pascual, E; Chkourko, H; Foster, M; Taskin, E; Zhandre, M; Reid, DA; Rothenberg, E; Delmar, M; Coetzee, WA				Hong, Miyoun; Bao, Li; Kefaloyianni, Eirini; Agullo-Pascual, Esperanza; Chkourko, Halina; Foster, Monique; Taskin, Eylem; Zhandre, Marine; Reid, Dylan A.; Rothenberg, Eli; Delmar, Mario; Coetzee, William A.			Heterogeneity of ATP-sensitive K+ Channels in Cardiac Myocytes ENRICHMENT AT THE INTERCALATED DISK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEART-MUSCLE CELLS; ADHERING JUNCTIONS; ANKYRIN-G; COLOCALIZATION ANALYSIS; MACROMOLECULAR COMPLEX; FLUORESCENT-PROBES; AREA-COMPOSITA; EXPRESSION; MICROSCOPY; PLAKOPHILIN-2	Ventricular ATP-sensitive potassium (K-ATP) channels link intracellular energy metabolism to membrane excitability and contractility. Our recent proteomics experiments identified plakoglobin and plakophilin-2 (PKP2) as putative K-ATP channel-associated proteins. We investigated whether the association of K-ATP channel subunits with junctional proteins translates to heterogeneous subcellular distribution within a cardiac myocyte. Co-immunoprecipitation experiments confirmed physical interaction between K-ATP channels and PKP2 and plakoglobin in rat heart. Immunolocalization experiments demonstrated that K-ATP channel subunits (Kir6.2 and SUR2A) are expressed at a higher density at the intercalated disk in mouse and rat hearts, where they co-localized with PKP2 and plakoglobin. Super-resolution microscopy demonstrate that K-ATP channels are clustered within nanometer distances from junctional proteins. The local K-ATP channel density, recorded in excised inside-out patches, was larger at the cell end when compared with local currents recorded from the cell center. The K-ATP channel unitary conductance, block by MgATP and activation by MgADP, did not differ between these two locations. Whole cell K-ATP channel current density (activated by metabolic inhibition) was similar to 40% smaller in myocytes from mice haploinsufficient for PKP2. Experiments with excised patches demonstrated that the regional heterogeneity of K-ATP channels was absent in the PKP2 deficient mice, but the K-ATP channel unitary conductance and nucleotide sensitivities remained unaltered. Our data demonstrate heterogeneity of K-ATP channel distribution within a cardiac myocyte. The higher K-ATP channel density at the intercalated disk implies a possible role at the intercellular junctions during cardiac ischemia.	[Coetzee, William A.] NYU, Sch Med, Dept Pediat, Alexandria Ctr Life Sci, New York, NY 10016 USA; [Agullo-Pascual, Esperanza; Chkourko, Halina; Delmar, Mario] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Coetzee, William A.] NYU, Sch Med, Dept Physiol & Neurosci, New York, NY 10016 USA; [Reid, Dylan A.; Rothenberg, Eli; Coetzee, William A.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA	New York University; New York University; New York University; New York University	Coetzee, WA (corresponding author), NYU, Sch Med, Dept Pediat, Alexandria Ctr Life Sci, 450 E 29th St,Floor 8 824, New York, NY 10016 USA.	william.coetzee@nyu.edu	Taskin, Eylem/AAD-6802-2020; Kefalogianni, Eirini/T-6913-2019	Rothenberg, Eli/0000-0002-1382-1380; Hong, Miyoun/0000-0003-4475-1140; Delmar, Mario/0000-0002-2085-5589; Taskin, Eylem/0000-0001-8172-4980; Kefalogianni, Eirini/0000-0001-9132-3902; Coetzee, William/0000-0003-1522-8326	National Institutes of Health [HL105046, R01-HL085820, R21-HL093563, R01-HL106632, P01-HL087226]; Leducq Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106632, R01HL085820, R21HL093563, P01HL087226, F32HL105046] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL105046 (to L. B.); R01-HL085820 and R21-HL093563 (to W. A. C.); and R01-HL106632 and P01-HL087226. This work was also supported by a grant from the Leducq Foundation (to M. D.).	Bao L, 2011, CIRC-ARRHYTHMIA ELEC, V4, P926, DOI 10.1161/CIRCEP.111.964643; Bao L, 2011, AM J PHYSIOL-HEART C, V300, pH262, DOI 10.1152/ajpheart.00857.2010; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Cerrone M, 2012, CARDIOVASC RES, V95, P460, DOI 10.1093/cvr/cvs218; Cheng L, 2011, J BIOL CHEM, V286, P20478, DOI 10.1074/jbc.M111.218560; Delmar M, 2004, HEART RHYTHM, V1, P12, DOI 10.1016/j.hrthm.2004.02.003; Delmar M, 2010, CIRC RES, V107, P700, DOI 10.1161/CIRCRESAHA.110.223412; Dhar-Chowdhury P, 2005, J BIOL CHEM, V280, P38464, DOI 10.1074/jbc.M508744200; Flagg TP, 2008, CIRC RES, V103, P1458, DOI 10.1161/CIRCRESAHA.108.178186; Franke WW, 2006, EUR J CELL BIOL, V85, P69, DOI 10.1016/j.ejcb.2005.11.003; Graciotti L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027034; Grossmann KS, 2004, J CELL BIOL, V167, P149, DOI 10.1083/jcb.200402096; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Henriques R, 2010, NAT METHODS, V7, P339, DOI 10.1038/nmeth0510-339; Hong MY, 2011, FASEB J, V25, P2456, DOI 10.1096/fj.10-176669; Kline CF, 2009, P NATL ACAD SCI USA, V106, P16669, DOI 10.1073/pnas.0907138106; Korchev YE, 2000, NAT CELL BIOL, V2, P616, DOI 10.1038/35023563; Li JF, 2012, J CELL SCI, V125, P1058, DOI 10.1242/jcs.098640; Li JF, 2010, DERMAT RES PRACT, V2010, DOI 10.1155/2010/207835; Li JD, 2010, J BIOL CHEM, V285, P28723, DOI 10.1074/jbc.M110.147868; Lin XM, 2011, HEART RHYTHM, V8, P1923, DOI 10.1016/j.hrthm.2011.07.016; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; Malkusch S, 2012, HISTOCHEM CELL BIOL, V137, P1, DOI 10.1007/s00418-011-0880-5; Milstein ML, 2012, P NATL ACAD SCI USA, V109, pE2134, DOI 10.1073/pnas.1109370109; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Morrissey Alison, 2005, BMC Physiol, V5, P1, DOI 10.1186/1472-6793-5-1; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Petitprez S, 2011, CIRC RES, V108, P294, DOI 10.1161/CIRCRESAHA.110.228312; Pieperhoff S, 2007, EUR J CELL BIOL, V86, P377, DOI 10.1016/j.ejcb.2007.04.001; Priebe L, 1996, J PHYSIOL-LONDON, V492, P405, DOI 10.1113/jphysiol.1996.sp021317; Rizzo S, 2012, CARDIOVASC RES, V95, P409, DOI 10.1093/cvr/cvs219; Rudini N, 2008, CURR BIOL, V18, pR1080, DOI 10.1016/j.cub.2008.09.018; Sato PY, 2011, CIRC RES, V109, P193, DOI 10.1161/CIRCRESAHA.111.247023; Sato PY, 2009, CIRC RES, V105, P523, DOI 10.1161/CIRCRESAHA.109.201418; Tong XY, 2006, AM J PHYSIOL-HEART C, V291, pH543, DOI 10.1152/ajpheart.00051.2006; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; Zingman LV, 2011, J MOL CELL CARDIOL, V51, P72, DOI 10.1016/j.yjmcc.2011.03.010; Zingman LV, 2002, P NATL ACAD SCI USA, V99, P13278, DOI 10.1073/pnas.212315199	38	19	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41258	41267		10.1074/jbc.M112.412122	http://dx.doi.org/10.1074/jbc.M112.412122			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23066018	Green Published, hybrid			2022-12-28	WOS:000311887600040
J	Duan, YY; Sun, Y; Zhang, F; Zhang, WK; Wang, D; Wang, Y; Cao, X; Hu, WB; Xie, CY; Cuppoletti, J; Magin, TM; Wang, HX; Wu, ZG; Li, N; Huang, PB				Duan, Yuanyuan; Sun, Ying; Zhang, Fan; Zhang, Wei Kevin; Wang, Dong; Wang, Yan; Cao, Xu; Hu, Wenbao; Xie, Changyan; Cuppoletti, John; Magin, Thomas M.; Wang, Haixia; Wu, Zhenguo; Li, Ning; Huang, Pingbo			Keratin K18 Increases Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Surface Expression by Binding to Its C-terminal Hydrophobic Patch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL EPITHELIAL-CELLS; INTERMEDIATE-FILAMENTS; PLASMA-MEMBRANE; MACROMOLECULAR COMPLEXES; APICAL MEMBRANE; PROTEIN-KINASE; MUTATION; MOUSE; LOCALIZATION; CYTOSKELETON	Malfunction of the cystic fibrosis transmembrane conductance regulator (CFTR) leads to cystic fibrosis, but the regulation of CFTR is not fully understood. Here, we identified the intermediate filament protein keratin K18 (K18) as a CFTR-binding protein by various approaches. We mapped a highly conserved "hydrophobic patch" ((FLVI1416)-F-1413) in the CFTR C-terminus, known to determine plasmalemmal CFTR stability, as the K18-binding site. On the other hand, the C-terminal tail of K18 was found to be a critical determinant for binding CFTR. Overexpression of K18 in cells robustly increased the surface expression of wild-type CFTR, whereas depletion of K18 through RNA interference specifically diminished it. K18 binding increased the surface expression of CFTR by accelerating its apical recycling rate without altering CFTR biosynthesis, maturation, or internalization. Importantly, CFTR surface expression was markedly reduced in duodenal and gallbladder epithelia of K18(-/-) mice. Taken together, our results suggest that K18 increases the cell surface expression of CFTR by interacting with the CFTR C-terminal hydrophobic patch. These findings offer novel insights into the regulation of CFTR and suggest that K18 and its dimerization partner, K8, may be modifier genes in cystic fibrosis.	[Duan, Yuanyuan; Sun, Ying; Zhang, Fan; Zhang, Wei Kevin; Wang, Dong; Wang, Yan; Cao, Xu; Hu, Wenbao; Xie, Changyan; Wang, Haixia; Wu, Zhenguo; Li, Ning; Huang, Pingbo] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Huang, Pingbo] Hong Kong Univ Sci & Technol, Div Biomed Engn, Kowloon, Hong Kong, Peoples R China; [Wu, Zhenguo; Huang, Pingbo] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Cuppoletti, John] Univ Cincinnati, Coll Med, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA; [Magin, Thomas M.] Univ Leipzig, Inst Biol, D-04103 Leipzig, Germany; [Magin, Thomas M.] Univ Leipzig, Translat Ctr Regenerat Med TRM, D-04103 Leipzig, Germany	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; University System of Ohio; University of Cincinnati; Leipzig University; Leipzig University	Huang, PB (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China.	bohuangp@ust.hk	Zhang, Fan/AAB-1175-2020; Zhang, Wei/M-4241-2019; Huang, Pingbo/I-1127-2019; Sun, Ying/F-9124-2019	Zhang, Wei/0000-0003-4960-6137; Huang, Pingbo/0000-0002-4560-8760; Wu, Zhenguo/0000-0003-3049-8324; ZHANG, FAN/0000-0002-7186-6317	Hong Kong Research Grants Council [GRF661008]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	This work was supported by Hong Kong Research Grants Council Grant GRF661008 (to P. H.).	Ameen NA, 2001, J CELL SCI, V114, P563; BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964; Cantiello HF, 2001, PFLUG ARCH EUR J PHY, V443, pS75; Caulin C, 2000, J CELL BIOL, V149, P17, DOI 10.1083/jcb.149.1.17; Davezac N, 2004, PROTEOMICS, V4, P3833, DOI 10.1002/pmic.200400850; Davidson D J, 2001, Expert Rev Mol Med, V2001, P1, DOI 10.1017/S1462399401002551; Desclozeaux M, 2008, AM J PHYSIOL-CELL PH, V295, pC545, DOI 10.1152/ajpcell.00097.2008; Dickinson P, 2002, HUM MOL GENET, V11, P243, DOI 10.1093/hmg/11.3.243; DORIN JR, 1992, NATURE, V359, P211, DOI 10.1038/359211a0; Gentzsch M, 2002, BIOCHEM J, V366, P541, DOI 10.1042/BJ20020511; Gentzsch M, 2001, J BIOL CHEM, V276, P1291, DOI 10.1074/jbc.M003672200; Gilbert S, 2001, J CELL BIOL, V154, P763, DOI 10.1083/jcb.200102130; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Guilbault C, 2007, AM J RESP CELL MOL, V36, P1, DOI 10.1165/rcmb.2006-0184TR; Haardt M, 1999, J BIOL CHEM, V274, P21873, DOI 10.1074/jbc.274.31.21873; Haggie PM, 2006, MOL BIOL CELL, V17, P4937, DOI 10.1091/mbc.E06-08-0670; Haggie PM, 2004, J BIOL CHEM, V279, P5494, DOI 10.1074/jbc.M312445200; Hallows KR, 2000, J CLIN INVEST, V105, P1711, DOI 10.1172/JCI9622; Inada H, 2001, J CELL BIOL, V155, P415, DOI 10.1083/jcb.200103078; Izawa I, 2000, J BIOL CHEM, V275, P34521, DOI 10.1074/jbc.M003492200; Li CY, 2005, PHARMACOL THERAPEUT, V108, P208, DOI 10.1016/j.pharmthera.2005.04.004; Li JQ, 2005, J BIOL CHEM, V280, P37634, DOI 10.1074/jbc.M502305200; Lipecka J, 2006, J PHARMACOL EXP THER, V317, P500, DOI 10.1124/jpet.105.097667; LISANTI MP, 1989, J CELL BIOL, V109, P2117, DOI 10.1083/jcb.109.5.2117; Magin TM, 1998, J CELL BIOL, V140, P1441, DOI 10.1083/jcb.140.6.1441; Magin TM, 2004, EXP CELL RES, V301, P91, DOI 10.1016/j.yexcr.2004.08.018; Mickle JE, 1998, HUM MOL GENET, V7, P729, DOI 10.1093/hmg/7.4.729; Milewski MI, 2005, FEBS LETT, V579, P483, DOI 10.1016/j.febslet.2004.11.106; Milewski MI, 2001, J CELL SCI, V114, P719; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Ostedgaard LS, 2003, P NATL ACAD SCI USA, V100, P1937, DOI 10.1073/pnas.2627982100; Paramio JM, 2002, BIOESSAYS, V24, P836, DOI 10.1002/bies.10140; Salas PJI, 1999, J CELL BIOL, V146, P645, DOI 10.1083/jcb.146.3.645; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Silvis MR, 2009, MOL BIOL CELL, V20, P2337, DOI 10.1091/mbc.E08-01-0084; Stanke F, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-62; Styers ML, 2004, MOL BIOL CELL, V15, P5369, DOI 10.1091/mbc.E04-03-0272; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Swiatecka-Urban A, 2004, J BIOL CHEM, V279, P38025, DOI 10.1074/jbc.M403141200; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Thelin WR, 2007, J CLIN INVEST, V117, P364, DOI 10.1172/JCI30376; Thelin WR, 2005, J BIOL CHEM, V280, P41512, DOI 10.1074/jbc.M507308200; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Toivola DM, 2004, J CELL BIOL, V164, P911, DOI 10.1083/jcb.200308103; Turvy D N, 2001, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1807s36; VANDOORNINCK JH, 1995, EMBO J, V14, P4403, DOI 10.1002/j.1460-2075.1995.tb00119.x; Vijayaraj Preethi, 2007, Methods Mol Biol, V360, P203; Vijayaraj P, 2010, EUR J CELL BIOL, V89, P299, DOI 10.1016/j.ejcb.2009.10.016; Vijayaraj P, 2009, J CELL BIOL, V187, P175, DOI 10.1083/jcb.200906094; Wald FA, 2005, MOL BIOL CELL, V16, P4096, DOI 10.1091/mbc.e05-03-0242; Wang D, 2008, AM J PHYSIOL-CELL PH, V294, pC1443, DOI 10.1152/ajpcell.00556.2007; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Weixel KM, 2001, J BIOL CHEM, V276, P46251, DOI 10.1074/jbc.M104545200; Weixel KM, 2000, J BIOL CHEM, V275, P3655, DOI 10.1074/jbc.275.5.3655	54	22	23	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40547	40559		10.1074/jbc.M112.403584	http://dx.doi.org/10.1074/jbc.M112.403584			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23045527	hybrid, Green Published			2022-12-28	WOS:000311448800045
J	Munoz, MC; Laulier, C; Gunn, A; Cheng, A; Robbiani, DF; Nussenzweig, A; Stark, JM				Munoz, Meilen C.; Laulier, Corentin; Gunn, Amanda; Cheng, Anita; Robbiani, Davide F.; Nussenzweig, Andre; Stark, Jeremy M.			Ring Finger Nuclear Factor RNF168 Is Important for Defects in Homologous Recombination Caused by Loss of the Breast Cancer Susceptibility Factor BRCA1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; CLASS SWITCH RECOMBINATION; MAMMALIAN-CELLS; DNA-DAMAGE; DIRECTED REPAIR; IONIZING-RADIATION; GENOMIC STABILITY; END RESECTION; GENE BRCA1; 53BP1	The RING finger nuclear factor RNF168 is required for recruitment of several DNA damage response factors to double strand breaks (DSBs), including 53BP1 and BRCA1. Because 53BP1 and BRCA1 function antagonistically during the DSB repair pathway homologous recombination (HR), the influence of RNF168 on HR has been unclear. We report that RNF168 depletion causes an elevated frequency of two distinct HR pathways (homology-directed repair and single strand annealing), suppresses defects in HR caused by BRCA1 silencing, but does not suppress HR defects caused by disruption of CtIP, RAD50, BRCA2, or RAD51. Furthermore, RNF168-depleted cells can form ionizing radiation-induced foci of the recombinase RAD51 without forming BRCA1 ionizing radiation-induced foci, indicating that this loss of BRCA1 recruitment to DSBs does not reflect a loss of function during HR. Additionally, we find that RNF168 and 53BP1 have a similar influence on HR. We suggest that RNF168 is important for HR defects caused by BRCA1 loss.	[Munoz, Meilen C.; Laulier, Corentin; Gunn, Amanda; Cheng, Anita; Stark, Jeremy M.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Radiat Biol, Duarte, CA 91010 USA; [Munoz, Meilen C.; Gunn, Amanda; Stark, Jeremy M.] City Hope Natl Med Ctr, Beckman Res Inst, Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA; [Robbiani, Davide F.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Nussenzweig, Andre] NCI, Lab Genome Integr, Bethesda, MD 20892 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Stark, JM (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Radiat Biol, 1500 E Duarte Rd, Duarte, CA 91010 USA.	jstark@coh.org		Robbiani, Davide F./0000-0001-7379-3484	National Institutes of Health [RO1CA120954]; Marsha Rivkin Center for Ovarian Cancer Research; University of California [181B-0046]; NATIONAL CANCER INSTITUTE [R01CA120954, ZIABC010283, ZIABC010959] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marsha Rivkin Center for Ovarian Cancer Research; University of California(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1CA120954 (to J. M. S.). This work was also supported by the Marsha Rivkin Center for Ovarian Cancer Research and by Regents of the University of California Breast Cancer Research Program Grant 181B-0046 (to J. M. S.).	Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bennardo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000683; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Bohgaki T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001381; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2012, MOL CELL, V46, P125, DOI 10.1016/j.molcel.2012.02.015; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Chan KL, 2011, SEMIN CELL DEV BIOL, V22, P906, DOI 10.1016/j.semcdb.2011.07.001; Coleman KA, 2011, J BIOL CHEM, V286, P13669, DOI 10.1074/jbc.M110.213728; Devgan SS, 2011, CELL DEATH DIFFER, V18, P1500, DOI 10.1038/cdd.2011.18; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Gunn Amanda, 2012, Methods Mol Biol, V920, P379, DOI 10.1007/978-1-61779-998-3_27; Gunn A, 2011, J BIOL CHEM, V286, P42470, DOI 10.1074/jbc.M111.309252; Haber JE, 2008, P NATL ACAD SCI USA, V105, P405, DOI 10.1073/pnas.0711334105; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Holthausen JT, 2010, DNA REPAIR, V9, P1264, DOI 10.1016/j.dnarep.2010.09.014; Hu YF, 2005, ONCOGENE, V24, P8343, DOI 10.1038/sj.onc.1208985; Hu YD, 2011, GENE DEV, V25, P685, DOI 10.1101/gad.2011011; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Iwabuchi K, 2003, J BIOL CHEM, V278, P36487, DOI 10.1074/jbc.M304066200; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Joukov V, 2001, P NATL ACAD SCI USA, V98, P12078, DOI 10.1073/pnas.211427098; Konishi H, 2011, P NATL ACAD SCI USA, V108, P17773, DOI 10.1073/pnas.1110969108; LaRocque JR, 2011, P NATL ACAD SCI USA, V108, P11971, DOI 10.1073/pnas.1104421108; Laulier C, 2011, NUCLEIC ACIDS RES, V39, P5935, DOI 10.1093/nar/gkr187; Lilley CE, 2010, EMBO J, V29, P943, DOI 10.1038/emboj.2009.400; Moskwa P, 2011, MOL CELL, V41, P210, DOI 10.1016/j.molcel.2010.12.005; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Nakada S, 2012, CANCER RES, V72, P4974, DOI 10.1158/0008-5472.CAN-12-1057; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pinato S, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-55; Ramachandran S, 2010, P NATL ACAD SCI USA, V107, P809, DOI 10.1073/pnas.0913790107; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schlegel BP, 2006, CANCER RES, V66, P5181, DOI 10.1158/0008-5472.CAN-05-3209; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Sy SMH, 2011, J BIOL CHEM, V286, P22355, DOI 10.1074/jbc.M111.232041; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Walsh T, 2011, P NATL ACAD SCI USA, V108, P18032, DOI 10.1073/pnas.1115052108; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Ward I, 2006, J BIOL CHEM, V281, P38472, DOI 10.1074/jbc.M607577200; Westermark UK, 2003, MOL CELL BIOL, V23, P7926, DOI 10.1128/MCB.23.21.7926-7936.2003; Wu JX, 2012, J BIOL CHEM, V287, P22919, DOI 10.1074/jbc.M112.351007; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Yang YG, 2006, EMBO J, V25, P5527, DOI 10.1038/sj.emboj.7601411; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	56	42	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40618	40628		10.1074/jbc.M112.410951	http://dx.doi.org/10.1074/jbc.M112.410951			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23055523	hybrid, Green Published			2022-12-28	WOS:000311448800051
J	Xu, XS; Keshwani, M; Meyer, K; Sarikas, A; Taylor, S; Pan, ZQ				Xu, Xinsong; Keshwani, Malik; Meyer, Kathleen; Sarikas, Antonio; Taylor, Susan; Pan, Zhen-Qiang			Identification of the Degradation Determinants of Insulin Receptor Substrate 1 for Signaling Cullin-RING E3 Ubiquitin Ligase 7-mediated Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTISITE PHOSPHORYLATION; TUBEROUS SCLEROSIS; MTOR; GROWTH; COMPLEX; CUL7; IRS1; INHIBITION; MECHANISM; MUSCLE	Hyperactivation of mechanistic target of rapamycin complex 1 (mTORC1) and its effector kinase S6 kinase 1 (S6K1) is known to trigger multisite seryl phosphorylation of insulin receptor substrate 1 (IRS1), leading to its ubiquitination and degradation. This negative feedback inhibition functions to restrain PI3K activity and plays critical roles in the pathogenesis of cancer and type II diabetes. Recent work has implicated a role for cullin-RING E3 ubiquitin ligase 7 (CRL7) in targeting IRS1 for mTORC1/S6K1-dependent degradation. In the present study we have employed both cell-based degradation and reconstituted ubiquitination approaches to define molecular features associated with IRS1 critical for CRL7-mediated ubiquitination and degradation. We have mapped IRS1 degradation signal sequence to its N-terminal 574 amino acid residues, of which the integrity of Ser-307/Ser-312 and Ser-527, each constituting a S6K1 phosphorylation consensus site, was indispensible for supporting CRL7-forced degradation. In vitro, S6K1 was able to support the ubiquitination of bacterially expressed IRS1 N-terminal fragment by CRL7 but at low levels. In contrast, CRL7 supported efficient ubiquitination of IRS1 N-terminal fragment in hyperphosphorylated form, which was isolated from infected insect cells, suggesting requirement of additional phosphorylation by kinases yet to be identified. Finally, removal of IRS1 amino acids 1-260 led to substantial reduction of ubiquitination efficiency, suggesting a role for this region in mediating productive interactions with CRL7. The requirement of multisite phosphorylation and the N terminus of IRS1 for its turnover may ensure that complete IRS1 degradation occurs only when mTORC1 and S6K1 reach exceedingly high levels.	[Xu, Xinsong; Pan, Zhen-Qiang] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Keshwani, Malik; Taylor, Susan] Univ Calif San Diego, Dept Pharmacol, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Meyer, Kathleen; Sarikas, Antonio] Tech Univ Munich, Inst Pharmacol & Toxicol, D-80802 Munich, Germany	Icahn School of Medicine at Mount Sinai; Howard Hughes Medical Institute; University of California System; University of California San Diego; Technical University of Munich	Pan, ZQ (corresponding author), Mt Sinai Sch Med, Dept Oncol Sci, 1 Gustave L Levy Pl, New York, NY 10029 USA.	zhen-qiang.pan@mssm.edu	Meyer, Kathleen/ABA-4397-2020	Meyer, Kathleen/0000-0002-5128-3616	National Institutes of Health [CA095634, GM61051, DK054441]; German Research Foundation [SA 1706/3-1]; Marie Curie International Reintegration Grant [256584]; NATIONAL CANCER INSTITUTE [R01CA095634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061051] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); Marie Curie International Reintegration Grant(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA095634 and GM61051 (to Z.-Q. P.), as well as DK054441 to S.T.; Supported by Research Grant SA 1706/3-1 from the German Research Foundation and Marie Curie International Reintegration Grant 256584.	Arai T, 2003, P NATL ACAD SCI USA, V100, P9855, DOI 10.1073/pnas.1733908100; Dias DC, 2002, P NATL ACAD SCI USA, V99, P16601, DOI 10.1073/pnas.252646399; Fisher TL, 2004, CURR BIOL, V14, pR1005, DOI 10.1016/j.cub.2004.11.024; Greene MW, 2003, J BIOL CHEM, V278, P8199, DOI 10.1074/jbc.M209153200; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Huber C, 2005, NAT GENET, V37, P1119, DOI 10.1038/ng1628; Huber C, 2009, EUR J HUM GENET, V17, P395, DOI 10.1038/ejhg.2008.200; Keshwani MM, 2008, PROTEIN EXPRES PURIF, V58, P32, DOI 10.1016/j.pep.2007.11.003; Koivomagi M, 2011, NATURE, V480, P128, DOI 10.1038/nature10560; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Nakao R, 2009, MOL CELL BIOL, V29, P4798, DOI 10.1128/MCB.01347-08; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Ponyeam W, 2012, CELL SIGNAL, V24, P290, DOI 10.1016/j.cellsig.2011.08.020; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Shah OJ, 2005, CELL CYCLE, V4, P46, DOI 10.4161/cc.4.1.1343; Shi J, 2011, DEV CELL, V21, P835, DOI 10.1016/j.devcel.2011.09.011; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Tsunematsu R, 2006, MOL CELL BIOL, V26, P6157, DOI 10.1128/MCB.00595-06; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wu K, 2000, MOL CELL BIOL, V20, P1382, DOI 10.1128/MCB.20.4.1382-1393.2000; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Zhande R, 2002, MOL CELL BIOL, V22, P1016, DOI 10.1128/MCB.22.4.1016-1026.2002; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	28	18	18	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40758	40766		10.1074/jbc.M112.405209	http://dx.doi.org/10.1074/jbc.M112.405209			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23045529	hybrid, Green Published			2022-12-28	WOS:000311448800064
J	Christel, CJ; Schaer, R; Wang, SY; Henzi, T; Kreiner, L; Grabs, D; Schwaller, B; Lee, A				Christel, Carl J.; Schaer, Raphael; Wang, Shiyi; Henzi, Thomas; Kreiner, Lisa; Grabs, Detlev; Schwaller, Beat; Lee, Amy			Calretinin Regulates Ca2+-dependent Inactivation and Facilitation of Ca(v)2.1 Ca2+ Channels through a Direct Interaction with the alpha(1)2.1 Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRESYNAPTIC CALCIUM CURRENT; PROTEIN-INTERACTION SITE; CA2+/CALMODULIN-DEPENDENT FACILITATION; SPLICE VARIANTS; GRANULE CELLS; BINDING; IDENTIFICATION; CALMODULIN; MODULATION; PARVALBUMIN	Voltage-gated Ca(v)2.1 Ca2+ channels undergo dual modulation by Ca2+, Ca2+-dependent inactivation (CDI), and Ca2+-dependent facilitation (CDF), which can influence synaptic plasticity in the nervous system. Although the molecular determinants controlling CDI and CDF have been the focus of intense research, little is known about the factors regulating these processes in neurons. Here, we show that calretinin (CR), a Ca2+-binding protein highly expressed in subpopulations of neurons in the brain, inhibits CDI and enhances CDF by binding directly to alpha(1)2.1. Screening of a phage display library with CR as bait revealed a highly basic CR-binding domain (CRB) present in multiple copies in the cytoplasmic linker between domains II and III of alpha(1)2.1. In pulldown assays, CR binding to fusion proteins containing these CRBs was largely Ca2+-dependent. alpha(1)2.1 coimmunoprecipitated with CR antibodies from transfected cells and mouse cerebellum, which confirmed the existence of CR-Ca(v)2.1 complexes in vitro and in vivo. In HEK293T cells, CR significantly decreased Ca(v)2.1 CDI and increased CDF. CR binding to alpha(1)2.1 was required for these effects, because they were not observed upon substitution of the II-III linker of alpha(1)2.1 with that from the Ca(v)1.2 alpha(1) subunit (alpha(1)1.2), which lacks the CRBs. In addition, coexpression of a protein containing the CRBs blocked the modulatory action of CR, most likely by competing with CR for interactions with alpha(1)2.1. Our findings highlight an unexpected role for CR in directly modulating effectors such as Ca(v)2.1, which may have major consequences for Ca2+ signaling and neuronal excitability.	[Schaer, Raphael; Henzi, Thomas; Grabs, Detlev; Schwaller, Beat] Univ Fribourg, Dept Med, Unit Anat, CH-1700 Fribourg, Switzerland; [Christel, Carl J.; Wang, Shiyi; Lee, Amy] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Christel, Carl J.; Wang, Shiyi; Lee, Amy] Univ Iowa, Dept Otolaryngol, Iowa City, IA 52242 USA; [Christel, Carl J.; Wang, Shiyi; Lee, Amy] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Kreiner, Lisa] Emory Univ, Dept Physiol, Atlanta, GA 30322 USA	University of Fribourg; University of Iowa; University of Iowa; University of Iowa; Emory University	Schwaller, B (corresponding author), Univ Fribourg, Dept Med, Unit Anat, Route Albert Gockel 1, CH-1700 Fribourg, Switzerland.	beat.schwaller@unifr.ch; amy-lee@uiowa.edu	Wang, Shiyi/AAC-9354-2019	Schwaller, Beat/0000-0002-8277-7555; Wang, Shiyi/0000-0003-3433-3025; Lee, Amy/0000-0001-8021-0443	National Institutes of Health [DC009433, R01 HL087120, T32007121]; Carver Research Program of Excellence award; Swiss National Science Foundation [113518, 130680]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R55DC009433, R01DC009433] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carver Research Program of Excellence award; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants DC009433 and R01 HL087120 (to A. L.) and T32007121 (to C. J. C.). This work was also supported by a Carver Research Program of Excellence award (to A. L.) and Swiss National Science Foundation Grants 113518 and 130680 (to B. S.).	ANDRESSEN C, 1993, CELL TISSUE RES, V271, P181, DOI 10.1007/BF00318606; AUGUSTINE GJ, 1986, J PHYSIOL-LONDON, V381, P619, DOI 10.1113/jphysiol.1986.sp016347; Bearzatto B, 2006, FASEB J, V20, P380, DOI 10.1096/fj.05-3785fje; Berggard T, 2002, J BIOL CHEM, V277, P16662, DOI 10.1074/jbc.M200415200; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; CASTELLANO A, 1993, J BIOL CHEM, V268, P12359; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Chaudhuri D, 2005, J NEUROSCI, V25, P8282, DOI 10.1523/JNEUROSCI.2253-05.2005; Chaudhuri D, 2004, J NEUROSCI, V24, P6334, DOI 10.1523/JNEUROSCI.1712-04.2004; Chaudhuri D, 2007, J GEN PHYSIOL, V129, P385, DOI 10.1085/jgp.200709749; Christel C, 2012, BBA-GEN SUBJECTS, V1820, P1243, DOI 10.1016/j.bbagen.2011.12.012; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dino MR, 1999, J NEUROCYTOL, V28, P99, DOI 10.1023/A:1007072105919; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Edmonds B, 2000, NAT NEUROSCI, V3, P786, DOI 10.1038/77687; Felmy F, 2004, EUR J NEUROSCI, V20, P1473, DOI 10.1111/j.1460-9568.2004.03604.x; Few AP, 2005, J NEUROSCI, V25, P7071, DOI 10.1523/JNEUROSCI.0452-05.2005; Findeisen F, 2009, J GEN PHYSIOL, V133, P327, DOI 10.1085/jgp.200810143; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Gall D, 2003, J NEUROSCI, V23, P9320; Hackney CM, 2005, J NEUROSCI, V25, P7867, DOI 10.1523/JNEUROSCI.1196-05.2005; Kreiner L, 2006, J BIOL CHEM, V281, P4691, DOI 10.1074/jbc.M511971200; Kreiner L, 2010, J NEUROPHYSIOL, V103, P371, DOI 10.1152/jn.00635.2009; Kreitzer AC, 2000, J NEUROSCI, V20, P1348; KUZNICKI J, 1995, BIOCHEM J, V308, P607; Lautermilch NJ, 2005, J NEUROSCI, V25, P7062, DOI 10.1523/JNEUROSCI.0447-05.2005; Lee A, 2003, P NATL ACAD SCI USA, V100, P16059, DOI 10.1073/pnas.2237000100; Lee A, 2000, J NEUROSCI, V20, P6830, DOI 10.1523/JNEUROSCI.20-18-06830.2000; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lee A, 2002, NAT NEUROSCI, V5, P210, DOI 10.1038/nn805; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Lin KH, 2012, J NEUROSCI, V32, P1261, DOI 10.1523/JNEUROSCI.3838-11.2012; Lorteije JAM, 2009, J NEUROSCI, V29, P13770, DOI 10.1523/JNEUROSCI.3285-09.2009; Marini AM, 1997, BRAIN RES BULL, V42, P279, DOI 10.1016/S0361-9230(96)00263-8; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; Mochida S, 2008, NEURON, V57, P210, DOI 10.1016/j.neuron.2007.11.036; Rajapaksha WRAKJS, 2008, J BIOL CHEM, V283, P15997, DOI 10.1074/jbc.M710544200; RANDALL A, 1995, J NEUROSCI, V15, P2995; Rogstam A, 2007, BIOCHEM J, V401, P353, DOI 10.1042/BJ20060918; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Schiffmann SN, 1999, P NATL ACAD SCI USA, V96, P5257, DOI 10.1073/pnas.96.9.5257; Schwaller B, 2004, ANTICANCER RES, V24, P4003; Schwaller B, 1997, J BIOL CHEM, V272, P29663, DOI 10.1074/jbc.272.47.29663; Schwaller B, 2009, CELL MOL LIFE SCI, V66, P275, DOI 10.1007/s00018-008-8564-6; Schwaller B., 2007, HDB NEUROCHEMISTRY M, P197, DOI 10.1007/978-0-387-30379-6_5.; Schwaller Beat, 2002, Cerebellum, V1, P241, DOI 10.1080/147342202320883551; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; Soong TW, 2002, J NEUROSCI, V22, P10142; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; Watanabe H, 2010, J NEUROSCI, V30, P655, DOI 10.1523/JNEUROSCI.3214-09.2010; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WINSKY L, 1995, J NEUROCHEM, V65, P381; Zamponi GW, 2003, J PHARMACOL SCI, V92, P79	58	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.406363	http://dx.doi.org/10.1074/jbc.M112.406363			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23033479	Green Published, hybrid			2022-12-28	WOS:000311233800045
J	Moncada-Pazos, A; Obaya, AJ; Llamazares, M; Heljasvaara, R; Suarez, MF; Colado, E; Noel, A; Cal, S; Lopez-Otin, C				Moncada-Pazos, Angela; Obaya, Alvaro J.; Llamazares, Maria; Heljasvaara, Ritva; Suarez, Maria F.; Colado, Enrique; Noel, Agnes; Cal, Santiago; Lopez-Otin, Carlos			ADAMTS-12 Metalloprotease Is Necessary for Normal Inflammatory Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL APOPTOSIS; SIGNALING PATHWAY; BOWEL-DISEASE; EXPRESSION; CANCER; CELLS; GENE; IDENTIFICATION; INTERLEUKIN-6; DISINTEGRIN	ADAMTSs (a disintegrin and metalloprotease with thrombospondin domains) are a family of enzymes with both proteolytic and protein interaction functions, which have been implicated in distinct pathologies. In this work, we have investigated the putative role of ADAMTS-12 in inflammation by using a mouse model deficient in this metalloprotease. Control and mutant mice were subjected to different experimental conditions to induce colitis, endotoxic sepsis, and pancreatitis. We have observed that Adamts12-deficient mice exhibit more severe inflammation and a delayed recovery from these challenges compared with their wild-type littermates. These changes are accompanied by an increase in inflammatory markers including several cytokines, as assessed by microarray expression analysis and proteomic-based approaches. Interestingly, the clinical symptoms observed in Adamts12-deficient mice are also concomitant with an elevation in the number of neutrophils in affected tissues. Finally, isolation and in vitro culture of human neutrophils demonstrate that the presence of ADAMTS-12 induces neutrophil apoptosis. On the basis of these results, we propose that ADAMTS-12 is implicated in the inflammatory response by modulating normal neutrophil apoptosis.	[Moncada-Pazos, Angela; Llamazares, Maria; Heljasvaara, Ritva; Suarez, Maria F.; Cal, Santiago; Lopez-Otin, Carlos] Univ Oviedo, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; [Obaya, Alvaro J.] Univ Oviedo, Inst Univ Oncol IUOPA, E-33006 Oviedo, Spain; [Heljasvaara, Ritva] Univ Oulu, Oulu Ctr Cell Matrix Res, Bioctr Oulu, FIN-90570 Oulu, Finland; [Heljasvaara, Ritva] Univ Oulu, Dept Med Biochem & Mol Biol, FIN-90570 Oulu, Finland; [Colado, Enrique] Hosp Univ Cent Asturias, Serv Hematol, Oviedo 33006, Spain; [Noel, Agnes] Univ Liege, Grp Interdisciplinaire Genoprote Appl Canc GIGA C, B-4000 Liege, Belgium	University of Oviedo; University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Oulu; University of Oulu; Central University Hospital Asturias; University of Liege	Moncada-Pazos, A (corresponding author), Univ Oviedo, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain.	amoncada@degradome.uniovi.es	Suárez, María Fernanda Valencia/F-8200-2019; López-Otín, Carlos/AAB-2106-2020; Obaya, Alvaro J./AAQ-6115-2021; Colado, Enrique/Z-6326-2019; Llamazares-Prada, Maria/ABX-0849-2022; Colado, Enrique/GXF-7705-2022	Suárez, María Fernanda Valencia/0000-0001-8987-8431; López-Otín, Carlos/0000-0001-6964-1904; Obaya, Alvaro J./0000-0002-4163-2173; Colado, Enrique/0000-0001-8675-8207; Heljasvaara, Ritva/0000-0003-4763-3844; Llamazares Prada, Maria/0000-0001-6559-9374; Noel, Agnes/0000-0002-7670-6179; MONCADA PAZOS, ANGELA/0000-0002-3871-2965	Ministerio de Economia y Competitividad-Spain; European Union; Fundacion M. Botin; Obra Social Cajastur; Accion Transversal del Cancer-RTICC; Finnish Cultural Foundation; Maud Kuistila Memorial Foundation	Ministerio de Economia y Competitividad-Spain; European Union(European Commission); Fundacion M. Botin; Obra Social Cajastur; Accion Transversal del Cancer-RTICC; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Maud Kuistila Memorial Foundation	This work was supported by grants from Ministerio de Economia y Competitividad-Spain, Fundacion M. Botin and European Union (FP7-Micro-EnviMet). The Instituto Universitario de Oncologia is supported by Obra Social Cajastur and Accion Transversal del Cancer-RTICC.; Supported by grants from Finnish Cultural Foundation and Maud Kuistila Memorial Foundation.	Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Arruda MA, 2004, J IMMUNOL, V173, P2023, DOI 10.4049/jimmunol.173.3.2023; Bespalova IN, 2012, NEUROMOL MED, V14, P53, DOI 10.1007/s12017-012-8169-y; Bratton DL, 2011, TRENDS IMMUNOL, V32, P350, DOI 10.1016/j.it.2011.04.009; Cal S, 2002, GENE, V283, P49, DOI 10.1016/S0378-1119(01)00861-7; Cal S, 2001, J BIOL CHEM, V276, P17932, DOI 10.1074/jbc.M100534200; Carey R, 2008, INFLAMM BOWEL DIS, V14, P446, DOI 10.1002/ibd.20342; Chauhan AK, 2008, J EXP MED, V205, P2065, DOI 10.1084/jem.20080130; Davis AK, 2009, TRANSFUSION, V49, P206, DOI 10.1111/j.1537-2995.2008.01978.x; El Hour M, 2010, ONCOGENE, V29, P3025, DOI 10.1038/onc.2010.49; Fielding CA, 2008, J IMMUNOL, V181, P2189, DOI 10.4049/jimmunol.181.3.2189; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; Kurz T, 2006, J ALLERGY CLIN IMMUN, V118, P396, DOI 10.1016/j.jaci.2006.04.036; Lamy L, 2007, J IMMUNOL, V178, P5930, DOI 10.4049/jimmunol.178.9.5930; Lawrence DW, 2009, EARLY HUM DEV, V85, P659, DOI 10.1016/j.earlhumdev.2009.09.005; Li Y, 2010, GUT, V59, P227, DOI 10.1136/gut.2009.184176; Lin EA, 2010, PROTEIN CELL, V1, P33, DOI 10.1007/s13238-010-0002-5; Liu CJ, 2006, J BIOL CHEM, V281, P15800, DOI 10.1074/jbc.M513433200; Llamazares M, 2007, J CELL SCI, V120, P3544, DOI 10.1242/jcs.005751; Lonkar P, 2011, INT J CANCER, V128, P1999, DOI 10.1002/ijc.25815; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Lopez-Otin C, 2010, NAT REV CANCER, V10, P278, DOI 10.1038/nrc2823; Luo Yi, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0320s22; Maianski NA, 2004, J IMMUNOL, V172, P7024, DOI 10.4049/jimmunol.172.11.7024; Majumdar MK, 2007, ARTHRITIS RHEUM, V56, P3670, DOI 10.1002/art.23027; Mikolajczyk TP, 2009, IMMUNOLOGY, V128, P103, DOI 10.1111/j.1365-2567.2009.03087.x; MITSUYAMA K, 1991, DIGESTION, V50, P104, DOI 10.1159/000200747; Moncada-Pazos A, 2009, J CELL SCI, V122, P2906, DOI 10.1242/jcs.050468; Nah SS, 2012, MOL MED REP, V6, P227, DOI 10.3892/mmr.2012.867; Quesada V, 2009, NUCLEIC ACIDS RES, V37, pD239, DOI 10.1093/nar/gkn570; Renz H, 2011, NAT IMMUNOL, V12, P273, DOI 10.1038/ni0411-273; Sen AI, 2010, EXP LUNG RES, V36, P615, DOI 10.3109/01902148.2010.497201; Wang D, 2011, DIGEST DIS SCI, V56, P3281, DOI 10.1007/s10620-011-1723-x; Wang K, 2010, WORLD J GASTROENTERO, V16, P2252, DOI 10.3748/wjg.v16.i18.2252; Warner RL, 2004, EXP MOL PATHOL, V76, P189, DOI 10.1016/j.yexmp.2004.01.003	37	32	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.408625	http://dx.doi.org/10.1074/jbc.M112.408625			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23019333	hybrid, Green Published			2022-12-28	WOS:000311233800026
J	Bobbs, AS; Saarela, AV; Yatskievych, TA; Antin, PB				Bobbs, Alexander S.; Saarela, Aleksi V.; Yatskievych, Tatiana A.; Antin, Parker B.			Fibroblast Growth Factor (FGF) Signaling during Gastrulation Negatively Modulates the Abundance of MicroRNAs That Regulate Proteins Required for Cell Migration and Embryo Patterning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMITIVE STREAK; CHICK-EMBRYO; SELF-RENEWAL; LET-7; EXPRESSION; LIN-28; DETERMINANTS; BIOGENESIS; MOVEMENT; COMPLEX	FGF signaling plays a pivotal role in regulating cell movements and lineage induction during gastrulation. Here we identify 44 microRNAs that are expressed in the primitive streak region of gastrula stage chicken embryos. We show that the primary effect of FGF signaling on microRNA abundance is to negatively regulate the levels of miR-let-7b, -9, -19b, -107, -130b, and -218. LIN28B inhibits microRNA processing and is positively regulated by FGF signaling. Gain- and loss-of-function experiments show that LIN28B negatively regulates the expression of miR-19b, -130b, and let-7b, whereas negative modulation of miR-9, -107, and -218 appears to be independent of LIN28B function. Predicted mRNA targets of the FGF-regulated microRNAs are over-represented in serine/threonine and tyrosine kinase receptors, including ACVR1, ACVR2B, PDGFRA, TGFBR1, and TGFBR3. Luciferase assays show that these and other candidates are targeted by FGF-regulated microRNAs. PDGFRA, a receptor whose activity is required for cell migration through the primitive streak, is a target of miR-130b and -218 in vivo. These results identify a novel mechanism by which FGF signaling regulates gene expression by negatively modulating microRNA abundance through both LIN28B-dependent and LIN28B-independent pathways.	[Yatskievych, Tatiana A.; Antin, Parker B.] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85724 USA; [Bobbs, Alexander S.; Saarela, Aleksi V.; Antin, Parker B.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85724 USA	University of Arizona; University of Arizona	Antin, PB (corresponding author), Univ Arizona, Dept Cellular & Mol Med, POB 245217,1656 E Mabel St, Tucson, AZ 85724 USA.	pba@email.arizona.edu		Antin, Parker/0000-0001-9066-7412	National Institutes of Health Grant [1 P41 HD064559]; American Heart Association grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P41HD064559] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association grant(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant 1 P41 HD064559 (to P. B. A.). This work was also supported by an American Heart Association grant (to P. B. A.).	Alev C, 2010, DEVELOPMENT, V137, P2863, DOI 10.1242/dev.053462; Antin P. B., 2012, GEISHA GALLUS EXPRES; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Chuai ML, 2006, DEV BIOL, V296, P137, DOI 10.1016/j.ydbio.2006.04.451; Chuai M, 2009, CURR OPIN GENET DEV, V19, P343, DOI 10.1016/j.gde.2009.06.007; Darnell DK, 2006, DEV DYNAM, V235, P3156, DOI 10.1002/dvdy.20956; Diecke S, 2008, CELLS TISSUES ORGANS, V188, P52, DOI 10.1159/000121282; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hardy KM, 2008, DEV BIOL, V320, P391, DOI 10.1016/j.ydbio.2008.05.546; Hardy KM, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-20; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee MR, 2010, STEM CELLS, V28, P1550, DOI 10.1002/stem.490; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mittal S, 2011, MOL BIOL CELL, V22, P748, DOI 10.1091/mbc.E10-11-0898; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Nakaya Y, 2009, CELL ADHES MIGR, V3, P160, DOI 10.4161/cam.3.2.7373; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; Page RL, 2009, CLONING STEM CELLS, V11, P417, DOI 10.1089/clo.2009.0015; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Sato K, 2009, NUCLEIC ACIDS RES, V37, pW277, DOI 10.1093/nar/gkp367; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; Song JL, 2012, DEV BIOL, V362, P104, DOI 10.1016/j.ydbio.2011.11.015; Sreekumar Rahul, 2011, Frontiers in Genetics, V2, P58, DOI 10.3389/fgene.2011.00058; STERN CD, 2004, GASTRULATION CELLS E, P219; Sweetman D, 2006, DEV DYNAM, V235, P2185, DOI 10.1002/dvdy.20881; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Wang FE, 2010, FASEB J, V24, P1552, DOI 10.1096/fj.08-125856; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Yang XS, 2008, DEVELOPMENT, V135, P3521, DOI 10.1242/dev.023416; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yeung ML, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-81; Yin VP, 2008, GENE DEV, V22, P728, DOI 10.1101/gad.1641808; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	52	21	22	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38505	38514		10.1074/jbc.M112.400598	http://dx.doi.org/10.1074/jbc.M112.400598			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22995917	Green Published, hybrid			2022-12-28	WOS:000310982800010
J	Byun, EH; Kim, WS; Kim, JS; Won, CJ; Choi, HG; Kim, HJ; Cho, SN; Lee, K; Zhang, T; Hur, GM; Shin, SJ				Byun, Eui-Hong; Kim, Woo Sik; Kim, Jong-Seok; Won, Choul-Jae; Choi, Han-Gyu; Kim, Hwa-Jung; Cho, Sang-Nae; Lee, Keehoon; Zhang, Tiejun; Hur, Gang Min; Shin, Sung Jae			Mycobacterium paratuberculosis CobT Activates Dendritic Cells via Engagement of Toll-like Receptor 4 Resulting in Th1 Cell Expansion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AVIUM SUBSP PARATUBERCULOSIS; FIBRONECTIN ATTACHMENT PROTEIN; IMMUNE-RESPONSES; CROHNS-DISEASE; IN-VITRO; ADAPTIVE IMMUNITY; CULTURE FILTRATE; LINKING INNATE; T-CELLS; TUBERCULOSIS	Mycobacterium avium subsp. paratuberculosis (MAP) is the causative agent of Johne disease in animals and MAP involvement in human Crohn disease has been recently emphasized. Evidence from M. tuberculosis studies suggests mycobacterial proteins activate dendritic cells (DCs) via Toll-like receptor (TLR) 4, eventually determining the fate of immune responses. Here, we investigated whether MAP CobT contributes to the development of T cell immunity through the activation of DCs. MAP CobT recognizes TLR4, and induces DC maturation and activation via the MyD88 and TRIF signaling cascades, which are followed by MAP kinases and NF-kappa B. We further found that MAP CobT-treated DCs activated naive T cells, effectively polarized CD4(+) and CD8(+) T cells to secrete IFN-gamma and IL-2, but not IL-4 and IL-10, and induced T cell proliferation. These data indicate that MAP CobT contributes to T helper (Th) 1 polarization of the immune response. MAP CobT-treated DCs specifically induced the expansion of CD4(+)/CD8(+)CD44(high)CD62L(low) memory T cells in the mesenteric lymph node of MAP-infected mice in a TLR4-dependent manner. Our results indicate that MAP CobT is a novel DC maturation-inducing antigen that drives Th1 polarized-naive/memory T cell expansion in a TLR4-dependent cascade, suggesting that MAP CobT potentially links innate and adaptive immunity against MAP.	[Byun, Eui-Hong; Kim, Woo Sik; Kim, Jong-Seok; Won, Choul-Jae; Cho, Sang-Nae; Lee, Keehoon; Shin, Sung Jae] Yonsei Univ, Coll Med, Dept Microbiol, Seoul, South Korea; [Byun, Eui-Hong; Kim, Woo Sik; Kim, Jong-Seok; Won, Choul-Jae; Cho, Sang-Nae; Lee, Keehoon; Shin, Sung Jae] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul, South Korea; [Choi, Han-Gyu; Kim, Hwa-Jung] Chungnam Natl Univ, Dept Microbiol, Taejon, South Korea; [Choi, Han-Gyu; Kim, Hwa-Jung] Chungnam Natl Univ, Res Inst Med Sci, Taejon, South Korea; [Zhang, Tiejun; Hur, Gang Min] Chungnam Natl Univ, Dept Phamacol, Coll Med, Taejon, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Chungnam National University; Chungnam National University; Chungnam National University	Shin, SJ (corresponding author), 50 Yonsei Ro, Seoul 120752, South Korea.	sjshin@yuhs.ac	Hur, Gang-min/ABF-9263-2021; Lee, Keehoon/GSO-0002-2022	Hur, Gang-min/0000-0003-4870-6574; Kim, Hwa-Jung/0000-0002-1127-0909; Shin, Sung Jae/0000-0003-0854-4582	National Research Foundation of Korea grant; Korea government (MEST) Grant [2012-0004927]	National Research Foundation of Korea grant(National Research Foundation of Korea); Korea government (MEST) Grant	This work was supported by a National Research Foundation of Korea grant funded by Korea government (MEST) Grant 2012-0004927.	Abel B, 2002, J IMMUNOL, V169, P3155, DOI 10.4049/jimmunol.169.6.3155; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Baksh FK, 2004, MODERN PATHOL, V17, P1289, DOI 10.1038/modpathol.3800184; Barton GM, 2002, CURR OPIN IMMUNOL, V14, P380, DOI 10.1016/S0952-7915(02)00343-6; Basagoudanavar SH, 2006, VET RES COMMUN, V30, P357, DOI 10.1007/s11259-006-3253-0; Batoni G, 2002, SCAND J IMMUNOL, V56, P43, DOI 10.1046/j.1365-3083.2002.01104.x; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Byun EH, 2012, FASEB J, V26, P2695, DOI 10.1096/fj.11-199588; Byun EH, 2012, J MOL MED, V90, P285, DOI 10.1007/s00109-011-0819-2; Chakir H, 2003, J IMMUNOL METHODS, V278, P157, DOI 10.1016/S0022-1759(03)00200-X; Cho DH, 2006, PROTEOMICS, V6, P5785, DOI 10.1002/pmic.200600207; Claas KR, 2010, J BACTERIOL, V192, P145, DOI 10.1128/JB.01159-09; Diebold SS, 2008, IMMUNOL CELL BIOL, V86, P389, DOI 10.1038/icb.2008.26; Druszczynska M, 2011, POSTEP HIG MED DOSW, V65, P28, DOI 10.5604/17322693.931545; Esser MT, 2003, VACCINE, V21, P419, DOI 10.1016/S0264-410X(02)00407-3; Gerberick GF, 1997, TOXICOL APPL PHARM, V146, P1, DOI 10.1006/taap.1997.8218; Greenstein RJ, 2003, LANCET INFECT DIS, V3, P507, DOI 10.1016/S1473-3099(03)00724-2; Guan HB, 2009, J IMMUNOL, V183, P172, DOI 10.4049/jimmunol.0802325; Hermon-Taylor J, 2000, WORLD J GASTROENTERO, V6, P630; Hoek A, 2010, VACCINE, V28, P5910, DOI 10.1016/j.vaccine.2010.06.042; Hogevold HE, 1997, PERFUSION-UK, V12, P9, DOI 10.1177/026765919701200103; Huntley JFJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-3; Jeon J, 2011, J ETHNOPHARMACOL, V137, P626, DOI 10.1016/j.jep.2011.06.022; Jung ID, 2011, CANCER RES, V71, P2858, DOI 10.1158/0008-5472.CAN-10-3487; Kathaperumal K, 2008, VACCINE, V26, P1652, DOI 10.1016/j.vaccine.2008.01.015; Lee JS, 2009, INFECT IMMUN, V77, P2979, DOI 10.1128/IAI.01411-08; Lei LY, 2007, VET IMMUNOL IMMUNOP, V120, P177, DOI 10.1016/j.vetimm.2007.06.031; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; McShane H, 2002, INFECT IMMUN, V70, P1623, DOI 10.1128/IAI.70.3.1623-1626.2002; Moll H, 2003, IMMUNOL LETT, V85, P153, DOI 10.1016/S0165-2478(02)00222-5; Noh KT, 2012, EXP MOL MED, V44, P340, DOI 10.3858/emm.2012.44.5.038; Palucka AK, 2007, IMMUNOL REV, V220, P129, DOI 10.1111/j.1600-065X.2007.00575.x; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Rogers PR, 2000, J IMMUNOL, V164, P2338, DOI 10.4049/jimmunol.164.5.2338; Rosenkrands I, 2000, ELECTROPHORESIS, V21, P935, DOI 10.1002/(SICI)1522-2683(20000301)21:5<935::AID-ELPS935>3.3.CO;2-G; Rosseels V, 2006, INFECT IMMUN, V74, P202, DOI 10.1128/IAI.74.1.202-212.2006; Roupie V, 2008, VACCINE, V26, P4783, DOI 10.1016/j.vaccine.2008.07.009; Roupie V, 2012, VET IMMUNOL IMMUNOP, V145, P74, DOI 10.1016/j.vetimm.2011.10.012; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Santema W, 2011, VACCINE, V29, P1364, DOI 10.1016/j.vaccine.2010.12.071; Santos F, 2008, MICROBIOL-SGM, V154, P81, DOI 10.1099/mic.0.2007/011569-0; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Shin AR, 2010, FEMS IMMUNOL MED MIC, V58, P128, DOI 10.1111/j.1574-695X.2009.00617.x; Shin SJ, 2005, INFECT IMMUN, V73, P5074, DOI 10.1128/IAI.73.8.5074-5085.2005; Sousa CRE, 2001, IMMUNITY, V14, P495; Steinman RM, 1999, J LEUKOCYTE BIOL, V66, P205, DOI 10.1002/jlb.66.2.205; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tjalsma H, 2000, MICROBIOL MOL BIOL R, V64, P515, DOI 10.1128/MMBR.64.3.515-547.2000; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Wille-Reece U, 2006, J EXP MED, V203, P1249, DOI 10.1084/jem.20052433	52	21	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38609	38624		10.1074/jbc.M112.391060	http://dx.doi.org/10.1074/jbc.M112.391060			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23019321	Green Published, hybrid			2022-12-28	WOS:000310982800021
J	Hitt, B; Riordan, SM; Kukreja, L; Eimer, WA; Rajapaksha, TW; Vassar, R				Hitt, Brian; Riordan, Sean M.; Kukreja, Lokesh; Eimer, William A.; Rajapaksha, Tharinda W.; Vassar, Robert			beta-Site Amyloid Precursor Protein (APP)-cleaving Enzyme 1 (BACE1)-deficient Mice Exhibit a Close Homolog of L1 (CHL1) Loss-of-function Phenotype Involving Axon Guidance Defects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL-CELL-ADHESION; OLFACTORY SENSORY NEURONS; ALZHEIMERS-DISEASE; MEMORY DEFICITS; KNOCKOUT MICE; A-BETA; SECRETASE; BACE1; MOLECULES; CLEAVAGE	BACE1 is the beta-secretase enzyme that initiates production of the beta-amyloid peptide involved in Alzheimer disease. However, little is known about the functions of BACE1. BACE1-deficient mice exhibit mild but complex neurological phenotypes suggesting therapeutic BACE1 inhibition may not be completely free of mechanism-based side effects. Recently, we have reported that BACE1 null mice have axon guidance defects in olfactory sensory neuron projections to glomeruli in the olfactory bulb. Here, we show that BACE1 deficiency also causes an axon guidance defect in the hippocampus, a shortened and disorganized infrapyramidal bundle of the mossy fiber projection from the dentate gyrus to CA3. Although we observed that a classical axon guidance molecule, EphA4, was cleaved by BACE1 when co-expressed with BACE1 in HEK293 cells, we could find no evidence of BACE1 processing of EphA4 in the brain. Remarkably, we discovered that the axon guidance defects of BACE1(-/-) mice were strikingly similar to those of mice deficient in a recently identified BACE1 substrate, the neural cell adhesion molecule close homolog of L1 (CHL1) that is involved in neurite outgrowth. CHL1 undergoes BACE1-dependent processing in BACE1(-/-), but not BACE1(-/-), hippocampus, and olfactory bulb, indicating that CHL1 is a BACE1 substrate in vivo. Finally, BACE1 and CHL1 co-localize in the terminals of hippocampal mossy fibers, olfactory sensory neuron axons, and growth cones of primary hippocampal neurons. We conclude that BACE1(-/-) axon guidance defects are likely the result of abrogated BACE1 processing of CHL1 and that BACE1 deficiency produces a CHL1 loss-of-function phenotype. Our results imply the possibility that axon mis-targeting may occur in adult neurogenic and/or regenerating neurons as a result of chronic BACE1 inhibition and add a note of caution to BACE1 inhibitor development.	[Hitt, Brian; Riordan, Sean M.; Kukreja, Lokesh; Eimer, William A.; Rajapaksha, Tharinda W.; Vassar, Robert] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Vassar, R (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave, Chicago, IL 60611 USA.	r-vassar@northwestern.edu	Riordan, Sean Michael/A-9053-2012	Riordan, Sean Michael/0000-0001-5727-1221; Eimer, William/0000-0003-1067-9339; Hitt, Brian/0000-0001-8720-6762	National Institutes of Health [R01AG022560]; Northwestern University Mechanisms of Aging and Dementia Training Grant [T32 AG20506]; Drug Discovery in Age-related Disorders Training Grant [T32 AG260-12]; Medical Scientist Training Program Training Grant [T32 GM08152-19]; Cellular and Molecular Basis of Disease Training Grant [T32 GM08061]; American Health Assistance Foundation Grant [A2012063]; National Institutes of Health from NCI [CCSG P30 CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061, T32GM008152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022560, T32AG020506, R01AG026012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northwestern University Mechanisms of Aging and Dementia Training Grant; Drug Discovery in Age-related Disorders Training Grant; Medical Scientist Training Program Training Grant; Cellular and Molecular Basis of Disease Training Grant; American Health Assistance Foundation Grant; National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AG022560 (to R. V.), Northwestern University Mechanisms of Aging and Dementia Training Grant T32 AG20506 (to L. K.), Drug Discovery in Age-related Disorders Training Grant T32 AG260-12 (to S. R.), Medical Scientist Training Program Training Grant T32 GM08152-19, and Cellular and Molecular Basis of Disease Training Grant T32 GM08061 (to B. H.). This work was also supported by American Health Assistance Foundation Grant A2012063 (to R. V.).; We acknowledge the Getsios (Northwestern University) and the Sakaguchi (Wakayama Medical University) laboratories for providing the EphA4 plasmids used in this work. We thank Drs. Aryeh Routtenberg, Adriana Ferreira, and Thomas Bozza (Northwestern University) for helpful discussions. Confocal imaging work was performed at the Northwestern University Cell Imaging Facility generously supported by National Institutes of Health Grants CCSG P30 CA060553 from NCI awarded to the Robert H. Lurie Comprehensive Cancer Center. Growth cone collapse imaging and axon length measurement was accomplished through the generosity of Keyence Corp. (Japan).	Bennett BD, 2000, J BIOL CHEM, V275, P37712, DOI 10.1074/jbc.M005339200; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Cao LX, 2012, SCI REP-UK, V2, DOI 10.1038/srep00231; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; Castellani V, 2002, EMBO J, V21, P6348, DOI 10.1093/emboj/cdf645; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Crusio WE, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-3; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Demyanenko GP, 1999, J NEUROSCI, V19, P4907; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Fransen E, 1998, HUM MOL GENET, V7, P999, DOI 10.1093/hmg/7.6.999; Galimberti I, 2010, NEURON, V65, P627, DOI 10.1016/j.neuron.2010.02.016; Giaccone G, 2010, ACTA NEUROPATHOL, V120, P803, DOI 10.1007/s00401-010-0747-1; Guaiquil V, 2009, MOL CELL BIOL, V29, P2694, DOI 10.1128/MCB.01460-08; Guaiquil VH, 2010, J MOL MED, V88, P497, DOI 10.1007/s00109-010-0591-8; Hemming ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008477; Heyden A, 2008, NEUROSCIENCE, V155, P221, DOI 10.1016/j.neuroscience.2008.04.080; Hitt BD, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-31; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Hu XY, 2010, J NEUROSCI, V30, P8819, DOI 10.1523/JNEUROSCI.1334-10.2010; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Inoue E, 2009, J CELL BIOL, V185, P551, DOI 10.1083/jcb.200809151; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; Montag-Sallaz M, 2002, MOL CELL BIOL, V22, P7967, DOI 10.1128/MCB.22.22.7967-7981.2002; Naus S, 2004, J BIOL CHEM, V279, P16083, DOI 10.1074/jbc.M400560200; O'Leary DDM, 2005, PROG BRAIN RES, V147, P43, DOI 10.1016/S0079-6123(04)47005-8; Ohno M, 2006, EUR J NEUROSCI, V23, P251, DOI 10.1111/j.1460-9568.2005.04551.x; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Pasquale EB, 2004, NAT NEUROSCI, V7, P417, DOI 10.1038/nn0504-417; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Rajapaksha TW, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-88; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; Schlatter MC, 2008, J NEUROCHEM, V104, P731, DOI 10.1111/j.1471-4159.2007.05013.x; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wright AG, 2007, J NEUROSCI, V27, P13667, DOI 10.1523/JNEUROSCI.2888-07.2007; Xu NJ, 2009, NAT NEUROSCI, V12, P268, DOI 10.1038/nn.2254; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yan XX, 2007, J COMP NEUROL, V501, P52, DOI 10.1002/cne.21239; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007; Zhou LJ, 2012, J BIOL CHEM, V287, P25927, DOI 10.1074/jbc.M112.377465	57	111	113	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38408	38425		10.1074/jbc.M112.415505	http://dx.doi.org/10.1074/jbc.M112.415505			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22988240	Green Published, hybrid			2022-12-28	WOS:000310982800001
J	Mathieu, Y; Prosper, P; Buee, M; Dumarcay, S; Favier, F; Gelhaye, E; Gerardin, P; Harvengt, L; Jacquot, JP; Lamant, T; Meux, E; Mathiot, S; Didierjean, C; Morel, M				Mathieu, Yann; Prosper, Pascalita; Buee, Marc; Dumarcay, Stephane; Favier, Frederique; Gelhaye, Eric; Gerardin, Philippe; Harvengt, Luc; Jacquot, Jean-Pierre; Lamant, Tiphaine; Meux, Edgar; Mathiot, Sandrine; Didierjean, Claude; Morel, Melanie			Characterization of a Phanerochaete chrysosporium Glutathione Transferase Reveals a Novel Structural and Functional Class with Ligandin Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-TRANSFERASE; CRYSTAL-STRUCTURE; X-RAY; BINDING; PROTEIN; SITE; GLUTAREDOXIN; IDENTIFICATION; PURIFICATION; EXPRESSION	Glutathione S-transferases (GSTs) form a superfamily of multifunctional proteins with essential roles in cellular detoxification processes. Anew fungal specific class of GST has been highlighted by genomic approaches. The biochemical and structural characterization of one isoform of this class in Phanerochaete chrysosporium revealed original properties. The three-dimensional structure showed a new dimerization mode and specific features by comparison with the canonical GST structure. An additional beta-hairpin motif in the N-terminal domain prevents the formation of the regular GST dimer and acts as a lid, which closes upon glutathione binding. Moreover, this isoform is the first described GST that contains all secondary structural elements, including helix alpha 4' in the C-terminal domain, of the pre-sumed common ancestor of cytosolic GSTs (i.e. glutaredoxin 2). A sulfate binding site has been identified close to the glutathione binding site and allows the binding of 8-anilino-1-naphtalene sulfonic acid. Competition experiments between 8-anilino-1-naphtalene sulfonic acid, which has fluorescent properties, and various molecules showed that this GST binds glutathionylated and sulfated compounds but also wood extractive molecules, such as vanillin, chloronitrobenzoic acid, hydroxyacetophenone, catechins, and aldehydes, in the glutathione pocket. This enzyme could thus function as a classical GST through the addition of glutathione mainly to phenethyl isothiocyanate, but alternatively and in a competitive way, it could also act as a ligandin of wood extractive compounds. These new structural and functional properties lead us to propose that this GST belongs to a new class that we name GSTFuA, for fungal specific GST class A.	[Didierjean, Claude] Univ Lorraine, UMR 7036, CRM2, Inst Jean Barriol,Fac Sci & Technol, F-54506 Vandoeuvre Les Nancy, France; [Mathieu, Yann; Gelhaye, Eric; Jacquot, Jean-Pierre; Lamant, Tiphaine; Meux, Edgar; Morel, Melanie] Univ Lorraine, UMR 1136, Inst Federatif Rech EFABA 110, F-54506 Vandoeuvre Les Nancy, France; [Mathieu, Yann; Buee, Marc; Gelhaye, Eric; Jacquot, Jean-Pierre; Lamant, Tiphaine; Meux, Edgar; Morel, Melanie] INRA, UMR 1136, F-54506 Vandoeuvre Les Nancy, France; [Prosper, Pascalita; Favier, Frederique; Mathiot, Sandrine; Didierjean, Claude] CNRS, CRM2, UMR 7036, F-54506 Vandoeuvre Les Nancy, France; [Dumarcay, Stephane; Gerardin, Philippe] Univ Lorraine, Lab Etud & Rech Mat Bois, EA 1093, F-54506 Vandoeuvre Les Nancy, France; [Mathieu, Yann; Harvengt, Luc] Inst Technol Foret Cellulose Bois Construct Ameub, Biotechnol Lab, F-33610 Cestas, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); CHU de Nancy; Universite de Lorraine; Universite de Lorraine; INRAE; Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Lorraine; Universite de Lorraine	Didierjean, C (corresponding author), Univ Lorraine, UMR 7036, CRM2, Inst Jean Barriol,Fac Sci & Technol, BP 70239, F-54506 Vandoeuvre Les Nancy, France.	Claude.Didierjean@crm2.uhp-nancy.fr; mmorel@scbiol.uhp-nancy.fr	gelhaye, eric/K-7390-2013; DIDIERJEAN, Claude/L-1493-2013; Harvengt, Luc/G-4569-2011; Favier, Frederique/B-3090-2013; Jacquot, Jean-Pierre/A-1571-2012	gelhaye, eric/0000-0002-0699-9113; DIDIERJEAN, Claude/0000-0002-3176-8974; Harvengt, Luc/0000-0003-1524-5273; Favier, Frederique/0000-0003-3249-997X; Buee, Marc/0000-0001-8614-3886; Morel-Rouhier, Melanie/0000-0001-5149-0474; Jacquot, Jean-Pierre/0000-0003-4975-8587; MATHIEU, Yann/0000-0001-6698-1911	Convention industrielle de formation par la recherche (CIFRE); Agence Nationale de la Recherche (ANR) [ANR-09-BLAN-0012]; Ministere de l'Enseignement Superieur, de la Recherche, et de la Technologie; Institut National de la Recherche Agronomique (INRA); CNRS	Convention industrielle de formation par la recherche (CIFRE); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur, de la Recherche, et de la Technologie; Institut National de la Recherche Agronomique (INRA); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by Convention industrielle de formation par la recherche (CIFRE) and Agence Nationale de la Recherche (ANR) Research Grant ANR-09-BLAN-0012; the Ministere de l'Enseignement Superieur, de la Recherche, et de la Technologie; the Institut National de la Recherche Agronomique (INRA); and CNRS.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agianian B, 2003, J MOL BIOL, V326, P151, DOI 10.1016/S0022-2836(02)01327-X; Allocati N, 1999, FEBS LETT, V445, P347, DOI 10.1016/S0014-5793(99)00147-7; BILANG J, 1993, PLANT PHYSIOL, V102, P29, DOI 10.1104/pp.102.1.29; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Burns C, 2005, FUNGAL GENET BIOL, V42, P319, DOI 10.1016/j.fgb.2005.01.001; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi JH, 1998, J BIOL CHEM, V273, P29915, DOI 10.1074/jbc.273.45.29915; Cocco R, 2001, J BIOL CHEM, V276, P32177, DOI 10.1074/jbc.M104057200; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Conn S, 2008, J EXP BOT, V59, P3621, DOI 10.1093/jxb/ern217; Couturier J, 2009, J BIOL CHEM, V284, P9299, DOI 10.1074/jbc.M807998200; D'Ambrosio K, 2003, ACTA CRYSTALLOGR D, V59, P1043, DOI 10.1107/S0907444903006814; DIRR H, 1994, EUR J BIOCHEM, V220, P645, DOI 10.1111/j.1432-1033.1994.tb18666.x; Dixon DP, 2008, J BIOL CHEM, V283, P20268, DOI 10.1074/jbc.M802026200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fraser JA, 2002, APPL ENVIRON MICROB, V68, P2802, DOI 10.1128/AEM.68.6.2802-2808.2002; Frova C, 2006, BIOMOL ENG, V23, P149, DOI 10.1016/j.bioeng.2006.05.020; Garcera A, 2006, BIOCHEM J, V398, P187, DOI 10.1042/BJ20060034; Gille C, 2006, PROTEIN SCI, V15, P208, DOI 10.1110/ps.051882006; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jeppesen MG, 2003, J BIOL CHEM, V278, P47190, DOI 10.1074/jbc.M306630200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim DE, 2005, PROTEIN EXPRES PURIF, V39, P107, DOI 10.1016/j.pep.2004.09.007; Kitamura S, 2004, PLANT J, V37, P104, DOI 10.1046/j.1365-313X.2003.01943.x; Koh CS, 2008, J BIOL CHEM, V283, P23062, DOI 10.1074/jbc.M802093200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lederer B, 2003, BBA-GEN SUBJECTS, V1621, P226, DOI 10.1016/S0304-4165(03)00073-4; Lee CY, 2009, BIOORG MED CHEM LETT, V19, P6326, DOI 10.1016/j.bmcl.2009.09.088; Lee S, 2012, BMB REP, V45, P265, DOI 10.5483/BMBRep.2012.45.5.265; Lian HY, 2006, BBA-PROTEINS PROTEOM, V1764, P535, DOI 10.1016/j.bbapap.2005.11.016; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Mannervik B, 2012, J BIOL CHEM, V287, P6072, DOI 10.1074/jbc.X112.342675; MARRS KA, 1995, NATURE, V375, P397, DOI 10.1038/375397a0; Masai E, 2003, J BACTERIOL, V185, P1768, DOI 10.1128/JB.185.6.1768-1775.2003; MASAI E, 1993, FEBS LETT, V323, P135, DOI 10.1016/0014-5793(93)81465-C; McGoldrick S, 2005, FEMS MICROBIOL LETT, V242, P1, DOI 10.1016/j.femsle.2004.10.033; Menchise V., 2000, Biopolymers, V56, P1, DOI 10.1002/1097-0282(2000)56:1<1::AID-BIP1036>3.0.CO;2-5; Meux E, 2011, J BIOL CHEM, V286, P9162, DOI 10.1074/jbc.M110.194548; Morel M, 2009, CELL MOL LIFE SCI, V66, P3711, DOI 10.1007/s00018-009-0104-5; Nakamura T, 2012, BIODEGRADATION, V23, P343, DOI 10.1007/s10532-011-9521-x; Oakley AJ, 1999, J MOL BIOL, V291, P913, DOI 10.1006/jmbi.1999.3029; Polekhina G, 2001, BIOCHEMISTRY-US, V40, P1567, DOI 10.1021/bi002249z; Reinemer P, 1996, J MOL BIOL, V255, P289, DOI 10.1006/jmbi.1996.0024; Rossjohn J, 1998, STRUCTURE, V6, P309, DOI 10.1016/S0969-2126(98)00034-3; SCHENK PM, 1995, BIOTECHNIQUES, V19, P196; Schonbrunn E, 2000, P NATL ACAD SCI USA, V97, P6345, DOI 10.1073/pnas.120120397; Shimizu M, 2005, PROTEOMICS, V5, P3919, DOI 10.1002/pmic.200401251; Shimizu M, 2005, APPL MICROBIOL BIOT, V68, P673, DOI 10.1007/s00253-005-1933-2; SINNING I, 1993, J MOL BIOL, V232, P192, DOI 10.1006/jmbi.1993.1376; Skopelitou K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034263; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Thuillier A., 2011, INT J EVOL BIOL, V2011; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xia B, 2001, J MOL BIOL, V310, P907, DOI 10.1006/jmbi.2001.4721; Zhang J, 2011, J AM CHEM SOC, V133, P14109, DOI 10.1021/ja205500y; Zhang ZR, 2008, J MOL BIOL, V384, P641, DOI 10.1016/j.jmb.2008.09.047	60	28	28	1	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39001	39011		10.1074/jbc.M112.402776	http://dx.doi.org/10.1074/jbc.M112.402776			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23007392	Green Published, hybrid			2022-12-28	WOS:000310982800056
J	Lee, CF; Bird, S; Shaw, M; Jean, L; Vaux, DJ				Lee, Chiu Fan; Bird, Sarah; Shaw, Michael; Jean, Letitia; Vaux, David J.			Combined Effects of Agitation, Macromolecular Crowding, and Interfaces on Amyloidogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIR-WATER-INTERFACE; BETA-AMYLOID PEPTIDE; ALPHA-SYNUCLEIN; SURFACE-TENSION; PHYSIOLOGICAL CONSEQUENCES; EXPERIMENTAL CONSTRAINTS; ADSORPTION-KINETICS; PROTEIN AGGREGATION; PARKINSONS-DISEASE; GLOBULAR-PROTEINS	Amyloid formation and accumulation is a hallmark of protein misfolding diseases and is associated with diverse pathologies including type II diabetes and Alzheimer's disease (AD). In vitro, amyloidogenesis is widely studied in conditions that do not simulate the crowded and viscous in vivo environment. A high volume fraction of most biological fluids is occupied by various macromolecules, a phenomenon known as macromolecular crowding. For some amyloid systems (e.g. alpha-synuclein) and under shaking condition, the excluded volume effect of macromolecular crowding favors aggregation, whereas increased viscosity reduces the kinetics of these reactions. Amyloidogenesis can also be catalyzed by hydrophobic-hydrophilic interfaces, represented by the air-water interface in vitro and diverse heterogeneous interfaces in vivo (e.g. membranes). In this study, we investigated the effects of two different crowding polymers (dextran and Ficoll) and two different experimental conditions (with and without shaking) on the fibrilization of amyloid-beta peptide, a major player in AD pathogenesis. Specifically, we demonstrate that, during macromolecular crowding, viscosity dominates over the excluded volume effect only when the system is spatially non homogeneous (i.e. an air-water interface is present). We also show that the surfactant activity of the crowding agents can critically influence the outcome of macromolecular crowding and that the structure of the amyloid species formed may depend on the polymer used. This suggests that, in vivo, the outcome of amyloidogenesis may be affected by both macromolecular crowding and spatial heterogeneity (e.g. membrane turn-over). More generally, our work suggests that any factors causing changes in crowding may be susceptibility factors in AD.	[Shaw, Michael; Jean, Letitia; Vaux, David J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Lee, Chiu Fan] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Bird, Sarah] Univ Oxford, Sch Clin, John Radcliffe Hosp, Med Sch,Med Sci Off, Oxford OX3 9DU, England	University of Oxford; Max Planck Society; University of Oxford	Vaux, DJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	david.vaux@path.ox.ac.uk		Vaux, David/0000-0002-4901-9795; Lee, Chiu Fan/0000-0003-4363-9050	Synaptica Ltd	Synaptica Ltd	This work was supported by a research grant from Synaptica Ltd (to L. J.).	Alvarez-Martinez MT, 2011, BBA-PROTEINS PROTEOM, V1814, P1305, DOI 10.1016/j.bbapap.2011.05.016; Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; BARBER BJ, 1995, J GERONTOL A-BIOL, V50, pB282, DOI 10.1093/gerona/50A.5.B282; Bokvist M, 2007, J AM CHEM SOC, V129, P14848, DOI 10.1021/ja076059o; Chi EY, 2010, BIOPHYS J, V98, P2299, DOI 10.1016/j.bpj.2010.01.056; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cottingham MG, 2004, LAB INVEST, V84, P523, DOI 10.1038/labinvest.3700054; Dupuis NF, 2009, J AM CHEM SOC, V131, P18283, DOI 10.1021/ja903814q; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; FULTON AB, 1982, CELL, V30, P345, DOI 10.1016/0092-8674(82)90231-8; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hatters DM, 2002, J BIOL CHEM, V277, P7824, DOI 10.1074/jbc.M110429200; Hortschansky P, 2005, PROTEIN SCI, V14, P1753, DOI 10.1110/ps.041266605; Hur JY, 2008, FEBS J, V275, P1174, DOI 10.1111/j.1742-4658.2008.06278.x; Jean L, 2012, BIOPHYS J, V102, P1154, DOI 10.1016/j.bpj.2012.01.041; Jean L, 2010, FASEB J, V24, P309, DOI 10.1096/fj.09-137653; Jiang DL, 2009, J PHYS CHEM B, V113, P3160, DOI 10.1021/jp8085792; Krishnan A, 2003, LANGMUIR, V19, P10342, DOI 10.1021/la035308t; Lee CF, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031922; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LIN SY, 1995, LANGMUIR, V11, P555, DOI 10.1021/la00002a033; Lopes DHJ, 2007, BIOPHYS J, V93, P3132, DOI 10.1529/biophysj.107.110635; LUBYPHELPS K, 1987, P NATL ACAD SCI USA, V84, P4910, DOI 10.1073/pnas.84.14.4910; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Minton AP, 2000, BIOPHYS J, V78, P101, DOI 10.1016/S0006-3495(00)76576-3; Morinaga A, 2010, BBA-PROTEINS PROTEOM, V1804, P986, DOI 10.1016/j.bbapap.2010.01.012; Morris VK, 2011, J BIOL CHEM, V286, P15955, DOI 10.1074/jbc.M110.214197; Mukherjee S, 2009, J MOL BIOL, V393, P227, DOI 10.1016/j.jmb.2009.08.016; Munishkina LA, 2004, J MOL RECOGNIT, V17, P456, DOI 10.1002/jmr.699; NABER D, 1979, EXP GERONTOL, V14, P59, DOI 10.1016/0531-5565(79)90010-X; Nagy I Z, 1982, Exp Brain Res, VSuppl 5, P118; Parhi P, 2009, BIOMATERIALS, V30, P6814, DOI 10.1016/j.biomaterials.2009.09.005; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Pronchik J, 2010, J AM CHEM SOC, V132, P9797, DOI 10.1021/ja102896h; ROTENBERG Y, 1983, J COLLOID INTERF SCI, V93, P169, DOI 10.1016/0021-9797(83)90396-X; SEGUR JB, 1951, IND ENG CHEM, V43, P2117, DOI 10.1021/ie50501a040; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Sgourakis NG, 2007, J MOL BIOL, V368, P1448, DOI 10.1016/j.jmb.2007.02.093; SHEN CL, 1995, BIOPHYS J, V69, P640, DOI 10.1016/S0006-3495(95)79940-4; Shtilerman MD, 2002, BIOCHEMISTRY-US, V41, P3855, DOI 10.1021/bi0120906; SNYDER SW, 1994, BIOPHYS J, V67, P1216, DOI 10.1016/S0006-3495(94)80591-0; SOREGHAN B, 1994, J BIOL CHEM, V269, P28551; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Sukenik S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015608; Terzi E, 1997, BIOCHEMISTRY-US, V36, P14845, DOI 10.1021/bi971843e; TRIPP BC, 1995, J COLLOID INTERF SCI, V173, P16, DOI 10.1006/jcis.1995.1291; Uversky VN, 2002, FEBS LETT, V515, P99, DOI 10.1016/S0014-5793(02)02446-8; Venturoli D, 2005, AM J PHYSIOL-RENAL, V288, pF605, DOI 10.1152/ajprenal.00171.2004; Wenner JR, 1999, BIOPHYS J, V77, P3234, DOI 10.1016/S0006-3495(99)77154-7; Zhou BR, 2008, BBA-PROTEINS PROTEOM, V1784, P472, DOI 10.1016/j.bbapap.2008.01.004; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; Zhou Z, 2009, J BIOL CHEM, V284, P30148, DOI 10.1074/jbc.M109.002832	59	54	54	0	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.400580	http://dx.doi.org/10.1074/jbc.M112.400580			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22988239	Green Published, hybrid			2022-12-28	WOS:000310642200035
J	Wawra, S; Agacan, M; Boddey, JA; Davidson, I; Gachon, CMM; Zanda, M; Grouffaud, S; Whisson, SC; Birch, PRJ; Porter, AJ; van West, P				Wawra, Stephan; Agacan, Mark; Boddey, Justin A.; Davidson, Ian; Gachon, Claire M. M.; Zanda, Matteo; Grouffaud, Severine; Whisson, Stephen C.; Birch, Paul R. J.; Porter, Andy J.; van West, Pieter			Avirulence Protein 3a (AVR3a) from the Potato Pathogen Phytophthora infestans Forms Homodimers through Its Predicted Translocation Region and Does Not Specifically Bind Phospholipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RXLR EFFECTOR AVR3A; ANIMAL HOST-CELLS; MOLECULAR CHAPERONE; PLANT IMMUNITY; CROSS-LINKING; OOMYCETE; DNAK; DIMERIZATION; MECHANISM; HSP70	The mechanism of translocation of RxLR effectors from plant pathogenic oomycetes into the cytoplasm of their host is currently the object of intense research activity and debate. Here, we report the biochemical and thermodynamic characterization of the Phytophthora infestans effector AVR3a in vitro. We show that the amino acids surrounding the RxLR leader mediate homodimerization of the protein. Dimerization was considerably attenuated by a localized mutation within the RxLR motif that was previously described to prevent translocation of the protein into host. Importantly, we confirm that the reported phospholipid-binding properties of AVR3a are mediated by its C-terminal effector domain, not its RxLR leader. However, we show that the observed phospholipid interaction is attributable to a weak association with denatured protein molecules and is therefore most likely physiologically irrelevant.	[Wawra, Stephan; Grouffaud, Severine; van West, Pieter] Univ Aberdeen, Aberdeen Oomycete Lab, Coll Life Sci & Med, Aberdeen AB25 2ZD, Scotland; [Davidson, Ian] Univ Aberdeen, Prote Facil, Aberdeen AB25 2ZD, Scotland; [Zanda, Matteo] Univ Aberdeen, Kosterlitz Ctr Therapeut, Aberdeen AB25 2ZD, Scotland; [Porter, Andy J.] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Agacan, Mark] Univ Dundee, Prote Facil, Coll Life Sci, Dundee DD1 5EH, Scotland; [Boddey, Justin A.] Univ Melbourne, Walter & Eliza Hall Inst, Div Infect & Immun, Parkville, Vic 3052, Australia; [Boddey, Justin A.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Gachon, Claire M. M.] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban PA37 1QA, Argyll, Scotland; [Zanda, Matteo] CNR, Ist Chim Riconoscimento Mol, I-20131 Milan, Italy; [Birch, Paul R. J.] Univ Dundee JHI, Coll Life Sci, Div Plant Sci, Dundee DD2 5DA, Scotland; [Grouffaud, Severine; Whisson, Stephen C.; Birch, Paul R. J.] Univ Dundee JHI, James Hutton Inst, Dundee DD2 5DA, Scotland	University of Aberdeen; University of Aberdeen; University of Aberdeen; University of Aberdeen; University of Dundee; University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; UHI Millennium Institute; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); University of Dundee; James Hutton Institute; University of Dundee	Wawra, S (corresponding author), Univ Aberdeen, Aberdeen Oomycete Lab, Coll Life Sci & Med, Foresterhill, Aberdeen AB25 2ZD, Scotland.	s.wawra@abdn.ac.uk; p.vanwest@abdn.ac.uk	Wawra, Stephan/D-2781-2013; Zanda, Matteo/AAC-2391-2022	Wawra, Stephan/0000-0001-8555-1618; Gachon, Claire/0000-0002-3702-7472; Boddey, Justin/0000-0001-7322-2040; van West, Pieter/0000-0002-0767-6017; Birch, Paul/0000-0002-6559-3746	Biotechnology and Biological Sciences Research Council (BBSRC); Natural Environmental Research Council (NERC); University of Aberdeen; University of Dundee; Scottish Government Rural and Environmental Science Analytical Services Division (RESAS); Royal Society; BBSRC [BB/E007120/1, BB/G015244/1] Funding Source: UKRI; NERC [NE/J00460X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E007120/1, BB/G015244/1] Funding Source: researchfish; Natural Environment Research Council [NE/J00460X/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environmental Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of Aberdeen; University of Dundee; Scottish Government Rural and Environmental Science Analytical Services Division (RESAS); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC; to S. W., P. R. J. B., A. J. P., and P. v. W.), the Natural Environmental Research Council (NERC; to S. W., C. M. M. G., and P. v. W.), the University of Aberdeen (to S. G., I. D., A. J. P., M. Z., and P. v. W.), the University of Dundee (to M. A. and P. R. J. B.), the Scottish Government Rural and Environmental Science Analytical Services Division (RESAS; to S. C. W.), and The Royal Society (to P. v. W.).	Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Birch PRJ, 2006, TRENDS MICROBIOL, V14, P8, DOI 10.1016/j.tim.2005.11.007; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Boutemy LS, 2011, J BIOL CHEM, V286, P35834, DOI 10.1074/jbc.M111.262303; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; BURROWS SD, 1994, BIOCHEMISTRY-US, V33, P12741, DOI 10.1021/bi00209a002; Ellis JG, 2011, P NATL ACAD SCI USA, V108, P14381, DOI 10.1073/pnas.1111668108; Ellis R. John, 1999, Current Opinion in Structural Biology, V9, P102, DOI 10.1016/S0959-440X(99)80013-X; Fidzinski P, 2012, BRAIN RES, V1430, P1, DOI 10.1016/j.brainres.2011.10.040; Gan PHP, 2010, PLANT SIGNAL BEHAV, V5, P1272, DOI 10.4161/psb.5.10.13013; Gu BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027217; Kale SD, 2011, CELL MICROBIOL, V13, P1839, DOI 10.1111/j.1462-5822.2011.01659.x; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Matulis D, 2000, J MOL BIOL, V296, P1053, DOI 10.1006/jmbi.1999.3470; Nickerson DP, 1997, PROTEIN ENG, V10, P1357, DOI 10.1093/protein/10.12.1357; Packschies L, 1997, BIOCHEMISTRY-US, V36, P3417, DOI 10.1021/bi962835l; Phillips AJ, 2008, TRENDS MICROBIOL, V16, P13, DOI 10.1016/j.tim.2007.10.013; PHIZICKY EM, 1995, MICROBIOL REV, V59, P94, DOI 10.1128/MMBR.59.1.94-123.1995; Plett JM, 2011, CURR BIOL, V21, P1197, DOI 10.1016/j.cub.2011.05.033; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Russell R, 1998, BIOCHEMISTRY-US, V37, P596, DOI 10.1021/bi972025p; Slepenkov SV, 2002, MOL MICROBIOL, V45, P1197, DOI 10.1046/j.1365-2958.2002.03093.x; Sutherland BW, 2008, J MASS SPECTROM, V43, P699, DOI 10.1002/jms.1415; Toews J, 2008, ANAL CHIM ACTA, V618, P168, DOI 10.1016/j.aca.2008.04.049; Wawra S, 2012, P NATL ACAD SCI USA, V109, P2096, DOI 10.1073/pnas.1113775109; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Yaeno T, 2011, P NATL ACAD SCI USA, V108, P14682, DOI 10.1073/pnas.1106002108	29	25	29	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.395129	http://dx.doi.org/10.1074/jbc.M112.395129			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22977236	Green Published, hybrid			2022-12-28	WOS:000310642200044
J	Lian, N; Lin, TH; Liu, WG; Wang, WG; Li, LZ; Sun, S; Nyman, JS; Yang, XL				Lian, Na; Lin, Tonghui; Liu, Wenguang; Wang, Weiguang; Li, Lingzhen; Sun, Stephanie; Nyman, Jeffry S.; Yang, Xiangli			Transforming Growth Factor beta Suppresses Osteoblast Differentiation via the Vimentin Activating Transcription Factor 4 (ATF4) Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICE LACKING VIMENTIN; MESENCHYMAL STEM-CELLS; TGF-BETA; INTERMEDIATE FILAMENT; GENE-EXPRESSION; PHOSPHATIDYLINOSITOL 3-KINASE; CLEIDOCRANIAL DYSPLASIA; CHEMOTACTIC RESPONSE; TARGETED DISRUPTION; SIGNAL-TRANSDUCTION	ATF4 is an osteoblast-enriched transcription factor of the leucine zipper family. We recently identified that vimentin, a leucine zipper-containing intermediate filament protein, suppresses ATF4-dependent osteocalcin (Ocn) transcription and osteoblast differentiation. Here we show that TGF beta inhibits ATF4-dependent activation of Ocn by up-regulation of vimentin expression. Osteoblasts lacking Atf4 (Atf4(-/-)) were less sensitive than wild-type (WT) cells to the inhibition by TGF beta on alkaline phosphatase activity, Ocn transcription and mineralization. Importantly, the anabolic effect of a monoclonal antibody neutralizing active TGF beta ligands on bone in WT mice was blunted in Atf4(-/-) mice. These data establish that ATF4 is required for TGF beta-related suppression of Ocn transcription and osteoblast differentiation in vitro and in vivo. Interestingly, TGF beta did not directly regulate the expression of ATF4; instead, it enhanced the expression of vimentin, a negative regulator of ATF4, at the post-transcriptional level. Accordingly, knockdown of endogenous vimentin in 2T3 osteoblasts abolished the inhibition of Ocn transcription by TGF beta, confirming an indirect mechanism by which TGF beta acts through vimentin to suppress ATF4-dependent Ocn activation. Furthermore, inhibition of PI3K/Akt/mTOR signaling, but not canonical Smad signaling, downstream of TGF beta, blocked TGF beta-induced synthesis of vimentin, and inhibited ATF4-dependent Ocn transcription in osteoblasts. Thus, our study identifies that TGF beta stimulates vimentin production via PI3K-Akt-mTOR signaling, which leads to suppression of ATF4-dependent Ocn transcription and osteoblast differentiation.	[Lian, Na; Lin, Tonghui; Liu, Wenguang; Wang, Weiguang; Li, Lingzhen; Sun, Stephanie; Nyman, Jeffry S.; Yang, Xiangli] Vanderbilt Univ Sch Med, Vanderbilt Ctr Bone Biol, Nashville, TN 37232 USA; [Lin, Tonghui; Liu, Wenguang; Li, Lingzhen; Sun, Stephanie; Yang, Xiangli] Vanderbilt Univ Sch Med, Dept Med, Nashville, TN 37232 USA; [Wang, Weiguang; Yang, Xiangli] Vanderbilt Univ Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; [Nyman, Jeffry S.] Vanderbilt Univ Sch Med, Dept Orthoped & Rehabil, Nashville, TN 37232 USA; [Nyman, Jeffry S.] Tennessee Valley Hlth Care Syst, Dept Vet Affairs, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Yang, XL (corresponding author), 2215B Garland Ave,1225F MRB 4, Nashville, TN 37232 USA.	xiangli.yang@vanderbilt.edu	Lin, Tonghui/L-7592-2016; Nyman, Jeffry/L-5736-2013	Lin, Tonghui/0000-0003-3512-9624; Nyman, Jeffry/0000-0001-7403-7605	Vanderbilt University; Dept. of Veterans Affairs, Biomedical Laboratory Research and Development; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE017111] Funding Source: NIH RePORTER	Vanderbilt University; Dept. of Veterans Affairs, Biomedical Laboratory Research and Development; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Vanderbilt University career developmental funds (to X. Y.) and the Dept. of Veterans Affairs, Biomedical Laboratory Research and Development (to J. S. N.).	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Bae SC, 2001, J BONE JOINT SURG AM, V83A, pS48; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; BREEN EC, 1994, J CELL PHYSIOL, V160, P323, DOI 10.1002/jcp.1041600214; Byfield SD, 2004, MOL PHARMACOL, V65, P744, DOI 10.1124/mol.65.3.744; CAPETANAKI Y, 1989, J CELL BIOL, V109, P1653, DOI 10.1083/jcb.109.4.1653; CAPETANAKI YG, 1984, P NATL ACAD SCI-BIOL, V81, P6909, DOI 10.1073/pnas.81.22.6909; CENTRELLA M, 1994, ENDOCR REV, V15, P27, DOI 10.1210/er.15.1.27; Colucci-Guyon E, 1999, GLIA, V25, P33, DOI 10.1002/(SICI)1098-1136(19990101)25:1<33::AID-GLIA4>3.0.CO;2-J; DASCH JR, 1989, J IMMUNOL, V142, P1536; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; ECAROTCHARRIER B, 1983, J CELL BIOL, V96, P639, DOI 10.1083/jcb.96.3.639; Eckes B, 2000, J CELL SCI, V113, P2455; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Edwards JR, 2010, J BONE MINER RES, V25, P2419, DOI 10.1002/jbmr.139; Erlebacher A, 1998, MOL BIOL CELL, V9, P1903, DOI 10.1091/mbc.9.7.1903; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Frey RS, 1997, CANCER RES, V57, P628; HAUSCHKA PV, 1986, HAEMOSTASIS, V16, P258; Henrion D, 1997, J CLIN INVEST, V100, P2909, DOI 10.1172/JCI119840; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Lee KW, 2010, STEM CELLS DEV, V19, P557, DOI 10.1089/scd.2009.0147; Lian N, 2009, J BIOL CHEM, V284, P30518, DOI 10.1074/jbc.M109.052373; LOMRI A, 1990, BONE MINER, V10, P1, DOI 10.1016/0169-6009(90)90045-H; LUCAS PA, 1989, BONE, V10, P459, DOI 10.1016/8756-3282(89)90079-3; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Masuoka HC, 2002, BLOOD, V99, P736, DOI 10.1182/blood.V99.3.736; MULDER KM, 1992, J BIOL CHEM, V267, P5029; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; MUNDY GR, 1991, CIBA F SYMP, V157, P137; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; OLSON EN, 1989, ONCOGENE, V4, P907; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; PFEILSCHIFTER J, 1990, J BONE MINER RES, V5, P825; Pinkas J, 2006, BIOCHEM PHARMACOL, V72, P523, DOI 10.1016/j.bcp.2006.03.004; Qiu T, 2010, NAT CELL BIOL, V12, P224, DOI 10.1038/ncb2022; ROBEY PG, 1987, J CELL BIOL, V105, P457, DOI 10.1083/jcb.105.1.457; Schinke T, 1999, J BIOL CHEM, V274, P30182, DOI 10.1074/jbc.274.42.30182; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Singha UK, 2008, J CELL BIOCHEM, V103, P434, DOI 10.1002/jcb.21411; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; TAPSCOTT SJ, 1981, DEV BIOL, V86, P40, DOI 10.1016/0012-1606(81)90313-4; Terzi F, 1997, J CLIN INVEST, V100, P1520, DOI 10.1172/JCI119675; Wang WG, 2009, DEVELOPMENT, V136, P4143, DOI 10.1242/dev.043281; Wilkes MC, 2005, CANCER RES, V65, P10431, DOI 10.1158/0008-5472.CAN-05-1522; Wu YZ, 2007, BBA-MOL CELL RES, V1773, P427, DOI 10.1016/j.bbamcr.2006.11.017; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; YAN ZF, 1994, J BIOL CHEM, V269, P13231; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yang XL, 2004, J BIOL CHEM, V279, P47109, DOI 10.1074/jbc.M410010200; Yang XL, 2000, J BIOL CHEM, V275, P1065, DOI 10.1074/jbc.275.2.1065; Yu SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007583; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	65	51	52	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35975	35984		10.1074/jbc.M112.372458	http://dx.doi.org/10.1074/jbc.M112.372458			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22952236	Green Published, hybrid			2022-12-28	WOS:000310364000019
J	Dall'Osto, L; Holt, NE; Kaligotla, S; Fuciman, M; Cazzaniga, S; Carbonera, D; Frank, HA; Alric, J; Bassi, R				Dall'Osto, Luca; Holt, Nancy E.; Kaligotla, Shanti; Fuciman, Marcel; Cazzaniga, Stefano; Carbonera, Donatella; Frank, Harry A.; Alric, Jean; Bassi, Roberto			Zeaxanthin Protects Plant Photosynthesis by Modulating Chlorophyll Triplet Yield in Specific Light-harvesting Antenna Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETECTED MAGNETIC-RESONANCE; PHOTOSYSTEM-II; XANTHOPHYLL CYCLE; IN-VIVO; EXTINCTION COEFFICIENTS; FUNCTIONAL ARCHITECTURE; PHOTOOXIDATIVE STRESS; VIOLAXANTHIN CYCLE; SINGLET OXYGEN; ARABIDOPSIS	Plants are particularly prone to photo-oxidative damage caused by excess light. Photoprotection is essential for photosynthesis to proceed in oxygenic environments either by scavenging harmful reactive intermediates or preventing their accumulation to avoid photoinhibition. Carotenoids play a key role in protecting photosynthesis from the toxic effect of over-excitation; under excess light conditions, plants accumulate a specific carotenoid, zeaxanthin, that was shown to increase photoprotection. In this work we genetically dissected different components of zeaxanthin-dependent photoprotection. By using time-resolved differential spectroscopy in vivo, we identified a zeaxanthin-dependent optical signal characterized by a red shift in the carotenoid peak of the triplet-minus-singlet spectrum of leaves and pigment-binding proteins. By fractionating thylakoids into their component pigment binding complexes, the signal was found to originate from the monomeric Lhcb4-6 antenna components of Photosystem II and the Lhca1-4 subunits of Photosystem I. By analyzing mutants based on their sensitivity to excess light, the red-shifted triplet-minussinglet signal was tightly correlated with photoprotection in the chloroplasts, suggesting the signal implies an increased efficiency of zeaxanthin in controlling chlorophyll triplet formation. Fluorescence-detected magnetic resonance analysis showed a decrease in the amplitude of signals assigned to chlorophyll triplets belonging to the monomeric antenna complexes of Photosystem II upon zeaxanthin binding; however, the amplitude of carotenoid triplet signal does not increase correspondingly. Results show that the high light-induced binding of zeaxanthin to specific proteins plays a major role in enhancing photoprotection by modulating the yield of potentially dangerous chlorophyll-excited states in vivo and preventing the production of singlet oxygen.	[Dall'Osto, Luca; Holt, Nancy E.; Cazzaniga, Stefano; Bassi, Roberto] Univ Verona, Dept Biotechnol, I-37134 Verona, Italy; [Holt, Nancy E.; Alric, Jean; Bassi, Roberto] Fac Sci Luminy, Lab Genet & Biophys Plantes, Case 901, F-13288 Marseille 9, France; [Kaligotla, Shanti; Fuciman, Marcel; Frank, Harry A.] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA; [Carbonera, Donatella] Univ Padua, Dipartimento Sci Chim, I-35131 Padua, Italy; [Alric, Jean] Univ Paris 06, Inst Biol Physicochim, CNRS, Unite Mixte Rech 7141, F-75005 Paris, France; [Bassi, Roberto] Phytosphare Forschungszentrum Julich, D-52425 Julich, Germany	University of Verona; CEA; University of Connecticut; University of Padua; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Helmholtz Association; Research Center Julich	Bassi, R (corresponding author), Univ Verona, Dept Biotechnol, Str Le Grazie 15, I-37134 Verona, Italy.	roberto.bassi@univr.it	Carbonera, Donatella/B-4219-2018; Alric, Jean/E-3538-2013; Cazzaniga, Stefano/ABG-3898-2021	Carbonera, Donatella/0000-0002-5499-1140; Alric, Jean/0000-0003-3574-2234; Cazzaniga, Stefano/0000-0002-2824-7916; bassi, roberto/0000-0002-4140-8446; Dall'Osto, Luca/0000-0001-9497-5156	Marie Curie Actions - Networks for Initial Training Harvest [PITN-GA-2009-238017]; PRIN Programmi di Ricerca di Interesse Nazionale [2008XB774B]; National Science Foundation [MCB-0913022]; UConn Research Foundation	Marie Curie Actions - Networks for Initial Training Harvest; PRIN Programmi di Ricerca di Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); National Science Foundation(National Science Foundation (NSF)); UConn Research Foundation	This work was supported by grants from the Marie Curie Actions - Networks for Initial Training Harvest (Grant no. PITN-GA-2009-238017) and PRIN Programmi di Ricerca di Interesse Nazionale (Grant no. 2008XB774B) (to R.B.). Work in the laboratory of H.A.F. was supported by grants from the National Science Foundation (MCB-0913022) and the UConn Research Foundation.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Arnoux P, 2009, PLANT CELL, V21, P2036, DOI 10.1105/tpc.109.068007; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Beal D, 1999, REV SCI INSTRUM, V70, P202, DOI 10.1063/1.1149566; Betterle N, 2010, ARCH BIOCHEM BIOPHYS, V504, P67, DOI 10.1016/j.abb.2010.05.016; Britton G., 2004, CAROTENOIDS B, P57; Bugos RC, 1996, P NATL ACAD SCI USA, V93, P6320, DOI 10.1073/pnas.93.13.6320; Caffarri S, 2001, J BIOL CHEM, V276, P35924, DOI 10.1074/jbc.M105199200; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; CARBONERA D, 1994, FEBS LETT, V343, P200, DOI 10.1016/0014-5793(94)80555-5; Carbonera D, 2012, BBA-BIOENERGETICS, V1817, P1608, DOI 10.1016/j.bbabio.2012.05.007; Casazza AP, 2001, PHOTOSYNTH RES, V68, P175, DOI 10.1023/A:1011818021875; Clarke RH, 1982, TRIPLET STATE ODMR S; Croce R, 2002, BBA-BIOENERGETICS, V1556, P29, DOI 10.1016/S0005-2728(02)00304-3; Croce R, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P421; Croce R, 2000, BIOCHEMISTRY-US, V39, P6341, DOI 10.1021/bi992659r; DAINESE P, 1990, PHOTOCHEM PHOTOBIOL, V51, P693, DOI 10.1111/php.1990.51.6.693; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Dall'Osto L, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-32; Dall'Osto L, 2010, MOL PLANT, V3, P576, DOI 10.1093/mp/ssp117; Davies MJ, 2004, PHOTOCH PHOTOBIO SCI, V3, P17, DOI 10.1039/b307576c; de Bianchi S, 2011, PLANT CELL, V23, P2659, DOI 10.1105/tpc.111.087320; Demmig-Adams B., 1989, PHOTOSYNTHESIS PLANT, V8; Driever Steven M., 2009, V479, P109, DOI 10.1007/978-1-59745-289-2_7; El-Agamey A, 2004, ARCH BIOCHEM BIOPHYS, V430, P37, DOI 10.1016/j.abb.2004.03.007; Flors C, 2006, J EXP BOT, V57, P1725, DOI 10.1093/jxb/erj181; Formaggio E, 2001, J MOL BIOL, V314, P1157, DOI 10.1006/jmbi.2000.5179; Frank HA, 1996, PHOTOCHEM PHOTOBIOL, V63, P257, DOI 10.1111/j.1751-1097.1996.tb03022.x; Gilmore AM, 1998, BIOCHEMISTRY-US, V37, P13582, DOI 10.1021/bi981384x; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; Girotti AW, 2004, ANTIOXID REDOX SIGN, V6, P301, DOI 10.1089/152308604322899369; GREEN MJ, 1984, METHOD ENZYMOL, V105, P3; Hartel H, 1996, PLANT PHYSIOL, V110, P471, DOI 10.1104/pp.110.2.471; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Havaux M, 2004, J BIOL CHEM, V279, P13878, DOI 10.1074/jbc.M311154200; Havaux M, 2001, PLANTA, V213, P953, DOI 10.1007/s004250100572; Havaux M, 2000, PLANT PHYSIOL, V124, P273, DOI 10.1104/pp.124.1.273; Havaux M, 2007, PLANT PHYSIOL, V145, P1506, DOI 10.1104/pp.107.108480; HIYAMA T, 1972, BIOCHIM BIOPHYS ACTA, V267, P160, DOI 10.1016/0005-2728(72)90147-8; Hoff A. J., 1989, OPTICALLY DETECTED M; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Jahns P, 2009, BBA-BIOENERGETICS, V1787, P3, DOI 10.1016/j.bbabio.2008.09.013; Johnson MP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702831200; Kim EH, 2009, BBA-BIOENERGETICS, V1787, P973, DOI 10.1016/j.bbabio.2009.04.009; KOK B, 1956, BIOCHIM BIOPHYS ACTA, V21, P234, DOI 10.1016/0006-3002(56)90003-8; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Leon R, 2005, BIOTECHNOL BIOENG, V92, P695, DOI 10.1002/bit.20660; Li XP, 2002, P NATL ACAD SCI USA, V99, P15222, DOI 10.1073/pnas.232447699; Liao PN, 2011, J PHYS CHEM A, V115, P4082, DOI 10.1021/jp1122486; Liao PN, 2010, J PHYS CHEM B, V114, P15650, DOI 10.1021/jp1034163; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; LONG SP, 1994, ANNU REV PLANT PHYS, V45, P633, DOI 10.1146/annurev.pp.45.060194.003221; Martinez GR, 2003, MUTAT RES-REV MUTAT, V544, P115, DOI 10.1016/j.mrrev.2003.05.005; MATHIS P, 1979, PHOTOCHEM PHOTOBIOL, V30, P603, DOI 10.1111/j.1751-1097.1979.tb07187.x; MOAN J, 1991, PHOTOCHEM PHOTOBIOL, V53, P549, DOI 10.1111/j.1751-1097.1991.tb03669.x; Morosinotto T, 2003, PHYSIOL PLANTARUM, V119, P347, DOI 10.1034/j.1399-3054.2003.00213.x; Morosinotto T, 2002, J BIOL CHEM, V277, P36913, DOI 10.1074/jbc.M205339200; Morosinotto T, 2006, FEBS J, V273, P4616, DOI 10.1111/j.1742-4658.2006.05465.x; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Mozzo M, 2008, J BIOL CHEM, V283, P6184, DOI 10.1074/jbc.M708961200; Nielsen BR, 1998, J PHOTOCH PHOTOBIO A, V112, P127, DOI 10.1016/S1010-6030(97)00285-2; Nilkens M, 2010, BBA-BIOENERGETICS, V1797, P466, DOI 10.1016/j.bbabio.2010.01.001; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 1997, PLANT CELL, V9, P1369, DOI 10.2307/3870388; Peterman EJG, 1995, BIOPHYS J, V69, P2670, DOI 10.1016/S0006-3495(95)80138-4; PLUMLEY FG, 1987, P NATL ACAD SCI USA, V84, P146, DOI 10.1073/pnas.84.1.146; Salvadori E, 2012, PHYS CHEM CHEM PHYS, V14, P12238, DOI 10.1039/c2cp40877e; Santabarbara S, 2005, PHOTOSYNTH RES, V86, P283, DOI 10.1007/s11120-005-2840-1; Santabarbara S, 2003, CHEM PHYS, V294, P257, DOI 10.1016/S0301-0104(03)00279-9; Santabarbara S, 2002, BIOCHEMISTRY-US, V41, P8184, DOI 10.1021/bi0201163; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Triantaphylides C, 2008, PLANT PHYSIOL, V148, P960, DOI 10.1104/pp.108.125690; WALTERS RG, 1991, PHOTOSYNTH RES, V27, P121, DOI 10.1007/BF00033251; Wehner A, 2004, J BIOL CHEM, V279, P26823, DOI 10.1074/jbc.M402399200; Wentworth M, 2000, FEBS LETT, V471, P71, DOI 10.1016/S0014-5793(00)01369-7; WITT HT, 1979, BIOCHIM BIOPHYS ACTA, V505, P355, DOI 10.1016/0304-4173(79)90008-9; Yakushevska AE, 2001, EUR J BIOCHEM, V268, P6020, DOI 10.1046/j.0014-2956.2001.02505.x	78	96	96	2	116	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41820	41834		10.1074/jbc.M112.405498	http://dx.doi.org/10.1074/jbc.M112.405498			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23066020	Green Published, hybrid			2022-12-28	WOS:000312103000023
J	Kato, M; Blanton, R; Wang, GR; Judson, TJ; Abe, Y; Myoishi, M; Karas, RH; Mendelsohn, ME				Kato, Mikio; Blanton, Robert; Wang, Guang-Rong; Judson, Timothy J.; Abe, Yuich; Myoishi, Masafumi; Karas, Richard H.; Mendelsohn, Michael E.			Direct Binding and Regulation of RhoA Protein by Cyclic GMP-dependent Protein Kinase I alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CONTRACTION; SIGNAL-TRANSDUCTION; CALCIUM SENSITIZATION; CA2+ SENSITIZATION; NITRIC-OXIDE; TRANSLOCATION; PHOSPHATASE; SUBSTRATE; PATHWAY; FAMILY	Vascular smooth muscle cell (VSMC) tone is regulated by the state of myosin light chain (MLC) phosphorylation, which is in turn regulated by the balance between MLC kinase and MLC phosphatase (MLCP) activities. RhoA activates Rho kinase, which phosphorylates the regulatory subunit of MLC phosphatase, thereby inhibiting MLC phosphatase activity and increasing contraction and vascular tone. Nitric oxide is an important mediator of VSMC relaxation and vasodilation, which acts by increasing cyclic GMP (cGMP) levels in VSMC, thereby activating cGMP-dependent protein kinase I alpha (PKGI alpha). PKGI is known to phosphorylate Rho kinase, preventing Rho-mediated inhibition of MLC phosphatase, promoting vasorelaxation, although the molecular mechanisms that mediate this are unclear. Here we identify RhoA as a target of activated PKGI alpha and show further that PKGI alpha binds directly to RhoA, inhibiting its activation and translocation. In protein pulldown and immunoprecipitation experiments, binding of RhoA and PKGI alpha was demonstrated via a direct interaction between the amino terminus of RhoA (residues 1-44), containing the switch I domain of RhoA, and the amino terminus of PKGI alpha (residues 1-59), which includes a leucine zipper heptad repeat motif. Affinity assays using cGMP-immobilized agarose showed that only activated PKGI alpha binds RhoA, and a leucine zipper mutant PKGI alpha was unable to bind RhoA even if activated. Furthermore, a catalytically inactive mutant of PKGI alpha bound RhoA but did not prevent RhoA activation and translocation. Collectively, these results support that RhoA is a PKGI alpha target and that direct binding of activated PKGI alpha to RhoA is central to cGMP-mediated inhibition of the VSMC Rho kinase contractile pathway.	[Kato, Mikio; Blanton, Robert; Wang, Guang-Rong; Judson, Timothy J.; Abe, Yuich; Myoishi, Masafumi; Karas, Richard H.; Mendelsohn, Michael E.] Tufts Univ, Sch Med, Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Blanton, R (corresponding author), 800 Washington St, Boston, MA 02111 USA.	rblanton@tuftsmedicalcenter.org			National Institutes of Health [HL55309]; American Heart Association [10SDG2630161]; Daiichi Sankyo Co., Ltd., Tokyo, Japan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG042367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Daiichi Sankyo Co., Ltd., Tokyo, Japan(Daiichi Sankyo Company Limited); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (HL55309, to M. E. M.), the American Heart Association (10SDG2630161, to R. M. B.), and by Daiichi Sankyo Co., Ltd., Tokyo, Japan.	Alverdi V, 2008, J MOL BIOL, V375, P1380, DOI 10.1016/j.jmb.2007.11.053; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Christensen EN, 2006, J BIOL CHEM, V281, P8409, DOI 10.1074/jbc.M512770200; Fleming IN, 1996, J BIOL CHEM, V271, P33067, DOI 10.1074/jbc.271.51.33067; Fujihara H, 1997, MOL BIOL CELL, V8, P2437, DOI 10.1091/mbc.8.12.2437; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Geiselhoringer A, 2004, EMBO J, V23, P4222, DOI 10.1038/sj.emboj.7600440; Gong MC, 1996, P NATL ACAD SCI USA, V93, P1340, DOI 10.1073/pnas.93.3.1340; Hofmann F, 2005, J BIOL CHEM, V280, P1, DOI 10.1074/jbc.R400035200; IGNARRO LJ, 1985, ANNU REV PHARMACOL, V25, P171, DOI 10.1146/annurev.pharmtox.25.1.171; Michael SK, 2008, P NATL ACAD SCI USA, V105, P6702, DOI 10.1073/pnas.0802128105; Murad F, 2006, NEW ENGL J MED, V355, P2003, DOI 10.1056/NEJMsa063904; Orstavik S, 1997, GENOMICS, V42, P311, DOI 10.1006/geno.1997.4743; Otto B, 1996, J PHYSIOL-LONDON, V496, P317, DOI 10.1113/jphysiol.1996.sp021687; Ridley AJ, 2001, TRAFFIC, V2, P303, DOI 10.1034/j.1600-0854.2001.002005303.x; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Sauzeau V, 2003, J BIOL CHEM, V278, P9472, DOI 10.1074/jbc.M212776200; Somlyo AP, 1997, NATURE, V389, P908, DOI 10.1038/40002; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Swayze RD, 2001, J BIOL CHEM, V276, P19729, DOI 10.1074/jbc.M005711200; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Wang YP, 2004, J BIOL CHEM, V279, P24420, DOI 10.1074/jbc.M313823200	25	45	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41342	41351		10.1074/jbc.M112.421040	http://dx.doi.org/10.1074/jbc.M112.421040			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23066013	hybrid, Green Published			2022-12-28	WOS:000311887600048
J	Stone, A; Chau, C; Eaton, C; Foran, E; Kapur, M; Prevatt, E; Belkin, N; Kerr, D; Kohlin, T; Williamson, P				Stone, Alex; Chau, Christopher; Eaton, Christian; Foran, Emily; Kapur, Mridu; Prevatt, Edward; Belkin, Nathan; Kerr, David; Kohlin, Torvald; Williamson, Patrick			Biochemical Characterization of P4-ATPase Mutations Identified in Patients with Progressive Familial Intrahepatic Cholestasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASES; YEAST PLASMA-MEMBRANE; SPIN-LABELED PHOSPHOLIPIDS; HEREDITARY CHOLESTASIS; SACCHAROMYCES-CEREVISIAE; AMINOPHOSPHOLIPID TRANSLOCASE; SUBCELLULAR-LOCALIZATION; CANALICULAR MEMBRANE; PROTEIN INTERACTIONS; P-4-ATPASE ATP8A2	Mutations in the P4-ATPase ATP8B1 cause the inherited liver disease progressive familial intrahepatic cholestasis. Several of these mutations are located in conserved regions of the transmembrane domain associated with substrate binding and transport. Assays for P4-ATPase-mediated transport in living yeast cells were developed and used to characterize the specificity and kinetic parameters of this transport. Progressive familial intrahepatic cholestasis mutations were introduced into the yeast plasma membrane P4-ATPase Dnf2p, and the effect of these mutations on its catalysis of phospholipid transport were determined. The results of these measurements have implications for the basis of the disease and for the mechanism of phospholipid transit through the enzyme during the reaction cycle.	[Stone, Alex; Chau, Christopher; Eaton, Christian; Foran, Emily; Kapur, Mridu; Prevatt, Edward; Belkin, Nathan; Kerr, David; Kohlin, Torvald; Williamson, Patrick] Amherst Coll, Dept Biol, Amherst, MA 01002 USA	Amherst College	Williamson, P (corresponding author), Amherst Coll, Dept Biol, McGuire Life Sci Bldg, Amherst, MA 01002 USA.	plwilliamson@amherst.edu	Kapur, Mridu/M-2669-2019	Kapur, Mridu/0000-0002-3313-5038; Kerr, David/0000-0002-2534-6476	National Science Foundation [0443858]; Howard Hughes Medical Institute; Amherst College	National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Amherst College	This work was supported in part by National Science Foundation Grant 0443858 (to P. W.), by a Howard Hughes Medical Institute Grant (to Amherst College), and by a Faculty Research Grant from Amherst College.	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Axelsen KB, 2001, PLANT PHYSIOL, V126, P696, DOI 10.1104/pp.126.2.696; Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; Bryde S, 2010, J BIOL CHEM, V285, P40562, DOI 10.1074/jbc.M110.139543; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Chen CY, 1999, J CELL BIOL, V147, P1223, DOI 10.1083/jcb.147.6.1223; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; Coleman JA, 2012, P NATL ACAD SCI USA, V109, P1449, DOI 10.1073/pnas.1108862109; Coleman JA, 2011, J BIOL CHEM, V286, P17205, DOI 10.1074/jbc.M111.229419; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Egawa H, 2002, LIVER TRANSPLANT, V8, P714, DOI 10.1053/jlts.2002.34384; Eppens EF, 2001, J HEPATOL, V35, P436, DOI 10.1016/S0168-8278(01)00158-1; Folmer DE, 2009, HEPATOLOGY, V50, P1597, DOI 10.1002/hep.23158; Grefen C., 2007, CURR PROTOC NEUROSCI, DOI DOI 10.1002/0471142301.NS0527S41; Grefen Christopher, 2009, V479, P217, DOI 10.1007/978-1-59745-289-2_14; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Kakkar T, 1999, DRUG METAB DISPOS, V27, P756; Katoh Y, 2004, ONCOL REP, V12, P939; Klomp LWJ, 2004, HEPATOLOGY, V40, P27, DOI 10.1002/hep.20285; Lenoir G, 2007, CURR OPIN CHEM BIOL, V11, P654, DOI 10.1016/j.cbpa.2007.09.008; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Ling MM, 1997, ANAL BIOCHEM, V254, P157, DOI 10.1006/abio.1997.2428; MADDOCK JR, 1994, GENETICS, V136, P833; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; MORIYAMA Y, 1988, J BIOL CHEM, V263, P8521; Mukerjee P., 1971, NSRDSNBS36; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Numakura C, 2011, PEDIATR INT, V53, P107, DOI 10.1111/j.1442-200X.2010.03238.x; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Paterson JK, 2006, BIOCHEMISTRY-US, V45, P5367, DOI 10.1021/bi052359b; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Paulusma CC, 2006, HEPATOLOGY, V44, P195, DOI 10.1002/hep.21212; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pomorski T, 1996, J CELL SCI, V109, P687; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Puts CF, 2012, J BIOL CHEM, V287, P30529, DOI 10.1074/jbc.M112.371088; Riekhof WR, 2009, BBA-MOL CELL BIOL L, V1791, P620, DOI 10.1016/j.bbalip.2009.02.013; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; Stapelbroek JM, 2009, P NATL ACAD SCI USA, V106, P9709, DOI 10.1073/pnas.0807919106; Stone Alex, 2012, J Chem Biol, V5, P131, DOI 10.1007/s12154-012-0078-x; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; van der Velden LM, 2010, J BIOL CHEM, V285, P40088, DOI 10.1074/jbc.M110.139006; van der Velden LM, 2010, HEPATOLOGY, V51, P286, DOI 10.1002/hep.23268; Verhulst PM, 2010, HEPATOLOGY, V51, P2049, DOI 10.1002/hep.23586; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106	51	15	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41139	41151		10.1074/jbc.M112.413039	http://dx.doi.org/10.1074/jbc.M112.413039			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23060447	hybrid, Green Published			2022-12-28	WOS:000311887600030
J	Takei, Y; Iizuka, R; Ueno, T; Funatsu, T				Takei, Yodai; Iizuka, Ryo; Ueno, Taro; Funatsu, Takashi			Single-molecule Observation of Protein Folding in Symmetric GroEL-(GroES)(2) Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROEL-GROES COMPLEXES; SUBSTRATE PROTEIN; CHAPERONIN GROEL; ATP; POLYPEPTIDE; CAVITY; CYCLE; ENCAPSULATION; CONFORMATION; CATALYSIS	The chaperonin, GroEL, is an essential molecular chaperone that mediates protein folding together with its cofactor, GroES, in Escherichia coli. It is widely believed that the two rings of GroEL alternate between the folding active state coupled to GroES binding during the reaction cycle. In other words, an asymmetric GroEL-GroES complex (the bullet-shaped complex) is formed throughout the cycle, whereas a symmetric GroEL-(GroES)(2) complex (the football-shaped complex) is not formed. We have recently shown that the football-shaped complex coexists with the bullet-shaped complex during the reaction cycle. However, how protein folding proceeds in the football-shaped complex remains poorly understood. Here, we used GFP as a substrate to visualize protein folding in the football-shaped complex by single-molecule fluorescence techniques. We directly showed that GFP folding occurs in both rings of the football-shaped complex. Remarkably, the folding was a sequential two-step reaction, and the kinetics were in excellent agreement with those in the bullet-shaped complex. These results demonstrate that the same reactions take place independently in both rings of the football-shaped complex to facilitate protein folding.	[Funatsu, Takashi] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Bioanalyt Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Funatsu, Takashi] Japan Sci & Technol Corp, Core Res Evolutionary Sci & Technol, Chiyoda Ku, Tokyo 1020075, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Funatsu, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Bioanalyt Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	funatsu@mail.ecc.u-tokyo.ac.jp	Funatsu, Takashi/Q-1404-2015	Funatsu, Takashi/0000-0002-9656-8308; Iizuka, Ryo/0000-0002-9328-5628	Ministry of Education, Culture, Sports, Science and Technology of Japan [24370061, 21121004, 22020006]; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partly supported by Grants-in-Aid for Scientific Research (B) 24370061 (to T. F.), Scientific Research on Innovative Areas 21121004 (to T. F.), and Scientific Research on Priority Areas 22020006 (to R. I.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. This research was also supported by the Funding Program for World-Leading Innovative R & D on Science and Technology (FIRST Program) from the Japan Society for the Promotion of Science.	AZEM A, 1994, SCIENCE, V265, P653, DOI 10.1126/science.7913553; Azem A, 1995, P NATL ACAD SCI USA, V92, P12021, DOI 10.1073/pnas.92.26.12021; Beissinger M, 1999, J MOL BIOL, V289, P1075, DOI 10.1006/jmbi.1999.2780; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; Cliff MJ, 1999, J MOL BIOL, V293, P667, DOI 10.1006/jmbi.1999.3138; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Grason JP, 2008, P NATL ACAD SCI USA, V105, P17334, DOI 10.1073/pnas.0807429105; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Horovitz A, 2005, CURR OPIN STRUC BIOL, V15, P646, DOI 10.1016/j.sbi.2005.10.001; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; Horwich AL, 2009, Q REV BIOPHYS, V42, P83, DOI 10.1017/S0033583509004764; ITAKURA S, 1993, BIOCHEM BIOPH RES CO, V196, P1504, DOI 10.1006/bbrc.1993.2422; Koike-Takeshita A, 2006, J BIOL CHEM, V281, P962, DOI 10.1074/jbc.M506298200; Koike-Takeshita A, 2008, J BIOL CHEM, V283, P23774, DOI 10.1074/jbc.M802542200; Li YL, 2009, J BIOL CHEM, V284, P4324, DOI 10.1074/jbc.M804818200; Llorca O, 1996, J BIOL CHEM, V271, P68, DOI 10.1074/jbc.271.1.68; Madan D, 2008, J BIOL CHEM, V283, P32003, DOI 10.1074/jbc.M802898200; Motojima F, 2003, J BIOL CHEM, V278, P26648, DOI 10.1074/jbc.M300806200; Motojima F, 2000, BIOCHEM BIOPH RES CO, V267, P842, DOI 10.1006/bbrc.1999.2020; Motojima F, 2010, EMBO J, V29, P4008, DOI 10.1038/emboj.2010.262; Murai N, 1996, J BIOL CHEM, V271, P28229, DOI 10.1074/jbc.271.45.28229; Neuweiler H, 2009, P NATL ACAD SCI USA, V106, P18569, DOI 10.1073/pnas.0910860106; Nojima T, 2012, J MOL BIOL, V422, P291, DOI 10.1016/j.jmb.2012.05.026; Nojima T, 2009, J BIOL CHEM, V284, P22834, DOI 10.1074/jbc.M109.020057; Rhoades E, 2003, P NATL ACAD SCI USA, V100, P3197, DOI 10.1073/pnas.2628068100; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Sakikawa C, 1999, J BIOL CHEM, V274, P21251, DOI 10.1074/jbc.274.30.21251; Sameshima T, 2008, J BIOL CHEM, V283, P23765, DOI 10.1074/jbc.M802541200; Sameshima T, 2010, J BIOL CHEM, V285, P23157, DOI 10.1074/jbc.M110.122101; Sameshima T, 2010, BIOCHEM J, V427, P247, DOI 10.1042/BJ20091845; SCHMIDT M, 1994, SCIENCE, V265, P656, DOI 10.1126/science.7913554; Sparrer H, 1997, P NATL ACAD SCI USA, V94, P1096, DOI 10.1073/pnas.94.4.1096; Suzuki M, 2008, J BIOL CHEM, V283, P23931, DOI 10.1074/jbc.M804090200; Taguchi H, 2004, J BIOL CHEM, V279, P45737, DOI 10.1074/jbc.M406795200; Taguchi H, 2001, NAT BIOTECHNOL, V19, P861, DOI 10.1038/nbt0901-861; Tanaka S, 2010, BBA-PROTEINS PROTEOM, V1804, P866, DOI 10.1016/j.bbapap.2009.12.016; Tokunaga M, 1997, BIOCHEM BIOPH RES CO, V235, P47, DOI 10.1006/bbrc.1997.6732; Ueno T, 2004, MOL CELL, V14, P423, DOI 10.1016/S1097-2765(04)00261-8; Yamasaki R, 1999, J MOL BIOL, V292, P965, DOI 10.1006/jmbi.1999.3129	42	24	26	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41118	41125		10.1074/jbc.M112.398628	http://dx.doi.org/10.1074/jbc.M112.398628			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23048033	hybrid, Green Published			2022-12-28	WOS:000311887600028
J	Suzuki, T; Tsuzuku, J; Hayashi, A; Shiomi, Y; Iwanari, H; Mochizuki, Y; Hamakubo, T; Kodama, T; Nishitani, H; Masai, H; Yamamoto, T				Suzuki, Toru; Tsuzuku, Junko; Hayashi, Akiyo; Shiomi, Yasushi; Iwanari, Hiroko; Mochizuki, Yasuhiro; Hamakubo, Takao; Kodama, Tatsuhiko; Nishitani, Hideo; Masai, Hisao; Yamamoto, Tadashi			Inhibition of DNA Damage-induced Apoptosis through Cdc7-mediated Stabilization of Tob	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UV-RADIATION; S PHASE; KINASE; CDC7; REPLICATION; CHECKPOINT; INITIATION; PHOSPHORYLATION; PROTEIN; DEGRADATION	Cells respond to DNA damage by activating alternate signaling pathways that induce proliferation arrest or apoptosis. The correct balance between these two pathways is important for maintaining genomic integrity and preventing unnecessary cell death. The mechanism by which DNA-damaged cells escape from apoptosis during DNA repair is poorly understood. We show that the DNA replication-initiating kinase Cdc7 actively prevents unnecessary death in DNA-damaged cells. In response to mild DNA damage, Tob levels increase through both a transcriptional mechanism and protein stabilization, resulting in inhibition of pro-apoptotic signaling. Cells lacking Cdc7 expression undergo apoptosis after mild DNA damage, where Cul4-DDB1(Cdt2) induces Tob ubiquitination and subsequent degradation. Cdc7 phosphorylates and interacts with Tob to inhibit the Cul4-DDB1(Cdt2)-dependent Tob degradation. Thus, Cdc7 defines an essential pro-survival signaling pathway by contributing to stabilization of Tob, thereby the viability of DNA-damaged cells being maintained.	[Suzuki, Toru; Yamamoto, Tadashi] Grad Univ, Okinawa Inst Sci & Technol, Cell Signal Unit, Kunigami, Okinawa 9040412, Japan; [Suzuki, Toru; Tsuzuku, Junko; Yamamoto, Tadashi] Univ Tokyo, Inst Med Sci, Div Oncol, Dept Canc Biol,Minato Ku, Tokyo 1088639, Japan; [Hayashi, Akiyo; Shiomi, Yasushi; Nishitani, Hideo] Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan; [Iwanari, Hiroko; Mochizuki, Yasuhiro; Hamakubo, Takao] Univ Tokyo, Dept Syst Biol & Med, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan; [Kodama, Tatsuhiko] Univ Tokyo, Dept Mol Biol & Med, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan; [Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Genome Dynam Project, Setagaya Ku, Tokyo 1568506, Japan	Okinawa Institute of Science & Technology Graduate University; University of Tokyo; University of Hyogo; University of Tokyo; University of Tokyo; Tokyo Metropolitan Institute of Medical Science	Yamamoto, T (corresponding author), Grad Univ, Okinawa Inst Sci & Technol, Cell Signal Unit, 1919-1 Onna Son, Kunigami, Okinawa 9040412, Japan.	tyamamot@ims.u-tokyo.ac.jp		Nishitani, Hideo/0000-0001-5907-9380; Hayashi, Akiyo/0000-0003-1900-4282	Ministry of Education, Culture, Sports, Science, and Technology of Japan; New Energy and Industrial Technology Development Organization	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by a grant for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the NFAT project of the New Energy and Industrial Technology Development Organization.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Billecke CA, 2002, ONCOGENE, V21, P4481, DOI 10.1038/sj.onc.1205546; Boiko AD, 2006, GENE DEV, V20, P236, DOI 10.1101/gad.1372606; Carlson CA, 2000, RADIAT RES, V154, P590, DOI 10.1667/0033-7587(2000)154[0590:LORPCW]2.0.CO;2; Clarke PR, 2009, TRENDS CELL BIOL, V19, P89, DOI 10.1016/j.tcb.2008.12.003; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; Dierov J, 2004, CANCER CELL, V5, P275, DOI 10.1016/S1535-6108(04)00056-X; Gerard A, 2006, EMBO REP, V7, P817, DOI 10.1038/sj.embor.7400750; Guardavaccaro D, 2000, MOL CELL BIOL, V20, P1797, DOI 10.1128/MCB.20.5.1797-1815.2000; Heffernan TP, 2007, J BIOL CHEM, V282, P9458, DOI 10.1074/jbc.M611292200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Lange SS, 2008, P NATL ACAD SCI USA, V105, P10320, DOI 10.1073/pnas.0803181105; Lange SS, 2009, MOL CARCINOGEN, V48, P571, DOI 10.1002/mc.20544; Masai H, 2000, J BIOL CHEM, V275, P29042, DOI 10.1074/jbc.M002713200; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Montagnoli A, 2008, NAT CHEM BIOL, V4, P357, DOI 10.1038/nchembio.90; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; O'Connell BC, 2007, CURR OPIN CELL BIOL, V19, P206, DOI 10.1016/j.ceb.2007.02.014; Ou YH, 2007, EMBO J, V26, P3968, DOI 10.1038/sj.emboj.7601825; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; Sasanuma H, 2008, GENE DEV, V22, P398, DOI 10.1101/gad.1626608; Suzuki T, 2002, GENE DEV, V16, P1356, DOI 10.1101/gad.962802; Suzuki T, 2009, ONCOGENE, V28, P401, DOI 10.1038/onc.2008.387; Suzuki T, 2011, BIOCHEM BIOPH RES CO, V409, P70, DOI 10.1016/j.bbrc.2011.04.107; Tanaka Toshiya, 2002, J Atheroscler Thromb, V9, P233; Tenca P, 2007, J BIOL CHEM, V282, P208, DOI 10.1074/jbc.M604457200; Tsuji T, 2008, MOL CELL, V32, P862, DOI 10.1016/j.molcel.2008.12.005; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Yoshida Y, 2003, GENE DEV, V17, P1201, DOI 10.1101/gad.1088003; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	33	13	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40256	40265		10.1074/jbc.M112.353805	http://dx.doi.org/10.1074/jbc.M112.353805			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23066029	Green Published, hybrid			2022-12-28	WOS:000311448800018
J	Bernard, JK; McCann, SP; Bhardwaj, V; Washington, MK; Frey, MR				Bernard, Jessica K.; McCann, Sean P.; Bhardwaj, Vrinda; Washington, Mary K.; Frey, Mark R.			Neuregulin-4 Is a Survival Factor for Colon Epithelial Cells both in Culture and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; BREAST-CANCER CELLS; TYROSINE KINASE; ERBB4 ISOFORM; TRANSGENIC MICE; EXPRESSION; APOPTOSIS; FAMILY; PROLIFERATION; TRANSACTIVATION	Expression of the ErbB4 tyrosine kinase is elevated in colonic epithelial cells during inflammatory bowel disease, whereas ErbB4 overexpression in cultured colonocytes blocks TNF-induced apoptosis in a ligand-dependent manner. Together, these observations suggest that ErbB4 induction may be a protective response. However, the effects of ErbB4 signaling in the colonic epithelium in vivo are not known. Furthermore, previous work on ErbB4 used ligands shared with other receptors, raising the question of whether the observed responses are explicitly due to ErbB4. In this study, we used the ErbB4-specific ligand neuregulin-4 (NRG4) to activate ErbB4 and define its role in colonocyte biology. NRG4 treatment, either in cultured cells or in mice, blocked colonic epithelial apoptosis induced by TNF and IFN-gamma. It was also protective in a murine experimental colitis model. NRG4 stimulated phosphorylation of ErbB4 but not other ErbB receptors, indicating that this is a specific response. Furthermore, in contrast to related ligands, NRG4 enhanced cell survival but not proliferation or migration, and stimulated phosphorylation of the anti-apoptotic mediator Akt but not ERK MAPK. Pharmacological inhibition of PI3K/Akt signaling reversed the anti-apoptotic effects of NRG4, confirming the role of this cascade in NRG4-induced cell survival. With regard to the potential clinical importance of this pathway, NRG4 expression was decreased in human inflammatory bowel disease samples and mouse models of colitis, suggesting that activation of ErbB4 is altered in disease. Thus, exogenous NRG4 may be beneficial for disorders in which epithelial apoptosis is part of the pathology.	[Bernard, Jessica K.; McCann, Sean P.; Bhardwaj, Vrinda; Frey, Mark R.] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Bernard, Jessica K.; McCann, Sean P.; Bhardwaj, Vrinda; Frey, Mark R.] Univ So Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90089 USA; [Frey, Mark R.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Washington, Mary K.] Vanderbilt Univ, Dept Pathol, Sch Med, Nashville, TN 37332 USA	Children's Hospital Los Angeles; University of Southern California; University of Southern California; Vanderbilt University	Frey, MR (corresponding author), Childrens Hosp Los Angeles, Saban Res Inst, 4650 Sunset Blvd,MS 137, Los Angeles, CA 90027 USA.	mfrey@chla.usc.edu	bhardwaj, vrinda/V-5234-2019; Frey, Mark/M-1739-2019; Bhardwaj, Vrinda/GLR-1727-2022	Frey, Mark/0000-0002-2561-5402; 	National Institutes of Health [K01DK077956, R03DK090295]; Crohn's and Colitis Foundation of America; Saban Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK077956, R03DK090295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Saban Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K01DK077956 and R03DK090295. This work was also supported by a Senior Research Award from the Crohn's and Colitis Foundation of America and a Research Career Development Award from the Saban Research Institute.	Bongers G, 2012, GASTROENTEROLOGY, V143, P730, DOI 10.1053/j.gastro.2012.05.034; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; Corredor J, 2003, AM J PHYSIOL-CELL PH, V284, pC953, DOI 10.1152/ajpcell.00309.2002; Di Sabatino A, 2003, DIS COLON RECTUM, V46, P1498, DOI 10.1007/s10350-004-6802-z; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Edwards J, 2006, CLIN CANCER RES, V12, P123, DOI 10.1158/1078-0432.CCR-05-1445; Egger B, 2000, SCAND J GASTROENTERO, V35, P1181; Erlich S, 2001, NEUROSCIENCE, V107, P353, DOI 10.1016/S0306-4522(01)00350-5; Feng YJ, 2012, ANN NY ACAD SCI, V1258, P71, DOI 10.1111/j.1749-6632.2012.06572.x; Feng YJ, 2012, AM J PHYSIOL-GASTR L, V302, pG236, DOI 10.1152/ajpgi.00142.2011; Frey MR, 2006, EMBO J, V25, P5683, DOI 10.1038/sj.emboj.7601457; Frey MR, 2010, LAB INVEST, V90, P1415, DOI 10.1038/labinvest.2010.117; Frey MR, 2009, GASTROENTEROLOGY, V136, P217, DOI 10.1053/j.gastro.2008.09.023; Frey MR, 2004, J BIOL CHEM, V279, P44513, DOI 10.1074/jbc.M406253200; Harari D, 1999, ONCOGENE, V18, P2681, DOI 10.1038/sj.onc.1202631; Hayes NVL, 2008, ONCOGENE, V27, P715, DOI 10.1038/sj.onc.1210689; Hilliard VC, 2011, AM J PHYSIOL-GASTR L, V301, pG338, DOI 10.1152/ajpgi.00057.2011; Huotari MA, 2002, ENDOCRINOLOGY, V143, P4437, DOI 10.1210/en.2002-220382; Jones JT, 1999, FEBS LETT, V447, P227, DOI 10.1016/S0014-5793(99)00283-5; Junttila TT, 2005, CANCER RES, V65, P1384, DOI 10.1158/0008-5472.CAN-04-3150; Kainulainen V, 2000, J BIOL CHEM, V275, P8641, DOI 10.1074/jbc.275.12.8641; Kaushansky A, 2008, CHEM BIOL, V15, P808, DOI 10.1016/j.chembiol.2008.07.006; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lee D, 2009, J CLIN INVEST, V119, P2702, DOI 10.1172/JCI36435; Lee JC, 2002, EUR J CANCER, V38, P1065, DOI 10.1016/S0959-8049(02)00004-7; Maatta JA, 2006, MOL BIOL CELL, V17, P67, DOI 10.1091/mbc.E05-05-0402; Macdonald-Obermann JL, 2012, P NATL ACAD SCI USA, V109, P137, DOI 10.1073/pnas.1111316109; McCole DF, 2002, J BIOL CHEM, V277, P42603, DOI 10.1074/jbc.M206487200; Memon AA, 2004, BRIT J CANCER, V91, P2034, DOI 10.1038/sj.bjc.6602251; Monsey J, 2010, J BIOL CHEM, V285, P7035, DOI 10.1074/jbc.M109.096032; Naresh A, 2006, CANCER RES, V66, P6412, DOI 10.1158/0008-5472.CAN-05-2368; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Qiu W, 2011, J CLIN INVEST, V121, P1722, DOI 10.1172/JCI42917; Robinson D, 1996, P NATL ACAD SCI USA, V93, P5958, DOI 10.1073/pnas.93.12.5958; Rotterud R, 2005, BJU INT, V95, P1344, DOI 10.1111/j.1464-410X.2005.05497.x; Saito T, 2004, ENDOCRINOLOGY, V145, P4232, DOI 10.1210/en.2004-0401; Srinivasan R, 2000, CANCER RES, V60, P1483; Srinivasan R, 1999, CLIN CANCER RES, V5, P2877; Starr A, 2006, INT J CANCER, V119, P269, DOI 10.1002/ijc.21818; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Sweeney C, 2000, J BIOL CHEM, V275, P19803, DOI 10.1074/jbc.C901015199; Tovey SM, 2004, BREAST CANCER RES, V6, pR246, DOI 10.1186/bcr783; Veikkolainen V, 2011, CELL CYCLE, V10, P2647, DOI 10.4161/cc.10.16.17194; Vidal GA, 2007, ONCOGENE, V26, P462, DOI 10.1038/sj.onc.1209794; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Whitehead RH, 2009, AM J PHYSIOL-GASTR L, V296, pG455, DOI 10.1152/ajpgi.90381.2008; Wieduwilt MJ, 2008, CELL MOL LIFE SCI, V65, P1566, DOI 10.1007/s00018-008-7440-8; Wilson KJ, 2009, PHARMACOL THERAPEUT, V122, P1, DOI 10.1016/j.pharmthera.2008.11.008; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370	50	35	39	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.400846	http://dx.doi.org/10.1074/jbc.M112.400846			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23033483	Green Published, hybrid			2022-12-28	WOS:000311233800053
J	Glekas, GD; Mulhern, BJ; Kroc, A; Duelfer, KA; Lei, V; Rao, CV; Ordal, GW				Glekas, George D.; Mulhern, Brendan J.; Kroc, Abigail; Duelfer, Keegan A.; Lei, Victor; Rao, Christopher V.; Ordal, George W.			The Bacillus subtilis Chemoreceptor McpC Senses Multiple Ligands Using Two Discrete Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MALTOSE CHEMORECEPTOR; CHEMOTAXIS; COMPLEX; KINASE; ASPARAGINE; METHIONINE; PROTEINS; ENCODES; SYSTEMS	Bacillus subtilis can perform chemotaxis toward all 20 L-amino acids normally found in proteins. Loss of a single chemoreceptor, McpC, was previously found to reduce chemotaxis to 19 of these amino acids. In this study, we investigated the amino acid-sensing mechanism of McpC. We show that McpC alone can support chemotaxis to 17 of these amino acids to varying degrees. Eleven amino acids were found to directly bind the amino-terminal sensing domain of McpC in vitro. Sequence analysis indicates that the McpC sensing domain exhibits a dual Per-Arnt-Sim (PAS) domain structure. Using this structure as a guide, we were able to isolate mutants that suggest that four amino acids (arginine, glutamine, lysine, and methionine) are sensed by an indirect mechanism. We identified four candidate binding lipoproteins associated with amino acid transporters that may function in indirect sensing: ArtP, GlnH, MetQ, and YckB. ArtP was found to bind arginine and lysine; GlnH, glutamine; MetQ, methionine; and YckB, tryptophan. In addition, we found that ArtP, MetQ, and YckB bind the sensing domain of McpC, suggesting that the three participate in the indirect sensing of arginine, lysine, methionine, and possibly tryptophan as well. Taken together, these results further our understanding of amino acid chemotaxis in B. subtilis and gain insight into how a single chemoreceptor is able to sense many amino acids.	[Rao, Christopher V.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Glekas, George D.; Mulhern, Brendan J.; Kroc, Abigail; Duelfer, Keegan A.; Lei, Victor; Ordal, George W.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rao, CV (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, 600 S Mathews,211 RAL, Urbana, IL 61801 USA.	chris@scs.uiuc.edu; ordal@uiuc.edu			National Institutes of Health [GM054365]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM054365, R01GM054365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM054365 (to G. W. O and C. V. R.).	ADLER J, 1973, J GEN MICROBIOL, V74, P77, DOI 10.1099/00221287-74-1-77; Auger S, 2002, J BACTERIOL, V184, P5179, DOI 10.1128/JB.184.18.5179-5186.2002; Bunai K, 2004, ELECTROPHORESIS, V25, P141, DOI 10.1002/elps.200305676; Burguiere P, 2004, J BACTERIOL, V186, P4875, DOI 10.1128/JB.186.15.4875-4884.2004; Chao XJ, 2006, CELL, V124, P561, DOI 10.1016/j.cell.2005.11.046; Garrity LF, 1997, MICROBIOL-UK, V143, P2945, DOI 10.1099/00221287-143-9-2945; Glekas GD, 2010, J BIOL CHEM, V285, P1870, DOI 10.1074/jbc.M109.072108; HANLON DW, 1994, J BIOL CHEM, V269, P14038; HAZELBAUER GL, 1975, J BACTERIOL, V122, P206, DOI 10.1128/JB.122.1.206-214.1975; Hullo MF, 2004, RES MICROBIOL, V155, P80, DOI 10.1016/j.resmic.2003.11.008; Karatan E, 2001, J BIOL CHEM, V276, P43618, DOI 10.1074/jbc.M104955200; KOSSMANN M, 1988, J BACTERIOL, V170, P4516, DOI 10.1128/jb.170.10.4516-4521.1988; Kristich CJ, 2002, J BIOL CHEM, V277, P25356, DOI 10.1074/jbc.M201334200; Muller J, 1997, MICROBIOL-UK, V143, P3231, DOI 10.1099/00221287-143-10-3231; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Neumann S, 2010, EMBO J, V29, P3484, DOI 10.1038/emboj.2010.224; ORDAL GW, 1977, J BACTERIOL, V129, P151, DOI 10.1128/JB.129.1.151-155.1977; ORDAL GW, 1977, J BACTERIOL, V129, P156, DOI 10.1128/JB.129.1.156-165.1977; Quentin Y, 1999, J MOL BIOL, V287, P467, DOI 10.1006/jmbi.1999.2624; Sekowska A, 2001, GENOME BIOL, V2; Szurmant H, 2003, J BIOL CHEM, V278, P48611, DOI 10.1074/jbc.M306180200; ULLAH AHJ, 1981, J BACTERIOL, V145, P958, DOI 10.1128/JB.145.2.958-965.1981; WU LJ, 1991, J BACTERIOL, V173, P4877, DOI 10.1128/jb.173.15.4877-4888.1991; Zhang YH, 1999, P NATL ACAD SCI USA, V96, P939, DOI 10.1073/pnas.96.3.939; Zhang Z, 2010, J MOL BIOL, V400, P335, DOI 10.1016/j.jmb.2010.04.049; Zimmer MA, 2002, MOL MICROBIOL, V45, P555, DOI 10.1046/j.1365-2958.2002.03035.x	26	60	62	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.413518	http://dx.doi.org/10.1074/jbc.M112.413518			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23038252	Green Published, hybrid			2022-12-28	WOS:000311233800013
J	Guzman, A; Zelman-Femiak, M; Boergermann, JH; Paschkowsky, S; Kreuzaler, PA; Fratzl, P; Harms, GS; Knaus, P				Guzman, Asja; Zelman-Femiak, Monika; Boergermann, Jan H.; Paschkowsky, Sandra; Kreuzaler, Peter A.; Fratzl, Peter; Harms, Gregory S.; Knaus, Petra			SMAD versus Non-SMAD Signaling Is Determined by Lateral Mobility of Bone Morphogenetic Protein (BMP) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN CYTOSKELETON REORGANIZATION; SINGLE-MOLECULE TRACKING; OSTEOBLAST DIFFERENTIATION; FUNCTIONAL-CHARACTERIZATION; SERINE/THREONINE KINASE; LIPID RAFTS; ACTIVATION; CELLS; COMPLEXES; REGULATOR	Bone (or body) morphogenetic proteins (BMPs) belong to the TGF beta superfamily and are crucial for embryonic patterning and organogenesis as well as for adult tissue homeostasis and repair. Activation of BMP receptors by their ligands leads to induction of several signaling cascades. Using fluorescence recovery after photobleaching, FRET, and single particle tracking microscopy, we demonstrate that BMP receptor type I and II (BMPRI and BMPRII) have distinct lateral mobility properties within the plasma membrane, which is mandatory for their involvement in different signaling pathways. Before ligand binding, BMPRI and a subpopulation of BMPRII exhibit confined motion, reflecting preassembled heteromeric receptor complexes. A second free diffusing BMPRII population only becomes restricted after ligand addition. This paper visualizes time-resolved BMP receptor complex formation and demonstrates that the lateral mobility of BMPRI has a major impact in stabilizing heteromeric BMPRI-BMPRII receptor complexes to differentially stimulate SMAD versus non-SMAD signaling.	[Harms, Gregory S.] Wilkes Univ, Dept Biol, Wilkes Barre, PA 18766 USA; [Harms, Gregory S.] Wilkes Univ, Dept Phys, Wilkes Barre, PA 18766 USA; [Guzman, Asja; Boergermann, Jan H.; Paschkowsky, Sandra; Kreuzaler, Peter A.; Knaus, Petra] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Zelman-Femiak, Monika; Harms, Gregory S.] Univ Wurzburg, Rudolf Virchow Ctr, Microscopy Grp, D-97080 Wurzburg, Germany; [Fratzl, Peter] Max Planck Inst Colloids & Interfaces, Dept Biomat, D-14424 Potsdam, Germany	Wilkes University; Wilkes University; Free University of Berlin; University of Wurzburg; Max Planck Society	Harms, GS (corresponding author), Wilkes Univ, Dept Biol, 84 S West St, Wilkes Barre, PA 18766 USA.	gregory.harms@imaging-microscopy.com; knaus@chemie.fu-berlin.de	Fratzl, Peter/H-9095-2012	Fratzl, Peter/0000-0003-4437-7830; Kreuzaler, Peter/0000-0001-8684-9424	Deutsche Forschungsgemeinschaft (DFG) [SFB 449, SFB 958]; Rudolf Virchow Center [FZ-82, GK-1342, GK-1048]; Bavarian Ministry of Science and Education for the Bio-Imaging Center; DFG	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Rudolf Virchow Center; Bavarian Ministry of Science and Education for the Bio-Imaging Center; DFG(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grants SFB 449 and SFB 958 (to P. K.), FZ-82 (for the Rudolf Virchow Center) (to G. S. H.), GK-1342 (to G. S. H.), and GK-1048 (to G. S. H.) and also by the Bavarian Ministry of Science and Education for the Bio-Imaging Center (to G. S. H.).; Member of the Berlin-Brandenburg School for Regenerative Therapies, a DFG-funded graduate school.	Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Arcaro A, 2007, CELL SIGNAL, V19, P1081, DOI 10.1016/j.cellsig.2006.12.003; Brdickova N, 2001, FEBS LETT, V507, P133, DOI 10.1016/S0014-5793(01)02955-6; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; de Keijzer S, 2011, BBA-BIOMEMBRANES, V1808, P1701, DOI 10.1016/j.bbamem.2011.02.009; Ebisawa T, 1999, J CELL SCI, V112, P3519; Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X; Gamell C, 2008, J CELL SCI, V121, P3960, DOI 10.1242/jcs.031286; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Gilboa L, 2000, MOL BIOL CELL, V11, P1023, DOI 10.1091/mbc.11.3.1023; Goto K, 2007, J BIOL CHEM, V282, P20603, DOI 10.1074/jbc.M702100200; Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060; Hartung A, 2006, MOL CELL BIOL, V26, P7791, DOI 10.1128/MCB.00022-06; Hassel S, 2003, J BONE JOINT SURG AM, V85A, P44, DOI 10.2106/00004623-200300003-00009; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kim J, 2008, CIRC RES, V102, P896, DOI 10.1161/CIRCRESAHA.107.163667; Kishigami S, 2005, CYTOKINE GROWTH F R, V16, P265, DOI 10.1016/j.cytogfr.2005.04.002; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Lill Y, 2005, CHEMPHYSCHEM, V6, P1633, DOI 10.1002/cphc.200500111; Limpert AS, 2007, MOL CELL BIOL, V27, P5686, DOI 10.1128/MCB.01109-06; Liu PS, 1997, P NATL ACAD SCI USA, V94, P13666, DOI 10.1073/pnas.94.25.13666; Luga V, 2009, BIOCHEM J, V421, P119, DOI 10.1042/BJ20081131; Ma XY, 2007, BIOCHEM BIOPH RES CO, V356, P67, DOI 10.1016/j.bbrc.2007.02.080; Marom B, 2011, J BIOL CHEM, V286, P19287, DOI 10.1074/jbc.M110.210377; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Nickel J, 2005, J MOL BIOL, V349, P933, DOI 10.1016/j.jmb.2005.04.015; Nohe A, 2005, J CELL SCI, V118, P643, DOI 10.1242/jcs.01402; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Parton RG, 2004, TRENDS CELL BIOL, V14, P141, DOI 10.1016/j.tcb.2004.02.001; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200; Sammar M, 2009, BIOCHEM BIOPH RES CO, V381, P1, DOI 10.1016/j.bbrc.2008.12.162; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Villalba M, 2001, J CELL BIOL, V155, P331, DOI 10.1083/jcb.200107080; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Xia Y, 2011, J IMMUNOL, V186, P1369, DOI 10.4049/jimmunol.1002047; Xiao ZY, 2008, J PHYS CHEM B, V112, P4140, DOI 10.1021/jp710302j; Yamabhai M, 2002, J BIOL CHEM, V277, P24843, DOI 10.1074/jbc.C200277200; Zelman-Femiak M, 2010, BIOTECHNIQUES, V49, P574, DOI 10.2144/000113466; Zhou Z, 2010, DEV CELL, V19, P90, DOI 10.1016/j.devcel.2010.06.016; Zuo W, 2009, MOL BIOL CELL, V20, P1020, DOI 10.1091/mbc.E08-09-0898	47	45	47	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.387639	http://dx.doi.org/10.1074/jbc.M112.387639			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	22961979	Green Published, hybrid			2022-12-28	WOS:000311233800021
J	Bond, LM; Arden, SD; Kendrick-Jones, J; Buss, F; Sellers, JR				Bond, Lisa M.; Arden, Susan D.; Kendrick-Jones, John; Buss, Folma; Sellers, James R.			Dynamic Exchange of Myosin VI on Endocytic Structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; SNELLS-WALTZER MICE; LARGE STEP-SIZE; CELLULAR FUNCTIONS; ACTIN-FILAMENTS; MOTOR; DEAFNESS; BINDING; DOMAIN; MYO6	The actin-based molecular motor myosin VI functions in the endocytic uptake pathway, both during the early stages of clathrin-mediated uptake and in later transport to/from early endosomes. This study uses fluorescence recovery after photobleaching (FRAP) to examine the turnover rate of myosin VI during endocytosis. The results demonstrate that myosin VI turns over dynamically on endocytic structures with a characteristic half-life common to both the large insert isoform of myosin VI on clathrin-coated structures and the no-insert isoform on early endosomes. This half-life is shared by the myosin VI-binding partner Dab2 and is identical for full-length myosin VI and the cargo-binding tail region. The 4-fold slower half-life of an artificially dimerized construct of myosin VI on clathrin-coated structures suggests that wild type myosin VI does not function as a stable dimer, but either as a monomer or in a monomer/dimer equilibrium. Taken together, these FRAP results offer insight into both the basic turnover dynamics and the monomer/dimer nature of myosin VI.	[Bond, Lisa M.; Arden, Susan D.; Buss, Folma] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Bond, Lisa M.; Sellers, James R.] NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Kendrick-Jones, John] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); MRC Laboratory Molecular Biology	Buss, F (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust Med Res Council Bldg,Hills Rd, Cambridge CB2 0XY, England.	fb1@mole.bio.cam.ac.uk; sellersj@nhlbi.nih.gov		Buss, Folma/0000-0003-4457-3479	NHLBI, National Institutes of Health, Intramural Program; Wellcome Trust; Winston Churchill Foundation of the United States; National Institutes of Health-Oxford-Cambridge Ph.D. studentship; Medical Research Council; Medical Research Council [MC_U105184323] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004232, ZICHL006019] Funding Source: NIH RePORTER; MRC [MC_U105184323] Funding Source: UKRI	NHLBI, National Institutes of Health, Intramural Program; Wellcome Trust(Wellcome Trust); Winston Churchill Foundation of the United States; National Institutes of Health-Oxford-Cambridge Ph.D. studentship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by the NHLBI, National Institutes of Health, Intramural Program (to J. R. S.). This work was also supported by the Wellcome Trust (to F. B.), a scholarship from the Winston Churchill Foundation of the United States (to L. M. B.), a National Institutes of Health-Oxford-Cambridge Ph.D. studentship (to L. M. B.), and the Medical Research Council (to J. K-J.). The Cambridge Institute for Medical Research received a strategic award from the Wellcome Trust.	Ahmed ZM, 2003, AM J HUM GENET, V72, P1315, DOI 10.1086/375122; Ameen N, 2007, TRAFFIC, V8, P998, DOI 10.1111/j.1600-0854.2007.00587.x; Aschenbrenner L, 2003, MOL BIOL CELL, V14, P2728, DOI 10.1091/mbc.E02-11-0767; Au JSY, 2007, J CELL BIOL, V177, P103, DOI 10.1083/jcb.200608126; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Biemesderfer D, 2002, AM J PHYSIOL-RENAL, V282, pF785, DOI 10.1152/ajprenal.00287.2001; Bond LM, 2011, MOL BIOL CELL, V22, P54, DOI 10.1091/mbc.E10-06-0553; Buss F, 2004, ANNU REV CELL DEV BI, V20, P649, DOI 10.1146/annurev.cellbio.20.012103.094243; Buss F, 2001, EMBO J, V20, P3676, DOI 10.1093/emboj/20.14.3676; Buss F, 2001, FEBS LETT, V508, P295, DOI 10.1016/S0014-5793(01)03065-4; Buss F, 2008, BIOCHEM BIOPH RES CO, V369, P165, DOI 10.1016/j.bbrc.2007.11.150; Chibalina MV, 2007, J CELL SCI, V120, P4278, DOI 10.1242/jcs.014217; Chibalina MV, 2010, TRAFFIC, V11, P1290, DOI 10.1111/j.1600-0854.2010.01101.x; Dunn TA, 2006, AM J PATHOL, V169, P1843, DOI 10.2353/ajpath.2006.060316; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Hasson T, 2003, J CELL SCI, V116, P3453, DOI 10.1242/jcs.00669; Inoue T, 2008, GENES CELLS, V13, P483, DOI 10.1111/j.1365-2443.2008.01184.x; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Knudsen B, 2006, AM J PATHOL, V169, P1523, DOI 10.2353/ajpath.2006.060712; Kondo T, 2011, BIOCHEM J, V435, P569, DOI 10.1042/BJ20100837; Lister I, 2004, EMBO J, V23, P1729, DOI 10.1038/sj.emboj.7600180; Massol RH, 2006, P NATL ACAD SCI USA, V103, P10265, DOI 10.1073/pnas.0603369103; Melchionda S, 2001, AM J HUM GENET, V69, P635, DOI 10.1086/323156; Mohiddin SA, 2004, J MED GENET, V41, P309, DOI 10.1136/jmg.2003.011973; Morris SM, 2002, TRAFFIC, V3, P331, DOI 10.1034/j.1600-0854.2002.30503.x; Murthy K, 2005, CURR BIOL, V15, P724, DOI 10.1016/j.cub.2005.02.055; Nishikawa S, 2002, BIOCHEM BIOPH RES CO, V290, P311, DOI 10.1006/bbrc.2001.6142; Okten Z, 2004, NAT STRUCT MOL BIOL, V11, P884, DOI 10.1038/nsmb815; Osterweil E, 2005, J CELL BIOL, V168, P329, DOI 10.1083/jcb.200410091; Park H, 2006, MOL CELL, V21, P331, DOI 10.1016/j.molcel.2005.12.015; Park H, 2007, P NATL ACAD SCI USA, V104, P778, DOI 10.1073/pnas.0610066104; Phichith D, 2009, P NATL ACAD SCI USA, V106, P17320, DOI 10.1073/pnas.0909748106; Rock RS, 2005, MOL CELL, V17, P603, DOI 10.1016/j.molcel.2005.01.015; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; Spink BJ, 2008, NAT STRUCT MOL BIOL, V15, P591, DOI 10.1038/nsmb.1429; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Spudich JA, 2010, NAT REV MOL CELL BIO, V11, P128, DOI 10.1038/nrm2833; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Trybus KM, 1997, P NATL ACAD SCI USA, V94, P48, DOI 10.1073/pnas.94.1.48; Umeki N, 2009, P NATL ACAD SCI USA, V106, P8483, DOI 10.1073/pnas.0812930106; Warner CL, 2003, EMBO J, V22, P569, DOI 10.1093/emboj/cdg055; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Wu XF, 2001, J CELL BIOL, V155, P291, DOI 10.1083/jcb.200104085; Yang Y, 2009, P NATL ACAD SCI USA, V106, P4189, DOI 10.1073/pnas.0808682106; Yeh E, 2008, CURR BIOL, V18, P81, DOI 10.1016/j.cub.2007.12.019; Yoshida H, 2004, P NATL ACAD SCI USA, V101, P8144, DOI 10.1073/pnas.0400400101; Yu C, 2009, CELL, V138, P537, DOI 10.1016/j.cell.2009.05.030	48	13	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38637	38646		10.1074/jbc.M112.373969	http://dx.doi.org/10.1074/jbc.M112.373969			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22992744	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000310982800023
J	Langlais, P; Dillon, JL; Mengos, A; Baluch, DP; Ardebili, R; Miranda, DN; Xie, XT; Heckmann, BL; Liu, J; Mandarino, LJ				Langlais, Paul; Dillon, James L.; Mengos, April; Baluch, Debra P.; Ardebili, Ranna; Miranda, Danielle N.; Xie, Xitao; Heckmann, Bradlee L.; Liu, Jun; Mandarino, Lawrence J.			Identification of a Role for CLASP2 in Insulin Action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AKT/PROTEIN KINASE-B; GLUT4 TRANSLOCATION; MICROTUBULE DYNAMICS; EXOCYST COMPLEX; PLASMA-MEMBRANE; CELL CORTEX; PHOSPHORYLATION; ADIPOCYTES; TRAFFICKING; TRANSPORT	Insulin stimulates the mobilization of glucose transporter 4 (GLUT4) storage vesicles to the plasma membrane, resulting in an influx of glucose into target tissues such as muscle and fat. We present evidence that CLIP-associating protein 2 (CLASP2), a protein previously unassociated with insulin action, is responsive to insulin stimulation. Using mass spectrometry-based protein identification combined with phosphoantibody immuno-precipitation in L6 myotubes, we detected a 4.8-fold increase of CLASP2 in the anti-phosphoserine immunoprecipitates upon insulin stimulation. Western blotting of CLASP2 immunoprecipitates with the phosphoantibody confirmed the finding that CLASP2 undergoes insulin-stimulated phosphorylation, and a number of novel phosphorylation sites were identified. Confocal imaging of L6 myotubes revealed that CLASP2 colocalizes with GLUT4 at the plasma membrane within areas of insulin-mediated cortical actin remodeling. CLASP2 is responsible for directing the distal end of microtubules to the cell cortex, and it has been shown that GLUT4 travels along microtubule tracks. In support of the concept that CLASP2 plays a role in the trafficking of GLUT4 at the cell periphery, CLASP2 knockdown by siRNA in L6 myotubes interfered with insulin-stimulated GLUT4 localization to the plasma membrane. Furthermore, siRNA mediated knockdown of CLASP2 in 3T3-L1 adipocytes inhibited insulin-stimulated glucose transport. We therefore propose a new model for CLASP2 in insulin action, where CLASP2 directs the delivery of GLUT4 to cell cortex landing zones important for insulin action.	[Mandarino, Lawrence J.] Arizona State Univ, Ctr Metab & Vasc Biol, Tempe, AZ 85287 USA; [Langlais, Paul; Mengos, April; Miranda, Danielle N.; Xie, Xitao; Heckmann, Bradlee L.; Liu, Jun; Mandarino, Lawrence J.] Mayo Clin Arizona, Scottsdale, AZ 85259 USA	Arizona State University; Arizona State University-Tempe; Mayo Clinic; Mayo Clinic Phoenix	Mandarino, LJ (corresponding author), Mayo Clin, Coll Med, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	mandarino.lawrence@mayo.edu	Baluch, Debra/AAO-1972-2021	Heckmann, Bradlee/0000-0002-3271-7183; Baluch, Debra/0000-0003-4043-5394	National Institutes of Health Grant [R01DK047936]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047936, R01DK089178] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK047936 (to L. J. M.).	Adachi A, 2010, J CELL SCI, V123, P3215, DOI 10.1242/jcs.063941; Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Chen SA, 2008, BIOCHEM J, V409, P449, DOI 10.1042/BJ20071114; Chen Y, 2008, FEBS J, V275, P705, DOI 10.1111/j.1742-4658.2007.06232.x; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Eyster CA, 2005, J BIOL CHEM, V280, P17978, DOI 10.1074/jbc.M409806200; Eyster CA, 2006, J BIOL CHEM, V281, P39719, DOI 10.1074/jbc.M607101200; Galjart N, 2005, NAT REV MOL CELL BIO, V6, P487, DOI 10.1038/nrm1664; Huang J, 2005, J BIOL CHEM, V280, P42300, DOI 10.1074/jbc.M510920200; Imamura T, 2003, MOL CELL BIOL, V23, P4892, DOI 10.1128/MCB.23.14.4892-4900.2003; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Katome T, 2003, J BIOL CHEM, V278, P28312, DOI 10.1074/jbc.M302094200; Khayat ZA, 2000, J CELL SCI, V113, P279; Kumar P, 2009, J CELL BIOL, V184, P895, DOI 10.1083/jcb.200901042; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Maiato H, 2003, CELL, V113, P891, DOI 10.1016/S0092-8674(03)00465-3; Miller PM, 2009, NAT CELL BIOL, V11, P1069, DOI 10.1038/ncb1920; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Patel N, 2003, MOL CELL BIOL, V23, P4611, DOI 10.1128/MCB.23.13.4611-4626.2003; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rowland AF, 2011, TRAFFIC, V12, P672, DOI 10.1111/j.1600-0854.2011.01178.x; Semiz S, 2003, EMBO J, V22, P2387, DOI 10.1093/emboj/cdg237; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Takabayashi T, 2010, J BIOL CHEM, V285, P16155, DOI 10.1074/jbc.M109.081901; Xu YK, 2007, BIOCHEM BIOPH RES CO, V359, P121, DOI 10.1016/j.bbrc.2007.05.075; Zaid H, 2008, BIOCHEM J, V413, P201, DOI 10.1042/BJ20080723; Zhou QOL, 2010, J BIOL CHEM, V285, P27581, DOI 10.1074/jbc.M110.146886; Zimmermann T, 2002, FEBS LETT, V531, P245, DOI 10.1016/S0014-5793(02)03508-1	33	11	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39245	39253		10.1074/jbc.M112.394148	http://dx.doi.org/10.1074/jbc.M112.394148			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22992739	Green Published, hybrid			2022-12-28	WOS:000310982800079
J	Unterer, B; Becker, CM; Villmann, C				Unterer, Bea; Becker, Cord-Michael; Villmann, Carmen			The Importance of TM3-4 Loop Subdomains for Functional Reconstitution of Glycine Receptors by Independent Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; X-RAY-STRUCTURE; SUBUNIT; DETERMINES; GEPHYRIN; GLRA1(SPD-OT); AGGREGATION; MODULATION; TOPOLOGY; MUTATION	Truncated glycine receptors that have been found in human patients suffering from the neuromotor disorder hyperekplexia or in spontaneous mouse models resulted in non-functional ion channels. Rescue of function experiments with the lacking protein portion expressed as a separate independent domain demonstrated restoration of glycine receptor functionality in vitro. This construct harbored most of the TM3-4 loop, TM4, and the C terminus and was required for concomitant transport of the truncated alpha 1 and the complementation domain from the endoplasmic reticulum toward the cell surface, thereby enabling complex formation of functional glycine receptors. Here, the complementation domain was stepwise truncated from its N terminus in the TM3-4 loop. Truncation of more than 49 amino acids led again to loss of functionality in the receptor complex expressed from two independent domain constructs. We identified residues 357-418 in the intracellular TM3-4 loop as being required for reconstitution of functional glycine-gated channels. All complementation constructs showed cell surface protein expression and correct orientation according to glycine receptor topology. Moreover, we demonstrated that the truncations did not result in a decreased protein-protein interaction between both glycine receptor domains. Rather, deletions of more than 49 amino acids abolished conformational changes necessary for ion channel opening. When the TM3-4 loop subdomain harboring residues 357-418 was expressed as a third independent construct together with the truncated N-terminal and C-terminal glycine receptor domains, functionality of the glycine receptor was again restored. Thus, residues 357-418 represent an important determinant in the process of conformational rearrangements following ligand binding resulting in channel opening.	[Unterer, Bea; Becker, Cord-Michael; Villmann, Carmen] Univ Erlangen Nurnberg, Inst Biochem, Emil Fischer Ctr, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Villmann, C (corresponding author), Univ Wurzburg, Inst Clin Neurobiol, Versbacherstr 5, D-97078 Wurzburg, Germany.	Villmann_C@klinik.uni-wuerzburg.de		Unterer, Bea/0000-0001-8610-6882	Deutsche Forschungsgemeinschaft [VI586]; EU Neurocypres; Johannes und Frieda Marohn Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU Neurocypres; Johannes und Frieda Marohn Stiftung	This work was supported by Deutsche Forschungsgemeinschaft Grant VI586, EU Neurocypres, and the Johannes und Frieda Marohn Stiftung.	Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Becker Kristina, 2006, Hum Mutat, V27, P1061, DOI 10.1002/humu.9455; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Breitinger HG, 2009, J BIOL CHEM, V284, P28624, DOI 10.1074/jbc.M109.043174; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Duret G, 2011, P NATL ACAD SCI USA, V108, P12143, DOI 10.1073/pnas.1104494108; Dutertre S, 2012, J NEUROCHEM, V122, P38, DOI 10.1111/j.1471-4159.2012.07755.x; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Haeger S, 2010, NAT STRUCT MOL BIOL, V17, P90, DOI 10.1038/nsmb.1721; Hessa T, 2005, SCIENCE, V307, P1427, DOI 10.1126/science.1109176; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Kang JQ, 2009, J NEUROSCI, V29, P2845, DOI 10.1523/JNEUROSCI.4772-08.2009; Kim EY, 2006, EMBO J, V25, P1385, DOI 10.1038/sj.emboj.7601029; Kling C, 1997, NEUROSCIENCE, V78, P411, DOI 10.1016/S0306-4522(96)00567-2; Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034; Melzer N, 2010, J BIOL CHEM, V285, P3730, DOI 10.1074/jbc.M109.030460; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Moraga-Cid G, 2011, ANESTHESIOLOGY, V115, P464, DOI 10.1097/ALN.0b013e31822550f7; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5596, DOI 10.1073/pnas.042681599; Peters TW, 2007, PRION, V1, P144, DOI 10.4161/pri.1.2.4630; Sadtler S, 2003, J BIOL CHEM, V278, P16782, DOI 10.1074/jbc.M213077200; Saiyed T, 2007, J BIOL CHEM, V282, P5625, DOI 10.1074/jbc.M610290200; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Specht CG, 2011, EMBO J, V30, P3842, DOI 10.1038/emboj.2011.276; Tsai CH, 2004, NEUROLOGY, V63, P893, DOI 10.1212/01.WNL.0000138566.65519.67; Valkova C, 2011, P NATL ACAD SCI USA, V108, P621, DOI 10.1073/pnas.1001624108; Villmann C., 2009, ION CHANNELS STRUCTU, P251; Villmann C, 2008, J NEUROCHEM, V107, P453, DOI 10.1111/j.1471-4159.2008.05623.x; Villmann C, 2009, J NEUROSCI, V29, P2440, DOI 10.1523/JNEUROSCI.4400-08.2009; Vogel N, 2009, J BIOL CHEM, V284, P36128, DOI 10.1074/jbc.M109.043448; Yevenes GE, 2008, P NATL ACAD SCI USA, V105, P20523, DOI 10.1073/pnas.0806257105; Yevenes GE, 2006, J BIOL CHEM, V281, P39300, DOI 10.1074/jbc.M608272200	37	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39205	39215		10.1074/jbc.M112.376053	http://dx.doi.org/10.1074/jbc.M112.376053			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22995908	Green Published, hybrid			2022-12-28	WOS:000310982800075
J	Casteel, DE; Turner, S; Schwappacher, R; Rangaswami, H; Su-Yuo, J; Zhuang, SH; Boss, GR; Pilz, RB				Casteel, Darren E.; Turner, Stephanie; Schwappacher, Raphaela; Rangaswami, Hema; Su-Yuo, Jacqueline; Zhuang, Shunhui; Boss, Gerry R.; Pilz, Renate B.			Rho Isoform-specific Interaction with IQGAP1 Promotes Breast Cancer Cell Proliferation and Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; BINDING-PROTEIN; FAMILY GTPASES; INVASION; KINASE; CDC42; METASTASIS; EXPRESSION; EFFECTOR; ADHESION	We performed a proteomics screen for Rho isoform-specific binding proteins to clarify the tumor-promoting effects of RhoA and C that contrast with the tumor-suppressive effects of RhoB. We found that the IQ-motif-containing GTPase-activating protein IQGAP1 interacts directly with GTP-bound, prenylated RhoA and RhoC, but not with RhoB. Co-immunoprecipitation of IQGAP1 with endogenous RhoA/C was enhanced when RhoA/C were activated by epidermal growth factor (EGF) or transfection of a constitutively active guanine nucleotide exchange factor (GEF). Overexpression of IQGAP1 increased GTP-loading of RhoA/C, while siRNA-mediated depletion of IQGAP1 prevented endogenous RhoA/C activation by growth factors. IQGAP1 knockdown also reduced the amount of GTP bound to GTPase-deficient RhoA/C mutants, suggesting that IQGAP enhances Rho activation by GEF(s) or stabilizes Rho-GTP. IQGAP1 depletion in MDA-MB-231 breast cancer cells blocked EGF- and RhoA-induced stimulation of DNA synthesis. Infecting cells with adenovirus encoding constitutively active RhoA(L63) and measuring absolute amounts of RhoA-GTP in infected cells demonstrated that the lack of RhoA(L63)-induced DNA synthesis in IQGAP1-depleted cells was not due to reduced GTP-bound RhoA. These data suggested that IQGAP1 functions downstream of RhoA. Overexpression of IQGAP1 in MDA-MB-231 cells increased DNA synthesis irrespective of siRNA-mediated RhoA knockdown. Breast cancer cell motility was increased by expressing a constitutively-active RhoC(V14) mutant or overexpressing IQGAP1. EGF- or RhoC-induced migration required IQGAP1, but IQGAP1-stimulated migration independently of RhoC, placing IQGAP1 downstream of RhoC. We conclude that IQGAP1 acts both upstream of RhoA/C, regulating their activation state, and downstream of RhoA/C, mediating their effects on breast cancer cell proliferation and migration, respectively.	[Pilz, Renate B.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Pilz, RB (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rpilz@ucsd.edu		Boss, Gerry/0000-0002-9758-8714	National Institutes of Health [K22-CA124517, R01-AR051300]; Deutsche Forschungsgemeinschaft;  [T32-HL007261]; NATIONAL CANCER INSTITUTE [K22CA124517] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051300] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants K22-CA124517 (to D. C.) and R01-AR051300 (to R. B. P.).; Supported by T32-HL007261.; Supported by a research fellowship grant from the Deutsche Forschungsgemeinschaft.	Bouzahzah B, 2001, MOL MED, V7, P816, DOI 10.1007/BF03401974; Brandt DT, 2007, EMBO REP, V8, P1019, DOI 10.1038/sj.embor.7401089; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Chen JC, 2003, J BIOL CHEM, V278, P2807, DOI 10.1074/jbc.M207943200; Chen Z, 2000, J BIOL CHEM, V275, P17974, DOI 10.1074/jbc.C000145200; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Del Re DP, 2008, J BIOL CHEM, V283, P35622, DOI 10.1074/jbc.M804036200; Gudi T, 2002, J BIOL CHEM, V277, P37382, DOI 10.1074/jbc.M204491200; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Hu S., 2009, CANCER RES, V69, P794; Jadeski L, 2008, J BIOL CHEM, V283, P1008, DOI 10.1074/jbc.M708466200; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Karnoub AE, 2004, BREAST CANCER RES TR, V84, P61, DOI 10.1023/B:BREA.0000018427.84929.5c; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Lammers M, 2008, J BIOL CHEM, V283, P35236, DOI 10.1074/jbc.M805634200; Li SH, 2000, MOL CELL BIOL, V20, P697, DOI 10.1128/MCB.20.2.697-701.2000; Liberto M, 2002, ONCOGENE, V21, P1590, DOI 10.1038/sj.onc.1205242; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Mataraza JM, 2007, CELL SIGNAL, V19, P1857, DOI 10.1016/j.cellsig.2007.04.011; Mataraza JM, 2003, J BIOL CHEM, V278, P41237, DOI 10.1074/jbc.M304838200; McCallum SJ, 1996, J BIOL CHEM, V271, P21732, DOI 10.1074/jbc.271.36.21732; McCallum SJ, 1998, J BIOL CHEM, V273, P22537, DOI 10.1074/jbc.273.35.22537; Mircescu H, 2002, EUR J BIOCHEM, V269, P6241, DOI 10.1046/j.1432-1033.2002.03343.x; Noritake J, 2004, MOL BIOL CELL, V15, P1065, DOI 10.1091/mbc.E03-08-0582; Owen D, 2008, J BIOL CHEM, V283, P1692, DOI 10.1074/jbc.M707257200; Pille JY, 2005, MOL THER, V11, P267, DOI 10.1016/j.ymthe.2004.08.029; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; Rangaswami H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001423; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sakurai-Yageta M, 2008, J CELL BIOL, V181, P985, DOI 10.1083/jcb.200709076; Simpson KJ, 2004, CANCER RES, V64, P8694, DOI 10.1158/0008-5472.CAN-04-2247; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Tang Y, 2008, FRONT BIOSCI-LANDMRK, V13, P759, DOI 10.2741/2718; Turner SJ, 2008, BIOCHEM PHARMACOL, V75, P405, DOI 10.1016/j.bcp.2007.08.031; van Golen KL, 2000, CANCER RES, V60, P5832; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Wang JB, 2009, J CELL SCI, V122, P2024, DOI 10.1242/jcs.044644; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; White CD, 2011, J BIOL CHEM, V286, P29734, DOI 10.1074/jbc.M111.220939; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Wu M, 2004, BREAST CANCER RES TR, V84, P3, DOI 10.1023/B:BREA.0000018426.76893.21; Wu M, 2010, CANCER-AM CANCER SOC, V116, P2768, DOI 10.1002/cncr.25181; Zeng PY, 2003, ONCOGENE, V22, P1124, DOI 10.1038/sj.onc.1206181; Zeng Y, 2006, J BIOL CHEM, V281, P16951, DOI 10.1074/jbc.M602099200	48	46	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.377499	http://dx.doi.org/10.1074/jbc.M112.377499			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22992742	Green Published, hybrid			2022-12-28	WOS:000310642200069
J	Shapiro, L				Shapiro, Lucy			Life in a Three-dimensional Grid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL-CELL-CYCLE; POLAR LOCALIZATION; RNA PHAGE; DNA; GENOME; RIBONUCLEOTIDES; CHEMORECEPTOR; TRANSCRIPTION; CAULOBACTER; REGULATOR	There have been two sharp demarcations in my life in science: the transition from fine arts to chemistry, which happened early in my career, and the move from New York to Stanford University, which initiated an ongoing collaboration with the physicist Harley McAdams. Both had a profound effect on the kinds of questions I posed and the means I used to arrive at answers. The outcome of these experiences, together with the extraordinary scientists I came to know along the way, was and is an abiding passion to fully understand a simple cell in all its complexity and beauty.	Stanford Univ, Beckman Ctr, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA	Stanford University	Shapiro, L (corresponding author), Stanford Univ, Beckman Ctr, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA.	shapiro@stanford.edu						ALLEY MRK, 1992, GENE DEV, V6, P825, DOI 10.1101/gad.6.5.825; AUGUST JT, 1963, COLD SPRING HARB SYM, V28, P95, DOI 10.1101/SQB.1963.028.01.019; BALTIMORE D, 1962, BIOCHEM BIOPH RES CO, V9, P388, DOI 10.1016/0006-291X(62)90021-9; BELLAMY AR, 1967, J MOL BIOL, V29, P1, DOI 10.1016/0022-2836(67)90177-5; Christen B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.58; Collier J, 2007, P NATL ACAD SCI USA, V104, P17111, DOI 10.1073/pnas.0708112104; HURWITZ J, 1961, COLD SPRING HARB SYM, V26, P91, DOI 10.1101/SQB.1961.026.01.014; Iniesta AA, 2008, P NATL ACAD SCI USA, V105, P16602, DOI 10.1073/pnas.0808807105; JACOB F, 1961, COLD SPRING HARB SYM, V26, P193, DOI 10.1101/SQB.1961.026.01.024; Jacobs C, 1999, CELL, V97, P111, DOI 10.1016/S0092-8674(00)80719-9; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699; MADDOCK JR, 1993, SCIENCE, V259, P1717; McAdams HH, 2011, J MOL BIOL, V409, P28, DOI 10.1016/j.jmb.2011.02.041; MCADAMS HH, 1995, SCIENCE, V269, P650, DOI 10.1126/science.7624793; McGrath PT, 2007, NAT BIOTECHNOL, V25, P584, DOI 10.1038/nbt1294; McGrath PT, 2006, CELL, V124, P535, DOI 10.1016/j.cell.2005.12.033; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2; Reisenauer A, 2002, EMBO J, V21, P4969, DOI 10.1093/emboj/cdf490; Shapiro L, 2009, SCIENCE, V326, P1225, DOI 10.1126/science.1175685; Shen XL, 2008, P NATL ACAD SCI USA, V105, P11340, DOI 10.1073/pnas.0805258105; WEISSMANN C, 1963, P NATL ACAD SCI USA, V49, P407, DOI 10.1073/pnas.49.3.407	23	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.X112.422337	http://dx.doi.org/10.1074/jbc.X112.422337			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	23007401	Green Published, hybrid			2022-12-28	WOS:000310642200061
J	Singh, K; Marchand, B; Rai, DK; Sharma, B; Michailidis, E; Ryan, EM; Matzek, KB; Leslie, MD; Hagedorn, AN; Li, Z; Norden, PR; Hachiya, A; Parniak, MA; Xu, HT; Wainberg, MA; Sarafianos, SG				Singh, Kamalendra; Marchand, Bruno; Rai, Devendra K.; Sharma, Bechan; Michailidis, Eleftherios; Ryan, Emily M.; Matzek, Kayla B.; Leslie, Maxwell D.; Hagedorn, Ariel N.; Li, Zhe; Norden, Pieter R.; Hachiya, Atsuko; Parniak, Michael A.; Xu, Hong-Tao; Wainberg, Mark A.; Sarafianos, Stefan G.			Biochemical Mechanism of HIV-1 Resistance to Rilpivirine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE INHIBITORS; SITE-DIRECTED MUTAGENESIS; DNA-POLYMERASE; NONNUCLEOSIDE INHIBITORS; 2-AMINOPURINE FLUORESCENCE; DRUG-RESISTANCE; CONNECTION SUBDOMAIN; CRYSTAL-STRUCTURES; RNA-POLYMERASE	Rilpivirine (RPV) is a second generation nonnucleoside reverse transcriptase (RT) inhibitor (NNRTI) that efficiently inhibits HIV-1 resistant to first generation NNRTIs. Virological failure during therapy with RPV and emtricitabine is associated with the appearance of E138K and M184I mutations in RT. Here we investigate the biochemical mechanism of RT inhibition and resistance to RPV. We used two transient kinetics approaches (quench-flow and stopped-flow) to determine how subunit-specific mutations in RT p66 or p51 affect association and dissociation of RPV to RT as well as their impact on binding of dNTP and DNA and the catalytic incorporation of nucleotide. We compared WT with four subunit-specific RT mutants, p66(M184I)/p51(WT), p66(E138K)/p51(E138K), p66(E138K/M184I)/p51(E138K), and p66(M184I)/p51(E138K). Ile-184 in p66 (p66(184I)) decreased the catalytic efficiency of RT (k(pol)/K-d.dNTP), primarily through a decrease in dNTP binding (K-d.dNTP). Lys-138 either in both sub-units or in p51 alone abrogated the negative effect of p66(184I) by restoring dNTP binding. Furthermore, p51(138K) reduced RPV susceptibility by altering the ratio of RPV dissociation to RPV association, resulting in a net reduction in RPV equilibrium binding affinity (K-d.RPV = k(off.RPV)/k(on.RPV)). Quantum mechanics/molecular mechanics hybrid molecular modeling revealed that p51(E138K) affects access to the RPV binding site by disrupting the salt bridge between p51(E138) and p66(K101). p66(184I) caused repositioning of the Tyr-183 active site residue and decreased the efficiency of RT, whereas the addition of p51(138K) restored Tyr-183 to a WT-like conformation, thus abrogating the Ile-184-induced functional defects.	[Ryan, Emily M.; Matzek, Kayla B.; Hagedorn, Ariel N.; Li, Zhe; Norden, Pieter R.] Univ Missouri, Sch Med, Christopher Bond Life Sci Ctr, Columbia, MO 65211 USA; [Singh, Kamalendra; Marchand, Bruno; Michailidis, Eleftherios; Sarafianos, Stefan G.] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA; [Sharma, Bechan] Univ Allahabad, Dept Biochem, Allahabad 211002, Uttar Pradesh, India; [Parniak, Michael A.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA; [Xu, Hong-Tao; Wainberg, Mark A.] McGill Univ, AIDS Ctr, Lady Davis Inst Med Res, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada; [Wainberg, Mark A.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3T 1E2, Canada; [Sarafianos, Stefan G.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Allahabad; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Lady Davis Institute; McGill University; McGill University; McGill University; University of Missouri System; University of Missouri Columbia	Sarafianos, SG (corresponding author), 471D Christopher Bond Life Sci Ctr, 1201 Rollins St, Columbia, MO 65211 USA.	sarafianoss@missouri.edu	Sharma, Bechan/G-6836-2015; Xu, Hongtao/AAA-2650-2021; Rai, Devendra/AAX-3100-2020; Rai, Devendra/J-3857-2013	Sharma, Bechan/0000-0002-7835-9406; Xu, Hongtao/0000-0002-8911-0649; Rai, Devendra/0000-0001-9035-685X; Michailidis, Eleftherios/0000-0002-9907-4346; Sarafianos, Stefan G/0000-0002-5840-154X; Norden, Pieter/0000-0002-5960-5245	National Institutes of Health [AI076119, AI074389, AI100890, AI079801]; Ministry of Knowledge and Economy, Bilateral International Collaborative Research and Development Program, Republic of Korea; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079801, R01AI074389, R01AI100890, R33AI079801, R01AI076119] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Knowledge and Economy, Bilateral International Collaborative Research and Development Program, Republic of Korea; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI076119, AI074389, and AI100890 (to S. G. S.) and AI079801 (to M. A. P.). This work was also supported by grants from the Ministry of Knowledge and Economy, Bilateral International Collaborative Research and Development Program, Republic of Korea.	Ahn SJ, 1996, NUCLEIC ACIDS RES, V24, P2623, DOI 10.1093/nar/24.13.2623; Arion D, 1998, BIOCHEMISTRY-US, V37, P15908, DOI 10.1021/bi981200e; Back NKT, 1996, EMBO J, V15, P4040, DOI 10.1002/j.1460-2075.1996.tb00777.x; BALZARINI J, 1993, J VIROL, V67, P5353, DOI 10.1128/JVI.67.9.5353-5359.1993; Bandwar RP, 2002, J MOL BIOL, V324, P63, DOI 10.1016/S0022-2836(02)01034-3; Bandwar RP, 2001, J BIOL CHEM, V276, P14075, DOI 10.1074/jbc.M011289200; Cancio R, 2005, ANTIMICROB AGENTS CH, V49, P4546, DOI 10.1128/AAC.49.11.4546-4554.2005; Cohen CJ, 2011, LANCET, V378, P229, DOI 10.1016/S0140-6736(11)60983-5; Das K, 2005, PROG BIOPHYS MOL BIO, V88, P209, DOI 10.1016/j.pbiomolbio.2004.07.001; Das K, 1996, J MOL BIOL, V264, P1085, DOI 10.1006/jmbi.1996.0698; Das K, 2004, J MED CHEM, V47, P2550, DOI 10.1021/jm030558s; Das K, 2008, P NATL ACAD SCI USA, V105, P1466, DOI 10.1073/pnas.0711209105; Das K, 2007, J MOL BIOL, V365, P77, DOI 10.1016/j.jmb.2006.08.097; Das K, 2012, NAT STRUCT MOL BIOL, V19, P253, DOI 10.1038/nsmb.2223; Das K, 2011, J MED CHEM, V54, P2727, DOI 10.1021/jm101536x; Daszykowski M, 2005, TALANTA, V68, P54, DOI 10.1016/j.talanta.2005.04.071; de Bethune MP, 2010, ANTIVIR RES, V85, P75, DOI 10.1016/j.antiviral.2009.09.008; De Clercq E, 2004, J CLIN VIROL, V30, P115, DOI 10.1016/j.jcv.2004.02.009; De Clercq Erik, 2005, Expert Opin Emerg Drugs, V10, P241, DOI 10.1517/14728214.10.2.241; de Jonge MR, 2005, J MED CHEM, V48, P2176, DOI 10.1021/jm049534r; Deval J, 2002, J BIOL CHEM, V277, P42097, DOI 10.1074/jbc.M206725200; Ditzler MA, 2011, NUCLEIC ACIDS RES, V39, P8237, DOI 10.1093/nar/gkr381; Domaoal RA, 2008, J BIOL CHEM, V283, P5452, DOI 10.1074/jbc.M707834200; Ehteshami M, 2008, J BIOL CHEM, V283, P22222, DOI 10.1074/jbc.M803521200; ERON JJ, 1995, NEW ENGL J MED, V333, P1662, DOI 10.1056/NEJM199512213332502; ESNOUF R, 1995, NAT STRUCT BIOL, V2, P303, DOI 10.1038/nsb0495-303; Feng JY, 1999, BIOCHEMISTRY-US, V38, P9440, DOI 10.1021/bi990709m; Frenkel YV, 2005, J MED CHEM, V48, P1974, DOI 10.1021/jm049439i; Furge LL, 1999, BIOCHEMISTRY-US, V38, P4818, DOI 10.1021/bi982163u; Gao HQ, 2000, J MOL BIOL, V300, P403, DOI 10.1006/jmbi.2000.3823; GU ZX, 1992, J VIROL, V66, P7128, DOI 10.1128/JVI.66.12.7128-7135.1992; Guillemont J, 2005, J MED CHEM, V48, P2072, DOI 10.1021/jm040838n; Hachiya A, 2008, J VIROL, V82, P3261, DOI 10.1128/JVI.01154-07; Hachiya A, 2009, ANTIVIR RES, V82, P115, DOI 10.1016/j.antiviral.2009.02.189; Harris D, 1998, BIOCHEMISTRY-US, V37, P9630, DOI 10.1021/bi980549z; Heeres J, 2005, J MED CHEM, V48, P1910, DOI 10.1021/jm040829e; Herschhorn A, 2008, BIOCHEMISTRY-US, V47, P490, DOI 10.1021/bi7018139; HSIEH JC, 1993, J BIOL CHEM, V268, P24607; Hu ZX, 2011, J VIROL, V85, P11309, DOI 10.1128/JVI.05578-11; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Jamburuthugoda VK, 2008, J BIOL CHEM, V283, P9206, DOI 10.1074/jbc.M710149200; Janssen PAJ, 2005, J MED CHEM, V48, P1901, DOI 10.1021/jm040840e; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Johnson KA, 2009, METHOD ENZYMOL, V467, P601, DOI 10.1016/S0076-6879(09)67023-3; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kellinger MW, 2011, BIOCHEMISTRY-US, V50, P5008, DOI 10.1021/bi200204m; Kellinger MW, 2010, P NATL ACAD SCI USA, V107, P7734, DOI 10.1073/pnas.0913946107; KLARMANN GJ, 1993, J BIOL CHEM, V268, P9793; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Kulkarni R, 2012, JAIDS-J ACQ IMM DEF, V59, P47, DOI 10.1097/QAI.0b013e31823aca74; Lai YT, 2012, NUCLEIC ACID THER, V22, P162, DOI 10.1089/nat.2011.0327; Lansdon EB, 2010, J MED CHEM, V53, P4295, DOI 10.1021/jm1002233; LARDER BA, 1995, SCIENCE, V269, P696, DOI 10.1126/science.7542804; Liu SX, 2008, SCIENCE, V322, P1092, DOI 10.1126/science.1163108; Mandal SS, 2002, BIOCHEMISTRY-US, V41, P4399, DOI 10.1021/bi015723p; Margot NA, 2002, AIDS, V16, P1227, DOI 10.1097/00002030-200206140-00004; Menendez-Arias L, 2002, TRENDS PHARMACOL SCI, V23, P381, DOI 10.1016/S0165-6147(02)02054-0; Menendez-Arias L, 2008, VIRUS RES, V134, P124, DOI 10.1016/j.virusres.2007.12.015; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; Michailidis E, 2009, J BIOL CHEM, V284, P35681, DOI 10.1074/jbc.M109.036616; Molina JM, 2011, LANCET, V378, P238, DOI 10.1016/S0140-6736(11)60936-7; National Institutes of Health, 2011, HIV ITS TREATM FDA A; Nikolenko GN, 2007, P NATL ACAD SCI USA, V104, P317, DOI 10.1073/pnas.0609642104; Njai HF, 2005, ANTIVIR THER, V10, P255; Pandey VN, 1996, BIOCHEMISTRY-US, V35, P2168, DOI 10.1021/bi9516642; Pelemans H, 2001, VIROLOGY, V280, P97, DOI 10.1006/viro.2000.0742; Purohit V, 2003, BIOCHEMISTRY-US, V42, P10200, DOI 10.1021/bi0341206; Ray AS, 2002, J BIOL CHEM, V277, P40479, DOI 10.1074/jbc.M205303200; Reha-Krantz Linda J., 2009, V521, P381, DOI [10.1007/978-1-60327-815-7_21, 10.1007/978-1-60327-817-5_21]; Ren JS, 2008, VIRUS RES, V134, P157, DOI 10.1016/j.virusres.2007.12.018; Sarafianos SG, 1999, P NATL ACAD SCI USA, V96, P10027, DOI 10.1073/pnas.96.18.10027; Sarafianos SG, 2004, CURR OPIN STRUC BIOL, V14, P716, DOI 10.1016/j.sbi.2004.10.013; SARAFIANOS SG, 1995, J BIOL CHEM, V270, P19729, DOI 10.1074/jbc.270.34.19729; SARAFIANOS SG, 1995, BIOCHEMISTRY-US, V34, P7207, DOI 10.1021/bi00021a036; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Schrijvers R, 2011, LANCET, V378, P201, DOI 10.1016/S0140-6736(11)60992-6; Schuckmann MM, 2010, J BIOL CHEM, V285, P38700, DOI 10.1074/jbc.M110.153783; SCHUURMAN R, 1995, J INFECT DIS, V171, P1411, DOI 10.1093/infdis/171.6.1411; Singh K, 2010, VIRUSES-BASEL, V2, P606, DOI 10.3390/v2020606; Sluis-Cremer N, 2000, CELL MOL LIFE SCI, V57, P1408, DOI 10.1007/PL00000626; Smidansky ED, 2011, BIOCHEMISTRY-US, V50, P5016, DOI 10.1021/bi200350d; Spence RA, 1996, BIOCHEMISTRY-US, V35, P1054, DOI 10.1021/bi952058+; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653; Tuske S, 2004, NAT STRUCT MOL BIOL, V11, P469, DOI 10.1038/nsmb760; Vu BC, 2011, ANTIMICROB AGENTS CH, V55, P2379, DOI 10.1128/AAC.01290-10; Wainberg MA, 1996, SCIENCE, V271, P1282, DOI 10.1126/science.271.5253.1282; WAINBERG MA, 1995, AIDS, V9, P351, DOI 10.1097/00002030-199509040-00006; Wainberg Mark A, 2004, Expert Rev Anti Infect Ther, V2, P147, DOI 10.1586/14787210.2.1.147; Wang LZ, 2004, J BIOL CHEM, V279, P38424, DOI 10.1074/jbc.M406241200; Wei X, 2003, VIROLOGY, V311, P202, DOI 10.1016/S0042-6822(03)00173-9; Wilson JE, 1996, J BIOL CHEM, V271, P13656, DOI 10.1074/jbc.271.23.13656; Xu HT, 2012, J VIROL, V86, P8422, DOI 10.1128/JVI.00271-12; Xu HT, 2011, J VIROL, V85, P11300, DOI 10.1128/JVI.05584-11; Xu HT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-80; Yap SH, 2007, PLOS MED, V4, P1887, DOI 10.1371/journal.pmed.0040335	97	45	46	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.398180	http://dx.doi.org/10.1074/jbc.M112.398180			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22955279	Green Published, hybrid			2022-12-28	WOS:000310642200045
J	Ekeruche-Makinde, J; Clement, M; Cole, DK; Edwards, ESJ; Ladell, K; Miles, JJ; Matthews, KK; Fuller, A; Lloyd, KA; Madura, F; Dolton, GM; Pentier, J; Lissina, A; Gostick, E; Baxter, TK; Baker, BM; Rizkallah, PJ; Price, DA; Wooldridge, L; Sewell, AK				Ekeruche-Makinde, Julia; Clement, Mathew; Cole, David K.; Edwards, Emily S. J.; Ladell, Kristin; Miles, John J.; Matthews, Katherine K.; Fuller, Anna; Lloyd, Katy A.; Madura, Florian; Dolton, Garry M.; Pentier, Johanne; Lissina, Anna; Gostick, Emma; Baxter, Tiffany K.; Baker, Brian M.; Rizkallah, Pierre J.; Price, David A.; Wooldridge, Linda; Sewell, Andrew K.			T-cell Receptor-optimized Peptide Skewing of the T-cell Repertoire Can Enhance Antigen Targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX CLASS-I; CARCINOEMBRYONIC ANTIGEN; TUMOR REACTIVITY; MOLECULAR-BASIS; CD8 CORECEPTOR; IMMUNE ESCAPE; SELF-ANTIGEN; TCR-BINDING; LYMPHOCYTES; VACCINATION	Altered peptide antigens that enhance T-cell immunogenicity have been used to improve peptide-based vaccination for a range of diseases. Although this strategy can prime T-cell responses of greater magnitude, the efficacy of constituent T-cell clonotypes within the primed population can be poor. To overcome this limitation, we isolated a CD8(+) T-cell clone (MEL5) with an enhanced ability to recognize the HLA A*0201-Melan A(27-35) (HLA A*0201-AAGIGILTV) antigen expressed on the surface of malignant melanoma cells. We used combinatorial peptide library screening to design an optimal peptide sequence that enhanced functional activation of the MEL5 clone, but not other CD8(+) T-cell clones that recognized HLA A*0201-AAGIGILTV poorly. Structural analysis revealed the potential for new contacts between the MEL5 T-cell receptor and the optimized peptide. Furthermore, the optimized peptide was able to prime CD8(+) T-cell populations in peripheral blood mononuclear cell isolates from multiple HLAA*0201(+) individuals that were capable of efficient HLA A*0201(+) melanoma cell destruction. This proof-of-concept study demonstrates that it is possible to design altered peptide antigens for the selection of superior T-cell clonotypes with enhanced antigen recognition properties.	[Ekeruche-Makinde, Julia; Clement, Mathew; Cole, David K.; Edwards, Emily S. J.; Ladell, Kristin; Miles, John J.; Matthews, Katherine K.; Fuller, Anna; Lloyd, Katy A.; Madura, Florian; Dolton, Garry M.; Pentier, Johanne; Lissina, Anna; Gostick, Emma; Rizkallah, Pierre J.; Price, David A.; Wooldridge, Linda; Sewell, Andrew K.] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales; [Miles, John J.] Queensland Inst Med Res, Australian Ctr Vaccine Dev, Human Immun Lab, Brisbane, Qld 4029, Australia; [Baxter, Tiffany K.; Baker, Brian M.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	Cardiff University; QIMR Berghofer Medical Research Institute; University of Notre Dame	Sewell, AK (corresponding author), Cardiff Univ, Sch Med, Inst Infect & Immun, Henry Wellcome Bldg,Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	SewellAK@cardiff.ac.uk	Sewell, Andrew/GPT-4220-2022; Ladell, Kristin/C-8301-2013; Miles, John J/ABC-1105-2020; Rizkallah, Pierre J/A-5367-2012; Price, David A/C-7876-2013; Ladell, Kristin/K-2475-2013; Edwards, Emily SJ/C-3219-2013; Edwards, Emily S.J./AAI-6037-2020	Sewell, Andrew/0000-0003-3194-3135; Ladell, Kristin/0000-0002-9856-2938; Miles, John J/0000-0001-5506-6304; Rizkallah, Pierre J/0000-0002-9290-0369; Price, David A/0000-0001-9416-2737; Edwards, Emily S.J./0000-0002-0240-4370; Cole, David/0000-0003-0028-9396; Wooldridge, Linda/0000-0002-6213-347X; Makinde, Julia/0000-0002-9906-7437; Fuller, Anna/0000-0002-8655-6741; Matthews, Katherine/0000-0002-4402-451X	Biotechnology and Biological Sciences Research Council [BB/H001085/1]; Wellcome Trust [WT086716, WT095767, WT079848MA]; National Institutes of Health Grant [GM067079]; Research Councils UK; Wales Office of Research and Development; The Medical Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067079] Funding Source: NIH RePORTER; Tenovus Cancer Care [PhD2009/L20] Funding Source: researchfish; BBSRC [BB/H001085/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Councils UK(UK Research & Innovation (UKRI)); Wales Office of Research and Development; The Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Tenovus Cancer Care; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (Grant BB/H001085/1), Wellcome Trust Grants WT086716 (to A. K. S.), WT095767 (to D. K. C.), and WT079848MA (to L. W.), and National Institutes of Health Grant GM067079 (to B. M. B.). Fellowship support was received from the Research Councils UK (to P. J. R.), Wales Office of Research and Development (to J. J. M.), and The Medical Research Council (to D. A. P.).	AlexanderMiller MA, 1996, P NATL ACAD SCI USA, V93, P4102, DOI 10.1073/pnas.93.9.4102; Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Ayyoub M, 2003, CLIN CANCER RES, V9, P669; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bangham CRM, 2009, EUR J IMMUNOL, V39, P1700, DOI 10.1002/eji.200939451; Bins A, 2007, J IMMUNOTHER, V30, P234, DOI 10.1097/01.cji.0000211333.06762.47; Borbulevych OY, 2007, J MOL BIOL, V372, P1123, DOI 10.1016/j.jmb.2007.07.025; Borbulevych OY, 2010, MOL IMMUNOL, V47, P2519, DOI 10.1016/j.molimm.2010.06.005; Bridgeman JS, 2012, IMMUNOLOGY, V135, P9, DOI 10.1111/j.1365-2567.2011.03515.x; CASANOVA JL, 1993, IMMUNOL TODAY, V14, P391, DOI 10.1016/0167-5699(93)90140-G; Chen Qiyuan, 2005, Cancer Immun, V5, P5; Cole DK, 2008, MOL IMMUNOL, V45, P2700, DOI 10.1016/j.molimm.2007.12.009; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Cole DK, 2007, PROTEINS, V67, P65, DOI 10.1002/prot.21176; Cole DK, 2010, J IMMUNOL, V185, P2600, DOI 10.4049/jimmunol.1000629; Cole DK, 2009, J BIOL CHEM, V284, P27281, DOI 10.1074/jbc.M109.022509; Cole DJ, 1997, CANCER RES, V57, P5320; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Derre L, 2007, J IMMUNOL, V179, P7635, DOI 10.4049/jimmunol.179.11.7635; Dietrich PY, 2003, J IMMUNOL, V170, P5103, DOI 10.4049/jimmunol.170.10.5103; Dutoit V, 2002, J EXP MED, V196, P207, DOI 10.1084/jem.20020242; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Hou YF, 2008, J IMMUNOL, V180, P1526, DOI 10.4049/jimmunol.180.3.1526; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; Jager E, 2002, INT J CANCER, V98, P376, DOI 10.1002/ijc.10165; Johnson LA, 2006, J IMMUNOL, V177, P6548, DOI 10.4049/jimmunol.177.9.6548; Kan-Mitchell J, 2006, J IMMUNOL, V176, P6690, DOI 10.4049/jimmunol.176.11.6690; KAWAKAMI Y, 1994, J EXP MED, V180, P347, DOI 10.1084/jem.180.1.347; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P3515, DOI 10.1073/pnas.91.9.3515; Khan AR, 2000, J IMMUNOL, V164, P6398, DOI 10.4049/jimmunol.164.12.6398; Laugel B, 2007, J BIOL CHEM, V282, P23799, DOI 10.1074/jbc.M700976200; Leslie A., 1992, 4 COLL COMP PROJ; Liddy N, 2012, NAT MED, V18, P980, DOI 10.1038/nm.2764; Linnemann T, 2001, EUR J IMMUNOL, V31, P156, DOI 10.1002/1521-4141(200101)31:1<156::AID-IMMU156>3.0.CO;2-P; Maryanski JL, 1999, MOL IMMUNOL, V36, P745, DOI 10.1016/S0161-5890(99)00088-7; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miles KM, 2011, MOL IMMUNOL, V48, P728, DOI 10.1016/j.molimm.2010.11.004; MURARO R, 1985, CANCER RES, V45, P5769; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PARKER KC, 1992, J IMMUNOL, V149, P3580; Pittet MJ, 2006, J IMMUNOL, V176, P2330, DOI 10.4049/jimmunol.176.4.2330; Price DA, 2005, J EXP MED, V202, P1349, DOI 10.1084/jem.20051357; Price DA, 2004, IMMUNITY, V21, P793, DOI 10.1016/j.immuni.2004.10.010; Price DA, 2009, J EXP MED, V206, P923, DOI 10.1084/jem.20081127; Rivoltini L, 1999, CANCER RES, V59, P301; Romero P, 1997, J IMMUNOL, V159, P2366; Rosenberg SA, 1998, NAT MED, V4, P321, DOI 10.1038/nm0398-321; Schaubert KL, 2010, EUR J IMMUNOL, V40, P1950, DOI 10.1002/eji.200940079; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Skipper JCA, 1999, INT J CANCER, V82, P669, DOI 10.1002/(SICI)1097-0215(19990827)82:5<669::AID-IJC9>3.0.CO;2-#; Speiser DE, 2008, P NATL ACAD SCI USA, V105, P3849, DOI 10.1073/pnas.0800080105; Speiser DE, 2002, EUR J IMMUNOL, V32, P731, DOI 10.1002/1521-4141(200203)32:3<731::AID-IMMU731>3.0.CO;2-H; STEWARD AM, 1974, CANCER-AM CANCER SOC, V33, P1246, DOI 10.1002/1097-0142(197405)33:5<1246::AID-CNCR2820330509>3.0.CO;2-O; TOPALIAN SL, 1989, J IMMUNOL, V142, P3714; Tumenjargal S, 2003, EUR J IMMUNOL, V33, P3175, DOI 10.1002/eji.200324244; Valmori D, 2000, J IMMUNOL, V165, P533, DOI 10.4049/jimmunol.165.1.533; Valmori D, 1998, J IMMUNOL, V161, P6956; Valmori D, 1998, J IMMUNOL, V160, P1750; Varela-Rohena A, 2008, NAT MED, V14, P1390, DOI 10.1038/nm.1779; Venturi V, 2008, NAT REV IMMUNOL, V8, P231, DOI 10.1038/nri2260; VINCENT RG, 1978, J THORAC CARDIOV SUR, V75, P734; Wieckowski S, 2009, J IMMUNOL, V183, P5397, DOI 10.4049/jimmunol.0901460; Wilson DB, 2004, MOL IMMUNOL, V40, P1047, DOI 10.1016/j.molimm.2003.11.022; Wooldridge L, 2005, J BIOL CHEM, V280, P27491, DOI 10.1074/jbc.M500555200; Wooldridge L, 2007, EUR J IMMUNOL, V37, P1323, DOI 10.1002/eji.200636765; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Wooldridge L, 2010, J IMMUNOL, V185, P4625, DOI 10.4049/jimmunol.1001480; Zaremba S, 1997, CANCER RES, V57, P4570; Zippelius A, 2002, J EXP MED, V195, P485, DOI 10.1084/jem.20011658	76	33	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37269	37281		10.1074/jbc.M112.386409	http://dx.doi.org/10.1074/jbc.M112.386409			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22952231	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000310588500059
J	Jia, M; Li, JC; Zhu, JW; Wen, WY; Zhang, MJ; Wang, WN				Jia, Min; Li, Jianchao; Zhu, Jinwei; Wen, Wenyu; Zhang, Mingjie; Wang, Wenning			Crystal Structures of the Scaffolding Protein LGN Reveal the General Mechanism by Which GoLoco Binding Motifs Inhibit the Release of GDP from G alpha(i)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASYMMETRIC CELL-DIVISION; REGULATES SPINDLE ORIENTATION; PINS; NUMA; POLARITY; ACTIVATION; COMPLEX; EXCHANGE; PARTNER; DOMAINS	GoLoco (GL) motif-containing proteins regulate G protein signaling by binding to G alpha subunit and acting as guanine nucleotide dissociation inhibitors. GLs of LGN are also known to bind the GDP form of G alpha(i/o) during asymmetric cell division. Here, we show that the C-terminal GL domain of LGN binds four molecules of G alpha(i).GDP. The crystal structures of G alpha(i).GDPin complex with LGN GL3 and GL4, respectively, reveal distinct GL/G alpha(i) interaction features when compared with the only high resolution structure known with GL/G alpha i interaction between RGS14 and G alpha(11). Only a few residues C-terminal to the conserved GL sequence are required for LGN GLs to bind to G alpha(i).GDP. A highly conserved "double Arg finger" sequence (R Psi(D/E)(D/E)QR) is responsible for LGN GL to bind to GDP bound to G alpha(i). Together with the sequence alignment, we suggest that the LGN GL/G alpha(i) interaction represents a general binding mode between GL motifs and G alpha(i). We also show that LGN GLs are potent guanine nucleotide dissociation inhibitors.	[Li, Jianchao; Zhu, Jinwei; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Zhang, Mingjie] Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, Kowloon, Hong Kong, Peoples R China; [Jia, Min; Zhu, Jinwei; Wen, Wenyu; Wang, Wenning] Fudan Univ, Dept Chem, Shanghai Key Lab Mol Catalysis & Innovat Mat, Shanghai 200433, Peoples R China; [Jia, Min; Zhu, Jinwei; Wen, Wenyu; Wang, Wenning] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Jia, Min] Fudan Univ, Dept Pharm, Shanghai 200433, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Fudan University; Fudan University; Fudan University	Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China.	mzhang@ust.hk; wnwang@fudan.edu.cn	LI, Jianchao/J-2053-2017; LI, Jianchao/J-2053-2017	LI, Jianchao/0000-0002-8921-1626; LI, Jianchao/0000-0003-1012-0076; Zhang, Mingjie/0000-0001-9404-0190	National Major Basic Research Program of China [2009CB918600, 2011CB808505]; National Science Foundation of China [20973040, 31070642]; Science & Technology Commission of Shanghai Municipality Grant [08DZ2270500]; Research Grants Council of Hong Kong [663808, 664009, 660709, 663610, 663811, HKUST6/CRF/10, SEG_H-KUST06]	National Major Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Commission of Shanghai Municipality Grant(Science & Technology Commission of Shanghai Municipality (STCSM)); Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by National Major Basic Research Program of China Grants 2009CB918600 and 2011CB808505, National Science Foundation of China Grants 20973040 and 31070642, Science & Technology Commission of Shanghai Municipality Grant 08DZ2270500), and by Grants 663808, 664009, 660709, 663610, 663811, HKUST6/CRF/10, and SEG_H-KUST06 from the Research Grants Council of Hong Kong to MZ.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adhikari A, 2003, J BIOL CHEM, V278, P51825, DOI 10.1074/jbc.M306300200; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Bosch DE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002553; Bosch DE, 2011, J BIOL CHEM, V286, P3351, DOI 10.1074/jbc.M110.190496; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2002, CURR BIOL, V12, P1928, DOI 10.1016/S0960-9822(02)01298-8; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Granderath S, 1999, DEVELOPMENT, V126, P1781; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Kaushik R, 2003, MOL BIOL CELL, V14, P3144, DOI 10.1091/mbc.E03-04-0212; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Kopein D, 2009, MOL BIOL CELL, V20, P3865, DOI 10.1091/mbc.E09-01-0021; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Malbon CC, 2005, NAT REV MOL CELL BIO, V6, P689, DOI 10.1038/nrm1716; McCudden CR, 2005, BBA-MOL CELL RES, V1745, P254, DOI 10.1016/j.bbamcr.2005.05.002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Natochin M, 2001, BIOCHEMISTRY-US, V40, P5322, DOI 10.1021/bi015505w; Nipper RW, 2007, P NATL ACAD SCI USA, V104, P14306, DOI 10.1073/pnas.0701812104; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ponting CP, 1999, J MOL MED, V77, P695, DOI 10.1007/s001099900054; Sammond DW, 2007, J MOL BIOL, V371, P1392, DOI 10.1016/j.jmb.2007.05.096; Sammond DW, 2011, J AM CHEM SOC, V133, P4190, DOI 10.1021/ja110296z; Sans N, 2005, NAT CELL BIOL, V7, P1179, DOI 10.1038/ncb1325; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; Smith NR, 2011, MOL CELL, V43, P540, DOI 10.1016/j.molcel.2011.06.030; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Sunahara RK, 1996, ANNU REV PHARMACOL, V36, P461, DOI 10.1146/annurev.pa.36.040196.002333; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Yoshiura S, 2012, DEV CELL, V22, P79, DOI 10.1016/j.devcel.2011.10.027; Yu FW, 2006, NEURON, V51, P13, DOI 10.1016/j.neuron.2006.06.016; Zhu JW, 2011, EMBO J, V30, P4986, DOI 10.1038/emboj.2011.428; Zhu JW, 2011, MOL CELL, V43, P418, DOI 10.1016/j.molcel.2011.07.011	45	19	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36766	36776		10.1074/jbc.M112.391607	http://dx.doi.org/10.1074/jbc.M112.391607			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22952234	hybrid, Green Published			2022-12-28	WOS:000310588500014
J	Velisetty, P; Chalamalasetti, SV; Chakrapani, S				Velisetty, Phanindra; Chalamalasetti, Sreevatsa V.; Chakrapani, Sudha			Conformational Transitions Underlying Pore Opening and Desensitization in Membrane-embedded Gloeobacter violaceus Ligand-gated Ion Channel (GLIC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; 2ND TRANSMEMBRANE SEGMENT; FRONTAL-LOBE EPILEPSY; CYS-LOOP RECEPTOR; X-RAY-STRUCTURE; SIDE-CHAINS; THERAPEUTIC TARGETS; EMERGING FRONTIERS; PROTEIN-STRUCTURE; CLINICAL SCIENCE	Direct structural insight into the mechanisms underlying activation and desensitization remain unavailable for the pentameric ligand-gated channel family. Here, we report the structural rearrangements underlying gating transitions in membrane-embedded GLIC, a prokaryotic homologue, using site-directed spin labeling and electron paramagnetic resonance (EPR) spectroscopy. We particularly probed the conformation of pore-lining second transmembrane segment (M2) under conditions that favor the closed and the ligand-bound desensitized states. The spin label mobility, intersubunit spin-spin proximity, and the solvent-accessibility parameters in the two states clearly delineate the underlying protein motions within M2. Our results show that during activation the extracellular hydrophobic region undergoes major changes involving an outward translational movement, away from the pore axis, leading to an increase in the pore diameter, whereas the lower end of M2 remains relatively immobile. Most notably, during desensitization, the intervening polar residues in the middle of M2 move closer to form a solvent-occluded barrier and thereby reveal the location of a distinct desensitization gate. In comparison with the crystal structure of GLIC, the structural dynamics of the channel in a membrane environment suggest a more loosely packed conformation with water-accessible intrasubunit vestibules penetrating from the extracellular end all the way to the middle of M2 in the closed state. These regions have been implicated to play a major role in alcohol and drug modulation. Overall, these findings represent a key step toward understanding the fundamentals of gating mechanisms in this class of channels.	[Velisetty, Phanindra; Chalamalasetti, Sreevatsa V.; Chakrapani, Sudha] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University	Chakrapani, S (corresponding author), 10900 Euclid Ave,Robbins Bldg,E620, Cleveland, OH 44106 USA.	sudha.chakrapani@case.edu		chakrapani, sudha/0000-0003-0722-2338				Altenbach C, 2005, BIOPHYS J, V89, P2103, DOI 10.1529/biophysj.105.059063; ALTENBACH C, 1994, P NATL ACAD SCI USA, V91, P1667, DOI 10.1073/pnas.91.5.1667; ALTENBACH C, 1990, SCIENCE, V248, P1088, DOI 10.1126/science.2160734; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; Auerbach A, 1998, J GEN PHYSIOL, V112, P181, DOI 10.1085/jgp.112.2.181; Barrantes FJ, 2002, MOL MEMBR BIOL, V19, P277, DOI 10.1080/09687680210166226; Bertrand S, 1998, BRIT J PHARMACOL, V125, P751, DOI 10.1038/sj.bjp.0702154; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Chakrapani S, 2007, J GEN PHYSIOL, V130, P465, DOI 10.1085/jgp.200709843; Chang YC, 1998, MOL PHARMACOL, V53, P511, DOI 10.1124/mol.53.3.511; Colon-Saez JO, 2011, J PHYSIOL-LONDON, V589, P3163, DOI 10.1113/jphysiol.2011.209494; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; Cortes DM, 2001, J GEN PHYSIOL, V117, P165, DOI 10.1085/jgp.117.2.165; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Cymes GD, 2002, BIOCHEMISTRY-US, V41, P5548, DOI 10.1021/bi011864f; daCosta CJB, 2009, J BIOL CHEM, V284, P17819, DOI 10.1074/jbc.M900030200; DELCOUR AH, 1989, BIOPHYS J, V56, P631, DOI 10.1016/S0006-3495(89)82710-9; Donnelly-Roberts D, 2011, BIOCHEM PHARMACOL, V82, P797, DOI 10.1016/j.bcp.2011.05.002; Duret G, 2011, P NATL ACAD SCI USA, V108, P12143, DOI 10.1073/pnas.1104494108; FARAHBAKHSH ZT, 1992, PHOTOCHEM PHOTOBIOL, V56, P1019, DOI 10.1111/j.1751-1097.1992.tb09725.x; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; Gonzalez-Gutierrez G, 2012, P NATL ACAD SCI USA, V109, P6331, DOI 10.1073/pnas.1119268109; Gonzalez-Gutierrez G, 2010, J MOL BIOL, V403, P693, DOI 10.1016/j.jmb.2010.09.026; Gopalakrishnan M, 2007, BIOCHEM PHARMACOL, V74, P1091, DOI 10.1016/j.bcp.2007.09.007; Goyal R, 2011, J BIOL CHEM, V286, P34635, DOI 10.1074/jbc.M111.269647; Gross A, 2002, BIOCHEMISTRY-US, V41, P1123, DOI 10.1021/bi015828s; Gross A, 1999, BIOCHEMISTRY-US, V38, P10324, DOI 10.1021/bi990856k; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2010, NAT STRUCT MOL BIOL, V17, P1330, DOI 10.1038/nsmb.1933; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Howard RJ, 2011, P NATL ACAD SCI USA, V108, P12149, DOI 10.1073/pnas.1104480108; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; Koteiche HA, 2003, BIOCHEMISTRY-US, V42, P6099, DOI 10.1021/bi0342867; Kuryatov A, 1997, J NEUROSCI, V17, P9035; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Mascia MP, 2000, P NATL ACAD SCI USA, V97, P9305, DOI 10.1073/pnas.160128797; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Milone M, 1997, J NEUROSCI, V17, P5651; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; OCHOA ELM, 1989, CELL MOL NEUROBIOL, V9, P141, DOI 10.1007/BF00713026; Parikh RB, 2011, J BIOL CHEM, V286, P14098, DOI 10.1074/jbc.M111.221895; Perozo E, 1998, NAT STRUCT BIOL, V5, P459, DOI 10.1038/nsb0698-459; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307; Purohit Y, 2006, J GEN PHYSIOL, V127, P703, DOI 10.1085/jgp.200509437; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; SCUKA M, 1992, PROG NEUROBIOL, V38, P19, DOI 10.1016/0301-0082(92)90033-B; SUNSHINE C, 1992, BIOCHIM BIOPHYS ACTA, V1108, P240, DOI 10.1016/0005-2736(92)90031-G; Tasneem A, 2005, GENOME BIOL, V6; Velisetty P, 2012, J BIOL CHEM, V287, P18467, DOI 10.1074/jbc.M112.348045; Wang HL, 2012, J BIOL CHEM, V287, P6482, DOI 10.1074/jbc.M111.305839; Weiland S, 1996, FEBS LETT, V398, P91, DOI 10.1016/S0014-5793(96)01215-X; Weng Y, 2010, ANESTH ANALG, V110, P59, DOI 10.1213/ANE.0b013e3181c4bc69; Williams DB, 1999, BIOPHYS J, V77, P2563, DOI 10.1016/S0006-3495(99)77091-8; Wilson GG, 2001, P NATL ACAD SCI USA, V98, P1241, DOI 10.1073/pnas.031567798; YAKEL JL, 1993, P NATL ACAD SCI USA, V90, P5030, DOI 10.1073/pnas.90.11.5030; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101	63	37	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36864	36872		10.1074/jbc.M112.401067	http://dx.doi.org/10.1074/jbc.M112.401067			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22977232	hybrid, Green Published			2022-12-28	WOS:000310588500023
J	Dunkel, Y; Ong, A; Notani, D; Mittal, Y; Lam, M; Mi, XY; Ghosh, P				Dunkel, Ying; Ong, Andrew; Notani, Dimple; Mittal, Yash; Lam, Michael; Mi, Xiaoyi; Ghosh, Pradipta			STAT3 Protein Up-regulates G alpha-interacting Vesicle-associated Protein (GIV)/Girdin Expression, and GIV Enhances STAT3 Activation in a Positive Feedback Loop during Wound Healing and Tumor Invasion/Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING ACTIVITY; BREAST-CANCER CELLS; SIGNAL TRANSDUCER; TYROSINE PHOSPHORYLATION; GENE-REGULATION; COLON-CANCER; GIRDIN; METASTASIS; ROLES; SCHIZOPHRENIA	G alpha-interacting vesicle-associated protein (GIV) is a guanine nucleotide exchange factor that modulates key signaling pathways during a diverse set of biological processes, e.g. wound healing, macrophage chemotaxis, tumor angiogenesis, vascular repair, and cancer invasion/metastasis. We recently demonstrated that GIV is a metastasis-related protein, which serves both as a therapeutic target and as a biomarker for prognostication in cancer patients. Here we report the discovery that GIV is a direct target of the transcription factor signal transducer and activator of transcription-3 (STAT3), which is commonly known as a central regulator of tumor metastasis. We identified a single STAT3-binding site on the GIV promoter that was necessary and sufficient for transcriptional activation of GIV during wound healing and cancer invasion. Immunohistochemical analysis of breast carcinomas showed significant correlation between STAT3 activation and elevated GIV expression. Furthermore, we provide evidence that GIV positively autoregulates its own transcription by enhancing STAT3 activation via its guanine nucleotide exchange factor activity. Our findings provide mechanistic insights into how STAT3 activation is directly integrated with the receptor tyrosine kinase-GIV-G protein signaling axis. The forward feedback regulation we describe here between GIV and STAT3 may have profound therapeutic implications for cancer and epithelial regeneration/repair and could help invent novel approaches in treating and prognosticating cancer.	[Ghosh, Pradipta] Univ Calif San Diego, Dept Med, George Palade Labs Cellular & Mol Med, La Jolla, CA 92093 USA; [Mi, Xiaoyi] China Med Univ, Dept Pathol, Shenyang 110001, Liaoning, Peoples R China	University of California System; University of California San Diego; China Medical University	Ghosh, P (corresponding author), Univ Calif San Diego, Dept Med, George Palade Labs Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	prghosh@ucsd.edu		Notani, Dimple/0000-0002-9460-8070	National Institutes of Health [5 T32 GM007198, T32 GM008666]; Burroughs Wellcome Fund; Doris Duke Charitable Foundation; American Cancer Society Grant [ACS-IRG 70-002]; United States Department of Defense Postdoctoral Fellowship Award [BC103858]; Sarah Rogers Fellowship (University of California, San Diego); Specialized Research Fund for the Doctoral Program of Higher Education of China Grant [20112104110017]; NATIONAL CANCER INSTITUTE [R01CA160911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666, T32GM007198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); American Cancer Society Grant(American Cancer Society); United States Department of Defense Postdoctoral Fellowship Award; Sarah Rogers Fellowship (University of California, San Diego); Specialized Research Fund for the Doctoral Program of Higher Education of China Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5 T32 GM007198 and T32 GM008666 (to M. L.). This work was also supported by the Burroughs Wellcome Fund, the Doris Duke Charitable Foundation, and American Cancer Society Grant ACS-IRG 70-002 (to P. G.).; Supported by United States Department of Defense Postdoctoral Fellowship Award BC103858.; Supported by the Sarah Rogers Fellowship (University of California, San Diego).; Supported by Specialized Research Fund for the Doctoral Program of Higher Education of China Grant 20112104110017.	Armanious H, 2010, INT J CLIN EXP PATHO, V3, P654; BAND V, 1990, CANCER RES, V50, P7351; Bousquet C, 2000, J CLIN INVEST, V106, P1417, DOI 10.1172/JCI11182; Bradshaw NJ, 2012, NEUROPHARMACOLOGY, V62, P1230, DOI 10.1016/j.neuropharm.2010.12.027; BRESALIER RS, 1987, CANCER RES, V47, P1398; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Cantwell CA, 1998, MOL CELL BIOL, V18, P2108, DOI 10.1128/MCB.18.4.2108; Darnell JE, 2005, NAT MED, V11, P595, DOI 10.1038/nm0605-595; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Devarajan E, 2009, CURR MOL MED, V9, P626, DOI 10.2174/156652409788488720; Diaz N, 2006, CLIN CANCER RES, V12, P20, DOI 10.1158/1078-0432.CCR-04-1749; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Enomoto A, 2009, NEURON, V63, P774, DOI 10.1016/j.neuron.2009.08.015; Feezor RJ, 2004, PHYSIOL GENOMICS, V16, P341, DOI 10.1152/physiolgenomics.00101.2003; Garcia-Marcos M, 2011, MOL BIOL CELL, V22, P673, DOI 10.1091/mbc.E10-08-0738; Garcia-Marcos M, 2012, P NATL ACAD SCI USA, V109, P1961, DOI 10.1073/pnas.1120538109; Garcia-Marcos M, 2011, FASEB J, V25, P590, DOI 10.1096/fj.10-167304; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh P, 2008, J CELL BIOL, V182, P381, DOI 10.1083/jcb.200712066; Ghosh P, 2011, CELL ADHES MIGR, V5, P237, DOI 10.4161/cam.5.3.15909; Ghosh P, 2010, MOL BIOL CELL, V21, P2338, DOI 10.1091/mbc.E10-01-0028; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Gu L, 2010, AM J PATHOL, V176, P1959, DOI 10.2353/ajpath.2010.090653; Jiang P, 2008, CANCER RES, V68, P1310, DOI 10.1158/0008-5472.CAN-07-5111; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Kuraishy A, 2011, IMMUNITY, V35, P467, DOI 10.1016/j.immuni.2011.09.006; Kusaba T, 2006, ONCOL REP, V15, P1445; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Lee H, 2010, NAT MED, V16, P1421, DOI 10.1038/nm.2250; Liddle FJ, 2006, BIOCHEMISTRY-US, V45, P5599, DOI 10.1021/bi0525674; Lin CS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002049; Lin L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-217; Ling Y, 2011, CANCER INVEST, V29, P405, DOI 10.3109/07357907.2011.568568; Liu CG, 2012, MED ONCOL, V29, P1554, DOI 10.1007/s12032-011-0087-6; Ma Xiang-Tao, 2003, Ai Zheng, V22, P1135; Mankan AK, 2011, EXPERT OPIN INV DRUG, V20, P1263, DOI 10.1517/13543784.2011.601739; Masciocchi D, 2011, FUTURE MED CHEM, V3, P567, DOI [10.4155/FMC.11.22, 10.4155/fmc.11.22]; Mittal Y, 2011, J BIOL CHEM, V286, P32404, DOI 10.1074/jbc.M111.275685; Miyake H, 2011, CIRC RES, V108, P1170, DOI 10.1161/CIRCRESAHA.110.236174; Morikawa T, 2011, CLIN CANCER RES, V17, P1452, DOI 10.1158/1078-0432.CCR-10-2694; Natsume A, 2012, ONCOGENE, V31, P2715, DOI 10.1038/onc.2011.466; Niu GL, 2005, MOL CELL BIOL, V25, P7432, DOI 10.1128/MCB.25.17.7432-7440.2005; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; NOONBERG SB, 1994, GENE, V149, P123, DOI 10.1016/0378-1119(94)90420-0; Nuutila K, 2012, WOUND REPAIR REGEN, V20, P830, DOI 10.1111/j.1524-475X.2012.00831.x; Page BDG, 2011, EXPERT OPIN THER PAT, V21, P65, DOI 10.1517/13543776.2011.539205; Park OK, 2000, J BIOL CHEM, V275, P32244, DOI 10.1074/jbc.M005082200; Puseenam A, 2009, EXP CELL RES, V315, P3370, DOI 10.1016/j.yexcr.2009.06.019; Qiao M, 2007, CANCER RES, V67, P5293, DOI 10.1158/0008-5472.CAN-07-0877; Sano S, 2008, J DERMATOL SCI, V50, P1, DOI 10.1016/j.jdermsci.2007.05.016; Sanz-Moreno V, 2011, CANCER CELL, V20, P229, DOI 10.1016/j.ccr.2011.06.018; Schiavone D, 2009, BIOCHEM J, V421, P283, DOI 10.1042/BJ20090061; Senft C, 2011, J NEURO-ONCOL, V101, P393, DOI 10.1007/s11060-010-0273-y; Syed ZA, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-180; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Walker SR, 2009, MOL CANCER RES, V7, P966, DOI 10.1158/1541-7786.MCR-08-0238; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Yamaguchi M, 2010, FRONT BIOSCI-LANDMRK, V15, P1164, DOI 10.2741/3668; Yang J, 2005, CANCER RES, V65, P939; Yang JB, 2008, CELL RES, V18, P443, DOI 10.1038/cr.2008.41; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166	64	37	41	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41667	41683		10.1074/jbc.M112.390781	http://dx.doi.org/10.1074/jbc.M112.390781			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23066027	hybrid, Green Published			2022-12-28	WOS:000312103000010
J	Ji, YR; Kim, HJ; Yu, DH; Bae, KB; Park, SJ; Yi, JK; Kim, N; Park, SJ; Oh, KB; Hwang, SS; Lee, S; Kim, SH; Kim, MO; Lee, JW; Ryoo, ZY				Ji, Young Rae; Kim, Hei Jung; Yu, Dong Hoon; Bae, Ki Beom; Park, Seo Jin; Yi, Jun Koo; Kim, Nari; Park, Si Jun; Oh, Keon Bong; Hwang, Sung Soo; Lee, Sanggyu; Kim, Sung-Hyun; Kim, Myoung Ok; Lee, Jeong Woong; Ryoo, Zae Young			Enforced Expression of Roquin Protein in T Cells Exacerbates the Incidence and Severity of Experimental Arthritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; CD28-DEFICIENT MICE; AUTOIMMUNITY; ICOS; ACTIVATION; RESPONSES; PATHWAYS; IMMUNE; CD28	To investigate the role of Roquin, a RING-type ubiquitin ligase family member, we used transgenic mice with enforced Roquin expression in T cells, with collagen-induced arthritis (CIA). Wild-type (WT) and Roquin transgenic (Tg) mice were immunized with bovine type II collagen (CII). Arthritis severity was evaluated by clinical score; histopathologic CIA severity; proinflammatory and anti-inflammatory cytokine levels; anti-CII antibody levels; and populations of Th1, Th2, germinal center B cells, and follicular helper T cells in CIA. T cell proliferation in vitro and cytokine levels were determined to assess the response to CII. Roquin Tg mice developed more severe CIA and joint destruction compared with WT mice. Production of TNF-alpha, IFN-gamma, IL-6, and pathogenic anti-collagen CII-specific IgG and IgG2a antibodies was increased in Roquin Tg mice. In addition, in vitro T cell assays showed increased proliferation and proinflammatory cytokine production in response to CII as a result of enforced Roquin expression in T cells. Furthermore, the Th1/Th2 balance was altered by an increased Th1 and decreased Th2 population. These findings suggest that overexpression of Roquin exacerbates the development of CIA and that enforced expression of Roquin in T cells may promote autoimmune diseases such as CIA.	[Lee, Jeong Woong] Korea Res Inst Biosci & Biotechnol, Regenerat Med Res Ctr, Taejon 305806, South Korea; [Ji, Young Rae; Kim, Hei Jung; Yu, Dong Hoon; Bae, Ki Beom; Park, Seo Jin; Yi, Jun Koo; Kim, Nari; Park, Si Jun; Lee, Sanggyu; Kim, Sung-Hyun; Ryoo, Zae Young] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Taegu 702701, South Korea; [Oh, Keon Bong; Hwang, Sung Soo] Natl Inst Anim Sci, Anim Biotechnol Div, Rural Dev Adm, Suwon 441706, South Korea; [Kim, Myoung Ok] Kyungpook Natl Univ, Sch Ecol & Environm Sci, Sangju 742211, Gyeongsangbuk D, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Kyungpook National University; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Kyungpook National University	Lee, JW (corresponding author), Korea Res Inst Biosci & Biotechnol, Regenerat Med Res Ctr, Taejon 305806, South Korea.	jwlee@kribb.re.kr; jaewoong64@hanmail.net	Ji, Youngrae/AAK-9724-2021; RYOO, ZAEYOUNG/AAQ-1573-2020; Ji, Youngrae/AAK-9711-2021	Ji, Youngrae/0000-0002-8825-9783; 	Rural Development Administration, Republic of Korea [PJ 008050, PJ007849]; National Research Foundation of Korea [2012-0000640]; Korea government (Ministry of Education, Science and Technology)	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Korea government (Ministry of Education, Science and Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by Next-Generation BioGreen21 Program Grant PJ 008050 from the Rural Development Administration, Republic of Korea and by National Research Foundation of Korea Grant 2012-0000640 funded by the Korea government (Ministry of Education, Science and Technology) and Woo Jang-Choon (PJ007849) projects from the Rural Development Administration, Republic of Korea.	AREND WP, 1995, ARTHRITIS RHEUM, V38, P151, DOI 10.1002/art.1780380202; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Bertossi A, 2011, J EXP MED, V208, P1749, DOI 10.1084/jem.20110578; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; HOLMDAHL R, 1986, ARTHRITIS RHEUM, V29, P106, DOI 10.1002/art.1780290114; HOLMDAHL R, 1990, IMMUNOL REV, V118, P193, DOI 10.1111/j.1600-065X.1990.tb00817.x; HOLMDAHL R, 1990, SCAND J IMMUNOL, V31, P147, DOI 10.1111/j.1365-3083.1990.tb02754.x; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; JUNE CH, 1990, IMMUNOL TODAY, V11, P211, DOI 10.1016/0167-5699(90)90085-N; Kageyama Y, 1998, J IMMUNOL, V161, P1542; Kim HJ, 2012, BIOCHEM BIOPH RES CO, V417, P280, DOI 10.1016/j.bbrc.2011.11.101; Kim YO, 2010, CLIN CHEM LAB MED, V48, P345, DOI 10.1515/CCLM.2010.074; LEDBETTER JA, 1990, BLOOD, V75, P1531; Lin AE, 2007, CURR OPIN IMMUNOL, V19, P665, DOI 10.1016/j.coi.2007.10.002; Mauri C, 1996, EUR J IMMUNOL, V26, P1511, DOI 10.1002/eji.1830260716; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Miossec P, 2004, CURR OPIN RHEUMATOL, V16, P218, DOI 10.1097/00002281-200405000-00009; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nurieva RI, 2005, CLIN IMMUNOL, V115, P19, DOI 10.1016/j.clim.2005.02.010; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Rottman JB, 2001, NAT IMMUNOL, V2, P605, DOI 10.1038/89750; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Sasai M, 1999, ARTHRITIS RHEUM, V42, P1635, DOI 10.1002/1529-0131(199908)42:8<1635::AID-ANR11>3.0.CO;2-Q; SEKI N, 1988, J IMMUNOL, V140, P1477; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; STUART JM, 1983, J EXP MED, V158, P378, DOI 10.1084/jem.158.2.378; Tada Y, 1999, J IMMUNOL, V162, P203; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; TERATO K, 1992, J IMMUNOL, V148, P2103; THOMPSON CB, 1989, P NATL ACAD SCI USA, V86, P1333, DOI 10.1073/pnas.86.4.1333; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; ZVAIFLER NJ, 1994, ARTHRITIS RHEUM, V37, P783, DOI 10.1002/art.1780370601	37	14	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42269	42277		10.1074/jbc.M112.374835	http://dx.doi.org/10.1074/jbc.M112.374835			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23066015	Green Published, hybrid			2022-12-28	WOS:000312103000062
J	Eichmann, TO; Kumari, M; Haas, JT; Farese, RV; Zimmermann, R; Lass, A; Zechner, R				Eichmann, Thomas O.; Kumari, Manju; Haas, Joel T.; Farese, Robert V., Jr.; Zimmermann, Robert; Lass, Achim; Zechner, Rudolf			Studies on the Substrate and Stereo/Regioselectivity of Adipose Triglyceride Lipase, Hormone-sensitive Lipase, and Diacylglycerol-O-acyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; NEUROPATHY TARGET ESTERASE; CHANARIN-DORFMAN-SYNDROME; PROTEIN KINASE-C; DEFICIENT MICE; STEREOSELECTIVE HYDROLYSIS; ENDOPLASMIC-RETICULUM; LIPOPROTEIN-LIPASE; LINGUAL LIPASE; PURIFICATION	Adipose triglyceride lipase (ATGL) is rate-limiting for the initial step of triacylglycerol (TAG) hydrolysis, generating diacylglycerol (DAG) and fatty acids. DAG exists in three stereochemical isoforms. Here we show that ATGL exhibits a strong preference for the hydrolysis of long-chain fatty acid esters at the sn-2 position of the glycerol backbone. The selectivity of ATGL broadens to the sn-1 position upon stimulation of the enzyme by its co-activator CGI-58. sn-1,3 DAG is the preferred substrate for the consecutive hydrolysis by hormone-sensitive lipase. Interestingly, diacylglycerol-O-acyltransferase 2, present at the endoplasmic reticulum and on lipid droplets, preferentially esterifies sn-1,3 DAG. This suggests that ATGL and diacylglycerol-O-acyltransferase 2 act coordinately in the hydrolysis/re-esterification cycle of TAGs on lipid droplets. Because ATGL preferentially generates sn-1,3 and sn-2,3, it suggests that TAG-derived DAG cannot directly enter phospholipid synthesis or activate protein kinase C without prior isomerization.	[Eichmann, Thomas O.; Kumari, Manju; Zimmermann, Robert; Lass, Achim; Zechner, Rudolf] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Haas, Joel T.; Farese, Robert V., Jr.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94141 USA; [Haas, Joel T.; Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94141 USA; [Haas, Joel T.; Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94141 USA	University of Graz; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lass, A (corresponding author), Graz Univ, Inst Mol Biosci, Heinrichstr 31, A-8010 Graz, Austria.	achim.lass@uni-graz.at; rudolf.zechner@uni-graz.at	Lass, Achim/C-3332-2008; Haas, Joel/R-6379-2018	Lass, Achim/0000-0002-8190-7151; Haas, Joel/0000-0002-0028-5988; Eichmann, Thomas O./0000-0002-8521-2795; Zimmermann, Robert/0000-0002-7354-870X; Zechner, Rudolf/0000-0001-5483-1182	grant "GOLD: Genomics Of Lipid-associated Disorders," which is part of the Austrian Genome Project " GEN-AU: Genome Research in Austria"; Austrian Ministry of Science and Research; Austrian Research Promotion Agency; Doktoratskolleg [W901-B05DK]; Wittgenstein Award [Z136]; Austrian Science Fund; City of Graz; Province of Styria;  [P21296];  [F30 SFB LIPOTOX]; Austrian Science Fund (FWF) [F 3002, W 901, Z 136] Funding Source: researchfish	grant "GOLD: Genomics Of Lipid-associated Disorders," which is part of the Austrian Genome Project " GEN-AU: Genome Research in Austria"; Austrian Ministry of Science and Research; Austrian Research Promotion Agency; Doktoratskolleg; Wittgenstein Award(Austrian Science Fund (FWF)); Austrian Science Fund(Austrian Science Fund (FWF)); City of Graz; Province of Styria; ; ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the grant "GOLD: Genomics Of Lipid-associated Disorders," which is part of the Austrian Genome Project " GEN-AU: Genome Research in Austria" funded by the Austrian Ministry of Science and Research and the Austrian Research Promotion Agency. This work was also supported by the Grants P21296, F30 SFB LIPOTOX, the Doktoratskolleg W901-B05DK (Molecular Enzymology), and the Wittgenstein Award Z136, which are funded by the Austrian Science Fund. Additional funding was obtained from the City of Graz and the Province of Styria.	Ahn K, 2008, CHEM REV, V108, P1687, DOI 10.1021/cr0782067; BONI LT, 1985, J BIOL CHEM, V260, P819; Carriere F, 1997, BIOORGAN MED CHEM, V5, P429, DOI 10.1016/S0968-0896(96)00251-9; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Farese RV, 2012, CELL METAB, V15, P570, DOI 10.1016/j.cmet.2012.03.004; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; FOLCH J, 1957, J BIOL CHEM, V226, P497; FREDRIKSON G, 1981, J BIOL CHEM, V256, P6311; Gibellini F, 2010, IUBMB LIFE, V62, P414, DOI 10.1002/iub.337; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Harada K, 2003, AM J PHYSIOL-ENDOC M, V285, pE1182, DOI 10.1152/ajpendo.00259.2003; ITABASHI Y, 1990, J LIPID RES, V31, P1711; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; JENSEN RG, 1982, LIPIDS, V17, P570, DOI 10.1007/BF02535386; Kienesberger PC, 2008, J BIOL CHEM, V283, P5908, DOI 10.1074/jbc.M709598200; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; MORLEY N, 1972, J BIOL CHEM, V247, P6389; Mulder H, 2003, J BIOL CHEM, V278, P36380, DOI 10.1074/jbc.M213032200; NOMURA H, 1986, BIOCHEM BIOPH RES CO, V140, P1143, DOI 10.1016/0006-291X(86)90754-0; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; PALTAUF F, 1974, FEBS LETT, V40, P119, DOI 10.1016/0014-5793(74)80907-5; Park SY, 2005, AM J PHYSIOL-ENDOC M, V289, pE30, DOI 10.1152/ajpendo.00251.2004; RANDO RR, 1984, BIOCHEM BIOPH RES CO, V122, P818, DOI 10.1016/S0006-291X(84)80107-2; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; Rodriguez JA, 2010, BBA-MOL CELL BIOL L, V1801, P77, DOI 10.1016/j.bbalip.2009.09.020; Roduit R, 2001, DIABETES, V50, P1970, DOI 10.2337/diabetes.50.9.1970; ROGALSKA E, 1993, CHIRALITY, V5, P24, DOI 10.1002/chir.530050106; ROGALSKA E, 1993, J BIOL CHEM, V268, P792; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; SATTLER W, 1991, ANAL BIOCHEM, V198, P184, DOI 10.1016/0003-2697(91)90526-Y; Schweiger M, 2008, J BIOL CHEM, V283, P17211, DOI 10.1074/jbc.M710566200; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Suzuki M, 2011, J ELECTRON MICROSC, V60, pS101, DOI 10.1093/jmicro/dfr016; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; Taschler U, 2011, J BIOL CHEM, V286, P17467, DOI 10.1074/jbc.M110.215434; TORNQVIST H, 1976, J BIOL CHEM, V251, P813; Turban S, 2011, FEBS LETT, V585, P269, DOI 10.1016/j.febslet.2010.12.022; van Tienhoven M, 2002, J BIOL CHEM, V277, P20942, DOI 10.1074/jbc.M200330200; Voshol PJ, 2003, ENDOCRINOLOGY, V144, P3456, DOI 10.1210/en.2002-0036; WANG CS, 1983, J BIOL CHEM, V258, P9197; Yan W, 2005, J BIOL CHEM, V280, P26669, DOI 10.1074/jbc.M502358200; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	50	136	138	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41446	41457		10.1074/jbc.M112.400416	http://dx.doi.org/10.1074/jbc.M112.400416			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23066022	Green Published, hybrid			2022-12-28	WOS:000311887600056
J	Sun, Y; Vashisht, AA; Tchieu, J; Wohlschlegel, JA; Dreier, L				Sun, Yu; Vashisht, Ajay A.; Tchieu, Jason; Wohlschlegel, James A.; Dreier, Lars			Voltage-dependent Anion Channels (VDACs) Recruit Parkin to Defective Mitochondria to Promote Mitochondrial Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PINK1; DEGRADATION; MITOPHAGY; PHOSPHORYLATION; COMPLEX; IMPORT	Mutations in the ubiquitin ligase Parkin and the serine/threonine kinase PINK1 can cause Parkinson disease. Both proteins function in the elimination of defective mitochondria by autophagy. In this process, activation of PINK1 mediates translocation of Parkin from the cytosol to mitochondria by an unknown mechanism. To better understand how Parkin is targeted to defective mitochondria, we purified affinity-tagged Parkin from mitochondria and identified Parkin-associated proteins by mass spectrometry. The three most abundant interacting proteins were the voltage-dependent anion channels 1, 2, and 3 (VDACs 1, 2, and 3), pore-forming proteins in the outer mitochondrial membrane. We demonstrate that Parkin specifically interacts with VDACs when the function of mitochondria is disrupted by treating cells with the proton uncoupler carbonyl cyanide p-chlorophenylhydrazone. In the absence of all three VDACs, the recruitment of Parkin to defective mitochondria and subsequent mitophagy are impaired. Each VDAC is sufficient to support Parkin recruitment and mitophagy, suggesting that VDACs can function redundantly. We hypothesize that VDACs serve as mitochondrial docking sites to recruit Parkin from the cytosol to defective mitochondria.	[Sun, Yu; Dreier, Lars] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Vashisht, Ajay A.; Tchieu, Jason; Wohlschlegel, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dreier, L (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, 695 Charles E Young Dr S, Los Angeles, CA 90095 USA.	larsdreier@ucla.edu	Tchieu, Jason/AAG-1551-2020	Tchieu, Jason/0000-0002-9793-9836	National Institutes of Health [R01GM089778]; Jonsson Comprehensive Cancer Center at UCLA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jonsson Comprehensive Cancer Center at UCLA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01GM089778. This work was also supported by funds from the Jonsson Comprehensive Cancer Center at UCLA (to J. A. W.).	Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Glauser L, 2011, J NEUROCHEM, V118, P636, DOI 10.1111/j.1471-4159.2011.07318.x; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Itakura E, 2012, J CELL SCI, V125, P1488, DOI 10.1242/jcs.094110; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002537; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Rakovic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016746; Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003; Sha D, 2010, HUM MOL GENET, V19, P352, DOI 10.1093/hmg/ddp501; Shoshan-Barmatz V, 2012, MITOCHONDRION, V12, P24, DOI 10.1016/j.mito.2011.04.001; Springer W, 2011, AUTOPHAGY, V7, P266, DOI 10.4161/auto.7.3.14348; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Vives-Bauza C, 2011, TRENDS MOL MED, V17, P158, DOI 10.1016/j.molmed.2010.11.002; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	33	152	154	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40652	40660		10.1074/jbc.M112.419721	http://dx.doi.org/10.1074/jbc.M112.419721			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23060438	hybrid, Green Published			2022-12-28	WOS:000311448800054
J	Luck, M; Mathes, T; Bruun, S; Fudim, R; Hagedorn, R; Tra, MTN; Kateriya, S; Kennis, JTM; Hildebrandt, P; Hegemann, P				Luck, Meike; Mathes, Tilo; Bruun, Sara; Fudim, Roman; Hagedorn, Rolf; Tra My Tran Nguyen; Kateriya, Suneel; Kennis, John T. M.; Hildebrandt, Peter; Hegemann, Peter			A Photochromic Histidine Kinase Rhodopsin (HKR1) That Is Bimodally Switched by Ultraviolet and Blue Light	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE RAMAN-SPECTROSCOPY; SENSORY RHODOPSIN; CHLAMYDOMONAS-REINHARDTII; VISUAL PIGMENTS; SCHIFF-BASE; CHROMOPHORE STRUCTURE; ELECTRON-TRANSFER; CRYSTAL-STRUCTURE; ADENYLYL-CYCLASE; CHANNELRHODOPSIN-2	Rhodopsins are light-activated chromoproteins that mediate signaling processes via transducer proteins or promote active or passive ion transport as ion pumps or directly light-activated channels. Here, we provide spectroscopic characterization of a rhodopsin from the Chlamydomonas eyespot. It belongs to a recently discovered but so far uncharacterized family of histidine kinase rhodopsins (HKRs). These are modular proteins consisting of rhodopsin, a histidine kinase, a response regulator, and in some cases an effector domain such as an adenylyl or guanylyl cyclase, all encoded in a single protein as a two-component system. The recombinant rhodopsin fragment, Rh, of HKR1 is a UVA receptor (lambda(max) = 380 nm) that is photoconverted by UV light into a stable blue light-absorbing meta state Rh-Bl (lambda(max) = 490 nm). Rh-Bl is converted back to Rh-UV by blue light. Raman spectroscopy revealed that the Rh-UV chromophore is in an unusual 13-cis, 15-anti configuration, which explains why the chromophore is deprotonated. The excited state lifetime of Rh-UV is exceptionally stable, probably caused by a relatively unpolar retinal binding pocket, converting into the photoproduct within about 100 ps, whereas the blue form reacts 100 times faster. We propose that the photochromic HKR1 plays a role in the adaptation of behavioral responses in the presence of UVA light.	[Luck, Meike; Mathes, Tilo; Bruun, Sara; Fudim, Roman; Hagedorn, Rolf; Tra My Tran Nguyen; Hegemann, Peter] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Mathes, Tilo; Kennis, John T. M.] Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, Biophys Grp, NL-1081 HV Amsterdam, Netherlands; [Bruun, Sara; Hildebrandt, Peter] Tech Univ Berlin, Inst Chem, D-10623 Berlin, Germany; [Kateriya, Suneel] Univ Delhi, Dept Biochem, New Delhi 110021, India	Humboldt University of Berlin; Vrije Universiteit Amsterdam; Technical University of Berlin; University of Delhi	Hegemann, P (corresponding author), Humboldt Univ, Inst Biol, D-10115 Berlin, Germany.	hegemann@rz.hu-berlin.de	Hildebrandt, Peter/J-5658-2014; Mathes, Tilo/C-5715-2011	Hildebrandt, Peter/0000-0003-1030-5900; Mathes, Tilo/0000-0002-9694-748X; Kateriya, Suneel/0000-0001-5428-4297	Deutsche Forschungsgemeinschaft [FOR1261, HE3824/19-1]; Cluster of Excellence Grant UniCat/BIG-NSE; LaserLab Europe access program [LCVU001753]; Chemical Sciences Council of The Netherlands Organization for Scientific Research through ECHO grant; NWO-DFG Bilateral program; Chemical Sciences Council of The Netherlands Organization for Scientific Research VICI grant	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence Grant UniCat/BIG-NSE; LaserLab Europe access program; Chemical Sciences Council of The Netherlands Organization for Scientific Research through ECHO grant; NWO-DFG Bilateral program; Chemical Sciences Council of The Netherlands Organization for Scientific Research VICI grant	This work was supported by Deutsche Forschungsgemeinschaft Grants FOR1261 (to P. Hegemann), HE3824/19-1 (to S. B. and P. Hildebrandt), and Cluster of Excellence Grant UniCat/BIG-NSE.; Supported by the LaserLab Europe access program LCVU001753.; Supported by the Chemical Sciences Council of The Netherlands Organization for Scientific Research through an ECHO grant (to J. T. M. K.). Supported by NWO-DFG Bilateral program.; Supported by a Chemical Sciences Council of The Netherlands Organization for Scientific Research VICI grant. Supported by NWO-DFG Bilateral program.	Bachilo SM, 1999, J PHYS CHEM A, V103, P2481, DOI 10.1021/jp983646a; Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Berera R, 2009, PHOTOSYNTH RES, V101, P105, DOI 10.1007/s11120-009-9454-y; Berthold P, 2008, PLANT CELL, V20, P1665, DOI 10.1105/tpc.108.057919; Bruun S, 2011, FEBS LETT, V585, P3998, DOI 10.1016/j.febslet.2011.11.007; Christie JM, 2012, SCIENCE, V335, P1492, DOI 10.1126/science.1218091; Curry B., 1985, ADV INFRARED RAMAN S, V12, P115; FODOR SPA, 1988, BIOCHEMISTRY-US, V27, P7097, DOI 10.1021/bi00418a064; Furutani Y, 2005, BIOCHEMISTRY-US, V44, P7988, DOI 10.1021/bi050219w; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Gerscher S, 1997, BIOCHEMISTRY-US, V36, P11012, DOI 10.1021/bi970722b; Imai H, 1999, PHOTOCHEM PHOTOBIOL, V70, P111, DOI 10.1111/j.1751-1097.1999.tb01956.x; Kateriya S, 2004, NEWS PHYSIOL SCI, V19, P133, DOI 10.1152/nips.01517.2004; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; KLEINSCHMIDT J, 1992, P NATL ACAD SCI USA, V89, P9181, DOI 10.1073/pnas.89.19.9181; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Kusnetzow AK, 2004, P NATL ACAD SCI USA, V101, P941, DOI 10.1073/pnas.0305206101; LANDERS GM, 1988, J CHROMATOGR, V438, P383, DOI 10.1016/S0021-9673(00)90269-3; Luecke H, 2001, SCIENCE, V293, P1499, DOI 10.1126/science.1062977; Luo DG, 2011, SCIENCE, V332, P1307, DOI 10.1126/science.1200172; Lutz I, 2001, P NATL ACAD SCI USA, V98, P962, DOI 10.1073/pnas.021560298; Ly HK, 2011, J ELECTROANAL CHEM, V660, P367, DOI 10.1016/j.jelechem.2010.12.020; Mathes T, 2012, J PHYS CHEM LETT, V3, P203, DOI 10.1021/jz201579y; Naumann H, 2006, J RAMAN SPECTROSC, V37, P436, DOI 10.1002/jrs.1459; Ozawa S, 2009, PLANT CELL, V21, P2424, DOI 10.1105/tpc.108.063313; POLLAND HJ, 1986, BIOPHYS J, V49, P651, DOI 10.1016/S0006-3495(86)83692-X; Ritter E, 2004, J BIOL CHEM, V279, P48102, DOI 10.1074/jbc.M406857200; SAITO T, 1993, J CELL BIOL, V122, P137, DOI 10.1083/jcb.122.1.137; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Snellenburg JJ, 2012, J STAT SOFTW, V49, P1, DOI 10.18637/jss.v049.i03; SPUDICH JL, 1984, NATURE, V312, P509, DOI 10.1038/312509a0; Stehfest K, 2010, J MOL BIOL, V398, P690, DOI 10.1016/j.jmb.2010.03.031; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Tarttelin EE, 2003, FEBS LETT, V554, P410, DOI 10.1016/S0014-5793(03)01212-2; Troein C, 2011, PLANT J, V66, P375, DOI 10.1111/j.1365-313X.2011.04489.x; Verhoefen MK, 2010, CHEMPHYSCHEM, V11, P3113, DOI 10.1002/cphc.201000181; Vogeley L, 2004, SCIENCE, V306, P1390, DOI 10.1126/science.1103943; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004	39	88	88	1	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.401604	http://dx.doi.org/10.1074/jbc.M112.401604			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23027869	Green Published, hybrid			2022-12-28	WOS:000311233800075
J	Pena, A; Matilla, I; Martin-Benito, J; Valpuesta, JM; Carrascosa, JL; de la Cruz, F; Cabezon, E; Arechaga, I				Pena, Alejandro; Matilla, Inmaculada; Martin-Benito, Jaime; Valpuesta, Jose M.; Carrascosa, Jose L.; de la Cruz, Fernando; Cabezon, Elena; Arechaga, Ignacio			The Hexameric Structure of a Conjugative VirB4 Protein ATPase Provides New Insights for a Functional and Phylogenetic Relationship with DNA Translocases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IV SECRETION SYSTEM; BACTERIAL CONJUGATION; ELECTRON-MICROSCOPY; AGROBACTERIUM-TUMEFACIENS; CHROMOSOME SEGREGATION; COMPARATIVE GENOMICS; PLASMID R388; CORE COMPLEX; BINDING; TRWB	VirB4 proteins are ATPases essential for pilus biogenesis and protein transport in type IV secretion systems. These proteins contain a motor domain that shares structural similarities with the motor domains of DNA translocases, such as the VirD4/TrwB conjugative coupling proteins and the chromosome segregation pump FtsK. Here, we report the three-dimensional structure of full-length TrwK, the VirB4 homologue in the conjugative plasmid R388, determined by single-particle electron microscopy. The structure consists of a hexameric double ring with a barrel-shaped structure. The C-terminal half of VirB4 proteins shares a striking structural similarity with the DNA translocase TrwB. Docking the atomic coordinates of the crystal structures of TrwB and FtsK into the EM map revealed a better fit for FtsK. Interestingly, we have found that like TrwB, TrwK is able to bind DNA with a higher affinity for G4 quadruplex structures than for single-stranded DNA. Furthermore, TrwK exerts a dominant negative effect on the ATPase activity of TrwB, which reflects an interaction between the two proteins. Our studies provide new insights into the structure-function relationship and the evolution of these DNA and protein translocases.	[Pena, Alejandro; Matilla, Inmaculada; de la Cruz, Fernando; Cabezon, Elena; Arechaga, Ignacio] Univ Cantabria, Dept Biol Mol, E-39005 Santander, Spain; [Pena, Alejandro; Matilla, Inmaculada; de la Cruz, Fernando; Cabezon, Elena; Arechaga, Ignacio] UC CSIC SODERCAN, Inst Biomed & Biotecnol Cantabria IBBTEC, Santander, Spain; [Martin-Benito, Jaime; Valpuesta, Jose M.; Carrascosa, Jose L.] Ctr Nacl Biotecnol CNB CSIC, Madrid 28049, Spain	Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Cabezon, E (corresponding author), Univ Cantabria, Dept Biol Mol, Fac Med, Santander 39011, Spain.	cabezone@unican.es; arechagai@unican.es	de la Cruz, Fernando/L-2812-2014; Valpuesta, Jose M/AAA-6002-2019; Arechaga, Ignacio/K-2198-2014; Cabezon, Elena/K-5874-2014; Valpuesta, José M/T-1977-2017	de la Cruz, Fernando/0000-0003-4758-6857; Arechaga, Ignacio/0000-0002-1342-9370; Valpuesta, José M/0000-0001-7468-8053; Martin-Benito Romero, Jaime/0000-0002-8541-4709; Cabezon, Elena/0000-0002-6177-5016; Pena, Alejandro/0000-0001-5674-7064	Ministerio de Economia y Competitividad (MINECO, Spain) [BFU2011-22874, BFU2011-29038, BFU2010-15703, BFU2008-00995/BMC]; European VII Framework Program [FP72009-248919]; MINECO	Ministerio de Economia y Competitividad (MINECO, Spain)(Spanish Government); European VII Framework Program; MINECO(Spanish Government)	This work was supported by Ministerio de Economia y Competitividad (MINECO, Spain) Grants BFU2011-22874 (to E. C. and I. A), BFU2011-29038 (to J. L. C.), BFU2010-15703 (to J. M. V.), BFU2008-00995/BMC, and FP72009-248919 from the European VII Framework Program (to F. C.). This work was also supported by a predoctoral fellowship from the MINECO (to A. P.).	Arechaga I, 2008, J BACTERIOL, V190, P5472, DOI 10.1128/JB.00321-08; Batchelor RA, 2004, MICROBIOL-SGM, V150, P3507, DOI 10.1099/mic.0.27112-0; BERGER BR, 1993, J BACTERIOL, V175, P1723, DOI 10.1128/JB.175.6.1723-1734.1993; Cabezon E, 2006, RES MICROBIOL, V157, P299, DOI 10.1016/j.resmic.2005.12.002; Cabezon E, 2012, CURR OPIN BIOTECH, V23, P537, DOI 10.1016/j.copbio.2011.11.031; Christie PJ, 2004, BBA-MOL CELL RES, V1694, P219, DOI 10.1016/j.bbamcr.2004.02.013; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; CROWTHER RA, 1971, J MOL BIOL, V60, P123, DOI 10.1016/0022-2836(71)90452-9; Dang TA, 1999, MOL MICROBIOL, V32, P1239, DOI 10.1046/j.1365-2958.1999.01436.x; Dang TAT, 1997, J BACTERIOL, V179, P453, DOI 10.1128/jb.179.2.453-462.1997; Durand E, 2010, J BACTERIOL, V192, P2315, DOI 10.1128/JB.01384-09; Fernandez-Lopez R, 2006, FEMS MICROBIOL REV, V30, P942, DOI 10.1111/j.1574-6976.2006.00042.x; Fronzes R, 2009, SCIENCE, V323, P266, DOI 10.1126/science.1166101; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hishida T, 2004, P NATL ACAD SCI USA, V101, P9573, DOI 10.1073/pnas.0403584101; Iyer LM, 2004, NUCLEIC ACIDS RES, V32, P5260, DOI 10.1093/nar/gkh828; Kerr JE, 2010, J BACTERIOL, V192, P4923, DOI 10.1128/JB.00557-10; KREUZER KN, 1983, METHOD ENZYMOL, V100, P144; Li F, 2012, J BACTERIOL, V194, P4041, DOI 10.1128/JB.00648-12; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; Matilla I, 2010, J BIOL CHEM, V285, P17537, DOI 10.1074/jbc.M109.084137; Middleton R, 2005, P NATL ACAD SCI USA, V102, P1685, DOI 10.1073/pnas.0409399102; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pascual-Montano A, 2001, J STRUCT BIOL, V133, P233, DOI 10.1006/jsbi.2001.4369; Pena A, 2011, J BIOL CHEM, V286, P17376, DOI 10.1074/jbc.M110.208942; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rabel C, 2003, J BACTERIOL, V185, P1045, DOI 10.1128/JB.185.3.1045-1058.2003; Ripoll-Rozada J., 2012, REGULATION TYPE 4, P17408; Rivas S, 1997, J BIOL CHEM, V272, P25583, DOI 10.1074/jbc.272.41.25583; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Tato I, 2005, P NATL ACAD SCI USA, V102, P8156, DOI 10.1073/pnas.0503402102; Vogelmann J, 2011, EMBO J, V30, P2246, DOI 10.1038/emboj.2011.121; Wallden K, 2012, P NATL ACAD SCI USA, V109, P11348, DOI 10.1073/pnas.1201428109; Waters V L, 1999, Front Biosci, V4, pD433, DOI 10.2741/Waters; WILLIAMSON JR, 1994, ANNU REV BIOPH BIOM, V23, P703, DOI 10.1146/annurev.bb.23.060194.003415; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080	42	48	49	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.413849	http://dx.doi.org/10.1074/jbc.M112.413849			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23035111	Green Published, hybrid			2022-12-28	WOS:000311233800060
J	Devaiah, BN; Singer, DS				Devaiah, Ballachanda N.; Singer, Dinah S.			Cross-talk Among RNA Polymerase II Kinases Modulates C-terminal Domain Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROMODOMAIN PROTEIN BRD4; ELONGATION-FACTOR-B; P-TEFB; CTD KINASE; TRANSCRIPTION; CHROMATIN; TAF7; COMPONENT; RELEASE; TFIIH	The RNA polymerase II (Pol II) C-terminal domain (CTD) serves as a docking site for numerous proteins, bridging various nuclear processes to transcription. The recruitment of these proteins is mediated by CTD phospho-epitopes generated during transcription. The mechanisms regulating the kinases that establish these phosphorylation patterns on the CTD are not known. We report that three CTD kinases, CDK7, CDK9, and BRD4, engage in cross-talk, modulating their subsequent CTD phosphorylation. BRD4 phosphorylates PTEFb/CDK9 at either Thr-29 or Thr-186, depending on its relative abundance, which represses or activates CDK9 CTD kinase activity, respectively. Conversely, CDK9 phosphorylates BRD4 enhancing its CTD kinase activity. The CTD Ser-5 kinase CDK7 also interacts with and phosphorylates BRD4, potently inhibiting BRD4 kinase activity. Additionally, the three kinases regulate each other indirectly through the general transcription factor TAF7. An inhibitor of CDK9 and CDK7 CTD kinase activities, TAF7 also binds to BRD4 and inhibits its kinase activity. Each of these kinases phosphorylates TAF7, affecting its subsequent ability to inhibit the other two. Thus, a complex regulatory network governs Pol II CTD kinases.	[Devaiah, Ballachanda N.; Singer, Dinah S.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Singer, DS (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	dinah.singer@nih.gov			NCI, Center for Cancer Research, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC011381] Funding Source: NIH RePORTER	NCI, Center for Cancer Research, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, by the Intramural Research Program of the NCI, Center for Cancer Research, National Institutes of Health.	Ai NP, 2011, NUCLEIC ACIDS RES, V39, P9592, DOI 10.1093/nar/gkr698; Bartkowiak B, 2011, GENET RES INT, V2011, DOI 10.4061/2011/623718; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Bataille AR, 2012, MOL CELL, V45, P158, DOI 10.1016/j.molcel.2011.11.024; Bisgrovet DA, 2007, P NATL ACAD SCI USA, V104, P13690, DOI 10.1073/pnas.0705053104; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Cho S, 2010, CELL CYCLE, V9, P1697, DOI 10.4161/cc.9.9.11346; Czudnochowski N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1846; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Devaiah BN, 2012, P NATL ACAD SCI USA, V109, P6927, DOI 10.1073/pnas.1120422109; Devaiah BN, 2010, J BIOL CHEM, V285, P38772, DOI 10.1074/jbc.M110.173864; Egloff S, 2012, TRENDS GENET, V28, P333, DOI 10.1016/j.tig.2012.03.007; Fisher RP, 2005, J CELL SCI, V118, P5171, DOI 10.1242/jcs.02718; Fujinaga K, 1998, J VIROL, V72, P7154, DOI 10.1128/JVI.72.9.7154-7159.1998; Gegonne A, 2006, P NATL ACAD SCI USA, V103, P602, DOI 10.1073/pnas.0510031103; Gegonne A, 2008, P NATL ACAD SCI USA, V105, P5367, DOI 10.1073/pnas.0801637105; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Phatnani HP, 2004, BIOCHEMISTRY-US, V43, P15702, DOI 10.1021/bi048364h; Prelich G, 2002, EUKARYOT CELL, V1, P153, DOI 10.1128/EC.1.2.153-162.2002; SERIZAWA H, 1995, NATURE, V374, P280, DOI 10.1038/374280a0; Wang RR, 2012, J BIOL CHEM, V287, P10738, DOI 10.1074/jbc.M111.323493; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Zhang DW, 2012, GENET RES INT, V2012, DOI 10.1155/2012/347214; Zhou MS, 2009, J VIROL, V83, P1036, DOI 10.1128/JVI.01316-08; Zhou MS, 2001, J BIOL CHEM, V276, P44633, DOI 10.1074/jbc.M107466200	27	43	43	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38755	38766		10.1074/jbc.M112.412015	http://dx.doi.org/10.1074/jbc.M112.412015			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23027873	Green Published, hybrid			2022-12-28	WOS:000310982800033
J	Haque, I; De, A; Majumder, M; Mehta, S; McGregor, D; Banerjee, SK; Van Veldhuizen, P; Banerjee, S				Haque, Inamul; De, Archana; Majumder, Monami; Mehta, Smita; McGregor, Douglas; Banerjee, Sushanta K.; Van Veldhuizen, Peter; Banerjee, Snigdha			The Matricellular Protein CCN1/Cyr61 Is a Critical Regulator of Sonic Hedgehog in Pancreatic Carcinogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL-TRANSITION; SMOOTH-MUSCLE-CELLS; CANCER CELLS; SIDE POPULATION; BREAST-CANCER; GROWTH-FACTOR; CCN PROTEINS; E-CADHERIN; PATHWAY; CYR61	CCN1 is a matricellular protein and a member of the CCN family of growth factors. CCN1 is associated with the development of various cancers including pancreatic ductal adenocarcinoma (PDAC). Our recent studies found that CCN1 plays a critical role in pancreatic carcinogenesis through the induction of EMT and stemness. CCN1 mRNA and protein were detected in the early precursor lesions, and their expression intensified with disease progression. However, biochemical activity and the molecular targets of CCN1 in pancreatic cancer cells are unknown. Here we show that CCN1 regulates the Sonic Hedgehog (SHh) signaling pathway, which is associated with the PDAC progression and poor prognosis. SHh regulation by CCN1 in pancreatic cancer cells is mediated through the active Notch-1. Notably, active Notch-1is recruited by CCN1 in these cells via the inhibition of proteasomal degradation results in stabilization of the receptor. We find that CCN1-induced activation of SHh signaling might be necessary for CCN1-dependent in vitro pancreatic cancer cell migration and tumorigenicity of the side population of pancreatic cancer cells (cancer stem cells) in a xenograft in nude mice. Moreover, the functional role of CCN1 could be mediated through the interaction with the alpha v beta 3 integrin receptor. These extensive studies propose that targeting CCN1 can provide a new treatment option for patients with pancreatic cancer since blocking CCN1 simultaneously blocks two critical pathways (i.e. SHh and Notch1) associated with the development of the disease as well as drug resistance.	[Haque, Inamul; De, Archana; Majumder, Monami; Mehta, Smita; McGregor, Douglas; Banerjee, Sushanta K.; Van Veldhuizen, Peter; Banerjee, Snigdha] Kansas City Vet Affairs Med Ctr, Canc Res Unit, Kansas City, MO 64128 USA; [Haque, Inamul; Majumder, Monami; Banerjee, Sushanta K.; Van Veldhuizen, Peter; Banerjee, Snigdha] Univ Kansas, Med Ctr, Div Hematol & Oncol, Kansas City, KS 66206 USA; [Banerjee, Sushanta K.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66206 USA; [McGregor, Douglas; Banerjee, Sushanta K.] Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS 66206 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Banerjee, S (corresponding author), VA Med Ctr, Canc Res Unit, Div Res, 4801 Linwood Blvd, Kansas City, MO 64128 USA.	sbanerjee@kumc.edu	Haque, Inamul/I-2482-2019	Haque, Inamul/0000-0002-1307-9446	Dept. of Veterans Affairs	Dept. of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a Merit review grant from the Dept. of Veterans Affairs (to S. B. and S. K. B.).	Bailey JM, 2009, ONCOGENE, V28, P3513, DOI 10.1038/onc.2009.220; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Banerjee S, 2006, MOL CARCINOGEN, V45, P871, DOI 10.1002/mc.20248; Banerjee SK, 2012, J CELL COMMUN SIGNAL, V6, P63, DOI 10.1007/s12079-012-0158-2; Beachy PA, 2004, NATURE, V431, P402, DOI 10.1038/431402a; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Dhar G, 2007, CANCER LETT, V254, P63, DOI 10.1016/j.canlet.2007.02.012; Dimou A, 2011, J PANCREAS, V12, P1; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Feldmann G, 2009, EXPERT OPIN DRUG DIS, V4, P429, DOI 10.1517/17460440902821657; Gupta Sachin, 2010, Ther Adv Med Oncol, V2, P237, DOI 10.1177/1758834010366430; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Haque I, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-8; Harris LG, 2012, ONCOGENE, V31, P3370, DOI 10.1038/onc.2011.496; Harris LG, 2011, MOL CANCER RES, V9, P1165, DOI 10.1158/1541-7786.MCR-11-0175; Hidalgo M, 2009, NEW ENGL J MED, V361, P2094, DOI 10.1056/NEJMcibr0905857; Hruban RH, 2000, CLIN CANCER RES, V6, P2969; Hruban RH, 2001, CANCER J, V7, P251; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Kabashima A, 2009, INT J CANCER, V124, P2771, DOI 10.1002/ijc.24349; Kambhampati S, 2010, MOL CANCER THER, V9, P523, DOI 10.1158/1535-7163.MCT-09-0845; Kern SE, 2011, J PATHOL, V223, P295, DOI 10.1002/path.2813; Kim MY, 2012, J BIOL CHEM, V287, P4690, DOI 10.1074/jbc.M111.289637; Kim MY, 2011, J CELL SCI, V124, P1831, DOI 10.1242/jcs.076117; Kim SK, 2001, GENE DEV, V15, P111, DOI 10.1101/gad.859401; Kireeva ML, 1996, MOL CELL BIOL, V16, P1326; Lai EC, 2002, CURR BIOL, V12, pR74, DOI 10.1016/S0960-9822(01)00679-0; Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Li JL, 2005, CANCER CELL, V8, P1, DOI 10.1016/j.ccr.2005.06.013; Lopez SL, 2003, DEVELOPMENT, V130, P2225, DOI 10.1242/dev.00443; Maitra A, 2006, BEST PRACT RES CL GA, V20, P211, DOI 10.1016/j.bpg.2005.10.002; McCarthy DM, 2001, HUM PATHOL, V32, P638, DOI 10.1053/hupa.2001.24991; Mo JS, 2007, MOL CELL BIOL, V27, P5565, DOI 10.1128/MCB.02372-06; Morrow D, 2009, ARTERIOSCL THROM VAS, V29, P1112, DOI 10.1161/ATVBAHA.109.186890; Morton JP, 2007, CELL CYCLE, V6, P1553, DOI 10.4161/cc.6.13.4467; Morton JP, 2007, P NATL ACAD SCI USA, V104, P5103, DOI 10.1073/pnas.0701158104; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Ray G, 2005, ONCOL REP, V13, P445; Sampath D, 2001, J CLIN ENDOCR METAB, V86, P1707, DOI 10.1210/jc.86.4.1707; Sengupta K, 2004, MOL CANCER RES, V2, P150; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Tong XJ, 2004, ONCOGENE, V23, P4847, DOI 10.1038/sj.onc.1207628; Tsai MS, 2002, ONCOGENE, V21, P964, DOI 10.1038/sj/onc/1205131; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; Wang YH, 2009, NEOPLASMA, V56, P371, DOI 10.4149/neo_2009_05_371; Wilentz R. E., 2001, EXOCRINE PANCREAS PA; Xie D, 2004, CANCER RES, V64, P1987, DOI 10.1158/0008-5472.CAN-03-0666; Yao J, 2011, SWISS MED WEEKLY, V31, P141; Yoo YA, 2008, CARCINOGENESIS, V29, P480, DOI 10.1093/carcin/bgm281; Zhou J, 2008, WORLD J GASTROENTERO, V14, P925, DOI 10.3748/wjg.14.925	55	42	45	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38569	38579		10.1074/jbc.M112.389064	http://dx.doi.org/10.1074/jbc.M112.389064			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23027863	Green Published, hybrid			2022-12-28	WOS:000310982800017
J	Riek, AE; Oh, J; Sprague, JE; Timpson, A; de las Fuentes, L; Bernal-Mizrachi, L; Schechtman, KB; Bernal-Mizrachi, C				Riek, Amy E.; Oh, Jisu; Sprague, Jennifer E.; Timpson, Alexandra; de las Fuentes, Lisa; Bernal-Mizrachi, Leon; Schechtman, Kenneth B.; Bernal-Mizrachi, Carlos			Vitamin D Suppression of Endoplasmic Reticulum Stress Promotes an Antiatherogenic Monocyte/Macrophage Phenotype in Type 2 Diabetic Patients	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADVANCED ATHEROSCLEROTIC LESIONS; UNFOLDED PROTEIN RESPONSE; MONOCYTE-DERIVED CELLS; MACROPHAGE DIFFERENTIATION; SUBCLINICAL ATHEROSCLEROSIS; PROINFLAMMATORY CYTOKINE; ALTERNATIVE ACTIVATION; CD14+CD16+ MONOCYTES; ADHESION MOLECULES; INSULIN-RESISTANCE	Cardiovascular disease is the leading cause of morbidity/mortality in patients with type 2 diabetes mellitus (T2DM), but there is a lack of knowledge about the mechanism(s) of increased atherosclerosis in these patients. In patients with T2DM, the prevalence of 25-hydroxy vitamin D (25(OH) D) deficiency is almost twice that for nondiabetics and doubles the relative risk of developing cardiovascular disease compared with diabetic patients with normal 25(OH) D. We tested the hypothesis that monocytes from vitamin D-deficient subjects will have a proatherogenic phenotype compared with vitamin D-sufficient subjects in 43 patients with T2DM. Serum 25(OH) D level inversely correlated with monocyte adhesion to endothelial cells even after adjustment for demographic and comorbidity characteristics. Vitamin D-sufficient patients (>= 30 ng/ml 25(OH) D) had lower monocyte endoplasmic reticulum (ER) stress, a predominance of M1 over M2 macrophage membrane receptors, and decreased mRNA expression of monocyte adhesion molecules PSGL-1, beta(1)-integrin, and beta(2)-integrin compared with patients with 25(OH) D levels of <30 ng/ml. In vitamin D-deficient macrophages, activation of ER stress increased adhesion and adhesion molecule expression and induced an M2-predominant phenotype. Moreover, adding 1,25(OH)(2)D-3 to vitamin D-deficient macrophages shifted their phenotype toward an M1-predominant phenotype with suppressed adhesion. Conversely, deletion of the vitamin D receptor in macrophages from diabetic patients activated ER stress, accelerated adhesion, and increased adhesion molecule expression. The absence of ER stress protein CCAAT enhancer-binding protein homologous protein suppressed monocyte adhesion, adhesion molecule expression, and the M2-predominant phenotype induced by vitamin D deficiency. Thus, vitamin D is a natural ER stress reliever that induced an antiatherogenic monocyte/macrophage phenotype.	[Bernal-Mizrachi, Carlos] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, Dept Internal Med, St Louis, MO 63110 USA; [Sprague, Jennifer E.] Washington Univ, Div Pediat Endocrinol & Diabet, St Louis, MO 63110 USA; [de las Fuentes, Lisa] Washington Univ, Div Cardiovasc Dis, St Louis, MO 63110 USA; [Schechtman, Kenneth B.] Washington Univ, Div Biostat, St Louis, MO 63110 USA; [Bernal-Mizrachi, Carlos] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Bernal-Mizrachi, Leon] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Emory University	Bernal-Mizrachi, C (corresponding author), Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, Dept Internal Med, 660 S Euclid Ave,Campus Box 8127, St Louis, MO 63110 USA.	cbernal@dom.wustl.edu		Jackson, Alexandra Malia/0000-0003-4423-1292; Bernal-Mizrachi, Carlos/0000-0002-8991-7522; de las Fuentes, Lisa/0000-0002-4689-325X	National Institutes of Health [R01HL094818-0, P30DK079333]; American Diabetes Association Grant [1-12-CT-08]; Endocrine Society; Endocrine Fellows Foundation, National Institutes of Health [UL1RR024992, KL2RR024994]; National Institutes of Health National Center for Research Resources, National Institutes of Health [UL1TR000448, KL2TR000450]; National Center for Advancing Translational Sciences; National Institutes of Health Roadmap for Medical Research; National Institutes of Health under Ruth L. Kirschstein National Research Service Award from the NICHD [2 T32 HD043010]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD043010] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, KL2TR000450] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Grant(American Diabetes Association); Endocrine Society; Endocrine Fellows Foundation, National Institutes of Health; National Institutes of Health National Center for Research Resources, National Institutes of Health; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health under Ruth L. Kirschstein National Research Service Award from the NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL094818-0 and P30DK079333. This work was also supported by American Diabetes Association Grant 1-12-CT-08.; Supported by the Endocrine Society, the Endocrine Fellows Foundation, National Institutes of Health UL1RR024992/Sub-Award KL2RR024994 from the National Institutes of Health National Center for Research Resources, National Institutes of Health UL1TR000448/Sub-Award KL2TR000450 from the National Center for Advancing Translational Sciences, and the National Institutes of Health Roadmap for Medical Research.; Supported by the National Institutes of Health under Ruth L. Kirschstein National Research Service Award 2 T32 HD043010 from the NICHD.g	Adams JS, 2009, J IMMUNOL, V182, P4289, DOI 10.4049/jimmunol.0803736; Bories G, 2012, DIABETES VASC DIS RE, V9, P189, DOI 10.1177/1479164111430242; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Chen NG, 1999, J CLIN ENDOCR METAB, V84, P3485, DOI 10.1210/jc.84.10.3485; Chen NG, 1999, CIRCULATION, V100, P940, DOI 10.1161/01.CIR.100.9.940; Chinetti-Gbaguidi G, 2011, CURR OPIN LIPIDOL, V22, P365, DOI 10.1097/MOL.0b013e32834a77b4; Chinetti-Gbaguidi G, 2011, CIRC RES, V108, P985, DOI 10.1161/CIRCRESAHA.110.233775; Cigolini M, 2006, DIABETES CARE, V29, P722, DOI 10.2337/diacare.29.03.06.dc05-2148; Dickhout JG, 2011, FASEB J, V25, P576, DOI 10.1096/fj.10-159319; Du T, 2009, DIABETES RES CLIN PR, V83, P208, DOI 10.1016/j.diabres.2008.09.046; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Fasching P, 1996, DIABETOLOGIA, V39, P1242, DOI 10.1007/BF02658518; Feig JE, 2011, P NATL ACAD SCI USA, V108, P7166, DOI 10.1073/pnas.1016086108; Feig JE, 2011, CIRCULATION, V123, P989, DOI 10.1161/CIRCULATIONAHA.110.984146; Feig JE, 2010, J CLIN INVEST, V120, P4415, DOI 10.1172/JCI38911; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Grey A, 2010, ARCH INTERN MED, V170, P1099, DOI 10.1001/archinternmed.2010.174; Han S, 2006, CELL METAB, V3, P257, DOI 10.1016/j.cmet.2006.02.008; HEWISON M, 1994, J IMMUNOL, V153, P5709; Hotamisligil G.S, 2000, DIABETES MELLITUS, P651; Hotamisligil GS, 2010, NAT MED, V16, P396, DOI 10.1038/nm0410-396; Isaia G, 2001, DIABETES CARE, V24, P1496, DOI 10.2337/diacare.24.8.1496; Jilma B, 1996, THROMB HAEMOSTASIS, V76, P328; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Komura T, 2010, DIABETES, V59, P634, DOI 10.2337/db09-0659; Kostidou E, 2009, CLIN BIOCHEM, V42, P634, DOI 10.1016/j.clinbiochem.2008.12.007; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mita T, 2010, BIOCHEM BIOPH RES CO, V395, P477, DOI 10.1016/j.bbrc.2010.04.031; Myoishi M, 2007, CIRCULATION, V116, P1226, DOI 10.1161/CIRCULATIONAHA.106.682054; Nemere I, 1998, BIOCHEM BIOPH RES CO, V248, P443, DOI 10.1006/bbrc.1998.8492; Oh J, 2012, J BIOL CHEM, V287, P11629, DOI 10.1074/jbc.M111.338673; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Patino R, 2000, AM J CARDIOL, V85, P1288, DOI 10.1016/S0002-9149(00)00757-8; Pittas AG, 2010, ANN INTERN MED, V152, P307, DOI 10.7326/0003-4819-152-5-201003020-00009; POLLA BS, 1986, J CLIN INVEST, V77, P1332, DOI 10.1172/JCI112438; Rogacev KS, 2010, EUR HEART J, V31, P369, DOI 10.1093/eurheartj/ehp308; Satoh Noriko, 2010, Diabetes Care, V33, pe7, DOI 10.2337/dc09-1315; SCHAEFER A, 1994, J BIOL CHEM, V269, P8786; Schlitt A, 2004, THROMB HAEMOSTASIS, V92, P419, DOI 10.1160/TH04-02-0095; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Shanmugam N, 2003, DIABETES, V52, P1256, DOI 10.2337/diabetes.52.5.1256; Szeto FL, 2012, MOL ENDOCRINOL, V26, P1091, DOI 10.1210/me.2011-1329; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; Ulrich C, 2008, AM J TRANSPLANT, V8, P103, DOI 10.1111/j.1600-6143.2007.02035.x; van Tits LJH, 2011, ATHEROSCLEROSIS, V214, P345, DOI 10.1016/j.atherosclerosis.2010.11.018; Wang L, 2010, ANN INTERN MED, V152, P315, DOI 10.7326/0003-4819-152-5-201003020-00010; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Zhang Y, 2012, J IMMUNOL, V188, P2127, DOI 10.4049/jimmunol.1102412; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1	61	78	83	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38482	38494		10.1074/jbc.M112.386912	http://dx.doi.org/10.1074/jbc.M112.386912			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23012375	Green Published, hybrid			2022-12-28	WOS:000310982800008
J	Blackford, JA; Guo, CH; Zhu, R; Dougherty, EJ; Chow, CC; Simons, SS				Blackford, John A., Jr.; Guo, Chunhua; Zhu, Rong; Dougherty, Edward J.; Chow, Carson C.; Simons, S. Stoney, Jr.			Identification of Location and Kinetically Defined Mechanism of Cofactors and Reporter Genes in the Cascade of Steroid-regulated Transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOCORTICOID-RECEPTOR BINDING; PARTIAL AGONIST ACTIVITY; PROSTATE-CANCER CELLS; DOSE-RESPONSE CURVES; INDUCTION PROPERTIES; CHROMATIN ACCESSIBILITY; TRANSCRIPTION FACTORS; ANTAGONIST COMPLEXES; HORMONE-RECEPTORS; IN-VIVO	A currently obscure area of steroid hormone action is where the component factors, including receptor and reporter gene, act. The DNA binding of factors can be precisely defined, but the location and timing of factor binding and action are usually not equivalent. These questions are addressed for several factors (e. g. glucocorticoid receptor (GR), reporter, TIF2, NCoR, NELF-A, sSMRT, and STAMP) using our recently developed competition assay. This assay reveals both the kinetically defined mechanism of factor action and where the above factors act relative to both each other and the equilibrium equivalent to the rate-limiting step, which we call the concentration limiting step (CLS). The utility of this competition assay would be greatly increased if the position of the CLS is invariant and if the factor acting at the CLS is known. Here we report that the exogenous GREtkLUC reporter acts at the CLS as an accelerator for gene induction by GRs in U2OS cells. This mechanism of reporter function at the CLS persists with different reporters, factors, receptors, and cell types. We, therefore, propose that the reporter gene always acts at the CLS during gene induction and constitutes a landmark around which one can order the actions of all other factors. Current data suggest that how and where GR and the short form of SMRT act is also constant. These results validate a novel and rational methodology for identifying distally acting factors that would be attractive targets for pharmaceutical intervention in the treatment of diseases involving GR-regulated genes.	[Simons, S. Stoney, Jr.] NIDDK, CEB, Steroid Hormones Sect, Lab Endocrinol & Receptor Biol,NIH, Bethesda, MD 20892 USA; [Chow, Carson C.] NIDDK, Lab Biol Modeling, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Simons, SS (corresponding author), NIDDK, CEB, Steroid Hormones Sect, Lab Endocrinol & Receptor Biol,NIH, Bldg 10,Rm 8N-307B, Bethesda, MD 20892 USA.	stoneys@helix.nih.gov	Guo, Chunhua/N-2586-2014	Dougherty, Edward/0000-0001-7664-9779	Intramural Research Program of the NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK047041, ZIADK075066, ZIADK047040, ZIADK057800, ZIADK075069] Funding Source: NIH RePORTER	Intramural Research Program of the NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the Intramural Research Program of the NIDDK, National Institutes of Health.	AVERY L, 1992, TRENDS GENET, V8, P312, DOI 10.1016/0168-9525(92)90263-4; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Biddie SC, 2010, TRENDS ENDOCRIN MET, V21, P3, DOI 10.1016/j.tem.2009.08.006; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chow CC, 2011, METHOD ENZYMOL, P465, DOI [10.1016/S0076-6879(11)87016-3, 10.1016/B978-0-12-381270-4.00016-0]; Dougherty EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030225; Fromm HJ, 1975, INITIAL RATE ENZYME; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Giannoukos G, 2001, MOL ENDOCRINOL, V15, P255, DOI 10.1210/me.15.2.255; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; He YZ, 2007, MOL CELL BIOL, V27, P1467, DOI 10.1128/MCB.01360-06; He YZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-128; He YZ, 2002, J BIOL CHEM, V277, P49256, DOI 10.1074/jbc.M205536200; Heemers HV, 2009, MOL ENDOCRINOL, V23, P572, DOI 10.1210/me.2008-0363; Ianculescu I, 2012, J BIOL CHEM, V287, P4000, DOI 10.1074/jbc.M111.300194; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Johnson AB, 2012, MOL CELL ENDOCRINOL, V348, P430, DOI 10.1016/j.mce.2011.04.021; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kaul S, 2002, J BIOL CHEM, V277, P12541, DOI 10.1074/jbc.M112330200; Kotekar AS, 2008, MOL CELL BIOL, V28, P7323, DOI 10.1128/MCB.00889-08; Lee GS, 2011, BIOCHEMISTRY-US, V50, P356, DOI 10.1021/bi101792d; Metivier R, 2006, EMBO REP, V7, P161, DOI 10.1038/sj.embor.7400626; Nagy L, 2004, TRENDS BIOCHEM SCI, V29, P317, DOI 10.1016/j.tibs.2004.04.006; Narita T, 2003, MOL CELL BIOL, V23, P1863, DOI 10.1128/MCB.23.6.1863-1873.2003; Ong KM, 2010, P NATL ACAD SCI USA, V107, P7107, DOI 10.1073/pnas.0911095107; Ordentlich P, 1999, P NATL ACAD SCI USA, V96, P2639, DOI 10.1073/pnas.96.6.2639; Paakinaho V, 2010, MOL ENDOCRINOL, V24, P511, DOI 10.1210/me.2009-0443; Price DH, 2008, MOL CELL, V30, P7, DOI 10.1016/j.molcel.2008.03.001; PRIOR JC, 1990, ENDOCR REV, V11, P386, DOI 10.1210/edrv-11-2-386; Rao NAS, 2011, GENOME RES, V21, P1404, DOI 10.1101/gr.118042.110; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Sarlis NJ, 1999, J STEROID BIOCHEM, V68, P89, DOI 10.1016/S0960-0760(99)00021-7; Segel I. H., 1993, NUCLEIC ACIDS RES; Simons SS, 2012, MOL CELL ENDOCRINOL, V348, P373, DOI 10.1016/j.mce.2011.05.030; Simons SS, 2003, TRENDS PHARMACOL SCI, V24, P253, DOI 10.1016/S0165-6147(03)00101-9; Soderstrom M, 1997, MOL ENDOCRINOL, V11, P682, DOI 10.1210/me.11.6.682; Song LN, 2001, J BIOL CHEM, V276, P24806, DOI 10.1074/jbc.M102610200; Sun JL, 2008, J CELL BIOCHEM, V103, P1798, DOI 10.1002/jcb.21568; Szapary D, 1996, J BIOL CHEM, V271, P30576, DOI 10.1074/jbc.271.48.30576; Szapary D, 2008, MOL CELL ENDOCRINOL, V283, P114, DOI 10.1016/j.mce.2007.11.031; Tao YG, 2008, BIOCHEMISTRY-US, V47, P7648, DOI 10.1021/bi800472w; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; TRUSS M, 1992, J STEROID BIOCHEM, V43, P365, DOI 10.1016/0960-0760(92)90071-P; Wan YH, 2002, MOL ENDOCRINOL, V16, P1204, DOI 10.1210/me.16.6.1204; Wang Q, 2004, J STEROID BIOCHEM, V91, P197, DOI 10.1016/j.jsbmb.2004.04.007; Wang Q, 2004, MOL ENDOCRINOL, V18, P1376, DOI 10.1210/me.2003-0421; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Ye QN, 2001, J CELL BIOL, V155, P911, DOI 10.1083/jcb.200108049; Ziegler R, 1998, STEROIDS, V63, P344, DOI 10.1016/S0039-128X(98)00022-1	50	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					40982	40995		10.1074/jbc.M112.414805	http://dx.doi.org/10.1074/jbc.M112.414805			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23055525	hybrid, Green Published			2022-12-28	WOS:000311887600016
J	Menotta, M; Biagiotti, S; Bianchi, M; Chessa, L; Magnani, M				Menotta, Michele; Biagiotti, Sara; Bianchi, Marzia; Chessa, Luciana; Magnani, Mauro			Dexamethasone Partially Rescues Ataxia Telangiectasia-mutated (ATM) Deficiency in Ataxia Telangiectasia by Promoting a Shortened Protein Variant Retaining Kinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROLOGICAL SYMPTOMS; FULL ACTIVATION; GENE-EXPRESSION; CELLS; BETAMETHASONE; PHENOTYPE; IMPROVEMENT; SEQUENCES; INSULIN	Ataxia telangiectasia (AT) is a rare genetic disease, still incurable, resulting from biallelic mutations in the ataxia telangiectasia-mutated (ATM) gene. Recently, short term treatment with glucocorticoid analogues improved neurological symptoms characteristic of this syndrome. Nevertheless, the molecular mechanism involved in glucocorticoid action in AT patients is not yet known. Here we describe, for the first time in mammalian cells, a short direct repeat-mediated noncanonical splicing event induced by dexamethasone, which leads to the skipping of mutations upstream of nucleotide residue 8450 of ATM coding sequence. The resulting transcript provides an alternative ORF translated in a new ATM variant with the complete kinase domain. This miniATM variant was also highlighted in lymphoblastoid cell lines from AT patients and was shown to be likely active. In conclusion, dexamethasone treatment may partly restore ATM activity in ataxia telangiectasia cells by a new molecular mechanism that overcomes most of the mutations so far described within this gene.	[Menotta, Michele; Biagiotti, Sara; Bianchi, Marzia; Magnani, Mauro] Univ Urbino Carlo Bo, Dept Biomol Sci, I-61029 Urbino, PU, Italy; [Chessa, Luciana] Univ Roma La Sapienza, Dept Clin & Mol Med, I-00185 Rome, Italy	University of Urbino; Sapienza University Rome	Menotta, M (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Via Saffi 2, I-61029 Urbino, PU, Italy.	michele.menotta@uniurb.it; sara.biagiotti@uniurb.it	Biagiotti, Sara/E-5043-2016; Magnani, Mauro/A-1919-2008	Magnani, Mauro/0000-0001-6456-6626; Bianchi, Marzia/0000-0001-9352-7319; Biagiotti, Sara/0000-0001-9554-7858	FanoAteneo; Associazione Nazionale AT "Davide De Marini"	FanoAteneo; Associazione Nazionale AT "Davide De Marini"	This work was supported in part by grants from FanoAteneo and Associazione Nazionale AT "Davide De Marini."	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Barlow C, 2000, P NATL ACAD SCI USA, V97, P871, DOI 10.1073/pnas.97.2.871; Biton S, 2008, DNA REPAIR, V7, P1028, DOI 10.1016/j.dnarep.2008.03.006; Boehrs JK, 2007, J NEUROCHEM, V100, P337, DOI 10.1111/j.1471-4159.2006.04254.x; Broccoletti T, 2008, EUR J NEUROL, V15, P223, DOI 10.1111/j.1468-1331.2008.02060.x; Broccoletti T, 2011, EUR J NEUROL, V18, P564, DOI 10.1111/j.1468-1331.2010.03203.x; Buoni S, 2006, ARCH NEUROL-CHICAGO, V63, P1479, DOI 10.1001/archneur.63.10.1479; Chun HH, 2004, DNA REPAIR, V3, P1187, DOI 10.1016/j.dnarep.2004.04.010; Fan J, 2007, J EXP BOT, V58, P3811, DOI 10.1093/jxb/erm231; Gatti RA, 2009, EUR J NEUROL, V16, P653, DOI 10.1111/j.1468-1331.2009.02597.x; Gilad S, 1998, AM J HUM GENET, V62, P551, DOI 10.1086/301755; Halaby MJ, 2008, CELL SIGNAL, V20, P1555, DOI 10.1016/j.cellsig.2008.04.011; Horiuchi T, 2006, BIOL CELL, V98, P135, DOI 10.1042/BC20050002; Houseley J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012271; Kim J, 2009, STEM CELLS, V27, P1987, DOI 10.1002/stem.125; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Li H, 2008, SCIENCE, V321, P1357, DOI 10.1126/science.1156725; Li JL, 2011, J NEUROSCI, V31, P7568, DOI 10.1523/JNEUROSCI.0778-11.2011; Nakada D, 2003, NUCLEIC ACIDS RES, V31, P1715, DOI 10.1093/nar/gkg252; Niu XL, 2010, J GENET GENOMICS, V37, P85, DOI 10.1016/S1673-8527(09)60028-X; Oka A, 1998, NEUROSCI LETT, V252, P195, DOI 10.1016/S0304-3940(98)00576-X; Platzer M, 1997, GENOME RES, V7, P592, DOI 10.1101/gr.7.6.592; Russo I, 2009, EUR J NEUROL, V16, P755, DOI 10.1111/j.1468-1331.2009.02600.x; Sarkaria JN, 1998, CANCER RES, V58, P4375; Savitsky K, 1997, NUCLEIC ACIDS RES, V25, P1678, DOI 10.1093/nar/25.9.1678; Shao XA, 2006, BIOINFORMATICS, V22, P692, DOI 10.1093/bioinformatics/bti795; Shiotani B, 2011, METHODS MOL BIOL, V782, P181, DOI 10.1007/978-1-61779-273-1_13; Viniegra JG, 2005, J BIOL CHEM, V280, P4029, DOI 10.1074/jbc.M410344200; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Xia F, 1995, Methods Mol Biol, V48, P151; Young DB, 2005, J BIOL CHEM, V280, P27587, DOI 10.1074/jbc.M411689200; Yuan JS, 2010, FEBS LETT, V584, P3717, DOI 10.1016/j.febslet.2010.05.021; Zannolli R, 2012, MOVEMENT DISORD, V27, P1312, DOI 10.1002/mds.25126; Zhang LQ, 2006, CELL SIGNAL, V18, P1386, DOI 10.1016/j.cellsig.2005.10.017	35	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41352	41363		10.1074/jbc.M112.344473	http://dx.doi.org/10.1074/jbc.M112.344473			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23055520	hybrid, Green Published			2022-12-28	WOS:000311887600049
J	Boiko, N; Kucher, V; Stockand, JD; Eaton, BA				Boiko, Nina; Kucher, Volodymyr; Stockand, James D.; Eaton, Benjamin A.			Pickpocket1 Is an Ionotropic Molecular Sensory Transducer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; CAENORHABDITIS-ELEGANS; MECHANOSENSORY TRANSDUCTION; DROSOPHILA-MELANOGASTER; TRP CHANNELS; C-ELEGANS; DEG/ENAC; NEURONS; SUBUNIT; MEC-4	The molecular transformation of an external stimulus into changes in sensory neuron activity is incompletely described. Although a number of molecules have been identified that can respond to stimuli, evidence that these molecules can transduce stimulation into useful neural activity is lacking. Here we demonstrate that pickpocket1 (ppk1), a Drosophila homolog of mammalian Degenerin/epithelial sodium channels, encodes an acid-sensing sodium channel that conducts a transient depolarizing current in multidendritic sensory neurons of Drosophila melanogaster. Stimulation of Ppk1 is sufficient to bring these sensory neurons to threshold, eliciting a burst of action potentials. The transient nature of the neural activity produced by Ppk1 activation is the result of Ppk1 channel gating properties. This model is supported by the observation of enhanced bursting activity in neurons expressing a gain of function ppk1 mutant harboring the degenerin mutation. These findings demonstrate that Ppk1 can function as an ionotropic molecular sensory transducer capable of transforming the perception of a stimulus into phasic neuronal activity in sensory neurons.	[Boiko, Nina; Kucher, Volodymyr; Stockand, James D.; Eaton, Benjamin A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Eaton, BA (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	eatonb@uthscsa.edu		Stockand, James/0000-0002-3817-4319	National Institutes of Health [RO1 NS062811]; American Heart Association [0640054N]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062811] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 NS062811 (to B. A. E.). This work was also supported by American Heart Association Established Investigator Award 0640054N (to J. D. S.).	Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; Ainsley JA, 2008, DEV BIOL, V322, P46, DOI 10.1016/j.ydbio.2008.07.003; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Bianchi L, 2002, NEURON, V34, P337, DOI 10.1016/S0896-6273(02)00687-6; Borzan J, 2010, ANESTHESIOLOGY, V113, P647, DOI 10.1097/ALN.0b013e3181eaa58a; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; Chatzigeorgiou M, 2010, NAT NEUROSCI, V13, P861, DOI 10.1038/nn.2581; Cheng LE, 2010, NEURON, V67, P373, DOI 10.1016/j.neuron.2010.07.004; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Darboux I, 1998, BIOCHEM BIOPH RES CO, V246, P210, DOI 10.1006/bbrc.1998.8183; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Geffeney SL, 2011, NEURON, V71, P845, DOI 10.1016/j.neuron.2011.06.038; GLOOR GB, 1993, GENETICS, V135, P81; Golic KG, 1996, GENETICS, V144, P1693; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Hong K, 2000, J NEUROSCI, V20, P2575; HONG KS, 1994, NATURE, V367, P470, DOI 10.1038/367470a0; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kang LJ, 2010, NEURON, V67, P381, DOI 10.1016/j.neuron.2010.06.032; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200; Lu YJ, 2009, NEURON, V64, P885, DOI 10.1016/j.neuron.2009.11.007; Mano I, 1999, BIOESSAYS, V21, P568, DOI 10.1002/(SICI)1521-1878(199907)21:7&lt;568::AID-BIES5&gt;3.0.CO;2-L; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Sicaeros Beatriz, 2007, J Vis Exp, P226, DOI 10.3791/226; Soll DR, 1995, INT REV CYTOL, V163, P43; Song W, 2007, P NATL ACAD SCI USA, V104, P5199, DOI 10.1073/pnas.0700895104; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057	35	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.411736	http://dx.doi.org/10.1074/jbc.M112.411736			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23033486	Green Published, hybrid			2022-12-28	WOS:000311233800056
J	Ghosh, A; Corbett, GT; Gonzalez, FJ; Pahan, K				Ghosh, Arunava; Corbett, Grant T.; Gonzalez, Frank J.; Pahan, Kalipada			Gemfibrozil and Fenofibrate, Food and Drug Administration-approved Lipid-lowering Drugs, Up-regulate Tripeptidyl-peptidase 1 in Brain Cells via Peroxisome Proliferator-activated Receptor alpha IMPLICATIONS FOR LATE INFANTILE BATTEN DISEASE THERAPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; RETINOID-X-RECEPTOR; DENSITY-LIPOPROTEIN-CHOLESTEROL; LYSOSOMAL STORAGE DISORDERS; KAPPA-B; MOUSE MODEL; ADOPTIVE TRANSFER; HUMAN ASTROCYTES; GENE-EXPRESSION; MESSENGER-RNAS	The classical late infantile neuronal ceroid lipofuscinosis (LINCLs) is an autosomal recessive disease, where the defective gene is Cln2, encoding tripeptidyl-peptidase I (TPP1). At the molecular level, LINCL is caused by accumulation of autofluorescent storage materials in neurons and other cell types. Currently, there is no established treatment for this fatal disease. This study reveals a novel use of gemfibrozil and fenofibrate, Food and Drug Administration-approved lipid-lowering drugs, in up-regulating TPP1 in brain cells. Both gemfibrozil and fenofibrate up-regulated mRNA, protein, and enzymatic activity of TPP1 in primary mouse neurons and astrocytes as well as human astrocytes and neuronal cells. Because gemfibrozil and fenofibrate are known to activate peroxisome proliferator-activated receptor-alpha (PPAR alpha), the role of PPAR alpha in gemfibrozil-and fenofibrate-mediated up-regulation of TPP1 was investigated revealing that both drugs up-regulated TPP1 mRNA, protein, and enzymatic activity both in vitro and in vivo in wild type (WT) and PPAR alpha(-/-), but not PPAR alpha(-/-), mice. In an attempt to delineate the mechanism of TPP1 up-regulation, it was found that the effects of the fibrate drugs were abrogated in the absence of retinoid X receptor-alpha (RXR alpha), a molecule known to form a heterodimer with PPAR alpha. Accordingly, all-trans-retinoic acid, alone or together with gemfibrozil, up-regulated TPP1. Co-immuno-precipitation and ChIP studies revealed the formation of a PPAR alpha/RXR alpha heterodimer and binding of the heterodimer to an RXR-binding site on the Cln2 promoter. Together, this study demonstrates a unique mechanism for the up-regulation of TPP1 by fibrate drugs via PPAR alpha /RXR alpha pathway.	[Ghosh, Arunava; Corbett, Grant T.; Pahan, Kalipada] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Rush University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pahan, K (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, 1735 W Harrison St,Ste Cohn 320, Chicago, IL 60612 USA.	Kalipada_Pahan@rush.edu		GHOSH, ARUNAVA/0000-0002-8471-8161; Corbett, Grant/0000-0003-3606-9686	National Institutes of Health [AT6681, NS64564, NS71479]; Noah's Hope Foundation; National Center for Complementary & Integrative Health [R01AT006681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071479, R21NS064564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Noah's Hope Foundation; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AT6681, NS64564, and NS71479. This work was also supported by a generous donation from Noah's Hope Foundation.	Bellettato CM, 2010, J INHERIT METAB DIS, V33, P347, DOI 10.1007/s10545-010-9075-9; Brahmachari S, 2007, J IMMUNOL, V179, P275, DOI 10.4049/jimmunol.179.1.275; Cabrera-Salazar MA, 2007, MOL THER, V15, P1782, DOI 10.1038/sj.mt.6300249; Chang M, 2008, MOL THER, V16, P649, DOI 10.1038/mt.2008.9; Corbett GT, 2012, J IMMUNOL, V189, P1002, DOI 10.4049/jimmunol.1102624; Cullingford TE, 1998, J NEUROCHEM, V70, P1366; Dasgupta S, 2004, J IMMUNOL, V173, P1344, DOI 10.4049/jimmunol.173.2.1344; Dasgupta S, 2007, MOL PHARMACOL, V72, P934, DOI 10.1124/mol.106.033787; Ghosh A, 2012, J BIOL CHEM, V287, P27189, DOI 10.1074/jbc.M112.346932; GIULIAN D, 1986, J NEUROSCI, V6, P2163; GOEBEL HH, 1995, J CHILD NEUROL, V10, P424, DOI 10.1177/088307389501000602; Hachiya Y, 2006, ACTA NEUROPATHOL, V111, P168, DOI 10.1007/s00401-005-0024-x; Hemsley KM, 2010, J INHERIT METAB DIS, V33, P363, DOI 10.1007/s10545-010-9078-6; Jackson TC, 2007, TRANSPL INT, V20, P277, DOI 10.1111/j.1432-2277.2006.00431.x; Jana A, 2010, J NEUROSCI, V30, P12676, DOI 10.1523/JNEUROSCI.1243-10.2010; Jana M, 2005, FREE RADICAL BIO MED, V39, P823, DOI 10.1016/j.freeradbiomed.2005.05.014; Jana M, 2007, NEUROCHEM RES, V32, P2015, DOI 10.1007/s11064-007-9340-y; Jana M, 2007, J IMMUNOL, V179, P4142, DOI 10.4049/jimmunol.179.6.4142; JUGEAUBRY CE, 1995, J BIOL CHEM, V270, P18117, DOI 10.1074/jbc.270.30.18117; Khasnavis S, 2012, J BIOL CHEM, V287, P29529, DOI 10.1074/jbc.M111.338012; Khasnavis S, 2012, J NEUROIMMUNE PHARM, V7, P424, DOI 10.1007/s11481-011-9286-3; KREY G, 1995, MOL ENDOCRINOL, V9, P219, DOI 10.1210/me.9.2.219; Lane SC, 1996, J NEUROCHEM, V67, P677; Marcus Sandra L., 1995, Gene Expression, V4, P227; Marx N, 2004, CIRC RES, V94, P1168, DOI 10.1161/01.RES.0000127122.22685.0A; Mole SE, 2005, NEUROGENETICS, V6, P107, DOI 10.1007/s10048-005-0218-3; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Nishizawa H, 2003, J REPROD DEVELOP, V49, P539, DOI 10.1262/jrd.49.539; Pahan K, 2002, J BIOL CHEM, V277, P45984, DOI 10.1074/jbc.M200250200; Robins SJ, 2001, JAMA-J AM MED ASSOC, V285, P1585, DOI 10.1001/jama.285.12.1585; Roy A, 2009, IMMUNOPHARM IMMUNOT, V31, P339, DOI 10.1080/08923970902785253; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; RUBINS HB, 1992, J INTERN MED, V231, P421, DOI 10.1111/j.1365-2796.1992.tb00954.x; Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101; Saha RN, 2006, J NEUROIMMUNE PHARM, V1, P212, DOI 10.1007/s11481-006-9020-8; Saha RN, 2007, FREE RADICAL BIO MED, V42, P1866, DOI 10.1016/j.freeradbiomed.2007.03.022; Sands MS, 2006, MOL THER, V13, P839, DOI 10.1016/j.ymthe.2006.01.006; Sleat DE, 2008, MOL GENET METAB, V94, P222, DOI 10.1016/j.ymgme.2008.01.014; Sleat DE, 1999, AM J HUM GENET, V64, P1511, DOI 10.1086/302427; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; Sohar I, 1999, J NEUROCHEM, V73, P700, DOI 10.1046/j.1471-4159.1999.0730700.x; Viglio S, 2001, ELECTROPHORESIS, V22, P2343, DOI 10.1002/1522-2683(20017)22:11<2343::AID-ELPS2343>3.0.CO;2-2; Vines DJ, 1999, FEBS LETT, V443, P131, DOI 10.1016/S0014-5793(98)01683-4; Vuillemenot BR, 2011, MOL GENET METAB, V104, P325, DOI 10.1016/j.ymgme.2011.06.018; Walus M, 2010, HUM MUTAT, V31, P710, DOI 10.1002/humu.21251; Worgall S, 2008, HUM GENE THER, V19, P463, DOI 10.1089/hum.2008.022; Xu JH, 2007, J NEUROCHEM, V103, P1801, DOI 10.1111/j.1471-4159.2007.04875.x; Xu S, 2011, MOL THER, V19, P1842, DOI 10.1038/mt.2011.130	48	37	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38922	38935		10.1074/jbc.M112.365148	http://dx.doi.org/10.1074/jbc.M112.365148			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22989886	Green Published, hybrid			2022-12-28	WOS:000310982800048
J	Wang, SP; Li, XL; Song, XL; Geng, ZR; Hu, X; Wang, ZL				Wang, Shuping; Li, Xiangli; Song, Xiaoli; Geng, Zhirong; Hu, Xin; Wang, Zhilin			Rapid Equilibrium Kinetic Analysis of Arsenite Methylation Catalyzed by Recombinant Human Arsenic (+3 Oxidation State) Methyltransferase (hAS3MT)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE SERUM-ALBUMIN; TRIVALENT ARSENICALS; CYSTEINE RESIDUES; DRINKING-WATER; PLUS B; ENZYME; METABOLISM; PROTEIN; IDENTIFICATION; FLUORESCENCE	In the human body, arsenic is metabolized by methylation. Understanding this process is important and provides insight into the relationship between arsenic and its related diseases. We used the rapid equilibrium kinetic model to study the reaction sequence of arsenite methylation. The results suggest that the mechanism for arsenite methylation is a completely ordered mechanism that is also of general interest in reaction systems with different reductants, such as tris(2-carboxyethyl)phosphine, cysteine, and glutathione. In the reaction, cysteine residues of recombinant human arsenic (+3 oxidation state) methyltransferase (hAS3MT) coordinate with arsenicals and involve the methyl transfer step. S-Adenosyl-L-methionine (AdoMet) is the first-order reactant, which modulates the conformation of hAS3MT to a best matched state by hydrophobic interaction. As the second-order reactant, reductant reduces the disulfide bond, most likely between Cys-250 and another cysteine residue of hAS3MT, and exposes the active site cysteine residues for binding trivalent inorganic arsenic(iAs(3+)) to give monomethylarsonic dicysteine (MADC(3+)). In addition, the reaction can be extended to further methylate MADC(3+) to dimethylarsinic cysteine (DAMC(3+)). In the methylation reaction, the beta-pleated sheet content of hAS3MT is increased, and the hydrophobicity of the microenvironment around the active sites is decreased. Similarly, we confirm that both the high beta-pleated sheet content of hAS3MT and the high dissociation ability of the enzyme-AdoMet-reductant improve the yield of dimethylated arsenicals.	[Wang, Shuping; Li, Xiangli; Song, Xiaoli; Geng, Zhirong; Wang, Zhilin] Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Coordinat Chem, Nanjing 210093, Jiangsu, Peoples R China; [Hu, Xin] Nanjing Univ, Modern Anal Ctr, Nanjing 210093, Jiangsu, Peoples R China; [Song, Xiaoli] Yangzhou Univ, Sch Chem & Chem Engn, Yangzhou 225002, Peoples R China	Nanjing University; Nanjing University; Yangzhou University	Wang, ZL (corresponding author), Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Coordinat Chem, Nanjing 210093, Jiangsu, Peoples R China.	wangzl@nju.edu.cn	Hu, Xin/B-1792-2009; Geng, Zhirong/HGC-1447-2022	Hu, Xin/0000-0003-3400-554X; Geng, Zhirong/0000-0003-3766-9034	National Natural Science Foundation of China [21075064, 21027013, 21021062, 21275072, 21201101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 21075064, 21027013, 21021062, 21275072, and 21201101.	Alberty RA, 2009, J PHYS CHEM B, V113, P10043, DOI 10.1021/jp9021097; Alberty RA, 2009, J PHYS CHEM B, V113, P1225, DOI 10.1021/jp8080436; Aposhian HV, 2006, CHEM RES TOXICOL, V19, P1, DOI 10.1021/tx050106d; Bi SY, 2005, SPECTROCHIM ACTA A, V61, P629, DOI 10.1016/j.saa.2004.05.028; CHALLENGER F, 1951, ADV ENZYMOL REL S BI, V12, P429; CHALLENGER F, 1945, CHEM REV, V36, P315, DOI 10.1021/cr60115a003; CHEN CJ, 1992, BRIT J CANCER, V66, P888, DOI 10.1038/bjc.1992.380; CHEN CJ, 1995, HYPERTENSION, V25, P53, DOI 10.1161/01.HYP.25.1.53; Concha G, 2002, INT ARCH OCC ENV HEA, V75, P576, DOI 10.1007/s00420-002-0361-1; Cui FL, 2008, PESTIC BIOCHEM PHYS, V90, P126, DOI 10.1016/j.pestbp.2007.11.002; CULLEN WR, 1984, J INORG BIOCHEM, V21, P179, DOI 10.1016/0162-0134(84)83002-0; Dopp E, 2004, TOXICOL APPL PHARM, V201, P156, DOI 10.1016/j.taap.2004.05.017; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; Geng ZR, 2009, J BIOL INORG CHEM, V14, P485, DOI 10.1007/s00775-008-0464-6; Hayakawa T, 2005, ARCH TOXICOL, V79, P183, DOI 10.1007/s00204-004-0620-x; Kitchin KT, 2005, TOXICOL APPL PHARM, V206, P66, DOI 10.1016/j.taap.2004.12.010; Kligerman AD, 2003, ENVIRON MOL MUTAGEN, V42, P192, DOI 10.1002/em.10192; Marapakala K, 2012, BIOCHEMISTRY-US, V51, P944, DOI 10.1021/bi201500c; Mass MJ, 2001, CHEM RES TOXICOL, V14, P355, DOI 10.1021/tx000251l; MYLLYLA R, 1977, EUR J BIOCHEM, V80, P349, DOI 10.1111/j.1432-1033.1977.tb11889.x; Naranmandura H, 2006, CHEM RES TOXICOL, V19, P1010, DOI 10.1021/tx060053f; Ortiz JGM, 2011, TOXICOL SCI, V121, P303, DOI 10.1093/toxsci/kfr074; Song XL, 2011, BIOCHIMIE, V93, P369, DOI 10.1016/j.biochi.2010.10.010; Song XL, 2010, BIOCHIMIE, V92, P1397, DOI 10.1016/j.biochi.2010.07.002; Song XL, 2009, CHEM-BIOL INTERACT, V179, P321, DOI 10.1016/j.cbi.2008.12.018; Sulkowska A, 2006, J MOL STRUCT, V792, P249, DOI 10.1016/j.molstruc.2006.01.002; Suzuki KT, 2007, TOXICOL APPL PHARM, V218, P166, DOI 10.1016/j.taap.2006.10.027; Tapio S, 2006, MUTAT RES-REV MUTAT, V612, P215, DOI 10.1016/j.mrrev.2006.02.001; Thomas DJ, 2007, TOXICOL APPL PHARM, V222, P365, DOI 10.1016/j.taap.2007.02.007; Thomas DJ, 2007, EXP BIOL MED, V232, P3; Thomas DJ, 2010, TOXICOL SCI, V113, P70, DOI 10.1093/toxsci/kfp250; Thomas DJ, 2009, TOXICOL SCI, V107, P309, DOI 10.1093/toxsci/kfn257; Thomas DJ, 2004, TOXICOL APPL PHARM, V198, P319, DOI 10.1016/j.taap.2003.10.020; Thomas DJ, 2001, TOXICOL APPL PHARM, V176, P127, DOI 10.1006/taap.2001.9258; Tian JN, 2005, BIOORGAN MED CHEM, V13, P4124, DOI 10.1016/j.bmc.2005.02.065; Tsai SM, 1999, ARCH ENVIRON HEALTH, V54, P186, DOI 10.1080/00039899909602258; Tseng CH, 2003, TOXICOL LETT, V137, P15, DOI 10.1016/S0378-4274(02)00377-6; Walton FS, 2003, CHEM RES TOXICOL, V16, P261, DOI 10.1021/tx025649r; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Zakharyan RA, 1999, TOXICOL APPL PHARM, V154, P287, DOI 10.1006/taap.1998.8587; Zhang LY, 2010, BIOPOLYMERS, V93, P141, DOI 10.1002/bip.21312; Zhang YZ, 2008, J FLUORESC, V18, P109, DOI 10.1007/s10895-007-0247-4	42	22	22	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38790	38799		10.1074/jbc.M112.368050	http://dx.doi.org/10.1074/jbc.M112.368050			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22955273	Green Published, hybrid			2022-12-28	WOS:000310982800036
J	Brugarolas, P; Movahedzadeh, F; Wang, YH; Zhang, N; Bartek, IL; Gao, YHN; Voskuil, MI; Franzblau, SG; He, C				Brugarolas, Pedro; Movahedzadeh, Farahnaz; Wang, Yuehong; Zhang, Nan; Bartek, Iona L.; Gao, Yihe N.; Voskuil, Martin I.; Franzblau, Scott G.; He, Chuan			The Oxidation-sensing Regulator (MosR) Is a New Redox-dependent Transcription Factor in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOBAL REGULATOR; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURES; REACTIVE OXYGEN; NITRIC-OXIDE; GENE; SURVIVAL; VIRULENCE; MECHANISM; DEFENSE	Mycobacterium tuberculosis thrives in oxidative environments such as the macrophage. To survive, the bacterium must sense and adapt to the oxidative conditions. Several antioxidant defenses including a thick cell wall, millimolar concentrations of small molecule thiols, and protective enzymes are known to help the bacterium withstand the oxidative stress. However, oxidation-sensing regulators that control these defenses have remained elusive. In this study, we report a new oxidation-sensing regulator, Rv1049 or MosR (M. tuberculosis oxidation-sensing regulator). MosR is a transcriptional repressor of the MarR family, which, similarly to Bacillus subtilis OhrR and Staphylococcus aureus MgrA, dissociates from DNA in the presence of oxidants, enabling transcription. MosR senses oxidation through a pair of cysteines near the N terminus (Cys-10 and Cys-12) that upon oxidation forms a disulfide bond. Disulfide formation rearranges a network of hydrogen bonds, which leads to a large conformational change of the protein and dissociation from DNA. MosR has been shown previously to play an important role in survival of the bacterium in the macrophage. In this study, we show that the main role of MosR is to up-regulate expression of rv1050 (a putative exported oxidoreductase that has not yet been characterized) in response to oxidants and propose that it is through this role that MosR contributes to the bacterium survival in the macrophage.	[Brugarolas, Pedro; Gao, Yihe N.; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Brugarolas, Pedro; Gao, Yihe N.; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Movahedzadeh, Farahnaz; Wang, Yuehong; Zhang, Nan; Franzblau, Scott G.] Univ Illinois, Coll Pharm, Inst TB Res, Chicago, IL 60612 USA; [Bartek, Iona L.; Voskuil, Martin I.] Univ Colorado Denver, Sch Med, Dept Microbiol, Aurora, CO 80045 USA	University of Chicago; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	He, C (corresponding author), Univ Chicago, Dept Chem, GCIS 319B,929 E 57th St, Chicago, IL 60637 USA.	chuanhe@uchicago.edu		Brugarolas, Pedro/0000-0002-7455-2743; Franzblau, Scott/0000-0002-8698-0243	National Institutes of Health from the NIAID [AI074658]; Chicago Biomedical Consortium; Chicago Community Trust; National Institutes of Health [R01 AI061505]; Fundacion Caja Madrid; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074658, R01AI061505] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Chicago Biomedical Consortium; Chicago Community Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacion Caja Madrid; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award(Burroughs Wellcome Fund); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI074658 (to C. H.) from the NIAID. This work was also supported by the Chicago Biomedical Consortium with support from The Searle Funds at the Chicago Community Trust (to C. H. and S. G. F.), a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award (to C. H.), National Institutes of Health Grant R01 AI061505 (to M. I. V.), and a Graduate Fellowship from Fundacion Caja Madrid (to P. B.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Antelmann H, 2011, ANTIOXID REDOX SIGN, V14, P1049, DOI 10.1089/ars.2010.3400; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798; Buchmeier N, 2006, FEMS MICROBIOL LETT, V264, P74, DOI 10.1111/j.1574-6968.2006.00441.x; Buchmeier NA, 2006, J BACTERIOL, V188, P6245, DOI 10.1128/JB.00393-06; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; Chen PR, 2006, NAT CHEM BIOL, V2, P591, DOI 10.1038/nchembio820; Chen PR, 2011, ANTIOXID REDOX SIGN, V14, P1107, DOI 10.1089/ars.2010.3374; Colangeli R, 2009, P NATL ACAD SCI USA, V106, P4414, DOI 10.1073/pnas.0810126106; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; den Hengst CD, 2008, BBA-GEN SUBJECTS, V1780, P1201, DOI 10.1016/j.bbagen.2008.01.008; Divangahi M, 2010, NAT IMMUNOL, V11, P751, DOI 10.1038/ni.1904; Dolan KT, 2011, J BIOL CHEM, V286, P22178, DOI 10.1074/jbc.M111.245258; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandes ND, 1999, J BACTERIOL, V181, P4266, DOI 10.1128/JB.181.14.4266-4274.1999; Flynn JL, 2001, INFECT IMMUN, V69, P4195, DOI 10.1128/IAI.69.7.4195-4201.2001; Fontan PA, 2009, J BACTERIOL, V191, P5628, DOI 10.1128/JB.00510-09; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Ha UW, 1999, INFECT IMMUN, V67, P5324, DOI 10.1128/IAI.67.10.5324-5331.1999; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; JACKETT PS, 1978, J GEN MICROBIOL, V104, P37, DOI 10.1099/00221287-104-1-37; Kobayashi K, 2004, J BIOCHEM, V136, P607, DOI 10.1093/jb/mvh168; Leblanc B, 1994, Methods Mol Biol, V30, P1; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Luong TT, 2006, J BACTERIOL, V188, P1899, DOI 10.1128/JB.188.5.1899-1910.2006; Luong TT, 2003, J BACTERIOL, V185, P3703, DOI 10.1128/JB.185.13.3703-3710.2003; Mahenthiralingam E, 1998, INFECT IMMUN, V66, P3626, DOI 10.1128/IAI.66.8.3626-3634.1998; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; Manca C, 1999, INFECT IMMUN, V67, P74, DOI 10.1128/IAI.67.1.74-79.1999; McCann JR, 2011, J BACTERIOL, V193, P854, DOI 10.1128/JB.01271-10; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Newberry KJ, 2007, MOL CELL, V28, P652, DOI 10.1016/j.molcel.2007.09.016; Ochsner UA, 2000, J BACTERIOL, V182, P4533, DOI 10.1128/JB.182.16.4533-4544.2000; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panmanee W, 2006, J BACTERIOL, V188, P1389, DOI 10.1128/JB.188.4.1389-1395.2006; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Petrova T, 2010, ACTA CRYSTALLOGR D, V66, P1075, DOI 10.1107/S0907444910033986; Piddington DL, 2001, INFECT IMMUN, V69, P4980, DOI 10.1128/IAI.69.8.4980-4987.2001; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Poor CB, 2009, J BIOL CHEM, V284, P23517, DOI 10.1074/jbc.M109.015826; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545; Ta P, 2011, J BACTERIOL, V193, P1981, DOI 10.1128/JB.01402-10; Voskuil MI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00105; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wilson M, 2001, Methods Mol Med, V54, P335, DOI 10.1385/1-59259-147-7:335; Wu QL, 1997, J BACTERIOL, V179, P2922, DOI 10.1128/jb.179.9.2922-2929.1997; Zahrt TC, 2001, MOL MICROBIOL, V39, P1174, DOI 10.1046/j.1365-2958.2001.02321.x	55	52	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.388611	http://dx.doi.org/10.1074/jbc.M112.388611			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22992749	hybrid, Green Published			2022-12-28	WOS:000310642200010
J	Illert, AL; Zech, M; Moll, C; Albers, C; Kreutmair, S; Peschel, C; Bassermann, F; Duyster, J				Illert, Anna Lena; Zech, Michael; Moll, Cathrin; Albers, Corinna; Kreutmair, Stefanie; Peschel, Christian; Bassermann, Florian; Duyster, Justus			Extracellular Signal-regulated Kinase 2 (ERK2) Mediates Phosphorylation and Inactivation of Nuclear Interaction Partner of Anaplastic Lymphoma Kinase (NIPA) at G(2)/M	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SCF UBIQUITIN-LIGASE; MAP KINASE; M-PHASE; CYCLIN D1; G1 PHASE; XENOPUS; IDENTIFICATION; PATHWAY; REQUIREMENT	NIPA is an F-box-like protein that contributes to the timing of mitotic entry. It targets nuclear cyclin B1 for ubiquitination in interphase, whereas in G(2)/M phase, NIPA is inactivated by phosphorylation to allow for cyclin B1 accumulation, a critical event for proper G(2)/M transition. We recently specified three serine residues of NIPA and demonstrated a sequential phosphorylation at G(2)/M, where initial Ser-354 and Ser-359 phosphorylation is most crucial for SCFNIPA inactivation. In this study, we identified ERK2 as the kinase responsible for this critical initial phosphorylation step. Using in vitro kinase assays, we found that both ERK1 and ERK2 phosphorylated NIPA with high efficiency. Mutation of either Ser-354 or Ser-359 abolished ERK-dependent NIPA phosphorylation. Pharmacologic inhibition of ERK1/2 in cell lines resulted in decreased NIPA phosphorylation at G(2)/M. By combining cell cycle synchronization with stable expression of shRNA targeting either ERK1 or ERK2, we showed that ERK2 but not ERK1 mediated NIPA inactivation at G(2)/M. ERK2 knockdown led to a delay at the G(2)/M transition, a phenotype also observed in cells expressing a phospho-deficient mutant of NIPA. Thus, our data add to the recently described divergent functions of ERK1 and ERK2 in cell cycle regulation, which may be due in part to the differential ability of these kinases to phosphorylate and inactivate NIPA at G(2)/M.	[Duyster, Justus] Univ Med Ctr Freiburg, Dept Hematol Oncol, D-79106 Freiburg, Germany; [Illert, Anna Lena; Zech, Michael; Moll, Cathrin; Albers, Corinna; Kreutmair, Stefanie; Peschel, Christian; Bassermann, Florian] Tech Univ Munich, Dept Internal Med 3, D-81675 Munich, Germany	University of Freiburg; Technical University of Munich; University of Munich	Duyster, J (corresponding author), Univ Med Ctr Freiburg, Dept Hematol Oncol, Hugstetter Str 55, D-79106 Freiburg, Germany.	direktion-med1@uniklinik-freiburg.de	Illert, Anna L/G-8127-2019; Kreutmair, Stefanie/GOK-2757-2022; Kreutmair, Stefanie/AAE-6952-2022	Kreutmair, Stefanie/0000-0001-8466-6675	Deutsche Jose Carreras Leukamie Stiftung (DJCLS) [R 08/02v]; Wilhelm Sander Stiftung; Technical University of Munich [KKF-B07-08]; German Research Foundation [DU 227/3-1, BA 2851/3-1]; German Cancer Aid Grant [109543]	Deutsche Jose Carreras Leukamie Stiftung (DJCLS); Wilhelm Sander Stiftung; Technical University of Munich; German Research Foundation(German Research Foundation (DFG)); German Cancer Aid Grant	This work was supported by Deutsche Jose Carreras Leukamie Stiftung (DJCLS) Grant R 08/02v and the Wilhelm Sander Stiftung (to J. D.), Technical University of Munich Research Grant KKF-B07-08 (to A. L. I.), German Research Foundation Grant DU 227/3-1 (to A. L. I. and J. D.), and German Research Foundation Grant BA 2851/3-1 and German Cancer Aid Grant 109543 (to F. B.).	Abrieu A, 1997, MOL BIOL CELL, V8, P249, DOI 10.1091/mbc.8.2.249; Abrieu A, 1997, EMBO J, V16, P6407, DOI 10.1093/emboj/16.21.6407; Abrieu A, 2001, J CELL SCI, V114, P257; Albers C, 2011, BLOOD, V118, P2200, DOI 10.1182/blood-2010-10-309583; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Balmanno K, 1999, ONCOGENE, V18, P3085, DOI 10.1038/sj.onc.1202647; Bassermann F, 2005, CELL CYCLE, V4, P1515, DOI 10.4161/cc.4.11.2192; Bassermann F, 2005, CELL, V122, P45, DOI 10.1016/j.cell.2005.04.034; Bassermann F, 2007, J BIOL CHEM, V282, P15965, DOI 10.1074/jbc.M610819200; Bessard A, 2008, ONCOGENE, V27, P5315, DOI 10.1038/onc.2008.163; Bhatt RR, 1999, SCIENCE, V286, P1362, DOI 10.1126/science.286.5443.1362; Bitangcol JC, 1998, MOL BIOL CELL, V9, P451, DOI 10.1091/mbc.9.2.451; Borgne A, 1996, J BIOL CHEM, V271, P27847, DOI 10.1074/jbc.271.44.27847; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Brummer T, 2003, ONCOGENE, V22, P8823, DOI 10.1038/sj.onc.1207185; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chau ASS, 1999, J BIOL CHEM, V274, P32085, DOI 10.1074/jbc.274.45.32085; Chuderland D, 2005, MOL BIOTECHNOL, V29, P57, DOI 10.1385/MB:29:1:57; CorbalanGarcia S, 1996, MOL CELL BIOL, V16, P5674; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dumesic PA, 2009, J CELL BIOL, V185, P409, DOI 10.1083/jcb.200804038; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Fremin C, 2007, HEPATOLOGY, V45, P1035, DOI 10.1002/hep.21551; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; Gross SD, 1999, SCIENCE, V286, P1365, DOI 10.1126/science.286.5443.1365; Guadagno TM, 1998, SCIENCE, V282, P1312, DOI 10.1126/science.282.5392.1312; Hatano N, 2003, GENES CELLS, V8, P847, DOI 10.1046/j.1365-2443.2003.00680.x; Hayne C, 2000, J BIOL CHEM, V275, P31876, DOI 10.1074/jbc.M002766200; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; Hindley A, 2002, J CELL SCI, V115, P1575; Illert AL, 2012, DEVELOPMENT, V139, P2523, DOI 10.1242/dev.073072; KING RW, 1994, CELL, V79, P563, DOI 10.1016/0092-8674(94)90542-8; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; KOSAKO H, 1994, EMBO J, V13, P2131, DOI 10.1002/j.1460-2075.1994.tb06489.x; KREK W, 1991, EMBO J, V10, P3331, DOI 10.1002/j.1460-2075.1991.tb04897.x; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Liu F, 1997, MOL CELL BIOL, V17, P571, DOI 10.1128/MCB.17.2.571; Liu X, 2004, ONCOGENE, V23, P763, DOI 10.1038/sj.onc.1207188; Lloyd Alison C, 2006, J Biol, V5, P13, DOI 10.1186/jbiol46; MACNICOL AM, 1995, MOL CELL BIOL, V15, P6686; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Murakami MS, 1998, DEVELOPMENT, V125, P237; Ouyang T, 2003, J BIOL CHEM, V278, P30028, DOI 10.1074/jbc.M300883200; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Roberts EC, 2002, MOL CELL BIOL, V22, P7226, DOI 10.1128/MCB.22.20.7226-7241.2002; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Tolwinski NS, 1999, J BIOL CHEM, V274, P6168, DOI 10.1074/jbc.274.10.6168; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; von Klitzing C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028998; Walsh S, 2003, MOL CANCER RES, V1, P280; Wang RN, 2007, CELL, V128, P1119, DOI 10.1016/j.cell.2006.11.053; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zecevic M, 1998, J CELL BIOL, V142, P1547, DOI 10.1083/jcb.142.6.1547	65	10	10	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.373464	http://dx.doi.org/10.1074/jbc.M112.373464			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22955283	hybrid, Green Published			2022-12-28	WOS:000310642200034
J	Foley, JP; Lam, D; Jiang, HM; Liao, J; Cheong, N; McDevitt, TM; Zaman, A; Wright, JR; Savani, RC				Foley, Joseph P.; Lam, David; Jiang, Hongmei; Liao, Jie; Cheong, Naeun; McDevitt, Theresa M.; Zaman, Aisha; Wright, Jo Rae; Savani, Rashmin C.			Toll-like Receptor 2 (TLR2), Transforming Growth Factor-beta, Hyaluronan (HA), and Receptor for HA-mediated Motility (RHAMM) Are Required for Surfactant Protein A-stimulated Macrophage Chemotaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PULMONARY SURFACTANT; INNATE IMMUNITY; CELLULAR-RESPONSE; ALPHA SECRETION; CD44; BINDING; INFLAMMATION; COLLECTINS; CELLS; RECOGNITION	The innate immune system protects the host from bacterial and viral invasion. Surfactant protein A (SPA), a lung-specific collectin, stimulates macrophage chemotaxis. However, the mechanisms regulating this function are unknown. Hyaluronan (HA) and its receptors RHAMM (receptor for HA-mediated motility, CD168) and CD44 also regulate cell migration and inflammation. Wetherefore examined the role of HA, RHAMM, and CD44 in SPA-stimulated macrophage chemotaxis. Using antibody blockade and murine macrophages, SPA-stimulated macrophage chemotaxis was dependent on TLR2 but not the other SPA receptors examined. Anti-TLR2 blocked SPA-induced production of TGF beta. In turn, TGF beta 1-stimulated chemotaxis was inhibited by HA-binding peptide and anti-RHAMM antibody but not anti-TLR2 antibody. Macrophages from TLR2(-/-) mice failed to migrate in response to SPA but responded normally to TGF beta 1 and HA, effects that were blocked by anti-RHAMM antibody. Macrophages from WT and CD44(-/-) mice had similar responses to SPA, whereas those from RHAMM(-/-) mice had decreased chemotaxis to SPA, TGF beta 1, and HA. In primary macrophages, SPA-stimulated TGF beta production was dependent on TLR2, JNK, and ERK but notp38.Pam3Cys,a specific TLR2agonist, stimulated phosphorylation of JNK, ERK, and p38, but only JNK and ERK inhibition blocked Pam3Cys-stimulated chemotaxis. We have uncovered a novel pathway for SPA-stimulated macrophage chemotaxis where SPA stimulation via TLR2 drives JNK- and ERK-dependent TGF beta production. TGF beta 1, in turn, stimulates macrophage chemotaxis in a RHAMM and HA-dependent manner. These findings are highly relevant to the regulation of innate immune responses by SPA with key roles for specific components of the extracellular matrix.	[Lam, David; Jiang, Hongmei; Liao, Jie; Cheong, Naeun; Savani, Rashmin C.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Div Pulm & Vasc Biol, Dallas, TX 75390 USA; [Foley, Joseph P.; Savani, Rashmin C.] Univ Sci Philadelphia, Dept Pharmaceut Sci, Div Pharmacol & Toxicol, Philadelphia, PA 19104 USA; [Foley, Joseph P.; McDevitt, Theresa M.; Zaman, Aisha; Savani, Rashmin C.] Univ Penn, Sch Med, Childrens Hosp Philadelphia, Dept Pediat,Div Neonatol, Philadelphia, PA 19104 USA; [Lam, David; Jiang, Hongmei; Liao, Jie; Cheong, Naeun; Savani, Rashmin C.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Div Neonatal Perinatal Med, Dallas, TX 75390 USA; [Wright, Jo Rae] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Texas System; University of Texas Southwestern Medical Center Dallas; Duke University	Savani, RC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Div Pulm & Vasc Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	rashmin.savani@utsouthwestern.edu	Lam, David/AAI-3657-2020; Rashmin C. Savani, MBChB/AAG-2041-2021	Rashmin C. Savani, MBChB/0000-0002-9533-5422	National Institutes of Health [HL62472, HL073896, HL068072]; Seikagaku Corp., Japan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068072, R01HL062472, R01HL073896] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Seikagaku Corp., Japan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL62472 and HL073896 (to R. C. S.) and HL068072 (to J. R. W.). This work was also supported by a Sponsored Research Agreement from Seikagaku Corp., Japan (to R. C. S.).	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Abreu MT, 2004, J PEDIATR-US, V144, P421, DOI 10.1016/j.jpeds.2004.01.057; ADAMS DH, 1991, J IMMUNOL, V147, P609; Adhikary G, 2008, J LEUKOCYTE BIOL, V83, P991, DOI 10.1189/jlb.1107783; Akira S, 2000, BIOCHEM SOC T, V28, P551, DOI 10.1042/bst0280551; Amara FM, 1996, J BIOL CHEM, V271, P15279, DOI 10.1074/jbc.271.25.15279; Borron P, 2000, AM J PHYSIOL-LUNG C, V278, pL840, DOI 10.1152/ajplung.2000.278.4.L840; Chroneos Z, 1995, AM J PHYSIOL-LUNG C, V269, pL721, DOI 10.1152/ajplung.1995.269.6.L721; Chroneos ZC, 1996, J BIOL CHEM, V271, P16375, DOI 10.1074/jbc.271.27.16375; Chroneos ZC, 2010, CELL PHYSIOL BIOCHEM, V25, P13, DOI 10.1159/000272047; Crouch E, 2001, ANNU REV PHYSIOL, V63, P521, DOI 10.1146/annurev.physiol.63.1.521; Crouch E, 2000, IMMUNOL REV, V173, P52, DOI 10.1034/j.1600-065X.2000.917311.x; DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119; DELPECH B, 1985, ANAL BIOCHEM, V149, P555, DOI 10.1016/0003-2697(85)90613-X; ENTWISTLE J, 1995, GENE, V163, P233, DOI 10.1016/0378-1119(95)00398-P; Fieber C, 1999, GENE, V226, P41, DOI 10.1016/S0378-1119(98)00566-6; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; GEERTSMA MF, 1994, AM J PHYSIOL-LUNG C, V267, pL578, DOI 10.1152/ajplung.1994.267.5.L578; HALL CL, 1994, J CELL BIOL, V126, P575, DOI 10.1083/jcb.126.2.575; Hall CL, 1996, ONCOGENE, V13, P2213; HELDIN P, 1989, BIOCHEM J, V258, P919, DOI 10.1042/bj2580919; Huang SP, 2012, CELL SIGNAL, V24, P569, DOI 10.1016/j.cellsig.2011.10.011; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI11638; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Katoh S, 2003, J CLIN INVEST, V111, P1563, DOI 10.1172/JCI200316583; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Kramer BW, 2001, AM J RESP CRIT CARE, V163, P158, DOI 10.1164/ajrccm.163.1.2005084; Kuroki Y, 2007, CELL MICROBIOL, V9, P1871, DOI 10.1111/j.1462-5822.2007.00953.x; McCormack FX, 2002, J CLIN INVEST, V109, P707, DOI 10.1172/JCI200215293; McIntosh JC, 1996, AM J RESP CELL MOL, V15, P509, DOI 10.1165/ajrcmb.15.4.8879185; Murakami S, 2002, J BIOL CHEM, V277, P6830, DOI 10.1074/jbc.M106671200; Nedvetzki S, 1999, J AUTOIMMUN, V13, P39, DOI 10.1006/jaut.1999.0294; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; PURE E, 1995, J EXP MED, V181, P55, DOI 10.1084/jem.181.1.55; Reidy MF, 2003, AM J PHYSIOL-LUNG C, V285, pL854, DOI 10.1152/ajplung.00439.2002; ROBERTS AB, 1990, ANN NY ACAD SCI, V580, P225, DOI 10.1111/j.1749-6632.1990.tb17931.x; SAMUEL SK, 1993, J CELL BIOL, V123, P749, DOI 10.1083/jcb.123.3.749; Sano H, 1999, J IMMUNOL, V163, P387; Sato M, 2003, J IMMUNOL, V171, P417, DOI 10.4049/jimmunol.171.1.417; Savani RC, 2000, AM J RESP CELL MOL, V23, P475, DOI 10.1165/ajrcmb.23.4.3944; SAVANI RC, 1995, J CLIN INVEST, V95, P1158, DOI 10.1172/JCI117764; SAVANI RC, 1995, P W PHARMACOL SOC, V38, P131; SAVANI RC, 2003, LUNG BIOL HEALTH DIS, V168, P73; Savanti R, 2000, BAS CLIN DERMATOL, P115; SHI YF, 1993, J IMMUNOL METHODS, V164, P149, DOI 10.1016/0022-1759(93)90307-S; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; TEDER P, 1995, AM J RESP CELL MOL, V12, P181, DOI 10.1165/ajrcmb.12.2.7532420; Tino MJ, 1999, AM J RESP CELL MOL, V20, P759, DOI 10.1165/ajrcmb.20.4.3439; Tino MJ, 1999, AM J PHYSIOL-LUNG C, V276, pL164, DOI 10.1152/ajplung.1999.276.1.L164; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788; Waters P, 2009, ADV EXP MED BIOL, V653, P74; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; WRIGHT JR, 1993, AM J PHYSIOL, V264, pL338, DOI 10.1152/ajplung.1993.264.4.L338; Yamada C, 2006, J BIOL CHEM, V281, P21771, DOI 10.1074/jbc.M513041200; Yamasaki K, 2009, J BIOL CHEM, V284, P12762, DOI 10.1074/jbc.M806084200; YANG BH, 1994, EMBO J, V13, P286, DOI 10.1002/j.1460-2075.1994.tb06261.x; Zaman A, 2005, AM J RESP CELL MOL, V33, P447, DOI 10.1165/rcmb.2004-0333OC; Zhang SW, 1998, J BIOL CHEM, V273, P11342, DOI 10.1074/jbc.273.18.11342; ZIGMOND SH, 1973, J EXP MED, V137, P387, DOI 10.1084/jem.137.2.387	63	40	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37406	37419		10.1074/jbc.M112.360982	http://dx.doi.org/10.1074/jbc.M112.360982			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22948158	Green Published, hybrid			2022-12-28	WOS:000310588500071
J	Kimberley, FC; van der Sloot, AM; Guadagnoli, M; Cameron, K; Schneider, P; Marquart, JA; Versloot, M; Serrano, L; Medema, JP				Kimberley, Fiona C.; van der Sloot, Almer M.; Guadagnoli, Marco; Cameron, Katherine; Schneider, Pascal; Marquart, J. Arnoud; Versloot, Miranda; Serrano, Luis; Medema, Jan Paul			The Design and Characterization of Receptor-selective APRIL Variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR FAMILY; NF-KAPPA-B; TNF RECEPTOR; BAFF-R; AGONIST ANTIBODY; TACI; LIGAND; APOPTOSIS; BINDING; BCMA	A proliferation-inducing ligand (APRIL), a member of the TNF ligand superfamily with an important role in humoral immunity, is also implicated in several cancers as a prosurvival factor. APRIL binds two different TNF receptors, B cell maturation antigen (BCMA) and transmembrane activator and cylclophilin ligand interactor (TACI), and also interacts independently with heparan sulfate proteoglycans. Because APRIL shares binding of the TNF receptors with B cell activation factor, separating the precise signaling pathways activated by either ligand in a given context has proven quite difficult. In this study, we have used the protein design algorithm FoldX to successfully generate a BCMA-specific variant of APRIL, APRIL-R206E, and two TACI-selective variants, D132F and D132Y. These APRIL variants show selective activity toward their receptors in several in vitro assays. Moreover, we have used these ligands to show that BCMA and TACI have a distinct role in APRIL-induced B cell stimulation. We conclude that these ligands are useful tools for studying APRIL biology in the context of individual receptor activation.	[Kimberley, Fiona C.; Guadagnoli, Marco; Cameron, Katherine; Versloot, Miranda; Medema, Jan Paul] Univ Amsterdam, Acad Med Ctr, Ctr Expt Mol Med, Lab Expt Oncol & Radiobiol, NL-1105 Amsterdam, Netherlands; [van der Sloot, Almer M.; Serrano, Luis] Univ Pompeu Fabra, Ctr Genom Regulat, EMBL CRG Syst Biol Res Unit, Barcelona 08003, Spain; [Schneider, Pascal] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Serrano, Luis] Inst Catalana Rec & Estudis Avancats, Barcelona 08010, Spain	University of Amsterdam; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Lausanne; ICREA	Serrano, L (corresponding author), C Dr Aiguader 88, Barcelona 08003, Spain.	luis.serrano@crg.es; j.p.medema@amc.uva.nl	van der Sloot, Almer/M-7083-2015; Serrano, Luis/B-3355-2013	van der Sloot, Almer/0000-0003-0049-2044; Serrano, Luis/0000-0002-5276-1392; Schneider, Pascal/0000-0003-0677-9409; Medema, Jan Paul/0000-0003-3045-2924	Dutch Cancer Society Grant [UvA 2007-3750]; Swiss National Science Foundation; European Union (PROSPECTS) [HEALTH-F4-2008-201648]; European Union (TRIDENT) [FP6-LIFESCIHEALTH-37686]; Juan de la Cierva fellowship; ICREA Funding Source: Custom	Dutch Cancer Society Grant(KWF Kankerbestrijding); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union (PROSPECTS); European Union (TRIDENT); Juan de la Cierva fellowship; ICREA(ICREA)	This work was supported by Dutch Cancer Society Grant UvA 2007-3750, the Swiss National Science Foundation (to P. S.), and the European Union (PROSPECTS (Grant Agreement HEALTH-F4-2008-201648) and TRIDENT (Grant Agreement FP6-LIFESCIHEALTH-37686); both to L. S.).; Supported in part by a Juan de la Cierva fellowship. Present address: Institute for Research in Immunology and Cancer, Universite de Montreal, Montreal, Quebec H3C 3J7, Canada.	Allen J. E., 2012, MOL CANC TH IN PRESS; Ameloot P, 2001, J BIOL CHEM, V276, P37426, DOI 10.1074/jbc.M102020200; Bischof D, 2006, BLOOD, V107, P3235, DOI 10.1182/blood-2005-01-0256; Bossen C, 2008, BLOOD, V111, P1004, DOI 10.1182/blood-2007-09-110874; Cancro MP, 2008, IMMUNITY, V28, P300, DOI 10.1016/j.immuni.2008.02.010; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; Day ES, 2005, BIOCHEMISTRY-US, V44, P1919, DOI 10.1021/bi048227k; Deshayes F, 2004, ONCOGENE, V23, P3005, DOI 10.1038/sj.onc.1207350; Gardam S, 2008, IMMUNITY, V28, P391, DOI 10.1016/j.immuni.2008.01.009; Guadagnoli M, 2011, BLOOD, V117, P6856, DOI 10.1182/blood-2011-01-330852; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; Hatzoglou A, 2000, J IMMUNOL, V165, P1322, DOI 10.4049/jimmunol.165.3.1322; He B, 2010, NAT IMMUNOL, V11, P836, DOI 10.1038/ni.1914; Hymowitz SG, 2005, J BIOL CHEM, V280, P7218, DOI 10.1074/jbc.M411714200; Ingold K, 2005, J EXP MED, V201, P1375, DOI 10.1084/jem.20042309; Kanno Y, 2010, J RECEPT SIG TRANSD, V30, P121, DOI 10.3109/10799891003634509; Kelley RF, 2005, J BIOL CHEM, V280, P2205, DOI 10.1074/jbc.M410660200; Kim HM, 2003, NAT STRUCT BIOL, V10, P342, DOI 10.1038/nsb925; Kimberley FC, 2009, RESULTS PROBL CELL D, V49, P161, DOI 10.1007/400_2008_19; Kimberley FC, 2009, FASEB J, V23, P1584, DOI 10.1096/fj.08-124669; Lascano V., 2012, CELL DEATH IN PRESS; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; Mhawech-Fauceglia P, 2006, J LEUKOCYTE BIOL, V80, P697, DOI 10.1189/jlb.1105655; Morishige T, 2010, BIOMATERIALS, V31, P3357, DOI 10.1016/j.biomaterials.2010.01.022; Motoki K, 2005, CLIN CANCER RES, V11, P3126, DOI 10.1158/1078-0432.CCR-04-1867; Mullauer FB, 2009, APOPTOSIS, V14, P191, DOI 10.1007/s10495-008-0290-x; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Reis CR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.61; Rennert P, 2000, J EXP MED, V192, P1677, DOI 10.1084/jem.192.11.1677; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Shibata H, 2008, J BIOL CHEM, V283, P998, DOI 10.1074/jbc.M707933200; Swee LK, 2009, J BIOL CHEM, V284, P27567, DOI 10.1074/jbc.M109.042259; Szegezdi E, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013730; Thilenius ARB, 1997, EUR J IMMUNOL, V27, P1108, DOI 10.1002/eji.1830270510; Tur V, 2008, J BIOL CHEM, V283, P20560, DOI 10.1074/jbc.M800457200; Van der Sloot AM, 2006, P NATL ACAD SCI USA, V103, P8634, DOI 10.1073/pnas.0510187103; van der Sloot AM, 2011, ADV EXP MED BIOL, V691, P521, DOI 10.1007/978-1-4419-6612-4_54; Van der Sloot AM, 2009, PROTEIN ENG DES SEL, V22, P537, DOI 10.1093/protein/gzp032; Wu YM, 2000, J BIOL CHEM, V275, P35478, DOI 10.1074/jbc.M005224200; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137; Yu G, 2000, NAT IMMUNOL, V1, P252, DOI 10.1038/79802	45	8	11	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37434	37446		10.1074/jbc.M112.406090	http://dx.doi.org/10.1074/jbc.M112.406090			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22961987	Green Published, hybrid			2022-12-28	WOS:000310588500073
J	Sapparapu, G; Planque, S; Mitsuda, Y; McLean, G; Nishiyama, Y; Paul, S				Sapparapu, Gopal; Planque, Stephanie; Mitsuda, Yukie; McLean, Gary; Nishiyama, Yasuhiro; Paul, Sudhir			Constant Domain-regulated Antibody Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; MYELIN BASIC-PROTEIN; BENCE-JONES PROTEINS; AMYLOID-BETA PEPTIDE; B-CELL; WALDENSTROMS MACROGLOBULINEMIA; IMMUNOGLOBULIN CONSTANT; PROTEOLYTIC ANTIBODIES; RHEUMATOID-ARTHRITIS; CHEMICAL-REACTIVITY	Some antibodies contain variable (V) domain catalytic sites. We report the superior amide and peptide bond-hydrolyzing activity of the same heavy and light chain V domains expressed in the IgM constant domain scaffold compared with the IgG scaffold. The superior catalytic activity of recombinant IgM was evident using two substrates, a small model peptide that is hydrolyzed without involvement of high affinity epitope binding, and HIV gp120, which is recognized specifically by noncovalent means prior to the hydrolytic reaction. The catalytic activity was inhibited by an electrophilic phosphonate diester, consistent with a nucleophilic catalytic mechanism. All 13 monoclonal IgMs tested displayed robust hydrolytic activities varying over a 91-fold range, consistent with expression of the catalytic functions at distinct levels by different V domains. The catalytic activity of polyclonal IgM was superior to polyclonal IgG from the same sera, indicating that on average IgMs express the catalytic function at levels greater than IgGs. The findings indicate a favorable effect of the remote IgM constant domain scaffold on the integrity of the V-domain catalytic site and provide a structural basis for conceiving antibody catalysis as a first line immune function expressed at high levels prior to development of mature IgG class antibodies.	[Sapparapu, Gopal; Planque, Stephanie; Mitsuda, Yukie; McLean, Gary; Nishiyama, Yasuhiro; Paul, Sudhir] Univ Texas Houston, Houston Med Sch, Chem Immunol Res Ctr, Dept Pathol & Lab Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Paul, S (corresponding author), Univ Texas Houston, Houston Med Sch, Chem Immunol Res Ctr, Dept Pathol & Lab Med, 6431 Fannin, Houston, TX 77030 USA.	sudhir.paul@uth.tmc.edu	Mclean, Gary/AAW-9525-2020	Sapparapu, Gopal/0000-0001-9670-1757	National Institutes of Health [AI071951, AI058865, AI067020, AI087527, AI093261]; Richard J. Massey Foundation for Arts and Sciences; Covalent Bioscience Inc; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067020, R41AI087527, R41AI093261, R21AI071951, R01AI058865] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard J. Massey Foundation for Arts and Sciences; Covalent Bioscience Inc; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI071951, AI058865, AI067020, AI087527, and AI093261. This work was also supported by The Richard J. Massey Foundation for Arts and Sciences and Covalent Bioscience Inc. Stephanie Planque, Yasuhiro Nishiyama, and Sudhir Paul have a financial interest in patents covering the catalytic antibody area. These individuals are also advisors for Covalent Bioscience Inc. and have a financial interest in the company.	Alvarez-Twose I, 2012, ALLERGY, V67, P813, DOI 10.1111/j.1398-9995.2012.02812.x; Auclair SM, 2012, PROTEIN SCI, V21, P13, DOI 10.1002/pro.757; BERBERIAN L, 1993, SCIENCE, V261, P1588, DOI 10.1126/science.7690497; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Bose B, 2005, IMMUNOLOGY, V116, P172, DOI 10.1111/j.1365-2567.2005.02208.x; Brown EL, 2012, J BIOL CHEM, V287, P9940, DOI 10.1074/jbc.M111.330043; CHEN TY, 1993, AM J HEMATOL, V44, P276, DOI 10.1002/ajh.2830440411; GAO QS, 1995, J MOL BIOL, V253, P658, DOI 10.1006/jmbi.1995.0580; Gololobov G, 1999, MOL IMMUNOL, V36, P1215, DOI 10.1016/S0161-5890(99)00141-8; Haury M, 1997, EUR J IMMUNOL, V27, P1557, DOI 10.1002/eji.1830270635; Hifumi E, 2008, J BIOL CHEM, V283, P899, DOI 10.1074/jbc.M705674200; Hifumi E, 2012, FASEB J, V26, P1607, DOI 10.1096/fj.11-195339; Janda A, 2010, MOL IMMUNOL, V47, P1421, DOI 10.1016/j.molimm.2010.02.018; KALAGA R, 1995, J IMMUNOL, V155, P2695; Kamalanathan AS, 2010, J MOL RECOGNIT, V23, P577, DOI 10.1002/jmr.1035; Karle S, 2004, AIDS, V18, P329, DOI 10.1097/00002030-200401230-00026; Karle S, 2003, VACCINE, V21, P1213, DOI 10.1016/S0264-410X(02)00504-2; Kriangkum J, 2007, CLIN CANCER RES, V13, P2005, DOI 10.1158/1078-0432.CCR-06-2788; Lacroix-Desmazes S, 2005, P NATL ACAD SCI USA, V102, P4109, DOI 10.1073/pnas.0500586102; Le Minoux D, 2012, MOL IMMUNOL, V50, P160, DOI 10.1016/j.molimm.2012.01.004; Lo Conte L, 1999, J MOL BIOL, V285, P2177; MATSUURA K, 1994, BIOCHEM BIOPH RES CO, V204, P57, DOI 10.1006/bbrc.1994.2425; McLean GR, 2000, MOL IMMUNOL, V37, P837, DOI 10.1016/S0161-5890(00)00101-2; Mitsuda Y, 2007, MOL BIOTECHNOL, V36, P113, DOI 10.1007/s12033-007-0003-7; Murre C, 2007, CURR OPIN GENET DEV, V17, P415, DOI 10.1016/j.gde.2007.08.006; Nishiyama Y, 2005, J MOL RECOGNIT, V18, P295, DOI 10.1002/jmr.734; Nishiyama Y, 2004, J BIOL CHEM, V279, P7877, DOI 10.1074/jbc.M310950200; Nishiyama Y, 2002, ARCH BIOCHEM BIOPHYS, V402, P281, DOI 10.1016/S0003-9861(02)00087-5; Odintsova ES, 2012, J MOL RECOGNIT, V25, P193, DOI 10.1002/jmr.2159; OLEKSYSZYN J, 1994, METHOD ENZYMOL, V244, P423; Paul S, 1997, J IMMUNOL, V159, P1530; Paul S, 2004, J BIOL CHEM, V279, P39611, DOI 10.1074/jbc.M406719200; PAUL S, 1995, J BIOL CHEM, V270, P15257, DOI 10.1074/jbc.270.25.15257; Paul S, 2003, J BIOL CHEM, V278, P20429, DOI 10.1074/jbc.M300870200; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; Paul S, 2001, J BIOL CHEM, V276, P28314, DOI 10.1074/jbc.M102530200; Paul S, 1996, MOL BIOTECHNOL, V5, P197, DOI 10.1007/BF02900358; Planque S, 2004, J BIOL CHEM, V279, P14024, DOI 10.1074/jbc.M312152200; Planque S, 2003, J BIOL CHEM, V278, P20436, DOI 10.1074/jbc.M301468200; Planque S, 2007, AIDS RES HUM RETROV, V23, P1541, DOI 10.1089/aid.2007.0081; Polosukhina DI, 2004, J CELL MOL MED, V8, P359, DOI 10.1111/j.1582-4934.2004.tb00325.x; Ponomarenko NA, 2006, P NATL ACAD SCI USA, V103, P281, DOI 10.1073/pnas.0509849103; Radisky ES, 2006, P NATL ACAD SCI USA, V103, P6835, DOI 10.1073/pnas.0601910103; Raghavan M, 1996, ANNU REV CELL DEV BI, V12, P181, DOI 10.1146/annurev.cellbio.12.1.181; Ramsland PA, 1999, IMMUNOTECHNOLOGY, V4, P217, DOI 10.1016/S1380-2933(98)00025-6; Ramsland PA, 2006, BIOCHEM J, V395, P473, DOI 10.1042/BJ20051739; Rollett RA, 2006, CLIN LYMPHOMA MYELOM, V7, P70, DOI 10.3816/CLM.2006.n.042; Roux KH, 1998, J IMMUNOL, V161, P4083; Sahota SS, 2002, BLOOD, V100, P1505, DOI 10.1182/blood.V100.4.1505.h81602001505_1505_1507; Sapparapu G, 2009, J BIOL CHEM, V284, P24622, DOI 10.1074/jbc.M109.011858; Sharma V, 2009, J BIOL CHEM, V284, P33079, DOI 10.1074/jbc.M109.036087; SHUSTER AM, 1992, SCIENCE, V256, P665, DOI 10.1126/science.1585181; Smirnov I, 2011, P NATL ACAD SCI USA, V108, P15954, DOI 10.1073/pnas.1108460108; Taguchi H, 2008, J BIOL CHEM, V283, P4714, DOI 10.1074/jbc.M707983200; Taguchi H, 2008, J BIOL CHEM, V283, P36724, DOI 10.1074/jbc.M806766200; Torres M, 2005, J IMMUNOL, V174, P2132, DOI 10.4049/jimmunol.174.4.2132; Torres M, 2008, TRENDS IMMUNOL, V29, P91, DOI 10.1016/j.it.2007.11.004; Walsh SH, 2005, LEUKEMIA RES, V29, P729, DOI 10.1016/j.leukres.2004.12.008; Wootla B, 2008, J IMMUNOL, V180, P8455, DOI 10.4049/jimmunol.180.12.8455; Wootla B, 2011, J AUTOIMMUN, V37, P144, DOI 10.1016/j.jaut.2011.05.007; Wootla B, 2011, BLOOD, V117, P2257, DOI 10.1182/blood-2010-07-296103; Yang YH, 2010, RHEUMATOLOGY, V49, P34, DOI 10.1093/rheumatology/kep328	62	12	12	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36096	36104		10.1074/jbc.M112.401075	http://dx.doi.org/10.1074/jbc.M112.401075			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22948159	Green Published, hybrid			2022-12-28	WOS:000310364000031
J	Herzenberg, LA; Herzenberg, LA				Herzenberg, Leonore A.; Herzenberg, Leonard A.			Our NIH Years: A Confluence of Beginnings	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							EPITOPE-SPECIFIC REGULATION; SOMATIC CELL VARIATION; STEM-CELLS; MONOCLONAL-ANTIBODIES; OXYGEN LEVELS; HISTIDINOL PHOSPHATE; ESCHERICHIA-COLI; DENDRITIC CELLS; KV1.3 CHANNELS; MOUSE LYMPHOMA		[Herzenberg, Leonore A.; Herzenberg, Leonard A.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	Stanford University	Herzenberg, LA (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	leeherz@darwin.stanford.edu						AMES BN, 1960, J GEN MICROBIOL, V22, P369, DOI 10.1099/00221287-22-2-369; AMES BN, 1957, J BIOL CHEM, V226, P583; AMES BN, 1955, J BIOL CHEM, V212, P687; Atkuri KR, 2007, P NATL ACAD SCI USA, V104, P4547, DOI 10.1073/pnas.0611732104; Atkuri KR, 2005, P NATL ACAD SCI USA, V102, P3756, DOI 10.1073/pnas.0409910102; Basciano L, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-12; BAUER SR, 1986, J IMMUNOL, V136, P4695; Betts DH, 2008, BIOGERONTOLOGY, V9, P19, DOI 10.1007/s10522-007-9113-7; Brent L, 1997, HUM IMMUNOL, V52, P75, DOI 10.1016/S0198-8859(96)00289-3; Burtis KC, 2003, GENETICS, V164, P1243; Busuttil RA, 2003, AGING CELL, V2, P287, DOI 10.1046/j.1474-9728.2003.00066.x; Caldwell CC, 2001, J IMMUNOL, V167, P6140, DOI 10.4049/jimmunol.167.11.6140; CANN HM, 1963, J EXP MED, V117, P267, DOI 10.1084/jem.117.2.267; CANN HM, 1963, J EXP MED, V117, P259, DOI 10.1084/jem.117.2.259; Coleman AE, 1999, LEUKEMIA, V13, P1592, DOI 10.1038/sj.leu.2401518; Conforti L, 2003, J IMMUNOL, V170, P695, DOI 10.4049/jimmunol.170.2.695; Crow JF, 1996, GENETICS, V144, P855; Csete M, 2005, ANN NY ACAD SCI, V1049, P1, DOI 10.1196/annals.1334.001; DANGL JL, 1982, CYTOMETRY, V2, P395; DANGL JL, 1988, EMBO J, V7, P1989, DOI 10.1002/j.1460-2075.1988.tb03037.x; Das R, 2010, TISSUE ENG PART B-RE, V16, P159, DOI 10.1089/ten.TEB.2009.0296; Diauxie, 2012, DIAUXIE; Forsyth NR, 2006, CLONING STEM CELLS, V8, P16, DOI 10.1089/clo.2006.8.16; Futalan D, 2011, MOL MED, V17, P910, DOI 10.2119/molmed.2011.00031; Goth SR, 2006, J IMMUNOL METHODS, V308, P179, DOI 10.1016/j.jim.2005.10.012; HERZENBERG L, 1961, ARCH BIOCHEM BIOPHYS, V93, P314, DOI 10.1016/0003-9861(61)90270-3; HERZENBERG L, 1961, P NATL ACAD SCI USA, V47, P762, DOI 10.1073/pnas.47.6.762; HERZENBERG LA, 1982, ANN NY ACAD SCI, V399, P368, DOI 10.1111/j.1749-6632.1982.tb25690.x; Herzenberg LA, 2000, IMMUNOL TODAY, V21, P383, DOI 10.1016/S0167-5699(00)01678-9; HERZENBERG LA, 1959, BIOCHIM BIOPHYS ACTA, V31, P525, DOI 10.1016/0006-3002(59)90029-0; Herzenberg LA, 2004, ANNU REV IMMUNOL, V22, P1, DOI 10.1146/annurev.immunol.22.012703.104727; HERZENBERG LA, 1980, EUR J IMMUNOL, V10, P1, DOI 10.1002/eji.1830100102; HERZENBERG LA, 1983, ANNU REV IMMUNOL, V1, P609, DOI 10.1146/annurev.iy.01.040183.003141; HERZENBERG LA, 1960, EXP CELL RES, V21, P430, DOI 10.1016/0014-4827(60)90275-5; HERZENBERG LA, 1971, ANN NY ACAD SCI, V190, P212, DOI 10.1111/j.1749-6632.1971.tb13536.x; Herzenberg L, 2008, ANNU REV GENET, V42, P19, DOI 10.1146/annurev.genet.072408.095841; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; Hirao M, 2007, J BONE MINER METAB, V25, P266, DOI 10.1007/s00774-007-0765-9; HUANG CM, 1983, IMMUNOGENETICS, V18, P311, DOI 10.1007/BF00372464; Ivanovic Z, 2009, J CELL PHYSIOL, V219, P271, DOI 10.1002/jcp.21690; JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102; Jerne NK, 2004, EUR J IMMUNOL, V34, P1234, DOI 10.1002/eji.200425132; MCCANN J, 1976, P NATL ACAD SCI USA, V73, P950, DOI 10.1073/pnas.73.3.950; McCord AM, 2009, MOL CANCER RES, V7, P489, DOI 10.1158/1541-7786.MCR-08-0360; Mehler A.H., 1957, INTRO ENZYMOLOGY; Millman JR, 2009, CURR OPIN ORGAN TRAN, V14, P694, DOI 10.1097/MOT.0b013e3283329d53; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; MORRISON SL, 1984, P NATL ACAD SCI-BIOL, V81, P6851, DOI 10.1073/pnas.81.21.6851; Moussavi-Harami Farid, 2004, Iowa Orthop J, V24, P15; Naldini A, 1997, J CELL PHYSIOL, V173, P335, DOI 10.1002/(SICI)1097-4652(199712)173:3<335::AID-JCP5>3.3.CO;2-T; NATHANS D, 1958, J EXP MED, V108, P121, DOI 10.1084/jem.108.1.121; Oi V T, 1978, Curr Top Microbiol Immunol, V81, P115; OI VT, 1983, P NATL ACAD SCI-BIOL, V80, P825, DOI 10.1073/pnas.80.3.825; OWEN RD, 1945, SCIENCE, V102, P400, DOI 10.1126/science.102.2651.400; OZER H L, 1962, Plast Reconstr Surg, V30, P52; PARKS DR, 1979, P NATL ACAD SCI USA, V76, P1962, DOI 10.1073/pnas.76.4.1962; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; PARSONS M, 1983, IMMUNOGENETICS, V18, P323, DOI 10.1007/BF00372465; Robbins JR, 2005, J PHYSIOL-LONDON, V564, P131, DOI 10.1113/jphysiol.2004.081893; ROOSA RA, 1962, J CELL COMPAR PHYSL, V60, P109, DOI 10.1002/jcp.1030600202; Sahaf B, 2008, P NATL ACAD SCI USA, V105, P5111, DOI 10.1073/pnas.0712363105; Stacpoole SRL, 2011, CELL DEATH DIFFER, V18, P1016, DOI 10.1038/cdd.2010.171; Szablowska-Gadomska I, 2011, ACTA NEUROBIOL EXP, V71, P86; Theory Catastrophe, 2012, CATASTROPHE THEORY; Toussaint O, 2011, J CELL PHYSIOL, V226, P315, DOI 10.1002/jcp.22416; Walther Guenther, 2009, Advances in Bioinformatics, V2009, P686759, DOI 10.1155/2009/686759	66	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					687	702		10.1074/jbc.X112.426742	http://dx.doi.org/10.1074/jbc.X112.426742			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23066019	Green Published, hybrid			2022-12-28	WOS:000313197200069
J	Cahill, KB; Quade, JH; Carleton, KL; Cote, RH				Cahill, Karyn B.; Quade, Jonathan H.; Carleton, Karen L.; Cote, Rick H.			Identification of Amino Acid Residues Responsible for the Selectivity of Tadalafil Binding to Two Closely Related Phosphodiesterases, PDE5 and PDE6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; CATALYTIC SITE; CGMP BINDING; INHIBITORS; POTENCY; ROD; SILDENAFIL; VARDENAFIL; MECHANISM; EFFICACY	The 11 families of the Class I cyclic nucleotide phosphodiesterases (PDEs) are critical for regulation of cyclic nucleotide signaling. PDE5 (important in regulating vascular smooth muscle contraction) and PDE6 (responsible for regulating visual transduction in vertebrate photoreceptors) are structurally similar but have several functional differences whose structural basis is poorly understood. Using evolutionary trace analysis and structural homology modeling in conjunction with site-directed mutagenesis, we have tested the hypothesis that class-specific differences between PDE5 and PDE6 account for the biochemical and pharmacological differences in the two enzyme families. Replacing human PDE5 residues in the M-loop region of the binding site for the PDE5-selective inhibitor tadalafil (Cialis (R)) with the corresponding class-specific cone PDE6 residues (P773E, I778V, E780L, F787W, E796V, D803P, L804M, N806D, I813L, S815K) reduces tadalafil binding affinity to levels characteristic of PDE6. These mutations fail to alter vardenafil (Levitra (R)) affinity for the active site. Class-specific differences in PDE5 versus cone PDE6 that contribute to the accelerated catalytic efficiency of PDE6 were identified but required heterologous expression of full-length PDE5 constructs. Introduction of PDE6 residues into the background of the PDE5 protein sequence often led to loss of catalytic activity and reduced protein solubility, supporting the idea that multiple structural elements of PDE6 are highly susceptible to misfolding during heterologous expression. This work validates the use of PDE5 as a template to identify functional differences between PDE5 and PDE6 that will accelerate efforts to develop the next generation of PDE5-selective inhibitors with fewer adverse side effects resulting from PDE6 inhibition.	[Cahill, Karyn B.; Quade, Jonathan H.; Cote, Rick H.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Carleton, Karen L.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System Of New Hampshire; University of New Hampshire; University System of Maryland; University of Maryland College Park	Cote, RH (corresponding author), Univ New Hampshire, Dept Mol Cellular & Biomed Sci, 46 Coll Rd, Durham, NH 03824 USA.	rick.cote@unh.edu	Cote, Rick H/G-3363-2013	Cote, Rick H/0000-0002-1573-6526; Carleton, Karen/0000-0001-6306-5643	National Institutes of Health [R01 EY05798-24]; New Hampshire Agricultural Experiment Station [2482]; NATIONAL EYE INSTITUTE [R01EY005798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Hampshire Agricultural Experiment Station; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 EY05798-24 (to R. H. C.) Partial funding was provided by the New Hampshire Agricultural Experiment Station; this is Scientific Contribution Number 2482.	Bischoff E, 2004, INT J IMPOT RES, V16, pS11, DOI 10.1038/sj.ijir.3901208; Blount MA, 2004, MOL PHARMACOL, V66, P144, DOI 10.1124/mol.66.1.144; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Card GL, 2004, STRUCTURE, V12, P2233, DOI 10.1016/j.str.2004.10.004; Carleton KL, 2005, J MOL EVOL, V61, P75, DOI 10.1007/s00239-004-0289-z; Chen G, 2008, BIOCHEM PHARMACOL, V75, P1717, DOI 10.1016/j.bcp.2008.01.019; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Cote R.H., 2006, CYCLIC NUCLEOTIDE PH, DOI DOI 10.1201/9781420020847.CH8; Cote RH, 2004, INT J IMPOT RES, V16, pS28, DOI 10.1038/sj.ijir.3901212; Cote RH, 2000, METHOD ENZYMOL, V315, P646; D'Amours MR, 1999, MOL PHARMACOL, V55, P508; Francis S, 2006, CYCLIC NUCLEOTIDE PH, P131; Francis SH, 2011, HANDB EXP PHARMACOL, V204, P47, DOI [10.1007/978-3-642-17969-3_2, 10.1007/978-3-642-13443-2_4]; GILLESPIE PG, 1989, MOL PHARMACOL, V36, P773; Goc A, 2010, J MOL BIOL, V401, P363, DOI 10.1016/j.jmb.2010.06.044; Granovsky AE, 1998, J BIOL CHEM, V273, P24485, DOI 10.1074/jbc.273.38.24485; Granovsky AE, 2001, J BIOL CHEM, V276, P21698, DOI 10.1074/jbc.M100626200; Huai Q, 2004, J BIOL CHEM, V279, P13095, DOI 10.1074/jbc.M311556200; Kajimura N, 2002, J STRUCT BIOL, V139, P27, DOI 10.1016/S1047-8477(02)00502-6; Kerr NM, 2009, CLIN EXP OPHTHALMOL, V37, P514, DOI 10.1111/j.1442-9071.2009.02070.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laties A, 2006, J SEX MED, V3, P12, DOI 10.1111/j.1743-6109.2005.00194.x; Laties AM, 2009, DRUG SAFETY, V32, P1, DOI 10.2165/00002018-200932010-00001; Lichtarge O, 2010, CURR OPIN STRUC BIOL, V20, P351, DOI 10.1016/j.sbi.2010.04.002; Muradov H, 2006, VISION RES, V46, P860, DOI 10.1016/j.visres.2005.09.015; Muradov H, 2009, J BIOL CHEM, V284, P32662, DOI 10.1074/jbc.M109.049916; Piriev N, 2003, MOL VIS, V9, P80; Rybalkin SD, 2003, EMBO J, V22, P469, DOI 10.1093/emboj/cdg051; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sung BJ, 2003, NATURE, V425, P98, DOI 10.1038/nature01914; Supuran CT, 2006, CURR PHARM DESIGN, V12, P3459, DOI 10.2174/138161206778343118; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Tcheudji JFK, 2001, J MOL BIOL, V310, P781, DOI 10.1006/jmbi.2001.4813; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang H, 2008, MOL PHARMACOL, V73, P104, DOI 10.1124/mol.107.040212; Wang HC, 2006, J BIOL CHEM, V281, P21469, DOI 10.1074/jbc.M512527200; White JB, 2004, MOL VIS, V10, P738; Zhang J, 2004, BIOCHEM PHARMACOL, V68, P867, DOI 10.1016/j.bcp.2004.05.015; Zhang KYJ, 2004, MOL CELL, V15, P279, DOI 10.1016/j.molcel.2004.07.005; Zhang XJ, 2005, INVEST OPHTH VIS SCI, V46, P3060, DOI 10.1167/iovs.05-0257; Zoraghi R, 2007, BIOCHEMISTRY-US, V46, P13554, DOI 10.1021/bi7010702	41	25	26	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41406	41416		10.1074/jbc.M112.389189	http://dx.doi.org/10.1074/jbc.M112.389189			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23033484	Green Published, hybrid			2022-12-28	WOS:000311887600053
J	Kikuchi, M; Kuroki, S; Kayama, M; Sakaguchi, S; Lee, KK; Yonehara, S				Kikuchi, Mina; Kuroki, Shunsuke; Kayama, Mitsuhiro; Sakaguchi, Shota; Lee, Kyung-Kwon; Yonehara, Shin			Protease Activity of Procaspase-8 Is Essential for Cell Survival by Inhibiting Both Apoptotic and Nonapoptotic Cell Death Dependent on Receptor-interacting Protein Kinase 1 (RIP1) and RIP3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAS-MEDIATED APOPTOSIS; CASPASE ACTIVATION; MOLECULAR-MECHANISMS; MOUSE CASPASE-8; T-CELLS; PATHWAY; PROLIFERATION; IDENTIFICATION; REQUIREMENT; PROTEOLYSIS	Caspase-8 has an important role as an initiator caspase during death receptor-mediated apoptosis. Moreover, it has been reported to contribute to the regulation of cell fate in various types of cells including T-cells. In this report, we show that caspase-8 has an essential role in cell survival in mouse T-lymphoma-derived L5178Y cells. The knockdown of caspase-8 expression decreased the growth rate and increased cell death, both of which were induced by the absence of protease activity of procaspase-8. The cell death was associated with reactive oxygen species (ROS) accumulation, caspase activation, and autophagosome formation. The cell death was inhibited completely by treatment with ROS scavengers, but only partly by treatment with caspase inhibitors, expression of Bcl-xL, and knockdown of caspase-3 or Atg-7 which completely inhibits apoptosis or autophagosome formation, respectively, indicating that apoptosis and autophagy-associated cell death are induced simultaneously by the knockdown of caspase-8 expression. Further analysis indicated that RIP1 and RIP3 regulate this multiple cell death, because the cell death as well as ROS production was completely inhibited by not only treatment with the RIP1 inhibitor necrostatin-1, but also by knockdown of RIP3. Thus, in the absence of protease activity of procaspase-8, RIP1 and RIP3 simultaneously induce not only nonapoptotic cell death conceivably including autophagic cell death and necroptosis but also apoptosis through ROS production in mouse T-lymphoma cells.	[Yonehara, Shin] Kyoto Univ, Grad Sch Biostudies, Lab Mol & Cellular Biol, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Yonehara, S (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Mol & Cellular Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	yonehara@lif.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; Alnemri ES, 1997, J CELL BIOCHEM, V64, P33, DOI 10.1002/(SICI)1097-4644(199701)64:1<33::AID-JCB6>3.0.CO;2-0; Bell BD, 2008, P NATL ACAD SCI USA, V105, P16677, DOI 10.1073/pnas.0808597105; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Ch'en IL, 2008, P NATL ACAD SCI USA, V105, P17463, DOI 10.1073/pnas.0808043105; Chinnaiyan AM, 1997, SCIENCE, V275, P1122, DOI 10.1126/science.275.5303.1122; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Cowling V, 2002, CELL DEATH DIFFER, V9, P1046, DOI 10.1038/sj.cdd.4401065; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Depraetere V, 1998, SCAND J IMMUNOL, V47, P523; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Inoue S, 2009, CELL DEATH DIFFER, V16, P1053, DOI 10.1038/cdd.2009.29; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Keller N, 2009, STRUCTURE, V17, P438, DOI 10.1016/j.str.2008.12.019; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; Kiriyama M, 2009, MOL CELL BIOL, V29, P4729, DOI 10.1128/MCB.00289-09; Kobayashi Y, 2009, CELL DEATH DIFFER, V16, P139, DOI 10.1038/cdd.2008.136; Lee KK, 2002, J BIOL CHEM, V277, P12351, DOI 10.1074/jbc.M108138200; Leverrier S, 2011, CELL DEATH DIFFER, V18, P90, DOI 10.1038/cdd.2010.69; Murakawa M, 2001, CELL DEATH DIFFER, V8, P298, DOI 10.1038/sj.cdd.4400811; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Okamoto K, 2006, GENES CELLS, V11, P177, DOI 10.1111/j.1365-2443.2006.00927.x; Pop C, 2007, BIOCHEMISTRY-US, V46, P4398, DOI 10.1021/bi602623b; RAZVI ES, 1995, AM J PATHOL, V147, P79; Sakamaki K, 1998, EUR J BIOCHEM, V253, P399, DOI 10.1046/j.1432-1327.1998.2530399.x; Sakamaki K, 2002, CELL DEATH DIFFER, V9, P1196, DOI 10.1038/sj.cdd.4401090; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhang J, 1996, MOL CELL BIOL, V16, P2756; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681	46	33	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41165	41173		10.1074/jbc.M112.419747	http://dx.doi.org/10.1074/jbc.M112.419747			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23071110	Green Published, hybrid			2022-12-28	WOS:000311887600032
J	Vial, D; McKeown-Longo, PJ				Vial, Daniel; McKeown-Longo, Paula J.			Epidermal Growth Factor (EGF) Regulates alpha 5 beta 1 Integrin Activation State in Human Cancer Cell Lines through the p90RSK-dependent Phosphorylation of Filamin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTOR; TUMOR-CELLS; AUTO-INHIBITION; BINDING; ADHESION; RESISTANCE; INVASION; TAIL	Cell adhesion, motility, and invasion are regulated by the ligand-binding activity of integrin receptors, transmembrane proteins that bind to the extracellular matrix. Integrins whose conformation allows for ligand binding and appropriate functional activity are said to be in an active state. Integrin activation and subsequent ligand binding are dynamically regulated by the association of cytoplasmic proteins with integrin intracellular domains. In this study, we evaluated the role of EGF in the regulation of the activation state of the alpha 5 beta 1 integrin receptor for fibronectin. The addition of EGF to either A431 squamous carcinoma cells or DiFi colon cancer cells resulted in loss of alpha 5 beta 1-dependent adhesion to fibronectin but no loss of integrin from the cell surface. EGF activated the EGF receptor/ERK/p90RSK and Rho/Rho kinase signaling pathways. Blocking either pathway inhibited EGF-mediated loss of adhesion, suggesting that they work in parallel to regulate integrin function. EGF treatment also resulted in phosphorylation of filamin A (FLNa), which binds and inactivates beta 1 integrins. EGF-mediated FLNa phosphorylation was completely blocked by an inhibitor of p90RSK and partially attenuated by an inhibitor of Rho kinase, suggesting that both pathways converge on FLNa to regulate integrin function. A431 clonal cell lines expressing non-phosphorylated dominant-negative FLNa were resistant to the inhibitory effects of EGF on integrin function, whereas clonal cell lines overexpressing wild-type FLNa were more sensitive to the inhibitory effect of EGF. These data suggest that EGF-dependent inactivation of alpha 5 beta 1 integrin is regulated through FLNa phosphorylation and cellular contractility.	[Vial, Daniel; McKeown-Longo, Paula J.] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA	Albany Medical College	McKeown-Longo, PJ (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, MC-165,47 New Scotland Ave, Albany, NY 12208 USA.	mckeowp@mail.amc.edu			National Institutes of Health [R01 CA58626]; NATIONAL CANCER INSTITUTE [R01CA058626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA58626.	Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Barkan D, 2011, CLIN CANCER RES, V17, P7219, DOI 10.1158/1078-0432.CCR-11-0642; Cabodi S, 2010, ADV EXP MED BIOL, V674, P43; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Carter CA, 2012, CURR OPIN ONCOL, V24, P123, DOI 10.1097/CCO.0b013e32834ec6a7; Chen HS, 2009, BIOPHYS J, V97, P3095, DOI 10.1016/j.bpj.2009.08.059; Frijns E, 2012, MOL BIOL CELL, V23, P1475, DOI 10.1091/mbc.E11-11-0957; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; Genersch E, 1996, J MOL MED-JMM, V74, P609, DOI 10.1007/s001090050064; Genersch E, 1998, INT J CANCER, V75, P205, DOI 10.1002/(SICI)1097-0215(19980119)75:2<205::AID-IJC7>3.0.CO;2-Y; GROSS ME, 1991, CANCER RES, V51, P1452; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kashyap T, 2011, LAB INVEST, V91, P1414, DOI 10.1038/labinvest.2011.104; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Klein CA, 2011, CURR OPIN GENET DEV, V21, P42, DOI 10.1016/j.gde.2010.10.011; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Lau MT, 2012, CANCER LETT, V320, P198, DOI 10.1016/j.canlet.2012.02.028; MASUI H, 1993, J CELL BIOL, V120, P85, DOI 10.1083/jcb.120.1.85; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; Mehra R, 2011, DRUG RESIST UPDATE, V14, P260, DOI 10.1016/j.drup.2011.08.002; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; O'Callaghan DS, 2010, J THORAC ONCOL, V5, P2024, DOI 10.1097/JTO.0b013e3181f387e4; Pentikainen U, 2009, J MOL BIOL, V393, P644, DOI 10.1016/j.jmb.2009.08.035; Ranganathan A, 2006, ARCH BIOCHEM BIOPHYS, V449, P8, DOI 10.1016/j.abb.2006.02.023; Richards SA, 2001, MOL CELL BIOL, V21, P7470, DOI 10.1128/MCB.21.21.7470-7480.2001; Ricono JM, 2009, CANCER RES, V69, P1383, DOI 10.1158/0008-5472.CAN-08-3612; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Woo MS, 2004, MOL CELL BIOL, V24, P3025, DOI 10.1128/MCB.24.7.3025-3035.2004; Zaru R, 2007, NAT IMMUNOL, V8, P1227, DOI 10.1038/ni1517	33	31	31	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40371	40380		10.1074/jbc.M112.389577	http://dx.doi.org/10.1074/jbc.M112.389577			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23007402	hybrid, Green Published			2022-12-28	WOS:000311448800028
J	Hansen, HG; Schmidt, JD; Soltoft, CL; Ramming, T; Geertz-Hansen, HM; Christensen, B; Sorensen, ES; Juncker, AS; Appenzeller-Herzog, C; Ellgaard, L				Hansen, Henning Gram; Schmidt, Jonas Damgard; Soltoft, Cecilie Lutzen; Ramming, Thomas; Geertz-Hansen, Henrik Marcus; Christensen, Brian; Sorensen, Esben Skipper; Juncker, Agnieszka Sierakowska; Appenzeller-Herzog, Christian; Ellgaard, Lars			Hyperactivity of the Ero1 alpha Oxidase Elicits Endoplasmic Reticulum Stress but No Broad Antioxidant Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE-BOND FORMATION; UNFOLDED PROTEIN RESPONSE; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; REDOX STATE; GLUTATHIONE; GENE; ACTIVATION; ISOMERASE; PATHWAY	Oxidizing equivalents for the process of oxidative protein folding in the endoplasmic reticulum (ER) of mammalian cells are mainly provided by the Ero1 alpha oxidase. The molecular mechanisms that regulate Ero1 alpha activity in order to harness its oxidative power are quite well understood. However, the overall cellular response to oxidative stress generated by Ero1 alpha in the lumen of the mammalian ER is poorly characterized. Here we investigate the effects of overexpressing a hyperactive mutant (C104A/C131A) of Ero1 alpha. We show that Ero1 alpha hyperactivity leads to hyperoxidation of the ER oxidoreductase ERp57 and induces expression of two established unfolded protein response (UPR) targets, BiP (immunoglobulin-binding protein) and HERP (homocysteine-induced ER protein). These effects could be reverted or aggravated by N-acetylcysteine and buthionine sulfoximine, respectively. Because both agents manipulate the cellular glutathione redox buffer, we conclude that the observed effects of Ero1 alpha-C104A/C131A overexpression are likely caused by an oxidative perturbation of the ER glutathione redox buffer. In accordance, we show that Ero1 alpha hyperactivity affects cell viability when cellular glutathione levels are compromised. Using microarray analysis, we demonstrate that the cell reacts to the oxidative challenge caused by Ero1 alpha hyperactivity by turning on the UPR. Moreover, this analysis allowed the identification of two new targets of the mammalian UPR, CRELD1 and c18orf45. Interestingly, a broad antioxidant response was not induced. Our findings suggest that the hyperoxidation generated by Ero1 alpha-C104A/C131A is addressed in the ER lumen and is unlikely to exert oxidative injury throughout the cell.	[Hansen, Henning Gram; Schmidt, Jonas Damgard; Soltoft, Cecilie Lutzen; Appenzeller-Herzog, Christian; Ellgaard, Lars] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen N, Denmark; [Ramming, Thomas; Appenzeller-Herzog, Christian] Univ Basel, Dept Pharmaceut Sci, CH-4056 Basel, Switzerland; [Geertz-Hansen, Henrik Marcus; Juncker, Agnieszka Sierakowska] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Geertz-Hansen, Henrik Marcus; Juncker, Agnieszka Sierakowska] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2970 Horsholm, Denmark; [Geertz-Hansen, Henrik Marcus] Novozymes AS, DK-2800 Bagsvaerd, Denmark; [Christensen, Brian; Sorensen, Esben Skipper] Aarhus Univ, Dept Mol Biol & Genet, Prot Chem Lab, DK-8000 Aarhus, Denmark	University of Copenhagen; University of Basel; Technical University of Denmark; Technical University of Denmark; Novozymes; Aarhus University	Ellgaard, L (corresponding author), Univ Copenhagen, Dept Biol, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	lellgaard@bio.ku.dk	Ellgaard, Lars/I-9034-2014; Appenzeller-Herzog, Christian/A-2894-2014; Søltoft, Cecilie L/B-4901-2015	Ellgaard, Lars/0000-0002-7018-0137; Appenzeller-Herzog, Christian/0000-0001-7430-294X; Søltoft, Cecilie L/0000-0002-3194-0287; Hansen, Henning Gram/0000-0002-2832-730X; Geertz-Hansen, Henrik Marcus/0000-0003-0425-7551; Sorensen, Esben Skipper/0000-0002-7050-3354	Lundbeckfonden; Faculty of Science at the University of Copenhagen; Danish Ministry of Science, Innovation, and Higher Education; Boehringer Ingelheim Fonds; Swiss National Science Foundation; Danish Council for Independent Research (Natural Sciences); Novo Nordisk Fonden; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	Lundbeckfonden(Lundbeckfonden); Faculty of Science at the University of Copenhagen; Danish Ministry of Science, Innovation, and Higher Education; Boehringer Ingelheim Fonds(Boehringer Ingelheim); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Danish Council for Independent Research (Natural Sciences)(Det Frie Forskningsrad (DFF)); Novo Nordisk Fonden(Novo Nordisk Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation)	Supported by a shared Ph.D. scholarship from Lundbeckfonden and the Faculty of Science at the University of Copenhagen and a recipient of an EliteForsk Travel Stipend from the Danish Ministry of Science, Innovation, and Higher Education.; Recipient of a Ph.D. fellowship from the Boehringer Ingelheim Fonds.; Recipient of an Ambizione grant from the Swiss National Science Foundation.; Supported by the Danish Council for Independent Research (Natural Sciences), Novo Nordisk Fonden, and by Lundbeckfonden. To whom correspondence should be addressed: Dept. of Biology, University of Copenhagen, Ole Maaloes Vej 5, 2200 Copenhagen N., Denmark. Tel.: 45-35321725; Fax: 45-35322128; E-mail: lellgaard@bio.ku.dk.	Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Appenzeller-Herzog C, 2008, ANTIOXID REDOX SIGN, V10, P55, DOI 10.1089/ars.2007.1837; Appenzeller-Herzog C, 2011, J CELL SCI, V124, P847, DOI 10.1242/jcs.080895; Appenzeller-Herzog C, 2010, EMBO J, V29, P3318, DOI 10.1038/emboj.2010.203; Araki K, 2011, J BIOL CHEM, V286, P32705, DOI 10.1074/jbc.M111.227181; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Baker KM, 2008, EMBO J, V27, P2988, DOI 10.1038/emboj.2008.230; BANNAI S, 1986, J MEMBRANE BIOL, V89, P1, DOI 10.1007/BF01870891; Benham AM, 2000, EMBO J, V19, P4493, DOI 10.1093/emboj/19.17.4493; Bertoli G, 2004, J BIOL CHEM, V279, P30047, DOI 10.1074/jbc.M403192200; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Bulleid NJ, 2011, TRENDS BIOCHEM SCI, V36, P485, DOI 10.1016/j.tibs.2011.05.004; Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827; Chakravarthi S, 2006, EMBO REP, V7, P271, DOI 10.1038/sj.embor.7400645; Chakravarthi S, 2004, J BIOL CHEM, V279, P39872, DOI 10.1074/jbc.M406912200; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Dean N, 1997, J BIOL CHEM, V272, P31908, DOI 10.1074/jbc.272.50.31908; Dias-Gunasekara S, 2005, J BIOL CHEM, V280, P33066, DOI 10.1074/jbc.M505023200; Garg AD, 2012, EMBO J, V31, P1062, DOI 10.1038/emboj.2011.497; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Heldman N, 2010, PROTEIN SCI, V19, P1863, DOI 10.1002/pro.473; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hsieh YH, 2007, BIOCHEM BIOPH RES CO, V359, P643, DOI 10.1016/j.bbrc.2007.05.154; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Inaba K, 2010, EMBO J, V29, P3330, DOI 10.1038/emboj.2010.222; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Itoh K, 2010, ANTIOXID REDOX SIGN, V13, P1665, DOI 10.1089/ars.2010.3222; Jessop CE, 2004, J BIOL CHEM, V279, P55341, DOI 10.1074/jbc.M411409200; Kaufman RJ, 2010, DIABETES OBES METAB, V12, P99, DOI 10.1111/j.1463-1326.2010.01281.x; Kim S, 2012, J CELL BIOL, V196, P713, DOI 10.1083/jcb.201110090; Kolossov VL, 2012, EXP BIOL MED, V237, P652, DOI 10.1258/ebm.2012.011436; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Mandal PK, 2010, J BIOL CHEM, V285, P22244, DOI 10.1074/jbc.M110.121327; Margittai E, 2012, ANTIOXID REDOX SIGN, V16, P1088, DOI 10.1089/ars.2011.4221; Merksamer PI, 2008, CELL, V135, P933, DOI 10.1016/j.cell.2008.10.011; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Molteni SN, 2004, J BIOL CHEM, V279, P32667, DOI 10.1074/jbc.M404992200; Nguyen VD, 2011, J MOL BIOL, V406, P503, DOI 10.1016/j.jmb.2010.12.039; Oh-hashi K, 2009, BIOCHEM BIOPH RES CO, V387, P504, DOI 10.1016/j.bbrc.2009.07.047; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Rutkevich LA, 2012, MOL BIOL CELL, V23, P2017, DOI 10.1091/mbc.E12-02-0102; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Sevier CS, 2006, MOL BIOL CELL, V17, P2256, DOI 10.1091/mbc.E05-05-0417; Tavender TJ, 2010, ANTIOXID REDOX SIGN, V13, P1177, DOI 10.1089/ars.2010.3230; Tavender TJ, 2010, J CELL SCI, V123, P2672, DOI 10.1242/jcs.067843; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2; Vene R, 2010, ANTIOXID REDOX SIGN, V13, P1145, DOI 10.1089/ars.2009.3078; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang L, 2011, BIOCHEM J, V434, P113, DOI 10.1042/BJ20101357; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Zhang HL, 2012, FASEB J, V26, P1442, DOI 10.1096/fj.11-199869; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010	62	47	52	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.405050	http://dx.doi.org/10.1074/jbc.M112.405050			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23027870	Green Published, hybrid			2022-12-28	WOS:000311233800023
J	Imai, S; Osawa, M; Mita, K; Toyonaga, S; Machiyama, A; Ueda, T; Takeuchi, K; Oiki, S; Shimada, I				Imai, Shunsuke; Osawa, Masanori; Mita, Kenichiro; Toyonaga, Shou; Machiyama, Asako; Ueda, Takumi; Takeuchi, Koh; Oiki, Shigetoshi; Shimada, Ichio			Functional Equilibrium of the KcsA Structure Revealed by NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM-CHANNEL; QUANTITATIVE DESCRIPTION; INACTIVATION; SELECTIVITY; STABILITY; NANODISCS; MECHANISM; PROTEINS; LIPIDS	KcsA is a tetrameric K+ channel that is activated by acidic pH. Under open conditions of the helix bundle crossing, the selectivity filter undergoes an equilibrium between permeable and impermeable conformations. Here we report that the population of the permeable conformation (p(perm)) positively correlates with the tetrameric stability and that the population in reconstituted high density lipoprotein, where KcsA is surrounded by the lipid bilayer, is lower than that in detergent micelles, indicating that dynamic properties of KcsA are different in these two media. Perturbation of the membrane environment by the addition of 1-3% 2,2,2-trifluoroethanol increases p(perm) and the open probability, revealed by NMR and single-channel recording analyses. These results demonstrate that KcsA inactivation is determined not only by the protein itself but also by the surrounding membrane environments.	[Imai, Shunsuke; Osawa, Masanori; Toyonaga, Shou; Machiyama, Asako; Ueda, Takumi; Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Mita, Kenichiro; Oiki, Shigetoshi] Univ Fukui, Fac Med Sci, Dept Mol Physiol & Biophys, Fukui 9101193, Japan; [Takeuchi, Koh; Shimada, Ichio] Natl Inst Adv Ind Sci & Technol, BIRC, Koto Ku, Tokyo 1350064, Japan	University of Tokyo; University of Fukui; National Institute of Advanced Industrial Science & Technology (AIST)	Shimada, I (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	shimada@iw-nmr.f.u-tokyo.ac.jp	Takeuchi, Koh/B-4971-2010; Osawa, Masanori/GRS-5726-2022	Takeuchi, Koh/0000-0002-6227-4627; Mita, Kenichiro/0000-0001-7177-110X; Imai, Shunsuke/0000-0001-9346-2359; Oiki, Shigetoshi/0000-0002-8438-6750; Osawa, Masanori/0000-0002-1285-4316	Japan New Energy and Industrial Technology Development Organization (NEDO); Ministry of Economy, Trade, and Industry (METI); Japanese Ministry of Education, Culture, Sports, Science, and Technology; Takeda Science Foundation; Grants-in-Aid for Scientific Research [23790064] Funding Source: KAKEN	Japan New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Economy, Trade, and Industry (METI); Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Japan New Energy and Industrial Technology Development Organization (NEDO) and the Ministry of Economy, Trade, and Industry (METI) (to I. S.), a grant-in-aid for Scientific Research on Priority Areas from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (to M. O. and I. S.), and a grant from the Takeda Science Foundation (to M. O.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; Chakrapani S, 2007, J GEN PHYSIOL, V130, P479, DOI 10.1085/jgp.200709844; Chakrapani S, 2007, J GEN PHYSIOL, V130, P465, DOI 10.1085/jgp.200709843; Chakrapani S, 2011, NAT STRUCT MOL BIOL, V18, P67, DOI 10.1038/nsmb.1968; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cuello LG, 1998, BIOCHEMISTRY-US, V37, P3229, DOI 10.1021/bi972997x; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Fedida D, 2001, PROG BIOPHYS MOL BIO, V75, P165, DOI 10.1016/S0079-6107(01)00006-2; Hong DP, 1999, J AM CHEM SOC, V121, P8427, DOI 10.1021/ja990833t; Imai S, 2010, P NATL ACAD SCI USA, V107, P6216, DOI 10.1073/pnas.0911270107; Irie K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1797; Iwamoto M, 2006, J BIOL CHEM, V281, P28379, DOI 10.1074/jbc.M602018200; Luo PZ, 1997, BIOCHEMISTRY-US, V36, P8413, DOI 10.1021/bi9707133; McCoy JG, 2012, BBA-BIOMEMBRANES, V1818, P272, DOI 10.1016/j.bbamem.2011.09.007; NELSON J W, 1986, Proteins Structure Function and Genetics, V1, P211, DOI 10.1002/prot.340010303; Shenkarev ZO, 2009, BIOCHEMISTRY-MOSCOW+, V74, P756, DOI 10.1134/S0006297909070086; Shimizu H, 2008, CELL, V132, P67, DOI 10.1016/j.cell.2007.11.040; Takeuchi K, 2007, J BIOL CHEM, V282, P15179, DOI 10.1074/jbc.M608264200; Uysal S, 2009, P NATL ACAD SCI USA, V106, P6644, DOI 10.1073/pnas.0810663106; Valiyaveetil FI, 2002, BIOCHEMISTRY-US, V41, P10771, DOI 10.1021/bi026215y; van Dalen A, 2002, FEBS LETT, V525, P33, DOI 10.1016/S0014-5793(02)03061-2; van den Brink-van der Laan E, 2004, BIOCHEMISTRY-US, V43, P4240, DOI 10.1021/bi036129d; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	28	42	42	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.401265	http://dx.doi.org/10.1074/jbc.M112.401265			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23024361	Green Published, hybrid			2022-12-28	WOS:000311233800033
J	Liu, YY; Lv, KS; Li, ZL; Yu, ACH; Chen, JG; Teng, JL				Liu, Yingying; Lv, Kaosheng; Li, Zenglong; Yu, Albert C. H.; Chen, Jianguo; Teng, Junlin			PACSIN1, a Tau-interacting Protein, Regulates Axonal Elongation and Branching by Facilitating Microtubule Instability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; CULTURED HIPPOCAMPAL-NEURONS; SYNDAPIN-I; DYNAMIC MICROTUBULES; PHOSPHORYLATION; ORGANIZATION; ACTIN; MEMBRANE; ISOFORMS; TUBULIN	Tau is a major member of the neuronal microtubule-associated proteins. It promotes tubulin assembly and stabilizes axonal microtubules. Previous studies have demonstrated that Tau forms cross-bridges between microtubules, with some particles located on cross-bridges, suggesting that some proteins interact with Tau and might be involved in regulating Tau-related microtubule dynamics. This study reports that PACSIN1 interacts with Tau in axon. PACSIN1 blockade results in impaired axonal elongation and a higher number of primary axonal branches in mouse dorsal root ganglia neurons, which is induced by increasing the binding ability of Tau to microtubules. In PACSIN1-blocked dorsal root ganglia neurons, a greater amount of Tau is inclined to accumulate in the central domain of growth cones, and it promotes the stability of the microtubule network. Taken together, these results suggest that PACSIN1 is an important Tau binding partner in regulating microtubule dynamics and forming axonal plasticity.	[Liu, Yingying; Lv, Kaosheng; Li, Zenglong; Chen, Jianguo; Teng, Junlin] Peking Univ, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing 100871, Peoples R China; [Liu, Yingying; Lv, Kaosheng; Li, Zenglong; Chen, Jianguo; Teng, Junlin] Peking Univ, State Key Lab Biomembrane & Membrane Bioengn, Coll Life Sci, Beijing 100871, Peoples R China; [Chen, Jianguo] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China; [Yu, Albert C. H.] Peking Univ, Neurosci Res Inst, Dept Neurobiol, Sch Basic Med Sci,Key Lab Neurosci,Minist Educ, Beijing 100191, Peoples R China; [Yu, Albert C. H.] Peking Univ, Neurosci Res Inst, Dept Neurobiol, Sch Basic Med Sci,Key Lab Neurosci,Minist Publ Hl, Beijing 100191, Peoples R China	Peking University; Peking University; Peking University; Peking University; Peking University	Chen, JG (corresponding author), Peking Univ, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing 100871, Peoples R China.	chenjg@pku.edu.cn; junlinteng@pku.edu.cn			National Natural Science Foundation of China [30670659, 31071177]; Major State Basic Research Development Program of China (973 Program) [2010CB833705]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China Grants 30670659 and 31071177 and Major State Basic Research Development Program of China (973 Program) Grant 2010CB833705.	Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Biernat J, 2002, MOL BIOL CELL, V13, P4013, DOI 10.1091/mbc.02-03-0046; Black MM, 1996, J NEUROSCI, V16, P3601; Braun A, 2005, MOL BIOL CELL, V16, P3642, DOI 10.1091/mbc.E05-01-0076; Buck KB, 2002, J NEUROSCI, V22, P9358; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; Clayton EL, 2009, J NEUROSCI, V29, P7706, DOI 10.1523/JNEUROSCI.1976-09.2009; Dent EW, 1999, J NEUROSCI, V19, P8894, DOI 10.1523/JNEUROSCI.19-20-08894.1999; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; Dharmalingam E, 2009, J NEUROSCI, V29, P13315, DOI 10.1523/JNEUROSCI.3973-09.2009; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; GOEDERT M, 1991, TRENDS NEUROSCI, V14, P193, DOI 10.1016/0166-2236(91)90105-4; Grimm-Gunter EMS, 2008, EXP CELL RES, V314, P1991, DOI 10.1016/j.yexcr.2008.03.015; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; HIROKAWA N, 1994, CURR OPIN CELL BIOL, V6, P74, DOI 10.1016/0955-0674(94)90119-8; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; HUGHES GB, 1981, OTOLARYNG HEAD NECK, V89, P767, DOI 10.1177/019459988108900515; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; KANAI Y, 1992, EMBO J, V11, P3953, DOI 10.1002/j.1460-2075.1992.tb05489.x; KANAI Y, 1989, J CELL BIOL, V109, P1173, DOI 10.1083/jcb.109.3.1173; Kessels MM, 2002, EMBO J, V21, P6083, DOI 10.1093/emboj/cdf604; Kornack DR, 2005, CURR OPIN NEUROBIOL, V15, P58, DOI 10.1016/j.conb.2005.01.009; Li HH, 2006, J CELL SCI, V119, P4452, DOI 10.1242/jcs.03219; Mantych KB, 2001, J NEUROSCI, V21, P6802, DOI 10.1523/JNEUROSCI.21-17-06802.2001; Modregger J, 2000, J CELL SCI, V113, P4511; Modregger J, 2002, HUM MOL GENET, V11, P2547, DOI 10.1093/hmg/11.21.2547; OKABE S, 1990, NATURE, V343, P479, DOI 10.1038/343479a0; Plomann M, 1998, EUR J BIOCHEM, V256, P201, DOI 10.1046/j.1432-1327.1998.2560201.x; Poulain FE, 2007, MOL CELL NEUROSCI, V34, P137, DOI 10.1016/j.mcn.2006.10.012; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Rao YJ, 2010, P NATL ACAD SCI USA, V107, P8213, DOI 10.1073/pnas.1003478107; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Sang HC, 2001, NEUROSCI LETT, V312, P141, DOI 10.1016/S0304-3940(01)02206-6; Sergeant N, 2005, BBA-MOL BASIS DIS, V1739, P179, DOI 10.1016/j.bbadis.2004.06.020; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Teng JL, 2001, J CELL BIOL, V155, P65, DOI 10.1083/jcb.200106025; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; Wagner U, 1996, J CELL SCI, V109, P1537; Wang Q, 2009, P NATL ACAD SCI USA, V106, P12700, DOI 10.1073/pnas.0902974106; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Witte H, 2008, CURR OPIN NEUROBIOL, V18, P479, DOI 10.1016/j.conb.2008.09.019; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; YU WQ, 1994, J NEUROSCI, V14, P5872	46	22	24	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.403451	http://dx.doi.org/10.1074/jbc.M112.403451			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23035120	Green Published, hybrid			2022-12-28	WOS:000311233800059
J	Wu, YC; Liu, CY; Chen, YH; Chen, RF; Huang, CJ; Wang, IJ				Wu, Yu-Ching; Liu, Chia-Yang; Chen, Yau-Hung; Chen, Ruei-Feng; Huang, Chang-Jen; Wang, I-Jong			Blood Vessel Epicardial Substance (Bves) Regulates Epidermal Tight Junction Integrity through Atypical Protein Kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION MOLECULE JAM; CELL POLARITY; SKELETAL-MUSCLE; PHOSPHORYLATION; EPITHELIA; BARRIER; COMPLEX; PAR-3	Bves is widely observed in the cell junction of the skin, epicardium, intestine, and cornea of both developmental embryos and mature adults. However, it is not clear how Bves confers its role in intercellular adhesion. Here, we identified the zebrafish bves (zBves) and found that the epidermal barrier function could be disrupted after knockdown of Bves, and these zBves morphants were sensitive to osmotic stress. A loss of zBves would affect the partitioning defective protein (PAR) junctional complex identified by the rescue experiment with tjp-2/ZO-2 or the PAR complex (par-3, par-6, and prkci/atypical (a)PKC) mRNAs, in which the survival rate of embryos increased 11, 24, 25, and 28%, respectively, after injection with junctional components; the tjp-2 and aPKC mRNA-rescued embryos also had 24 and 45% decreases in the defective rate. Immunofluorescent studies demonstrated that the aggregation of aPKC around the cell junctions had disintegrated in zBves morphants. However, the expression and assembly of zBves were not influenced by aPKC-MO. These results indicate that a loss of zBves affects the proteins involved in the pathway of the PAR junctional complex, especially aPKC, and both aPKC and Bves are indispensable to claudin expression.	[Wu, Yu-Ching; Chen, Ruei-Feng] Natl Taiwan Univ, Inst Zool, Coll Life Sci, Taipei 10673, Taiwan; [Liu, Chia-Yang] Univ Cincinnati, Coll Med, Dept Ophthalmol, Grad Program Neurosci, Cincinnati, OH 45267 USA; [Chen, Yau-Hung] Tamkang Univ, Grad Inst Life Sci, Tamsui 25137, Taiwan; [Huang, Chang-Jen] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Wang, I-Jong] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei 10002, Taiwan	Academia Sinica - Taiwan; National Taiwan University; University System of Ohio; University of Cincinnati; Tamkang University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital	Wang, IJ (corresponding author), Natl Taiwan Univ Hosp, Dept Ophthalmol, Chug Shan S Rd, Taipei 100, Taiwan.	ijong@ms8.hinet.net		CHEN, RUEI-FENG/0000-0002-7505-5415; Liu, Chia-yang/0000-0002-8398-5516; Wang, I-Jong/0000-0002-3045-0614	National Science Council [983112B002040, 993112B002029, 992314B002039MY3]; National Taiwan University Hospital [98S-1105]	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This work was supported in part by National Science Council Grants 983112B002040, 993112B002029, and 992314B002039MY3 and by National Taiwan University Hospital Grant 98S-1105.	Andree B, 2000, DEV BIOL, V223, P371, DOI 10.1006/dbio.2000.9751; Andree B, 2002, MOL CELL BIOL, V22, P1504, DOI 10.1128/MCB.22.5.1504-1512.2002; Aono S, 2008, EXP CELL RES, V314, P3326, DOI 10.1016/j.yexcr.2008.08.012; Bilder D, 2001, CURR BIOL, V11, pR132, DOI 10.1016/S0960-9822(01)00060-4; Denning MF, 2007, J INVEST DERMATOL, V127, P742, DOI 10.1038/sj.jid.5700694; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Helfrich I, 2007, J INVEST DERMATOL, V127, P782, DOI 10.1038/sj.jid.5700621; Itoh M, 2001, J CELL BIOL, V154, P491, DOI 10.1083/jcb.200103047; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Osler ME, 2005, J CELL SCI, V118, P4667, DOI 10.1242/jcs.02588; Reese DE, 1999, DEV BIOL, V209, P159, DOI 10.1006/dbio.1999.9246; Ripley AN, 2004, INVEST OPHTH VIS SCI, V45, P2475, DOI 10.1167/iovs.04-0013; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Suzuki T, 2009, P NATL ACAD SCI USA, V106, P61, DOI 10.1073/pnas.0802741106; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Westerfield M., 1995, ZEBRAFISH BOOK, P2; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Yamanaka T, 2001, GENES CELLS, V6, P721, DOI 10.1046/j.1365-2443.2001.00453.x	19	14	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.372078	http://dx.doi.org/10.1074/jbc.M112.372078			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23019331	hybrid, Green Published			2022-12-28	WOS:000311233800057
J	Butt, AQ; Ahmed, S; Maratha, A; Miggin, SM				Butt, Aisha Qasim; Ahmed, Suaad; Maratha, Ashwini; Miggin, Sinead M.			14-3-3 is an element of and 14-3-3 sigma Inhibit Toll-like Receptor (TLR)-mediated Proinflammatory Cytokine Induction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MYD88 ADAPTER-LIKE; RNA VIRUSES; PROTEINS; EPSILON; RECOGNITION; PATHWAY; OSTEOARTHRITIS; ACTIVATION; COMPONENTS	Toll-like receptors (TLRs) are a group of pattern recognition receptors that play a crucial role in the induction of the innate immune response against bacterial and viral infections. TLR3 has emerged as a key sensor of viral double-stranded RNA. Thus, a clearer understanding of the biological processes that modulate TLR3 signaling is essential. Limited studies have applied proteomics toward understanding the dynamics of TLR signaling. Herein, a proteomics approach identified 14-3-3 is an element of and 14-3-3 sigma proteins as new members of the TLR signaling complex. Toward the functional characterization of 14-3-3 is an element of and 14-3-3 sigma in TLR signaling, we have shown that both of these proteins impair TLR2, TLR3, TLR4, TLR7/8, and TLR9 ligand-induced IL-6, TNF alpha, and IFN-beta production. We also show that 14-3-3 is an element of and 14-3-3 sigma impair TLR2-, TLR3-, TLR4-, TLR7/8-, and TLR9-mediated NF-kappa B and IFN-beta reporter gene activity. Interestingly, although the 14-3-3 proteins inhibit poly(I: C)mediated RANTES production, 14-3-3 proteins augment Pam(3)CSK(4), LPS, R848, and CpG-mediated production of RANTES (regulated on activation normal T cell expressed and secreted) in a Mal (MyD88 adaptor-like)/MyD88-dependent manner. 14-3-3 is an element of and 14-3-3 sigma also bind to the TLR adaptors and to both TRAF3 and TRAF6. Our study conclusively shows that 14-3-3 is an element of and 14-3-3 sigma play a major regulatory role in balancing the host inflammatory response to viral and bacterial infections through modulation of the TLR signaling pathway. Thus, manipulation of 14-3-3 proteins may represent novel therapeutic targets for inflammatory conditions and infections.	[Butt, Aisha Qasim; Ahmed, Suaad; Maratha, Ashwini; Miggin, Sinead M.] Natl Univ Ireland, Dept Biol, Inst Immunol, Immune Signaling Grp, Maynooth, Kildare, Ireland	Maynooth University	Miggin, SM (corresponding author), Natl Univ Ireland, Dept Biol, Inst Immunol, Immune Signaling Grp, Maynooth, Kildare, Ireland.	sinead.miggin@nuim.ie			Science Foundation Ireland award	Science Foundation Ireland award(Science Foundation Ireland)	This work was supported by a Science Foundation Ireland award (to S. M.).	Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Faisal A, 2008, J BIOL CHEM, V283, P18591, DOI 10.1074/jbc.M710330200; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; HEUKESHOVEN J, 1985, J CHROMATOGR, V326, P91, DOI 10.1016/S0021-9673(01)87434-3; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Kumar D, 2009, J IMMUNOL, V182, P1011, DOI 10.4049/jimmunol.182.2.1011; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Liu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030873; Matijevic T, 2010, CURR PHARM DESIGN, V16, P1081, DOI 10.2174/138161210790963779; McCormack WJ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2729; Miggin SM, 2006, J LEUKOCYTE BIOL, V80, P220, DOI 10.1189/jlb.1105672; Mullen E, 2010, INT J MOL MED, V25, P445, DOI 10.3892/ijmm_00000364; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Obsilova V, 2008, PHYSIOL RES, V57, pS11, DOI 10.33549/physiolres.931598; Ohman T, 2010, J PROTEOME RES, V9, P1549, DOI 10.1021/pr901040u; Qi WQ, 2005, INT J CANCER, V113, P359, DOI 10.1002/ijc.20492; Sacre SM, 2007, AM J PATHOL, V170, P518, DOI 10.2353/ajpath.2007.060657; Saurin AT, 2008, NAT CELL BIOL, V10, P891, DOI 10.1038/ncb1749; Scanzello CR, 2008, CURR OPIN RHEUMATOL, V20, P565, DOI 10.1097/BOR.0b013e32830aba34; Schuster TB, 2011, J PROTEOME RES, V10, P4661, DOI 10.1021/pr200461p; Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159; Siednienko J, 2011, J BIOL CHEM, V286, P44750, DOI 10.1074/jbc.M111.250894; Siednienko J, 2011, J IMMUNOL, V186, P2514, DOI 10.4049/jimmunol.1003093; Siednienko J, 2010, EUR J IMMUNOL, V40, P3150, DOI 10.1002/eji.201040547; Vercammen E, 2008, CLIN MICROBIOL REV, V21, P13, DOI 10.1128/CMR.00022-07; Wickremasinghe MI, 2004, J BIOL CHEM, V279, P27199, DOI 10.1074/jbc.M403107200; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yu M, 2011, CYTOKINE GROWTH F R, V22, P63, DOI 10.1016/j.cytogfr.2011.02.001; Zhao J, 2011, SEMIN CELL DEV BIOL, V22, P705, DOI 10.1016/j.semcdb.2011.09.012; Zhou Y, 2010, IMMUNOLOGY, V131, P40, DOI 10.1111/j.1365-2567.2010.03270.x; Zuo SA, 2010, J PROTEOME RES, V9, P3465, DOI 10.1021/pr9011377	37	26	27	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38665	38679		10.1074/jbc.M112.367490	http://dx.doi.org/10.1074/jbc.M112.367490			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22984265	hybrid, Green Published			2022-12-28	WOS:000310982800026
J	Hougland, JL; Gangopadhyay, SA; Fierke, CA				Hougland, James L.; Gangopadhyay, Soumyashree A.; Fierke, Carol A.			Expansion of Protein Farnesyltransferase Specificity Using "Tunable" Active Site Interactions DEVELOPMENT OF BIOENGINEERED PRENYLATION PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL DETERMINANTS; SUBSTRATE-SPECIFICITY; K-RAS; PEPTIDE; FARNESYL; GERANYLGERANYLTRANSFERASE; PRENYLTRANSFERASES; ISOPRENYLATION; TRANSFERASE; ENZYMOLOGY	Post-translational modifications play essential roles in regulating protein structure and function. Protein farnesyltransferase (FTase) catalyzes the biologically relevant lipidation of up to several hundred cellular proteins. Site-directed mutagenesis of FTase coupled with peptide selectivity measurements demonstrates that molecular recognition is determined by a combination of multiple interactions. Targeted randomization of these interactions yields FTase variants with altered and, in some cases, bio-orthogonal selectivity. We demonstrate that FTase specificity can be "tuned" using a small number of active site contacts that play essential roles in discriminating against non-substrates in the wild-type enzyme. This tunable selectivity extends in vivo, with FTase variants enabling the creation of bioengineered parallel prenylation pathways with altered substrate selectivity within a cell. Engineered FTase variants provide a novel avenue for probing both the selectivity of prenylation pathway enzymes and the effects of prenylation pathway modifications on the cellular function of a protein.	[Hougland, James L.] Syracuse Univ, Dept Chem, Ctr Sci & Technol 1 014, Syracuse, NY 13244 USA; [Fierke, Carol A.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	Syracuse University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hougland, JL (corresponding author), Syracuse Univ, Dept Chem, Ctr Sci & Technol 1 014, Syracuse, NY 13244 USA.	hougland@syr.edu; fierke@umich.edu	Gangopadhyay, Soumyashree/J-1172-2019	Gangopadhyay, Soumyashree/0000-0002-8764-1788; Hougland, James/0000-0003-0444-1017	National Institutes of Health Grant [GM040602]; National Institutes of Health Postdoctoral Fellowship [GM078894]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM040602, R01GM040602, F32GM078894] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM040602 (to C. A. F.) and National Institutes of Health Postdoctoral Fellowship GM078894 (to J. L. H.).	Allal C, 2000, J BIOL CHEM, V275, P31001, DOI 10.1074/jbc.M005264200; Allal C, 2002, CELL CYCLE, V1, P430, DOI 10.4161/cc.1.6.272; Benetka W, 2006, MONATSH CHEM, V137, P1241, DOI 10.1007/s00706-006-0534-9; Bergo MO, 2000, J BIOL CHEM, V275, P17605, DOI 10.1074/jbc.C000079200; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; CASEY PJ, 1994, CURR OPIN CELL BIOL, V6, P219, DOI 10.1016/0955-0674(94)90139-2; CASSIDY PB, 1995, METHOD ENZYMOL, V250, P30; Chen Z, 2000, J BIOL CHEM, V275, P41251, DOI 10.1074/jbc.M006687200; Crowell DN, 2000, PROG LIPID RES, V39, P393, DOI 10.1016/S0163-7827(00)00010-2; Erijman A, 2011, BIOCHEMISTRY-US, V50, P602, DOI 10.1021/bi101563v; FERSHT A, 1999, STRUCTURE MECH PROTE, P110; Fu HW, 1999, RECENT PROG HORM RES, V54, P315; GOLDSTEIN JL, 1991, J BIOL CHEM, V266, P15575; Hanker AB, 2010, ONCOGENE, V29, P380, DOI 10.1038/onc.2009.336; Hedstrom L, 1996, BIOL CHEM, V377, P465; Hicks KA, 2005, BIOCHEMISTRY-US, V44, P15325, DOI 10.1021/bi050951v; Hightower KE, 2001, BIOCHEMISTRY-US, V40, P1002, DOI 10.1021/bi002237d; Hightower KE, 1998, BIOCHEMISTRY-US, V37, P15555, DOI 10.1021/bi981525v; Hougland JL, 2010, J MOL BIOL, V395, P176, DOI 10.1016/j.jmb.2009.10.038; Hougland JL, 2009, BIOCHEMISTRY-US, V48, P1691, DOI 10.1021/bi801710g; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kho Y, 2004, P NATL ACAD SCI USA, V101, P12479, DOI 10.1073/pnas.0403413101; Krzysiak AJ, 2007, BIOORG MED CHEM LETT, V17, P5548, DOI 10.1016/j.bmcl.2007.08.024; Krzysiak AJ, 2010, BIOORG MED CHEM LETT, V20, P767, DOI 10.1016/j.bmcl.2009.11.011; Kurth T, 1997, BIOCHEMISTRY-US, V36, P10098, DOI 10.1021/bi970937l; London N, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002170; Marino F, 2010, J BIOL CHEM, V285, P19145, DOI 10.1074/jbc.M110.119875; MARSHALL CJ, 1993, SCIENCE, V259, P1865, DOI 10.1126/science.8456312; Maurer-Stroh S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r55; Maurer-Stroh S, 2007, PLOS COMPUT BIOL, V3, P634, DOI 10.1371/journal.pcbi.0030066; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; MOORES SL, 1991, J BIOL CHEM, V266, P14603; Nguyen UTT, 2009, NAT CHEM BIOL, V5, P227, DOI 10.1038/nchembio.149; OMER CA, 1993, BIOCHEMISTRY-US, V32, P5167, DOI 10.1021/bi00070a028; Onono FO, 2010, MOL CELL PROTEOMICS, V9, P742, DOI 10.1074/mcp.M900597-MCP200; Patrick WM, 2003, PROTEIN ENG, V16, P451, DOI 10.1093/protein/gzg057; Pickett JS, 2003, BIOCHEMISTRY-US, V42, P9741, DOI 10.1021/bi0346852; Reid TS, 2004, J MOL BIOL, V343, P417, DOI 10.1016/j.jmb.2004.08.056; Reigard SA, 2005, BIOCHEMISTRY-US, V44, P11214, DOI 10.1021/bi050725l; REISS Y, 1991, J BIOL CHEM, V266, P10672; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Terry KL, 2006, BIOCHEMISTRY-US, V45, P9746, DOI 10.1021/bi060295e; Tong H, 2008, ANAL BIOCHEM, V378, P138, DOI 10.1016/j.ab.2008.04.021; Varadarajan N, 2008, NAT CHEM BIOL, V4, P290, DOI 10.1038/nchembio.80; Wouters MA, 2003, MOL CELL, V12, P343, DOI 10.1016/S1097-2765(03)00308-3; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zimmerman KK, 1998, PROTEIN EXPRES PURIF, V14, P395, DOI 10.1006/prep.1998.0979	50	15	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.404954	http://dx.doi.org/10.1074/jbc.M112.404954			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22992747	hybrid, Green Published			2022-12-28	WOS:000310642200043
J	Reid, AT; Lord, T; Stanger, SJ; Roman, SD; McCluskey, A; Robinson, PJ; Aitken, RJ; Nixon, B				Reid, Andrew T.; Lord, Tessa; Stanger, Simone J.; Roman, Shaun D.; McCluskey, Adam; Robinson, Phillip J.; Aitken, R. John; Nixon, Brett			Dynamin Regulates Specific Membrane Fusion Events Necessary for Acrosomal Exocytosis in Mouse Spermatozoa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-TESTIS BARRIER; ZONA-PELLUCIDA; SPERM; PROTEIN; ENDOCYTOSIS; SERTOLI; PHOSPHORYLATION; EXPRESSION; COMPLEXES; GTPASE	Mammalian spermatozoa must complete an acrosome reaction prior to fertilizing an oocyte. The acrosome reaction is a unique exocytotic event involving a series of prolonged membrane fusions that ultimately result in the production of membrane vesicles and release of the acrosomal contents. This event requires the concerted action of a large number of fusion-competent signaling and scaffolding proteins. Here we show that two different members of the dynamin GTPase family localize to the developing acrosome of maturing mouse germ cells. Both dynamin 1 and 2 also remain within the periacrosomal region of mature mouse spermatozoa and are thus well positioned to regulate the acrosome reaction. Two pharmacological inhibitors of dynamin, dynasore and Dyngo-4a, blocked the in vitro induction of acrosomal exocytosis by progesterone, but not by the calcium ionophore A23187, and elicited a concomitant reduction of in vitro fertilization. In vivo treatment with these inhibitors also resulted in spermatozoa displaying reduced acrosome reaction potential. Dynamin 1 and 2 phosphorylation increased on progesterone treatment, and this was also selectively blocked by dynasore. On the basis of our collective data, we propose that dynamin could regulate specific membrane fusion events necessary for acrosomal exocytosis in mouse spermatozoa.	[Reid, Andrew T.; Lord, Tessa; Stanger, Simone J.; Roman, Shaun D.; Aitken, R. John; Nixon, Brett] Univ Newcastle, Sch Environm & Life Sci, Discipline Biol Sci, Callaghan, NSW 2308, Australia; [McCluskey, Adam] Univ Newcastle, Sch Environm & Life Sci, Discipline Chem, Callaghan, NSW 2308, Australia; [Robinson, Phillip J.] Univ Sydney, Childrens Med Res Inst, Westmead, NSW 2145, Australia	University of Newcastle; University of Newcastle; Children's Medical Research Institute - Australia; University of Sydney	Nixon, B (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Discipline Biol Sci, Univ Dr, Callaghan, NSW 2308, Australia.	Brett.Nixon@newcastle.edu.au	Roman, Shaun/AFR-5087-2022; Aitken, Robert John/AAY-8238-2020; Robinson, Phillip J/G-4008-2011; McCluskey, Adam/F-1894-2011; Nixon, Brett/B-5121-2012; ROMAN, SHAUN/G-7047-2013	Aitken, Robert John/0000-0002-9152-156X; Robinson, Phillip J/0000-0002-7878-0313; McCluskey, Adam/0000-0001-7125-863X; Nixon, Brett/0000-0003-2745-8188; ROMAN, SHAUN/0000-0002-7758-7757; Reid, Andrew/0000-0001-5751-7025; Lord, Tessa/0000-0002-1199-0375				Abou-Haila A, 2000, ARCH BIOCHEM BIOPHYS, V379, P173, DOI 10.1006/abbi.2000.1880; Abou-Haila A, 2003, HISTOCHEM CELL BIOL, V119, P179, DOI 10.1007/s00418-003-0504-9; AITKEN RJ, 1993, J ANDROL, V14, P132; Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Anantharam A, 2011, MOL BIOL CELL, V22, P1907, DOI 10.1091/mbc.E11-02-0101; Arnoult C, 1996, P NATL ACAD SCI USA, V93, P13004, DOI 10.1073/pnas.93.23.13004; Asquith KL, 2004, J CELL SCI, V117, P3645, DOI 10.1242/jcs.01214; AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581; Baleato RM, 2005, DEV BIOL, V286, P78, DOI 10.1016/j.ydbio.2005.07.009; BARROS C, 1967, J CELL BIOL, V34, pC1, DOI 10.1083/jcb.34.3.C1; BIGGERS J. D., 1971, Methods in mammalian embryology, P86; Burmann F, 2011, MOL MICROBIOL, V79, P1294, DOI 10.1111/j.1365-2958.2011.07523.x; Buffone MG, 2008, INT J DEV BIOL, V52, P511, DOI 10.1387/ijdb.072532mb; Cao H, 2000, J CELL SCI, V113, P1993; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790; Chircop M, 2011, BBA-MOL CELL RES, V1813, P1689, DOI 10.1016/j.bbamcr.2010.12.018; Clayton EL, 2010, NAT NEUROSCI, V13, P845, DOI 10.1038/nn.2571; Daly C, 2002, J BIOL CHEM, V277, P9010, DOI 10.1074/jbc.M110815200; De Blas GA, 2005, PLOS BIOL, V3, P1801, DOI 10.1371/journal.pbio.0030323; DJAKIEW D, 1988, BIOL REPROD, V39, P1193, DOI 10.1095/biolreprod39.5.1193; ENDERS GC, 1994, DEV BIOL, V163, P331, DOI 10.1006/dbio.1994.1152; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; FAWCETT DW, 1963, Z ZELLFORSCH MIK ANA, V60, P276, DOI 10.1007/BF00350481; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Gilleron J, 2011, INT J BIOCHEM CELL B, V43, P1208, DOI 10.1016/j.biocel.2011.04.014; Gorini G, 2010, FEBS LETT, V584, P845, DOI 10.1016/j.febslet.2009.12.061; Grimmer S, 2005, TRAFFIC, V6, P144, DOI 10.1111/j.1600-0854.2005.00258.x; Guttman JA, 2004, BIOL REPROD, V71, P548, DOI 10.1095/biolreprod.104.028803; Harper CB, 2011, J BIOL CHEM, V286, P35966, DOI 10.1074/jbc.M111.283879; Harper CV, 2008, J CELL SCI, V121, P2130, DOI 10.1242/jcs.030379; Hill TA, 2010, J MED CHEM, V53, P4094, DOI 10.1021/jm100119c; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Jaiswal JK, 2009, CELL, V137, P1308, DOI 10.1016/j.cell.2009.04.064; Jin M, 2011, P NATL ACAD SCI USA, V108, P4892, DOI 10.1073/pnas.1018202108; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Kang-Decker N, 2001, SCIENCE, V294, P1531, DOI 10.1126/science.1063665; Kessels MM, 2006, J CELL SCI, V119, P1504, DOI 10.1242/jcs.02877; Kierszenbaum AL, 2003, MOL BIOL CELL, V14, P4628, DOI 10.1091/mbc.E03-04-0226; Kreitzer G, 2000, NAT CELL BIOL, V2, P125, DOI 10.1038/35000081; Kusumi N, 2007, CELL STRUCT FUNCT, V32, P101, DOI 10.1247/csf.07024; Larsen MR, 2004, MOL CELL PROTEOMICS, V3, P456, DOI 10.1074/mcp.M300105-MCP200; LEBLOND CP, 1952, ANN NY ACAD SCI, V55, P548, DOI 10.1111/j.1749-6632.1952.tb26576.x; Lie PPY, 2006, J ENDOCRINOL, V191, P571, DOI 10.1677/joe.1.06996; Lin YN, 2007, MOL CELL BIOL, V27, P6794, DOI 10.1128/MCB.01029-07; Liu DY, 2003, FERTIL STERIL, V79, P74, DOI 10.1016/S0015-0282(02)04555-7; LIU JP, 1994, J BIOL CHEM, V269, P21043; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Moreno RD, 2000, BIOL REPROD, V63, P89, DOI 10.1095/biolreprod63.1.89; Morita M, 2010, J BIOCHEM, V148, P533, DOI 10.1093/jb/mvq116; Nakanishi A, 2008, ACTA MED OKAYAMA, V62, P385; Nixon B, 2006, BIOL REPROD, V74, P275, DOI 10.1095/biolreprod.105.044644; Nixon B, 2009, J CELL PHYSIOL, V218, P122, DOI 10.1002/jcp.21575; Odell LR, 2009, CHEMMEDCHEM, V4, P1182, DOI 10.1002/cmdc.200900054; Otsuka A, 2009, BIOCHEM BIOPH RES CO, V378, P478, DOI 10.1016/j.bbrc.2008.11.066; PAGE KC, 1992, BIOCHEM CELL BIOL, V70, P496, DOI 10.1139/o92-077; Peters C, 2004, CELL, V119, P667, DOI 10.1016/j.cell.2004.11.023; Pietrobon EO, 2005, MOL REPROD DEV, V70, P58, DOI 10.1002/mrd.20190; QUINN P, 1985, FERTIL STERIL, V44, P493; Raimondi A, 2011, NEURON, V70, P1100, DOI 10.1016/j.neuron.2011.04.031; Reid AT, 2011, ASIAN J ANDROL, V13, P88, DOI 10.1038/aja.2010.74; ROBINSON PJ, 1993, NATURE, V365, P163, DOI 10.1038/365163a0; ROLDAN ERS, 1994, SCIENCE, V266, P1578, DOI 10.1126/science.7985030; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Ryan TA, 2003, P NATL ACAD SCI USA, V100, P2171, DOI 10.1073/pnas.0530260100; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; SONTAG JM, 1994, J BIOL CHEM, V269, P4547; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takeo T, 2011, BIOL REPROD, V85, P1066, DOI 10.1095/biolreprod.111.092536; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Vaid KS, 2007, J CELL PHYSIOL, V210, P644, DOI 10.1002/jcp.20855; Viggiano JM, 1996, J ANDROL, V17, P692; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Vogl AW, 2008, ADV EXP MED BIOL, V636, P186, DOI 10.1007/978-0-387-09597-4_11; WALENSKY LD, 1995, J CELL BIOL, V130, P857, DOI 10.1083/jcb.130.4.857; YANAGIMACHI R, 1970, AM J ANAT, V128, P429, DOI 10.1002/aja.1001280404; Zhao LM, 2007, MOL REPROD DEV, V74, P750, DOI 10.1002/mrd.20660	81	40	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.392803	http://dx.doi.org/10.1074/jbc.M112.392803			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22977254	hybrid, Green Published			2022-12-28	WOS:000310642200007
J	Spelat, R; Ferro, F; Curcio, F				Spelat, Renza; Ferro, Federico; Curcio, Francesco			Serine 111 Phosphorylation Regulates OCT4A Protein Subcellular Distribution and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; SELF-RENEWAL; DNA-BINDING; STEM-CELLS; PLURIPOTENCY; OCT-4; EXPRESSION; UBIQUITIN; SOX2; DIFFERENTIATION	Embryonic stem cell self-renewal properties are attributed to critical amounts of OCT4A, but little is known about its post-translational regulation. Sequence analysis revealed that OCT4A contains five putative ERK1/2 phosphorylation sites. Consistent with the hypothesis that OCT4A is a putative ERK1/2 substrate, we demonstrate that OCT4A interacts with ERK1/2 by using both in vitro GST pulldown and in vivo co-immunoprecipitation assays. MS analysis identified phosphorylation of OCT4A at Ser-111. To investigate the possibility that ERK1/2 activation can enhance OCT4A degradation, we analyzed endogenous ubiquitination in cells transfected with FLAG-OCT4A alone or with constitutively active MEK1 (MEK1(CA)), and we observed that the extent of OCT4 ubiquitination was clearly increased when MEK1(CA) was coexpressed and that this increase was more evident after MG132 treatment. These results suggest an increase in OCT4A ubiquitination downstream of MEK1 activation, and this could account for the protein loss observed after FGF2 treatment and MEK1(CA) transfection. Understanding and controlling the mechanism by which stem cells balance self-renewal would substantially advance our knowledge of stem cells.	[Spelat, Renza; Ferro, Federico; Curcio, Francesco] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy	University of Udine	Spelat, R (corresponding author), Univ Udine, Dept Med & Biol Sci, Ple M Kolbe 4, I-33100 Udine, Italy.	renzaspelat@yahoo.it	Spelat, Renza/AAZ-2980-2021; Ferro, Federico/GPK-8383-2022; Curcio, Francesco/K-4669-2014	Spelat, Renza/0000-0001-5794-8976; Ferro, Federico/0000-0002-6023-8227; CURCIO, Francesco/0000-0002-9070-4807				Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Baltus GA, 2009, STEM CELLS, V27, P2175, DOI 10.1002/stem.168; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Hansis C, 2000, MOL HUM REPROD, V6, P999, DOI 10.1093/molehr/6.11.999; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; Lee J, 2006, J BIOL CHEM, V281, P33554, DOI 10.1074/jbc.M603937200; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mayer RJ, 2000, NAT REV MOL CELL BIO, V1, P145; Naujokat C, 2002, LAB INVEST, V82, P965, DOI 10.1097/01.LAB.0000022226.23741.37; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Pal R, 2006, CELL PROLIFERAT, V39, P585, DOI 10.1111/j.1365-2184.2006.00400.x; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Saxe JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004467; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; Swaney DL, 2009, P NATL ACAD SCI USA, V106, P995, DOI 10.1073/pnas.0811964106; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsuruzoe S, 2006, BIOCHEM BIOPH RES CO, V351, P920, DOI 10.1016/j.bbrc.2006.10.130; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Xu HM, 2009, CELL RES, V19, P561, DOI 10.1038/cr.2009.31; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	36	29	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.386755	http://dx.doi.org/10.1074/jbc.M112.386755			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	23024368	Green Published, hybrid			2022-12-28	WOS:000310642200060
J	Garg, R; Blando, J; Perez, CJ; Wang, HB; Benavides, FJ; Kazanietz, MG				Garg, Rachana; Blando, Jorge; Perez, Carlos J.; Wang, HongBin; Benavides, Fernando J.; Kazanietz, Marcelo G.			Activation of Nuclear Factor kappa B (NF-kappa B) in Prostate Cancer Is Mediated by Protein Kinase C epsilon (PKC epsilon)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTER-INDUCED APOPTOSIS; CONSTITUTIVE ACTIVATION; TNF-ALPHA; DELTA-PKC; CELLS; GROWTH; INFLAMMATION; EXPRESSION; CARCINOMA; TARGET	Protein kinase C epsilon (PKC epsilon) has emerged as an oncogenic kinase and plays important roles in cell survival, mitogenesis and invasion. PKC epsilon is up-regulated in most epithelial cancers, including prostate, breast, and lung cancer. Here we report that PKC epsilon is an essential mediator of NF-kappa B activation in prostate cancer cells. A strong correlation exists between PKC epsilon overexpression and NF-kappa B activation status in prostate cancer cells. Moreover, transgenic overexpression of PKC epsilon in the mouse prostate causes preneoplastic lesions that display significant NF-kappa B hyperactivation. PKC epsilon RNAi depletion or inhibition in prostate cancer cells diminishes NF-kappa B translocation to the nucleus with subsequent impairment of both activation of NF-kappa B transcription and induction of NF-kappa B responsive genes in response to the proinflammatory cytokine tumor necrosis factor alpha (TNF alpha). On the other hand, PKC epsilon overexpression in normal prostate cells enhances activation of the NF-kappa B pathway. A mechanistic analysis revealed that TNF alpha activates PKC epsilon via a C1 domain/diacylglycerol-dependent mechanism that involves phosphatidylcholine-phospholipase C. Moreover, PKC epsilon facilitates the assembly of the TNF receptor-I signaling complex to trigger NF-kappa B activation. Our studies identified a molecular link between PKC epsilon and NF-kappa B that controls key responses implicated in prostate cancer progression.	[Garg, Rachana; Wang, HongBin; Kazanietz, Marcelo G.] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Blando, Jorge] Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, Austin, TX 78712 USA; [Perez, Carlos J.; Benavides, Fernando J.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA	University of Pennsylvania; Pennsylvania Medicine; University of Texas System; University of Texas Austin; University of Texas System; UTMD Anderson Cancer Center	Kazanietz, MG (corresponding author), Univ Penn, Perelman Sch Med, Dept Pharmacol, 1256 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	marcelog@upenn.edu	Garg, Rachana/AAQ-9518-2020	Garg, Rachana/0000-0002-7808-1053; Benavides, Fernando/0000-0003-1275-4320	National Institutes of Health Grant [R01-CA89202]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA089202] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA89202 (to M. G. K.).	Aziz MH, 2007, CANCER RES, V67, P8828, DOI 10.1158/0008-5472.CAN-07-1604; Bae KM, 2007, CANCER RES, V67, P6053, DOI 10.1158/0008-5472.CAN-06-4037; Bao LW, 2009, CANCER RES, V69, P5829, DOI 10.1158/0008-5472.CAN-08-3465; Basu A, 2007, CELL SIGNAL, V19, P1633, DOI 10.1016/j.cellsig.2007.04.008; Begley R, 2004, BIOCHEM BIOPH RES CO, V318, P949, DOI 10.1016/j.bbrc.2004.04.121; Benavides F, 2011, CELL CYCLE, V10, P268, DOI 10.4161/cc.10.2.14469; Bin Hafeez B, 2011, CANCER RES, V71, P2318, DOI 10.1158/0008-5472.CAN-10-4170; Caino MC, 2012, ONCOGENE, V31, P2593, DOI 10.1038/onc.2011.428; Caino MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031714; Caino MC, 2011, J BIOL CHEM, V286, P11254, DOI 10.1074/jbc.M110.194332; Caloca MJ, 1997, J BIOL CHEM, V272, P26488, DOI 10.1074/jbc.272.42.26488; Chang Q, 2003, BRIT J PHARMACOL, V140, P41, DOI 10.1038/sj.bjp.0705398; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Cornford P, 1999, AM J PATHOL, V154, P137, DOI 10.1016/S0002-9440(10)65260-1; Diaz-Meco MT, 2012, IMMUNOL REV, V246, P154, DOI 10.1111/j.1600-065X.2012.01093.x; Fernandez-Marcos PJ, 2009, P NATL ACAD SCI USA, V106, P12962, DOI 10.1073/pnas.0813055106; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Garg R, 2008, TOXICOL APPL PHARM, V232, P428, DOI 10.1016/j.taap.2008.07.007; Garg R, 2008, CARCINOGENESIS, V29, P1249, DOI 10.1093/carcin/bgn114; Gavrielides MV, 2004, CURR DRUG TARGETS, V5, P431, DOI 10.2174/1389450043345380; Gonzalez-Guerrico AM, 2005, J BIOL CHEM, V280, P38982, DOI 10.1074/jbc.M506767200; Gorin MA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-9; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Griner EM, 2010, J BIOL CHEM, V285, P16931, DOI 10.1074/jbc.M109.099036; Hammond G, 2004, CURR TOP MICROBIOL, V282, P177; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Holden NS, 2008, CELL SIGNAL, V20, P1338, DOI 10.1016/j.cellsig.2008.03.001; Ishiguro H, 2009, P NATL ACAD SCI USA, V106, P16369, DOI 10.1073/pnas.0907044106; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; Jin RJ, 2008, CANCER RES, V68, P6762, DOI 10.1158/0008-5472.CAN-08-0107; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kilpatrick LE, 2004, AM J PHYSIOL-CELL PH, V287, pC633, DOI 10.1152/ajpcell.00486.2003; Koren R, 2004, ONCOL REP, V11, P321; Koyanagi T, 2007, J MOL CELL CARDIOL, V43, P517, DOI 10.1016/j.yjmcc.2007.06.003; LaValle Courtney R., 2010, BMC Chemical Biology, V10, P5, DOI 10.1186/1472-6769-10-5; Lu ZG, 2009, CANCER RES, V69, P5927, DOI 10.1158/0008-5472.CAN-08-4786; MacEwan DJ, 2002, BRIT J PHARMACOL, V135, P855, DOI 10.1038/sj.bjp.0704549; Madrid Lee V, 2003, Methods Mol Biol, V223, P523; May MJ, 1997, SEMIN CANCER BIOL, V8, P63, DOI 10.1006/scbi.1997.0057; Meshki J, 2010, J BIOL CHEM, V285, P26033, DOI 10.1074/jbc.M110.128371; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Satoh A, 2004, AM J PHYSIOL-GASTR L, V287, pG582, DOI 10.1152/ajpgi.00087.2004; SCHUTZE S, 1991, J EXP MED, V174, P975, DOI 10.1084/jem.174.5.975; Shinohara H, 2001, BIOCHEM BIOPH RES CO, V284, P1162, DOI 10.1006/bbrc.2001.5104; Shukla S, 2004, NEOPLASIA, V6, P390, DOI 10.1593/neo.04112; Stock D, 2008, UROL CLIN N AM, V35, P117, DOI 10.1016/j.ucl.2007.09.006; Suh JH, 2002, PROSTATE, V52, P183, DOI 10.1002/pros.10082; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; von Burstin VA, 2010, MOL PHARMACOL, V78, P325, DOI 10.1124/mol.110.064741; Wang HB, 2010, MOL BIOL CELL, V21, P1398, DOI 10.1091/mbc.E09-08-0735; Wang SM, 1996, J MED CHEM, V39, P2541, DOI 10.1021/jm950403n; Win HY, 2008, CANCER LETT, V270, P302, DOI 10.1016/j.canlet.2008.05.023; Wu DQ, 2002, CANCER RES, V62, P2423; Yang DZ, 2010, CANCER RES, V70, P7905, DOI 10.1158/0008-5472.CAN-09-4729; Yemelyanov A, 2006, ONCOGENE, V25, P387, DOI 10.1038/sj.onc.1209066; Zerbini LF, 2003, CANCER RES, V63, P2206	61	48	51	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37570	37582		10.1074/jbc.M112.398925	http://dx.doi.org/10.1074/jbc.M112.398925			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22955280	Green Published, hybrid			2022-12-28	WOS:000310588500085
J	Shniffer, A; Visschedyk, DD; Ravulapalli, R; Suarez, G; Turgeon, ZJ; Petrie, AA; Chopra, AK; Merrill, AR				Shniffer, Adin; Visschedyk, Danielle D.; Ravulapalli, Ravikiran; Suarez, Giovanni; Turgeon, Zachari J.; Petrie, Anthony A.; Chopra, Ashok K.; Merrill, A. Rod			Characterization of an Actin-targeting ADP-ribosyltransferase from Aeromonas hydrophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA EXOTOXIN; MULTIPLE SEQUENCE ALIGNMENTS; PERFRINGENS IOTA-TOXIN; RIBOSYLATES ACTIN; MEMBRANE-PROTEINS; VIRULENCE FACTORS; CRYSTAL-STRUCTURE; DOMAIN-III; CELL-DEATH; IDENTIFICATION	The mono-ADP-ribosyltransferase (mART) toxins are contributing factors to a number of human diseases, including cholera, diphtheria, traveler's diarrhea, and whooping cough. VahC is a cytotoxic, actin-targeting mART from Aeromonas hydrophila PPD134/91. This bacterium is implicated primarily in diseases among freshwater fish species but also contributes to gastrointestinal and extraintestinal infections in humans. VahC was shown to ADP-ribosylate Arg-177 of actin, and the kinetic parameters were K-m(NAD(+)) = 6 mu M, K-m(actin) = 24 mu M, and k(cat) = 22 s(-1). VahC activity caused depolymerization of actin filaments, which induced caspase-mediated apoptosis in HeLa Tet-Off cells. Alanine-scanning mutagenesis of predicted catalytic residues showed the predicted loss of in vitro mART activity and cytotoxicity. Bioinformatic and kinetic analysis also identified three residues in the active site loop that were critical for the catalytic mechanism. A 1.9 angstrom crystal structure supported the proposed roles of these residues and their conserved nature among toxin homologues. Several small molecules were characterized as inhibitors of in vitro VahC mART activity and suramin was the best inhibitor (IC50 = 20 mu M). Inhibitor activity was also characterized against two other actin-targeting mART toxins. Notably, these inhibitors represent the first report of broad spectrum inhibition of actin-targeting mART toxins.	[Shniffer, Adin; Visschedyk, Danielle D.; Ravulapalli, Ravikiran; Turgeon, Zachari J.; Petrie, Anthony A.; Merrill, A. Rod] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Suarez, Giovanni; Chopra, Ashok K.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA	University of Guelph; University of Texas System; University of Texas Medical Branch Galveston	Merrill, AR (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	rmerrill@uoguelph.ca	Merrill, Rod/M-8313-2014	Turgeon, Zachari/0000-0002-0883-8292	Natural Sciences and Engineering Research Council (NSERC); NSERC; Canadian Institutes of Health Research; Human Frontier Science Program	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Human Frontier Science Program(Human Frontier Science Program)	Supported by a Natural Sciences and Engineering Research Council (NSERC) studentship.; Supported by an NSERC Undergraduate Student Research Awards Program summer award.; Supported by the Canadian Institutes of Health Research and the Human Frontier Science Program. To whom correspondence should be addressed. Fax: 519-837-1802; E-mail: rmerrill@uoguelph.ca.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Aktories K, 2011, FEBS J, V278, P4526, DOI 10.1111/j.1742-4658.2011.08113.x; Armstrong S, 2001, ANAL BIOCHEM, V292, P26, DOI 10.1006/abio.2001.5052; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beattie BK, 1999, J BIOL CHEM, V274, P15646, DOI 10.1074/jbc.274.22.15646; Beattie BK, 1996, BIOCHEMISTRY-US, V35, P15134, DOI 10.1021/bi961985t; Browne SH, 2008, FEMS IMMUNOL MED MIC, V52, P194, DOI 10.1111/j.1574-695X.2007.00364.x; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; COHEN JJ, 1992, ANNU REV IMMUNOL, V10, P267, DOI 10.1146/annurev.immunol.10.1.267; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Coye LH, 2004, MOL MICROBIOL, V54, P89, DOI 10.1111/j.1365-2958.2004.04262.x; DeLano WL, 2002, PYMOL USERS MANUAL; Edberg SC, 2007, CRIT REV MICROBIOL, V33, P89, DOI 10.1080/10408410601172180; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escaich S, 2008, CURR OPIN CHEM BIOL, V12, P400, DOI 10.1016/j.cbpa.2008.06.022; Escaich S, 2010, EXPERT OPIN THER PAT, V20, P1401, DOI 10.1517/13543776.2010.511176; FANG FC, 1991, J BACTERIOL, V173, P6783, DOI 10.1128/jb.173.21.6783-6789.1991; Fehr D, 2007, J BIOL CHEM, V282, P28843, DOI 10.1074/jbc.M704797200; Fieldhouse RJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001029; Fieldhouse RJ, 2008, TRENDS BIOCHEM SCI, V33, P546, DOI 10.1016/j.tibs.2008.08.003; GILL DM, 1978, P NATL ACAD SCI USA, V75, P3050, DOI 10.1073/pnas.75.7.3050; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Heine K, 2008, INFECT IMMUN, V76, P4600, DOI 10.1128/IAI.00651-08; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Jeppesen MG, 2003, J BIOL CHEM, V278, P47190, DOI 10.1074/jbc.M306630200; Jorgensen R, 2008, EMBO REP, V9, P802, DOI 10.1038/embor.2008.90; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khajanchi BK, 2010, APPL ENVIRON MICROB, V76, P2313, DOI 10.1128/AEM.02535-09; Kozinska A, 2012, SCI WORLD J, P1, DOI 10.1100/2012/949358; Laohachai KN, 2003, TOXICON, V42, P687, DOI 10.1016/j.toxicon.2003.08.010; Lesnick ML, 2001, MOL MICROBIOL, V39, P1464, DOI 10.1046/j.1365-2958.2001.02360.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Monette S, 2006, VET PATHOL, V43, P302, DOI 10.1354/vp.43-3-302; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; Pemberton JM, 1997, FEMS MICROBIOL LETT, V152, P1, DOI 10.1016/S0378-1097(97)00186-9; Pepe CM, 1996, MOL MICROBIOL, V19, P857, DOI 10.1046/j.1365-2958.1996.431958.x; Presley SM, 2006, ENVIRON SCI TECHNOL, V40, P468, DOI 10.1021/es052219p; Pust S, 2007, J BIOL CHEM, V282, P10272, DOI 10.1074/jbc.M610254200; QUINN DM, 1993, INFECT IMMUN, V61, P371, DOI 10.1128/IAI.61.2.371-377.1993; Sakurai J, 2003, ADV ENZYME REGUL, V43, P361, DOI 10.1016/S0065-2571(02)00044-4; Schmitt CK, 1999, EMERG INFECT DIS, V5, P224, DOI 10.3201/eid0502.990206; Sha J, 2007, MICROB PATHOGENESIS, V43, P127, DOI 10.1016/j.micpath.2007.05.002; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Suarez G, 2010, J BACTERIOL, V192, P155, DOI 10.1128/JB.01260-09; Taly JF, 2011, NAT PROTOC, V6, P1669, DOI 10.1038/nprot.2011.393; Tsuge H, 2003, J MOL BIOL, V325, P471, DOI 10.1016/S0022-2836(02)01247-0; Tsuge H, 2008, P NATL ACAD SCI USA, V105, P7399, DOI 10.1073/pnas.0801215105; Turgeon Z, 2011, ANTIMICROB AGENTS CH, V55, P983, DOI 10.1128/AAC.01164-10; Turgeon Z, 2009, FEMS MICROBIOL LETT, V300, P97, DOI 10.1111/j.1574-6968.2009.01777.x; Uckay I, 2008, J HOSP INFECT, V68, P1, DOI 10.1016/j.jhin.2007.10.018; Visschedyk DD, 2010, J BIOL CHEM, V285, P13525, DOI 10.1074/jbc.M109.077339; WEIGT C, 1989, FEBS LETT, V246, P181, DOI 10.1016/0014-5793(89)80279-0; Wu HJ, 2008, CURR OPIN CHEM BIOL, V12, P93, DOI 10.1016/j.cbpa.2008.01.023; Yates SP, 2007, ARCH BIOCHEM BIOPHYS, V466, P58, DOI 10.1016/j.abb.2007.07.018; Yu HB, 2005, APPL ENVIRON MICROB, V71, P4469, DOI 10.1128/AEM.71.8.4469-4477.2005; Zhang YL, 2002, INFECT IMMUN, V70, P2326, DOI 10.1128/IAI.70.5.2326-2335.2002	60	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37030	37041		10.1074/jbc.M112.397612	http://dx.doi.org/10.1074/jbc.M112.397612			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22969084	Green Published, hybrid			2022-12-28	WOS:000310588500038
J	Sun, RH; Fan, HT; Gao, F; Lin, YJ; Zhang, LX; Gong, WM; Liu, L				Sun, Renhua; Fan, Haitian; Gao, Feng; Lin, Yajing; Zhang, Lixin; Gong, Weimin; Liu, Lin			Crystal Structure of Arabidopsis Deg2 Protein Reveals an Internal PDZ Ligand Locking the Hexameric Resting State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTODAMAGED D1 PROTEIN; PHOTOSYSTEM-II; QUALITY-CONTROL; HTRA FAMILY; PROTEASES; LIGHT; PHOTOINHIBITION; DEGRADATION; ADAPTATION; SYSTEM	Eukaryotic organelles have developed elaborate protein quality control systems to ensure their normal activity, among which Deg/HtrA proteases play an essential role. Plant Deg2 protease is a homologue of prokaryotic DegQ/DegP proteases and is located in the chloroplast stroma, where its proteolytic activity is required to maintain the efficiency of photosynthetic machinery during stress. Here, we demonstrate that Deg2 exhibits dual protease-chaperone activities, and we present the hexameric structure of Deg2 complexed with co-purified peptides. The structure shows that Deg2 contains a unique second PDZ domain (PDZ2) following a conventional PDZ domain (PDZ1), with PDZ2 orchestrating the cage assembly of Deg2. We discovered a conserved internal ligand for PDZ2 that mediates hexamer formation and thus locks the protease in the resting state. These findings provide insight into the diverse modes of PDZ domain-mediated regulation of Deg proteases.	[Fan, Haitian; Gao, Feng; Lin, Yajing; Gong, Weimin] Chinese Acad Sci, Inst Biophys, Lab Noncoding RNA, Beijing 100101, Peoples R China; [Sun, Renhua; Zhang, Lixin; Liu, Lin] Chinese Acad Sci, Inst Bot, Photosynthesis Res Ctr, Lab Photobiol, Beijing 100093, Peoples R China; [Sun, Renhua] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gong, WM (corresponding author), Chinese Acad Sci, Inst Biophys, Lab Noncoding RNA, Beijing 100101, Peoples R China.	wgong@ibp.ac.cn; liulin@ibcas.ac.cn		Fan, Haitian/0000-0003-4337-665X; Sun (Genuine), Renhua/0000-0002-8203-4946	Ministry of Science and Technology of China [2011CBA00901]; National Natural Science Foundation of China [31170688]; Hundred Talents Program of Chinese Academy of Sciences	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talents Program of Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by Ministry of Science and Technology of China Grant 2011CBA00901, National Natural Science Foundation of China Grant 31170688, and the Hundred Talents Program of Chinese Academy of Sciences.	Adam Z, 2006, CURR OPIN PLANT BIOL, V9, P234, DOI 10.1016/j.pbi.2006.03.010; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allahverdiyeva Y., 2011, PHOTOSYNTHESIS PLAST, P275; Bai XC, 2011, STRUCTURE, V19, P1328, DOI 10.1016/j.str.2011.06.013; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Haussuhl K, 2001, EMBO J, V20, P713, DOI 10.1093/emboj/20.4.713; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Huesgen PF, 2005, PHYSIOL PLANTARUM, V123, P413, DOI 10.1111/j.1399-3054.2005.00458.x; Huesgen PF, 2006, FEBS LETT, V580, P6929, DOI 10.1016/j.febslet.2006.11.058; Jiang JS, 2008, P NATL ACAD SCI USA, V105, P11939, DOI 10.1073/pnas.0805464105; Kapri-Pardes E, 2007, PLANT CELL, V19, P1039, DOI 10.1105/tpc.106.046573; Kim S, 2011, CELL, V145, P67, DOI 10.1016/j.cell.2011.02.024; Kley J, 2011, NAT STRUCT MOL BIOL, V18, P728, DOI 10.1038/nsmb.2055; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LONG SP, 1994, ANNU REV PLANT PHYS, V45, P633, DOI 10.1146/annurev.pp.45.060194.003221; Lucinski R, 2011, NEW PHYTOL, V192, P74, DOI 10.1111/j.1469-8137.2011.03782.x; Malet H, 2012, NAT STRUCT MOL BIOL, V19, P152, DOI 10.1038/nsmb.2210; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Sawa J, 2011, J BIOL CHEM, V286, P30680, DOI 10.1074/jbc.M111.243832; Shen QT, 2009, P NATL ACAD SCI USA, V106, P4858, DOI 10.1073/pnas.0811780106; Skorko-Glonek J, 2007, ARCH BIOCHEM BIOPHYS, V464, P80, DOI 10.1016/j.abb.2007.04.006; Sun XW, 2007, PLANT CELL, V19, P1347, DOI 10.1105/tpc.106.049510; Sun XW, 2010, PLANT J, V62, P240, DOI 10.1111/j.1365-313X.2010.04140.x; Wrase R, 2011, P NATL ACAD SCI USA, V108, P10490, DOI 10.1073/pnas.1101084108; Yamamoto Y, 2008, PHOTOSYNTH RES, V98, P589, DOI 10.1007/s11120-008-9372-4	33	25	26	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37564	37569		10.1074/jbc.M112.394585	http://dx.doi.org/10.1074/jbc.M112.394585			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22961982	Green Published, hybrid			2022-12-28	WOS:000310588500084
J	Green, AR; Hayes, RP; Xun, LY; Kang, C				Green, Abigail R.; Hayes, Robert P.; Xun, Luying; Kang, ChulHee			Structural Understanding of the Glutathione-dependent Reduction Mechanism of Glutathionyl-Hydroquinone Reductases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-GLUTATHIONYL-(CHLORO)HYDROQUINONE REDUCTASES; OMEGA CLASS; IDENTIFICATION; TRANSFERASES	Glutathionyl-hydroquinone reductases (GS- HQRs) are a newly identified group of glutathione transferases, and they are widely distributed in bacteria, halobacteria, fungi, and plants. GS-HQRs catalyze glutathione (GSH)-dependent reduction of glutathionyl-hydroquinones (GS-hydroquinones) to hydroquinones. GS-hydroquinones can be spontaneously formed from benzoquinones reacting with reduced GSH via Michael addition, and GS-HQRs convert the conjugates to hydroquinones. In this report we have determined the structures of two bacterial GS-HQRs, PcpF of Sphingobium chlorophenolicum and YqjG of Escherichia coli. The two structures and the previously reported structure of a fungal GS-HQR shared many features and displayed complete conservation for all the critical residues. Furthermore, we obtained the binary complex structures with GS-menadione, which in its reduced form, GS-menadiol, is a substrate. The structure revealed a large H-site that could accommodate various substituted hydroquinones and a hydrogen network of three Tyr residues that could provide the proton for reductive deglutathionylation. Mutation of the Tyr residues and the position of two GSH molecules confirmed the proposed mechanism of GS-HQRs. The conservation of GS-HQRs across bacteria, halobacteria, fungi, and plants potentiates the physiological role of these enzymes in quinone metabolism.	[Green, Abigail R.; Xun, Luying; Kang, ChulHee] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Hayes, Robert P.; Kang, ChulHee] Washington State Univ, Dept Chem, Pullman, WA 99164 USA	Washington State University; Washington State University	Xun, LY (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	luying_xun@wsu.edu; chkang@wsu.edu		Kang, ChulHee/0000-0002-0693-7860; Hayes, Robert/0000-0003-4947-4410	National Science Foundation [MCB 1021148, DBI 0959778]; M. J. Murdock Charitable Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); M. J. Murdock Charitable Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grants MCB 1021148 and DBI 0959778 and by the M. J. Murdock Charitable Trust.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Belchik SM, 2011, DRUG METAB REV, V43, P307, DOI 10.3109/03602532.2011.552909; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; BRUNMARK A, 1988, CHEM-BIOL INTERACT, V68, P273, DOI 10.1016/0009-2797(88)90021-X; Dixon DP, 2002, J BIOL CHEM, V277, P30859, DOI 10.1074/jbc.M202919200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; HILL BA, 1993, CHEM RES TOXICOL, V6, P459, DOI 10.1021/tx00034a012; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huang Y, 2008, J BACTERIOL, V190, P7595, DOI 10.1128/JB.00489-08; Lam LKM, 2012, BIOCHEMISTRY-US, V51, P5014, DOI 10.1021/bi300477z; Li J, 2005, PROTEIN SCI, V14, P2361, DOI 10.1110/ps.051463905; Meux E, 2011, J BIOL CHEM, V286, P9162, DOI 10.1074/jbc.M110.194548; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; NERLAND DE, 1990, DRUG METAB DISPOS, V18, P958; NICKERSON WJ, 1963, BIOCHEMISTRY-US, V2, P537, DOI 10.1021/bi00903a025; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; WEFERS H, 1983, ARCH BIOCHEM BIOPHYS, V224, P568, DOI 10.1016/0003-9861(83)90244-8; Whitbread AK, 2005, METHOD ENZYMOL, V401, P78, DOI 10.1016/S0076-6879(05)01005-0; Xun LY, 2010, BIOCHEM J, V428, P419, DOI 10.1042/BJ20091863	23	11	13	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35838	35848		10.1074/jbc.M112.395541	http://dx.doi.org/10.1074/jbc.M112.395541			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22955277	Green Published, hybrid			2022-12-28	WOS:000310364000007
J	An, HL; Lu, SQ; Li, JW; Meng, XY; Zhan, Y; Cui, M; Long, M; Zhang, HL; Logothetis, DE				An, Hai-Long; Lu, Shou-Qin; Li, Jun-Wei; Meng, Xuan-Yu; Zhan, Yong; Cui, Meng; Long, Mian; Zhang, Hai-Lin; Logothetis, Diomedes E.			The Cytosolic GH Loop Regulates the Phosphatidylinositol 4,5-Bisphosphate-induced Gating Kinetics of Kir2 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; K+ CHANNEL; CRYSTAL-STRUCTURE; G-PROTEINS; POTASSIUM CHANNELS; STRUCTURAL BASIS; PIP2; ACTIVATION; CONDUCTION; SITES	Inwardly rectifying K+ (Kir) channels set the resting membrane potential and regulate cellular excitability. The activity of Kir channels depends critically on the phospholipid PIP2. The molecular mechanism by which PIP2 regulates Kir channel gating is poorly understood. Here, we utilized a combination of computational and electrophysiological approaches to discern structural elements involved in regulating the PIP2-induced gating kinetics of Kir2 channels. We identify a novel role for the cytosolic GH loop. Mutations that directly or indirectly affect GH loop flexibility (e.g. V223L, E272G, D292G) increase both the on- and especially the off-gating kinetics. These effects are consistent with a model in which competing interactions between the CD and GH loops for the N terminus regulate the gating of the intracellular G loop gate.	[Lu, Shou-Qin; Long, Mian] Chinese Acad Sci, Inst Mech, Key Lab Micrograv, Natl Micrograv Lab, Beijing 100190, Peoples R China; [Lu, Shou-Qin; Long, Mian] Chinese Acad Sci, Inst Mech, Ctr Biomech & Bioengn, Beijing 100190, Peoples R China; [An, Hai-Long; Meng, Xuan-Yu; Cui, Meng; Logothetis, Diomedes E.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23298 USA; [An, Hai-Long; Li, Jun-Wei; Zhan, Yong] Hebei Univ Technol, Inst Biophys, Sch Sci, Tianjin 300401, Peoples R China; [Zhang, Hai-Lin] Hebei Med Univ, Key Lab Pharmacol & Toxicol New Drug, Key Lab Neural & Vasc Biol, Minist Educ,Dept Pharmacol, Shijiazhuang 050017, Hebei Province, Peoples R China	Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; Institute of Mechanics, CAS; Virginia Commonwealth University; Hebei University of Technology; Hebei Medical University	Long, M (corresponding author), Chinese Acad Sci, Inst Mech, Key Lab Micrograv, Natl Micrograv Lab, Beijing 100190, Peoples R China.	mlong@imech.ac.cn; z.hailin@yahoo.com; delogothetis@vcu.edu	Li, Junwei/B-6936-2019	Li, Junwei/0000-0002-1724-4752	National Institutes of Health [HL059949, S10RR027411]; NSFC (National Natural Science Foundation of China) [11145003, 10975045, C2009000029, 30730031]; 973 Program [2007CB512100, C2009001104]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027411] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC (National Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by grant National Institutes of Health Grant HL059949 (to D.L.). This work was also supported by NSFC (National Natural Science Foundation of China) Grants 11145003 (to H.A.), 10975045 and C2009000029 (to Y.Z.), and 30730031 (to H.Z.) and by 973 Program Grants 2007CB512100 and C2009001104 (to H.Z.). Computations performed at VCU were supported by the Center for High Performance Computing (CHiPC) and by the National Institutes of Health Grant S10RR027411 (to M.C.).	Alam A, 2009, NAT STRUCT MOL BIOL, V16, P30, DOI 10.1038/nsmb.1531; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; BEECE D, 1980, BIOCHEMISTRY-US, V19, P5147, DOI 10.1021/bi00564a001; Bjelkmar P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000289; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Ding SH, 2005, J GEN PHYSIOL, V126, P213, DOI 10.1085/jgp.200509287; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; Frauenfelder H, 2009, P NATL ACAD SCI USA, V106, P5129, DOI 10.1073/pnas.0900336106; Guo DL, 2003, J GEN PHYSIOL, V122, P485, DOI 10.1085/jgp.200308890; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Horn R, 2005, SCI STKE, V307, P50; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; Inanobe A, 2007, CHANNELS, V1, P40, DOI 10.4161/chan.3842; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; Kukita F, 2000, J PHYSIOL-LONDON, V522, P357, DOI 10.1111/j.1469-7793.2000.00357.x; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Lupyan D, 2010, BIOPHYS J, V98, P240, DOI 10.1016/j.bpj.2009.09.063; MacKerell AD., 1998, ENCY COMPUTATIONAL C, V1, P271; Meng XY, 2012, BIOPHYS J, V102, P2049, DOI 10.1016/j.bpj.2012.03.050; Mezei M, 2006, J COMPUT AID MOL DES, V20, P97, DOI 10.1007/s10822-006-9039-1; Mezei M, 1997, J COMPUT CHEM, V18, P812, DOI 10.1002/(SICI)1096-987X(19970430)18:6<812::AID-JCC6>3.0.CO;2-V; Mezei M, 2003, J MOL GRAPH MODEL, V21, P463, DOI 10.1016/S1093-3263(02)00203-6; Mezei M, 2010, J COMPUT CHEM, V31, P2658, DOI 10.1002/jcc.21551; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Rodriguez-Menchaca AA, 2012, P NATL ACAD SCI USA, V109, pE2399, DOI 10.1073/pnas.1207901109; Roux B, 2008, BIOPHYS J, V95, P4205, DOI 10.1529/biophysj.108.136499; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Schulte U, 2000, EUR J BIOCHEM, V267, P5837, DOI 10.1046/j.1432-1327.2000.01671.x; Soom M, 2001, FEBS LETT, V490, P49, DOI 10.1016/S0014-5793(01)02136-6; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Yang JQ, 2010, NEURON, V66, P871, DOI 10.1016/j.neuron.2010.05.009; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	45	17	17	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42278	42287		10.1074/jbc.M112.418640	http://dx.doi.org/10.1074/jbc.M112.418640			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23033482	Green Published, hybrid			2022-12-28	WOS:000312103000063
J	Dieteren, CEJ; Koopman, WJH; Swarts, HG; Peters, JGP; Maczuga, P; van Gemst, JJ; Masereeuw, R; Smeitink, JAM; Nijtmans, LGJ; Willems, PHGM				Dieteren, Cindy E. J.; Koopman, Werner J. H.; Swarts, Herman G.; Peters, Janny G. P.; Maczuga, Piotr; van Gemst, Jasper J.; Masereeuw, Rosalinde; Smeitink, Jan A. M.; Nijtmans, Leo G. J.; Willems, Peter H. G. M.			Subunit-specific Incorporation Efficiency and Kinetics in Mitochondrial Complex I Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; ENCODED SUBUNITS; ASSEMBLY KINETICS; IDENTIFICATION; SUBCOMPLEXES; DEFECTS; PROTEIN	Studies employing native PAGE suggest that most nDNA-encoded CI subunits form subassemblies before assembling into holo-CI. In addition, in vitro evidence suggests that some subunits can directly exchange in holo-CI. Presently, data on the kinetics of these two incorporation modes for individual CI subunits during CI maintenance are sparse. Here, we used inducible HEK293 cell lines stably expressing AcGFP1-tagged CI subunits and quantified the amount of tagged subunit in mitoplasts and holo-CI by non-native and native PAGE, respectively, to determine their CI incorporation efficiency. Analysis of time courses of induction revealed three subunit-specific patterns. A first pattern, represented by NDUFS1, showed overlapping time courses, indicating that imported subunits predominantly incorporate into holo-CI. A second pattern, represented by NDUFV1, consisted of parallel time courses, which were, however, not quantitatively overlapping, suggesting that imported subunits incorporate at similar rates into holo-CI and CI assembly intermediates. The third pattern, represented by NDUFS3 and NDUFA2, revealed a delayed incorporation into holo-CI, suggesting their prior appearance in CI assembly intermediates and/or as free monomers. Our analysis showed the same maximum incorporation into holo-CI for NDUFV1, NDUFV2, NDUFS1, NDUFS3, NDUFS4, NDUFA2, and NDUFA12 with nearly complete loss of endogenous subunit at 24 h of induction, indicative of an equimolar stoichiometry and unexpectedly rapid turnover. In conclusion, the results presented demonstrate that newly formed nDNA-encoded CI subunits rapidly incorporate into holo-CI in a subunit-specific manner.	[Dieteren, Cindy E. J.; Koopman, Werner J. H.; Swarts, Herman G.; Willems, Peter H. G. M.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Med Ctr, Dept Biochem, NL-6500 HB Nijmegen, Netherlands; [Dieteren, Cindy E. J.; Maczuga, Piotr; van Gemst, Jasper J.; Smeitink, Jan A. M.; Nijtmans, Leo G. J.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Med Ctr, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; [Dieteren, Cindy E. J.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Med Ctr, Dept Cell Biol, NL-6500 HB Nijmegen, Netherlands; [Peters, Janny G. P.; Masereeuw, Rosalinde] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Med Ctr, Dept Pharmacol & Toxicol, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Willems, PHGM (corresponding author), Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Med Ctr, Dept Biochem, POB 9101, NL-6500 HB Nijmegen, Netherlands.	p.willems@ncmls.ru.nl	Masereeuw, Roos/N-3582-2014; Peters, J.G.P./L-4570-2015; Willems, P.H.G.M./L-4759-2015; Koopman, Werner J.H./AAC-9668-2020; Koopman, Werner J.H./D-3592-2009; Nijtmans, L.G.J./L-4549-2015; Dieteren, Cindy E.J./D-6042-2011; Masereeuw, Roos/I-5276-2016; Smeitink, Jan/C-1351-2013	Willems, P.H.G.M./0000-0002-0915-1599; Koopman, Werner J.H./0000-0002-5340-6747; Koopman, Werner J.H./0000-0002-5340-6747; Masereeuw, Roos/0000-0002-1560-1074; 	Netherlands Organization for Scientific Research [911-02-008]; Radboud University Nijmegen Medical Centre	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Radboud University Nijmegen Medical Centre	This work was supported by the Netherlands Organization for Scientific Research (Grant 911-02-008) and a grant from the Radboud University Nijmegen Medical Centre (to W. J. H. K. and L. G. J. N).	Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Bourges I, 2004, BIOCHEM J, V383, P491, DOI 10.1042/BJ20040256; Calvaruso MA, 2008, METHODS, V46, P281, DOI 10.1016/j.ymeth.2008.09.023; Dieteren CEJ, 2011, BBA-BIOENERGETICS, V1807, P1624, DOI 10.1016/j.bbabio.2011.09.013; Dieteren CEJ, 2011, P NATL ACAD SCI USA, V108, P8657, DOI 10.1073/pnas.1017581108; Dieteren CEJ, 2009, METHOD ENZYMOL, V456, P133, DOI 10.1016/S0076-6879(08)04407-8; Dieteren CEJ, 2008, J BIOL CHEM, V283, P34753, DOI 10.1074/jbc.M807323200; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; FINEL M, 1992, BIOCHEMISTRY-US, V31, P11425, DOI 10.1021/bi00161a022; Friedrich T, 1997, J THEOR BIOL, V187, P529, DOI 10.1006/jtbi.1996.0387; HALL RE, 1990, J BIOL CHEM, V265, P16484; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; Koopman Werner J H, 2010, Antioxid Redox Signal, V12, P1431, DOI 10.1089/ars.2009.2743; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; Moreno-Lastres D, 2012, CELL METAB, V15, P324, DOI 10.1016/j.cmet.2012.01.015; Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303; Perales-Clemente E, 2010, MOL CELL BIOL, V30, P3038, DOI 10.1128/MCB.00025-10; PILKINGTON SJ, 1991, BIOCHEMISTRY-US, V30, P2166, DOI 10.1021/bi00222a021; Potluri P, 2004, EUR J BIOCHEM, V271, P3265, DOI 10.1111/j.1432-1033.2004.04260.x; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schneider D, 2008, BBA-BIOENERGETICS, V1777, P735, DOI 10.1016/j.bbabio.2008.03.003; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Triepels RH, 2001, J BIOL CHEM, V276, P8892, DOI 10.1074/jbc.M009903200; Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262; VIDEIRA A, 1989, EUR J BIOCHEM, V181, P493, DOI 10.1111/j.1432-1033.1989.tb14751.x; Vogel RO, 2007, BBA-BIOENERGETICS, V1767, P1215, DOI 10.1016/j.bbabio.2007.07.008; Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200; Yadava N, 2004, J BIOL CHEM, V279, P12406, DOI 10.1074/jbc.M313588200; YAMAGUCHI M, 1993, BIOCHEMISTRY-US, V32, P1935, DOI 10.1021/bi00059a008; Zuo DM, 2007, NUCLEIC ACIDS RES, V35, pD680, DOI 10.1093/nar/gkl898	32	30	32	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41851	41860		10.1074/jbc.M112.391151	http://dx.doi.org/10.1074/jbc.M112.391151			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23038253	hybrid, Green Published			2022-12-28	WOS:000312103000026
J	Xu, Y; Ishizuka, T; Yang, J; Ito, K; Katada, H; Komiyama, M; Hayashi, T				Xu, Yan; Ishizuka, Takumi; Yang, Jie; Ito, Kenichiro; Katada, Hitoshi; Komiyama, Makoto; Hayashi, Tetsuya			Oligonucleotide Models of Telomeric DNA and RNA Form a Hybrid G-quadruplex Structure as a Potential Component of Telomeres	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPEAT-CONTAINING RNA; NEWLY SYNTHESIZED PROTEINS; K+ SOLUTION; MAMMALIAN TELOMERES; BINDING-PROTEIN; SEQUENCE FORMS; IN-VITRO; CELLS; TERRA; SENESCENCE	Telomeric repeat-containing RNA, a non-coding RNA molecule, has recently been found in mammalian cells. The detailed structural features and functions of the telomeric RNA at human chromosome ends remain unclear, although this RNA molecule may be a key component of the telomere machinery. In this study, using model human telomeric DNA and RNA sequences, we demonstrated that human telomeric RNA and DNA oligonucleotides form a DNA-RNA G-quadruplex. We next employed chemistry-based oligonucleotide probes to mimic the naturally formed telomeric DNA-RNA G-quadruplexes in living cells, suggesting that the process of DNA-RNA G-quadruplex formation with oligonucleotide models of telomeric DNA and RNA could occur in cells. Furthermore, we investigated the possible roles of this DNA-RNA G-quadruplex. The formation of the DNA-RNA G-quadruplex causes a significant increase in the clonogenic capacity of cells and has an effect on inhibition of cellular senescence. Here, we have used a model system to provide evidence about the formation of G-quadruplex structures involving telomeric DNA and RNA sequences that have the potential to provide a protective capping structure for telomere ends.	[Xu, Yan; Yang, Jie; Hayashi, Tetsuya] Miyazaki Univ, Div Chem, Dept Med Sci, Fac Med, Kiyotake, Miyazaki 8891692, Japan; [Ishizuka, Takumi; Ito, Kenichiro; Katada, Hitoshi; Komiyama, Makoto] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan	University of Miyazaki; University of Tokyo	Xu, Y (corresponding author), Miyazaki Univ, Div Chem, Dept Med Sci, Fac Med, 5200 Kihara, Kiyotake, Miyazaki 8891692, Japan.	xuyan@fc.miyazaki-u.ac.jp	Ishizuka, Takumi/E-9491-2012; Hayashi, Tetsuya/ABA-1074-2020	Ishizuka, Takumi/0000-0003-0956-784X; Ito, Kenichiro/0000-0001-7231-6838; Xu, Yan/0000-0003-0379-8866	Ministry of Education, Science, Sports, Culture, and Technology, Japan [22350071]; Grants-in-Aid for Scientific Research [22350071] Funding Source: KAKEN	Ministry of Education, Science, Sports, Culture, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by Ministry of Education, Science, Sports, Culture, and Technology, Japan Grant-in-aid for Scientific Research (B) 22350071. This work was also supported by grants from the Takeda Science Foundation, the Naito Foundation and Mochida Memorial Foundation for Medical and Pharmaceutical Research.	Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Beatty KE, 2005, J AM CHEM SOC, V127, P14150, DOI 10.1021/ja054643W; Beatty KE, 2006, ANGEW CHEM INT EDIT, V45, P7364, DOI 10.1002/anie.200602114; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Clark CL, 1997, NUCLEIC ACIDS RES, V25, P4098, DOI 10.1093/nar/25.20.4098; Collie GW, 2010, NUCLEIC ACIDS RES, V38, P5569, DOI 10.1093/nar/gkq259; Dai XY, 2010, EMBO J, V29, P2788, DOI 10.1038/emboj.2010.156; de Lange T, 2004, NAT REV MOL CELL BIO, V5, P323, DOI 10.1038/nrm1359; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; El-Sagheer AH, 2010, CHEM SOC REV, V39, P1388, DOI 10.1039/b901971p; Flynn RL, 2011, NATURE, V471, P532, DOI 10.1038/nature09772; GIRALDO R, 1994, EMBO J, V13, P2411, DOI 10.1002/j.1460-2075.1994.tb06526.x; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hayashi N, 2002, MOL GENET GENOMICS, V267, P806, DOI 10.1007/s00438-002-0712-3; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Krishnan-Ghosh Y, 2004, J AM CHEM SOC, V126, P5944, DOI 10.1021/ja031508f; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Li GZ, 2004, EXP CELL RES, V301, P189, DOI 10.1016/j.yexcr.2004.08.019; Li GZ, 2003, P NATL ACAD SCI USA, V100, P527, DOI 10.1073/pnas.0235444100; Luke B, 2009, EMBO J, V28, P2503, DOI 10.1038/emboj.2009.166; Luu KN, 2006, J AM CHEM SOC, V128, P9963, DOI 10.1021/ja062791w; Martadinata H, 2009, J AM CHEM SOC, V131, P2570, DOI 10.1021/ja806592z; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Phan AT, 2003, J AM CHEM SOC, V125, P15021, DOI 10.1021/ja037616j; Randall A, 2009, J BIOL CHEM, V284, P13980, DOI 10.1074/jbc.M900631200; Rueda M, 2006, J AM CHEM SOC, V128, P3608, DOI 10.1021/ja055936s; Schaffitzel C, 2001, P NATL ACAD SCI USA, V98, P8572, DOI 10.1073/pnas.141229498; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Schoeftner S, 2009, EMBO J, V28, P2323, DOI 10.1038/emboj.2009.197; Sedoris KC, 2012, MOL CANCER THER, V11, P66, DOI 10.1158/1535-7163.MCT-11-0515; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Sivakumar K, 2004, ORG LETT, V6, P4603, DOI 10.1021/ol047955x; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Wang H, 2011, J BIOL CHEM, V286, P7479, DOI 10.1074/jbc.M110.205641; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; Xu Y, 2008, J AM CHEM SOC, V130, P11179, DOI 10.1021/ja8031532; Xu Y, 2006, BIOORGAN MED CHEM, V14, P5584, DOI 10.1016/j.bmc.2006.04.033; Xu Y, 2012, METHODS, V57, P100, DOI 10.1016/j.ymeth.2012.02.015; Xu Y, 2011, CHEM SOC REV, V40, P2719, DOI 10.1039/c0cs00134a; Xu Y, 2010, P NATL ACAD SCI USA, V107, P14579, DOI 10.1073/pnas.1001177107; Xu Y, 2010, J AM CHEM SOC, V132, P7231, DOI 10.1021/ja909708a; Xu Y, 2009, ANGEW CHEM INT EDIT, V48, P7833, DOI 10.1002/anie.200903858; Xu Y, 2009, ANGEW CHEM INT EDIT, V48, P3281, DOI 10.1002/anie.200806306; Zaug AJ, 2005, P NATL ACAD SCI USA, V102, P10864, DOI 10.1073/pnas.0504744102; Zhou Z, 2004, J AM CHEM SOC, V126, P8862, DOI 10.1021/ja049684r	49	43	45	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41787	41796		10.1074/jbc.M112.342030	http://dx.doi.org/10.1074/jbc.M112.342030			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23012368	hybrid, Green Published			2022-12-28	WOS:000312103000020
J	Miyamoto, L; Ebihara, K; Kusakabe, T; Aotani, D; Yamamoto-Kataoka, S; Sakai, T; Aizawa-Abe, M; Yamamoto, Y; Fujikura, J; Hayashi, T; Hosoda, K; Nakao, K				Miyamoto, Licht; Ebihara, Ken; Kusakabe, Toru; Aotani, Daisuke; Yamamoto-Kataoka, Sachiko; Sakai, Takeru; Aizawa-Abe, Megumi; Yamamoto, Yuji; Fujikura, Junji; Hayashi, Tatsuya; Hosoda, Kiminori; Nakao, Kazuwa			Leptin Activates Hepatic 5 '-AMP-activated Protein Kinase through Sympathetic Nervous System and alpha 1-Adrenergic Receptor A POTENTIAL MECHANISM FOR IMPROVEMENT OF FATTY LIVER IN LIPODYSTROPHY BY LEPTIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSES INSULIN-RESISTANCE; ACETYL-COA CARBOXYLASE; SKELETAL-MUSCLE; GLUCOSE-HOMEOSTASIS; REPLACEMENT THERAPY; DIABETES-MELLITUS; RATS; MICE; METABOLISM; MOUSE	Leptin is an adipocyte-derived hormone that regulates energy homeostasis. Leptin treatment strikingly ameliorates metabolic disorders of lipodystrophy, which exhibits ectopic fat accumulation and severe insulin-resistant diabetes due to a paucity of adipose tissue. Although leptin is shown to activate 5'-AMP-activated protein kinase (AMPK) in the skeletal muscle, the effect of leptin in the liver is still unclear. We investigated the effect of leptin on hepatic AMPK and its pathophysiological relevance in A-ZIP/F-1 mice, a model of generalized lipodystrophy. Here, we demonstrated that leptin activates hepatic AMPK through the central nervous system and alpha-adrenergic sympathetic nerves. AMPK activities were decreased in the fatty liver of A-ZIP/F-1 mice, and leptin administration increased AMPK activities in the liver as well as in skeletal muscle with significant reduction in triglyceride content. Activation of hepatic AMPK with A769662 also led to a decrease in hepatic triglyceride content and blood glucose levels in A-ZIP/F-1 mice. These results indicate that the down-regulation of hepatic AMPK activities plays a pathophysiological role in the metabolic disturbances of lipodystrophy, and the hepatic AMPK activation is involved in the therapeutic effects of leptin.	[Miyamoto, Licht; Ebihara, Ken; Kusakabe, Toru; Aotani, Daisuke; Yamamoto-Kataoka, Sachiko; Sakai, Takeru; Aizawa-Abe, Megumi; Yamamoto, Yuji; Fujikura, Junji; Hosoda, Kiminori; Nakao, Kazuwa] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Kyoto 6068507, Japan; [Ebihara, Ken; Aizawa-Abe, Megumi; Hosoda, Kiminori; Nakao, Kazuwa] Kyoto Univ Hosp, Translat Res Ctr, Sakyo Ku, Kyoto 6068507, Japan; [Hayashi, Tatsuya] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan; [Hosoda, Kiminori] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University	Ebihara, K (corresponding author), 54 Shogoin Kawahara Cho,Sakyo Ku, Kyoto 6068507, Japan.	kebihara@kuhp.kyoto-u.ac.jp	Fujikura, Junji/AAR-2684-2020; Miyamoto, Licht/K-8947-2012	hayashi, Tatsuya/0000-0001-7600-4735	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Takeda Medical Research Foundation; Japan Foundation of Applied Enzymology; Eli Lilly and Co.; Nakatomi Foundation; Grants-in-Aid for Scientific Research [21229013, 22126012] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Medical Research Foundation; Japan Foundation of Applied Enzymology(Japan Foundation of Applied Enzymology); Eli Lilly and Co.(Eli Lilly); Nakatomi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Ministry of Health, Labor and Welfare of Japan, The Takeda Medical Research Foundation, The Japan Foundation of Applied Enzymology, Eli Lilly and Co., and The Nakatomi Foundation.	Andreelli F, 2006, ENDOCRINOLOGY, V147, P2432, DOI 10.1210/en.2005-0898; Assifi MM, 2005, AM J PHYSIOL-ENDOC M, V289, pE794, DOI 10.1152/ajpendo.00144.2005; Barnes BR, 2002, DIABETES, V51, P2703, DOI 10.2337/diabetes.51.9.2703; Bergeron R, 2001, DIABETES, V50, P1076, DOI 10.2337/diabetes.50.5.1076; Brabant G, 2005, FASEB J, V19, P1048, DOI 10.1096/fj.04-2846fje; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; DAVIES SP, 1992, EUR J BIOCHEM, V203, P615, DOI 10.1111/j.1432-1033.1992.tb16591.x; Dzamko NL, 2009, ACTA PHYSIOL, V196, P115, DOI 10.1111/j.1748-1716.2009.01969.x; Ebihara K, 2001, DIABETES, V50, P1440, DOI 10.2337/diabetes.50.6.1440; Ebihara K, 2007, J CLIN ENDOCR METAB, V92, P532, DOI 10.1210/jc.2006-1546; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; German J, 2009, ENDOCRINOLOGY, V150, P4502, DOI 10.1210/en.2009-0445; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Hutchinson DS, 2006, DIABETES, V55, P682, DOI 10.2337/diabetes.55.03.06.db05-0901; Kim JK, 2000, J BIOL CHEM, V275, P8456, DOI 10.1074/jbc.275.12.8456; Koh HJ, 2007, BIOCHEM J, V403, P473, DOI 10.1042/BJ20061479; Kusakabe T, 2009, DIABETOLOGIA, V52, P675, DOI 10.1007/s00125-009-1258-2; Lee Y, 2002, P NATL ACAD SCI USA, V99, P11848, DOI 10.1073/pnas.182420899; LEE Y, 1994, P NATL ACAD SCI USA, V91, P10878, DOI 10.1073/pnas.91.23.10878; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Miyamoto L, 2007, J APPL PHYSIOL, V102, P1007, DOI 10.1152/japplphysiol.01034.2006; Miyanaga F, 2003, DIABETOLOGIA, V46, P1329, DOI 10.1007/s00125-003-1193-6; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Naito M, 2011, DIABETES, V60, P2265, DOI 10.2337/db10-1795; Ogawa Y, 1999, DIABETES, V48, P1822, DOI 10.2337/diabetes.48.9.1822; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI0215001, 10.1172/JCI200215001]; Pocai A, 2005, CELL METAB, V1, P53, DOI 10.1016/j.cmet.2004.11.001; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Uotani S, 2006, BIOCHEM BIOPH RES CO, V351, P171, DOI 10.1016/j.bbrc.2006.10.015; Uyama N, 2004, ANAT REC PART A, V280A, P808, DOI 10.1002/ar.a.20086; Wang MY, 2010, P NATL ACAD SCI USA, V107, P4813, DOI 10.1073/pnas.0909422107; Winder WW, 1997, J APPL PHYSIOL, V82, P219, DOI 10.1152/jappl.1997.82.1.219; Xu Ming, 2007, Shengli Xuebao, V59, P175; Yu X, 2004, DIABETOLOGIA, V47, P2012, DOI 10.1007/s00125-004-1570-9	38	58	59	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40441	40447		10.1074/jbc.M112.384545	http://dx.doi.org/10.1074/jbc.M112.384545			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23024365	Green Published, hybrid			2022-12-28	WOS:000311448800035
J	Stephenson, FA				Stephenson, F. Anne			Introduction to Thematic Minireview Series on Celebrating the Discovery of the Cysteine Loop Ligand-gated Ion Channel Superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NICOTINIC ACETYLCHOLINE-RECEPTORS; FUNCTIONAL EXPRESSION; GLYCINE RECEPTOR; MESSENGER-RNA; PURIFICATION; TRANSLATION; OOCYTES; BINDING; SHOWS	The year 2012 marks the 25th anniversary of the discovery of the Cys loop ligand-gated ion channel superfamily of neurotransmitter receptors. This minireview series celebrates this with a series of articles reviewing current information for each of the family members, nicotinic acetylcholine receptors, glycine receptors, GABA(A) receptors, serotonin-3 (5-HT3) receptors, and glutamate-gated chloride ion channels of proteasome invertebrate phyla.	UCL, Sch Pharm, London WC1N 1AX, England	University of London; University College London; University of London School of Pharmacy	Stephenson, FA (corresponding author), UCL, Sch Pharm, London WC1N 1AX, England.	astephenson@asbmb.org			BBSRC [BB/G003718/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G003718/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		BARNARD EA, 1982, PROC R SOC SER B-BIO, V215, P241, DOI 10.1098/rspb.1982.0040; Changeux J. P., 2012, J BIOL CHEM IN PRESS, V287; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; GURDON JB, 1971, NATURE, V233, P177, DOI 10.1038/233177a0; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; LEFKOWITZ RJ, 1973, J BIOL CHEM, V248, P342; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; PFEIFFER F, 1982, J BIOL CHEM, V257, P9389; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SIGEL E, 1983, J BIOL CHEM, V258, P6965; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101	12	4	4	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40205	40206		10.1074/jbc.R112.424812	http://dx.doi.org/10.1074/jbc.R112.424812			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23038255	Green Published, hybrid			2022-12-28	WOS:000311448800011
J	Bei, L; Shah, C; Wang, H; Huang, WQ; Roy, R; Eklund, EA				Bei, Ling; Shah, Chirag; Wang, Hao; Huang, Weiqi; Roy, Rupali; Eklund, Elizabeth A.			beta-Catenin Activates the HOXA10 and CDX4 Genes in Myeloid Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HEMATOPOIETIC-CELLS; BONE-MARROW-CELLS; STEM-CELLS; IN-VITRO; DNA-BINDING; EXPRESSION; LEUKEMIA; TRANSCRIPTION; MLL; DIFFERENTIATION	HoxA10 is a homeodomain transcription factor that is involved in maintenance of the myeloid progenitor population and implicated in myeloid leukemogenesis. Previously, we found that FGF2 and CDX4 are direct target genes of HoxA10 and that HOXA10 is a Cdx4 target gene. We also found that increased production of fibroblast growth factor 2 (Fgf2) by HoxA10-overexpressing myeloid progenitor cells results in activation of beta-catenin in an autocrine manner. In this study, we identify novel cis elements in the CDX4 and HOXA10 genes that are activated by beta-catenin in myeloid progenitor cells. We determine that beta-catenin interacts with these cis elements, identifying both CDX4 and HOXA10 as beta-catenin target genes in this context. We demonstrate that HoxA10-induced CDX4 transcription is influenced by Fgf2-dependent beta-catenin activation. Similarly, Cdx4-induced HOXA10 transcription is influenced by beta-catenin in an Fgf2-dependent manner. Increased expression of a set of Hox proteins, including HoxA10, is associated with poor prognosis in acute myeloid leukemia. Cdx4 contributes to leukemogenesis in Hox-overexpressing acute myeloid leukemia, and increased beta-catenin activity is also associated with poor prognosis. The current studies identify a molecular mechanisms through which increased expression of HoxA10 increases Cdx4 expression by direct CDX4 activation and by Fgf2-induced beta-catenin activity. This results in Cdx4-induced HoxA10-expression, creating a positive feedback mechanism.	[Bei, Ling; Shah, Chirag; Wang, Hao; Huang, Weiqi; Roy, Rupali; Eklund, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Bei, Ling; Shah, Chirag; Wang, Hao; Huang, Weiqi; Roy, Rupali; Eklund, Elizabeth A.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Eklund, Elizabeth A.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Eklund, EA (corresponding author), Northwestern Univ, Feinberg Sch, Dept Med, 303 E Super,Lurie 5-105, Chicago, IL 60611 USA.	e-eklund@northwestern.edu		Wang, Hao/0000-0003-2131-0377	National Institutes of Health [R01-HL87717]; Veterans Affairs Merit Review; NATIONAL CANCER INSTITUTE [R01CA195642] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL87717. This work was also supported by a Veterans Affairs Merit Review (to E. A. E.).	ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; Aguayo A, 2000, BLOOD, V96, P2240, DOI 10.1182/blood.V96.6.2240.h8002240_2240_2245; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Bansal D, 2006, P NATL ACAD SCI USA, V103, P16924, DOI 10.1073/pnas.0604579103; Bei L, 2007, J BIOL CHEM, V282, P16846, DOI 10.1074/jbc.M609744200; Bei L, 2011, J BIOL CHEM, V286, P19047, DOI 10.1074/jbc.M110.213983; Bjornsson JM, 2001, BLOOD, V98, P3301, DOI 10.1182/blood.V98.12.3301; Buske C, 2001, BLOOD, V97, P2286, DOI 10.1182/blood.V97.8.2286; Calvo KR, 2000, MOL CELL BIOL, V20, P3274, DOI 10.1128/MCB.20.9.3274-3285.2000; Camos M, 2006, CANCER RES, V66, P6947, DOI 10.1158/0008-5472.CAN-05-4601; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Eklund EA, 1998, J BIOL CHEM, V273, P13957, DOI 10.1074/jbc.273.22.13957; Eklund EA, 2000, J BIOL CHEM, V275, P20117, DOI 10.1074/jbc.M907915199; Ernst P, 2004, CURR BIOL, V14, P2063, DOI 10.1016/j.cub.2004.11.012; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Horton SJ, 2005, CANCER RES, V65, P9245, DOI 10.1158/0008-5472.CAN-05-1691; Kawagoe H, 1999, LEUKEMIA, V13, P687, DOI 10.1038/sj.leu.2401410; Keenan ID, 2006, DEV BIOL, V299, P478, DOI 10.1016/j.ydbio.2006.08.040; Kim K, 2000, MOL BIOL CELL, V11, P3509, DOI 10.1091/mbc.11.10.3509; LARRICK JW, 1980, J IMMUNOL, V125, P6; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; LOWNEY P, 1991, NUCLEIC ACIDS RES, V19, P3443, DOI 10.1093/nar/19.12.3443; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Oberley MJ, 2003, METHOD ENZYMOL, V371, P577; Pilon N, 2006, DEV BIOL, V289, P55, DOI 10.1016/j.ydbio.2005.10.005; SATOKATA I, 1995, NATURE, V374, P460, DOI 10.1038/374460a0; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Shah CA, 2012, J BIOL CHEM, V287, P18230, DOI 10.1074/jbc.M111.328401; Shah CA, 2011, J BIOL CHEM, V286, P3161, DOI 10.1074/jbc.M110.183251; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wang H, 2007, J BIOL CHEM, V282, P16164, DOI 10.1074/jbc.M610556200; Wang H, 2009, J BIOL CHEM, V284, P2549, DOI 10.1074/jbc.M804704200; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; WILSON EL, 1991, BLOOD, V77, P954	45	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.402172	http://dx.doi.org/10.1074/jbc.M112.402172			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23038246	Green Published, hybrid			2022-12-28	WOS:000311233800029
J	Clausen, JD; Vandecaetsbeek, I; Wuytack, F; Vangheluwe, P; Andersen, JP				Clausen, Johannes D.; Vandecaetsbeek, Ilse; Wuytack, Frank; Vangheluwe, Peter; Andersen, Jens Peter			Distinct Roles of the C-terminal 11th Transmembrane Helix and Luminal Extension in the Partial Reactions Determining the High Ca2+ Affinity of Sarco(endo) plasmic Reticulum Ca2+-ATPase Isoform 2b (SERCA2b)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM; FUNCTIONAL CONSEQUENCES; CRYSTAL-STRUCTURE; STEADY-STATE; PHOSPHORYLATION; CA-2+-ATPASE; DEPHOSPHORYLATION; LOCALIZATION; DISSECTION; EFFICIENCY	The molecular mechanism underlying the characteristic high apparent Ca2+ affinity of SERCA2b relative to SERCA1a and SERCA2a isoforms was studied. The C-terminal tail of SERCA2b consists of an 11th transmembrane helix (TM11) with an associated 11-amino acid luminal extension (LE). The effects of each of these parts and their interactions with the SERCA environment were examined by transient kinetic analysis of the partial reaction steps in the Ca2+ transport cycle in mutant and chimeric Ca2+-ATPase constructs. Manipulations to the LE of SERCA2b markedly increased the rate of Ca2+ dissociation from Ca(2)E1. Addition of the SERCA2b tail to SERCA1a slowed Ca2+ dissociation, but only when the luminal L7/8 loop of SERCA1 was simultaneously replaced with that of SERCA2, thus suggesting that the LE interacts with L7/8 in Ca(2)E1. The interaction of LE with L7/8 is also important for the low rate of the Ca(2)E1P -> E2P conformational transition. These findings can be rationalized in terms of stabilization of the Ca(2)E1 and Ca(2)E1P forms by docking of the LE near L7/8. By contrast, low rates of E2P dephosphorylation and E2 -> E1 transition in SERCA2b depend critically on TM11, particularly in a SERCA2 environment, but do not at all depend on the LE or L7/8. This indicates that interaction of TM11 with SERCA2-specific sequence element(s) elsewhere in the structure is critical in the Ca2+-free E2/E2P states. Collectively these properties ensure a higher Ca2+ affinity of SERCA2b relative to other SERCA isoforms, not only on the cytosolic side, but also on the luminal side.	[Clausen, Johannes D.; Andersen, Jens Peter] Aarhus Univ, Danish Natl Res Fdn, PUMPKIN, Dept Biomed,Ctr Membrane Pumps Cells & Dis, DK-8000 Aarhus C, Denmark; [Clausen, Johannes D.] Aarhus Univ, Danish Natl Res Fdn, PUMPKIN, Dept Mol Biol & Genet,Ctr Membrane Pumps Cells &, DK-8000 Aarhus C, Denmark; [Vandecaetsbeek, Ilse; Wuytack, Frank; Vangheluwe, Peter] Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Cellular Transport Syst, B-3000 Louvain, Belgium	Aarhus University; Danmarks Grundforskningsfond; Aarhus University; Danmarks Grundforskningsfond; KU Leuven	Andersen, JP (corresponding author), Ole Worms Alle 4,Bldg 1160, DK-8000 Aarhus C, Denmark.	jpa@fi.au.dk	Vangheluwe, Peter/P-5476-2017	Vangheluwe, Peter/0000-0002-7822-2944; Andersen, Jens Peter/0000-0003-0654-4300	Lundbeck Foundation; Danish Medical Research Council; Novo Nordisk Foundation; Danish National Research Foundation (PUMPKIN Centre); Research Program of the Flanders Research Foundation (FWO-Vlaanderen) [G.0646.08, G.0442.12]; Interuniversity Attraction Poles Program of the Belgian State, Federal Office for Scientific Technical and Cultural Affairs [P6/28]	Lundbeck Foundation(Lundbeckfonden); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish National Research Foundation (PUMPKIN Centre)(Danmarks Grundforskningsfond); Research Program of the Flanders Research Foundation (FWO-Vlaanderen)(FWO); Interuniversity Attraction Poles Program of the Belgian State, Federal Office for Scientific Technical and Cultural Affairs	This work was supported in part by grants from the Lundbeck Foundation (to J. D. C.), the Danish Medical Research Council (to J. P. A.), the Novo Nordisk Foundation (to J. P. A.), the Danish National Research Foundation (PUMPKIN Centre), Research Program of the Flanders Research Foundation (FWO-Vlaanderen) Grants G.0646.08 and G.0442.12, and the Interuniversity Attraction Poles Program P6/28 of the Belgian State, Federal Office for Scientific Technical and Cultural Affairs.	Andersen JP, 2001, J BIOL CHEM, V276, P23312, DOI 10.1074/jbc.M102384200; BAYLE D, 1995, J BIOL CHEM, V270, P25678, DOI 10.1074/jbc.270.43.25678; BEIL FU, 1977, EUR J BIOCHEM, V81, P151, DOI 10.1111/j.1432-1033.1977.tb11936.x; Bobe R, 2004, J BIOL CHEM, V279, P24297, DOI 10.1074/jbc.M314286200; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; Clausen JD, 2004, J BIOL CHEM, V279, P54426, DOI 10.1074/jbc.M410204200; Dally S, 2006, BIOCHEM J, V395, P249, DOI 10.1042/BJ20051427; Dode L, 2003, J BIOL CHEM, V278, P47877, DOI 10.1074/jbc.M306784200; Dode L, 2002, J BIOL CHEM, V277, P45579, DOI 10.1074/jbc.M207778200; FORGE V, 1993, J BIOL CHEM, V268, P10961; Gorski PA, 2012, J BIOL CHEM, V287, P19876, DOI 10.1074/jbc.M111.335620; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; LYTTON J, 1988, J BIOL CHEM, V263, P15024; Marchand A, 2008, J BIOL CHEM, V283, P14867, DOI 10.1074/jbc.M710165200; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; PUNZENGRUBER C, 1978, EUR J BIOCHEM, V92, P349, DOI 10.1111/j.1432-1033.1978.tb12754.x; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Sorensen T, 1997, J BIOL CHEM, V272, P30244, DOI 10.1074/jbc.272.48.30244; Sorensen TLM, 2004, J BIOL CHEM, V279, P46355, DOI 10.1074/jbc.C400414200; Sorensen TLM, 2000, J BIOL CHEM, V275, P5400, DOI 10.1074/jbc.275.8.5400; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Vandecaetsbeek I, 2009, P NATL ACAD SCI USA, V106, P18533, DOI 10.1073/pnas.0906797106; VERBOOMEN H, 1992, BIOCHEM J, V286, P591, DOI 10.1042/bj2860591; VERBOOMEN H, 1994, BIOCHEM J, V303, P979, DOI 10.1042/bj3030979; VILSEN B, 1989, J BIOL CHEM, V264, P21024	28	13	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.397331	http://dx.doi.org/10.1074/jbc.M112.397331			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23024360	Green Published, hybrid			2022-12-28	WOS:000311233800018
J	Dai, RY; Li, JJ; Fu, J; Chen, Y; Wang, RY; Zhao, XF; Luo, T; Zhu, JJ; Ren, YB; Cao, J; Qian, YW; Li, N; Wang, HY				Dai, Rongyang; Li, Juanjuan; Fu, Jing; Chen, Yao; Wang, Ruoyu; Zhao, Xiaofang; Luo, Tao; Zhu, Junjie; Ren, Yibin; Cao, Jie; Qian, Youwen; Li, Ning; Wang, Hongyang			The Tyrosine Kinase c-Met Contributes to the Pro-tumorigenic Function of the p38 Kinase in Human Bile Duct Cholangiocarcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HEPATOCYTE GROWTH-FACTOR; BREAST-CANCER CELLS; FACTOR-RECEPTOR; THERAPEUTIC INHIBITION; SIGNALING PATHWAYS; PHOSPHATASE DEP-1; GENE-EXPRESSION; STEM-CELLS; CYCLIN D1	Pro-tumorigenic function of the p38 kinase plays a critical role in human cholangiocarcinogenesis. However, the underlying mechanism remains incompletely understood. Here, we report that c-Met, the tyrosine kinase receptor for hepatocyte growth factor (HGF), contributes to the pro-tumorigenic ability of p38 in human cholangiocarcinoma cells. Both p38 and c-Met promote the proliferation and invasion of human cholangiocarcinoma cells. Importantly, inhibition or knockdown of p38 decreased the basal activation of c-Met. Tyrosine phosphatase inhibitor studies revealed that p38 promotes the activity of c-Met, at least in part, by inhibiting dephosphorylation of the receptor. Moreover, density enhanced phosphatase-1 (DEP-1) is involved in p38-mediated inhibiting dephosphorylation of c-Met. Furthermore, p38 inhibits the degradation of c-Met. Taken together, these data provide a potential mechanism to explain how p38 promotes human cholangiocarcinoma cell proliferation and invasion. We propose that the link between p38 and c-Met is implicated in the progression of human cholangiocarcinoma.	[Dai, Rongyang; Li, Juanjuan; Fu, Jing; Chen, Yao; Wang, Ruoyu; Zhao, Xiaofang; Luo, Tao; Zhu, Junjie; Ren, Yibin; Cao, Jie; Qian, Youwen; Li, Ning; Wang, Hongyang] Second Mil Med Univ, Eastern Hepatobiliary Surg Inst, Int Cooperat Lab Signal Transduct, Shanghai 200438, Peoples R China; [Dai, Rongyang] Luzhou Med Coll, Dept Biochem, Luzhou 646000, Sichuan, Peoples R China; [Dai, Rongyang; Li, Ning; Wang, Hongyang] Shanghai Jiao Tong Univ, Renji Hosp, Inst Canc, State Key Lab Oncogenes & Related Genes, Shanghai 200032, Peoples R China	Naval Medical University; Southwest Medical University; Shanghai Jiao Tong University	Wang, HY (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Inst, Int Cooperat Lab Signal Transduct, Shanghai 200438, Peoples R China.	hywangk@vip.sina.com			National Natural Science Foundation of China [81000886, 81170377, 81101714, 30921006, 91029732]; State Key Project for Infectious Diseases Grant [2012ZX10002-009, 2012ZX10002-010, 2012ZX10002-011]; New Century Excellent Talents in University Grant [NCET-11-1058]; State Key Laboratory of Oncogenes and Related Genes [91-10-02, 90-10-03, 10JC1418500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Project for Infectious Diseases Grant; New Century Excellent Talents in University Grant(Program for New Century Excellent Talents in University (NCET)); State Key Laboratory of Oncogenes and Related Genes	This work was supported by National Natural Science Foundation of China Grants 81000886, 81170377, 81101714, 30921006, and 91029732, State Key Project for Infectious Diseases Grant 2012ZX10002-009 and -011, New Century Excellent Talents in University Grant NCET-11-1058, and State Key Laboratory of Oncogenes and Related Genes Grants 91-10-02, 90-10-03, and 10JC1418500.	Arora D, 2011, J BIOL CHEM, V286, P10918, DOI 10.1074/jbc.M110.205021; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Bulavin DV, 2004, ADV CANCER RES, V92, P95, DOI 10.1016/S0065-230X(04)92005-2; Carter S, 2004, J BIOL CHEM, V279, P52835, DOI 10.1074/jbc.M407769200; Christensen JG, 2005, CANCER LETT, V225, P1, DOI 10.1016/j.canlet.2004.09.044; Corso S, 2005, TRENDS MOL MED, V11, P284, DOI 10.1016/j.molmed.2005.04.005; Dai RY, 2012, J BIOL CHEM, V287, P14586, DOI 10.1074/jbc.M111.333435; Enslen H, 1998, J BIOL CHEM, V273, P1741, DOI 10.1074/jbc.273.3.1741; Farazi PA, 2006, CANCER RES, V66, P6622, DOI 10.1158/0008-5472.CAN-05-4609; FERRACINI R, 1991, J BIOL CHEM, V266, P19558; Figueras J, 2000, NEW ENGL J MED, V342, P663; Forte G, 2006, STEM CELLS, V24, P23, DOI 10.1634/stemcells.2004-0176; Gay B, 1999, J BIOL CHEM, V274, P23311, DOI 10.1074/jbc.274.33.23311; GRAZIANI A, 1991, J BIOL CHEM, V266, P22087; Han C, 2005, J BIOL CHEM, V280, P24053, DOI 10.1074/jbc.M500562200; Hui LJ, 2007, CELL CYCLE, V6, P2429, DOI 10.4161/cc.6.20.4774; Jeffers M, 1998, P NATL ACAD SCI USA, V95, P14417, DOI 10.1073/pnas.95.24.14417; Jeffers M, 1997, P NATL ACAD SCI USA, V94, P11445, DOI 10.1073/pnas.94.21.11445; Jeffers M, 1997, MOL CELL BIOL, V17, P799, DOI 10.1128/MCB.17.2.799; Kermorgant S, 2003, J BIOL CHEM, V278, P28921, DOI 10.1074/jbc.M302116200; Kogai T, 2012, J BIOL CHEM, V287, P3292, DOI 10.1074/jbc.M111.315523; Lee RJ, 1999, J BIOL CHEM, V274, P7341, DOI 10.1074/jbc.274.11.7341; Leelawat K, 2006, J SURG RES, V136, P78, DOI 10.1016/j.jss.2006.05.031; Li Ning, 2008, V457, P305, DOI 10.1007/978-1-59745-261-8_23; Ma PC, 2003, CANCER METAST REV, V22, P309, DOI 10.1023/A:1023768811842; Maher P, 1999, J BIOL CHEM, V274, P17491, DOI 10.1074/jbc.274.25.17491; Matsumoto T, 1999, J BIOL CHEM, V274, P13954, DOI 10.1074/jbc.274.20.13954; Miyamoto M, 2011, BRIT J CANCER, V105, P131, DOI 10.1038/bjc.2011.199; Neve RM, 2002, ONCOGENE, V21, P4567, DOI 10.1038/sj.onc.1205555; Olnes MJ, 2004, ONCOLOGY-BASEL, V66, P167, DOI 10.1159/000077991; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; Park J, 1999, HEPATOLOGY, V30, P1128, DOI 10.1002/hep.510300522; Patel T, 2006, NAT CLIN PRACT GASTR, V3, P33, DOI 10.1038/ncpgasthep0389; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Recio JA, 2002, ONCOGENE, V21, P1000, DOI 10.1038/sj.onc.1205150; Schmidt L, 1999, ONCOGENE, V18, P2343, DOI 10.1038/sj.onc.1202547; Sirica AE, 2005, HEPATOLOGY, V41, P5, DOI 10.1002/hep.20537; Tadlock L, 2001, HEPATOLOGY, V33, P43, DOI 10.1053/jhep.2001.20676; TAJIMA H, 1992, EXP CELL RES, V202, P423, DOI 10.1016/0014-4827(92)90095-P; Tan FLS, 2010, INT J CANCER, V126, P2353, DOI 10.1002/ijc.24944; Terada T, 1998, HUM PATHOL, V29, P175, DOI 10.1016/S0046-8177(98)90229-5; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang ZQ, 2010, J CELL PHYSIOL, V224, P559, DOI 10.1002/jcp.22160; Wehbe H, 2006, CANCER RES, V66, P10517, DOI 10.1158/0008-5472.CAN-06-2130; Xu LH, 2006, J BIOL CHEM, V281, P33982, DOI 10.1074/jbc.M600135200; Yamagiwa Y, 2003, HEPATOLOGY, V38, P158, DOI 10.1053/jhep.2003.50257; You HN, 2011, HEPATOLOGY, V54, P879, DOI 10.1002/hep.24450; Zhang YW, 2003, P NATL ACAD SCI USA, V100, P12718, DOI 10.1073/pnas.2135113100	53	13	14	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.406520	http://dx.doi.org/10.1074/jbc.M112.406520			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23024367	Green Published, hybrid			2022-12-28	WOS:000311233800049
J	Prantner, D; Perkins, DJ; Lai, W; Williams, MS; Sharma, S; Fitzgerald, KA; Vogel, SN				Prantner, Daniel; Perkins, Darren J.; Lai, Wendy; Williams, Mark S.; Sharma, Shruti; Fitzgerald, Katherine A.; Vogel, Stefanie N.			5,6-Dimethylxanthenone-4-acetic Acid (DMXAA) Activates Stimulator of Interferon Gene (STING)-dependent Innate Immune Pathways and Is Regulated by Mitochondrial Membrane Potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CHRONIC GRANULOMATOUS-DISEASE; TYROSINE-PHOSPHATASE 1B; DOUBLE-STRANDED-RNA; IFN-BETA; RIG-I; ADAPTER PROTEIN; AGENT DMXAA; TETRAZOLIUM REDUCTION; FACTOR-3 ACTIVATION	The chemotherapeutic agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) is a potent inducer of type I IFNs and other cytokines. This ability is essential for its chemotherapeutic benefit in a mouse cancer model and suggests that it might also be useful as an antiviral agent. However, the mechanism underlying DMXAA-induced type I IFNs, including the host proteins involved, remains unclear. Recently, it was reported that the antioxidant N-acetylcysteine (NAC) decreased DMXAA-induced TNF-alpha and IL-6, suggesting that oxidative stress may play a role. The goal of this study was to identify host proteins involved in DMXAA-dependent signaling and determine how antioxidants modulate this response. We found that expression of IFN-beta in response to DMXAA in mouse macrophages requires the mitochondrial and endoplasmic reticulum resident protein STING. Addition of the antioxidant diphenylene iodonium (DPI) diminished DMXAA-induced IFN-beta, but this decrease was independent of both the NADPH oxidase, Nox2, and de novo generation of reactive oxygen species. Additionally, IFN-beta up-regulation by DMXAA was inhibited by agents that target the mitochondrial electron transport chain and, conversely, loss of mitochondrial membrane potential correlated with diminished innate immune signaling in response to DMXAA. Up-regulation of Ifnb1 gene expression mediated by cyclic dinucleotides was also impaired by DPI, whereas up-regulation of Ifnb1 mRNA due to cytosolic double-stranded DNA was not. Although both stimuli signal through STING, cyclic dinucleotides interact directly with STING, suggesting that recognition of DMXAA by STING may also be mediated by direct interaction.	[Prantner, Daniel; Perkins, Darren J.; Lai, Wendy; Williams, Mark S.; Vogel, Stefanie N.] Univ Maryland, Sch Med UMB, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Williams, Mark S.] Univ Maryland, Sch Med UMB, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Sharma, Shruti; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Massachusetts System; University of Massachusetts Worcester	Vogel, SN (corresponding author), 685 W Baltimore St,Rm 380, Baltimore, MD 21201 USA.	svogel@som.umaryland.edu	Fitzgerald, Katherine/ABE-6317-2020	Fitzgerald, Kate/0000-0003-3175-609X	National Institutes of Health [AI-18797, AI-070823, AI-067497]; Ruth L. Kirchstein National Research Service Award for Individual Postdoctoral Fellows; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070823, R01AI067497, R37AI018797, R56AI018797, R56AI067497, R01AI018797, R37AI067497] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirchstein National Research Service Award for Individual Postdoctoral Fellows(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-18797 (to S. N. V.), AI-070823 (to M. S. W.), and AI-067497 (to K. A. F.) and a Ruth L. Kirchstein National Research Service Award for Individual Postdoctoral Fellows (to D. P.).	ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; BAGINSKY ML, 1969, J BIOL CHEM, V244, P5313; Baguley BC, 2003, LANCET ONCOL, V4, P141, DOI 10.1016/S1470-2045(03)01018-0; Brauer R, 2010, NEOPLASIA, V12, P755, DOI 10.1593/neo.10636; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Byun HO, 2008, J CELL BIOCHEM, V104, P1747, DOI 10.1002/jcb.21741; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; CHAPPELL JB, 1965, BIOCHEM J, V95, P707, DOI 10.1042/bj0950707; Cheng GJ, 2011, AM J RESP CELL MOL, V45, P480, DOI 10.1165/rcmb.2010-0288OC; Cheng GJ, 2010, J BIOL CHEM, V285, P10553, DOI 10.1074/jbc.M109.065631; Ching LM, 2004, BRIT J CANCER, V90, P906, DOI 10.1038/sj.bjc.6601606; Ching LM, 2002, BRIT J CANCER, V86, P1937, DOI 10.1038/sj.bjc.6600368; de Almeida LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023135; de Souza WR, 2011, J BIOENERG BIOMEMBR, V43, P237, DOI 10.1007/s10863-011-9357-4; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; DU W, 1992, P NATL ACAD SCI USA, V89, P2150, DOI 10.1073/pnas.89.6.2150; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; GUTMAN M, 1970, P NATL ACAD SCI USA, V65, P763, DOI 10.1073/pnas.65.3.763; HANCOCK JT, 1987, BIOCHEM J, V242, P103, DOI 10.1042/bj2420103; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; HOLLAND PC, 1972, BIOCHEM J, V129, P39, DOI 10.1042/bj1290039; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hutchinson DS, 2007, CELL SIGNAL, V19, P1610, DOI 10.1016/j.cellsig.2007.02.006; Indukuri H, 2006, VIROLOGY, V353, P155, DOI 10.1016/j.virol.2006.05.022; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jassar AS, 2005, CANCER RES, V65, P11752, DOI 10.1158/0008-5472.CAN-05-1658; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; KESSLER RJ, 1976, P NATL ACAD SCI USA, V73, P3141, DOI 10.1073/pnas.73.9.3141; Koshiba T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001147; Lara PN, 2011, J CLIN ONCOL, V29, P2965, DOI 10.1200/JCO.2011.35.0660; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; LENARDO MJ, 1989, CELL, V57, P287, DOI 10.1016/0092-8674(89)90966-5; Li NY, 2003, FREE RADICAL BIO MED, V34, P465, DOI 10.1016/S0891-5849(02)01325-4; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Lippmann J, 2011, CELL MICROBIOL, V13, P1668, DOI 10.1111/j.1462-5822.2011.01646.x; Liu XY, 2010, CELL RES, V20, P994, DOI 10.1038/cr.2010.103; Lohrke B, 2010, CYTOM PART A, V77A, P310, DOI 10.1002/cyto.a.20873; McKeage MJ, 2008, BRIT J CANCER, V99, P2006, DOI 10.1038/sj.bjc.6604808; McKeage MJ, 2009, LUNG CANCER, V65, P192, DOI 10.1016/j.lungcan.2009.03.027; MCPHAIL LC, 1976, J CLIN INVEST, V58, P774, DOI 10.1172/JCI108528; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NATHAN DG, 1969, J CLIN INVEST, V48, P1895, DOI 10.1172/JCI106156; PERERA PY, 1994, J IMMUNOL, V153, P4684; PICK E, 1981, J RETICULOENDOTH SOC, V30, P581; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; PORTER CD, 1993, BLOOD, V82, P2196; Prantner D, 2010, J IMMUNOL, V184, P2551, DOI 10.4049/jimmunol.0903704; Prantner D, 2009, INFECT IMMUN, V77, P76, DOI 10.1128/IAI.00963-08; RAGAN CI, 1977, BIOCHEM J, V163, P605, DOI 10.1042/bj1630605; RAGAN CI, 1978, BIOCHEM J, V174, P783, DOI 10.1042/bj1740783; Roberts ZJ, 2008, J INTERF CYTOK RES, V28, P133, DOI 10.1089/jir.2007.0992; Roberts ZJ, 2007, J EXP MED, V204, P1559, DOI 10.1084/jem.20061845; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shirey KA, 2011, J LEUKOCYTE BIOL, V89, P351, DOI 10.1189/jlb.0410216; Soucy-Faulkner A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000930; Sun J, 2011, BIOCHEM PHARMACOL, V82, P1175, DOI 10.1016/j.bcp.2011.07.086; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; TOLEDANO MB, 1991, P NATL ACAD SCI USA, V88, P4328, DOI 10.1073/pnas.88.10.4328; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	83	129	141	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.382986	http://dx.doi.org/10.1074/jbc.M112.382986			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23027866	Green Published, hybrid			2022-12-28	WOS:000311233800046
J	Wang, XW; Zhuang, XX; Cao, D; Chu, YJ; Yao, P; Liu, W; Liu, LF; Adams, G; Fang, GW; Dou, Z; Ding, X; Huang, YJ; Wang, DM; Yao, XB				Wang, Xiwei; Zhuang, Xiaoxuan; Cao, Dan; Chu, Youjun; Yao, Phil; Liu, Wei; Liu, Lifang; Adams, Gregory; Fang, Guowei; Dou, Zhen; Ding, Xia; Huang, Yuejia; Wang, Dongmei; Yao, Xuebiao			Mitotic Regulator SKAP Forms a Link between Kinetochore Core Complex KMN and Dynamic Spindle Microtubules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AURORA-B KINASE; PLUS-END TRACKING; CENP-E; CHROMOSOME SEGREGATION; ANAPHASE TRANSITION; PROTEIN E; MITOSIS; CHECKPOINT; ATTACHMENT; INTERACTS	Chromosome segregation in mitosis is orchestrated by the dynamic interactions between the kinetochore and spindle microtubules. Our recent study shows that mitotic motor CENP-E cooperates with SKAP to orchestrate an accurate chromosome movement in mitosis. However, it remains elusive how kinetochore core microtubule binding activity KMN (KNL1-MIS12-NDC80) regulates microtubule plus-end dynamics. Here, we identify a novel interaction between MIS13 and SKAP that orchestrates accurate interaction between kinetochore and dynamic spindle microtubules. SKAP physically interacts with MIS13 and specifies kinetochore localization of SKAP. Suppression of MIS13 by small interfering RNA abrogates the kinetochore localization of SKAP. Total internal reflection fluorescence microscopic assays demonstrate that SKAP exhibits an EB1-dependent, microtubule plus-end loading and tracking in vitro. Importantly, SKAP is essential for kinetochore oscillations and dynamics of microtubule plus-ends during live cell mitosis. Based on those findings, we reason that SKAP constitutes a dynamic link between spindle microtubule plus-ends and mitotic chromosomes to achieve faithful cell division.	[Wang, Xiwei; Zhuang, Xiaoxuan; Cao, Dan; Chu, Youjun; Liu, Wei; Liu, Lifang; Fang, Guowei; Dou, Zhen; Huang, Yuejia; Wang, Dongmei; Yao, Xuebiao] Anhui Key Lab Cellular Dynam, Hefei 230027, Peoples R China; [Wang, Xiwei; Zhuang, Xiaoxuan; Cao, Dan; Chu, Youjun; Liu, Wei; Liu, Lifang; Fang, Guowei; Dou, Zhen; Huang, Yuejia; Wang, Dongmei; Yao, Xuebiao] Univ Sci & Technol China, Hefei 230027, Peoples R China; [Wang, Xiwei; Zhuang, Xiaoxuan; Cao, Dan; Adams, Gregory; Dou, Zhen; Ding, Xia; Huang, Yuejia; Wang, Dongmei; Yao, Xuebiao] Hefei Natl Lab Phys Sci Microscale, Joint Res Grp Cellular Dynam, Anhui Morehouse Sch Med, Hefei 230027, Peoples R China; [Wang, Xiwei; Chu, Youjun; Yao, Phil; Adams, Gregory; Huang, Yuejia] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA; [Yao, Phil] Georgia Inst Technol, Sch Engn, Atlanta, GA 30310 USA; [Liu, Lifang] AF Gen Hosp, Beijing 100036, Peoples R China; [Adams, Gregory; Ding, Xia] Beijing Univ Chinese Med, Beijing 100029, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Morehouse School of Medicine; University System of Georgia; Georgia Institute of Technology; Beijing University of Chinese Medicine	Wang, DM (corresponding author), Anhui Key Lab Cellular Dynam, Hefei 230027, Peoples R China.	douzhen@ustc.edu.cn; wangdm@ustc.edu.cn	Yao, Xuebiao/P-5771-2014; DOU, ZHEN/N-2022-2013; Zhuang, Xiaoxuan/R-7836-2019; liu, li/HGC-0900-2022	Zhuang, Xiaoxuan/0000-0003-4004-5329; Xia, Peng/0000-0002-5419-7756; DOU, ZHEN/0000-0003-3303-9393	National Institutes of Health [DK56292, CA164133, G12RR03034, UL1 RR025008, CA132389]; Chinese 973 Project [2010CB912103, 2012CB917204, 2012CB945002, 2002CB713700]; Chinese Academy of Science [KSCX2-YW-H-10]; Anhui Province Key Project [08040102005]; International Collaboration Grant [2009DFA31010]; Chinese Natural Science Foundation [90508002, 91129714, 31071184, 81270466, 90913016, MOE20113402130010]; Chinese Postdoctoral Fellowship [2012M510210]; Fundamental Research Funds for Central Universities [WK2060190018, WK2340000021]; NATIONAL CANCER INSTITUTE [P20CA132389, R01CA164133] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034, UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292, R01DK115812] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese 973 Project(National Basic Research Program of China); Chinese Academy of Science(Chinese Academy of Sciences); Anhui Province Key Project; International Collaboration Grant; Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Fellowship; Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants DK56292, CA164133, G12RR03034, UL1 RR025008, and CA132389. This work was also supported by Chinese 973 Project Grants 2010CB912103, 2012CB917204, 2012CB945002, and 2002CB713700; Chinese Academy of Science Grant KSCX2-YW-H-10; Anhui Province Key Project Grant 08040102005; International Collaboration Grant 2009DFA31010; Chinese Natural Science Foundation Grants 90508002, 91129714, 31071184, 81270466, 90913016, MOE20113402130010, Chinese Postdoctoral Fellowship 2012M510210; and the Fundamental Research Funds for Central Universities (WK2060190018 and WK2340000021).	Amaro AC, 2010, NAT CELL BIOL, V12, P319, DOI 10.1038/ncb2033; Bakhoum SF, 2009, CURR BIOL, V19, P1937, DOI 10.1016/j.cub.2009.09.055; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Chu LL, 2012, J MOL CELL BIOL, V4, P331, DOI 10.1093/jmcb/mjs023; Chu YJ, 2011, J MOL CELL BIOL, V3, P260, DOI 10.1093/jmcb/mjq037; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Ding X, 2010, CELL RES, V20, P1386, DOI 10.1038/cr.2010.167; Dixit R, 2009, P NATL ACAD SCI USA, V106, P492, DOI 10.1073/pnas.0807614106; Dixit R, 2010, METHOD CELL BIOL, V95, P543, DOI 10.1016/S0091-679X(10)95027-9; Dou Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018793; Dunsch AK, 2011, J CELL BIOL, V192, P959, DOI 10.1083/jcb.201008023; Fang L, 2009, CELL CYCLE, V8, P2819, DOI 10.4161/cc.8.17.9514; Huang YJ, 2012, J BIOL CHEM, V287, P1500, DOI 10.1074/jbc.M111.277194; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kline SL, 2006, J CELL BIOL, V173, P9, DOI 10.1083/jcb.200509158; Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208; Liu D, 2007, J BIOL CHEM, V282, P21415, DOI 10.1074/jbc.M609026200; Liu J, 2009, J BIOL CHEM, V284, P23059, DOI 10.1074/jbc.M109.009670; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Manning AL, 2010, EMBO J, V29, P3531, DOI 10.1038/emboj.2010.230; McEwen BF, 2001, MOL BIOL CELL, V12, P2776, DOI 10.1091/mbc.12.9.2776; McIntosh JR, 2008, CELL, V135, P322, DOI 10.1016/j.cell.2008.08.038; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nishino T, 2012, CELL, V148, P487, DOI 10.1016/j.cell.2011.11.061; Schmidt JC, 2010, J CELL BIOL, V191, P269, DOI 10.1083/jcb.201006129; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Tao YY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1779; Thein KH, 2007, J CELL BIOL, V178, P345, DOI 10.1083/jcb.200701163; Wang HM, 2004, J BIOL CHEM, V279, P54590, DOI 10.1074/jbc.M407588200; Welburn JPI, 2008, DEV CELL, V15, P645, DOI 10.1016/j.devcel.2008.10.011; Xia P, 2012, P NATL ACAD SCI USA, V109, P16564, DOI 10.1073/pnas.1202639109; Yang Y, 2008, J BIOL CHEM, V283, P26726, DOI 10.1074/jbc.M804207200; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yao XB, 2009, CELL RES, V19, P152, DOI 10.1038/cr.2009.7; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721; ZHAI Y, 1994, J CELL SCI, V107, P881; Zhu M, 2008, J BIOL CHEM, V283, P18916, DOI 10.1074/jbc.M710591200	43	35	40	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.406652	http://dx.doi.org/10.1074/jbc.M112.406652			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23035123	Green Published, hybrid			2022-12-28	WOS:000311233800010
J	Chen, CL; Calhoun, JD; Zhang, YQ; Lopez-Santiago, L; Zhou, N; Davis, TH; Salzer, JL; Isom, LL				Chen, Chunling; Calhoun, Jeffrey D.; Zhang, Yanqing; Lopez-Santiago, Luis; Zhou, Ningna; Davis, Tigwa H.; Salzer, James L.; Isom, Lori L.			Identification of the Cysteine Residue Responsible for Disulfide Linkage of Na+ Channel alpha and beta 2 Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED SODIUM-CHANNELS; HOMOPHILIC CELL-ADHESION; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; PROTEIN; NODES; SEGMENTS; SEIZURES; MUTATION; ANKYRIN	Voltage-gated Na+ channels in the brain are composed of a single pore-forming alpha subunit, one non-covalently linked beta subunit (beta 1 or beta 3), and one disulfide-linked beta subunit (beta 2 or beta 4). The final step in Na+ channel biosynthesis in central neurons is concomitant alpha-beta 2 disulfide linkage and insertion into the plasma membrane. Consistent with this, Scn2b (encoding beta 2) null mice have reduced Na+ channel cell surface expression in neurons, and action potential conduction is compromised. Here we generated a series of mutant beta 2 cDNA constructs to investigate the cysteine residue(s) responsible for alpha-beta 2 subunit covalent linkage. We demonstrate that a single cysteine-to-alanine substitution at extracellular residue Cys-26, located within the immunoglobulin (Ig) domain, abolishes the covalent linkage between alpha and beta 2 subunits. Loss of alpha-beta 2 covalent complex formation disrupts the targeting of beta 2 to nodes of Ranvier in a myelinating co-culture system and to the axon initial segment in primary hippocampal neurons, suggesting that linkage with alpha is required for normal beta 2 subcellular localization in vivo. WT beta 2 subunits are resistant to live cell Triton X-100 detergent extraction from the hippocampal axon initial segment, whereas mutant beta 2 subunits, which cannot form disulfide bonds with alpha, are removed by detergent. Taken together, our results demonstrate that alpha-beta 2 covalent association via a single, extracellular disulfide bond is required for beta 2 targeting to specialized neuronal subcellular domains and for beta 2 association with the neuronal cytoskeleton within those domains.	[Chen, Chunling; Calhoun, Jeffrey D.; Lopez-Santiago, Luis; Zhou, Ningna; Davis, Tigwa H.; Isom, Lori L.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Chen, Chunling; Calhoun, Jeffrey D.; Lopez-Santiago, Luis; Zhou, Ningna; Davis, Tigwa H.; Isom, Lori L.] Univ Michigan, Sch Med, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA; [Zhang, Yanqing; Salzer, James L.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Zhang, Yanqing; Salzer, James L.] NYU, Sch Med, Dept Neurol, New York, NY 10016 USA; [Zhang, Yanqing; Salzer, James L.] NYU, Sch Med, Inst Neurosci, New York, NY 10016 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; New York University; New York University; New York University	Isom, LL (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, SPC 5632,1301 Catherine St, Ann Arbor, MI 48109 USA.	lisom@umich.edu		Zhang, Yanqing/0000-0003-3413-6726; Salzer, James/0000-0001-9126-7197; Calhoun, Jeffrey/0000-0003-0554-2231; Isom, Lori/0000-0002-9479-6729	National Institutes of Health [NS076752, NS 064245, NS043474]; National Multiple Sclerosis Society [RG 4748A13, RG 3771A4/3]; American Epilepsy Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064245, R37NS076752, R01NS043474, R01NS076752, R56NS076752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); American Epilepsy Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS076752 and NS 064245 (to L. L. I.) and NS043474 (to J. L. S.). This work was also supported by National Multiple Sclerosis Society Grants RG 4748A13 (to J. L. S.) and RG 3771A4/3 (to L. L. I.).; Supported by a fellowship from the American Epilepsy Society.	Brackenbury WJ, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00053; Catterall WA, 2012, J PHYSIOL-LONDON, V590, P2577, DOI 10.1113/jphysiol.2011.224204; Chen CL, 2002, P NATL ACAD SCI USA, V99, P17072, DOI 10.1073/pnas.212638099; Dzhashiashvili Y, 2007, J CELL BIOL, V177, P857, DOI 10.1083/jcb.200612012; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Kaplan MR, 2001, NEURON, V30, P105, DOI 10.1016/S0896-6273(01)00266-5; Kazarinova-Noyes K, 2001, J NEUROSCI, V21, P7517, DOI 10.1523/JNEUROSCI.21-19-07517.2001; Kim DY, 2007, NAT CELL BIOL, V9, P755, DOI 10.1038/ncb1602; Liu ZG, 2012, PROTEINS, V80, P307, DOI 10.1002/prot.23164; Lopez-Santiago LF, 2006, J NEUROSCI, V26, P7984, DOI 10.1523/JNEUROSCI.2211-06.2006; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; Malhotra JD, 2001, CIRCULATION, V103, P1303; McCormick KA, 1998, J BIOL CHEM, V273, P3954, DOI 10.1074/jbc.273.7.3954; McEwen DP, 2004, J BIOL CHEM, V279, P52744, DOI 10.1074/jbc.M405990200; McEwen DP, 2009, NEUROSCI LETT, V462, P272, DOI 10.1016/j.neulet.2009.07.020; Meadows LS, 2002, J NEUROSCI, V22, P10699; O'Malley HA, 2009, MOL CELL NEUROSCI, V40, P143, DOI 10.1016/j.mcn.2008.10.001; Patino GA, 2011, J NEUROSCI, V31, P14577, DOI 10.1523/JNEUROSCI.0361-11.2011; Patino GA, 2009, J NEUROSCI, V29, P10764, DOI 10.1523/JNEUROSCI.2475-09.2009; Pertin M, 2005, J NEUROSCI, V25, P10970, DOI 10.1523/JNEUROSCI.3066-05.2005; Qu YS, 1999, J BIOL CHEM, V274, P32647, DOI 10.1074/jbc.274.46.32647; Rusconi R, 2007, J NEUROSCI, V27, P11037, DOI 10.1523/JNEUROSCI.3515-07.2007; SCHMIDT JW, 1986, CELL, V46, P437, DOI 10.1016/0092-8674(86)90664-1; Shapiro L, 1996, NEURON, V17, P435, DOI 10.1016/S0896-6273(00)80176-2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Watanabe H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P268, DOI 10.1161/CIRCEP.108.779181; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Yu FH, 2003, J NEUROSCI, V23, P7577; Zhang YQ, 2012, NEURON, V73, P92, DOI 10.1016/j.neuron.2011.10.016	30	55	57	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39061	39069		10.1074/jbc.M112.397646	http://dx.doi.org/10.1074/jbc.M112.397646			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22992729	Green Published, hybrid			2022-12-28	WOS:000310982800062
J	Friedrich, MG; Lam, J; Truscott, RJW				Friedrich, Michael G.; Lam, Jackson; Truscott, Roger J. W.			Degradation of an Old Human Protein AGE-DEPENDENT CLEAVAGE OF gamma S-CRYSTALLIN GENERATES A PEPTIDE THAT BINDS TO CELL MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LENS CRYSTALLINS; AGING HUMAN LENS; ALPHA-B-CRYSTALLIN; DE-NOVO PEPTIDE; MASS-SPECTROMETRY; POSTTRANSLATIONAL MODIFICATIONS; PENETRATING-PEPTIDES; STRUCTURE PREDICTION; LIFELONG PROTEINS; BASIC RESIDUES	Long-lived proteins exist in a number of tissues in the human body; however, little is known about the reactions involved in their degradation over time. Lens proteins, which do not turn over, provide a useful system to examine such processes. Using a combination of Western blotting and proteomic methodology, age-related changes to a major protein, gamma S-crystallin, were studied. By teenage years, insoluble intact gamma S-crystallin was detected, indicative of protein denaturation. This was not the only change, however, because blots revealed evidence of significant cross-linking as well as cleavage of gamma S-crystallin in all adult lenses. Cleavage at a serine residue near the C terminus was a major reaction that caused the release of a 12-residue peptide, SPAVQSFRRIVE, which bound tightly to lens cell membranes. Several other crystallin-derived peptides with double basic residues also lodged in the cell membrane fraction. Model studies showed that once cleaved from gamma S-crystallin, SPAVQSFRRIVE adopts a markedly different shape from that in the intact protein. Further, the acquired helical conformation may explain why the peptide seems to affect water permeability. This observation may help explain the changes to cell membranes known to be associated with aging in human lenses. Age-related cleavage of long-lived proteins may therefore yield peptides with untoward biological activity.	[Friedrich, Michael G.; Truscott, Roger J. W.] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2500, Australia; [Friedrich, Michael G.; Lam, Jackson; Truscott, Roger J. W.] Save Sight Inst, Sydney, NSW 2001, Australia	University of Wollongong; University of Sydney	Truscott, RJW (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2500, Australia.	rjwt@uow.edu.au	Friedrich, Michael/C-8669-2016	Friedrich, Michael/0000-0002-8274-1552	National Health and Medical Research Council [512334]; Claffy Foundation	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Claffy Foundation	This work was supported by National Health and Medical Research Council Grant 512334 and the Claffy Foundation.	Asomugha CO, 2011, MOL VIS, V17, P2407; Asomugha CO, 2010, MOL VIS, V16, P476; Ball LE, 2004, BIOCHEMISTRY-US, V43, P9856, DOI 10.1021/bi0496034; BenTal N, 1996, BIOPHYS J, V71, P561, DOI 10.1016/S0006-3495(96)79280-9; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; Cascales L, 2011, J BIOL CHEM, V286, P36932, DOI 10.1074/jbc.M111.264424; CLARKE ND, 1994, P NATL ACAD SCI USA, V91, P11084, DOI 10.1073/pnas.91.23.11084; CLARKE S, 1987, INT J PEPT PROT RES, V30, P808, DOI 10.1111/j.1399-3011.1987.tb03390.x; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; DOVRAT A, 1984, MECH AGEING DEV, V28, P187, DOI 10.1016/0047-6374(84)90019-8; Friedrich MG, 2009, INVEST OPHTH VIS SCI, V50, P4786, DOI 10.1167/iovs.09-3588; FUJII N, 1994, BBA-PROTEIN STRUCT M, V1204, P157, DOI 10.1016/0167-4838(94)90003-5; Grey AC, 2009, INVEST OPHTH VIS SCI, V50, P4319, DOI 10.1167/iovs.09-3522; Hains PG, 2010, INVEST OPHTH VIS SCI, V51, P3107, DOI 10.1167/iovs.09-4308; Harrington V, 2004, MOL VIS, V10, P476; Herce HD, 2009, BIOPHYS J, V97, P1917, DOI 10.1016/j.bpj.2009.05.066; Hooi MYS, 2011, AGE, V33, P131, DOI 10.1007/s11357-010-9171-7; KIM JY, 1991, BIOPHYS J, V60, P135, DOI 10.1016/S0006-3495(91)82037-9; Korlimbinis A, 2009, EXP EYE RES, V88, P966, DOI 10.1016/j.exer.2008.12.008; Lamaziere A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000201; Lampi KJ, 1998, EXP EYE RES, V67, P31, DOI 10.1006/exer.1998.0481; Lapko VN, 2005, PROTEIN SCI, V14, P45, DOI 10.1110/ps.04738505; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Lynnerup N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001529; Lyons B, 2011, INT J PEPT RES THER, V17, P131, DOI 10.1007/s10989-011-9250-3; Maupetit J, 2010, J COMPUT CHEM, V31, P726, DOI 10.1002/jcc.21365; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; MCFALLNGAI MJ, 1985, EXP EYE RES, V41, P745, DOI 10.1016/0014-4835(85)90183-6; Mishra S, 2012, FEBS LETT, V586, P330, DOI 10.1016/j.febslet.2012.01.019; Mortazavi SM, 2007, J BIOTECHNOL, V129, P604, DOI 10.1016/j.jbiotec.2007.02.005; Nowakowski RS, 2006, P NATL ACAD SCI USA, V103, P12219, DOI 10.1073/pnas.0605605103; Parasassi T, 1998, J FLUORESC, V8, P365, DOI 10.1023/A:1020528716621; Reis-Rodrigues P, 2012, AGING CELL, V11, P120, DOI 10.1111/j.1474-9726.2011.00765.x; Robertson LJG, 2008, INVEST OPHTH VIS SCI, V49, P1016, DOI 10.1167/iovs.07-0792; ROY D, 1976, P NATL ACAD SCI USA, V73, P3484, DOI 10.1073/pnas.73.10.3484; Santhoshkumar P, 2008, J BIOL CHEM, V283, P8477, DOI 10.1074/jbc.M705876200; Santhoshkumar P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019291; Scheglmann D, 2002, PROTEIN ENG, V15, P521, DOI 10.1093/protein/15.6.521; SHAPIRO SD, 1991, J CLIN INVEST, V87, P1828, DOI 10.1172/JCI115204; Sharma KK, 1996, CURR EYE RES, V15, P363, DOI 10.3109/02713689608995826; Shestopalov VI, 2000, J CELL SCI, V113, P1913; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Srivastava OP, 2004, J BIOL CHEM, V279, P10901, DOI 10.1074/jbc.M308884200; SRIVASTAVA OP, 1988, EXP EYE RES, V47, P525, DOI 10.1016/0014-4835(88)90092-9; Srivastava OP, 1998, BIOCHEM BIOPH RES CO, V253, P288, DOI 10.1006/bbrc.1998.9728; Su SP, 2012, AGING CELL, V11, P1125, DOI 10.1111/j.1474-9726.2012.00860.x; Su SP, 2011, BBA-PROTEINS PROTEOM, V1814, P647, DOI 10.1016/j.bbapap.2011.03.014; Su SP, 2010, EXP EYE RES, V91, P97, DOI 10.1016/j.exer.2010.04.010; THOMSON JA, 1985, EXP EYE RES, V40, P393, DOI 10.1016/0014-4835(85)90152-6; Truscott RJW, 2012, EXP EYE RES, V99, P48, DOI 10.1016/j.exer.2012.04.002; Truscott RJW, 2010, REJUV RES, V13, P83, DOI 10.1089/rej.2009.0938; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; VOORTER CEM, 1988, J BIOL CHEM, V263, P19020; WEBER G, 1979, BIOCHEMISTRY-US, V18, P3075, DOI 10.1021/bi00581a025; Wilmarth PA, 2006, J PROTEOME RES, V5, P2554, DOI 10.1021/pr050473a; Yamaguchi T, 2007, J GERONTOL A-BIOL, V62, P481, DOI 10.1093/gerona/62.5.481; YOSHIDA H, 1984, BIOCHIM BIOPHYS ACTA, V798, P252, DOI 10.1016/0304-4165(84)90313-1; Zhu XJ, 2010, REJUV RES, V13, P553, DOI 10.1089/rej.2009.1009; Zhu XJ, 2010, INVEST OPHTH VIS SCI, V51, P5162, DOI 10.1167/iovs.09-4947	61	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39012	39020		10.1074/jbc.M112.391565	http://dx.doi.org/10.1074/jbc.M112.391565			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22995907	Green Published, hybrid			2022-12-28	WOS:000310982800057
J	Sakurikar, N; Eichhorn, JM; Chambers, TC				Sakurikar, Nandini; Eichhorn, Joshua M.; Chambers, Timothy C.			Cyclin-dependent Kinase-1 (Cdk1)/Cyclin B1 Dictates Cell Fate after Mitotic Arrest via Phosphoregulation of Antiapoptotic Bcl-2 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; CANCER-CELLS; PHOSPHORYLATION; APOPTOSIS; MITOSIS; MCL-1; CDK1; IDENTIFICATION; DRUGS; TIME	The prevailing model suggests that cell fate after mitotic arrest depends on two independent and competing networks that control cyclin B1 degradation and the generation of death signals. However, recent evidence for Cdk1/cyclin B1-mediated phosphorylation and inactivation of antiapoptotic Bcl-2 proteins suggests the existence of significant cross-talk and inter-dependence between these pathways. Further, the nature of the mitotic death signals has remained elusive. In this study, we sought to test the hypothesis that fate after mitotic arrest is dictated by the robustness of Cdk1/cyclin B1 signaling to Bcl-2 proteins and to identify signals that may represent a mitotic death signature. We show that when treated with Taxol, slippage-resistant HT29 colon carcinoma cells display robust Cdk1 activity and extensive Mcl-1/Bcl-x(L) phosphorylation and die in mitosis, whereas slippage-prone DLD-1 colon carcinoma cells display weak Cdk1 activity and partial and transient Mcl-1/Bcl-x(L) phosphorylation and die in subsequent interphase or survive. Furthermore, modulation of this signaling axis, either by inhibition of Cdk1 in slippage-resistant HT29 or by enforcing mitotic arrest in slippage-prone DLD-1 cells, evokes a switch in fate, indicating that the strength of Cdk1 signaling to Bcl-2 proteins is a key determinant of outcome. These findings provide novel insight into the pathways that regulate mitotic death, suggest that the robustness of these signaling events may be useful as a marker to define susceptibility to antimitotic drugs, and encourage a revision in the current model describing fate after mitotic arrest.	[Sakurikar, Nandini; Eichhorn, Joshua M.; Chambers, Timothy C.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Chambers, TC (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Mail Slot 516,4301 W Markham St, Little Rock, AR 72205 USA.	chamberstimothyc@uams.edu			National Institutes of Health from NCI [CA-109821]; Translational Research Institute Grant [UL1TR000039]; NATIONAL CANCER INSTITUTE [R01CA109821] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000039] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Translational Research Institute Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-109821 from the NCI (to T.C.C.). This work was also supported in part by pilot funds from Translational Research Institute Grant UL1TR000039.	Allan LA, 2007, MOL CELL, V26, P301, DOI 10.1016/j.molcel.2007.03.019; Andersen JL, 2009, EMBO J, V28, P3216, DOI 10.1038/emboj.2009.253; Chu R, 2012, BIOCHEM PHARMACOL, V83, P199, DOI 10.1016/j.bcp.2011.10.008; Clarke PR, 2010, CELL CYCLE, V9, P4035, DOI 10.4161/cc.9.20.13522; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Gascoigne KE, 2009, J CELL SCI, V122, P2579, DOI 10.1242/jcs.039719; Harley ME, 2010, EMBO J, V29, P2407, DOI 10.1038/emboj.2010.112; Huang HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015724; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Manchado E, 2012, CELL DEATH DIFFER, V19, P369, DOI 10.1038/cdd.2011.197; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; O'Connor DS, 2002, CANCER CELL, V2, P43, DOI 10.1016/S1535-6108(02)00084-3; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Rosania GR, 1999, P NATL ACAD SCI USA, V96, P4797, DOI 10.1073/pnas.96.9.4797; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; SHEN DW, 1986, J BIOL CHEM, V261, P7762; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Taylor SS, 2004, CHROMOSOME RES, V12, P599, DOI 10.1023/B:CHRO.0000036610.78380.51; Terrano DT, 2010, MOL CELL BIOL, V30, P640, DOI 10.1128/MCB.00882-09; Tunquist BJ, 2010, MOL CANCER THER, V9, P2046, DOI 10.1158/1535-7163.MCT-10-0033; Upreti M, 2008, J BIOL CHEM, V283, P35517, DOI 10.1074/jbc.M805019200; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Wolf F, 2007, CELL CYCLE, V6, P1408	26	44	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39193	39204		10.1074/jbc.M112.391854	http://dx.doi.org/10.1074/jbc.M112.391854			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22965228	Green Published, hybrid			2022-12-28	WOS:000310982800074
J	Brock, SE; Rendon, BE; Yaddanapudi, K; Mitchell, RA				Brock, Stephanie E.; Rendon, Beatriz E.; Yaddanapudi, Kavitha; Mitchell, Robert A.			Negative Regulation of AMP-activated Protein Kinase (AMPK) Activity by Macrophage Migration Inhibitory Factor (MIF) Family Members in Non-small Cell Lung Carcinomas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-DOPACHROME TAUTOMERASE; ACETYL-COA CARBOXYLASE; ENERGY STRESS; CANCER; EXPRESSION; GROWTH; LKB1; GENE; PHOSPHORYLATION; BETA	AMP-activated protein kinase (AMPK) is a nutrient-and metabolic stress-sensing enzyme activated by the tumor suppressor kinase, LKB1. Because macrophage migration inhibitory factor (MIF) and its functional homolog, D-dopachrome tautomerase (D-DT), have protumorigenic functions in non-small cell lung carcinomas (NSCLCs) but have AMPK-activating properties in nonmalignant cell types, we set out to investigate this apparent paradox. Our data now suggest that, in contrast to MIF and D-DTs AMPK-activating properties in nontransformed cells, MIF and D-DT act cooperatively to inhibit steady-state phosphorylation and activation of AMPK in LKB1 wild type and LKB1 mutant human NSCLC cell lines. Our data further indicate that MIF and D-DT, acting through their shared cell surface receptor, CD74, antagonize NSCLC AMPK activation by maintaining glucose uptake, ATP production, and redox balance, resulting in reduced Ca2+/calmodulin-dependent kinase kinase beta-dependent AMPK activation. Combined, these studies indicate that MIF and D-DT cooperate to inhibit AMPK activation in an LKB1-independent manner.	[Brock, Stephanie E.; Rendon, Beatriz E.; Yaddanapudi, Kavitha; Mitchell, Robert A.] Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Louisville, KY 40202 USA; [Mitchell, Robert A.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40202 USA	University of Louisville; University of Louisville	Mitchell, RA (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Clin & Translat Res Bldg,Suite 404,505 S Hancock, Louisville, KY 40202 USA.	robert.mitchell@louisville.edu			National Institutes of Health [CA129967]; NATIONAL CANCER INSTITUTE [R01CA129967] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA129967 (to R. A. M).	Bacher M, 2003, AM J PATHOL, V162, P11, DOI 10.1016/S0002-9440(10)63793-5; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Benigni F, 2000, J CLIN INVEST, V106, P1291, DOI 10.1172/JCI9900; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Carretero J, 2004, ONCOGENE, V23, P4037, DOI 10.1038/sj.onc.1207502; Coleman AM, 2008, J IMMUNOL, V181, P2330, DOI 10.4049/jimmunol.181.4.2330; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Gusarova GA, 2011, MOL CELL BIOL, V31, P3546, DOI 10.1128/MCB.05114-11; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Heinrichs D, 2011, P NATL ACAD SCI USA, V108, P17444, DOI 10.1073/pnas.1107023108; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Iwata T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033402; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Luo ZJ, 2010, FUTURE ONCOL, V6, P457, DOI 10.2217/FON.09.174; Makowski L, 2008, BRIT J CANCER, V99, P683, DOI 10.1038/sj.bjc.6604515; MARSH BJ, 1995, J CELL BIOL, V130, P1081, DOI 10.1083/jcb.130.5.1081; Martin J, 2009, FASEB J, V23, P720, DOI 10.1096/fj.08-119628; Matsumoto S, 2007, ONCOGENE, V26, P5911, DOI 10.1038/sj.onc.1210418; McClelland M, 2009, AM J PATHOL, V174, P638, DOI 10.2353/ajpath.2009.080463; Merk M, 2012, CYTOKINE, V59, P10, DOI 10.1016/j.cyto.2012.03.014; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; MUNDAY MR, 1988, EUR J BIOCHEM, V175, P331, DOI 10.1111/j.1432-1033.1988.tb14201.x; Mungai PT, 2011, MOL CELL BIOL, V31, P3531, DOI 10.1128/MCB.05124-11; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Rendon BE, 2007, J BIOL CHEM, V282, P29910, DOI 10.1074/jbc.M704898200; Rocha GZ, 2011, CLIN CANCER RES, V17, P3993, DOI 10.1158/1078-0432.CCR-10-2243; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; SIM ATR, 1988, FEBS LETT, V233, P294, DOI 10.1016/0014-5793(88)80445-9; Swinnen JV, 2005, CANCER RES, V65, P2441, DOI 10.1158/0008-5472.CAN-04-3025; Tarnowski M, 2010, MOL CANCER RES, V8, P1328, DOI 10.1158/1541-7786.MCR-10-0288; Waeber G, 1997, P NATL ACAD SCI USA, V94, P4782, DOI 10.1073/pnas.94.9.4782; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Weber C, 2008, P NATL ACAD SCI USA, V105, P16278, DOI 10.1073/pnas.0804017105; Welford SM, 2006, GENE DEV, V20, P3366, DOI 10.1101/gad.1471106; White ES, 2003, CLIN CANCER RES, V9, P853; Winner M, 2008, CANCER RES, V68, P7253, DOI 10.1158/0008-5472.CAN-07-6227; Winner M, 2007, CANCER RES, V67, P186, DOI 10.1158/0008-5472.CAN-06-3292; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Xin D, 2010, MOL CANCER RES, V8, P1601, DOI 10.1158/1541-7786.MCR-10-0101	47	29	30	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.378299	http://dx.doi.org/10.1074/jbc.M112.378299			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22988252	hybrid, Green Published			2022-12-28	WOS:000310642200027
J	Lu, CF; Mi, LZ; Schurpf, T; Walz, T; Springer, TA				Lu, Chafen; Mi, Li-Zhi; Schuerpf, Thomas; Walz, Thomas; Springer, Timothy A.			Mechanisms for Kinase-mediated Dimerization of the Epidermal Growth Factor Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ACTIVATION; DOMAIN; EGFR; REGION; VISUALIZATION; COMPLEXES; AFFINITY; BINDING; CANCER	We study a mechanism by which dimerization of the EGF receptor (EGFR) cytoplasmic domain is transmitted to the ectodomain. Therapeutic and other small molecule antagonists to the kinase domain that stabilize its active conformation, but not those that stabilize an inactive conformation, stabilize ectodomain dimerization. Inhibitor-induced dimerization requires an asymmetric kinase domain interface associated with activation. EGF and kinase inhibitors stimulate formation of identical dimer interfaces in the EGFR transmembrane domain, as shown by disulfide cross-linking. Disulfide cross-linking at an interface in domain IV in the ectodomain was also stimulated similarly; however, EGF but not inhibitors stimulated cross-linking in domain II. Inhibitors similarly induced noncovalent dimerization in nearly full-length, detergent-solubilized EGFR as shown by gel filtration. EGFR ectodomain deletion resulted in spontaneous dimerization, whereas deletion of exons 2-7, in which extracellular domains III and IV are retained, did not. In EM, kinase inhibitor-induced dimers lacked any well defined orientation between the ectodomain monomers. Fab of the therapeutic antibody cetuximab to domain III confirmed a variable position and orientation of this domain in inhibitor-induced dimers but suggested that the C termini of domain IV of the two monomers were in close proximity, consistent with dimerization in the transmembrane domains. The results provide insights into the relative energetics of intracellular and extracellular dimerization in EGFR and have significance for physiologic dimerization through the asymmetric kinase interface, bidirectional signal transmission in EGFR, and mechanism of action of therapeutics.	[Lu, Chafen; Mi, Li-Zhi; Schuerpf, Thomas; Springer, Timothy A.] Harvard Univ, Sch Med, Childrens Hosp Boston, Immune Dis Inst, Boston, MA 02115 USA; [Lu, Chafen; Mi, Li-Zhi; Schuerpf, Thomas; Springer, Timothy A.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Walz, Thomas] Howard Hughes Med Inst, Boston, MA 02115 USA; [Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Springer, TA (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Immune Dis Inst, 3 Blackfan Circle, Boston, MA 02115 USA.	springer@idi.harvard.edu	Mi, Li-Zhi/B-1371-2016; Schürpf, Thomas/E-7380-2012	Mi, Li-Zhi/0000-0001-9907-5245; Schurpf, Thomas/0000-0003-3023-1136; Walz, Thomas/0000-0003-2606-2835	National Institutes of Health [HL-103526]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-103526. This work was also supported by the Howard Hughes Medical Institute (to T. W.).	Alvarado D, 2009, NATURE, V461, P287, DOI 10.1038/nature08297; Arteaga CL, 1997, J BIOL CHEM, V272, P23247, DOI 10.1074/jbc.272.37.23247; Arteaga CL, 2003, EXP CELL RES, V284, P122, DOI 10.1016/S0014-4827(02)00104-0; Blair JA, 2007, NAT CHEM BIOL, V3, P229, DOI 10.1038/nchembio866; CHANTRY A, 1995, J BIOL CHEM, V270, P3068; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Dawson JP, 2005, MOL CELL BIOL, V25, P7734, DOI 10.1128/MCB.25.17.7734-7742.2005; Eck MJ, 2010, BBA-PROTEINS PROTEOM, V1804, P559, DOI 10.1016/j.bbapap.2009.12.010; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gan HK, 2007, J BIOL CHEM, V282, P2840, DOI 10.1074/jbc.M605136200; Garrett TPJ, 2009, P NATL ACAD SCI USA, V106, P5082, DOI 10.1073/pnas.0811559106; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Lichtner RB, 2001, CANCER RES, V61, P5790; Lu CF, 2010, MOL CELL BIOL, V30, P5432, DOI 10.1128/MCB.00742-10; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; Mi LZ, 2008, BIOCHEMISTRY-US, V47, P10314, DOI 10.1021/bi801006s; Mi LZ, 2011, NAT STRUCT MOL BIOL, V18, P984, DOI 10.1038/nsmb.2092; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	32	53	54	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.414391	http://dx.doi.org/10.1074/jbc.M112.414391			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22988250	Green Published, hybrid			2022-12-28	WOS:000310642200057
J	Ruecker, A; Shea, M; Hackett, F; Suarez, C; Hirst, EMA; Milutinovic, K; Withers-Martinez, C; Blackman, MJ				Ruecker, Andrea; Shea, Michael; Hackett, Fiona; Suarez, Catherine; Hirst, Elizabeth M. A.; Milutinovic, Katarina; Withers-Martinez, Chrislaine; Blackman, Michael J.			Proteolytic Activation of the Essential Parasitophorous Vacuole Cysteine Protease SERA6 Accompanies Malaria Parasite Egress from Its Host Erythrocyte	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMODIUM-FALCIPARUM MEROZOITES; SUBTILISIN-LIKE PROTEASE-1; AUTOPROTEOLYTIC CLEAVAGE SITES; HUMAN PROCATHEPSIN L; RED-BLOOD-CELL; INFECTED ERYTHROCYTES; SURFACE PROTEIN-1; STREPTOLYSIN-O; SERINE; ANTIGEN	The malaria parasite replicates within an intraerythrocytic parasitophorous vacuole (PV). The PV and host cell membranes eventually rupture, releasing merozoites in a process called egress. Certain inhibitors of serine and cysteine proteases block egress, indicating a crucial role for proteases. The Plasmodium falciparum genome encodes nine serine-repeat antigens (SERAs), each of which contains a central domain homologous to the papain-like (clan CA, family C1) protease family. SERA5 and SERA6 are indispensable in blood-stage parasites, but the function of neither is known. Here we show that SERA6 localizes to the PV where it is precisely cleaved just prior to egress by an essential serine protease called PfSUB1. Mutations that replace the predicted catalytic Cys of SERA6, or that block SERA6 processing by PfSUB1, could not be stably introduced into the parasite genomic sera6 locus, indicating that SERA6 is an essential enzyme and that processing is important for its function. We demonstrate that cleavage of SERA6 by PfSUB1 converts it to an active cysteine protease. Our observations reveal a proteolytic activation step in the malarial PV that may be required for release of the parasite from its host erythrocyte.	[Ruecker, Andrea; Shea, Michael; Hackett, Fiona; Suarez, Catherine; Hirst, Elizabeth M. A.; Milutinovic, Katarina; Withers-Martinez, Chrislaine; Blackman, Michael J.] Natl Inst Med Res, MRC, Div Parasitol, London NW7 1AA, England	MRC National Institute for Medical Research	Blackman, MJ (corresponding author), Natl Inst Med Res, MRC, Div Parasitol, Mill Hill, London NW7 1AA, England.	mblackm@nimr.mrc.ac.uk		Suarez, Catherine/0000-0003-2984-7881; Ruecker, Andrea/0000-0003-3804-9670	United Kingdom Medical Research Council [U117532063]; Medical Research Council; Swiss National Science Foundation; European Union [PITN-GA-2008-215281]; MRC [MC_U117532063] Funding Source: UKRI; Medical Research Council [MC_U117532063] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by United Kingdom Medical Research Council Grant U117532063.; Recipient of a Medical Research Council Ph.D. studentship.; Supported by a Swiss National Science Foundation Postdoctoral Fellowship.; Supported by European Union Framework Programme 7-funded Marie Curie Initial Training Network InterMalTraining Contract PITN-GA-2008-215281 and by a Swiss National Science Foundation Fellowship for Prospective Researchers.	Aly ASI, 2005, J EXP MED, V202, P225, DOI 10.1084/jem.20050545; Ansorge I, 1997, MOL BIOCHEM PARASIT, V84, P259, DOI 10.1016/S0166-6851(96)02806-X; Ansorge I, 1996, BIOCHEM J, V315, P307, DOI 10.1042/bj3150307; Aoki S, 2002, J BIOL CHEM, V277, P47533, DOI 10.1074/jbc.M207145200; Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Arisue N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017775; Blackman MJ, 2008, CELL MICROBIOL, V10, P1925, DOI 10.1111/j.1462-5822.2008.01176.x; Blackman MJ, 2002, BIOCHEMISTRY-US, V41, P12244, DOI 10.1021/bi0263661; BLACKMAN MJ, 1994, METHOD CELL BIOL, V45, P213; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P35, DOI 10.1016/0166-6851(91)90128-S; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Burghaus PA, 2001, J BIOL CHEM, V276, P26838, DOI 10.1074/jbc.M100111200; Chandramohanadas R, 2009, SCIENCE, V324, P794, DOI 10.1126/science.1171085; Child MA, 2010, MOL MICROBIOL, V78, P187, DOI 10.1111/j.1365-2958.2010.07324.x; CLARK PI, 1978, EUR J BIOCHEM, V84, P293, DOI 10.1111/j.1432-1033.1978.tb12168.x; Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; Crabb BS, 2004, METH MOL B, V270, P263; de Monerri NCS, 2011, INFECT IMMUN, V79, P1086, DOI 10.1128/IAI.00902-10; DEBRABANT A, 1992, MOL BIOCHEM PARASIT, V53, P89, DOI 10.1016/0166-6851(92)90010-H; DELPLACE P, 1988, BIOL CELL, V64, P215, DOI 10.1016/0248-4900(88)90080-9; DELPLACE P, 1985, MOL BIOCHEM PARASIT, V17, P239, DOI 10.1016/0166-6851(85)90021-0; DELPLACE P, 1987, MOL BIOCHEM PARASIT, V23, P193, DOI 10.1016/0166-6851(87)90026-0; Doran JD, 1999, EUR J BIOCHEM, V263, P145, DOI 10.1046/j.1432-1327.1999.00473.x; Glushakova S, 2009, CELL MICROBIOL, V11, P95, DOI 10.1111/j.1462-5822.2008.01242.x; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; Hodder AN, 2003, J BIOL CHEM, V278, P48169, DOI 10.1074/jbc.M306755200; Hodder AN, 2009, J MOL BIOL, V392, P154, DOI 10.1016/j.jmb.2009.07.007; Jean L, 2003, J BIOL CHEM, V278, P28572, DOI 10.1074/jbc.M303827200; KNAPP B, 1991, MOL BIOCHEM PARASIT, V44, P1, DOI 10.1016/0166-6851(91)90215-R; Koussis K, 2009, EMBO J, V28, P725, DOI 10.1038/emboj.2009.22; Li H, 2002, PARASITOL INT, V51, P343, DOI 10.1016/S1383-5769(02)00042-9; McCoubrie JE, 2007, INFECT IMMUN, V75, P5565, DOI 10.1128/IAI.00405-07; Menard R, 1998, J BIOL CHEM, V273, P4478, DOI 10.1074/jbc.273.8.4478; Miller SK, 2002, J BIOL CHEM, V277, P47524, DOI 10.1074/jbc.M206974200; Nyalwidhe J, 2006, PROTEOMICS, V6, P1563, DOI 10.1002/pmic.200500379; Olivieri A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002448; Pungercar JR, 2009, FEBS J, V276, P660, DOI 10.1111/j.1742-4658.2008.06815.x; Putrianti ED, 2010, CELL MICROBIOL, V12, P725, DOI 10.1111/j.1462-5822.2009.01419.x; Quraishi O, 2001, J BIOL CHEM, V276, P8118, DOI 10.1074/jbc.M005851200; Sajid M, 2003, MOL BIOCHEM PARASIT, V131, P65, DOI 10.1016/S0166-6851(03)00194-4; Salmon BL, 2001, P NATL ACAD SCI USA, V98, P271, DOI 10.1073/pnas.011413198; Schmidt-Christensen A, 2008, CELL MICROBIOL, V10, P1723, DOI 10.1111/j.1462-5822.2008.01162.x; Soni S, 2005, BLOOD CELL MOL DIS, V35, P201, DOI 10.1016/j.bcmd.2005.05.006; Wickham ME, 2003, J BIOL CHEM, V278, P37658, DOI 10.1074/jbc.M305252200; Withers-Martinez C, 2002, J BIOL CHEM, V277, P29698, DOI 10.1074/jbc.M203088200; Withers-Martinez C, 2012, INT J PARASITOL, V42, P597, DOI 10.1016/j.ijpara.2012.04.005; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049	47	44	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.400820	http://dx.doi.org/10.1074/jbc.M112.400820			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22984267	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000310642200030
J	Xiong, YB; Song, C; Snyder, GA; Sundberg, EJ; Medvedev, AE				Xiong, Yanbao; Song, Chang; Snyder, Greg A.; Sundberg, Eric J.; Medvedev, Andrei E.			R753Q Polymorphism Inhibits Toll-like Receptor (TLR) 2 Tyrosine Phosphorylation, Dimerization with TLR6, and Recruitment of Myeloid Differentiation Primary Response Protein 88	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; SIGNAL-TRANSDUCTION; CUTTING EDGE; MYCOBACTERIUM-TUBERCULOSIS; LIVER-TRANSPLANTATION; BACTERIAL-INFECTIONS; ENDOTOXIN TOLERANCE; PATTERN-RECOGNITION; LEPROMATOUS LEPROSY	The R753Q polymorphism in the Toll-IL-1 receptor domain of Toll-like receptor 2 (TLR2) has been linked to increased incidence of tuberculosis and other infectious diseases, but the mechanisms by which it affects TLR2 functions are unclear. Here, we studied the impact of the R753Q polymorphism on TLR2 expression, hetero-dimerization with TLR6, tyrosine phosphorylation, and recruitment of myeloid differentiation primary response protein (MyD) 88 and MyD88 adapter-like (Mal). Complementation of HEK293 cells with transfected WT or R753Q TLR2 revealed their comparable total levels and only minimal changes in cell surface expression of the mutant species. Notably, even a 100-fold increase in amounts of transfected R753Q TLR2 versus WT variant did not overcome the compromised ability of the mutant TLR2 to activate nuclear factor kappa B (NF-kappa B), indicating that a minimal decrease in cell surface levels of the R753Q TLR2 cannot account for the signaling deficiency. Molecular modeling studies suggested that the R753Q mutation changes the electrostatic potential of the DD loop and results in a discrete movement of the residues critical for protein-protein interactions. Confirming these predictions, biochemical assays demonstrated that R753Q TLR2 exhibits deficient agonist-induced tyrosine phosphorylation, hetero-dimerization with TLR6, and recruitment of Mal and MyD88. These proximal signaling deficiencies correlated with impaired capacities of the R753Q TLR2 to mediate p38 phosphorylation, NF-kappa B activation, and induction of IL-8 mRNA in transfected HEK293 cells challenged with inactivated Mycobacterium tuberculosis or mycobacterial components. Thus, the R753Q polymorphism renders TLR2 signaling-incompetent by impairing its tyrosine phosphorylation, dimerization with TLR6, and recruitment of Mal and MyD88.	[Xiong, Yanbao; Song, Chang; Sundberg, Eric J.; Medvedev, Andrei E.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Snyder, Greg A.; Sundberg, Eric J.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Snyder, Greg A.; Sundberg, Eric J.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Medvedev, AE (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, 685 W Baltimore St,HSF I Bldg,Rm 380, Baltimore, MD 21201 USA.	amedvedev@som.umaryland.edu		Sundberg, Eric/0000-0003-0478-3033	National Institutes of Health [R21 AI067468, RO1 AI059524]; University of Maryland Baltimore-University of Maryland College Park National Institutes of Health Seed Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI067468, R01AI059524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland Baltimore-University of Maryland College Park National Institutes of Health Seed Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 AI067468 and RO1 AI059524 and the University of Maryland Baltimore-University of Maryland College Park National Institutes of Health Seed Grant (to A. E. M.).	Abe T, 2005, J VIROL, V79, P2847, DOI 10.1128/JVI.79.5.2847-2858.2005; Ahmad-Nejad P, 2004, J ALLERGY CLIN IMMUN, V113, P565, DOI 10.1016/j.jaci.2003.12.583; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Basith S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023989; Ben-Ali M, 2004, CLIN DIAGN LAB IMMUN, V11, P625, DOI 10.1128/CDLI.11.3.625-626.2004; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Buwitt-Beckmann U, 2005, EUR J IMMUNOL, V35, P282, DOI 10.1002/eji.200424955; Cheng H, 2007, BIOCHEM BIOPH RES CO, V352, P609, DOI 10.1016/j.bbrc.2006.11.068; Chockalingam A, 2012, J IMMUNOL, V188, P527, DOI 10.4049/jimmunol.1102713; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Drage MG, 2009, CELL IMMUNOL, V258, P29, DOI 10.1016/j.cellimm.2009.03.008; Drennan MB, 2004, AM J PATHOL, V164, P49, DOI 10.1016/S0002-9440(10)63095-7; Du X, 1999, BLOOD CELL MOL DIS, V25, P328, DOI 10.1006/bcmd.1999.0262; Etokebe GE, 2010, SCAND J IMMUNOL, V71, P369, DOI 10.1111/j.1365-3083.2010.02379.x; Ferwerda B, 2007, AIDS, V21, P1375, DOI 10.1097/QAD.0b013e32814e6b2d; Figueroa L, 2012, J IMMUNOL, V188, P4506, DOI 10.4049/jimmunol.1200202; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Grell L, 2006, BIOCHEM MOL BIOL EDU, V34, P402, DOI 10.1002/bmb.2006.494034062672; Guggemoos S, 2008, J IMMUNOL, V180, P438, DOI 10.4049/jimmunol.180.1.438; Hayes MW, 2012, J VIROL, V86, P7216, DOI 10.1128/JVI.06508-11; Heggelund L, 2004, CLIN INFECT DIS, V39, P264, DOI 10.1086/421780; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kajava AV, 2010, J BIOL CHEM, V285, P6227, DOI 10.1074/jbc.M109.063669; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kang SH, 2012, J INFECT DIS, V205, P639, DOI 10.1093/infdis/jir819; Kang TJ, 2002, CYTOKINE, V20, P56, DOI 10.1006/cyto.2002.1982; Kang TJ, 2001, FEMS IMMUNOL MED MIC, V31, P53, DOI 10.1111/j.1574-695X.2001.tb01586.x; Kaufmann SHE, 2006, IMMUNITY, V24, P351, DOI 10.1016/j.immuni.2006.04.003; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Lamothe B, 2008, J BIOL CHEM, V283, P24871, DOI 10.1074/jbc.M802749200; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Lee SO, 2011, LIVER TRANSPLANT, V17, P1081, DOI 10.1002/lt.22327; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li XX, 2008, EUR J IMMUNOL, V38, P614, DOI 10.1002/eji.200838161; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Means TK, 1999, J IMMUNOL, V163, P3920; Medvedev AE, 2005, J IMMUNOL, V174, P6587, DOI 10.4049/jimmunol.174.11.6587; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mrabet-Dahbi S, 2008, J ALLERGY CLIN IMMUN, V121, P1013, DOI 10.1016/j.jaci.2007.11.029; Nagpal K, 2009, J BIOL CHEM, V284, P25742, DOI 10.1074/jbc.M109.014886; Nakamura K, 2008, J IMMUNOL, V180, P4067, DOI 10.4049/jimmunol.180.6.4067; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Piao W, 2008, J BIOL CHEM, V283, P3109, DOI 10.1074/jbc.M707400200; Piao W, 2009, J LEUKOCYTE BIOL, V86, P863, DOI 10.1189/jlb.0309189; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Quevedo-Diaz MA, 2010, J LEUKOCYTE BIOL, V88, P675, DOI 10.1189/jlb.1009674; Salpietro C, 2011, INT J IMMUNOPATH PH, V24, P33, DOI 10.1177/03946320110240S408; Sarkar SN, 2007, J BIOL CHEM, V282, P3423, DOI 10.1074/jbc.C600226200; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Smith CA, 2008, J MOL BIOL, V380, P742, DOI 10.1016/j.jmb.2008.05.023; Soylu A, 2011, INFLAMMATION, V34, P379, DOI 10.1007/s10753-010-9245-9; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; Xiong YB, 2011, J BIOL CHEM, V286, P7905, DOI 10.1074/jbc.M110.182873; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182	78	60	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.375493	http://dx.doi.org/10.1074/jbc.M112.375493			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22992740	Green Published, hybrid			2022-12-28	WOS:000310642200065
J	Phuan, PW; Anderson, MO; Tradtrantip, L; Zhang, H; Tan, J; Lam, C; Bennett, JL; Verkman, AS				Phuan, Puay-Wah; Anderson, Marc O.; Tradtrantip, Lukmanee; Zhang, Hua; Tan, Joseph; Lam, Chiwah; Bennett, Jeffrey L.; Verkman, A. S.			A Small-molecule Screen Yields Idiotype-specific Blockers of Neuromyelitis Optica Immunoglobulin G Binding to Aquaporin-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WATER CHANNEL AQUAPORIN-4; ORTHOGONAL ARRAYS; IGG BINDING; ANTIBODIES; CELLS; AUTOANTIBODIES; CYTOTOXICITY; NATALIZUMAB; PREDICTION; INHIBITORS	Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the central nervous system caused by binding of anti-aquaporin-4 (AQP4) autoantibodies (NMO-IgG) to AQP4 on astrocytes. A screen was developed to identify inhibitors of NMO-IgG-dependent, complement-dependent cytotoxicity. Screening of 50,000 synthetic small molecules was done using CHO cells expressing human AQP4 and a human NMO recombinant monoclonal antibody (rAb-53). The screen yielded pyrano[2,3-c]pyrazoles that blocked rAb-53 binding to AQP4 and prevented cytotoxicity in cell culture and spinal cord slice models of NMO. Structure-activity analysis of 82 analogs yielded a blocker with IC50 similar to 6 mu M. Analysis of the blocker mechanism indicated idiotype specificity, as (i) pyrano[2,3-c] pyrazoles did not prevent AQP4 binding or cytotoxicity of other NMO-IgGs, and (ii) surface plasmon resonance showed specific rAb-53 binding. Antibody structure modeling and docking suggested a putative binding site near the complementarity-determining regions. Small molecules with idiotype-specific antibody targeting may be useful as research tools and therapeutics.	[Phuan, Puay-Wah; Tradtrantip, Lukmanee; Zhang, Hua; Tan, Joseph; Verkman, A. S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Phuan, Puay-Wah; Tradtrantip, Lukmanee; Zhang, Hua; Tan, Joseph; Verkman, A. S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Anderson, Marc O.] San Francisco State Univ, Dept Chem & Biochem, San Francisco, CA 94132 USA; [Lam, Chiwah; Bennett, Jeffrey L.] Univ Colorado Denver, Dept Neurol, Aurora, CO 80045 USA; [Lam, Chiwah; Bennett, Jeffrey L.] Univ Colorado Denver, Dept Ophthalmol, Aurora, CO 80045 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; California State University System; San Francisco State University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Verkman, AS (corresponding author), Univ Calif San Francisco, Dept Med, 1246 Hlth Sci E Tower, San Francisco, CA 94143 USA.	alan.verkman@ucsf.edu			National Institutes of Health Grants [EY13574, EB00415, DK35124, HL73856, DK86125, DK72517]; Guthy-Jackson Charitable Foundation; National Multiple Sclerosis Society [RG4320]; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415, R01EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035124, R37DK035124, P30DK072517, RC1DK086125] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Guthy-Jackson Charitable Foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants EY13574, EB00415, DK35124, HL73856, DK86125, and DK72517 (to A. S. V.). This work was also supported by grants from the Guthy-Jackson Charitable Foundation (to A. S. V. and J. L. B.) and Grant RG4320 from the National Multiple Sclerosis Society (to J. L. B.).	Abdelrazek FM, 2006, ARCH PHARM, V339, P456, DOI 10.1002/ardp.200600057; Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Crane JM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227298; Cree B, 2008, CURR NEUROL NEUROSCI, V8, P427, DOI 10.1007/s11910-008-0066-2; Foloppe N, 2006, BIOORGAN MED CHEM, V14, P4792, DOI 10.1016/j.bmc.2006.03.021; Hinson SR, 2007, NEUROLOGY, V69, P2221, DOI 10.1212/01.WNL.0000289761.64862.ce; Irani SR, 2011, CURR NEUROL NEUROSCI, V11, P298, DOI 10.1007/s11910-011-0186-y; Jarius S, 2010, NAT REV NEUROL, V6, P383, DOI 10.1038/nrneurol.2010.72; Khatri BO, 2009, NEUROLOGY, V72, P402, DOI 10.1212/01.wnl.0000341766.59028.9d; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Litvinov YM, 2009, J COMB CHEM, V11, P914, DOI 10.1021/cc900076j; Lozeron P, 2007, CURR OPIN NEUROL, V20, P536; Ma TH, 1997, J CLIN INVEST, V100, P957, DOI 10.1172/JCI231; Marcatili P, 2008, BIOINFORMATICS, V24, P1953, DOI 10.1093/bioinformatics/btn341; Marignier R, 2010, BRAIN, V133, P2578, DOI 10.1093/brain/awq177; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Nielsen S, 1997, J NEUROSCI, V17, P171; Papadopoulos MC, 2012, LANCET NEUROL, V11, P535, DOI 10.1016/S1474-4422(12)70133-3; Parratt JDE, 2010, MULT SCLER J, V16, P1156, DOI 10.1177/1352458510382324; Phuan PW, 2012, J BIOL CHEM, V287, P13829, DOI 10.1074/jbc.M112.344325; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Tradtrantip L, 2012, FASEB J, V26, P2197, DOI 10.1096/fj.11-201608; Tradtrantip L, 2012, ANN NEUROL, V71, P314, DOI 10.1002/ana.22657; Verbavatz JM, 1997, J CELL SCI, V110, P2855; Verkman AS, 2011, J CELL SCI, V124, P2107, DOI 10.1242/jcs.079467; Vincent A, 2011, LANCET NEUROL, V10, P759, DOI 10.1016/S1474-4422(11)70096-5; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; Wang Q, 2008, NAT PROTOC, V3, P1832, DOI 10.1038/nprot.2008.184; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Yang BX, 1996, J BIOL CHEM, V271, P4577; Zaki MEA, 2006, Z NATURFORSCH C, V61, P1; Zhang H, 2011, ANN NEUROL, V70, P943, DOI 10.1002/ana.22551	33	11	15	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36837	36844		10.1074/jbc.M112.408716	http://dx.doi.org/10.1074/jbc.M112.408716			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22989877	Green Published, hybrid			2022-12-28	WOS:000310588500020
J	Bartholomeeusen, K; Xiang, YH; Fujinaga, K; Peterlin, BM				Bartholomeeusen, Koen; Xiang, Yanhui; Fujinaga, Koh; Peterlin, B. Matija			Bromodomain and Extra-terminal (BET) Bromodomain Inhibition Activate Transcription via Transient Release of Positive Transcription Elongation Factor b (P-TEFb) from 7SK Small Nuclear Ribonucleoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST CELL-GROWTH; GENE-EXPRESSION; RNA; HIV; COMPLEX; HEXIM1; TAT; REPLICATION; RECRUITMENT; CHROMATIN	By phosphorylating elongation factors and the C-terminal domain of RNA polymerase II, the positive transcription elongation factor b (P-TEFb) is the critical kinase for transcription elongation and co-transcriptional processing of eukaryotic genes. It exists in inactive small nuclear ribonucleoprotein (7SK snRNP) and active (free P-TEFb) complexes in cells. The P-TEFb equilibrium determines the state of cellular activation, proliferation, and differentiation. Free P-TEFb, which is required for growth, can be recruited to RNA polymerase II via transcription factors, BRD4, or the super elongation complex (SEC). UV light, various signaling cascades, transcriptional blockade, or compounds such as hexamethylene bisacetamide (HMBA), suberoylanilide hydroxamic acid (SAHA), and other histone deacetylase inhibitors lead to a rapid release of free P-TEFb, followed by its reassembly into the 7SK snRNP. As a consequence, transcription of HEXIM1, a critical 7SK snRNP subunit, and HIV is induced. In this study, we found that a bromodomain and extra-terminal (BET) bromodomain inhibitor, JQ1, which inhibits BRD4 by blocking its association with chromatin, also leads to the rapid release of free P-TEFb from the 7SK snRNP. Indeed, JQ1 transiently increased levels of free P-TEFb and BRD4.P-TEFb and SEC.P-TEFb complexes in cells. As a consequence, the levels of HEXIM1 and HIV proteins rose. Importantly, the knockdown of ELL2, a subunit of the SEC, blocked the ability of JQ1 to increase HIV transcription. Finally, the effects of JQ1 and HMBA or SAHA on the P-TEFb equilibrium were cooperative. We conclude that HMBA, SAHA, and JQ1 affect transcription elongation by a similar and convergent mechanism.	[Peterlin, B. Matija] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Peterlin, BM (corresponding author), Univ Calif San Francisco, Dept Med, Rm U432,533 Parnassus Ave, San Francisco, CA 94143 USA.	matija.peterlin@ucsf.edu	bartholomeeusen, koen/J-1843-2015	bartholomeeusen, koen/0000-0001-9576-2400	National Institutes of Health CARE Center [U19 AI076113]; University of California San Francisco Center for AIDS Research; amfAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, R01AI049104, U19AI096113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250] Funding Source: NIH RePORTER	National Institutes of Health CARE Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco Center for AIDS Research(University of California System); amfAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health CARE Center Grant U19 AI076113. This work was also supported by grants from the University of California San Francisco Center for AIDS Research (to K. B.) and amfAR (to K. F.).	Ai NP, 2011, NUCLEIC ACIDS RES, V39, P9592, DOI 10.1093/nar/gkr698; ANTONI BA, 1994, VIROLOGY, V202, P684, DOI 10.1006/viro.1994.1390; Banerjee C., 2012, J LEUKOCYTE BIOL, V92, P1; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Biglione S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-47; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Chiang K, 2012, J VIROL, V86, P3244, DOI 10.1128/JVI.05065-11; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Czudnochowski N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1846; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; He NH, 2006, MOL CELL BIOL, V26, P7068, DOI 10.1128/MCB.00778-06; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Krueger BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012335; Lenasi T, 2008, CELL HOST MICROBE, V4, P123, DOI 10.1016/j.chom.2008.05.016; Li J, 2011, CURR OPIN GENET DEV, V21, P231, DOI 10.1016/j.gde.2011.01.010; Luo ZJ, 2012, MOL CELL BIOL, V32, P2608, DOI 10.1128/MCB.00182-12; Martincic K, 2009, NAT IMMUNOL, V10, P1102, DOI 10.1038/ni.1786; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Mueller D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000249; Nechaev S, 2011, BBA-GENE REGUL MECH, V1809, P34, DOI 10.1016/j.bbagrm.2010.11.001; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Peterlin BM, 2012, WIRES RNA, V3, P92, DOI 10.1002/wrna.106; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schroder S, 2012, J BIOL CHEM, V287, P1090, DOI 10.1074/jbc.M111.282855; Sedore SC, 2007, NUCLEIC ACIDS RES, V35, P4347, DOI 10.1093/nar/gkm443; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Sung TL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000263; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Wittmann BM, 2005, ONCOGENE, V24, P5576, DOI 10.1038/sj.onc.1208728; Wittmann BM, 2003, CANCER RES, V63, P5151; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Zhao R, 2011, NAT CELL BIOL, V13, P1295, DOI 10.1038/ncb2341; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	40	150	176	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36609	36616		10.1074/jbc.M112.410746	http://dx.doi.org/10.1074/jbc.M112.410746			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22952229	Green Published, hybrid			2022-12-28	WOS:000310364000080
J	Nagamatsu, G; Saito, S; Kosaka, T; Takubo, K; Kinoshita, T; Oya, M; Horimoto, K; Suda, T				Nagamatsu, Go; Saito, Shigeru; Kosaka, Takeo; Takubo, Keiyo; Kinoshita, Taisuke; Oya, Mototsugu; Horimoto, Katsuhisa; Suda, Toshio			Optimal Ratio of Transcription Factors for Somatic Cell Reprogramming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; MOUSE FIBROBLASTS; DIRECT CONVERSION; DEFINED FACTORS; SELF-RENEWAL; E-CADHERIN; EXPRESSION; INDUCTION; DIFFERENTIATION; GENERATION	Somatic cell reprogramming is achieved by four reprogramming transcription factors (RTFs), Oct3/4, Sox2, Klf4, and c-Myc. However, in addition to the induction of pluripotent cells, these RTFs also generate pseudo-pluripotent cells, which do not show Nanog promoter activity. Therefore, it should be possible to fine-tune the RTFs to produce only fully pluripotent cells. For this study, a tagging system was developed to sort induced pluripotent stem (iPS) cells according to the expression levels of each of the four RTFs. Using this system, the most effective ratio (Oct3/4-high, Sox2-low, Klf4-high, c-Myc-high) of the RTFs was 88 times more efficient at producing iPS cells than the worst effective ratio (Oct3/4-low, Sox2-high, Klf4-low, c-Myc-low). Among the various RTF combinations, Oct3/4-high and Sox2-low produced the most efficient results. To investigate the molecular basis, microarray analysis was performed on iPS cells generated under high (Oct3/4-high and Sox2-low) and low (Oct3/4-low and Sox2-high) efficiency reprogramming conditions. Pathway analysis revealed that the G protein-coupled receptor (GPCR) pathway was up-regulated significantly under the high efficiency condition and treatment with the chemokine, C-C motif ligand 2, a member of the GPCR family, enhanced somatic cell reprogramming 12.3 times. Furthermore, data from the analysis of the signature gene expression profiles of mouse embryonic fibroblasts at 2 days after RTF infection revealed that the genetic modifier, Whsc1l1 (variant 1), also improved the efficiency of somatic cell reprogramming. Finally, comparison of the overall gene expression profiles between the high and low efficiency conditions will provide novel insights into mechanisms underlying somatic cell reprogramming.	[Nagamatsu, Go] Keio Univ, Dept Cell Differentiat, Sakaguchi Lab, Sch Med,Shinju Ku, Tokyo 1608582, Japan; [Kosaka, Takeo; Oya, Mototsugu] Keio Univ, Dept Urol, Sch Med, Tokyo 1608582, Japan; [Saito, Shigeru; Horimoto, Katsuhisa] Natl Inst Ind Sci & Technol AIST, CBRC, Tokyo 1350064, Japan; [Nagamatsu, Go] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Saito, Shigeru] INFOCOM Corp, Chem & Bio Informat Dept, Tokyo 1500001, Japan; [Horimoto, Katsuhisa] Shanghai Univ, Inst Syst Biol, Shanghai 200444, Peoples R China	Keio University; Keio University; National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); Shanghai University	Nagamatsu, G (corresponding author), Keio Univ, Dept Cell Differentiat, Sakaguchi Lab, Sch Med,Shinju Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	gonag@z2.keio.jp	Suda, Toshio/H-6761-2013; Oya, Mototsugu/K-8592-2013; Takubo, Keiyo/AAX-5546-2020; Saito, Shigeru/B-2785-2012	Suda, Toshio/0000-0001-7540-1771; Takubo, Keiyo/0000-0002-1736-7592; Saito, Shigeru/0000-0002-8708-9102	PRESTO of the Japan Science and Technology Agency; MEXT; Global century COE program from MEXT; Keio University Medical Science Fund; Project for Realization of Regenerative Medicine	PRESTO of the Japan Science and Technology Agency; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global century COE program from MEXT; Keio University Medical Science Fund; Project for Realization of Regenerative Medicine(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by PRESTO of the Japan Science and Technology Agency and Scientific Research (C), a grant from the Project for Realization of Regenerative Medicine, support for the core institutes for iPS cell research was provided by MEXT, a grant-in-aid for the Global century COE program from MEXT to Keio University, and the Keio University Medical Science Fund.	Araki R, 2010, STEM CELLS, V28, P213, DOI 10.1002/stem.282; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Chen TT, 2010, STEM CELLS, V28, P1315, DOI 10.1002/stem.456; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Han DW, 2011, NAT CELL BIOL, V13, P66, DOI 10.1038/ncb2136; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hasegawa K, 2007, STEM CELLS, V25, P1707, DOI 10.1634/stemcells.2006-0813; Hasegawa Y, 2011, STEM CELLS, V29, P1196, DOI 10.1002/stem.673; Hirai H, 2011, STEM CELLS, V29, P1349, DOI 10.1002/stem.684; Komine O, 2003, J EXP MED, V198, P51, DOI 10.1084/jem.20021200; Lin ZY, 2011, STEM CELLS, V29, P1963, DOI 10.1002/stem.752; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Nagamatsu G, 2011, J BIOL CHEM, V286, P10641, DOI 10.1074/jbc.M110.216390; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Redmer T, 2011, EMBO REP, V12, P720, DOI 10.1038/embor.2011.88; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stec I, 2001, GENOMICS, V76, P5, DOI 10.1006/geno.2001.6581; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang Y, 2011, EMBO REP, V12, P373, DOI 10.1038/embor.2011.11; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Xu PF, 2010, P NATL ACAD SCI USA, V107, P2521, DOI 10.1073/pnas.0914396107; Yamaguchi S, 2011, STEM CELL RES, V6, P177, DOI 10.1016/j.scr.2010.09.004; Yamasaki S, 2006, NAT IMMUNOL, V7, P67, DOI 10.1038/ni1290; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	32	22	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36273	36282		10.1074/jbc.M112.380683	http://dx.doi.org/10.1074/jbc.M112.380683			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22955270	Green Published, hybrid			2022-12-28	WOS:000310364000048
J	Lan, X; Farnham, PJ; Jin, VX				Lan, Xun; Farnham, Peggy J.; Jin, Victor X.			Uncovering Transcription Factor Modules Using One- and Three-dimensional Analyses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CIS-REGULATORY MODULES; GENOME-WIDE IDENTIFICATION; FACTOR-BINDING SITES; CHIP-SEQ TECHNOLOGY; CHROMATIN IMMUNOPRECIPITATION; GENE-EXPRESSION; PROTEIN; COMBINATIONS; METHYLATIONS; PLURIPOTENT	Transcriptional regulation is a critical mediator of many normal cellular processes, as well as disease progression. Transcription factors (TFs) often co-localize at cis-regulatory elements on the DNA, form protein complexes, and collaboratively regulate gene expression. Machine learning and Bayesian approaches have been used to identify TF modules in a one-dimensional context. However, recent studies using high throughput technologies have shown that TF interactions should also be considered in three-dimensional nuclear space. Here, we describe methods for identifying TF modules and discuss how moving from a one-dimensional to a three-dimensional paradigm, along with integrated experimental and computational approaches, can lead to a better understanding of TF association networks.	[Lan, Xun; Jin, Victor X.] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Farnham, Peggy J.] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Farnham, Peggy J.] Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA	University System of Ohio; Ohio State University; University of Southern California; University of Southern California	Jin, VX (corresponding author), Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA.	victor.jin@osumc.edu		Lan, Xun/0000-0002-6523-046X; Farnham, Peggy/0000-0003-4469-7914	National Institutes of Health from the United States Public Health Service [CA45250, 1U54HG004558]; Department of Biomedical Informatics of The Ohio State University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004558] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; Department of Biomedical Informatics of The Ohio State University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA45250 and 1U54HG004558 from the United States Public Health Service (to P. J. F.). This work was also supported by the Department of Biomedical Informatics of The Ohio State University (to V. X. J.). This is the fourth article in the Thematic Minireview Series on Results from the ENCODE Project: Integrative Global Analyses of Regulatory Regions in the Human Genome.	Agrawal R, 1994, P 20 VLDB C SANT CHI, V1215, P487; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Blahnik KR, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1012; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Botta M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.79; Cai XH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-567; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chen Z, 2011, EMBO J, V30, P2405, DOI 10.1038/emboj.2011.154; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Ding J, 2012, PLANT PHYSIOL, V158, P145, DOI 10.1104/pp.111.186080; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Eaton D., 2009, P 12 INT WORKSH ART, V5, P145; Elnitski L, 2006, GENOME RES, V16, P1455, DOI 10.1101/gr.4140006; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; FRIEDMAN N, 1998, P 14 C UNC ART INT, P139; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gondor A, 2009, NATURE, V461, P212, DOI 10.1038/nature08453; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Howard ML, 2004, DEV BIOL, V271, P109, DOI 10.1016/j.ydbio.2004.03.031; Hsu PY, 2010, GENOME RES, V20, P733, DOI 10.1101/gr.101923.109; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Jin VX, 2006, GENOME RES, V16, P1585, DOI 10.1101/gr.5520206; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Joseph R, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.109; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; King DC, 2005, GENOME RES, V15, P1051, DOI 10.1101/gr.3642605; Korb K. B., 2004, TRENDS ARTIFICIAL IN, V8, P322; Lan X, 2012, NUCLEIC ACIDS RES, V40, P7690, DOI 10.1093/nar/gks501; Lan X, 2011, BIOINFORMATICS, V27, P428, DOI 10.1093/bioinformatics/btq669; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lefrancois P, 2010, METHOD ENZYMOL, V470, P77, DOI 10.1016/S0076-6879(10)70004-5; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Mead J, 2002, MOL CELL BIOL, V22, P4607, DOI 10.1128/MCB.22.13.4607-4621.2002; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; O'Geen H, 2011, METHODS MOL BIOL, V791, P265, DOI 10.1007/978-1-61779-316-5_20; O'Geen H, 2010, METHODS MOL BIOL, V649, P437, DOI 10.1007/978-1-60761-753-2_27; Oberley MJ, 2004, METHOD ENZYMOL, V376, P315; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Pollack JR, 2002, NAT GENET, V32, P515, DOI 10.1038/ng1035; PRICE MA, 1995, EMBO J, V14, P2589, DOI 10.1002/j.1460-2075.1995.tb07257.x; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Riechmann JL, 1996, P NATL ACAD SCI USA, V93, P4793, DOI 10.1073/pnas.93.10.4793; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; Tian Jin, 2001, P 17 C UNCERTAINTY A, P512; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; van Steensel B, 2010, NAT BIOTECHNOL, V28, P1089, DOI 10.1038/nbt.1680; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148; Wada Y, 2009, P NATL ACAD SCI USA, V106, P18357, DOI 10.1073/pnas.0902573106; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang XK, 2011, BIOMETRICS, V67, P151, DOI 10.1111/j.1541-0420.2010.01441.x; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang ZD, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000158; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891; Zhou Q, 2004, P NATL ACAD SCI USA, V101, P12114, DOI 10.1073/pnas.0402858101	80	4	4	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					30914	30921		10.1074/jbc.R111.309229	http://dx.doi.org/10.1074/jbc.R111.309229			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22952238	Green Published, hybrid			2022-12-28	WOS:000308791300005
J	Fernandez-Garcia, P; Pelaez, R; Herrero, P; Moreno, F				Fernandez-Garcia, Paula; Pelaez, Rafael; Herrero, Pilar; Moreno, Fernando			Phosphorylation of Yeast Hexokinase 2 Regulates Its Nucleocytoplasmic Shuttling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SNF1 PROTEIN-KINASE; TRANSCRIPTION FACTOR PHO4; IN-VIVO PHOSPHORYLATION; SACCHAROMYCES-CEREVISIAE; NUCLEAR-LOCALIZATION; GLUCOSE REPRESSION; SIGNALING PATHWAY; UPSTREAM KINASES; ACTIVATES SNF1; MIG1 REPRESSOR	Nucleocytoplasmic shuttling of Hxk2 induced by glucose levels has been reported recently. Here we present evidence that indicates that Hxk2 nucleocytoplasmic traffic is regulated by phosphorylation and dephosphorylation at serine 14. Moreover, we identified the protein kinase Snf1 and the protein phosphatase Glc7-Reg1 as novel regulatory partners for the nucleocytoplasmic shuttling of Hxk2. Functional studies revealed that, in contrast to the wild-type protein, the dephosphorylation-mimicking mutant of Hxk2 retains its nuclear localization in low glucose conditions, and the phosphomimetic mutant of Hxk2 retains its cytoplasmic localization in high glucose conditions. Interaction experiments of Hxk2 with Kap60 and Xpo1 indicated that nuclear import of the S14D mutant of Hxk2 is severely decreased but that the export is significantly enhanced. Conversely, nuclear import of the S14A mutant of Hxk2 was significantly enhanced, although the export was severely decreased. The interaction of Hxk2 with Kap60 and Xpo1 was found to occur in the dephosphorylated and phosphorylated states of the protein, respectively. In addition, we found that Hxk2 is a substrate for Snf1. Mutational analysis indicated that serine 14 is a major in vitro and in vivo phosphorylation site for Snf1. We also provide evidence that dephosphorylation of Hxk2 at serine 14 is a protein phosphatase Glc7-Reg1-dependent process. Taken together, this study establishes a functional link between Hxk2, Reg1, and Snf1 signaling, which involves the regulation of Hxk2 nucleocytoplasmic shuttling by phosphorylation-dephosphorylation of serine 14.	[Fernandez-Garcia, Paula; Pelaez, Rafael; Herrero, Pilar; Moreno, Fernando] Univ Oviedo, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain	University of Oviedo	Moreno, F (corresponding author), Univ Oviedo, Dept Bioquim & Biol Mol, Campus El Cristo, E-33006 Oviedo, Spain.	fmoreno@uniovi.es	Fernández García, Paula/L-8101-2014; Peláez, Rafael/R-9458-2019; Fernández-García, Paula/M-5227-2019	Peláez, Rafael/0000-0002-4047-6017; Fernández-García, Paula/0000-0002-8128-7028; Herrero-Espilez, Pilar/0000-0002-3668-4294	Ministerio de Ciencia e Innovacion (MICINN) (Spain) Grant [BFU2010-19628-C02-01]; Formacion de Personal Investigador fellowship-associated Grant from the MICINN (Spain) [BFU2007-66063-C02-02]; Severo Ochoa fellowship from Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia Foundation (Principado de Asturias)	Ministerio de Ciencia e Innovacion (MICINN) (Spain) Grant; Formacion de Personal Investigador fellowship-associated Grant from the MICINN (Spain); Severo Ochoa fellowship from Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia Foundation (Principado de Asturias)	This work was supported in part by Ministerio de Ciencia e Innovacion (MICINN) (Spain) Grant BFU2010-19628-C02-01.; Supported by Formacion de Personal Investigador fellowship-associated Grant BFU2007-66063-C02-02 from the MICINN (Spain).; Supported by a Severo Ochoa fellowship from Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia Foundation (Principado de Asturias). Present address: Centro de Investigacion Medica Aplicada, Universidad de Navarra, 31008 Pamplona, Spain.	Ahuatzi D, 2004, J BIOL CHEM, V279, P14440, DOI 10.1074/jbc.M313431200; Ahuatzi D, 2007, J BIOL CHEM, V282, P4485, DOI 10.1074/jbc.M606854200; Benzeno S, 2006, ONCOGENE, V25, P6291, DOI 10.1038/sj.onc.1209644; CELENZA JL, 1986, SCIENCE, V233, P1175, DOI 10.1126/science.3526554; Cho YH, 2006, CELL, V127, P579, DOI 10.1016/j.cell.2006.09.028; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; de la Cera T, 2002, J MOL BIOL, V319, P703, DOI 10.1016/S0022-2836(02)00377-7; De Wever V, 2005, EMBO J, V24, P4115, DOI 10.1038/sj.emboj.7600871; DeVit MJ, 1999, CURR BIOL, V9, P1231, DOI 10.1016/S0960-9822(99)80503-X; Fagerlund R, 2002, J BIOL CHEM, V277, P30072, DOI 10.1074/jbc.M202943200; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Hahn JS, 2004, J BIOL CHEM, V279, P5169, DOI 10.1074/jbc.M311005200; Hammell CM, 2002, MOL CELL BIOL, V22, P6441, DOI 10.1128/MCB.22.18.6441-6457.2002; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; HARTLEY AD, 1994, GENETICS, V136, P465; Herrero P, 1998, FEBS LETT, V434, P71, DOI 10.1016/S0014-5793(98)00872-2; HERRERO P, 1995, YEAST, V11, P137, DOI 10.1002/yea.320110205; Hong SP, 2007, J BIOL CHEM, V282, P16838, DOI 10.1074/jbc.M700146200; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; KADOWAKI H, 1989, GENE, V76, P161, DOI 10.1016/0378-1119(89)90018-8; Kafadar KA, 2003, GENE DEV, V17, P2698, DOI 10.1101/gad.1140603; Kaffman A, 1998, GENE DEV, V12, P2673, DOI 10.1101/gad.12.17.2673; Kettner K, 2012, FEBS LETT, V586, P455, DOI 10.1016/j.febslet.2012.01.030; Komeili A, 1999, SCIENCE, V284, P977, DOI 10.1126/science.284.5416.977; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; KRIEGEL TM, 1994, BIOCHEMISTRY-US, V33, P148, DOI 10.1021/bi00167a019; Kuser PR, 2000, J BIOL CHEM, V275, P20814, DOI 10.1074/jbc.M910412199; Lee P, 2008, MOL MICROBIOL, V70, P882, DOI 10.1111/j.1365-2958.2008.06450.x; Leslie DM, 2006, METHODS, V39, P291, DOI 10.1016/j.ymeth.2006.07.013; Livas D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-405; MA H, 1986, MOL CELL BIOL, V6, P4046, DOI 10.1128/MCB.6.11.4046; Matschinsky Franz M, 2005, Curr Diab Rep, V5, P171, DOI 10.1007/s11892-005-0005-4; Mayer FV, 2011, CELL METAB, V14, P707, DOI 10.1016/j.cmet.2011.09.009; Mayordomo I, 2001, YEAST, V18, P923, DOI 10.1002/yea.737; MAZON MJ, 1993, EUR J BIOCHEM, V213, P501, DOI 10.1111/j.1432-1033.1993.tb17787.x; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Moreno F, 2005, BIOCHEM SOC T, V33, P265, DOI 10.1042/BST0330265; Moriya H, 2001, GENE DEV, V15, P1217, DOI 10.1101/gad.884001; Nath N, 2003, MOL CELL BIOL, V23, P3909, DOI 10.1128/MCB.23.11.3909-3917.2003; NEHLIN JO, 1990, EMBO J, V9, P2891, DOI 10.1002/j.1460-2075.1990.tb07479.x; Ostling J, 1998, EUR J BIOCHEM, V252, P162, DOI 10.1046/j.1432-1327.1998.2520162.x; Palomino A, 2006, NUCLEIC ACIDS RES, V34, P1427, DOI 10.1093/nar/gkl028; Pelaez R, 2012, J BIOL CHEM, V287, P3518, DOI 10.1074/jbc.M111.317230; Pelaez R, 2010, BIOCHEM J, V432, P181, DOI 10.1042/BJ20100663; Pelaez R, 2009, J BIOL CHEM, V284, P20548, DOI 10.1074/jbc.M109.013730; Randez-Gil F, 1998, FEBS LETT, V425, P475, DOI 10.1016/S0014-5793(98)00289-0; Randez-Gil F, 1998, MOL CELL BIOL, V18, P2940, DOI 10.1128/MCB.18.5.2940; Rodriguez A, 2001, BIOCHEM J, V355, P625, DOI 10.1042/bj3550625; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rubenstein EM, 2008, J BIOL CHEM, V283, P222, DOI 10.1074/jbc.M707957200; Sanz P, 2000, MOL CELL BIOL, V20, P1321, DOI 10.1128/MCB.20.4.1321-1328.2000; Smith A, 1998, EMBO J, V17, P3556, DOI 10.1093/emboj/17.13.3556; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; Tomas-Cobos L, 2002, BIOCHEM J, V368, P657, DOI 10.1042/BJ20020984; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; TU JL, 1995, EMBO J, V14, P5939, DOI 10.1002/j.1460-2075.1995.tb00282.x; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	59	54	54	3	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42151	42164		10.1074/jbc.M112.401679	http://dx.doi.org/10.1074/jbc.M112.401679			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23066030	Green Published, hybrid			2022-12-28	WOS:000312103000053
J	Ma, L; Dong, FM; Zaid, M; Kumar, A; Zha, XH				Ma, Loretta; Dong, Fumin; Zaid, Maryam; Kumar, Ashok; Zha, Xiaohui			ABCA1 Protein Enhances Toll-like Receptor 4 (TLR4)-stimulated Interleukin-10 (IL-10) Secretion through Protein Kinase A (PKA) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-CHOLESTEROL ACCUMULATION; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; LIPID RAFTS; IN-VIVO; MACROPHAGES; TRANSPORTER; ATHEROSCLEROSIS; HDL; RETENTION	Nonresolving inflammatory response from macrophages is a major characteristic of atherosclerosis. Macrophage ABCA1 has been previously shown to suppress the secretion of proinflammatory cytokine. In the present study, we demonstrate that ABCA1 also promotes the secretion of IL-10, an anti-inflammatory cytokine critical for inflammation resolution. ABCA1(+/+) bone marrow-derived macrophages secrete more IL-10 but less proinflammatory cytokines than ABCA1(-/-) bone marrow-derived macrophages, similar to alternatively activated ( M2) macrophages. We present evidence that ABCA1 activates PKA and that this elevated PKA activity contributes to M2-like inflammatory response from ABCA1(+/+) bone marrow-derived macrophages. Furthermore, cholesterol lowering by statins, methyl-beta-cyclodextrin, or filipin also activates PKA and, consequently, transforms macrophages toward M2-like phenotype. Conversely, cholesterol enrichment suppresses PKA activity and promotes M1-like inflammatory response. As the primary function of ABCA1 is cholesterol removal, our results suggest that ABCA1 activates PKA by regulating cholesterol. Indeed, forced cholesterol enrichment in ABCA1-expressing macrophages suppresses PKA activation and elicits M1-like response. Collectively, these findings reveal a novel protective process by ABCA1-activated PKA in macrophages. They also suggest cholesterol lowering in extra-hepatic tissues by statins as an anti-inflammation strategy.	[Ma, Loretta; Zaid, Maryam; Zha, Xiaohui] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Dong, Fumin; Zha, Xiaohui] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Kumar, Ashok] Childrens Hosp E Ontario, Ottawa, ON K1H 8L6, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Zha, XH (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	xzha@ohri.ca			Heart and Stroke Foundation of Ontario [T 7054]; Bell Canada Graduate Scholarship	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Bell Canada Graduate Scholarship	This work was supported by a grant from the Heart and Stroke Foundation of Ontario (Grant T 7054).; Supported by a Bell Canada Graduate Scholarship.	Alvarez Y, 2009, J IMMUNOL, V183, P1471, DOI 10.4049/jimmunol.0900312; Attie AD, 2001, J LIPID RES, V42, P1717; BOURNE HR, 1974, SCIENCE, V184, P19, DOI 10.1126/science.184.4132.19; Caligiuri G, 2003, MOL MED, V9, P10, DOI 10.1007/BF03402102; Deng B, 2012, J IMMUNOL, V189, P3669, DOI 10.4049/jimmunol.1103180; Escoubet-Lozach L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002401; Gao XL, 2012, MOL BIOL CELL, V23, P503, DOI 10.1091/mbc.E11-07-0658; Haidar B, 2004, J BIOL CHEM, V279, P9963, DOI 10.1074/jbc.M313487200; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Ma L, 2011, J BIOL CHEM, V286, P3370, DOI 10.1074/jbc.M110.173666; Mallat Z, 1999, CIRC RES, V85, pE17, DOI 10.1161/01.RES.85.8.e17; Mellett M, 2011, J IMMUNOL, V186, P4925, DOI 10.4049/jimmunol.1002739; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; Oram JF, 2001, J LIPID RES, V42, P1173; Oslund LJP, 1999, ARTERIOSCL THROM VAS, V19, P2847, DOI 10.1161/01.ATV.19.12.2847; PITHA J, 1988, LIFE SCI, V43, P493, DOI 10.1016/0024-3205(88)90150-6; Pontier SM, 2008, J BIOL CHEM, V283, P24659, DOI 10.1074/jbc.M800778200; Pradel LC, 2009, EUR J IMMUNOL, V39, P2270, DOI 10.1002/eji.200838867; Pradervand S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r11; Schwartz K, 2000, BIOCHEM BIOPH RES CO, V274, P794, DOI 10.1006/bbrc.2000.3243; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sun Y, 2009, CIRC RES, V104, P455, DOI 10.1161/CIRCRESAHA.108.182568; Tang CR, 2009, J BIOL CHEM, V284, P32336, DOI 10.1074/jbc.M109.047472; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Vaughan AM, 2003, J LIPID RES, V44, P1373, DOI 10.1194/jlr.M300078-JLR200; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; Wall EA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000202; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200; Zhu XW, 2010, J LIPID RES, V51, P3196, DOI 10.1194/jlr.M006486	34	43	52	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40502	40512		10.1074/jbc.M112.413245	http://dx.doi.org/10.1074/jbc.M112.413245			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23055522	Green Published, hybrid			2022-12-28	WOS:000311448800041
J	Ohto, U; Yamakawa, N; Akashi-Takamura, S; Miyake, K; Shimizu, T				Ohto, Umeharu; Yamakawa, Natsuko; Akashi-Takamura, Sachiko; Miyake, Kensuke; Shimizu, Toshiyuki			Structural Analyses of Human Toll-like Receptor 4 Polymorphisms D299G and T399I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY SYNCYTIAL VIRUS; TLR4 POLYMORPHISMS; ENDOTOXIN; MD-2; RESPONSIVENESS; MUTATIONS; BACTERIAL; VARIANT; SEPSIS	Toll-like receptor 4 (TLR4) and its coreceptor MD-2 recognize bacterial lipopolysaccharide (LPS) and signal the innate immune response. Two single nucleotide polymorphisms (SNPs) of human TLR4, D299G and T399I, have been identified and suggested to be associated with LPS hyporesponsiveness. Moreover, the SNPs have been proposed to be associated with a variety of infectious and noninfectious diseases. However, how the SNPs affect the function of TLR4 remains largely unknown. Here, we report the crystal structure of the human TLR4 (D299G/T399I).MD-2.LPS complex at 2.4 angstrom resolution. The ternary complex exhibited an agonistic "m"-shaped 2: 2: 2 architecture that was similar to that of the human wild type TLR4.MD2.LPS complex. Local structural differences that might affect the binding of the ligands were observed around D299G, but not around T399I, SNP site.	[Ohto, Umeharu; Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Yamakawa, Natsuko; Akashi-Takamura, Sachiko; Miyake, Kensuke] Univ Tokyo, Inst Med Sci, Div Infect Genet, Minato Ku, Tokyo 1088639, Japan; [Ohto, Umeharu; Shimizu, Toshiyuki] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan	University of Tokyo; University of Tokyo; RIKEN	Shimizu, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	shimizu@mol.f.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [3106]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research (B) and Grant-in-Aid for Scientific Research on Innovative Areas (3106) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Awomoyi AA, 2007, J IMMUNOL, V179, P3171, DOI 10.4049/jimmunol.179.5.3171; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; Figueroa L, 2012, J IMMUNOL, V188, P4506, DOI 10.4049/jimmunol.1200202; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Ohto U, 2012, P NATL ACAD SCI USA, V109, P7421, DOI 10.1073/pnas.1201193109; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Prohinar P, 2007, J BIOL CHEM, V282, P1010, DOI 10.1074/jbc.M609400200; Prohinar P, 2010, J IMMUNOL, V184, P4362, DOI 10.4049/jimmunol.0903142; Radstake TRDJ, 2004, ARTHRITIS RHEUM, V50, P999, DOI 10.1002/art.20114; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rallabhandi P, 2006, J IMMUNOL, V177, P322, DOI 10.4049/jimmunol.177.1.322; Rangel-Frausto MS, 2005, ARCH MED RES, V36, P672, DOI 10.1016/j.arcmed.2005.06.006; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; RIETSCHEL ET, 1993, IMMUNOBIOLOGY, V187, P169, DOI 10.1016/S0171-2985(11)80338-4; Schletter J, 1995, ARCH MICROBIOL, V164, P383, DOI 10.1007/BF02529735; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Tulic MK, 2007, J IMMUNOL, V179, P132, DOI 10.4049/jimmunol.179.1.132; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yamakawa N., 2012, INT IMMUNOL IN PRESS	34	100	103	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40611	40617		10.1074/jbc.M112.404608	http://dx.doi.org/10.1074/jbc.M112.404608			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23055527	Green Published, hybrid			2022-12-28	WOS:000311448800050
J	Park, HJ; Shabashvili, D; Nekorchuk, MD; Shyqyriu, E; Jung, JI; Ladd, TB; Moore, BD; Felsenstein, KM; Golde, TE; Kim, SH				Park, Hyo-Jin; Shabashvili, Daniil; Nekorchuk, Michael D.; Shyqyriu, Eva; Jung, Joo In; Ladd, Thomas B.; Moore, Brenda D.; Felsenstein, Kevin M.; Golde, Todd E.; Kim, Seong-Hun			Retention in Endoplasmic Reticulum 1 (RER1) Modulates Amyloid-beta (A beta) Production by Altering Trafficking of gamma-Secretase and Amyloid Precursor Protein (APP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; INTRAMEMBRANE PROTEOLYSIS; SUBCELLULAR-LOCALIZATION; SACCHAROMYCES-CEREVISIAE; HIPPOCAMPAL-NEURONS; COMPLEX COMPONENT; PLASMA-MEMBRANE; GOLGI-APPARATUS; IN-VIVO; PRESENILIN-1	The presence of neuritic plaques containing aggregated amyloid-beta (A beta) peptides in the brain parenchyma is a pathological hallmark of Alzheimer disease (AD). A beta is generated by sequential cleavage of the amyloid beta precursor protein (APP) by beta- and gamma-secretase, respectively. As APP processing to A beta requires transport through the secretory pathway, trafficking of the substrate and access to the secretases are key factors that can influence A beta production (Thinakaran, G., and Koo, E. H. (2008) Amyloid precursor protein trafficking, processing, and function. J. Biol. Chem. 283, 29615-29619). Here, we report that retention in endoplasmic reticulum 1 (RER1) associates with gamma-secretase in early secretory compartments and regulates the intracellular trafficking of gamma-secretase. RER1 overexpression decreases both gamma-secretase localization on the cell surface and A beta secretion and conversely RER1 knockdown increases the level of cell surface gamma-secretase and increases A beta secretion. Furthermore, we find that increased RER1 levels decrease mature APP and increase immature APP, resulting in less surface accumulation of APP. These data show that RER1 influences the trafficking and localization of both gamma-secretase and APP, thereby regulating the production and secretion of A beta peptides.	[Park, Hyo-Jin; Jung, Joo In; Ladd, Thomas B.; Moore, Brenda D.; Felsenstein, Kevin M.; Golde, Todd E.] Univ Florida, Coll Med, McKnight Brain Inst, Ctr Translat Res Neurodegenerat Dis,Dept Neurosci, Gainesville, FL 32610 USA; [Park, Hyo-Jin; Shabashvili, Daniil; Nekorchuk, Michael D.; Shyqyriu, Eva; Kim, Seong-Hun] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Golde, TE (corresponding author), Univ Florida, Coll Med, McKnight Brain Inst, Ctr Translat Res Neurodegenerat Dis,Dept Neurosci, POB 100159,1275 Ctr Dr, Gainesville, FL 32610 USA.	tgolde@mbi.ufl.edu; skim0925@hotmail.com		Moore, Brenda/0000-0002-9685-6561	National Institutes of Health [AG033138, AG020206]; NIA; NATIONAL INSTITUTE ON AGING [R01AG033138, P01AG020206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG033138 and AG020206 from the NIA.	Ahn K, 2010, P NATL ACAD SCI USA, V107, P21435, DOI 10.1073/pnas.1013246107; Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Boehm J, 1997, J CELL SCI, V110, P991; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Chyung ASC, 1997, J CELL BIOL, V138, P671, DOI 10.1083/jcb.138.3.671; Chyung JH, 2005, J BIOL CHEM, V280, P4383, DOI 10.1074/jbc.M409272200; Cupers P, 2001, J CELL BIOL, V154, P731, DOI 10.1083/jcb.200104045; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; DESTROOPER B, 1993, J CELL BIOL, V121, P295, DOI 10.1083/jcb.121.2.295; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Fullekrug J, 1997, EUR J CELL BIOL, V74, P31; Fullekrug J, 1999, MOL BIOL CELL, V10, P1939, DOI 10.1091/mbc.10.6.1939; Glabe CC, 2005, SUB CELL BIOCHEM, V38, P167; Golde TE, 2010, EXP NEUROL, V223, P252, DOI 10.1016/j.expneurol.2009.07.035; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Huse JT, 2001, TRAFFIC, V2, P75, DOI 10.1034/j.1600-0854.2001.020201.x; Ikeuchi T, 2003, J BIOL CHEM, V278, P7010, DOI 10.1074/jbc.M209252200; Iwatsubo T, 2004, CURR OPIN NEUROBIOL, V14, P379, DOI 10.1016/j.conb.2004.05.010; Kaether C, 2002, J CELL BIOL, V158, P551, DOI 10.1083/jcb.200201123; Kaether C, 2007, EMBO REP, V8, P743, DOI 10.1038/sj.embor.7401027; Kim J, 2007, J CELL BIOL, V179, P951, DOI 10.1083/jcb.200709012; Kim SH, 2000, NEUROBIOL DIS, V7, P99, DOI 10.1006/nbdi.1999.0280; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kim SH, 2005, J BIOL CHEM, V280, P1992, DOI 10.1074/jbc.M412404200; Kim SH, 2004, J BIOL CHEM, V279, P48615, DOI 10.1074/jbc.C400396200; Kim SH, 2003, J BIOL CHEM, V278, P33992, DOI 10.1074/jbc.M305834200; Kim SH, 2002, J BIOL CHEM, V277, P1872, DOI 10.1074/jbc.M108739200; Kim SH, 2001, J BIOL CHEM, V276, P43343, DOI 10.1074/jbc.M108245200; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lee EB, 2005, J CELL BIOL, V168, P291, DOI 10.1083/jcb.200407070; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Levites Y, 2006, J CLIN INVEST, V116, P193, DOI 10.1172/JCI25410; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Massaad MJ, 1999, EUR J CELL BIOL, V78, P435, DOI 10.1016/S0171-9335(99)80070-3; NISHIKAWA S, 1993, P NATL ACAD SCI USA, V90, P8179, DOI 10.1073/pnas.90.17.8179; Pamren A, 2011, J BIOL CHEM, V286, P31153, DOI 10.1074/jbc.C111.235267; Parvathy S, 1999, BIOCHEMISTRY-US, V38, P9728, DOI 10.1021/bi9906827; Periz G, 2004, J NEUROSCI RES, V77, P309, DOI 10.1002/jnr.20203; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; Placanica L, 2009, J BIOL CHEM, V284, P2967, DOI 10.1074/jbc.M807269200; Portelius E., 2006, J NEUROL S1, V66, pS69; Saito Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022108; SATO K, 1995, MOL BIOL CELL, V6, P1459, DOI 10.1091/mbc.6.11.1459; Sato K, 1997, P NATL ACAD SCI USA, V94, P9693, DOI 10.1073/pnas.94.18.9693; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Soriano S, 1999, J BIOL CHEM, V274, P32295, DOI 10.1074/jbc.274.45.32295; Spasic D, 2008, J CELL SCI, V121, P413, DOI 10.1242/jcs.015255; Spasic D, 2007, J CELL BIOL, V176, P629, DOI 10.1083/jcb.200609180; Suga K, 2009, J BIOCHEM, V146, P905, DOI 10.1093/jb/mvp138; Tarassishin L, 2004, P NATL ACAD SCI USA, V101, P17050, DOI 10.1073/pnas.0408007101; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tienari PJ, 1997, P NATL ACAD SCI USA, V94, P4125, DOI 10.1073/pnas.94.8.4125; VANNOSTRAND WE, 1989, NATURE, V341, P546; Vetrivel KS, 2006, NEUROLOGY, V66, pS69, DOI 10.1212/01.wnl.0000192107.17175.39; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; Vlad AM, 2002, J EXP MED, V196, P1435, DOI 10.1084/jem.20020493; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Walter J, 2001, CURR OPIN NEUROBIOL, V11, P585, DOI 10.1016/S0959-4388(00)00253-1; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P8534, DOI 10.1073/pnas.1202691109	69	26	27	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40629	40640		10.1074/jbc.M112.418442	http://dx.doi.org/10.1074/jbc.M112.418442			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23043097	Green Published, hybrid			2022-12-28	WOS:000311448800052
J	Suntharalingam, A; Abisambra, JF; O'Leary, JC; Koren, J; Zhang, B; Joe, MK; Blair, LJ; Hill, SE; Jinwal, UK; Cockman, M; Duerfeldt, AS; Tomarev, S; Blagg, BSJ; Lieberman, RL; Dickey, CA				Suntharalingam, Amirthaa; Abisambra, Jose F.; O'Leary, John C., III; Koren, John, III; Zhang, Bo; Joe, Myung Kuk; Blair, Laura J.; Hill, Shannon E.; Jinwal, Umesh K.; Cockman, Matthew; Duerfeldt, Adam S.; Tomarev, Stanislav; Blagg, Brian S. J.; Lieberman, Raquel L.; Dickey, Chad A.			Glucose-regulated Protein 94 Triage of Mutant Myocilin through Endoplasmic Reticulum-associated Degradation Subverts a More Efficient Autophagic Clearance Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; OLFACTOMEDIN-HOMOLOGY DOMAIN; CHEMICAL CHAPERONE; POINT MUTANTS; MOUSE MODEL; ER STRESS; GLAUCOMA; APOPTOSIS; RESCUE; GRP94	Clearance of misfolded proteins in the endoplasmic reticulum (ER) is traditionally handled by ER-associated degradation (ERAD), a process that requires retro-translocation and ubiquitination mediated by a luminal chaperone network. Here we investigated whether the secreted, glaucoma-associated protein myocilin was processed by this pathway. Myocilin is typically transported through the ER/Golgi network, but inherited mutations in myocilin lead to its misfolding and aggregation within trabecular meshwork cells, and ultimately, ER stress-induced cell death. Using targeted knockdown strategies, we determined that glucose-regulated protein 94 (Grp94), the ER equivalent of heat shock protein 90 (Hsp90), specifically recognizes mutant myocilin, triaging it through ERAD. The addition of mutant myocilin to the short list of Grp94 clients strengthens the hypothesis that beta-strand secondary structure drives client association with Grp94. Interestingly, the ERAD pathway is incapable of efficiently handling the removal of mutant myocilin, but when Grp94 is depleted, degradation of mutant myocilin is shunted away from ERAD toward a more robust clearance pathway for aggregation-prone proteins, the autophagy system. Thus ERAD inefficiency for distinct aggregation-prone proteins can be subverted by manipulating ER chaperones, leading to more effective clearance by the autophagic/lysosomal pathway. General Hsp90 inhibitors and a selective Grp94 inhibitor also facilitate clearance of mutant myocilin, suggesting that therapeutic approaches aimed at inhibiting Grp94 could be beneficial for patients suffering from some cases of myocilin glaucoma.	[Suntharalingam, Amirthaa; Abisambra, Jose F.; O'Leary, John C., III; Koren, John, III; Zhang, Bo; Blair, Laura J.; Cockman, Matthew; Dickey, Chad A.] Univ S Florida, Dept Mol Med, Tampa, FL 33613 USA; [Suntharalingam, Amirthaa; Abisambra, Jose F.; O'Leary, John C., III; Koren, John, III; Zhang, Bo; Blair, Laura J.; Cockman, Matthew; Dickey, Chad A.] Univ S Florida, Byrd Alzheimers Res Inst, Tampa, FL 33613 USA; [Jinwal, Umesh K.] Univ S Florida, Coll Pharm, Tampa, FL 33613 USA; [Joe, Myung Kuk; Tomarev, Stanislav] NEI, Lab Retinal Cell & Mol Biol, NIH, Bethesda, MD 20892 USA; [Hill, Shannon E.; Lieberman, Raquel L.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Duerfeldt, Adam S.; Blagg, Brian S. J.] Univ Kansas, Dept Med Chem, Lawrence, KS 66049 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University System of Georgia; Georgia Institute of Technology; University of Kansas	Dickey, CA (corresponding author), Univ S Florida, Dept Mol Med, Tampa, FL 33613 USA.	cdickey@health.usf.edu	Abisambra, Joe/AAP-3269-2020; blagg, brian s j/X-7770-2018; Abisambra, Jose/V-6860-2019	blagg, brian s j/0000-0002-6200-3480; Abisambra, Jose/0000-0001-6341-679X; Koren, John/0000-0002-6017-1763; Blair, Laura/0000-0002-4981-5564	National Institutes of Health [R00AG031291, R01NS073899, R01EY021205]; American Health Assistance Foundation; NATIONAL EYE INSTITUTE [R01EY021205, ZIAEY000318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG031291] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the National Institutes of Health Grants R00AG031291 (to C. A. D.), R01NS073899 (to C. A. D.), and R01EY021205 (to R. L. L.). This work was also supported by the American Health Assistance Foundation.	Abisambra JF, 2012, J MOL BIOL, V421, P653, DOI 10.1016/j.jmb.2012.02.003; Abisambra JF, 2010, J NEUROSCI, V30, P15374, DOI 10.1523/JNEUROSCI.3155-10.2010; Adam MF, 1997, HUM MOL GENET, V6, P2091, DOI 10.1093/hmg/6.12.2091; Alvarez-Erviti L, 2010, ARCH NEUROL-CHICAGO, V67, P1464, DOI 10.1001/archneurol.2010.198; Alward WLM, 1998, NEW ENGL J MED, V339, P1298, DOI 10.1056/NEJM199810293391808; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Burns JN, 2011, BIOCHEMISTRY-US, V50, P5824, DOI 10.1021/bi200231x; Burns JN, 2010, ACS CHEM BIOL, V5, P477, DOI 10.1021/cb900282e; Carbone MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004216; Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Eletto D, 2010, SEMIN CELL DEV BIOL, V21, P479, DOI 10.1016/j.semcdb.2010.03.004; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Garriga P, 1996, P NATL ACAD SCI USA, V93, P4560, DOI 10.1073/pnas.93.10.4560; Ge J, 2000, CHINESE MED J-PEKING, V113, P195; Gobeil S, 2006, EXP EYE RES, V82, P1017, DOI 10.1016/j.exer.2005.11.002; Gong G, 2004, HUM MOL GENET, V13, pR91, DOI 10.1093/hmg/ddh074; Gould DB, 2006, MOL CELL BIOL, V26, P8427, DOI 10.1128/MCB.01127-06; Hardy KM, 2005, J BIOL CHEM, V280, P28917, DOI 10.1074/jbc.M504803200; Jia LY, 2009, INVEST OPHTH VIS SCI, V50, P3743, DOI 10.1167/iovs.08-3151; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; Joe MK, 2010, AM J PATHOL, V176, P2880, DOI 10.2353/ajpath.2010.090853; Kamal A, 2004, TRENDS MOL MED, V10, P283, DOI 10.1016/j.molmed.2004.04.006; Koga H, 2011, NEUROBIOL DIS, V43, P29, DOI 10.1016/j.nbd.2010.07.006; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Lam DSC, 2000, INVEST OPHTH VIS SCI, V41, P1386; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liou B, 2006, J BIOL CHEM, V281, P4242, DOI 10.1074/jbc.M511110200; Liton PB, 2009, AUTOPHAGY, V5, P122, DOI 10.4161/auto.5.1.7304; Liu H, 2009, FASEB J, V23, P3383, DOI 10.1096/fj.09-134296; Liu X, 1996, P NATL ACAD SCI USA, V93, P4554, DOI 10.1073/pnas.93.10.4554; Liu YH, 2004, HUM MOL GENET, V13, P1193, DOI 10.1093/hmg/ddh128; Liu YH, 2008, J CELL BIOL, V182, P185, DOI 10.1083/jcb.200709176; Luo WJ, 2007, P NATL ACAD SCI USA, V104, P9511, DOI 10.1073/pnas.0701055104; Marzec M, 2012, BBA-MOL CELL RES, V1823, P774, DOI 10.1016/j.bbamcr.2011.10.013; Maynard JC, 2010, DEV BIOL, V339, P295, DOI 10.1016/j.ydbio.2009.12.023; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Morales C, 2009, J IMMUNOL, V183, P5121, DOI 10.4049/jimmunol.0900811; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Orwig SD, 2012, J MOL BIOL, V421, P242, DOI 10.1016/j.jmb.2011.12.016; Perkumas KM, 2007, EXP EYE RES, V84, P209, DOI 10.1016/j.exer.2006.09.020; Rajan RS, 2011, CURR MED CHEM, V18, P1; Resch ZT, 2009, EXP EYE RES, V88, P704, DOI 10.1016/j.exer.2008.08.011; Ron I, 2005, HUM MOL GENET, V14, P2387, DOI 10.1093/hmg/ddi240; Rozsa F W, 1998, Mol Vis, V4, P20; Santambrogio L, 2011, AUTOPHAGY, V7, P652, DOI 10.4161/auto.7.6.15287; Shepard AR, 2007, HUM MOL GENET, V16, P609, DOI 10.1093/hmg/ddm001; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Vollrath D, 2006, EXP EYE RES, V82, P1030, DOI 10.1016/j.exer.2005.10.007; Wang L, 2007, MOL VIS, V13, P618; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Yam GHT, 2007, INVEST OPHTH VIS SCI, V48, P1683, DOI 10.1167/iovs.06-0943; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Zhou ZH, 1999, HUM MOL GENET, V8, P2221, DOI 10.1093/hmg/8.12.2221; Zode GS, 2012, INVEST OPHTH VIS SCI, V53, P1557, DOI 10.1167/iovs.11-8837; Zode GS, 2011, J CLIN INVEST, V121, P3542, DOI 10.1172/JCI58183	65	55	58	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40661	40669		10.1074/jbc.M112.384800	http://dx.doi.org/10.1074/jbc.M112.384800			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23035116	Green Published, hybrid			2022-12-28	WOS:000311448800055
J	Zhang, Q; Hunke, C; Yau, YH; Seow, V; Lee, S; Tanner, LB; Guan, XL; Wenk, MR; Fibriansah, G; Chew, PL; Kukkaro, P; Biukovic, G; Shi, PY; Shochat, SG; Gruber, G; Lok, SM				Zhang, Qian; Hunke, Cornelia; Yau, Yin Hoe; Seow, Vernon; Lee, Sumarlin; Tanner, Lukas Bahati; Guan, Xue Li; Wenk, Markus R.; Fibriansah, Guntur; Chew, Pau Ling; Kukkaro, Petra; Biukovic, Goran; Shi, Pei-Yong; Shochat, Susana Geifman; Grueber, Gerhard; Lok, Shee-Mei			The Stem Region of Premembrane Protein Plays an Important Role in the Virus Surface Protein Rearrangement during Dengue Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORNE ENCEPHALITIS-VIRUS; ENVELOPE GLYCOPROTEIN; MEMBRANE-FUSION; PH; PURIFICATION; LIPIDS	Newly assembled dengue viruses (DENV) undergo maturation to become infectious particles. The maturation process involves major rearrangement of virus surface premembrane (prM) and envelope (E) proteins. The prM-E complexes on immature viruses are first assembled as trimeric spikes in the neutral pH environment of the endoplasmic reticulum. When the virus is transported to the low pH environment of the exosomes, these spikes rearrange into dimeric structures, which lie parallel to the virus lipid envelope. The proteins involved in driving this process are unknown. Previous cryoelectron microscopy studies of the mature DENV showed that the prM-stem region (residues 111-131) is membrane-associated and may interact with the E proteins. Here we investigated the prM-stem region in modulating the virus maturation process. The binding of the prM-stem region to the E protein was shown to increase significantly at low pH compared with neutral pH in ELISAs and surface plasmon resonance studies. In addition, the affinity of the prM-stem region for the liposome, as measured by fluorescence correlation spectroscopy, was also increased when pH is lowered. These results suggest that the prM-stem region forms a tight association with the virus membrane and attracts the associated E protein in the low pH environment of exosomes. This will lead to the surface protein rearrangement observed during maturation.	[Zhang, Qian; Seow, Vernon; Lee, Sumarlin; Fibriansah, Guntur; Chew, Pau Ling; Kukkaro, Petra; Lok, Shee-Mei] Duke NUS Grad Med Sch, Program Emerging Infect Dis, Singapore 169857, Singapore; [Zhang, Qian; Seow, Vernon; Lee, Sumarlin; Fibriansah, Guntur; Chew, Pau Ling; Kukkaro, Petra; Lok, Shee-Mei] Natl Univ Singapore, Dept Biol Sci, Ctr Bioimaging Sci, Singapore 119077, Singapore; [Hunke, Cornelia; Yau, Yin Hoe; Biukovic, Goran; Shochat, Susana Geifman; Grueber, Gerhard] Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 637551, Singapore; [Shi, Pei-Yong] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [Tanner, Lukas Bahati; Wenk, Markus R.] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore; [Guan, Xue Li] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, CH-4002 Basel, Switzerland	National University of Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; State University of New York (SUNY) System; Wadsworth Center; National University of Singapore; University of Basel; Swiss Tropical & Public Health Institute	Lok, SM (corresponding author), Duke NUS Grad Med Sch, Program Emerging Infect Dis, KTP Bldg,8 Coll Rd, Singapore 169857, Singapore.	sheemei.lok@duke-nus.edu.sg	Guan, Xue Li/D-2935-2014; Hoe, YAU Yin/A-2817-2011; Wenk, Markus Rene/D-1441-2014; Fibriansah, Guntur/P-1201-2015	Guan, Xue Li/0000-0002-5189-8178; Hoe, YAU Yin/0000-0001-8136-2393; Fibriansah, Guntur/0000-0002-9990-3335; Lok, Shee-Mei/0000-0003-4631-8041	Duke-NUS Graduate Medical School Block Grant [R913-200-039-304]; Biomedical Research Council [R-913-300-019-304]	Duke-NUS Graduate Medical School Block Grant; Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	This work was supported by Duke-NUS Graduate Medical School Block Grant R913-200-039-304 and Biomedical Research Council Grant R-913-300-019-304 (to S.-M. L.).	ALLISON SL, 1995, J VIROL, V69, P695, DOI 10.1128/JVI.69.2.695-700.1995; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; DAVISON SC, 1974, BIOCHEMISTRY-US, V140, P461, DOI 10.1042/bj1400461; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Hunke C, 2007, PROTEIN EXPRES PURIF, V53, P378, DOI 10.1016/j.pep.2007.01.009; Kampmann T, 2006, STRUCTURE, V14, P1481, DOI 10.1016/j.str.2006.07.011; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263; Lindenbach B., 2011, FIELDS VIROLOGY, V5th ed., P1101; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Rotzschke O, 2002, P NATL ACAD SCI USA, V99, P16946, DOI 10.1073/pnas.212643999; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wimmer R, 2006, BIOCHEMISTRY-US, V45, P481, DOI 10.1021/bi051876r; World Health Organization, 1997, DENG HAEM FEV DIAGN, P12; Yu IM, 2009, J VIROL, V83, P12101, DOI 10.1128/JVI.01637-09; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019; Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270; Zybert IA, 2008, J GEN VIROL, V89, P3047, DOI 10.1099/vir.0.2008/002535-0	26	38	40	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40525	40534		10.1074/jbc.M112.384446	http://dx.doi.org/10.1074/jbc.M112.384446			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23035113	Green Published, hybrid			2022-12-28	WOS:000311448800043
J	Okano, J; Levy, C; Lichti, U; Sun, HW; Yuspa, SH; Sakai, Y; Morasso, MI				Okano, Junko; Levy, Clara; Lichti, Ulrike; Sun, Hong-Wei; Yuspa, Stuart H.; Sakai, Yasuo; Morasso, Maria I.			Cutaneous Retinoic Acid Levels Determine Hair Follicle Development and Downgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN ACTIVITY; DERMAL PAPILLA CELLS; GENE-EXPRESSION; SEBACEOUS GLAND; THYROID-HORMONE; SONIC HEDGEHOG; KERATIN GENE; RNA-SEQ; DIFFERENTIATION; GROWTH	Retinoic acid (RA) is essential during embryogenesis and for tissue homeostasis, whereas excess RA is well known as a teratogen. In humans, excess RA is associated with hair loss. In the present study, we demonstrate that specific levels of RA, regulated by Cyp26b1, one of the RA-degrading enzymes, are required for hair follicle (hf) morphogenesis. Mice with embryonic ablation of Cyp26b1 (Cyp26b1(-/-)) have excessive endogenous RA, resulting in arrest of hf growth at the hair germ stage. The altered hf development is rescued by grafting the mutant skin on immunodeficient mice. Our results show that normalization of RA levels is associated with reinitiation of hf development. Conditional deficiency of Cyp26b1 in the dermis (En1Cre; Cyp26b1f/-) results in decreased hair follicle density and specific effect on hair type, indicating that RA levels also influence regulators of hair bending. Our results support the model of RA-dependent dermal signals regulating hf downgrowth and bending. To elucidate target gene pathways of RA, we performed microarray and RNA-Seq profiling of genes differentially expressed in Cyp26b1(-/-) skin and En1Cre; Cyp26b1f/- tissues. We show specific effects on the Wnt-catenin pathway and on members of the Runx, Fox, and Sox transcription factor families, indicating that RA modulates pathways and factors implicated in hf downgrowth and bending. Our results establish that proper RA distribution is essential for morphogenesis, development, and differentiation of hfs.	[Okano, Junko; Levy, Clara; Morasso, Maria I.] NIAMS, Dev Skin Biol Sect, NIH, Bethesda, MD 20892 USA; [Lichti, Ulrike; Yuspa, Stuart H.] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA; [Sun, Hong-Wei] NIAMS, Biodata Min & Discovery Sect, NIH, Bethesda, MD 20892 USA; [Sakai, Yasuo] Osaka Univ, Dept Plast Surg, Sch Med, Suita, Osaka 5650871, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Osaka University	Morasso, MI (corresponding author), NIAMS, Dev Skin Biol Sect, NIH, 50 South Dr,Rm 1523, Bethesda, MD 20892 USA.	morassom@mail.nih.gov		Meaders, Clara/0000-0002-4620-141X	National Institutes of Health grant from the Intramural Research Program of the NIAMS; NATIONAL CANCER INSTITUTE [ZIABC005445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIHAR041173, ZICAR041186, ZIAAR041171] Funding Source: NIH RePORTER	National Institutes of Health grant from the Intramural Research Program of the NIAMS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a National Institutes of Health grant from the Intramural Research Program of the NIAMS.	Abu-Abed S, 2002, MECH DEVELOP, V110, P173, DOI 10.1016/S0925-4773(01)00572-X; Atit R, 2006, DEV BIOL, V296, P164, DOI 10.1016/j.ydbio.2006.04.449; Beildeck ME, 2010, EXP CELL RES, V316, P1763, DOI 10.1016/j.yexcr.2010.02.001; BLUMENBERG M, 1992, J INVEST DERMATOL, V98, pS42, DOI 10.1111/1523-1747.ep12462194; Botchkarev VA, 2004, DIFFERENTIATION, V72, P512, DOI 10.1111/j.1432-0436.2004.07209005.x; Brancaccio A, 2004, HUM MOL GENET, V13, P2595, DOI 10.1093/hmg/ddh292; Chen DM, 2012, DEVELOPMENT, V139, P1522, DOI 10.1242/dev.076463; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; Cui CY, 2006, P NATL ACAD SCI USA, V103, P9142, DOI 10.1073/pnas.0509678103; Cui CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010009; Cui CY, 2003, HUM MOL GENET, V12, P2931, DOI 10.1093/hmg/ddg325; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Driskell RR, 2011, J CELL SCI, V124, P1179, DOI 10.1242/jcs.082446; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Duverger O, 2009, BIRTH DEFECTS RES C, V87, P263, DOI 10.1002/bdrc.20158; Enshell-Seijffers D, 2010, DEV CELL, V18, P633, DOI 10.1016/j.devcel.2010.01.016; Everts HB, 2012, BBA-MOL CELL BIOL L, V1821, P222, DOI 10.1016/j.bbalip.2011.08.017; Foitzik K, 2005, J INVEST DERMATOL, V124, P1119, DOI 10.1111/j.0022-202X.2005.23686.x; Hammerschmidt B, 2007, DEV BIOL, V305, P246, DOI 10.1016/j.ydbio.2007.02.010; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Headon DJ, 2001, NATURE, V414, P913, DOI 10.1038/414913a; Hembree JR, 1996, J CELL PHYSIOL, V167, P556, DOI 10.1002/(SICI)1097-4652(199606)167:3<556::AID-JCP19>3.0.CO;2-1; Hwang J, 2008, DEVELOPMENT, V135, P3149, DOI 10.1242/dev.022202; Johannesson M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004794; Laue K, 2011, AM J HUM GENET, V89, P595, DOI 10.1016/j.ajhg.2011.09.015; Mikkola ML, 2007, SEMIN CELL DEV BIOL, V18, P225, DOI 10.1016/j.semcdb.2007.01.007; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Morasso MI, 2010, METHODS MOL BIOL, V585, P253, DOI 10.1007/978-1-60761-380-0_17; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; Narhi K, 2008, DEVELOPMENT, V135, P1019, DOI 10.1242/dev.016550; Ning Y, 2006, MOL ENDOCRINOL, V20, P2173, DOI 10.1210/me.2005-0196; Ohtsuki Mamitaro, 1992, Journal of Dermatology (Tokyo), V19, P774; Okano J, 2012, J CELL SCI, V125, P1827, DOI 10.1242/jcs.101550; Pennisi D, 2000, NAT GENET, V24, P434, DOI 10.1038/74301; Pennisi D, 2000, MOL CELL BIOL, V20, P9331, DOI 10.1128/MCB.20.24.9331-9336.2000; Raveh E, 2006, MECH DEVELOP, V123, P842, DOI 10.1016/j.mod.2006.08.002; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Ross AC, 2011, ANNU REV NUTR, V31, P65, DOI 10.1146/annurev-nutr-072610-145127; Samarut E, 2012, MOL CELL ENDOCRINOL, V348, P348, DOI 10.1016/j.mce.2011.03.025; Schlake T, 2005, MECH DEVELOP, V122, P988, DOI 10.1016/j.mod.2005.04.012; Schlake T, 2007, SEMIN CELL DEV BIOL, V18, P267, DOI 10.1016/j.semcdb.2007.01.005; Schlake T, 2006, MECH DEVELOP, V123, P641, DOI 10.1016/j.mod.2006.06.001; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Srivastava AK, 2001, HUM MOL GENET, V10, P2973, DOI 10.1093/hmg/10.26.2973; TOMICCANIC M, 1992, J INVEST DERMATOL, V99, P842, DOI 10.1111/1523-1747.ep12614806; Topletz AR, 2012, BIOCHEM PHARMACOL, V83, P149, DOI 10.1016/j.bcp.2011.10.007; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Weger N, 2005, J INVEST DERMATOL, V125, P873, DOI 10.1111/j.0022-202X.2005.23946.x; Widelitz Randall B, 2008, Organogenesis, V4, P123; Yang CC, 2010, J DERMATOL SCI, V57, P2, DOI 10.1016/j.jdermsci.2009.11.005	54	22	23	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.397273	http://dx.doi.org/10.1074/jbc.M112.397273			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23007396	Green Published, hybrid			2022-12-28	WOS:000311233800003
J	Plenge, P; Shi, L; Beuming, T; Te, J; Newman, AH; Weinstein, H; Gether, U; Loland, CJ				Plenge, Per; Shi, Lei; Beuming, Thijs; Te, Jerez; Newman, Amy Hauck; Weinstein, Harel; Gether, Ulrik; Loland, Claus J.			Steric Hindrance Mutagenesis in the Conserved Extracellular Vestibule Impedes Allosteric Binding of Antidepressants to the Serotonin Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTRANSMITTER-SODIUM SYMPORTER; HIGH-AFFINITY; R-CITALOPRAM; DOPAMINE TRANSPORTER; H-3 IMIPRAMINE; BACTERIAL HOMOLOG; 5-HT TRANSPORTER; IN-VITRO; SITE; SUBSTRATE	The serotonin transporter (SERT) controls synaptic serotonin levels and is the primary target for antidepressants, including selective serotonin reuptake inhibitors (e.g. (S)-citalopram) and tricyclic antidepressants (e.g. clomipramine). In addition to a high affinity binding site, SERT possesses a low affinity allosteric site for antidepressants. Binding to the allosteric site impedes dissociation of antidepressants from the high affinity site, which may enhance antidepressant efficacy. Here we employ an induced fit docking/molecular dynamics protocol to identify the residues that may be involved in the allosteric binding in the extracellular vestibule located above the central substrate binding (S1) site. Indeed, mutagenesis of selected residues in the vestibule reduces the allosteric potency of (S)-citalopram and clomipramine. The identified site is further supported by the inhibitory effects of Zn2+ binding in an engineered site and the covalent attachment of benzocaine-methanethiosulfonate to a cysteine introduced in the extracellular vestibule. The data provide a mechanistic explanation for the allosteric action of antidepressants at SERT and suggest that the role of the vestibule is evolutionarily conserved among neurotransmitter: sodium symporter proteins as a binding pocket for small molecule ligands.	[Shi, Lei; Te, Jerez; Weinstein, Harel] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Shi, Lei; Weinstein, Harel] Cornell Univ, Weill Med Coll, Inst Computat Biomed, New York, NY 10021 USA; [Plenge, Per; Gether, Ulrik; Loland, Claus J.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Mol Neuropharmacol Lab, DK-2200 Copenhagen, Denmark; [Beuming, Thijs] Schrodinger Inc, New York, NY 10036 USA; [Newman, Amy Hauck] NIDA, Med Chem Sect, Mol Targets & Medicat Discovery Branch, Intramural Res Program,Dept Hlth & Human Serv,NIH, Baltimore, MD 21224 USA	Cornell University; Cornell University; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Shi, L (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA.	les2007@med.cornell.edu; cllo@sund.ku.dk	Shi, Lei/AAV-1321-2020; Loland, Claus/E-5975-2014; WEINSTEIN, HAREL/O-8245-2019	Shi, Lei/0000-0002-4137-096X; Loland, Claus/0000-0002-1773-1446; WEINSTEIN, HAREL/0000-0003-3473-9818; Gether, Ulrik/0000-0002-0020-3807	National Institutes of Health [DA12408, DA023694]; National Institutes of Health, NIDA, Intramural Research Program; Danish Independent Research Council-Sapere Aude; Danish Health Science Research Council; Lundbeck Foundation; Novo Nordic Foundation; Maersk Foundation; BioSCART center of excellence program; Lundbeck A/S; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIDA, Intramural Research Program; Danish Independent Research Council-Sapere Aude; Danish Health Science Research Council; Lundbeck Foundation(Lundbeckfonden); Novo Nordic Foundation(Novo Nordisk Foundation); Maersk Foundation; BioSCART center of excellence program; Lundbeck A/S; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA12408 (to U. G. and H. W.) and DA023694 (to L. S.) and the National Institutes of Health, NIDA, Intramural Research Program (to A. H. N.). This work was also supported in part by the Danish Independent Research Council-Sapere Aude (to C. J. L.), the Danish Health Science Research Council (to C. J. L. and U. G.), the Lundbeck Foundation (to C. J. L. and U. G.), the Novo Nordic Foundation (to C. J. L. and U. G.), the Maersk Foundation (to C. J. L.), the BioSCART center of excellence program (to C. J. L. and U. G.), and Lundbeck A/S (to P. P.).	Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Andersen J, 2011, P NATL ACAD SCI USA, V108, P12137, DOI 10.1073/pnas.1103060108; Andersen J, 2010, J BIOL CHEM, V285, P2051, DOI 10.1074/jbc.M109.072587; Andersen J, 2009, J BIOL CHEM, V284, P10276, DOI 10.1074/jbc.M806907200; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Bisgaard H, 2011, NEUROPHARMACOLOGY, V60, P182, DOI 10.1016/j.neuropharm.2010.08.021; Bowers K.J., 2006, SCALABLE ALGORITHMS; Chen FH, 2005, EUR NEUROPSYCHOPHARM, V15, P193, DOI 10.1016/j.euroneuro.2004.08.008; Chen FH, 2005, J NEUROCHEM, V92, P21, DOI 10.1111/j.1471-4159.2004.02835.x; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; El Mansari M, 2007, INT J NEUROPSYCHOPH, V10, P31, DOI 10.1017/S1461145705006462; Guptaroy B, 2009, MOL PHARMACOL, V75, P514, DOI 10.1124/mol.108.048744; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; Holst B, 1998, MOL PHARMACOL, V53, P166, DOI 10.1124/mol.53.1.166; Keller PC, 2004, BIOCHEMISTRY-US, V43, P8510, DOI 10.1021/bi035971g; Koldso H, 2010, J AM CHEM SOC, V132, P1311, DOI 10.1021/ja906923j; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Loland CJ, 1999, J BIOL CHEM, V274, P36928, DOI 10.1074/jbc.274.52.36928; Mnie-Filali O, 2007, NEUROREPORT, V18, P1553, DOI 10.1097/WNR.0b013e3282f04047; Mork A, 2003, NEUROPHARMACOLOGY, V45, P167, DOI 10.1016/S0028-3908(03)00138-2; Neubauer HA, 2006, MOL PHARMACOL, V69, P1242, DOI 10.1124/mol.105.018507; Piscitelli CL, 2010, NATURE, V468, P1129, DOI 10.1038/nature09581; PLENGE P, 1991, EUR J PHARM-MOLEC PH, V206, P243, DOI 10.1016/S0922-4106(05)80025-2; PLENGE P, 1985, EUR J PHARMACOL, V119, P1, DOI 10.1016/0014-2999(85)90314-0; Plenge P, 1997, PHARMACOL TOXICOL, V80, P197, DOI 10.1111/j.1600-0773.1997.tb00396.x; Plenge P, 2007, EUR J PHARMACOL, V567, P1, DOI 10.1016/j.ejphar.2007.03.055; Quick M, 2012, NAT STRUCT MOL BIOL, V19, P207, DOI 10.1038/nsmb.2197; Roth B L, 1994, Ann Clin Psychiatry, V6, P67, DOI 10.3109/10401239409148985; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Sanchez C, 2004, PSYCHOPHARMACOLOGY, V174, P163, DOI 10.1007/s00213-004-1865-z; Sanchez C, 2006, BASIC CLIN PHARMACOL, V99, P91, DOI 10.1111/j.1742-7843.2006.pto_295.x; Sarker S, 2010, MOL PHARMACOL, V78, P1026, DOI 10.1124/mol.110.067538; Schloss P, 1998, J PSYCHOPHARMACOL, V12, P115, DOI 10.1177/026988119801200201; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Shan JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016350; Sheline YI, 1997, J CLIN PSYCHOPHARM, V17, P11, DOI 10.1097/00004714-199702000-00003; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Shi L, 2010, BIOPHYS J, V99, pL103, DOI 10.1016/j.bpj.2010.10.003; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Sinning S, 2010, J BIOL CHEM, V285, P8363, DOI 10.1074/jbc.M109.045401; Storustovu SI, 2004, BRIT J PHARMACOL, V142, P172, DOI 10.1038/sj.bjp.0705738; Wang H, 2012, EMBO REP, V13, P861, DOI 10.1038/embor.2012.110; Wang H, 2012, NAT STRUCT MOL BIOL, V19, P212, DOI 10.1038/nsmb.2215; WENNOGLE LP, 1982, EUR J PHARMACOL, V86, P303, DOI 10.1016/0014-2999(82)90333-8; White KJ, 2006, PROTEIN SCI, V15, P2411, DOI 10.1110/ps.062386106; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zhong HL, 2009, NEUROSCI LETT, V462, P207, DOI 10.1016/j.neulet.2009.07.030; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602	53	71	73	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.371765	http://dx.doi.org/10.1074/jbc.M112.371765			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23007398	Green Published, hybrid			2022-12-28	WOS:000311233800004
J	Kim, IH; Carlson, BR; Heindel, CC; Kim, H; Soderling, SH				Kim, Il Hwan; Carlson, Benjamin R.; Heindel, Clifford C.; Kim, Hyun; Soderling, Scott H.			Disruption of Wave-associated Rac GTPase-activating Protein (Wrp) Leads to Abnormal Adult Neural Progenitor Migration Associated with Hydrocephalus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; CHOROID-PLEXUS FUNCTION; F-BAR DOMAIN; STEM-CELLS; NEURONAL MIGRATION; FACTOR RECEPTOR; BRAIN; EXPRESSION; DAMAGE; MICE	Hydrocephalus is the most common developmental disability and leading cause of brain surgery for children. Current treatments are limited to surgical intervention, as the factors that contribute to the initiation of hydrocephalus are poorly understood. Here, we describe the development of obstructive hydrocephalus in mice that are null for Wrp (Srgap3). Wrp is highly expressed in the ventricular stem cell niche, and it is a gene required for cytoskeletal organization and is associated with syndromic and psychiatric disorders in humans. During the postnatal period of progenitor cell expansion and ventricular wall remodeling, loss of Wrp results in the abnormal migration of lineage-tagged cells from the ventricular region into the corpus callosum. Within this region, mutant progenitors appear to give rise to abnormal astroglial cells and induce periventricular lesions and hemorrhage that leads to cerebral aqueductal occlusion. These results indicate that periventricular abnormalities arising from abnormal migration from the ventricular niche can be an initiating cause of noncommunicating hydrocephalus.	[Kim, Il Hwan; Carlson, Benjamin R.; Heindel, Clifford C.; Soderling, Scott H.] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA; [Kim, Hyun] Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea	Duke University; Korea University; Korea University Medicine (KU Medicine)	Soderling, SH (corresponding author), Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA.	s.soderling@cellbio.duke.edu		Kim, Hyun/0000-0002-7210-5798; Carlson, Benjamin/0000-0002-9797-3196	National Institutes of Health [R01 NS059957]; March of Dimes [6-FY10-289]; Duke Neonatal-Perinatal Research Institute award; Duke Institute for Brain Science "Postdoctoral Training Program in Fundamental and Translational Neuroscience" award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Duke Neonatal-Perinatal Research Institute award; Duke Institute for Brain Science "Postdoctoral Training Program in Fundamental and Translational Neuroscience" award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS059957. This work was also supported by March of Dimes Grant 6-FY10-289, a Duke Neonatal-Perinatal Research Institute award (to S. H. S.), and by a Duke Institute for Brain Science "Postdoctoral Training Program in Fundamental and Translational Neuroscience" award (to I. K.).	Arenkiel BR, 2008, NAT METHODS, V5, P299, DOI [10.1038/NMETH.1190, 10.1038/nmeth.1190]; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Badea A, 2007, NEUROIMAGE, V37, P683, DOI 10.1016/j.neuroimage.2007.05.046; Banizs B, 2005, DEVELOPMENT, V132, P5329, DOI 10.1242/dev.02153; Beni-Adani L, 2006, CHILD NERV SYST, V22, P1543, DOI 10.1007/s00381-006-0193-5; Carlson BR, 2011, J NEUROSCI, V31, P2447, DOI 10.1523/JNEUROSCI.4433-10.2011; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Craig CG, 1996, J NEUROSCI, V16, P2649; Davy BE, 2003, HUM MOL GENET, V12, P1163, DOI 10.1093/hmg/ddg122; Del Bigio MR, 2004, BRAIN PATHOL, V14, P317; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Endo M, 1999, MICROVASC RES, V58, P89, DOI 10.1006/mvre.1999.2158; Faiz M, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-26; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Goto J, 2008, MOL CELL NEUROSCI, V38, P203, DOI 10.1016/j.mcn.2008.02.009; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Hatano M, 2005, NEOPLASIA, V7, P717, DOI 10.1593/neo.05277; Hattingen E, 2010, NEUROSURGERY, V66, P917, DOI 10.1227/01.NEU.0000367801.35654.EC; Hayashi Y, 2007, NEOPLASIA, V9, P777, DOI 10.1593/neo.07454; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Kanno S, 2011, J NEUROL, V258, P1949, DOI 10.1007/s00415-011-6038-5; Kariya S, 2000, INT J PEDIATR OTORHI, V56, P71, DOI 10.1016/S0165-5876(00)00409-2; Kim IH, 2004, MOL BRAIN RES, V124, P12, DOI 10.1016/j.molbrainres.2003.12.016; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Lindeman GJ, 1998, GENE DEV, V12, P1092, DOI 10.1101/gad.12.8.1092; Mccoy E, 2007, GLIA, V55, P1034, DOI 10.1002/glia.20524; Mendoza-Torreblanca JG, 2008, NEUROSCI RES, V60, P289, DOI 10.1016/j.neures.2007.11.013; Ohmiya M, 2001, J NEUROSCI RES, V65, P228, DOI 10.1002/jnr.1146; Rolf B, 2001, BRAIN RES, V891, P247, DOI 10.1016/S0006-8993(00)03219-4; Roy NS, 2000, J NEUROSCI RES, V59, P321, DOI 10.1002/(SICI)1097-4547(20000201)59:3<321::AID-JNR5>3.0.CO;2-9; Saadoun S, 2002, BRIT J CANCER, V87, P621, DOI 10.1038/sj.bjc.6600512; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; Stiles CD, 2008, NEURON, V58, P832, DOI 10.1016/j.neuron.2008.05.031; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Utriainen A, 2004, HUM MOL GENET, V13, P2089, DOI 10.1093/hmg/ddh213; WELLER RO, 1975, ARCH DIS CHILD, V50, P763, DOI 10.1136/adc.50.10.763; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Wykosky J, 2005, MOL CANCER RES, V3, P541, DOI 10.1158/1541-7786.MCR-05-0056; Yang Y, 2006, EXP CELL RES, V312, P2379, DOI 10.1016/j.yexcr.2006.04.001; Zhang W, 2006, MOL CELL BIOL, V26, P3764, DOI 10.1128/MCB.26.10.3764-3772.2006	50	11	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39263	39274		10.1074/jbc.M112.398834	http://dx.doi.org/10.1074/jbc.M112.398834			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23007397	Green Published, hybrid			2022-12-28	WOS:000310982800081
J	Krem, MM; Luo, P; Ing, BI; Horwitz, MS				Krem, Maxwell M.; Luo, Ping; Ing, Brandon I.; Horwitz, Marshall S.			The Kelch Protein KLHDC8B Guards against Mitotic Errors, Centrosomal Amplification, and Chromosomal Instability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REED-STERNBERG CELLS; IMMUNOGLOBULIN GENE REARRANGEMENTS; PERIPHERAL-BLOOD LYMPHOCYTES; 3D NUCLEAR-ORGANIZATION; HODGKINS-LYMPHOMA; REPEAT SUPERFAMILY; BASE-LINE; B-CELLS; DISEASE; MUTATIONS	The malignant cell in classical Hodgkin lymphoma (HL) is the binucleated giant Reed-Sternberg cell. Chromosomal instability and mitotic errors may contribute to HL pathogenesis; one potential mitotic regulator is the kelch protein KLHDC8B, which localizes to the midbody, is expressed during mitosis, and is mutated in a subset of familial and sporadic HL. We report that disrupting KLHDC8B function in HeLa cells, B lymphoblasts, and fibroblasts leads to significant increases in multinucleation, multipolar mitoses, failed abscission, asymmetric segregation of daughter nuclei, formation of anucleated daughter cells, centrosomal amplification, and aneuploidy. We recapitulated the major pathologic features of the Reed-Sternberg cell and concluded that KLHDC8B is essential for mitotic integrity and maintenance of chromosomal stability. The significant impact of KLHDC8B implicates the central roles of mitotic regulation and chromosomal segregation in the pathogenesis of HL and provides a novel molecular mechanism for chromosomal instability in HL.	[Krem, Maxwell M.] Univ Washington, Sch Med, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA; Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Krem, MM (corresponding author), Univ Washington, Sch Med, Inst Stem Cell & Regenerat Med, Campus Box 358056,850 Republican St, Seattle, WA 98109 USA.	mkrem@u.washington.edu		Horwitz, Marshall/0000-0002-1683-1680	Leukemia and Lymphoma Society; Conquer Cancer Foundation of the American Society of Clinical Oncology; St. Baldrick's Foundation	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Conquer Cancer Foundation of the American Society of Clinical Oncology; St. Baldrick's Foundation	Recipient of funding from the Leukemia and Lymphoma Society, the Conquer Cancer Foundation of the American Society of Clinical Oncology, and the St. Baldrick's Foundation. To whom correspondence should be addressed: Institute for Stem Cell and Regenerative Medicine, Campus Box 358056, University of Washington School of Medicine, 850 Republican St., Seattle, WA 98109. Tel.: 206-616-4567; Fax: 206-897-1775; E-mail: mkrem@u.washington.edu.	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; BARRIOS L, 1988, HUM GENET, V78, P320, DOI 10.1007/BF00291727; Boveri T, 1929, FRAGE ENTSTEHUNG MAL; Conery AR, 2010, P NATL ACAD SCI USA, V107, P15455, DOI 10.1073/pnas.1010627107; Daniels MJ, 2004, SCIENCE, V306, P876, DOI 10.1126/science.1102574; DREXLER HG, 1989, INT J CANCER, V43, P1083, DOI 10.1002/ijc.2910430622; Falzetti D, 1999, HAEMATOLOGICA, V84, P298; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Godinho S, 2009, CANCER METAST REV, V28, P85, DOI 10.1007/s10555-008-9163-6; Guffei A, 2010, HAEMATOL-HEMATOL J, V95, P2038, DOI 10.3324/haematol.2010.030171; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Harvey EB, 1919, BIOL BULL-US, V37, P96, DOI 10.2307/1536351; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jonsdottir AB, 2009, CELL ONCOL, V31, P191, DOI 10.3233/CLO-2009-0465; Kanzler H, 1996, J EXP MED, V184, P1495, DOI 10.1084/jem.184.4.1495; Knecht H, 2009, LEUKEMIA, V23, P565, DOI 10.1038/leu.2008.314; Knecht H, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-99; Kramer A, 2003, LEUKEMIA, V17, P2207, DOI 10.1038/sj.leu.2403142; Krem MM, 2010, CELL CYCLE, V9, P670, DOI 10.4161/cc.9.4.10780; Kroll J, 2005, MOL CELL BIOL, V25, P8531, DOI 10.1128/MCB.25.19.8531-8540.2005; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; KUPPERS R, 1994, P NATL ACAD SCI USA, V91, P10962, DOI 10.1073/pnas.91.23.10962; Kuppers R, 2001, BLOOD, V97, P818, DOI 10.1182/blood.V97.3.818; Leoncini L, 1997, LEUKEMIA LYMPHOMA, V26, P307, DOI 10.3109/10428199709051780; Lingle WL, 2005, ADV EXP MED BIOL, V570, P393, DOI 10.1007/1-4020-3764-3_14; M'kacher R, 2003, INT J RADIAT ONCOL, V57, P321, DOI 10.1016/S0360-3016(03)00578-9; Maerki S, 2009, J CELL BIOL, V187, P791, DOI 10.1083/jcb.200906117; Marafioti T, 2000, BLOOD, V95, P1443, DOI 10.1182/blood.V95.4.1443.004k55_1443_1450; Martin-Subero JI, 2003, LEUKEMIA, V17, P2214, DOI 10.1038/sj.leu.2403129; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Matsuura S, 2006, AM J MED GENET A, V140A, P358, DOI 10.1002/ajmg.a.31069; NEWCOM SR, 1988, INT J CELL CLONING, V6, P417, DOI 10.1002/stem.5530060606; Norppa Hannu, 2004, IARC Sci Publ, P179; Pihan GA, 1998, CANCER RES, V58, P3974; Prag S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-42; Re D, 2002, ANN ONCOL, V13, P19, DOI 10.1093/annonc/13.S1.19; Re D, 2005, J CLIN ONCOL, V23, P6379, DOI 10.1200/JCO.2005.55.013; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; Rieder CL, 2011, CHROMOSOME RES, V19, P291, DOI 10.1007/s10577-010-9178-z; Salipante SJ, 2009, P NATL ACAD SCI USA, V106, P14920, DOI 10.1073/pnas.0904231106; Sambuughin N, 2010, AM J HUM GENET, V87, P842, DOI 10.1016/j.ajhg.2010.10.020; Schwartz JL, 2004, MUTAGENESIS, V19, P477, DOI 10.1093/mutage/geh060; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; STORKUS WJ, 1989, P NATL ACAD SCI USA, V86, P2361, DOI 10.1073/pnas.86.7.2361; Taylor SM, 2010, BLOOD, V116, P3108, DOI 10.1182/blood-2010-01-266197; Watanabe A, 2004, CLIN LAB HAEMATOL, V26, P25, DOI 10.1111/j.0141-9854.2003.00574.x; Zyss D, 2009, TRENDS CELL BIOL, V19, P334, DOI 10.1016/j.tcb.2009.04.001	49	12	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39083	39093		10.1074/jbc.M112.390088	http://dx.doi.org/10.1074/jbc.M112.390088			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22988245	Green Published, hybrid			2022-12-28	WOS:000310982800064
J	Benbow, JH; Mann, T; Keeler, C; Fan, CP; Hodsdon, ME; Lolis, E; DeGray, B; Ehrlich, BE				Benbow, Jennifer H.; Mann, Taylor; Keeler, Camille; Fan, Chengpeng; Hodsdon, Michael E.; Lolis, Elias; DeGray, Brenda; Ehrlich, Barbara E.			Inhibition of Paclitaxel-induced Decreases in Calcium Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; NEUROPATHIC PAIN; PERIPHERAL NEUROPATHY; CHEMICAL-SHIFT; RAT MODELS; SENSOR-1; LITHIUM; IBUDILAST; PROTEIN; OSCILLATIONS	Peripheral neuropathy is one of the most severe and irreversible side effects caused by treatment from several chemotherapeutic drugs, including paclitaxel (Taxol (R)) and vincristine. Strategies are needed that inhibit this unwanted side effect without altering the chemotherapeutic action of these drugs. We previously identified two proteins in the cellular pathway that lead to Taxol-induced peripheral neuropathy, neuronal calcium sensor-1 (NCS-1) and calpain. Prolonged treatment with Taxol induces activation of calpain, degradation of NCS-1, and loss of intracellular calcium signaling. This paper has focused on understanding the molecular basis for prevention of peripheral neuropathy by testing the effects of addition of two candidate compounds to the existing chemotherapeutic drug regime: lithium and ibudilast. We found that the co-administration of either lithium or ibudilast to neuroblastoma cells that were treated with Taxol or vincristine inhibited activation of calpain and the reductions in NCS-1 levels and calcium signaling associated with these chemotherapeutic drugs. The ability of Taxol to alter microtubule formation was unchanged by the addition of either candidate compound. These results allow us to suggest that it is possible to prevent the unnecessary and irreversible damage caused by chemotherapeutic drugs while still maintaining therapeutic efficacy. Specifically, the addition of either lithium or ibudilast to existing chemotherapy treatment protocols has the potential to prevent chemotherapy-induced peripheral neuropathy.	[Benbow, Jennifer H.; Mann, Taylor; Fan, Chengpeng; Lolis, Elias; DeGray, Brenda; Ehrlich, Barbara E.] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA; [Keeler, Camille; Hodsdon, Michael E.] Yale Univ, Dept Lab Med, New Haven, CT 06520 USA; [Ehrlich, Barbara E.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Ehrlich, BE (corresponding author), Yale Univ, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	barbara.ehrlich@yale.edu	/AAX-8408-2021	/0000-0001-9657-9704; Lolis, Elias/0000-0002-7902-7868	National Institutes of Health [DK57751, DK61747, 5T32DK 007356-32]; Department of Defense for Breast Cancer Research Grant [J00181]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007356, R01DK061747, P01DK057751] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense for Breast Cancer Research Grant(United States Department of Defense); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK57751 and DK61747 and National Institutes of Health Training Grant 5T32DK 007356-32 administered by the Department of Digestive Diseases at Yale University. This work was also supported by Department of Defense for Breast Cancer Research Grant J00181.	Aravind P, 2008, J MOL BIOL, V376, P1100, DOI 10.1016/j.jmb.2007.12.033; Benbow JH, 2011, J BIOL CHEM, V286, P34575, DOI 10.1074/jbc.M111.265751; Blachford C, 2009, CELL CALCIUM, V46, P257, DOI 10.1016/j.ceca.2009.08.002; Boehmerle W, 2007, P NATL ACAD SCI USA, V104, P11103, DOI 10.1073/pnas.0701546104; Boehmerle W, 2006, P NATL ACAD SCI USA, V103, P18356, DOI 10.1073/pnas.0607240103; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Cho Y, 2010, P NATL ACAD SCI USA, V107, P11313, DOI 10.1073/pnas.1002716107; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; EHRLICH BE, 1980, J MEMBRANE BIOL, V52, P187, DOI 10.1007/BF01869189; Estrada M, 2006, J CELL SCI, V119, P733, DOI 10.1242/jcs.02775; Hama AT, 2012, J NEUROTRAUM, V29, P600, DOI 10.1089/neu.2011.1863; HENNEQUIN C, 1995, BRIT J CANCER, V71, P1194, DOI 10.1038/bjc.1995.232; Hilkens P H, 1997, J Peripher Nerv Syst, V2, P350; Koh PO, 2003, P NATL ACAD SCI USA, V100, P313, DOI 10.1073/pnas.232693499; Ledeboer A, 2006, NEURON GLIA BIOL, V2, P279, DOI 10.1017/S1740925X0700035X; Ledeboer A, 2007, EXPERT OPIN INV DRUG, V16, P935, DOI 10.1517/13543784.16.7.935; Lyseng-Williamson KA, 2005, DRUGS, V65, P2513, DOI 10.2165/00003495-200565170-00007; Mielke S, 2006, EUR J CANCER, V42, P24, DOI 10.1016/j.ejca.2005.06.030; Mo M., 2012, FASEB J IN PRESS; Muthuraman A, 2011, FOOD CHEM TOXICOL, V49, P2557, DOI 10.1016/j.fct.2011.06.069; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Philippov PP, 2006, NEURONAL CALCIUM SEN; Pourmohammadi N, 2012, BASIC CLIN PHARMACOL, V110, P231, DOI 10.1111/j.1742-7843.2011.00795.x; Preston N J, 1996, Eur J Cancer Care (Engl), V5, P147, DOI 10.1111/j.1365-2354.1996.tb00226.x; Ramos-Franco J, 1998, BIOPHYS J, V75, P2783, DOI 10.1016/S0006-3495(98)77721-5; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Schlecker C, 2006, J CLIN INVEST, V116, P1668, DOI 10.1172/JCI22466; Shimizu T, 2000, PAIN, V85, P59, DOI 10.1016/S0304-3959(99)00249-3; SPENCER CM, 1994, DRUGS, V48, P794, DOI 10.2165/00003495-199448050-00009; Wang MS, 2004, BRAIN, V127, P671, DOI 10.1093/brain/awh078; WISHART DS, 1994, J BIOMOL NMR, V4, P171	32	22	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.385070	http://dx.doi.org/10.1074/jbc.M112.385070			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22988235	Green Published, hybrid			2022-12-28	WOS:000310642200026
J	Lin, TY; Werther, T; Jeoung, JH; Dobbek, H				Lin, Tzong-Yuan; Werther, Tobias; Jeoung, Jae-Hun; Dobbek, Holger			Suppression of Electron Transfer to Dioxygen by Charge Transfer and Electron Transfer Complexes in the FAD-dependent Reductase Component of Toluene Dioxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-REDUCTASE; PSEUDOMONAS-PUTIDA; PROTEIN COMPLEXES; CRYSTAL-STRUCTURE; BINDING-SITE; PURIFICATION; MECHANISM; ENZYME; ELECTROSTATICS; FERREDOXINTOL	The three-component toluene dioxygenase system consists of an FAD-containing reductase, a Rieske-type [2Fe-2S] ferredoxin, and a Rieske-type dioxygenase. The task of the FAD-containing reductase is to shuttle electrons from NADH to the ferredoxin, a reaction the enzyme has to catalyze in the presence of dioxygen. We investigated the kinetics of the reductase in the reductive and oxidative half-reaction and detected a stable charge transfer complex between the reduced reductase and NAD(+) at the end of the reductive half-reaction, which is substantially less reactive toward dioxygen than the reduced reductase in the absence of NAD(+). A plausible reason for the low reactivity toward dioxygen is revealed by the crystal structure of the complex between NAD(+) and reduced reductase, which shows that the nicotinamide ring and the protein matrix shield the reactive C4a position of the isoalloxazine ring and force the tricycle into an atypical planar conformation, both factors disfavoring the reaction of the reduced flavin with dioxygen. A rapid electron transfer from the charge transfer complex to electron acceptors further reduces the risk of unwanted side reactions, and the crystal structure of a complex between the reductase and its cognate ferredoxin shows a short distance between the electron-donating and -accepting cofactors. Attraction between the two proteins is likely mediated by opposite charges at one large patch of the complex interface. The stability, specificity, and reactivity of the observed charge transfer and electron transfer complexes are thought to prevent the reaction of reductase(TOL) with dioxygen and thus present a solution toward conflicting requirements.	[Lin, Tzong-Yuan; Werther, Tobias; Jeoung, Jae-Hun; Dobbek, Holger] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany	Humboldt University of Berlin	Dobbek, H (corresponding author), Humboldt Univ, Inst Biol, Unter Linden 6, D-10115 Berlin, Germany.	Holger.Dobbek@biologie.hu-berlin.de		Lin, Tzong-Yuan/0000-0002-0708-8127	Deutsche Forschungsgemeinschaft [DO 785/2-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant DO 785/2-2 (to H. D.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Churbanova IY, 2008, J BIOL CHEM, V283, P5622, DOI 10.1074/jbc.M709147200; Crowley PB, 2003, ACCOUNTS CHEM RES, V36, P723, DOI 10.1021/ar0200955; Crowley PB, 2004, PROTEINS, V55, P603, DOI 10.1002/prot.20043; DeLano W.L, PYMOL MOL GRAPHICS S; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferraro DJ, 2005, BIOCHEM BIOPH RES CO, V338, P175, DOI 10.1016/j.bbrc.2005.08.222; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Friemann R, 2009, ACTA CRYSTALLOGR D, V65, P24, DOI 10.1107/S0907444908036524; Frisch MJ, 2003, GAUSSIAN03; GIBSON DT, 1968, BIOCHEMISTRY-US, V7, P2653, DOI 10.1021/bi00847a031; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; KARPLUS PA, 1989, J MOL BIOL, V210, P163, DOI 10.1016/0022-2836(89)90298-2; KARPLUS PA, 1989, EUR J BIOCHEM, V178, P693, DOI 10.1111/j.1432-1033.1989.tb14500.x; Lee K, 2005, ACTA CRYSTALLOGR F, V61, P669, DOI 10.1107/S1744309105017549; LOCKRIDGE O, 1972, J BIOL CHEM, V247, P8097; MASSEY V, 1974, ANN NY ACAD SCI, V227, P446, DOI 10.1111/j.1749-6632.1974.tb14407.x; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Ojha S, 2007, PLOS COMPUT BIOL, V3, P1268, DOI 10.1371/journal.pcbi.0030121; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Prudencio M, 2004, J MOL RECOGNIT, V17, P524, DOI 10.1002/jmr.686; SAKURAI T, 1966, BIOCHIM BIOPHYS ACTA, V112, P459, DOI 10.1016/0926-6585(66)90248-2; Sambrook J., 2001, MOL CLONING LAB MANU; Senda M, 2007, J MOL BIOL, V373, P382, DOI 10.1016/j.jmb.2007.08.002; Senda T, 2000, J MOL BIOL, V304, P397, DOI 10.1006/jmbi.2000.4200; Senda T, 2009, ANTIOXID REDOX SIGN, V11, P1741, DOI 10.1089/ARS.2008.2348; Sevrioukova IF, 2004, J MOL BIOL, V336, P889, DOI 10.1016/j.jmb.2003.12.067; Sevrioukova IF, 2009, J MOL BIOL, V390, P924, DOI 10.1016/j.jmb.2009.05.013; STRICKLAND S, 1973, J BIOL CHEM, V248, P2953; SUBRAMANIAN V, 1981, J BIOL CHEM, V256, P2723; SUBRAMANIAN V, 1985, J BIOL CHEM, V260, P2355; Tezcan FA, 2001, P NATL ACAD SCI USA, V98, P5002, DOI 10.1073/pnas.081072898	35	14	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.374918	http://dx.doi.org/10.1074/jbc.M112.374918			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22992736	Green Published, hybrid			2022-12-28	WOS:000310642200066
J	Pinto, JR; Gomes, AV; Jones, MA; Liang, JS; Nguyen, S; Miller, T; Parvatiyar, MS; Potter, JD				Pinto, Jose Renato; Gomes, Aldrin V.; Jones, Michelle A.; Liang, Jingsheng; Nguyen, Susan; Miller, Todd; Parvatiyar, Michelle S.; Potter, James D.			The Functional Properties of Human Slow Skeletal Troponin T Isoforms in Cardiac Muscle Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; MESSENGER-RNA; FORCE DEVELOPMENT; CA2+ SENSITIVITY; CONTRACTION; HEART; IDENTIFICATION; TROPOMYOSIN; EXPRESSION; BINDING	Human slow skeletal troponin T (HSSTnT) shares a high degree of homology with cardiac TnT (CTnT). Although the presence of HSSTnT has not been confirmed in the heart at the protein level, detectable levels of HSSTnT mRNA have been found. Whether HSSTnT isoforms are expressed transiently remains unknown. Because transient re- expression of HSSTnT may be a potential mechanism of regulating function, we explored the effect of HSSTnT on the regulation of cardiac muscle. At least three HSSTnT isoforms have been found to exist in slow skeletal muscle: HSSTnT1 (+exons 5 and 12), HSSTnT2 (+exon 5, -exon 12), and HSSTnT3 (-exons 5 and 12). Another isoform, HSSTnT hypothetical (Hyp) (-exon 5, +exon 12), has only been found at the mRNA level. Compared with HCTnT3 (adult isoform), Tn complexes containing HSSTnT1, -2, and -3 did not alter the actomyosin ATPase activation and inhibition in the presence and absence of Ca2+, respectively. HSSTnTHyp was not evaluated as it did not form a Tn complex under a variety of conditions. Porcine papillary skinned fibers displaced with HSSTnT1, -2, or -3 and reconstituted with human cardiac troponin I and troponin C (HCTnI.TnC) complex showed a decrease in the Ca2+ sensitivity of force development and an increase in maximal recovered force (HSSTnT1 and -3) compared with HCTnT3. In contrast, HSSTnTHyp showed an increase in the Ca2+ sensitivity of force development. This suggests that re- or overexpression of specific SSTnT isoforms might have therapeutic potential in the failing heart because they increase the maximal force of contraction. In addition, circular dichroism and proteolytic digestion experiments revealed structural differences between HSSTnT isoforms and HCTnT3 and that HSSTnT1 is more susceptible to calpain and trypsin proteolysis than the other HSSTnTs. Overall, HSSTnT isoforms despite being homologues of CTnT may display distinct functional properties in muscle regulation.	[Pinto, Jose Renato] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Pinto, Jose Renato; Jones, Michelle A.; Liang, Jingsheng; Miller, Todd; Parvatiyar, Michelle S.; Potter, James D.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Gomes, Aldrin V.; Nguyen, Susan] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Parvatiyar, Michelle S.] Univ Calif Los Angeles, Dept Anesthesiol, Los Angeles, CA 90095 USA	State University System of Florida; Florida State University; University of Miami; University of California System; University of California Davis; University of California System; University of California Los Angeles	Pinto, JR (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Rm 1350-H,1115 W Call St, Tallahassee, FL 32306 USA.	jose.pinto@med.fsu.edu	parvatiyar, michelle/ABH-7542-2020; Gomes, Aldrin V/I-6529-2018; Pinto, Jose Renato/H-2631-2017	Gomes, Aldrin V/0000-0002-9819-3036; Pinto, Jose Renato/0000-0001-9092-4976; Parvatiyar, Michelle/0000-0002-9416-0069	National Institutes of Health [HL096819, AR050199, HL042325]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL110632, R01HL096819, R37HL042325, R01HL042325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL096819 (to A. V. G.), AR050199, and HL042325 (to J. D. P.).	ANDERSON PAW, 1991, CIRC RES, V69, P1226, DOI 10.1161/01.RES.69.5.1226; Barton PJR, 2004, MOL CELL BIOCHEM, V263, P91, DOI 10.1023/B:MCBI.0000041851.53074.72; Bodor GS, 1997, CLIN CHEM, V43, P476; Chandra M, 2006, BIOPHYS J, V90, P2867, DOI 10.1529/biophysj.105.076950; Cullen ME, 2004, MOL CELL BIOCHEM, V263, P81, DOI 10.1023/B:MCBI.0000041850.37415.b8; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; Fiske CH, 1925, J BIOL CHEM, V66, P375; Fredericks S, 2007, CLIN BIOCHEM, V40, P423, DOI 10.1016/j.clinbiochem.2006.12.008; GAHLMANN R, 1987, J BIOL CHEM, V262, P16122; GOLL DE, 1992, BIOCHIMIE, V74, P225, DOI 10.1016/0300-9084(92)90121-T; Gomes AV, 2002, J BIOL CHEM, V277, P35341, DOI 10.1074/jbc.M204118200; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Huang QQ, 2008, AM J PHYSIOL-CELL PH, V294, pC213, DOI 10.1152/ajpcell.00146.2007; IZUMO S, 1987, J CLIN INVEST, V79, P970, DOI 10.1172/JCI112908; Krishan K, 2000, J MUSCLE RES CELL M, V21, P527, DOI 10.1023/A:1026541803317; Lang R, 2002, J BIOL CHEM, V277, P11670, DOI 10.1074/jbc.M108912200; Larsson L, 2008, AM J PHYSIOL-CELL PH, V295, pC722, DOI 10.1152/ajpcell.00110.2008; LOMPRE AM, 1979, NATURE, V282, P105, DOI 10.1038/282105a0; McCall SJ, 2006, PEDIATR RES, V60, P276, DOI 10.1203/01.pdr.0000233004.95404.1f; Nosek TM, 2004, ARCH BIOCHEM BIOPHYS, V430, P178, DOI 10.1016/j.abb.2004.07.014; Oliveira DM, 2000, J BIOL CHEM, V275, P27513; PEARLSTONE JR, 1981, FEBS LETT, V128, P119, DOI 10.1016/0014-5793(81)81095-2; Perry SV, 1998, J MUSCLE RES CELL M, V19, P575; Pinto JR, 2008, J BIOL CHEM, V283, P2156, DOI 10.1074/jbc.M707066200; Ricchiuti V, 1999, CLIN CHEM, V45, P2129; SABRY MA, 1991, J MUSCLE RES CELL M, V12, P262, DOI 10.1007/BF01745116; SAGGIN L, 1990, DEVELOPMENT, V110, P547; SAMSON F, 1994, BIOCHEM BIOPH RES CO, V199, P841, DOI 10.1006/bbrc.1994.1305; SCHACHAT FH, 1987, J MOL BIOL, V198, P551, DOI 10.1016/0022-2836(87)90300-7; Szczesna D, 2001, J BIOL CHEM, V276, P7086, DOI 10.1074/jbc.M009823200; Szczesna D, 2000, J BIOL CHEM, V275, P624, DOI 10.1074/jbc.275.1.624; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; TOBACMAN LS, 1987, J BIOL CHEM, V262, P4059; Wang Q, 2001, ANAT RECORD, V263, P72, DOI 10.1002/ar.1078; ZOT AS, 1987, ANNU REV BIOPHYS BIO, V16, P535	36	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37362	37370		10.1074/jbc.M112.364927	http://dx.doi.org/10.1074/jbc.M112.364927			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22977240	hybrid, Green Published			2022-12-28	WOS:000310588500067
J	Lamanna, WC; Lawrence, R; Sarrazin, S; Lameda-Diaz, C; Gordts, PLSM; Moremen, KW; Esko, JD				Lamanna, William C.; Lawrence, Roger; Sarrazin, Stephane; Lameda-Diaz, Carlos; Gordts, Philip L. S. M.; Moremen, Kelley W.; Esko, Jeffrey D.			A Genetic Model of Substrate Reduction Therapy for Mucopolysaccharidosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME REPLACEMENT THERAPY; HEPARAN-SULFATE; MOUSE MODEL; GLYCOSAMINOGLYCAN SYNTHESIS; LYSOSOMAL STORAGE; DEPRIVATION THERAPY; RHODAMINE-B; GENISTEIN; DISEASE; PROTEOGLYCANS	Inherited defects in the ability to catabolize glycosaminoglycans result in lysosomal storage disorders known as mucopolysaccharidoses (MPS), causing severe pathology, particularly in the brain. Enzyme replacement therapy has been used to treat mucopolysaccharidoses; however, neuropathology has remained refractory to this approach. To test directly whether substrate reduction might be feasible for treating MPS disease, we developed a genetic model for substrate reduction therapy by crossing MPS IIIa mice with animals partially deficient in heparan sulfate biosynthesis due to heterozygosity in Ext1 and Ext2, genes that encode the copolymerase required for heparan sulfate chain assembly. Reduction of heparan sulfate by 30-50% using this genetic strategy ameliorated the amount of disease-specific biomarker and pathology in multiple tissues, including the brain. In addition, we were able to demonstrate that substrate reduction therapy can improve the efficacy of enzyme replacement therapy in cell culture and in mice. These results provide proof of principle that targeted inhibition of heparan sulfate biosynthetic enzymes together with enzyme replacement might prove beneficial for treating mucopolysaccharidoses.	[Lamanna, William C.; Lawrence, Roger; Sarrazin, Stephane; Lameda-Diaz, Carlos; Gordts, Philip L. S. M.; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Moremen, Kelley W.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University of California System; University of California San Diego; University System of Georgia; University of Georgia	Esko, JD (corresponding author), 9500 Gilman Dr,Rm 1055,CMM E, La Jolla, CA 92093 USA.	jesko@ucsd.edu	Moremen, Kelley/AAD-4661-2019	Gordts, Philip/0000-0001-7224-4328	National Institutes of Health through NIGMS [P41GM103390]; NHLBI [HL107150]; National Mucopolysaccharidosis Society; Kirschstein National Research Service Award [DK085905]; European Community [PIOF-GA-2010-273994]; National Center for Research Resources [P41RR005351]; National Institutes of Health [HL107150]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK085905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390] Funding Source: NIH RePORTER	National Institutes of Health through NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Mucopolysaccharidosis Society; Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community(European Commission); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health through NIGMS Grant P41GM103390 and NHLBI Grant HL107150 (to J. D. E). This work was also supported by a grant from the National Mucopolysaccharidosis Society, Kirschstein National Research Service Award DK085905 (to W. C. L.), European Community FP7 Award PIOF-GA-2010-273994 (to P. L. S. M. G.), and National Center for Research Resources Grant P41RR005351.; Histological staining was provided by Dr. Nissi Varki and her staff at the University of California San Diego Mouse Histopathology Core with support from National Institutes of Health program Project Grant HL107150 from the. We also thank Drs. Kazuhiro Ohmi and Elizabeth F. Neufeld for suggestions and analysis of phosphorylated Tau.	Banerjee S, 2008, CANCER LETT, V269, P226, DOI 10.1016/j.canlet.2008.03.052; Bhattacharyya R, 2001, GLYCOBIOLOGY, V11, P99, DOI 10.1093/glycob/11.1.99; Bhaumik M, 1999, GLYCOBIOLOGY, V9, P1389, DOI 10.1093/glycob/9.12.1389; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Blanch L, 1997, HUM MOL GENET, V6, P787, DOI 10.1093/hmg/6.5.787; Brady RO, 2006, ANNU REV MED, V57, P283, DOI 10.1146/annurev.med.57.110104.115650; Cox T, 2000, LANCET, V355, P1481, DOI 10.1016/S0140-6736(00)02161-9; Crawley AC, 2006, BRAIN RES, V1104, P1, DOI 10.1016/j.brainres.2006.05.079; de Ruijter J, 2012, ANN NEUROL, V71, P110, DOI 10.1002/ana.22643; Delgadillo V, 2011, J INHERIT METAB DIS, V34, P1039, DOI 10.1007/s10545-011-9342-4; Dickson PI, 2011, CURR PHARM BIOTECHNO, V12, P946, DOI 1389-2010/11 $58.00+.00; Dziedzic D, 2010, EUR J HUM GENET, V18, P200, DOI 10.1038/ejhg.2009.144; Esko J. D., 1993, CURRENT PROTOCOLS MO; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Friso A, 2010, BRIT J PHARMACOL, V159, P1082, DOI 10.1111/j.1476-5381.2009.00565.x; Jakobkiewicz-Banecka J, 2011, CURR PHARM BIOTECHNO, V12, P1860, DOI 10.2174/138920111798376932; Jakobkiewicz-Banecka J, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-26; Jeyakumar M, 1999, P NATL ACAD SCI USA, V96, P6388, DOI 10.1073/pnas.96.11.6388; Kaidonis X, 2010, EUR J HUM GENET, V18, P194, DOI 10.1038/ejhg.2009.143; Lachmann RH, 2001, EXPERT OPIN INV DRUG, V10, P455, DOI 10.1517/13543784.10.3.455; Lamanna WC, 2011, J BIOL CHEM, V286, P6955, DOI 10.1074/jbc.M110.192062; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; Lawrence R, 2012, NAT CHEM BIOL, V8, P197, DOI 10.1038/nchembio.766; Li HH, 2002, J NEUROSCI RES, V69, P30, DOI 10.1002/jnr.10278; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Liu YJ, 1999, J CLIN INVEST, V103, P497, DOI 10.1172/JCI5542; Malinowska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014192; Malinowska M, 2009, MOL GENET METAB, V98, P235, DOI 10.1016/j.ymgme.2009.06.013; NEUFELD EF, 1975, ANNU REV BIOCHEM, V44, P357, DOI 10.1146/annurev.bi.44.070175.002041; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Ohmi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027461; Platt FM, 1997, SCIENCE, V276, P428, DOI 10.1126/science.276.5311.428; Platt FM, 2009, BBA-MOL CELL RES, V1793, P737, DOI 10.1016/j.bbamcr.2008.08.009; Polkowski K, 2000, Acta Pol Pharm, V57, P135; Roberts ALK, 2006, PEDIATR RES, V60, P309, DOI 10.1203/01.pdr.0000233037.00707.da; Savas PS, 2004, MOL GENET METAB, V82, P273, DOI 10.1016/j.ymgme.2004.05.005; Settembre C, 2008, AUTOPHAGY, V4, P113, DOI 10.4161/auto.5227; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; SHELLEY WB, 1969, HISTOCHEMISTRY, V20, P244, DOI 10.1007/BF00306012; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; WASTESON A, 1971, J CHROMATOGR, V59, P87, DOI 10.1016/S0021-9673(01)80009-1; Wegrzyn A, 2012, IUBMB LIFE, V64, P307, DOI 10.1002/iub.1007; Wraith JE, 2009, INT J CLIN PHARM TH, V47, pS63; YANAGISHITA M, 1984, J BIOL CHEM, V259, P270; Zak BM, 2011, BONE, V48, P979, DOI 10.1016/j.bone.2011.02.001	47	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36283	36290		10.1074/jbc.M112.403360	http://dx.doi.org/10.1074/jbc.M112.403360			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22952226	Green Published, hybrid			2022-12-28	WOS:000310364000049
J	Lindsey-Boltz, LA; Reardon, JT; Wold, MS; Sancar, A				Lindsey-Boltz, Laura A.; Reardon, Joyce T.; Wold, Marc S.; Sancar, Aziz			In Vitro Analysis of the Role of Replication Protein A (RPA) and RPA Phosphorylation in ATR-mediated Checkpoint Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE CHECKPOINT; ATAXIA-TELANGIECTASIA; EXCISION NUCLEASE; BINDING PROTEIN; BASIC CLEFT; REPAIR; KINASE; DOMAIN; RECONSTITUTION; ACTIVATION	Replication protein A (RPA) plays essential roles in DNA metabolism, including replication, checkpoint, and repair. Recently, wedescribed an in vitro system in which the phosphorylation of human Chk1 kinase by ATR (ataxia telangiectasia mutated and Rad3-related) is dependent on RPA bound to single-stranded DNA. Here, we report that phosphorylation of other ATR targets, p53 and Rad17, has the same requirements and that RPA is also phosphorylated in this system. At high p53 or Rad17 concentrations, RPAphosphorylation is inhibited and, in this system, RPA with phosphomimetic mutations cannot support ATR kinase function, whereas a non-phosphorylatable RPA mutant exhibits full activity. Phosphorylation of these ATR substrates depends on the recruitment of ATR and the substrates by RPA to the RPA-ssDNA complex. Finally, mutant RPAs lacking checkpoint function exhibit essentially normal activity in nucleotide excision repair, revealing RPA separation of function for checkpoint and excision repair.	[Lindsey-Boltz, Laura A.; Reardon, Joyce T.; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Wold, Marc S.] Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Iowa	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, CB 7260, Chapel Hill, NC 27599 USA.	Aziz_Sancar@med.unc.edu	Lindsey-Boltz, Laura/A-3121-2010	Lindsey-Boltz, Laura/0000-0001-6493-8194; Wold, Marc/0000-0002-4580-1624	National Institutes of Health [GM32833, GM44721]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044721, R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM32833 (to A.S.) and GM44721 (to M.S.W.).	Abramova NA, 1997, P NATL ACAD SCI USA, V94, P7186, DOI 10.1073/pnas.94.14.7186; Anantha RW, 2007, J BIOL CHEM, V282, P35910, DOI 10.1074/jbc.M704645200; Anantha RW, 2008, P NATL ACAD SCI USA, V105, P12903, DOI 10.1073/pnas.0803001105; Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Barr SM, 2003, CURR BIOL, V13, P1047, DOI 10.1016/S0960-9822(03)00376-2; Bessho T, 1997, J BIOL CHEM, V272, P3833, DOI 10.1074/jbc.272.6.3833; Binz SK, 2008, J BIOL CHEM, V283, P21559, DOI 10.1074/jbc.M802450200; Binz SK, 2003, J BIOL CHEM, V278, P35584, DOI 10.1074/jbc.M305388200; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; CARTY MP, 1994, EMBO J, V13, P2114, DOI 10.1002/j.1460-2075.1994.tb06487.x; Chang MS, 1999, J BIOL CHEM, V274, P36544, DOI 10.1074/jbc.274.51.36544; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Choi JH, 2009, METHODS, V48, P3, DOI 10.1016/j.ymeth.2009.02.006; Choi JH, 2009, NUCLEIC ACIDS RES, V37, P1501, DOI 10.1093/nar/gkn1075; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; de Laat WL, 1998, GENE DEV, V12, P2598, DOI 10.1101/gad.12.16.2598; DUTTA A, 1993, NATURE, V365, P79, DOI 10.1038/365079a0; DUTTA A, 1992, EMBO J, V11, P2189, DOI 10.1002/j.1460-2075.1992.tb05278.x; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Fisher LA, 2011, J MOL BIOL, V413, P337, DOI 10.1016/j.jmb.2011.08.034; FOTEDAR R, 1992, EMBO J, V11, P2177, DOI 10.1002/j.1460-2075.1992.tb05277.x; Furuya K, 2010, MOL CELL, V40, P606, DOI 10.1016/j.molcel.2010.10.026; Guo SL, 2006, J BIOL CHEM, V281, P21607, DOI 10.1074/jbc.M603504200; Haring SJ, 2008, J BIOL CHEM, V283, P19095, DOI 10.1074/jbc.M800881200; Hass CS, 2010, MOL CANCER RES, V8, P1017, DOI 10.1158/1541-7786.MCR-10-0161; HE ZG, 1995, NATURE, V374, P566, DOI 10.1038/374566a0; HE ZG, 1993, CELL, V73, P1223, DOI 10.1016/0092-8674(93)90650-F; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Jacobs DM, 1999, J BIOMOL NMR, V14, P321, DOI 10.1023/A:1008373009786; Kang TH, 2010, P NATL ACAD SCI USA, V107, P4890, DOI 10.1073/pnas.0915085107; Kim HS, 2001, MOL CELL BIOL, V21, P3725, DOI 10.1128/MCB.21.11.3725-3737.2001; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lindsey-Boltz LA, 2011, J BIOL CHEM, V286, P19229, DOI 10.1074/jbc.M111.237958; Lindsey-Boltz LA, 2009, J BIOL CHEM, V284, P33107, DOI 10.1074/jbc.M109.064485; Liu JS, 2006, DNA REPAIR, V5, P369, DOI 10.1016/j.dnarep.2005.11.007; LIU VF, 1993, MOL CELL BIOL, V13, P7222, DOI 10.1128/MCB.13.12.7222; Majka J, 2006, J BIOL CHEM, V281, P27855, DOI 10.1074/jbc.M605176200; Matsunaga T, 1996, J BIOL CHEM, V271, P11047, DOI 10.1074/jbc.271.19.11047; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Namiki Y, 2006, P NATL ACAD SCI USA, V103, P580, DOI 10.1073/pnas.0510223103; Oakley GG, 2003, BIOCHEMISTRY-US, V42, P3255, DOI 10.1021/bi026377u; Oakley GG, 2010, FRONT BIOSCI-LANDMRK, V15, P883, DOI 10.2741/3652; Oakley GG, 2009, BIOCHEMISTRY-US, V48, P7473, DOI 10.1021/bi900694p; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; PAN ZQ, 1995, P NATL ACAD SCI USA, V92, P4636, DOI 10.1073/pnas.92.10.4636; Patrick SM, 2005, BIOCHEMISTRY-US, V44, P8438, DOI 10.1021/bi048057b; Reardon JT, 2006, METHOD ENZYMOL, V408, P189, DOI 10.1016/S0076-6879(06)08012-8; SALAHUDDIN, 1990, GENE DEV, V4, P968, DOI 10.1101/gad.4.6.968; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Umezu K, 1998, GENETICS, V148, P989; Unsal-Kacmaz K, 2004, MOL CELL BIOL, V24, P1292, DOI 10.1128/MCB.24.3.1292-1300.2003; Vassin VM, 2009, J CELL SCI, V122, P4070, DOI 10.1242/jcs.053702; Vassin VM, 2004, MOL CELL BIOL, V24, P1930, DOI 10.1128/MCB.24.5.1930-1943.2004; Wang YX, 2005, NAT GENET, V37, P750, DOI 10.1038/ng1587; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wu XM, 2005, ONCOGENE, V24, P4728, DOI 10.1038/sj.onc.1208674; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	62	19	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36123	36131		10.1074/jbc.M112.407825	http://dx.doi.org/10.1074/jbc.M112.407825			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22948311	Green Published, hybrid			2022-12-28	WOS:000310364000034
J	Goyal, A; Poluzzi, C; Willis, CD; Smythies, J; Shellard, A; Neill, T; Iozzo, RV				Goyal, Atul; Poluzzi, Chiara; Willis, Chris D.; Smythies, James; Shellard, Adam; Neill, Thomas; Iozzo, Renato V.			Endorepellin Affects Angiogenesis by Antagonizing Diverse Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)-evoked Signaling Pathways TRANSCRIPTIONAL REPRESSION OF HYPOXIA-INDUCIBLE FACTOR 1 alpha AND VEGFA AND CONCURRENT INHIBITION OF NUCLEAR FACTOR OF ACTIVATED T CELL 1 (NFAT1) ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; BASEMENT-MEMBRANE PROTEOGLYCANS; COLON CARCINOMA-CELLS; PERLECAN PROTEIN CORE; CANCER GROWTH; TUMOR-GROWTH; ALPHA-2-BETA-1 INTEGRIN; ANGIOSTATIC ACTIVITY; VEGF RECEPTOR-2; DOMAIN-III	Endorepellin, the angiostatic C-terminal domain of the heparan sulfate proteoglycan perlecan, inhibits angiogenesis by simultaneously binding to the alpha 2 beta 1 integrin and the vascular endothelial growth factor (VEGF) receptor 2 (VEGFR2) on endothelial cells. This interaction triggers the down-regulation of both receptors and the concurrent activation of the tyrosine phosphatase SHP-1, which leads to a signaling cascade resulting in angiostasis. Here, we provide evidence that endorepellin is capable of attenuating both the PI3K/PDK1/Akt/mTOR and the PKC/JNK/AP1 pathways. We show that hypoxia-inducible factor 1 alpha (HIF-1 alpha) transcriptional activity induced by VEGFA was inhibited by endorepellin independent of oxygen concentration and that only a combination of both PI3K and calcineurin inhibitors completely blocked the suppressive activity evoked by endorepellin on HIF1A and VEGFA promoter activity. Moreover, endorepellin inhibited the PKC/JNK/AP1 axis induced by the recruitment of phospholipase gamma and attenuated the VEGFA-induced activation of NFAT1, a process dependent on calcineurin activity. Finally, endorepellin inhibited VEGFA-evoked nuclear translocation of NFAT1 and promoted NFAT1 stability. Thus, we provide evidence for a novel downstream signaling axis for an angiostatic fragment and for the key components involved in the dual antagonistic activity of endorepellin, highlighting its potential use as a therapeutic agent.	[Iozzo, Renato V.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Kimmel Canc Ctr, Canc Cell Biol & Signaling Program, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Iozzo, RV (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Pathol Anat & Cell Biol, 1020 Locust St,Suite 336 JAH, Philadelphia, PA 19107 USA.	iozzo@kimmelcancercenter.org	Iozzo, Renato/AAS-1980-2020; Poluzzi, Chiara/T-3376-2019	Shellard, Adam/0000-0002-7609-9049; Willis, Chris/0000-0002-6639-6568; Iozzo, Renato/0000-0002-5908-5112	National Institutes of Health [R01 CA39481, R01 CA47282, R01 CA120975]; National Institutes of Health Training Grant [T32 AR060715, T32 AA07463]; NATIONAL CANCER INSTITUTE [R01CA047282, R01CA120975, R01CA039481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR060715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA39481, R01 CA47282, and R01 CA120975 (to R.V.I.).; Supported by National Institutes of Health Training Grant T32 AR060715.; Supported by National Institutes of Health Training Grant T32 AA07463.	Aviezer D, 1997, MOL CELL BIOL, V17, P1938, DOI 10.1128/MCB.17.4.1938; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bix G, 2005, TRENDS CELL BIOL, V15, P52, DOI 10.1016/j.tcb.2004.11.008; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; Bix G, 2008, MICROSC RES TECHNIQ, V71, P339, DOI 10.1002/jemt.20562; Bix G, 2007, BLOOD, V109, P3745, DOI 10.1182/blood-2006-08-039925; Bix G, 2006, J NATL CANCER I, V98, P1634, DOI 10.1093/jnci/djj441; Buraschi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045559; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Cailhier JF, 2008, J BIOL CHEM, V283, P27220, DOI 10.1074/jbc.M801164200; CARSON DD, 1993, DEV BIOL, V155, P97, DOI 10.1006/dbio.1993.1010; Chuang CY, 2010, BIOCHEMISTRY-US, V49, P5524, DOI 10.1021/bi1005199; COHEN IR, 1993, P NATL ACAD SCI USA, V90, P10404, DOI 10.1073/pnas.90.21.10404; COHEN IR, 1994, CANCER RES, V54, P5771; Contois L, 2009, SEMIN CANCER BIOL, V19, P318, DOI 10.1016/j.semcancer.2009.05.002; Costell M, 2002, CIRC RES, V91, P158, DOI 10.1161/01.RES.0000026056.81424.DA; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; COUCHMAN JR, 1989, MATRIX, V9, P311, DOI 10.1016/S0934-8832(89)80007-1; COUCHMAN JR, 1995, J HISTOCHEM CYTOCHEM, V43, P955, DOI 10.1177/43.9.7543915; Datta S, 2006, INT J BIOCHEM CELL B, V38, P1855, DOI 10.1016/j.biocel.2006.03.022; Farach-Carson MC, 2007, GLYCOBIOLOGY, V17, P897, DOI 10.1093/glycob/cwm043; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fong TAT, 1999, CANCER RES, V59, P99; Fuki IV, 2000, J BIOL CHEM, V275, P25742, DOI 10.1074/jbc.M909173199; Gonzalez EM, 2005, J BIOL CHEM, V280, P7080, DOI 10.1074/jbc.M409841200; Gonzalez EM, 2003, J BIOL CHEM, V278, P38113, DOI 10.1074/jbc.C300310200; Goyal A, 2011, J BIOL CHEM, V286, P25947, DOI 10.1074/jbc.M111.243626; Handler M, 1997, DEV DYNAM, V210, P130, DOI 10.1002/(SICI)1097-0177(199710)210:2<130::AID-AJA6>3.0.CO;2-H; HASSELL JR, 1980, P NATL ACAD SCI-BIOL, V77, P4494, DOI 10.1073/pnas.77.8.4494; HASSELL JR, 1985, J BIOL CHEM, V260, P8098; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; Iozzo RV, 2011, J BIOL CHEM, V286, P34712, DOI 10.1074/jbc.M111.262766; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Iozzo RV, 2009, MOL CELLS, V27, P503, DOI 10.1007/s10059-009-0069-0; IOZZO RV, 1987, J BIOL CHEM, V262, P1888; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; IOZZO RV, 1994, BIOCHEM J, V302, P625, DOI 10.1042/bj3020625; IOZZO RV, 1989, ARCH BIOCHEM BIOPHYS, V269, P239, DOI 10.1016/0003-9861(89)90105-7; Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738; IOZZO RV, 1994, MATRIX BIOL, V14, P203, DOI 10.1016/0945-053X(94)90183-X; Iozzo RV, 1997, J BIOL CHEM, V272, P5219, DOI 10.1074/jbc.272.8.5219; IOZZO RV, 1984, J CELL BIOL, V99, P403, DOI 10.1083/jcb.99.2.403; Jiang XN, 2003, J HISTOCHEM CYTOCHEM, V51, P1393, DOI 10.1177/002215540305101101; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Knox S, 2002, J BIOL CHEM, V277, P14657, DOI 10.1074/jbc.M111826200; Knox SM, 2006, CELL MOL LIFE SCI, V63, P2435, DOI 10.1007/s00018-006-6162-z; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Laplante P, 2006, J BIOL CHEM, V281, P30383, DOI 10.1074/jbc.M606412200; Lee SJ, 2010, LAB INVEST, V90, P374, DOI 10.1038/labinvest.2009.136; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu YV, 2007, J BIOL CHEM, V282, P37064, DOI 10.1074/jbc.M705015200; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; Molinaro P, 2011, J NEUROSCI, V31, P7312, DOI 10.1523/JNEUROSCI.6296-10.2011; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Mongiat M, 2001, J BIOL CHEM, V276, P10263, DOI 10.1074/jbc.M011493200; Mongiat M, 2000, J BIOL CHEM, V275, P7095, DOI 10.1074/jbc.275.10.7095; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Mukhopadhyay D, 1997, MOL CELL BIOL, V17, P5629, DOI 10.1128/MCB.17.9.5629; MURDOCH AD, 1994, J HISTOCHEM CYTOCHEM, V42, P239, DOI 10.1177/42.2.7507142; MURDOCH AD, 1993, VIRCHOWS ARCH A, V423, P237, DOI 10.1007/BF01606885; Niu GL, 2008, MOL CANCER RES, V6, P1099, DOI 10.1158/1541-7786.MCR-07-2177; Nugent MA, 2000, INT J BIOCHEM CELL B, V32, P115, DOI 10.1016/S1357-2725(99)00123-5; Nugent MA, 2000, P NATL ACAD SCI USA, V97, P6722, DOI 10.1073/pnas.97.12.6722; Nystrom A, 2009, BLOOD, V114, P4897, DOI 10.1182/blood-2009-02-207134; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Papo N, 2011, P NATL ACAD SCI USA, V108, P14067, DOI 10.1073/pnas.1016635108; Patel VN, 2007, DEVELOPMENT, V134, P4177, DOI 10.1242/dev.011171; Rauch J, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-23; Reiland J, 2004, J BIOL CHEM, V279, P8047, DOI 10.1074/jbc.M304872200; Roehrl MHA, 2004, P NATL ACAD SCI USA, V101, P7554, DOI 10.1073/pnas.0401835101; RYYNANEN M, 1992, J CLIN INVEST, V89, P974, DOI 10.1172/JCI115680; Sai JQ, 2008, J BIOL CHEM, V283, P26538, DOI 10.1074/jbc.M805611200; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; San Antonio JD, 2009, AM J PATHOL, V175, P1338, DOI 10.2353/ajpath.2009.090234; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sharma B, 1998, J BIOL CHEM, V273, P4642, DOI 10.1074/jbc.273.8.4642; Sharma B, 1998, J CLIN INVEST, V102, P1599, DOI 10.1172/JCI3793; Sher I, 2006, J BIOL CHEM, V281, P5178, DOI 10.1074/jbc.M509500200; Sweeney SM, 2003, J BIOL CHEM, V278, P30516, DOI 10.1074/jbc.M304237200; Szeto GL, 2011, J BIOL CHEM, V286, P11275, DOI 10.1074/jbc.M110.210518; Thadikkaran L, 2005, CLIN CHIM ACTA, V360, P27, DOI 10.1016/j.cccn.2005.04.018; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Tvorogov D, 2010, CANCER CELL, V18, P630, DOI 10.1016/j.ccr.2010.11.001; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; Whitelock JM, 1999, MATRIX BIOL, V18, P163, DOI 10.1016/S0945-053X(99)00014-1; Whitelock JM, 2008, BIOCHEMISTRY-US, V47, P11174, DOI 10.1021/bi8013938; Woodall BP, 2008, J BIOL CHEM, V283, P2335, DOI 10.1074/jbc.M708364200; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006; YURCHENCO PD, 1987, J BIOL CHEM, V262, P17668; Zhang XF, 2009, FASEB J, V23, P3368, DOI 10.1096/fj.09-131649; Zoeller JJ, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-7; Zoeller JJ, 2008, J CELL BIOL, V181, P381, DOI 10.1083/jcb.200708022; Zoeller JJ, 2009, MATRIX BIOL, V28, P284, DOI 10.1016/j.matbio.2009.04.010	98	56	58	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43543	43556		10.1074/jbc.M112.401786	http://dx.doi.org/10.1074/jbc.M112.401786			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23060442	hybrid, Green Published			2022-12-28	WOS:000312940800035
J	Kasiappan, R; Shen, Z; Tse, AKW; Jinwal, U; Tang, JF; Lungchukiet, P; Sun, YF; Kruk, P; Nicosia, SV; Zhang, XH; Bai, WL				Kasiappan, Ravi; Shen, Zheng; Tse, Anfernee K-W; Jinwal, Umesh; Tang, Jinfu; Lungchukiet, Panida; Sun, Yuefeng; Kruk, Patricia; Nicosia, Santo V.; Zhang, Xiaohong; Bai, Wenlong			1,25-Dihydroxyvitamin D3 Suppresses Telomerase Expression and Human Cancer Growth through MicroRNA-498	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; HUMAN OVARIAN-CANCER; DOWN-REGULATION; MAMMALIAN-CELLS; PROSTATE-CANCER; GENE-EXPRESSION; HTERT GENE; MECHANISMS; PROTEIN; D-3	Telomerase is an essential enzyme that counteracts the telomere attrition accompanying DNA replication during cell division. Regulation of the promoter activity of the gene encoding its catalytic subunit, the telomerase reverse transcriptase, is established as the dominant mechanism conferring the high telomerase activity in proliferating cells, such as embryonic stem and cancer cells. This study reveals a new mechanism of telomerase regulation through non-coding small RNA by showing that microRNA-498 (miR-498) induced by 1,25-dihydroxyvitamin D3 (1,25(OH)(2)D-3) decreases the mRNA expression of the human telomerase reverse transcriptase. MiR-498 was first identified in a microarray analysis as the most induced microRNA by 1,25(OH)(2)D-3 in ovarian cancer cells and subsequently validated by quantitative polymerase chain reaction assays in multiple human cancer types. A functional vitamin D response element was defined in the 5-prime regulatory region of the miR-498 genome, which is occupied by the vitamin D receptor and its coactivators. Further studies showed that miR-498 targeted the 3-prime untranslated region of human telomerase reverse transcriptase mRNA and decreased its expression. The levels of miR-498 expression were decreased in malignant human ovarian tumors as well as human ovarian cancer cell lines. The ability of 1,25(OH)(2)D-3 to decrease human telomerase reverse transcriptase mRNA and to suppress ovarian cancer growth was compromised when miR-498 was depleted using the sponges in cell lines and mouse tumor models. Taken together, our studies define a novel mechanism of telomerase regulation by small non-coding RNAs and identify miR-498 as an important mediator for the anti-tumor activity of 1,25(OH)(2)D-3.	[Kasiappan, Ravi; Shen, Zheng; Tse, Anfernee K-W; Jinwal, Umesh; Tang, Jinfu; Lungchukiet, Panida; Sun, Yuefeng; Kruk, Patricia; Nicosia, Santo V.; Zhang, Xiaohong; Bai, Wenlong] Univ S Florida, Coll Med, Dept Pathol & Cell Biol, Tampa, FL 33612 USA; [Kruk, Patricia; Nicosia, Santo V.; Zhang, Xiaohong; Bai, Wenlong] Univ S Florida, Coll Med, Dept Oncol Sci, Tampa, FL 33612 USA; [Zhang, Xiaohong; Bai, Wenlong] H Lee Moffitt Canc Ctr & Res Inst, Program Mol Oncol, Tampa, FL 33612 USA; [Nicosia, Santo V.] H Lee Moffitt Canc Ctr & Res Inst, Program Expt Therapeut, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Bai, WL (corresponding author), Univ S Florida, Coll Med, Dept Pathol & Cell Biol, 12901 Bruce B Downs Blvd,MDC 64, Tampa, FL 33612 USA.	wbai@health.usf.edu	Bai, Wenlong/A-8977-2013	Bai, Wenlong/0000-0002-9536-0556; Kasiappan, Ravi/0000-0002-5351-9098; Tse, Kai Wing/0000-0002-0046-9808; Sun, Yuefeng/0000-0003-4578-856X	National Institutes of Health [CA111334, CA93666]; United States Department of Defense [BC085205]; Ovarian Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA093666, P30CA076292, R01CA111334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); Ovarian Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA111334 and CA93666 (Public Health Service). This work was also supported by an idea grant from Breast Cancer Research Program of the United States Department of Defense Grant BC085205 and a program development grant from Ovarian Cancer Research Fund.	AMFO K, 1995, ONCOGENE, V11, P351; BAKER AR, 1988, P NATL ACAD SCI USA, V85, P3294, DOI 10.1073/pnas.85.10.3294; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bicher A, 1997, GYNECOL ONCOL, V66, P36, DOI 10.1006/gyno.1997.4709; Bieche I, 2000, CLIN CANCER RES, V6, P452; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; BLASCO MA, 1995, SCIENCE, V269, P1267, DOI 10.1126/science.7544492; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Deng S, 2008, CELL CYCLE, V7, P2643, DOI 10.4161/cc.7.17.6597; Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Garland CF, 2006, AM J PUBLIC HEALTH, V96, P252, DOI 10.2105/AJPH.2004.045260; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hammond SM, 2007, NAT GENET, V39, P582, DOI 10.1038/ng0507-582; Harrington L, 1997, SCIENCE, V275, P973, DOI 10.1126/science.275.5302.973; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jiang F, 2004, J BIOL CHEM, V279, P53213, DOI 10.1074/jbc.M410395200; Jiang F, 2003, J BIOL CHEM, V278, P48030, DOI 10.1074/jbc.M308430200; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li PF, 2004, J BIOL CHEM, V279, P25260, DOI 10.1074/jbc.M311052200; Li PF, 2003, MOL CELL BIOL, V23, P104, DOI 10.1128/MCB.23.1.104-118.2003; Liu KB, 2001, J IMMUNOL, V166, P4826, DOI 10.4049/jimmunol.166.8.4826; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; MORRISON NA, 1989, SCIENCE, V246, P1158, DOI 10.1126/science.2588000; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; NODA M, 1990, P NATL ACAD SCI USA, V87, P9995, DOI 10.1073/pnas.87.24.9995; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Shen Z, 2011, MOL CELL ENDOCRINOL, V338, P58, DOI 10.1016/j.mce.2011.02.023; Smith LL, 2003, NAT CELL BIOL, V5, P474, DOI 10.1038/ncb985; Sun PM, 2007, EUR J OBSTET GYN R B, V130, P249, DOI 10.1016/j.ejogrb.2006.01.028; Toell A, 2000, BIOCHEM J, V352, P301, DOI 10.1042/0264-6021:3520301; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Valastyan S, 2009, RNA BIOL, V6, P541, DOI 10.4161/rna.6.5.10081; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Wang SW, 2003, J BIOL CHEM, V278, P18842, DOI 10.1074/jbc.M209544200; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Xie CQ, 2009, MOL ENDOCRINOL, V23, P724, DOI 10.1210/me.2008-0465; Yamamoto H, 2003, J BIOL CHEM, V278, P31756, DOI 10.1074/jbc.M304737200; Zhang XH, 2005, CLIN CANCER RES, V11, P323; Zhang XH, 2006, CURR CANCER DRUG TAR, V6, P229, DOI 10.2174/156800906776842939; Zou AH, 1997, J BIOL CHEM, V272, P19027, DOI 10.1074/jbc.272.30.19027	57	91	92	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41297	41309		10.1074/jbc.M112.407189	http://dx.doi.org/10.1074/jbc.M112.407189			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23055531	hybrid, Green Published			2022-12-28	WOS:000311887600044
J	Samuel, CE				Samuel, Charles E.			Introduction to Thematic Minireview Series: Understanding Human Immunodeficiency Virus-Host Interactions at the Biochemical Level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Samuel, CE (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	samuel@lifesci.ucsb.edu			NIAID NIH HHS [R01 AI012520, AI-20611, R37 AI012520, AI-12520, R01 AI020611] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI012520, R01AI012520, R01AI020611] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Blumenthal R, 2012, J BIOL CHEM, V287, P40841, DOI 10.1074/jbc.R112.406272; Harris RS, 2012, J BIOL CHEM, V287, P40875, DOI 10.1074/jbc.R112.416925; Klase Z, 2012, J BIOL CHEM, V287, P40884, DOI 10.1074/jbc.R112.415448; Knipe DM, 2007, FIELDS VIROLOGY; Krishnan L, 2012, J BIOL CHEM, V287, P40858, DOI 10.1074/jbc.R112.397760; Le Grice SFJ, 2012, J BIOL CHEM, V287, P40850, DOI 10.1074/jbc.R112.389056; Lee SK, 2012, J BIOL CHEM, V287, P40867, DOI 10.1074/jbc.R112.399444; Samuel CE, 2006, J BIOL CHEM, V281, P8305, DOI 10.1074/jbc.R500032200	8	2	2	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					40838	40840		10.1074/jbc.R112.422436	http://dx.doi.org/10.1074/jbc.R112.422436			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23043103	hybrid, Green Published			2022-12-28	WOS:000311887600001
J	Yao, JJ; Gao, XF; Chow, CW; Zhan, XQ; Hu, CL; Mei, YA				Yao, Jin-Jing; Gao, Xiao-Fei; Chow, Chi-Wing; Zhan, Xiao-Qin; Hu, Chang-Long; Mei, Yan-Ai			Neuritin Activates Insulin Receptor Pathway to Up-regulate Kv4.2-mediated Transient Outward K+ Current in Rat Cerebellar Granule Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-IODOMELATONIN PREVENTS APOPTOSIS; IN-VIVO; TRANSLATIONAL CONTROL; POTASSIUM CHANNEL; PAIN HYPERSENSITIVITY; SYNAPTIC PLASTICITY; SIGNALING PATHWAYS; INFLAMMATORY PAIN; NERVOUS-SYSTEM; SPINAL NEURONS	Neuritin is a new neurotrophic factor discovered in a screen to identify genes involved in activity-dependent synaptic plasticity. Neuritin also plays multiple roles in the process of neural development and synaptic plasticity. The receptors for binding neuritin and its downstream signaling effectors, however, remain unclear. Here, we report that neuritin specifically increases the densities of transient outward K+ currents (I-A) in rat cerebellar granule neurons (CGNs) in a time-and concentration-dependent manner. Neuritin-induced amplification of I-A is mediated by increased mRNA and protein expression of Kv4.2, the main alpha-subunit of I-A. Exposure of CGNs to neuritin markedly induces phosphorylation of ERK (pERK), Akt (pAkt), and mammalian target of rapamycin (pmTOR). Neuritin-induced I-A and increased expression of Kv4.2 are attenuated by ERK, Akt, or mTOR inhibitors. Unexpectedly, pharmacological blockade of insulin receptor, but not the insulin-like growth factor 1 receptor, abrogates the effect of neuritin on I-A amplification and Kv4.2 induction. Indeed, neuritin activates downstream signaling effectors of the insulin receptor in CGNs and HeLa. Our data reveal, for the first time, an unanticipated role of the insulin receptor in previously unrecognized neuritin-mediated signaling.	[Yao, Jin-Jing; Gao, Xiao-Fei; Zhan, Xiao-Qin; Hu, Chang-Long; Mei, Yan-Ai] Fudan Univ, Sch Life Sci, Inst Brain Sci, Shanghai 200433, Peoples R China; [Yao, Jin-Jing; Gao, Xiao-Fei; Zhan, Xiao-Qin; Hu, Chang-Long; Mei, Yan-Ai] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Chow, Chi-Wing] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Fudan University; Fudan University; Yeshiva University; Albert Einstein College of Medicine	Mei, YA (corresponding author), Fudan Univ, Sch Life Sci, Inst Brain Sci, 220 Handan Rd, Shanghai 200433, Peoples R China.	yamei@fudan.edu.cn	Hu, Changlong/AAQ-8348-2020	Hu, Changlong/0000-0002-8609-8947	National Natural Science Foundation of China [NSFC 31070745]; Shanghai Leading Academic Discipline Project [B111]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090481] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Natural Science Foundation of China Grant NSFC 31070745 and the Shanghai Leading Academic Discipline Project B111.	Akten B, 2011, P NATL ACAD SCI USA, V108, P10337, DOI 10.1073/pnas.1104928108; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Avruch J, 2005, CURR OPIN CLIN NUTR, V8, P67, DOI 10.1097/00075197-200501000-00010; Bernard C, 2004, SCIENCE, V305, P532, DOI 10.1126/science.1097065; Cantallops I, 2000, NAT NEUROSCI, V3, P1004, DOI 10.1038/79823; Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014; Chiu SL, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-7; DOURADO MM, 1994, J PHYSIOL-LONDON, V474, P367, DOI 10.1113/jphysiol.1994.sp020029; Fujino T, 2008, J COMP NEUROL, V507, P1831, DOI 10.1002/cne.21649; Harwell C, 2005, J NEUROBIOL, V65, P85, DOI 10.1002/neu.20176; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Hu CL, 2008, J NEUROCHEM, V106, P1125, DOI 10.1111/j.1471-4159.2008.05449.x; Hu CL, 2005, J PINEAL RES, V38, P53, DOI 10.1111/j.1600-079X.2004.00174.x; Hu HJ, 2007, J NEUROSCI, V27, P13181, DOI 10.1523/JNEUROSCI.0269-07.2007; Javaherian A, 2005, NEURON, V45, P505, DOI 10.1016/j.neuron.2004.12.051; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Ji RR, 2002, J NEUROSCI, V22, P478, DOI 10.1523/JNEUROSCI.22-02-00478.2002; Jiao S, 2004, J PINEAL RES, V36, P109, DOI 10.1046/j.1600-079X.2003.00104.x; Karamoysoyli E, 2008, DIABETES, V57, P181, DOI 10.2337/db07-0895; Karim F, 2001, J NEUROSCI, V21, P3771, DOI 10.1523/JNEUROSCI.21-11-03771.2001; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Liu LY, 2007, J NEUROCHEM, V102, P333, DOI 10.1111/j.1471-4159.2007.04669.x; Liu LY, 2005, NEUROPHARMACOLOGY, V48, P918, DOI 10.1016/j.neuropharm.2004.12.020; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mathie A, 2003, CEREBELLUM, V2, P11, DOI 10.1080/14734220310015593; Mei YA, 2004, EUR J NEUROSCI, V19, P1446, DOI 10.1111/j.1460-9568.2004.03227.x; Mei YA, 2000, BRAIN RES, V873, P46, DOI 10.1016/S0006-8993(00)02469-0; Naeve GS, 1997, P NATL ACAD SCI USA, V94, P2648, DOI 10.1073/pnas.94.6.2648; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; Parsons RG, 2006, J NEUROSCI, V26, P12977, DOI 10.1523/JNEUROSCI.4209-06.2006; Plant LD, 2006, NEUROBIOL AGING, V27, P1673, DOI 10.1016/j.neurobiolaging.2005.09.038; Putz U, 2005, NAT NEUROSCI, V8, P322, DOI 10.1038/nn1407; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Schrader LA, 2006, AM J PHYSIOL-CELL PH, V290, pC852, DOI 10.1152/ajpcell.00358.2005; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; Shibasaki K, 2004, J NEUROCHEM, V89, P897, DOI 10.1111/j.1471-4159.2004.02368.x; Shibata R, 2000, J NEUROSCI, V20, P4145; Shibata R, 1999, DEV NEUROSCI-BASEL, V21, P87, DOI 10.1159/000017370; Song WJ, 1998, J NEUROSCI, V18, P3124; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Swiech L, 2008, BBA-PROTEINS PROTEOM, V1784, P116, DOI 10.1016/j.bbapap.2007.08.015; Tkatch T, 2000, J NEUROSCI, V20, P579, DOI 10.1523/JNEUROSCI.20-02-00579.2000; Vaudry D, 2003, SCIENCE, V300, P1532, DOI 10.1126/science.1085260; Wang LJ, 2000, AM J PHYSIOL-HEART C, V278, pH1056, DOI 10.1152/ajpheart.2000.278.4.H1056; Wibrand K, 2006, EUR J NEUROSCI, V23, P1501, DOI 10.1111/j.1460-9568.2006.04687.x; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1; Wolff M, 1998, J PHYSIOL-LONDON, V509, P767, DOI 10.1111/j.1469-7793.1998.767bm.x; Xie F, 2004, J NEUROCHEM, V90, P1521, DOI 10.1111/j.1471-4159.2004.02685.x; Yang F, 2001, NAT NEUROSCI, V4, P1071, DOI 10.1038/nn734; Yang TTC, 2003, J BIOL CHEM, V278, P15874, DOI 10.1074/jbc.M211560200; Zhang YM, 2012, J BIOL CHEM, V287, P18562, DOI 10.1074/jbc.M111.322271; Zhuang JL, 2012, J CELL PHYSIOL, V227, P297, DOI 10.1002/jcp.22735	56	37	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41534	41545		10.1074/jbc.M112.390260	http://dx.doi.org/10.1074/jbc.M112.390260			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23066017	Green Published, hybrid			2022-12-28	WOS:000311887600063
J	Coelho, C; Mahro, M; Trincao, J; Carvalho, ATP; Ramos, MJ; Terao, M; Garattini, E; Leimkuhler, S; Romao, MJ				Coelho, Catarina; Mahro, Martin; Trincao, Jose; Carvalho, Alexandra T. P.; Ramos, Maria Joao; Terao, Mineko; Garattini, Enrico; Leimkuehler, Silke; Romao, Maria Joao			The First Mammalian Aldehyde Oxidase Crystal Structure INSIGHTS INTO SUBSTRATE SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; XANTHINE-OXIDASE; MOLYBDO-FLAVOENZYMES; GENE-CLUSTER; ACTIVE-SITE; OXIDOREDUCTASE; DEHYDROGENASE; MECHANISM; PURIFICATION; INHIBITION	Aldehyde oxidases (AOXs) are homodimeric proteins belonging to the xanthine oxidase family of molybdenum-containing enzymes. Each 150-kDa monomer contains a FAD redox cofactor, two spectroscopically distinct [2Fe-2S] clusters, and a molybdenum cofactor located within the protein active site. AOXs are characterized by broad range substrate specificity, oxidizing different aldehydes and aromatic N-heterocycles. Despite increasing recognition of its role in the metabolism of drugs and xenobiotics, the physiological function of the protein is still largely unknown. We have crystallized and solved the crystal structure of mouse liver aldehyde oxidase 3 to 2.9 angstrom. This is the first mammalian AOX whose structure has been solved. The structure provides important insights into the protein active center and further evidence on the catalytic differences characterizing AOX and xanthine oxidoreductase. The mouse liver aldehyde oxidase 3 three-dimensional structure combined with kinetic, mutagenesis data, molecular docking, and molecular dynamics studies make a decisive contribution to understand the molecular basis of its rather broad substrate specificity.	[Coelho, Catarina; Trincao, Jose; Romao, Maria Joao] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, Requimte, P-2829516 Caparica, Portugal; [Mahro, Martin; Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany; [Carvalho, Alexandra T. P.; Ramos, Maria Joao] Univ Porto, Fac Ciencias, Dept Quim & Bioquim, REQUIMTE, P-4169007 Oporto, Portugal; [Terao, Mineko; Garattini, Enrico] Ist Ric Farmacol Mario Negri, Mol Biol Lab, Dept Biochem & Mol Pharmacol, I-20156 Milan, Italy	Universidade Nova de Lisboa; University of Potsdam; Universidade do Porto; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Romao, MJ (corresponding author), Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, Requimte, P-2829516 Caparica, Portugal.	maria.romao@fct.unl.pt	terao, mineko/AAU-8089-2020; Romao, Maria J/A-4115-2013; Garattini, Enrico/AAI-1998-2019; Carvalho, Alexandra T. P./J-1192-2018; UCIBIO, U Cienc Biom Apl/F-7948-2017; Coelho, Catarina M C/D-2073-2013; Terao, Mineko/AAA-6415-2020; Ramos, Maria J/D-6183-2013	Romao, Maria J/0000-0002-3004-0543; Carvalho, Alexandra T. P./0000-0003-2827-5527; UCIBIO, U Cienc Biom Apl/0000-0002-3004-0543; Coelho, Catarina M C/0000-0003-1852-5406; Terao, Mineko/0000-0002-9976-9869; Ramos, Maria J/0000-0002-7554-8324; Leimkuhler, Silke/0000-0003-3238-2122; Garattini, Enrico/0000-0001-8983-886X	Portuguese Science and Technology Foundation (FCT-MCTES) [PTDC/BIA-PRO/118377/2010, SFRH/BD/37948/2007]; Deutsche Forschungsgemeinschaft; DAAD-GRICES; Associazione Italiana per la Ricerca controil Cancro(AIRC); Fondazione Italo Monzino; Negri-Weizmann Foundation; Fundação para a Ciência e a Tecnologia [PTDC/BIA-PRO/118377/2010] Funding Source: FCT	Portuguese Science and Technology Foundation (FCT-MCTES)(Portuguese Foundation for Science and Technology); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DAAD-GRICES(Deutscher Akademischer Austausch Dienst (DAAD)); Associazione Italiana per la Ricerca controil Cancro(AIRC)(Fondazione AIRC per la ricerca sul cancroEuropean Commission); Fondazione Italo Monzino; Negri-Weizmann Foundation; Fundação para a Ciência e a Tecnologia	This work was supported by the Portuguese Science and Technology Foundation (FCT-MCTES) through Project PTDC/BIA-PRO/118377/2010 and Grant SFRH/BD/37948/2007(to C. C.) and by the Cluster of Excellence "Unifying Concepts in Catalysis" (to S. L. and M. M.) coordinated by the Technische Universitat Berlin and funded by the Deutsche Forschungsgemeinschaft. The exchange of researchers among laboratories was funded by the DAAD-GRICES program (to M. J. R. and S. L.). The work was also supported by grants from the Associazione Italiana per la Ricerca controil Cancro(AIRC), the Fondazione Italo Monzino, and the Negri-Weizmann Foundation (to E. G.).	Afonine P., 2005, CCP4 NEWSLETTER, V42; Alfaro JF, 2008, J ORG CHEM, V73, P9469, DOI 10.1021/jo801053u; [Anonymous], PYMOL MOL GRAPH SYST; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barr JT, 2011, DRUG METAB DISPOS, V39, P2381, DOI 10.1124/dmd.111.041806; Calzi ML, 1995, J BIOL CHEM, V270, P31037, DOI 10.1074/jbc.270.52.31037; Cao HN, 2010, J BIOL CHEM, V285, P28044, DOI 10.1074/jbc.M110.128561; CORNISHB.A, 1974, BIOCHEM J, V137, P143, DOI 10.1042/bj1370143; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Dietzel U, 2009, J BIOL CHEM, V284, P8759, DOI 10.1074/jbc.M808114200; Eger BT, 2000, ACTA CRYSTALLOGR D, V56, P1656, DOI 10.1107/S0907444900012890; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; Garattini E, 2008, CELL MOL LIFE SCI, V65, P1019, DOI 10.1007/s00018-007-7398-y; Garattini E, 2003, BIOCHEM J, V372, P15, DOI 10.1042/BJ20030121; Garattini E, 2011, DRUG METAB REV, V43, P374, DOI 10.3109/03602532.2011.560606; Garattini Enrico, 2009, Human Genomics, V4, P119; GURTOO HL, 1971, J BIOL CHEM, V246, P286; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Ishikita H, 2012, J AM CHEM SOC, V134, P999, DOI 10.1021/ja207173p; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Koiwai H, 2000, J BIOCHEM-TOKYO, V127, P659, DOI 10.1093/oxfordjournals.jbchem.a022654; Kurosaki M, 2004, J BIOL CHEM, V279, P50482, DOI 10.1074/jbc.M408734200; Kuwabara Y, 2003, P NATL ACAD SCI USA, V100, P8170, DOI 10.1073/pnas.1431485100; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Mahro M, 2011, DRUG METAB DISPOS, V39, P1939, DOI 10.1124/dmd.111.040873; McManaman JL, 1996, ARCH BIOCHEM BIOPHYS, V332, P135, DOI 10.1006/abbi.1996.0325; MORIWAKI Y, 1993, BIOCHEM PHARMACOL, V46, P975, DOI 10.1016/0006-2952(93)90661-F; Nishino T, 2005, J BIOL CHEM, V280, P24888, DOI 10.1074/jbc.M501830200; Nishino T, 2008, FEBS J, V275, P3278, DOI 10.1111/j.1742-4658.2008.06489.x; Obach RS, 2004, DRUG METAB DISPOS, V32, P89, DOI 10.1124/dmd.32.1.89; Okamoto K, 2004, P NATL ACAD SCI USA, V101, P7931, DOI 10.1073/pnas.0400973101; Okamoto K, 2008, NUCLEOS NUCLEOT NUCL, V27, P888, DOI 10.1080/15257770802146577; Okamoto K, 2010, J AM CHEM SOC, V132, P17080, DOI 10.1021/ja1077574; Okamoto Ken, 2008, Journal of Nippon Medical School, V75, P2, DOI 10.1272/jnms.75.2; Pauff JM, 2008, J BIOL CHEM, V283, P4818, DOI 10.1074/jbc.M707918200; Pryde DC, 2010, J MED CHEM, V53, P8441, DOI 10.1021/jm100888d; Rebelo JM, 2001, J BIOL INORG CHEM, V6, P791, DOI 10.1007/s007750100255; Rodriguez-Trelles F, 2003, P NATL ACAD SCI USA, V100, P13413, DOI 10.1073/pnas.1835646100; ROMAO MJ, 1995, SCIENCE, V270, P1170, DOI 10.1126/science.270.5239.1170; Schumann S, 2008, J BIOL CHEM, V283, P16602, DOI 10.1074/jbc.M709894200; Schumann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005348; Team R.D.C, 2010, R LANG ENV STAT COMP; Terao M, 2000, J BIOL CHEM, V275, P30690, DOI 10.1074/jbc.M005355200; Terao M, 1998, BIOCHEM J, V332, P383, DOI 10.1042/bj3320383; Terao M, 2001, J BIOL CHEM, V276, P46347, DOI 10.1074/jbc.M105744200; Terao M, 2006, J BIOL CHEM, V281, P19748, DOI 10.1074/jbc.M600850200; Terao M, 2009, MOL CELL BIOL, V29, P357, DOI 10.1128/MCB.01385-08; Truglio JJ, 2002, STRUCTURE, V10, P115, DOI 10.1016/S0969-2126(01)00697-9; Vila R, 2004, J BIOL CHEM, V279, P8668, DOI 10.1074/jbc.M308137200; Yamaguchi Y, 2007, J BIOCHEM, V141, P513, DOI 10.1093/jb/mvm053	52	80	81	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40690	40702		10.1074/jbc.M112.390419	http://dx.doi.org/10.1074/jbc.M112.390419			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23019336	Green Published, hybrid			2022-12-28	WOS:000311448800058
J	Li, TB; Yang, YS; Canessa, CM				Li, Tianbo; Yang, Youshan; Canessa, Cecilia M.			Impact of Recovery from Desensitization on Acid-sensing Ion Channel-1a (ASIC1a) Current and Response to High Frequency Stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1A; CONTRIBUTES; SELECTIVITY; MODULATION; EXPRESSION; PLASTICITY; RESIDUES; KINETICS; NEURONS; CELLS	ASIC1a is a neuronal sodium channel activated by external H+ ions. To date, all the characterization of ASIC1a has been conducted applying long H+ stimuli lasting several seconds. Such experimental protocols weaken and even silence ASIC1a currents to repetitive stimulation. In this work, we examined ASIC1a currents by methods that use rapid application and removal of H+. We found that brief H+ stimuli, < 100 ms, even if applied at high frequency, prevent desensitization thereby generate full and steady peak currents of human ASIC1a. Kinetic analysis of recovery from desensitization of hASIC1a revealed two desensitized states: short- and long-lasting with time constants of tau(Ds) <= 0.5 and tau(Dl) = 229 s, while in chicken ASIC1a the two desensitized states have similar values tau(D) 4.5 s. It is the large difference in stability of the two desensitized states that makes hASIC1a desensitization more pronounced and complex than in cASIC1a. Furthermore, recovery from desensitization was unrelated to cytosolic variations in pH, ATP, PIP2, or redox state but was dependent on the hydrophobicity of key residues in the first transmembrane segment (TM1). In conclusion, brief H+-stimuli maintain steady the magnitude of peak currents thereby the ASIC1a channel is well poised to partake in high frequency signals in the brain.	[Li, Tianbo; Yang, Youshan; Canessa, Cecilia M.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University	Canessa, CM (corresponding author), Yale Univ, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA.	Cecilia.canessa@yale.edu						Arteaga MF, 2008, P NATL ACAD SCI USA, V105, P4459, DOI 10.1073/pnas.0800958105; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Chen XM, 2006, J GEN PHYSIOL, V127, P267, DOI 10.1085/jgp.200509409; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Chu XP, 2006, J NEUROSCI, V26, P5329, DOI 10.1523/JNEUROSCI.0938-06.2006; Colquhoun D., 1995, G SINGLE CHANNEL REC; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P81, DOI 10.1085/jgp.200910344; Gitterman DP, 2005, J PHYSIOL-LONDON, V562, P759, DOI 10.1113/jphysiol.2004.075069; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Gunthorpe NJ, 2001, PFLUG ARCH EUR J PHY, V442, P668; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kaila K., 1998, PH BRAIN FUNCTION; Kusama N, 2010, J BIOL CHEM, V285, P17425, DOI 10.1074/jbc.M109.091561; Li TB, 2010, J BIOL CHEM, V285, P31285, DOI 10.1074/jbc.M110.160382; Li TB, 2010, AM J PHYSIOL-CELL PH, V299, pC66, DOI 10.1152/ajpcell.00100.2010; Neaga E, 2005, J NEUROSCI METH, V144, P241, DOI 10.1016/j.jneumeth.2004.11.012; Pochynyuk O, 2007, J GEN PHYSIOL, V130, P399, DOI 10.1085/jgp.200709800; Wang WZ, 2006, J BIOL CHEM, V281, P29369, DOI 10.1074/jbc.M605122200; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Weng JY, 2010, J NEUROSCI, V30, P6548, DOI 10.1523/JNEUROSCI.0582-10.2010; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200	29	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40680	40689		10.1074/jbc.M112.418400	http://dx.doi.org/10.1074/jbc.M112.418400			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23048040	Green Published, hybrid			2022-12-28	WOS:000311448800057
J	Aleshin, AE; Drag, M; Gombosuren, N; Wei, G; Mikolajczyk, J; Satterthwait, AC; Strongin, AY; Liddington, RC; Salvesen, GS				Aleshin, Alexander E.; Drag, Marcin; Gombosuren, Naran; Wei, Ge; Mikolajczyk, Jowita; Satterthwait, Arnold C.; Strongin, Alex Y.; Liddington, Robert C.; Salvesen, Guy S.			Activity, Specificity, and Probe Design for the Smallpox Virus Protease K7L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ADENOVIRUS PROTEINASE; UNEXPECTED SPECIFICITY; CRYSTAL-STRUCTURE; CLEAVAGE; UBIQUITIN; DNA; MORPHOGENESIS; POLYPEPTIDE; PROTEOLYSIS; PEPTIDASE	The K7L gene product of the smallpox virus is a protease implicated in the maturation of viral proteins. K7L belongs to protease Clan CE, which includes distantly related cysteine proteases from eukaryotes, pathogenic bacteria, and viruses. Here, we describe its recombinant high level expression, biochemical mechanism, substrate preference, and regulation. Earlier studies inferred that the orthologous I7L vaccinia protease cleaves at an AG-X motif in six viral proteins. Our data for K7L suggest that the AG-X motif is necessary but not sufficient for optimal cleavage activity. Thus, K7L requires peptides extended into the P7 and P8 positions for efficient substrate cleavage. Catalytic activity of K7L is substantially enhanced by homodimerization, by the substrate protein P25K as well as by glycerol. RNA and DNA also enhance cleavage of the P25K protein but not of synthetic peptides, suggesting that nucleic acids augment the interaction of K7L with its protein substrate. Library-based peptide preference analyses enabled us to design an activity-based probe that covalently and selectively labels K7L in lysates of transfected and infected cells. Our study thus provides proof-of-concept for the design of inhibitors and probes that may contribute both to a better understanding of the role of K7L in the virus life cycle and the design of novel anti-virals.	[Liddington, Robert C.] Sanford Burnham Med Res Inst, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA; Sanford Burnham Med Res Inst, Program Infect Dis, La Jolla, CA 92037 USA; Sanford Burnham Med Res Inst, Program Tumor Microenvironm, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Liddington, RC (corresponding author), Sanford Burnham Med Res Inst, Program Apoptosis & Cell Death Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rlidding@sanfordburnham.org; salvesen@sansfordburnham.org	Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016	National Institutes of Health [AI061139]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI061139] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI061139 (to R. C. L., G. S. S., and A. Y. S.).	Aleshin AE, 2009, STRUCTURE, V17, P1465, DOI 10.1016/j.str.2009.09.009; ANDERSON CW, 1990, VIROLOGY, V177, P259, DOI 10.1016/0042-6822(90)90479-B; Andres G, 2001, J BIOL CHEM, V276, P780, DOI 10.1074/jbc.M006844200; Ansarah-Sobrinho C, 2004, J VIROL, V78, P6855, DOI 10.1128/JVI.78.13.6855-6863.2004; Ansarah-Sobrinho C, 2004, J VIROL, V78, P6335, DOI 10.1128/JVI.78.12.6335-6343.2004; Balakirev MY, 2002, J VIROL, V76, P6323, DOI 10.1128/JVI.76.12.6323-6331.2002; Barrett AJ, 2001, BIOL CHEM, V382, P727, DOI 10.1515/BC.2001.088; Bayliss CD, 1997, NUCLEIC ACIDS RES, V25, P3984, DOI 10.1093/nar/25.20.3984; Brown MT, 2002, J BIOL CHEM, V277, P46298, DOI 10.1074/jbc.M202988200; BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991; Byrd CA, 2003, J VIROL, V77, P11279, DOI 10.1128/JVI.77.20.11279-11283.2003; Byrd CM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-63; Byrd CM, 2006, REV MED VIROL, V16, P187, DOI 10.1002/rmv.499; Byrd CM, 2004, J VIROL, V78, P12147, DOI 10.1128/JVI.78.22.12147-12156.2004; Byrd CM, 2002, J VIROL, V76, P8973, DOI 10.1128/JVI.76.17.8973-8976.2002; Catic A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000381; CHEN PH, 1993, J VIROL, V67, P3507, DOI 10.1128/JVI.67.6.3507-3514.1993; Ding JZ, 1996, EMBO J, V15, P1778, DOI 10.1002/j.1460-2075.1996.tb00526.x; Drag M, 2008, BIOCHEM J, V415, P367, DOI 10.1042/BJ20080779; Drag M, 2008, IUBMB LIFE, V60, P734, DOI 10.1002/iub.113; Drag M, 2008, BIOCHEM J, V409, P461, DOI 10.1042/BJ20070940; Golicnik M, 2011, BIOCHEM ENG J, V53, P234, DOI 10.1016/j.bej.2010.10.012; Harrison SC, 2004, P NATL ACAD SCI USA, V101, P11178, DOI 10.1073/pnas.0403600101; Hedengren-Olcott M, 2004, J VIROL, V78, P9947, DOI 10.1128/JVI.78.18.9947-9953.2004; Isaacs S. N., 2004, VACCINIA VIRUS POXVI, P101; KANE EM, 1993, J VIROL, V67, P2689, DOI 10.1128/JVI.67.5.2689-2698.1993; Katritch V, 2007, J COMPUT AID MOL DES, V21, P549, DOI 10.1007/s10822-007-9138-7; KATZ E, 1970, P NATL ACAD SCI USA, V66, P677, DOI 10.1073/pnas.66.3.677; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; LEE PY, 1995, VIROLOGY, V207, P229, DOI 10.1006/viro.1995.1069; LEE PY, 1993, J VIROL, V67, P4252, DOI 10.1128/JVI.67.7.4252-4263.1993; LEE PY, 1994, J BIOL CHEM, V269, P8616; LOPEZOTIN C, 1989, J BIOL CHEM, V264, P9107; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; MANGEL WF, 1993, NATURE, V361, P274, DOI 10.1038/361274a0; McGrath WJ, 1996, VIROLOGY, V217, P131, DOI 10.1006/viro.1996.0100; McGrath WJ, 2001, BIOCHEMISTRY-US, V40, P13237, DOI 10.1021/bi0111653; Moss B, 2001, FIELDS VIROLOGY, P2849; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Quesada V, 2004, BIOCHEM BIOPH RES CO, V314, P54, DOI 10.1016/j.bbrc.2003.12.050; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Roden J, 2004, MOL PLANT MICROBE IN, V17, P633, DOI 10.1094/MPMI.2004.17.6.633; Rytkonen A, 2007, P NATL ACAD SCI USA, V104, P3502, DOI 10.1073/pnas.0610095104; Vedrenne E, 2005, SYNLETT, P670, DOI 10.1055/s-2005-862375; WHITEHEAD SS, 1994, J VIROL, V68, P7603, DOI 10.1128/JVI.68.11.7603-7608.1994; Yang SJ, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-73	47	10	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.388678	http://dx.doi.org/10.1074/jbc.M112.388678			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23012361	hybrid, Green Published			2022-12-28	WOS:000311233800019
J	Faure, E; Starek, G; McGuire, H; Berneche, S; Blunck, R				Faure, Elise; Starek, Greg; McGuire, Hugo; Berneche, Simon; Blunck, Rikard			A Limited 4 angstrom Radial Displacement of the S4-S5 Linker Is Sufficient for Internal Gate Closing in Kv Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; SHAKER POTASSIUM CHANNEL; VOLTAGE-SENSING RESIDUES; DEPENDENT K+ CHANNEL; GATING CHARGE; STRUCTURAL BASIS; LIPID-MEMBRANE; RESTING STATE; CLOSED-STATE; SENSOR	Voltage-gated ion channels are responsible for the generation of action potentials in our nervous system. Conformational rearrangements in their voltage sensor domains in response to changes of the membrane potential control pore opening and thus ion conduction. Crystal structures of the open channel in combination with a wealth of biophysical data and molecular dynamics simulations led to a consensus on the voltage sensor movement. However, the coupling between voltage sensor movement and pore opening, the electromechanical coupling, occurs at the cytosolic face of the channel, from where no structural information is available yet. In particular, the question how far the cytosolic pore gate has to close to prevent ion conduction remains controversial. In cells, spectroscopic methods are hindered because labeling of internal sites remains difficult, whereas liposomes or detergent solutions containing purified ion channels lack voltage control. Here, to overcome these problems, we controlled the state of the channel by varying the lipid environment. This way, we directly measured the position of the S4-S5 linker in both the open and the closed state of a prokaryotic Kv channel (KvAP) in a lipid environment using Lanthanide-based resonance energy transfer. We were able to reconstruct the movement of the covalent link between the voltage sensor and the pore domain and used this information as restraints for molecular dynamics simulations of the closed state structure. We found that a small decrease of the pore radius of about 3-4 angstrom is sufficient to prevent ion permeation through the pore.	[McGuire, Hugo; Blunck, Rikard] Univ Montreal, Dept Phys, Montreal, PQ H3C 3J7, Canada; [Faure, Elise; McGuire, Hugo; Blunck, Rikard] Univ Montreal, Grp Etud Prot Membranaires GEPROM, Montreal, PQ H3C 3J7, Canada; [Faure, Elise; Blunck, Rikard] Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada; [Starek, Greg; Berneche, Simon] Univ Basel, Swiss Inst Bioinformat, CH-4056 Basel, Switzerland; [Starek, Greg; Berneche, Simon] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Starek, Greg] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	Universite de Montreal; Universite de Montreal; Universite de Montreal; Swiss Institute of Bioinformatics; University of Basel; University of Basel; University of California System; University of California Irvine	Blunck, R (corresponding author), Univ Montreal, Dept Phys, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	rikard.blunck@umontreal.ca	Bernèche, Simon/L-6389-2013; Blunck, Rikard/L-4226-2013; Blunck, Rikard/AAM-3078-2020	Bernèche, Simon/0000-0002-6274-4094; Blunck, Rikard/0000-0003-4484-2907; Blunck, Rikard/0000-0003-4484-2907	Canadian Institutes for Health Research Grant [MOP-102689]; Canadian Foundation for Innovation; Swiss National Science Foundation [118928]; Fonds de recherche du Quebec - Nature et technologies (FRQNT); Fonds de la recherche en sante du Quebec (FRSQ)	Canadian Institutes for Health Research Grant(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fonds de recherche du Quebec - Nature et technologies (FRQNT); Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work was funded by the Canadian Institutes for Health Research Grant MOP-102689 (to R. B.), the Canadian Foundation for Innovation (to R. B.), and the Swiss National Science Foundation (SNF-Professorship Number 118928) (to S. B).; Recipients of student fellowships of Fonds de recherche du Quebec - Nature et technologies (FRQNT).; We thank Mireille Marsolais and Michel Brunette for technical assistance and Drs. William Skene and Matthieu Starck for help in synthesizing terbium chelate. The molecular dynamics simulations were performed at the Swiss National Super-computing Center (CSCS). GEPROM is a research group funded by the Fonds de la recherche en sante du Quebec (FRSQ).	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Ashcroft F., 1999, ION CHANNELS DIS, P97; Barghaan J, 2009, J GEN PHYSIOL, V133, P205, DOI 10.1085/jgp.200810073; Batulan Z, 2010, J BIOL CHEM, V285, P14005, DOI 10.1074/jbc.M109.097717; Bjelkmar P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000289; Blunck R, 2004, BIOPHYS J, V86, P3966, DOI 10.1529/biophysj.103.034512; Blunck R, 2001, J IMMUNOL, V166, P1009, DOI 10.4049/jimmunol.166.2.1009; Blunck R, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00166; Blunck R, 2008, P NATL ACAD SCI USA, V105, P20263, DOI 10.1073/pnas.0807056106; Borjesson SI, 2008, BIOPHYS J, V95, P2242, DOI 10.1529/biophysj.108.130757; Borjesson SI, 2011, J GEN PHYSIOL, V137, P563, DOI 10.1085/jgp.201110599; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Chapman ML, 2005, J GEN PHYSIOL, V126, P87, DOI 10.1085/jgp.200509253; Chen JY, 1999, BIOCONJUGATE CHEM, V10, P311, DOI 10.1021/bc980113w; Ge PH, 2003, BIOCONJUGATE CHEM, V14, P870, DOI 10.1021/bc034029e; Haddad GA, 2011, J GEN PHYSIOL, V137, P455, DOI 10.1085/jgp.201010573; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Im W, 2003, BIOPHYS J, V85, P2900, DOI 10.1016/S0006-3495(03)74712-2; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Khalili-Araghi F, 2010, BIOPHYS J, V98, P2189, DOI 10.1016/j.bpj.2010.02.056; Labro AJ, 2008, J GEN PHYSIOL, V132, P667, DOI 10.1085/jgp.200810048; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; Lin MCA, 2010, J GEN PHYSIOL, V135, P415, DOI 10.1085/jgp.200910320; Liu YS, 2001, NAT STRUCT BIOL, V8, P883, DOI 10.1038/nsb1001-883; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Posson DJ, 2005, NATURE, V436, P848, DOI 10.1038/nature03819; Ramu Y, 2007, P NATL ACAD SCI USA, V104, P6448, DOI 10.1073/pnas.0701354104; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Richardson J, 2006, P NATL ACAD SCI USA, V103, P15865, DOI 10.1073/pnas.0607532103; Sandtner W, 2007, BIOPHYS J, V93, pL45, DOI 10.1529/biophysj.107.119073; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Schmidt D, 2009, J MOL BIOL, V390, P902, DOI 10.1016/j.jmb.2009.05.062; Schmidt D, 2008, P NATL ACAD SCI USA, V105, P19276, DOI 10.1073/pnas.0810187105; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Vargas E, 2011, NEURON, V72, P713, DOI 10.1016/j.neuron.2011.09.024; Villalba-Galea CA, 2008, P NATL ACAD SCI USA, V105, P17600, DOI 10.1073/pnas.0807387105; Xu XP, 2008, EPILEPSY RES, V80, P57, DOI 10.1016/j.eplepsyres.2008.03.013; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; Yarov-Yarovoy V, 2012, P NATL ACAD SCI USA, V109, pE93, DOI 10.1073/pnas.1118434109; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; Zheng H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1254; Zuidam NJ, 1997, BBA-BIOMEMBRANES, V1329, P211, DOI 10.1016/S0005-2736(97)00110-7	53	24	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.415497	http://dx.doi.org/10.1074/jbc.M112.415497			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23019337	Green Published, hybrid			2022-12-28	WOS:000311233800076
J	Grinter, R; Roszak, AW; Cogdell, RJ; Milner, JJ; Walker, D				Grinter, Rhys; Roszak, Aleksander W.; Cogdell, Richard J.; Milner, Joel J.; Walker, Daniel			The Crystal Structure of the Lipid II-degrading Bacteriocin Syringacin M Suggests Unexpected Evolutionary Relationships between Colicin M-like Bacteriocins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; IMMUNITY PROTEIN; PEPTIDOGLYCAN PRECURSORS; DOMAIN; MAGNESIUM; BINDING; ENZYME; SUPERFAMILY; SELECTION	Colicin-like bacteriocins show potential as next generation antibiotics with clinical and agricultural applications. Key to these potential applications is their high potency and species specificity that enables a single pathogenic species to be targeted with minimal disturbance of the wider microbial community. Here we present the structure and function of the colicin M-like bacteriocin, syringacin M from Pseudomonas syringae pv. tomato DC3000. Syringacin M kills susceptible cells through a highly specific phosphatase activity that targets lipid II, ultimately inhibiting peptidoglycan synthesis. Comparison of the structures of syringacin M and colicin M reveals that, in addition to the expected similarity between the homologous C-terminal catalytic domains, the receptor binding domains of these proteins, which share no discernible sequence homology, share a striking structural similarity. This indicates that the generation of the novel receptor binding and species specificities of these bacteriocins has been driven by diversifying selection rather than diversifying recombination as suggested previously. Additionally, the structure of syringacin M reveals the presence of an active site calcium ion that is coordinated by a conserved aspartic acid side chain and is essential for catalytic activity. We show that mutation of this residue to alanine inactivates syringacin M and that the metal ion is absent from the structure of the mutant protein. Consistent with the presence of Ca2+ in the active site, we show that syringacin M activity is supported by Ca2+, along with Mg2+ and Mn2+, and the protein is catalytically inactive in the absence of these ions.	[Grinter, Rhys; Walker, Daniel] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland; [Cogdell, Richard J.] Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow G12 8TA, Lanark, Scotland; [Milner, Joel J.] Univ Glasgow, Coll Med Vet & Life Sci, Sch Life Sci, Glasgow G12 8TA, Lanark, Scotland; [Roszak, Aleksander W.] Univ Glasgow, Coll Sci & Engn, Sch Chem, WestCHEM, Glasgow G12 8TA, Lanark, Scotland	University of Glasgow; University of Glasgow; University of Glasgow; University of Glasgow	Walker, D (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland.	Daniel.Walker@glasgow.ac.uk		Walker, Daniel/0000-0002-4206-2942; Grinter, Rhys/0000-0002-8195-5348				Arnold T, 2009, J BIOL CHEM, V284, P6403, DOI 10.1074/jbc.M808504200; BAJAJ M, 1984, ANNU REV BIOPHYS BIO, V13, P453; Barreteau H, 2010, J BIOL CHEM, V285, P12378, DOI 10.1074/jbc.M109.093583; Barreteau H, 2009, J BACTERIOL, V191, P3657, DOI 10.1128/JB.01824-08; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; CHANG CF, 1986, J BACTERIOL, V167, P935, DOI 10.1128/jb.167.3.935-939.1986; Chuang DY, 2007, J BACTERIOL, V189, P620, DOI 10.1128/JB.01090-06; Clarke TB, 2009, BIOCHEMISTRY-US, V48, P2675, DOI 10.1021/bi801993x; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; El Ghachi M, 2006, J BIOL CHEM, V281, P22761, DOI 10.1074/jbc.M602834200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feldgarden M, 1998, EVOLUTION, V52, P1270, DOI 10.1111/j.1558-5646.1998.tb02008.x; FYFE JAM, 1984, J CLIN MICROBIOL, V20, P47, DOI 10.1128/JCM.20.1.47-50.1984; Gorrec F, 2009, J APPL CRYSTALLOGR, V42, P1035, DOI 10.1107/S0021889809042022; GRAHAM AC, 1977, J BACTERIOL, V130, P1214, DOI 10.1128/JB.130.3.1214-1223.1977; Grinter R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033033; HARKNESS RE, 1989, J BIOL CHEM, V264, P6177; Helbig S, 2011, J BACTERIOL, V193, P815, DOI 10.1128/JB.01206-10; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Holm L, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P140; Jones HE, 2002, CELL CALCIUM, V32, P183, DOI 10.1016/S0143416002001537; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katz AK, 1996, J AM CHEM SOC, V118, P5752, DOI 10.1021/ja953943i; Kleanthous C, 2001, TRENDS BIOCHEM SCI, V26, P624, DOI 10.1016/S0968-0004(01)01941-7; Kleanthous C, 2010, NAT REV MICROBIOL, V8, P843, DOI 10.1038/nrmicro2454; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lloyd AJ, 2008, J BIOL CHEM, V283, P6402, DOI 10.1074/jbc.M708105200; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lu Z, 2008, P NATL ACAD SCI USA, V105, P5687, DOI 10.1073/pnas.0710800105; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michel-Briand Y, 2002, BIOCHIMIE, V84, P499, DOI 10.1016/S0300-9084(02)01422-0; Moncrief MBC, 1999, J BIOL INORG CHEM, V4, P523, DOI 10.1007/s007750050374; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PILSL H, 1993, MOL GEN GENET, V240, P103, DOI 10.1007/BF00276889; Ridder IS, 1999, BIOCHEM J, V339, P223, DOI 10.1042/0264-6021:3390223; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Riley MA, 1998, ANNU REV GENET, V32, P255, DOI 10.1146/annurev.genet.32.1.255; Roh E, 2010, APPL ENVIRON MICROB, V76, P7541, DOI 10.1128/AEM.03103-09; SANO Y, 1993, J BACTERIOL, V175, P6179, DOI 10.1128/JB.175.19.6179-6185.1993; SCHALLER K, 1981, J BACTERIOL, V146, P54, DOI 10.1128/JB.146.1.54-63.1981; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Smith EE, 2005, J BACTERIOL, V187, P2138, DOI 10.1128/JB.187.6.2138-2147.2005; Soelaiman S, 2001, MOL CELL, V8, P1053, DOI 10.1016/S1097-2765(01)00396-3; Tummler B, 2005, J BACTERIOL, V187, P3289, DOI 10.1128/JB.187.10.3289-3292.2005; Uson I, 2012, J STRUCT BIOL, V178, P45, DOI 10.1016/j.jsb.2012.02.004; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Walker D, 2003, BIOCHEMISTRY-US, V42, P4161, DOI 10.1021/bi0273720; Wiener M, 1997, NATURE, V385, P461, DOI 10.1038/385461a0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wojdyla JA, 2012, J MOL BIOL, V417, P79, DOI 10.1016/j.jmb.2012.01.019; Zeth K, 2008, J BIOL CHEM, V283, P25324, DOI 10.1074/jbc.M802591200; Zhang XYZ, 2010, J BIOL CHEM, V285, P38053, DOI 10.1074/jbc.M110.144071; Zheng H, 2008, J INORG BIOCHEM, V102, P1765, DOI 10.1016/j.jinorgbio.2008.05.006	59	26	26	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38876	38888		10.1074/jbc.M112.400150	http://dx.doi.org/10.1074/jbc.M112.400150			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22995910	hybrid, Green Published			2022-12-28	WOS:000310982800044
J	Kopp, K; Buntru, A; Pils, S; Zimmermann, T; Frank, R; Zumbusch, A; Hauck, CR				Kopp, Kathrin; Buntru, Alexander; Pils, Stefan; Zimmermann, Timo; Frank, Ronald; Zumbusch, Andreas; Hauck, Christof R.			Grb14 Is a Negative Regulator of CEACAM3-mediated Phagocytosis of Pathogenic Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEISSERIA-GONORRHOEAE; INSULIN-RECEPTOR; PROTEINS; ANTIGEN; CEACAM3; KINASE; CELLS; FAMILY; DOMAIN; QUANTIFICATION	Carcinoembryonic antigen-related cell adhesion molecule 3 (CEACAM3) is a phagocytic receptor on human granulocytes, which mediates the opsonin-independent recognition and internalization of a restricted set of Gram-negative bacteria such as Neisseria gonorrhoeae. In an unbiased screen using a SH2 domain microarray we identified the SH2 domain of growth factor receptor-bound protein 14 (Grb14) as a novel binding partner of CEACAM3. Biochemical assays and microscopic studies demonstrated that the Grb14 SH2 domain promoted the rapid recruitment of this adaptor protein to the immunoreceptor-based activation motif (ITAM)-like sequence within the cytoplasmic domain of CEACAM3. Furthermore, FRET-FLIM analyses confirmed the direct association of Grb14 and CEACAM3 in intact cells at the sites of bacteria-host cell contact. Knockdown of endogenous Grb14 by RNA interference as well as Grb14 overexpression indicate an inhibitory role for this adapter protein in CEACAM3-mediated phagocytosis. Therefore, Grb14 is the first negative regulator of CEACAM3-initiated bacterial phagocytosis and might help to focus granulocyte responses to the subcellular sites of pathogen-host cell contact.	[Kopp, Kathrin; Buntru, Alexander; Pils, Stefan; Hauck, Christof R.] Univ Konstanz, Lehrstuhl Zellbiol, D-78457 Constance, Germany; [Buntru, Alexander; Zumbusch, Andreas; Hauck, Christof R.] Univ Konstanz, Konstanz Res Sch Chem Biol, D-78457 Constance, Germany; [Zimmermann, Timo] CRG, Adv Light Microscopy Unit, Barcelona 08003, Spain; [Frank, Ronald] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Zumbusch, Andreas] Univ Konstanz, Lehrstuhl Phys Chem, D-78457 Constance, Germany	University of Konstanz; University of Konstanz; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); University of Konstanz	Hauck, CR (corresponding author), Univ Konstanz, Lehrstuhl Zellbiol, Postfach X908, D-78457 Constance, Germany.	christof.hauck@uni-konstanz.de	Zimmermann, Timo/G-1681-2015	Zimmermann, Timo/0000-0001-7098-0700	Landesstiftung BW [LS-Prot-66]; Ministry of Science; Zukunftskolleg of the University of Konstanz; Research and the Arts of Baden-Wurttemberg [CAP17]	Landesstiftung BW; Ministry of Science(Ministry of Science, ICT & Future Planning, Republic of Korea); Zukunftskolleg of the University of Konstanz; Research and the Arts of Baden-Wurttemberg	This study was supported by funds from the Landesstiftung BW (LS-Prot-66) and by a grant from the Ministry of Science, Research and the Arts of Baden-Wurttemberg (CAP17) (to C.R.H.).; Recipient of a fellowship according to the LGFG, Baden-Wurttemberg and acknowledges support by the Zukunftskolleg of the University of Konstanz.	Bereziat V, 2002, J BIOL CHEM, V277, P4845, DOI 10.1074/jbc.M106574200; Buntru A, 2012, ARCH BIOCHEM BIOPHYS, V524, P77, DOI 10.1016/j.abb.2012.03.020; Buntru A, 2011, J BIOL CHEM, V286, P9555, DOI 10.1074/jbc.M110.216085; Buntru A, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-81; Chen T, 1996, P NATL ACAD SCI USA, V93, P14851, DOI 10.1073/pnas.93.25.14851; Cooney GJ, 2004, EMBO J, V23, P582, DOI 10.1038/sj.emboj.7600082; Daly RJ, 1996, J BIOL CHEM, V271, P12502, DOI 10.1074/jbc.271.21.12502; Depetris RS, 2005, MOL CELL, V20, P325, DOI 10.1016/j.molcel.2005.09.001; DVEKSLER GS, 1993, J VIROL, V67, P1; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Gratton E, 2003, J BIOMED OPT, V8, P381, DOI 10.1117/1.1586704; Han DC, 2001, ONCOGENE, V20, P6315, DOI 10.1038/sj.onc.1204775; Hauck CR, 1998, EMBO J, V17, P443, DOI 10.1093/emboj/17.2.443; Hauck CR, 2001, J BIOL CHEM, V276, P17653, DOI 10.1074/jbc.M009329200; Hemmila E, 2004, J VIROL, V78, P10156, DOI 10.1128/JVI.78.18.10156-10165.2004; Holt LJ, 2005, BIOCHEM J, V388, P393, DOI 10.1042/BJ20050216; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Kammerer R, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-12; Kuespert K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014609; KUPSCH EM, 1993, EMBO J, V12, P641, DOI 10.1002/j.1460-2075.1993.tb05697.x; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; McCaw SE, 2003, MOL MICROBIOL, V49, P623, DOI 10.1046/j.1365-2958.2003.03591.x; Mehlitz A, 2010, J CELL BIOL, V190, P143, DOI 10.1083/jcb.200909095; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; Pils S, 2008, INT J MED MICROBIOL, V298, P553, DOI 10.1016/j.ijmm.2008.04.005; Pils S, 2006, J MICROBIOL METH, V65, P301, DOI 10.1016/j.mimet.2005.08.013; Pils S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032808; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; Schmitter T, 2004, J EXP MED, V199, P35, DOI 10.1084/jem.20030204; Schmitter T, 2007, INFECT IMMUN, V75, P4116, DOI 10.1128/IAI.01835-06; Schmitter T, 2007, J IMMUNOL, V178, P3797, DOI 10.4049/jimmunol.178.6.3797; Tramier M, 2002, BIOPHYS J, V83, P3570, DOI 10.1016/S0006-3495(02)75357-5; Voges M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-117; Wolf-Yadlin A, 2009, CURR OPIN CHEM BIOL, V13, P398, DOI 10.1016/j.cbpa.2009.06.027	37	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39158	39170		10.1074/jbc.M112.395228	http://dx.doi.org/10.1074/jbc.M112.395228			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22948154	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000310982800071
J	Ma, Y; Li, CL; Gu, JJ; Tang, F; Li, C; Li, P; Ping, P; Yang, S; Li, Z; Jin, Y				Ma, Yu; Li, Chunliang; Gu, Junjie; Tang, Fan; Li, Chun; Li, Peng; Ping, Ping; Yang, Shi; Li, Zheng; Jin, Ying			Aberrant Gene Expression Profiles in Pluripotent Stem Cells Induced from Fibroblasts of a Klinefelter Syndrome Patient	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-CHROMOSOME INACTIVATION; DIFFERENTIATION; DERIVATION; PROTEINS; DISEASE; LINES	Klinefelter syndrome (KS) is the most common male chromosome aneuploidy. Its pathophysiology is largely unexplained due to the lack of adequate models. Here, we report the derivation of induced pluripotent stem cell (iPSCs) lines from a KS patient with a karyotype of 47, XXY. Derived KS-iPSCs meet all criteria of normal iPSCs with the potential for germ cell differentiation. Although X chromosome inactivation occurs in all KS-iPSCs, genome-wide transcriptome analysis identifies aberrantly expressed genes associated with the clinical features of KS. Our KS-iPSCs can serve as a cellular model for KS research. Identified genes may become biomarkers for early diagnosis or potential therapeutic targets for KS and significantly accelerate the understanding, diagnosis, and treatment of Klinefelter syndrome.	[Ma, Yu; Li, Chunliang; Gu, Junjie; Tang, Fan; Li, Chun; Jin, Ying] Shanghai Jiao Tong Univ, Sch Med, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai 200030, Peoples R China; [Ma, Yu; Li, Chunliang; Gu, Junjie; Tang, Fan; Li, Chun; Jin, Ying] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Ma, Yu; Li, Chunliang; Gu, Junjie; Tang, Fan; Li, Chun; Jin, Ying] Shanghai Jiao Tong Univ, Sch Med, Shanghai Stem Cell Inst, Shanghai 200025, Peoples R China; [Li, Peng; Ping, Ping; Yang, Shi; Li, Zheng] Shanghai Jiao Tong Univ, Dept Urol,Sperm Dev & Genet Lab, Shanghai Human Sperm Bank,Shanghai Inst Androl, Renji Hosp,Sch Med, Shanghai 200001, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Li, Z (corresponding author), 145 Shandong Zhong Rd, Shanghai 200001, Peoples R China.	doc.zheng.li@gmail.com; yjin@sibs.ac.cn	, chunliang.li@stjude.org/P-4373-2018	, chunliang.li@stjude.org/0000-0002-5938-5510; , jin ying/0000-0003-0070-2048	National High Technology Research and Development Program of China [2010CB945200, 2011DFB300100, 2011CB965101, 2009CB941103]; National Natural Science Foundation [91019023]; Chinese Academy of Science [XDA01010102]; Shanghai Leading Academic Discipline Project [S30201]; Shanghai Municipal Education Commission [10ZZ70]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was supported by National High Technology Research and Development Program of China Grants 2010CB945200, 2011DFB300100, 2011CB965101, and 2009CB941103, National Natural Science Foundation Grant 91019023, Chinese Academy of Science Grant XDA01010102, Shanghai Leading Academic Discipline Project Grant S30201, and Key Project of Shanghai Municipal Education Commission Grant 10ZZ70.	Al-Kandari W, 2007, J MOL BIOL, V369, P1175, DOI 10.1016/j.jmb.2007.04.033; Barker PA, 2002, J NEUROSCI RES, V67, P705, DOI 10.1002/jnr.10160; Bojesen A, 2011, OSTEOPOROSIS INT, V22, P1441, DOI 10.1007/s00198-010-1354-7; Brinton LA, 2011, ACTA PAEDIATR, V100, P814, DOI 10.1111/j.1651-2227.2010.02131.x; Bucay N, 2009, STEM CELLS, V27, P68, DOI 10.1634/stemcells.2007-1018; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Cheung AYL, 2011, HUM MOL GENET, V20, P2103, DOI 10.1093/hmg/ddr093; Eguizabal C, 2011, STEM CELLS, V29, P1186, DOI 10.1002/stem.672; Forti G, 2010, SEX DEV, V4, P249, DOI 10.1159/000316604; Giltay JC, 2010, EXPERT REV MOL DIAGN, V10, P765, DOI [10.1586/erm.10.63, 10.1586/ERM.10.63]; Gravholt CH, 2011, ACTA PAEDIATR, V100, P871, DOI 10.1111/j.1651-2227.2011.02233.x; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Iitsuka Y, 2001, AM J MED GENET, V98, P25, DOI 10.1002/1096-8628(20010101)98:1<25::AID-AJMG1015>3.3.CO;2-O; Kawakami T, 2004, ONCOGENE, V23, P6163, DOI 10.1038/sj.onc.1207808; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Li CL, 2010, IN VITRO CELL DEV-AN, V46, P186, DOI 10.1007/s11626-010-9304-4; Li CL, 2009, HUM MOL GENET, V18, P4340, DOI 10.1093/hmg/ddp386; Li CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006724; Li LJ, 2010, P NATL ACAD SCI USA, V107, P1402, DOI 10.1073/pnas.0905657107; Lossos IS, 2003, LEUKEMIA, V17, P789, DOI 10.1038/sj.leu.2402880; Panula S, 2011, HUM MOL GENET, V20, P752, DOI 10.1093/hmg/ddq520; Poplinski A, 2010, EUR J ENDOCRINOL, V162, P169, DOI 10.1530/EJE-09-0768; Ross JL, 2008, AM J MED GENET A, V146A, P708, DOI 10.1002/ajmg.a.32232; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Scofield RH, 2008, ARTHRITIS RHEUM-US, V58, P2511, DOI 10.1002/art.23701; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Tuttelmann F, 2010, MOL HUM REPROD, V16, P386, DOI 10.1093/molehr/gaq019; Vawter MP, 2007, AM J MED GENET B, V144B, P728, DOI 10.1002/ajmg.b.30454	34	24	27	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38970	38979		10.1074/jbc.M112.380204	http://dx.doi.org/10.1074/jbc.M112.380204			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23019320	Green Published, hybrid			2022-12-28	WOS:000310982800053
J	Manzo, C; Torreno-Pina, JA; Joosten, B; Reinieren-Beeren, I; Gualda, EJ; Loza-Alvarez, P; Figdor, CG; Garcia-Parajo, MF; Cambi, A				Manzo, Carlo; Torreno-Pina, Juan A.; Joosten, Ben; Reinieren-Beeren, Inge; Gualda, Emilio J.; Loza-Alvarez, Pablo; Figdor, Carl G.; Garcia-Parajo, Maria F.; Cambi, Alessandra			The Neck Region of the C-type Lectin DC-SIGN Regulates Its Surface Spatiotemporal Organization and Virus-binding Capacity on Antigen-presenting Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC-CELL; IN-VIVO; IMMUNODEFICIENCY-VIRUS; LATERAL MOBILITY; RECEPTOR; INFECTION; MICRODOMAINS; MICROSCOPY; MECHANISM; ADHESION	The C-type lectin DC-SIGN expressed on dendritic cells (DCs) facilitates capture and internalization of a plethora of different pathogens. Although it is known that DC-SIGN organizes in nanoclusters at the surface of DCs, the molecular mechanisms responsible for this well defined nanopatterning and role in viral binding remain enigmatic. By combining biochemical and advanced biophysical techniques, including optical super-resolution and single particle tracking, we demonstrate that DC-SIGN intrinsic nanoclustering strictly depends on its molecular structure. DC-SIGN nanoclusters exhibited free, Brownian diffusion on the cell membrane. Truncation of the extracellular neck region, known to abrogate tetramerization, significantly reduced nanoclustering and concomitantly increased lateral diffusion. Importantly, DC-SIGN nanocluster dissolution exclusively compromised binding to nanoscale size pathogens. Monte Carlo simulations revealed that heterogeneity on nanocluster density and spatial distribution confers broader binding capabilities to DC-SIGN. As such, our results underscore a direct relationship between spatial nanopatterning, driven by intermolecular interactions between the neck regions, and receptor diffusion to provide DC-SIGN with the exquisite ability to dock pathogens at the virus length scale. Insight into how virus receptors are organized prior to virus binding and how they assemble into functional platforms for virus docking is helpful to develop novel strategies to prevent virus entry and infection.	[Manzo, Carlo; Torreno-Pina, Juan A.; Gualda, Emilio J.; Loza-Alvarez, Pablo; Garcia-Parajo, Maria F.] Inst Ciencies Fotoniques, Castelldefels 08860, Barcelona, Spain; [Joosten, Ben; Reinieren-Beeren, Inge; Figdor, Carl G.; Cambi, Alessandra] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Tumor Immunol, NL-6500 HB Nijmegen, Netherlands; [Garcia-Parajo, Maria F.] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain; [Cambi, Alessandra] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Nanobiophys Grp, NL-7500 AE Enschede, Netherlands	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); Radboud University Nijmegen; ICREA; University of Twente	Garcia-Parajo, MF (corresponding author), Inst Ciencies Fotoniques, Mediterranean Technol Pk, Castelldefels 08860, Barcelona, Spain.	maria.garcia-parajo@icfo.es; a.cambi@ncmls.ru.nl	Joosten, Ben HGM/Q-5527-2016; Figdor, Carl G/A-4232-2010; Loza-Alvarez, Pablo/AAA-9118-2020; Garcia-Parajo, Maria F./I-4610-2015; Gualda, Emilio J/C-8935-2014; Loza Alvarez, Pablo/M-2564-2014; Torreno-Pina, Juan Andres/P-3010-2014; Manzo, Carlo/B-9745-2012; Cambi, Alessandra/L-4242-2015	Figdor, Carl G/0000-0002-2366-9212; Loza-Alvarez, Pablo/0000-0002-3129-1213; Garcia-Parajo, Maria F./0000-0001-6618-3944; Gualda, Emilio J/0000-0001-5948-5493; Loza Alvarez, Pablo/0000-0002-3129-1213; Manzo, Carlo/0000-0002-8625-0996; Cambi, Alessandra/0000-0003-1597-1582	Spanish Ministry of Science and Technology [MAT2010-19898]; Generalitat de Catalunya [2009 SGR 597]; Netherlands Organization for Scientific Research (NWO) [916.66.028]; Human Frontier Science Program Young Investigator grant; NWO TOP; ICREA Funding Source: Custom	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Human Frontier Science Program Young Investigator grant(Human Frontier Science Program); NWO TOP(Netherlands Organization for Scientific Research (NWO)); ICREA(ICREA)	This work was supported by Spanish Ministry of Science and Technology Grant MAT2010-19898 and Generalitat de Catalunya Grant 2009 SGR 597 (to M. F. G.-P.), Netherlands Organization for Scientific Research (NWO) Veni Grant 916.66.028 and a Human Frontier Science Program Young Investigator grant (to A. C.), and partially by an NWO TOP grant (to C. G. F.).	Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Cambi A, 2004, J CELL BIOL, V164, P145, DOI 10.1083/jcb.200306112; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; Cambi A, 2003, EUR J IMMUNOL, V33, P532, DOI 10.1002/immu.200310029; Cambi A, 2007, NANO LETT, V7, P970, DOI 10.1021/nl0700503; Cambi A, 2009, EUR J IMMUNOL, V39, P1923, DOI 10.1002/eji.200939351; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; de Bakker BI, 2007, CHEMPHYSCHEM, V8, P1473, DOI 10.1002/cphc.200700169; de Witte L, 2006, J VIROL, V80, P3477, DOI 10.1128/JVI.80.7.3477-3486.2006; Feinberg H, 2005, J BIOL CHEM, V280, P1327, DOI 10.1074/jbc.M409925200; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Gaborski TR, 2008, BIOPHYS J, V95, P4934, DOI 10.1529/biophysj.108.132886; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Itano MS, 2012, BIOPHYS J, V102, P1534, DOI 10.1016/j.bpj.2012.02.022; Itano MS, 2011, BIOPHYS J, V100, P2662, DOI 10.1016/j.bpj.2011.04.044; Bakker GJ, 2012, P NATL ACAD SCI USA, V109, P4869, DOI 10.1073/pnas.1116425109; Khoo US, 2008, J MOL MED, V86, P861, DOI 10.1007/s00109-008-0350-2; Koopman M, 2004, FEBS LETT, V573, P6, DOI 10.1016/j.febslet.2004.07.035; Liu HL, 2005, EUR J HUM GENET, V13, P707, DOI 10.1038/sj.ejhg.5201409; Liu P, 2012, TRAFFIC, V13, P715, DOI 10.1111/j.1600-0854.2012.01337.x; Lozach PY, 2011, CELL HOST MICROBE, V10, P75, DOI 10.1016/j.chom.2011.06.007; Lozach PY, 2004, J BIOL CHEM, V279, P32035, DOI 10.1074/jbc.M402296200; Ludwig IS, 2004, J VIROL, V78, P8322, DOI 10.1128/jvi.78.15.8322-8332.2004; Menon S, 2009, P NATL ACAD SCI USA, V106, P11524, DOI 10.1073/pnas.0901783106; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Neumann AK, 2008, J CELL SCI, V121, P634, DOI 10.1242/jcs.022418; Pohlmann S, 2001, J VIROL, V75, P10523, DOI 10.1128/JVI.75.21.10523-10526.2001; Puig-Kroger A, 2004, J BIOL CHEM, V279, P25680, DOI 10.1074/jbc.M311516200; Rappocciolo G, 2008, J VIROL, V82, P4793, DOI 10.1128/JVI.01587-07; Regan AD, 2008, J VIROL, V82, P11992, DOI 10.1128/JVI.01094-08; Serrano-Gomez D, 2008, J BIOL CHEM, V283, P3889, DOI 10.1074/jbc.M706004200; Sierra-Filardi E, 2010, MOL IMMUNOL, V47, P840, DOI 10.1016/j.molimm.2009.09.036; Simmons G, 2003, VIROLOGY, V305, P115, DOI 10.1006/viro.2002.1730; Smith AL, 2007, J EXP MED, V204, P421, DOI 10.1084/jem.20061604; Soilleux EJ, 2002, J LEUKOCYTE BIOL, V71, P445; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Tacken PJ, 2007, NAT REV IMMUNOL, V7, P790, DOI 10.1038/nri2173; Tacken PJ, 2011, BLOOD, V118, P4111, DOI 10.1182/blood-2011-04-346957; Thery C, 2001, CURR OPIN IMMUNOL, V13, P45, DOI 10.1016/S0952-7915(00)00180-1; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; Yu QD, 2009, J MOL BIOL, V387, P1075, DOI 10.1016/j.jmb.2009.02.046; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100	50	35	35	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38946	38955		10.1074/jbc.M112.380121	http://dx.doi.org/10.1074/jbc.M112.380121			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23019323	hybrid, Green Published			2022-12-28	WOS:000310982800050
J	Serventi, F; Youard, ZA; Murset, V; Huwiler, S; Buhler, D; Richter, M; Luchsinger, R; Fischer, HM; Brogioli, R; Niederer, M; Hennecke, H				Serventi, Fabio; Youard, Zeb Andrew; Murset, Valerie; Huwiler, Simona; Buehler, Doris; Richter, Miriam; Luchsinger, Ronny; Fischer, Hans-Martin; Brogioli, Robert; Niederer, Martina; Hennecke, Hauke			Copper Starvation-inducible Protein for Cytochrome Oxidase Biogenesis in Bradyrhizobium japonicum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-OXIDASE; RHIZOBIUM-JAPONICUM; AEROBIC RESPIRATION; NITROGEN-FIXATION; GENES; INSIGHTS; BINDING; IDENTIFICATION; SUPERFAMILY; ACQUISITION	Microarray analysis of Bradyrhizobium japonicum grown under copper limitation uncovered five genes named pcuABCDE, which are co-transcribed and co-regulated as an operon. The predicted gene products are periplasmic proteins (PcuA, PcuC, and PcuD), a TonB-dependent outer membrane receptor (PcuB), and a cytoplasmic membrane-integral protein (PcuE). Homologs of PcuC and PcuE had been discovered in other bacteria, namely PCuAC and YcnJ, where they play a role in cytochrome oxidase biogenesis and copper transport, respectively. Deletion of the pcuABCDE operon led to a pleiotropic phenotype, including defects in the aa(3)-type cytochrome oxidase, symbiotic nitrogen fixation, and anoxic nitrate respiration. Complementation analyses revealed that, under our assay conditions, the tested functions depended only on the pcuC gene and not on pcuA, pcuB, pcuD, or pcuE. The B. japonicum genome harbors a second pcuC-like gene (blr7088), which, however, did not functionally replace the mutated pcuC. The PcuC protein was overexpressed in Escherichia coli, purified to homogeneity, and shown to bind Cu(I) with high affinity in a 1: 1 stoichiometry. The replacement of His(79), Met(90), His(113), and Met(115) by alanine perturbed copper binding. This corroborates the previously purported role of this protein as a periplasmic copper chaperone for the formation of the Cu-A center on the aa(3)-type cytochrome oxidase. In addition, we provide evidence that PcuC and the copper chaperone ScoI are important for the symbiotically essential, Cu-A-free cbb(3)-type cytochrome oxidase specifically in endosymbiotic bacteroids of soybean root nodules, which could explain the symbiosis-defective phenotype of the pcuC and scoI mutants.	[Serventi, Fabio; Youard, Zeb Andrew; Murset, Valerie; Huwiler, Simona; Buehler, Doris; Richter, Miriam; Luchsinger, Ronny; Fischer, Hans-Martin; Hennecke, Hauke] Swiss Fed Inst Technol, Inst Microbiol, CH-8093 Zurich, Switzerland; [Brogioli, Robert] Swiss Fed Inst Technol, Inorgan Chem Lab, CH-8093 Zurich, Switzerland; [Niederer, Martina] Swiss Fed Inst Technol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Hennecke, H (corresponding author), Swiss Fed Inst Technol, Inst Microbiol, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	hennecke@micro.biol.ethz.ch	Huwiler, Simona G./AAK-1322-2020	Huwiler, Simona G./0000-0002-4876-9308	Swiss National Foundation for Scientific Research; ETH Zurich	Swiss National Foundation for Scientific Research(Swiss National Science Foundation (SNSF)); ETH Zurich(ETH Zurich)	This work was supported by grants from the Swiss National Foundation for Scientific Research and the ETH Zurich.	Abramson J, 2000, NAT STRUCT BIOL, V7, P910; Abriata LA, 2008, NAT CHEM BIOL, V4, P599, DOI 10.1038/nchembio.110; Arunothayanan H, 2010, PLANT CELL PHYSIOL, V51, P1242, DOI 10.1093/pcp/pcq079; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Beck C, 1997, J BACTERIOL, V179, P364, DOI 10.1128/jb.179.2.364-369.1997; Becker A, 2004, MOL PLANT MICROBE IN, V17, P292, DOI 10.1094/MPMI.2004.17.3.292; BENDER CL, 1986, J BACTERIOL, V165, P534, DOI 10.1128/jb.165.2.534-541.1986; BISHOP PE, 1976, PLANT PHYSIOL, V57, P542, DOI 10.1104/pp.57.4.542; BOTT M, 1990, MOL MICROBIOL, V4, P2147, DOI 10.1111/j.1365-2958.1990.tb00576.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buhler D, 2010, J BIOL CHEM, V285, P15704, DOI 10.1074/jbc.M109.085217; Buschmann S, 2010, SCIENCE, V329, P327, DOI 10.1126/science.1187303; Cawthorn TR, 2009, BIOCHEMISTRY-US, V48, P4448, DOI 10.1021/bi802288m; Chillappagari S, 2009, J BACTERIOL, V191, P2362, DOI 10.1128/JB.01616-08; Cobine PA, 2006, BBA-MOL CELL RES, V1763, P759, DOI 10.1016/j.bbamcr.2006.03.002; DANIEL RM, 1972, BIOCHIM BIOPHYS ACTA, V275, P347, DOI 10.1016/0005-2728(72)90215-0; Delmotte N, 2010, PROTEOMICS, V10, P1391, DOI 10.1002/pmic.200900710; Ducluzeau AL, 2008, MOL BIOL EVOL, V25, P1158, DOI 10.1093/molbev/msn062; Ekici S, 2012, MBIO, V3, DOI 10.1128/mBio.00293-11; Ekici S, 2012, BBA-BIOENERGETICS, V1817, P898, DOI 10.1016/j.bbabio.2011.10.011; FISCHER HM, 1993, EMBO J, V12, P2901, DOI 10.1002/j.1460-2075.1993.tb05952.x; Frangipani E, 2009, FEMS MICROBIOL LETT, V298, P234, DOI 10.1111/j.1574-6968.2009.01726.x; GARCIAHORSMAN JA, 1994, J BACTERIOL, V176, P5587, DOI 10.1128/JB.176.18.5587-5600.1994; GERHUS E, 1990, J BACTERIOL, V172, P2392, DOI 10.1128/jb.172.5.2392-2400.1990; GOTTFERT M, 1990, P NATL ACAD SCI USA, V87, P2680, DOI 10.1073/pnas.87.7.2680; GOTTFERT M, 1990, MOL PLANT MICROBE IN, V3, P308, DOI 10.1094/MPMI-3-308; HAHN M, 1984, MOL GEN GENET, V193, P46, DOI 10.1007/BF00327412; Han HZ, 2011, P NATL ACAD SCI USA, V108, P14109, DOI 10.1073/pnas.1018958108; Hassani BK, 2010, J BIOL CHEM, V285, P19330, DOI 10.1074/jbc.M110.116020; Hauser F, 2007, MOL GENET GENOMICS, V278, P255, DOI 10.1007/s00438-007-0246-9; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hiser L, 2000, J BIOL CHEM, V275, P619, DOI 10.1074/jbc.275.1.619; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Koch HG, 2000, J MOL BIOL, V297, P49, DOI 10.1006/jmbi.2000.3555; Krewulak KD, 2011, BIOCHEM CELL BIOL, V89, P87, DOI [10.1139/o10-141, 10.1139/O10-141]; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lindemann A, 2007, J BACTERIOL, V189, P8928, DOI 10.1128/JB.01088-07; LOFERER H, 1993, EMBO J, V12, P3373, DOI 10.1002/j.1460-2075.1993.tb06011.x; Lohmeyer E, 2012, BBA-BIOENERGETICS, V1817, P2005, DOI 10.1016/j.bbabio.2012.06.621; Mesa S, 2008, J BACTERIOL, V190, P6568, DOI 10.1128/JB.00748-08; Mesa S, 2009, P NATL ACAD SCI USA, V106, P21860, DOI 10.1073/pnas.0908097106; Miller J. H., 1972, EXPT MOL GENETICS, P433; NICHOLAS DJD, 1957, METHOD ENZYMOL, V3, P981; PARKS TD, 1994, ANAL BIOCHEM, V216, P413, DOI 10.1006/abio.1994.1060; Poole RK, 2000, ADV MICROB PHYSIOL, V43, P165, DOI 10.1016/S0065-2911(00)43005-5; Preisig O, 1996, J BACTERIOL, V178, P1532, DOI 10.1128/JB.178.6.1532-1538.1996; Preisig O, 1996, ARCH MICROBIOL, V165, P297, DOI 10.1007/s002030050330; PREISIG O, 1993, P NATL ACAD SCI USA, V90, P3309, DOI 10.1073/pnas.90.8.3309; REGENSBURGER B, 1983, ARCH MICROBIOL, V135, P103, DOI 10.1007/BF00408017; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Sarma AD, 2005, PROTEOMICS, V5, P4170, DOI 10.1002/pmic.200401296; Schulz H, 1998, SCIENCE, V281, P1197, DOI 10.1126/science.281.5380.1197; SMITH GF, 1953, ANAL CHEM, V25, P510, DOI 10.1021/ac60075a037; Sousa FL, 2012, BBA-BIOENERGETICS, V1817, P629, DOI 10.1016/j.bbabio.2011.09.020; Thompson AK, 2012, BBA-BIOENERGETICS, V1817, P955, DOI 10.1016/j.bbabio.2012.01.003; Thompson AK, 2010, BIOCHEMISTRY-US, V49, P5651, DOI 10.1021/bi1003876; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; VANDEROOST J, 1991, J BIOENERG BIOMEMBR, V23, P257, DOI 10.1007/BF00762221; Velasco L, 2001, BBA-GENE STRUCT EXPR, V1521, P130, DOI 10.1016/S0167-4781(01)00279-2; VINCENT J. M., 1970, A Manual for the Practical Study of the Root- Bacteria.; ZAK B, 1958, CLIN CHIM ACTA, V3, P328, DOI 10.1016/0009-8981(58)90021-4; Zhou L, 2008, BIOCHEM J, V413, P459, DOI 10.1042/BJ20080467	63	30	30	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38812	38823		10.1074/jbc.M112.406173	http://dx.doi.org/10.1074/jbc.M112.406173			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23012364	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000310982800038
J	Grimm, PR; Taneja, TK; Liu, J; Coleman, R; Chen, YY; Delpire, E; Wade, JB; Welling, PA				Grimm, P. Richard; Taneja, Tarvinder K.; Liu, Jie; Coleman, Richard; Chen, Yang-Yi; Delpire, Eric; Wade, James B.; Welling, Paul A.			SPAK Isoforms and OSR1 Regulate Sodium-Chloride Co-transporters in a Nephron-specific Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-CL-COTRANSPORTER; ALANINE-RICH KINASE; NA+-K+-2CL(-) COTRANSPORTER; NA-K-2CL COTRANSPORTER; BLOOD-PRESSURE; DISTAL TUBULE; ANGIOTENSIN-II; DIETARY SALT; MOUSE MODEL; ACTIVATION	STE20/SPS-1-related proline-alanine-rich protein kinase (SPAK) and oxidative stress-related kinase (OSR1) activate the potassium-dependent sodium-chloride co-transporter, NKCC2, and thiazide-sensitive sodium-chloride cotransporter, NCC, in vitro, and both co-localize with a kinase regulatory molecule, Cab39/MO25 alpha, at the apical membrane of the thick ascending limb (TAL) and distal convoluted tubule (DCT). Yet genetic ablation of SPAK in mice causes a selective loss of NCC function, whereas NKCC2 becomes hyperphosphorylated. Here, we explore the underlying mechanisms in wild-type and SPAK-null mice. Unlike in the DCT, OSR1 remains at the TAL apical membrane of KO mice where it is accompanied by an increase in the active, phosphorylated form of AMP-activated kinase. We found an alterative SPAK isoform (putative SPAK2 form), which modestly inhibits cotransporter activity in vitro, is more abundant in the medulla than the cortex. Thus, enhanced NKCC2 phosphorylation in the SPAK knock-out may be explained by removal of inhibitory SPAK2, sustained activity of OSR1, and activation of other kinases. By contrast, the OSR1/SPAK/M025 alpha signaling apparatus is disrupted in the DCT. OSR1 becomes largely inactive and displaced from M025 alpha and NCC at the apical membrane, and redistributes to dense punctate structures, containing WNK1, within the cytoplasm. These changes are paralleled by a decrease in NCC phosphorylation and a decrease in the mass of the distal convoluted tubule, exclusive to DCT1. As a result of the dependent nature of OSR1 on SPAK in the DCT, NCC is unable to be activated. Consequently, SPAK(-/-) mice are highly sensitive to dietary salt restriction, displaying prolonged negative sodium balance and hypotension.	[Grimm, P. Richard; Taneja, Tarvinder K.; Liu, Jie; Coleman, Richard; Chen, Yang-Yi; Wade, James B.; Welling, Paul A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Delpire, Eric] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37232 USA	University System of Maryland; University of Maryland Baltimore; Vanderbilt University	Welling, PA (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	pwelling@umaryland.edu		Grimm, Paul/0000-0002-9368-0601	National Institutes of Health [1RC1DK086817, DK32839, GM074771, 5T32HL072751]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032839, RC1DK086817, R01DK063049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074771] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1RC1DK086817 (to P. A. W.), DK32839 (to J. B. W.), GM074771 (to E. D.), and 5T32HL072751 (to P. R. G.).	[Anonymous], 1968, MIKROSKOPIE, V22, P132; Belge H, 2007, P NATL ACAD SCI USA, V104, P14849, DOI 10.1073/pnas.0702810104; Carmosino M, 2010, MOL BIOL CELL, V21, P3985, DOI 10.1091/mbc.E10-05-0456; Castaneda-Bueno M, 2012, P NATL ACAD SCI USA, V109, P7929, DOI 10.1073/pnas.1200947109; Chiga M, 2008, KIDNEY INT, V74, P1403, DOI 10.1038/ki.2008.451; Coleman RA, 2000, AM J PHYSIOL-RENAL, V279, pF874, DOI 10.1152/ajprenal.2000.279.5.F874; Delpire E, 2008, BIOCHEM J, V409, P321, DOI 10.1042/BJ20071324; Delpire E, 2011, AM J PHYSIOL-CELL PH, V301, pC1074, DOI 10.1152/ajpcell.00131.2011; Delpire E, 2009, PFLUG ARCH EUR J PHY, V458, P953, DOI 10.1007/s00424-009-0674-y; Filippi BM, 2011, EMBO J, V30, P1730, DOI 10.1038/emboj.2011.78; Flemmer AW, 2002, J BIOL CHEM, V277, P37551, DOI 10.1074/jbc.M206294200; Fraser SA, 2007, BIOCHEM J, V405, P85, DOI 10.1042/BJ20061850; Gagnon KBE, 2006, MOL CELL BIOL, V26, P689, DOI 10.1128/MCB.26.2.689-698.2006; Gagnon KB, 2011, CELL PHYSIOL BIOCHEM, V28, P1219, DOI 10.1159/000335854; Geng Y, 2009, J BIOL CHEM, V284, P14020, DOI 10.1074/jbc.M900142200; GORDON RD, 1986, HYPERTENSION, V8, P93, DOI 10.1161/01.HYP.8.2.93; Kim GH, 1999, AM J PHYSIOL-RENAL, V276, pF96, DOI 10.1152/ajprenal.1999.276.1.F96; Lalioti MD, 2006, NAT GENET, V38, P1124, DOI 10.1038/ng1877; Lee SJ, 2009, PROTEIN SCI, V18, P304, DOI 10.1002/pro.27; Lin SH, 2011, P NATL ACAD SCI USA, V108, P17538, DOI 10.1073/pnas.1107452108; Loffing J, 2004, J AM SOC NEPHROL, V15, P2276, DOI 10.1097/01.ASN.0000138234.18569.63; Loffing J, 1996, KIDNEY INT, V50, P1180, DOI 10.1038/ki.1996.426; McCormick JA, 2011, CELL METAB, V14, P352, DOI 10.1016/j.cmet.2011.07.009; Pacheco-Alvarez D, 2006, J BIOL CHEM, V281, P28755, DOI 10.1074/jbc.M603773200; Piechotta K, 2003, J BIOL CHEM, V278, P52848, DOI 10.1074/jbc.M309436200; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; Reiche J, 2010, MOL CELL BIOL, V30, P3027, DOI 10.1128/MCB.01560-09; Reilly RF, 2000, PHYSIOL REV, V80, P277, DOI 10.1152/physrev.2000.80.1.277; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Richardson C, 2011, J CELL SCI, V124, P789, DOI 10.1242/jcs.077230; San-Cristobal P, 2009, P NATL ACAD SCI USA, V106, P4384, DOI 10.1073/pnas.0813238106; SCHAMBELAN M, 1981, KIDNEY INT, V19, P716, DOI 10.1038/ki.1981.72; Simon DB, 1996, AM J PHYSIOL-RENAL, V271, pF961, DOI 10.1152/ajprenal.1996.271.5.F961; STANTON BA, 1989, AM J PHYSIOL, V257, pF1, DOI 10.1152/ajprenal.1989.257.1.F1; Vallon V, 2009, AM J PHYSIOL-RENAL, V297, pF704, DOI 10.1152/ajprenal.00030.2009; Wagner CA, 2008, AM J PHYSIOL-RENAL, V294, pF1373, DOI 10.1152/ajprenal.00613.2007; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Yang CL, 2005, J CLIN INVEST, V115, P1379, DOI 10.1172/JCI200522452; Yang SS, 2010, J AM SOC NEPHROL, V21, P1868, DOI 10.1681/ASN.2009121295; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377	41	94	94	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.402800	http://dx.doi.org/10.1074/jbc.M112.402800			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22977235	hybrid, Green Published			2022-12-28	WOS:000310642200008
J	Hance, MW; Dole, K; Gopal, U; Bohonowych, JE; Jezierska-Drutel, A; Neumann, CA; Liu, HB; Garraway, IP; Isaacs, JS				Hance, Michael W.; Dole, Krystal; Gopal, Udhayakumar; Bohonowych, Jessica E.; Jezierska-Drutel, Agnieszka; Neumann, Carola A.; Liu, Haibo; Garraway, Isla P.; Isaacs, Jennifer S.			Secreted Hsp90 Is a Novel Regulator of the Epithelial to Mesenchymal Transition (EMT) in Prostate Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SNAIL; RECEPTOR-RELATED PROTEIN; UP-REGULATION; HEPATOCELLULAR-CARCINOMA; EXTRACELLULAR HSP90; GENE-EXPRESSION; BONE METASTASIS; GROWTH; ACTIVATION; CELLS	Prostate cancer (PCa) is the most frequently diagnosed malignancy in men, and the second highest contributor of male cancer related lethality. Disease mortality is due primarily to metastatic spread, highlighting the urgent need to identify factors involved in this progression. Activation of the genetic epithelial to mesenchymal transition (EMT) program is implicated as a major contributor of PCa progression. Initiation of EMT confers invasive and metastatic behavior in preclinical models and is correlated with poor clinical prognosis. Extracellular Hsp90 (eHsp90) promotes cell motility and invasion in cancer cells and metastasis in preclinical models, however, the mechanistic basis for its widespread tumorigenic function remains unclear. We have identified a novel and pivotal role for eHsp90 in driving EMT events in PCa. In support of this notion, more metastatic PCa lines exhibited increased eHsp90 expression relative to their lineage-related nonmetastatic counterparts. We demonstrate that eHsp90 promoted cell motility in an ERK and matrix metalloproteinase-2/9-dependent manner, and shifted cellular morphology toward a mesenchymal phenotype. Conversely, inhibition of eHsp90 attenuated pro-motility signaling, blocked PCa migration, and shifted cell morphology toward an epithelial phenotype. Last, we report that surface eHsp90 was found in primary PCa tumor specimens, and elevated eHsp90 expression was associated with increased levels of matrix metalloproteinase-2/9 transcripts. We conclude that eHsp90 serves as a driver of EMT events, providing a mechanistic basis for its ability to promote cancer progression and metastasis in preclinical models. Furthermore, its newly identified expression in PCa specimens, and potential regulation of pro-metastatic genes, supports a putative clinical role for eHsp90 in PCa progression.	[Hance, Michael W.; Dole, Krystal; Gopal, Udhayakumar; Bohonowych, Jessica E.; Jezierska-Drutel, Agnieszka; Neumann, Carola A.; Isaacs, Jennifer S.] Med Univ S Carolina, Dept Cell & Mol Pharmacol, Charleston, SC 29425 USA; [Liu, Haibo; Garraway, Isla P.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA	Medical University of South Carolina; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Isaacs, JS (corresponding author), Hollings Canc Ctr, 86 Jonathan Lucas St, Charleston, SC 29425 USA.	isaacsj@musc.edu	Gopal, Udhayakumar/K-9092-2019	Neumann, Carola/0000-0003-2801-9531; gopal, Udhayakumar/0000-0003-2110-0601	National Institutes of Health [R01 CA135297, T32 CA119945, K12 GM081265]; Cancer Center Support Grant [P30 CA138313]; NATIONAL CANCER INSTITUTE [R01CA135297, F31CA177015, R01CA131350, P30CA138313, T32CA119945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM081265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA135297 (to J. S. I.) and Training Grant T32 CA119945 (to M. W. H.) and Institutional Research and Academic Career Development Award Training Grant K12 GM081265 (to J. E. B.).; We thank Joy Ware for the P69 and M12 cells, Chris Lindsey and Craig Beeson for synthesis of DMAG-N-oxide (NPGA), and Enzo Life Sciences for generous reagent support. Imaging facilities for this research were supported, in part, by Cancer Center Support Grant P30 CA138313 to the Hollings Cancer Center, Medical University of South Carolina. We also thank Phillip Howe and Simon Hayward for critical comments on this manuscript.	Acevedo VD, 2007, CANCER CELL, V12, P559, DOI 10.1016/j.ccr.2007.11.004; Andriole GL, 2009, NAT REV UROL, V6, P188, DOI 10.1038/nrurol.2009.46; Arya M, 2006, SURG ONCOL, V15, P117, DOI 10.1016/j.suronc.2006.10.002; Bae VL, 1998, PROSTATE, V34, P275, DOI 10.1002/(SICI)1097-0045(19980301)34:4<275::AID-PROS5>3.0.CO;2-G; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Becker B, 2004, EXP DERMATOL, V13, P27, DOI 10.1111/j.0906-6705.2004.00114.x; Bohonowych JE, 2010, J ONCOL, V2010, DOI 10.1155/2010/412985; Burgess EF, 2008, PROTEOM CLIN APPL, V2, P1223, DOI 10.1002/prca.200780073; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Cheng C. Yan, 2008, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V8, P1, DOI 10.2174/187152208783790778; Contreras HR, 2010, UROL ONCOL-SEMIN ORI, V28, P534, DOI 10.1016/j.urolonc.2009.03.018; Crawford ED, 2009, UROLOGY, V73, P4, DOI 10.1016/j.urology.2009.03.001; Culp S, 2009, BJU INT, V104, P1457, DOI 10.1111/j.1464-410X.2009.08646.x; David JM, 2012, CANCER RES, V72, P2917, DOI 10.1158/0008-5472.CAN-11-3498; Doehn U, 2009, MOL CELL, V35, P511, DOI 10.1016/j.molcel.2009.08.002; Efstathiou E, 2010, CLIN CANCER RES, V16, P1100, DOI 10.1158/1078-0432.CCR-09-1215; Ellenrieder V, 2001, CANCER RES, V61, P4222; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Figueiredo C, 2009, BLOOD, V113, P3008, DOI 10.1182/blood-2008-06-162727; FU XY, 1992, INT J CANCER, V52, P987; Garraway IP, 2010, PROSTATE, V70, P491, DOI 10.1002/pros.21083; Gopal U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017649; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Hahn-Dantona E, 2001, J BIOL CHEM, V276, P15498, DOI 10.1074/jbc.M100121200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanschen M., 2008, COLD SPRING HARBOR P, V86, P710; He H, 2010, PROSTATE, V70, P518, DOI 10.1002/pros.21086; HINCK L, 1994, J CELL BIOL, V125, P1327, DOI 10.1083/jcb.125.6.1327; Isaacs JS, 2003, CANCER CELL, V3, P213, DOI 10.1016/S1535-6108(03)00029-1; Ito H, 2004, CANCER RES, V64, P7439, DOI 10.1158/0008-5472.CAN-04-1177; Janda CY, 2010, NATURE, V465, P507, DOI 10.1038/nature08870; Johnson JL, 2011, ARTERIOSCL THROM VAS, V31, pE35, DOI 10.1161/ATVBAHA.111.225623; Johnson TR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-148; Jorda M, 2005, J CELL SCI, V118, P3371, DOI 10.1242/jcs.02465; Josson S, 2011, CANCER RES, V71, P2600, DOI 10.1158/0008-5472.CAN-10-3382; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Lagarrigue F, 2010, CANCER RES, V70, P6978, DOI 10.1158/0008-5472.CAN-10-0861; Langlois B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011584; Liwosz A, 2006, J BIOL CHEM, V281, P23138, DOI 10.1074/jbc.M512621200; Lue HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027720; Luo LY, 2002, BRIT J CANCER, V87, P339, DOI 10.1038/sj.bjc.6600439; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008; Markert EK, 2011, P NATL ACAD SCI USA, V108, P21276, DOI 10.1073/pnas.1117029108; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Orr AW, 2003, J CELL BIOL, V161, P1179, DOI 10.1083/jcb.200302069; Polette M, 2005, CANCER RES, V65, P7691, DOI 10.1158/0008-5472.CAN-04-4230; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Qin Z, 2010, VIROLOGY, V403, P92, DOI 10.1016/j.virol.2010.03.052; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Rojas A, 2011, ONCOGENE, V30, P2345, DOI 10.1038/onc.2010.605; Sahu D, 2012, MOL BIOL CELL, V23, P602, DOI 10.1091/mbc.E11-06-0575; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Sidera K, 2008, J BIOL CHEM, V283, P2031, DOI 10.1074/jbc.M701803200; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sims JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018848; Smolen GA, 2010, GENE DEV, V24, P2654, DOI 10.1101/gad.1989110; Song XM, 2010, J BIOL CHEM, V285, P40039, DOI 10.1074/jbc.M110.181941; Stellas D, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-51; STEPHENSON RA, 1992, J NATL CANCER I, V84, P951, DOI 10.1093/jnci/84.12.951; Strope SA, 2010, NAT REV UROL, V7, P487, DOI 10.1038/nrurol.2010.120; Sun LM, 2008, MOL CANCER RES, V6, P10, DOI 10.1158/1541-7786.MCR-07-0208; Sun YT, 2012, CANCER RES, V72, P527, DOI 10.1158/0008-5472.CAN-11-3004; Tanaka H, 2010, NAT MED, V16, P1414, DOI 10.1038/nm.2236; THALMANN GN, 1994, CANCER RES, V54, P2577; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Tsutsumi S, 2008, ONCOGENE, V27, P2478, DOI 10.1038/sj.onc.1210897; ULLRICH SJ, 1986, P NATL ACAD SCI USA, V83, P3121, DOI 10.1073/pnas.83.10.3121; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Vidal CI, 2004, ONCOGENE, V23, P8859, DOI 10.1038/sj.onc.1208082; Wang XF, 2009, P NATL ACAD SCI USA, V106, P21288, DOI 10.1073/pnas.0908151106; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xie DX, 2010, P NATL ACAD SCI USA, V107, P2485, DOI 10.1073/pnas.0908133107; Xu JC, 2006, PROSTATE, V66, P1664, DOI 10.1002/pros.20488; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang YH, 2008, CANCER RES, V68, P4833, DOI 10.1158/0008-5472.CAN-08-0644; Yoshida T, 2006, ONCOGENE, V25, P6056, DOI 10.1038/sj.onc.1209635; Zhang Q, 2009, CLIN CANCER RES, V15, P3557, DOI 10.1158/1078-0432.CCR-08-1656; Zhang XP, 2009, MOL CANCER THER, V8, P499, DOI 10.1158/1535-7163.MCT-08-0544; Zhao XL, 2011, J CELL MOL MED, V15, P691, DOI 10.1111/j.1582-4934.2010.01052.x; Zhau Haiyen E., 2000, Cancer, V88, P2995, DOI 10.1002/1097-0142(20000615)88:12+<2995::AID-CNCR15>3.0.CO;2-Y; Zhau HE, 2008, CLIN EXP METASTAS, V25, P601, DOI 10.1007/s10585-008-9183-1; Zhau HYE, 1996, P NATL ACAD SCI USA, V93, P15152, DOI 10.1073/pnas.93.26.15152	87	98	102	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.389015	http://dx.doi.org/10.1074/jbc.M112.389015			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22989880	Green Published, hybrid			2022-12-28	WOS:000310642200013
J	Lee, RJ; Foskett, JK				Lee, Robert J.; Foskett, J. Kevin			Why Mouse Airway Submucosal Gland Serous Cells Do Not Secrete Fluid in Response to cAMP Stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; CYSTIC-FIBROSIS; MUCUS SECRETION; ACINAR-CELLS; CL-SECRETION; CFTR GENE; ACTIVATION; MODEL; MODULATION; PORCINE	Airway submucosal glands are important sites of cystic fibrosis transmembrane conductance regulator (CFTR) chloride (Cl-) channel expression and fluid secretion in the airway. Whereas both mouse and human submucosal glands and their serous acinar cells express CFTR, human glands and serous cells secrete much more robustly than mouse cells/glands in response to cAMP-generating agonists such as forskolin and vasoactive intestinal peptide. In this study, we examined mouse and human serous acinar cells to explain this difference and reveal further insights into the mechanisms of serous cell secretion. We found that mouse serous cells possess a robust cAMP-activated CFTR-dependent Cl- permeability, but they lack cAMP-activated calcium (Ca2+) signaling observed in human cells. Similar to human cells, basal K+ conductance is extremely small in mouse acinar cells. Lack of cAMP-activated Ca2+ signaling in mouse cells results in the absence of K+ conductances required for secretion. However, cAMP activates CFTR-dependent fluid secretion during low-level cholinergic stimulation that fails to activate secretion on its own. Robust CFTR-dependent fluid secretion was also observed when cAMP stimulation was combined with direct pharmacological activation of epithelial K+ channels with 1-ethyl-2-benzimidazolinone (EBIO). Our data suggest that mouse serous cells lack cAMP-mediated Ca2+ signaling to activate basolateral membrane K+ conductance, resulting in weak cAMP-driven serous cell fluid secretion, providing the likely explanation for reduced cAMP-driven secretion observed in mouse compared with human glands.	[Lee, Robert J.; Foskett, J. Kevin] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Foskett, J. Kevin] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Foskett, JK (corresponding author), Univ Penn, Dept Physiol, Perelman Sch Med, 726 Clin Res Bldg, Philadelphia, PA 19104 USA.	foskett@mail.med.upenn.edu	Foskett, Kevin/R-2549-2019; Lee, Robert J./L-4397-2017	Lee, Robert J./0000-0001-5826-6686; Foskett, J. Kevin/0000-0002-8854-0268	Cystic Fibrosis Foundation [LEE09F0, FOSKET11G0]	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	This work was supported by a Cystic Fibrosis Foundation postdoctoral fellowship (to R. J. L.) (LEE09F0) and a research grant (to J. K. F.) (FOSKET11G0).	Ballard ST, 2004, J PHYSIOL-LONDON, V556, P1, DOI 10.1113/jphysiol.2003.052779; Ballard ST, 2007, RESP PHYSIOL NEUROBI, V159, P271, DOI 10.1016/j.resp.2007.06.017; Boucher R C, 2001, Trans Am Clin Climatol Assoc, V112, P99; Cho HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024424; Cho HJ, 2010, AM J PHYSIOL-LUNG C, V299, pL124, DOI 10.1152/ajplung.00049.2010; Choi JY, 2007, J CLIN INVEST, V117, P3118, DOI 10.1172/JCI31992; Choi JY, 2009, J CLIN INVEST, V119, P1189, DOI 10.1172/JCI37284; Cuthbert AW, 1999, AM J PHYSIOL-CELL PH, V277, pC111, DOI 10.1152/ajpcell.1999.277.1.C111; Devor DC, 1996, AM J PHYSIOL-LUNG C, V271, pL785, DOI 10.1152/ajplung.1996.271.5.L785; Devor DC, 1996, AM J PHYSIOL-LUNG C, V271, pL775, DOI 10.1152/ajplung.1996.271.5.L775; DHO S, 1993, BIOCHIM BIOPHYS ACTA, V1152, P83, DOI 10.1016/0005-2736(93)90234-Q; FOSKETT JK, 1988, AM J PHYSIOL, V255, pC566, DOI 10.1152/ajpcell.1988.255.4.C566; FOSKETT JK, 1990, AM J PHYSIOL, V259, pC998; FOSKETT JK, 1989, P NATL ACAD SCI USA, V86, P167, DOI 10.1073/pnas.86.1.167; FOSKETT JK, 1989, SCIENCE, V244, P1582, DOI 10.1126/science.2500708; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; Hougaard C, 2009, J PHARMACOL EXP THER, V328, P28, DOI 10.1124/jpet.108.143123; Ianowski JP, 2007, J PHYSIOL-LONDON, V580, P301, DOI 10.1113/jphysiol.2006.123653; Ianowski JP, 2008, PFLUG ARCH EUR J PHY, V457, P529, DOI 10.1007/s00424-008-0527-0; Jensen BS, 1998, AM J PHYSIOL-CELL PH, V275, pC848, DOI 10.1152/ajpcell.1998.275.3.C848; Joo NS, 2010, J CLIN INVEST, V120, P3161, DOI 10.1172/JCI43466; Joo NS, 2006, J BIOL CHEM, V281, P7392, DOI 10.1074/jbc.M512766200; Joo NS, 2002, J BIOL CHEM, V277, P50710, DOI 10.1074/jbc.M208826200; Joo NS, 2001, AM J PHYSIOL-LUNG C, V281, pL458, DOI 10.1152/ajplung.2001.281.2.L458; Joo NS, 2002, J BIOL CHEM, V277, P28167, DOI 10.1074/jbc.M202712200; Keiser NW, 2011, CURR OPIN PULM MED, V17, P478, DOI 10.1097/MCP.0b013e32834b14c9; Lee RJ, 2008, J GEN PHYSIOL, V132, P161, DOI 10.1085/jgp.200810017; Lee RJ, 2007, J PHYSIOL-LONDON, V582, P1099, DOI 10.1113/jphysiol.2007.131995; Lee RJ, 2010, J CLIN INVEST, V120, P3137, DOI 10.1172/JCI42992; Lee RJ, 2010, AM J PHYSIOL-LUNG C, V298, pL210, DOI 10.1152/ajplung.00342.2009; MacVinish LJ, 2001, PFLUG ARCH EUR J PHY, V443, pS127; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; Meyerholz DK, 2010, AM J PATHOL, V176, P1377, DOI 10.2353/ajpath.2010.090849; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rogers CS, 2008, AM J PHYSIOL-LUNG C, V295, pL240, DOI 10.1152/ajplung.90203.2008; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Song YL, 2001, J BIOL CHEM, V276, P41288, DOI 10.1074/jbc.M107257200; Sun X, 2008, J CLIN INVEST, V118, P1578, DOI 10.1172/JCI34599; Sun XS, 2010, J CLIN INVEST, V120, P3149, DOI 10.1172/JCI43052; Syme CA, 2000, AM J PHYSIOL-CELL PH, V278, pC570, DOI 10.1152/ajpcell.2000.278.3.C570; Verkman AS, 2007, RESP PHYSIOL NEUROBI, V159, P324, DOI 10.1016/j.resp.2007.02.012; Wine JJ, 2007, AUTON NEUROSCI-BASIC, V133, P35, DOI 10.1016/j.autneu.2007.01.008; Wine Jeffrey J, 2004, Proc Am Thorac Soc, V1, P47, DOI 10.1513/pats.2306015	43	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.412817	http://dx.doi.org/10.1074/jbc.M112.412817			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22989883	Green Published, hybrid			2022-12-28	WOS:000310642200064
J	Zheng, XF; Yang, SY; Han, YC; Zhao, XY; Zhao, L; Tian, T; Tong, JY; Xu, PF; Xiong, C; Meng, AM				Zheng, Xiaofeng; Yang, Shuyan; Han, Yanchao; Zhao, Xinyi; Zhao, Long; Tian, Tian; Tong, Jingyuan; Xu, Pengfei; Xiong, Cong; Meng, Anming			Loss of Zygotic NUP107 Protein Causes Missing of Pharyngeal Skeleton and Other Tissue Defects with Impaired Nuclear Pore Function in Zebrafish Embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX; EXPRESSION; NUCLEOPORIN; GENE; REVEALS; DEATH; DIFFERENTIATION; DISRUPTION; COMPONENT; APOPTOSIS	The Nup107-160 multiprotein subcomplex is essential for the assembly of nuclear pore complexes. The developmental functions of individual constituents of this subcomplex in vertebrates remain elusive. In particular, it is unknown whether Nup107 plays an important role in development of vertebrate embryos. Zebrafish nup107 is maternally expressed and its zygotic expression becomes prominent in the head region and the intestine from 24 h postfertilization (hpf) onward. In this study, we generate a zebrafish mutant line, nup107(tsu068Gt), in which the nup107 locus is disrupted by an insertion of Tol2 transposon element in the first intron and as a result it fails to produce normal transcripts. Homozygous nup107(tsu068Gt) mutant embryos exhibit tissue-specific defects after 3 days postfertilization (dpf), including loss of the pharyngeal skeletons, degeneration of the intestine, absence of the swim bladder, and smaller eyes. These mutants die at 5-6 days. Extensive apoptosis occurs in the affected tissues, which is partially dependent on p53 apoptotic pathways. In cells of the defective tissues, FG-repeat nucleoporins are disturbed and nuclear pore number is reduced, leading to impaired translocation of mRNAs from the nucleus to the cytoplasm. Our findings shed new light on developmental function of Nup107 in vertebrates.	[Zheng, Xiaofeng; Yang, Shuyan; Han, Yanchao; Zhao, Xinyi; Zhao, Long; Tian, Tian; Tong, Jingyuan; Xu, Pengfei; Xiong, Cong; Meng, Anming] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Engn, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Yang, Shuyan; Meng, Anming] Chinese Acad Sci, Inst Zool, Beijing 100101, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Zoology, CAS	Meng, AM (corresponding author), Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Engn, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.	mengam@mail.tsinghua.edu.cn	Zhao, Long/A-6439-2014; Meng, Anming/A-4785-2012	Zhao, Long/0000-0003-2691-7055; Meng, Anming/0000-0001-7228-3431	Major Science Programs of China [2011CB943800]	Major Science Programs of China	This work was supported by grants from the Major Science Programs of China (2011CB943800).	AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Andre M, 2000, INT J DEV BIOL, V44, P249; Basel-Vanagaite L, 2006, ANN NEUROL, V60, P214, DOI 10.1002/ana.20902; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Boehmer T, 2003, P NATL ACAD SCI USA, V100, P981, DOI 10.1073/pnas.252749899; Chiang EFL, 2001, DEV BIOL, V231, P149, DOI 10.1006/dbio.2000.0129; Cronshaw JM, 2003, P NATL ACAD SCI USA, V100, P5823, DOI 10.1073/pnas.1031047100; Dauer WT, 2009, DEV CELL, V17, P626, DOI 10.1016/j.devcel.2009.10.016; DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552; Davuluri G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000240; de Jong-Curtain TA, 2009, GASTROENTEROLOGY, V136, P902, DOI 10.1053/j.gastro.2008.11.012; Faria AMC, 2006, IMMUNITY, V24, P295, DOI 10.1016/j.immuni.2006.01.014; Fernandez-Martinez J, 2009, CURR OPIN CELL BIOL, V21, P603, DOI 10.1016/j.ceb.2009.05.001; Gao N, 2011, GASTROENTEROLOGY, V140, P1547, DOI 10.1053/j.gastro.2011.01.048; Gonzalez-Aguilera C., 2012, NUCLEUS, V3; Han YC, 2011, HUM MOL GENET, V20, P3213, DOI 10.1093/hmg/ddr234; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Jamali T, 2011, INT REV CEL MOL BIO, V287, P233, DOI 10.1016/B978-0-12-386043-9.00006-2; Kimmel CB, 1998, DEV BIOL, V203, P245, DOI 10.1006/dbio.1998.9016; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Knight RD, 2006, ADV EXP MED BIOL, V589, P120; Lupu F, 2008, DEV CELL, V14, P831, DOI 10.1016/j.devcel.2008.03.011; Neilson DE, 2009, AM J HUM GENET, V84, P44, DOI 10.1016/j.ajhg.2008.12.009; Okita K, 2004, GENES CELLS, V9, P1083, DOI 10.1111/j.1365-2443.2004.00791.x; Plaster N, 2006, CELL DEATH DIFFER, V13, P223, DOI 10.1038/sj.cdd.4401747; Rodenas E, 2012, MOL BIOL CELL, V23, P930, DOI 10.1091/mbc.E11-11-0927; Schilling TF, 1997, DEVELOPMENT, V124, P2945; SCHILLING TF, 1994, DEVELOPMENT, V120, P483; Schwend T, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-59; Senger S, 2011, DEVELOPMENT, V138, P2133, DOI 10.1242/dev.057372; Vasu S, 2001, J CELL BIOL, V155, P339, DOI 10.1083/jcb.200108007; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Wu XS, 2001, P NATL ACAD SCI USA, V98, P3191, DOI 10.1073/pnas.051631598; YAN YL, 1995, DEV DYNAM, V203, P363, DOI 10.1002/aja.1002030308; Zhang XQ, 2008, CELL, V135, P1017, DOI 10.1016/j.cell.2008.10.022; Zhang Y, 2009, J CELL SCI, V122, P2197, DOI 10.1242/jcs.040659; Zhao L, 2008, CARDIOVASC RES, V80, P200, DOI 10.1093/cvr/cvn177; Zhao XY, 2010, J BIOL CHEM, V285, P27924, DOI 10.1074/jbc.M110.136077	39	18	19	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.408997	http://dx.doi.org/10.1074/jbc.M112.408997			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22965233	hybrid, Green Published			2022-12-28	WOS:000310642200058
J	Ma, LQ; Zhang, XX; Zhou, M; Chen, HJ				Ma, Liqun; Zhang, Xuexin; Zhou, Min; Chen, Haijun			Acid-sensitive TWIK and TASK Two-pore Domain Potassium Channels Change Ion Selectivity and Become Permeable to Sodium in Extracellular Acidification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE INACTIVATION; K+ CHANNEL; ENDOPLASMIC-RETICULUM; PH-SENSITIVITY; N-TYPE; PORE; EXPRESSION; CURRENTS; HISTIDINE; FILTER	Two-pore domain K+ channels (K2P) mediate background K+ conductance and play a key role in a variety of cellular functions. Among the 15 mammalian K2P isoforms, TWIK-1, TASK-1, and TASK-3 K+ channels are sensitive to extracellular acidification. Lowered or acidic extracellular pH (pHo) strongly inhibits outward currents through these K2P channels. However, the mechanism of how low pHo affects these acid-sensitive K2P channels is not well understood. Here we show that in Na+ based bath solutions with physiological K+ gradients, lowered pHo largely shifts the reversal potential of TWIK-1, TASK-1, and TASK-3 K+ channels, which are heterologously expressed in Chinese hamster ovary cells, into the depolarizing direction and significantly increases their Na+ to K+ relative permeability. Low pHo-induced inhibitions in these acid-sensitive K2P channels are more profound in Na+-based bath solutions than in channel-impermeable N-methyl-D-glucamine-based bath solutions, consistent with increases in the Na+ to K+ relative permeability and decreases in electrochemical driving forces of outward K+ currents of the channels. These findings indicate that TWIK-1, TASK-1, and TASK-3 K+ channels change ion selectivity in response to lowered pHo, provide insights on the understanding of how extracellular acidification modulates acid-sensitive K2P channels, and imply that these acid-sensitive K2P channels may regulate cellular function with dynamic changes in their ion selectivity.	[Ma, Liqun; Zhang, Xuexin; Chen, Haijun] SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA; [Ma, Liqun; Zhang, Xuexin; Chen, Haijun] SUNY Albany, Neurosci Res Ctr, Albany, NY 12222 USA; [Zhou, Min] Ohio State Univ, Wexner Med Ctr, Dept Neurosci, Columbus, OH 43210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University System of Ohio; Ohio State University	Chen, HJ (corresponding author), SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA.	hchen01@albany.edu	Zhang, Xuexin/I-7600-2013; 张学新, XUEXIN ZHANG/AAD-7645-2019	张学新, XUEXIN ZHANG/0000-0001-8276-3885; Zhou, Min/0000-0001-6249-2977	National Institutes of Health through NIGMS [1R01GM102943-01A1]; American Heart Association [11GRNT7270014]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102943] Funding Source: NIH RePORTER	National Institutes of Health through NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01GM102943-01A1 (to H. C.) through the NIGMS. This work was also supported by American Heart Association (11GRNT7270014) (to H. C.).	Chatelain FC, 2012, P NATL ACAD SCI USA, V109, P5499, DOI 10.1073/pnas.1201132109; Clarke CE, 2008, J BIOL CHEM, V283, P16985, DOI 10.1074/jbc.M801368200; Claydon TW, 2002, AM J PHYSIOL-CELL PH, V283, pC1114, DOI 10.1152/ajpcell.00542.2001; Claydon TW, 2000, J PHYSIOL-LONDON, V526, P253, DOI 10.1111/j.1469-7793.2000.00253.x; Cohen A, 2009, EUR BIOPHYS J BIOPHY, V39, P61, DOI 10.1007/s00249-009-0457-6; Cohen A, 2008, J BIOL CHEM, V283, P19448, DOI 10.1074/jbc.M801273200; COULTER KL, 1995, NEURON, V15, P1157, DOI 10.1016/0896-6273(95)90103-5; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Feliciangeli S, 2010, J BIOL CHEM, V285, P4798, DOI 10.1074/jbc.M109.078535; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Goldstein SAN, 2005, PHARMACOL REV, V57, P527, DOI 10.1124/pr.57.4.12; Goldstein SAN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002225; HILLE B, 2001, ION CHANNELS EXCITAB, P469; Kang D, 2004, J BIOL CHEM, V279, P28063, DOI 10.1074/jbc.M402940200; Kehl SJ, 2002, J PHYSIOL-LONDON, V541, P9, DOI 10.1113/jphysiol.2001.014456; Keshavaprasad B, 2005, ANESTH ANALG, V101, P1042, DOI 10.1213/01.ane.0000168447.87557.5a; Kim Y, 1999, AM J PHYSIOL-HEART C, V277, pH1669, DOI 10.1152/ajpheart.1999.277.5.H1669; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; Kiss L, 1999, BIOPHYS J, V76, P253, DOI 10.1016/S0006-3495(99)77194-8; Lesage F, 1997, FEBS LETT, V402, P28, DOI 10.1016/S0014-5793(96)01491-3; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Lesage F, 2011, PHYSIOLOGY, V26, P424, DOI 10.1152/physiol.00029.2011; Li XY, 2003, AM J PHYSIOL-HEART C, V284, pH71, DOI 10.1152/ajpheart.00392.2002; Lopes CMB, 2001, J BIOL CHEM, V276, P24449, DOI 10.1074/jbc.C100184200; Lopes CMB, 2000, J BIOL CHEM, V275, P16969, DOI 10.1074/jbc.M001948200; Lotshaw DP, 2007, CELL BIOCHEM BIOPHYS, V47, P209, DOI 10.1007/s12013-007-0007-8; Ma LQ, 2012, BIOPHYS J, V102, pL34, DOI 10.1016/j.bpj.2012.03.011; Ma LQ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001726; Mathie A, 2010, J PHYSIOL-LONDON, V588, P3149, DOI 10.1113/jphysiol.2010.192344; Meadows HJ, 2001, NEUROPHARMACOLOGY, V40, P551, DOI 10.1016/S0028-3908(00)00189-1; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Nie X, 2005, PFLUG ARCH EUR J PHY, V451, P479, DOI 10.1007/s00424-005-1480-9; O'Connell AD, 2005, J PHYSIOL-LONDON, V562, P687, DOI 10.1113/jphysiol.2004.079020; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Ordog B, 2006, INT J CARDIOL, V111, P386, DOI 10.1016/j.ijcard.2005.07.063; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Rajan S, 2000, J BIOL CHEM, V275, P16650, DOI 10.1074/jbc.M000030200; Renigunta V, 2006, TRAFFIC, V7, P168, DOI 10.1111/j.1600-0854.2005.00375.x; Stansfeld PJ, 2008, BIOCHEMISTRY-US, V47, P7414, DOI 10.1021/bi800475j; Steidl JV, 1999, MOL PHARMACOL, V55, P812; Yuill K, 2004, PFLUG ARCH EUR J PHY, V448, P63, DOI 10.1007/s00424-003-1218-5; Zhou M, 2009, J NEUROSCI, V29, P8551, DOI 10.1523/JNEUROSCI.5784-08.2009; Zilberberg N, 2001, NEURON, V32, P635, DOI 10.1016/S0896-6273(01)00503-7	44	36	37	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37145	37153		10.1074/jbc.M112.398164	http://dx.doi.org/10.1074/jbc.M112.398164			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22948150	hybrid, Green Published			2022-12-28	WOS:000310588500048
J	Pignatelli, J; LaLonde, SE; LaLonde, DP; Clarke, D; Turner, CE				Pignatelli, Jeanine; LaLonde, Sara E.; LaLonde, David P.; Clarke, Dominic; Turner, Christopher E.			Actopaxin (alpha-Parvin) Phosphorylation Is Required for Matrix Degradation and Cancer Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN-LINKED KINASE; FOCAL ADHESION PROTEIN; BREAST EPITHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; EXTRACELLULAR-MATRIX; P21-ACTIVATED KINASES; INVADOPODIA FORMATION; EXCHANGE FACTOR; UP-REGULATION; P38 MAPK	Dysregulation of cell adhesion and motility is known to be an important factor in the development of tumor malignancy. Actopaxin (alpha-parvin) is a paxillin, integrin-linked kinase, and F-actin binding focal adhesion protein with several serine phosphorylation sites in the amino terminus that contribute to the regulation of cell spreading and migration. Here, phosphorylation of actopaxin is shown to contribute to the regulation of matrix degradation and cell invasion. Osteosarcoma cells stably expressing wild type (WT), nonphosphorylatable (Quint), and phosphomimetic (S4D/S8D) actopaxin demonstrate that actopaxin phosphorylation is necessary for efficient Src and matrix metalloproteinase-driven degradation of extracellular matrix. Rac1 was found to be required for actopaxin-induced matrix degradation whereas inhibition of myosin contractility promoted degradation in the phosphomutant-expressing Quint cells, indicating that a balance of Rho GTPase signaling and regulation of cellular tension are important for the process. Furthermore, actopaxin forms a complex with the Rac1/Cdc42 GEF beta-PIX and Rac1/Cdc42 effector PAK1, to regulate actopaxin-dependent matrix degradation. Actopaxin phosphorylation is elevated in the invasive breast cancer cell line MDA-MB-231 compared with normal breast epithelial MCF10A cells. Expression of the nonphosphorylatable Quint actopaxin in MDA-MB-231 cells inhibits cell invasion whereas overexpression of WT actopaxin promotes invasion in MCF10A cells. Taken together, this study demonstrates a new role for actopaxin phosphorylation in matrix degradation and cell invasion via regulation of Rho GTPase signaling.	[Pignatelli, Jeanine; Turner, Christopher E.] SUNY Syracuse, Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA; [LaLonde, Sara E.] Cornell Univ, Coll Vet Med, Anim Hlth Diagnost Ctr, Ithaca, NY 14853 USA; [LaLonde, David P.] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA; [Clarke, Dominic] Charter Med Inc, Dept Cellular Therapy, Winston Salem, NC 27103 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Cornell University; Cornell University	Turner, CE (corresponding author), SUNY Syracuse, Upstate Med Univ, Dept Cell & Dev Biol, 750 E Adams St, Syracuse, NY 13210 USA.	turnerce@upstate.edu			National Institutes of Health [R01HL070244, R01GM47607]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL070244 and R01GM47607 (to C. E. T.).	Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Attwell S, 2003, MOL BIOL CELL, V14, P4813, DOI 10.1091/mbc.E03-05-0308; Ayala I, 2008, J CELL SCI, V121, P369, DOI 10.1242/jcs.008037; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Bakin AV, 2002, J CELL SCI, V115, P3193; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bowden ET, 2006, EXP CELL RES, V312, P1240, DOI 10.1016/j.yexcr.2005.12.012; Brown MC, 2002, MOL BIOL CELL, V13, P1550, DOI 10.1091/mbc.02-02-0015; Buccione R, 2009, CANCER METAST REV, V28, P137, DOI 10.1007/s10555-008-9176-1; Burgstaller G, 2004, J CELL SCI, V117, P223, DOI 10.1242/jcs.00839; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Clarke DM, 2004, J CELL BIOL, V166, P901, DOI 10.1083/jcb.200404024; Courtneidge SA, 2005, COLD SH Q B, V70, P167, DOI 10.1101/sqb.2005.70.014; Curtis M, 2002, BIOCHEM J, V363, P233, DOI 10.1042/0264-6021:3630233; Destaing O, 2011, CURR OPIN CELL BIOL, V23, P597, DOI 10.1016/j.ceb.2011.04.002; Feng QY, 2010, J BIOL CHEM, V285, P18806, DOI 10.1074/jbc.M109.098079; Feng QY, 2002, J BIOL CHEM, V277, P5644, DOI 10.1074/jbc.M107704200; Fukuda T, 2003, J BIOL CHEM, V278, P51324, DOI 10.1074/jbc.M309122200; Furmaniak-Kazmierczak E, 2007, CIRC RES, V100, P1328, DOI 10.1161/CIRCRESAHA.106.147744; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gringel A, 2006, J CELL PHYSIOL, V209, P568, DOI 10.1002/jcp.20777; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Johnstone CN, 2008, MOL CELL BIOL, V28, P687, DOI 10.1128/MCB.01617-06; Kim ES, 2004, INT J ONCOL, V25, P1375; Kim MS, 2003, CANCER RES, V63, P5454; Kogata N, 2009, GENE DEV, V23, P2278, DOI 10.1101/gad.535409; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; LaLonde DP, 2006, CURR BIOL, V16, P1375, DOI 10.1016/j.cub.2006.05.057; Lange A, 2009, NATURE, V461, P1002, DOI 10.1038/nature08468; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Matsuda C, 2008, FEBS LETT, V582, P1189, DOI 10.1016/j.febslet.2008.01.064; Mongroo PS, 2004, ONCOGENE, V23, P8959, DOI 10.1038/sj.onc.1208112; Montanez E, 2009, EMBO J, V28, P3132, DOI 10.1038/emboj.2009.295; Nikolopoulos SN, 2002, J BIOL CHEM, V277, P1568, DOI 10.1074/jbc.M108612200; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Nyalendo C, 2007, J BIOL CHEM, V282, P15690, DOI 10.1074/jbc.M608045200; Olski TM, 2001, J CELL SCI, V114, P525; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Pignatelli J, 2012, J CELL BIOL, V197, P421, DOI 10.1083/jcb.201108143; Rosenberger G, 2003, HUM MOL GENET, V12, P155, DOI 10.1093/hmg/ddg019; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Sepulveda JL, 2006, CELL MOL LIFE SCI, V63, P25, DOI 10.1007/s00018-005-5355-1; Shin EY, 2002, J BIOL CHEM, V277, P44417, DOI 10.1074/jbc.M203754200; Tu YZ, 2001, J CELL BIOL, V153, P585, DOI 10.1083/jcb.153.3.585; Tumbarello DA, 2007, J CELL PHYSIOL, V211, P736, DOI 10.1002/jcp.20991; Webb BA, 2005, AM J PHYSIOL-CELL PH, V289, pC898, DOI 10.1152/ajpcell.00095.2005; Webb BA, 2007, EUR J CELL BIOL, V86, P189, DOI 10.1016/j.ejcb.2007.01.003; Webb BA, 2006, ARCH BIOCHEM BIOPHYS, V456, P183, DOI 10.1016/j.abb.2006.06.011; Wormer D, 2012, CYTOSKELETON, V69, P644, DOI 10.1002/cm.21057; Yong HY, 2010, INT J ONCOL, V36, P501, DOI 10.3892/ijo_00000524; Zhang YJ, 2004, J BIOL CHEM, V279, P41695, DOI 10.1074/jbc.M401563200	52	23	25	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37309	37320		10.1074/jbc.M112.385229	http://dx.doi.org/10.1074/jbc.M112.385229			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22955285	hybrid, Green Published			2022-12-28	WOS:000310588500062
J	Vandersteen, A; Masman, MF; De Baets, G; Jonckheere, W; van der Werf, K; Marrink, SJ; Rozenski, J; Benilova, I; De Strooper, B; Subramaniam, V; Schymkowitz, J; Rousseau, F; Broersen, K				Vandersteen, Annelies; Masman, Marcelo F.; De Baets, Greet; Jonckheere, Wim; van der Werf, Kees; Marrink, Siewert J.; Rozenski, Jef; Benilova, Iryna; De Strooper, Bart; Subramaniam, Vinod; Schymkowitz, Joost; Rousseau, Frederic; Broersen, Kerensa			Molecular Plasticity Regulates Oligomerization and Cytotoxicity of the Multipeptide-length Amyloid-beta Peptide Pool	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN A-BETA; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; PRECURSOR PROTEIN; CEREBROSPINAL-FLUID; INTRAMEMBRANE CLEAVAGE; TERMINAL FRAGMENT; IN-SILICO; MECHANISM; A-BETA-42	Current therapeutic approaches under development for Alzheimer disease, including gamma-secretase modulating therapy, aim at increasing the production of A beta(1-38) and A beta(1-40) at the cost of longer A beta peptides. Here, we consider the aggregation of A beta(1-38) and A beta(1-43) in addition to A beta(1-40) and A beta(1-42), in particular their behavior in mixtures representing the complex in vivo A beta pool. We demonstrate that A beta(1-38) and A beta(1-43) aggregate similar to A beta(1-40) and A beta(1-42), respectively, but display a variation in the kinetics of assembly and toxicity due to differences in short timescale conformational plasticity. In biologically relevant mixtures of A beta, A beta(1-38) and A beta(1-43) significantly affect the behaviors of A beta(1-40) and A beta(1-42). The short timescale conformational flexibility of A beta(1-38) is suggested to be responsible for enhancing toxicity of A beta(1-40) while exerting a cyto-protective effect on A beta(1-42). Our results indicate that the complex in vivo A beta peptide array and variations thereof is critical in Alzheimer disease, which can influence the selection of current and new therapeutic strategies.	[Broersen, Kerensa] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Fac Sci & Technol, Nanobiophys Grp, NL-7500 AE Enschede, Netherlands; [Vandersteen, Annelies; van der Werf, Kees; Subramaniam, Vinod; Broersen, Kerensa] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands; [Vandersteen, Annelies; De Baets, Greet; Jonckheere, Wim; Schymkowitz, Joost; Rousseau, Frederic] VIB, SWITCH Lab, B-3000 Louvain, Belgium; [Vandersteen, Annelies; De Baets, Greet; Schymkowitz, Joost; Rousseau, Frederic] Katholieke Univ Leuven, Dept Mol Cell Biol, B-3000 Louvain, Belgium; [Vandersteen, Annelies; De Baets, Greet; Jonckheere, Wim; Broersen, Kerensa] Vrije Univ Brussel, B-1050 Brussels, Belgium; [Vandersteen, Annelies; De Baets, Greet; Jonckheere, Wim; Broersen, Kerensa] VIB, B-1050 Brussels, Belgium; [Masman, Marcelo F.] Univ Groningen, Dept Mol Neurobiol, NL-9747 AG Groningen, Netherlands; [Masman, Marcelo F.; Marrink, Siewert J.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Masman, Marcelo F.; Marrink, Siewert J.] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands; [Rozenski, Jef] Catholic Univ Louvain, Rega Inst Med Res, Med Chem Lab, B-3000 Louvain, Belgium; [Benilova, Iryna; De Strooper, Bart] Katholieke Univ Leuven VIB, VIB Ctr Biol Dis, B-3000 Louvain, Belgium; [Benilova, Iryna; De Strooper, Bart] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium	University of Twente; University of Twente; Flanders Institute for Biotechnology (VIB); KU Leuven; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); University of Groningen; University of Groningen; University of Groningen; KU Leuven; Universite Catholique Louvain; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven	Broersen, K (corresponding author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, Fac Sci & Technol, Nanobiophys Grp, POB 217, NL-7500 AE Enschede, Netherlands.	k.broersen@utwente.nl	Institute, Zernike/W-7033-2019; Subramaniam, Vinod/B-4197-2010; Marrink, Siewert J/G-3706-2014; Rousseau, Frederic/J-9044-2016; De Strooper, Bart/F-6507-2012; Benilova, Iryna/H-6533-2019; Schymkowitz, Joost/AAV-3680-2021; de+Strooper, Bart/Z-1638-2019; De Baets, Greet/J-1881-2014; Schymkowitz, Joost/K-7764-2016	Subramaniam, Vinod/0000-0001-6712-7266; Marrink, Siewert J/0000-0001-8423-5277; Rousseau, Frederic/0000-0002-9189-7399; De Strooper, Bart/0000-0001-5455-5819; De Baets, Greet/0000-0001-8844-800X; Schymkowitz, Joost/0000-0003-2020-0168; Masman, Marcelo Fabricio/0000-0002-9849-3901; Rozenski, Jef/0000-0001-9624-5536	Agency for Innovation by Science and Technology in Flanders (IWT); "Stichting voor Alzheimer Onderzoek" (SAO); Odysseus grant from the National Funds for Scientific Research Flanders (FWO); Alzheimer Research UK (ARUK) grant; European Molecular Biology Organization Short-term Fellowship	Agency for Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); "Stichting voor Alzheimer Onderzoek" (SAO); Odysseus grant from the National Funds for Scientific Research Flanders (FWO)(FWO); Alzheimer Research UK (ARUK) grant(Alzheimer's Research UK (ARUK)); European Molecular Biology Organization Short-term Fellowship	This work was supported by the Agency for Innovation by Science and Technology in Flanders (IWT), a project grant from the "Stichting voor Alzheimer Onderzoek" (SAO), an Odysseus grant from the National Funds for Scientific Research Flanders (FWO), an Alzheimer Research UK (ARUK) grant, and a European Molecular Biology Organization Short-term Fellowship.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Baumketner A, 2006, PROTEIN SCI, V15, P1239, DOI 10.1110/ps.062076806; Benseny-Cases N, 2007, BIOCHEM BIOPH RES CO, V361, P916, DOI 10.1016/j.bbrc.2007.07.082; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bibl M, 2007, J NEURAL TRANSM, V114, P621, DOI 10.1007/s00702-006-0618-z; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Borreguero JM, 2005, P NATL ACAD SCI USA, V102, P6015, DOI 10.1073/pnas.0502006102; Broersen K, 2011, PROTEIN ENG DES SEL, V24, P743, DOI 10.1093/protein/gzr020; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Choi UB, 2011, STRUCTURE, V19, P566, DOI 10.1016/j.str.2011.01.011; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Golde TE, 2012, EMBO J, V31, P2237, DOI 10.1038/emboj.2012.111; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Imbimbo BP, 2011, CURR TOP MED CHEM, V11, P1555; Ito M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017587; Iwatsubo T, 1996, AM J PATHOL, V149, P1823; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Krishnan R, 2012, P NATL ACAD SCI USA, V109, P11172, DOI 10.1073/pnas.1209527109; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Ladiwala ARA, 2012, J BIOL CHEM, V287, P24765, DOI 10.1074/jbc.M111.329763; Laino C, 2009, NEUROL TODAY, V9, P21; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lazo ND, 2005, PROTEIN SCI, V14, P1581, DOI 10.1110/ps.041292205; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lewczuk P, 2003, RAPID COMMUN MASS SP, V17, P1291, DOI 10.1002/rcm.1048; Maddalena AS, 2004, NEURODEGENER DIS, V1, P231, DOI 10.1159/000080991; Mann DMA, 1996, AM J PATHOL, V148, P1257; Masman MF, 2009, J PHYS CHEM B, V113, P11710, DOI 10.1021/jp901057w; Nerelius C, 2009, P NATL ACAD SCI USA, V106, P9191, DOI 10.1073/pnas.0810364106; Oehlrich D, 2011, J MED CHEM, V54, P669, DOI 10.1021/jm101168r; Paivio A, 2004, PROTEIN SCI, V13, P1251, DOI 10.1110/ps.03442404; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Rohrig UF, 2006, BIOPHYS J, V91, P3217, DOI 10.1529/biophysj.106.088542; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Shen L, 2008, J PHYS CHEM B, V112, P3164, DOI 10.1021/jp7108237; Stine WB, 1996, J PROTEIN CHEM, V15, P193, DOI 10.1007/BF01887400; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; VIGOPELFREY C, 1993, J NEUROCHEM, V61, P1965, DOI 10.1111/j.1471-4159.1993.tb09841.x; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Welander H, 2009, J NEUROCHEM, V110, P697, DOI 10.1111/j.1471-4159.2009.06170.x; Wiltfang J, 2002, J NEUROCHEM, V81, P481, DOI 10.1046/j.1471-4159.2002.00818.x; Wisniewski T, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S5; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Younkin SG, 1998, J PHYSIOLOGY-PARIS, V92, P289, DOI 10.1016/S0928-4257(98)80035-1	63	34	35	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36732	36743		10.1074/jbc.M112.394635	http://dx.doi.org/10.1074/jbc.M112.394635			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22992745	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000310588500011
J	Kazi, JU; Sun, JM; Phung, B; Zadjali, F; Flores-Morales, A; Ronnstrand, L				Kazi, Julhash U.; Sun, Jianmin; Phung, Bengt; Zadjali, Fahad; Flores-Morales, Amilcar; Ronnstrand, Lars			Suppressor of Cytokine Signaling 6 (SOCS6) Negatively Regulates Flt3 Signal Transduction through Direct Binding to Phosphorylated Tyrosines 591 and 919 of Flt3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC FAMILY KINASES; INSULIN-RECEPTOR; ACTIVATION; DOMAIN; JUXTAMEMBRANE; SPECIFICITY; INHIBITION; MUTATIONS; PROTEINS; SITES	The receptor tyrosine kinase Flt3 is an important growth factor receptor in hematopoiesis, and gain-of-function mutations of the receptor contribute to the transformation of acute myeloid leukemia. SOCS6 ( suppressor of cytokine signaling 6) is a member of the SOCS family of E3 ubiquitin ligases that can regulate receptor tyrosine kinase signal transduction. In this study, we analyzed the role of SOCS6 in Flt3 signal transduction. The results show that ligand stimulation of Flt3 can induce association of SOCS6 and Flt3 and tyrosine phosphorylation of SOCS6. Phosphopeptide fishing indicated that SOCS6 binds directly to phosphotyrosines 591 and 919 of Flt3. By using stably transfected Ba/F3 cells with Flt3 and/or SOCS6, we show that the presence of SOCS6 can enhance ubiquitination of Flt3, as well as internalization and degradation of the receptor. The presence of SOCS6 also induces weaker activation of Erk1/2, but not Akt, in transfected Ba/F3 and UT-7 cells and in OCI-AML-5 cells. The absence of SOCS6 promotes Ba/F3 and UT-7 cell proliferation induced by oncogenic internal tandem duplications of Flt3. Taken together, these results suggest that SOCS6 negatively regulates Flt3 activation, the downstream Erk signaling pathway, and cell proliferation.	[Kazi, Julhash U.; Sun, Jianmin; Phung, Bengt; Ronnstrand, Lars] Lund Univ, Dept Lab Med, Skane Univ Hosp, Wallenberg Lab, S-20502 Malmo, Sweden; [Zadjali, Fahad] Sultan Qaboos Univ, Dept Biochem, Coll Med & Hlth Sci, Muscat 123, Oman; [Flores-Morales, Amilcar] Univ Copenhagen, Novo Nordisk Fdn, Ctr Prot Res, Fac Hlth Sci, DK-2200 Copenhagen, Denmark	Lund University; Skane University Hospital; Sultan Qaboos University; Novo Nordisk Foundation; University of Copenhagen	Ronnstrand, L (corresponding author), Lund Univ, Dept Lab Med, Skane Univ Hosp, Wallenberg Lab, S-20502 Malmo, Sweden.	lars.ronnstrand@med.lu.se	Sun, Jianmin/AAX-5094-2021; ZADJALI, FAHAD/B-5091-2019; Kazi, Julhash U./D-9190-2011	Sun, Jianmin/0000-0003-2327-4285; ZADJALI, FAHAD/0000-0001-5891-4700; Kazi, Julhash U./0000-0002-0719-5336; Ronnstrand, Lars/0000-0003-1275-5809; Phung, Bengt/0000-0002-9923-0847	Swedish Cancer Society; Swedish Children's Cancer Organization; Swedish Research Council; Wenner-Gren Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Children's Cancer Organization; Swedish Research Council(Swedish Research CouncilEuropean Commission); Wenner-Gren Foundation	This work was supported in part by the Swedish Cancer Society, the Swedish Children's Cancer Organization, and the Swedish Research Council.; Supported by the Wenner-Gren Foundation.	Bayle J, 2004, J BIOL CHEM, V279, P12249, DOI 10.1074/jbc.M313381200; BLUMEJENSEN P, 1993, EMBO J, V12, P4199, DOI 10.1002/j.1460-2075.1993.tb06104.x; Choi YB, 2010, J BIOL CHEM, V285, P7271, DOI 10.1074/jbc.M109.073726; De Sepulveda P, 1999, EMBO J, V18, P904; Elliott J, 2008, BIOCHEM SOC T, V36, P464, DOI 10.1042/BST0360464; Gelderloos JA, 1998, J BIOL CHEM, V273, P5908, DOI 10.1074/jbc.273.10.5908; Heiss E, 2006, BLOOD, V108, P1542, DOI 10.1182/blood-2005-07-008896; Ishiko J, 2005, ONCOGENE, V24, P8144, DOI 10.1038/sj.onc.1208957; Krebs DL, 2002, MOL CELL BIOL, V22, P4567, DOI 10.1128/MCB.22.13.4567-4578.2002; Lai RH, 2010, CANCER LETT, V288, P75, DOI 10.1016/j.canlet.2009.06.025; Levis M, 2003, LEUKEMIA, V17, P1738, DOI 10.1038/sj.leu.2403099; Masson K, 2009, CELL SIGNAL, V21, P1717, DOI 10.1016/j.cellsig.2009.06.002; Masson K, 2009, BRIT J HAEMATOL, V146, P193, DOI 10.1111/j.1365-2141.2009.07725.x; Meshinchi S, 2006, BLOOD, V108, P3654, DOI 10.1182/blood-2006-03-009233; Mooney RA, 2001, J BIOL CHEM, V276, P25889, DOI 10.1074/jbc.M010579200; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Peschard P, 2003, CANCER CELL, V3, P519, DOI 10.1016/S1535-6108(03)00136-3; Price DJ, 1999, BIOCHEM BIOPH RES CO, V259, P611, DOI 10.1006/bbrc.1999.0840; Razumovskaya E, 2009, EXP HEMATOL, V37, P979, DOI 10.1016/j.exphem.2009.05.008; Reindl C, 2009, CLIN CANCER RES, V15, P2238, DOI 10.1158/1078-0432.CCR-08-1325; Sargin B, 2007, BLOOD, V110, P1004, DOI 10.1182/blood-2007-01-066076; Stirewalt DL, 2006, BLOOD, V107, P3724, DOI 10.1182/blood-2005-08-3453; Takahashi S, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-13; Valgeirsdottir S, 1998, ONCOGENE, V16, P505, DOI 10.1038/sj.onc.1201555; Voytyuk O, 2003, J BIOL CHEM, V278, P9159, DOI 10.1074/jbc.M211726200; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zadjali F, 2011, J BIOL CHEM, V286, P480, DOI 10.1074/jbc.M110.173526; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071	29	51	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36509	36517		10.1074/jbc.M112.376111	http://dx.doi.org/10.1074/jbc.M112.376111			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22952242	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000310364000070
J	Dach, I; Olesen, C; Signor, L; Nissen, P; le Maire, M; Moller, JV; Ebel, C				Dach, Ingrid; Olesen, Claus; Signor, Luca; Nissen, Poul; le Maire, Marc; Moller, Jesper V.; Ebel, Christine			Active Detergent-solubilized H+,K+-ATPase Is a Monomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; BOVINE ADP/ATP CARRIER; ALPHA-BETA-UNITS; ANALYTICAL ULTRACENTRIFUGATION; GASTRIC H+,K+-ATPASE; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; LIGHT-SCATTERING; FUNCTIONAL-CHARACTERIZATION; SEDIMENTATION-VELOCITY	The H+,K+-ATPase pumps protons or hydronium ions and is responsible for the acidification of the gastric fluid. It is made up of an alpha-catalytic and a beta-glycosylated subunit. The relation between cation translocation and the organization of the protein in the membrane are not well understood. We describe here how pure and functionally active pig gastric H+,K+-ATPase with an apparent Stokes radius of 6.3 nm can be obtained after solubilization with the non-ionic detergent C12E8, followed by exchange of C12E8 with Tween 20 on a Superose 6 column. Mass spectroscopy indicates that the beta-subunit bears an excess mass of 9 kDa attributable to glycosylation. From chemical analysis, there are 0.25 g of phospholipids and around 0.024 g of cholesterol bound per g of protein. Analytical ultracentrifugation shows one main complex, sedimenting at s(20,w) = 7.2 +/- 0.1 S, together with minor amounts of irreversibly aggregated material. From these data, a buoyant molecular mass is calculated, corresponding to an H+,K+-ATPase alpha,beta-protomer of 147.3 kDa. Complementary sedimentation velocity with deuterated water gives a picture of an alpha,beta-protomer with 0.9-1.4 g/g of bound detergent and lipids and a reasonable frictional ratio of 1.5, corresponding to a Stokes radius of 7.1 nm. An alpha(2),beta(2) dimer is rejected by the data. Light scattering coupled to gel filtration confirms the monomeric state of solubilized H+,K+-ATPase. Thus, alpha,beta H+,K+-ATPase is active at least in detergent and may plausibly function as a monomer, as has been established for other P-type ATPases, Ca2+-ATPase and Na+,K+-ATPase.	[Dach, Ingrid; Olesen, Claus; Moller, Jesper V.] Univ Aarhus, Dept Biomed, DK-8000 Aarhus, Denmark; [Dach, Ingrid; Olesen, Claus; Moller, Jesper V.] Danish Res Fdn, Ctr Membrane Pumps Cells & Dis, DK-8000 Aarhus, Denmark; [Dach, Ingrid; Nissen, Poul] Univ Aarhus, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Signor, Luca; Ebel, Christine] Inst Biol Struct Jean Pierre Ebel, Commissariat Energie Atom & Energies Alternat, F-38027 Grenoble 1, France; [Signor, Luca; Ebel, Christine] Univ Grenoble 1, Inst Biol Struct, F-38027 Grenoble 1, France; [Signor, Luca; Ebel, Christine] CNRS, Inst Biol Struct, F-38027 Grenoble 1, France; [le Maire, Marc] Commissariat Energie Atom & Energies Alternat, Inst Biol & Technol iBiTec S, F-91191 Gif Sur Yvette, France; [le Maire, Marc] Univ Paris 11, CEA Saclay, PC 103, CNRS,UMR 8221, Paris, France; [le Maire, Marc] Univ Paris 11, F-91400 Orsay, France	Aarhus University; Aarhus University; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Olesen, C (corresponding author), Univ Aarhus, Dept Biomed, DK-8000 Aarhus, Denmark.	co@biophys.au.dk; marc.lemaire@cea.fr; jvm@biophys.au.dk; christine.ebel@ibs.fr	Signor, Luca/O-7489-2014	Signor, Luca/0000-0003-3880-2466; Olesen, Claus/0000-0002-0462-1686; Ebel, Christine/0000-0002-6912-500X; Nissen, Poul/0000-0003-0948-6628	CNRS; Commissariat a l'Energie Atomique; Universite Joseph Fourier-Grenoble 1; Universite Paris-Sud; European Union [226507-NMI3]; Agence Nationale de la Recherche (Programme blanc DHYN-FHAC)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Commissariat a l'Energie Atomique(French Atomic Energy Commission); Universite Joseph Fourier-Grenoble 1; Universite Paris-Sud; European Union(European Commission); Agence Nationale de la Recherche (Programme blanc DHYN-FHAC)(French National Research Agency (ANR))	This work was supported by CNRS, by the Commissariat a l'Energie Atomique, by the Universite Joseph Fourier-Grenoble 1, by the Universite Paris-Sud, and by grants from the European Union (FP7 Grant Agreement 226507-NMI3) and the Agence Nationale de la Recherche (Programme blanc DHYN-FHAC).	Abe K, 2005, J BIOCHEM, V138, P293, DOI 10.1093/jb/mvi127; Abe K, 2003, BIOCHEMISTRY-US, V42, P15132, DOI 10.1021/bi035686x; Abe K, 2002, BIOCHEMISTRY-US, V41, P2438, DOI 10.1021/bi015622r; Abe K, 2010, J STRUCT BIOL, V170, P60, DOI 10.1016/j.jsb.2009.12.008; Abe K, 2009, EMBO J, V28, P1637, DOI 10.1038/emboj.2009.102; ANDERSEN JP, 1989, BIOCHIM BIOPHYS ACTA, V988, P47, DOI 10.1016/0304-4157(89)90003-8; Ayorinde FO, 2000, RAPID COMMUN MASS SP, V14, P2116, DOI 10.1002/1097-0231(20001130)14:22<2116::AID-RCM142>3.0.CO;2-1; Bamford M, 2009, PROGR MED CHEM, V47, P75, DOI 10.1016/S0079-6468(08)00203-8; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BERI RG, 1993, CARBOHYD RES, V238, P11, DOI 10.1016/0008-6215(93)87002-A; Boulanger P, 1996, BIOCHEMISTRY-US, V35, P14216, DOI 10.1021/bi9608673; BROTHERUS JR, 1983, BIOCHIM BIOPHYS ACTA, V731, P290, DOI 10.1016/0005-2736(83)90021-4; Brown P, 2011, TLS-TIMES LIT SUPPL, P6; Bublitz M, 2011, J CELL SCI, V124, P2515, DOI 10.1242/jcs.088716; Cardi D, 2010, J BIOL CHEM, V285, P26406, DOI 10.1074/jbc.M109.090340; Champeil P, 2000, J BIOL CHEM, V275, P18623, DOI 10.1074/jbc.M000470200; Cohen E, 2005, J BIOL CHEM, V280, P16610, DOI 10.1074/jbc.M414290200; Dahout-Gonzalez C, 2003, ACTA CRYSTALLOGR D, V59, P2353, DOI 10.1107/S0907444903020699; DEFORESTA B, 1989, BIOCHEMISTRY-US, V28, P2558, DOI 10.1021/bi00432a032; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Durr KL, 2009, J BIOL CHEM, V284, P20147, DOI 10.1074/jbc.M109.005769; Durr KL, 2008, BIOCHEMISTRY-US, V47, P4288, DOI 10.1021/bi800092k; Ebel C, 2011, METHODS, V54, P56, DOI 10.1016/j.ymeth.2010.11.003; EDELSTEIN SJ, 1967, J BIOL CHEM, V242, P306; ESMANN M, 1988, METHOD ENZYMOL, V156, P105; ESMANN M, 1980, BIOCHIM BIOPHYS ACTA, V603, P1, DOI 10.1016/0005-2736(80)90386-7; Fedosova NU, 2003, BIOCHEMISTRY-US, V42, P3536, DOI 10.1021/bi0268302; Fedosova NU, 1998, BIOCHEMISTRY-US, V37, P13634, DOI 10.1021/bi980703h; Galian C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019677; Gohon Y, 2004, ANAL BIOCHEM, V334, P318, DOI 10.1016/j.ab.2004.07.033; HARDWICKE PM, 1974, EUR J BIOCHEM, V42, P183; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; HAYASHI Y, 1989, METHOD ENZYMOL, V172, P514; HAYASHI Y, 1989, BIOCHIM BIOPHYS ACTA, V983, P217, DOI 10.1016/0005-2736(89)90237-X; HEEGAARD CW, 1990, J BIOL CHEM, V265, P12020; Jidenko M, 2005, P NATL ACAD SCI USA, V102, P11687, DOI 10.1073/pnas.0503986102; Kobayashi T, 2007, J BIOCHEM, V142, P157, DOI 10.1093/jb/mvm150; Lacapere JJ, 2000, BIOCHEM J, V345, P239, DOI 10.1042/0264-6021:3450239; Lauger P., 1991, ELECTROGENIC ION PUM, P224; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; le Maire M., 1986, SARCOPLASMIC RETICUL, V1, P101; Le Maire M, 2008, NAT PROTOC, V3, P1782, DOI 10.1038/nprot.2008.177; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; LEMAIRE M, 1978, J BIOL CHEM, V253, P7051; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUND S, 1988, J BIOL CHEM, V263, P1654; Mahaney JE, 2005, BIOCHEMISTRY-US, V44, P7713, DOI 10.1021/bi048011i; Mahaney JE, 2004, BIOCHEMISTRY-US, V43, P4400, DOI 10.1021/bi035068g; Manon F., 2010, INSTRUMENTAL ANAL IN, P433; Mimura K, 2008, BIOCHEMISTRY-US, V47, P6039, DOI 10.1021/bi800445f; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; MOLLER JV, 1980, J BIOL CHEM, V255, P1912; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Morii M, 2008, J BIOL CHEM, V283, P16876, DOI 10.1074/jbc.M800563200; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; Mullin JM, 2009, DRUG DISCOV TODAY, V14, P647, DOI 10.1016/j.drudis.2009.03.014; Musatov A, 2002, BIOCHEMISTRY-US, V41, P4371, DOI 10.1021/bi016080g; Nishizawa T, 2008, J STRUCT BIOL, V162, P219, DOI 10.1016/j.jsb.2007.12.005; Nury H, 2008, BIOCHEMISTRY-US, V47, P12319, DOI 10.1021/bi801053m; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; PHILO J, 1994, J BIOL CHEM, V269, P27840; Picard M, 2006, BIOCHEMISTRY-US, V45, P1861, DOI 10.1021/bi051954a; RABON EC, 1988, J BIOL CHEM, V263, P16189; RABON EC, 1990, BIOCHIM BIOPHYS ACTA, V1039, P277, DOI 10.1016/0167-4838(90)90260-M; Ravaud S, 2006, BIOCHEM J, V395, P345, DOI 10.1042/BJ20051719; REYNOLDS JA, 1976, P NATL ACAD SCI USA, V73, P4467, DOI 10.1073/pnas.73.12.4467; Riske KA, 1997, CHEM PHYS LIPIDS, V89, P31, DOI 10.1016/S0009-3084(97)00058-3; SACHS G, 1982, CURR TOP MEMBR TRANS, V16, P135; SACHS G, 1989, J BIOENERG BIOMEMBR, V21, P573, DOI 10.1007/BF00808114; Sachs G, 2007, J CLIN GASTROENTEROL, V41, pS226, DOI 10.1097/MCG.0b013e31803233b7; Salvay AG, 2007, J BIOL PHYS, V33, P399, DOI 10.1007/s10867-008-9058-3; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Shin JM, 2009, PFLUG ARCH EUR J PHY, V457, P609, DOI 10.1007/s00424-008-0495-4; Shin JM, 2005, BIOCHEMISTRY-US, V44, P16321, DOI 10.1021/bi051342q; Shin JM, 1996, J BIOL CHEM, V271, P1904, DOI 10.1074/jbc.271.4.1904; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SKRABANJA ATP, 1987, BIOCHIM BIOPHYS ACTA, V903, P434, DOI 10.1016/0005-2736(87)90050-2; SOUMARMON A, 1983, BIOCHIM BIOPHYS ACTA, V732, P579, DOI 10.1016/0005-2736(83)90234-1; SOUMARMON A, 1986, BIOCHIM BIOPHYS ACTA, V860, P109, DOI 10.1016/0005-2736(86)90504-3; TANFORD C, 1974, BIOCHEMISTRY-US, V13, P2369, DOI 10.1021/bi00708a021; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Tyagarajan K, 1997, BIOCHEMISTRY-US, V36, P10200, DOI 10.1021/bi9706125; VILSEN B, 1987, J BIOL CHEM, V262, P10511; Xian YJ, 1997, J STRUCT BIOL, V118, P169, DOI 10.1006/jsbi.1997.3847	88	8	8	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41963	41978		10.1074/jbc.M112.398768	http://dx.doi.org/10.1074/jbc.M112.398768			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23055529	Green Published, hybrid			2022-12-28	WOS:000312103000036
J	Hassan, MQ; Maeda, Y; Taipaleenmaki, H; Zhang, WB; Jafferji, M; Gordon, JAR; Li, ZY; Croce, CM; van Wijnen, AJ; Stein, JL; Stein, GS; Lian, JB				Hassan, Mohammad Q.; Maeda, Yukiko; Taipaleenmaki, Hanna; Zhang, Weibing; Jafferji, Mohammad; Gordon, Jonathan A. R.; Li, Zhaoyong; Croce, Carlo M.; van Wijnen, Andre J.; Stein, Janet L.; Stein, Gary S.; Lian, Jane B.			miR-218 Directs a Wnt Signaling Circuit to Promote Differentiation of Osteoblasts and Osteomimicry of Metastatic Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE SIALOPROTEIN; WNT/BETA-CATENIN; BREAST; PROGRESSION; SCLEROSTIN; RUNX2; GENE; OSTEOPONTIN; INHIBITORS; MICRORNAS	MicroRNAs (miRNAs) negatively and post-transcriptionally regulate expression of multiple target genes to support anabolic pathways for bone formation. Here, we show that miR-218 is induced during osteoblast differentiation and has potent osteogenic properties. miR-218 promotes commitment and differentiation of bone marrow stromal cells by activating a positive Wnt signaling loop. In a feed forward mechanism, miR-218 stimulates the Wnt pathway by down-regulating three Wnt signaling inhibitors during the process of osteogenesis: Sclerostin (SOST), Dickkopf2 (DKK2), and secreted frizzled-related protein2 (SFRP2). In turn, miR-218 expression is up-regulated in response to stimulated Wnt signaling and functionally drives Wnt-related transcription and osteoblast differentiation, thereby creating a positive feedback loop. Furthermore, in metastatic breast cancer cells but not in normal mammary epithelial cells, miR-218 enhances Wnt activity and abnormal expression of osteoblastic genes (osteomimicry) that contribute to homing and growth of cells metastatic to bone. Thus, miR-218/Wnt signaling circuit amplifies both the osteoblast phenotype and osteomimicry-related tumor activity.	[Hassan, Mohammad Q.; Maeda, Yukiko; Taipaleenmaki, Hanna; Zhang, Weibing; Jafferji, Mohammad; Gordon, Jonathan A. R.; Li, Zhaoyong; van Wijnen, Andre J.; Stein, Janet L.; Stein, Gary S.; Lian, Jane B.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [Hassan, Mohammad Q.; Maeda, Yukiko; Taipaleenmaki, Hanna; Zhang, Weibing; Jafferji, Mohammad; Gordon, Jonathan A. R.; Li, Zhaoyong; van Wijnen, Andre J.; Stein, Janet L.; Stein, Gary S.; Lian, Jane B.] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01655 USA; [Croce, Carlo M.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Croce, Carlo M.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Lian, JB (corresponding author), Univ Vermont, Dept Biochem, 89 Beaumont Ave, Burlington, VT 05405 USA.	Jane.Lian@med.uvm.edu	Hassan, Mohammad/GZA-7507-2022; Li, zhao-yong/N-4288-2013; Gordon, Jonathan/B-3904-2016; Young, Richard A/F-6495-2012; Taipaleennmäki, Hanna/GRX-7143-2022; van Wijnen, Andre J./AAG-3578-2019	Hassan, Mohammad/0000-0002-1712-0004; Gordon, Jonathan/0000-0003-2644-696X; Young, Richard A/0000-0001-8855-8647; van Wijnen, Andre J./0000-0002-4458-0946	National Institutes of Health [R01AR039588, R37DE012528, R01AR049069, P01 CA 082834]; NATIONAL CANCER INSTITUTE [P01CA082834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049069, R01AR039588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE012528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part by National Institutes of Health Grants R01AR039588 (to G.S.S. and J.B.L.), R37DE012528 (to J.B.L.), R01AR049069 (to A.V.W.), and P01 CA 082834 (to G.S.S.).	Alajez NM, 2011, CANCER RES, V71, P2381, DOI 10.1158/0008-5472.CAN-10-2754; Bengestrate L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021305; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Botchkareva NV, 2012, CELL CYCLE, V11, P468, DOI 10.4161/cc.11.3.19058; Canalis E, 2009, J CELL BIOCHEM, V108, P769, DOI 10.1002/jcb.22322; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Chimge NO, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3073; Devine CA, 2008, DEV BIOL, V313, P371, DOI 10.1016/j.ydbio.2007.10.040; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Ewan K, 2010, CANCER RES, V70, P5963, DOI 10.1158/0008-5472.CAN-10-1028; Fedarko NS, 2001, CLIN CANCER RES, V7, P4060; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gaur T, 2010, DEV BIOL, V340, P10, DOI 10.1016/j.ydbio.2010.01.008; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; Hoeppner LH, 2011, J BIOL CHEM, V286, P10950, DOI 10.1074/jbc.M110.165100; Ibrahim T, 2000, CLIN EXP METASTAS, V18, P253, DOI 10.1023/A:1006754605901; Kamiya N, 2008, DEVELOPMENT, V135, P3801, DOI 10.1242/dev.025825; Kamiya N, 2010, J BONE MINER RES, V25, P200, DOI 10.1359/jbmr.090806; Kapinas K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3325; Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137; Komori T, 2011, J CELL BIOCHEM, V112, P750, DOI 10.1002/jcb.22994; Krause C, 2010, J BIOL CHEM, V285, P41614, DOI 10.1074/jbc.M110.153890; Li XF, 2005, NAT GENET, V37, P945, DOI 10.1038/ng1614; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Liu N, 2010, DEV CELL, V18, P510, DOI 10.1016/j.devcel.2010.03.010; Long FX, 2008, CELL CYCLE, V7, P2106, DOI 10.4161/cc.7.14.6257; Long FX, 2008, CELL, V135, P795, DOI 10.1016/j.cell.2008.11.007; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mizoguchi F, 2010, J CELL BIOCHEM, V109, P866, DOI 10.1002/jcb.22228; Monroe DG, 2012, GENE, V492, P1, DOI 10.1016/j.gene.2011.10.044; Nana-Sinkam SP, 2011, MOL ONCOL, V5, P483, DOI 10.1016/j.molonc.2011.10.003; Niziolek PJ, 2011, BONE, V49, P1010, DOI 10.1016/j.bone.2011.07.034; Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003; Rucci Nadia, 2010, Front Biosci (Schol Ed), V2, P907; Sathi GA, 2009, ORAL ONCOL, V45, P856, DOI 10.1016/j.oraloncology.2009.02.001; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Schmid BC, 2007, BREAST CANCER RES TR, V106, P333, DOI 10.1007/s10549-007-9504-0; Sethi N, 2011, BONE, V48, P16, DOI 10.1016/j.bone.2010.07.005; Small EM, 2010, CIRC RES, V107, P1336, DOI 10.1161/CIRCRESAHA.110.227926; Sugatani T, 2009, J BIOL CHEM, V284, P4667, DOI 10.1074/jbc.M805777200; Sun HL, 2009, CELLS TISSUES ORGANS, V190, P69, DOI 10.1159/000178020; Taipaleenmaki H, 2011, EUR J ENDOCRINOL; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Wang JH, 2006, CANCER METAST REV, V25, P573, DOI 10.1007/s10555-006-9019-x; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; White NMA, 2011, NAT REV CLIN ONCOL, V8, P75, DOI 10.1038/nrclinonc.2010.173; Wu CI, 2012, DEVELOPMENT, V139, P2118, DOI 10.1242/dev.076067; Yan Y, 2009, J CELL SCI, V122, P3566, DOI 10.1242/jcs.051904; Yoshida Y, 2000, CELL, V103, P1085, DOI 10.1016/S0092-8674(00)00211-7; Zhang J, 2011, J BONE MINER RES, V26, P1953, DOI 10.1002/jbmr.377; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108	55	219	238	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42084	42092		10.1074/jbc.M112.377515	http://dx.doi.org/10.1074/jbc.M112.377515			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23060446	Green Published, hybrid			2022-12-28	WOS:000312103000047
J	Youmans, KL; Tai, LM; Nwabuisi-Heath, E; Jungbauer, L; Kanekiyo, T; Gan, M; Kim, J; Eimer, WA; Estus, S; Rebeck, GW; Weeber, EJ; Bu, GJ; Yu, CJ; LaDu, MJ				Youmans, Katherine L.; Tai, Leon M.; Nwabuisi-Heath, Evelyn; Jungbauer, Lisa; Kanekiyo, Takahisa; Gan, Ming; Kim, Jungsu; Eimer, William A.; Estus, Steve; Rebeck, G. William; Weeber, Edwin J.; Bu, Guojun; Yu, Chunjiang; LaDu, Mary Jo			APOE4-specific Changes in A beta Accumulation in a New Transgenic Mouse Model of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN-E LEVELS; DENSITY-LIPOPROTEIN RECEPTOR; APOE ISOFORM; NEURITIC DEGENERATION; TARGETED REPLACEMENT; THERAPEUTIC TARGET; DOMAIN INTERACTION; PLAQUE-FORMATION; E GENOTYPE	APOE4 is the greatest risk factor for Alzheimer disease (AD) and synergistic effects with amyloid-beta peptide (A beta) suggest interactions among apoE isoforms and different forms of A beta accumulation. However, it remains unclear how the APOE genotype affects plaque morphology, intraneuronal A beta, soluble A beta 42, and oligomeric A beta (oA beta), particularly in vivo. As the introduction of human APOE significantly delays amyloid deposition in transgenic mice expressing familial AD (FAD) mutations (FAD-Tg), 5xFAD-Tg mice, which exhibit amyloid deposition by age 2 months, were crossed with apoE-targeted replacement mice to produce the new EFAD-Tg mice. Compared with 5xFAD mice, A beta deposition was delayed by similar to 4 months in the EFAD mice, allowing detection of early changes in A beta accumulation from 2-6 months. Although plaque deposition is generally greater in E4FAD mice, E2/E3FAD mice have significantly more diffuse and E4FAD more compact plaques. As a first report in FAD-Tg mice, the APOE genotypes had no effect on intraneuronal A beta accumulation in EFAD mice. In E4FAD mice, total apoE levels were lower and total A beta levels higher than in E2FAD and E3FAD mice. Profiles from sequential three-step extractions (TBS, detergent, and formic acid) demonstrated that the lower level of total apoE4 is reflected only in the detergent-soluble fraction, indicating that less apoE4 is lipoprotein-associated, and perhaps less lipidated, compared with apoE2 and apoE3. Soluble A beta 42 and oA beta levels were highest in E4FAD mice, although soluble apoE2, apoE3, and apoE4 levels were comparable, suggesting that the differences in soluble A beta 42 and oA beta result from functional differences among the apoE isoforms. Thus, APOE differentially regulates multiple aspects of A beta accumulation.	[Youmans, Katherine L.; Tai, Leon M.; Nwabuisi-Heath, Evelyn; Jungbauer, Lisa; Yu, Chunjiang; LaDu, Mary Jo] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA; [Kanekiyo, Takahisa; Gan, Ming; Bu, Guojun] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Kim, Jungsu] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Eimer, William A.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Estus, Steve] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Rebeck, G. William] Georgetown Univ, Dept Neurosci, Washington, DC 20057 USA; [Weeber, Edwin J.] Univ S Florida, Dept Mol Pharmacol & Physiol, Tampa, FL 33613 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Mayo Clinic; Washington University (WUSTL); Northwestern University; Feinberg School of Medicine; University of Kentucky; Georgetown University; State University System of Florida; University of South Florida	LaDu, MJ (corresponding author), Univ Illinois, Dept Anat & Cell Biol, 808 S Wood St,M-C 512, Chicago, IL 60612 USA.	mladu@uic.edu	Weeber, Edwin J/A-5396-2012; Rebeck, George William/J-2192-2012; Kim, Jungsu/F-2457-2012	Rebeck, George William/0000-0001-6276-248X; Eimer, William/0000-0003-1067-9339; Jungbauer Nikolas, Lisa/0000-0002-5429-3393; LaDu, Mary Jo/0000-0003-2141-1450; Kim, Jungsu/0000-0002-6931-8581	National Institutes of Health [P01AG030128, P01AG030128-03S1, 5T32-AG036697]; Alzheimer's Association Grant [ZEN-08-899000]; University of Illinois at Chicago Center for Clinical and Translational Science Grant [UL1RR029879]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS074969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027924, P01AG030128, R01AG035355, T32AG036697, R01AG035379] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association Grant(Alzheimer's Association); University of Illinois at Chicago Center for Clinical and Translational Science Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01AG030128 (through the NIA) (to M. J. L.), P01AG030128-03S1 (through the NIA) (to E. N. H.), and 5T32-AG036697 (to K. L. Y.); Alzheimer's Association Grant ZEN-08-899000 (to M. J. L.); and a University of Illinois at Chicago Center for Clinical and Translational Science Grant UL1RR029879 (to M. J. L.).	Bachmeier C., 2012, J MOL NEURO IN PRESS; Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; Basak JM, 2012, J BIOL CHEM, V287, P13959, DOI 10.1074/jbc.M111.288746; Bayer TA, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00008; Beffert U, 1999, BRAIN RES, V843, P87, DOI 10.1016/S0006-8993(99)01894-6; Berlau DJ, 2007, ARCH NEUROL-CHICAGO, V64, P1193, DOI 10.1001/archneur.64.8.1193; Berlau DJ, 2009, NEUROLOGY, V72, P829, DOI 10.1212/01.wnl.0000343853.00346.a4; BERTRAND P, 1995, MOL BRAIN RES, V33, P174, DOI 10.1016/0169-328X(95)00097-C; Bien-Ly N, 2012, J NEUROSCI, V32, P4803, DOI 10.1523/JNEUROSCI.0033-12.2012; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Buttini M, 2002, J NEUROSCI, V22, P10539; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Cerf E, 2011, FASEB J, V25, P1585, DOI 10.1096/fj.10-175976; Christensen DZ, 2010, ACTA NEUROPATHOL, V119, P555, DOI 10.1007/s00401-010-0666-1; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Cruchaga C, 2012, HUM MOL GENET, V21, P4558, DOI 10.1093/hmg/dds296; Cushley RJ, 2002, ANNU REV BIOPH BIOM, V31, P177, DOI 10.1146/annurev.biophys.31.101101.140910; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; D'Andrea MR, 2002, NEUROSCI LETT, V333, P163, DOI 10.1016/S0304-3940(02)00875-3; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; Drzezga A, 2009, NEUROLOGY, V72, P1487, DOI 10.1212/WNL.0b013e3181a2e8d0; Fernandez-Vizarra P, 2004, HISTOL HISTOPATHOL, V19, P823, DOI 10.14670/HH-19.823; Fiala JC, 2007, ACTA NEUROPATHOL, V114, P551, DOI 10.1007/s00401-007-0284-8; Fryer JD, 2005, J NEUROSCI, V25, P2803, DOI 10.1523/JNEUROSCI.5170-04.2005; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Gangabadage CS, 2008, J BIOL CHEM, V283, P17416, DOI 10.1074/jbc.M800756200; Glockner F, 2002, NEUROSCIENCE, V114, P1103; Gong JS, 2002, J BIOL CHEM, V277, P29919, DOI 10.1074/jbc.M203934200; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Grimmer T, 2010, BIOL PSYCHIAT, V68, P879, DOI 10.1016/j.biopsych.2010.05.013; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hauser PS, 2011, PROG LIPID RES, V50, P62, DOI 10.1016/j.plipres.2010.09.001; Hawkes CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041636; Hirsch-Reinshagen V, 2005, J BIOL CHEM, V280, P43243, DOI 10.1074/jbc.M508781200; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Jones PB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014586; Kim D, 2009, CELL, V137, P997, DOI 10.1016/j.cell.2009.05.042; Kim J, 2011, J NEUROSCI, V31, P18007, DOI 10.1523/JNEUROSCI.3773-11.2011; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Krul ES, 1996, METHOD ENZYMOL, V263, P170; Kuo YM, 1996, J BIOL CHEM, V271, P4077; LaDu MJ, 2012, BBA-MOL CELL BIOL L, V1821, P295, DOI 10.1016/j.bbalip.2011.11.005; LaDu MJ, 1997, J NEUROSCI RES, V49, P9, DOI 10.1002/(SICI)1097-4547(19970701)49:1<9::AID-JNR2>3.0.CO;2-H; LaDu MJ, 2006, BIOCHEMISTRY-US, V45, P381, DOI 10.1021/bi051765s; LADU MJ, 1994, J BIOL CHEM, V269, P23403; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Manelli AM, 2004, J MOL NEUROSCI, V23, P235, DOI 10.1385/JMN:23:3:235; Manelli AM, 2007, NEUROBIOL AGING, V28, P1139, DOI 10.1016/j.neurobiolaging.2006.05.024; Moore BD, 2009, BIOCHEMISTRY-US, V48, P11796, DOI 10.1021/bi901571t; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Petrlova J, 2011, PROTEINS, V79, P402, DOI 10.1002/prot.22891; Poirier J, 2005, NEUROBIOL AGING, V26, P355, DOI 10.1016/j.neurobiolaging.2004.09.003; Poirier J, 2008, ALZHEIMERS DEMENT, V4, pS91, DOI 10.1016/j.jalz.2007.11.012; Raffai RL, 2001, P NATL ACAD SCI USA, V98, P11587, DOI 10.1073/pnas.201279298; Ramaswamy G, 2005, J NEUROSCI, V25, P10658, DOI 10.1523/JNEUROSCI.1922-05.2005; Riddell DR, 2008, J NEUROSCI, V28, P11445, DOI 10.1523/JNEUROSCI.1972-08.2008; Sadowski MJ, 2006, P NATL ACAD SCI USA, V103, P18787, DOI 10.1073/pnas.0604011103; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Spires-Jones TL, 2011, METHODS, V53, P201, DOI 10.1016/j.ymeth.2010.12.009; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Sullivan PM, 2011, NEUROBIOL AGING, V32, P791, DOI 10.1016/j.neurobiolaging.2009.05.011; Sullivan PM, 2004, NEUROSCIENCE, V124, P725, DOI 10.1016/j.neuroscience.2003.10.011; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Sullivan PM, 1998, J CLIN INVEST, V102, P130, DOI 10.1172/JCI2673; Tai L.M., 2011, INT J ALZHEIMERS DIS, V2011; Thal DR, 2012, EXP NEUROL, V236, P1, DOI 10.1016/j.expneurol.2012.04.021; THAL DR, 2006, SCI AGING KNOWLEDGE, pRE1, DOI DOI 10.1126/SAGEKE.2006.6.RE1; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Trommer BL, 2005, NEUROBIOL DIS, V18, P75, DOI 10.1016/j.nbd.2004.08.011; Vekrellis K, 2000, J NEUROSCI, V20, P1657; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Vitek MP, 2009, NEUROBIOL AGING, V30, P1350, DOI 10.1016/j.neurobiolaging.2007.11.014; Wang H, 2007, NEUROSCIENCE, V144, P1324, DOI 10.1016/j.neuroscience.2006.11.017; Wang N, 1996, J BIOL CHEM, V271, P21001, DOI 10.1074/jbc.271.35.21001; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Winton MJ, 2011, J NEUROSCI, V31, P7691, DOI 10.1523/JNEUROSCI.6637-10.2011; Wirths O, 2012, LIFE SCI, V91, P1148, DOI 10.1016/j.lfs.2012.02.001; Xia WM, 2009, ARCH NEUROL-CHICAGO, V66, P190, DOI 10.1001/archneurol.2008.565; Youmans KL, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-8; Youmans KL, 2011, J NEUROSCI METH, V196, P51, DOI 10.1016/j.jneumeth.2010.12.025	89	178	181	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41774	41786		10.1074/jbc.M112.407957	http://dx.doi.org/10.1074/jbc.M112.407957			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23060451	Green Published, hybrid			2022-12-28	WOS:000312103000019
J	Visschedyk, D; Rochon, A; Tempel, W; Dimov, S; Park, HW; Merrill, AR				Visschedyk, Danielle; Rochon, Amanda; Tempel, Wolfram; Dimov, Svetoslav; Park, Hee-Won; Merrill, A. Rod			Certhrax Toxin, an Anthrax-related ADP-ribosyltransferase from Bacillus cereus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFRINGENS IOTA-TOXIN; CRYSTAL-STRUCTURE; LETHAL FACTOR; CLOSTRIDIUM-BOTULINUM; EXFOLIATIVE TOXIN; CATALYTIC DOMAIN; MECHANISM; EXOTOXIN; BINDING; PROTEIN	We identified Certhrax, the first anthrax-like mART toxin from the pathogenic G9241 strain of Bacillus cereus. Certhrax shares 31% sequence identity with anthrax lethal factor from Bacillus anthracis; however, we have shown that the toxicity of Certhrax resides in the mART domain, whereas anthrax uses a metalloprotease mechanism. Like anthrax lethal factor, Certhrax was found to require protective antigen for host cell entry. This two-domain enzyme was shown to be 60-fold more toxic to mammalian cells than anthrax lethal factor. Certhrax localizes to distinct regions within mouse RAW264.7 cells by 10 min postinfection and is extranuclear in its cellular location. Substitution of catalytic residues shows that the mART function is responsible for the toxicity, and it binds NAD(+) with high affinity (K-D = 52.3 +/- 12.2 mu M). We report the 2.2 angstrom Certhrax structure, highlighting its structural similarities and differences with anthrax lethal factor. We also determined the crystal structures of two good inhibitors (P6 (K-D = 1.7 +/- 0.2 mu M, K-i = 1.8 +/- 0.4 mu M) and PJ34 (K-D = 5.8 +/- 2.6 mu M, K-i = 9.6 +/- 0.3 mu M)) in complex with Certhrax. As with other toxins in this family, the phosphate-nicotinamide loop moves toward the NAD(+) binding site with bound inhibitor. These results indicate that Certhrax may be important in the pathogenesis of B. cereus.	[Visschedyk, Danielle; Rochon, Amanda; Merrill, A. Rod] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Tempel, Wolfram; Dimov, Svetoslav; Park, Hee-Won] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Park, Hee-Won] Univ Toronto, Dept Pharmacol, Toronto, ON M5G 1L7, Canada	University of Guelph; University of Toronto; Structural Genomics Consortium; University of Toronto	Merrill, AR (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	rmerrill@uoguelph.ca	Merrill, Rod/M-8313-2014		Canadian Institutes of Health Research; Cystic Fibrosis Canada; Human Frontier Science Program; National Sciences and Engineering Research Council; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck and Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada; Human Frontier Science Program(Human Frontier Science Program); National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck and Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	This study was funded by the Canadian Institutes of Health Research (to A. R. M. and H. W. P.), Cystic Fibrosis Canada (to A. R. M.), the Human Frontier Science Program (to A. R. M.), and a National Sciences and Engineering Research Council graduate fellowship (to D. V.). The Structural Genomics Consortium is a registered charity (Number 1097737) and receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck and Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.; We thank Dawn White for excellent technical assistance. We acknowledge Xinyu (Johnny) Guan for the crystallization of the N-domain of Certhrax<SUP>4</SUP> and thank Limin Shen for providing multiple clones for Certhrax. We are grateful to Bum-Soo Hong for early work on the crystallography and to Kyung-Phil Kim for help with DNA sequencing. We thank Zachari Turgeon for initial work on Certhrax cytotoxicity and inhibitor development and testing. We also thank Dr. Robert Fieldhouse for bioinformatics analysis of Certhrax and for insightful discussions. Research described here was performed using beamline 08ID-1 at the Canadian Light Source, which is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Abrami L, 2008, CELL MICROBIOL, V10, P2509, DOI 10.1111/j.1462-5822.2008.01226.x; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AKTORIES K, 1988, EUR J BIOCHEM, V172, P445, DOI 10.1111/j.1432-1033.1988.tb13908.x; AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Armstrong S, 2001, ANAL BIOCHEM, V292, P26, DOI 10.1006/abio.2001.5052; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Avashia SB, 2007, CLIN INFECT DIS, V44, P414, DOI 10.1086/510429; Barth H, 1998, J BIOL CHEM, V273, P29506, DOI 10.1074/jbc.273.45.29506; Bell CE, 1996, BIOCHEMISTRY-US, V35, P1137, DOI 10.1021/bi9520848; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Burns D., 2003, BACTERIAL PROTEIN TO; Candela T, 2006, MOL MICROBIOL, V60, P1091, DOI 10.1111/j.1365-2958.2006.05179.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Deng Q, 2008, ANNU REV MICROBIOL, V62, P271, DOI 10.1146/annurev.micro.62.081307.162848; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fieldhouse RJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001029; Fieldhouse RJ, 2008, TRENDS BIOCHEM SCI, V33, P546, DOI 10.1016/j.tibs.2008.08.003; Grochulski P, 2011, J SYNCHROTRON RADIAT, V18, P681, DOI 10.1107/S0909049511019431; Gupta P, 2001, BIOCHEM BIOPH RES CO, V280, P158, DOI 10.1006/bbrc.2000.4099; Han S, 1999, NAT STRUCT BIOL, V6, P932, DOI 10.1038/13300; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jorgensen R, 2008, EMBO REP, V9, P802, DOI 10.1038/embor.2008.90; JUST I, 1992, J BIOL CHEM, V267, P10274; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Laing S, 2011, AMINO ACIDS, V41, P257, DOI 10.1007/s00726-010-0676-2; Li M, 1996, P NATL ACAD SCI USA, V93, P6902, DOI 10.1073/pnas.93.14.6902; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melnyk RA, 2006, J BIOL CHEM, V281, P1630, DOI 10.1074/jbc.M511164200; Menetrey J, 2002, J BIOL CHEM, V277, P30950, DOI 10.1074/jbc.M201844200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEMOTO Y, 1991, J BIOL CHEM, V266, P19312; Oh SY, 2011, MOL MICROBIOL, V80, P455, DOI 10.1111/j.1365-2958.2011.07582.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Papazisi L, 2011, GENOMICS, V98, P26, DOI 10.1016/j.ygeno.2011.03.008; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; QUINN CP, 1991, J BIOL CHEM, V266, P20124; Rasko DA, 2007, J BACTERIOL, V189, P52, DOI 10.1128/JB.01313-06; Sakurai J, 2003, ADV ENZYME REGUL, V43, P361, DOI 10.1016/S0065-2571(02)00044-4; Salter SJ, 2011, NAT REV MICROBIOL, V9, P83, DOI 10.1038/nrmicro2506; Shen YQ, 2005, EMBO J, V24, P929, DOI 10.1038/sj.emboj.7600574; SINGH Y, 1989, J BIOL CHEM, V264, P11099; Tonello F, 2009, MOL ASPECTS MED, V30, P431, DOI 10.1016/j.mam.2009.07.006; Tsuge H, 2003, J MOL BIOL, V325, P471, DOI 10.1016/S0022-2836(02)01247-0; Turgeon Z, 2011, ANTIMICROB AGENTS CH, V55, P983, DOI 10.1128/AAC.01164-10; Turgeon Z, 2009, FEMS MICROBIOL LETT, V300, P97, DOI 10.1111/j.1574-6968.2009.01777.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VANDEKERCKHOVE J, 1987, FEBS LETT, V225, P48, DOI 10.1016/0014-5793(87)81129-8; Visschedyk DD, 2010, J BIOL CHEM, V285, P13525, DOI 10.1074/jbc.M109.077339; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Vogelsgesang M, 2006, BIOCHEMISTRY-US, V45, P1017, DOI 10.1021/bi052253g; Wilde C, 2002, BIOCHEMISTRY-US, V41, P1539, DOI 10.1021/bi015809i; Yamaguchi T, 2002, INFECT IMMUN, V70, P5835, DOI 10.1128/IAI.70.10.5835-5845.2002; Yamaguchi T, 2001, INFECT IMMUN, V69, P7760, DOI 10.1128/IAI.69.12.7760-7771.2001; Yates SP, 2006, TRENDS BIOCHEM SCI, V31, P123, DOI 10.1016/j.tibs.2005.12.007; Yates SP, 2005, BIOCHEM J, V385, P667, DOI 10.1042/BJ20041480; Zornetta I, 2010, CELL MICROBIOL, V12, P1435, DOI 10.1111/j.1462-5822.2010.01480.x	64	24	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41089	41102		10.1074/jbc.M112.412809	http://dx.doi.org/10.1074/jbc.M112.412809			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	22992735	Green Published, hybrid			2022-12-28	WOS:000311887600026
J	Alemu, EA; Lamark, T; Torgersen, KM; Birgisdottir, AB; Larsen, KB; Jain, A; Olsvik, H; Overvatn, A; Kirkin, V; Johansen, T				Alemu, Endalkachew Ashenafi; Lamark, Trond; Torgersen, Knut Martin; Birgisdottir, Aasa Birna; Larsen, Kenneth Bowitz; Jain, Ashish; Olsvik, Hallvard; Overvatn, Aud; Kirkin, Vladimir; Johansen, Terje			ATG8 Family Proteins Act as Scaffolds for Assembly of the ULK Complex SEQUENCE REQUIREMENTS FOR LC3-INTERACTING REGION (LIR) MOTIFS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE AUTOPHAGY; INTERACTING MOTIF; STRUCTURAL BASIS; MAMMALIAN-CELLS; KINASE; LC3; DEGRADATION; P62/SQSTM1; BINDING; IDENTIFICATION	Autophagy is a lysosome-dependent degradation system conserved among eukaryotes. The mammalian Atg1 homologues, Unc-51 like kinase (ULK) 1 and 2, are multifunctional proteins with roles in autophagy, neurite outgrowth, and vesicle transport. The mammalian ULK complex involved in autophagy consists of ULK1, ULK2, ATG13, FIP200, and ATG101. We have used pulldown and peptide array overlay assays to study interactions between the ULK complex and six different ATG8 family proteins. Strikingly, in addition to ULK1 and ULK2, ATG13 and FIP200 interacted with human ATG8 proteins, all with strong preference for the GABARAP subfamily. Similarly, yeast and Drosophila Atg1 interacted with their respective Atg8 proteins, demonstrating the evolutionary conservation of the interaction. Use of peptide arrays allowed precise mapping of the functional LIR motifs, and two-dimensional scans of the ULK1 and ATG13 LIR motifs revealed which substitutions that were tolerated. This information, combined with an analysis of known LIR motifs, provides us with a clearer picture of sequence requirements for LIR motifs. In addition to the known requirements of the aromatic and hydrophobic residues of the core motif, we found the interactions to depend strongly on acidic residues surrounding the central core LIR motifs. A preference for either a hydrophobic residue or an acidic residue following the aromatic residue in the LIR motif is also evident. Importantly, the LIR motif is required for starvation-induced association of ULK1 with autophagosomes. Our data suggest that ATG8 proteins act as scaffolds for assembly of the ULK complex at the phagophore.	[Larsen, Kenneth Bowitz; Jain, Ashish; Olsvik, Hallvard; Overvatn, Aud; Johansen, Terje] Univ Tromso, Inst Med Biol, Mol Canc Res Grp, N-9037 Tromso, Norway; [Torgersen, Knut Martin] Univ Oslo, Biotechnol Ctr Oslo, N-0317 Oslo, Norway; [Kirkin, Vladimir] Merck KGaA, D-64293 Darmstadt, Germany	UiT The Arctic University of Tromso; University of Oslo; Merck KGaA	Johansen, T (corresponding author), Univ Tromso, Inst Med Biol, Mol Canc Res Grp, N-9037 Tromso, Norway.	terje.johansen@uit.no	Johansen, Terje/AAY-1753-2021; Johansen, Terje/N-2971-2015; Larsen, Kenneth/HDO-5510-2022	Johansen, Terje/0000-0003-1451-9578; Johansen, Terje/0000-0003-1451-9578; Birgisdottir, Asa Birna/0000-0003-1080-3619; Lamark, Trond/0000-0001-6338-3342; Kirkin, Vladimir/0000-0002-8049-3663; Olsvik, Hallvard/0000-0003-3489-7461	FUGE program of the Norwegian Research Council; FRIBIO program of the Norwegian Research Council; Norwegian Cancer Society; Blix Foundation	FUGE program of the Norwegian Research Council; FRIBIO program of the Norwegian Research Council; Norwegian Cancer Society(Norwegian Cancer Society); Blix Foundation	This work was supported in part by grants from the FUGE and FRIBIO programs of the Norwegian Research Council, the Norwegian Cancer Society, and the Blix Foundation (to T. J.).	Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bodemann BO, 2011, CELL, V144, P253, DOI 10.1016/j.cell.2010.12.018; Chan EY, 2012, ANTIOXID REDOX SIGN, V17, P775, DOI 10.1089/ars.2011.4396; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hosokawa N, 2009, AUTOPHAGY, V5, P973, DOI 10.4161/auto.5.7.9296; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Itoh T, 2011, J CELL BIOL, V192, P839, DOI 10.1083/jcb.201008107; Jiang SX, 2011, BIOCHEM BIOPH RES CO, V413, P420, DOI 10.1016/j.bbrc.2011.08.106; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Joo JH, 2011, MOL CELL, V43, P572, DOI 10.1016/j.molcel.2011.06.018; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kraft C, 2012, EMBO J, V31, P3691, DOI 10.1038/emboj.2012.225; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Larsen KB, 2010, AUTOPHAGY, V6, P784, DOI 10.4161/auto.6.6.12510; Le Grand JN, 2011, AUTOPHAGY, V7, P1302, DOI 10.4161/auto.7.11.16723; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Longatti A, 2009, CELL DEATH DIFFER, V16, P956, DOI 10.1038/cdd.2009.39; Mercer CA, 2009, AUTOPHAGY, V5, P649, DOI 10.4161/auto.5.5.8249; Mohrluder J, 2007, BIOCHEMISTRY-US, V46, P14537, DOI 10.1021/bi7018145; Mohrluder J, 2007, FEBS J, V274, P5543, DOI 10.1111/j.1742-4658.2007.06073.x; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nakatogawa H, 2012, J BIOL CHEM, V287, P28503, DOI 10.1074/jbc.C112.387514; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Okazaki N, 2000, MOL BRAIN RES, V85, P1, DOI 10.1016/S0169-328X(00)00218-7; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Polson HEJ, 2010, AUTOPHAGY, V6, P506, DOI 10.4161/auto.6.4.11863; Popovic D, 2012, MOL CELL BIOL, V32, P1733, DOI 10.1128/MCB.06717-11; Sancho A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034034; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; Shpilka T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-226; Shvets E, 2008, J CELL SCI, V121, P2685, DOI 10.1242/jcs.026005; Suttangkakul A, 2011, PLANT CELL, V23, P3761, DOI 10.1105/tpc.111.090993; Svenning S, 2011, AUTOPHAGY, V7, P993, DOI 10.4161/auto.7.9.16389; Tomoda T, 1999, NEURON, V24, P833, DOI 10.1016/S0896-6273(00)81031-4; Weidberg H, 2011, ANNU REV BIOCHEM, V80, P125, DOI 10.1146/annurev-biochem-052709-094552; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Yamaguchi M, 2010, J BIOL CHEM, V285, P29599, DOI 10.1074/jbc.M110.113670; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Young AJ, 2006, MED SCI SPORT EXER, V38, P1, DOI 10.1249/01.mss.0000196708.08925.8b	55	213	223	4	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.378109	http://dx.doi.org/10.1074/jbc.M112.378109			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23043107	Green Published, hybrid			2022-12-28	WOS:000311233800001
J	Ali, MF; Chachadi, VB; Petrosyan, A; Cheng, PW				Ali, Mohamed F.; Chachadi, Vishwanath B.; Petrosyan, Armen; Cheng, Pi-Wan			Golgi Phosphoprotein 3 Determines Cell Binding Properties under Dynamic Flow by Controlling Golgi Localization of Core 2 N-Acetylglucosaminyltransferase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WISKOTT-ALDRICH SYNDROME; INTERCELLULAR-ADHESION MOLECULE-1; FRONTAL AFFINITY-CHROMATOGRAPHY; O-LINKED OLIGOSACCHARIDES; P-SELECTIN; MEMBRANE-GLYCOPROTEINS; ENDOPLASMIC-RETICULUM; IMMUNE-RESPONSES; TUMOR-METASTASIS; CYTOPLASMIC TAIL	Core 2 N-acetylglucosaminyltransferase 1 (C2GnT1) is a key enzyme participating in the synthesis of core 2-associated sialyl Lewis x (C2-O-sLe(x)), a ligand involved in selectin-mediated leukocyte trafficking and cancer metastasis. To accomplish that, C2GnT1 needs to be localized to the Golgi and this step requires interaction of its cytoplasmic tail (CT) with a protein that has not been identified. Employing C2GnT1 CT as the bait to perform a yeast two-hybrid screen, we have identified Golgi phosphoprotein 3 (GOLPH3) as a principal candidate protein that interacts with C2GnT1 and demonstrated that C2GnT1 binds to GOLPH3 via the LLRRR9 sequence in the CT. Confocal fluorescence microscopic analysis shows substantial Golgi co-localization of C2GnT1 and GOLPH3. Upon GOLPH3 knockdown, C2GnT1 is found mainly in the endoplasmic reticulum and decorated with complex-typeN-glycans, indicating that the enzyme has been transported to the Golgi but is not retained. Also, we have found that a recombinant protein consisting of C2GnT1 CT1-16-Leu(17-32)-Gly(33-42)-GFP is localized to the Golgi although the same construct with mutated CT (AAAAA(9)) is not. The data demonstrate that the C2GnT1 CT is necessary and sufficient for Golgi localization of C2GnT1. Furthermore, GOLPH3 knockdown results in reduced synthesis of C2-O-sLe(x) associated with P-selectin glycoprotein ligand-1, reduced cell tethering to and rolling on immobilized P- or E-selectin, and compromised E-selectin-induced activation of spleen tyrosine kinase and cell adhesion to intercellular adhesion molecule-1 under dynamic flow. Our results reveal that GOLPH3 can regulate cell-cell interaction by controlling Golgi retention of C2GnT1.	[Ali, Mohamed F.; Chachadi, Vishwanath B.; Petrosyan, Armen; Cheng, Pi-Wan] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Coll Med, Omaha, NE 68198 USA; [Cheng, Pi-Wan] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Ali, Mohamed F.; Chachadi, Vishwanath B.; Petrosyan, Armen; Cheng, Pi-Wan] Vet Affairs Nebraska Western Iowa Hlth Care Syst, Dept Res Serv, Omaha, NE 68105 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System	Cheng, PW (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Coll Med, 985870 Nebraska Med Ctr, Omaha, NE 68198 USA.	pcheng@unmc.edu	Chachadi, Vishwanath/ABG-8002-2021; Petrosyan, Armen/T-7071-2018	Chachadi, Vishwanath/0000-0002-4488-419X; Petrosyan, Armen/0000-0003-3895-3993	National Institutes of Health [1R21HL097238, 2RO1HL48282]; Office of Research and Development, Medical Research Service, Dept. of Veterans Affairs [VA 1I1BX000985]; State of Nebraska [LB506]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL097238, R01HL048282] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000985] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research and Development, Medical Research Service, Dept. of Veterans Affairs; State of Nebraska; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants 1R21HL097238 and 2RO1HL48282, the Office of Research and Development, Medical Research Service, Dept. of Veterans Affairs Grant VA 1I1BX000985, and State of Nebraska Grant LB506 (to P.W.C.).	Bell AW, 2001, J BIOL CHEM, V276, P5152, DOI 10.1074/jbc.M006143200; Beum PV, 1999, J BIOL CHEM, V274, P24641, DOI 10.1074/jbc.274.35.24641; Beum PV, 2001, ADV EXP MED BIOL, V491, P279; Borsig L, 2002, P NATL ACAD SCI USA, V99, P2193, DOI 10.1073/pnas.261704098; Bugarcic A, 2011, TRAFFIC, V12, P1759, DOI 10.1111/j.1600-0854.2011.01284.x; Carlow DA, 2009, IMMUNOL REV, V230, P75, DOI 10.1111/j.1600-065X.2009.00797.x; Chen SH, 2006, METHOD ENZYMOL, V416, P371, DOI 10.1016/S0076-6879(06)16024-3; Cheng PW, 2011, ADV EXP MED BIOL, V705, P465, DOI 10.1007/978-1-4419-7877-6_25; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; Dejgaard SY, 2007, J HISTOCHEM CYTOCHEM, V55, P709, DOI 10.1369/jhc.6A7090.2007; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; FEIZI T, 1980, REV FR TRANSFUS IMMU, V23, P563, DOI 10.1016/S0338-4535(80)80160-7; GONATAS JO, 1989, J BIOL CHEM, V264, P4264; Gopalan PK, 1997, J IMMUNOL, V158, P367; Graham TR, 2011, TRENDS CELL BIOL, V21, P113, DOI 10.1016/j.tcb.2010.10.002; HIGGINS EA, 1991, J BIOL CHEM, V266, P6280; Jacobson DA, 2006, AM J PHYSIOL-ENDOC M, V291, pE587, DOI 10.1152/ajpendo.00612.2005; Kikuchi J, 2005, LEUKEMIA, V19, P1934, DOI 10.1038/sj.leu.2403951; Krull M, 1999, J IMMUNOL, V162, P4834; Kumar R, 1996, BLOOD, V88, P3872, DOI 10.1182/blood.V88.10.3872.bloodjournal88103872; Kunigou O, 2011, ONCOL REP, V26, P1337, DOI 10.3892/or.2011.1413; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li FG, 1996, J BIOL CHEM, V271, P3255, DOI 10.1074/jbc.271.6.3255; Li XY, 2011, J NEURO-ONCOL, V105, P159, DOI 10.1007/s11060-011-0573-x; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; McEver RP, 1997, J CLIN INVEST, V100, P485, DOI 10.1172/JCI119556; MEGA T, 1992, J BIOCHEM-TOKYO, V111, P396, DOI 10.1093/oxfordjournals.jbchem.a123768; Moll T, 1999, METH MOL B, V96, P77; Nakamura M, 1998, J BIOL CHEM, V273, P26779, DOI 10.1074/jbc.273.41.26779; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nakashima-Kamimura N, 2005, J CELL SCI, V118, P5357, DOI 10.1242/jcs.02645; OCHS HD, 1986, CLIN IMMUNOL IMMUNOP, V40, P94, DOI 10.1016/0090-1229(86)90072-3; OHYAMA Y, 1985, J BIOL CHEM, V260, P6882; Okamoto M, 2008, EUKARYOT CELL, V7, P310, DOI 10.1128/EC.00333-07; Osman N, 1996, J BIOL CHEM, V271, P33105, DOI 10.1074/jbc.271.51.33105; PARK JK, 1991, NATURE, V350, P706, DOI 10.1038/350706a0; Petrosyan A, 2012, INT J BIOCHEM CELL B, V44, P1153, DOI 10.1016/j.biocel.2012.04.004; PILLER F, 1991, J EXP MED, V173, P1501, DOI 10.1084/jem.173.6.1501; Quintero CA, 2008, BIOCHEM J, V412, P19, DOI 10.1042/BJ20071725; Radhakrishnan P, 2011, BIOCHEM BIOPH RES CO, V409, P436, DOI 10.1016/j.bbrc.2011.05.019; Ross JM, 1998, THROMB HAEMOSTASIS, V79, P155; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; Scott KL, 2010, CLIN CANCER RES, V16, P2229, DOI 10.1158/1078-0432.CCR-09-1695; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Skrincosky D, 1997, J BIOL CHEM, V272, P22695, DOI 10.1074/jbc.272.36.22695; Sours-Brothers S, 2009, FRONT BIOSCI-LANDMRK, V14, P1851, DOI 10.2741/3346; Sperandio M, 2001, BLOOD, V97, P3812, DOI 10.1182/blood.V97.12.3812; Sriramarao P, 1996, J IMMUNOL, V157, P4672; St Hill CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016281; Tarr JM, 2012, CELL SIGNAL, V24, P873, DOI 10.1016/j.cellsig.2011.12.003; Tateno H, 2009, GLYCOBIOLOGY, V19, P527, DOI 10.1093/glycob/cwp016; Tsuboi S, 1998, J BIOL CHEM, V273, P30680, DOI 10.1074/jbc.273.46.30680; Tsuboi S, 1997, EMBO J, V16, P6364, DOI 10.1093/emboj/16.21.6364; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Tu LN, 2010, CELL MOL LIFE SCI, V67, P29, DOI 10.1007/s00018-009-0126-z; Uliana AS, 2006, TRAFFIC, V7, P604, DOI 10.1111/j.1600-0854.2006.00413.x; Urzainqui A, 2002, IMMUNITY, V17, P401, DOI 10.1016/S1074-7613(02)00420-X; van den Berg TK, 2001, IMMUNOL REV, V184, P45, DOI 10.1034/j.1600-065x.2001.1840105.x; Varki A., 2009, ESSENTIALS GLYCOBIOL; Walcheck B, 2002, BLOOD, V99, P4063, DOI 10.1182/blood-2001-12-0265; Wang XM, 2004, BIOMED ENVIRON SCI, V17, P341; Wassler MJ, 2001, J CELL SCI, V114, P2291; Wiese Georg, 2009, J Vis Exp, DOI 10.3791/1009; Wood CS, 2009, J CELL BIOL, V187, P967, DOI 10.1083/jcb.200909063; Yago T, 2010, BLOOD, V116, P485, DOI 10.1182/blood-2009-12-259556; YAMAGUCHI N, 1995, J BIOL CHEM, V270, P12170, DOI 10.1074/jbc.270.20.12170; Zarbock A, 2007, IMMUNITY, V26, P773, DOI 10.1016/j.immuni.2007.04.011; Zerfaoui M, 2002, GLYCOBIOLOGY, V12, P15, DOI 10.1093/glycob/12.1.15	70	52	58	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.346528	http://dx.doi.org/10.1074/jbc.M112.346528			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23027862	hybrid, Green Published			2022-12-28	WOS:000311233800027
J	Baumann, T; Affentranger, S; Niggli, V				Baumann, Tommy; Affentranger, Sarah; Niggli, Verena			Evidence for Chemokine-mediated Coalescence of Preformed Flotillin Hetero-oligomers in Human T-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGGIE/FLOTILLIN PROTEINS; MEMBRANE MICRODOMAINS; FLUORESCENT PROTEIN; REGGIE-1/FLOTILLIN-2; OLIGOMERIZATION; ASSOCIATION; CHEMOTAXIS; MIGRATION; INTERACT; UROPOD	We have shown previously that endogenous flotillin-1 and -2, closely related proteins implicated in scaffolding of membrane microdomains, are rapidly recruited to the uropods of chemoattractant-stimulated human neutrophils and T-cells and are involved in cell polarization. Coexpressed flotillin-1 and -2, but not singly expressed proteins, are also targeted to the uropod of T-cells and neutrophils. Biochemical studies suggest formation of flotillin homo- and hetero-oligomers in other cell types, but so far knowledge is lacking on in situ flotillin organization in leukocytes. We have now analyzed flotillin organization in human T-cells using fluorescence resonance energy transfer (FRET). Coexpressed C-terminally tagged flotillin-1-mCherry and flotillin-2-enhanced green fluorescent protein (EGFP) show significant FRET when analyzed in intact human T-cells in the absence and presence of chemokine. In contrast, little FRET was observed between coexpressed flotillin-1-mCherry and flotillin-1-EGFP before or after chemokine addition, indicating predominant formation of heterodimers and/or -oligomers. Interestingly coexpression of untagged flotillin-2 strongly enhanced FRET between differently tagged flotillin-1 molecules in resting and chemokine-stimulated cells, indicating that close contacts of flotillin-1 molecules only occur in flotillin-2-containing hetero-oligomers. Comparable results were obtained for tagged flotillin-2. We further show that disruption of the actin network, depletion of intracellular calcium, and inhibition of phospholipase C all result in suppression of chemokine-induced polarization and flotillin cap formation, but do not abolish FRET between tagged flotillin-1 and -2. Our results support predominant formation of flotillin-1 and -2 hetero-oligomers in resting and chemokine-stimulated human T-cells which may importantly contribute to structuring of the uropod.	[Baumann, Tommy; Affentranger, Sarah; Niggli, Verena] Univ Bern, Inst Pathol, CH-3010 Bern, Switzerland	University of Bern	Niggli, V (corresponding author), Univ Bern, Inst Pathol, Murtenstr 31, CH-3010 Bern, Switzerland.	verena.niggli@pathology.unibe.ch		Baumann, Tommy/0000-0002-5950-4137	Swiss National Science Foundation Grant [3100A_129655/1]	Swiss National Science Foundation Grant(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Science Foundation Grant 3100A_129655/1 (to V. N.).	Affentranger S, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-28; Albertazzi L, 2009, PHOTOCHEM PHOTOBIOL, V85, P287, DOI 10.1111/j.1751-1097.2008.00435.x; Babuke T, 2009, CELL SIGNAL, V21, P1287, DOI 10.1016/j.cellsig.2009.03.012; Bach TL, 2007, J IMMUNOL, V179, P2223, DOI 10.4049/jimmunol.179.4.2223; Bagorda A, 2008, J CELL SCI, V121, P2621, DOI 10.1242/jcs.018077; Banning A, 2011, CURR PROTEIN PEPT SC, V12, P725, DOI 10.2174/138920311798841708; Fernow I, 2007, EUR J CELL BIOL, V86, P345, DOI 10.1016/j.ejcb.2007.03.004; Frick M., CURR BIOL, V17, P1151; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Krummel MF, 2006, NAT IMMUNOL, V7, P1143, DOI 10.1038/ni1404; Ludwig A, 2010, J CELL BIOL, V191, P771, DOI 10.1083/jcb.201005140; Manes S, 2006, MOL MEMBR BIOL, V23, P59, DOI 10.1080/09687860500430069; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Rivera-Milla E, 2006, CELL MOL LIFE SCI, V63, P343, DOI 10.1007/s00018-005-5434-3; Rossy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005403; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Svensson L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015090; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	18	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.412742	http://dx.doi.org/10.1074/jbc.M112.412742			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23012365	Green Published, hybrid			2022-12-28	WOS:000311233800036
J	Lee, KH; Biswas, A; Liu, YJ; Kobayashi, KS				Lee, Kyoung-Hee; Biswas, Amlan; Liu, Yuen-Joyce; Kobayashi, Koichi S.			Proteasomal Degradation of Nod2 Protein Mediates Tolerance to Bacterial Cell Wall Components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPAIRED ANTIGEN PRESENTATION; INNATE IMMUNE-RESPONSES; MONOPHOSPHORYL-LIPID-A; NF-KAPPA-B; ENDOTOXIN TOLERANCE; HUMAN MONOCYTES; MURAMYL-DIPEPTIDE; BLAU-SYNDROME; SEPTIC SHOCK; MOLECULAR-MECHANISMS	The innate immune system serves as the first line of defense by detecting microbes and initiating inflammatory responses. Although both Toll-like receptor (TLR) and nucleotide binding domain and leucine-rich repeat (NLR) proteins are important for this process, their excessive activation is hazardous to hosts; thus, tight regulation is required. Endotoxin tolerance is refractory to repeated lipopolysaccharide (LPS) stimulation and serves as a host defense mechanism against septic shock caused by an excessive TLR4 response during Gram-negative bacterial infection. Gram-positive bacteria as well as their cell wall components also induce shock. However, the mechanism underlying tolerance is not understood. Here, we show that activation of Nod2 by its ligand, muramyl dipeptide (MDP) in the bacterial cell wall, induces rapid degradation of Nod2, which confers MDP tolerance in vitro and in vivo. Nod2 is constitutively associated with a chaperone protein, Hsp90, which is required for Nod2 stability and protects Nod2 from degradation. Upon MDP stimulation, Hsp90 rapidly dissociates from Nod2, which subsequently undergoes ubiquitination and proteasomal degradation. The SOCS-3 protein induced by Nod2 activation further facilitates this degradation process. Therefore, Nod2 protein stability is a key factor in determining responsiveness to MDP stimulation. This indicates that TLRs and NLRs induce a tolerant state through distinct molecular mechanisms that protect the host from septic shock.	[Kobayashi, Koichi S.] Texas A&M Hlth Sci Ctr, Coll Med, Dept Microbial & Mol Pathogenesis, College Stn, TX 77843 USA; [Lee, Kyoung-Hee; Biswas, Amlan; Liu, Yuen-Joyce; Kobayashi, Koichi S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02215 USA; [Lee, Kyoung-Hee; Biswas, Amlan; Kobayashi, Koichi S.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02215 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Kobayashi, KS (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Dept Microbial & Mol Pathogenesis, 415A Reynolds Med Bldg, College Stn, TX 77843 USA.	kobayashi@medicine.tamhsc.edu		Kobayashi, Koichi/0000-0003-2930-0114; Liu, Yuen-Joyce/0000-0003-1772-0082	National Institutes of Health [R01DK074738]; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074738] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK074738 (to K. S. K.). This work was also supported by a grant from the Crohn's and Colitis Foundation of America (to K. S. K.).; Recipient of Crohn's and Colits Foundation of America research fellowship.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; Biswas A, 2010, P NATL ACAD SCI USA, V107, P14739, DOI 10.1073/pnas.1003363107; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; BONE RC, 1994, ARCH INTERN MED, V154, P26, DOI 10.1001/archinte.154.1.26; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; DANNER RL, 1991, CHEST, V99, P169, DOI 10.1378/chest.99.1.169; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; del Fresno C, 2009, J IMMUNOL, V182, P6494, DOI 10.4049/jimmunol.0803350; Draisma A, 2009, CRIT CARE MED, V37, P1261, DOI 10.1097/CCM.0b013e31819c3c67; Escoll P, 2003, BIOCHEM BIOPH RES CO, V311, P465, DOI 10.1016/j.bbrc.2003.10.019; Fan HK, 2004, J ENDOTOXIN RES, V10, P71, DOI 10.1179/096805104225003997; Ferreira MES, 2001, AM J PHYSIOL-REG I, V281, pR162, DOI 10.1152/ajpregu.2001.281.1.R162; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; FRANKENBERGER M, 1995, J INFLAMM, V45, P56; Fujimoto M, 2003, TRENDS IMMUNOL, V24, P659, DOI 10.1016/j.it.2003.10.008; GALLIS HA, 1976, INFECT IMMUN, V13, P1459, DOI 10.1128/IAI.13.5.1459-1466.1976; Gustafson G L, 1995, Prog Clin Biol Res, V392, P567; HAAS JG, 1990, P NATL ACAD SCI USA, V87, P9563, DOI 10.1073/pnas.87.24.9563; Hasegawa M, 2006, J BIOL CHEM, V281, P29054, DOI 10.1074/jbc.M602638200; Hedl M, 2007, P NATL ACAD SCI USA, V104, P19440, DOI 10.1073/pnas.0706097104; Hedl M, 2011, GASTROENTEROLOGY, V140, P231, DOI 10.1053/j.gastro.2010.09.009; HENRICSON BE, 1990, INFECT IMMUN, V58, P2429, DOI 10.1128/IAI.58.8.2429-2437.1990; Herskovits AA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030051; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ilangumaran S, 2004, SEMIN IMMUNOL, V16, P351, DOI 10.1016/j.smim.2004.08.015; Kadota Y, 2010, TRENDS BIOCHEM SCI, V35, P199, DOI 10.1016/j.tibs.2009.12.005; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kim YG, 2008, IMMUNITY, V28, P246, DOI 10.1016/j.immuni.2007.12.012; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lopez-Collazo E, 2006, CURR OPIN INFECT DIS, V19, P237, DOI 10.1097/01.qco.0000224817.35105.7d; Mages J, 2007, IMMUNOBIOLOGY, V212, P723, DOI 10.1016/j.imbio.2007.09.015; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; Meshcheryakova E, 2001, INT IMMUNOPHARMACOL, V1, P1857, DOI 10.1016/S1567-5769(01)00111-4; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Monneret G, 2004, IMMUNOL LETT, V95, P193, DOI 10.1016/j.imlet.2004.07.009; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Ogawa Chikako, 2011, Curr Bioact Compd, V7, P180; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; RANDOW F, 1995, J EXP MED, V181, P1887, DOI 10.1084/jem.181.5.1887; Rose CD, 2005, J RHEUMATOL, V32, P373; Salkowski CA, 1998, INFECT IMMUN, V66, P3569, DOI 10.1128/IAI.66.8.3569-3578.1998; Sangster TA, 2005, CURR OPIN PLANT BIOL, V8, P86, DOI 10.1016/j.pbi.2004.11.012; Schulze-Lefert P, 2004, CURR BIOL, V14, pR22, DOI 10.1016/j.cub.2003.12.017; Shimauchi H, 1999, INFECT IMMUN, V67, P2153, DOI 10.1128/IAI.67.5.2153-2159.1999; Shirasu K, 2003, TRENDS PLANT SCI, V8, P252, DOI 10.1016/S1360-1385(03)00104-3; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; TAKADA H, 1987, INFECT IMMUN, V55, P409, DOI 10.1128/IAI.55.2.409-413.1987; Takada H, 2002, J ENDOTOXIN RES, V8, P337, DOI 10.1179/096805102125000669; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Tsai WH, 2011, CELL MICROBIOL, V13, P717, DOI 10.1111/j.1462-5822.2010.01567.x; VIRCA GD, 1989, J BIOL CHEM, V264, P21951; Wang J, 2009, J IMMUNOL, V183, P1384, DOI 10.4049/jimmunol.0803987; Watanabe T, 2008, J CLIN INVEST, V118, P545, DOI [10.1172/JC133145, 10.1172/JCI33145]; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wilmanski JM, 2008, J LEUKOCYTE BIOL, V83, P13, DOI 10.1189/jlb.0607402; Wolk K, 2000, BLOOD, V96, P218, DOI 10.1182/blood.V96.1.218.013k04_218_223	68	61	71	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.410027	http://dx.doi.org/10.1074/jbc.M112.410027			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23019338	hybrid, Green Published			2022-12-28	WOS:000311233800048
J	Sanchez-Solana, B; Motwani, M; Li, DQ; Eswaran, J; Kumar, R				Sanchez-Solana, Beatriz; Motwani, Mona; Li, Da-Qiang; Eswaran, Jeyanthy; Kumar, Rakesh			p21-activated Kinase-1 Signaling Regulates Transcription of Tissue Factor and Tissue Factor Pathway Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM-STIMULATED FIBROBLASTS; FACTOR GENE-EXPRESSION; TUMOR-NECROSIS-FACTOR; SMOOTH-MUSCLE-CELLS; BREAST-CANCER CELLS; ENDOTHELIAL-CELLS; C-JUN; KINASE; PROTEIN; ACTIVATION	Tissue factor (TF) is a cell-surface glycoprotein responsible for initiating the coagulation cascade. Besides its role in homeostasis, studies have shown the implication of TF in embryonic development, cancer-related events, and inflammation via coagulation-dependent and -independent (signaling) mechanisms. Tissue factor pathway inhibitor (TFPI) plays an important role in regulating TF-initiated blood coagulation. Therefore, transcriptional regulation of TF expression and its physiological inhibitor TFPI would allow us to understand the critical step that controls many different processes. From a gene profiling study aimed at identifying differentially regulated genes between wild-type (WT) and p21-activated kinase 1-null (PAK1-KO) mouse embryonic fibroblasts (MEFs), we found TF and TFPI are differentially expressed in the PAK1-KO MEFs in comparison with wild-type MEFs. Based on these findings, we further investigated in this study the transcriptional regulation of TF and TFPI by PAK1, a serine/threonine kinase. We found that the PAK1.c-Jun complex stimulates the transcription of TF and consequently its procoagulant activity. Moreover, PAK1 negatively regulates the expression of TFPI and additionally contributes to increased TF activity. For the first time, this study implicates PAK1 in coagulation processes, through its dual transcriptional regulation of TF and its inhibitor.	[Sanchez-Solana, Beatriz; Motwani, Mona; Li, Da-Qiang; Kumar, Rakesh] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [Eswaran, Jeyanthy] George Washington Univ, Sch Med & Hlth Sci, McCormick Prote & Genom Ctr, Washington, DC 20037 USA	George Washington University; George Washington University	Kumar, R (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	bcmrxk@gwu.edu	Motwani, Mona/AAV-8162-2020; Kumar, Rakesh/ABD-1065-2020	Motwani, Mona/0000-0003-0912-5478; Kumar, Rakesh/0000-0001-7664-0803; Eswaran, Jeyanthy/0000-0003-0260-9517; Sanchez-Solana, Beatriz/0000-0003-1155-5194	National Institutes of Health Grant [CA90970]; McCormick Proteomic and Genomic Center; NATIONAL CANCER INSTITUTE [R01CA090970] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McCormick Proteomic and Genomic Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA90970 (to R. K.). This work was also supported by the McCormick Proteomic and Genomic Center.	Adam L, 2000, J BIOL CHEM, V275, P12041, DOI 10.1074/jbc.275.16.12041; Amirkhosravi A, 2007, SEMIN THROMB HEMOST, V33, P643, DOI 10.1055/s-2007-991531; Angus-Hill ML, 2011, P NATL ACAD SCI USA, V108, P4914, DOI 10.1073/pnas.1102300108; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Bajaj MS, 2001, THROMB HAEMOSTASIS, V86, P959; Bajaj MS, 1999, THROMB HAEMOSTASIS, V82, P1663; Balasenthil S, 2004, J BIOL CHEM, V279, P1422, DOI 10.1074/jbc.M309937200; BARNES C, 2003, NAT STRUCT BIOL, V31, P10; BIERHAUS A, 1995, J BIOL CHEM, V270, P26419, DOI 10.1074/jbc.270.44.26419; Brown JL, 1996, CURR BIOL, V6, P598, DOI 10.1016/S0960-9822(02)00546-8; BROWN PH, 1994, ONCOGENE, V9, P791; Bugge TH, 1996, P NATL ACAD SCI USA, V93, P6258, DOI 10.1073/pnas.93.13.6258; CARSON SD, 1986, THROMB RES, V41, P185, DOI 10.1016/0049-3848(86)90228-8; Carson SD, 1996, BLOOD COAGUL FIBRIN, V7, P303, DOI 10.1097/00001721-199604000-00004; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; Contrino J, 1996, NAT MED, V2, P209, DOI 10.1038/nm0296-209; CUI MZ, 1994, ARTERIOSCLER THROMB, V14, P807, DOI 10.1161/01.ATV.14.5.807; Diebold I, 2010, ANTIOXID REDOX SIGN, V13, P399, DOI 10.1089/ars.2009.3013; DRAKE TA, 1989, AM J PATHOL, V134, P1087; FELTS SJ, 1995, BIOCHEMISTRY-US, V34, P12355, DOI 10.1021/bi00038a032; Gorlach A, 2005, THROMB HAEMOSTASIS, V93, P1168, DOI 10.1160/TH05-01-0006; Hembrough TA, 2001, J BIOL CHEM, V276, P12241, DOI 10.1074/jbc.M010395200; Khanna A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017979; Kumar R, 2002, NATURE, V418, P654, DOI 10.1038/nature00889; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; LEVI M, 1994, J CLIN INVEST, V93, P114, DOI 10.1172/JCI116934; Li DQ, 2011, P NATL ACAD SCI USA, V108, P8791, DOI 10.1073/pnas.1018389108; Li DQ, 2010, J BIOL CHEM, V285, P10044, DOI 10.1074/jbc.M109.079095; Li F, 2002, EMBO REP, V3, P767, DOI 10.1093/embo-reports/kvf157; Li TT, 2011, CARCINOGENESIS, V32, P659, DOI 10.1093/carcin/bgq271; Mackman N, 1996, HAEMOSTASIS, V26, P17; MACKMAN N, 1990, P NATL ACAD SCI USA, V87, P2254, DOI 10.1073/pnas.87.6.2254; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MCVEY JH, 1994, BAILLIERE CLIN HAEM, V7, P469, DOI 10.1016/S0950-3536(05)80094-0; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Molli PR, 2010, J CELL BIOL, V190, P101, DOI 10.1083/jcb.200908050; NEMERSON Y, 1988, BLOOD, V71, P1; Pendurthi UR, 2002, VITAM HORM, V64, P323, DOI 10.1016/S0083-6729(02)64009-9; Rickles FR, 2001, ACTA HAEMATOL-BASEL, V106, P6, DOI 10.1159/000046583; Ruf W, 2011, J THROMB HAEMOST, V9, P306, DOI 10.1111/j.1538-7836.2011.04318.x; Ruf W, 2007, THROMB RES, V120, pS7, DOI 10.1016/S0049-3848(07)70125-1; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Shen Q, 2008, ONCOGENE, V27, P366, DOI 10.1038/sj.onc.1210643; Singh RR, 2005, J BIOL CHEM, V280, P18130, DOI 10.1074/jbc.M412607200; Soprano DR, 2004, ANNU REV NUTR, V24, P201, DOI 10.1146/annurev.nutr.24.012003.132407; Tanikawa M, 2011, BRIT J CANCER, V104, P1349, DOI 10.1038/bjc.2011.75; Tsakiridis T, 1996, J BIOL CHEM, V271, P19664, DOI 10.1074/jbc.271.33.19664; Vadlamudi RK, 2003, CANCER METAST REV, V22, P385, DOI 10.1023/A:1023729130497; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; VANDERPOLL T, 1990, NEW ENGL J MED, V322, P1622, DOI 10.1056/NEJM199006073222302; Versteeg HH, 2006, SEMIN THROMB HEMOST, V32, P24, DOI 10.1055/s-2006-933337; Zheng Rena, 2010, Genes Cancer, V1, P1178, DOI 10.1177/1947601911404223	54	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.404061	http://dx.doi.org/10.1074/jbc.M112.404061			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23038262	hybrid, Green Published			2022-12-28	WOS:000311233800002
J	Tran, NQ; Lee, SJ; Akabayov, B; Johnson, DE; Richardson, CC				Tran, Ngoc Q.; Lee, Seung-Joo; Akabayov, Barak; Johnson, Donald E.; Richardson, Charles C.			Thioredoxin, the Processivity Factor, Sequesters an Exposed Cysteine in the Thumb Domain of Bacteriophage T7 DNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI THIOREDOXIN; RAY SOLUTION SCATTERING; DEOXYRIBONUCLEIC-ACID; CONFERS PROCESSIVITY; SULFHYDRYL-GROUPS; HELICASE-PRIMASE; BINDING-PROTEIN; III HOLOENZYME; REPLICATION; CLAMP	Gene 5 protein (gp5) of bacteriophage T7 is a non-processive DNA polymerase. It achieves processivity by binding to Escherichia coli thioredoxin (trx). gp5/trx complex binds tightly to a primer-DNA template enabling the polymerization of hundreds of nucleotides per binding event. gp5 contains 10 cysteines. Under non-reducing condition, exposed cysteines form intermolecular disulfide linkages resulting in the loss of polymerase activity. No disulfide linkage is detected when Cys-275 and Cys-313 are replaced with serines. Cys-275 and Cys-313 are located on loop A and loop B of the thioredoxin binding domain, respectively. Replacement of either cysteine with serine (gp5-C275S, gp5-C313S) drastically decreases polymerase activity of gp5 on dA(350)/dT(25). On this primer-template gp5/trx in which Cys-313 or Cys-275 is replaced with serine have 50 and 90%, respectively, of the polymerase activity observed with wild-type gp5/trx. With single-stranded M13 DNA as a template gp5-C275S/trx retains 60% of the polymerase activity of wild-type gp5/trx. In contrast, gp5-C313S/trx has only one-tenth of the polymerase activity of wild-type gp5/trx on M13 DNA. Both wild-type gp5/trx and gp5-C275S/trx catalyze the synthesis of the entire complementary strand of M13 DNA, whereas gp5-C313S/trx has difficulty in synthesizing DNA through sites of secondary structure. gp5-C313S fails to form a functional complex with trx as measured by the apparent binding affinity as well as by the lack of a physical interaction with thioredoxin during hydroxyapatite-phosphate chromatography. Small angle x-ray scattering reveals an elongated conformation of gp5-C313S in comparison to a compact and spherical conformation of wild-type gp5.	[Tran, Ngoc Q.; Lee, Seung-Joo; Akabayov, Barak; Johnson, Donald E.; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	ccr@hms.harvard.edu	Akabayov, Barak/Y-5786-2019	Akabayov, Barak/0000-0002-3882-2742	National Institutes of Health [GM54397]; United States Department of Energy, Office of Basic Energy Sciences [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54397.; Use of the National Synchrotron Light Source, Brookhaven National Laboratory, was supported by the United States Department of Energy, Office of Basic Energy Sciences, under Contract DE-AC02-98CH10886.	ADLER S, 1983, J BIOL CHEM, V258, P6956; Akabayov B, 2010, P NATL ACAD SCI USA, V107, P15033, DOI 10.1073/pnas.1010141107; Allaire M, 2011, J SYNCHROTRON RADIAT, V18, P41, DOI 10.1107/S0909049510036022; Andraos N, 2004, J BIOL CHEM, V279, P50609, DOI 10.1074/jbc.M408428200; Bedford E, 1997, P NATL ACAD SCI USA, V94, P479, DOI 10.1073/pnas.94.2.479; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354; Camacho A, 2010, FEMS MICROBIOL REV, V34, P828, DOI 10.1111/j.1574-6976.2010.00219.x; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; EKLUND H, 1991, PROTEINS, V11, P13, DOI 10.1002/prot.340110103; Etson CM, 2010, P NATL ACAD SCI USA, V107, P1900, DOI 10.1073/pnas.0912664107; Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020; Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102; Himawan JS, 1996, J BIOL CHEM, V271, P19999, DOI 10.1074/jbc.271.33.19999; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HUBBARD J, 1993, NACCESS COMPUTER PRO; HUBER HE, 1986, J BIOL CHEM, V261, P5006; HUBER HE, 1987, J BIOL CHEM, V262, P16224; Indiani C, 2006, NAT REV MOL CELL BIO, V7, P751, DOI 10.1038/nrm2022; Johnson DE, 2003, J BIOL CHEM, V278, P23762, DOI 10.1074/jbc.M301366200; JOVIN TM, 1969, J BIOL CHEM, V244, P3009; KALLIS GB, 1980, J BIOL CHEM, V255, P261; Kelman Z, 1998, STRUCTURE, V6, P121, DOI 10.1016/S0969-2126(98)00014-8; Lee SJ, 2006, J BIOL CHEM, V281, P25841, DOI 10.1074/jbc.M604602200; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; MODRICH P, 1975, J BIOL CHEM, V250, P5508; Mueser TC, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-359; MYERS TW, 1988, J BIOL CHEM, V263, P17006; OLLIS DL, 1985, NATURE, V313, P818, DOI 10.1038/313818a0; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun D., 1992, J APPL CRYSTALLOGR, V25, P8; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TABOR S, 1987, J BIOL CHEM, V262, P16212; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614; Yang JS, 2004, P NATL ACAD SCI USA, V101, P8289, DOI 10.1073/pnas.0402625101; Yang XM, 1997, J BIOL CHEM, V272, P6599, DOI 10.1074/jbc.272.10.6599; Yao N, 2000, J BIOL CHEM, V275, P11440, DOI 10.1074/jbc.275.15.11440	39	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.409235	http://dx.doi.org/10.1074/jbc.M112.409235			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23012374	Green Published, hybrid			2022-12-28	WOS:000311233800042
J	Zhang, L; Chen, B; Zhao, Y; Dubielecka, PM; Wei, L; Qin, GJ; Chin, YE; Wang, YG; Zhao, TC				Zhang, Ling; Chen, Bing; Zhao, Yu; Dubielecka, Patrycja M.; Wei, Lei; Qin, Gang J.; Chin, Y. Eugene; Wang, Yigang; Zhao, Ting C.			Inhibition of Histone Deacetylase-induced Myocardial Repair Is Mediated by c-kit in Infarcted Hearts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; CARDIAC-HYPERTROPHY; BONE-MARROW; REGENERATION; DIFFERENTIATION; SURVIVAL; INJURY; CARDIOPROTECTION; PERFORMANCE; PROGENITOR	Histone deacetylases (HDACs) play a critical role in the regulation of gene transcription, cardiac development, and diseases. The aim of this study was to test whether inhibition of HDACs induces myocardial repair and cardiac function restoration through c-kit signaling in mouse myocardial infarction models. Myocardial infarction in wild type Kit(+/+) and Kit(W)/Kit(W-v) mice was created following thoracotomy by applying permanent ligation to the left anterior descending artery. The HDAC inhibitor, trichostatin A (TSA, 0.1 mg/kg), was intraperitoneally injected daily for a consecutive 8 weeks after myocardial infarction. 5-Bromo-2-deoxyuridine (BrdU, 50 mg/kg) was intraperitoneally delivered every other day to pulse-chase label in vivo endogenous cardiac replication. Eight weeks later, inhibition of HDACs in vivo resulted in an improvement in ventricular functional recovery and the prevention of myocardial remodeling in Kit(+/+) mice, which was eliminated in Kit(W)/Kit(W-v) mice. HDAC inhibition promoted cardiac repairs and neovascularization in the infarcted myocardium, which were absent in Kit(W)/Kit(W-v) mice. Re-introduction of TSA-treated wild type c-kit(+) CSCs into Kit(W)/Kit(W-v) myocardial infarction heart restored myocardial functional improvement and cardiac repair. To further validate that HDAC inhibition stimulates c-kit(+) cardiac stem cells (CSCs) to facilitate myocardial repair, GFP(+) c-kit(+) CSCs were preconditioned with TSA (50 nmol/liter) for 24 h and re-introduced into infarcted hearts for 2 weeks. Preconditioning of c-kit(+) CSCs via HDAC inhibition with trichostatin A significantly increased c-kit(+) CSC-derived myocytes and microvessels and enhanced functional recovery in myocardial infarction hearts in vivo. Our results provide evidence that HDAC inhibition promotes myocardial repair and prevents cardiac remodeling, which is dependent upon c-kit signaling.	[Zhao, Ting C.] Boston Univ, Sch Med, Cardiovasc Labs, Dept Surg,Roger Williams Med Ctr, Providence, RI 02908 USA; [Zhang, Ling; Chin, Y. Eugene] Brown Univ, Sch Med, Rhode Isl Hosp, Dept Med, Providence, RI 02905 USA; [Wei, Lei] Brown Univ, Sch Med, Rhode Isl Hosp, Dept Orthopaed, Providence, RI 02905 USA; [Qin, Gang J.] Northwestern Univ, Feinberg Sch Med, Cardiovasc Inst, Chicago, IL 60611 USA; [Wang, Yigang] Univ Cincinnati, Dept Pathol & Lab Med, Coll Med, Cincinnati, OH 45267 USA	Boston University; Roger Williams Medical Center; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Northwestern University; Feinberg School of Medicine; University System of Ohio; University of Cincinnati	Zhao, TC (corresponding author), Boston Univ, Sch Med, Cardiovasc Labs, Dept Surg,Roger Williams Med Ctr, 50 Maude St, Providence, RI 02908 USA.	tzhao@bu.edu	Dubielecka, Patrycja/AAF-8128-2019		National Institutes of Health from NHLBI [R01 HL089405]; American Heart Association-National Center [0735458N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089405] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association-National Center(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL089405 from NHLBI. This work was also supported by American Heart Association-National Center, Grant 0735458N (to T. C. Z.).	Antos CL, 2003, J BIOL CHEM, V278, P28930, DOI 10.1074/jbc.M303113200; Ayach BB, 2006, P NATL ACAD SCI USA, V103, P2304, DOI 10.1073/pnas.0510997103; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Cheng K, 2010, CIRC RES, V106, P1570, DOI 10.1161/CIRCRESAHA.109.212589; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Ellison GM, 2011, J AM COLL CARDIOL, V58, P977, DOI 10.1016/j.jacc.2011.05.013; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; Fransioli J, 2008, STEM CELLS, V26, P1315, DOI 10.1634/stemcells.2007-0751; Granger A, 2008, FASEB J, V22, P3549, DOI 10.1096/fj.08-108548; Hansen JC, 1998, BIOCHEMISTRY-US, V37, P17637, DOI 10.1021/bi982409v; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lee TM, 2007, AM J PHYSIOL-HEART C, V293, pH968, DOI 10.1152/ajpheart.00891.2006; Limana F, 2005, CIRC RES, V97, pE73, DOI 10.1161/01.RES.0000186276.06104.04; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Swijnenburg RJ, 2008, P NATL ACAD SCI USA, V105, P12991, DOI 10.1073/pnas.0805802105; Tseng A, 2010, CARDIOVASC RES, V87, P704, DOI 10.1093/cvr/cvq110; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Vigushin DM, 2004, CURR CANCER DRUG TAR, V4, P205, DOI 10.2174/1568009043481560; Zhang LX, 2010, AM J PHYSIOL-HEART C, V298, pH2154, DOI 10.1152/ajpheart.01015.2009; Zhang L, 2012, J PHARMACOL EXP THER, V341, P285, DOI 10.1124/jpet.111.189910; Zhao TC, 2007, CARDIOVASC RES, V76, P473, DOI 10.1016/j.cardiores.2007.08.010; Zhao TC, 2010, BBA-MOL CELL RES, V1803, P872, DOI 10.1016/j.bbamcr.2010.04.007	31	56	64	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.379115	http://dx.doi.org/10.1074/jbc.M112.379115			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23024362	Green Published, hybrid			2022-12-28	WOS:000311233800006
J	Ding, ZW; Taneva, SG; Huang, HKH; Campbell, SA; Semenec, L; Chen, NS; Cornell, RB				Ding, Ziwei; Taneva, Svetla G.; Huang, Harris K. H.; Campbell, Stephanie A.; Semenec, Lucie; Chen, Nansheng; Cornell, Rosemary B.			A 22-mer Segment in the Structurally Pliable Regulatory Domain of Metazoan CTP: Phosphocholine Cytidylyltransferase Facilitates Both Silencing and Activating Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-BINDING DOMAIN; RAT-LIVER CTP; PHOSPHATIDYLCHOLINE SYNTHESIS; CTPPHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; ALPHA-SYNUCLEIN; PHYSICAL-PROPERTIES; AMPHIPATHIC HELIX; LIPID REGULATION; AMINO-ACIDS; IDENTIFICATION	CTP:phosphocholine cytidylyltransferase (CCT), an amphitropic enzyme that regulates phosphatidylcholine synthesis, is composed of a catalytic head domain and a regulatory tail. The tail region has dual functions as a regulator of membrane binding/enzyme activation and as an inhibitor of catalysis in the unbound form of the enzyme, suggesting conformational plasticity. These functions are well conserved in CCTs across diverse phyla, although the sequences of the tail regions are not. CCT regulatory tails of diverse origins are composed of a long membrane lipid-inducible amphipathic helix (m-AH) followed by a highly disordered segment, reminiscent of the Parkinson disease-linked protein, alpha-synuclein, which we show shares a novel sequence motif with vertebrate CCTs. To unravel features required for silencing, we created chimeric enzymes by fusing the catalytic domain of rat CCT alpha to the regulatory tail of CCTs from Drosophila, Caenorhabditis elegans, or Saccharomyces cerevisiae or to alpha-synuclein. Only the tail domains of the two invertebrate CCTs were competent for both suppression of catalytic activity and for activation by lipid vesicles. Thus, both silencing and activating functions of the m-AH can tolerate significant changes in length and sequence. We identified a highly amphipathic 22-residue segment in the m-AH with features conserved among animal CCTs but not yeast CCT or alpha-synuclein. Deletion of this segment from rat CCT increased the lipid-independent V-max by 10-fold, equivalent to the effect of deleting the entire tail, and severely weakened membrane binding affinity. However, membrane binding was required for additional increases in catalytic efficiency. Thus, full activation of CCT may require not only loss of a silencing conformation in the m-AH but a gain of an activating conformation, promoted by membrane binding.	[Ding, Ziwei; Taneva, Svetla G.; Huang, Harris K. H.; Campbell, Stephanie A.; Semenec, Lucie; Chen, Nansheng; Cornell, Rosemary B.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Cornell, Rosemary B.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Cornell, RB (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	cornell@sfu.ca	Campbell, Stephanie Ann/AAC-6076-2019	Campbell, Stephanie Ann/0000-0003-1709-9249; Semenec, Lucie/0000-0002-1021-7751	Canadian Institutes for Health Research; Natural Science and Engineering Research Council	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a grant from the Canadian Institutes for Health Research (to R. B. C.) and a Natural Science and Engineering Research Council Discovery Grant (to N. C.).	Arnold RS, 1996, BIOCHEMISTRY-US, V35, P9917, DOI 10.1021/bi960397c; Attard GS, 2000, P NATL ACAD SCI USA, V97, P9032, DOI 10.1073/pnas.160260697; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; BECK R, 1994, NUCLEIC ACIDS RES, V22, P886, DOI 10.1093/nar/22.5.886; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Bogan MJ, 2005, J BIOL CHEM, V280, P19613, DOI 10.1074/jbc.M414028200; Braker JD, 2009, ARCH BIOCHEM BIOPHYS, V492, P10, DOI 10.1016/j.abb.2009.10.004; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; CORNELL RB, 1991, BIOCHEMISTRY-US, V30, P5881, DOI 10.1021/bi00238a011; CORNELL RB, 1995, BIOCHEM J, V310, P699, DOI 10.1042/bj3100699; Cornell RB, 1998, BIOCHEM SOC T, V26, P539, DOI 10.1042/bst0260539; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; CRAIG L, 1994, J BIOL CHEM, V269, P3311; Davies SMA, 2001, BIOCHEMISTRY-US, V40, P10522, DOI 10.1021/bi010904c; Dennis MK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201715; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Drobnies AE, 2002, BBA-BIOMEMBRANES, V1564, P82, DOI 10.1016/S0005-2736(02)00404-2; Dunne SJ, 1996, BIOCHEMISTRY-US, V35, P11975, DOI 10.1021/bi960821+; Eisenberg D., 1982, NATURE, V299, P271; Fauchere J., 1983, EUR J MED CHEM, V8, P369; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Friesen JA, 1999, J BIOL CHEM, V274, P13384, DOI 10.1074/jbc.274.19.13384; Friesen JA, 2001, PROTEIN EXPRES PURIF, V21, P141, DOI 10.1006/prep.2000.1354; Friesen JA, 2001, BBA-MOL CELL BIOL L, V1533, P86, DOI 10.1016/S1388-1981(01)00145-7; Frost A, 2011, CURR BIOL, V21, pR811, DOI 10.1016/j.cub.2011.08.045; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Gehrig K, 2009, J LIPID RES, V50, P966, DOI 10.1194/jlr.M800632-JLR200; Georgieva ER, 2010, J BIOL CHEM, V285, P28261, DOI 10.1074/jbc.M110.157214; Helmink BA, 2004, BBA-MOL CELL BIOL L, V1683, P78, DOI 10.1016/j.bbalip.2004.04.008; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; JAMIL H, 1993, BIOCHEM J, V291, P419, DOI 10.1042/bj2910419; Johnson JE, 1997, BBA-BIOMEMBRANES, V1324, P273, DOI 10.1016/S0005-2736(96)00233-7; JOHNSON JE, 1994, BIOCHEMISTRY-US, V33, P4327, DOI 10.1021/bi00180a029; Johnson JE, 2003, J BIOL CHEM, V278, P514, DOI 10.1074/jbc.M206072200; Johnson JE, 1998, BIOCHEMISTRY-US, V37, P9509, DOI 10.1021/bi980340l; JOHNSON JE, 1992, BIOCHEM J, V285, P815, DOI 10.1042/bj2850815; KALMAR GB, 1990, P NATL ACAD SCI USA, V87, P6029, DOI 10.1073/pnas.87.16.6029; Larvor MP, 2003, BIOCHEM J, V375, P653, DOI 10.1042/BJ20031011; Lee JY, 2009, J BIOL CHEM, V284, P33535, DOI 10.1074/jbc.M109.053363; Lokappa SB, 2011, J BIOL CHEM, V286, P21450, DOI 10.1074/jbc.M111.224055; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; McGuffin LJ, 2008, BIOINFORMATICS, V24, P1798, DOI 10.1093/bioinformatics/btn326; Neumann P, 2008, P NATL ACAD SCI USA, V105, P17390, DOI 10.1073/pnas.0805027105; Ng MNP, 2004, BBA-MOL CELL BIOL L, V1686, P85, DOI 10.1016/j.bbalip.2004.09.001; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Ridsdale R, 2010, AM J RESP CELL MOL, V43, P74, DOI 10.1165/rcmb.2009-0231OC; Shih YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021425; Taneva S, 2003, BIOCHEMISTRY-US, V42, P11768, DOI 10.1021/bi035234k; Taneva S, 2008, J BIOL CHEM, V283, P28137, DOI 10.1074/jbc.M802595200; Taneva SG, 2012, BBA-BIOMEMBRANES, V1818, P1173, DOI 10.1016/j.bbamem.2012.01.006; WALKEY CJ, 1994, J BIOL CHEM, V269, P5742; WANG XM, 1990, PLANT PHYSIOL, V93, P250, DOI 10.1104/pp.93.1.250; WANG Y, 1995, J BIOL CHEM, V270, P18948, DOI 10.1074/jbc.270.32.18948; Weidner A, 2009, J MOL CATAL B-ENZYM, V61, P88, DOI 10.1016/j.molcatb.2009.02.020; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Xie MT, 2004, J BIOL CHEM, V279, P28817, DOI 10.1074/jbc.M403311200; Yang JL, 1997, BIOCHEM J, V325, P29, DOI 10.1042/bj3250029; YANG W, 1995, J BIOL CHEM, V270, P23951, DOI 10.1074/jbc.270.41.23951	60	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38980	38991		10.1074/jbc.M112.402081	http://dx.doi.org/10.1074/jbc.M112.402081			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22988242	hybrid, Green Published			2022-12-28	WOS:000310982800054
J	Gonzalez-Flores, JN; Gupta, N; DeMong, LW; Copeland, PR				Gonzalez-Flores, Jonathan N.; Gupta, Nirupama; DeMong, Louise W.; Copeland, Paul R.			The Selenocysteine-specific Elongation Factor Contains a Novel and Multi-functional Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELENOPROTEIN MESSENGER-RNAS; EUKARYOTIC SECIS ELEMENTS; TRANSLATION FACTOR SELB; GTP HYDROLYSIS; MAMMALIAN SELENOPROTEIN; INCORPORATION MACHINERY; DECODING APPARATUS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; BINDING PROTEIN	The selenocysteine (Sec)-specific eukaryotic elongation factor (eEFSec) delivers the aminoacylated selenocysteine-tRNA (Sec-tRNA(Sec)) to the ribosome and suppresses UGA codons that are upstream of Sec insertion sequence (SECIS) elements bound by SECIS-binding protein 2 (SBP2). Multiple studies have highlighted the importance of SBP2 forming a complex with the SECIS element, but it is not clear how this regulates eEFSec during Sec incorporation. Compared with the canonical elongation factor eEF1A, eEFSec has a unique C-terminal extension called Domain IV. To understand the role of Domain IV in Sec incorporation, we examined a series of mutant proteins for all of the known molecular functions for eEFSec: GTP hydrolysis, Sec-tRNA(Sec) binding, and SBP2/SECIS binding. In addition, wildtype and mutant versions of eEFSec were analyzed for Sec incorporation activity in a novel eEFSec-dependent translation extract. We have found that Domain IV is essential for both tRNA and SBP2 binding as well as regulating GTPase activity. We propose a model where the SBP2/SECIS complex activates eEFSec by directing functional interactions between Domain IV and the ribosome to promote Sec-tRNA(Sec) binding and accommodation into the ribosomal A-site.	[Gonzalez-Flores, Jonathan N.; Gupta, Nirupama; DeMong, Louise W.; Copeland, Paul R.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Copeland, PR (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, 675 Hoes Lane, Piscataway, NJ 08854 USA.	paul.copeland@umdnj.edu		Copeland, Paul/0000-0003-3343-0587	Rutgers-University of Medicine and Dentistry of New Jersey Biotechnology National Institutes of Health [2T32GM008339-21]; Public Health Service [GM077073]; National Science Foundation Directorate of Graduate Education [0333196]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008339, R01GM077073] Funding Source: NIH RePORTER	Rutgers-University of Medicine and Dentistry of New Jersey Biotechnology National Institutes of Health; Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Science Foundation Directorate of Graduate Education; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Rutgers-University of Medicine and Dentistry of New Jersey Biotechnology National Institutes of Health 2T32GM008339-21, Public Health Service Grant GM077073, and the graduate fellowship programs of Integrative Graduate Education and Research Traineeship Biointerfaces National Science Foundation Directorate of Graduate Education 0333196.	BARON C, 1993, P NATL ACAD SCI USA, V90, P4181, DOI 10.1073/pnas.90.9.4181; BERRY MJ, 1993, EMBO J, V12, P3315, DOI 10.1002/j.1460-2075.1993.tb06001.x; Burakovskii D E, 2007, Mol Biol (Mosk), V41, P1031; Caban K, 2006, CELL MOL LIFE SCI, V63, P73, DOI 10.1007/s00018-005-5402-y; Caban K, 2007, MOL CELL BIOL, V27, P6350, DOI 10.1128/MCB.00632-07; Caban K, 2012, J BIOL CHEM, V287, P10664, DOI 10.1074/jbc.M111.320929; Chapple CE, 2009, BIOINFORMATICS, V25, P674, DOI 10.1093/bioinformatics/btp020; Clery A, 2007, NUCLEIC ACIDS RES, V35, P1868, DOI 10.1093/nar/gkm066; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; Donovan J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-229; Donovan J, 2008, J BIOL CHEM, V283, P35129, DOI 10.1074/jbc.M806008200; Ezure T, 2006, BIOTECHNOL PROGR, V22, P1570, DOI 10.1021/bp060110v; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; Fletcher JE, 2001, RNA, V7, P1442; Fourmy D, 2002, J MOL BIOL, V324, P137, DOI 10.1016/S0022-2836(02)01030-6; Hauryliuk V, 2006, BIOCHIMIE, V88, P747, DOI 10.1016/j.biochi.2006.06.001; Huttenhofer A, 1998, BIOCHEMISTRY-US, V37, P885, DOI 10.1021/bi972298k; Itoh Y, 2009, NUCLEIC ACIDS RES, V37, P6259, DOI 10.1093/nar/gkp648; Jenner L, 2010, NAT STRUCT MOL BIOL, V17, P1072, DOI 10.1038/nsmb.1880; Kinzy SA, 2005, NUCLEIC ACIDS RES, V33, P5172, DOI 10.1093/nar/gki826; Kohrer C, 2008, METHODS, V44, P129, DOI 10.1016/j.ymeth.2007.10.006; Korotkov KV, 2002, MOL CELL BIOL, V22, P1402, DOI 10.1128/MCB.22.5.1402-1411.2002; Kromayer M, 1996, J MOL BIOL, V262, P413, DOI 10.1006/jmbi.1996.0525; La Teana A, 2001, RNA, V7, P1173, DOI 10.1017/S1355838201010366; Latreche L, 2009, NUCLEIC ACIDS RES, V37, P5868, DOI 10.1093/nar/gkp635; Leibundgut M, 2005, EMBO J, V24, P11, DOI 10.1038/sj.emboj.7600505; Mehta A, 2004, J BIOL CHEM, V279, P37852, DOI 10.1074/jbc.M404639200; Noble CG, 2008, CELL MOL LIFE SCI, V65, P1335, DOI 10.1007/s00018-008-7495-6; Ose T, 2007, STRUCTURE, V15, P577, DOI 10.1016/j.str.2007.03.007; Paleskava A, 2012, J BIOL CHEM, V287, P27906, DOI 10.1074/jbc.M112.366120; Paleskava A, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.081380; Rebsch CM, 2006, CELL RES, V16, P940, DOI 10.1038/sj.cr.7310117; Selmer M, 2002, EMBO J, V21, P4145, DOI 10.1093/emboj/cdf408; Sergiev PV, 2005, FEBS LETT, V579, P5439, DOI 10.1016/j.febslet.2005.09.010; Soler N, 2007, J MOL BIOL, V370, P728, DOI 10.1016/j.jmb.2007.05.001; Steinbrenner H, 2009, BBA-GEN SUBJECTS, V1790, P1478, DOI 10.1016/j.bbagen.2009.02.014; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; Unbehaun A, 2007, EMBO J, V26, P3109, DOI 10.1038/sj.emboj.7601751; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Walczak R, 1996, RNA, V2, P367; Yoshizawa S, 2005, NAT STRUCT MOL BIOL, V12, P198, DOI 10.1038/nsmb890; Zavacki AM, 2003, MOL CELL, V11, P773, DOI 10.1016/S1097-2765(03)00064-9	43	22	22	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38936	38945		10.1074/jbc.M112.415463	http://dx.doi.org/10.1074/jbc.M112.415463			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22992746	Green Published, hybrid			2022-12-28	WOS:000310982800049
J	Kroh, HK; Bock, PE				Kroh, Heather K.; Bock, Paul E.			Effect of Zymogen Domains and Active Site Occupation on Activation of Prothrombin by von Willebrand Factor-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-COAGULATION PROTEINASES; PEPTIDE CHLOROMETHYL KETONES; REGULATORY EXOSITE-I; SUBSTRATE RECOGNITION; FLUORESCENCE PROBES; CRYSTAL-STRUCTURE; MEMBRANE-BINDING; STRUCTURAL BASIS; KINETIC-DATA; FACTOR-VIIA	Prothrombin is conformationally activated by von Willebrand factor-binding protein (vWbp) from Staphylococcus aureus through insertion of the NH2-terminal residues of vWbp into the prothrombin catalytic domain. The rate of prothrombin activation by vWbp(1-263) is controlled by a hysteretic kinetic mechanism initiated by substrate binding. The present study evaluates activation of prothrombin by full-length vWbp(1-474) through activity progress curve analysis. Additional interactions from the COOH-terminal half of vWbp(1-474) strengthened the initial binding of vWbp to prothrombin, resulting in higher activity and an similar to 100-fold enhancement in affinity. The affinities of vWbp(1-263) or vWbp(1-474) were compared by equilibrium binding to the prothrombin derivatives prethrombin 1, prethrombin 2, thrombin, meizothrombin, and meizothrombin(des-fragment 1) and their corresponding active site-blocked analogs. Loss of fragment 1 in prethrombin 1 enhanced affinity for both vWbp(1-263) and vWbp(1-474), with a 30-45% increase in Gibbs free energy, implicating a regulatory role for fragment 1 in the activation mechanism. Active site labeling of all prothrombin derivatives with D-Phe-Pro-Arg-chloromethyl ketone, analogous to irreversible binding of a substrate, decreased their K-D values for vWbp into the subnanomolar range, reflecting the dependence of the activating conformational change on substrate binding. The results suggest a role for prothrombin domains in the pathophysiological activation of prothrombin by vWbp, and may reveal a function for autocatalysis of the vWbp.prothrombin complexes during initiation of blood coagulation.	[Kroh, Heather K.; Bock, Paul E.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Sch Med, Nashville, TN 37232 USA	Vanderbilt University	Bock, PE (corresponding author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Sch Med, C-3321A Med Ctr N,1161 21st Ave S, Nashville, TN 37232 USA.	paul.bock@vanderbilt.edu			National Institutes of Health from the NHLBI [R37 HL071544]; National Institutes of Health [T32 HL007751]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL071544, T32HL007751] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 HL071544 from the NHLBI (to P. E. B.).; Supported in part by National Institutes of Health Grant T32 HL007751.	Anderson PJ, 2000, J BIOL CHEM, V275, P16428, DOI 10.1074/jbc.M001254200; Anderson PJ, 2003, J BIOL CHEM, V278, P44482, DOI 10.1074/jbc.M306917200; Anderson PJ, 2003, J BIOL CHEM, V278, P44489, DOI 10.1074/jbc.M306916200; Atkinson BT, 2010, BLOOD, V116, P4675, DOI 10.1182/blood-2010-05-283986; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Bock PE, 1997, J BIOL CHEM, V272, P19837, DOI 10.1074/jbc.272.32.19837; BOCK PE, 1992, J BIOL CHEM, V267, P14963; BOCK PE, 1992, J BIOL CHEM, V267, P14974; CARLISLE TL, 1990, J BIOL CHEM, V265, P22044; Changeux Jean-Pierre, 2011, F1000 Biol Rep, V3, P19, DOI 10.3410/B3-19; Chen ZW, 2010, P NATL ACAD SCI USA, V107, P19278, DOI 10.1073/pnas.1010262107; CHURCH FC, 1985, ARCH BIOCHEM BIOPHYS, V240, P607, DOI 10.1016/0003-9861(85)90067-0; DOYLE MF, 1990, J BIOL CHEM, V265, P10693; Eigenbrot C, 2002, TRENDS CARDIOVAS MED, V12, P19, DOI 10.1016/S1050-1738(01)00139-6; FRIEDEN C, 1979, ANNU REV BIOCHEM, V48, P471, DOI 10.1146/annurev.bi.48.070179.002351; FRIEDEN C, 1970, J BIOL CHEM, V245, P5788; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Huang MD, 2003, NAT STRUCT BIOL, V10, P751, DOI 10.1038/nsb971; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kamath P, 2008, J BIOL CHEM, V283, P30164, DOI 10.1074/jbc.M806158200; Kamath P, 2010, J BIOL CHEM, V285, P28651, DOI 10.1074/jbc.M110.154914; Khan AR, 1998, PROTEIN SCI, V7, P815; Kroh HK, 2009, P NATL ACAD SCI USA, V106, P7786, DOI 10.1073/pnas.0811750106; Mac Sweeney A, 2000, ACTA CRYSTALLOGR D, V56, P280, DOI 10.1107/S0907444999016583; Monteiro RQ, 2001, PROTEIN SCI, V10, P1897, DOI 10.1110/ps.09001; NARAYANA SVL, 1994, J MOL BIOL, V235, P695, DOI 10.1006/jmbi.1994.1021; NESHEIM ME, 1988, J BIOL CHEM, V263, P1037; Newell-Caito JL, 2011, J BIOL CHEM, V286, P38286, DOI 10.1074/jbc.M111.247122; Olsen OH, 2008, CELL MOL LIFE SCI, V65, P953, DOI 10.1007/s00018-007-7480-5; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; Page MJ, 2005, J THROMB HAEMOST, V3, P2401, DOI 10.1111/j.1538-7836.2005.01456.x; Panizzi P, 2006, J BIOL CHEM, V281, P1179, DOI 10.1074/jbc.M507956200; Panizzi P, 2006, J BIOL CHEM, V281, P1169, DOI 10.1074/jbc.M507955200; Panizzi P, 2004, CELL MOL LIFE SCI, V61, P2793, DOI 10.1007/s00018-004-4285-7; Petrera NS, 2009, J BIOL CHEM, V284, P25620, DOI 10.1074/jbc.M109.000042; Petrovan RJ, 1998, BIOCHEMISTRY-US, V37, P1185, DOI 10.1021/bi971948h; Petrovan RJ, 2002, BIOCHEMISTRY-US, V41, P9302, DOI 10.1021/bi0202169; SORIANOGARCIA M, 1992, BIOCHEMISTRY-US, V31, P2554, DOI 10.1021/bi00124a016; SORIANOGARCIA M, 1989, BIOCHEMISTRY-US, V28, P6805, DOI 10.1021/bi00443a004; Stevens WK, 1996, J BIOL CHEM, V271, P8062, DOI 10.1074/jbc.271.14.8062; Verhamme IM, 2002, J BIOL CHEM, V277, P6788, DOI 10.1074/jbc.M110257200; VIJAYALAKSHMI J, 1994, PROTEIN SCI, V3, P2254, DOI 10.1002/pro.5560031211; YE J, 1992, J BIOL CHEM, V267, P11023	46	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39149	39157		10.1074/jbc.M112.415562	http://dx.doi.org/10.1074/jbc.M112.415562			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23012355	Green Published, hybrid			2022-12-28	WOS:000310982800070
J	Shim, JY; Bertalovitz, AC; Kendall, DA				Shim, Joong-Youn; Bertalovitz, Alexander C.; Kendall, Debra A.			Probing the Interaction of SR141716A with the CB1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CANNABINOID RECEPTOR; MOLECULAR-DYNAMICS; TRANSMEMBRANE HELICES; CONFORMATIONAL-ANALYSIS; CRYSTAL-STRUCTURE; FORCE-FIELD; ACTIVATION; RHODOPSIN; CHOLESTEROL	SR141716A binds selectively to the brain cannabinoid (CB1) receptor and exhibits a potent inverse agonist/antagonist activity. Although SR141716A, also known as rimonabant, has been withdrawn from the market due to severe side effects, there remains interest in some of its many potential medical applications. Consequently, it is imperative to understand the mechanism by which SR141716A exerts its inverse agonist activity. As a result of using an approach combining mutagenesis and molecular dynamics simulations, we determined the binding mode of SR141716A. We found from the simulation of the CB1-SR141716A complex that SR141716A projects toward TM5 to interact tightly with the major binding pocket, replacing the coordinated water molecules, and secures the Trp-356(6.48) rotameric switch in the inactive state to promote the formation of an extensive water-mediated H-bonding network to the highly conserved SLAXAD and NPXXY motifs in TM2/TM7. We identify for the first time the involvement of the minor binding pocket formed by TM2/TM3/TM7 for SR141716A binding, which complements the major binding pocket formed by TM3/TM5/TM6. Simulation of the F174(2.61)A mutant CB1-SR141716A complex demonstrates the perturbation of TM2 that attenuates SR141716A binding indirectly. These results suggest SR141716A exerts inverse agonist activity through the stabilization of both TM2 and TM5, securing the Trp-356(6.48) rotameric switch and restraining it from activation.	[Shim, Joong-Youn] N Carolina Cent Univ, JL Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA; [Bertalovitz, Alexander C.; Kendall, Debra A.] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA	University of North Carolina; North Carolina Central University; University of Connecticut	Shim, JY (corresponding author), N Carolina Cent Univ, JL Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA.	jyshim@nccu.edu			National Institutes of Health [DA020663, DA020763]; National Science Foundation [ACI-0338618l, OCI-0451237, OCI-0535258, OCI-0504075, OCI-1053575]; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA020663, R01DA020763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA020663 (to J.-Y.S.) and Grant DA020763 (to D.A.K.). This work was also supported by National Science Foundation Grants ACI-0338618l, OCI-0451237, OCI-0535258, and OCI-0504075.; J.-Y.S. acknowledges the Texas Advanced Computing Center at University of Texas at Austin for providing HPC resources that have contributed to the research results. This work used the Extreme Science and Engineering Discovery Environment, which is supported by National Science Foundation Grant OCI-1053575.	Ahn KH, 2009, MOL PHARMACOL, V76, P833, DOI 10.1124/mol.109.057356; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BRENEMAN CM, 1990, J COMPUT CHEM, V11, P361, DOI 10.1002/jcc.540110311; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Buck M, 2006, BIOPHYS J, V90, pL36, DOI 10.1529/biophysj.105.078154; Carlsson J, 2011, NAT CHEM BIOL, V7, P769, DOI 10.1038/nchembio.662; Chen JH, 2006, J AM CHEM SOC, V128, P3728, DOI 10.1021/ja057216r; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chugunov AO, 2010, MOL PHARMACOL, V78, P394, DOI 10.1124/mol.110.063578; Colombo G, 1998, LIFE SCI, V63, pPL113, DOI 10.1016/S0024-3205(98)00322-1; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Francisco MEY, 2002, J MED CHEM, V45, P2708, DOI 10.1021/jm010498v; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Hurst DP, 2002, MOL PHARMACOL, V62, P1274, DOI 10.1124/mol.62.6.1274; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Kleinau G, 2011, J BIOL CHEM, V286, P25859, DOI 10.1074/jbc.M110.196980; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Lan RX, 1999, J MED CHEM, V42, P769, DOI 10.1021/jm980363y; Lazary J, 2011, TRENDS PHARMACOL SCI, V32, P270, DOI 10.1016/j.tips.2011.02.013; Lei S, 2002, J BIOL CHEM, V277, P40989, DOI 10.1074/jbc.M206801200; Lin LS, 2008, J MED CHEM, V51, P2108, DOI 10.1021/jm7014974; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Makriyannis A, 2001, PCT int. Appl, Patent No. 2001029007; McAllister SD, 2004, J BIOL CHEM, V279, P48024, DOI 10.1074/jbc.M406648200; McAllister SD, 2003, J MED CHEM, V46, P5139, DOI 10.1021/jm0302647; McAllister SD, 2002, BIOCHEM PHARMACOL, V63, P2121, DOI 10.1016/S0006-2952(02)01031-6; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Oates J, 2011, CURR OPIN STRUC BIOL, V21, P802, DOI 10.1016/j.sbi.2011.09.007; Oddi S, 2011, J NEUROCHEM, V116, P858, DOI 10.1111/j.1471-4159.2010.07041.x; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Robson P, 2001, BRIT J PSYCHIAT, V178, P107, DOI 10.1192/bjp.178.2.107; Saam J, 2002, BIOPHYS J, V83, P3097, DOI 10.1016/S0006-3495(02)75314-9; Salo OMH, 2004, J MED CHEM, V47, P3048, DOI 10.1021/jm031052c; Shim JY, 2011, J BIOL CHEM, V286, P33422, DOI 10.1074/jbc.M111.261651; Shim JY, 2002, J MED CHEM, V45, P1447, DOI 10.1021/jm010267o; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Shire D, 1999, LIFE SCI, V65, P627, DOI 10.1016/S0024-3205(99)00285-4; Silvestri R, 2008, J MED CHEM, V51, P1560, DOI 10.1021/jm070566z; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wiley JL, 2001, J PHARMACOL EXP THER, V296, P1013	52	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38741	38754		10.1074/jbc.M112.390955	http://dx.doi.org/10.1074/jbc.M112.390955			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22995906	hybrid, Green Published			2022-12-28	WOS:000310982800032
J	Bouchecareilh, M; Hutt, DM; Szajner, P; Flotte, TR; Balch, WE				Bouchecareilh, Marion; Hutt, Darren M.; Szajner, Patricia; Flotte, Terence R.; Balch, William E.			Histone Deacetylase Inhibitor (HDACi) Suberoylanilide Hydroxamic Acid (SAHA)-mediated Correction of alpha 1-Antitrypsin Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; MEDIATE INCREASED SECRETION; ENDOPLASMIC-RETICULUM; MUTANT ALPHA-1-ANTITRYPSIN; ALPHA(1)-ANTITRYPSIN DEFICIENCY; OXIDATIVE STRESS; QUALITY-CONTROL; MOLECULAR-MECHANISMS; THERAPEUTIC PARADIGM; LIVER-DISEASE	alpha 1-Antitrypsin (alpha 1AT) deficiency (alpha 1ATD) is a consequence of defective folding, trafficking, and secretion of alpha 1AT in response to a defect in its interaction with the endoplasmic reticulum proteostasis machineries. The most common and severe form of alpha 1ATD is caused by the Z-variant and is characterized by the accumulation of alpha 1AT polymers in the endoplasmic reticulum of the liver leading to a severe reduction (>85%) of alpha 1AT in the serum and its anti-protease activity in the lung. In this organ alpha 1AT is critical for ensuring tissue integrity by inhibiting neutrophil elastase, a protease that degrades elastin. Given the limited therapeutic options in alpha 1ATD, a more detailed understanding of the folding and trafficking biology governing alpha 1AT biogenesis and its response to small molecule regulators is required. Herein we report the correction of Z-alpha 1AT secretion in response to treatment with the histone deacetylase (HDAC) inhibitor suberoylanilide hydroxamic acid (SAHA), acting in part through HDAC7 silencing and involving a calnexin-sensitive mechanism. SAHA-mediated correction restores Z-alpha 1AT secretion and serpin activity to a level 50% that observed for wild-type alpha 1AT. These data suggest that HDAC activity can influence Z-alpha 1AT protein traffic and that SAHA may represent a potential therapeutic approach for alpha 1ATD and other protein misfolding diseases.	[Bouchecareilh, Marion; Hutt, Darren M.; Szajner, Patricia; Balch, William E.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA; [Flotte, Terence R.] UMass Med Sch, Dept Pediat, Worcester, MA 01655 USA; [Flotte, Terence R.] UMass Med Sch, Gene Therapy Ctr, Worcester, MA 01655 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Balch, WE (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	webalch@scripps.edu			National Institutes of Health [GM33301, GM42336, HL15674]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095524, R01HL079442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042336, R01GM033301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM33301, GM42336, and HL15674 (to W. E. B.).	Aka Juliette Adjo, 2011, Handb Exp Pharmacol, V206, P1, DOI 10.1007/978-3-642-21631-2_1; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Alam S, 2012, J HEPATOL, V57, P116, DOI 10.1016/j.jhep.2012.02.025; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Balch WE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004499; Banerjee Audreesh, 2012, Am J Respir Cell Mol Biol, V46, P132, DOI 10.1165/rcmb.2010-0276OC; Belorgey D, 2011, METHODS, V53, P255, DOI 10.1016/j.ymeth.2010.11.008; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bouchecareilh M, 2012, CURR MOL MED, V12, P815, DOI 10.2174/156652412801318782; Bouchecareilh Marion, 2011, Proc Am Thorac Soc, V8, P189, DOI 10.1513/pats.201008-055MS; Buckland Jenny, 2011, Nat Rev Rheumatol, V7, P682, DOI 10.1038/nrrheum.2011.162; Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796; Cabral CM, 2002, MOL BIOL CELL, V13, P2639, DOI 10.1091/mbc.E02-02-0068; Cameron PH, 2009, J BIOL CHEM, V284, P34570, DOI 10.1074/jbc.M109.053165; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Christensen DP, 2011, MOL MED, V17, P378, DOI 10.2119/molmed.2011.00021; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Chung KF, 2010, ANN NY ACAD SCI, V1203, P85, DOI 10.1111/j.1749-6632.2010.05600.x; Cook C., 2012, J ALZHEIMER IN PRESS; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; Dokmanovic M, 2007, MOL CANCER THER, V6, P2525, DOI 10.1158/1535-7163.MCT-07-0251; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; Ekeowa UI, 2011, EXPERT REV CLIN IMMU, V7, P243, DOI [10.1586/eci.10.95, 10.1586/ECI.10.95]; Ekeowa UI, 2010, P NATL ACAD SCI USA, V107, P17146, DOI 10.1073/pnas.1004785107; Flotte TR, 2011, HUM MOL GENET, V20, pR87, DOI 10.1093/hmg/ddr156; Galli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016304; Gidalevitz T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a009704; Gnad F, 2010, BIOINFORMATICS, V26, P1666, DOI 10.1093/bioinformatics/btq260; Gooptu B, 2009, EUR RESPIR J, V34, P475, DOI 10.1183/09031936.00096508; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; Gosai SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015460; Grabiec AM, 2011, CRIT REV IMMUNOL, V31, P233, DOI 10.1615/CritRevImmunol.v31.i3.40; GRAHAM KS, 1990, J BIOL CHEM, V265, P20463; Hageman J, 2011, BIOCHEM J, V435, P127, DOI 10.1042/BJ20101247; Halili MA, 2009, CURR TOP MED CHEM, V9, P309, DOI 10.2174/156802609788085250; Hathorn T, 2011, NEUROBIOL DIS, V41, P43, DOI 10.1016/j.nbd.2010.08.017; Hidvegi T, 2011, METHOD ENZYMOL, V499, P33, DOI [10.1016/B978-0-12-386471-0.00003-1, 10.1016/13978-0-12-386471-0.00003-1]; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hosokawa N, 2006, GENES CELLS, V11, P465, DOI 10.1111/j.1365-2443.2006.00957.x; Hutt D. M., 2012, COLD SPRING IN PRESS; Hutt D, 2010, SCIENCE, V329, P766, DOI 10.1126/science.1194160; Hutt DM, 2011, ACS MED CHEM LETT, V2, P703, DOI 10.1021/ml200136e; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; Isajevs S, 2011, RESPIRATION, V81, P362, DOI 10.1159/000322560; Jagannath S, 2010, LEUKEMIA RES, V34, P1111, DOI 10.1016/j.leukres.2010.04.001; Kahali S, 2012, FASEB J, V26, P2437, DOI 10.1096/fj.11-193706; Kaushal S, 2010, EXP BIOL MED, V235, P700, DOI 10.1258/ebm.2010.009297; Kekatpure VD, 2009, J BIOL CHEM, V284, P7436, DOI 10.1074/jbc.M808999200; Kelly E, 2010, RESP MED, V104, P763, DOI 10.1016/j.rmed.2010.01.016; Kikis EA, 2010, ADV EXP MED BIOL, V694, P138; Kitamura M, 2011, INT REV IMMUNOL, V30, P4, DOI 10.3109/08830185.2010.522281; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Leggatt GR, 2012, IMMUNOL CELL BIOL, V90, P33, DOI 10.1038/icb.2011.94; Lindquist SL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004507; Lu J, 2011, P NATL ACAD SCI USA, V108, P21200, DOI 10.1073/pnas.1119181109; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Marciniak SJ, 2010, NEW ENGL J MED, V363, P1863, DOI 10.1056/NEJMcibr1008007; Marcus NY, 2000, J BIOL CHEM, V275, P1987, DOI 10.1074/jbc.275.3.1987; Marks PA, 2005, EXPERT OPIN INV DRUG, V14, P1497, DOI 10.1517/13543784.14.12.1497; Marks PA, 2010, EXPERT OPIN INV DRUG, V19, P1049, DOI 10.1517/13543784.2010.510514; Marwick JA, 2007, EXPERT OPIN THER TAR, V11, P745, DOI 10.1517/14728222.11.6.745; Marwick JA, 2010, DRUGS, V70, P929, DOI 10.2165/10898520-000000000-00000; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; Mercado N, 2011, BIOCHEM BIOPH RES CO, V406, P292, DOI 10.1016/j.bbrc.2011.02.035; Mielcarek M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027746; Min T, 2011, J MOL MED, V89, P577, DOI 10.1007/s00109-011-0732-8; Mizuno S, 2011, AM J PHYSIOL-LUNG C, V300, pL402, DOI 10.1152/ajplung.00207.2010; Mollapour M, 2012, BBA-MOL CELL RES, V1823, P648, DOI 10.1016/j.bbamcr.2011.07.018; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Murphy PJM, 2005, J BIOL CHEM, V280, P33792, DOI 10.1074/jbc.M506997200; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Norez C, 2006, FEBS LETT, V580, P2081, DOI 10.1016/j.febslet.2006.03.010; Nyfeler B, 2008, J CELL BIOL, V180, P705, DOI 10.1083/jcb.200709100; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; OGUSHI F, 1987, J CLIN INVEST, V80, P1366, DOI 10.1172/JCI113214; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Ong DST, 2011, CURR OPIN CELL BIOL, V23, P231, DOI 10.1016/j.ceb.2010.11.002; Pan SJ, 2011, MOL BIOL CELL, V22, P2810, DOI 10.1091/mbc.E11-02-0118; Pan SJ, 2009, HEPATOLOGY, V50, P275, DOI 10.1002/hep.22974; Papp E, 2006, FASEB J, V20, P1018, DOI 10.1096/fj.05-5065fje; Perlmutter DH, 2011, ANNU REV MED, V62, P333, DOI 10.1146/annurev-med-042409-151920; PERLMUTTER DH, 2011, COLD SPRING HARB PER, V3, P1, DOI DOI 10.1101/CSHPERSPECT.A005801; Peserico A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/371832; Pipalia NH, 2011, P NATL ACAD SCI USA, V108, P5620, DOI 10.1073/pnas.1014890108; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Rajendrasozhan S, 2009, COPD, V6, P291, DOI 10.1080/15412550903049132; Reiterer V, 2010, TRAFFIC, V11, P1044, DOI 10.1111/j.1600-0854.2010.01078.x; Roth DM, 2011, CURR OPIN CELL BIOL, V23, P126, DOI 10.1016/j.ceb.2010.11.001; Schmidt BZ, 2005, AM J PHYSIOL-GASTR L, V289, pG444, DOI 10.1152/ajpgi.00237.2004; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Shakespear MR, 2011, TRENDS IMMUNOL, V32, P335, DOI 10.1016/j.it.2011.04.001; Shen YX, 2006, BIOCHEM BIOPH RES CO, V349, P1285, DOI 10.1016/j.bbrc.2006.08.173; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sifers Richard N, 2010, Proc Am Thorac Soc, V7, P376, DOI 10.1513/pats.201001-011AW; Sifers RN, 2010, SCIENCE, V329, P154, DOI 10.1126/science.1192681; Singh S, 2010, FREE RADICAL RES, V44, P1267, DOI 10.3109/10715762.2010.507670; Stoller JK, 2012, AM J RESP CRIT CARE, V185, P246, DOI 10.1164/rccm.201108-1428CI; Taylor RC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004440; Thomas EA, 2008, P NATL ACAD SCI USA, V105, P15564, DOI 10.1073/pnas.0804249105; To M, 2012, CHEST, V141, P1233, DOI 10.1378/chest.11-1536; Topic A, 2011, FETAL PEDIATR PATHOL, V30, P312, DOI 10.3109/15513815.2011.572961; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Yamasaki M, 2011, EMBO REP, V12, P1011, DOI 10.1038/embor.2011.171; Yi C, 2012, SCIENCE, V336, P474, DOI 10.1126/science.1216990; Zeng L, 2009, GERIATR GERONTOL INT, V9, P7, DOI 10.1111/j.1447-0594.2008.00504.x; Zhang LJ, 2009, J BIOL CHEM, V284, P6156, DOI 10.1074/jbc.M807713200	111	53	57	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.404707	http://dx.doi.org/10.1074/jbc.M112.404707			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22995909	hybrid, Green Published			2022-12-28	WOS:000310642200059
J	Sigala, PA; Crowley, JR; Hsieh, S; Henderson, JP; Goldberg, DE				Sigala, Paul A.; Crowley, Jan R.; Hsieh, Samantha; Henderson, Jeffrey P.; Goldberg, Daniel E.			Direct Tests of Enzymatic Heme Degradation by the Malaria Parasite Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYTOCHROME CHROMOPHORE; BILIVERDIN REDUCTASE; FOOD VACUOLE; OXYGENASE; BIOSYNTHESIS; EXPRESSION; PROTEIN; METABOLISM; IRON; TRAFFICKING	Malaria parasites generate vast quantities of heme during blood stage infection via hemoglobin digestion and limited de novo biosynthesis, but it remains unclear if parasites metabolize heme for utilization or disposal. Recent in vitro experiments with a heme oxygenase (HO)-like protein from Plasmodium falciparum suggested that parasites may enzymatically degrade some heme to the canonical HO product, biliverdin (BV), or its downstream metabolite, bilirubin (BR). To directly test for BV and BR production by P. falciparum parasites, we DMSO-extracted equal numbers of infected and uninfected erythrocytes and developed a sensitive LC-MS/MS assay to quantify these tetrapyrroles. We found comparable low levels of BV and BR in both samples, suggesting the absence of HO activity in parasites. We further tested live parasites by targeted expression of a fluorescent BV-binding protein within the parasite cytosol, mitochondrion, and plant-like plastid. This probe could detect exogenously added BV but gave no signal indicative of endogenous BV production within parasites. Finally, we recombinantly expressed and tested the proposed heme degrading activity of the HO-like protein, PfHO. Although PfHO bound heme and protoporphyrin IX with modest affinity, it did not catalyze heme degradation in vivo within bacteria or in vitro in UV absorbance and HPLC assays. These observations are consistent with PfHO's lack of a heme-coordinating His residue and suggest an alternative function within parasites. We conclude that P. falciparum parasites lack a canonical HO pathway for heme degradation and thus rely fully on alternative mechanisms for heme detoxification and iron acquisition during blood stage infection.	[Goldberg, Daniel E.] Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Med, St Louis, MO 63110 USA; [Crowley, Jan R.; Henderson, Jeffrey P.; Goldberg, Daniel E.] Washington Univ, Sch Med, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL)	Goldberg, DE (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Med, 660 S Euclid Ave,Campus Box 8230, St Louis, MO 63110 USA.	goldberg@borcim.wustl.edu	Henderson, Jeffrey P/D-3337-2015	Hsieh, Samantha/0000-0002-1846-2583; Sigala, Paul/0000-0002-3464-3042	National Institutes of Health [HD001459, HL101263, DK064540, P41-RR00954, P60-DK20579, P30-DK56341]; Helen Hay Whitney Foundation; Washington University; Burroughs Wellcome Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001459] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P30HL101263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, P50DK064540, P30DK056341, P60DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Foundation; Washington University; Burroughs Wellcome Fund(Burroughs Wellcome Fund); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants HD001459, HL101263, and DK064540 (to J. P. H.).; Supported in part by a postdoctoral fellowship from the Helen Hay Whitney Foundation.; Supported in part by National Institutes of Health Grants P41-RR00954, P60-DK20579, and P30-DK56341.; Supported in part by a summer undergraduate research fellowship from Washington University.; Recipient of a career award for medical scientists from the Burroughs Wellcome Fund.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; BEALE SI, 1993, CHEM REV, V93, P785, DOI 10.1021/cr00018a008; Biegert A, 2009, P NATL ACAD SCI USA, V106, P3770, DOI 10.1073/pnas.0810767106; BRODERSEN R, 1979, J BIOL CHEM, V254, P2364; CAMMACK R, 1977, BIOCHEM J, V168, P205, DOI 10.1042/bj1680205; Chaturvedi KS, 2012, NAT CHEM BIOL, V8, P731, DOI [10.1038/NCHEMBIO.1020, 10.1038/nchembio.1020]; Cornejo J, 1998, PLANT J, V15, P99, DOI 10.1046/j.1365-313X.1998.00186.x; Davis SJ, 2001, PLANT PHYSIOL, V126, P656, DOI 10.1104/pp.126.2.656; de Montellano PRO, 2000, CURR OPIN CHEM BIOL, V4, P221; DELANO WL, 2007, MACPYMOL PYMOL BASED; Drew ME, 2008, J BIOL CHEM, V283, P12870, DOI 10.1074/jbc.M708949200; ECKMAN JR, 1977, J LAB CLIN MED, V90, P767; Egan TJ, 2002, BIOCHEM J, V365, P343, DOI 10.1042/BJ20020793; Ehlgen F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038781; Emborg TJ, 2006, PLANT PHYSIOL, V140, P856, DOI 10.1104/pp.105.074211; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; Fufezan C, 2008, PROTEINS, V73, P690, DOI 10.1002/prot.22097; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; Ganesan SM, 2011, MOL BIOCHEM PARASIT, V177, P29, DOI 10.1016/j.molbiopara.2011.01.004; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gisk B, 2010, BIOCHEM J, V425, P425, DOI 10.1042/BJ20090775; Hanke GT, 2004, PLANT PHYSIOL, V134, P255, DOI 10.1104/pp.103.032755; Istvan ES, 2011, P NATL ACAD SCI USA, V108, P1627, DOI 10.1073/pnas.1011560108; Jani D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000053; Kimata-Ariga Y, 2007, J BIOCHEM, V141, P421, DOI 10.1093/jb/mvm046; Kirkby KA, 2006, AM J PHYSIOL-RENAL, V290, pF563, DOI 10.1152/ajprenal.00220.2005; Klemba M, 2004, J CELL BIOL, V164, P47, DOI 10.1083/jcb200307147; KNOBLER E, 1989, HEPATOLOGY, V10, P995, DOI 10.1002/hep.1840100617; Lara FA, 2003, J EXP BIOL, V206, P1707, DOI 10.1242/jeb.00334; Liu Y, 2000, J BIOL CHEM, V275, P34501, DOI 10.1074/jbc.M004245200; Loria P, 1999, BIOCHEM J, V339, P363, DOI 10.1042/0264-6021:3390363; Maines MD, 2005, PHYSIOLOGY, V20, P382, DOI 10.1152/physiol.00029.2005; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; MCDONAGH AF, 1980, BIOCHEM J, V189, P193, DOI 10.1042/bj1890193; MCLAREN CE, 1987, AM J PHYSIOL, V252, pH857, DOI 10.1152/ajpheart.1987.252.4.H857; Migita CT, 2003, EUR J BIOCHEM, V270, P687, DOI 10.1046/j.1432-1033.2003.03421.x; Muramoto T, 2002, PLANT PHYSIOL, V130, P1958, DOI 10.1104/pp.008128; Nagababu E, 2004, ANTIOXID REDOX SIGN, V6, P967, DOI 10.1089/1523086042259823; Nagaraj VA, 2009, MOL BIOCHEM PARASIT, V168, P109, DOI 10.1016/j.molbiopara.2009.05.008; Okada K, 2009, FEBS LETT, V583, P313, DOI 10.1016/j.febslet.2008.12.015; Oliveira MF, 2005, FEBS LETT, V579, P6010, DOI 10.1016/j.febslet.2005.09.035; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Paiva-Silva GO, 2006, P NATL ACAD SCI USA, V103, P8030, DOI 10.1073/pnas.0602224103; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; Ponpuak M, 2007, MOL MICROBIOL, V63, P314, DOI 10.1111/j.1365-2958.2006.05443.x; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Quinn KD, 2012, RAPID COMMUN MASS SP, V26, P1767, DOI 10.1002/rcm.6287; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Roux-Dalvai F, 2008, MOL CELL PROTEOMICS, V7, P2254, DOI 10.1074/mcp.M800037-MCP200; Russo I, 2009, MOL MICROBIOL, V72, P229, DOI 10.1111/j.1365-2958.2009.06639.x; Rydzanicz R, 2005, NUCLEIC ACIDS RES, V33, pW521, DOI 10.1093/nar/gki380; Sartorello R, 2010, CELL BIOL INT, V34, P859, DOI 10.1042/CBI20090427; Scholl PF, 2005, CURR TOP MICROBIOL, V295, P293; Seeber F, 2010, INT REV CEL MOL BIO, V281, P161, DOI 10.1016/S1937-6448(10)81005-6; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Sigman JA, 2001, J AM CHEM SOC, V123, P6945, DOI 10.1021/ja015776u; SLATER AFG, 1991, P NATL ACAD SCI USA, V88, P325, DOI 10.1073/pnas.88.2.325; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Sugishima M, 2004, EUR J BIOCHEM, V271, P4517, DOI 10.1111/j.1432-1033.2004.04411.x; Suits MDL, 2005, P NATL ACAD SCI USA, V102, P16955, DOI 10.1073/pnas.0504289102; SUROLIA N, 1992, BIOCHEM BIOPH RES CO, V187, P744, DOI 10.1016/0006-291X(92)91258-R; Toh SQ, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-108; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Unno M, 2007, NAT PROD REP, V24, P553, DOI 10.1039/b604180a; van Dooren GG, 2012, ANTIOXID REDOX SIGN, V17, P634, DOI 10.1089/ars.2012.4539; Vitek L, 2009, CURR PHARM DESIGN, V15, P2869, DOI 10.2174/138161209789058237; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Weinberg ED, 2009, DRUG METAB REV, V41, P644, DOI 10.1080/03602530903178905; WILKS A, 1995, BIOCHEMISTRY-US, V34, P4421, DOI 10.1021/bi00013a034; Wilks A, 1998, J BIOL CHEM, V273, P837, DOI 10.1074/jbc.273.2.837; Wilks A, 2002, ANTIOXID REDOX SIGN, V4, P603, DOI 10.1089/15230860260220102; Wilks A, 2007, NAT PROD REP, V24, P511, DOI 10.1039/b604193k; Zhang JM, 1999, MOL BIOCHEM PARASIT, V99, P129, DOI 10.1016/S0166-6851(99)00008-0; Zuegge J, 2001, GENE, V280, P19, DOI 10.1016/S0378-1119(01)00776-4	79	39	41	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.414078	http://dx.doi.org/10.1074/jbc.M112.414078			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22992734	Green Published, hybrid			2022-12-28	WOS:000310642200018
J	Qadri, I; Choudhury, M; Rahman, SM; Knotts, TA; Janssen, RC; Schaack, J; Iwahashi, M; Puljak, L; Simon, FR; Kilic, G; Fitz, JG; Friedman, JE				Qadri, Ishtiaq; Choudhury, Mahua; Rahman, Shaikh Mizanoor; Knotts, Trina A.; Janssen, Rachel C.; Schaack, Jerome; Iwahashi, Mieko; Puljak, Livia; Simon, Francis R.; Kilic, Gordan; Fitz, J. Gregory; Friedman, Jacob E.			Increased Phosphoenolpyruvate Carboxykinase Gene Expression and Steatosis during Hepatitis C Virus Subgenome Replication ROLE OF NONSTRUCTURAL COMPONENT 5A AND CCAAT/ENHANCER-BINDING PROTEIN beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; CCAAT/ENHANCER-BINDING-PROTEIN; SERINE PHOSPHORYLATION; LIPID-ACCUMULATION; GLUCOSE-PRODUCTION; DIABETES-MELLITUS; GLUCONEOGENESIS; TRANSCRIPTION; INFECTION; RESISTANCE	Chronic hepatitis C virus (HCV) infection greatly increases the risk for type 2 diabetes and nonalcoholic steatohepatitis; however, the pathogenic mechanisms remain incompletely understood. Here we report gluconeogenic enzyme phosphoenolpyruvate carboxykinase (PEPCK) transcription and associated transcription factors are dramatically up-regulated in Huh.8 cells, which stably express an HCV subgenome replicon. HCV increased activation of cAMP response element-binding protein (CREB), CCAAT/enhancer-binding protein (C/EBP beta), forkhead box protein O1 (FOXO1), and peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) and involved activation of the cAMP response element in the PEPCK promoter. Infection with dominant-negative CREB or C/EBP beta-shRNA significantly reduced or normalized PEPCK expression, with no change in PGC-1 alpha or FOXO1 levels. Notably, expression of HCV nonstructural component NS5A in Huh7 or primary hepatocytes stimulated PEPCK gene expression and glucose output in HepG2 cells, whereas a deletion in NS5A reduced PEPCK expression and lowered cellular lipids but was without effect on insulin resistance, as demonstrated by the inability of insulin to stimulate mobilization of a pool of insulin-responsive vesicles to the plasma membrane. HCV-replicating cells demonstrated increases in cellular lipids with insulin resistance at the level of the insulin receptor, increased insulin receptor substrate 1 (Ser-312), and decreased Akt (Ser-473) activation in response to insulin. C/EBP beta-RNAi normalized lipogenic genes sterol regulatory element-binding protein-1c, peroxisome proliferator-activated receptor beta, and liver X receptor alpha but was unable to reduce accumulation of triglycerides in Huh.8 cells or reverse the increase in ApoB expression, suggesting a role for increased lipid retention in steatotic hepatocytes. Collectively, these data reveal an important role of NS5A, C/EBP beta, and pCREB in promoting HCV-induced gluconeogenic gene expression and suggest that increased C/EBP beta and NS5A may be essential components leading to increased gluconeogenesis associated with HCV infection.	[Qadri, Ishtiaq; Choudhury, Mahua; Rahman, Shaikh Mizanoor; Knotts, Trina A.; Janssen, Rachel C.; Friedman, Jacob E.] Univ Colorado Denver, Dept Pediat, Aurora, CO 80045 USA; [Schaack, Jerome] Univ Colorado Denver, Dept Microbiol, Aurora, CO 80045 USA; [Friedman, Jacob E.] Univ Colorado Denver, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Iwahashi, Mieko; Simon, Francis R.] Univ Colorado Denver, Dept Med, Div Gastroenterol & Hepatol, Aurora, CO 80045 USA; [Puljak, Livia; Kilic, Gordan; Fitz, J. Gregory] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Texas System; University of Texas Southwestern Medical Center Dallas	Friedman, JE (corresponding author), Univ Colorado Denver, Dept Pediat, Mail Stop 8106,12801 E 17th Ave, Aurora, CO 80045 USA.	Jed.Friedman@ucdenver.edu	Rahman, Shaikh Mizanoor/GLN-7518-2022; Qadri, Ishtiaq/I-6889-2013; Puljak, Livia/D-5080-2017	Rahman, Shaikh Mizanoor/0000-0002-4879-2663; Puljak, Livia/0000-0002-8467-6061; Qadri, Ishtiaq/0000-0003-4334-0585	National Institutes of Health [R01-DK46802, R01-DK43278, R01-DK46082, R01-DK59767]; Herman Lopeta Memorial Award; American Liver Foundation; American Diabetes Association Mentored Post-Doctoral Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059767, R01DK043278, R01DK046082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Herman Lopeta Memorial Award; American Liver Foundation; American Diabetes Association Mentored Post-Doctoral Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK46802 (to G. K.), R01-DK43278 (to J. G. F.), R01-DK46082 (to J. G. F.), and R01-DK59767 (to J. E. F.). This work was also supported by funding from the Herman Lopeta Memorial Award and the American Liver Foundation (to I. Q.) and by an American Diabetes Association Mentored Post-Doctoral Fellowship (to M. C.).	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Arizmendi C, 1999, J BIOL CHEM, V274, P13033, DOI 10.1074/jbc.274.19.13033; Aytug S, 2003, HEPATOLOGY, V38, P1384, DOI 10.1016/j.hep.2003.09.012; Banerjee S, 2008, J VIROL, V82, P2606, DOI 10.1128/JVI.01672-07; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Bevan P, 2001, J CELL SCI, V114, P1429; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Bugianesi E, 2012, J HEPATOL, V56, pS56, DOI 10.1016/S0168-8278(12)60007-5; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Choudhury M, 2008, ALCOHOL CLIN EXP RES, V32, P829, DOI 10.1111/j.1530-0277.2008.00630.x; Davis RA, 1999, BBA-MOL CELL BIOL L, V1440, P1, DOI 10.1016/S1388-1981(99)00083-9; Davis RC, 2010, DIABETES, V59, P1616, DOI 10.2337/db09-0878; De Gottardi A, 2006, ALIMENT PHARM THER, V23, P107, DOI 10.1111/j.1365-2036.2006.02729.x; Deng L, 2011, J VIROL, V85, P8556, DOI 10.1128/JVI.00146-11; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hong C, 2008, CURR OPIN GENET DEV, V18, P461, DOI 10.1016/j.gde.2008.07.016; Hui JM, 2003, GASTROENTEROLOGY, V125, P1695, DOI 10.1053/j.gastro.2003.08.032; Jackel-Cram C, 2010, J GEN VIROL, V91, P1388, DOI 10.1099/vir.0.017418-0; Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JCI32914, 10.1172/JC132914]; Kawaguchi T, 2004, AM J PATHOL, V165, P1499, DOI 10.1016/S0002-9440(10)63408-6; Kawaguchi T, 2010, WORLD J GASTROENTERO, V16, P1943, DOI 10.3748/wjg.v16.i16.1943; Kilic G, 2001, J BIOL CHEM, V276, P26762, DOI 10.1074/jbc.M100992200; Kim KH, 2007, BIOCHEM BIOPH RES CO, V355, P883, DOI 10.1016/j.bbrc.2007.02.044; Kim WR, 2002, MICROBES INFECT, V4, P1219, DOI 10.1016/S1286-4579(02)01649-0; Lerat H, 2002, GASTROENTEROLOGY, V122, P352, DOI 10.1053/gast.2002.31001; Lerat H, 2009, J BIOL CHEM, V284, P33466, DOI 10.1074/jbc.M109.019810; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; McLauchlan J, 2009, BIOCHEM SOC T, V37, P986, DOI 10.1042/BST0370986; Monto A, 2002, HEPATOLOGY, V36, P729, DOI 10.1053/jhep.2002.35064; Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527; Ortiz V, 2002, AM J GASTROENTEROL, V97, P2408, DOI 10.1111/j.1572-0241.2002.05995.x; OSHINO N, 1966, BIOCHIM BIOPHYS ACTA, V128, P13, DOI 10.1016/0926-6593(66)90137-8; Park CY, 2009, J BIOL CHEM, V284, P9237, DOI 10.1074/jbc.M808773200; PARK EA, 1993, J BIOL CHEM, V268, P613; Perdomo G, 2004, J BIOL CHEM, V279, P27177, DOI 10.1074/jbc.M403566200; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Qadri I, 2004, BIOCHEM J, V378, P919, DOI 10.1042/BJ20031587; Rahman S. M., 2012, J BIOL CHEM IN PRESS; Rahman SM, 2007, HEPATOLOGY, V45, P1108, DOI 10.1002/hep.21614; Rahman SM, 2009, J LIPID RES, V50, P2193, DOI 10.1194/jlr.M800633-JLR200; Routes JM, 2000, BIOCHEM J, V352, P335, DOI 10.1042/0264-6021:3520335; Schroeder-Gloeckler JM, 2007, J BIOL CHEM, V282, P15717, DOI 10.1074/jbc.M701329200; Shao JH, 2005, DIABETES, V54, P976, DOI 10.2337/diabetes.54.4.976; Shintani Y, 2004, GASTROENTEROLOGY, V126, P840, DOI 10.1053/j.gastro.2003.11.056; Shoji I, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2011.00278; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Singh A, 2010, MOL BIOL CELL, V21, P1140, DOI 10.1091/mbc.E09-09-0795; Syed GH, 2010, TRENDS ENDOCRIN MET, V21, P33, DOI 10.1016/j.tem.2009.07.005; Tanti JF, 2004, ANN ENDOCRINOL-PARIS, V65, P43, DOI 10.1016/S0003-4266(04)95629-6; Tellinghuisen TL, 2006, J VIROL, V80, P7450, DOI 10.1128/JVI.00358-06; Thuluvath PJ, 2003, AM J GASTROENTEROL, V98, P438, DOI 10.1016/S0002-9270(02)05924-5; Villanueva CJ, 2009, HEPATOLOGY, V50, P434, DOI 10.1002/hep.22980; Wang CS, 2003, AM J EPIDEMIOL, V158, P1154, DOI 10.1093/aje/kwg259; Weigert C, 2008, MOL ENDOCRINOL, V22, P2729, DOI 10.1210/me.2008-0102; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	57	18	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37340	37351		10.1074/jbc.M112.384743	http://dx.doi.org/10.1074/jbc.M112.384743			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22955269	hybrid, Green Published			2022-12-28	WOS:000310588500065
J	Lew, QJ; Chia, YL; Chu, KL; Lam, YT; Gurumurthy, M; Xu, SL; Lam, KP; Cheong, N; Chao, SH				Lew, Qiao Jing; Chia, Yi Ling; Chu, Kai Ling; Lam, Yuen Ting; Gurumurthy, Meera; Xu, Shengli; Lam, Kong Peng; Cheong, Nge; Chao, Sheng-Hao			Identification of HEXIM1 as a Positive Regulator of p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; ELONGATION-FACTOR-B; DEPENDENT KINASE INHIBITORS; CDK9 PHOSPHORYLATES P53; PROLYL ISOMERASE PIN1; BREAST CELL-GROWTH; P-TEFB; TRANSCRIPTION ELONGATION; 7SK SNRNA; NUCLEAR ACCUMULATION	Hexamethylene bisacetamide-inducible protein 1 (HEXIM1) is best known as the inhibitor of positive transcription elongation factor b (P-TEFb), which regulates the transcription elongation of RNA polymerase II and controls 60-70% of mRNA synthesis. Our previous studies show that HEXIM1 interacts with two key p53 regulators, nucleophosmin and human double minute-2 protein (HDM2), implying a possible connection between HEXIM1 and the p53 signaling pathway. Here we report the interaction between p53 and HEXIM1 in breast cancer, acute myeloid leukemia, and colorectal carcinoma cells. The C-terminal regions of p53 and HEXIM1 are required for the protein-protein interaction. Overexpression of HEXIM1 prevents the ubiquitination of p53 by HDM2 and enhances the protein stability of p53, resulting in up-regulation of p53 target genes, such as Puma and p21. Induction of p53 can be achieved by several means, such as UV radiation and treatment with anticancer agents (including doxorubicin, etoposide, roscovitine, flavopiridol, and nutlin-3). Under all the conditions examined, elevated protein levels of p53 are found to associate with the increased p53-HEXIM1 interaction. In addition, knockdown of HEXIM1 significantly inhibits the induction of p53 and releases the cell cycle arrest caused by p53. Finally, the transcription of the p53 target genes is regulated by HEXIM1 in a p53-dependent fashion. Our results not only identify HEXIM1 as a positive regulator of p53, but also propose a novel molecular mechanism of p53 activation caused by the anti-cancer drugs and compounds.	[Cheong, Nge; Chao, Sheng-Hao] ASTAR, Bioproc Technol Inst, Express Engn, Singapore 138668, Singapore; [Xu, Shengli; Lam, Kong Peng] ASTAR, Bioproc Technol Inst, Immunol Grp, Singapore 138668, Singapore; [Xu, Shengli; Lam, Kong Peng] Natl Univ Singapore, Dept Physiol, Singapore 117597, Singapore; [Lam, Kong Peng; Chao, Sheng-Hao] Natl Univ Singapore, Dept Microbiol, Singapore 117597, Singapore; [Lam, Kong Peng] Natl Univ Singapore, Dept Paediat, Singapore 117597, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); National University of Singapore; National University of Singapore; National University of Singapore	Chao, SH (corresponding author), ASTAR, Bioproc Technol Inst, 20 Biopolis Way,06-01 Centros, Singapore 138668, Singapore.	jimmy_chao@bti.a-star.edu.sg		Lam, Kong-Peng/0000-0002-1316-4333	Agency for Science, Technology, and Research (A*STAR), Singapore	Agency for Science, Technology, and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work is supported by the Agency for Science, Technology, and Research (A*STAR), Singapore.	Barboric M, 2005, EMBO J, V24, P4291, DOI 10.1038/sj.emboj.7600883; Blaydes JP, 2001, J BIOL CHEM, V276, P4699, DOI 10.1074/jbc.M003485200; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Byers SA, 2005, J BIOL CHEM, V280, P16360, DOI 10.1074/jbc.M500424200; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Claudio PP, 2006, J CELL PHYSIOL, V208, P602, DOI 10.1002/jcp.20698; Czudnochowski N, 2010, J MOL BIOL, V395, P28, DOI 10.1016/j.jmb.2009.10.055; Demidenko ZN, 2004, CANCER RES, V64, P3653, DOI 10.1158/0008-5472.CAN-04-0204; Dey A, 2007, CELL CYCLE, V6, P1856, DOI 10.4161/cc.6.15.4556; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Fraldi A, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-42; FRITSCHE M, 1993, ONCOGENE, V8, P307; Galatioto J, 2010, J CELL SCI, V123, P3789, DOI 10.1242/jcs.073387; GRANA X, 1994, P NATL ACAD SCI USA, V91, P3834, DOI 10.1073/pnas.91.9.3834; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Gurumurthy M, 2008, J MOL BIOL, V378, P302, DOI 10.1016/j.jmb.2008.02.055; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Ketchart W, 2011, ONCOGENE, V30, P3563, DOI 10.1038/onc.2011.76; Krystof V, 2010, CURR DRUG TARGETS, V11, P291, DOI 10.2174/138945010790711950; KWOK TT, 1994, CANCER RES, V54, P2834; Lau J, 2009, CELL CYCLE, V8, P2247, DOI 10.4161/cc.8.14.9015; Lew QJ, 2011, CELL CYCLE, V10, P1978, DOI 10.4161/cc.10.12.15859; Li QT, 2005, J BIOL CHEM, V280, P28819, DOI 10.1074/jbc.M502712200; Ljungman M, 1999, ONCOGENE, V18, P583, DOI 10.1038/sj.onc.1202356; Ljungman M, 2001, MOL PHARMACOL, V60, P785; MALTZMAN W, 1984, MOL CELL BIOL, V4, P1689, DOI 10.1128/MCB.4.9.1689; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Napolitano G, 2007, CELL CYCLE, V6, P1126, DOI 10.4161/cc.6.9.4137; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Ouchida R, 2003, GENES CELLS, V8, P95, DOI 10.1046/j.1365-2443.2003.00618.x; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Poyurovsky MV, 2010, NAT STRUCT MOL BIOL, V17, P982, DOI 10.1038/nsmb.1872; Pumfery A, 2006, CURR PHARM DESIGN, V12, P1949, DOI 10.2174/138161206777442083; Radhakrishnan SK, 2006, CELL CYCLE, V5, P519, DOI 10.4161/cc.5.5.2514; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Sano M, 2002, NAT MED, V8, P1310, DOI 10.1038/nm778; Shen H, 2011, CURR PHARM DESIGN, V17, P560, DOI 10.2174/138161211795222603; Shimizu N, 2005, P NATL ACAD SCI USA, V102, P8555, DOI 10.1073/pnas.0409863102; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; STINSKI MF, 1976, J VIROL, V19, P594, DOI 10.1128/JVI.19.2.594-609.1976; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wittmann BM, 2005, ONCOGENE, V24, P5576, DOI 10.1038/sj.onc.1208728; Wittmann BM, 2003, CANCER RES, V63, P5151; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	59	21	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36443	36454		10.1074/jbc.M112.374157	http://dx.doi.org/10.1074/jbc.M112.374157			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22948151	hybrid, Green Published			2022-12-28	WOS:000310364000064
J	Baniecki, ML; McGrath, WJ; Mangel, WF				Baniecki, Mary Lynn; McGrath, William J.; Mangel, Walter F.			Regulation of a Viral Proteinase by a Peptide and DNA in One-dimensional Space III. ATOMIC RESOLUTION STRUCTURE OF THE NASCENT FORM OF THE ADENOVIRUS PROTEINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; SEROTYPE-2 PROTEINASE; COFACTOR; PROTEASE; CRYSTALLIZATION; POLYPEPTIDE; ACTIVATION; MECHANISM; SEQUENCE; COMPLEX	The adenovirus proteinase (AVP), the first member of a new class of cysteine proteinases, is essential for the production of infectious virus, and here we report its structure at 0.98 angstrom resolution. AVP, initially synthesized as an inactive enzyme, requires two cofactors for maximal activity: pVIc, an 11-amino acid peptide, and the viral DNA. Comparison of the structure of AVP with that of an active form, the AVP-pVIc complex, reveals why AVP is inactive. Both forms have an alpha + beta fold; the major structural differences between them lie in the beta-sheet domain. In AVP-pVIc, the general base His-54N delta 1 is 3.9 angstrom away from the Cys-122 S gamma, thereby rendering it nucleophilic. In AVP, however, His-54 N delta 1 is 7.0 angstrom away from Cys-122 S gamma, too far away to be able to abstract the proton from Cys-122. In AVP-pVIc, Tyr-84 forms a cation-pi interaction with His-54 that should raise the pK(a) of His-54 and freeze the imidazole ring in the place optimal for forming an ion pair with Cys-122. In AVP, however, Tyr-84 is more than 11 angstrom away from its position in AVP-pVIc. Based on the structural differences between AVP and AVP-pVIc, we present a model that postulates that activation of AVP by pVIc occurs via a 62-amino acid-long activation pathway in which the binding of pVIc initiates contiguous conformational changes, analogous to falling dominos. There is a common pathway that branches into a pathway that leads to the repositioning of His-54 and another pathway that leads to the repositioning of Tyr-84.	[Baniecki, Mary Lynn; McGrath, William J.; Mangel, Walter F.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	Mangel, WF (corresponding author), Brookhaven Natl Lab, Dept Biol, 50 Bell Ave, Upton, NY 11973 USA.	mangel@bnl.gov		McGrath, William/0000-0002-9375-624X	National Institutes of Health [AI R0141599]; Office of Biological and Environmental Research of the United States Department of Energy [DE-AC0298CH10886]; Brookhaven National Laboratory; Office of Biological and Environmental Research; Office of Basic Energy Sciences of the United States Department of Energy; National Center for Research Resources [P41RR012408]; NIGMS of the National Institutes of Health [P41GM103473]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041599, R21AI113565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103473] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Biological and Environmental Research of the United States Department of Energy(United States Department of Energy (DOE)); Brookhaven National Laboratory(United States Department of Energy (DOE)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI R0141599 (to W. F. M.). This work was also supported by the Office of Biological and Environmental Research of the United States Department of Energy under Prime Contract DE-AC0298CH10886 with Brookhaven National Laboratory.; We thank Zbigniew Dauter for advice during data collection and analysis. We also thank Michael Becker and Annie Heroux for assistance in data collection. Data for this study were measured at beam line X-25 of the National Synchrotron Light Source. Financial support comes principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy, and from the National Center for Research Resources (Grant P41RR012408) and the NIGMS (Grant P41GM103473) of the National Institutes of Health. The National Synchrotron Light Source, Brookhaven National Laboratory, is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract Number DE-AC02-98CH10886.	ANDERSON CW, 1993, PROTEIN EXPRES PURIF, V4, P8, DOI 10.1006/prep.1993.1002; Andres G, 2001, J BIOL CHEM, V276, P780, DOI 10.1074/jbc.M006844200; Ansarah-Sobrinho C, 2004, J VIROL, V78, P6335, DOI 10.1128/JVI.78.12.6335-6343.2004; Baniecki ML, 2002, ACTA CRYSTALLOGR D, V58, P1462, DOI 10.1107/S0907444902008429; Baniecki ML, 2001, BIOCHEMISTRY-US, V40, P12349, DOI 10.1021/bi0109008; Blainey PC, 2013, J BIOL CHEM, V288, P2092, DOI 10.1074/jbc.M112.407460; BLOW DM, 1976, ACCOUNTS CHEM RES, V9, P145, DOI 10.1021/ar50100a004; BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0; Brown MT, 1996, FEBS LETT, V388, P233, DOI 10.1016/0014-5793(96)00569-8; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Casjens S., 1997, STRUCTURAL BIOL VIRU, P3; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Ding JZ, 1996, EMBO J, V15, P1778, DOI 10.1002/j.1460-2075.1996.tb00526.x; Drenth J, 1971, ENZYMES, V3, P485; EDVARDSSON B, 1976, J VIROL, V19, P533, DOI 10.1128/JVI.19.2.533-547.1976; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Graziano V, 2013, J BIOL CHEM, V288, P2059, DOI 10.1074/jbc.M112.377150; Graziano V, 2013, J BIOL CHEM, V288, P2068, DOI 10.1074/jbc.M112.407312; KEEFE LJ, 1995, PROTEIN SCI, V4, P1658, DOI 10.1002/pro.5560040826; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; LOEWENTHAL R, 1992, J MOL BIOL, V224, P759, DOI 10.1016/0022-2836(92)90560-7; MANGEL WF, 1993, NATURE, V361, P274, DOI 10.1038/361274a0; Mangel WF, 1996, J BIOL CHEM, V271, P536, DOI 10.1074/jbc.271.1.536; Mangenot S, 2003, BIOPHYS J, V85, P1817, DOI 10.1016/S0006-3495(03)74610-4; McGrath WJ, 2003, BBA-PROTEINS PROTEOM, V1648, P1, DOI 10.1016/S1570-9639(03)00024-4; McGrath WJ, 1996, J STRUCT BIOL, V117, P77, DOI 10.1006/jsbi.1996.0072; McGrath WJ, 2002, VIROLOGY, V296, P234, DOI 10.1006/viro.2002.1394; McGrath WJ, 2001, BIOCHEMISTRY-US, V40, P13237, DOI 10.1021/bi0111653; McGrath WJ, 2001, BIOCHEMISTRY-US, V40, P14468, DOI 10.1021/bi011562d; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez-Berna AJ, 2009, J MOL BIOL, V392, P547, DOI 10.1016/j.jmb.2009.06.057; POLGAR L, 1974, FEBS LETT, V47, P15, DOI 10.1016/0014-5793(74)80415-1; RAMAKRISHNAN C, 1965, BIOPHYS J, V5, P909, DOI 10.1016/S0006-3495(65)86759-5; Sevcik J, 1996, ACTA CRYSTALLOGR D, V52, P327, DOI 10.1107/S0907444995007669; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; STRAUSS MG, 1990, NUCL INSTRUM METH A, V297, P275, DOI 10.1016/0168-9002(90)91376-M; WEBER J, 1976, J VIROL, V17, P462, DOI 10.1128/JVI.17.2.462-471.1976; WEBSTER A, 1993, CELL, V72, P97, DOI 10.1016/0092-8674(93)90053-S; WEBSTER A, 1993, J GEN VIROL, V74, P1415, DOI 10.1099/0022-1317-74-7-1415; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	45	9	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					2081	2091		10.1074/jbc.M112.407429	http://dx.doi.org/10.1074/jbc.M112.407429			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23043139	Green Published, hybrid			2022-12-28	WOS:000313751400059
J	Chandrasekaran, P; Buckley, M; Moore, V; Wang, LQ; Kehrl, JH; Venkatesan, S				Chandrasekaran, Prabha; Buckley, Monica; Moore, Victoria; Wang, Long Qin; Kehrl, John H.; Venkatesan, Sundararajan			HIV-1 Nef Impairs Heterotrimeric G-protein Signaling by Targeting G alpha(i2) for Degradation through Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 NEF; T-CELLS; MEDIATED MODULATION; CHEMOKINE RECEPTORS; ACTIN CYTOSKELETON; ALPHA-SUBUNIT; DOMAIN; PATHWAY; CHEMOTAXIS	The HIV Nef protein is an important pathogenic factor that modulates cell surface receptor trafficking and impairs cell motility, presumably by interfering at multiple steps with chemotactic receptor signaling. Here, we report that a dominant effect of Nef is to trigger AIP4 E3 ligase-mediated G alpha(i2) ubiquitination, which leads to G alpha(i2) endolysosomal sequestration and destruction. The loss of the G alpha(i2) subunit was demonstrable in many cell types in the context of gene transfection, HIV infection, or Nef protein transduction. Nef directly interacts with G alpha(i2) and ternary complexes containing AIP4, Nef, and G alpha(i2) form. Asubstantial reversal of G alpha(i2) loss and a partial recovery of impaired chemotaxis occurred following siRNA knockdown of AIP4 or NEDD4 or by inhibiting dynamin. The N-terminal myristoyl group, (EEEE65)-E-62 motif, and (PXXP75)-P-72 motif of Nef are critical for this effect to occur. Nef expression does not affect a Gq(i5) chimera where the five C-terminal residues of Gq are replaced with those of G alpha(i2). Lysine at position 296 of G alpha(i2) was identified as the critical determinant of Nef-induced degradation. By specifically degrading G alpha(i2), Nef directly subverts leukocyte migration and homing. Impaired trafficking and homing of HIV Nef-expressing lymphocytes probably contributes to early immune dysfunction following HIV infection.	[Chandrasekaran, Prabha; Buckley, Monica; Moore, Victoria; Wang, Long Qin; Venkatesan, Sundararajan] NIAID, LMI, NIH, Bethesda, MD 20892 USA; [Kehrl, John H.] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Venkatesan, S (corresponding author), NIAID, LMI, NIH, Bldg 10,Rm 11N117, Bethesda, MD 20892 USA.	sv1s@nih.gov	Kehrl, John/AAE-6292-2019	Kehrl, John/0000-0002-6526-159X	National Institutes of Health, NIAID, Intramural Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000738] Funding Source: NIH RePORTER	National Institutes of Health, NIAID, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health, NIAID, Intramural Research Program.	Amella CA, 2005, J VIROL, V79, P5625, DOI 10.1128/JVI.79.9.5625-5631.2005; Arrode G, 2008, VACCINE, V26, P3795, DOI 10.1016/j.vaccine.2008.05.057; Bhandari D, 2009, MOL BIOL CELL, V20, P1324, DOI 10.1091/mbc.E08-03-0308; Brainard DM, 2007, J VIROL, V81, P8439, DOI 10.1128/JVI.00199-07; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Busconi L, 2000, J BIOL CHEM, V275, P1565, DOI 10.1074/jbc.275.3.1565; Campbell EM, 2004, J VIROL, V78, P5745, DOI 10.1128/JVI.78.11.5745-5755.2004; Cappell SD, 2010, MOL CELL, V38, P746, DOI 10.1016/j.molcel.2010.05.026; Cartier C, 2003, J BIOL CHEM, V278, P35211, DOI 10.1074/jbc.M301257200; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cho H, 2007, J CELL BIOL, V178, P245, DOI 10.1083/jcb.200604114; Choe EY, 2002, J BIOL CHEM, V277, P46079, DOI 10.1074/jbc.M204698200; Chrobak P, 2010, J IMMUNOL, V185, P3948, DOI 10.4049/jimmunol.1001064; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Delon J, 2002, IMMUNOL REV, V189, P51, DOI 10.1034/j.1600-065X.2002.18906.x; Fischer T, 2003, P NATL ACAD SCI USA, V100, P8270, DOI 10.1073/pnas.1432965100; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; Haller C, 2006, J BIOL CHEM, V281, P19618, DOI 10.1074/jbc.M513802200; Hamilton MH, 2003, P NATL ACAD SCI USA, V100, P5081, DOI 10.1073/pnas.0831228100; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Harvey KF, 1999, TRENDS CELL BIOL, V9, P166, DOI 10.1016/S0962-8924(99)01541-X; Hrecka K, 2005, J VIROL, V79, P10650, DOI 10.1128/JVI.79.16.10650-10659.2005; Hu H, 2004, PROTEOMICS, V4, P643, DOI 10.1002/pmic.200300632; Ingham RJ, 2005, J BIOL CHEM, V280, P34133, DOI 10.1074/jbc.M507831200; Janardhan A, 2004, PLOS BIOL, V2, P65, DOI 10.1371/journal.pbio.0020006; Kinter A, 2000, IMMUNOL REV, V177, P88, DOI 10.1034/j.1600-065X.2000.17708.x; Kirchhoff F, 2008, CELL MOL LIFE SCI, V65, P2621, DOI 10.1007/s00018-008-8094-2; Kirchhoff F, 1999, J VIROL, V73, P8371, DOI 10.1128/JVI.73.10.8371-8383.1999; Kourtis AP, 1996, NEW ENGL J MED, V335, P1431, DOI 10.1056/NEJM199611073351904; Krumins AM, 2006, J BIOL CHEM, V281, P10250, DOI 10.1074/jbc.M511551200; Kwan J, 2004, J IMMUNOL, V172, P3999, DOI 10.4049/jimmunol.172.7.3999; Laguette N, 2010, MOL ASPECTS MED, V31, P418, DOI 10.1016/j.mam.2010.05.003; Lee CMY, 2008, VIRAL IMMUNOL, V21, P347, DOI 10.1089/vim.2007.0093; LEE CH, 1995, EMBO J, V14, P5006, DOI 10.1002/j.1460-2075.1995.tb00183.x; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Lu TC, 2008, J BIOL CHEM, V283, P8173, DOI 10.1074/jbc.M708920200; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MAGHAZACHI AA, 1994, J IMMUNOL, V153, P4969; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marotti LA, 2002, BIOCHEMISTRY-US, V41, P5067, DOI 10.1021/bi015940q; Michel N, 2006, MOL BIOL CELL, V17, P3578, DOI 10.1091/mbc.E06-02-0117; Misra RS, 2010, J EXP MED, V207, P1775, DOI 10.1084/jem.20092735; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; Naviglio S, 2004, CELL SIGNAL, V16, P1229, DOI 10.1016/j.cellsig.2004.03.012; Obin M, 2002, J BIOL CHEM, V277, P44566, DOI 10.1074/jbc.M205308200; Ogasawara J, 2004, BIOCHEM BIOPH RES CO, V323, P1109, DOI 10.1016/j.bbrc.2004.08.202; Otte L, 2003, PROTEIN SCI, V12, P491, DOI 10.1110/ps.0233203; Pantaleo G, 1996, ANNU REV MICROBIOL, V50, P825, DOI 10.1146/annurev.micro.50.1.825; Park IW, 2009, J LEUKOCYTE BIOL, V86, P1171, DOI 10.1189/jlb.0409261; Pirozzi G, 1997, J BIOL CHEM, V272, P14611, DOI 10.1074/jbc.272.23.14611; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; Quaranta MG, 2003, FASEB J, V17, P2025, DOI 10.1096/fj.03-0272com; Rabbi MF, 1997, VIROLOGY, V237, P422, DOI 10.1006/viro.1997.8798; Roeth JF, 2006, MICROBIOL MOL BIOL R, V70, P548, DOI 10.1128/MMBR.00042-05; Rose JJ, 2008, J BIOMED SCI, V15, P441, DOI 10.1007/s11373-008-9239-x; Rose JJ, 2004, J BIOL CHEM, V279, P24372, DOI 10.1074/jbc.M401364200; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Shi GX, 2007, J EXP MED, V204, P2705, DOI 10.1084/jem.20071267; SKOWRONSKI J, 1993, EMBO J, V12, P703, DOI 10.1002/j.1460-2075.1993.tb05704.x; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; SOZZANI S, 1994, J IMMUNOL, V152, P3615; Stolp B, 2009, CELL HOST MICROBE, V6, P174, DOI 10.1016/j.chom.2009.06.004; Tang T, 2008, BIOCHEM BIOPH RES CO, V377, P679, DOI 10.1016/j.bbrc.2008.10.054; Torres MP, 2009, J BIOL CHEM, V284, P8931, DOI 10.1074/jbc.M809058200; Trampont PC, 2010, NAT IMMUNOL, V11, P162, DOI 10.1038/ni.1830; Venkatesan S, 2001, J BIOL CHEM, V276, P40133, DOI 10.1074/jbc.M105722200; Wang YQ, 2005, J BIOL CHEM, V280, P284, DOI 10.1074/jbc.M411624200; Welker R, 1996, VIROLOGY, V219, P228, DOI 10.1006/viro.1996.0240; Wilkie TM, 2005, CURR BIOL, V15, pR843, DOI 10.1016/j.cub.2005.10.008; Winberg G, 2000, MOL CELL BIOL, V20, P8526, DOI 10.1128/MCB.20.22.8526-8535.2000; Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753; Yang LV, 2005, BLOOD, V105, P1127, DOI 10.1182/blood-2004-05-1916; Yi L, 2010, J BIOL CHEM, V285, P30884, DOI 10.1074/jbc.M110.135947	80	8	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41481	41498		10.1074/jbc.M112.361782	http://dx.doi.org/10.1074/jbc.M112.361782			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23071112	hybrid, Green Published			2022-12-28	WOS:000311887600059
J	Mohammad, S; Ozaki, T; Takeuchi, K; Unno, K; Yamoto, K; Morioka, E; Takiguchi, S; Ikeda, M				Mohammad, Shahid; Ozaki, Tomoya; Takeuchi, Kouhei; Unno, Katsuya; Yamoto, Kurumi; Morioka, Eri; Takiguchi, Soichi; Ikeda, Masayuki			Functional Compensation between Cholecystokinin-1 and -2 Receptors in Murine Paraventricular Nucleus Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DORSAL VAGAL COMPLEX; CCK-A RECEPTORS; FOOD-INTAKE; SUPRACHIASMATIC NUCLEUS; MOLECULAR-CLONING; RAT NODOSE; EXPRESSION; SATIETY; ORGANIZATION; LACKING	Cholecystokinin (CCK) and its receptor subtypes CCK-1 and -2 have diverse homeostatic functions. CCK-1 and -2 receptors share a common phosphatidylinositol signaling pathway, yet little is known regarding their possible functional coupling. We focused on CCK-mediated Ca2+ signaling in parvocellular paraventricular nucleus (PVN) cells, which control satiety and other autonomic functions. Analysis of mouse hypothalamic slices demonstrated that the general CCK receptor agonist CCK-8s (10 nM) triggered Ca2+ transients most significantly in the posterior subregion of the PVN (PaPo). This 10 nM CCK-8s-induced response was absent in CCK-1 receptor knock-out (CCK1R(-/-)) slices, showing that the response is mediated by CCK-1 receptors. CCK-8s concentrations higher than 30 nM triggered a Ca2+ rise similarly in wild-type and CCK1R(-/-) slices. The large CCK-8s (100 nM)-induced Ca2+ responses in CCK1R(-/-) slices were blocked by a CCK-2 receptor antagonist (CI-988), whereas those in wild-type slices required a mixture of CI-988 and lorglumide (a CCK-1 receptor antagonist) for complete antagonism. Therefore, CCK-1 and -2 receptors may function synergistically in single PaPo neurons and deletion of CCK-1 receptors may facilitate CCK-2 receptor signaling. This hypothesis was supported by results of real-time RT-PCR, immunofluorescence double labeling and Western blotting assays, which indicated CCK-2 receptor overexpression in PaPo neurons of CCK1R(-/-) mice. Furthermore, behavioral studies showed that intraperitoneal injections of lorglumide up-regulated food accesses in wild-type but not in CCK1R(-/-) mice, whereas CI-988 injections up-regulated food accesses in CCK1R(-/-) but not in wild-type mice. Compensatory CCK signaling via CCK-2 receptors in CCK1R(-/-) mice shed light on currently controversial satiety-controlling mechanisms.	[Ikeda, Masayuki] Toyama Univ, Fac Sci, Dept Biol, Grad Sch Innovat Life Sci, Toyama 9308555, Japan; [Takeuchi, Kouhei; Unno, Katsuya; Yamoto, Kurumi; Ikeda, Masayuki] Toyama Univ, Grad Sch Sci & Engn, Toyama 9308555, Japan; [Takiguchi, Soichi] Kyushu Natl Canc Ctr, Inst Clin Res, Minami Ku, Fukuoka 8111395, Japan	University of Toyama; University of Toyama	Ikeda, M (corresponding author), Toyama Univ, Fac Sci, Dept Biol, Grad Sch Innovat Life Sci, Rm B214,3190 Gofuku, Toyama 9308555, Japan.	msikeda@sci.u-toyama.ac.jp		Ikeda, Masayuki/0000-0002-6833-9495; Shahid, Mohammad/0000-0001-5239-7861	Ministry of Education, Culture, Sports, Science, and Technology Japan [22300108]	Ministry of Education, Culture, Sports, Science, and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research (22300108) from the Ministry of Education, Culture, Sports, Science, and Technology Japan (to M. I.).	Appleyard SM, 2007, J NEUROSCI, V27, P13292, DOI 10.1523/JNEUROSCI.3502-07.2007; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; Berna MJ, 2007, CURR OPIN PHARMACOL, V7, P583, DOI 10.1016/j.coph.2007.09.011; Bi S, 2004, ENDOCRINOLOGY, V145, P3873, DOI 10.1210/en.2004-0284; Blevins JE, 2009, BRAIN RES, V1255, P98, DOI 10.1016/j.brainres.2008.12.015; Broberger C, 2001, BRAIN RES, V903, P128, DOI 10.1016/S0006-8993(01)02468-4; Cheng ZJ, 2003, J BIOL CHEM, V278, P52972, DOI 10.1074/jbc.M310090200; CRAWLEY JN, 1991, J PHARMACOL EXP THER, V257, P1076; GIBBS J, 1973, NATURE, V245, P323, DOI 10.1038/245323a0; Guard DB, 2009, BRAIN RES, V1266, P37, DOI 10.1016/j.brainres.2009.02.003; Hashimoto H, 2005, AUTON NEUROSCI-BASIC, V121, P16, DOI 10.1016/j.autneu.2005.05.002; HINKS GL, 1995, NEUROSCIENCE, V68, P765, DOI 10.1016/0306-4522(95)00148-C; HIROSUE Y, 1993, AM J PHYSIOL, V265, pR481, DOI 10.1152/ajpregu.1993.265.3.R481; HONDA T, 1993, MOL CELL NEUROSCI, V4, P143, DOI 10.1006/mcne.1993.1018; Ikeda M, 2003, NEURON, V38, P253, DOI 10.1016/S0896-6273(03)00164-8; Ikeda M, 2003, EUR J NEUROSCI, V17, P58, DOI 10.1046/j.1460-9568.2003.02427.x; Ivy AC, 1928, AM J PHYSIOL, V86, P599, DOI 10.1152/ajplegacy.1928.86.3.599; Kopin AS, 1999, J CLIN INVEST, V103, P383, DOI 10.1172/JCI4901; KOPIN AS, 1992, P NATL ACAD SCI USA, V89, P3605, DOI 10.1073/pnas.89.8.3605; Koutcherov Y, 2000, J COMP NEUROL, V423, P299; Li Y, 2011, AM J PHYSIOL-GASTR L, V300, pG217, DOI 10.1152/ajpgi.00356.2010; Lo CM, 2008, AM J PHYSIOL-REG I, V294, pR803, DOI 10.1152/ajpregu.00682.2007; Monnikes H, 2000, DIGESTION, V62, P178, DOI 10.1159/000007811; Monnikes H, 1997, AM J PHYSIOL-REG I, V273, pR2059, DOI 10.1152/ajpregu.1997.273.6.R2059; MORAN TH, 1992, AM J PHYSIOL, V262, pR46, DOI 10.1152/ajpregu.1992.262.1.R46; Moran TH, 1998, AM J PHYSIOL-REG I, V274, pR618, DOI 10.1152/ajpregu.1998.274.3.R618; Muramatsu Y, 2005, BIOCHEM BIOPH RES CO, V331, P1270, DOI 10.1016/j.bbrc.2005.04.040; Ozaki T., 2011, Society for Neuroscience Abstract Viewer and Itinerary Planner, V41; Panicker AK, 1998, AM J PHYSIOL-REG I, V275, pR158, DOI 10.1152/ajpregu.1998.275.1.R158; Raboin SJ, 2008, REGUL PEPTIDES, V150, P73, DOI 10.1016/j.regpep.2008.06.007; Reidelberger RD, 2004, AM J PHYSIOL-REG I, V286, pR1005, DOI 10.1152/ajpregu.00646.2003; RINAMAN L, 1993, J COMP NEUROL, V338, P475, DOI 10.1002/cne.903380402; Shimazoe T, 2008, FASEB J, V22, P1479, DOI 10.1096/fj.07-9372com; Simmons RD, 1999, PHARMACOL BIOCHEM BE, V62, P549, DOI 10.1016/S0091-3057(98)00186-5; SMITH GP, 1981, SCIENCE, V213, P1036, DOI 10.1126/science.7268408; Sorimachi M, 2001, NEUROSCI LETT, V300, P91, DOI 10.1016/S0304-3940(01)01553-1; Stern JE, 2001, J PHYSIOL-LONDON, V537, P161, DOI 10.1111/j.1469-7793.2001.0161k.x; SWANSON LW, 1980, J COMP NEUROL, V194, P555, DOI 10.1002/cne.901940306; SWANSON LW, 1983, ANNU REV NEUROSCI, V6, P269, DOI 10.1146/annurev.ne.06.030183.001413; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Takiguchi S, 2002, PANCREAS, V24, P276, DOI 10.1097/00006676-200204000-00011; Takiguchi S, 1997, GENE, V197, P169, DOI 10.1016/S0378-1119(97)00259-X; Uchoa ET, 2009, HORM BEHAV, V56, P532, DOI 10.1016/j.yhbeh.2009.09.007; ULRICH CD, 1993, BIOCHEM BIOPH RES CO, V193, P204, DOI 10.1006/bbrc.1993.1610; VANDENPOL AN, 1985, NEUROSCIENCE, V15, P1049, DOI 10.1016/0306-4522(85)90254-4; Wang LX, 2000, REGUL PEPTIDES, V92, P79, DOI 10.1016/S0167-0115(00)00153-1; WANK SA, 1992, P NATL ACAD SCI USA, V89, P3125, DOI 10.1073/pnas.89.7.3125; WANK SA, 1992, P NATL ACAD SCI USA, V89, P8691, DOI 10.1073/pnas.89.18.8691; Washington MC, 2011, PEPTIDES, V32, P272, DOI 10.1016/j.peptides.2010.11.010; Yang L, 2009, J NEUROSCI, V29, P179, DOI 10.1523/JNEUROSCI.4379-08.2009	50	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.416214	http://dx.doi.org/10.1074/jbc.M112.416214			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23038256	Green Published, hybrid			2022-12-28	WOS:000311233800011
J	Kong, HK; Yoon, S; Park, JH				Kong, Hyun Kyung; Yoon, Sukjoon; Park, Jong Hoon			The Regulatory Mechanism of the LY6K Gene Expression in Human Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; DNA-BINDING ACTIVITIES; LY-6K GENE; AP-1; JUN; METHYLATION; PROTEINS; GROWTH; MEMBER; FOS	LY6K is a cancer biomarker and a therapeutic target that induces invasion and metastasis. However, the molecular mechanisms that determine human LY6K transcription are completely unknown. To elucidate the mechanisms involved in human LY6K gene regulation and expression, multiple cis-elements were predicted using TRANSFAC software, and the LY6K regulatory region was identified using the luciferase assay in the human LY6K gene promoter. We performed ChIP, EMSA, and supershift assays to investigate the transcription factor activity on the LY6K promoter, and the effect of a SNP and CpG site methylation on AP-1 transcription factor binding affinity. AP-1 and the CREB transcription factor bound to LY6K promoter within -550/-1, which was essential for LY6K expression, but only the AP-1 heterodimer, JunD, and Fra-1, modulates LY6K gene transcriptional level. A decrease in LY6K was associated with the SNP242 C allele, a polymorphic G/C-SNP at the 242 nucleotide in the LY6K promoter region (rs2585175), or methylation of the CpG site, which was closely located with the AP-1 site by interfering with binding of the AP-1 transcription factor to the LY6K promoter. Our findings reveal an important role for AP-1 activation in promoting LY6K gene expression that regulates cell mobility of breast cancer cells, whereas the SNP242 C allele or methylation of the CpG site may reduce the risk of invasion or metastasis by interfering AP-1 activation.	[Kong, Hyun Kyung; Yoon, Sukjoon; Park, Jong Hoon] Sookmyung Womens Univ, Dept Biol Sci, Seoul 140742, South Korea	Sookmyung Women's University	Park, JH (corresponding author), Sookmyung Womens Univ, Dept Biol Sci, Seoul 140742, South Korea.	parkjh@sookmyung.ac.kr			National Research Foundation of Korea [2011-0028816]; Korean government (Ministry of Education, Science and Technology) (Science Research Center program) [2011-0001382]; Bio & Medical Technology Development Program (Korea Genetically Engineered Mouse Center Program)	National Research Foundation of Korea(National Research Foundation of Korea); Korean government (Ministry of Education, Science and Technology) (Science Research Center program); Bio & Medical Technology Development Program (Korea Genetically Engineered Mouse Center Program)	This work was supported by the National Research Foundation of Korea grant funded by the Korean government (Ministry of Education, Science and Technology) (Science Research Center program, 2011-0001382), the Bio & Medical Technology Development Program (Korea Genetically Engineered Mouse Center Program), and the National Research Foundation of Korea 2011-0028816 (National Leading Research Lab program).	Adermann K, 1999, PROTEIN SCI, V8, P810, DOI 10.1110/ps.8.4.810; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; Boutant M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035810; BRAKENHOFF RH, 1995, J CELL BIOL, V129, P1677, DOI 10.1083/jcb.129.6.1677; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Choi SH, 2009, INT J ONCOL, V35, P601, DOI 10.3892/ijo_00000371; Dalen AGD, 2003, INT J CANCER, V103, P768, DOI 10.1002/ijc.10903; Dang J, 1999, EUR J BIOCHEM, V264, P92, DOI 10.1046/j.1432-1327.1999.00583.x; Del Rosso M, 2011, BLOOD, V117, P3941, DOI 10.1182/blood-2011-02-337733; Deng GR, 2001, ONCOGENE, V20, P7120, DOI 10.1038/sj.onc.1204891; Engle LJ, 2006, ONCOGENE, V25, P1594, DOI 10.1038/sj.onc.1209368; Horie M, 1998, GENOMICS, V53, P365, DOI 10.1006/geno.1998.5462; Ishikawa N, 2007, CANCER RES, V67, P11601, DOI 10.1158/0008-5472.CAN-07-3243; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Lee JW, 2006, ONCOL REP, V16, P1211; Lengyel E, 1996, J BIOL CHEM, V271, P23176, DOI 10.1074/jbc.271.38.23176; Lin F, 2000, CANCER RES, V60, P3271; Liu YM, 2002, ONCOGENE, V21, P7680, DOI 10.1038/sj.onc.1205883; Ludes-Meyers JH, 2001, ONCOGENE, V20, P2771, DOI 10.1038/sj.onc.1204377; Matsuda R, 2011, BRIT J CANCER, V104, P376, DOI 10.1038/sj.bjc.6605990; Mechta F, 1997, ONCOGENE, V14, P837, DOI 10.1038/sj.onc.1200900; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; Nayak MS, 2007, CANCER RES, V67, P5831, DOI 10.1158/0008-5472.CAN-06-4533; PALFREE RGE, 1991, IMMUNOL TODAY, V12, P170, DOI 10.1016/0167-5699(91)90086-9; PLOUG M, 1994, FEBS LETT, V349, P163, DOI 10.1016/0014-5793(94)00674-1; Pospelova TV, 1999, GENE EXPRESSION, V8, P19; RYSECK RP, 1991, ONCOGENE, V6, P533; Sawai H, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-8; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shen Q, 2008, ONCOGENE, V27, P366, DOI 10.1038/sj.onc.1210643; Smith LM, 1999, ONCOGENE, V18, P6063, DOI 10.1038/sj.onc.1202989; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Vogt PK, 2002, NAT REV CANCER, V2, P465, DOI 10.1038/nrc818; Zhang B, 2012, BIOMARKERS, V17, P372, DOI 10.3109/1354750X.2012.680609	36	23	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38889	38900		10.1074/jbc.M112.394270	http://dx.doi.org/10.1074/jbc.M112.394270			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22988241	hybrid, Green Published			2022-12-28	WOS:000310982800045
J	Matilla, MA; Stockmann, H; Leeper, FJ; Salmond, GPC				Matilla, Miguel A.; Stoeckmann, Henning; Leeper, Finian J.; Salmond, George P. C.			Bacterial Biosynthetic Gene Clusters Encoding the Anti-cancer Haterumalide Class of Molecules BIOGENESIS OF THE BROAD SPECTRUM ANTIFUNGAL AND ANTI-OOMYCETE COMPOUND, OOCYDIN A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBAPENEM ANTIBIOTIC PRODUCTION; POLYKETIDE SYNTHASE; PEPTIDE SYNTHETASE; SERRATIA-MARCESCENS; CRYSTAL-STRUCTURE; IN-VIVO; IDENTIFICATION; PRODIGIOSIN; PATHWAY; CLONING	Haterumalides are halogenated macrolides with strong antitumor properties, making them attractive targets for chemical synthesis. Unfortunately, current synthetic routes to these molecules are inefficient. The potent haterumalide, oocydin A, was previously identified from two plant-associated bacteria through its high bioactivity against plant pathogenic fungi and oomycetes. In this study, we describe oocydin A (ooc) biosynthetic gene clusters identified by genome sequencing, comparative genomics, and chemical analysis in four plant-associated enterobacteria of the Serratia and Dickeya genera. Disruption of the ooc gene cluster abolished oocydin A production and bioactivity against fungi and oomycetes. The ooc gene clusters span between 77 and 80 kb and encode five multimodular polyketide synthase (PKS) proteins, a hydroxymethylglutaryl-CoA synthase cassette and three flavin-dependent tailoring enzymes. The presence of two free-standing acyltransferase proteins classifies the oocydin A gene cluster within the growing family of trans-AT PKSs. The amino acid sequences and organization of the PKS domains are consistent with the chemical predictions and functional peculiarities associated with trans-acyltransferase PKS. Based on extensive in silico analysis of the gene cluster, we propose a biosynthetic model for the production of oocydin A and, by extension, for other members of the haterumalide family of halogenated macrolides exhibiting anti-cancer, antifungal, and other interesting biological properties.	[Matilla, Miguel A.; Salmond, George P. C.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Stoeckmann, Henning; Leeper, Finian J.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge; University of Cambridge	Salmond, GPC (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	gpcs2@cam.ac.uk	Matilla, Miguel A./G-8839-2015; Stockmann, Henning/A-1891-2012	Matilla, Miguel A./0000-0002-8468-9604; Leeper, Finian James/0000-0003-3408-5199; Stockmann, Henning/0000-0002-2409-5476	Spanish Government Postdoctoral Research [BVA-2009-0200]; Cancer Research UK [6934] Funding Source: researchfish	Spanish Government Postdoctoral Research; Cancer Research UK(Cancer Research UK)	Supported by a Spanish Government Postdoctoral Research Contract BVA-2009-0200.	Anderson JLR, 2006, MOL BIOSYST, V2, P350, DOI 10.1039/b607813c; Aparicio JF, 1996, GENE, V169, P9, DOI 10.1016/0378-1119(95)00800-4; BAINTON NJ, 1992, BIOCHEM J, V288, P997, DOI 10.1042/bj2880997; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berg G, 2002, APPL ENVIRON MICROB, V68, P3328, DOI 10.1128/AEM.68.7.3328-3338.2002; Bumpus SB, 2008, J AM CHEM SOC, V130, P11614, DOI 10.1021/ja8040042; Cadel-Six S, 2008, MOL BIOL EVOL, V25, P2031, DOI 10.1093/molbev/msn150; Chandler D, 2011, PHILOS T R SOC B, V366, P1987, DOI 10.1098/rstb.2010.0390; Chen XH, 2006, J BACTERIOL, V188, P4024, DOI 10.1128/JB.00052-06; Coulthurst SJ, 2006, MICROBIOL-SGM, V152, P1899, DOI 10.1099/mic.0.28803-0; Coulthurst SJ, 2004, MICROBIOL-SGM, V150, P1901, DOI 10.1099/mic.0.26946-0; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; Dennis JJ, 1998, APPL ENVIRON MICROB, V64, P2710; Dickschat JS, 2011, CHEMBIOCHEM, V12, P2408, DOI 10.1002/cbic.201100474; El-Sayed AK, 2003, CHEM BIOL, V10, P419, DOI 10.1016/S1074-5521(03)00091-7; Fineran PC, 2005, MICROBIOL-SGM, V151, P3833, DOI 10.1099/mic.0.28251-0; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Foulston LC, 2010, P NATL ACAD SCI USA, V107, P13461, DOI 10.1073/pnas.1008285107; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Fujimori DG, 2007, P NATL ACAD SCI USA, V104, P16498, DOI 10.1073/pnas.0708242104; Geders TW, 2007, J BIOL CHEM, V282, P35954, DOI 10.1074/jbc.M703921200; GRINTER NJ, 1983, GENE, V21, P133, DOI 10.1016/0378-1119(83)90155-5; Gu LC, 2006, J AM CHEM SOC, V128, P9014, DOI 10.1021/ja0626382; Gurney R, 2011, APPL MICROBIOL BIOT, V90, P11, DOI 10.1007/s00253-011-3128-3; Harris AKP, 2004, MICROBIOL-SGM, V150, P3547, DOI 10.1099/mic.0.27222-0; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Hokeberg M, 1997, EUR J PLANT PATHOL, V103, P25, DOI 10.1023/A:1008681608400; Hoye TR, 2005, J AM CHEM SOC, V127, P6950, DOI 10.1021/ja051749i; Irschik H, 2010, CHEMBIOCHEM, V11, P1840, DOI 10.1002/cbic.201000313; Jensen K, 2012, CHEM BIOL, V19, P329, DOI 10.1016/j.chembiol.2012.01.005; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Keatinge-Clay A, 2008, J MOL BIOL, V384, P941, DOI 10.1016/j.jmb.2008.09.084; Keatinge-Clay AT, 2003, STRUCTURE, V11, P147, DOI 10.1016/S0969-2126(03)00004-2; Kigoshi H, 2003, ORG LETT, V5, P957, DOI 10.1021/ol0341804; Konz D, 1999, CHEM BIOL, V6, pR39, DOI 10.1016/S1074-5521(99)80002-7; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; Lopanik NB, 2008, CHEM BIOL, V15, P1175, DOI 10.1016/j.chembiol.2008.09.013; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Marahiel MA, 1997, CHEM BIOL, V4, P561, DOI 10.1016/S1074-5521(97)90242-8; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Mattheus W, 2010, CHEM BIOL, V17, P149, DOI 10.1016/j.chembiol.2010.01.014; McGowan SJ, 1996, MOL MICROBIOL, V22, P415, DOI 10.1046/j.1365-2958.1996.00125.x; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Menche D, 2008, J AM CHEM SOC, V130, P14234, DOI 10.1021/ja804194c; Neumann CS, 2008, CHEM BIOL, V15, P99, DOI 10.1016/j.chembiol.2008.01.006; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Partida-Martinez LP, 2007, CHEMBIOCHEM, V8, P41, DOI 10.1002/cbic.200600393; Perlova O, 2006, J BIOTECHNOL, V121, P174, DOI 10.1016/j.jbiotec.2005.10.011; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Piel J, 2004, P NATL ACAD SCI USA, V101, P16222, DOI 10.1073/pnas.0405976101; Piel J, 2010, NAT PROD REP, V27, P996, DOI 10.1039/b816430b; Pistorius D, 2012, CHEMBIOCHEM, V13, P416, DOI 10.1002/cbic.201100575; Podzelinska K, 2010, J MOL BIOL, V397, P316, DOI 10.1016/j.jmb.2010.01.020; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Ramsay JP, 2011, P NATL ACAD SCI USA, V108, P14932, DOI 10.1073/pnas.1109169108; Reeves CD, 2008, APPL ENVIRON MICROB, V74, P5121, DOI 10.1128/AEM.00478-08; Reid R, 2003, BIOCHEMISTRY-US, V42, P72, DOI 10.1021/bi0268706; Roberts K.J., 2010, THESIS U CAMBRIDGE C; Sambrook J., 1989, MOL CLONING LAB MANU; Sato B, 2005, J ANTIBIOT, V58, P634, DOI 10.1038/ja.2005.87; Sattely ES, 2008, NAT PROD REP, V25, P757, DOI 10.1039/b801747f; Simunovic V, 2006, CHEMBIOCHEM, V7, P1206, DOI 10.1002/cbic.200600075; Slater H, 2003, MOL MICROBIOL, V47, P303, DOI 10.1046/j.1365-2958.2003.03295.x; Strobel G, 1999, MICROBIOL-UK, V145, P3557, DOI 10.1099/00221287-145-12-3557; Sudek S, 2007, J NAT PROD, V70, P67, DOI 10.1021/np060361d; Sun YH, 2008, CHEMBIOCHEM, V9, P150, DOI 10.1002/cbic.200700492; Takada N, 1999, TETRAHEDRON LETT, V40, P6309, DOI 10.1016/S0040-4039(99)01291-5; Tang GL, 2006, J NAT PROD, V69, P387, DOI 10.1021/np050467t; Teruya T, 2005, TETRAHEDRON, V61, P6561, DOI 10.1016/j.tet.2005.04.052; Teruya T, 2004, CHEM LETT, V33, P1184, DOI 10.1246/cl.2004.1184; Teta R, 2010, CHEMBIOCHEM, V11, P2506, DOI 10.1002/cbic.201000542; Thaning C, 2001, SOIL BIOL BIOCHEM, V33, P1817, DOI 10.1016/S0038-0717(01)00109-2; Ueda M, 2009, J ORG CHEM, V74, P3370, DOI 10.1021/jo802806z; Van Domselaar GH, 2005, NUCLEIC ACIDS RES, V33, pW455, DOI 10.1093/nar/gki593; Wagner C, 2009, J NAT PROD, V72, P540, DOI 10.1021/np800651m; Weber T, 2008, CHEM BIOL, V15, P175, DOI 10.1016/j.chembiol.2007.12.009; Williamson NR, 2005, MOL MICROBIOL, V56, P971, DOI 10.1111/j.1365-2958.2005.04602.x; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469; Xiao Y, 2011, J AM CHEM SOC, V133, P1092, DOI 10.1021/ja109445q; Yadav G, 2003, J MOL BIOL, V328, P335, DOI 10.1016/S0022-2836(03)00232-8; Zhao CH, 2010, J BIOL CHEM, V285, P20097, DOI 10.1074/jbc.M109.090092	84	56	57	2	38	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39125	39138		10.1074/jbc.M112.401026	http://dx.doi.org/10.1074/jbc.M112.401026			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23012376	hybrid, Green Published			2022-12-28	WOS:000310982800068
J	Gu, DS; Fan, QP; Zhang, XL; Xie, JW				Gu, Dongsheng; Fan, Qipeng; Zhang, Xiaoli; Xie, Jingwu			A Role for Transcription Factor STAT3 Signaling in Oncogene Smoothened-driven Carcinogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASAL-CELL CARCINOMAS; INTERLEUKIN-11 RECEPTOR; HEDGEHOG PATHWAY; SONIC HEDGEHOG; MOUSE MODEL; STEM-CELLS; EPITHELIAL CARCINOGENESIS; FAS EXPRESSION; HAIR FOLLICLE; HUMAN HOMOLOG	Activation of the Hedgehog (Hh) pathway is known to drive development of basal cell carcinoma and medulloblastomas and to associate with many other types of cancer, but the exact molecular mechanisms underlying the carcinogenesis process remain elusive. We discovered that skin tumors derived from epidermal expression of oncogenic Smo, SmoM2, have elevated levels of IL-11, IL-11R alpha, and STAT3 phosphorylation at Tyr(705). The relevance of our data to human conditions was reflected by the fact that all human basal cell carcinomas examined have detectable STAT3 phosphorylation, mostly in keratinocytes. The functional relevance of STAT3 in Smo-mediated carcinogenesis was revealed by epidermal specific knockout of STAT3. We showed that removal of STAT3 from mouse epidermis dramatically reduced SmoM2-mediated cell proliferation, leading to a significant decrease in epidermal thickness and tumor development. We also observed a significant reduction of epidermal stem/progenitor cell population and cyclin D1 expression in mice with epidermis-specific knockout of STAT3. Our evidence indicates that STAT3 signaling activation may be mediated by the IL-11/IL-11R alpha signaling axis. We showed that tumor development was reduced after induced expression of SmoM2 in IL-11R alpha null mice. Similarly, neutralizing antibodies for IL-11 reduced the tumor size. In two Hh-responsive cell lines, ES14 and C3H10T1/2, we found that addition of Smo agonist purmorphamine is sufficient to induce STAT3 phosphorylation at Tyr705, but this effect was abolished after IL-11R alpha down-regulation by shRNAs. Taken together, our results support an important role of the IL-11R alpha/STAT3 signaling axis for Hh signaling-mediated signaling and carcinogenesis.	Indiana Univ Sch Med, Simon Canc Ctr, Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46074 USA; Indiana Univ Sch Med, Simon Canc Ctr, Wells Ctr Pediat Res, Dept Biochem Mol Biol, Indianapolis, IN 46074 USA; Indiana Univ Sch Med, Simon Canc Ctr, Wells Ctr Pediat Res, Dept Pharmacol Toxicol, Indianapolis, IN 46074 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Xie, JW (corresponding author), Well Ctr Pediat Res, 1044 W Walnut St, Indianapolis, IN 46202 USA.	jinxie@iupui.edu			National Cancer Institute [R01CA155086, R01CA94160]; Wells Center for Pediatric Research; Indiana University Simon Cancer Center; NATIONAL CANCER INSTITUTE [R01CA155086, R01CA094160] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wells Center for Pediatric Research; Indiana University Simon Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute Grants R01CA155086 and R01CA94160, by the Wells Center for Pediatric Research, and by the Indiana University Simon Cancer Center.	Aszterbaum M, 1999, NAT MED, V5, P1285, DOI 10.1038/15242; Athar M, 2004, CANCER RES, V64, P7545, DOI 10.1158/0008-5472.CAN-04-1393; Bigelow RLH, 2004, J BIOL CHEM, V279, P1197, DOI 10.1074/jbc.M310589200; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Campbell CL, 2001, AM J PATHOL, V158, P25, DOI 10.1016/S0002-9440(10)63940-5; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Chan KS, 2004, CANCER RES, V64, P2382, DOI 10.1158/0008-5472.CAN-03-3197; Chi SM, 2012, CELL SIGNAL, V24, P1222, DOI 10.1016/j.cellsig.2012.02.004; Diermeier-Daucher S, 2009, CYTOM PART A, V75A, P535, DOI 10.1002/cyto.a.20712; Dijkgraaf GJP, 2011, CANCER RES, V71, P435, DOI 10.1158/0008-5472.CAN-10-2876; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Ernst M, 2008, J CLIN INVEST, V118, P1727, DOI 10.1172/JCI34944; Fan QP, 2010, J BIOL CHEM, V285, P36570, DOI 10.1074/jbc.C110.164442; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gao J, 2009, CELL STEM CELL, V4, P548, DOI 10.1016/j.stem.2009.03.015; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Grachtchouk M, 2011, J CLIN INVEST, V121, P1768, DOI 10.1172/JCI46307; Grad JM, 2000, CURR OPIN ONCOL, V12, P543, DOI 10.1097/00001622-200011000-00006; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hahn H, 1996, J BIOL CHEM, V271, P12125, DOI 10.1074/jbc.271.21.12125; Hahn H, 1998, NAT MED, V4, P619, DOI 10.1038/nm0598-619; Hatanaka H, 2010, CANCER SCI, V101, P60, DOI 10.1111/j.1349-7006.2009.01355.x; He J, 2006, J BIOL CHEM, V281, P35598, DOI 10.1074/jbc.C600200200; Hofmann I, 2009, CELL STEM CELL, V4, P559, DOI 10.1016/j.stem.2009.03.016; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kano A, 2003, J EXP MED, V198, P1517, DOI 10.1084/jem.20030077; Kiang JG, 1998, PHARMACOL THERAPEUT, V80, P183, DOI 10.1016/S0163-7258(98)00028-X; Kim DJ, 2007, MOL CARCINOGEN, V46, P725, DOI 10.1002/mc.20342; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Lewis VO, 2009, CANCER RES, V69, P1995, DOI 10.1158/0008-5472.CAN-08-4845; Li CX, 2004, ONCOGENE, V23, P1608, DOI 10.1038/sj.onc.1207273; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Metcalfe C, 2011, CANCER RES, V71, P5057, DOI 10.1158/0008-5472.CAN-11-0923; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Nakayama T, 2007, INT J ONCOL, V30, P825; Nandurkar HH, 1997, BLOOD, V90, P2148; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; Park HL, 2000, DEVELOPMENT, V127, P1593; Parkin CA, 2008, AM J PHYSIOL-GASTR L, V294, pG363, DOI 10.1152/ajpgi.00457.2007; Putoczki T, 2010, J LEUKOCYTE BIOL, V88, P1109, DOI 10.1189/jlb.0410226; Regl G, 2004, CANCER RES, V64, P7724, DOI 10.1158/0008-5472.CAN-04-1085; Reifenberger J, 2005, BRIT J DERMATOL, V152, P43, DOI 10.1111/J.1365-2133.2005.06353.X; Reifenberger J, 1998, CANCER RES, V58, P1798; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Sinibaldi D, 2000, ONCOGENE, V19, P5419, DOI 10.1038/sj.onc.1203947; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wang GY, 2011, CANCER CELL, V19, P114, DOI 10.1016/j.ccr.2010.11.007; Xie JW, 2001, P NATL ACAD SCI USA, V98, P9255, DOI 10.1073/pnas.151173398; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yang L, 2010, ONCOGENE, V29, P469, DOI 10.1038/onc.2009.392; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zurita AJ, 2004, CANCER RES, V64, P435, DOI 10.1158/0008-5472.CAN-03-2675	59	25	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.377382	http://dx.doi.org/10.1074/jbc.M112.377382			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22992748	hybrid, Green Published			2022-12-28	WOS:000310642200068
J	Fujimori, H; Shikanai, M; Teraoka, H; Masutani, M; Yoshioka, K				Fujimori, Hiroaki; Shikanai, Mima; Teraoka, Hirobumi; Masutani, Mitsuko; Yoshioka, Ken-ichi			Induction of Cancerous Stem Cells during Embryonic Stem Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; STEM/PROGENITOR CELLS; CHECKPOINT; SENESCENCE; TUMORIGENICITY; TRANSFORMATION; PROLIFERATION; INSTABILITY; FIBROBLASTS; SENSITIVITY	Stem cell maintenance depends on their surrounding microenvironment, and aberrancies in the environment have been associated with tumorigenesis. However, it remains to be elucidated whether an environmental aberrancy can act as a carcinogenic stress for cellular transformation of differentiating stem cells into cancer stem cells. Here, utilizing mouse embryonic stem cells as a model, it was illustrated that environmental aberrancy during differentiation leads to the emergence of pluripotent cells showing cancerous characteristics. Analogous to precancerous stages, DNA lesions were spontaneously accumulated during embryonic stem cell differentiation under aberrational environments, which activates barrier responses such as senescence and apoptosis. However, overwhelming such barrier responses, piled-up spheres were subsequently induced from the previously senescent cells. The sphere cells exhibit aneuploidy and dysfunction of the Arf-p53 module as well as enhanced tumorigenicity and a strong self-renewal capacity, suggesting development of cancerous stem cells. Our current study suggests that stem cells differentiating in an aberrational environment are at risk of cellular transformation into malignant counterparts.	[Fujimori, Hiroaki; Masutani, Mitsuko; Yoshioka, Ken-ichi] Natl Canc Ctr, Div Genome Stabil Res, Chuo Ku, Tokyo 1040045, Japan; [Fujimori, Hiroaki; Shikanai, Mima; Teraoka, Hirobumi; Yoshioka, Ken-ichi] Tokyo Med & Dent Univ, Med Res Inst, Dept Pathol Biochem, Chiyoda Ku, Tokyo 1010062, Japan	National Cancer Center - Japan; Tokyo Medical & Dental University (TMDU)	Yoshioka, K (corresponding author), Natl Canc Ctr, Div Genome Stabil Res, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	kyoshiok@ncc.go.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan KAKENHI [20770136, 20659047]; Third Term Comprehensive 10-Year Strategy for Cancer Control [10103833]; National Cancer Center Research and Development Fund [23-C-10]	Ministry of Education, Culture, Sports, Science, and Technology of Japan KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Third Term Comprehensive 10-Year Strategy for Cancer Control(Ministry of Health, Labour and Welfare, Japan); National Cancer Center Research and Development Fund(National Cancer Center - Japan)	This work was supported, in whole or in part, by Ministry of Education, Culture, Sports, Science, and Technology of Japan KAKENHI (20770136, 20659047), Grant-in-aid and the Third Term Comprehensive 10-Year Strategy for Cancer Control (10103833), and the National Cancer Center Research and Development Fund (23-C-10).	Atsumi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023432; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bunting KD, 2002, STEM CELLS, V20, P11, DOI 10.1002/stem.200011; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chiba T, 2007, GASTROENTEROLOGY, V133, P937, DOI 10.1053/j.gastro.2007.06.016; Deckbar D, 2007, J CELL BIOL, V176, P749, DOI 10.1083/jcb.200612047; Dontu G, 2004, TRENDS ENDOCRIN MET, V15, P193, DOI 10.1016/j.tem.2004.05.011; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Ferrandina G, 2009, EXPERT OPIN THER TAR, V13, P823, DOI 10.1517/14728220903005616; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Fujimori H, 2008, J HEPATOL, V48, P962, DOI 10.1016/j.jhep.2008.01.031; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guachalla LM, 2010, CELL CYCLE, V9, P4058, DOI 10.4161/cc.9.20.13577; Ichijima Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008821; Jain AK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001268; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; KIM JH, 1978, SCIENCE, V200, P206, DOI 10.1126/science.635582; Knoepfler PS, 2009, STEM CELLS, V27, P1050, DOI 10.1002/stem.37; Kondoh H, 2005, CANCER RES, V65, P177; Leahy A, 1999, J EXP ZOOL, V284, P67, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;67::AID-JEZ10&gt;3.0.CO;2-O; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Liu YQ, 2009, CELL STEM CELL, V4, P336, DOI 10.1016/j.stem.2009.02.015; Marusyk A, 2007, MOL CELL BIOL, V27, P5336, DOI 10.1128/MCB.01316-06; Masaki H, 2007, J BIOL CHEM, V282, P33034, DOI 10.1074/jbc.M703245200; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Mitsiades CS, 2004, CURR CANCER DRUG TAR, V4, P235, DOI 10.2174/1568009043333032; Morange M, 2006, J BIOSCIENCES, V31, P537, DOI 10.1007/BF02708404; Nitou M, 2002, EXP CELL RES, V279, P330, DOI 10.1006/excr.2002.5615; Oh SKW, 2006, CLIN EXP PHARMACOL P, V33, P489, DOI 10.1111/j.1440-1681.2006.04397.x; Oh SJ, 2012, ENDOCR-RELAT CANCER, V19, P305, DOI 10.1530/ERC-11-0298; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Seaberg RM, 2003, TRENDS NEUROSCI, V26, P125, DOI 10.1016/S0166-2236(03)00031-6; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Smith JA, 2012, AGING DIS, V3, P260; Spierings DCJ, 2003, J PATHOL, V200, P137, DOI 10.1002/path.1373; Sun Hong, 2007, V383, P303, DOI 10.1007/978-1-59745-335-6_19; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Werbowetski-Ogilvie TE, 2008, TRENDS MOL MED, V14, P323, DOI 10.1016/j.molmed.2008.06.005; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; WILES MV, 1991, DEVELOPMENT, V111, P259; Woo RA, 2004, GENE DEV, V18, P1317, DOI 10.1101/gad.1165204; Wylie C, 1999, CELL, V96, P165, DOI 10.1016/S0092-8674(00)80557-7; Yang YM, 2008, CANCER INVEST, V26, P741, DOI 10.1080/07357900801901856; Yoshioka K, 2012, INT J MOL SCI, V13, P6492, DOI 10.3390/ijms13056492; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958	49	28	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36777	36791		10.1074/jbc.M112.372557	http://dx.doi.org/10.1074/jbc.M112.372557			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22961983	hybrid, Green Published			2022-12-28	WOS:000310588500015
J	Lee, BK; Iyer, VR				Lee, Bum-Kyu; Iyer, Vishwanath R.			Genome-wide Studies of CCCTC-binding Factor (CTCF) and Cohesin Provide Insight into Chromatin Structure and Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RNA-POLYMERASE-II; DE-LANGE-SYNDROME; PROTEIN CTCF; INSULATOR PROTEIN; C-MYC; NUCLEAR-ORGANIZATION; TRANSCRIPTION FACTOR; ENHANCER BLOCKING; DNA METHYLATION; CONTROL REGION	Eukaryotic genomes are organized into higher order chromatin architectures by protein-mediated long-range interactions in the nucleus. CCCTC-binding factor (CTCF), a sequence-specific transcription factor, serves as a chromatin organizer in building this complex chromatin structure by linking chromosomal domains. Recent genome-wide studies mapping the binding sites of CTCF and its interacting partner, cohesin, using chromatin immunoprecipitation coupled with deep sequencing (ChIP-seq) revealded that CTCF globally co-localizes with cohesin. This partnership between CTCF and cohesin is emerging as a novel and perhaps pivotal aspect of gene regulatory mechanisms, in addition to playing a role in the organization of higher order chromatin architecture.	[Lee, Bum-Kyu; Iyer, Vishwanath R.] Univ Texas Austin, Ctr Syst & Synthet Biol, Inst Cellular & Mol Biol, Sect Mol Genet & Microbiol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Iyer, VR (corresponding author), Univ Texas Austin, Ctr Syst & Synthet Biol, Inst Cellular & Mol Biol, Sect Mol Genet & Microbiol, Austin, TX 78712 USA.	vishy.iyer@gmail.com		Lee, Bum Kyu/0000-0001-7835-419X	National Institutes of Health [CA130075, CA095548, HG004563]; Cancer Prevention and Research Institute of Texas [RP120194]; NATIONAL CANCER INSTITUTE [R01CA095548, R01CA130075] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA130075, CA095548, and HG004563. This work was also supported by Cancer Prevention and Research Institute of Texas Grant RP120194. This is the third article in the Thematic Minireview Series on Results from the ENCODE Project: Integrative Global Analyses of Regulatory Regions in the Human Genome.	Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Botta M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.79; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chernukhin I, 2007, MOL CELL BIOL, V27, P1631, DOI 10.1128/MCB.01993-06; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; de Almeida CR, 2009, J IMMUNOL, V182, P999, DOI 10.4049/jimmunol.182.2.999; Degner SC, 2011, P NATL ACAD SCI USA, V108, P9566, DOI 10.1073/pnas.1019391108; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dorsett D, 2011, CURR OPIN GENET DEV, V21, P199, DOI 10.1016/j.gde.2011.01.018; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Dunn KL, 2003, EXP CELL RES, V288, P218, DOI 10.1016/S0014-4827(03)00185-X; El-Kady A, 2005, FEBS LETT, V579, P1424, DOI 10.1016/j.febslet.2005.01.044; Fay A, 2011, CURR BIOL, V21, P1624, DOI 10.1016/j.cub.2011.08.036; Filippova GN, 2002, CANCER RES, V62, P48; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gause M, 2008, BIOESSAYS, V30, P715, DOI 10.1002/bies.20787; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Guerrero PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016401; Guo CY, 2011, CELL, V147, P332, DOI 10.1016/j.cell.2011.08.049; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kanduri M, 2002, MOL CELL BIOL, V22, P3339, DOI 10.1128/MCB.22.10.3339-3344.2002; Kawauchi S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000650; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kim YJ, 2011, P NATL ACAD SCI USA, V108, P7391, DOI 10.1073/pnas.1018279108; Kitchen NS, 2010, J CELL BIOCHEM, V111, P665, DOI 10.1002/jcb.22751; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Klenova EM, 2001, MOL CELL BIOL, V21, P2221, DOI 10.1128/MCB.21.6.2221-2234.2001; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Lee BK, 2012, GENOME RES, V22, P9, DOI 10.1101/gr.127597.111; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Liu JL, 2008, ANNU REV GENOM HUM G, V9, P303, DOI 10.1146/annurev.genom.9.081307.164211; Liu JL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000119; Liu Z, 2011, CELL, V146, P720, DOI 10.1016/j.cell.2011.08.005; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; Lutz M, 2000, BIOCHEM SOC T, V28, P386, DOI 10.1042/0300-5127:0280386; MacPherson MJ, 2009, MOL CELL BIOL, V29, P714, DOI 10.1128/MCB.00825-08; Mishiro T, 2009, EMBO J, V28, P1234, DOI 10.1038/emboj.2009.81; Mukhopadhyay R, 2004, GENOME RES, V14, P1594, DOI 10.1101/gr.2408304; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Nitzsche A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019470; Ohlsson R, 2010, BIOESSAYS, V32, P37, DOI 10.1002/bies.200900118; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Qi CF, 2003, P NATL ACAD SCI USA, V100, P633, DOI 10.1073/pnas.0237127100; Rhodes JM, 2010, DEV BIOL, V344, P637, DOI 10.1016/j.ydbio.2010.05.493; RISTIMAKI A, 1991, J CLIN ENDOCR METAB, V72, P623, DOI 10.1210/jcem-72-3-623; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Schaaf CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006202; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Szabo PE, 2000, CURR BIOL, V10, P607, DOI 10.1016/S0960-9822(00)00489-9; Torrano V, 2005, J BIOL CHEM, V280, P28152, DOI 10.1074/jbc.M501481200; Vostrov AA, 1997, J BIOL CHEM, V272, P33353, DOI 10.1074/jbc.272.52.33353; Wada Y, 2009, P NATL ACAD SCI USA, V106, P18357, DOI 10.1073/pnas.0902573106; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wood AJ, 2010, NAT REV GENET, V11, P391, DOI 10.1038/nrg2794; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Yeh E, 2008, CURR BIOL, V18, P81, DOI 10.1016/j.cub.2007.12.019; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhao H, 2006, J BIOL CHEM, V281, P30573, DOI 10.1074/jbc.M606803200; Zlatanova J, 2009, J CELL SCI, V122, P1275, DOI 10.1242/jcs.039990	92	76	77	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					30906	30913		10.1074/jbc.R111.324962	http://dx.doi.org/10.1074/jbc.R111.324962			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22952237	hybrid, Green Published			2022-12-28	WOS:000308791300004
J	Takao, T; Asanoma, K; Tsunematsu, R; Kato, K; Wake, N				Takao, Tomoka; Asanoma, Kazuo; Tsunematsu, Ryosuke; Kato, Kiyoko; Wake, Norio			The Maternally Expressed Gene Tssc3 Regulates the Expression of MASH2 Transcription Factor in Mouse Trophoblast Stem Cells through the AKT-Sp1 Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION; RAT; GROWTH; BINDING; PROTEIN; LACKING; TDAG51; MICE; SP1; IPL	Tssc3 is a maternally expressed/paternally silenced imprinted gene. Recent evidence suggests that the loss of TSSC3 results in placental overgrowth in mice. These findings showed that the TSSC3 gene functions as a negative regulator of placental growth. In this study, we describe the function of TSSC3 and its signaling pathway in mouse trophoblast stem (TS) cell differentiation. First of all, we tested Tssc3 expression levels in TS cells. TS cells expressed Tssc3, and its expression level was the highest from day 1 to 4 but was down-regulated at day 5 after the induction of differentiation. Overexpression of TSSC3 in TS cells up-regulated Gcm1 and Mash2, which are marker genes of mouse trophoblast differentiation. Down-regulation of TSSC3 by siRNA enhanced Pl1 and Tpbpa expression in TS cells cultured under stem cell conditions, suggesting the contribution of TSSC3 to the differentiation from TS to trophoblast progenitors and/or labyrinth trophoblasts. TSSC3 activated the PI3K/AKT pathway through binding with phosphatidylinositol phosphate lipids and enhanced the activity of a promoter containing an E-box structure, which is the binding sequence of the Mash2 downstream target gene promoter. PI3K inhibitor suppressed the promoter activity induced by TSSC3. TSSC3 induced Sp1 translocation from cytoplasm to nucleus through the PI3K/AKT pathway. Nuclear Sp1 activated the Mash2 transcription by Sp1 binding with a consensus Sp1-binding motif. This is the first report describing that TSSC3 plays an important role in the differentiation from TS to trophoblast progenitors and/or labyrinth trophoblasts through the TSSC3/PI3K/AKT/MASH2 signaling pathway.	[Takao, Tomoka; Wake, Norio] Kyushu Univ, Res Ctr Environm & Dev Med Sci, Higashi Ku, Fukuoka 8128582, Japan; [Asanoma, Kazuo; Tsunematsu, Ryosuke; Kato, Kiyoko] Kyushu Univ, Dept Obstet & Gynecol, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University; Kyushu University	Takao, T (corresponding author), Kyushu Univ, Res Ctr Environm & Dev Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ttakao@gynob.med.kyushu-u.ac.jp	Takao, Tomoka/K-1568-2015	Takao, Tomoka/0000-0002-6519-2301	Ministry of Education, Culture, Sports, Science, and Technology, Japan [23249075, 23592405]; Grants-in-Aid for Scientific Research [23592405] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid 23249075 and 23592405 from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Ain R, 2003, DEV BIOL, V260, P176, DOI 10.1016/S0012-1606(03)00210-0; Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; Caspary T, 1999, GENE DEV, V13, P3115, DOI 10.1101/gad.13.23.3115; Cross JC, 2002, RECENT PROG HORM RES, V57, P221, DOI 10.1210/rp.57.1.221; CROSS JC, 1995, DEVELOPMENT, V121, P2513; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; FARIA TN, 1991, ENDOCRINOLOGY, V129, P2895, DOI 10.1210/endo-129-6-2895; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; Frank D, 2002, P NATL ACAD SCI USA, V99, P7490, DOI 10.1073/pnas.122039999; Frank D, 1999, MAMM GENOME, V10, P1150, DOI 10.1007/s003359901182; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; Iwatsuki K, 2000, BIOL REPROD, V62, P1352, DOI 10.1095/biolreprod62.5.1352; JOHNSON JE, 1992, P NATL ACAD SCI USA, V89, P3596, DOI 10.1073/pnas.89.8.3596; Johnson W, 1999, MOL ENDOCRINOL, V13, P1963, DOI 10.1210/me.13.11.1963; Kamei T, 2002, MOL ENDOCRINOL, V16, P1469, DOI 10.1210/me.16.7.1469; Kato H, 2005, DIAGN MOL PATHOL, V14, P164, DOI 10.1097/01.pas.0000162757.91649.a3; Kuckenberg P, 2010, MOL CELL BIOL, V30, P3310, DOI 10.1128/MCB.01215-09; Lee MP, 1998, CANCER RES, V58, P1052; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo JM, 1997, NATURE, V388, P778, DOI 10.1038/42022; Maher ER, 2000, J CLIN INVEST, V105, P247, DOI 10.1172/JCI9340; Mireuta M, 2010, GROWTH FACTORS, V28, P243, DOI 10.3109/08977191003745472; Natale DRC, 2009, DEV BIOL, V335, P120, DOI 10.1016/j.ydbio.2009.08.022; Oh-McGinnis R, 2011, DEV BIOL, V351, P277, DOI 10.1016/j.ydbio.2011.01.008; Okamoto Y, 2001, BIOCHEM BIOPH RES CO, V288, P940, DOI 10.1006/bbrc.2001.5860; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Qian N, 1997, HUM MOL GENET, V6, P2021, DOI 10.1093/hmg/6.12.2021; Riley P, 1998, NAT GENET, V18, P271, DOI 10.1038/ng0398-271; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Salas M, 2004, MECH DEVELOP, V121, P1199, DOI 10.1016/j.mod.2004.05.017; Saxena A, 2002, J BIOL CHEM, V277, P49935, DOI 10.1074/jbc.M206497200; Scott IC, 2000, MOL CELL BIOL, V20, P530, DOI 10.1128/MCB.20.2.530-541.2000; Stecca B, 2002, MECH DEVELOP, V115, P27, DOI 10.1016/S0925-4773(02)00095-3; Takao T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021990; Tanaka M, 1997, DEV BIOL, V190, P55, DOI 10.1006/dbio.1997.8685; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tremblay GB, 2001, GENE DEV, V15, P833, DOI 10.1101/gad.873401; Udelhoven M, 2010, J MOL ENDOCRINOL, V44, P99, DOI 10.1677/JME-08-0182; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	42	30	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42685	42694		10.1074/jbc.M112.388777	http://dx.doi.org/10.1074/jbc.M112.388777			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23071113	Green Published, hybrid			2022-12-28	WOS:000312501600029
J	Bush, KT; Crawford, BE; Garner, OB; Nigam, KB; Esko, JD; Nigam, SK				Bush, Kevin T.; Crawford, Brett E.; Garner, Omai B.; Nigam, Kabir B.; Esko, Jeffrey D.; Nigam, Sanjay K.			N-Sulfation of Heparan Sulfate Regulates Early Branching Events in the Developing Mammary Gland	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URETERAL BUD; NEONATAL LETHALITY; MICE DEFICIENT; BASAL LAMINA; MAST-CELLS; GENE; MORPHOGENESIS; KIDNEY; GLYCOSAMINOGLYCANS; DEFECTS	Branching morphogenesis, a fundamental process in the development of epithelial organs (e.g. breast, kidney, lung, salivary gland, prostate, pancreas), is in part dependent on sulfation of heparan sulfate proteoglycans. Proper sulfation is mediated by biosynthetic enzymes, including exostosin-2 (Ext2), N-deacetylase/N-sulfotransferases and heparan sulfate O-sulfotransferases. Recent conditional knockouts indicate that whereas primary branching is dependent on heparan sulfate, other stages are dependent upon selective addition of N-sulfate and/or 2-O sulfation (Crawford, B. E., Garner, O. B., Bishop, J. R., Zhang, D. Y., Bush, K. T., Nigam, S. K., and Esko, J. D. (2010) PLoS One 5, e10691; Garner, O. B., Bush, K. T., Nigam, S. K., Yamaguchi, Y., Xu, D., Esko, J. D., and Nigam, S. K. (2011) Dev. Biol. 355, 394-403). Here, we analyzed the effect of deleting both Ndst2 and Ndst1. Whereas deletion of Ndst1 has no major effect on primary or secondary branching, deletion of Ndst2 appears to result in a mild increase in branching. When both genes were deleted, ductal growth was variably diminished (likely due to variable Cre-recombinase activity), but an overabundance of branched structures was evident irrespective of the extent of gland growth or postnatal age. "Hyperbranching" is an unusual phenotype. The effects on N-sulfation and growth factor binding were confirmed biochemically. The results indicate that N-sulfation or a factor requiring N-sulfation regulates primary and secondary branching events in the developing mammary gland. Together with previous work, the data indicate that different stages of ductal branching and lobuloalveolar formation are regulated by distinct sets of heparan sulfate biosynthetic enzymes in an appropriate growth factor context.	[Crawford, Brett E.; Garner, Omai B.; Nigam, Kabir B.; Esko, Jeffrey D.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Bush, Kevin T.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Crawford, Brett E.; Garner, Omai B.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Esko, Jeffrey D.] Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Nigam, Sanjay K.] Univ Calif San Diego, Div Nephrol & Hypertens, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Esko, JD (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jesko@ucsd.edu; snigam@ucsd.edu			National Institutes of Health [GM33063, HL57345, DK57286, DK65831, DK79784]; National Research Service Award Grant [AI058916]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI058916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065831, R01DK057286, R01DK079784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033063, R37GM033063] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM33063 and HL57345 (to J. D. E.) and DK57286, DK65831, and DK79784 (to S. K. N.).; Supported by National Research Service Award Grant AI058916.	BAME KJ, 1989, J BIOL CHEM, V264, P8059; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Crawford BE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010691; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Garner OB, 2011, DEV BIOL, V355, P394, DOI 10.1016/j.ydbio.2011.04.035; GORDON JR, 1980, DEV BIOL, V74, P118, DOI 10.1016/0012-1606(80)90056-1; Grobe K, 2005, DEVELOPMENT, V132, P3777, DOI 10.1242/dev.01935; Habuchi H, 2007, J BIOL CHEM, V282, P15578, DOI 10.1074/jbc.M607434200; HajMohammadi S, 2003, J CLIN INVEST, V111, P989, DOI 10.1172/JCI200315809; Hasegawa H, 2008, J COMP NEUROL, V511, P543, DOI 10.1002/cne.21862; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; IMAGAWA W, 1990, ENDOCR REV, V11, P494, DOI 10.1210/edrv-11-4-494; Ip MM, 2000, J MAMMARY GLAND BIOL, V5, P117, DOI 10.1023/A:1026435103940; Izvolsky KI, 2008, GENESIS, V46, P8, DOI 10.1002/dvg.20355; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; LI M, 2000, METHODS MAMMARY GLAN, P233; Nigam SK, 2009, J AM SOC NEPHROL, V20, P1465, DOI 10.1681/ASN.2008020132; Pullan S, 1996, J CELL SCI, V109, P631; Ringvall M, 2000, J BIOL CHEM, V275, P25926, DOI 10.1074/jbc.C000359200; Sampogna RV, 2004, PHYSIOLOGY, V19, P339, DOI 10.1152/physiol.00025.2004; Schuksz M, 2008, P NATL ACAD SCI USA, V105, P13075, DOI 10.1073/pnas.0805862105; Shah MM, 2011, DEV BIOL, V356, P19, DOI 10.1016/j.ydbio.2011.05.004; Shah MM, 2010, DEV BIOL, V339, P354, DOI 10.1016/j.ydbio.2009.12.033; Shah MM, 2009, AM J PHYSIOL-RENAL, V297, pF1330, DOI 10.1152/ajprenal.00125.2009; Shah MM, 2004, DEVELOPMENT, V131, P1449, DOI 10.1242/dev.01089; SILBERSTEIN GB, 1982, DEV BIOL, V90, P215, DOI 10.1016/0012-1606(82)90228-7; Steer DL, 2004, DEV BIOL, V272, P310, DOI 10.1016/j.ydbio.2004.04.029; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Sternlicht MD, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1368; Sunil N, 2000, ACTA PHYSIOL SCAND, V168, P385, DOI 10.1046/j.1365-201x.2000.00675.x; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007	33	13	13	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42064	42070		10.1074/jbc.M112.423327	http://dx.doi.org/10.1074/jbc.M112.423327			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23060443	Green Published, hybrid			2022-12-28	WOS:000312103000045
J	Diniz, LP; Almeida, JC; Tortelli, V; Lopes, CV; Setti-Perdigao, P; Stipursky, J; Kahn, SA; Romao, LF; de Miranda, J; Alves-Leon, SV; de Souza, JM; Castro, NG; Panizzutti, R; Gomes, FCA				Diniz, Luan Pereira; Almeida, Juliana Carvalho; Tortelli, Vanessa; Lopes, Charles Vargas; Setti-Perdigao, Pedro; Stipursky, Joice; Kahn, Suzana Assad; Romao, Luciana Ferreira; de Miranda, Joari; Alves-Leon, Soniza Vieira; de Souza, Jorge Marcondes; Castro, Newton G.; Panizzutti, Rogerio; Alcantara Gomes, Flavia Carvalho			Astrocyte-induced Synaptogenesis Is Mediated by Transforming Growth Factor beta Signaling through Modulation of D-Serine Levels in Cerebral Cortex Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; NMDA RECEPTOR-ACTIVITY; GFAP GENE PROMOTER; TGF-BETA; NEUROMUSCULAR-JUNCTION; CULTURED ASTROCYTES; CNS SYNAPTOGENESIS; SECRETED PROTEINS; SYNAPTIC ACTIVITY; NERVOUS-SYSTEM	Assembly of synapses requires proper coordination between pre- and postsynaptic elements. Identification of cellular and molecular events in synapse formation and maintenance is a key step to understand human perception, learning, memory, and cognition. A key role for astrocytes in synapse formation and function has been proposed. Here, we show that transforming growth factor beta (TGF-beta) signaling is a novel synaptogenic pathway for cortical neurons induced by murine and human astrocytes. By combining gain and loss of function approaches, we show that TGF-beta 1 induces the formation of functional synapses in mice. Further, TGF-beta 1-induced synaptogenesis involves neuronal activity and secretion of the co-agonist of the NMDA receptor, D-serine. Manipulation of D-serine signaling, by either genetic or pharmacological inhibition, prevented the TGF-beta 1 synaptogenic effect. Our data show a novel molecular mechanism that might impact synaptic function and emphasize the evolutionary aspect of the synaptogenic property of astrocytes, thus shedding light on new potential therapeutic targets for synaptic deficit diseases.	[Diniz, Luan Pereira; Almeida, Juliana Carvalho; Tortelli, Vanessa; Lopes, Charles Vargas; Setti-Perdigao, Pedro; Stipursky, Joice; Kahn, Suzana Assad; Romao, Luciana Ferreira; de Miranda, Joari; Castro, Newton G.; Panizzutti, Rogerio; Alcantara Gomes, Flavia Carvalho] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941590 Rio De Janeiro, RJ, Brazil; [Alves-Leon, Soniza Vieira; de Souza, Jorge Marcondes] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, BR-21941590 Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Gomes, FCA (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21949590 Rio De Janeiro, RJ, Brazil.	fgomes@icb.ufrj.br	Castro, Newton/AGX-7014-2022; Castro, Newton G/C-3263-2009; Setti-Perdigão, Pedro/I-8191-2012; Romao, Luciana/I-4291-2015; Neurociencia, Inct/I-1011-2013; Stipursky, Joice/Y-1961-2019; Gomes, Flavia/AAX-6354-2021; Leon, Soniza V Alves/J-7786-2012; Gomes, Flavia/C-5383-2013	Castro, Newton/0000-0001-9570-7428; Castro, Newton G/0000-0001-9570-7428; Setti-Perdigão, Pedro/0000-0002-2105-1451; Gomes, Flavia/0000-0003-2966-0638	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Institute of Glia (iGLIA/CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Institute of Glia (iGLIA/CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Institute of Glia (iGLIA/CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ).	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Ashwood P, 2008, J NEUROIMMUNOL, V204, P149, DOI 10.1016/j.jneuroim.2008.07.006; Bado P, 2011, PSYCHOPHARMACOLOGY, V218, P461, DOI 10.1007/s00213-011-2330-4; Bae J.J., 2011, INT J PHYSL PATHOPHY, V3, P9; Barker AJ, 2010, NEUROSCIENTIST, V16, P40, DOI 10.1177/1073858409339215; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9; Chin J, 2002, J NEUROSCI, V22; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Chung WS, 2012, CURR OPIN NEUROBIOL, V22, P438, DOI 10.1016/j.conb.2011.10.003; De Sampaio E., 2002, EUR J NEUROSCI, V16, P2059, DOI [10.1046/j.1460-9568.2002.02283.x, DOI 10.1046/J.1460-9568.2002.02283.X]; DeGroot CJA, 1997, J NEUROSCI RES, V49, P342, DOI 10.1002/(SICI)1097-4547(19970801)49:3<342::AID-JNR9>3.0.CO;2-C; DeVito LM, 2011, GENES BRAIN BEHAV, V10, P210, DOI 10.1111/j.1601-183X.2010.00656.x; Elmariah SB, 2005, J NEUROSCI, V25, P3638, DOI 10.1523/JNEUROSCI.3980-04.2005; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Feng Z, 2008, J NEUROSCI, V28, P9599, DOI 10.1523/JNEUROSCI.2589-08.2008; Fester L, 2009, HIPPOCAMPUS, V19, P692, DOI 10.1002/hipo.20548; FLETCHER TL, 1994, J NEUROSCI, V14, P6695; Fong SW, 2010, P NATL ACAD SCI USA, V107, P13515, DOI 10.1073/pnas.1001695107; Fossat P, 2012, CEREB CORTEX, V22, P595, DOI 10.1093/cercor/bhr130; Fujii K, 2006, MOL PSYCHIATR, V11, P150, DOI 10.1038/sj.mp.4001776; Fukushima T, 2007, HIPPOCAMPUS, V17, P5, DOI 10.1002/hipo.20243; Garcia CM, 2004, DEV BRAIN RES, V152, P25, DOI 10.1016/j.devbrainres.2004.05.008; Garcia O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014200; Garrett AM, 2009, J NEUROSCI, V29, P11723, DOI 10.1523/JNEUROSCI.2818-09.2009; Gomes FCA, 1999, GLIA, V26, P97; Gomes FCA, 2005, INT J DEV NEUROSCI, V23, P413, DOI 10.1016/j.ijdevneu.2005.04.001; Goritz C, 2005, MOL CELL NEUROSCI, V29, P190, DOI 10.1016/j.mcn.2005.02.006; Graciarena M, 2010, BRAIN BEHAV IMMUN, V24, P1301, DOI 10.1016/j.bbi.2010.06.005; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Hama H, 2004, NEURON, V41, P405, DOI 10.1016/S0896-6273(04)00007-8; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Heupel K, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-25; Hughes EG, 2010, MOL CELL NEUROSCI, V43, P136, DOI 10.1016/j.mcn.2009.10.004; Ikeda H, 2010, J BIOL CHEM, V285, P38415, DOI 10.1074/jbc.M110.109827; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Krieglstein K, 2011, TRENDS NEUROSCI, V34, P421, DOI 10.1016/j.tins.2011.06.002; Kucukdereli H, 2011, P NATL ACAD SCI USA, V108, pE440, DOI 10.1073/pnas.1104977108; Lacmann A, 2007, NEUROSCIENCE, V150, P647, DOI 10.1016/j.neuroscience.2007.09.046; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; Mecha M, 2008, DEV DYNAM, V237, P1709, DOI 10.1002/dvdy.21558; Packard M, 2003, NAT REV NEUROSCI, V4, P113, DOI 10.1038/nrn1036; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Panizzutti R, 2001, P NATL ACAD SCI USA, V98, P5294, DOI 10.1073/pnas.091002298; Pfrieger FW, 2010, BRAIN RES REV, V63, P39, DOI 10.1016/j.brainresrev.2009.11.002; Pfrieger FW, 1996, CURR OPIN NEUROBIOL, V6, P615, DOI 10.1016/S0959-4388(96)80093-6; Pyka M, 2011, EUR J NEUROSCI, V33, P2187, DOI 10.1111/j.1460-9568.2011.07690.x; Rajan I, 1999, J NEUROBIOL, V38, P357, DOI 10.1002/(SICI)1097-4695(19990215)38:3<357::AID-NEU5>3.0.CO;2-#; Romao LF, 2008, J NEUROCHEM, V106, P746, DOI 10.1111/j.1471-4159.2008.05428.x; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; Sanyal S, 2004, NEURON, V41, P845, DOI 10.1016/S0896-6273(04)00152-7; Schell MJ, 1997, J NEUROSCI, V17, P1604; Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Sousa VD, 2004, EUR J NEUROSCI, V19, P1721, DOI 10.1111/j.1460.9568.2004.03249.x; Stipursky J, 2007, GLIA, V55, P1023, DOI 10.1002/glia.20522; Stipursky J, 2011, LIFE SCI, V89, P524, DOI 10.1016/j.lfs.2011.04.005; Sun M, 2007, J NEUROSCI, V27, P7740, DOI 10.1523/JNEUROSCI.1604-07.2007; Sun M, 2010, J NEUROSCI, V30, P6025, DOI 10.1523/JNEUROSCI.0789-10.2010; Tomoda T, 1996, DEV BIOL, V179, P79, DOI 10.1006/dbio.1996.0242; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Vargas-Lopes C, 2011, J NEUROCHEM, V116, P281, DOI 10.1111/j.1471-4159.2010.07102.x; Vashlishan AB, 2008, NEURON, V58, P346, DOI 10.1016/j.neuron.2008.02.019; Vincze C, 2010, J COMP NEUROL, V518, P3752, DOI 10.1002/cne.22422; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Zhao B, 2012, CELL RES, V22, P1467, DOI 10.1038/cr.2012.92; Zhuang P, 2004, CLIN NEUROPHYSIOL, V115, P2542, DOI 10.1016/j.clinph.2004.06.006; Zhuang ZY, 2010, J NEUROSCI, V30, P16015, DOI 10.1523/JNEUROSCI.0481-10.2010	73	145	153	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41432	41445		10.1074/jbc.M112.380824	http://dx.doi.org/10.1074/jbc.M112.380824			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23055518	Green Published, hybrid			2022-12-28	WOS:000311887600055
J	Liu, PY; Ge, XM; Ding, HZ; Jiang, HL; Christensen, BM; Li, JY				Liu, Pingyang; Ge, Xiaomei; Ding, Haizhen; Jiang, Honglin; Christensen, Bruce M.; Li, Jianyong			Role of Glutamate Decarboxylase-like Protein 1 (GADL1) in Taurine Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ALANINE SUPPLEMENTATION; SULFINIC ACID DECARBOXYLASE; MUSCLE CARNOSINE SYNTHESIS; ESCHERICHIA-COLI; MICE LACKING; GABA; BRAIN; TISSUES; NEUROPROTECTION; DEHYDROGENASE	This manuscript concerns the tissue-specific transcription of mouse and cattle glutamate decarboxylase-like protein 1 (GADL1) and the biochemical activities of human GADL1 recombinant protein. Bioinformatic analysis suggested that GADL1 appears late in evolution, only being found in reptiles, birds, and mammals. RT-PCR determined that GADL1 mRNA is transcribed at high levels in mouse and cattle skeletal muscles and also in mouse kidneys. Substrate screening determined that GADL1, unlike its name implies, has no detectable GAD activity, but it is able to efficiently catalyze decarboxylation of aspartate, cysteine sulfinic acid, and cysteic acid to beta-alanine, hypotaurine, and taurine, respectively. Western blot analysis verified the presence of GADL1 in mouse muscles, kidneys, C2C12 myoblasts, and C2C12 myotubes. Incubation of the supernatant of fresh muscle or kidney extracts with cysteine sulfinic acid resulted in the detection of hypotaurine or taurine in the reaction mixtures, suggesting the possible involvement of GADL1 in taurine biosynthesis. However, when the tissue samples were incubated with aspartate, no beta-alanine production was observed. We proposed several possibilities that might explain the inactivation of ADC activity of GADL1 in tissue protein extracts. Although beta-alanine-producing activity was not detected in the supernatant of tissue protein extracts, its potential role in beta-alanine synthesis cannot be excluded. There are several inhibitors of the ADC activity of GADL1 identified. The discovery of GADL1 biochemical activities, in conjunction with its expression and activities in muscles and kidneys, provides some tangible insight toward establishing its physiological function(s).	[Liu, Pingyang; Ding, Haizhen; Li, Jianyong] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA; [Ge, Xiaomei; Jiang, Honglin] Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA; [Christensen, Bruce M.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; University of Wisconsin System; University of Wisconsin Madison	Li, JY (corresponding author), Virginia Polytech Inst & State Univ, Dept Biochem, Engel Hall 204, Blacksburg, VA 24061 USA.	lij@vt.edu	Liu, Pingyang/G-7796-2014; mo, qin/O-7877-2014	Liu, Pingyang/0000-0001-5060-5807; , Honglin/0000-0001-9540-5788	National Institutes of Health [AI19769]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R22AI019769, R37AI019769, R01AI019769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI19769.	Artioli GG, 2010, MED SCI SPORT EXER, V42, P1162, DOI 10.1249/MSS.0b013e3181c74e38; Asada H, 1996, BIOCHEM BIOPH RES CO, V229, P891, DOI 10.1006/bbrc.1996.1898; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Aydin AF, 2010, BIOGERONTOLOGY, V11, P103, DOI 10.1007/s10522-009-9232-4; BAKARDJIEV A, 1994, EUR J BIOCHEM, V225, P617, DOI 10.1111/j.1432-1033.1994.00617.x; Battaglioli G, 2003, J NEUROCHEM, V86, P879, DOI 10.1046/j.1471-4159.2003.01910.x; Boldyrev A A, 1995, Vestn Ross Akad Med Nauk, P3; BOLDYREV AA, 1993, INT J BIOCHEM, V25, P1101, DOI 10.1016/0020-711X(93)90587-5; Bouche N, 2003, TRENDS CELL BIOL, V13, P607, DOI 10.1016/j.tcb.2003.10.001; Bouche N, 2003, P NATL ACAD SCI USA, V100, P6843, DOI 10.1073/pnas.1037532100; BROWN GM, 1982, ADV ENZYMOL RAMB, V53, P345; Bulygina YR, 1995, VOP MED KHIM, V41, P27; Capitani G, 2003, EMBO J, V22, P4027, DOI 10.1093/emboj/cdg403; Chevrot R, 2006, P NATL ACAD SCI USA, V103, P7460, DOI 10.1073/pnas.0600313103; Chez MG, 2002, J CHILD NEUROL, V17, P833, DOI 10.1177/08830738020170111501; CRONAN JE, 1980, J BACTERIOL, V141, P1291, DOI 10.1128/JB.141.3.1291-1297.1980; Decombaz J, 2012, AMINO ACIDS, V43, P67, DOI 10.1007/s00726-011-1169-7; Derave W, 2007, J APPL PHYSIOL, V103, P1736, DOI 10.1152/japplphysiol.00397.2007; Derave W, 2010, SPORTS MED, V40, P247, DOI 10.2165/11530310-000000000-00000; Drozak J, 2010, J BIOL CHEM, V285, P9346, DOI 10.1074/jbc.M109.095505; Fenalti G, 2007, NAT STRUCT MOL BIOL, V14, P280, DOI 10.1038/nsmb1228; Harris RC, 2006, AMINO ACIDS, V30, P279, DOI 10.1007/s00726-006-0299-9; Heller-Stilb B, 2001, FASEB J, V15, P231, DOI 10.1096/fj.01-0691fje; Hill CA, 2007, AMINO ACIDS, V32, P225, DOI 10.1007/s00726-006-0364-4; Hipkiss AR, 2009, ADV FOOD NUTR RES, V57, P87, DOI 10.1016/S1043-4526(09)57003-9; Hipkiss AR, 2009, EXP GERONTOL, V44, P237, DOI 10.1016/j.exger.2008.11.001; HIPKISS AR, 1995, FEBS LETT, V371, P81, DOI 10.1016/0014-5793(95)00849-5; HORINISHI H, 1978, J NEUROCHEM, V31, P909, DOI 10.1111/j.1471-4159.1978.tb00127.x; Horning MS, 2000, BRAIN RES, V852, P56, DOI 10.1016/S0006-8993(99)02215-5; Ito T, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S20; Jackson MC, 1996, INFLAMM RES, V45, P132, DOI 10.1007/BF02265166; Kendrick IP, 2008, AMINO ACIDS, V34, P547, DOI 10.1007/s00726-007-0008-3; Kendrick IP, 2009, EUR J APPL PHYSIOL, V106, P131, DOI 10.1007/s00421-009-0998-5; Liu PY, 2013, AMINO ACIDS, V44, P391, DOI 10.1007/s00726-012-1342-7; Liu PY, 2012, INSECT BIOCHEM MOLEC, V42, P396, DOI 10.1016/j.ibmb.2012.02.001; Lohkamp B, 2010, BBA-PROTEINS PROTEOM, V1804, P2198, DOI 10.1016/j.bbapap.2010.08.014; NG RH, 1978, J NEUROCHEM, V30, P187, DOI 10.1111/j.1471-4159.1978.tb07051.x; Park E, 2002, BBA-GENE STRUCT EXPR, V1574, P403, DOI 10.1016/S0167-4781(01)00364-5; Richardson G, 2010, MOL BIOL REP, V37, P3199, DOI 10.1007/s11033-009-9902-y; Schmitzberger F, 2003, EMBO J, V22, P6193, DOI 10.1093/emboj/cdg575; Skoldberg F, 2004, J CLIN ENDOCR METAB, V89, P1636, DOI 10.1210/jc.2003-031161; Stellingwerff T, 2012, AMINO ACIDS, V43, P57, DOI 10.1007/s00726-012-1245-7; Trombley PQ, 2000, BIOCHEMISTRY-MOSCOW+, V65, P807; Ubuka T, 2008, AMINO ACIDS, V35, P53, DOI 10.1007/s00726-007-0633-x; Warskulat U, 2007, METHOD ENZYMOL, V428, P439, DOI 10.1016/S0076-6879(07)28025-5; Webb ME, 2004, NAT PROD REP, V21, P695, DOI 10.1039/b316419p; Wu JY, 1998, ADV EXP MED BIOL, V442, P339; WU JY, 1982, P NATL ACAD SCI-BIOL, V79, P4270, DOI 10.1073/pnas.79.14.4270; Zaloga G P, 1996, New Horiz, V4, P26; Zaloga GP, 1997, AM J PHYSIOL-HEART C, V272, pH462, DOI 10.1152/ajpheart.1997.272.1.H462	50	31	36	5	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					40898	40906		10.1074/jbc.M112.393728	http://dx.doi.org/10.1074/jbc.M112.393728			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23038267	hybrid, Green Published			2022-12-28	WOS:000311887600009
J	Liu, Y; Wang, DL; Chen, S; Zhao, L; Sun, FL				Liu, Yan; Wang, Da-Liang; Chen, Su; Zhao, Lei; Sun, Fang-Lin			Oncogene Ras/Phosphatidylinositol 3-Kinase Signaling Targets Histone H3 Acetylation at Lysine 56	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; DNA-DAMAGE RESPONSE; ACETYLTRANSFERASE ACTIVITY; H3K56 ACETYLATION; ONCOPROTEIN E1A; CANCER CELLS; ACTIVATION; PATHWAY; CYCLE; RAS	It is well established that the small GTPase Ras promotes tumor initiation by activating at least three different mediators: Raf, PI3K, and Ras-like (Ral) guanine nucleotide exchange factors. However, the exact mechanisms that underlie these different Ras signaling pathways, which are involved in tumor progression, remain to be elucidated. In this study, we report that the Ras-PI3K pathway, but not Raf or the Ral guanine nucleotide exchange factors, specifically targets the acetylation of H3 at lysine 56 (H3K56ac), thereby regulating tumor cell activity. We demonstrate that the Ras-PI3K-induced reduction in H3K56ac is associated with the proliferation and migration of tumor cells by targeting the transcription of tumor-associated genes. The depletion of the histone deacetyltransferases Sirt1 and Sirt2 rescues the Ras-PI3K-induced decrease in H3K56ac, gene transcription, tumor cell proliferation, and tumor cell migration. Furthermore, we demonstrate that the Ras-PI3K-AKT pathway regulates H3K56ac via the MDM2-dependent degradation of CREB-binding protein/p300. Taken together, the results of this study demonstrate that the Ras-PI3K signaling pathway targets specific epigenetic modifications in tumor cells.	[Liu, Yan; Wang, Da-Liang; Zhao, Lei; Sun, Fang-Lin] Tsinghua Univ, Inst Epigenet & Canc Res, Sch Med, Beijing 100084, Peoples R China; [Chen, Su; Sun, Fang-Lin] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Liu, Yan] Hebei United Univ, Dept Bioengn, Coll Life Sci, Tangshan 063000, Hebei, Peoples R China	Tsinghua University; Tongji University; North China University of Science & Technology	Sun, FL (corresponding author), Tsinghua Univ, Inst Epigenet & Canc Res, Sch Med, Beijing 100084, Peoples R China.	sfl@tongji.edu.cn						Ait-Si-Ali S, 1998, NATURE, V396, P184, DOI 10.1038/24190; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Cascone I, 2008, EMBO J, V27, P2375, DOI 10.1038/emboj.2008.166; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chakravarti D, 1999, CELL, V96, P393, DOI 10.1016/S0092-8674(00)80552-8; Chari R, 2010, CANCER METAST REV, V29, P73, DOI 10.1007/s10555-010-9199-2; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Downs JA, 2008, DNA REPAIR, V7, P2020, DOI 10.1016/j.dnarep.2008.08.016; Erkmann JA, 2009, DNA REPAIR, V8, P1371, DOI 10.1016/j.dnarep.2009.09.004; Feig LA, 2003, TRENDS CELL BIOL, V13, P419, DOI 10.1016/S0962-8924(03)00152-1; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Gibbons James J, 2009, Semin Oncol, V36 Suppl 3, pS3, DOI 10.1053/j.seminoncol.2009.10.011; Hamamori Y, 1999, CELL, V96, P405, DOI 10.1016/S0092-8674(00)80553-X; Hansen CA, 2008, CELL CYCLE, V7, P325, DOI 10.4161/cc.7.3.5354; Hebert C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r51; Hiraga S, 2008, J CELL BIOL, V183, P641, DOI 10.1083/jcb.200806065; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; Hosoda H, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-34; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Jin YT, 2004, J BIOL CHEM, V279, P20035, DOI 10.1074/jbc.M309916200; Kaeser MD, 2008, J BIOL CHEM, V283, P32254, DOI 10.1074/jbc.M806061200; Kaplan T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000270; Kaur B, 2009, CANCER RES, V69, P1212, DOI 10.1158/0008-5472.CAN-08-1166; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee KB, 2012, CANCER LETT, V315, P86, DOI 10.1016/j.canlet.2011.10.016; Legube G, 2002, EMBO J, V21, P1704, DOI 10.1093/emboj/21.7.1704; Lim KH, 2005, CANCER CELL, V8, P381, DOI 10.1016/j.ccr.2005.10.014; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Mailand N, 2002, NAT CELL BIOL, V4, P317, DOI 10.1038/ncb777; Martelli AM, 2010, HISTOL HISTOPATHOL, V25, P669, DOI 10.14670/HH-25.669; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Miller A, 2008, DIABETES RES CLIN PR, V80, P1, DOI 10.1016/SO168-8227(08)00123-X; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; North BJ, 2007, J BIOL CHEM, V282, P19546, DOI 10.1074/jbc.M702990200; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Perissi V, 1999, P NATL ACAD SCI USA, V96, P3652, DOI 10.1073/pnas.96.7.3652; Rosman DS, 2008, CANCER RES, V68, P1319, DOI 10.1158/0008-5472.CAN-07-5424; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Sanchez-Molina S, 2006, BIOCHEM J, V398, P215, DOI 10.1042/BJ20060052; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Seligson DB, 2009, AM J PATHOL, V174, P1619, DOI 10.2353/ajpath.2009.080874; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Thaminy S, 2007, J BIOL CHEM, V282, P37805, DOI 10.1074/jbc.M706384200; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Vempati R. K., 2010, J BIOL CHEM, V10, P1074; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Xu F, 2007, MOL CELL, V27, P890, DOI 10.1016/j.molcel.2007.07.021; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	58	41	45	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41469	41480		10.1074/jbc.M112.367847	http://dx.doi.org/10.1074/jbc.M112.367847			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	22982396	hybrid, Green Published			2022-12-28	WOS:000311887600058
J	Barber, AF; Liang, QS; Covarrubias, M				Barber, Annika F.; Liang, Qiansheng; Covarrubias, Manuel			Novel Activation of Voltage-gated K+ Channels by Sevoflurane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENERAL-ANESTHETICS; POTASSIUM CHANNEL; INHALATIONAL ANESTHETICS; VOLATILE ANESTHETICS; MOLECULAR TARGETS; CALCIUM CURRENT; ISOFLURANE; RECEPTORS; SITE; ALCOHOLS	Voltage-gated ion channels are modulated by halogenated inhaled general anesthetics, but the underlying molecular mechanisms are not understood. Alkanols and halogenated inhaled anesthetics such as halothane and isoflurane inhibit the archetypical voltage-gated Kv3 channel homolog K-Shaw2 by stabilizing the resting/closed states. By contrast, sevoflurane, a more heavily fluorinated ether commonly used in general anesthesia, specifically activates K-Shaw2 currents at relevant concentrations (0.05-1 mM) in a rapid and reversible manner. The concentration dependence of this modulation is consistent with the presence of high and low affinity interactions (K-D = 0.06 and 4 mM, respectively). Sevoflurane (< 1 mM) induces a negative shift in the conductance-voltage relation and increases the maximum conductance. Furthermore, suggesting possible roles in general anesthesia, mammalian Kv1.2 and Kv1.5 channels display similar changes. Quantitative description of the observations by an economical allosteric model indicates that sevoflurane binding favors activation gating and eliminates an unstable inactivated state outside the activation pathway. This study casts light on the mechanism of the novel sevoflurane-dependent activation of Kv channels, which helps explain how closely related inhaled anesthetics achieve specific actions and suggests strategies to develop novel Kv channel activators.	[Barber, Annika F.; Liang, Qiansheng; Covarrubias, Manuel] Thomas Jefferson Univ, Jefferson Med Coll, Farber Inst Neurosci, Philadelphia, PA 19107 USA; [Barber, Annika F.] Thomas Jefferson Univ, Jefferson Med Coll, Grad Program Cell & Dev Biol, Philadelphia, PA 19107 USA; [Barber, Annika F.; Liang, Qiansheng; Covarrubias, Manuel] Thomas Jefferson Univ, Jefferson Med Coll, Dept Neurosci, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University	Covarrubias, M (corresponding author), 900 Walnut St,JHN 417, Philadelphia, PA 19107 USA.	manuel.covarrubias@jefferson.edu	Barber, Annika/AAA-6082-2022	Barber, Annika/0000-0002-5058-939X; Covarrubias, Manuel/0000-0002-0881-4143	NIAAA, National Institutes of Health [AA010615, AA007463]; NINDS, National Institutes of Health [F31 NS077689]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS077689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007463, R01AA010615] Funding Source: NIH RePORTER	NIAAA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by NIAAA, National Institutes of Health Grants AA010615, AA007463 (to M. C.) and NINDS, National Institutes of Health Grant F31 NS077689 (to A. F. B.).	Barber AF, 2011, BIOPHYS J, V101, P1613, DOI 10.1016/j.bpj.2011.08.026; Bhattacharji A, 2006, MOL PHARMACOL, V70, P1542, DOI 10.1124/mol.106.026187; Bhattacharji A, 2010, BRIT J PHARMACOL, V159, P1475, DOI 10.1111/j.1476-5381.2010.00642.x; Brannigan G, 2010, P NATL ACAD SCI USA, V107, P14122, DOI 10.1073/pnas.1008534107; Cacheaux LP, 2005, J PHARMACOL EXP THER, V315, P517, DOI 10.1124/jpet.105.091801; COVARRUBIAS M, 1993, P NATL ACAD SCI USA, V90, P6957, DOI 10.1073/pnas.90.15.6957; COVARRUBIAS M, 1995, J BIOL CHEM, V270, P19408, DOI 10.1074/jbc.270.33.19408; Downie DL, 1996, BRIT J PHARMACOL, V118, P493, DOI 10.1111/j.1476-5381.1996.tb15430.x; Eckenhoff RG, 2011, CURR BIOL, V21, pR985, DOI 10.1016/j.cub.2011.11.012; Eckenhoff RG, 2010, ACS CHEM NEUROSCI, V1, P139, DOI 10.1021/cn900014m; Forman SA, 2011, ANESTHESIOLOGY, V114, P695, DOI 10.1097/ALN.0b013e3181ff72b5; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Franks NP, 2006, BRIT J PHARMACOL, V147, pS72, DOI 10.1038/sj.bjp.0706441; Franks NP, 1996, ANESTHESIOLOGY, V84, P716, DOI 10.1097/00000542-199603000-00027; Friederich P, 2001, ANESTHESIOLOGY, V95, P954, DOI 10.1097/00000542-200110000-00026; Hapfelmeier G, 2001, EUR J ANAESTH, V18, P377, DOI 10.1046/j.0265-0215.2001.00848.x; Harris T, 2000, J BIOL CHEM, V275, P4928, DOI 10.1074/jbc.275.7.4928; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Herold KF, 2009, ANESTHESIOLOGY, V111, P591, DOI 10.1097/ALN.0b013e3181af64d4; HERRINGTON J, 1991, J NEUROSCI, V11, P2226; Horishita T, 2008, ANESTH ANALG, V107, P1579, DOI 10.1213/ane.0b013e318184b966; Jenkins A, 1996, BRIT J PHARMACOL, V117, P1507, DOI 10.1111/j.1476-5381.1996.tb15314.x; Krasowski MD, 1999, CELL MOL LIFE SCI, V55, P1278, DOI 10.1007/s000180050371; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Ouyang W, 2009, ANESTHESIOLOGY, V110, P582, DOI 10.1097/ALN.0b013e318197941e; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Putzke C, 2007, AM J PHYSIOL-CELL PH, V293, pC1319, DOI 10.1152/ajpcell.00100.2007; Scheller M, 1997, ANESTHESIOLOGY, V86, P118, DOI 10.1097/00000542-199701000-00016; Shiraishi M, 2004, J PHARMACOL EXP THER, V309, P987, DOI 10.1124/jpet.103.064063; Singaram VK, 2011, CURR BIOL, V21, P2070, DOI 10.1016/j.cub.2011.10.042; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P399, DOI 10.1085/jgp.111.3.399; Stevens R, 2005, J PHARMACOL EXP THER, V314, P338, DOI 10.1124/jpet.105.085076; Stevens RJN, 2005, ANESTH ANALG, V100, P1696, DOI 10.1213/01.ANE.0000151720.36988.09; Suzuki T, 2002, ANESTHESIOLOGY, V96, P699, DOI 10.1097/00000542-200203000-00028; TAKENOSHITA M, 1991, J NEUROSCI, V11, P1404; Todorovic SM, 2000, MOL PHARMACOL, V58, P98, DOI 10.1124/mol.58.1.98; TSUNODA S, 1995, J NEUROSCI, V15, P1741, DOI 10.1523/JNEUROSCI.15-03-01741.1995; Urban B. W., 2008, V182, P3, DOI 10.1007/978-3-540-74806-9_1; Vedula LS, 2009, J BIOL CHEM, V284, P24176, DOI 10.1074/jbc.M109.017814; Wei OY, 2007, ANESTHESIOLOGY, V107, P91, DOI 10.1097/01.anes.0000268390.28362.4a; Willenbring D, 2011, BIOPHYS J, V101, P1905, DOI 10.1016/j.bpj.2011.09.026; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321	43	30	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40425	40432		10.1074/jbc.M112.405787	http://dx.doi.org/10.1074/jbc.M112.405787			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23038249	Green Published, hybrid			2022-12-28	WOS:000311448800033
J	Cheng, JJ; Goldstein, R; Stec, B; Gershenson, A; Roberts, MF				Cheng, Jiongjia; Goldstein, Rebecca; Stec, Boguslaw; Gershenson, Anne; Roberts, Mary F.			Competition between Anion Binding and Dimerization Modulates Staphylococcus aureus Phosphatidylinositol-specific Phospholipase C Enzymatic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; X-RAY-DIFFRACTION; PHOSPHATIDYLCHOLINE-ACTIVATION; CRYSTALLOGRAPHY; SYSTEM; TOOL	Staphylococcus aureus phosphatidylinositol-specific phospholipase C (PI-PLC) is a secreted virulence factor for this pathogenic bacterium. A novel crystal structure shows that this PI-PLC can form a dimer via helix B, a structural feature present in all secreted, bacterial PI-PLCs that is important for membrane binding. Despite the small size of this interface, it is critical for optimal enzyme activity. Kinetic evidence, increased enzyme specific activity with increasing enzyme concentration, supports a mechanism where the PI-PLC dimerization is enhanced in membranes containing phosphatidylcholine (PC). Mutagenesis of key residues confirm that the zwitterionic phospholipid acts not by specific binding to the protein, but rather by reducing anionic lipid interactions with a cationic pocket on the surface of the S. aureus enzyme that stabilizes monomeric protein. Despite its structural and sequence similarity to PI-PLCs from other Gram-positive pathogenic bacteria, S. aureus PI-PLC appears to have a unique mechanism where enzyme activity is modulated by competition between binding of soluble anions or anionic lipids to the cationic sensor and transient dimerization on the membrane.	[Cheng, Jiongjia; Goldstein, Rebecca; Roberts, Mary F.] Boston Coll, Dept Chem, Chestnut Hill, MA 02467 USA; [Stec, Boguslaw] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Gershenson, Anne] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA	Boston College; Sanford Burnham Prebys Medical Discovery Institute; University of Massachusetts System; University of Massachusetts Amherst	Roberts, MF (corresponding author), Boston Coll, Dept Chem, Chestnut Hill, MA 02467 USA.	mary.roberts@bc.edu	Cheng, Jiongjia/AAM-9464-2020	Cheng, Jiongjia/0000-0002-0908-3880; Stec, Boguslaw/0000-0002-8696-0349; Gershenson, Anne/0000-0003-3124-9610	National Institutes of Health [R01 GM60418]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, by National Institutes of Health Grant R01 GM60418 (to M. F. R.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berg OG, 2004, BIOCHEMISTRY-US, V43, P2080, DOI 10.1021/bi035063j; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burlak C, 2007, CELL MICROBIOL, V9, P1172, DOI 10.1111/j.1462-5822.2006.00858.x; Chen W, 2009, BIOCHEMISTRY-US, V48, P3578, DOI 10.1021/bi802312d; DAUGHERTY S, 1993, INFECT IMMUN, V61, P5078, DOI 10.1128/IAI.61.12.5078-5089.1993; DYE ES, 1980, INFECT IMMUN, V30, P198, DOI 10.1128/IAI.30.1.198-203.1980; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng JW, 2002, J BIOL CHEM, V277, P19867, DOI 10.1074/jbc.M200938200; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Goldstein R, 2012, BIOCHEMISTRY-US, V51, P2579, DOI 10.1021/bi300057q; HEINZ DW, 1995, EMBO J, V14, P3855, DOI 10.1002/j.1460-2075.1995.tb00057.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pu MM, 2010, J BIOL CHEM, V285, P26916, DOI 10.1074/jbc.M110.123083; Pu MM, 2009, BIOCHEMISTRY-US, V48, P6835, DOI 10.1021/bi900633p; Pu MM, 2009, J BIOL CHEM, V284, P16099, DOI 10.1074/jbc.M809600200; Qian XQ, 1998, BIOCHEMISTRY-US, V37, P6513, DOI 10.1021/bi972650u; Rusu L, 2004, BIOPHYS J, V87, P1044, DOI 10.1529/biophysj.104.039958; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shi XM, 2009, J BIOL CHEM, V284, P15607, DOI 10.1074/jbc.M901601200; Thompson NL, 1991, TOPICS FLUORESCENCE, P337; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Zhou C, 1997, BIOCHEMISTRY-US, V36, P10089, DOI 10.1021/bi970846o	30	10	10	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40317	40327		10.1074/jbc.M112.395277	http://dx.doi.org/10.1074/jbc.M112.395277			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23038258	hybrid, Green Published			2022-12-28	WOS:000311448800023
J	Kikuchi, H; Kuribayashi, F; Imajoh-Ohmi, S; Nishitoh, H; Takami, Y; Nakayama, T				Kikuchi, Hidehiko; Kuribayashi, Futoshi; Imajoh-Ohmi, Shinobu; Nishitoh, Hideki; Takami, Yasunari; Nakayama, Tatsuo			GCN5 Protects Vertebrate Cells against UV-irradiation via Controlling Gene Expression of DNA Polymerase eta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; HISTONE ACETYLTRANSFERASE; TRANSLESION SYNTHESIS; STAGA COMPLEX; ACETYLATION; ACTIVATION; APOPTOSIS; BINDING; COACTIVATOR; INHIBITORS	By UV-irradiation, cells are subjected to DNA damage followed by mutation, cell death and/or carcinogenesis. DNA repair systems such as nucleotide excision repair (NER) and translesion DNA synthesis (TLS) protect cells against UV-irradiation. To understand the role of histone acetyltransferase GCN5 in regulation of DNA repair, we studied the sensitivity of GCN5-deficient DT40, GCN5(-/-), to various DNA-damaging agents including UV-irradiation, and effects of GCN5-deficiency on the expression of NER- and TLS-related genes. After UV-irradiation, cell death and DNA fragmentation of GCN5(-/-) were appreciably accelerated as compared with those of DT40. Interestingly, GCN5(-/-) showed a remarkable sensitivity to only UV-irradiation but not to other DNA-damaging agents tested. Semiquantitative RT-PCR showed that transcription of DNA polymerase eta (POLH) gene whose deficiency is responsible for a variant form of xeroderma pigmentosum was drastically down-regulated in GCN5(-/-) (to similar to 25%). In addition, ectopic expression of human POLH in GCN5(-/-) dramatically reversed the sensitivity to UV-irradiation of GCN5(-/-) to almost the same level of wild type DT40. Moreover, chromatin immunoprecipitation assay revealed that GCN5 binds to the chicken POLH gene 5'-flanking region that contains a typical CpG island and acetylates Lys-9 of histone H3, but not Lys-14 in vivo. These data suggest that GCN5 takes part in transcription regulation of POLH gene through alterations in the chromatin structure by direct interaction with its 5'-flanking region, and protects vertebrate cells against UV-induced DNA damage via controlling POLH gene expression.	[Kikuchi, Hidehiko; Nishitoh, Hideki; Takami, Yasunari; Nakayama, Tatsuo] Miyazaki Univ, Sect Biochem & Mol Biol, Dept Med Sci, Miyazaki Med Coll, Miyazaki 8891692, Japan; [Kuribayashi, Futoshi] Kawasaki Med Sch, Dept Biochem, Kurashiki, Okayama 7010192, Japan; [Imajoh-Ohmi, Shinobu] Univ Tokyo, Med Prote Lab, Grad Sch Frontier Sci, Inst Med Sci, Tokyo 1088639, Japan	University of Miyazaki; Kawasaki Medical School; University of Tokyo	Kikuchi, H (corresponding author), Miyazaki Univ, Sect Biochem & Mol Biol, Dept Med Sci, Miyazaki Med Coll, 5200 Kihara, Miyazaki 8891692, Japan.	masakari@med.miyazaki-u.ac.jp		Nishitoh, Hideki/0000-0002-8652-4109	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22510203]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (No. 22510203) (to H. K. and T. N.).	Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Balajee AS, 2000, GENE, V250, P15, DOI 10.1016/S0378-1119(00)00172-4; Brand M, 2001, EMBO J, V20, P3187, DOI 10.1093/emboj/20.12.3187; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; DiGiovanna JJ, 2012, J INVEST DERMATOL, V132, P785, DOI 10.1038/jid.2011.426; Fatemi M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni180; Furdas SD, 2012, ARCH PHARM, V345, P7, DOI 10.1002/ardp.201100209; Gamper AM, 2008, MOL CELL BIOL, V28, P2517, DOI 10.1128/MCB.01461-07; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Gray SG, 2006, EPIGENETICS-US, V1, P67, DOI 10.4161/epi.1.2.2678; Guo RF, 2011, NUCLEIC ACIDS RES, V39, P1390, DOI 10.1093/nar/gkq983; Hirota K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001151; Ikehata H, 2011, J RADIAT RES, V52, P115, DOI 10.1269/jrr.10175; KIKUCHI H, 1995, CELL DEATH DIFFER, V2, P195; Kikuchi H, 2005, GENE, V347, P83, DOI 10.1016/j.gene.2004.12.007; Kikuchi H, 2008, GENE, V419, P48, DOI 10.1016/j.gene.2008.04.014; Kikuchi H, 2012, BIOCHEM BIOPH RES CO, V422, P780, DOI 10.1016/j.bbrc.2012.05.099; Kikuchi H, 2011, BIOCHEM BIOPH RES CO, V405, P657, DOI 10.1016/j.bbrc.2011.01.088; Kikuchi H, 2011, J IMMUNOL, V186, P3015, DOI 10.4049/jimmunol.1000364; Kikuchi H, 2009, BBA-MOL CELL RES, V1793, P1304, DOI 10.1016/j.bbamcr.2009.04.016; Kikuchi Hidehiko, 2006, Subcell Biochem, V40, P225; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lans H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000941; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Lehmann AR, 2006, EXP CELL RES, V312, P2673, DOI 10.1016/j.yexcr.2006.06.010; Lehmann AR, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-70; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Steele EJ, 2009, MOL IMMUNOL, V46, P305, DOI 10.1016/j.molimm.2008.10.021; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Teng YM, 2002, J MOL BIOL, V316, P489, DOI 10.1006/jmbi.2001.5383; Waters Raymond, 2008, SEB Exp Biol Ser, V59, P189; Xu WT, 2000, NAT GENET, V26, P229, DOI 10.1038/79973; Yamauchi T, 2000, P NATL ACAD SCI USA, V97, P11303, DOI 10.1073/pnas.97.21.11303; Yu YC, 2005, P NATL ACAD SCI USA, V102, P8650, DOI 10.1073/pnas.0501458102	39	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.406389	http://dx.doi.org/10.1074/jbc.M112.406389			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23033487	Green Published, hybrid			2022-12-28	WOS:000311233800052
J	Kurimura, Y; Nishitani, C; Ariki, S; Saito, A; Hasegawa, Y; Takahashi, M; Hashimoto, J; Takahashi, S; Tsukamoto, T; Kuroki, Y				Kurimura, Yuichiro; Nishitani, Chiaki; Ariki, Shigeru; Saito, Atsushi; Hasegawa, Yoshihiro; Takahashi, Motoko; Hashimoto, Jiro; Takahashi, Satoshi; Tsukamoto, Taiji; Kuroki, Yoshio			Surfactant Protein D Inhibits Adherence of Uropathogenic Escherichia coli to the Bladder Epithelial Cells and the Bacterium-induced Cytotoxicity A POSSIBLE FUNCTION IN URINARY TRACT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION DOMAIN; PULMONARY COLLECTINS; D BINDS; INNATE IMMUNITY; MYCOBACTERIUM-AVIUM; UROPLAKIN-IA; HOST-DEFENSE; FIMH ADHESIN; LUNG; INFECTION	The adherence of uropathogenic Escherichia coli (UPEC) to the host urothelial surface is the first step for establishing UPEC infection. Uroplakin Ia (UPIa), a glycoprotein expressed on bladder urothelium, serves as a receptor for FimH, a lectin located at bacterial pili, and their interaction initiates UPEC infection. Surfactant protein D (SP-D) is known to be expressed on mucosal surfaces in various tissues besides the lung. However, the functions of SP-D in the non-pulmonary tissues are poorly understood. The purposes of this study were to investigate the possible function of SP-D expressed in the bladder urothelium and the mechanisms by which SP-D functions. SP-D was expressed in human bladder mucosa, and its mRNA was increased in the bladder of the UPEC infection model in mice. SP-D directly bound to UPEC and strongly agglutinated them in a Ca2+-dependent manner. Co-incubation of SP-D with UPEC decreased the bacterial adherence to 5637 cells, the human bladder cell line, and the UPEC-induced cytotoxicity. In addition, preincubation of SP-D with 5637 cells resulted in the decreased adherence of UPEC to the cells and in a reduced number of cells injured by UPEC. SP-D directly bound to UPIa and competed with FimH for UPIa binding. Consistent with the in vitro data, the exogenous administration of SP-D inhibited UPEC adherence to the bladder and dampened UPEC-induced inflammation in mice. These results support the conclusion that SP-D can protect the bladder urothelium against UPEC infection and suggest a possible function of SP-D in urinary tract.	[Nishitani, Chiaki] Sapporo Med Univ, Sch Med, Dept Biochem, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Kurimura, Yuichiro; Hashimoto, Jiro; Takahashi, Satoshi; Tsukamoto, Taiji] Sapporo Med Univ, Sch Med, Dept Urol, Sapporo, Hokkaido 0608556, Japan; [Saito, Atsushi; Hasegawa, Yoshihiro] Sapporo Med Univ, Sch Med, Dept Internal Med 3, Sapporo, Hokkaido 0608556, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Nishitani, C (corresponding author), Sapporo Med Univ, Sch Med, Dept Biochem, Chuo Ku, South 1,West 17, Sapporo, Hokkaido 0608556, Japan.	nchiaki@sapmed.ac.jp	Saito, Atsushi/M-7382-2018; Ariki, Shigeru/E-3861-2014; Takahashi, Motoko/I-3154-2013	Saito, Atsushi/0000-0003-3430-884X; Ariki, Shigeru/0000-0001-5838-499X; Takahashi, Motoko/0000-0002-2112-6142	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Adaptable and Seamless Technology Transfer Program through Target-driven Research and Development from the Japan Science and Technology Agency, Japan; Gohtaro Sugawara Research Fund for Urological Diseases; Grants-in-Aid for Scientific Research [24591173] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Adaptable and Seamless Technology Transfer Program through Target-driven Research and Development from the Japan Science and Technology Agency, Japan; Gohtaro Sugawara Research Fund for Urological Diseases; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; by the Adaptable and Seamless Technology Transfer Program through Target-driven Research and Development from the Japan Science and Technology Agency, Japan; and by a grant from the Gohtaro Sugawara Research Fund for Urological Diseases.	Ariki S, 2011, J IMMUNOL, V187, P2586, DOI 10.4049/jimmunol.1100024; Chiba H, 2002, J BIOL CHEM, V277, P20379, DOI 10.1074/jbc.M201089200; Connell I, 1996, P NATL ACAD SCI USA, V93, P9827, DOI DOI 10.1073/PNAS.93.18.9827; Crouch E, 2001, ANNU REV PHYSIOL, V63, P521, DOI 10.1146/annurev.physiol.63.1.521; CROUCH E, 1994, J BIOL CHEM, V269, P15808; Crouch E, 2000, IMMUNOL REV, V173, P52, DOI 10.1034/j.1600-065X.2000.917311.x; DAY AJ, 1994, BIOCHEM SOC T, V22, P83, DOI 10.1042/bst0220083; Ferguson JS, 1999, J IMMUNOL, V163, P312; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Hartshorn KL, 1998, AM J PHYSIOL-LUNG C, V274, pL958, DOI 10.1152/ajplung.1998.274.6.L958; Hooton TM, 1996, NEW ENGL J MED, V335, P468, DOI 10.1056/NEJM199608153350703; JANN B, 1993, CARBOHYD RES, V248, P241, DOI 10.1016/0008-6215(93)84131-O; Kingstone R. E., 1992, CURRENT PROTOCOLS MO, P16141; KUAN SF, 1992, J CLIN INVEST, V90, P97, DOI 10.1172/JCI115861; Kudo K, 2004, J IMMUNOL, V172, P7592, DOI 10.4049/jimmunol.172.12.7592; KUROKI Y, 1994, J BIOL CHEM, V269, P25943; Kuroki Y, 1997, FEBS LETT, V414, P387, DOI 10.1016/S0014-5793(97)01022-3; Kuroki Y, 2007, CELL MICROBIOL, V9, P1871, DOI 10.1111/j.1462-5822.2007.00953.x; Lane MC, 2007, KIDNEY INT, V72, P19, DOI 10.1038/sj.ki.5002230; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; Liu J, 2010, TOHOKU J EXP MED, V221, P35, DOI 10.1620/tjem.221.35; Madan T, 2001, INFECT IMMUN, V69, P2728, DOI 10.1128/IAI.69.4.2728-2731.2001; Madsen J, 2000, J IMMUNOL, V164, P5866, DOI 10.4049/jimmunol.164.11.5866; Mason RJ, 1998, EUR RESPIR J, V12, P1147, DOI 10.1183/09031936.98.12051147; Mulvey MA, 2002, CELL MICROBIOL, V4, P257, DOI 10.1046/j.1462-5822.2002.00193.x; Oberley RE, 2005, PROSTATE, V65, P241, DOI 10.1002/pros.20292; Oberley RE, 2007, MOL HUM REPROD, V13, P863, DOI 10.1093/molehr/gam074; Oberley RE, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-42; Ohya M, 2006, BIOCHEMISTRY-US, V45, P8657, DOI 10.1021/bi060176z; PERSSON A, 1990, J BIOL CHEM, V265, P5755; Sahly H, 2002, J IMMUNOL, V169, P3267, DOI 10.4049/jimmunol.169.6.3267; Sawada K, 2010, J BIOL CHEM, V285, P8434, DOI 10.1074/jbc.M109.074765; Schembri MA, 2000, FEMS MICROBIOL LETT, V188, P147, DOI 10.1111/j.1574-6968.2000.tb09186.x; Stahlman MT, 2002, J HISTOCHEM CYTOCHEM, V50, P651, DOI 10.1177/002215540205000506; Tu LY, 2002, MOL BIOL CELL, V13, P4221, DOI 10.1091/mbc.E02-04-0211; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Wu XR, 1996, P NATL ACAD SCI USA, V93, P9630, DOI 10.1073/pnas.93.18.9630; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; Xie B, 2006, J BIOL CHEM, V281, P14644, DOI 10.1074/jbc.M600877200; Yamazoe M, 2008, J BIOL CHEM, V283, P35878, DOI 10.1074/jbc.M807268200; Zhou G, 2001, J CELL SCI, V114, P4095	41	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.380287	http://dx.doi.org/10.1074/jbc.M112.380287			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23012359	Green Published, hybrid			2022-12-28	WOS:000311233800028
J	Holloway, RW; Bogachev, O; Bharadwaj, AG; McCluskey, GD; Majdalawieh, AF; Zhang, L; Ro, HS				Holloway, Ryan W.; Bogachev, Oleg; Bharadwaj, Alamelu G.; McCluskey, Greg D.; Majdalawieh, Amin F.; Zhang, Lei; Ro, Hyo-Sung			Stromal Adipocyte Enhancer-binding Protein (AEBP1) Promotes Mammary Epithelial Cell Hyperplasia via Proinflammatory and Hedgehog Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; SONIC-HEDGEHOG; EXPRESSION; PATHWAY; GROWTH; GENE; INFLAMMATION; ACTIVATION; AKT	Disruption of mammary stromal-epithelial communication leads to aberrant mammary gland development and induces mammary tumorigenesis. Macrophages have been implicated in carcinogenesis primarily by creating an inflammatory microenvironment, which promotes growth of the adjacent epithelial cells. Adipocyte enhancer-binding protein 1 (AEBP1), a novel proinflammatory mediator, promotes macrophage inflammatory responsiveness by inducing NF-kappa B activity, which has been implicated in tumor cell growth and survival by aberrant sonic hedgehog (Shh) expression. Here, we show that stromal macrophage AEBP1 overexpression results in precocious alveologenesis in the virgin AEBP1 transgenic (AEBP1(TG)) mice, and the onset of ductal hyperplasia was accelerated in AEBP1TG mice fed a high fat diet, which induces endogenous AEBP1 expression. Transplantation of AEBP1(TG) bone marrow cells into non-transgenic (AEBP1(NT)) mice resulted in alveolar hyperplasia with up-regulation of NF-kappa B activity and TNF alpha expression as displayed in the AEBP1(TG) mammary macrophages and epithelium. Shh expression was induced in AEBP1(TG) macrophages and RAW264.7 macrophages overexpressing AEBP1. The Shh target genes Gli1 and Bmi1 expression was induced in the AEBP1(TG) mammary epithelium and HC11 mammary epithelial cells co-cultured with AEBP1(TG) peritoneal macrophages. The conditioned AEBP1(TG) macrophage culture media promoted NF-kappa B activity and survival signal, Akt activation, in HC11 cells, whereas such effects were abolished by TNF alpha neutralizing antibody treatment. Furthermore, HC11 cells displayed enhanced proliferation in response to AEBP1(TG) macrophages and their conditioned media. Our findings highlight the role of AEBP1 in the signaling pathways regulating the cross-talk between mammary epithelium and stroma that could predispose the mammary tissue to tumorigenesis.	[Ro, Hyo-Sung] Dalhousie Univ, Dept Biochem & Mol Biol, Fac Med, Halifax, NS B3H 1X5, Canada	Dalhousie University	Ro, HS (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Fac Med, Sir Charles Tupper Med Bld, Halifax, NS B3H 1X5, Canada.	hsro@dal.ca	Majdalawieh, Amin/AAZ-9349-2020	Majdalawieh, Amin/0000-0002-0240-1057; McCluskey, Gregory/0000-0002-6594-4665; Ro, Hyo-Sung/0000-0003-4411-0386	Canadian Institute of Health Research Grant [MOP-57675]; Canadian Breast Cancer Research Alliance Grant [019454]; Beatrice Hunter Cancer Research Institute Cancer Research Training Program fellowship	Canadian Institute of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Research Alliance Grant; Beatrice Hunter Cancer Research Institute Cancer Research Training Program fellowship	This work was supported by Canadian Institute of Health Research Grant MOP-57675 and Canadian Breast Cancer Research Alliance Grant 019454 (to H.S.R.).; Supported by a Beatrice Hunter Cancer Research Institute Cancer Research Training Program fellowship.	Altaba ARI, 1999, NAT CELL BIOL, V1, pE147, DOI 10.1038/14099; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bhat-Nakshatri P, 2002, ONCOGENE, V21, P2066, DOI 10.1038/sj.onc.1205243; Bigelow RLH, 2004, J BIOL CHEM, V279, P1197, DOI 10.1074/jbc.M310589200; Bogachev O, 2011, MOL MED, V17, P1056, DOI 10.2119/molmed.2011.00141; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cui W, 2010, CANCER SCI, V101, P927, DOI 10.1111/j.1349-7006.2010.01495.x; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Fan L, 2004, ENDOCRINOLOGY, V145, P3961, DOI 10.1210/en.2004-0079; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Grigoriadis A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1604; Guy RK, 2000, P NATL ACAD SCI USA, V97, P7307, DOI 10.1073/pnas.97.13.7307; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kasperczyk H, 2009, FASEB J, V23, P21, DOI 10.1096/fj.08-111096; Kim SW, 2001, J BIOL CHEM, V276, P10199, DOI 10.1074/jbc.M010640200; Kim WK, 2009, MOL ENDOCRINOL, V23, P1532, DOI 10.1210/me.2008-0453; Li X, 2006, ONCOGENE, V25, P609, DOI 10.1038/sj.onc.1209077; Li Z, 2006, CARCINOGENESIS, V27, P1054, DOI 10.1093/carcin/bgi324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maertens GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006380; Majdalawieh A, 2006, P NATL ACAD SCI USA, V103, P2346, DOI 10.1073/pnas.0508139103; Majdalawieh A, 2007, MOL BIOL CELL, V18, P930, DOI 10.1091/mbc.E06-03-0217; Majdalawieh Amin, 2010, Nucl Recept Signal, V8, pe004, DOI 10.1621/nrs.08004; Majdalawieh A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/823821; Majdalawieh A, 2009, INT J BIOCHEM CELL B, V41, P1518, DOI 10.1016/j.biocel.2009.01.003; Nakashima H, 2006, CANCER RES, V66, P7041, DOI 10.1158/0008-5472.CAN-05-4588; Neumark E, 2003, INT J CANCER, V106, P879, DOI 10.1002/ijc.11337; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Prueitt RL, 2007, INT J CANCER, V120, P796, DOI 10.1002/ijc.22336; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Reddy SP, 2008, CLIN CANCER RES, V14, P2978, DOI 10.1158/1078-0432.CCR-07-4821; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Ro HS, 2001, GENE, V280, P123, DOI 10.1016/S0378-1119(01)00771-5; Ro HS, 2007, OBESITY, V15, P288, DOI 10.1038/oby.2007.569; Schwertfeger KL, 2006, J MAMMARY GLAND BIOL, V11, P229, DOI 10.1007/s10911-006-9028-y; Soria G, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-130; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Wang X, 2012, ONCOGENE, V31, P187, DOI 10.1038/onc.2011.232; Warren MA, 2009, MOL CANCER THER, V8, P2655, DOI 10.1158/1535-7163.MCT-09-0358; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Yamasaki A, 2010, CANCER IMMUNOL IMMUN, V59, P675, DOI 10.1007/s00262-009-0783-7; Yoo YA, 2011, CANCER RES, V71, P7061, DOI 10.1158/0008-5472.CAN-11-1338; Zhang L, 2005, ALGORITHMICA, V43, P1, DOI 10.1007/s00453-005-1154-1; Zhang LJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028432, 10.1371/journal.pone.0020963, 10.1371/journal.pone.0026129, 10.1371/journal.pone.0028953]	49	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39171	39181		10.1074/jbc.M112.404293	http://dx.doi.org/10.1074/jbc.M112.404293			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22995915	Green Published, hybrid			2022-12-28	WOS:000310982800072
J	Hukkelhoven, E; Liu, YH; Yeh, N; Ciznadija, D; Blain, SW; Koff, A				Hukkelhoven, Ellen; Liu, Yuhui; Yeh, Nancy; Ciznadija, Daniel; Blain, Stacy W.; Koff, Andrew			Tyrosine Phosphorylation of the p21 Cyclin-dependent Kinase Inhibitor Facilitates the Development of Proneural Glioma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDK INHIBITORS; P27(KIP1); P21(CIP1); CELLS; P21(WAF1/CIP1); TRANSCRIPTION; PROGENITORS; ACTIVATION; SUBCLASSES; COMPLEXES	Phosphorylation of Tyr-88/Tyr-89 in the 3(10) helix of p27 reduces its cyclin-dependent kinase (CDK) inhibitory activity. This modification does not affect the interaction of p27 with cyclin-CDK complexes but does interfere with van der Waals and hydrogen bond contacts between p27 and amino acids in the catalytic cleft of the CDK. Thus, it had been suggested that phosphorylation of this site could switch the tumor-suppressive CDK inhibitory activity to an oncogenic activity. Here, we examined this hypothesis in the RCAS-PDGF-HA/nestin-TvA proneural glioma mouse model, in which p21 facilitates accumulation of nuclear cyclin D1-CDK4 and promotes tumor development. In these tumor cells, approximately one-third of the p21 is phosphorylated at Tyr-76 in the 3(10) helix. Mutation of this residue to glutamate reduced inhibitory activity in vitro. Mutation of this residue to phenylalanine reduced the tumor promoting activity of p21 in the animal model, whereas glutamate or alanine substitution allowed tumor formation. Consequently, we conclude that tyrosine phosphorylation contributes to the conversion of CDK inhibitors from tumor-suppressive roles to oncogenic roles.	[Hukkelhoven, Ellen; Koff, Andrew] Mem Sloan Kettering Canc Ctr, Gerstner Sch Biomed Sci, New York, NY 10021 USA; [Liu, Yuhui; Yeh, Nancy; Ciznadija, Daniel; Koff, Andrew] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, New York, NY 10021 USA; [Blain, Stacy W.] Suny Downstate Med Ctr, Dept Pediat, Brooklyn, NY 11203 USA; [Blain, Stacy W.] Suny Downstate Med Ctr, Dept Anat & Cell Biol, Brooklyn, NY 11203 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Koff, A (corresponding author), Mem Sloan Kettering Canc Ctr, RRL917C,POB 207,1275 York Ave, New York, NY 10065 USA.	a-koff@ski.mskcc.org		Koff, Andrew/0000-0003-3271-3067	National Institutes of Health from NCI [CA89563]; NCI; Golfers Against Cancer and Cycle for Survival; Joel A. Gingras, Jr. American Brain Tumor Association basic research fellowship; Geoffrey Beene graduate student fellowship; Grayer fellowship; NATIONAL CANCER INSTITUTE [R01CA089563, P30CA008748] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Golfers Against Cancer and Cycle for Survival; Joel A. Gingras, Jr. American Brain Tumor Association basic research fellowship; Geoffrey Beene graduate student fellowship; Grayer fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA89563 from NCI (to A. K.). This work was also supported by a cancer center core grant from NCI (to the Memorial Sloan-Kettering Cancer Center), Golfers Against Cancer and Cycle for Survival (to A. K.), a Joel A. Gingras, Jr. American Brain Tumor Association basic research fellowship (to D. C.), and a Geoffrey Beene graduate student fellowship and a Grayer fellowship (to E. H.).	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Alt JR, 2002, J BIOL CHEM, V277, P8517, DOI 10.1074/jbc.M108867200; Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Bansal R, 2005, J NEUROSCI RES, V80, P360, DOI 10.1002/jnr.20454; Besson A, 2007, GENE DEV, V21, P1731, DOI 10.1101/gad.1556607; Blagosklonny MV, 2002, CELL CYCLE, V1, P391, DOI 10.4161/cc.1.6.262; Blain SW, 1997, J BIOL CHEM, V272, P25863, DOI 10.1074/jbc.272.41.25863; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Ciznadija D, 2011, CANCER RES, V71, P6174, DOI 10.1158/0008-5472.CAN-11-1031; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Denicourt C, 2004, GENE DEV, V18, P851, DOI 10.1101/gad.1205304; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Dong Y, 2004, CELL SIGNAL, V16, P263, DOI 10.1016/S0898-6568(03)00136-0; Fisher GH, 1999, ONCOGENE, V18, P5253, DOI 10.1038/sj.onc.1203087; Gao H, 2004, P NATL ACAD SCI USA, V101, P17204, DOI 10.1073/pnas.0407693101; Gartel AL, 2002, MOL CANCER THER, V1, P639; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Hashimoto Y, 1998, J BIOL CHEM, V273, P16544, DOI 10.1074/jbc.273.26.16544; Hengst L, 1998, GENE DEV, V12, P3882, DOI 10.1101/gad.12.24.3882; Holland EC, 2001, NAT REV GENET, V2, P120, DOI 10.1038/35052535; Jakel H, 2011, ONCOGENE, V30, P3502, DOI 10.1038/onc.2011.68; James MK, 2008, MOL CELL BIOL, V28, P498, DOI 10.1128/MCB.02171-06; Jones JM, 1999, CELL GROWTH DIFFER, V10, P213; Kardinal C, 2006, BLOOD, V107, P1133, DOI 10.1182/blood-2005-05-1771; Kavurma MM, 2004, J CELL BIOCHEM, V93, P904, DOI 10.1002/jcb.20238; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lacy ER, 2005, J MOL BIOL, V349, P764, DOI 10.1016/j.jmb.2005.04.019; Lacy ER, 2004, NAT STRUCT MOL BIOL, V11, P358, DOI 10.1038/nsmb746; Landis MW, 2006, CANCER CELL, V9, P13, DOI 10.1016/j.ccr.2005.12.019; Larrea MD, 2008, MOL CELL BIOL, V28, P6462, DOI 10.1128/MCB.02300-07; Lee S, 2004, J BIOL CHEM, V279, P1885, DOI 10.1074/jbc.M306968200; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Liu Y, 2007, EMBO J, V26, P4683, DOI 10.1038/sj.emboj.7601886; Moeller SJ, 2003, MOL CELL BIOL, V23, P3735, DOI 10.1128/MCB.23.11.3735-3752.2003; Muraoka RS, 2002, MOL CELL BIOL, V22, P2204, DOI 10.1128/MCB.22.7.2204-2219.2002; Ou L, 2011, J BIOL CHEM, V286, P30142, DOI 10.1074/jbc.M111.244095; Perkins ND, 2002, CELL CYCLE, V1, P39, DOI 10.4161/cc.1.1.98; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Robinson S, 2001, NEUROSURGERY, V48, P864, DOI 10.1097/00006123-200104000-00035; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Salpietro Maria, 2005, Clin Neurosurg, V52, P104; See WL, 2010, ONCOGENE, V29, P1720, DOI 10.1038/onc.2009.465; See WL, 2010, CELL CYCLE, V9, P1562, DOI 10.4161/cc.9.8.11259; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shim J, 1996, NATURE, V381, P804, DOI 10.1038/381804a0; Soos T J, 1998, Results Probl Cell Differ, V22, P111; Soos TJ, 1996, CELL GROWTH DIFFER, V7, P135; TUDOS E, 1990, INT J PEPT PROT RES, V36, P236; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vidal A, 2005, P NATL ACAD SCI USA, V102, P6890, DOI 10.1073/pnas.0405823102; Wang YF, 2011, NAT CHEM BIOL, V7, P214, DOI 10.1038/NCHEMBIO.536; Weiss RH, 2000, J BIOL CHEM, V275, P10285, DOI 10.1074/jbc.275.14.10285	56	15	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38523	38530		10.1074/jbc.M112.366542	http://dx.doi.org/10.1074/jbc.M112.366542			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23007395	Green Published, hybrid			2022-12-28	WOS:000310982800012
J	Obara, K; Yamamoto, H; Kihara, A				Obara, Keisuke; Yamamoto, Hayashi; Kihara, Akio			Membrane Protein Rim21 Plays a Central Role in Sensing Ambient pH in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPERGILLUS-NIDULANS; GENE-EXPRESSION; PLASMA-MEMBRANE; RIM101 PATHWAY; YEAST; COMPLEX; ACTIVATION; TOPOLOGY; SYSTEM; FUNGI	External alkalization activates the Rim101 pathway in Saccharomyces cerevisiae. In this pathway, three integral membrane proteins, Rim21, Dfg16, and Rim9, are considered to be the components of the pH sensor machinery. However, how these proteins are involved in pH sensing is totally unknown. In this work, we investigated the localization, physical interaction, and interrelationship of Rim21, Dfg16, and Rim9. These proteins were found to form a complex and to localize to the plasma membrane in a patchy and mutually dependent manner. Their cellular level was also mutually dependent. In particular, the Rim21 level was significantly decreased in dfg16 Delta and rim9 Delta cells. Upon external alkalization, the proteins were internalized and degraded. We also demonstrate that the transient degradation of Rim21 completely suppressed the Rim101 pathway but that the degradation of Dfg16 or Rim9 did not. This finding strongly suggests that Rim21 is the pH sensor protein and that Dfg16 and Rim9 play auxiliary functions through maintaining the level of Rim21 and assisting in its plasma membrane localization. Even without external alkalization, the Rim101 pathway was activated in a Rim21-dependent manner by either protonophore treatment or depletion of phosphatidylserine in the inner leaflet of the plasma membrane, both of which caused plasma membrane depolarization like the external alkalization. Therefore, plasma membrane depolarization seems to be one of the key signals for the pH sensor molecule Rim21.	[Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Yamamoto, Hayashi] Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 2268503, Japan	Hokkaido University; Tokyo Institute of Technology	Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Kita 12 Jo,Nishi 6 Chome, Sapporo, Hokkaido 0600812, Japan.	kihara@pharm.hokudai.ac.jp	Obara, Keisuke/A-3824-2012; KIHARA, AKIO/A-3802-2012	KIHARA, AKIO/0000-0001-5889-0788	Japan Society for the Promotion of Science (JSPS) [23770135, 23657120]; The Naito Foundation Subsidy for Promotion of Specific Research Projects from The Naito Foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); The Naito Foundation Subsidy for Promotion of Specific Research Projects from The Naito Foundation	This work was supported by Grant-in-aid for Young Scientists (B) 23770135 (to K. O.) and Grant-in-aid for Challenging Exploratory Research 23657120 (to A. K.) from the Japan Society for the Promotion of Science (JSPS) and The Naito Foundation Subsidy for Promotion of Specific Research Projects from The Naito Foundation (to K. O.).	Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Barwell KJ, 2005, EUKARYOT CELL, V4, P890, DOI 10.1128/EC.4.5.890-899.2005; Calcagno-Pizarelli AM, 2007, EUKARYOT CELL, V6, P2365, DOI 10.1128/EC.00275-07; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Davis DA, 2009, CURR OPIN MICROBIOL, V12, P365, DOI 10.1016/j.mib.2009.05.006; Gurtovenko AA, 2008, J PHYS CHEM B, V112, P4629, DOI 10.1021/jp8001993; Han GS, 2004, J BIOL CHEM, V279, P53707, DOI 10.1074/jbc.M410014200; Hanson PK, 2001, J BIOL CHEM, V276, P9861, DOI 10.1074/jbc.M009065200; Hayashi M, 2005, MOL CELL BIOL, V25, P9478, DOI 10.1128/MCB.25.21.9478-9490.2005; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Herranz S, 2005, P NATL ACAD SCI USA, V102, P12141, DOI 10.1073/pnas.0504776102; HIKIJI T, 1988, J BIOCHEM-TOKYO, V104, P894, DOI 10.1093/oxfordjournals.jbchem.a122579; Ikeda M, 2008, MOL BIOL CELL, V19, P1922, DOI 10.1091/mbc.E07-08-0806; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kihara A, 2008, J BIOL CHEM, V283, P11199, DOI 10.1074/jbc.M708993200; Lamb TM, 2003, MOL CELL BIOL, V23, P677, DOI 10.1128/MCB.23.2.677-686.2003; Lamb TM, 2001, J BIOL CHEM, V276, P1850, DOI 10.1074/jbc.M008381200; LETTS VA, 1983, P NATL ACAD SCI-BIOL, V80, P7279, DOI 10.1073/pnas.80.23.7279; Li WS, 1997, GENETICS, V145, P63; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Negrete-Urtasun S, 1999, MOL MICROBIOL, V33, P994, DOI 10.1046/j.1365-2958.1999.01540.x; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Obara K, 2006, MOL BIOL CELL, V17, P1527, DOI 10.1091/mbc.E05-09-0841; Penalva MA, 2002, MICROBIOL MOL BIOL R, V66, P426, DOI 10.1128/MMBR.66.3.426-446.2002; Penalva MA, 2004, ANNU REV MICROBIOL, V58, P425, DOI 10.1146/annurev.micro.58.030603.123715; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Serrano R, 2002, MOL MICROBIOL, V46, P1319, DOI 10.1046/j.1365-2958.2002.03246.x; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; SIKORSKI RS, 1989, GENETICS, V122, P19; Stevens HC, 2007, J BIOL CHEM, V282, P17563, DOI 10.1074/jbc.M700454200; Treton B, 2000, MOL GEN GENET, V263, P505, DOI 10.1007/s004380051195; Walther TC, 2006, NATURE, V439, P998, DOI 10.1038/nature04472; Weiss P, 2009, BIOCHEM J, V424, P89, DOI 10.1042/BJ20090957; Xu WJ, 2001, J BACTERIOL, V183, P6917, DOI 10.1128/JB.183.23.6917-6923.2001; Xu WJ, 2004, MOL BIOL CELL, V15, P5528, DOI 10.1091/mbc.E04-08-0666; Yamagata M, 2011, BIOCHEM BIOPH RES CO, V410, P786, DOI 10.1016/j.bbrc.2011.06.061	37	51	52	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38473	38481		10.1074/jbc.M112.394205	http://dx.doi.org/10.1074/jbc.M112.394205			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23019326	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000310982800007
J	Valton, J; Dupuy, A; Daboussi, F; Thomas, S; Marechal, A; Macmaster, R; Melliand, K; Juillerat, A; Duchateau, P				Valton, Julien; Dupuy, Aurelie; Daboussi, Fayza; Thomas, Severine; Marechal, Alan; Macmaster, Rachel; Melliand, Kevin; Juillerat, Alexandre; Duchateau, Philippe			Overcoming Transcription Activator-like Effector (TALE) DNA Binding Domain Sensitivity to Cytosine Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE; CANCER; RECOGNITION	Within the past 2 years, transcription activator-like effector (TALE) DNA binding domains have emerged as the new generation of engineerable platform for production of custom DNA binding domains. However, their recently described sensitivity to cytosine methylation represents a major bottleneck for genome engineering applications. Using a combination of biochemical, structural, and cellular approaches, we were able to identify the molecular basis of such sensitivity and propose a simple, drug-free, and universal method to overcome it.	[Valton, Julien; Dupuy, Aurelie; Daboussi, Fayza; Thomas, Severine; Marechal, Alan; Macmaster, Rachel; Melliand, Kevin; Juillerat, Alexandre; Duchateau, Philippe] Cellectis SA, F-75013 Paris, France		Valton, J (corresponding author), Cellectis SA, 8 Rue Croix Jarry, F-75013 Paris, France.	julien.valton@cellectis.com; philippe.duchateau@cellectis.com		Valton, Julien/0000-0003-0826-5401; Daboussi, Fayza/0000-0001-7689-7975				Arosio D, 2004, J BIOL CHEM, V279, P42826, DOI 10.1074/jbc.M406529200; BARDSLEY WG, 1987, J THEOR BIOL, V126, P183, DOI 10.1016/S0022-5193(87)80228-X; Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Bultmann S, 2012, NUCLEIC ACIDS RES, V40, P5368, DOI 10.1093/nar/gks199; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Grizot S, 2009, NUCLEIC ACIDS RES, V37, P5405, DOI 10.1093/nar/gkp548; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Khan SG, 2002, NUCLEIC ACIDS RES, V30, P3624, DOI 10.1093/nar/gkf469; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Morbitzer R, 2010, P NATL ACAD SCI USA, V107, P21617, DOI 10.1073/pnas.1013133107; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Murakami MT, 2010, PROTEINS, V78, P3386, DOI 10.1002/prot.22846; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Ohm JE, 2010, CANCER RES, V70, P7662, DOI 10.1158/0008-5472.CAN-10-1361; Palii SS, 2008, MOL CELL BIOL, V28, P752, DOI 10.1128/MCB.01799-07; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Valton J, 2012, J BIOL CHEM, V287, P30139, DOI 10.1074/jbc.M112.379966; Vanyushin BF, 2011, BBA-GENE REGUL MECH, V1809, P360, DOI 10.1016/j.bbagrm.2011.04.006; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	26	145	174	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38427	38432		10.1074/jbc.C112.408864	http://dx.doi.org/10.1074/jbc.C112.408864			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23019344	Green Published, hybrid			2022-12-28	WOS:000310982800002
J	Ma, F; Wu, D; Deng, LW; Secrest, P; Zhao, J; Varki, N; Lindheim, S; Gagneux, P				Ma, Fang; Wu, Diana; Deng, Liwen; Secrest, Patrick; Zhao, June; Varki, Nissi; Lindheim, Steven; Gagneux, Pascal			Sialidases on Mammalian Sperm Mediate Deciduous Sialylation during Capacitation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO CAPACITATION; SIALIC-ACID; LEUKOCYTIC REACTION; MOUSE SPERMATOZOA; BINDING-SITE; SURFACE; IDENTIFICATION; GANGLIOSIDE; EXPRESSION; PROTEINS	Sialic acids (Sias) mediate many biological functions, including molecular recognition during development, immune response, and fertilization. A Sia-rich glycocalyx coats the surface of sperm, allowing them to survive as allogeneic cells in the female reproductive tract despite female immunity. During capacitation, sperm lose a fraction of their Sias. We quantified shed Sia monosaccharides released from capacitated sperm and measured sperm sialidase activity. We report the presence of two sialidases (neuraminidases Neu1 and Neu3) on mammalian sperm. These are themselves shed from sperm during capacitation. Inhibiting sialidase activity interferes with sperm binding to the zona pellucida of the ovum. A survey of human sperm samples for the presence of sialidases NEU1 and NEU3 identified a lack of one or both sialidases in sperm of some male idiopathic infertility cases. The results contribute new insights into the dynamic remodeling of the sperm glycocalyx prior to fertilization.	[Ma, Fang; Deng, Liwen; Secrest, Patrick; Varki, Nissi; Gagneux, Pascal] Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Ma, Fang; Deng, Liwen; Secrest, Patrick; Varki, Nissi; Gagneux, Pascal] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Zhao, June] Univ Calif San Diego, Dept Transgen Mouse Core, La Jolla, CA 92093 USA; [Wu, Diana; Lindheim, Steven] Univ Cincinnati, Ctr Reprod Hlth, Cincinnati, OH 45219 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University System of Ohio; University of Cincinnati	Gagneux, P (corresponding author), Univ Calif San Diego, Glycobiol Res & Training Ctr, 9500 Gilman Dr, La Jolla, CA 92093 USA.	pgagneux@ucsd.edu		Deng, Liwen/0000-0002-7984-8471; Ma, Fang/0000-0002-7781-821X	National Institutes of Health [R01 GM095882, P30 NS047101]; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM095882. This work was also supported by the G. Harold and Leila Y. Mathers Charitable Foundation.; We gratefully acknowledge the Neuroscience Microscopy Facility of the University of California, San Diego (supported by National Institutes of Health Grant P30 NS047101). We thank Stevan Springer for help with the figures.	BERNAL A, 1980, BIOL REPROD, V23, P290, DOI 10.1095/biolreprod23.2.290; Brandtzaeg P, 1997, J REPROD IMMUNOL, V36, P23, DOI 10.1016/S0165-0378(97)00061-2; Cheng MC, 1998, ANAL BIOCHEM, V260, P154, DOI 10.1006/abio.1998.2701; Chiu PCN, 2007, J BIOL CHEM, V282, P5378, DOI 10.1074/jbc.M607482200; Coutinho MF, 2012, CLIN GENET, V81, P379, DOI 10.1111/j.1399-0004.2011.01625.x; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; DAVIS BK, 1980, P NATL ACAD SCI-BIOL, V77, P1546, DOI 10.1073/pnas.77.3.1546; Drobnis E Z, 1992, Oxf Rev Reprod Biol, V14, P1; FAMILIARI G, 1980, ACTA BIOL ACAD SCI H, V31, P57; FOCARELLI R, 1995, HUM REPROD, V10, P2755, DOI 10.1093/oxfordjournals.humrep.a135787; FOCARELLI R, 1990, J ANDROL, V11, P97; FOURNIER.S, 1973, CR SOC BIOL, V167, P1989; GANGULY S, 1976, ACTA ENDOCRINOL-COP, V81, P574, DOI 10.1530/acta.0.0810574; Velasquez JG, 2007, MOL REPROD DEV, V74, P617, DOI 10.1002/mrd.20619; Hasegawa T, 2000, J BIOL CHEM, V275, P8007, DOI 10.1074/jbc.275.11.8007; LASSALLE B, 1994, J REPROD FERTIL, V101, P703; Lewis AL, 2004, P NATL ACAD SCI USA, V101, P11123, DOI 10.1073/pnas.0403010101; MANZI AE, 1990, ANAL BIOCHEM, V188, P20, DOI 10.1016/0003-2697(90)90523-C; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; Miyagi T., 2012, GLYCOCONJ J IN PRESS; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; Moore ML, 2007, J IMMUNOL, V178, P2651, DOI 10.4049/jimmunol.178.5.2651; MUNNE S, 1993, HUM REPROD, V8, P581, DOI 10.1093/oxfordjournals.humrep.a138100; Nixon B, 2006, BIOL REPROD, V74, P275, DOI 10.1095/biolreprod.105.044644; Osheroff JE, 1999, MOL HUM REPROD, V5, P1017, DOI 10.1093/molehr/5.11.1017; PANDYA IJ, 1985, FERTIL STERIL, V43, P417; Pang PC, 2011, SCIENCE, V333, P1761, DOI 10.1126/science.1207438; Ram S, 1998, J EXP MED, V187, P743, DOI 10.1084/jem.187.5.743; Schauer R, 2004, ZOOLOGY, V107, P49, DOI 10.1016/j.zool.2003.10.002; SCHAUER R, 1982, ADV CARBOHYD CHEM BI, V40, P131, DOI 10.1016/S0065-2318(08)60109-2; Schroter S, 1999, J BIOL CHEM, V274, P29862, DOI 10.1074/jbc.274.42.29862; Schroter S, 1999, HUM REPROD UPDATE, V5, P302, DOI 10.1093/humupd/5.4.302; Shetty J, 2001, ELECTROPHORESIS, V22, P3053, DOI 10.1002/1522-2683(200108)22:14<3053::AID-ELPS3053>3.0.CO;2-K; Singavarapu R, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-98; SRIVASTAVA PN, 1970, BIOCHEM BIOPH RES CO, V39, P575, DOI 10.1016/0006-291X(70)90242-1; Stamatos NM, 2010, J LEUKOCYTE BIOL, V88, P1227, DOI 10.1189/jlb.1209776; Tash JS, 1998, BIOCHEM BIOPH RES CO, V251, P557, DOI 10.1006/bbrc.1998.9516; THOMPSON LA, 1992, AM J REPROD IMMUNOL, V28, P85, DOI 10.1111/j.1600-0897.1992.tb00765.x; Tijani HA, 2010, HUM FERTIL, V13, P226, DOI 10.3109/14647273.2010.533811; TOSHIMORI K, 1991, ARCH ANDROLOGY, V27, P79, DOI 10.3109/01485019108987656; Varki A, 2009, ESSENTIALS GLYCOBIOL, P199; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Wang JF, 2009, J IMMUNOL, V182, P4036, DOI 10.4049/jimmunol.0802981; Yamauchi Y, 2007, BIOL REPROD, V77, P636, DOI 10.1095/biolreprod.107.062406; Yudin AI, 2005, BIOL REPROD, V73, P1243, DOI 10.1095/biolreprod.105.042432	45	48	54	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.380584	http://dx.doi.org/10.1074/jbc.M112.380584			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22989879	hybrid, Green Published			2022-12-28	WOS:000310642200041
J	Wu, ZT; Yang, M; Liu, HJ; Guo, HC; Wang, Y; Cheng, H; Chen, LY				Wu, Zhaoting; Yang, Meng; Liu, Hongjie; Guo, Hongchao; Wang, Yuan; Cheng, Hong; Chen, Lingyi			Role of Nuclear Receptor Coactivator 3 (Ncoa3) in Pluripotency Maintenance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTIONAL COACTIVATOR; GENE-EXPRESSION; SELF-RENEWAL; PROTEIN METHYLTRANSFERASE; SRC-3/AIB1 COACTIVATOR; P160 COACTIVATORS; HORMONE RECEPTOR; OCT4 EXPRESSION; MOUSE EMBRYOS	Nuclear receptors, including Esrrb, Dax1, and Nr5a2, have been shown to be involved in pluripotency maintenance. Yet, the role of their coactivators in mouse embryonic stem cells remains unexplored. Here, we demonstrated that the nuclear receptor coactivator 3 (Ncoa3) is essential for pluripotency maintenance. Knockdown of Ncoa3 not only compromises the expression of pluripotency markers but also impairs in vitro and in vivo differentiation potential of mouse ESCs. Ncoa3 binds to the Nanog promoter and recruits the histone acetyltransferase CREB binding protein (CBP) and the histone arginine methyltransferase CARM1 to activate Nanog expression. Moreover, glycogen synthase kinase 3 GSK3 signaling down-regulates the Ncoa3 protein level to suppress Nanog expression. Thus, Ncoa3 not only contributes to self-renewal by activating Nanog but also facilitates ESC differentiation as a break point to disrupt the core transcriptional circuitry of pluripotency.	[Wu, Zhaoting; Yang, Meng; Liu, Hongjie; Guo, Hongchao; Chen, Lingyi] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Wu, Zhaoting; Yang, Meng; Liu, Hongjie; Guo, Hongchao; Chen, Lingyi] Nankai Univ, Collaborat Innovat Ctr Tianjin Med Epigenet 2011, Tianjin 300071, Peoples R China; [Wang, Yuan] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Wang, Yuan] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Cheng, Hong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Cell Biol, Shanghai 200031, Peoples R China	Nankai University; Nankai University; East China Normal University; East China Normal University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chen, LY (corresponding author), Nankai Univ, Coll Life Sci, 94 Weijin Rd, Tianjin 300071, Peoples R China.	lingyichen@nankai.edu.cn	Guo, Hongchao/AAG-8981-2020; Guo, Hongchao/AAM-4717-2020; Chen, Lingyi/G-6309-2013	Guo, Hongchao/0000-0002-8884-7358; wang, Yuan/0000-0002-0939-1269; Yang, Meng/0000-0003-3669-721X	National Natural Science Foundation of China [90919009, 31271547]; National Basic Research Program of China [2009CB941000, 2010CB833603]; Ministry of Agriculture of China [2009ZX08006-010B, 2009ZX08006-011B]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This work was supported by National Natural Science Foundation of China Grant 90919009 and 31271547, by National Basic Research Program of China Grants 2009CB941000 and 2010CB833603, and by the Transgenic Program from Ministry of Agriculture of China Grants 2009ZX08006-010B and 2009ZX08006-011B.	Anafi M, 2000, MOL ENDOCRINOL, V14, P718, DOI 10.1210/me.14.5.718; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Belandia B, 2000, J BIOL CHEM, V275, P30801, DOI 10.1074/jbc.C000484200; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Chen LY, 2009, CELL RES, V19, P1052, DOI 10.1038/cr.2009.79; Chen SL, 2000, GENE DEV, V14, P1209; Chen XA, 2010, MOL ENDOCRINOL, V24, P1917, DOI 10.1210/me.2010-0201; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; de Mora JF, 2000, MOL CELL BIOL, V20, P5041, DOI 10.1128/MCB.20.14.5041-5047.2000; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Gehin M, 2002, MOL CELL BIOL, V22, P5923, DOI 10.1128/MCB.22.16.5923-5937.2002; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Guan XY, 1996, CANCER RES, V56, P3446; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kelly VR, 2010, MOL ENDOCRINOL, V24, P2281, DOI 10.1210/me.2010-0133; Khalfallah O, 2009, STEM CELLS, V27, P1529, DOI 10.1002/stem.78; Kim JH, 2003, MOL CELL, V12, P1537, DOI 10.1016/S1097-2765(03)00450-7; Koh SS, 2001, J BIOL CHEM, V276, P1089, DOI 10.1074/jbc.M004228200; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; Lu R, 2011, J BIOL CHEM, V286, P8425, DOI 10.1074/jbc.M110.202150; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Naeem H, 2007, MOL CELL BIOL, V27, P120, DOI 10.1128/MCB.00815-06; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2001, DEVELOPMENT, V128, P2333; Oh AS, 2008, MOL CELL BIOL, V28, P6580, DOI 10.1128/MCB.00118-08; ONATE SA, 1995, SCIENCE, V270, P1354; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Sun CH, 2009, MOL CELL BIOL, V29, P4574, DOI 10.1128/MCB.01863-08; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; van den Berg DLC, 2008, MOL CELL BIOL, V28, P5986, DOI 10.1128/MCB.00301-08; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wagner RT, 2010, STEM CELLS, V28, P1794, DOI 10.1002/stem.502; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang ZY, 2000, P NATL ACAD SCI USA, V97, P13549, DOI 10.1073/pnas.260463097; Wu HJ, 2006, J BIOL CHEM, V281, P21848, DOI 10.1074/jbc.M603772200; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Wu RC, 2004, MOL CELL, V15, P937, DOI 10.1016/j.molcel.2004.08.019; Xie CQ, 2009, MOL ENDOCRINOL, V23, P724, DOI 10.1210/me.2008-0465; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; York B, 2010, J BIOL CHEM, V285, P38743, DOI 10.1074/jbc.R110.193367; Zhang XF, 2008, J BIOL CHEM, V283, P35825, DOI 10.1074/jbc.M803481200	53	33	35	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.373092	http://dx.doi.org/10.1074/jbc.M112.373092			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22977234	Green Published, hybrid			2022-12-28	WOS:000310642200062
J	Bojesen, KB; Clausen, O; Rohde, K; Christensen, C; Zhang, LJ; Li, SZ; Kohler, L; Nielbo, S; Nielsen, J; Gjorlund, MD; Poulsen, FM; Bock, E; Berezin, V				Bojesen, Kirsten B.; Clausen, Ole; Rohde, Kristian; Christensen, Claus; Zhang, Lanjun; Li, Shizhong; Kohler, Lene; Nielbo, Steen; Nielsen, Janne; Gjorlund, Michelle D.; Poulsen, Flemming M.; Bock, Elisabeth; Berezin, Vladimir			Nectin-1 Binds and Signals through the Fibroblast Growth Factor Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULES; FGF-RECEPTOR; NEURITE OUTGROWTH; V-DOMAIN; AFADIN; IMMUNOGLOBULIN; EXPRESSION; INTERACTS; CADHERIN; FAMILY	Nectins belong to a family of immunoglobulin (Ig)-like celladhesion molecules comprising four members, nectin-1 through nectin-4. Nectins are involved in formation of the mechanical adhesive puncta adherentia junctions of synapses. Nectins share the same overall structural topology with an extracellular region containing three Ig modules, a transmembrane region, and a cytoplasmic region. In nectin-1, the first and second Ig module in the extracellular region are necessary for the trans-interaction with nectin-3 and formation of cis-dimers, respectively. The function of the third Ig module of nectin-1 remains unknown. We here report the structure in solution of the third, membrane-proximal Ig module of mouse nectin-1 (nectin-1 Ig3) solved by means of nuclear magnetic resonance (NMR) spectroscopy. It belongs to the C1 set of the Ig superfamily. Nectin-1 Ig3 was produced as a recombinant protein and induced neurite outgrowth in primary cultures of hippocampal and cerebellar granule neurons, an effect abolished by treatment with the fibroblast growth factor receptor (FGFR) inhibitor SU5402, or by transfection with a dominant-negative FGFR1 construct. We showed by surface plasmon resonance (SPR) analysis that nectin-1 Ig3 directly interacted with various isoforms of FGFR. Nectin-1 Ig3 induced phosphorylation of FGFR1c in the same manner as the whole nectin-1 ectodomain, and promoted survival of cerebellar granule neurons induced to undergo apoptosis. Finally, we constructed a peptide, nectide, by employing in silico modeling of various FGFR ligand-binding sites. Nectide mimicked all the effects of nectin-1 Ig3. We suggest that FGFR is a downstream signaling partner of nectin-1.	[Bojesen, Kirsten B.; Clausen, Ole; Rohde, Kristian; Christensen, Claus; Zhang, Lanjun; Li, Shizhong; Kohler, Lene; Nielsen, Janne; Gjorlund, Michelle D.; Bock, Elisabeth; Berezin, Vladimir] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, Prot Lab, DK-2200 Copenhagen, Denmark; [Clausen, Ole; Nielbo, Steen; Poulsen, Flemming M.] Univ Copenhagen, Dept Biol, SBiN Lab, DK-2200 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Berezin, V (corresponding author), Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, Prot Lab, Blegdamsvej 3C, DK-2200 Copenhagen, Denmark.	berezin@sund.ku.dk	Nielsen, Janne/J-5987-2014	Nielsen, Janne/0000-0001-8521-7353; Rohde, Kristian/0000-0002-5077-0607; Bojesen, Kirsten/0000-0002-7996-3154	Seventh Framework Programme (FP7) European Union Collaborative Project MemStick Grant [201600]; Lundbeck Foundation; Danish Research Councils; John and Birthe Meyer Foundation; Carlsberg Foundation	Seventh Framework Programme (FP7) European Union Collaborative Project MemStick Grant; Lundbeck Foundation(Lundbeckfonden); Danish Research Councils(Det Frie Forskningsrad (DFF)); John and Birthe Meyer Foundation; Carlsberg Foundation(Carlsberg Foundation)	This work was supported by Seventh Framework Programme (FP7) European Union Collaborative Project MemStick Grant 201600, the Lundbeck Foundation, the Danish Research Councils, the John and Birthe Meyer Foundation, and the Carlsberg Foundation.	Chothia C, 1997, ANNU REV BIOCHEM, V66, P823, DOI 10.1146/annurev.biochem.66.1.823; CHOTHIA C, 1988, EMBO J, V7, P3745, DOI 10.1002/j.1460-2075.1988.tb03258.x; Christensen C, 2006, FEBS LETT, V580, P3386, DOI 10.1016/j.febslet.2006.05.008; Christensen C, 2011, NEUROREPORT, V22, P727, DOI 10.1097/WNR.0b013e3283491682; Contestabile Antonio, 2002, Cerebellum, V1, P41, DOI 10.1080/147342202753203087; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fabre S, 2002, J BIOL CHEM, V277, P27006, DOI 10.1074/jbc.M203228200; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Haarr L, 2001, VIROLOGY, V287, P301, DOI 10.1006/viro.2001.1041; Hossain MA, 1998, EUR J NEUROSCI, V10, P2490, DOI 10.1046/j.1460-9568.1998.00259.x; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Kanzaki N, 2008, J CELL SCI, V121, P2008, DOI 10.1242/jcs.024620; Kim J, 2011, J NEUROCHEM, V119, P945, DOI 10.1111/j.1471-4159.2011.07479.x; Kim J, 2010, J BIOL CHEM, V285, P22917, DOI 10.1074/jbc.M110.126649; Kirschbaum K, 2009, J BIOL CHEM, V284, P28533, DOI 10.1074/jbc.M109.004440; Kiselyov VV, 2006, PROTEIN SCI, V15, P2318, DOI 10.1110/ps.062206106; Kiselyov VV, 2005, J NEUROCHEM, V94, P1169, DOI 10.1111/j.1471-4159.2005.03284.x; Kiselyov VV, 2003, STRUCTURE, V11, P691, DOI 10.1016/S0969-2126(03)00096-0; KJAER M, 1994, METHODS ENZYMOL, V239, P288; Kruman I, 1997, J NEUROSCI, V17, P5089; Kulahin N, 2008, MOL CELL NEUROSCI, V37, P528, DOI 10.1016/j.mcn.2007.12.001; Li SZ, 2008, J NEUROCHEM, V104, P667, DOI 10.1111/j.1471-4159.2007.05070.x; Lim ST, 2012, J NEUROCHEM, V120, P741, DOI 10.1111/j.1471-4159.2011.07592.x; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Mizoguchi A, 2002, J CELL BIOL, V156, P555, DOI 10.1083/jcb.200103113; MORRISON ME, 1992, J VIROL, V66, P2807, DOI 10.1128/JVI.66.5.2807-2813.1992; Narita H, 2011, ACTA CRYSTALLOGR F, V67, P344, DOI 10.1107/S174430911100337X; Narita H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.197368; Neiiendam JL, 2004, J NEUROCHEM, V91, P920, DOI 10.1111/j.1471-4159.2004.02779.x; Olsen SK, 2004, P NATL ACAD SCI USA, V101, P935, DOI 10.1073/pnas.0307287101; Owczarek S, 2010, FASEB J, V24, P1139, DOI 10.1096/fj.09-140509; Reymond N, 2000, GENE, V255, P347, DOI 10.1016/S0378-1119(00)00316-4; Reymond N, 2001, J BIOL CHEM, V276, P43205, DOI 10.1074/jbc.M103810200; Ronn LCB, 1999, NAT BIOTECHNOL, V17, P1000, DOI 10.1038/13697; Ronn LCB, 2000, J NEUROSCI METH, V100, P25, DOI 10.1016/S0165-0270(00)00228-4; Saffell JL, 1997, NEURON, V18, P231, DOI 10.1016/S0896-6273(00)80264-0; Satoh-Horikawa K, 2000, J BIOL CHEM, V275, P10291, DOI 10.1074/jbc.275.14.10291; SCHOUSBOE A, 1989, NEUROCHEM RES, V14, P871, DOI 10.1007/BF00964817; Shukla D, 2006, APPL IMMUNOHISTO M M, V14, P341, DOI 10.1097/00129039-200609000-00014; Sleeman M, 2001, GENE, V271, P171, DOI 10.1016/S0378-1119(01)00518-2; Smith DK, 1997, J MOL BIOL, V274, P530, DOI 10.1006/jmbi.1997.1432; Suzuki K, 2000, NAT GENET, V25, P427, DOI 10.1038/78119; Tachibana K, 2000, J CELL BIOL, V150, P1161, DOI 10.1083/jcb.150.5.1161; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Togashi H, 2006, J CELL BIOL, V174, P141, DOI 10.1083/jcb.200601089; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; Yasumi M, 2003, BIOCHEM BIOPH RES CO, V302, P61, DOI 10.1016/S0006-291X(03)00106-2; YAZAKI N, 1994, J NEUROSCI RES, V37, P445, DOI 10.1002/jnr.490370403	52	27	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37420	37433		10.1074/jbc.M112.345215	http://dx.doi.org/10.1074/jbc.M112.345215			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22955284	hybrid, Green Published			2022-12-28	WOS:000310588500072
J	Gregory, KJ; Sexton, PM; Tobin, AB; Christopoulos, A				Gregory, Karen J.; Sexton, Patrick M.; Tobin, Andrew B.; Christopoulos, Arthur			Stimulus Bias Provides Evidence for Conformational Constraints in the Structure of a G Protein-coupled Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTORS; PARATHYROID-HORMONE RECEPTOR; BETA-ARRESTIN; 7-TRANSMEMBRANE RECEPTORS; FUNCTIONAL SELECTIVITY; DRUG DISCOVERY; N-DESMETHYLCLOZAPINE; ALLOSTERIC SITE; LIGAND; ACTIVATION	A key characteristic of G protein-coupled receptors (GPCRs) is that they activate a plethora of signaling pathways. It is now clear that a GPCR coupling to these pathways can be regulated selectively by ligands that differentially drive signaling down one pathway in preference to another. This concept, termed stimulus bias, is revolutionizing receptor biology and drug discovery by providing a means of selectively targeting receptor signaling pathways that have therapeutic impact. Herein, we utilized a novel quantitative method that determines stimulus bias of synthetic GPCR ligands in a manner that nullifies the impact of both the cellular background and the "natural bias" of the endogenous ligand. By applying this method to the M-2 muscarinic acetylcholine receptor, a prototypical GPCR, we found that mutation of key residues (Tyr-802.61 and Trp-993.28) in an allosteric binding pocket introduces stimulus bias in response to the atypical ligands AC-42 (4-n-butyl-1-(4-(2-methylphenyl)-4-oxo-1-butyl) piperidine HCl) and 77-LH-28-1 (1-(3-(4-butyl-1-piperidinyl) propyl)-3,3-dihydro-2(1H)-quinolinone). By comparing stimulus bias factors among receptor internalization, G protein activation, extracellular-regulated protein kinase 1/2 (ERK1/2) signaling, and receptor phosphorylation, we provide evidence that Tyr-802.61 and Trp-993.28 act either as molecular switches or as gatekeeper residues that introduce constraints limiting the active conformation of the M2 muscarinic acetylcholine receptor and thereby regulate stimulus bias. Furthermore, we provide evidence that downstream signaling pathways previously considered to be related to each other (i.e. receptor phosphorylation, internalization, and activation of ERK1/2) can act independently.	[Tobin, Andrew B.] Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England; [Gregory, Karen J.; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Clayton, Vic 3800, Australia; [Gregory, Karen J.; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Dept Pharmacol, Clayton, Vic 3800, Australia	University of Leicester; Monash University; Monash University	Tobin, AB (corresponding author), Univ Leicester, MRC, Toxicol Unit, Lancaster Rd, Leicester LE1 9HN, Leics, England.	tba@leicester.ac.uk; arthur.christopoulos@monash.edu	Sexton, Patrick M/B-1319-2008; Christopoulos, Arthur/B-6207-2013	Sexton, Patrick M/0000-0001-8902-2473; Christopoulos, Arthur/0000-0003-4442-3294; Gregory, Karen/0000-0002-3833-2137	National Health and Medical Research Council (NHMRC) of Australia [519461]; NHMRC; Dowd Foundation; Monash University; Medical Research Council (MRC), United Kingdom; MRC [MC_UP_A600_1110] Funding Source: UKRI; Medical Research Council [MC_UP_A600_1110] Funding Source: researchfish	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Dowd Foundation; Monash University(Monash University); Medical Research Council (MRC), United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Program Grant 519461 from the National Health and Medical Research Council (NHMRC) of Australia.; Recipient of an NHMRC biomedical postgraduate research scholarship, a Dowd Foundation postgraduate scholarship for neuroscience, and a Monash University postgraduate publication award.; Supported by the Medical Research Council (MRC), United Kingdom. To whom correspondence may be addressed: MRC Toxicology Unit, University of Leicester, Lancaster Rd., Leicester, LE1 9HN, United Kingdom. Tel.: 44-116-2522935; E-mail: tba@leicester.ac.uk.	[Anonymous], 2008, NAT REV DRUG DISCOV, V7, P339; Avlani V, 2004, J PHARMACOL EXP THER, V308, P1062, DOI 10.1124/jpet.103.059840; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Avlani VA, 2010, MOL PHARMACOL, V78, P94, DOI 10.1124/mol.110.064345; BARKER EL, 1994, J BIOL CHEM, V269, P11687; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Blanpain C, 2002, MOL BIOL CELL, V13, P723, DOI 10.1091/mbc.01-03-0129; Christopoulos A, 1998, TRENDS PHARMACOL SCI, V19, P351, DOI 10.1016/S0165-6147(98)01240-1; Evans BA, 2011, MOL PHARMACOL, V79, P298, DOI 10.1124/mol.110.067454; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Gesty-Palmer D, 2011, BRIT J PHARMACOL, V164, P59, DOI 10.1111/j.1476-5381.2011.01450.x; Gregory KJ, 2010, J BIOL CHEM, V285, P7459, DOI 10.1074/jbc.M109.094011; Kenakin T, 2005, NAT REV DRUG DISCOV, V4, P919, DOI 10.1038/nrd1875; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Koole C, 2010, MOL PHARMACOL, V78, P456, DOI 10.1124/mol.110.065664; LABRECQUE J, 1995, MOL PHARMACOL, V48, P150; Lebon G, 2009, MOL PHARMACOL, V75, P331, DOI 10.1124/mol.108.050963; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; MATSUI H, 1995, MOL PHARMACOL, V47, P88; May LT, 2007, MOL PHARMACOL, V72, P463, DOI 10.1124/mol.107.037630; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Rajagopal S, 2011, MOL PHARMACOL, V80, P367, DOI 10.1124/mol.111.072801; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Roettger BF, 1997, MOL PHARMACOL, V51, P357; Rosethorne EM, 2011, MOL PHARMACOL, V79, P749, DOI 10.1124/mol.110.068395; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Spalding TA, 2002, MOL PHARMACOL, V61, P1297, DOI 10.1124/mol.61.6.1297; Spalding TA, 2006, MOL PHARMACOL, V70, P1974, DOI 10.1124/mol.106.024901; Sur C, 2003, P NATL ACAD SCI USA, V100, P13674, DOI 10.1073/pnas.1835612100; Valant C, 2008, J BIOL CHEM, V283, P29312, DOI 10.1074/jbc.M803801200; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Violin JD, 2010, J PHARMACOL EXP THER, V335, P572, DOI 10.1124/jpet.110.173005; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104	37	25	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37066	37077		10.1074/jbc.M112.408534	http://dx.doi.org/10.1074/jbc.M112.408534			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22965232	Green Published, hybrid			2022-12-28	WOS:000310588500041
J	Konig, M; Holzhutter, HG				Koenig, Matthias; Holzhuetter, Hermann-Georg			Kinetic Modeling of Human Hepatic Glucose Metabolism in Type 2 Diabetes Mellitus Predicts Higher Risk of Hypoglycemic Events in Rigorous Insulin Therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTPRANDIAL HYPERGLYCEMIA; PYRUVATE-KINASE; GLUCAGON; GLUCONEOGENESIS; COUNTERREGULATION; SECRETION; COMPLICATIONS; SUPPRESSION; INFUSION; LOAD	A major problem in the insulin therapy of patients with diabetes type 2 (T2DM) is the increased occurrence of hypoglycemic events which, if left untreated, may cause confusion or fainting and in severe cases seizures, coma, and even death. To elucidate the potential contribution of the liver to hypoglycemia in T2DM we applied a detailed kinetic model of human hepatic glucose metabolism to simulate changes in glycolysis, gluconeogenesis, and glycogen metabolism induced by deviations of the hormones insulin, glucagon, and epinephrine from their normal plasma profiles. Our simulations reveal in line with experimental and clinical data from a multitude of studies in T2DM, (i) significant changes in the relative contribution of glycolysis, gluconeogenesis, and glycogen metabolism to hepatic glucose production and hepatic glucose utilization; (ii) decreased postprandial glycogen storage as well as increased glycogen depletion in overnight fasting and short term fasting; and (iii) a shift of the set point defining the switch between hepatic glucose production and hepatic glucose utilization to elevated plasma glucose levels, respectively, in T2DM relative to normal, healthy subjects. Intriguingly, our model simulations predict a restricted gluconeogenic response of the liver under impaired hormonal signals observed in T2DM, resulting in an increased risk of hypoglycemia. The inability of hepatic glucose metabolism to effectively counterbalance a decline of the blood glucose level becomes even more pronounced in case of tightly controlled insulin treatment. Given this Janus face mode of action of insulin, our model simulations underline the great potential that normalization of the plasma glucagon profile may have for the treatment of T2DM.	[Koenig, Matthias; Holzhuetter, Hermann-Georg] Charite, Inst Biochem, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Konig, M (corresponding author), Charite Crossover CCO, Virchowweg 6, D-10117 Berlin, Germany.	matthias.koenig@charite.de		Konig, Matthias/0000-0003-1725-179X; Holzhutter, Hermann-Georg/0000-0002-5054-6023	Federal Ministry of Education and Research (BMBF, Germany) under Virtual Liver Network VLN Grant [0315741]	Federal Ministry of Education and Research (BMBF, Germany) under Virtual Liver Network VLN Grant(Federal Ministry of Education & Research (BMBF))	This work was supported by the Federal Ministry of Education and Research (BMBF, Germany) under Virtual Liver Network VLN Grant 0315741.	Akram K, 2006, J DIABETES COMPLICAT, V20, P402, DOI 10.1016/j.jdiacomp.2005.08.005; Ali S, 2009, AM J PHYSIOL-ENDOC M, V296, pE415, DOI 10.1152/ajpendo.90887.2008; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Basu A, 2009, DIABETES CARE, V32, P866, DOI 10.2337/dc08-1826; Basu R, 2004, DIABETES, V53, P2042, DOI 10.2337/diabetes.53.8.2042; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; BEAVO JA, 1974, P NATL ACAD SCI USA, V71, P3580, DOI 10.1073/pnas.71.9.3580; Boden G, 2001, AM J PHYSIOL-ENDOC M, V280, pE23, DOI 10.1152/ajpendo.2001.280.1.E23; BOGARDUS C, 1984, J CLIN INVEST, V74, P1238, DOI 10.1172/JCI111533; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; BUTLER PC, 1991, DIABETES, V40, P73, DOI 10.2337/diabetes.40.1.73; CONSOLI A, 1989, DIABETES, V38, P550, DOI 10.2337/diabetes.38.5.550; Cryer PE, 2003, DIABETES CARE, V26, P1902, DOI 10.2337/diacare.26.6.1902; CRYER PE, 1993, AM J PHYSIOL, V264, pE149, DOI 10.1152/ajpendo.1993.264.2.E149; Cryer PE, 2007, NAT CLIN PRACT ENDOC, V3, P4, DOI 10.1038/ncpendmet0355; DCCT Res Grp, 1991, AM J MED, V90, P450, DOI 10.1016/0002-9343(91)80085-Z; Degenhardt TP, 1998, CELL MOL BIOL, V44, P1139; Degn KB, 2004, DIABETES, V53, P2397, DOI 10.2337/diabetes.53.9.2397; FERRANNINI E, 1988, METABOLISM, V37, P79, DOI 10.1016/0026-0495(88)90033-9; FERY F, 1993, METABOLISM, V42, P522, DOI 10.1016/0026-0495(93)90113-3; Gastaldelli A, 2006, J CLIN ENDOCR METAB, V91, P806, DOI 10.1210/jc.2005-1159; Gastaldelli A, 2001, DIABETES, V50, P1807, DOI 10.2337/diabetes.50.8.1807; GERICH JE, 1993, BAILLIERE CLIN ENDOC, V7, P551, DOI 10.1016/S0950-351X(05)80207-1; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Henkel E, 2005, METABOLISM, V54, P1168, DOI 10.1016/j.metabol.2005.03.024; Hirsch IB, 2005, NEW ENGL J MED, V352, P174, DOI 10.1056/NEJMra040832; ISHIBASHI H, 1978, J BIOL CHEM, V253, P8767; Israelian Z, 2006, METABOLISM, V55, P593, DOI 10.1016/j.metabol.2005.11.013; Jones TW, 1998, NEW ENGL J MED, V338, P1657, DOI 10.1056/NEJM199806043382303; Knop FK, 2007, DIABETOLOGIA, V50, P797, DOI 10.1007/s00125-006-0566-z; Konig M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002577; Krssak M, 2004, DIABETES, V53, P3048, DOI 10.2337/diabetes.53.12.3048; Lerche S, 2009, CLIN ENDOCRINOL, V71, P500, DOI 10.1111/j.1365-2265.2008.03510.x; Levy CJ, 1998, DIABETES CARE, V21, P1330, DOI 10.2337/diacare.21.8.1330; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; MITRAKOU A, 1992, NEW ENGL J MED, V326, P22, DOI 10.1056/NEJM199201023260104; MITRAKOU A, 1991, AM J PHYSIOL, V260, pE67, DOI 10.1152/ajpendo.1991.260.1.E67; MULLER WA, 1970, NEW ENGL J MED, V283, P109, DOI 10.1056/NEJM197007162830301; NAUCK MA, 1993, DIABETOLOGIA, V36, P741, DOI 10.1007/BF00401145; Nuttall FQ, 2008, DIABETES-METAB RES, V24, P438, DOI 10.1002/dmrr.863; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Rizza RA, 2010, DIABETES, V59, P2697, DOI 10.2337/db10-1032; Segel SA, 2002, DIABETES, V51, P724, DOI 10.2337/diabetes.51.3.724; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Skyler JS, 1996, ENDOCRIN METAB CLIN, V25, P243, DOI 10.1016/S0889-8529(05)70323-6; Sloop KW, 2005, EXPERT OPIN THER TAR, V9, P593, DOI 10.1517/14728222.9.3.593; Spellman CW, 2010, J AM OSTEOPATH ASSOC, V110, pS2; Swinnen SG, 2009, DIABETES CARE, V32, pS253, DOI 10.2337/dc09-S318; VANBERKEL TJC, 1978, EUR J BIOCHEM, V92, P553; Wajngot A, 2001, METABOLISM, V50, P47, DOI 10.1053/meta.2001.19422; Woerle HJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE67, DOI 10.1152/ajpendo.00529.2004; Yan H, 2009, J PHARMACOL EXP THER, V329, P102, DOI 10.1124/jpet.108.147009	52	10	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36978	36989		10.1074/jbc.M112.382069	http://dx.doi.org/10.1074/jbc.M112.382069			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22977253	Green Published, hybrid			2022-12-28	WOS:000310588500033
J	Gagan, J; Dey, BK; Layer, R; Yan, Z; Dutta, A				Gagan, Jeffrey; Dey, Bijan K.; Layer, Ryan; Yan, Zhen; Dutta, Anindya			Notch3 and Mef2c Proteins Are Mutually Antagonistic via Mkp1 Protein and miR-1/206 MicroRNAs in Differentiating Myoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE PROGENITOR CELLS; HELIX-LOOP-HELIX; TRANSCRIPTION FACTOR; SATELLITE CELL; MYOGENIC BHLH; ACTIVATION; P38; BINDING; GENE; REGENERATION	The Notch signaling pathway is a well known regulator of skeletal muscle stem cells known as satellite cells. Loss of Notch1 signaling leads to spontaneous myogenic differentiation. Notch1, normally expressed in satellite cells, is targeted for proteasomal degradation by Numb during differentiation. A homolog of Notch1, Notch3, is also expressed in these cells but is not inhibited by Numb. We find that Notch3 is paradoxically up-regulated during the early stages of differentiation by an enhancer that requires both MyoD and activated Notch1. Notch3 itself strongly inhibits the myogenic transcription factor Mef2c, most likely by increasing the p38 phosphatase Mkp1, which inhibits the Mef2c activator p38 MAP kinase. Active Notch3 decreases differentiation. Mef2c, however, induces microRNAs miR-1 and miR-206, which directly down-regulate Notch3 and allow differentiation to proceed. Thus, the myogenic differentiation-induced microRNAs miR-1 and -206 are important for differentiation at least partly because they turn off Notch3. We suggest that the transient expression of Notch3 early in differentiation generates a temporal lag between myoblast activation by MyoD and terminal differentiation into myotubes directed by Mef2c.	[Gagan, Jeffrey; Dey, Bijan K.; Dutta, Anindya] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Layer, Ryan] Univ Virginia, Sch Med, Robert M Berne Cardiovasc Res Ctr, Dept Comp Sci, Charlottesville, VA 22908 USA; [Yan, Zhen] Univ Virginia, Sch Med, Robert M Berne Cardiovasc Res Ctr, Dept Med & Pharmacol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Dutta, A (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Robert M Berne Cardiovasc Res Ctr, 1334 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	ad8q@virginia.edu	Dutta, Anindya/P-3203-2016	Yan, Zhen/0000-0002-4826-9813; Dey, Bijan/0000-0001-9386-2475; Dutta, Anindya/0000-0002-4319-0073	National Institutes of Health [R01 AR053948, R01 AR050429]; Cell and Molecular Biology Training Grant [T32 GM008136]; Heart and Stroke Foundation of Canada; NATIONAL CANCER INSTITUTE [P30CA044579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053948, R01AR050429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008136, T32GM007267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cell and Molecular Biology Training Grant; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR053948 (to A. D.) and R01 AR050429 (to Z. Y.).; Supported by Cell and Molecular Biology Training Grant T32 GM008136.; Supported by a postdoctoral fellowship from the Heart and Stroke Foundation of Canada.	Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Boutet SC, 2012, CELL STEM CELL, V10, P327, DOI 10.1016/j.stem.2012.01.017; Briata P, 2012, CELL DEATH DIFFER, V19, P478, DOI 10.1038/cdd.2011.117; Brohl D, 2012, DEV CELL, V23, P469, DOI 10.1016/j.devcel.2012.07.014; Buas MF, 2010, EXP CELL RES, V316, P3028, DOI 10.1016/j.yexcr.2010.05.002; Cabane C, 2004, CELL SIGNAL, V16, P1405, DOI 10.1016/j.cellsig.2004.05.003; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; DOU SB, 1994, MOL CELL BIOL, V14, P3310, DOI 10.1128/MCB.14.5.3310; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Gagan J, 2012, CURR OPIN PHARMACOL, V12, P383, DOI 10.1016/j.coph.2012.02.001; Gagan J, 2011, J BIOL CHEM, V286, P19431, DOI 10.1074/jbc.M111.219006; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Haraguchi T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp040; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kitamoto T, 2010, STEM CELLS, V28, P2205, DOI 10.1002/stem.547; Kondoh K, 2007, J BIOL CHEM, V282, P3058, DOI 10.1074/jbc.M607630200; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Luo B, 1997, MOL CELL BIOL, V17, P6057, DOI 10.1128/MCB.17.10.6057; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; MCMAHON DK, 1994, AM J PHYSIOL, V266, pC1795, DOI 10.1152/ajpcell.1994.266.6.C1795; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; Raimondi L, 2012, CELL DEATH DIFFER, V19, P871, DOI 10.1038/cdd.2011.171; Shawber C, 1996, DEVELOPMENT, V122, P3765; Shi H, 2010, FASEB J, V24, P2985, DOI 10.1096/fj.09-150045; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Song GS, 2009, J BIOL CHEM, V284, P31921, DOI 10.1074/jbc.M109.046862; Vasyutina E, 2007, P NATL ACAD SCI USA, V104, P4443, DOI 10.1073/pnas.0610647104; Wang DZ, 2001, DEVELOPMENT, V128, P4623; Wang HF, 2011, P NATL ACAD SCI USA, V108, P14908, DOI 10.1073/pnas.1109023108; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Wilson-Rawls J, 1999, MOL CELL BIOL, V19, P2853; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Yuasa K, 2008, CELL STRUCT FUNCT, V33, P163, DOI 10.1247/csf.08022; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193	50	70	77	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40360	40370		10.1074/jbc.M112.378414	http://dx.doi.org/10.1074/jbc.M112.378414			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23055528	hybrid, Green Published			2022-12-28	WOS:000311448800027
J	Pakala, SB; Nair, VS; Reddy, SD; Kumar, R				Pakala, Suresh B.; Nair, Vasudha S.; Reddy, Sirigiri DivijendraNatha; Kumar, Rakesh			Signaling-dependent Phosphorylation of Mitotic Centromere-associated Kinesin Regulates Microtubule Depolymerization and Its Centrosomal Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; AURORA-A; MCAK; SUBSTRATE; MITOSIS; GROWTH; ORGANIZATION; EXPRESSION; TUBULIN; PROTEIN	Although p21-activated kinase 1 (PAK1) and microtubule (MT) dynamics regulate numerous fundamental processes including cytoskeleton remodeling, directional motility, and mitotic functions, the significance of PAK1 signaling in regulating the functions of MT-destabilizing protein mitotic centromere-associated kinesin (MCAK) remains unknown. Here we found that MCAK is a cognate substrate of PAK1 wherein PAK1 phosphorylates MCAK on serines 192 and 111 both in vivo and in vitro. Furthermore, we found that PAK1 phosphorylation of MCAK on serines 192 and 111 preferentially regulates its microtubule depolymerization activity and localization to centrosomes, respectively, in the mammalian cells.	[Pakala, Suresh B.; Nair, Vasudha S.; Reddy, Sirigiri DivijendraNatha; Kumar, Rakesh] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Washington, DC 20037 USA	George Washington University	Kumar, R (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	bcmrxk@gwu.edu	Kumar, Rakesh/ABD-1065-2020; sirigiri, divijendra reddy/E-1031-2017	Kumar, Rakesh/0000-0001-7664-0803; sirigiri, divijendra reddy/0000-0003-4657-2285; Pakala, Suresh Babu/0000-0002-5679-4837	National Institutes of Health [CA90970]; NATIONAL CANCER INSTITUTE [R01CA090970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA90970 (to R. K.).	Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Aoki S, 2005, FEBS J, V272, P2132, DOI 10.1111/j.1742-4658.2005.04600.x; Bagheri-Yarmand R, 2000, J BIOL CHEM, V275, P39451, DOI 10.1074/jbc.M006150200; Balasenthil S, 2004, J BIOL CHEM, V279, P1422, DOI 10.1074/jbc.M309937200; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Brzeska H, 2004, CELL MOTIL CYTOSKEL, V58, P186, DOI 10.1002/cm.20009; Cau J, 2001, J CELL BIOL, V155, P1029, DOI 10.1083/jcb.200104123; Charvet C, 2002, J BIOL CHEM, V277, P15376, DOI 10.1074/jbc.M111627200; Domnitz SB, 2012, J CELL BIOL, V197, P231, DOI 10.1083/jcb.201108147; Eswaran J, 2009, CANCER METAST REV, V28, P209, DOI 10.1007/s10555-008-9181-4; Katayama H, 2008, CELL CYCLE, V7, P2691, DOI 10.4161/cc.7.17.6460; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Li F, 2002, EMBO REP, V3, P767, DOI 10.1093/embo-reports/kvf157; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; Maney T, 2001, J BIOL CHEM, V276, P34753, DOI 10.1074/jbc.M106626200; Manning AL, 2007, MOL BIOL CELL, V18, P2970, DOI 10.1091/mbc.E07-02-0110; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Meunier S, 2011, NAT CELL BIOL, V13, P1406, DOI 10.1038/ncb2372; Molli PR, 2010, J CELL BIOL, V190, P101, DOI 10.1083/jcb.200908050; Ohi R, 2007, CURR BIOL, V17, P953, DOI 10.1016/j.cub.2007.04.057; Purohit A, 1999, J CELL BIOL, V147, P481, DOI 10.1083/jcb.147.3.481; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Sanhaji M, 2011, ONCOTARGET, V2, P935; Sanhaji M, 2010, MOL CELL BIOL, V30, P2594, DOI 10.1128/MCB.00098-10; Senger DL, 2002, CANCER RES, V62, P2131; SHU HB, 1995, J CELL BIOL, V130, P1137, DOI 10.1083/jcb.130.5.1137; Tanenbaum Marvin E, 2011, Bioarchitecture, V1, P80; Vadlamudi RK, 2005, MOL CELL BIOL, V25, P3726, DOI 10.1128/MCB.25.9.3726-3736.2005; Vadlamudi RK, 2004, EMBO REP, V5, P154, DOI 10.1038/sj.embor.7400079; Vadlamudi RK, 2000, J BIOL CHEM, V275, P36238, DOI 10.1074/jbc.M002138200; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; WORDEMAN L, 1995, J CELL BIOL, V128, P95, DOI 10.1083/jcb.128.1.95; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhang LY, 2011, J BIOL CHEM, V286, P3033, DOI 10.1074/jbc.M110.165340; Zhang X, 2008, MOL BIOL CELL, V19, P2752, DOI 10.1091/mbc.E08-02-0198; Zhang X, 2007, MOL BIOL CELL, V18, P3264, DOI 10.1091/mbc.E07-01-0086; Zhao ZS, 2005, MOL CELL, V20, P237, DOI 10.1016/j.molcel.2005.08.035; Zhou FF, 2004, BIOCHEM BIOPH RES CO, V325, P1443, DOI 10.1016/j.bbrc.2004.11.001	40	18	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40560	40569		10.1074/jbc.M112.399576	http://dx.doi.org/10.1074/jbc.M112.399576			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23055517	Green Published, hybrid			2022-12-28	WOS:000311448800046
J	Whiteley, G; Collins, RF; Kitmitto, A				Whiteley, Gareth; Collins, Richard F.; Kitmitto, Ashraf			Characterization of the Molecular Architecture of Human Caveolin-3 and Interaction with the Skeletal Muscle Ryanodine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-RELEASE CHANNEL; C-TERMINAL DOMAIN; ELECTRON CRYOMICROSCOPY; MEMBRANE ATTACHMENT; SCAFFOLDING DOMAIN; MICE SHOW; IN-VIVO; PROTEIN; BINDING; IDENTIFICATION	Caveolin-3 (cav-3), an integral membrane protein, is a building block of caveolae as well as a regulator of a number of physiological processes by facilitating the formation of multiprotein signaling complexes. We report that the expression of cav-3 in insect (Sf9) cells induces caveola formation, comparable in size with those observed in native tissue. We have also purified the recombinant cav-3 determining that it forms an oligomer of similar to 220 kDa. We present the first three-dimensional structure for cav-3 (using transmission electron microscopy and single particle analysis methods) and show that nine cav-3 monomers assemble to form a complex that is toroidal in shape, similar to 16.5 nm in diameter and similar to 5.5 nm in height. Labeling experiments and reconstitution of the purified cav-3 into liposomes have allowed a proposal for the orientation of the protein with respect to the membrane. We have identified multiple caveolin-binding motifs within the ryanodine receptor (RyR1) sequence employing a bioinformatic analysis. We have then shown experimentally that there is a direct interaction between recombinant cav-3 nonamers and purified RyR1 homotetramers that would imply that at least one of the predicted cav-3-binding sites is exposed within the fully assembled RyR1 structure. The cav-3 three-dimensional model provides new insights as to how a cav-3 oligomer can bind multiple partners in close proximity to form signaling complexes. Furthermore, a direct interaction with RyR1 suggests a possible role for cav-3 as a modifier of muscle excitation-contraction coupling and/or for localization of the receptor to regions of the sarcoplasmic reticulum.	[Whiteley, Gareth; Kitmitto, Ashraf] Univ Manchester, Fac Med & Human Sci, Cardiovasc Grp, Sch Biomed, Manchester M13 9NT, Lancs, England; [Collins, Richard F.] Univ Manchester, Fac Life Sci, Manchester M13 9PL, Lancs, England	University of Manchester; University of Manchester	Kitmitto, A (corresponding author), Univ Manchester, Fac Med & Human Sci, Cardiovasc Grp, Sch Biomed, 3rd Floor Core Technol Facil,Grafton St, Manchester M13 9NT, Lancs, England.	ashraf.kitmitto@manchester.ac.uk		Whiteley, Gareth/0000-0001-7828-6270	British Heart Foundation [FS/08/038/25262]; British Heart Foundation [RG/11/2/28701] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation Grant FS/08/038/25262 (to G. W. and A. K.).	Adair B, 2008, BIOPHYS J, V94, P2106, DOI 10.1529/biophysj.107.118562; Aoki S, 2010, J BIOL CHEM, V285, P33371, DOI 10.1074/jbc.M110.153569; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Boscher C, 2012, ADV EXP MED BIOL, V729, P29, DOI 10.1007/978-1-4614-1222-9_3; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; CHU A, 1988, METHOD ENZYMOL, V157, P36; CHU A, 1990, MOL PHARMACOL, V37, P735; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Couchoux H, 2007, J PHYSIOL-LONDON, V580, P745, DOI 10.1113/jphysiol.2006.124198; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; De Souza AP, 2005, MAGN RESON IMAGING, V23, P61, DOI 10.1016/j.mri.2004.11.011; DIETZEN DJ, 1995, J BIOL CHEM, V270, P6838, DOI 10.1074/jbc.270.12.6838; Fernandez I, 2002, P NATL ACAD SCI USA, V99, P11193, DOI 10.1073/pnas.172196599; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fujimoto T, 2000, J CELL SCI, V113, P3509; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Gennis R. B., 1989, BIOMEMBRANES MOL STR, P91; Gerbal M, 2000, IN VITRO CELL DEV-AN, V36, P117, DOI 10.1290/1071-2690(2000)036<0117:AOAICL>2.0.CO;2; GLENNEY JR, 1992, FEBS LETT, V314, P45, DOI 10.1016/0014-5793(92)81458-X; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Ikonen E, 2000, TRAFFIC, V1, P212, DOI 10.1034/j.1600-0854.2000.010303.x; Juretic D, 2002, J CHEM INF COMP SCI, V42, P620, DOI 10.1021/ci010263s; Kocsis E, 1995, ULTRAMICROSCOPY, V60, P219, DOI 10.1016/0304-3991(95)00070-2; Kogo H, 2002, ARCH BIOCHEM BIOPHYS, V401, P108, DOI 10.1016/S0003-9861(02)00009-7; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li CL, 2006, BIOCHEM BIOPH RES CO, V344, P1135, DOI 10.1016/j.bbrc.2006.04.024; Li SW, 1996, J BIOL CHEM, V271, P28647, DOI 10.1074/jbc.271.45.28647; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Markandeya YS, 2011, J BIOL CHEM, V286, P2433, DOI 10.1074/jbc.M110.182550; Meng X, 2009, J MOL BIOL, V387, P320, DOI 10.1016/j.jmb.2009.01.059; Minetti C, 2002, AM J PATHOL, V160, P265, DOI 10.1016/S0002-9440(10)64370-2; Monnier N, 2001, HUM MOL GENET, V10, P2581, DOI 10.1093/hmg/10.22.2581; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Needleman DH, 1997, ANAL BIOCHEM, V248, P173, DOI 10.1006/abio.1997.2125; Ostermeyer AG, 2004, J CELL BIOL, V164, P69, DOI 10.1083/jcb.200303037; Park DS, 2002, AM J PATHOL, V160, P2207, DOI 10.1016/S0002-9440(10)61168-6; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Razani B, 2002, MOL CELL BIOL, V22, P2329, DOI 10.1128/MCB.22.7.2329-2344.2002; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; SCHERER PE, 1995, J BIOL CHEM, V270, P16395, DOI 10.1074/jbc.270.27.16395; Schlegel A, 2000, J BIOL CHEM, V275, P21605, DOI 10.1074/jbc.M002558200; Schlegel A, 1999, J BIOL CHEM, V274, P22660, DOI 10.1074/jbc.274.32.22660; Scriven DRL, 2005, BIOPHYS J, V89, P1893, DOI 10.1529/biophysj.105.064212; Serysheva II, 1999, BIOPHYS J, V77, P1936, DOI 10.1016/S0006-3495(99)77035-9; SERYSHEVA II, 1995, NAT STRUCT BIOL, V2, P18, DOI 10.1038/nsb0195-18; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Song KS, 1997, J BIOL CHEM, V272, P4398, DOI 10.1074/jbc.272.7.4398; SORRENTINO V, 1993, TRENDS PHARMACOL SCI, V14, P98, DOI 10.1016/0165-6147(93)90072-R; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Vassilopoulos S, 2010, BIOCHEMISTRY-US, V49, P6130, DOI 10.1021/bi100796v; Walsh CP, 2009, J BIOL CHEM, V284, P22310, DOI 10.1074/jbc.M109.017152; Way M, 1996, FEBS LETT, V378, P101, DOI 10.1016/0014-5793(96)82884-5; Woodman SE, 2002, J BIOL CHEM, V277, P38988, DOI 10.1074/jbc.M205511200	64	34	34	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40302	40316		10.1074/jbc.M112.377085	http://dx.doi.org/10.1074/jbc.M112.377085			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23071107	Green Published, hybrid			2022-12-28	WOS:000311448800022
J	Yang, T; Jian, W; Luo, Y; Fu, XQ; Noguchi, C; Bungert, J; Huang, SM; Qiu, Y				Yang, Tao; Jian, Wei; Luo, Yi; Fu, Xueqi; Noguchi, Constance; Bungert, Joerg; Huang, Suming; Qiu, Yi			Acetylation of Histone Deacetylase 1 Regulates NuRD Corepressor Complex Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; LOCUS-CONTROL REGION; BETA-GLOBIN LOCUS; ERYTHROID-DIFFERENTIATION; CELL-DIFFERENTIATION; CHROMATIN OCCUPANCY; GENE-EXPRESSION; DEPENDENT REGULATION; DISTINCT FUNCTIONS; LEUKEMIC-CELLS	Histone deacetylases (HDACs) play important roles in regulating cell proliferation and differentiation. The HDAC1-containing NuRD complex is generally considered as a corepressor complex and is required for GATA-1-mediated repression. However, recent studies also show that the NuRD complex is involved in GATA-1-mediated gene activation. We tested whether the GATA-1-associated NuRD complex loses its deacetylase activity and commits the GATA-1 complex to become an activator during erythropoiesis. We found that GATA-1-associated deacetylase activity gradually decreased upon induction of erythroid differentiation. GATA-1-associated HDAC1 is increasingly acetylated after differentiation. It has been demonstrated earlier that acetylated HDAC1 has no deacetylase activity. Indeed, overexpression of an HDAC1 mutant, which mimics acetylated HDAC1, promotes GATA-1-mediated transcription and erythroid differentiation. Furthermore, during erythroid differentiation, acetylated HDAC1 recruitment is increased at GATA-1-activated genes, whereas it is significantly decreased at GATA-1-repressed genes. Interestingly, deacetylase activity is not required for Mi2 remodeling activity, suggesting that remodeling activity may be required for both activation and repression. Thus, our data suggest that NuRD can function as a coactivator or repressor and that acetylated HDAC1 converts the NuRD complex from a repressor to an activator during GATA-1-directed erythroid differentiation.	[Yang, Tao; Jian, Wei; Luo, Yi; Qiu, Yi] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; [Bungert, Joerg; Huang, Suming] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Yang, Tao; Fu, Xueqi] Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China; [Noguchi, Constance] NIDDK, Mol Med Branch, NIH, Bethesda, MD 20892 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Jilin University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Qiu, Y (corresponding author), 2033 Mowry Rd,Rm 356, Gainesville, FL 32610 USA.	qiuy@ufl.edu	cheng, yong/I-4270-2012; yang, tao/J-2418-2015	yang, tao/0000-0002-4182-9793; , Yi/0000-0002-3282-6072	National Institutes of Health [R01 HL095674, R01 HL091929, R01091929-01A1S1, R01 DK 83389, R01 DK 52356]; Florida Bankhead Coley Research Foundation; NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Bankhead Coley Research Foundation; NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL095674 (to Y. Q.); R01 HL091929, R01091929-01A1S1-the American Recovery and Reinvestment Act Administrative Supplement, and R01 HL 090589 (to S. H.); and R01 DK 83389 and R01 DK 52356 (to J. B.). This work was also supported by a grant from the Florida Bankhead Coley Research Foundation (to Y. Q.). Supported by the Intramural Research programs, NIDDK, National Institutes of Health.	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Blobel GA, 1998, P NATL ACAD SCI USA, V95, P2061, DOI 10.1073/pnas.95.5.2061; Brunmeir R, 2009, INT J DEV BIOL, V53, P275, DOI 10.1387/ijdb.082649rb; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Cho YS, 2005, GENOMICS, V86, P606, DOI 10.1016/j.ygeno.2005.07.007; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; Crispino JD, 2005, SEMIN CELL DEV BIOL, V16, P137, DOI 10.1016/j.semcdb.2004.11.002; Crispino JD, 1999, MOL CELL, V3, P219, DOI 10.1016/S1097-2765(00)80312-3; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; Fatemi M, 2006, J CELL SCI, V119, P3033, DOI 10.1242/jcs.03099; Feng Q, 2002, MOL CELL BIOL, V22, P536, DOI 10.1128/MCB.22.2.536-546.2002; Feng Q, 2001, GENE DEV, V15, P827; Foglietti C, 2006, J BIOL CHEM, V281, P17968, DOI 10.1074/jbc.M511945200; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Glaser KB, 2003, BIOCHEM BIOPH RES CO, V310, P529, DOI 10.1016/j.bbrc.2003.09.043; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Grass JA, 2006, MOL CELL BIOL, V26, P7056, DOI 10.1128/MCB.01033-06; Gregory T, 1999, BLOOD, V94, P87, DOI 10.1182/blood.V94.1.87.413k41_87_96; Haberland M, 2009, P NATL ACAD SCI USA, V106, P7751, DOI 10.1073/pnas.0903139106; Hamiche A, 2004, METHOD ENZYMOL, V377, P353; Harju-Baker S, 2008, MOL CELL BIOL, V28, P3101, DOI 10.1128/MCB.01858-07; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Horak CE, 2002, P NATL ACAD SCI USA, V99, P2924, DOI 10.1073/pnas.052706999; Hu X, 2009, P NATL ACAD SCI USA, V106, P10141, DOI 10.1073/pnas.0900437106; Huang S, 2000, MOL CELL BIOL, V20, P2248, DOI 10.1128/MCB.20.6.2248-2259.2000; Huang SM, 2000, EMBO J, V19, P6792, DOI 10.1093/emboj/19.24.6792; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Hutchins AS, 2002, MOL CELL, V10, P81, DOI 10.1016/S1097-2765(02)00564-6; Inoue S, 2006, CANCER RES, V66, P6785, DOI 10.1158/0008-5472.CAN-05-4563; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; Kim SI, 2007, ONCOGENE, V26, P6777, DOI 10.1038/sj.onc.1210761; Kim SI, 2007, MOL CELL BIOL, V27, P4551, DOI 10.1128/MCB.00235-07; Kim SI, 2009, P NATL ACAD SCI USA, V106, P2259, DOI 10.1073/pnas.0806420106; Kobayashi M, 2007, J BIOCHEM, V142, P1, DOI 10.1093/jb/mvm122; Kransdorf EP, 2006, BLOOD, V108, P2836, DOI 10.1182/blood-2006-04-016394; Kuendgen A, 2007, CANCER-AM CANCER SOC, V110, P943, DOI 10.1002/cncr.22891; Lagger G, 2003, MOL CELL BIOL, V23, P2669, DOI 10.1128/MCB.23.8.2669-2679.2003; Lee HY, 2009, MOL CELL, V36, P984, DOI 10.1016/j.molcel.2009.11.005; Letting DL, 2004, P NATL ACAD SCI USA, V101, P476, DOI 10.1073/pnas.0306315101; Letting DL, 2003, MOL CELL BIOL, V23, P1334, DOI 10.1128/MCB.23.4.1334-1340.2003; Luo Y, 2009, J BIOL CHEM, V284, P34901, DOI 10.1074/jbc.M109.038356; Mahajan MC, 2005, P NATL ACAD SCI USA, V102, P15012, DOI 10.1073/pnas.0507596102; Mahajan MC, 2007, J CELL BIOCHEM, V102, P801, DOI 10.1002/jcb.21507; Martowicz ML, 2005, J BIOL CHEM, V280, P1724, DOI 10.1074/jbc.M406038200; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; Migliaccio AR, 2005, ANN NY ACAD SCI, V1044, P142, DOI 10.1196/annals.1349.019; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Oh YM, 2009, NAT CELL BIOL, V11, P295, DOI 10.1038/ncb1837; Pal S, 2004, P NATL ACAD SCI USA, V101, P980, DOI 10.1073/pnas.0307612100; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Qiu Y, 2011, J BIOL CHEM, V286, P7641, DOI 10.1074/jbc.M110.185488; Rodriguez P, 2005, EMBO J, V24, P2354, DOI 10.1038/sj.emboj.7600702; Rylski M, 2003, MOL CELL BIOL, V23, P5031, DOI 10.1128/MCB.23.14.5031-5042.2003; Sawado T, 2001, P NATL ACAD SCI USA, V98, P10226, DOI 10.1073/pnas.181344198; Siegel D, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-31; Snow JW, 2009, J BIOL CHEM, V284, P29310, DOI 10.1074/jbc.M109.043497; TSAI SF, 1991, GENE DEV, V5, P919, DOI 10.1101/gad.5.6.919; TSIFTSOGLOU AS, 1985, ANTICANCER RES, V5, P81; Valverde-Garduno V, 2004, BLOOD, V104, P3106, DOI 10.1182/blood-2004-04-1333; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; WEISS MJ, 1995, EXP HEMATOL, V23, P99; Weiss MJ, 1997, MOL CELL BIOL, V17, P1642, DOI 10.1128/MCB.17.3.1642; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Wu WS, 2011, GENOME RES, V21, P1659, DOI 10.1101/gr.125088.111; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	71	25	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40279	40291		10.1074/jbc.M112.349704	http://dx.doi.org/10.1074/jbc.M112.349704			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23014989	Green Published, hybrid			2022-12-28	WOS:000311448800020
J	East, MP; Bowzard, JB; Dacks, JB; Kahn, RA				East, Michael P.; Bowzard, J. Bradford; Dacks, Joel B.; Kahn, Richard A.			ELMO Domains, Evolutionary and Functional Characterization of a Novel GTPase-activating Protein (GAP) Domain for Arf Protein Family GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; LIPID DROPLETS; CELL-MIGRATION; C-ELEGANS; CRKII/DOCK180/RAC PATHWAY; MAXIMUM-LIKELIHOOD; BINDING PROTEINS; MAMMALIAN-CELLS; CANDIDATE GENE; MIXED MODELS	The human family of ELMO domain-containing proteins (ELMODs) consists of six members and is defined by the presence of the ELMO domain. Within this family are two subclassifications of proteins, based on primary sequence conservation, protein size, and domain architecture, deemed ELMOD and ELMO. In this study, we used homology searching and phylogenetics to identify ELMOD family homologs in genomes from across eukaryotic diversity. This demonstrated not only that the protein family is ancient but also that ELMOs are potentially restricted to the supergroup Opisthokonta (Metazoa and Fungi), whereas proteins with the ELMOD organization are found in diverse eukaryotes and thus were likely the form present in the last eukaryotic common ancestor. The segregation of the ELMO clade from the larger ELMOD group is consistent with their contrasting functions as unconventional Rac1 guanine nucleotide exchange factors and the Arf family GTPase-activating proteins, respectively. We used unbiased, phylogenetic sorting and sequence alignments to identify the most highly conserved residues within the ELMO domain to identify a putative GAP domain within the ELMODs. Three independent but complementary assays were used to provide an initial characterization of this domain. We identified a highly conserved arginine residue critical for both the biochemical and cellular GAP activity of ELMODs. We also provide initial evidence of the function of human ELMOD1 as an Arf family GAP at the Golgi. These findings provide the basis for the future study of the ELMOD family of proteins and a new avenue for the study of Arf family GTPases.	[East, Michael P.; Bowzard, J. Bradford; Kahn, Richard A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Dacks, Joel B.] Univ Alberta, Fac Med & Dent, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada	Emory University; University of Alberta	Kahn, RA (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.	rkahn@emory.edu	Kahn, Richard/ABD-2666-2020; Dacks, Joel/AAE-3308-2021	Kahn, Richard/0000-0002-0259-0601; Dacks, Joel/0000-0003-4520-5694	National Institutes of Health [R01-GM090158]; NINDS [P30-NS055077]; American Heart Association [09PRE2140029]; Natural Sciences and Engineering Research Council of Canada; Alberta Innovates Technology Futures Discovery grant; New Faculty award; Canada Research Chairs Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367, R01GM090158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates Technology Futures Discovery grant; New Faculty award; Canada Research Chairs Program(Canada Research Chairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM090158 (to R. A. K.) and Grant P30-NS055077 from NINDS (to the Viral Vector and Microscopy Cores of the Emory Neuroscience Core Facilities). This work was also supported by American Heart Association Grant 09PRE2140029 (to M. P. E.), Natural Sciences and Engineering Research Council of Canada, and an Alberta Innovates Technology Futures Discovery grant and New Faculty award (to J. B. D.).; Recipient of support from the Canada Research Chairs Program.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Austin C, 2002, BIOCHEMISTRY-US, V41, P4669, DOI 10.1021/bi016064j; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; Bouchoux J, 2011, BIOL CELL, V103, P499, DOI 10.1042/BC20110024; Bowzard JB, 2007, J BIOL CHEM, V282, P17568, DOI 10.1074/jbc.M701347200; Bowzard JB, 2005, METHOD ENZYMOL, V404, P453, DOI 10.1016/S0076-6879(05)04040-1; Brasaemle DL, 2006, CURR PROTOC CELL BIO, DOI DOI 10.1002/0471143030.CB0315S29; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Brzostowski Joseph A., 2009, Communicative & Integrative Biology, V2, P337; Burd CG, 2004, TRENDS CELL BIOL, V14, P687, DOI 10.1016/j.tcb.2004.10.004; Burki F, 2012, P ROY SOC B-BIOL SCI, V279, P2246, DOI 10.1098/rspb.2011.2301; Cavenagh MM, 1996, J BIOL CHEM, V271, P21767, DOI 10.1074/jbc.271.36.21767; Chung SB, 2000, NAT CELL BIOL, V2, P931, DOI 10.1038/35046585; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; Cuthbert EJ, 2008, AM J PHYSIOL-CELL PH, V294, pC263, DOI 10.1152/ajpcell.00292.2007; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dacks JB, 2007, J CELL SCI, V120, P2977, DOI 10.1242/jcs.013250; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; East MP, 2011, SEMIN CELL DEV BIOL, V22, P3, DOI 10.1016/j.semcdb.2010.07.002; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elias M, 2010, MOL MEMBR BIOL, V27, P469, DOI 10.3109/09687688.2010.521201; Elliott MR, 2010, ANN NY ACAD SCI, V1209, P30, DOI 10.1111/j.1749-6632.2010.05764.x; Elliott MR, 2010, NATURE, V467, P333, DOI 10.1038/nature09356; Field MC, 2007, ADV EXP MED BIOL, V607, P84; Graham DJ, 2011, CURR BIOL, V21, pR914, DOI 10.1016/j.cub.2011.10.003; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hirst J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001170; Hodges BDM, 2010, J LIPID RES, V51, P262, DOI 10.1194/jlr.R003582; Hodgson U, 2006, AM J HUM GENET, V79, P149, DOI 10.1086/504639; Hommel A, 2010, MOL CELL BIOL, V30, P1231, DOI 10.1128/MCB.01269-09; Isik N, 2008, DEV CELL, V15, P590, DOI 10.1016/j.devcel.2008.08.006; Johnson KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036074; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; KAHN RA, 1991, J BIOL CHEM, V266, P15595; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Kalantari F, 2010, MOL MEMBR BIOL, V27, P462, DOI 10.3109/09687688.2010.538936; Katz LA, 2011, PROTIST, V162, P762, DOI 10.1016/j.protis.2011.05.002; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Koumandou VL, 2011, J CELL SCI, V124, P1496, DOI 10.1242/jcs.081596; Kuhnel K, 2006, STRUCTURE, V14, P367, DOI 10.1016/j.str.2005.11.008; Larkins CE, 2011, MOL BIOL CELL, V22, P4694, DOI 10.1091/mbc.E10-12-0994; Li YJ, 2010, J CELL BIOL, V189, P1039, DOI 10.1083/jcb.200912001; Liu YW, 2005, MOL BIOL CELL, V16, P4024, DOI 10.1091/mbc.E05-01-0023; Lu MJ, 2004, NAT STRUCT MOL BIOL, V11, P756, DOI 10.1038/nsmb800; Muromoto R, 2008, INT IMMUNOL, V20, P395, DOI 10.1093/intimm/dxm154; Nakamura N, 2005, BIOCHEM BIOPH RES CO, V335, P117, DOI 10.1016/j.bbrc.2005.07.050; Nakamura N, 2004, BIOCHEM BIOPH RES CO, V322, P957, DOI 10.1016/j.bbrc.2004.08.010; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Para A, 2009, MOL BIOL CELL, V20, P699, DOI 10.1091/mbc.E08-09-0899; Patel M, 2011, J BIOL CHEM, V286, P38969, DOI 10.1074/jbc.M111.274191; Pulkkinen V, 2010, FASEB J, V24, P1167, DOI 10.1096/fj.09-138545; Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Sebe-Pedros A, 2010, P NATL ACAD SCI USA, V107, P10142, DOI 10.1073/pnas.1002257107; Sevajol M, 2012, BIOCHIMIE, V94, P823, DOI 10.1016/j.biochi.2011.11.014; Shimazaki A, 2006, KIDNEY INT, V70, P1769, DOI 10.1038/sj.ki.5001939; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tian GL, 1999, J BIOL CHEM, V274, P24054, DOI 10.1074/jbc.274.34.24054; VALNES K, 1985, J HISTOCHEM CYTOCHEM, V33, P755, DOI 10.1177/33.8.3926864; Veltel S, 2008, FEBS LETT, V582, P2501, DOI 10.1016/j.febslet.2008.05.053; Veltel S, 2008, NAT STRUCT MOL BIOL, V15, P373, DOI 10.1038/nsmb.1396; Walker G, 2011, PARASITOLOGY, V138, P1638, DOI 10.1017/S0031182010001708; Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Yang C, 2011, CELL SIGNAL, V23, P99, DOI 10.1016/j.cellsig.2010.08.008; Yin JH, 2004, ARCH BIOCHEM BIOPHYS, V429, P23, DOI 10.1016/j.abb.2004.05.014; Yu S, 2002, MOL BIOL CELL, V13, P2559, DOI 10.1091/mbc.E02-04-0189; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2	74	38	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.417477	http://dx.doi.org/10.1074/jbc.M112.417477			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23014990	Green Published, hybrid			2022-12-28	WOS:000311233800025
J	Larrouy-Maumus, G; Skovierova, H; Dhouib, R; Angala, SK; Zuberogoitia, S; Pham, H; Villela, AD; Mikusova, K; Noguera, A; Gilleron, M; Valentinova, L; Kordulakova, J; Brennan, PJ; Puzo, G; Nigou, J; Jackson, M				Larrouy-Maumus, Gerald; Skovierova, Henrieta; Dhouib, Rabeb; Angala, Shiva Kumar; Zuberogoitia, Sophie; Ha Pham; Villela, Anne Drumond; Mikusova, Katarina; Noguera, Audrey; Gilleron, Martine; Valentinova, Lucia; Kordulakova, Jana; Brennan, Patrick. J.; Puzo, Germain; Nigou, Jerome; Jackson, Mary			A Small Multidrug Resistance-like Transporter Involved in the Arabinosylation of Arabinogalactan and Lipoarabinomannan in Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL 2-HYBRID SYSTEM; ESCHERICHIA-COLI; O-ANTIGEN; CELL-WALL; FUNCTIONAL-ANALYSIS; LIPID INTERMEDIATE; SHIGELLA-FLEXNERI; BIOSYNTHESIS; TUBERCULOSIS; GENE	The biosynthesis of the major cell envelope glycoconjugates of Mycobacterium tuberculosis is topologically split across the plasma membrane, yet nothing is known of the transporters required for the translocation of lipid-linked sugar donors and oligosaccharide intermediates from the cytoplasmic to the periplasmic side of the membrane in mycobacteria. One of the mechanisms used by prokaryotes to translocate lipid-linked phosphate sugars across the plasma membrane relies on translocases that share resemblance with small multidrug resistance transporters. The presence of an small multidrug resistance-like gene, Rv3789, located immediately upstream from dprE1/dprE2 responsible for the formation of decaprenyl-monophosphoryl-beta-D-arabinose (DPA) in the genome of M. tuberculosis led us to investigate its potential involvement in the formation of the major arabinosylated glycopolymers, lipoarabinomannan (LAM) and arabinogalactan (AG). Disruption of the ortholog of Rv3789 in Mycobacterium smegmatis resulted in a reduction of the arabinose content of both AG and LAM that accompanied the accumulation of DPA in the mutant cells. Interestingly, AG and LAM synthesis was restored in the mutant not only upon expression of Rv3789 but also upon that of the undecaprenyl phosphate aminoarabinose flippase arnE/F genes from Escherichia coli. A bacterial two-hybrid system further indicated that Rv3789 interacts in vivo with the galactosyltransferase that initiates the elongation of the galactan domain of AG. Biochemical and genetic evidence is thus consistent with Rv3789 belonging to an AG biosynthetic complex, where its role is to reorient DPA to the periplasm, allowing this arabinose donor to then be used in the buildup of the arabinan domains of AG and LAM.	[Larrouy-Maumus, Gerald; Zuberogoitia, Sophie; Noguera, Audrey; Gilleron, Martine; Puzo, Germain; Nigou, Jerome] CNRS, Dept Mecanismes Mol Infect Mycobacteriennes, IPBS, F-31077 Toulouse, France; [Larrouy-Maumus, Gerald; Zuberogoitia, Sophie; Noguera, Audrey; Gilleron, Martine; Puzo, Germain; Nigou, Jerome] Univ Toulouse 3, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France; [Skovierova, Henrieta; Dhouib, Rabeb; Angala, Shiva Kumar; Ha Pham; Villela, Anne Drumond; Brennan, Patrick. J.; Jackson, Mary] Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Skovierova, Henrieta; Mikusova, Katarina; Valentinova, Lucia; Kordulakova, Jana] Comenius Univ, Dept Biochem, Fac Nat Sci, Bratislava 84215, Slovakia	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Colorado State University; Comenius University Bratislava	Nigou, J (corresponding author), CNRS, Dept Mecanismes Mol Infect Mycobacteriennes, IPBS, 205 Route Narbonne, F-31077 Toulouse, France.	Jerome.Nigou@ipbs.fr; Mary.Jackson@colostate.edu	Mikusova, Katarina/I-3622-2014; Nigou, Jérôme/D-6802-2019; Brennan, Patrick J/G-6896-2017; Kordulakova, Jana/I-3887-2014; Jackson, Mary/D-5345-2017	Nigou, Jérôme/0000-0002-6233-2487; Kordulakova, Jana/0000-0003-2834-0165; Jackson, Mary/0000-0002-9212-0258; Larrouy-Maumus, Gerald/0000-0001-6614-8698; GILLERON, Martine/0000-0002-2581-3302; Mikusova, Katarina/0000-0002-0100-4877	National Institutes of Health [AI064798]; Slovak Research and Development Agency [RPEU-0012-06]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Slovak Research and Development Agency(Slovak Research and Development Agency); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI064798. This work was also supported by Slovak Research and Development Agency Contract RPEU-0012-06.	Alaimo C, 2006, EMBO J, V25, P967, DOI 10.1038/sj.emboj.7601024; Baulard AR, 2003, J BIOL CHEM, V278, P2242, DOI 10.1074/jbc.M207922200; Bay DC, 2008, BBA-BIOMEMBRANES, V1778, P1814, DOI 10.1016/j.bbamem.2007.08.015; Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Clarke BR, 2009, J BIOL CHEM, V284, P30662, DOI 10.1074/jbc.M109.052878; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; De Rossi E, 1998, J BACTERIOL, V180, P6068, DOI 10.1128/JB.180.22.6068-6071.1998; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; Goude R, 2008, J BACTERIOL, V190, P4335, DOI 10.1128/JB.01825-07; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Guan S, 1999, MICROBIOL-UK, V145, P1263, DOI 10.1099/13500872-145-5-1263; Henriques AO, 1998, MOL MICROBIOL, V28, P235, DOI 10.1046/j.1365-2958.1998.00766.x; Hug I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000819; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kaur D, 2007, J BIOL CHEM, V282, P27133, DOI 10.1074/jbc.M703389200; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Korres H, 2005, BIOCHEM BIOPH RES CO, V328, P1252, DOI 10.1016/j.bbrc.2005.01.087; Kremer L, 2001, J BIOL CHEM, V276, P26430, DOI 10.1074/jbc.M102022200; Liu D, 1996, J BACTERIOL, V178, P2102, DOI 10.1128/jb.178.7.2102-2107.1996; Marolda CL, 1999, MICROBIOL-UK, V145, P2485, DOI 10.1099/00221287-145-9-2485; Marolda CL, 2004, MICROBIOL-SGM, V150, P4095, DOI 10.1099/mic.0.27456-0; Marolda CL, 2006, J BACTERIOL, V188, P5124, DOI 10.1128/JB.00461-06; Mikusova K, 2000, J BIOL CHEM, V275, P33890, DOI 10.1074/jbc.M006875200; Mikusova K, 2006, J BACTERIOL, V188, P6592, DOI 10.1128/JB.00489-06; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; Ninio S, 2001, J BIOL CHEM, V276, P48250, DOI 10.1074/jbc.M108231200; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rick PD, 2003, J BIOL CHEM, V278, P16534, DOI 10.1074/jbc.M301750200; Scherman MS, 1996, J BIOL CHEM, V271, P29652, DOI 10.1074/jbc.271.47.29652; Schuldiner S, 2009, BBA-PROTEINS PROTEOM, V1794, P748, DOI 10.1016/j.bbapap.2008.12.018; Skovierova H, 2010, J BIOL CHEM, V285, P41348, DOI 10.1074/jbc.M110.188110; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; WOLUCKA BA, 1994, J BIOL CHEM, V269, P23328; Wolucka BA, 2008, FEBS J, V275, P2691, DOI 10.1111/j.1742-4658.2008.06395.x; Yan AX, 2007, J BIOL CHEM, V282, P36077, DOI 10.1074/jbc.M706172200	37	18	21	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.400986	http://dx.doi.org/10.1074/jbc.M112.400986			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23038254	Green Published, hybrid			2022-12-28	WOS:000311233800061
J	Lin, CW; Liao, MY; Lin, WW; Wang, YP; Lu, TY; Wu, HC				Lin, Cheng-Wei; Liao, Mei-Yin; Lin, Wen-Wei; Wang, Yi-Ping; Lu, Tung-Yin; Wu, Han-Chung			Epithelial Cell Adhesion Molecule Regulates Tumor Initiation and Tumorigenesis via Activating Reprogramming Factors and Epithelial-Mesenchymal Transition Gene Expression in Colon Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; BREAST-CANCER; SELF-RENEWAL; EP-CAM; C-MYC; EPCAM; MAINTENANCE; GROWTH; ANTIBODY; MARKER	Epithelial cell adhesion molecule (EpCAM) is highly expressed in epithelial-transformed neoplasia and tumor-initiated cells (TICs), but the role that EpCAM plays in the stemness properties of TICs is still unclear. Here we show that EpCAM and reprogramming factors (c-Myc, Oct4, Nanog, and Sox2) were concomitantly elevated in TICs, which were shown to have superior self-renewal, invasiveness, and tumor-initiating abilities. Elevation of EpCAM enhanced tumorsphere formation and tumor initiation. Knock-down of EpCAM inhibited the expressions of reprogramming factors and epithelial-mesenchymal transition genes, thereby suppressing tumor initiation, self-renewal, and invasiveness. In addition, EpCAM, especially intracellular domain of EpCAM (EpICD), bound to and activated the promoter of reprogramming factors. Treatment with the inhibitor of gamma-secretase (DAPT) led to the blockage of the expressions of reprogramming factors and epithelial-mesenchymal transition genes, which was accompanied by the reduction of tumor self-renewal and invasion. Furthermore, the increased release of EpEX enhanced production of EpICD and regulated the expression of reprogramming factors. Together, these findings suggest that EpCAM plays an important role in regulating cancer-initiating abilities in TICs of colon cancer. This discovery can be used in the development of new strategies for cancer therapy.	[Lin, Cheng-Wei; Liao, Mei-Yin; Lin, Wen-Wei; Wang, Yi-Ping; Lu, Tung-Yin; Wu, Han-Chung] Acad Sinica, Inst Cellular Organism Biol, Taipei 115, Taiwan; [Wu, Han-Chung] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Lin, Cheng-Wei] Taipei Med Univ, Sch Med, Dept Biochem, Taipei 110, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Taipei Medical University	Wu, HC (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	hcw0928@gate.sinica.edu.tw	Wu, Han-Chung/B-1209-2011	Wu, Han-Chung/0000-0002-5185-1169; Wang, Yi-Ping/0000-0001-9574-2194	Academia Sinica; Taiwan National Science Council [NSC-99-3111-B-001-007, NSC-100-2325-B-001-011]	Academia Sinica(Academia Sinica - Taiwan); Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by Academia Sinica and Taiwan National Science Council Grants NSC-99-3111-B-001-007 and NSC-100-2325-B-001-011 (to H.-C.W.).	Bae KM, 2010, J UROLOGY, V183, P2045, DOI 10.1016/j.juro.2009.12.092; Burges A, 2007, CLIN CANCER RES, V13, P3899, DOI 10.1158/1078-0432.CCR-06-2769; Chaves-Perez A, 2013, ONCOGENE, V32, P641, DOI 10.1038/onc.2012.75; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Denzel S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-402; El-Sahwi K, 2010, MOL CANCER THER, V9, P57, DOI 10.1158/1535-7163.MCT-09-0675; Farnie G, 2007, JNCI-J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; Gonzalez B, 2009, STEM CELLS, V27, P1782, DOI 10.1002/stem.97; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Herrmann I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013474; Huang HP, 2011, J BIOL CHEM, V286, P33520, DOI 10.1074/jbc.M111.256164; Hwang WL, 2011, GASTROENTEROLOGY, V141, P279, DOI 10.1053/j.gastro.2011.04.008; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Kanwar SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-212; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Litvinov SV, 1997, J CELL BIOL, V139, P1337, DOI 10.1083/jcb.139.5.1337; Litvinov SV, 1996, AM J PATHOL, V148, P865; Liu MR, 2009, P NATL ACAD SCI USA, V106, P19035, DOI 10.1073/pnas.0910009106; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Miyamoto A, 2006, J BIOL CHEM, V281, P10089, DOI 10.1074/jbc.M600298200; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Najy AJ, 2008, J BIOL CHEM, V283, P18393, DOI 10.1074/jbc.M801329200; Nubel T, 2009, MOL CANCER RES, V7, P285, DOI 10.1158/1541-7786.MCR-08-0200; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Ralhan R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014130; Ralhan R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-331; Sankpal NV, 2009, CANCER RES, V69, P753, DOI 10.1158/0008-5472.CAN-08-2708; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Terris B, 2010, J HEPATOL, V52, P280, DOI 10.1016/j.jhep.2009.10.026; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Winkler J, 2009, MOL CANCER THER, V8, P2674, DOI 10.1158/1535-7163.MCT-09-0402; Xu J, 2010, CELL TRANSPLANT, V19, P43, DOI 10.3727/096368909X474339; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137	42	78	81	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.386235	http://dx.doi.org/10.1074/jbc.M112.386235			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	22989882	Green Published, hybrid			2022-12-28	WOS:000311233800017
J	Rol, N; Favre, L; Benyacoub, J; Corthesy, B				Rol, Nicolas; Favre, Laurent; Benyacoub, Jalil; Corthesy, Blaise			The Role of Secretory Immunoglobulin A in the Natural Sensing of Commensal Bacteria by Mouse Peyer's Patch Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL MICROBIOTA; IMMUNE-RESPONSES; MUCOSAL HOMEOSTASIS; IGA RESPONSE; T-CELL; GUT; HOST; CD8-ALPHA(+); RECEPTOR; SUBSETS	The mammalian gastrointestinal (GI) tract harbors a diverse population of commensal species collectively known as the microbiota, which interact continuously with the host. From very early in life, secretory IgA (SIgA) is found in association with intestinal bacteria. It is considered that this helps to ensure self-limiting growth of the microbiota and hence participates in symbiosis. However, the importance of this association in contributing to the mechanisms ensuring natural host-microorganism communication is in need of further investigation. In the present work, we examined the possible role of SIgA in the transport of commensal bacteria across the GI epithelium. Using an intestinal loop mouse model and fluorescently labeled bacteria, we found that entry of commensal bacteria in Peyer's patches (PP) via the M cell pathway was mediated by their association with SIgA. Preassociation of bacteria with nonspecific SIgA increased their dynamics of entry and restored the reduced transport observed in germ-free mice known to have a marked reduction in intestinal SIgA production. Selective SIgA-mediated targeting of bacteria is restricted to the tolerogenic CD11c(+)CD11b(+)CD8(-) dendritic cell subset located in the subepithelial dome region of PPs, confirming that the host is not ignorant of its resident commensals. In conclusion, our work supports the concept that SIgA-mediated monitoring of commensal bacteria targeting dendritic cells in the subepithelial dome region of PPs represents a mechanism whereby the host mucosal immune system controls the continuous dialogue between the host and commensal bacteria.	[Rol, Nicolas; Corthesy, Blaise] CHU Vaudois, Res & Dev Lab, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland; [Favre, Laurent; Benyacoub, Jalil] Nestle Res Ctr, Dept Nutr & Hlth, CH-1000 Lausanne 26, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Nestle SA	Corthesy, B (corresponding author), CHU Vaudois, Res & Dev Lab, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland.	blaise.corthesy@chuv.ch		Rol, Nicolas/0000-0002-1977-2743	Swiss Science Research Foundation [3100-138422]	Swiss Science Research Foundation(Swiss National Science Foundation (SNSF))	This work was supported by Swiss Science Research Foundation Grant 3100-138422 (to B. C.).	Bos NA, 1996, INFECT IMMUN, V64, P616, DOI 10.1128/IAI.64.2.616-623.1996; Cebra J J, 1998, Dev Immunol, V6, P13, DOI 10.1155/1998/68382; CEBRA JJ, 1994, ADV EXP MED BIOL, V355, P255; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Chung Y, 2005, BLOOD, V106, P201, DOI 10.1182/blood-2004-11-4240; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Corthesy B, 2007, J IMMUNOL, V178, P27, DOI 10.4049/jimmunol.178.1.27; Duc M, 2010, J BIOL CHEM, V285, P953, DOI 10.1074/jbc.M109.059220; Favre L, 2005, J IMMUNOL, V175, P2793, DOI 10.4049/jimmunol.175.5.2793; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Harris NL, 2006, J IMMUNOL, V177, P6256, DOI 10.4049/jimmunol.177.9.6256; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Iwasaki A, 2001, J IMMUNOL, V166, P4884, DOI 10.4049/jimmunol.166.8.4884; Jiang HQ, 2004, VACCINE, V22, P805, DOI 10.1016/j.vaccine.2003.11.022; Kadaoui KA, 2007, J IMMUNOL, V179, P7751, DOI 10.4049/jimmunol.179.11.7751; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Macpherson AJ, 2009, SEMIN IMMUNOPATHOL, V31, P145, DOI 10.1007/s00281-009-0174-3; Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41; Mantis NJ, 2002, J IMMUNOL, V169, P1844, DOI 10.4049/jimmunol.169.4.1844; Mathias A, 2011, J BIOL CHEM, V286, P17239, DOI 10.1074/jbc.M110.209015; Mathias A, 2010, J BIOL CHEM, V285, P33906, DOI 10.1074/jbc.M110.135111; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Neutra MR, 1996, CELL, V86, P345, DOI 10.1016/S0092-8674(00)80106-3; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Obata T, 2010, P NATL ACAD SCI USA, V107, P7419, DOI 10.1073/pnas.1001061107; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Pron B, 2001, CELL MICROBIOL, V3, P331, DOI 10.1046/j.1462-5822.2001.00120.x; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rey J, 2004, J IMMUNOL, V172, P3026, DOI 10.4049/jimmunol.172.5.3026; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sait LC, 2007, INT IMMUNOL, V19, P257, DOI 10.1093/intimm/dxl142; Sansonetti PJ, 2011, MUCOSAL IMMUNOL, V4, P8, DOI 10.1038/mi.2010.77; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Shulzhenko N, 2011, NAT MED, V17, P1585, DOI 10.1038/nm.2505; Smith PD, 2011, MUCOSAL IMMUNOL, V4, P31, DOI 10.1038/mi.2010.66; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; vanderWaaij LA, 1996, GUT, V38, P348, DOI 10.1136/gut.38.3.348; Willing BP, 2010, GUT MICROBES, V1, P213, DOI 10.4161/gmic.1.4.12520	44	38	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.405001	http://dx.doi.org/10.1074/jbc.M112.405001			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23027876	Green Published, hybrid			2022-12-28	WOS:000311233800074
J	Seddik, R; Jungblut, SP; Silander, OK; Rajalu, M; Fritzius, T; Besseyrias, V; Jacquier, V; Fakler, B; Gassmann, M; Bettler, B				Seddik, Riad; Jungblut, Stefan P.; Silander, Olin K.; Rajalu, Mathieu; Fritzius, Thorsten; Besseyrias, Valerie; Jacquier, Valerie; Fakler, Bernd; Gassmann, Martin; Bettler, Bernhard			Opposite Effects of KCTD Subunit Domains on GABA(B) Receptor-mediated Desensitization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; ACID(B) RECEPTORS; GIRK CURRENTS; RGS PROTEINS; K+ CHANNELS; B RECEPTOR; NEURONS; PHOSPHORYLATION; ACTIVATION; INHIBITION	GABA(B) receptors assemble from principle and auxiliary subunits. The principle subunits GABA(B1) and GABA(B2) form functional heteromeric GABA(B(1,2)) receptors that associate with homotetramers of auxiliary KCTD8, -12, -12b, or -16 (named after their K+ channel tetramerization domain) subunits. These auxiliary subunits constitute receptor subtypes with distinct functional properties. KCTD12 and -12b generate desensitizing receptor responses while KCTD8 and -16 generate largely non-desensitizing receptor responses. The structural elements of the KCTDs underlying these differences in desensitization are unknown. KCTDs are modular proteins comprising a T1 tetramerization domain, which binds to GABA(B2), and a H1 homology domain. KCTD8 and -16 contain an additional C-terminal H2 homology domain that is not sequence-related to the H1 domains. No functions are known for the H1 and H2 domains. Here we addressed which domains and sequence motifs in KCTD proteins regulate desensitization of the receptor response. We found that the H1 domains in KCTD12 and -12b mediate desensitization through a particular sequence motif, T/NFLEQ, which is not present in the H1 domains of KCTD8 and -16. In addition, the H2 domains in KCTD8 and -16 inhibit desensitization when expressed C-terminal to the H1 domains but not when expressed as a separate protein in trans. Intriguingly, the inhibitory effect of the H2 domain is sequence-independent, suggesting that the H2 domain sterically hinders desensitization by the H1 domain. Evolutionary analysis supports that KCTD12 and -12b evolved desensitizing properties by liberating their H1 domains from antagonistic H2 domains and acquisition of the T/NFLEQ motif.	[Gassmann, Martin; Bettler, Bernhard] Univ Basel, Dept Biomed, Pharmazentrum, CH-4056 Basel, Switzerland; [Silander, Olin K.] Univ Basel, Core Program Computat & Syst Biol, Biozentrum, CH-4056 Basel, Switzerland; [Fakler, Bernd] Univ Freiburg, Inst Physiol 2, D-79108 Freiburg, Germany; [Fakler, Bernd] Ctr Biol Signaling Studies Bioss, D-79104 Freiburg, Germany	University of Basel; University of Basel; University of Freiburg	Gassmann, M (corresponding author), Univ Basel, Dept Biomed, Pharmazentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	martin.gassmann@unibas.ch; bernhard.bettler@unibas.ch	bettler, bernhard/AAO-8018-2020	Bettler, Bernhard/0000-0003-0842-8207; Gassmann, Martin/0000-0001-6201-3032; Silander, Olin/0000-0003-4105-8316	Swiss National Science Foundation [3100A0-117816]; National Center for Competence in Research (NCCR) "Synapsy, Synaptic Bases of Mental Health Disease"; European Community's Seventh Framework Programme (FP7) [201714]; Ambizione fellowship from the Swiss National Science Foundation; Marie Heim-Vogtlin fellowship from the Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center for Competence in Research (NCCR) "Synapsy, Synaptic Bases of Mental Health Disease"; European Community's Seventh Framework Programme (FP7)(European Commission); Ambizione fellowship from the Swiss National Science Foundation; Marie Heim-Vogtlin fellowship from the Swiss National Science Foundation	This work was supported by grants from the Swiss National Science Foundation (3100A0-117816), the National Center for Competence in Research (NCCR) "Synapsy, Synaptic Bases of Mental Health Disease" (to B. B.), the European Community's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement 201714 (to B. B.), an Ambizione fellowship from the Swiss National Science Foundation (to O. K. S.), and a Marie Heim-Vogtlin fellowship from the Swiss National Science Foundation (to V. J.).	Bartoi T, 2010, J BIOL CHEM, V285, P20625, DOI 10.1074/jbc.M109.049700; Bayon Y, 2008, FEBS J, V275, P3900, DOI 10.1111/j.1742-4658.2008.06537.x; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Biermann B, 2010, J NEUROSCI, V30, P1385, DOI 10.1523/JNEUROSCI.3172-09.2010; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chalifoux JR, 2011, CURR OPIN NEUROBIOL, V21, P339, DOI 10.1016/j.conb.2011.02.004; Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908; Couve A, 2002, NAT NEUROSCI, V5, P415, DOI 10.1038/nn833; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; Dittman JS, 2008, J NEUROSCI, V28, P7104, DOI 10.1523/JNEUROSCI.0378-08.2008; Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Gamse JT, 2005, DEVELOPMENT, V132, P4869, DOI 10.1242/dev.02046; Gassmann M, 2012, NAT REV NEUROSCI, V13, P380, DOI 10.1038/nrn3249; Hamm HE, 2001, P NATL ACAD SCI USA, V98, P4819, DOI 10.1073/pnas.011099798; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Johnston CA, 2005, STRUCTURE, V13, P1069, DOI 10.1016/j.str.2005.04.007; Kisselev OG, 2003, STRUCTURE, V11, P367, DOI 10.1016/S0969-2126(03)00045-5; Kisselev OG, 1998, P NATL ACAD SCI USA, V95, P4270, DOI 10.1073/pnas.95.8.4270; Kusunoki H, 1998, BIOCHEMISTRY-US, V37, P4782, DOI 10.1021/bi972756p; Labouebe G, 2007, NAT NEUROSCI, V10, P1559, DOI 10.1038/nn2006; Maity B, 2012, J BIOL CHEM, V287, P4972, DOI 10.1074/jbc.M111.297218; Metz M, 2011, J COMP NEUROL, V519, P1435, DOI 10.1002/cne.22610; Mezler M, 2001, EUR J NEUROSCI, V13, P477, DOI 10.1046/j.1460-9568.2001.01410.x; Mutneja M, 2005, PFLUG ARCH EUR J PHY, V450, P61, DOI 10.1007/s00424-004-1367-1; Okuno T, 2003, J BIOL CHEM, V278, P41500, DOI 10.1074/jbc.M307335200; Pennock RL, 2012, J NEUROSCI, V32, P10192, DOI 10.1523/JNEUROSCI.1227-12.2012; Perroy J, 2003, EMBO J, V22, P3816, DOI 10.1093/emboj/cdg383; Robbins MJ, 2001, J NEUROSCI, V21, P8043, DOI 10.1523/JNEUROSCI.21-20-08043.2001; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schultheis C, 2011, J NEUROPHYSIOL, V106, P817, DOI 10.1152/jn.00578.2010; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Sickmann T, 2003, J NEUROPHYSIOL, V90, P2494, DOI 10.1152/jn.00112.2003; Sodickson DL, 1996, J NEUROSCI, V16, P6374; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Taylor RW, 2011, J NEUROSCI, V31, P9869, DOI 10.1523/JNEUROSCI.0435-11.2011; Urwyler S, 2001, MOL PHARMACOL, V60, P963, DOI 10.1124/mol.60.5.963; Vashlishan AB, 2008, NEURON, V58, P346, DOI 10.1016/j.neuron.2008.02.019; Wetherington JP, 2002, J PHYSIOL-LONDON, V544, P459, DOI 10.1113/jphysiol.2002.023093; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wischmeyer E, 1997, MOL CELL NEUROSCI, V9, P194, DOI 10.1006/mcne.1997.0614; Xie KQ, 2010, NAT NEUROSCI, V13, P661, DOI 10.1038/nn.2549	46	35	36	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.412767	http://dx.doi.org/10.1074/jbc.M112.412767			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23035119	Green Published, hybrid			2022-12-28	WOS:000311233800055
J	Zandberg, WF; Kumarasamy, J; Pinto, BM; Vocadlo, DJ				Zandberg, Wesley F.; Kumarasamy, Jayakanthan; Pinto, B. Mario; Vocadlo, David J.			Metabolic Inhibition of Sialyl-Lewis X Biosynthesis by 5-Thiofucose Remodels the Cell Surface and Impairs Selectin-Mediated Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUCOSYL-TRANSFERASES; INCREASED EXPRESSION; GDP-FUCOSE; ANTIGEN; OLIGOSACCHARIDES; METASTASIS; CARCINOMA; GLYCANS; ANALOGS; LIGAND	Sialyl-Lewis X (sLe(X)) is a tetrasaccharide that serves as a ligand for the set of cell adhesion proteins known as selectins. This interaction enables adhesion of leukocytes and cancer cells to endothelial cells within capillaries, resulting in their extravasation into tissues. The last step in sLe(X) biosynthesis is the alpha 1,3-fucosyltrasferase (FUT)-catalyzed transfer of an L-fucose residue to carbohydrate acceptors. Impairing FUT activity compromises leukocyte homing to sites of inflammation and renders cancer cells less malignant. Inhibition of FUTs is, consequently, of great interest, but efforts to generate glycosyltransferase inhibitors, including FUT inhibitors, has proven challenging. Here we describe a metabolic engineering strategy to inhibit the biosynthesis of sLe(X) in cancer cells using peracetylated 5-thio-L-fucose (5T-Fuc). We show that 5T-Fuc is taken up by cancer cells and then converted into a sugar nucleotide analog, GDP-5T-Fuc, that blocks FUT activity and limits sLe(X) presentation on HepG2 cells with an EC50 in the low micromolar range. GDP-5T-Fuc itself does not get transferred by either FUT3 or FUT7 at a measurable rate. We further demonstrate that treatment of cells with 5T-Fuc impaired their adhesive properties to immobilized adhesion molecules and human endothelial cells. 5T-Fuc, therefore, is a useful probe that can be used to modulate sLe(X) levels in cells to evaluate the consequences of inhibiting FUT-mediated sLe(X) formation. These data also reveal the utility of using sugar analogues that lead to formation of donor substrate analogues within cells as a general approach to blocking glycosyltransferases in cells.	[Zandberg, Wesley F.; Kumarasamy, Jayakanthan; Pinto, B. Mario; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Vocadlo, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Vocadlo, DJ (corresponding author), Simon Fraser Univ, Dept Chem, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	dvocadlo@sfu.ca	Vocadlo, David J/E-5508-2014; Zandberg, Wesley/AAX-5568-2021	Vocadlo, David J/0000-0001-6897-5558; Kumarasamy, Jayakanthan/0000-0002-7926-9752	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC).	Akamatsu S, 1996, GLYCOCONJUGATE J, V13, P1021, DOI 10.1007/BF01053198; Barthel SR, 2008, GLYCOBIOLOGY, V18, P806, DOI 10.1093/glycob/cwn070; Barthel SR, 2011, J BIOL CHEM, V286, P21717, DOI 10.1074/jbc.M110.194597; Barthel SR, 2009, P NATL ACAD SCI USA, V106, P19491, DOI 10.1073/pnas.0906074106; Clarke JL, 1996, J BIOL CHEM, V271, P10317, DOI 10.1074/jbc.271.17.10317; Coyne MJ, 2005, SCIENCE, V307, P1778, DOI 10.1126/science.1106469; DENNIS JW, 1986, CANCER RES, V46, P5131; ETZIONI A, 1992, NEW ENGL J MED, V327, P1789, DOI 10.1056/NEJM199212173272505; Foster MM, 2003, CANCER RES, V63, P2775; FUKUSHIMA K, 1984, CANCER RES, V44, P5279; Gadhoum SZ, 2008, NAT CHEM BIOL, V4, P751, DOI 10.1038/nchembio.116; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Grabenhorst E, 1998, J BIOL CHEM, V273, P30985, DOI 10.1074/jbc.273.47.30985; Gravel P., 2002, PROTEIN PROTOCOLS HD, P779; HASHIMOTO H, 1990, J CARBOHYD CHEM, V9, P683, DOI 10.1080/07328309008543863; Hiller KM, 2000, MOL CARCINOGEN, V27, P280, DOI 10.1002/(SICI)1098-2744(200004)27:4<280::AID-MC6>3.0.CO;2-L; HOFF SD, 1989, CANCER RES, V49, P6883; Johnson PC, 1995, BIOREMED SER, V3, P1; Kannagi R, 1997, GLYCOCONJUGATE J, V14, P577, DOI 10.1023/A:1018532409041; Koji HT, 2003, ANAL SCI, V19, P85, DOI 10.2116/analsci.19.85; Kretzschmar G, 1998, TETRAHEDRON, V54, P3765, DOI 10.1016/S0040-4020(98)00105-7; Luhn K, 2001, BLOOD, V97, P330, DOI 10.1182/blood.V97.1.330; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Marathe DD, 2010, BLOOD, V115, P1303, DOI 10.1182/blood-2009-07-231480; MEHTA S, 1995, J AM CHEM SOC, V117, P9783, DOI 10.1021/ja00144a001; MUROI K, 1992, BLOOD, V79, P713; NAKAGOE T, 1993, CANCER, V72, P2323, DOI 10.1002/1097-0142(19931015)72:8<2323::AID-CNCR2820720807>3.0.CO;2-C; NAKAMORI S, 1993, CANCER RES, V53, P3632; NARITA T, 1993, CANCER, V71, P3044, DOI 10.1002/1097-0142(19930515)71:10<3044::AID-CNCR2820711026>3.0.CO;2-R; Norris AJ, 2004, BIOORG MED CHEM LETT, V14, P571, DOI 10.1016/j.bmcl.2003.12.003; Numahata K, 2002, CANCER, V94, P673, DOI 10.1002/cncr.10268; Ohyama C, 1999, EMBO J, V18, P1516, DOI 10.1093/emboj/18.6.1516; Pang PC, 2011, SCIENCE, V333, P1761, DOI 10.1126/science.1207438; PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Rillahan CD, 2011, ANGEW CHEM INT EDIT, V50, P12534, DOI 10.1002/anie.201105065; Rinnbauer M, 2003, GLYCOBIOLOGY, V13, P435, DOI 10.1093/glycob/cwg043; SARKAR AK, 1995, P NATL ACAD SCI USA, V92, P3323, DOI 10.1073/pnas.92.8.3323; Sawa M, 2006, P NATL ACAD SCI USA, V103, P12371, DOI 10.1073/pnas.0605418103; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; St Hill CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016281; Sullivan FX, 1998, J BIOL CHEM, V273, P8193, DOI 10.1074/jbc.273.14.8193; TIEMEYER M, 1991, P NATL ACAD SCI USA, V88, P1138, DOI 10.1073/pnas.88.4.1138; Togayachi A, 1999, INT J CANCER, V83, P70, DOI 10.1002/(SICI)1097-0215(19990924)83:1<70::AID-IJC14>3.0.CO;2-K; Trinchera M, 2011, INT J BIOCHEM CELL B, V43, P130, DOI 10.1016/j.biocel.2010.10.004; Tsuruta O, 2003, J ORG CHEM, V68, P6400, DOI 10.1021/jo0300035; Tsuruta O, 1999, BIOORG MED CHEM LETT, V9, P1019, DOI 10.1016/S0960-894X(99)00124-9; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Weston BW, 1999, CANCER RES, V59, P2127; YAMASHITA K, 1985, J BIOL CHEM, V260, P4688; Zandberg WF, 2012, CHEMBIOCHEM, V13, P392, DOI 10.1002/cbic.201100647; Zhao GH, 2010, NAT PROTOC, V5, P636, DOI 10.1038/nprot.2010.3	52	35	39	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.403568	http://dx.doi.org/10.1074/jbc.M112.403568			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23019334	Green Published, hybrid			2022-12-28	WOS:000311233800069
J	Cao, DS; Wang, CB; Tang, RH; Chen, HQ; Zhang, Z; Tatsuguchi, M; Wang, DZ				Cao, Dongsun; Wang, Chunbo; Tang, Ruhang; Chen, Huaqun; Zhang, Zheng; Tatsuguchi, Mariko; Wang, Da-Zhi			Acetylation of Myocardin Is Required for the Activation of Cardiac and Smooth Muscle Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; TRANSCRIPTION FACTOR-B; CARDIOVASCULAR DEVELOPMENT; HISTONE ACETYLTRANSFERASES; DNA-BINDING; IN-VIVO; DIFFERENTIATION; EXPRESSION; MYOD; COACTIVATORS	Myocardin belongs to the SAF-A/B, Acinus, PIAS (SAP) domain family of transcription factors and is specifically expressed in cardiac and smooth muscle. Myocardin functions as a transcriptional coactivator of SRF and is sufficient and necessary for smooth muscle gene expression. We have previously found that myocardin induces the acetylation of nucleosomal histones surrounding SRF-binding sites in the control regions of cardiac and smooth muscle genes through recruiting chromatin-modifying enzyme p300, yet no studies have determined whether myocardin itself is similarly modified. In this study, we show that myocardin is a direct target for p300-mediated acetylation. p300 acetylates lysine residues at the N terminus of the myocardin protein. Interestingly, a direct interaction between p300 and myocardin, which is mediated by the C terminus of myocardin, is required for the acetylation event. Acetylation of myocardin by p300 enhances the association of myocardin and SRF as well as the formation of the myocardin-SRF-CArG box ternary complex. Conversely, acetylation of myocardin decreases the binding of histone deacetylase 5 (HDAC5) to myocardin. Acetylation of myocardin is required for myocardin to activate smooth muscle genes. Our study demonstrates that acetylation plays a key role in modulating myocardin function in controlling cardiac and smooth muscle gene expression.	[Chen, Huaqun; Zhang, Zheng; Tatsuguchi, Mariko; Wang, Da-Zhi] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Cardiol, Boston, MA 02115 USA; [Cao, Dongsun; Wang, Chunbo; Tang, Ruhang; Tatsuguchi, Mariko; Wang, Da-Zhi] Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Cao, Dongsun; Wang, Chunbo; Tang, Ruhang; Tatsuguchi, Mariko; Wang, Da-Zhi] Univ N Carolina, McAllister Heart Inst, Sch Med, Chapel Hill, NC 27599 USA; [Chen, Huaqun] Nanjing Normal Univ, Sch Life Sci, Nanjing 210023, Jiangsu, Peoples R China; [Zhang, Zheng] Chongqing Med Univ, Dept Cell Biol & Genet, Chongqing 400016, Peoples R China	Harvard University; Boston Children's Hospital; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Nanjing Normal University; Chongqing Medical University	Wang, DZ (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Cardiol, 320 Longwood Ave, Boston, MA 02115 USA.	dwang@enders.tch.harvard.edu	zhang, zheng/AAG-9966-2020	Tang, Ruhang/0000-0003-4918-3525	National Institutes of Health from the NHLBI [HL085635, HL075251]; March of Dimes Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075251, R01HL085635] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); March of Dimes Foundation(March of Dimes); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL085635 and HL075251 from the NHLBI. This work was also supported by the March of Dimes Foundation.	Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Callis TE, 2005, CIRC RES, V97, P992, DOI 10.1161/01.RES.0000190670.92879.7d; Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Feng BA, 2008, AM J PHYSIOL-ENDOC M, V294, pE1119, DOI 10.1152/ajpendo.00029.2008; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Haberland M, 2007, MOL CELL BIOL, V27, P518, DOI 10.1128/MCB.01415-06; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Han P, 2011, CIRC RES, V108, P378, DOI 10.1161/CIRCRESAHA.110.224287; Hasselgren PO, 2007, J CELL PHYSIOL, V213, P679, DOI 10.1002/jcp.21190; Li J, 2005, P NATL ACAD SCI USA, V102, P8916, DOI 10.1073/pnas.0503741102; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Long XC, 2007, P NATL ACAD SCI USA, V104, P16570, DOI 10.1073/pnas.0708253104; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Mal A, 2001, EMBO J, V20, P1739, DOI 10.1093/emboj/20.7.1739; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; Meadows SM, 2008, P NATL ACAD SCI USA, V105, P1545, DOI 10.1073/pnas.0703918105; Miano JM, 2004, CIRC RES, V95, P340, DOI 10.1161/01.RES.0000140893.16465.2d; Milyavsky M, 2007, CANCER CELL, V11, P133, DOI 10.1016/j.ccr.2006.11.022; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Oh JY, 2005, P NATL ACAD SCI USA, V102, P15122, DOI 10.1073/pnas.0507346102; Olson Eric N, 2006, Novartis Found Symp, V274, P3; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Polesskaya A, 2000, J BIOL CHEM, V275, P34359, DOI 10.1074/jbc.M003815200; Polesskaya A, 2001, J BIOL CHEM, V276, P44502, DOI 10.1074/jbc.M106501200; Qiu P, 2005, CIRC RES, V97, P983, DOI 10.1161/01.RES.0000190604.90049.71; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Small EM, 2005, DEVELOPMENT, V132, P987, DOI 10.1242/dev.01684; Sun Y, 2006, MOL CELL BIOL, V26, P5809, DOI 10.1128/MCB.00024-06; Tang RH, 2008, P NATL ACAD SCI USA, V105, P3362, DOI 10.1073/pnas.0705842105; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang DZ, 2004, CURR OPIN GENET DEV, V14, P558, DOI 10.1016/j.gde.2004.08.003; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	47	29	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38495	38504		10.1074/jbc.M112.353649	http://dx.doi.org/10.1074/jbc.M112.353649			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23007391	hybrid, Green Published			2022-12-28	WOS:000310982800009
J	Hinrichs, MH; Jalal, A; Brenner, B; Mandelkow, E; Kumar, S; Scholz, T				Hinrichs, Maike H.; Jalal, Avesta; Brenner, Bernhard; Mandelkow, Eckhard; Kumar, Satish; Scholz, Tim			Tau Protein Diffuses along the Microtubule Lattice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXONAL-TRANSPORT; CYTOPLASMIC DYNEIN; KINESIN-1 MOTOR; IN-VIVO; BINDING; TUBULIN; PROCESSIVITY; MOVEMENT; NEURONS; COMPLEX	Current models for the intracellular transport of Tau protein suggest motor protein-dependent co-transport with microtubule fragments and diffusion of Tau in the cytoplasm, whereas Tau is believed to be stationary while bound to microtubules and in equilibrium with free diffusion in the cytosol. Observations that members of the microtubule-dependent kinesin family show Brownian motion along microtubules led us to hypothesize that diffusion along microtubules could also be relevant in the case of Tau. We used single-molecule total internal reflection fluorescence microscopy to probe for diffusion of individual fluorescently labeled Tau molecules along microtubules. This allowed us to avoid the problem that microtubule-dependent diffusion could be masked by excess of labeled Tau in solution that might occur in in vivo overexpression experiments. We found that approximately half of the individually detected Tau molecules moved bidirectionally along microtubules over distances up to several micrometers. Diffusion parameters such as diffusion coefficient, interaction time, and scanned microtubule length did not change with Tau concentration. Tau binding and diffusion along the microtubule lattice, however, were sensitive to ionic strength and pH and drastically reduced upon enzymatic removal of the negatively charged C termini of tubulin. We propose one-dimensional Tau diffusion guided by the microtubule lattice as one possible additional mechanism for Tau distribution. By such one-dimensional microtubule lattice diffusion, Tau could be guided to both microtubule ends, i.e. the sites where Tau is needed during microtubule polymerization, independently of directed motor-dependent transport. This could be important in conditions where active transport along microtubules might be compromised.	[Hinrichs, Maike H.; Jalal, Avesta; Brenner, Bernhard; Scholz, Tim] Hannover Med Sch, Inst Mol & Cell Physiol, D-30625 Hannover, Germany; [Mandelkow, Eckhard; Kumar, Satish] German Ctr Neurodegenerat Dis, German Ctr Neurodegenerat Dis, D-53175 Bonn, Germany; [Mandelkow, Eckhard; Kumar, Satish] CAESAR Res Ctr, D-53175 Bonn, Germany	Hannover Medical School; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Center of Advanced European Studies & Research (CAESAR)	Scholz, T (corresponding author), Hannover Med Sch, Inst Mol & Cell Physiol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	scholz.tim@mh-hannover.de	Scholz, Tim/A-7798-2013; Kumar, Satish/AAF-3112-2019	Kumar, Satish/0000-0002-2993-3694; Scholz, Tim/0000-0002-2127-9843	Deutsche Forschungsgemeinschaft Research Unit [FOR629]	Deutsche Forschungsgemeinschaft Research Unit(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft Research Unit FOR629 grants (to T. S. and E. M.).	Ali MY, 2007, P NATL ACAD SCI USA, V104, P4332, DOI 10.1073/pnas.0611471104; Baas PW, 2006, TRAFFIC, V7, P490, DOI 10.1111/j.1600-0854.2006.00392.x; Bormuth V, 2009, SCIENCE, V325, P870, DOI 10.1126/science.1174923; BURTON RF, 1983, COMP BIOCHEM PHYS B, V76, P663, DOI 10.1016/0305-0491(83)90375-9; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Cooper JR, 2009, CURR OPIN CELL BIOL, V21, P68, DOI 10.1016/j.ceb.2009.01.005; Cuchillo-Ibanez I, 2008, FASEB J, V22, P3186, DOI 10.1096/fj.08-109181; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Furuta K, 2008, J BIOL CHEM, V283, P36465, DOI 10.1074/jbc.M803730200; Gestaut DR, 2008, NAT CELL BIOL, V10, P407, DOI 10.1038/ncb1702; Goode BL, 1997, MOL BIOL CELL, V8, P353, DOI 10.1091/mbc.8.2.353; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Howard J, 2011, NAT REV MOL CELL BIO, V12, P392, DOI 10.1038/nrm3120; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; Jeganathan S, 2008, BIOCHEMISTRY-US, V47, P10526, DOI 10.1021/bi800783d; Kapitein LC, 2008, J CELL BIOL, V182, P421, DOI 10.1083/jcb.200801145; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; Kim Y, 2008, J CELL BIOL, V181, P411, DOI 10.1083/jcb.200802189; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; Konzack S, 2007, J NEUROSCI, V27, P9916, DOI 10.1523/JNEUROSCI.0927-07.2007; Lu HL, 2009, TRAFFIC, V10, P1429, DOI 10.1111/j.1600-0854.2009.00964.x; Makrides V, 2004, P NATL ACAD SCI USA, V101, P6746, DOI 10.1073/pnas.0400992101; McVicker DP, 2011, J BIOL CHEM, V286, P42873, DOI 10.1074/jbc.M111.292987; Mercken M, 1995, J NEUROSCI, V15, P8259; Minoura I, 2010, BIOPHYS J, V98, P1589, DOI 10.1016/j.bpj.2009.12.4323; Motegi F, 2011, NAT CELL BIOL, V13, P1361, DOI 10.1038/ncb2354; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; NAKATA T, 1993, BIOPHYS J, V65, P2504, DOI 10.1016/S0006-3495(93)81304-3; Nakata T, 2011, J CELL BIOL, V194, P245, DOI 10.1083/jcb.201104034; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045; Ramey VH, 2011, MOL BIOL CELL, V22, P457, DOI 10.1091/mbc.E10-10-0841; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Rump A, 2011, J CELL SCI, V124, P2521, DOI 10.1242/jcs.084335; Samsonov A, 2004, J CELL SCI, V117, P6129, DOI 10.1242/jcs.01531; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Schaap IAT, 2004, EUR BIOPHYS J BIOPHY, V33, P462, DOI 10.1007/s00249-003-0386-8; Scholz T, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/9/095707; Seitz A, 2002, EMBO J, V21, P4896, DOI 10.1093/emboj/cdf503; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Steffen W, 1996, J STRUCT BIOL, V117, P227, DOI 10.1006/jsbi.1996.0087; Stoothoff W, 2009, J NEUROCHEM, V111, P417, DOI 10.1111/j.1471-4159.2009.06316.x; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Utton MA, 2005, J CELL SCI, V118, P4645, DOI 10.1242/jcs.02558; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Wang L, 2002, CURR BIOL, V12, P1496, DOI 10.1016/S0960-9822(02)01078-3; Wang ZH, 1999, CELL STRUCT FUNCT, V24, P373, DOI 10.1247/csf.24.373; Weinger JS, 2011, CURR BIOL, V21, P154, DOI 10.1016/j.cub.2010.12.038; Zimmermann D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025473	54	91	91	0	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38559	38568		10.1074/jbc.M112.369785	http://dx.doi.org/10.1074/jbc.M112.369785			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23019339	hybrid, Green Published			2022-12-28	WOS:000310982800016
J	Huelsenbeck, SC; Schorr, A; Roos, WP; Huelsenbeck, J; Henninger, C; Kaina, B; Fritz, G				Huelsenbeck, Stefanie C.; Schorr, Anne; Roos, Wynand P.; Huelsenbeck, Johannes; Henninger, Christian; Kaina, Bernd; Fritz, Gerhard			Rac1 Protein Signaling Is Required for DNA Damage Response Stimulated by Topoisomerase II Poisons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; ANTHRACYCLINE-INDUCED CARDIOTOXICITY; SMALL-MOLECULE INHIBITOR; HUMAN ENDOTHELIAL-CELLS; CLINICAL HEART-FAILURE; TERM-FOLLOW-UP; IONIZING-RADIATION; DOXORUBICIN CARDIOTOXICITY; H2AX PHOSPHORYLATION; RHO GTPASES	To investigate the potency of the topoisomerase II (topo II) poisons doxorubicin and etoposide to stimulate the DNA damage response (DDR), S139 phosphorylation of histone H2AX (gamma H2AX) was analyzed using rat cardiomyoblast cells (H9c2). Etoposide caused a dose-dependent increase in the gamma H2AX level as shown by Western blotting. By contrast, the doxorubicin response was bell-shaped with high doses failing to increase H2AX phosphorylation. Identical results were obtained by immunohistochemical analysis of gamma H2AX focus formation, comet assay-based DNA strand break analysis, and measuring the formation of the topo II-DNA cleavable complex. At low dose, doxorubicin activated ataxia telangiectasia mutated (ATM) but not ATM and Rad3-related (ATR). Both the lipid-lowering drug lovastatin and the Rac1-specific inhibitor NSC23766 attenuated doxorubicin- and etoposide-stimulated H2AX phosphorylation, induction of DNA strand breaks, and topo II-DNA complex formation. Lovastatin and NSC23766 acted in an additive manner. They did not attenuate doxorubicin- induced increase in p-ATM and p-Chk2 levels. DDR stimulated by topo II poisons was partially blocked by inhibition of type I p21-associated kinases. DDR evoked by the topoisomerase I poison topotecan remained unaffected by lovastatin. The data show that the mechanisms involved in DDR stimulated by topo II poisons are agent-specific with anthracyclines lacking DDR-stimulating activity at high doses. Pharmacological inhibition of Rac1 signaling counteracts doxorubicin- and etoposide-stimulated DDR by disabling the formation of the topo II-DNA cleavable complex. Based on the data we suggest that Rac1-regulated mechanisms are required for DNA damage induction and subsequent activation of the DDR following treatment with topo II but not topo I poisons.	[Schorr, Anne; Henninger, Christian; Fritz, Gerhard] Univ Dusseldorf, Inst Toxicol, D-40225 Dusseldorf, Germany; [Huelsenbeck, Stefanie C.; Roos, Wynand P.; Huelsenbeck, Johannes; Kaina, Bernd] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Toxicol, D-55131 Mainz, Germany	Heinrich Heine University Dusseldorf; Johannes Gutenberg University of Mainz	Fritz, G (corresponding author), Univ Dusseldorf, Inst Toxicol, Moorenstr 5, D-40225 Dusseldorf, Germany.	fritz@uni-duesseldorf.de	Kaina, Bernd/AAE-4692-2020; Roos, Wynand/B-4846-2008	Roos, Wynand/0000-0002-0474-7414; Henninger, Christian/0000-0001-6050-1518	Deutsche Krebshilfe Grant [107361]	Deutsche Krebshilfe Grant(Deutsche Krebshilfe)	This work was supported by Deutsche Krebshilfe Grant 107361.	Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO;2-Q; Azarova AM, 2007, P NATL ACAD SCI USA, V104, P11014, DOI 10.1073/pnas.0704002104; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Boege F, 1996, J BIOL CHEM, V271, P2262, DOI 10.1074/jbc.271.4.2262; Brenner B, 1997, J BIOL CHEM, V272, P22173, DOI 10.1074/jbc.272.35.22173; Canman CE, 1996, NATURE, V384, P213, DOI 10.1038/384213a0; Corna G, 2004, J BIOL CHEM, V279, P13738, DOI 10.1074/jbc.M310106200; Coso OA, 1996, J BIOL CHEM, V271, P3963; Damrot J, 2006, BRIT J PHARMACOL, V149, P988, DOI 10.1038/sj.bjp.0706953; de Feraudy S, 2010, P NATL ACAD SCI USA, V107, P6870, DOI 10.1073/pnas.1002175107; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Feleszko W, 2000, CLIN CANCER RES, V6, P2044; Ferreira A. L. A., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P278, DOI 10.2174/187152508785909474; Fogli S, 2004, FASEB J, V18, P664, DOI 10.1096/fj.03-0724rev; Fritz G, 2009, CURR CANCER DRUG TAR, V9, P626, DOI 10.2174/156800909789057033; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hayakawa J, 2003, J BIOL CHEM, V278, P20582, DOI 10.1074/jbc.M210992200; Haydont V, 2007, INT J RADIAT ONCOL, V68, P1471, DOI 10.1016/j.ijrobp.2007.03.044; Herrlich P, 2008, MOL CELL, V29, P279, DOI 10.1016/j.molcel.2008.01.001; Hortobagyi GN, 1997, DRUGS, V54, P1, DOI 10.2165/00003495-199700544-00003; Huelsenbeck J, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.65; Jefferies CA, 2000, J BIOL CHEM, V275, P3114, DOI 10.1074/jbc.275.5.3114; Jeggo P, 2006, RADIAT PROT DOSIM, V122, P124, DOI 10.1093/rpd/ncl495; Kalfalah FM, 2011, MOL NUTR FOOD RES, V55, pS127, DOI 10.1002/mnfr.201000509; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kobayashi J, 2004, DNA REPAIR, V3, P855, DOI 10.1016/j.dnarep.2004.03.023; Kremer LCM, 2001, J CLIN ONCOL, V19, P191, DOI 10.1200/JCO.2001.19.1.191; Lavin MF, 2007, ONCOGENE, V26, P7749, DOI 10.1038/sj.onc.1210880; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; Lyu YL, 2007, CANCER RES, V67, P8839, DOI 10.1158/0008-5472.CAN-07-1649; Mahmoudi M, 2008, CIRC RES, V103, P717, DOI 10.1161/CIRCRESAHA.108.182899; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; MEYER P, 1993, TOXICOL LETT, V67, P325, DOI 10.1016/0378-4274(93)90065-6; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Nitiss John L, 2002, Curr Opin Investig Drugs, V3, P1512; Nubel T, 2006, CLIN CANCER RES, V12, P933, DOI 10.1158/1078-0432.CCR-05-1903; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Pernice F, 2006, EUR J PHARMACOL, V532, P223, DOI 10.1016/j.ejphar.2006.01.003; Rashid M, 2009, CIRC J, V73, P361, DOI 10.1253/circj.CJ-08-0817; Riad A, 2009, CANCER RES, V69, P695, DOI 10.1158/0008-5472.CAN-08-3076; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Roig J, 1999, J BIOL CHEM, V274, P31119, DOI 10.1074/jbc.274.44.31119; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Sandrock K, 2010, TRAFFIC, V11, P198, DOI 10.1111/j.1600-0854.2009.01015.x; Seiter Karen, 2005, Expert Opin Drug Saf, V4, P219, DOI 10.1517/14740338.4.2.219; Simunek T, 2009, PHARMACOL REP, V61, P154; Sordet Olivier, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P271, DOI 10.2174/1568011033482378; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; van Dalen EC, 2006, EUR J CANCER, V42, P3191, DOI 10.1016/j.ejca.2006.08.005; WELLS NJ, 1994, J BIOL CHEM, V269, P29746; Willmore E, 1998, MOL PHARMACOL, V54, P78, DOI 10.1124/mol.54.1.78; Woodcock SA, 2010, CURR BIOL, V20, P669, DOI 10.1016/j.cub.2010.02.033; Yan TD, 2009, MOL CANCER THER, V8, P1075, DOI 10.1158/1535-7163.MCT-09-0139; Yoshida M, 2009, J MOL CELL CARDIOL, V47, P698, DOI 10.1016/j.yjmcc.2009.07.024; Zhang BL, 1998, J BIOL CHEM, V273, P8776, DOI 10.1074/jbc.273.15.8776; Zhao YY, 2010, CANCER RES, V70, P9287, DOI 10.1158/0008-5472.CAN-10-2664; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhou Q, 2010, CIRC J, V74, P818, DOI 10.1253/circj.CJ-10-0110	64	45	47	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38590	38599		10.1074/jbc.M112.377903	http://dx.doi.org/10.1074/jbc.M112.377903			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23012366	Green Published, hybrid			2022-12-28	WOS:000310982800019
J	Bogdanov, M; Dowhan, W				Bogdanov, Mikhail; Dowhan, William			Lipid-dependent Generation of Dual Topology for a Membrane Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; MONOCLONAL-ANTIBODY 4B1; ESCHERICHIA-COLI; LACTOSE PERMEASE; PHOSPHOLIPID-COMPOSITION; BACILLUS-SUBTILIS; PHOSPHATIDYLETHANOLAMINE; TOPOGENESIS; TRANSLOCATION; LOCALIZATION	The mechanism by which membrane proteins exhibit structural and functional duality in the same membrane or different membranes is unknown. We posit that such duality is determined by both the protein sequence and the membrane lipid composition wherein a spatial or temporal change in the latter can result in a post-assembly change in protein structure and function. To investigate whether co-existence of multiple topological conformers is dependent on the membrane lipid composition, we determined the topological organization of lactose permease in an Escherichia coli model cell system in which phosphatidylethanolamine membrane content can be systematically varied. At intermediate levels of phosphatidylethanolamine a mixture of native and topologically mis-oriented conformers co-existed. There was no threshold level of phosphatidylethanolamine determining a sharp transition from one conformer to the other. Co-existing conformers were not in rapid equilibrium at a static lipid composition indicating that duality of topology is established during an early folding step. Depletion of intermediate levels of phosphatidylethanolamine after final protein assembly resulted in complete mis-orientation of the native conformer. Combined with previous results, such topological dynamics are reversible in both directions. We propose a thermodynamically based model for how lipid-protein interactions can result in a mixed topological organization and how changes in lipid composition can result in changes in the ratio of topologically distinct conformers of proteins. These observations demonstrate a potential lipid-dependent biological switch for generating dynamic structural and functional heterogeneity for a protein within the same membrane or between different membranes in more complex eukaryotic cells.	[Bogdanov, Mikhail; Dowhan, William] Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX 77303 USA	University of Texas System; University of Texas Health Science Center Houston	Bogdanov, M (corresponding author), Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX 77303 USA.	mikhail.v.bogdanov@uth.tmc.edu; William.Dowhan@uth.tmc.edu	Bogdanov, Mikhail/J-3695-2017		National Institutes of Health [GM R37 20478]; John Dunn Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Dunn Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM R37 20478 and a grant from the John Dunn Research Foundation (to W. D.).	BELTZER JP, 1991, J BIOL CHEM, V266, P973; Bertram R, 2008, MICROB BIOTECHNOL, V1, P2, DOI 10.1111/j.1751-7915.2007.00001.x; Bogdanov M, 2002, EMBO J, V21, P2107, DOI 10.1093/emboj/21.9.2107; Bogdanov M, 1999, J BIOL CHEM, V274, P36827, DOI 10.1074/jbc.274.52.36827; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; Bogdanov M, 1998, EMBO J, V17, P5255, DOI 10.1093/emboj/17.18.5255; Bogdanov M, 1996, J BIOL CHEM, V271, P11615, DOI 10.1074/jbc.271.20.11615; Bogdanov M, 2008, J CELL BIOL, V182, P925, DOI 10.1083/jcb.200803097; Bogdanov M, 2010, P NATL ACAD SCI USA, V107, P15057, DOI 10.1073/pnas.1006286107; Bogdanov M, 2010, METHODS MOL BIOL, V619, P79, DOI 10.1007/978-1-60327-412-8_5; Bogdanov M, 2009, J BIOL CHEM, V284, P9637, DOI 10.1074/jbc.R800081200; Bogdanov Mikhail, 2008, V49, P197, DOI 10.1007/978-1-4020-8831-5_8; Bowie JU, 2006, NAT STRUCT MOL BIOL, V13, P94, DOI 10.1038/nsmb0206-94; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P5323; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Diaz-Espinoza R, 2010, PRION, V4, P1, DOI 10.4161/pri.4.2.11960; Dorobantu C, 2011, J VIROL, V85, P13373, DOI 10.1128/JVI.05423-11; Dowhan W, 2011, BIOCHEM SOC T, V39, P767, DOI 10.1042/BST0390767; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Dowhan W, 2009, J LIPID RES, V50, pS305, DOI 10.1194/jlr.R800041-JLR200; Emoto K, 1996, P NATL ACAD SCI USA, V93, P12867, DOI 10.1073/pnas.93.23.12867; FINE JB, 1982, J LIPID RES, V23, P660; Fontaine F, 2011, J BIOL CHEM, V286, P32464, DOI 10.1074/jbc.M111.245696; Frillingos S, 1997, BIOCHEMISTRY-US, V36, P6408, DOI 10.1021/bi970233b; Goder V, 2004, MOL BIOL CELL, V15, P1470, DOI 10.1091/mbc.E03-08-0599; Hickey K. D., 2011, LIPIDS, V2011; Kida Y, 2007, J CELL BIOL, V179, P1441, DOI 10.1083/jcb.200707050; Kim SJ, 2002, MOL BIOL CELL, V13, P3775, DOI 10.1091/mbc.E02-05-0293; Levy D, 1996, Essays Biochem, V31, P49; Luirink J, 2012, BBA-BIOENERGETICS, V1817, P965, DOI 10.1016/j.bbabio.2011.12.006; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; McGinnes LW, 2003, J VIROL, V77, P1951, DOI 10.1128/JVI.77.3.1951-1963.2003; Mileykovskaya E, 1998, J BACTERIOL, V180, P4252, DOI 10.1128/JB.180.16.4252-4257.1998; Moss K, 1998, MOL BIOL CELL, V9, P2681, DOI 10.1091/mbc.9.9.2681; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; Nagamori S, 2003, J BIOL CHEM, V278, P14820, DOI 10.1074/jbc.M300332200; Nesic I, 2012, AGING CELL, V11, P63, DOI 10.1111/j.1474-9726.2011.00760.x; NILSSON IM, 1990, CELL, V62, P1135, DOI 10.1016/0092-8674(90)90390-Z; Nishibori A, 2005, J BACTERIOL, V187, P2163, DOI 10.1128/JB.187.6.2163-2174.2005; Pedersen LB, 1999, J BACTERIOL, V181, P3201, DOI 10.1128/JB.181.10.3201-3211.1999; Prange R, 2004, J GEN VIROL, V85, P1221, DOI 10.1099/vir.0.19737-0; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Saaf A, 1999, P NATL ACAD SCI USA, V96, P8540, DOI 10.1073/pnas.96.15.8540; Schuldiner S, 2007, SCIENCE, V317, P748; Schuldiner S, 2012, TRENDS BIOCHEM SCI, V37, P215, DOI 10.1016/j.tibs.2012.02.006; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; Skach WR, 2009, NAT STRUCT MOL BIOL, V16, P606, DOI 10.1038/nsmb.1600; Sun JZ, 1996, BIOCHEMISTRY-US, V35, P990, DOI 10.1021/bi952166w; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vitrac H, 2011, J BIOL CHEM, V286, P15182, DOI 10.1074/jbc.M110.214387; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; Wang XY, 2002, EMBO J, V21, P5673, DOI 10.1093/emboj/cdf571; Weinglass AB, 2000, P NATL ACAD SCI USA, V97, P8938, DOI 10.1073/pnas.140224497; Wikstrom M, 2009, J BIOL CHEM, V284, P954, DOI 10.1074/jbc.M804482200; Wurie HR, 2011, J BIOL CHEM, V286, P36238, DOI 10.1074/jbc.M111.251900; Xie J, 2006, J BIOL CHEM, V281, P19172, DOI 10.1074/jbc.M602565200; Yamamoto H, 2012, BIOCHEMISTRY-US, V51, P3596, DOI 10.1021/bi2018915; Zhang W, 2005, J BIOL CHEM, V280, P26032, DOI 10.1074/jbc.M504929200; Zhang W, 2003, J BIOL CHEM, V278, P50128, DOI 10.1074/jbc.M309840200; Zhu QS, 1999, J BIOL CHEM, V274, P27898, DOI 10.1074/jbc.274.39.27898	64	45	45	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.404103	http://dx.doi.org/10.1074/jbc.M112.404103			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22969082	Green Published, hybrid			2022-12-28	WOS:000310642200029
J	Chen, CJ; Porche, K; Rayment, I; Gilbert, SP				Chen, Chun Ju; Porche, Ken; Rayment, Ivan; Gilbert, Susan P.			The ATPase Pathway That Drives the Kinesin-14 Kar3Vik1 Powerstroke	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTOR PROTEIN; MITOTIC MOTORS; NCD; DROSOPHILA; MICROTUBULES; CIK1; PROCESSIVITY; SEGREGATION; ROTATION; KINETICS	Kar3, a Saccharomyces cerevisiae microtubule minus-end-directed kinesin-14, dimerizes with either Vik1 or Cik1. The C-terminal globular domain of Vik1 exhibits the structure of a kinesin motor domain and binds microtubules independently of Kar3 but lacks a nucleotide binding site. The only known function of Kar3Vik1 is to cross-link parallel microtubules at the spindle poles during mitosis. In contrast, Kar3Cik1 depolymerizes microtubules during mating but cross-links antiparallel microtubules in the spindle overlap zone during mitosis. A recent study showed that Kar3Vik1 binds across adjacent microtubule protofilaments and uses a minus-end-directed power-stroke to drive ATP-dependent motility. The presteady-state experiments presented here extend this study and establish an ATPase model for the power-stroke mechanism. The results incorporated into the model indicate that Kar3Vik1 collides with the microtubule at 2.4 mu M-1 s(-1) through Vik1, promoting microtubule binding by Kar3 followed by ADP release at 14 s(-1). The tight binding of Kar3 to the microtubule destabilizes the Vik1 interaction with the microtubule, positioning Kar3Vik1 for the start of the powerstroke. Rapid ATP binding to Kar3 is associated with rotation of the coiled-coil stalk, and the post-powerstroke ATP hydrolysis at 26 s(-1) is independent of Vik1, providing further evidence that Vik1 rotates with the coiled coil during the powerstroke. Detachment of Kar3Vik1 from the microtubule at 6 s(-1) completes the cycle and allows the motor to return to its initial conformation. The results also reveal key differences in the ATPase cycles of Kar3Vik1 and Kar3Cik1, supporting the fact that these two motors have distinctive biological functions.	[Chen, Chun Ju; Porche, Ken; Gilbert, Susan P.] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; [Chen, Chun Ju; Porche, Ken; Gilbert, Susan P.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Rayment, Ivan] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; University of Wisconsin System; University of Wisconsin Madison	Gilbert, SP (corresponding author), Rensselaer Polytech Inst, Dept Biol, 110 8th St, Troy, NY 12180 USA.	sgilbert@rpi.edu	Porche, Ken/ABE-4218-2020; rayment, ivan/A-2720-2008	Porche, Ken/0000-0002-2616-5853; rayment, ivan/0000-0001-9279-7835	National Institutes of Health [GM54141, GM086351]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086351, R37GM054141, R01GM054141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM54141 (to S. P. G.) and GM086351 (to I. R.).	Allingham JS, 2007, CELL, V128, P1161, DOI 10.1016/j.cell.2006.12.046; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Barrett JG, 2000, MOL BIOL CELL, V11, P2373, DOI 10.1091/mbc.11.7.2373; Braun M, 2009, NAT CELL BIOL, V11, P724, DOI 10.1038/ncb1878; Cai S, 2009, MOL BIOL CELL, V20, P1348, DOI 10.1091/mbc.E08-09-0971; Chen CJ, 2011, J BIOL CHEM, V286, P29261, DOI 10.1074/jbc.M111.255554; Cope J, 2010, J STRUCT BIOL, V170, P257, DOI 10.1016/j.jsb.2009.12.004; deCastro MJ, 2000, NAT CELL BIOL, V2, P724, DOI 10.1038/35036357; Endow SA, 1996, J CELL SCI, V109, P2429; ENDOW SA, 1990, NATURE, V345, P81, DOI 10.1038/345081a0; Endres NF, 2006, NATURE, V439, P875, DOI 10.1038/nature04320; Fink G, 2009, NAT CELL BIOL, V11, P717, DOI 10.1038/ncb1877; Foster KA, 1998, J BIOL CHEM, V273, P35307, DOI 10.1074/jbc.273.52.35307; Foster KA, 2000, BIOCHEMISTRY-US, V39, P1784, DOI 10.1021/bi991500b; Foster KA, 2001, J BIOL CHEM, V276, P19259, DOI 10.1074/jbc.M008347200; Gardner MK, 2008, J CELL BIOL, V180, P91, DOI 10.1083/jcb.200710164; Gilbert SP, 2011, COMPREHENSIVE BIOPHYSICS, VOL 4: MOLECULAR MOTORS AND MOTILITY, P321, DOI 10.1016/B978-0-12-374920-8.00421-5; GILBERT SP, 1995, NATURE, V373, P671, DOI 10.1038/373671a0; Gilbert SP, 2000, METHODS, V22, P337, DOI 10.1006/meth.2000.1086; Goshima G, 2005, J CELL BIOL, V171, P229, DOI 10.1083/jcb.200505107; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; Hentrich C, 2010, J CELL BIOL, V189, P465, DOI 10.1083/jcb.200910125; Hirose K, 2006, MOL CELL, V23, P913, DOI 10.1016/j.molcel.2006.07.020; Kaseda K, 2003, NAT CELL BIOL, V5, P1079, DOI 10.1038/ncb1067; Krzysiak TC, 2006, J BIOL CHEM, V281, P39444, DOI 10.1074/jbc.M608056200; Mackey AT, 2004, J BIOL CHEM, V279, P51354, DOI 10.1074/jbc.M406268200; Mackey AT, 2003, J BIOL CHEM, V278, P3527, DOI 10.1074/jbc.M206219200; Manning BD, 1999, J CELL BIOL, V144, P1219, DOI 10.1083/jcb.144.6.1219; Manning BD, 2000, TRENDS CELL BIOL, V10, P281, DOI 10.1016/S0962-8924(00)01774-8; MCDONALD HB, 1990, CELL, V63, P1159, DOI 10.1016/0092-8674(90)90412-8; MCDONALD HB, 1990, CELL, V61, P991, DOI 10.1016/0092-8674(90)90064-L; MELUH PB, 1990, CELL, V60, P1029, DOI 10.1016/0092-8674(90)90351-E; Mountain V, 1999, J CELL BIOL, V147, P351, DOI 10.1083/jcb.147.2.351; Oladipo A, 2007, MOL BIOL CELL, V18, P3601, DOI 10.1091/mbc.e06-12-1085; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; PAGE BD, 1992, GENE DEV, V6, P1414, DOI 10.1101/gad.6.8.1414; PAGE BD, 1994, J CELL BIOL, V124, P507, DOI 10.1083/jcb.124.4.507; Pechatnikova E, 1999, BIOPHYS J, V77, P1003, DOI 10.1016/S0006-3495(99)76951-1; Rank KC, 2012, J CELL BIOL, V197, P957, DOI 10.1083/jcb.201201132; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; SAUNDERS WS, 1992, CELL, V70, P451, DOI 10.1016/0092-8674(92)90169-D; Sharp DJ, 2000, MOL BIOL CELL, V11, P241, DOI 10.1091/mbc.11.1.241; Sharp DJ, 1999, NAT CELL BIOL, V1, P51, DOI 10.1038/9025; Sosa H, 1997, CELL, V90, P217, DOI 10.1016/S0092-8674(00)80330-X; Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066; Vale RD, 1997, ANNU REV CELL DEV BI, V13, P745, DOI 10.1146/annurev.cellbio.13.1.745; WALKER RA, 1990, NATURE, V347, P780, DOI 10.1038/347780a0; Wendt TG, 2002, EMBO J, V21, P5969, DOI 10.1093/emboj/cdf622; Winey M, 2012, GENETICS, V190, P1197, DOI 10.1534/genetics.111.128710; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yun M, 2003, EMBO J, V22, P5382, DOI 10.1093/emboj/cdg531	51	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36673	36682		10.1074/jbc.M112.395590	http://dx.doi.org/10.1074/jbc.M112.395590			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22977241	hybrid, Green Published			2022-12-28	WOS:000310588500005
J	Kim, YD; Li, TG; Ahn, SW; Kim, DK; Lee, JM; Hwang, SL; Kim, YH; Lee, CH; Lee, IK; Chiang, JYL; Choi, HS				Kim, Yong Deuk; Li, Tiangang; Ahn, Seung-Won; Kim, Don-Kyu; Lee, Ji-Min; Hwang, Seung-Lark; Kim, Yong-Hoon; Lee, Chul-Ho; Lee, In-Kyu; Chiang, John Y. L.; Choi, Hueng-Sik			Orphan Nuclear Receptor Small Heterodimer Partner Negatively Regulates Growth Hormone-mediated Induction of Hepatic Gluconeogenesis through Inhibition of Signal Transducer and Activator of Transcription 5 (STAT5) Transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; GLUCOSE-6-PHOSPHATASE GENE; ATAXIA-TELANGIECTASIA; AMPK; ATM; METFORMIN; GLUCOSE; INVOLVEMENT; EXPRESSION; MECHANISM	Growth hormone (GH) is a key metabolic regulator mediating glucose and lipid metabolism. Ataxia telangiectasia mutated (ATM) is a member of the phosphatidylinositol 3-kinase superfamily and regulates cell cycle progression. The orphan nuclear receptor small heterodimer partner (SHP: NR0B2) plays a pivotal role in regulating metabolic processes. Here, we studied the role of ATM on GH-dependent regulation of hepatic gluconeogenesis in the liver. GH induced phosphoenolpyruvate carboxykinase (PEPCK) and glucose 6-phosphatase gene expression in primary hepatocytes. GH treatment and adenovirus-mediated STAT5 overexpression in hepatocytes increased glucose production, which was blocked by a JAK2 inhibitor, AG490, dominant negative STAT5, and STAT5 knockdown. We identified a STAT5 binding site on the PEPCK gene promoter using reporter assays and point mutation analysis. Up-regulation of SHP by metformin-mediated activation of the ATM-AMP-activated protein kinase pathway led to inhibition of GH-mediated induction of hepatic gluconeogenesis, which was abolished by an ATM inhibitor, KU-55933. Immunoprecipitation studies showed that SHP physically interacted with STAT5 and inhibited STAT5 recruitment on the PEPCK gene promoter. GH-induced hepatic gluconeogenesis was decreased by either metformin or Ad-SHP, whereas the inhibition by metformin was abolished by SHP knockdown. Finally, the increase of hepatic gluconeogenesis following GH treatment was significantly higher in the liver of SHP null mice compared with that of wildtype mice. Overall, our results suggest that the ATM-AMP-activated protein kinase-SHP network, as a novel mechanism for regulating hepatic glucose homeostasis via a GH-dependent pathway, may be a potential therapeutic target for insulin resistance.	[Kim, Yong Deuk; Ahn, Seung-Won; Kim, Don-Kyu; Lee, Ji-Min; Choi, Hueng-Sik] Chonnam Natl Univ, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Dept Biomed Sci, Sch Med, Res Inst Med Sci, Kwangju 501746, South Korea; [Kim, Yong Deuk; Hwang, Seung-Lark; Lee, In-Kyu] Kyungpook Natl Univ, Res Inst Aging & Metab, World Class Univ Program, Sch Med, Taegu 700721, South Korea; [Li, Tiangang; Chiang, John Y. L.] NE Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH 44272 USA; [Kim, Yong-Hoon; Lee, Chul-Ho] Univ Sci & Technol, Lab Anim Ctr, Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea	Chonnam National University; Chonnam National University; Kyungpook National University; Northeast Ohio Medical University (NEOMED); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Choi, HS (corresponding author), Chonnam Natl Univ, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea.	hsc@chonnam.ac.kr	Lee, In-Kyu/AAR-6374-2021; Chiang, John Y. L./G-2658-2011	Chiang, John Y. L./0000-0001-9360-7650	National Creative Research Initiatives Center for Nuclear Receptor Signals Grant, Korean Ministry of Education, Science and Technology [20110018305]; National Research Foundation of Korea; Ministry of Education, Science and Technology [20100019512, R32-10064]; Ministry of Health Welfare [A111345]; World Class University Program through National Research Foundation of Korea; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK058379, R01DK044442] Funding Source: NIH RePORTER	National Creative Research Initiatives Center for Nuclear Receptor Signals Grant, Korean Ministry of Education, Science and Technology; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Health Welfare; World Class University Program through National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Creative Research Initiatives Center for Nuclear Receptor Signals Grant 20110018305 from the Korean Ministry of Education, Science and Technology and the Future-based Technology Development Program (BIO Fields) through the National Research Foundation of Korea funded by Ministry of Education, Science and Technology Grant 20100019512 (to H. S. C.) and a grant of the Korea Health Technology R & D Project, Ministry of Health & Welfare Grant A111345, World Class University Program through the National Research Foundation of Korea funded by Ministry of Education, Science and Technology Grant R32-10064 (to I.-K. L.).	Barclay JL, 2011, ENDOCRINOLOGY, V152, P181, DOI 10.1210/en.2010-0537; Buitenhuis M, 2004, INT J BIOCHEM CELL B, V36, P2120, DOI 10.1016/j.biocel.2003.11.008; CarterSu C, 1996, ANNU REV PHYSIOL, V58, P187, DOI 10.1146/annurev.ph.58.030196.001155; Chanda D, 2008, AM J PHYSIOL-ENDOC M, V295, pE368, DOI 10.1152/ajpendo.00800.2007; Chanda D, 2008, ENDOCR J, V55, P253, DOI 10.1507/endocrj.K07E-103; Chanda D, 2009, J BIOL CHEM, V284, P28510, DOI 10.1074/jbc.M109.022244; Cho Y, 2006, ENDOCRINOLOGY, V147, P5374, DOI 10.1210/en.2006-0518; DAVIDSON MB, 1987, J ENDOCRINOL INVEST, V10, P569, DOI 10.1007/BF03346996; Dominici FP, 2002, EXP BIOL MED, V227, P149, DOI 10.1177/153537020222700301; Ghanaat F, 2005, METABOLISM, V54, P604, DOI 10.1016/j.metabol.2004.12.003; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Hogan JC, 2005, DIABETES, V54, P1968, DOI 10.2337/diabetes.54.7.1968; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim JY, 2004, MOL ENDOCRINOL, V18, P2880, DOI 10.1210/me.2004-0211; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Lahuna O, 2000, MOL ENDOCRINOL, V14, P285, DOI 10.1210/me.14.2.285; Lanning NJ, 2006, REV ENDOCR METAB DIS, V7, P225, DOI 10.1007/s11154-007-9025-5; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lee JM, 2010, J BIOL CHEM, V285, P32182, DOI 10.1074/jbc.M110.134890; Lee YS, 2008, BIOCHEM J, V413, P559, DOI 10.1042/BJ20071637; Lee YS, 2007, INT REV CYTOL, V261, P117, DOI 10.1016/S0074-7696(07)61003-1; Massillon D, 2001, J BIOL CHEM, V276, P4055, DOI 10.1074/jbc.M007939200; McKinnon PJ, 2004, EMBO REP, V5, P772, DOI 10.1038/sj.embor.7400210; Miles PD, 2007, AM J PHYSIOL-ENDOC M, V293, pE70, DOI 10.1152/ajpendo.00259.2006; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; Park YJ, 2011, J LIPID RES, V52, P2234, DOI 10.1194/jlr.M016048; Rotella CM, 2006, CURR DIABETES REV, V2, P307, DOI 10.2174/157339906777950651; SCHALCH DS, 1970, NEW ENGL J MED, V282, P1396, DOI 10.1056/NEJM197006182822503; Schmoll D, 2001, BIOCHEM J, V357, P867, DOI 10.1042/0264-6021:3570867; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Sun Y, 2007, MOL CELL BIOCHEM, V306, P239, DOI 10.1007/s11010-007-9575-6; Suzuki A, 2004, BIOCHEM BIOPH RES CO, V324, P986, DOI 10.1016/j.bbrc.2004.09.145; Vijayakumar A, 2010, GROWTH HORM IGF RES, V20, P1, DOI 10.1016/j.ghir.2009.09.002; White UA, 2007, DIABETES, V56, P1623, DOI 10.2337/db06-1286; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zhou KX, 2011, NAT GENET, V43, P117, DOI 10.1038/ng.735	39	30	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37098	37108		10.1074/jbc.M112.339887	http://dx.doi.org/10.1074/jbc.M112.339887			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22977252	hybrid, Green Published			2022-12-28	WOS:000310588500044
J	Varma, S; Cao, YX; Tagne, JB; Lakshminarayanan, M; Li, J; Friedman, TB; Morell, RJ; Warburton, D; Kotton, DN; Ramirez, MI				Varma, Saaket; Cao, Yuxia; Tagne, Jean-Bosco; Lakshminarayanan, Meenakshi; Li, Jun; Friedman, Thomas B.; Morell, Robert J.; Warburton, David; Kotton, Darrell N.; Ramirez, Maria I.			The Transcription Factors Grainyhead-like 2 and NK2-Homeobox 1 Form a Regulatory Loop That Coordinates Lung Epithelial Cell Morphogenesis and Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; PROBE LEVEL DATA; FACTOR-I; GENE-EXPRESSION; EPIDERMAL DIFFERENTIATION; BRANCHING MORPHOGENESIS; STEM-CELLS; TELOMERASE; PROTEIN; MOUSE	The Grainyhead family of transcription factors controls morphogenesis and differentiation of epithelial cell layers in multicellular organisms by regulating cell junction- and proliferation-related genes. Grainyhead-like 2 (Grhl2) is expressed in developing mouse lung epithelium and is required for normal lung organogenesis. The specific epithelial cells expressing Grhl2 and the genes regulated by Grhl2 in normal lungs are mostly unknown. In these studies we identified the NK2-homeobox 1 transcription factor (Nkx2-1) as a direct transcriptional target of Grhl2. By binding and transcriptional assays and by confocal microscopy we showed that these two transcription factors form a positive feedback loop in vivo and in cell lines and are co-expressed in lung bronchiolar and alveolar type II cells. The morphological changes observed in flattening lung alveolar type II cells in culture are associated with down-regulation of Grhl2 and Nkx2-1. Reduction of Grhl2 in lung epithelial cell lines results in lower expression levels of Nkx2-1 and of known Grhl2 target genes. By microarray analysis we identified that in addition to Cadherin1 and Claudin4, Grhl2 regulates other cell interaction genes such as semaphorins and their receptors, which also play a functional role in developing lung epithelium. Impaired collective cell migration observed in Grhl2 knock-down cell monolayers is associated with reduced expression of these genes and may contribute to the altered epithelial phenotype reported in Grhl2 mutant mice. Thus, Grhl2 functions at the nexus of a novel regulatory network, connecting lung epithelial cell identity, migration, and cell-cell interactions.	[Varma, Saaket; Cao, Yuxia; Tagne, Jean-Bosco; Lakshminarayanan, Meenakshi; Li, Jun; Kotton, Darrell N.; Ramirez, Maria I.] Boston Univ, Sch Med, Dept Med, Ctr Pulm, Boston, MA 02118 USA; [Warburton, David] Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Friedman, Thomas B.; Morell, Robert J.] NIDCD, Sect Human Genet, Mol Genet Lab, NIH, Rockville, MD 20850 USA	Boston University; Children's Hospital Los Angeles; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Ramirez, MI (corresponding author), 72 E Concord St,R304, Boston, MA 02118 USA.	mramirez@bu.edu	Warburton, David/AAD-5709-2020; Morell, Robert James/Q-2042-2019	Cao, Yu-Xia/0000-0001-7396-9988; Ramirez, Maria Isabel/0000-0001-6294-4419; Kotton, Darrell/0000-0002-9604-8476; Morell, Robert/0000-0003-1537-7356; Tagne, Jean-Bosco/0000-0003-1830-9156	National Institutes of Health Grant [R01 HL0833034, P01 HL47049]; California Institute of Regenerative Medicine [TG2-01168]; NIDCD, National Institutes of Health, Intramural Funds [DC000039-15]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025771] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083034, P01HL047049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000039] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NIDCD, National Institutes of Health, Intramural Funds; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL0833034 (NHLBI; to M. I. R., D. N. K., and S. V.) and in part by P01 HL47049 (NHLBI; to M. I. R. and D. N. K.). This work was also supported by the California Institute of Regenerative Medicine TG2-01168 (to S. V. and D. W.).; Supported by NIDCD, National Institutes of Health, Intramural Funds DC000039-15.	Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Boglev Y, 2011, DEV BIOL, V349, P512, DOI 10.1016/j.ydbio.2010.11.011; Borok Z, 1998, AM J PHYSIOL-LUNG C, V275, pL155, DOI 10.1152/ajplung.1998.275.1.L155; Cao YX, 2010, J BIOL CHEM, V285, P2152, DOI 10.1074/jbc.M109.039172; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chen W, 2010, J BIOL CHEM, V285, P40852, DOI 10.1074/jbc.M110.103812; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Das A, 2011, AM J PHYSIOL-LUNG C, V301, pL427, DOI 10.1152/ajplung.00090.2011; Driscoll B, 2000, AM J PHYSIOL-LUNG C, V279, pL1191, DOI 10.1152/ajplung.2000.279.6.L1191; Fridlender ZG, 2007, EUR RESPIR J, V30, P205, DOI 10.1183/09031936.00009407; Galambos C, 2010, AM J RESP CRIT CARE, V182, P549, DOI 10.1164/rccm.201002-0167CR; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Gustavsson P, 2008, BIRTH DEFECTS RES A, V82, P728, DOI 10.1002/bdra.20494; Hemphala J, 2003, DEVELOPMENT, V130, P249, DOI 10.1242/dev.00218; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ito T, 2000, MECH DEVELOP, V97, P35, DOI 10.1016/S0925-4773(00)00401-9; Janicke M, 2010, INT J DEV BIOL, V54, P837, DOI 10.1387/ijdb.092877mj; Kagoshima M, 2001, GENES CELLS, V6, P559, DOI 10.1046/j.1365-2443.2001.00441.x; Kang X, 2009, ONCOGENE, V28, P565, DOI 10.1038/onc.2008.404; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Li CG, 2000, BBA-GENE STRUCT EXPR, V1490, P213, DOI 10.1016/S0167-4781(99)00183-9; Lo B, 2008, J IMMUNOL, V180, P881, DOI 10.4049/jimmunol.180.2.881; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.3.CO;2-Q; Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Olsen CE, 2005, EXP LUNG RES, V31, P461, DOI 10.1080/01902140590918830; Osborne NJ, 2005, DEV DYNAM, V232, P939, DOI 10.1002/dvdy.20258; Peters LM, 2002, HUM MOL GENET, V11, P2877, DOI 10.1093/hmg/11.23.2877; Porter SE, 2001, AM J PHYSIOL-LUNG C, V280, pL1282, DOI 10.1152/ajplung.2001.280.6.L1282; POTIRON V, 2005, SCI STKE, pPE24; Pyrgaki C, 2011, DEV BIOL, V353, P38, DOI 10.1016/j.ydbio.2011.02.027; Ramirez MI, 1997, J BIOL CHEM, V272, P26285, DOI 10.1074/jbc.272.42.26285; Reynolds SD, 2002, AM J RESP CRIT CARE, V166, P1498, DOI 10.1164/rccm.200204-285OC; Roth C, 2000, GENOMICS, V63, P384, DOI 10.1006/geno.1999.6084; Saito RA, 2009, CANCER RES, V69, P2783, DOI 10.1158/0008-5472.CAN-08-3490; Schwartz B, 2007, ONCOGENE, V26, P4049, DOI 10.1038/sj.onc.1210193; Shaw-White JR, 1999, J BIOL CHEM, V274, P2658, DOI 10.1074/jbc.274.5.2658; Shimamura T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020804; Tagne JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029907; Tanaka Y, 2008, J HEPATOL, V49, P746, DOI 10.1016/j.jhep.2008.06.019; Tao JN, 2005, DEVELOPMENT, V132, P1021, DOI 10.1242/dev.01641; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Warburton David, 2004, Paediatr Respir Rev, V5 Suppl A, pS283, DOI 10.1016/S1526-0542(04)90052-8; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; Werth M, 2010, DEVELOPMENT, V137, P3835, DOI 10.1242/dev.055483; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Wilanowski T, 2008, EMBO J, V27, P886, DOI 10.1038/emboj.2008.24; Williams MC, 1996, AM J RESP CELL MOL, V14, P577, DOI 10.1165/ajrcmb.14.6.8652186; Wilson AA, 2008, AM J RESP CELL MOL, V39, P133, DOI 10.1165/rcmb.2007-0133OC; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Yu ZQ, 2008, DEV BIOL, V319, P56, DOI 10.1016/j.ydbio.2008.04.001; Yu ZQ, 2006, DEV BIOL, V299, P122, DOI 10.1016/j.ydbio.2006.07.015; Yu ZQ, 2009, EMBO J, V28, P1890, DOI 10.1038/emboj.2009.142; Yuan BB, 2000, DEV DYNAM, V217, P180, DOI 10.1002/(SICI)1097-0177(200002)217:2<180::AID-DVDY5>3.0.CO;2-3	60	57	60	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37282	37295		10.1074/jbc.M112.408401	http://dx.doi.org/10.1074/jbc.M112.408401			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22955271	Green Published, hybrid			2022-12-28	WOS:000310588500060
J	Medina, B; Paraskevopoulos, K; Boehringer, J; Sznajder, A; Robertson, M; Endicott, J; Gordon, C				Medina, Bethan; Paraskevopoulos, Konstantinos; Boehringer, Jonas; Sznajder, Anna; Robertson, Morag; Endicott, Jane; Gordon, Colin			The Ubiquitin-associated (UBA) 1 Domain of Schizosaccharomyces pombe Rhp23 Is Essential for the Recognition of Ubiquitin-proteasome System Substrates Both in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIUBIQUITIN CHAIN-BINDING; ANAPHASE-PROMOTING COMPLEX; PROTEIN LIGASE SYSTEM; STRUCTURAL DETERMINANTS; POLYUBIQUITIN CHAINS; FISSION YEAST; SUBUNIT; RAD23; DEGRADATION; CELLS	The ubiquitin-proteasome system is essential for maintaining a functional cell. Not only does it remove incorrectly folded proteins, it also regulates protein levels to ensure their appropriate spatial and temporal distribution. Proteins marked for degradation by the addition of Lys(48)-linked ubiquitin (Ub) chains are recognized by shuttle factors and transported to the 26 S proteasome. One of these shuttle factors, Schizosaccharomyces pombe Rhp23, has an unusual domain architecture. It comprises an N-terminal ubiquitin-like domain that can recognize the proteasome followed by two ubiquitin-associated (UBA) domains, termed UBA1 and UBA2, which can bind Ub. This architecture is conserved up to humans, suggesting that both domains are important for Rhp23 function. Such an extent of conservation raises the question as to why, in contrast to all other shuttle proteins, does Rhp23 require two UBA domains? We performed in vitro Ub binding assays using domain swap chimeric proteins and mutated domains in isolation as well as in the context of the full-length protein to reveal that the Ub binding properties of the UBA domains are context-dependent. In vivo, the internal Rhp23 UBA1 domain provides sufficient Ub recognition for the protein to function without UBA2.	[Medina, Bethan; Paraskevopoulos, Konstantinos; Sznajder, Anna; Robertson, Morag; Gordon, Colin] Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Boehringer, Jonas; Endicott, Jane] Univ Oxford, Dept Biochem, Lab Mol Biophys, Oxford OX1 3QU, England	University of Edinburgh; University of Oxford	Endicott, J (corresponding author), No Inst Canc Res, Sch Med, Paul OGorman Bldg,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	jane.endicott@ncl.ac.uk; C.Gordon@hgu.mrc.ac.uk		Endicott, Jane/0000-0003-4868-0116	United Kingdom Medical Research Council; Role of Ubiquitin and Ubiquitin-like Modifiers in Cellular Regulation (RUBICON) network of excellence; Wellcome Trust; MRC [G0700053] Funding Source: UKRI; Medical Research Council [G0700053] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Role of Ubiquitin and Ubiquitin-like Modifiers in Cellular Regulation (RUBICON) network of excellence; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the United Kingdom Medical Research Council, Role of Ubiquitin and Ubiquitin-like Modifiers in Cellular Regulation (RUBICON) network of excellence, and Wellcome Trust.	Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Bohn S, 2010, P NATL ACAD SCI USA, V107, P20992, DOI 10.1073/pnas.1015530107; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; CIECHANOVER A, 1981, P NATL ACAD SCI-BIOL, V78, P761, DOI 10.1073/pnas.78.2.761; Dantuma NP, 2009, DNA REPAIR, V8, P449, DOI 10.1016/j.dnarep.2009.01.005; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Dieckmann T, 1998, NAT STRUCT BIOL, V5, P1042, DOI 10.1038/4220; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Engelbert D, 2008, ONCOGENE, V27, P907, DOI 10.1038/sj.onc.1210703; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; Fu HY, 1998, J BIOL CHEM, V273, P1970, DOI 10.1074/jbc.273.4.1970; Hartmann-Petersen R, 2003, INT J BIOCHEM CELL B, V35, P629, DOI 10.1016/S1357-2725(02)00393-X; Heessen S, 2005, MOL CELL, V18, P225, DOI 10.1016/j.molcel.2005.03.015; Heinen C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1179; HERSHKO A, 1982, J BIOL CHEM, V257, P3964; HERSHKO A, 1986, J BIOL CHEM, V261, P1992; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mueller TD, 2003, EMBO J, V22, P4634, DOI 10.1093/emboj/cdg467; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Nandi D, 2006, J BIOSCIENCES, V31, P137, DOI 10.1007/BF02705243; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Rao H, 2002, J BIOL CHEM, V277, P11691, DOI 10.1074/jbc.M200245200; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Ryu KS, 2003, J BIOL CHEM, V278, P36621, DOI 10.1074/jbc.M304628200; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Seeger M, 2003, J BIOL CHEM, V278, P16791, DOI 10.1074/jbc.M208281200; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; vanderSpek PJ, 1996, NUCLEIC ACIDS RES, V24, P2551, DOI 10.1093/nar/24.13.2551; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Wang Q, 2003, ONCOGENE, V22, P1486, DOI 10.1038/sj.onc.1206224; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Wilkinson CRM, 2000, J BIOL CHEM, V275, P15182, DOI 10.1074/jbc.275.20.15182; Wu T, 2010, P NATL ACAD SCI USA, V107, P1355, DOI 10.1073/pnas.0912802107	41	4	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42344	42351		10.1074/jbc.M112.419838	http://dx.doi.org/10.1074/jbc.M112.419838			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23038266	Green Published, hybrid			2022-12-28	WOS:000312103000069
J	Morales, M; Mate, MJ; Romero, A; Martinez, MJ; Martinez, AT; Ruiz-Duenas, FJ				Morales, Maria; Mate, Maria J.; Romero, Antonio; Jesus Martinez, Maria; Martinez, Angel T.; Ruiz-Duenas, Francisco J.			Two Oxidation Sites for Low Redox Potential Substrates A DIRECTED MUTAGENESIS, KINETIC, AND CRYSTALLOGRAPHIC STUDY ON PLEUROTUS ERYNGII VERSATILE PEROXIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGNIN PEROXIDASE; HORSERADISH-PEROXIDASE; ESCHERICHIA-COLI; COMPOUND-II; BASIDIOMYCETE; BINDING; EPR	Versatile peroxidase shares with manganese peroxidase and lignin peroxidase the ability to oxidize Mn2+ and high redox potential aromatic compounds, respectively. Moreover, it is also able to oxidize phenols (and low redox potential dyes) at two catalytic sites, as shown by biphasic kinetics. A high efficiency site (with 2,6-dimethoxyphenol and p-hydroquinone catalytic efficiencies of similar to 70 and similar to 700 s(-1) mM(-1), respectively) was localized at the same exposed Trp-164 responsible for high redox potential substrate oxidation (as shown by activity loss in the W164S variant). The second site, characterized by low catalytic efficiency (similar to 3 and similar to 50 s(-1) mM(-1) for 2,6-dimethoxyphenol and p-hydroquinone, respectively) was localized at the main heme access channel. Steady-state and transient-state kinetics for oxidation of phenols and dyes at the latter site were improved when side chains of residues forming the heme channel edge were removed in single and multiple variants. Among them, the E140G/K176G, E140G/P141G/K176G, and E140G/W164S/K176G variants attained catalytic efficiencies for oxidation of 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonate) at the heme channel similar to those of the exposed tryptophan site. The heme channel enlargement shown by x-ray diffraction of the E140G, P141G, K176G, and E140G/K176G variants would allow a better substrate accommodation near the heme, as revealed by the up to 26-fold lower K-m values (compared with native VP). The resulting interactions were shown by the x-ray structure of the E140G-guaiacol complex, which includes two H-bonds of the substrate with Arg-43 and Pro-139 in the distal heme pocket (at the end of the heme channel) and several hydrophobic interactions with other residues and the heme cofactor.	[Morales, Maria; Mate, Maria J.; Romero, Antonio; Jesus Martinez, Maria; Martinez, Angel T.; Ruiz-Duenas, Francisco J.] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Martinez, AT (corresponding author), CSIC, Ctr Invest Biol, Ramiro de Maeztu 9, E-28040 Madrid, Spain.	ATMartinez@cib.csic.es; FJRuiz@cib.csic.es	Ruiz-Dueñas, Francisco J/L-9837-2015; Martinez, Maria Jesus/F-9147-2015; Martínez, Angel T/G-7284-2017; del Puerto Morales Herrero, Maria/A-4558-2011; Romero, Antonio/K-5754-2014	Ruiz-Dueñas, Francisco J/0000-0002-9837-5665; Martinez, Maria Jesus/0000-0003-2166-1097; Martínez, Angel T/0000-0002-1584-2863; del Puerto Morales Herrero, Maria/0000-0002-7290-7029; Romero, Antonio/0000-0002-6990-6973	Spanish Ministry of Economy and Competitiveness (MINECO) [BIO2008-01533, BIO2011-26694, BFU2011-24615]; PEROXICATS European project [KBBE-2010-4-265397]; Consejo Superior de Investigaciones Cientificas (CSIC) I3P fellowship; MINECO Ramon y Cajal contract	Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); PEROXICATS European project; Consejo Superior de Investigaciones Cientificas (CSIC) I3P fellowship; MINECO Ramon y Cajal contract(Spanish Government)	This work was supported by the RAPERO (BIO2008-01533), HIPOP (BIO2011-26694), and STRUANTIVIRU (BFU2011-24615) project grants of the Spanish Ministry of Economy and Competitiveness (MINECO) (to A. T. M., F. J. R.-D., and A. R., respectively) and by the PEROXICATS (KBBE-2010-4-265397) European project (to A. T. M.).; Supported by a Consejo Superior de Investigaciones Cientificas (CSIC) I3P fellowship.; Supported by a MINECO Ramon y Cajal contract.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blodig W, 2001, J MOL BIOL, V305, P851, DOI 10.1006/jmbi.2000.4346; CHUNG N, 1995, ARCH BIOCHEM BIOPHYS, V316, P851, DOI 10.1006/abbi.1995.1114; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Doyle WA, 1998, BIOCHEMISTRY-US, V37, P15097, DOI 10.1021/bi981633h; Dunford H. B., 1999, HEME PEROXIDASES; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Fueyo E, 2012, P NATL ACAD SCI USA, V109, P5458, DOI 10.1073/pnas.1119912109; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Gerini MF, 2003, BIOPHYS J, V84, P3883, DOI 10.1016/S0006-3495(03)75116-9; Gold MH, 2000, MET IONS BIOL SYST, V37, P559; Gumiero A, 2010, ARCH BIOCHEM BIOPHYS, V500, P13, DOI 10.1016/j.abb.2010.02.015; HAMMEL KE, 1986, J BIOL CHEM, V261, P6948; Hammel KE, 2008, CURR OPIN PLANT BIOL, V11, P349, DOI 10.1016/j.pbi.2008.02.003; HARVEY PJ, 1990, J BIOTECHNOL, V13, P169, DOI 10.1016/0168-1656(90)90102-H; Heinfling A, 1998, FEBS LETT, V428, P141, DOI 10.1016/S0014-5793(98)00512-2; Henriksen A, 1999, J BIOL CHEM, V274, P35005, DOI 10.1074/jbc.274.49.35005; Hilden K, 2005, FUNGAL GENET BIOL, V42, P403, DOI 10.1016/j.fgb.2005.01.008; KODURI RS, 1995, J BIOL CHEM, V270, P22254, DOI 10.1074/jbc.270.38.22254; LEIGH JS, 1975, FEBS LETT, V51, P304, DOI 10.1016/0014-5793(75)80913-6; Martinez AT, 2009, CURR OPIN BIOTECH, V20, P348, DOI 10.1016/j.copbio.2009.05.002; Martinez AT, 2002, ENZYME MICROB TECH, V30, P425, DOI 10.1016/S0141-0229(01)00521-X; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Mester T, 2001, J BIOL CHEM, V276, P22985, DOI 10.1074/jbc.M010739200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Patel PK, 1997, BBA-PROTEIN STRUCT M, V1339, P79, DOI 10.1016/S0167-4838(96)00219-1; Perez-Boada M, 2005, J MOL BIOL, V354, P385, DOI 10.1016/j.jmb.2005.09.047; Perez-Boada M, 2002, ENZYME MICROB TECH, V30, P518, DOI 10.1016/S0141-0229(02)00008-X; Pogni R, 2006, J BIOL CHEM, V281, P9517, DOI 10.1074/jbc.M510424200; Rodriguez-Lopez JN, 2000, BIOCHEMISTRY-US, V39, P13201, DOI 10.1021/bi001150p; Ruiz-Duenas FJ, 1999, MOL MICROBIOL, V31, P223, DOI 10.1046/j.1365-2958.1999.01164.x; Ruiz-Duenas FJ, 2001, BIOCHEM SOC T, V29, P116, DOI 10.1042/BST0290116; Ruiz-Duenas FJ, 2008, BIOCHEMISTRY-US, V47, P1685, DOI 10.1021/bi7020298; Ruiz-Duenas FJ, 2007, BIOCHEMISTRY-US, V46, P66, DOI 10.1021/bi061542h; Ruiz-Duenas FJ, 2011, CR BIOL, V334, P795, DOI 10.1016/j.crvi.2011.06.004; Ruiz-Duenas FJ, 2009, MICROB BIOTECHNOL, V2, P164, DOI 10.1111/j.1751-7915.2008.00078.x; Ruiz-Duenas FJ, 2009, J EXP BOT, V60, P441, DOI 10.1093/jxb/ern261; Ruiz-Duenas FJ, 2009, J BIOL CHEM, V284, P7986, DOI 10.1074/jbc.M808069200; RUIZDUENAS FJ, 2008, Patent No. 200801292; Sambrook J., 2001, MOL CLONING; Smith AT, 1998, CURR OPIN CHEM BIOL, V2, P269, DOI 10.1016/S1367-5931(98)80069-0; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127	42	61	62	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41053	41067		10.1074/jbc.M112.405548	http://dx.doi.org/10.1074/jbc.M112.405548			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23071108	Green Published, hybrid			2022-12-28	WOS:000311887600023
J	Xiang, BG; Zhang, GY; Stefanini, L; Bergmeier, W; Gartner, TK; Whiteheart, SW; Li, ZY				Xiang, Binggang; Zhang, Guoying; Stefanini, Lucia; Bergmeier, Wolfgang; Gartner, T. Kent; Whiteheart, Sidney W.; Li, Zhenyu			The Src Family Kinases and Protein Kinase C Synergize to Mediate G(q)-dependent Platelet Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; AKT PHOSPHORYLATION; PHOSPHOINOSITIDE 3-KINASES; GRANULE SECRETION; THROMBOXANE A(2); CALDAG-GEFI; RECEPTOR 4; LYN; AGGREGATION; PATHWAYS	The Src family kinases (SFKs) play essential roles in collagen- and von Willebrand factor (VWF)-mediated platelet activation. However, the roles of SFKs in G protein-coupled receptor-mediated platelet activation and the molecular mechanisms whereby SFKs are activated by G protein-coupled receptor stimulation are not fully understood. Here we show that the thrombin receptor protease-activated receptor 4 agonist peptide AYPGKF elicited SFK phosphorylation in P2Y(12) deficient platelets but stimulated minimal SFK phosphorylation in platelets lacking G(q). We have previously shown that thrombin-induced SFK phosphorylation was inhibited by the calcium chelator 5,5'-dimethyl-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (dimethyl-BAPTA). The calcium ionophore A23187 induced SFK phosphorylation in both wild-type and G(q) deficient platelets. Together, these results indicate that SFK phosphorylation in response to thrombin receptor stimulation is downstream from G(q)/Ca2+ signaling. Moreover, A23187-induced thromboxane A(2) synthesis, platelet aggregation, and secretion were inhibited by preincubation of platelets with a selective SFK inhibitor, PP2. AYPGKF-induced thromboxane A(2) production in wild-type and P2Y(12) deficient platelets was abolished by PP2, and AYPGKF-mediated P-selectin expression, integrin alpha(IIb)beta(3) activation, and aggregation of P2Y(12) deficient platelets were partially inhibited by the PKC inhibitor Ro-31-8220, PP2, dimethyl-BAPTA, or LY294002, but were abolished by Ro-31-8220 plus PP2, dimethyl-BAPTA, or LY294002. These data indicate that Ca2+/SFKs/PI3K and PKC represent two alternative signaling pathways mediating G(q)-dependent platelet activation.	[Xiang, Binggang; Zhang, Guoying; Li, Zhenyu] Univ Kentucky, Coll Med, Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA; [Stefanini, Lucia; Bergmeier, Wolfgang] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Gartner, T. Kent] Univ Memphis, Dept Biol, Memphis, TN 38152 USA; [Whiteheart, Sidney W.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky; University of North Carolina; University of North Carolina Chapel Hill; University of Memphis; University of Kentucky	Li, ZY (corresponding author), Univ Kentucky, Coll Med, Saha Cardiovasc Res Ctr, 741 S Limestone St,BBSRB Bldg,Rm 251, Lexington, KY 40536 USA.	zhenyuli08@uky.edu	stefanini, lucia/K-3992-2016; Stefanini, Lucia/H-6344-2015; Xiang, Binggang/N-6494-2013	stefanini, lucia/0000-0001-7420-301X; Stefanini, Lucia/0000-0001-7420-301X; Whiteheart, Sidney/0000-0001-5577-0473	American Heart Association [0855698G]; Centers of Biomedical Research Excellence (COBRE) in Obesity and Cardiovascular Disease from the National Institutes of Health/National Center for Research Resources [P20 RR021954]; Lexington VA Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056652, R01HL094594] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Centers of Biomedical Research Excellence (COBRE) in Obesity and Cardiovascular Disease from the National Institutes of Health/National Center for Research Resources; Lexington VA Medical Center(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by American Heart Association Midwest affiliate Grand-in-Aid 0855698G (to Z. L.) and in part by Centers of Biomedical Research Excellence (COBRE) in Obesity and Cardiovascular Disease Grant P20 RR021954 from the National Institutes of Health/National Center for Research Resources and the Lexington VA Medical Center.	Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Brass LF, 1997, THROMB HAEMOSTASIS, V78, P581; Briddon SJ, 1999, BIOCHEM J, V338, P203, DOI 10.1042/0264-6021:3380203; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; Chari R, 2009, ARTERIOSCL THROM VAS, V29, P699, DOI 10.1161/ATVBAHA.109.184010; Cho MJ, 2002, BLOOD, V99, P2442, DOI 10.1182/blood.V99.7.2442; Cifuni SM, 2008, BLOOD, V112, P1696, DOI 10.1182/blood-2008-02-139733; Cohen S, 2011, FEBS LETT, V585, P3208, DOI 10.1016/j.febslet.2011.09.014; Cohen S, 2009, BIOCHEM BIOPH RES CO, V385, P22, DOI 10.1016/j.bbrc.2009.05.021; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; de la Fuente M, 2012, J BIOL CHEM, V287, P10414, DOI 10.1074/jbc.M112.341438; de Virgilio M, 2004, J CELL BIOL, V165, P305, DOI 10.1083/jcb.200402064; Dorsam RT, 2005, BLOOD, V105, P2749, DOI 10.1182/blood-2004-07-2821; Du XP, 2007, CURR OPIN HEMATOL, V14, P262, DOI 10.1097/MOH.0b013e3280dce51a; Ezumi Y, 1998, J EXP MED, V188, P267, DOI 10.1084/jem.188.2.267; Faruqi TR, 2000, J BIOL CHEM, V275, P19728, DOI 10.1074/jbc.M909960199; Flevaris P, 2007, J CELL BIOL, V179, P553, DOI 10.1083/jcb.200703185; Foster CJ, 2001, J CLIN INVEST, V107, P1591, DOI 10.1172/JCI12242; Garcia A, 2005, BLOOD, V106, P3410, DOI 10.1182/blood-2005-05-1933; GOLDEN A, 1986, P NATL ACAD SCI USA, V83, P852, DOI 10.1073/pnas.83.4.852; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hardy AR, 2004, BLOOD, V104, P1745, DOI 10.1182/blood-2004-02-0534; Hirsch E, 2001, FASEB J, V15, P2019, DOI 10.1096/fj.00-0810fje; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; Kasirer-Friede A, 2004, BLOOD, V103, P3403, DOI 10.1182/blood-2003-10-3664; Kim S, 2006, BLOOD, V107, P947, DOI 10.1182/blood-2005-07-3040; Kim S, 2011, J BIOL CHEM, V286, P24170, DOI 10.1074/jbc.M110.212274; Klages B, 1999, J CELL BIOL, V144, P745, DOI 10.1083/jcb.144.4.745; Konopatskaya O, 2009, J CLIN INVEST, V119, P399, DOI 10.1172/JCI34665; Li DJ, 2011, J BIOL CHEM, V286, P3805, DOI 10.1074/jbc.M110.118018; Li ZY, 2010, ARTERIOSCL THROM VAS, V30, P2341, DOI 10.1161/ATVBAHA.110.207522; Li ZY, 2010, J BIOL CHEM, V285, P12559, DOI 10.1074/jbc.M109.098756; Li ZY, 2003, J BIOL CHEM, V278, P30725, DOI 10.1074/jbc.M301838200; Lian LR, 2009, BLOOD, V113, P3577, DOI 10.1182/blood-2008-09-178913; Liu JL, 2005, BLOOD, V106, P2750, DOI 10.1182/blood-2005-04-1667; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Marshall SJ, 2004, BLOOD, V103, P2601, DOI 10.1182/blood-2003-09-3319; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Nagy B, 2009, BLOOD, V113, P2557, DOI 10.1182/blood-2008-07-169268; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Pestina TI, 1997, ARTERIOSCL THROM VAS, V17, P3278, DOI 10.1161/01.ATV.17.11.3278; Rittenhouse SE, 1996, BLOOD, V88, P4401, DOI 10.1182/blood.V88.12.4401.bloodjournal88124401; Schmaier AA, 2009, P NATL ACAD SCI USA, V106, P21167, DOI 10.1073/pnas.0906436106; Shankar H, 2006, BLOOD, V108, P3027, DOI 10.1182/blood-2006-03-010330; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Suzuki-Inoue K, 2002, J BIOL CHEM, V277, P21561, DOI 10.1074/jbc.M201012200; Thomas DW, 1998, J CLIN INVEST, V102, P1994, DOI 10.1172/JCI5116; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x; Xiang B, 2010, J THROMB HAEMOST, V8, P2032, DOI 10.1111/j.1538-7836.2010.03969.x; Yin H, 2008, BLOOD, V112, P1139, DOI 10.1182/blood-2008-02-140970; Zhang GY, 2011, J BIOL CHEM, V286, P39466, DOI 10.1074/jbc.M111.239608; ZHANG J, 1995, J BIOL CHEM, V270, P6589, DOI 10.1074/jbc.270.12.6589; ZHAO YH, 1992, P NATL ACAD SCI USA, V89, P8298, DOI 10.1073/pnas.89.17.8298	56	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41277	41287		10.1074/jbc.M112.393124	http://dx.doi.org/10.1074/jbc.M112.393124			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23066026	hybrid, Green Published			2022-12-28	WOS:000311887600042
J	Wolstenholme, AJ				Wolstenholme, Adrian J.			Glutamate-gated Chloride Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							UNPAIRED MEDIAN NEURONS; GAMMA-AMINOBUTYRIC-ACID; NEMATODE HAEMONCHUS-CONTORTUS; LOCUST MUSCLE-FIBERS; CAENORHABDITIS-ELEGANS; DROSOPHILA-MELANOGASTER; PHARYNGEAL MUSCLE; IVERMECTIN SENSITIVITY; PARASITIC NEMATODE; ASCARIS-SUUM	Glutamate-gated chloride channels (GluCls) are found only in protostome invertebrate phyla but are closely related to mammalian glycine receptors. They have a number of roles in these animals, controlling locomotion and feeding and mediating sensory inputs into behavior. In nematodes and arthropods, they are targeted by the macrocyclic lactone family of anthelmintics and pesticides, making the GluCls of considerable medical and economic importance. Recently, the three-dimensional structure of a GluCl was solved, the first for any eukaryotic ligand-gated anion channel, revealing a macrocyclic lactone-binding site between the channel domains of adjacent subunits. This minireview will highlight some unique features of the GluCls and illustrate their contribution to our knowledge of the entire Cys loop ligand-gated ion channel superfamily.	[Wolstenholme, Adrian J.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Wolstenholme, Adrian J.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Wolstenholme, AJ (corresponding author), Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.	adrianw@uga.edu	Wolstenholme, Adrian/AAY-1611-2020	Wolstenholme, Adrian/0000-0001-7989-3929				Adelsberger H, 1997, NEUROSCI LETT, V230, P183, DOI 10.1016/S0304-3940(97)00512-0; Anctil M, 2009, COMP BIOCHEM PHYS D, V4, P268, DOI 10.1016/j.cbd.2009.07.001; ARENA JP, 1992, MOL BRAIN RES, V15, P339, DOI 10.1016/0169-328X(92)90127-W; AVERY L, 1993, J EXP BIOL, V175, P283; Beech RN, 2010, TRENDS PARASITOL, V26, P334, DOI 10.1016/j.pt.2010.04.003; Beg AA, 2003, NAT NEUROSCI, V6, P1145, DOI 10.1038/nn1136; BIDAUT M, 1980, J NEUROPHYSIOL, V44, P1089, DOI 10.1152/jn.1980.44.6.1089; Brownlee DJA, 1997, PARASITOLOGY, V115, P553, DOI 10.1017/S0031182097001601; Campbell WC, 2012, CURR PHARM BIOTECHNO, V13, P853; Cebada J, 2007, J EXP BIOL, V210, P3962, DOI 10.1242/jeb.006577; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Cleland TA, 1996, MOL NEUROBIOL, V13, P97, DOI 10.1007/BF02740637; Collins B, 2012, NEURON, V74, P706, DOI 10.1016/j.neuron.2012.02.034; Cook A, 2006, MOL BIOCHEM PARASIT, V147, P118, DOI 10.1016/j.molbiopara.2006.02.003; CULLCANDY SG, 1976, J PHYSIOL-LONDON, V255, P449, DOI 10.1113/jphysiol.1976.sp011289; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; Cully DF, 1996, J BIOL CHEM, V271, P20187, DOI 10.1074/jbc.271.33.20187; Cully DF, 1996, PARASITOLOGY, V113, pS191, DOI 10.1017/S0031182000077970; Cupp EW, 2011, ACTA TROP, V120, pS100, DOI 10.1016/j.actatropica.2010.08.009; Dale RP, 2010, INSECT MOL BIOL, V19, P141, DOI 10.1111/j.1365-2583.2009.00975.x; Dent JA, 2000, P NATL ACAD SCI USA, V97, P2674, DOI 10.1073/pnas.97.6.2674; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; Dermauw W, 2012, INSECT BIOCHEM MOLEC, V42, P455, DOI 10.1016/j.ibmb.2012.03.002; Forrester SG, 2002, BIOCHEM PHARMACOL, V63, P1061, DOI 10.1016/S0006-2952(02)00852-3; Gengs CX, 2002, J BIOL CHEM, V277, P42113, DOI 10.1074/jbc.M207133200; Ghosh R, 2012, SCIENCE, V335, P574, DOI 10.1126/science.1214318; Gisselmann G, 2002, NAT NEUROSCI, V5, P11, DOI 10.1038/nn787; Glendinning SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022390; GRATION KAF, 1979, BRAIN RES, V171, P360, DOI 10.1016/0006-8993(79)90343-3; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Holden-Dye L, 2006, INT J PARASITOL, V36, P395, DOI 10.1016/j.ijpara.2005.11.006; Hong ST, 2006, J NEUROSCI, V26, P7245, DOI 10.1523/JNEUROSCI.5426-05.2006; Horoszok L, 2001, BRIT J PHARMACOL, V132, P1247, DOI 10.1038/sj.bjp.0703937; Hukema RK, 2008, LEARN MEMORY, V15, P829, DOI 10.1101/lm.994408; Iovchev M, 2002, J NEUROGENET, V16, P249, DOI 10.1080/01677060216293; Janssen D, 2007, J NEUROPHYSIOL, V97, P2642, DOI 10.1152/jn.01234.2006; Janssen D, 2010, J NEUROPHYSIOL, V103, P2587, DOI 10.1152/jn.00466.2009; Jones AK, 2010, HEREDITY, V104, P247, DOI 10.1038/hdy.2009.97; Jones AK, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-327; Kane NS, 2000, P NATL ACAD SCI USA, V97, P13949, DOI 10.1073/pnas.240464697; Keane J, 2003, GENETICS, V164, P153; Kehoe J, 2009, J MOL EVOL, V69, P125, DOI 10.1007/s00239-009-9256-z; Knipple DC, 2010, PESTIC BIOCHEM PHYS, V97, P140, DOI 10.1016/j.pestbp.2009.09.002; Kotze AC, 2012, INT J PARASITOL-DRUG, V2, P29, DOI 10.1016/j.ijpddr.2011.10.002; Laughton DL, 1997, J EXP BIOL, V200, P1509; Lerchner W, 2007, NEURON, V54, P35, DOI 10.1016/j.neuron.2007.02.030; Li P, 2002, FEBS LETT, V528, P77, DOI 10.1016/S0014-5793(02)03245-3; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Liu J, 2004, MOL BIOCHEM PARASIT, V134, P267, DOI 10.1016/j.molbiopara.2004.01.002; Liu J, 2010, NAT NEUROSCI, V13, P1225, DOI 10.1038/nn.2633; Ludmerer SW, 2002, BIOCHEMISTRY-US, V41, P6548, DOI 10.1021/bi015920o; Lynagh T, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00060; Lynagh T, 2011, J BIOL CHEM, V286, P43913, DOI 10.1074/jbc.M111.262634; Lynagh T, 2010, INT J PARASITOL, V40, P1477, DOI 10.1016/j.ijpara.2010.07.010; MARDER E, 1978, J PHYSIOL-LONDON, V280, P213, DOI 10.1113/jphysiol.1978.sp012381; MARDER E, 1984, J NEUROPHYSIOL, V51, P1362, DOI 10.1152/jn.1984.51.6.1362; Martin RJ, 1996, PARASITOLOGY, V112, P247, DOI 10.1017/S0031182000084833; McCarthy EV, 2011, J NEUROSCI, V31, P8181, DOI 10.1523/JNEUROSCI.2017-10.2011; McCavera S, 2009, MOL PHARMACOL, V75, P1347, DOI 10.1124/mol.108.053363; McCoole MD, 2011, J EXP BIOL, V214, P1773, DOI 10.1242/jeb.054486; Moreno Y, 2010, P NATL ACAD SCI USA, V107, P20120, DOI 10.1073/pnas.1011983107; Narahashi T, 2010, PESTIC BIOCHEM PHYS, V97, P149, DOI 10.1016/j.pestbp.2009.07.008; Njue AI, 2004, J NEUROCHEM, V89, P1137, DOI 10.1111/j.1471-4159.2004.02379.x; Ohnishi N, 2011, EMBO J, V30, P1376, DOI 10.1038/emboj.2011.13; Ottesen EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000317; Pantazis A, 2008, J NEUROSCI, V28, P7250, DOI 10.1523/JNEUROSCI.1654-08.2008; Pemberton DJ, 2001, MOL PHARMACOL, V59, P1037, DOI 10.1124/mol.59.5.1037; Pirri JK, 2009, NEURON, V62, P526, DOI 10.1016/j.neuron.2009.04.013; Portillo V, 2003, J COMP NEUROL, V462, P213, DOI 10.1002/cne.10735; Putrenko I, 2005, J BIOL CHEM, V280, P6392, DOI 10.1074/jbc.M412644200; RAIZEN DM, 1994, NEURON, V12, P483, DOI 10.1016/0896-6273(94)90207-0; Ranganathan R, 2000, NATURE, V408, P470, DOI 10.1038/35044083; Ringstad N, 2009, SCIENCE, V325, P96, DOI 10.1126/science.1169243; Ruggieri RD, 2004, COMP BIOCHEM PHYS A, V138, P193, DOI 10.1016/j.cbpb.2004.03.015; Schnizler K, 2005, J BIOL CHEM, V280, P16254, DOI 10.1074/jbc.M411759200; Semenov EP, 1999, J NEUROCHEM, V72, P66, DOI 10.1046/j.1471-4159.1999.0720066.x; Slimko EM, 2002, J NEUROSCI, V22, P7373; Strycharz JP, 2011, J MED ENTOMOL, V48, P1174, DOI 10.1603/ME11051; Tribble ND, 2007, J VET PHARMACOL THER, V30, P163, DOI 10.1111/j.1365-2885.2007.00823.x; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vassilatis DK, 1997, J BIOL CHEM, V272, P33167, DOI 10.1074/jbc.272.52.33167; Vassilatis DK, 1997, J MOL EVOL, V44, P501, DOI 10.1007/PL00006174; Washio H, 2002, ZOOL SCI, V19, P153, DOI 10.2108/zsj.19.153; Williamson Sally M., 2007, Invertebrate Neuroscience, V7, P219, DOI 10.1007/s10158-007-0056-0; Wolstenholme AJ, 2005, PARASITOLOGY, V131, pS85, DOI 10.1017/S0031182005008218; Yamaguchi M, 2012, BIOCHEM BIOPH RES CO, V419, P562, DOI 10.1016/j.bbrc.2012.02.062; Yang DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032283; Yates DM, 2003, INT J PARASITOL, V33, P1183, DOI 10.1016/S0020-7519(03)00172-3; Yusein S, 2010, J INSECT PHYSIOL, V56, P21, DOI 10.1016/j.jinsphys.2009.08.016; Yusein Shazie, 2008, Invertebrate Neuroscience, V8, P211, DOI 10.1007/s10158-008-0078-2; Zhao XL, 2010, PESTIC BIOCHEM PHYS, V97, P153, DOI 10.1016/j.pestbp.2009.10.002; Zhao XL, 2004, J PHARMACOL EXP THER, V310, P192, DOI 10.1124/jpet.104.065516; Zheng YC, 2002, J BIOL CHEM, V277, P2000, DOI 10.1074/jbc.M107635200	94	154	158	5	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40232	40238		10.1074/jbc.R112.406280	http://dx.doi.org/10.1074/jbc.R112.406280			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23038250	hybrid, Green Published			2022-12-28	WOS:000311448800015
J	Deacon, K; Onion, D; Kumari, R; Watson, SA; Knox, AJ				Deacon, Karl; Onion, David; Kumari, Rajendra; Watson, Susan A.; Knox, Alan J.			Elevated SP-1 Transcription Factor Expression and Activity Drives Basal and Hypoxia-induced Vascular Endothelial Growth Factor (VEGF) Expression in Non-Small Cell Lung Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; TUMOR ANGIOGENESIS; PATIENT SURVIVAL; GENE-EXPRESSION; MESSENGER-RNA; HUMAN GLIOMA; SP1 ACTIVITY; HIF-ALPHA; IN-VIVO; BINDING	VEGF plays a central role in angiogenesis in cancer. Non-small cell lung cancer (NSCLC) tumors have increased microvascular density, localized hypoxia, and high VEGF expression levels; however, there is a lack of understanding of how oncogenic and tumor microenvironment changes such as hypoxia lead to greater VEGF expression in lung and other cancers. We show that NSCLC cells secreted higher levels of VEGF than normal airway epithelial cells. Actinomycin D inhibited all NSCLC VEGF secretion, and VEGF minimal promoter-luciferase reporter constructs were constitutively active until the last 85 base pairs before the transcription start site containing three SP-1 transcription factor-binding sites; mutation of these VEGF promoter SP-1-binding sites eliminated VEGF promoter activity. Furthermore, dominant negative SP-1, mithramycin A, and SP-1 shRNA decreased VEGF promoter activity, whereas overexpression of SP-1 increased VEGF promoter activity. Chromatin immunoprecipitation assays demonstrated SP-1, p300, and PCA/F histone acetyltransferase binding and histone H4 hyper-acetylation at the VEGF promoter in NSCLC cells. Cultured NSCLC cells expressed higher levels of SP-1 protein than normal airway epithelial cells, and double-fluorescence immunohistochemistry showed a strong correlation between SP-1 and VEGF in human NSCLC tumors. In addition, hypoxia-driven VEGF expression in NSCLC cells was SP-1-dependent, with hypoxia increasing SP-1 activity and binding to the VEGF promoter. These studies are the first to demonstrate that overexpression of SP-1 plays a central role in hypoxia-induced VEGF secretion.	[Deacon, Karl; Knox, Alan J.] Univ Nottingham, Ctr Resp Res, Nottingham NG5 1PB, England; [Onion, David; Kumari, Rajendra; Watson, Susan A.] Univ Nottingham, Div Preclin Oncol, Nottingham NG5 1PB, England	University of Nottingham; University of Nottingham	Deacon, K (corresponding author), City Hosp Nottingham, Ctr Resp Res, Clin Sci Bldg,Hucknall Rd, Nottingham NG5 1PB, England.	karl.deacon@nottingham.ac.uk		Knox, Alan/0000-0002-5906-4143; Onion, David/0000-0002-4522-2307				Arany Z, 2008, P NATL ACAD SCI USA, V105, P4721, DOI 10.1073/pnas.0800979105; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Bouchard F, 2010, BLOOD, V116, P759, DOI 10.1182/blood-2009-12-257030; Bradbury D, 2005, J BIOL CHEM, V280, P29993, DOI 10.1074/jbc.M414530200; Brown LM, 2006, MOL PHARMACOL, V69, P411, DOI 10.1124/mol.105.015743; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Clark PE, 2009, KIDNEY INT, V76, P939, DOI 10.1038/ki.2009.296; De Luca A, 2008, J CELL PHYSIOL, V214, P559, DOI 10.1002/jcp.21260; Deacon K, 1997, J BIOL CHEM, V272, P14489, DOI 10.1074/jbc.272.22.14489; Deacon K, 2010, J BIOL CHEM, V285, P25913, DOI 10.1074/jbc.M110.139485; Decaussin M, 1999, J PATHOL, V188, P369; Discher DJ, 1998, J BIOL CHEM, V273, P26087, DOI 10.1074/jbc.273.40.26087; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 2010, MOL BIOL CELL, V21, P687, DOI 10.1091/mbc.E09-07-0590; FINKENZELLER G, 1995, BIOCHEM BIOPH RES CO, V208, P432, DOI 10.1006/bbrc.1995.1356; Finkenzeller G, 1997, ONCOGENE, V15, P669, DOI 10.1038/sj.onc.1201219; FOLKMAN J, 1963, CANCER, V16, P453, DOI 10.1002/1097-0142(196304)16:4<453::AID-CNCR2820160407>3.0.CO;2-Y; Gately S, 2000, CANCER METAST REV, V19, P19, DOI 10.1023/A:1026575610124; Gerber HP, 2005, CANCER RES, V65, P671; Graves EE, 2010, CLIN CANCER RES, V16, P4843, DOI 10.1158/1078-0432.CCR-10-1206; Guan HY, 2012, INT J CANCER, V130, P593, DOI 10.1002/ijc.26049; Han H, 2001, ANN SURG ONCOL, V8, P72, DOI 10.1245/aso.2001.8.1.72; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaluz S, 2003, CANCER RES, V63, P917; Kamimura M, 2004, HYPERTENSION, V44, P944, DOI 10.1161/01.HYP.0000146908.75091.99; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Kong LM, 2010, CANCER SCI, V101, P1463, DOI 10.1111/j.1349-7006.2010.01554.x; Koshiji M, 2005, MOL CELL, V17, P793, DOI 10.1016/j.molcel.2005.02.015; Ladomery MR, 2007, CANCER LETT, V249, P133, DOI 10.1016/j.canlet.2006.08.015; Lee CG, 2000, AM J RESP CELL MOL, V23, P662, DOI 10.1165/ajrcmb.23.5.4188; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Lim JH, 2008, J CELL BIOCHEM, V105, P1117, DOI 10.1002/jcb.21914; Lou Z, 2005, CANCER RES, V65, P1007; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mizukami Y, 2004, CANCER RES, V64, P1765, DOI 10.1158/0008-5472.CAN-03-3017; Rak J, 2000, J INVEST DERM SYMP P, V5, P24, DOI 10.1046/j.1087-0024.2000.00012.x; Shi Q, 2001, CANCER RES, V61, P4143; Shimoyamada H, 2010, AM J PATHOL, V177, P70, DOI 10.2353/ajpath.2010.091164; Spinella F, 2004, J BIOL CHEM, V279, P46700, DOI 10.1074/jbc.M408584200; Takayama K, 2007, CANCER GENE THER, V14, P105, DOI 10.1038/sj.cgt.7700991; Textor B, 2006, ANN NY ACAD SCI, V1091, P310, DOI 10.1196/annals.1378.076; TSAI JC, 1995, J NEUROSURG, V82, P864, DOI 10.3171/jns.1995.82.5.0864; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Xu Q, 2000, J BIOL CHEM, V275, P24583, DOI 10.1074/jbc.M003894200; Yao JC, 2004, CLIN CANCER RES, V10, P4109, DOI 10.1158/1078-0432.CCR-03-0628; Yoo PS, 2006, WORLD J GASTROENTERO, V12, P4937, DOI 10.3748/wjg.v12.i31.4937; Yuan A, 2000, INT J CANCER, V89, P475, DOI 10.1002/1097-0215(20001120)89:6<475::AID-IJC2>3.0.CO;2-T; Yuan A, 2001, J CLIN ONCOL, V19, P432, DOI 10.1200/JCO.2001.19.2.432; Zannetti A, 2000, CANCER RES, V60, P1546	52	38	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.397042	http://dx.doi.org/10.1074/jbc.M112.397042			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	22992725	Green Published, hybrid			2022-12-28	WOS:000311233800064
J	Gustafsson, TN; Sahlin, M; Lu, J; Sjoberg, BM; Holmgren, A				Gustafsson, Tomas N.; Sahlin, Margareta; Lu, Jun; Sjoberg, Britt-Marie; Holmgren, Arne			Bacillus anthracis Thioredoxin Systems, Characterization and Role as Electron Donors for Ribonucleotide Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI-B; HELICOBACTER-PYLORI; DIPHOSPHATE REDUCTASE; GENOME SEQUENCE; HYDROGEN DONOR; NRDH-REDOXIN; HIGH-LEVEL; IN-VIVO; SUBTILIS; PROTEIN	Bacillus anthracis is the causative agent of anthrax, which is associated with a high mortality rate. Like several medically important bacteria, B. anthracis lacks glutathione but encodes many genes annotated as thioredoxins, thioredoxin reductases, and glutaredoxin-like proteins. We have cloned, expressed, and characterized three potential thioredoxins, two potential thioredoxin reductases, and three glutaredoxin-like proteins. Of these, thioredoxin 1 (Trx1) and NrdH reduced insulin, 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB), and the manganese-containing type Ib ribonucleotide reductase (RNR) from B. anthracis in the presence of NADPH and thioredoxin reductase 1 (TR1), whereas thioredoxin 2 (Trx2) could only reduce DTNB. Potential TR2 was verified as an FAD-containing protein reducible by dithiothreitol but not by NAD(P)H. The recently discovered monothiol bacillithiol did not work as a reductant for RNR, either directly or via any of the redoxins. The catalytic efficiency of Trx1 was 3 and 20 times higher than that of Trx2 and NrdH, respectively, as substrates for TR1. Additionally, the catalytic efficiency of Trx1 as an electron donor for RNR was 7-fold higher than that of NrdH. In extracts of B. anthracis, Trx1 was responsible for almost all of the disulfide reductase activity, whereas Western blots showed that the level of Trx1 was 15 and 60 times higher than that of Trx2 and NrdH, respectively. Our findings demonstrate that the most important general disulfide reductase system in B. anthracis is TR1/Trx1 and that Trx1 is the physiologically relevant electron donor for RNR. This information may provide a basis for the development of novel antimicrobial therapies targeting this severe pathogen.	[Gustafsson, Tomas N.; Lu, Jun; Holmgren, Arne] Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, SE-17177 Stockholm, Sweden; [Sahlin, Margareta; Sjoberg, Britt-Marie] Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; [Sahlin, Margareta] Stockholm Univ, Dept Mol Biol & Funct Genom, SE-10691 Stockholm, Sweden	Karolinska Institutet; Stockholm University; Stockholm University	Holmgren, A (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, Scheeles Vag 2, SE-17177 Stockholm, Sweden.	arne.holmgren@ki.se	Lu, Jun/E-9701-2017	Lu, Jun/0000-0002-1699-8835; Sjoberg, Britt-Marie/0000-0001-5953-3360; Gustafsson, Tomas/0000-0002-4495-8267	Swedish Research Council [3529, 2978]; Swedish Cancer Society [961, 814]; K. A. Wallenberg Foundation; Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); K. A. Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Karolinska Institutet(Karolinska Institutet)	This work was supported in part by Swedish Research Council Grants 3529 (to A. H.) and 2978 (to B. M. S.), Swedish Cancer Society Grants 961 (to A. H.) and 814 (to B. M. S.), and the K. A. Wallenberg Foundation (to A. H.).; Recipient of an M.D.-Ph.D. program fellowship from the Karolinska Institutet.	Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Baker LMS, 2001, J BACTERIOL, V183, P1961, DOI 10.1128/JB.183.6.1961-1973.2001; Block H, 2009, METHOD ENZYMOL, V463, P439, DOI 10.1016/S0076-6879(09)63027-5; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Cotruvo JA, 2011, BIOCHEMISTRY-US, V50, P1672, DOI 10.1021/bi101881d; Cotruvo JA, 2010, BIOCHEMISTRY-US, V49, P1297, DOI 10.1021/bi902106n; Crona M, 2011, J BIOL CHEM, V286, P33053, DOI 10.1074/jbc.M111.278119; FAHEY RC, 1978, J BACTERIOL, V133, P1126, DOI 10.1128/JB.133.3.1126-1129.1978; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Fieschi F, 1998, J BIOL CHEM, V273, P4329, DOI 10.1074/jbc.273.8.4329; FUCHS JA, 1972, NATURE-NEW BIOL, V238, P69, DOI 10.1038/newbio238069a0; Gaballa A, 2010, P NATL ACAD SCI USA, V107, P6482, DOI 10.1073/pnas.1000928107; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Gon S, 2006, ANTIOXID REDOX SIGN, V8, P735, DOI 10.1089/ars.2006.8.735; Gustafsson TN, 2007, ACTA CRYSTALLOGR D, V63, P833, DOI 10.1107/S0907444907026303; Hofer A, 1998, J BIOL CHEM, V273, P34098, DOI 10.1074/jbc.273.51.34098; HOLMGREN A, 1968, EUR J BIOCHEM, V6, P475, DOI 10.1111/j.1432-1033.1968.tb00470.x; HOLMGREN A, 1979, J BIOL CHEM, V254, P3672; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; HOLMGREN A, 1976, P NATL ACAD SCI USA, V73, P2275, DOI 10.1073/pnas.73.7.2275; Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811; Huson D. H., 2012, SYSTEMATIC BIOL; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Johansson R, 2010, FEBS J, V277, P4265, DOI 10.1111/j.1742-4658.2010.07815.x; JORDAN A, 1994, P NATL ACAD SCI USA, V91, P12892, DOI 10.1073/pnas.91.26.12892; Jordan A, 1997, J BIOL CHEM, V272, P18044, DOI 10.1074/jbc.272.29.18044; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kolsto AB, 2009, ANNU REV MICROBIOL, V63, P451, DOI 10.1146/annurev.micro.091208.073255; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Livermore DM, 2004, CLIN MICROBIOL INFEC, V10, P1, DOI 10.1111/j.1465-0691.2004.1004.x; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; MCKINNEY MM, 1987, J IMMUNOL METHODS, V96, P271, DOI 10.1016/0022-1759(87)90324-3; Messens J, 2006, J MOL BIOL, V362, P1, DOI 10.1016/j.jmb.2006.07.002; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Mohamed SF, 1998, BIOFACTORS, V7, P337, DOI 10.1002/biof.5520070405; Moller MC, 2008, J BACTERIOL, V190, P4660, DOI 10.1128/JB.00252-08; Mostertz J, 2008, PROTEOMICS, V8, P2676, DOI 10.1002/pmic.200701015; Mulrooney SB, 1997, PROTEIN EXPRES PURIF, V9, P372, DOI 10.1006/prep.1996.0698; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; Parsonage D, 2010, BIOCHEMISTRY-US, V49, P8398, DOI 10.1021/bi100698n; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; PRONGAY AJ, 1989, J BIOL CHEM, V264, P2656; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rabinovitch I, 2010, J BACTERIOL, V192, P4963, DOI 10.1128/JB.00539-10; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Scharf C, 1998, J BACTERIOL, V180, P1869, DOI 10.1128/JB.180.7.1869-1877.1998; Smits WK, 2005, J BACTERIOL, V187, P3921, DOI 10.1128/JB.187.12.3921-3930.2005; Spencer RC, 2003, J CLIN PATHOL, V56, P182, DOI 10.1136/jcp.56.3.182; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; THELANDER L, 1973, J BIOL CHEM, V248, P4591; Torrents E, 2005, P NATL ACAD SCI USA, V102, P17946, DOI 10.1073/pnas.0506410102; Uziel O, 2004, J BACTERIOL, V186, P326, DOI 10.1128/JB.186.2.326-334.2004; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Williams CH, 2000, EUR J BIOCHEM, V267, P6110, DOI 10.1046/j.1432-1327.2000.01702.x; Windle HJ, 2000, J BIOL CHEM, V275, P5081, DOI 10.1074/jbc.275.7.5081; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	62	29	30	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.413427	http://dx.doi.org/10.1074/jbc.M112.413427			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23012357	Green Published, hybrid			2022-12-28	WOS:000311233800038
J	Pietka, TA; Sulkin, MS; Kuda, O; Wang, W; Zhou, DQ; Yamada, KA; Yang, K; Su, X; Gross, RW; Nerbonne, JM; Efimov, IR; Abumrad, NA				Pietka, Terri A.; Sulkin, Matthew S.; Kuda, Ondrej; Wang, Wei; Zhou, Dequan; Yamada, Kathryn A.; Yang, Kui; Su, Xiong; Gross, Richard W.; Nerbonne, Jeanne M.; Efimov, Igor R.; Abumrad, Nada A.			CD36 Protein Influences Myocardial Ca2+ Homeostasis and Phospholipid Metabolism CONDUCTION ANOMALIES IN CD36-DEFICIENT MICE DURING FASTING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID TRANSPORT; SARCOPLASMIC-RETICULUM; PHOSPHOLAMBAN PHOSPHORYLATION; CONTRACTILE DYSFUNCTION; CARDIOVASCULAR-DISEASES; CALORIC RESTRICTION; SIGNALING PATHWAYS; LIPID-METABOLISM; SKELETAL-MUSCLE; RAT-HEART	Sarcolemmal CD36 facilitates myocardial fatty acid (FA) uptake, which is markedly reduced in CD36-deficient rodents and humans. CD36 also mediates signal transduction events involving a number of cellular pathways. In taste cells and macrophages, CD36 signaling was recently shown to regulate store-responsive Ca2+ flux and activation of Ca2+-dependent phospholipases A(2) that cycle polyunsaturated FA into phospholipids. It is unknown whether CD36 deficiency influences myocardial Ca2+ handling and phospholipid metabolism, which could compromise the heart, typically during stresses. Myocardial function was examined in fed or fasted (18-22 h) CD36(-/-) and WT mice. Echocardiography and telemetry identified conduction anomalies that were associated with the incidence of sudden death in fasted CD36(-/-) mice. No anomalies or death occurred in WT mice during fasting. Optical imaging of perfused hearts from fasted CD36(-/-) mice documented prolongation of Ca2+ transients. Consistent with this, knockdown of CD36 in cardiomyocytes delayed clearance of cytosolic Ca2+. Hearts of CD36(-/-) mice (fed or fasted) had 3-fold higher SERCA2a and 40% lower phospholamban levels. Phospholamban phosphorylation by protein kinase A (PKA) was enhanced after fasting reflecting increased PKA activity and cAMP levels in CD36(-/-) hearts. Abnormal Ca2+ homeostasis in the CD36(-/-) myocardium associated with increased lysophospholipid content and a higher proportion of 22: 6 FA in phospholipids suggests altered phospholipase A2 activity and changes in membrane dynamics. The data support the role of CD36 in coordinating Ca2+ homeostasis and lipid metabolism and the importance of this role during myocardial adaptation to fasting. Potential relevance of the findings to CD36-deficient humans would need to be determined.	[Su, Xiong; Abumrad, Nada A.] Washington Univ, Ctr Human Nutr, St Louis, MO 63110 USA; [Yamada, Kathryn A.; Gross, Richard W.; Nerbonne, Jeanne M.; Abumrad, Nada A.] Washington Univ, Cardiovasc Res Ctr, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Div Bioorgan Chem, Dept Med, St Louis, MO 63110 USA; [Wang, Wei] Washington Univ, Dept Dev Biol, St Louis, MO 63110 USA; [Sulkin, Matthew S.; Efimov, Igor R.] Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA; [Kuda, Ondrej] Acad Sci Czech Republ, Inst Physiol, Dept Adipose Tissue Biol, CR-14220 Prague, Czech Republic	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Abumrad, NA (corresponding author), Washington Univ, Ctr Human Nutr, Campus Box 8031, St Louis, MO 63110 USA.	NAbumrad@dom.wustl.edu	zhou, dequan/J-9937-2012; Efimov, Igor R/B-8040-2010; Efimov, Igor/R-5544-2017; Kuda, Ondrej/B-7990-2012; Efimov, Igor R./AAJ-3234-2021	zhou, dequan/0000-0002-2662-2882; Efimov, Igor R/0000-0002-1483-5039; Efimov, Igor/0000-0002-1483-5039; Kuda, Ondrej/0000-0001-7034-4536; 	National Institutes of Health [P01 HL057278, R01 DK33301, R01 HL034161, R01 HL085369, R21 HL108617, R01 HL114395, DK56341]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085369, R21HL108617, R01HL114395, R01HL034161, P01HL057278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, R01DK033301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL057278 (to R. W. G. and N. A. A.), R01 DK33301 (to N. A. A.), R01 HL034161 (to J. M. N.), R01 HL085369, R21 HL108617, and R01 HL114395 (to I. R. E.), and DK56341 (to Nutrition Obesity Research Center, Washington University).	Abbott MJ, 2009, AM J PHYSIOL-REG I, V297, pR1724, DOI 10.1152/ajpregu.00179.2009; ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Angin Y., 2012, BIOCH J IN PRESS, pJ; Aoyama H, 2011, CARDIOVASC RES, V89, P79, DOI 10.1093/cvr/cvq252; Ashrafian H, 2011, CIRC RES, V109, P86, DOI 10.1161/CIRCRESAHA.111.242974; Bessi VL, 2012, CARDIOVASC RES, V96, P99, DOI 10.1093/cvr/cvs225; Bharadwaj KG, 2010, J BIOL CHEM, V285, P37976, DOI 10.1074/jbc.M110.174458; Ceylan-Isik AF, 2011, J MOL CELL CARDIOL, V50, P107, DOI 10.1016/j.yjmcc.2010.10.023; Chen C, 2008, J BIOL CHEM, V283, P4543, DOI 10.1074/jbc.M706299200; Chen J, 2012, AM J PHYSIOL-HEART C, V302, pH538, DOI 10.1152/ajpheart.00701.2011; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; Chossat N, 2001, CARDIOVASC RES, V49, P288, DOI 10.1016/S0008-6363(00)00234-0; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Dramane G, 2012, J CLIN INVEST, V122, P2267, DOI 10.1172/JCI59953; Farook VS, 2012, OBESITY, V20, P2083, DOI 10.1038/oby.2012.74; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Febbraio M, 2007, INT J BIOCHEM CELL B, V39, P2012, DOI 10.1016/j.biocel.2007.03.012; Fukuchi K, 1999, J NUCL MED, V40, P239; Garber AJ, 2004, MED CLIN N AM, V88, P837, DOI 10.1016/j.mcna.2004.04.001; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Glazer HP, 2009, CELL CYCLE, V8, P1738, DOI 10.4161/cc.8.11.8619; Goldberg IJ, 2009, J LIPID RES, V50, pS86, DOI 10.1194/jlr.R800085-JLR200; Hall D, 2011, J HYPERTENS, V29, P690, DOI 10.1097/HJH.0b013e3283440115; Han XL, 2004, ANAL BIOCHEM, V330, P317, DOI 10.1016/j.ab.2004.04.004; Heather LC, 2006, CARDIOVASC RES, V72, P430, DOI 10.1016/j.cardiores.2006.08.020; Heather LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026326; Hirano K, 2003, TRENDS CARDIOVAS MED, V13, P136, DOI 10.1016/S1050-1738(03)00026-4; Hui DY, 2012, CURR OPIN LIPIDOL, V23, P235, DOI 10.1097/MOL.0b013e328351b439; Hund TJ, 2004, CIRCULATION, V110, P3168, DOI 10.1161/01.CIR.0000147231.69595.D3; Jenkins CM, 2009, CARDIOVASC RES, V82, P240, DOI 10.1093/cvr/cvn346; Jeong MY, 2010, AM J PHYSIOL-HEART C, V298, pH1719, DOI 10.1152/ajpheart.00937.2009; Jeppesen J, 2011, J LIPID RES, V52, P699, DOI 10.1194/jlr.M007138; Jump DB, 2011, CURR OPIN CLIN NUTR, V14, P115, DOI 10.1097/MCO.0b013e328342991c; Koonen DPY, 2007, CIRCULATION, V116, P2139, DOI 10.1161/CIRCULATIONAHA.107.712901; Kuda O, 2011, J BIOL CHEM, V286, P17785, DOI 10.1074/jbc.M111.232975; Lally JSV, 2012, ACTA PHYSIOL, V205, P71, DOI 10.1111/j.1748-1716.2012.02396.x; Laughner JI, 2012, AM J PHYSIOL-HEART C, V303, pH753, DOI 10.1152/ajpheart.00404.2012; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Liu G, 2004, J PHYSIOL-LONDON, V555, P267, DOI 10.1113/jphysiol.2003.054064; London B, 2001, CIRC RES, V88, P940, DOI 10.1161/hh0901.090929; Love-Gregory L, 2008, HUM MOL GENET, V17, P1695, DOI 10.1093/hmg/ddn060; Love-Gregory L, 2011, HUM MOL GENET, V20, P193, DOI 10.1093/hmg/ddq449; Ma XW, 2004, HUM MOL GENET, V13, P2197, DOI 10.1093/hmg/ddh233; Mager DE, 2006, FASEB J, V20, P631, DOI 10.1096/fj.05-5263com; Mancuso DJ, 2007, J BIOL CHEM, V282, P9216, DOI 10.1074/jbc.M607307200; Mattiazzi A, 2005, CARDIOVASC RES, V68, P366, DOI 10.1016/j.cardiores.2005.08.010; Nahle Z, 2008, J BIOL CHEM, V283, P14317, DOI 10.1074/jbc.M706478200; Negretti N, 2000, J PHYSIOL-LONDON, V523, P367, DOI 10.1111/j.1469-7793.2000.t01-1-00367.x; Noel SE, 2010, ATHEROSCLEROSIS, V211, P210, DOI 10.1016/j.atherosclerosis.2010.02.009; Norris SM, 2010, AM J PHYSIOL-CELL PH, V298, pC521, DOI 10.1152/ajpcell.00479.2009; Nozaki S, 1999, MOL CELL BIOCHEM, V192, P129, DOI 10.1023/A:1006816702425; O'Neill LA, 2008, NAT CLIN PRACT RHEUM, V4, P319, DOI 10.1038/ncprheum0802; Pidoux G, 2010, J MOL ENDOCRINOL, V44, P271, DOI 10.1677/JME-10-0010; Pinz I, 2011, J BIOL CHEM, V286, P10163, DOI 10.1074/jbc.M110.210757; Richter W, 2011, BASIC RES CARDIOL, V106, P249, DOI 10.1007/s00395-010-0138-8; Roberts W, 2010, BLOOD, V116, P4297, DOI 10.1182/blood-2010-01-265561; Rottman JN, 2003, J AM SOC ECHOCARDIOG, V16, P1150, DOI 10.1067/S0894-7317(03)00471-1; Sampath H, 2005, ANNU REV NUTR, V25, P317, DOI 10.1146/annurev.nutr.25.051804.101917; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; Sung MMY, 2011, J MOL MED, V89, P459, DOI 10.1007/s00109-010-0720-4; SWANSON JE, 1989, J NUTR, V119, P364, DOI 10.1093/jn/119.3.364; Swoap SJ, 2008, BIOCHEM PHARMACOL, V76, P817, DOI 10.1016/j.bcp.2008.06.017; TAFFET GE, 1993, J MEMBRANE BIOL, V131, P35, DOI 10.1007/BF02258532; Taki J, 2007, EUR J NUCL MED MOL I, V34, pS34, DOI 10.1007/s00259-007-0439-9; Tanaka T, 2001, J LIPID RES, V42, P751; Weiss JN, 2011, CIRC RES, V108, P98, DOI 10.1161/CIRCRESAHA.110.223586; Yang J, 2007, CIRC RES, V100, P1208, DOI 10.1161/01.RES.0000264104.25265.b6; Yuasa-Kawase M, 2012, J ATHEROSCLER THROMB, V19, P263, DOI 10.5551/jat.10603; Zhou D., 2012, FASEB J IN PRESS	73	26	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38901	38912		10.1074/jbc.M112.413609	http://dx.doi.org/10.1074/jbc.M112.413609			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23019328	Green Published, hybrid			2022-12-28	WOS:000310982800046
J	Nairn, AV; Aoki, K; dela Rosa, M; Porterfield, M; Lim, JM; Kulik, M; Pierce, JM; Wells, L; Dalton, S; Tiemeyer, M; Moremen, KW				Nairn, Alison V.; Aoki, Kazuhiro; dela Rosa, Mitche; Porterfield, Mindy; Lim, Jae-Min; Kulik, Michael; Pierce, J. Michael; Wells, Lance; Dalton, Stephen; Tiemeyer, Michael; Moremen, Kelley W.			Regulation of Glycan Structures in Murine Embryonic Stem Cells COMBINED TRANSCRIPT PROFILING OF GLYCAN-RELATED GENES AND GLYCAN STRUCTURAL ANALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED OLIGOSACCHARIDES; STAGE-SPECIFIC EXPRESSION; SPERM RECEPTOR-ACTIVITY; ADHESION MOLECULE NCAM; HUMAN FACTOR-IX; POLYSIALIC ACID; MONOCLONAL-ANTIBODIES; MOUSE EMBRYOGENESIS; DROSOPHILA-MELANOGASTER; BRAIN-DEVELOPMENT	The abundance and structural diversity of glycans on glycoproteins and glycolipids are highly regulated and play important roles during vertebrate development. Because of the challenges associated with studying glycan regulation in vertebrate embryos, we have chosen to study mouse embryonic stem (ES) cells as they differentiate into embryoid bodies (EBs) or into extraembryonic endodermal (ExE) cells as a model for cellular differentiation. We profiled N- and O-glycan structures isolated from these cell populations and examined transcripts encoding the corresponding enzymatic machinery for glycan biosynthesis in an effort to probe the mechanisms that drive the regulation of glycan diversity. During differentiation from mouse ES cells to either EBs or ExE cells, general trends were detected. The predominance of high mannose N-glycans in ES cells shifted to an equal abundance of complex and high mannose structures, increased sialylation, and increased alpha-Gal termination in the differentiated cell populations. Whereas core 1 O-glycan structures predominated in all three cell populations, increased sialylation and increased core diversity characterized the O-glycans of both differentiated cell types. Increased polysialylation was also found in both differentiated cell types. Differences between the two differentiated cell types included greater sialylation of N-glycans in EBs, whereas alpha-Gal-capped structures were more prevalent in ExE cells. Changes in glycan structures generally, but not uniformly, correlated with alterations in transcript abundance for the corresponding biosynthetic enzymes, suggesting that transcriptional regulation contributes significantly to the regulation of glycan expression. Knowledge of glycan structural diversity and transcript regulation should provide greater understanding of the roles of protein glycosylation in vertebrate development.	[Nairn, Alison V.; Aoki, Kazuhiro; dela Rosa, Mitche; Porterfield, Mindy; Lim, Jae-Min; Pierce, J. Michael; Wells, Lance; Tiemeyer, Michael; Moremen, Kelley W.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Kulik, Michael; Pierce, J. Michael; Wells, Lance; Dalton, Stephen; Tiemeyer, Michael; Moremen, Kelley W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Tiemeyer, M (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.	mtiemeyer@ccrc.uga.edu; moremen@uga.edu	Wells, Lance/H-3118-2013; Aoki, Kazuhiro/H-8283-2014; Moremen, Kelley/AAD-4661-2019	Dalton, Stephen/0000-0002-3450-1263; Aoki, Kazuhiro/0000-0003-0029-4291; Nairn, Alison/0000-0002-4453-7593; Wells, Lance/0000-0003-4956-5363	National Institutes of Health [P41RR018502, P41GM103490, P01GM085354]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM085354, P41GM103490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P41RR018502 and P41GM103490 (to J. M. P.) and P01GM085354 (to S. D.).	Akama TO, 2002, SCIENCE, V295, P124, DOI 10.1126/science.1065570; Alvarez-Manilla G, 2010, J PROTEOME RES, V9, P2062, DOI 10.1021/pr8007489; Amado M, 1999, BBA-GEN SUBJECTS, V1473, P35, DOI 10.1016/S0304-4165(99)00168-3; Amano M, 2010, MOL CELL PROTEOMICS, V9, P523, DOI 10.1074/mcp.M900559-MCP200; An HJ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010660; Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; Angata K, 2010, METHOD ENZYMOL, V479, P25, DOI 10.1016/S0076-6879(10)79002-9; ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Aoki K, 2010, METHOD ENZYMOL, V480, P297, DOI 10.1016/S0076-6879(10)80014-X; Badcock G, 1999, CANCER RES, V59, P4715; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; BIERHUIZEN MFA, 1992, P NATL ACAD SCI USA, V89, P9326, DOI 10.1073/pnas.89.19.9326; Biswas A, 2007, STEM CELLS DEV, V16, P213, DOI 10.1089/scd.2006.0081; BLANCHARD D, 1983, J BIOL CHEM, V258, P7691; BLEIL JD, 1988, P NATL ACAD SCI USA, V85, P6778, DOI 10.1073/pnas.85.18.6778; BOURRILLON R, 1989, INT REV CYTOL, V116, P257; CHAMOW SM, 1986, FEBS LETT, V206, P353, DOI 10.1016/0014-5793(86)81011-0; Chiba A, 1997, J BIOL CHEM, V272, P2156; Colley KJ, 2010, ADV EXP MED BIOL, V663, P111, DOI 10.1007/978-1-4419-1170-4_7; Coutinho PM, 1999, ROY SOC CH, P3; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Daley GQ, 2003, ANN NY ACAD SCI, V996, P122, DOI 10.1111/j.1749-6632.2003.tb03240.x; Dasgupta S, 1996, GLYCOCONJUGATE J, V13, P367, DOI 10.1007/BF00731469; Dennis JW, 2009, TRAFFIC, V10, P1569, DOI 10.1111/j.1600-0854.2009.00981.x; Desbaillets I, 2000, EXP PHYSIOL, V85, P645, DOI 10.1017/S0958067000021047; DOHERTY P, 1990, NEURON, V5, P209, DOI 10.1016/0896-6273(90)90310-C; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; FEIZI T, 1985, NATURE, V314, P53, DOI 10.1038/314053a0; FENDERSON BA, 1990, BIOESSAYS, V12, P173, DOI 10.1002/bies.950120406; FERGUSON MW, 1988, CURR MICROBIOL, V17, P127, DOI 10.1007/BF01573467; FLEMING S, 1990, J ANAT, V170, P151; FLORMAN HM, 1985, CELL, V41, P313, DOI 10.1016/0092-8674(85)90084-4; Freeze HH, 2007, CURR MOL MED, V7, P389, DOI 10.2174/156652407780831548; FUKUDA M, 1981, J SUPRAMOL STR CELL, V17, P313, DOI 10.1002/jsscb.380170403; Furukawa T, 1999, J HUM GENET, V44, P397, DOI 10.1007/s100380050186; GILLESPIE W, 1992, J BIOL CHEM, V267, P21004; Guo S, 2001, GLYCOBIOLOGY, V11, P813, DOI 10.1093/glycob/11.10.813; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; HARRIS RJ, 1993, BIOCHEMISTRY-US, V32, P6539, DOI 10.1021/bi00077a007; HART GW, 1976, J BIOL CHEM, V251, P6513; Hedrick Jerry L, 2007, Soc Reprod Fertil Suppl, V63, P409; Huang CL, 2010, J CELL PHYSIOL, V225, P92, DOI 10.1002/jcp.22200; JESSELL TM, 1990, ANNU REV NEUROSCI, V13, P227, DOI 10.1146/annurev.ne.13.030190.001303; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Johnston DS, 1998, J BIOL CHEM, V273, P1888, DOI 10.1074/jbc.273.4.1888; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; JUNGALWALA FB, 1994, NEUROCHEM RES, V19, P945, DOI 10.1007/BF00968704; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kim PTW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014146; Kiss JZ, 1997, CURR OPIN NEUROBIOL, V7, P640, DOI 10.1016/S0959-4388(97)80083-9; Knowles B B, 1978, Curr Top Microbiol Immunol, V81, P51; Kwak DH, 2011, EXP MOL MED, V43, P379, DOI 10.3858/emm.2011.43.7.048; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARK M P, 1990, International Journal of Developmental Biology, V34, P191; Marth J. D., 1999, ESSENTIALS GLYCOBIOL; Martinez-Ceballos E, 2005, J BIOL CHEM, V280, P16484, DOI 10.1074/jbc.M414397200; MIYAKE M, 1988, CANCER RES, V48, P7150; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Muhlenhoff M, 2009, BIOL CHEM, V390, P567, DOI 10.1515/BC.2009.078; MURAMATSU T, 1988, J CELL BIOCHEM, V36, P1, DOI 10.1002/jcb.240360102; MURAMATSU T, 1980, J EMBRYOL EXP MORPH, V57, P25; Muramatsu T, 2004, GLYCOCONJUGATE J, V21, P41, DOI 10.1023/B:GLYC.0000043746.77504.28; Nairn A, 2009, HANDBOOK OF GLYCOMICS, P95; Nairn AV, 2008, J BIOL CHEM, V283, P17298, DOI 10.1074/jbc.M801964200; Nairn AV, 2007, J PROTEOME RES, V6, P4374, DOI 10.1021/pr070446f; Nairn AV, 2010, METHOD ENZYMOL, V479, P73, DOI 10.1016/S0076-6879(10)79004-2; NISHIMURA H, 1992, J BIOL CHEM, V267, P17520; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Oka M, 2002, MOL BIOL CELL, V13, P1274, DOI 10.1091/mbc.02-01-0600; Okajima T, 1999, J BIOL CHEM, V274, P30557, DOI 10.1074/jbc.274.43.30557; Oltmann-Norden I, 2008, J BIOL CHEM, V283, P1463, DOI 10.1074/jbc.M708463200; OZAWA M, 1985, CELL DIFFER DEV, V16, P169, DOI 10.1016/0045-6039(85)90514-7; Park H, 2010, J LIPID RES, V51, P480, DOI 10.1194/jlr.M000984; Pattathil S, 2010, PLANT PHYSIOL, V153, P514, DOI 10.1104/pp.109.151985; PENNINGTON JE, 1985, J EMBRYOL EXP MORPH, V90, P335; Poirier F, 1997, MOL HUM REPROD, V3, P907, DOI 10.1093/molehr/3.10.907; Porterfield M., 2013, J PROTEOME IN PRESS; Quill TA, 1996, ARCH BIOCHEM BIOPHYS, V333, P326, DOI 10.1006/abbi.1996.0398; Rendic D, 2010, GLYCOBIOLOGY, V20, P1353, DOI 10.1093/glycob/cwq119; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sakamoto Y, 2000, J BIOL CHEM, V275, P36029, DOI 10.1074/jbc.M005860200; SASAKI K, 1993, J BIOL CHEM, V268, P22782; Sathananthan Henry, 2002, Reprod Biomed Online, V4, P56; Satomaa T, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-42; Schwientek T, 1999, J BIOL CHEM, V274, P4504, DOI 10.1074/jbc.274.8.4504; Smith ER, 2001, J BIOL CHEM, V276, P47303, DOI 10.1074/jbc.M106158200; SMITH PL, 1994, J BIOL CHEM, V269, P15162; Solter D, 1979, Curr Top Dev Biol, V13 Pt 1, P139; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Stalnaker SH, 2011, CURR OPIN STRUC BIOL, V21, P603, DOI 10.1016/j.sbi.2011.09.001; Stanton LW, 2007, CURR OPIN CHEM BIOL, V11, P399, DOI 10.1016/j.cbpa.2007.05.029; SUTTONSMITH M, 2002, BIOCH SOC S, V69, P105; Taniguchi N., 2002, HDB GLYCOSYLTRANSFER; Taylor ME, 2007, CURR OPIN CELL BIOL, V19, P572, DOI 10.1016/j.ceb.2007.09.004; Taylor ME, 2009, GLYCOBIOLOGY, V19, P1155, DOI 10.1093/glycob/cwp076; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; Ujita M, 1999, J BIOL CHEM, V274, P9296, DOI 10.1074/jbc.274.14.9296; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Varki A., 2008, ESSENTIALS GLYCOBIOL, P513; WEINSTEIN J, 1982, J BIOL CHEM, V257, P13845; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Wobus Anna M., 2001, Molecular Aspects of Medicine, V22, P149, DOI 10.1016/S0098-2997(01)00006-1; Wong NK, 2003, J BIOL CHEM, V278, P28619, DOI 10.1074/jbc.M302741200; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200; Yeh JC, 1999, J BIOL CHEM, V274, P3215, DOI 10.1074/jbc.274.5.3215; Yoon JH, 2009, MOL CELL NEUROSCI, V41, P448, DOI 10.1016/j.mcn.2009.04.013	116	69	70	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.405233	http://dx.doi.org/10.1074/jbc.M112.405233			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22988249	Green Published, hybrid			2022-12-28	WOS:000310642200021
J	Petrosyan, A; Ali, MF; Cheng, PW				Petrosyan, Armen; Ali, Mohamed F.; Cheng, Pi-Wan			Glycosyltransferase-specific Golgi-targeting Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETHERING PROTEIN P115; ENDOPLASMIC-RETICULUM; INTERMEDIATE COMPARTMENT; MOLECULAR CHAPERONE; GIANTIN INTERACTS; SECRETORY PATHWAY; CYTOPLASMIC TAIL; O-GLYCOSYLATION; MATRIX PROTEIN; GM130	Glycosylation of secreted and membrane-bound mucins is carried out by glycosyltransferases localized to specific Golgi compartments according to the step in which each enzyme participates. However, the Golgi-targeting mechanisms of these enzymes are not clear. Herein, we investigate the Golgi-targeting mechanisms of core 1 beta 3 galactosyltransferase (C1GalT1) and core 2 beta 1,6-N-acetylglucosaminyltransferase-2 or mucus type (C2GnT-M), which participate in the early O-glycosylation steps. siRNAs, co-immunoprecipitation, and confocal fluorescence microscopy were employed to identify the golgins involved in the Golgi docking of vesicular complexes (VCs) that carry these two enzymes. We have found that these VCs use different golgins for docking: C2GnT-M-carrying VC (C2GnT-M-VC) utilizes Giantin, whereas C1GalT1-VC employs GM130-GRASP65 complex. However, in the absence of GRASP65, C1GalT1-VC utilizes GM130-Giantin complex. Also, we have found that these VCs are 1.1-1.2 mu m in diameter, specific for each enzyme, and independent of coat protein complex II and I (COPII and COPI). These two fluorescently tagged enzymes exhibit different fluorescence recovery times in the Golgi after photobleaching. Thus, novel enzyme-specific Golgi-targeting mechanisms are employed by glycosyltransferases, and multiple Golgi docking strategies are utilized by C1GalT1.	[Petrosyan, Armen; Ali, Mohamed F.; Cheng, Pi-Wan] Univ Nebraska Med Ctr, Coll Med, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; Vet Affairs Nebraska Western Iowa Hlth Care Syst, Dept Res Serv, Omaha, NE 68105 USA; [Cheng, Pi-Wan] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; University of Nebraska System; University of Nebraska Medical Center	Cheng, PW (corresponding author), Univ Nebraska Med Ctr, Coll Med, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	pcheng@unmc.edu	Petrosyan, Armen/T-7071-2018	Petrosyan, Armen/0000-0003-3895-3993	Office of Research and Development, Department of Veterans Affairs [VA 1I1BX000985]; National Institutes of Health [1R21HL097238, 2RO1HL48282]; State of Nebraska [LB506]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL097238, R01HL048282] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000985] Funding Source: NIH RePORTER	Office of Research and Development, Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Nebraska; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by the Office of Research and Development, Department of Veterans Affairs (Grant VA 1I1BX000985), the National Institutes of Health (Grants 1R21HL097238 and 2RO1HL48282) (to P. W. C.), and the State of Nebraska (Grant LB506) (to P.W.C.).	Alvarez C, 2001, J BIOL CHEM, V276, P2693, DOI 10.1074/jbc.M007957200; Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Cao XC, 1998, EMBO J, V17, P2156, DOI 10.1093/emboj/17.8.2156; Cheng P. W., 2011, MOL IMMUNOLOGY COMPL, V705, P465; Choi KH, 2005, GLYCOCONJUGATE J, V22, P63, DOI 10.1007/s10719-005-0326-1; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; Fan JY, 2003, HISTOCHEM CELL BIOL, V120, P455, DOI 10.1007/s00418-003-0597-1; Fromme JC, 2005, CURR OPIN CELL BIOL, V17, P345, DOI 10.1016/j.ceb.2005.06.004; Hanisch FA, 2001, BIOL CHEM, V382, P143, DOI 10.1515/BC.2001.022; Hauri HP, 2000, J CELL SCI, V113, P587; Huang MC, 2006, ONCOGENE, V25, P3267, DOI 10.1038/sj.onc.1209350; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Kodani A, 2008, MOL BIOL CELL, V19, P745, DOI 10.1091/mbc.E07-08-0847; Lesa GM, 2000, J BIOL CHEM, V275, P2831, DOI 10.1074/jbc.275.4.2831; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Marra P, 2001, NAT CELL BIOL, V3, P1101, DOI 10.1038/ncb1201-1101; Marra P, 2007, MOL BIOL CELL, V18, P1595, DOI 10.1091/mbc.E06-10-0886; Martinez-Alonso E, 2005, TRAFFIC, V6, P32, DOI 10.1111/j.1600-0854.2004.00242.x; Moyer BD, 2001, TRAFFIC, V2, P268, DOI 10.1034/j.1600-0854.2001.1o007.x; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Narimatsu Y, 2008, BIOCHEM BIOPH RES CO, V366, P199, DOI 10.1016/j.bbrc.2007.11.121; Nickel W, 2002, J CELL SCI, V115, P3235; Petrosyan A, 2012, INT J BIOCHEM CELL B, V44, P1153, DOI 10.1016/j.biocel.2012.04.004; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Quintero CA, 2010, J BIOL CHEM, V285, P30340, DOI 10.1074/jbc.M110.128868; Rosing M, 2007, EXP CELL RES, V313, P2318, DOI 10.1016/j.yexcr.2007.03.031; Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7; Shorter J, 2002, J CELL BIOL, V157, P45, DOI 10.1083/jcb.200112127; Simpson JC, 2006, MOL BIOL CELL, V17, P723, DOI 10.1091/mbc.E05-06-0580; Singh J, 2004, J BIOL CHEM, V279, P38969, DOI 10.1074/jbc.M401046200; Stanley P., 2009, ESSENTIALS GLYCOBIOL; Stephens DJ, 2001, J CELL SCI, V114, P1053; Stone EL, 2009, MOL CELL BIOL, V29, P3770, DOI 10.1128/MCB.00204-09; Tu LN, 2010, CELL MOL LIFE SCI, V67, P29, DOI 10.1007/s00018-009-0126-z; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; Weide T, 2001, EMBO REP, V2, P336, DOI 10.1093/embo-reports/kve065; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112	39	36	38	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.C112.403006	http://dx.doi.org/10.1074/jbc.C112.403006			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22988244	hybrid, Green Published			2022-12-28	WOS:000310642200004
J	Pradhan, A; Khalaf, H; Ochsner, SA; Sreenivasan, R; Koskinen, J; Karlsson, M; Karlsson, J; McKenna, NJ; Orban, L; Olsson, PE				Pradhan, Ajay; Khalaf, Hazem; Ochsner, Scott A.; Sreenivasan, Rajini; Koskinen, Jarno; Karlsson, Marie; Karlsson, Jesper; McKenna, Neil J.; Orban, Laszlo; Olsson, Per-Erik			Activation of NF-kappa B Protein Prevents the Transition from Juvenile Ovary to Testis and Promotes Ovarian Development in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; SEX-DIFFERENTIATION; GENE-EXPRESSION; DANIO-RERIO; CELL LINE; GERM-LINE; MECHANISMS; SOX9; INFLAMMATION; APOPTOSIS	Testis differentiation in zebrafish involves juvenile ovary to testis transformation initiated by an apoptotic wave. The molecular regulation of this transformation process is not fully understood. NF-kappa B is activated at an early stage of development and has been shown to interact with steroidogenic factor-1 in mammals, leading to the suppression of anti-Mullerian hormone (Amh) gene expression. Because steroidogenic factor-1 and Amh are important for proper testis development, NF-kappa B-mediated induction of anti-apoptotic genes could, therefore, also play a role in zebrafish gonad differentiation. The aim of this study was to examine the potential role of NF-kappa B in zebrafish gonad differentiation. Exposure of juvenile zebrafish to heat-killed Escherichia coli activated the NF-kappa B pathways and resulted in an increased ratio of females from 30 to 85%. Microarray and quantitative real-time-PCR analysis of gonads showed elevated expression of NF-kappa B-regulated genes. To confirm the involvement of NF-kappa B-induced anti-apoptotic effects, zebrafish were treated with sodium deoxycholate, a known inducer of NF-kappa B or NF-kappa B activation inhibitor (NAI). Sodium deoxycholate treatment mimicked the effect of heat-killed bacteria and resulted in an increased proportion of females from 25 to 45%, whereas the inhibition of NF-kappa B using NAI resulted in a decrease in females from 45 to 20%. This study provides proof for an essential role of NF-kappa B in gonadal differentiation of zebrafish and represents an important step toward the complete understanding of the complicated process of sex differentiation in this species and possibly other cyprinid teleosts as well.	[Pradhan, Ajay; Khalaf, Hazem; Koskinen, Jarno; Karlsson, Marie; Karlsson, Jesper; Olsson, Per-Erik] Univ Orebro, Sch Sci & Technol, Orebro Life Sci Ctr, Dept Biol, SE-70182 Orebro, Sweden; [Ochsner, Scott A.; McKenna, Neil J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Sreenivasan, Rajini; Orban, Laszlo] Temasek Life Sci Lab, Strateg Res Program, Dept Reprod Genom, Singapore 117604, Singapore; [Orban, Laszlo] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Orban, Laszlo] Univ Pannonia, Georgikon Fac, Dept Anim Sci & Breeding, H-8360 Keszthely, Hungary	Orebro University; Baylor College of Medicine; National University of Singapore; University of Pannonia	Olsson, PE (corresponding author), Univ Orebro, Sch Sci & Technol, Orebro Life Sci Ctr, Dept Biol, SE-70182 Orebro, Sweden.	per-erik.olsson@oru.se	Orbán, László/A-3030-2009; Sreenivasan, Rajini/G-6930-2019	Orbán, László/0000-0001-5435-5948; Sreenivasan, Rajini/0000-0002-6357-5392; Khalaf, Hazem/0000-0002-3373-7864; Pradhan, Ajay/0000-0003-2305-8574; Olsson, Per-Erik/0000-0001-7336-6335; Ochsner, Scott/0000-0003-1099-7863; McKenna, Neil/0000-0001-6689-0104	Swedish Research Council; Knowledge Foundation, Sweden; Orebro University; Agri-Food and Veterinary Authority; Temasek Life Sciences Laboratory, Singapore	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knowledge Foundation, Sweden; Orebro University; Agri-Food and Veterinary Authority; Temasek Life Sciences Laboratory, Singapore(National University of Singapore)	This research was financed by the Swedish Research Council, the Knowledge Foundation, Sweden, and Orebro University (to P.E.-O.) and by the Agri-Food and Veterinary Authority as well as Temasek Life Sciences Laboratory, Singapore (to L.O.).	Aggarwal BB, 2006, CURR SIGNAL TRANSD T, V1, P25, DOI 10.2174/157436206775269235; Anderson JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040701; Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bradley KM, 2011, G3-GENES GENOM GENET, V1, P3, DOI 10.1534/g3.111.000190; Delfino F, 1998, MOL ENDOCRINOL, V12, P1696, DOI 10.1210/me.12.11.1696; FINCO TS, 1995, IMMUNITY, V3, P263, DOI 10.1016/1074-7613(95)90112-4; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gilardelli CN, 2004, DEV DYNAM, V230, P494, DOI 10.1002/dvdy.20073; Hong CY, 2003, MOL CELL BIOL, V23, P6000, DOI 10.1128/MCB.23.17.6000-6012.2003; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Lasala C, 2004, DNA CELL BIOL, V23, P572, DOI 10.1089/dna.2004.23.572; Lasala C, 2011, AM J PHYSIOL-ENDOC M, V301, pE539, DOI 10.1152/ajpendo.00187.2011; Liew WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034397; Lister A, 2002, J EXP ZOOL, V292, P477, DOI 10.1002/jez.10066; Meijer AH, 2008, DEV COMP IMMUNOL, V32, P36, DOI 10.1016/j.dci.2007.04.003; Murakami S, 2000, J BIOL CHEM, V275, P3687, DOI 10.1074/jbc.275.5.3687; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Orban L, 2009, MOL CELL ENDOCRINOL, V312, P35, DOI 10.1016/j.mce.2009.04.014; Palvimo JJ, 1996, J BIOL CHEM, V271, P24151, DOI 10.1074/jbc.271.39.24151; Payne CM, 2007, CARCINOGENESIS, V28, P215, DOI 10.1093/carcin/bgl139; Rao NAS, 2011, GENOME RES, V21, P1404, DOI 10.1101/gr.118042.110; Rigou P, 2009, EMBO J, V28, P1576, DOI 10.1038/emboj.2009.106; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rodriguez-Mari A, 2005, GENE EXPR PATTERNS, V5, P655, DOI 10.1016/j.modgep.2005.02.008; Rodriguez-Mari A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001034; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sekiguchi T, 2004, EXP CELL RES, V300, P213, DOI 10.1016/j.yexcr.2004.07.005; Shiozaki EN, 2004, TRENDS BIOCHEM SCI, V29, P486, DOI 10.1016/j.tibs.2004.07.003; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Siegfried KR, 2008, DEV BIOL, V324, P277, DOI 10.1016/j.ydbio.2008.09.025; Singer A, 2002, GENETICS, V160, P649; Slanchev K, 2005, P NATL ACAD SCI USA, V102, P4074, DOI 10.1073/pnas.0407475102; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sola L, 2001, GENETICA, V111, P397, DOI 10.1023/A:1013776323077; Sreenivasan R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001791; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; TAKAHASHI H, 1977, Bulletin of the Faculty of Fisheries Hokkaido University, V28, P57; Tobe M, 2003, BIOORGAN MED CHEM, V11, P3869, DOI 10.1016/S0968-0896(03)00438-3; Uchida D, 2002, J EXP BIOL, V205, P711; von Hofsten J, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-63; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wallace BMN, 2003, HEREDITY, V90, P136, DOI 10.1038/sj.hdy.6800184; Wang XG, 2007, J FISH BIOL, V70, P33, DOI 10.1111/j.1095-8649.2007.01363.x; Xiao WH, 2004, CELL MOL IMMUNOL, V1, P425	47	47	48	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.386284	http://dx.doi.org/10.1074/jbc.M112.386284			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22988238	Green Published, hybrid			2022-12-28	WOS:000310642200028
J	Ramachandran, L; Manu, KA; Shanmugam, MK; Li, F; Siveen, KS; Vali, S; Kapoor, S; Abbasi, T; Surana, R; Smoot, DT; Ashktorab, H; Tan, P; Ahn, KS; Yap, CW; Kumar, AP; Sethi, G				Ramachandran, Lalitha; Manu, Kanjoormana Aryan; Shanmugam, Muthu K.; Li, Feng; Siveen, Kodappully Sivaraman; Vali, Shireen; Kapoor, Shweta; Abbasi, Taher; Surana, Rohit; Smoot, Duane T.; Ashktorab, Hassan; Tan, Patrick; Ahn, Kwang Seok; Yap, Chun Wei; Kumar, Alan Prem; Sethi, Gautam			Isorhamnetin Inhibits Proliferation and Invasion and Induces Apoptosis through the Modulation of Peroxisome Proliferator-activated Receptor gamma Activation Pathway in Gastric Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; QUERCETIN; CELLS; CARCINOGENESIS; MECHANISMS; PREVENTION; DOCKING; BREAST; GROWTH	Gastric cancer (GC) is a lethal malignancy and the second most common cause of cancer-related deaths. Although treatment options such as chemotherapy, radiotherapy, and surgery have led to a decline in the mortality rate due to GC, chemoresistance remains as one of the major causes for poor prognosis and high recurrence rate. In this study, we investigated the potential effects of isorhamnetin (IH), a 3'-O-methylated metabolite of quercetin on the peroxisome proliferator-activated receptor gamma (PPAR-gamma) signaling cascade using proteomics technology platform, GC cell lines, and xenograft mice model. We observed that IH exerted a strong antiproliferative effect and increased cytotoxicity in combination with chemotherapeutic drugs. IH also inhibited the migratory/invasive properties of GC cells, which could be reversed in the presence of PPAR-gamma inhibitor. We found that IH increased PPAR-gamma activity and modulated the expression of PPAR-gamma regulated genes in GC cells. Also, the increase in PPAR-gamma activity was reversed in the presence of PPAR-gamma-specific inhibitor and a mutated PPAR-gamma dominant negative plasmid, supporting our hypothesis that IH can act as a ligand of PPAR-gamma. Using molecular docking analysis, we demonstrate that IH formed interactions with seven polar residues and six nonpolar residues within the ligand-binding pocket of PPAR-gamma that are reported to be critical for its activity and could competitively bind to PPAR-gamma. IH significantly increased the expression of PPAR-gamma in tumor tissues obtained from xenograft model of GC. Overall, our findings clearly indicate that antitumor effects of IH may be mediated through modulation of the PPAR-gamma activation pathway in GC.	[Surana, Rohit; Tan, Patrick; Kumar, Alan Prem; Sethi, Gautam] Natl Univ Singapore, Canc Sci Inst Singapore, Ctr Translat Med, Singapore 117599, Singapore; [Ramachandran, Lalitha; Manu, Kanjoormana Aryan; Shanmugam, Muthu K.; Li, Feng; Siveen, Kodappully Sivaraman; Surana, Rohit; Kumar, Alan Prem; Sethi, Gautam] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117597, Singapore; [Vali, Shireen; Kapoor, Shweta; Abbasi, Taher] Cellworks Res India Pvt Ltd, Bangalore, Karnataka, India; [Vali, Shireen; Kapoor, Shweta; Abbasi, Taher] Cellworks Grp Inc, Saratoga, CA 95070 USA; [Smoot, Duane T.; Ashktorab, Hassan] Howard Univ, Dept Med, Washington, DC 20060 USA; [Smoot, Duane T.; Ashktorab, Hassan] Howard Univ, Ctr Canc, Washington, DC 20060 USA; [Tan, Patrick] Genome Inst Singapore, Singapore 138672, Singapore; [Tan, Patrick] Duke Natl Univ Singapore, Grad Sch Med, Singapore 169857, Singapore; [Ahn, Kwang Seok] Kyung Hee Univ, Coll Oriental Med, Seoul 130701, South Korea; [Yap, Chun Wei] Natl Univ Singapore, Dept Pharm, Pharmaceut Data Explorat Lab, Singapore 117543, Singapore; [Kumar, Alan Prem] Curtin Univ Technol, Fac Hlth Sci, Sch Biomed Sci, Perth, WA 6845, Australia; [Kumar, Alan Prem] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA	National University of Singapore; National University of Singapore; Howard University; Howard University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Kyung Hee University; National University of Singapore; Curtin University; University of North Texas System; University of North Texas Denton	Kumar, AP (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Ctr Translat Med, Singapore 117599, Singapore.	csiapk@nus.edu.sg; phcgs@nus.edu.sg	Sethi, Gautam/F-2372-2011; Ashktorab, hassan/AAJ-2908-2020; Aryan, Manu/C-6609-2015; Yap, Chun Wei/B-2587-2010; Ahn, Kwang Seok/G-4249-2013; Kumar, Alan Prem/ABE-7492-2020	Sethi, Gautam/0000-0002-8677-8475; Yap, Chun Wei/0000-0002-2004-3492; Kumar, Alan Prem/0000-0002-3754-5712; Siveen, Kodappully Sivaraman/0000-0003-4669-1890; Kanjoormana Aryan, Manu/0000-0002-4437-6486	NUS Academic Research Fund [R-184-000-170-112]; National Medical Research Council of Singapore [R-184-000-211-213, R-713-000-124-213]; Cancer Science Institute of Singapore, Experimental Therapeutics I Program Grant [R-713-001-011-271]	NUS Academic Research Fund; National Medical Research Council of Singapore(National Medical Research Council, Singapore); Cancer Science Institute of Singapore, Experimental Therapeutics I Program Grant	This work was supported by NUS Academic Research Fund Grant R-184-000-170-112 (to G. S.), National Medical Research Council of Singapore Grant R-184-000-211-213, National Medical Research Council of Singapore Grant R-713-000-124-213 (to A. P. K.), and Cancer Science Institute of Singapore, Experimental Therapeutics I Program Grant R-713-001-011-271 (to A. P. K.).	Asensi M, 2011, CRIT REV CL LAB SCI, V48, P197, DOI 10.3109/10408363.2011.631268; Bishop-Bailey D, 2011, BIOCHEM SOC T, V39, P1601, DOI 10.1042/BST20110643; Boik John C., 2008, BMC Pharmacology, V8, P13, DOI 10.1186/1471-2210-8-13; Burris TP, 2012, CHEM BIOL, V19, P51, DOI 10.1016/j.chembiol.2011.12.011; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chen YC, 2012, MOL NEUROBIOL, V46, P114, DOI 10.1007/s12035-012-8259-8; Choi KC, 2010, FOOD CHEM TOXICOL, V48, P2747, DOI 10.1016/j.fct.2010.07.001; Cushnie TPT, 2011, INT J ANTIMICROB AG, V38, P99, DOI 10.1016/j.ijantimicag.2011.02.014; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Ford AC, 2011, BEST PRACT RES CL GA, V25, P581, DOI 10.1016/j.bpg.2011.09.002; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hannelien V, 2012, BBA-REV CANCER, V1825, P117, DOI 10.1016/j.bbcan.2011.10.008; Jaramillo S, 2010, J AGR FOOD CHEM, V58, P10869, DOI 10.1021/jf102669p; Kannaiyan R, 2011, BRIT J PHARMACOL, V164, P1506, DOI 10.1111/j.1476-5381.2011.01449.x; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Kim JE, 2011, CANCER PREV RES, V4, P582, DOI 10.1158/1940-6207.CAPR-11-0032; Koeffler HP, 2003, CLIN CANCER RES, V9, P1; Kumar AP, 2009, CANCER RES, V69, P8636, DOI 10.1158/0008-5472.CAN-09-0219; Lee HJ, 2008, CANCER LETT, V270, P342, DOI 10.1016/j.canlet.2008.05.040; Lochhead P, 2008, BRIT MED BULL, V85, P87, DOI 10.1093/bmb/ldn007; Lu J, 2005, CANCER RES, V65, P4769, DOI 10.1158/0008-5472.CAN-04-2293; Mannelli M, 2010, NEUROENDOCRINOLOGY, V92, P23, DOI 10.1159/000314312; Manu KA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-107; Nickkho-Amiry M, 2012, MOL CANCER RES, V10, P441, DOI 10.1158/1541-7786.MCR-11-0233; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Ohtsu A, 2008, J GASTROENTEROL, V43, P256, DOI 10.1007/s00535-008-2177-6; Oyekan A, 2011, CLIN EXP HYPERTENS, V33, P287, DOI 10.3109/10641963.2010.531845; Papi A, 2010, CANCER LETT, V297, P65, DOI 10.1016/j.canlet.2010.04.026; Patel LR, 2011, FUTURE ONCOL, V7, P1285, DOI [10.2217/fon.11.112, 10.2217/FON.11.112]; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Reka AK, 2011, LUNG CANCER, V72, P154, DOI 10.1016/j.lungcan.2011.01.019; Roukos DH, 2005, NAT CLIN PRACT ONCOL, V2, P98, DOI 10.1038/ncponc0099; Salam NK, 2008, CHEM BIOL DRUG DES, V71, P57, DOI 10.1111/j.1747-0285.2007.00606.x; Schmidt MV, 2010, THESCIENTIFICWORLDJO, V10, P2181, DOI 10.1100/tsw.2010.213; Selgrad M, 2010, HELICOBACTER, V15, P40, DOI 10.1111/j.1523-5378.2010.00783.x; Shanmugam MK, 2011, J MOL MED, V89, P713, DOI 10.1007/s00109-011-0746-2; Takahashi N, 1999, FEBS LETT, V455, P135, DOI 10.1016/S0014-5793(99)00871-6; Wan ZQ, 2011, MOL CELL BIOCHEM, V349, P1, DOI 10.1007/s11010-010-0637-9; Wang P, 2012, TOXICOL IN VITRO, V26, P221, DOI 10.1016/j.tiv.2011.11.015; Wang PW, 2012, NUTR CANCER, V64, P580, DOI 10.1080/01635581.2012.661514; Wang TT, 2006, CRIT REV ONCOL HEMAT, V58, P1, DOI 10.1016/j.critrevonc.2005.08.011; Wilding J. P., 2012, DIABETES OB IN PRESS; Woo CC, 2011, BIOCHEM PHARMACOL, V82, P464, DOI 10.1016/j.bcp.2011.05.030; Yao H, 2011, J ENVIRON SCI HEAL C, V29, P1, DOI 10.1080/10590501.2011.551317; Yao LP, 2010, HYBRIDOMA, V29, P341, DOI 10.1089/hyb.2010.0013; Yeoh KG, 2007, J GASTROEN HEPATOL, V22, P970, DOI 10.1111/j.1440-1746.2007.04956.x; Yokoyama Y, 2011, J CANCER RES CLIN, V137, P1219, DOI 10.1007/s00432-011-0993-1	47	103	114	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.388702	http://dx.doi.org/10.1074/jbc.M112.388702			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22992727	Green Published, hybrid			2022-12-28	WOS:000310642200037
J	Takahashi, H; Sun, XY; Hamamoto, M; Yashiroda, Y; Yoshida, M				Takahashi, Hidekazu; Sun, Xiaoying; Hamamoto, Makiko; Yashiroda, Yoko; Yoshida, Minoru			The SAGA Histone Acetyltransferase Complex Regulates Leucine Uptake through the Agp3 Permease in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; NITROGEN STARVATION; UBIQUITIN LIGASE; GENE-EXPRESSION; CELL-GROWTH; ACETYLATION; STRESS; TOR2; DIFFERENTIATION	Metabolic responses of unicellular organisms are mostly acute, transient, and cell-autonomous. Regulation of nutrient uptake in yeast is one such rapid response. High quality nitrogen sources such as NH4+ inhibit uptake of poor nitrogen sources, such as amino acids. Both transcriptional and posttranscriptional mechanisms operate in nutrient uptake regulation; however, many components of this system remain uncharacterized in the fission yeast, Schizosaccharomyces pombe. Here, we demonstrate that the Spt-Ada-Gcn acetyltransferase (SAGA) complex modulates leucine uptake. Initially, we noticed that a branched-chain amino acid auxotroph exhibits a peculiar adaptive growth phenotype on solid minimal media containing certain nitrogen sources. In fact, the growth of many auxotrophic strains is inhibited by excess NH4Cl, possibly through nitrogen-mediated uptake inhibition of the corresponding nutrients. Surprisingly, DNA microarray analysis revealed that the transcriptional reprogramming during the adaptation of the branched-chain amino acid auxotroph was highly correlated with reprogramming observed in deletions of the SAGA histone acetyltransferase module genes. Deletion of gcn5(+) increased leucine uptake in the prototrophic background and rendered the leucine auxotroph resistant to NH4Cl. Deletion of tra1(+) caused the opposite phenotypes. The increase in leucine uptake in the gcn5 Delta mutant was dependent on an amino acid permease gene, SPCC965.11c(+). The closest budding yeast homolog of this permease is a relatively nonspecific amino acid permease AGP3, which functions in poor nutrient conditions. Our analysis identified the regulation of nutrient uptake as a physiological function for the SAGA complex, providing a potential link between cellular metabolism and chromatin regulation.	[Takahashi, Hidekazu; Sun, Xiaoying; Yashiroda, Yoko; Yoshida, Minoru] RIKEN, Adv Sci Inst, Chem Genet Lab, Chem Genom Res Grp, Wako, Saitama 3510198, Japan; [Sun, Xiaoying; Hamamoto, Makiko] Meiji Univ, Sch Agr, Dept Life Sci, Kawasaki, Kanagawa 2148571, Japan; [Yoshida, Minoru] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST Res Project, Kawaguchi, Saitama 3320012, Japan	RIKEN; Meiji University; Japan Science & Technology Agency (JST)	Yoshida, M (corresponding author), RIKEN, Adv Sci Inst, Chem Genet Lab, Chem Genom Res Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	yoshidam@riken.jp	Yashiroda, Yoko/C-8769-2014; Yoshida, Minoru/C-8049-2014	Yoshida, Minoru/0000-0002-4376-5674	CREST from the Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan	CREST from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant from CREST from the Japan Science and Technology Agency (to M. Y.) and by Grant-in-aid for Scientific Research on Innovative Areas 3307 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to H. T.)	Alvarez B, 2006, J CELL SCI, V119, P4475, DOI 10.1242/jcs.03241; Aspuria PJ, 2008, MOL GENET GENOMICS, V279, P441, DOI 10.1007/s00438-008-0320-y; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Calonge TM, 2010, GENETICS, V185, P81, DOI 10.1534/genetics.110.114769; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Collart M. A., 2001, CURRENT PROTOCOLS MO; Eden A, 1998, YEAST, V14, P189, DOI 10.1002/(SICI)1097-0061(19980130)14:2<189::AID-YEA210>3.0.CO;2-V; Friis RMN, 2009, NUCLEIC ACIDS RES, V37, P3969, DOI 10.1093/nar/gkp270; Godard P, 2007, MOL CELL BIOL, V27, P3065, DOI 10.1128/MCB.01084-06; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Hansen KR, 2005, MOL CELL BIOL, V25, P590, DOI 10.1128/MCB.25.2.590-601.2005; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Helmlinger D, 2011, EMBO J, V30, P2843, DOI 10.1038/emboj.2011.181; Helmlinger D, 2008, GENE DEV, V22, P3184, DOI 10.1101/gad.1719908; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hunt C, 2001, YEAST, V18, P355, DOI 10.1002/1097-0061(20010315)18:4<355::AID-YEA676>3.0.CO;2-P; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnsson A, 2009, EMBO REP, V10, P1009, DOI 10.1038/embor.2009.127; Karagiannis J, 1999, CURR GENET, V35, P593, DOI 10.1007/s002940050457; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kohler A, 2008, NAT CELL BIOL, V10, P707, DOI 10.1038/ncb1733; Koutelou E, 2010, CURR OPIN CELL BIOL, V22, P374, DOI 10.1016/j.ceb.2010.03.005; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Matsumoto S, 2002, GENETICS, V161, P1053; Matsuo T, 2007, MOL CELL BIOL, V27, P3154, DOI 10.1128/MCB.01039-06; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakase Y, 2006, GENETICS, V173, P569, DOI 10.1534/genetics.106.056895; Nugent RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-59; Otsubo Y, 2008, CRIT REV BIOCHEM MOL, V43, P277, DOI [10.1080/10409230802254911, 10.1080/10409230802254911 ]; Saleki R, 1997, MOL GEN GENET, V254, P520, DOI 10.1007/s004380050447; Schreve JL, 2004, BIOCHEM BIOPH RES CO, V313, P745, DOI 10.1016/j.bbrc.2003.11.172; Sterner DE, 1999, MOL CELL BIOL, V19, P86; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Takahashi H, 2011, BIOCHEM BIOPH RES CO, V406, P42, DOI 10.1016/j.bbrc.2011.01.103; Udagawa T, 2008, J BIOL CHEM, V283, P22063, DOI 10.1074/jbc.M710017200; van Slegtenhorst M, 2004, J BIOL CHEM, V279, P12706, DOI 10.1074/jbc.M313874200; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Weisman R, 2005, GENETICS, V169, P539, DOI 10.1534/genetics.104.034983; Weisman R, 2007, GENETICS, V175, P1153, DOI 10.1534/genetics.106.064170	40	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.411165	http://dx.doi.org/10.1074/jbc.M112.411165			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22992726	Green Published, hybrid			2022-12-28	WOS:000310642200049
J	Wu-Zhang, AX; Murphy, AN; Bachman, M; Newton, AC				Wu-Zhang, Alyssa X.; Murphy, Anne N.; Bachman, Mackenzie; Newton, Alexandra C.			Isozyme-specific Interaction of Protein Kinase C delta with Mitochondria Dissected Using Live Cell Fluorescence Imaging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNNATURAL NUCLEOTIDE SPECIFICITY; ACTIVATION LOOP PHOSPHORYLATION; PYRUVATE-DEHYDROGENASE COMPLEX; DAMAGE-INDUCED APOPTOSIS; PKC-DELTA; TYROSINE PHOSPHORYLATION; ENERGY HOMEOSTASIS; ACTIVITY REPORTER; STRUCTURAL BASIS; PHORBOL ESTERS	PKC delta signaling to mitochondria has been implicated in both mitochondrial apoptosis and metabolism. However, the mechanism by which PKC delta interacts with mitochondria is not well understood. Using FRET-based imaging, we show that PKC delta interacts with mitochondria by a novel and isozyme-specific mechanism distinct from its canonical recruitment to other membranes such as the plasma membrane or Golgi. Specifically, we show that PKC delta interacts with mitochondria following stimulation with phorbol esters or, in L6 myocytes, with insulin via a mechanism that requires two steps. In the first step, PKC delta trans-locates acutely to mitochondria by a mechanism that requires its C1A and C1B domains and a Leu-Asn sequence in its turn motif. In the second step, PKC delta is retained at mitochondria by a mechanism that depends on its C2 domain, a unique Glu residue in its activation loop, intrinsic catalytic activity, and the mitochondrial membrane potential. In contrast, of these determinants, only the C1B domain is required for the phorbol ester-stimulated translocation of PKC delta to other membranes. PKC delta also basally localizes to mitochondria and increases mitochondrial respiration via many of the same determinants that promote its agonist-evoked interaction. PKC delta localized to mitochondria has robust activity, as revealed by a FRET reporter of PKC delta-specific activity (delta CKAR). These data support a model in which multiple determinants unique to PKC delta drive a specific interaction with mitochondria that promotes mitochondrial respiration.	[Wu-Zhang, Alyssa X.; Murphy, Anne N.; Bachman, Mackenzie; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Wu-Zhang, Alyssa X.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Newton, AC (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	anewton@ucsd.edu	Murphy, Anne N/H-3217-2016	Murphy, Anne N/0000-0002-5222-9902	National Institutes of Health [GM43154, P01 DK054441]; University of California from the National Institute of General Medical Sciences [T32 GM007752]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R01GM043154, R37GM043154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California from the National Institute of General Medical Sciences; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM43154 (to A. C. N.) and P01 DK054441 (to A. C. N. and A. N. M.).; Supported in part by the University of California San Diego Graduate Training Program in Cellular and Molecular Pharmacology through Training Grant T32 GM007752 from the National Institute of General Medical Sciences.	Acin-Perez R, 2010, FASEB J, V24, P5033, DOI 10.1096/fj.10-166934; Acin-Perez R, 2010, FASEB J, V24, P627, DOI 10.1096/fj.09-142281; Adwan TS, 2011, J BIOL CHEM, V286, P35716, DOI 10.1074/jbc.M111.255950; BAIER G, 1993, J BIOL CHEM, V268, P4997; Basu A, 2003, J CELL MOL MED, V7, P341, DOI 10.1111/j.1582-4934.2003.tb00237.x; Basu A, 2001, CELL DEATH DIFFER, V8, P899, DOI 10.1038/sj.cdd.4400885; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Bishop AC, 1998, CURR BIOL, V8, P257, DOI 10.1016/S0960-9822(98)70198-8; Blass M, 2002, MOL CELL BIOL, V22, P182, DOI 10.1128/MCB.22.1.182-195.2002; Cameron AJ, 2007, BIOCHEM SOC T, V35, P1013, DOI 10.1042/BST0351013; Caruso M, 2001, J BIOL CHEM, V276, P45088, DOI 10.1074/jbc.M105451200; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Denning MF, 2002, CELL DEATH DIFFER, V9, P40, DOI 10.1038/sj.cdd.4400929; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Gallegos LL, 2008, IUBMB LIFE, V60, P782, DOI 10.1002/iub.122; Giorgione JR, 2006, J BIOL CHEM, V281, P1660, DOI 10.1074/jbc.M510251200; Gong JL, 2012, FASEB J, V26, P3537, DOI 10.1096/fj.11-197376; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hoshi N, 2010, MOL CELL, V37, P541, DOI 10.1016/j.molcel.2010.01.014; Humphries MJ, 2008, ONCOGENE, V27, P3045, DOI 10.1038/sj.onc.1210967; Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Kajimoto T, 2010, J BIOL CHEM, V285, P41896, DOI 10.1074/jbc.M110.184028; Kanaji S, 2000, J CELL BIOL, V151, P277, DOI 10.1083/jcb.151.2.277; Kaul S, 2005, J BIOL CHEM, V280, P28721, DOI 10.1074/jbc.M501092200; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P14679, DOI 10.1074/jbc.270.24.14679; Konishi H, 2001, P NATL ACAD SCI USA, V98, P6587, DOI 10.1073/pnas.111158798; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Leitges M, 2001, J CLIN INVEST, V108, P1505; Li LW, 1999, MOL CELL BIOL, V19, P8547; Liu Y, 2006, J BIOL CHEM, V281, P12102, DOI 10.1074/jbc.M600508200; Liu Y, 1998, CHEM BIOL, V5, P91, DOI 10.1016/S1074-5521(98)90143-0; Majumder PK, 2000, J BIOL CHEM, V275, P21793, DOI 10.1074/jbc.C000048200; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Matassa AA, 2001, J BIOL CHEM, V276, P29719, DOI 10.1074/jbc.M100273200; Mayr M, 2004, AM J PHYSIOL-HEART C, V287, pH946, DOI 10.1152/ajpheart.00878.2003; Mayr M, 2004, AM J PHYSIOL-HEART C, V287, pH937, DOI 10.1152/ajpheart.00877.2003; Mayr M, 2004, CIRC RES, V94, pE87, DOI 10.1161/01.RES.0000131496.49135.1d; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Nguyen T, 2008, J BIOL CHEM, V283, P29831, DOI 10.1074/jbc.M801642200; OSADA S, 1992, MOL CELL BIOL, V12, P3930, DOI 10.1128/MCB.12.9.3930; Pu YM, 2009, J BIOL CHEM, V284, P1302, DOI 10.1074/jbc.M804796200; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Rybin VO, 2007, J BIOL CHEM, V282, P23631, DOI 10.1074/jbc.M701676200; Rybin VO, 2004, J BIOL CHEM, V279, P19350, DOI 10.1074/jbc.M311096200; Sasaki K, 2003, J BIOL CHEM, V278, P30945, DOI 10.1074/jbc.M212167200; Sato T, 1998, CIRC RES, V83, P110, DOI 10.1161/01.RES.83.1.110; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Siwko S, 2007, INT J BIOCHEM CELL B, V39, P978, DOI 10.1016/j.biocel.2007.01.018; Slater SJ, 2002, CHEM PHYS LIPIDS, V116, P75, DOI 10.1016/S0009-3084(02)00021-X; Soltoff SP, 2001, J BIOL CHEM, V276, P37986; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Sossin WS, 2007, LEARN MEMORY, V14, P236, DOI 10.1101/lm.469707; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Stempka L, 1999, J BIOL CHEM, V274, P8886, DOI 10.1074/jbc.274.13.8886; TRAN PL, 1985, CARCINOGENESIS, V6, P433, DOI 10.1093/carcin/6.3.433; Violin JD, 2003, IUBMB LIFE, V55, P653, DOI 10.1080/152165401310001642216; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125	62	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.412635	http://dx.doi.org/10.1074/jbc.M112.412635			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22988234	hybrid, Green Published			2022-12-28	WOS:000310642200025
J	Fruhwald, J; Londono, JC; Dembla, S; Mannebach, S; Lis, A; Drews, A; Wissenbach, U; Oberwinkler, J; Philipp, SE				Fruehwald, Julia; Londono, Julia Camacho; Dembla, Sandeep; Mannebach, Stefanie; Lis, Annette; Drews, Anna; Wissenbach, Ulrich; Oberwinkler, Johannes; Philipp, Stephan E.			Alternative Splicing of a Protein Domain Indispensable for Function of Transient Receptor Potential Melastatin 3 (TRPM3) Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; PREDICTION; EXPRESSION; MECHANISM; PCR	TRPM3 channels form ionotropic steroid receptors in the plasma membrane of pancreatic beta and dorsal root ganglion cells and link steroid hormone signaling to insulin release and pain perception, respectively. We identified and compared the function of a number of TRPM3 splice variants present in mouse, rat and human tissues. Wefound that variants lacking a region of 18 amino acid residues display neither Ca2+ entry nor ionic currents when expressed alone. Hence, splicing removes a region that is indispensable for channel function, which is called the ICF region. TRPM3 variants devoid of this region (TRPM3 Delta ICF), are ubiquitously present in different tissues and cell types where their transcripts constitute up to 15% of the TRPM3 isoforms. The ICF region is conserved throughout the TRPM family, and its presence in TRPM8 proteins is also necessary for function. Within the ICF region, 10 amino acid residues form a domain essential for the formation of operative TRPM3 channels. TRPM3 Delta ICF variants showed reduced interaction with other TRPM3 isoforms, and their occurrence at the cell membrane was diminished. Correspondingly, coexpression of Delta ICF proteins with functional TRPM3 subunits not only reduced the number of channels but also impaired TRPM3-mediated Ca2+ entry. We conclude that TRPM3 Delta ICF variants are regulatory channel subunits fine-tuning TRPM3 channel activity.	[Lis, Annette] Univ Saarland, Inst Biophys, D-66421 Homburg, Germany; [Drews, Anna] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Oberwinkler, Johannes] Univ Marburg, Inst Physiol & Pathophysiol, D-35037 Marburg, Germany	Saarland University; University of Cambridge; Philipps University Marburg	Philipp, SE (corresponding author), Univ Saarland, Inst Biophys, Gebaude 46, D-66421 Homburg, Germany.	stephan.philipp@uks.eu	Philipp, Stephan/AAR-7519-2020	Philipp, Stephan/0000-0003-1959-9167; Oberwinkler, Johannes/0000-0002-8541-3626; Dembla, Sandeep/0000-0003-2708-4390	Deutsche Forschungsgemeinschaft [SFB 530]; Emmy-Noether Programm [GK 1326]; Universitat des Saarlandes (Homburger Forschungsforderungsprogramm)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Emmy-Noether Programm(German Research Foundation (DFG)); Universitat des Saarlandes (Homburger Forschungsforderungsprogramm)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 530 (to J. F. and S. E. P.), Emmy-Noether Programm (to J. O.), GK 1326 (to J. C. L., S. D., and A. D.), and the Universitat des Saarlandes (Homburger Forschungsforderungsprogramm).	Ando S, 2001, MOL ENDOCRINOL, V15, P1529, DOI 10.1210/me.15.9.1529; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Bodding M, 2007, CELL CALCIUM, V42, P618, DOI 10.1016/j.ceca.2007.03.005; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; COCAPRADOS M, 1986, P NATL ACAD SCI USA, V83, P8754, DOI 10.1073/pnas.83.22.8754; Hindle KL, 2009, PROTEINS, V77, P342, DOI 10.1002/prot.22440; Hoffmann A, 2010, J NEUROCHEM, V114, P654, DOI 10.1111/j.1471-4159.2010.06644.x; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Lambert S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202945; Latorre R, 2009, Q REV BIOPHYS, V42, P201, DOI 10.1017/S0033583509990072; Lee N, 2003, J BIOL CHEM, V278, P20890, DOI 10.1074/jbc.M211232200; Mery L, 2002, J CELL SCI, V115, P3497; Moiseenkova-Bell VY, 2009, J GEN PHYSIOL, V133, P239, DOI 10.1085/jgp.200810123; Naylor J, 2010, CIRC RES, V106, P1507, DOI 10.1161/CIRCRESAHA.110.219329; Oberwinkler J., 2007, V179, P253; Oberwinkler J, 2005, J BIOL CHEM, V280, P22540, DOI 10.1074/jbc.M503092200; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philipp S, 2000, J BIOL CHEM, V275, P23965, DOI 10.1074/jbc.M003408200; Philipp S, 2003, J BIOL CHEM, V278, P26629, DOI 10.1074/jbc.M304044200; Po SS, 2001, AM J PHYSIOL-HEART C, V281, pH2518, DOI 10.1152/ajpheart.2001.281.6.H2518; Schroeter A, 2010, J MOL CELL CARDIOL, V49, P16, DOI 10.1016/j.yjmcc.2010.04.004; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Tseng CN, 2003, J BIOL CHEM, V278, P17236, DOI 10.1074/jbc.M300282200; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Wagner TFJ, 2010, PFLUG ARCH EUR J PHY, V460, P755, DOI 10.1007/s00424-010-0838-9; Wagner TFJ, 2008, NAT CELL BIOL, V10, P1421, DOI 10.1038/ncb1801; Wang CB, 2004, J BIOL CHEM, V279, P37423, DOI 10.1074/jbc.M407205200; Warnat J, 1999, J PHYSIOL-LONDON, V518, P631, DOI 10.1111/j.1469-7793.1999.0631p.x; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Xu XZS, 2001, P NATL ACAD SCI USA, V98, P10692, DOI 10.1073/pnas.191360198	33	49	49	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36663	36672		10.1074/jbc.M112.396663	http://dx.doi.org/10.1074/jbc.M112.396663			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22961981	Green Published, hybrid			2022-12-28	WOS:000310588500004
J	Brambillasca, S; Altkrueger, A; Colombo, SF; Friederich, A; Eickelmann, P; Mark, M; Borgese, N; Solimena, M				Brambillasca, Silvia; Altkrueger, Anke; Colombo, Sara Francesca; Friederich, Anne; Eickelmann, Peter; Mark, Michael; Borgese, Nica; Solimena, Michele			CDK5 Regulatory Subunit-associated Protein 1-Like 1 (CDKAL1) Is a Tail-anchored Protein in the Endoplasmic Reticulum (ER) of Insulinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; MEMBRANE-PROTEINS; GENE-EXPRESSION; SECRETION; INSERTION; ICA512; IDENTIFICATION; BIOSYNTHESIS; EXOCYTOSIS; PSORIASIS	Genome-wide association studies have led to the identification of numerous susceptibility genes for type 2 diabetes. Among them is Cdkal1, which is associated with reduced beta-cell function and insulin release. Recently, CDKAL1has been shown to be a methylthiotransferase that modifies tRNA(Lys) to enhance translational fidelity of transcripts, including the one encoding proinsulin. Here, we report that out of several CDKAL1 isoforms deposited in public databases, only isoform 1, which migrates as a 61-kDa protein by SDS-PAGE, is expressed in human islets and pancreatic insulinoma INS-1 and MIN6 cells. We show that CDKAL1 is a novel member of the tail-anchored protein family and exploits the TCR40/Get3-assisted pathway for insertion of its C-terminal transmembrane domain into the endoplasmic reticulum. Using endo-beta-N-acetylglucosaminidase H and peptide: N-glycosidase F sensitivity assays on CDKAL1 constructs carrying an N-glycosylation site within the luminal domain, we further established that CDKAL1 is an endoplasmic reticulum-resident protein. Moreover, we observed that silencingCDKAL1in INS-1 cells reduces the expression of secretory granule proteins prochromogranin A and proICA512/ICA512-TMF, in addition to proinsulin and insulin. This correlated with reduced glucose-stimulated insulin secretion. Taken together, our findings provide new insight into the role of CDKAL1 in insulin-producing cells and help to understand its involvement in the pathogenesis of diabetes.	[Brambillasca, Silvia; Altkrueger, Anke; Friederich, Anne; Solimena, Michele] Tech Univ Dresden, Uniklinikum Carl Gustav Carus, Paul Langerhans Inst Dresden, D-01307 Dresden, Germany; [Colombo, Sara Francesca; Borgese, Nica] Univ Milan, CNR, Inst Neurosci, I-20129 Milan, Italy; [Colombo, Sara Francesca; Borgese, Nica] Univ Milan, Biometra Dept, I-20129 Milan, Italy; [Eickelmann, Peter; Mark, Michael] Boehringer Ingelheim Pharma GmbH & Co KG, Dept CardioMetab Dis Res, D-88397 Biberach, Germany; [Borgese, Nica] Univ Catanzaro Magna Graecia, Dept Hlth Sci, I-88100 Catanzaro, Italy; [Solimena, Michele] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Technische Universitat Dresden; Consiglio Nazionale delle Ricerche (CNR); University of Milan; University of Milan; Boehringer Ingelheim; Magna Graecia University of Catanzaro; Max Planck Society	Solimena, M (corresponding author), Tech Univ Dresden, Uniklinikum Carl Gustav Carus, Paul Langerhans Inst Dresden, Fetscherstr 74, D-01307 Dresden, Germany.	michele.solimena@tu-dresden.de	Borgese, Nica/GWZ-8895-2022; Solimena, Michele/GVS-5990-2022; Solimena, Michele/E-1275-2011	Borgese, Nica/0000-0002-7537-3974; COLOMBO, SARA FRANCESCA/0000-0001-9714-3961	German Ministry for Education and Research; Boehringer Ingelheim; Italian Association for Cancer Research [IG9040]; Dresden University of Technology Medical School	German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Boehringer Ingelheim(Boehringer Ingelheim); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Dresden University of Technology Medical School	This work was supported in part by funds from the German Ministry for Education and Research to the German Centre for Diabetes Research, a research grant from Boehringer Ingelheim (to M. S.), and by Italian Association for Cancer Research Grant IG9040 (to the N. B. laboratory).; Recipient of a MedDrive grant from the Dresden University of Technology Medical School.	Abell BM, 2003, J BIOL CHEM, V278, P5669, DOI 10.1074/jbc.M209968200; ADAMUS G, 1991, J NEUROIMMUNOL, V34, P89, DOI 10.1016/0165-5728(91)90118-Q; Arragain S, 2010, J BIOL CHEM, V285, P28425, DOI 10.1074/jbc.M110.106831; BAILYES EM, 1991, ENZYME, V45, P301, DOI 10.1159/000468903; Bonnefond A, 2010, TRENDS MOL MED, V16, P407, DOI 10.1016/j.molmed.2010.06.004; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; Brambillasca S, 2005, EMBO J, V24, P2533, DOI 10.1038/sj.emboj.7600730; Ching YP, 2002, J BIOL CHEM, V277, P15237, DOI 10.1074/jbc.C200032200; Colombo SF, 2009, J CELL SCI, V122, P2383, DOI 10.1242/jcs.049460; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Groenewoud MJ, 2008, DIABETOLOGIA, V51, P1659, DOI 10.1007/s00125-008-1083-z; Gustilo EM, 2008, CURR OPIN MICROBIOL, V11, P134, DOI 10.1016/j.mib.2008.02.003; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Hegde RS, 1996, CELL, V85, P217, DOI 10.1016/S0092-8674(00)81098-3; Hermel JM, 1999, EUR J NEUROSCI, V11, P2609, DOI 10.1046/j.1460-9568.1999.00677.x; Kao G, 2007, CELL, V128, P577, DOI 10.1016/j.cell.2006.12.031; Kirchhoff K, 2008, DIABETOLOGIA, V51, P597, DOI 10.1007/s00125-008-0926-y; Lang S, 2012, J CELL SCI, V125, P1958, DOI 10.1242/jcs.096727; Li YH, 2009, J INVEST DERMATOL, V129, P629, DOI 10.1038/jid.2008.297; Lilja L, 2004, J BIOL CHEM, V279, P29534, DOI 10.1074/jbc.M312711200; Lilja L, 2001, J BIOL CHEM, V276, P34199, DOI 10.1074/jbc.M103776200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ohara-Imaizumi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015553; Ort T, 2001, EMBO J, V20, P4013, DOI 10.1093/emboj/20.15.4013; Pedrazzini E, 2000, J CELL BIOL, V148, P899, DOI 10.1083/jcb.148.5.899; Quaranta M, 2009, GENES IMMUN, V10, P654, DOI 10.1038/gene.2009.51; Ronchi P, 2008, J CELL BIOL, V181, P105, DOI 10.1083/jcb.200710093; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schubert S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012929; SCHUIT FC, 1988, P NATL ACAD SCI USA, V85, P3865, DOI 10.1073/pnas.85.11.3865; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Steiner DF, 1996, DIABETES METAB, V22, P94; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Trajkovski M, 2004, J CELL BIOL, V167, P1063, DOI 10.1083/jcb.200408172; Trajkovski M, 2008, J BIOL CHEM, V283, P33719, DOI 10.1074/jbc.M804928200; Varadi A, 2006, DIABETOLOGIA, V49, P1567, DOI 10.1007/s00125-006-0257-9; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wei FY, 2011, J CLIN INVEST, V121, P3598, DOI 10.1172/JCI58056; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; Wolf N, 2008, J MED GENET, V45, P114, DOI 10.1136/jmg.2007.053595; YU Y, 1990, J CELL BIOL, V111, P1335, DOI 10.1083/jcb.111.4.1335; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745	44	26	28	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41808	41819		10.1074/jbc.M112.376558	http://dx.doi.org/10.1074/jbc.M112.376558			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23048041	hybrid, Green Published			2022-12-28	WOS:000312103000022
J	Forteza, RM; Casalino-Matsuda, SM; Falcon, NS; Gattas, MV; Monzon, ME				Forteza, Rosanna Malbran; Casalino-Matsuda, S. Marina; Falcon, Nieves S.; Gattas, Monica Valencia; Monzon, Maria E.			Hyaluronan and Layilin Mediate Loss of Airway Epithelial Barrier Function Induced by Cigarette Smoke by Decreasing E-cadherin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTOR ACTIVATION; ALPHA-TRYPSIN INHIBITOR; GROWTH-FACTOR; SIDESTREAM SMOKE; GENE-EXPRESSION; TIGHT JUNCTIONS; TUMOR INVASION; CD44 ISOFORMS; TOBACCO-SMOKE; PERMEABILITY	Cigarette smoke (CigS) exposure is associated with increased bronchial epithelial permeability and impaired barrier function. Primary cultures of normal human bronchial epithelial cells exposed to CigS exhibit decreased E-cadherin expression and reduced transepithelial electrical resistance. These effects were mediated by hyaluronan (HA) because inhibition of its synthesis with 4-methylumbelliferone prevented these effects, and exposure to HA fragments of <70 kDa mimicked these effects. We show that the HA receptor layilin is expressed apically in human airway epithelium and that cells infected with lentivirus expressing layilin siRNAs were protected against increased permeability triggered by both CigS and HA. We identified RhoA/Rho-associated protein kinase (ROCK) as the signaling effectors downstream layilin. We conclude that HA fragments generated by CigS bind to layilin and signal through Rho/ROCK to inhibit the E-cadherin gene and protein expression, leading to a loss of epithelial cell-cell contact. These studies suggest that HA functions as a master switch protecting or disrupting the epithelial barrier in its high versus low molecular weight form and that its depolymerization is a first and necessary step triggering the inflammatory response to CigS.	[Forteza, Rosanna Malbran; Falcon, Nieves S.; Monzon, Maria E.] Univ Miami, Miller Sch Med, Div Pulm Crit Care Sleep & Allergy Med, Miami, FL 33136 USA; [Gattas, Monica Valencia] Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA; [Casalino-Matsuda, S. Marina] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA	University of Miami; University of Miami; Northwestern University; Feinberg School of Medicine	Monzon, ME (corresponding author), Univ Miami, Miller Sch Med, Div Pulm Crit Care Sleep & Allergy Med, 1600 NW 10th Ave, Miami, FL 33136 USA.	mmonzonmedina@med.miami.edu	Matsuda, Marina/AAH-2959-2019	Matsuda, Marina/0000-0002-7566-4560	National Institutes of Health [HL073156, HL08992]; Flight Attendant Medical Research Institute; James and Esther King Foundation [JEK12292, JEK 07KN-02 12324 1]; American Heart Association [635093N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute; James and Esther King Foundation; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL073156 and HL08992. This work was also supported by grants from the Flight Attendant Medical Research Institute (to M. E. M.), Bridge Award JEK12292 from the James and Esther King Foundation, a Clinical Innovator Award from Flight Attendant Medical Research Institute (to R. M. F.), Scientist Development Grant 635093N from the American Heart Association, and James and Esther King Foundation Grant JEK 07KN-02 12324 1 (to S. M. C. M.).	Aggarwal AN, 2004, INDIAN J MED RES, V119, P18; ANDERSON JM, 1995, AM J PHYSIOL-GASTR L, V269, pG467, DOI 10.1152/ajpgi.1995.269.4.G467; Aufderheide M, 2008, MUTAT RES-GEN TOX EN, V656, P82, DOI 10.1016/j.mrgentox.2008.07.008; Bernacki SH, 1999, AM J RESP CELL MOL, V20, P595, DOI 10.1165/ajrcmb.20.4.3442; Bharadwaj AG, 2011, EXP CELL RES, V317, P1214, DOI 10.1016/j.yexcr.2011.01.026; Bono P, 2005, EXP CELL RES, V308, P177, DOI 10.1016/j.yexcr.2005.04.017; Bono P, 2001, MOL BIOL CELL, V12, P891, DOI 10.1091/mbc.12.4.891; Borowsky ML, 1998, J CELL BIOL, V143, P429, DOI 10.1083/jcb.143.2.429; Bracke KR, 2010, AM J RESP CELL MOL, V42, P753, DOI 10.1165/rcmb.2008-0424OC; Cantor Jerome O., 2006, Inflammation & Allergy Drug Targets, V5, P257, DOI 10.2174/187152806779010936; Casalino-Matsuda SM, 2009, AM J RESP CELL MOL, V40, P277, DOI 10.1165/rcmb.2008-0073OC; Casalino-Matsuda SM, 2006, AM J RESP CELL MOL, V34, P581, DOI 10.1165/rcmb.2005-0386OC; Casalino-Matsuda SM, 2004, J BIOL CHEM, V279, P21606, DOI 10.1074/jbc.M309950200; Cereijido M, 1998, ANNU REV PHYSIOL, V60, P161, DOI 10.1146/annurev.physiol.60.1.161; Cereijido M., 2002, CELL CELL INTERACTIO, P71; Chen ZT, 2008, BIOTECHNOL APPL BIOC, V50, P89, DOI 10.1042/BA20070138; Cywes C, 2001, NATURE, V414, P648, DOI 10.1038/414648a; Day A. J., 2001, GLYCOFORUM HYALURONA; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; Forteza R, 2001, FASEB J, V15, P2179, DOI 10.1096/fj.01-0036com; Forteza R, 1999, AM J RESP CELL MOL, V21, P666, DOI 10.1165/ajrcmb.21.6.3651; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Garantziotis S, 2008, AM J RESP CRIT CARE, V178, P939, DOI 10.1164/rccm.200803-386OC; Garantziotis S, 2009, J BIOL CHEM, V284, P11309, DOI 10.1074/jbc.M802400200; Hogg JC, 2009, ANNU REV PATHOL-MECH, V4, P435, DOI 10.1146/annurev.pathol.4.110807.092145; Holgate ST, 2002, MOL BIOTECHNOL, V22, P179, DOI 10.1385/MB:22:2:179; Hopkins AM, 2003, J CELL SCI, V116, P725, DOI 10.1242/jcs.00300; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; JEFFERY PK, 1992, RESPIRATION, V59, P13; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jindal SK, 2004, INDIAN J MED RES, V120, P443; KASPER M, 1995, AM J RESP CELL MOL, V13, P648, DOI 10.1165/ajrcmb.13.6.7576702; KENNEDY SM, 1984, AM REV RESPIR DIS, V129, P143; KJELLMAN NIM, 1981, LANCET, V1, P993; KNIGHT DA, 1994, CLIN EXP ALLERGY, V24, P698, DOI 10.1111/j.1365-2222.1994.tb00980.x; Kuwabara H, 2011, PATHOL INT, V61, P262, DOI 10.1111/j.1440-1827.2011.02660.x; Lackie PM, 1997, AM J RESP CELL MOL, V16, P14, DOI 10.1165/ajrcmb.16.1.8998074; Lauer ME, 2009, J BIOL CHEM, V284, P5313, DOI 10.1074/jbc.M807979200; LEE HG, 1994, ANAL BIOCHEM, V219, P278, DOI 10.1006/abio.1994.1267; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madara JL, 1998, ANNU REV PHYSIOL, V60, P143, DOI 10.1146/annurev.physiol.60.1.143; Manzanares D, 2007, AM J RESP CELL MOL, V37, P160, DOI 10.1165/rcmb.2006-0413OC; MASON RJ, 1985, AM REV RESPIR DIS, V132, P1133; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Maytin EV, 2004, AM J PATHOL, V165, P1331, DOI 10.1016/S0002-9440(10)63391-3; MCDEVITT CA, 1989, LUNG, V167, P237, DOI 10.1007/BF02714952; Miyoshi J, 2008, BBA-BIOMEMBRANES, V1778, P670, DOI 10.1016/j.bbamem.2007.12.014; Monzon ME, 2010, J BIOL CHEM, V285, P26126, DOI 10.1074/jbc.M110.135194; Monzon ME, 2008, AM J RESP CELL MOL, V39, P289, DOI 10.1165/rcmb.2007-0361OC; Monzon ME, 2006, AM J RESP CELL MOL, V34, P135, DOI 10.1165/rcmb.2005-0256OC; Morrison D, 1999, AM J RESP CRIT CARE, V159, P473, DOI 10.1164/ajrccm.159.2.9804080; Murai T, 2004, J BIOL CHEM, V279, P4541, DOI 10.1074/jbc.M307356200; NISHIKAWA M, 1990, AM REV RESPIR DIS, V142, P177, DOI 10.1164/ajrccm/142.1.177; Nlend MC, 2002, AM J RESP CELL MOL, V27, P436, DOI 10.1165/rcmb.2002-0012OC; Olivera D, 2010, EXP TOXICOL PATHOL, V62, P133, DOI 10.1016/j.etp.2009.03.002; Olivera DS, 2007, INHAL TOXICOL, V19, P13, DOI 10.1080/08958370600985768; Peroni DG, 1996, EUR RESPIR J, V9, P2236, DOI 10.1183/09031936.96.09112236; Petecchia L, 2009, CHEST, V135, P1502, DOI 10.1378/chest.08-1780; Pienimaki JP, 2001, J BIOL CHEM, V276, P20428, DOI 10.1074/jbc.M007601200; Prabhakar V, 2005, BIOCHEM J, V386, P103, DOI 10.1042/BJ20041222; PRYOR WA, 1993, ANN NY ACAD SCI, V686, P12, DOI 10.1111/j.1749-6632.1993.tb39148.x; Rahman I, 1996, FREE RADICAL BIO MED, V21, P669, DOI 10.1016/0891-5849(96)00155-4; Reid L M, 1989, Symp Soc Exp Biol, V43, P201; Rodgers LS, 2006, CIRC RES, V99, P583, DOI 10.1161/01.RES.0000242561.95978.43; Rusznak C, 1999, AM J RESP CELL MOL, V20, P1238, DOI 10.1165/ajrcmb.20.6.3226; Rusznak C, 2000, AM J RESP CELL MOL, V23, P530, DOI 10.1165/ajrcmb.23.4.3959; Samarin SN, 2007, MOL BIOL CELL, V18, P3429, DOI 10.1091/mbc.E07-04-0315; Schick S, 2005, TOB CONTROL, V14, P396, DOI 10.1136/tc.2005.011288; SCHMEKEL B, 1995, CHEST, V108, P62, DOI 10.1378/chest.108.1.62; Schmid A, 2010, J BIOL CHEM, V285, P29998, DOI 10.1074/jbc.M110.113621; Shaykhiev R, 2011, CELL MOL LIFE SCI, V68, P877, DOI 10.1007/s00018-010-0500-x; Singleton PA, 2006, J BIOL CHEM, V281, P34381, DOI 10.1074/jbc.M603680200; Skold CM, 1996, RESP MED, V90, P523, DOI 10.1016/S0954-6111(96)90144-4; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Sugahara KN, 2003, J BIOL CHEM, V278, P32259, DOI 10.1074/jbc.M300347200; Takahashi Y, 2005, J BIOL CHEM, V280, P24195, DOI 10.1074/jbc.M411913200; TENGBLAD A, 1979, BIOCHIM BIOPHYS ACTA, V578, P281, DOI 10.1016/0005-2795(79)90158-2; THURLBEC.WM, 1967, AM REV RESPIR DIS, V95, P752; Walker D C, 1988, Prog Clin Biol Res, V263, P25; Wang MH, 2003, CARCINOGENESIS, V24, P1291, DOI 10.1093/carcin/bgg089; Wimmel A, 1997, LUNG CANCER, V16, P151, DOI 10.1016/S0169-5002(96)00625-3; Wimmel A, 2001, CANCER, V92, P1231, DOI 10.1002/1097-0142(20010901)92:5<1231::AID-CNCR1442>3.0.CO;2-Z; Xu Y, 2003, J BIOL CHEM, V278, P8661, DOI 10.1074/jbc.M208181200; Yamazaki Kenji, 2003, Pathophysiology, V9, P215, DOI 10.1016/S0928-4680(03)00024-5; Yates DH, 1996, AUST NZ J MED, V26, P513, DOI 10.1111/j.1445-5994.1996.tb00597.x; Zhu L, 2010, INT ARCH ALLERGY IMM, V153, P223, DOI 10.1159/000314362; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	87	56	58	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42288	42298		10.1074/jbc.M112.387795	http://dx.doi.org/10.1074/jbc.M112.387795			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23048036	hybrid, Green Published			2022-12-28	WOS:000312103000064
J	Wang, GY; Duan, DD				Wang, Guangyu; Duan, Dayue Darrel			Regulation of Activation and Processing of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) by a Complex Electrostatic Interaction between the Regulatory Domain and Cytoplasmic Loop 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							R-DOMAIN; PHOSPHORYLATION SITES; NUCLEOTIDE-BINDING; CHLORIDE CHANNEL; PROTEIN; REGION	NEG2, a short C-terminal segment (817-838) of the unique regulatory (R) domain of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel, has been reported to regulate CFTR gating in response to cAMP-dependent R domain phosphorylation. The underlying mechanism, however, is unclear. Here, Lys-946 of cytoplasmic loop 3 (CL3) is proposed as counter-ion of Asp-835, Asp-836, or Glu-838 of NEG2 to prevent the channel activation by PKA. Arg-764 or Arg-766 of the Ser-768 phosphorylation site of the R domain is proposed to promote the channel activation possibly by weakening the putative CL3-NEG2 electrostatic attraction. First, not only D835A, D836A, and E838A but also K946A reduced the PKA-dependent CFTR activation. Second, both K946D and D835R/D836R/E838R mutants were activated by ATP and curcumin to a different extent. Third, R764A and R766A mutants enhanced the PKA-dependent activation. However, it is very exciting that D835R/D836R/E838R and K946D/H950D and H950R exhibited normal channel processing and activity whereas D835R/D836R/E838R/K946D/H950D was fractionally misprocessed and silent in response to forskolin. Further, D836R and E838R played a critical role in the asymmetric electrostatic regulation of CFTR processing, and Ser-768 phosphorylation may not be involved. Thus, a complex interfacial interaction among CL3, NEG2, and the Ser-768 phosphorylation site may be responsible for the asymmetric electrostatic regulation of CFTR activation and processing.	[Wang, Guangyu; Duan, Dayue Darrel] Univ Nevada, Sch Med, Dept Pharmacol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Wang, GY (corresponding author), Univ Nevada, Sch Med, Dept Pharmacol, 1664 N Virginia St,MS318,Manville Med Bldg,Rm 19, Reno, NV 89557 USA.	wangg@medicine.nevada.edu		Wang, Guangyu/0000-0002-5581-6926	National Institutes of Health [R21 HL 106256]; American Heart Association (AHA) [10SDG4120011]; AHA Western State Affiliate [11GRNT7610161]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL106256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); AHA Western State Affiliate; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 HL 106256 (to D. D. D). This work was also supported by American Heart Association (AHA) Grant 10SDG4120011 (to G. W.) and AHA Western State Affiliate Grant-in-aid 11GRNT7610161 (to D. D. D.).	Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Clain J, 2001, J BIOL CHEM, V276, P9045, DOI 10.1074/jbc.M008979200; Csanady L, 2005, J GEN PHYSIOL, V125, P171, DOI 10.1085/jgp.200409076; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Drevillon L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018334; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; El Hiani Y, 2012, BIOCHEMISTRY-US, V51, P3971, DOI 10.1021/bi300065z; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; Kongsuphol P, 2009, J BIOL CHEM, V284, P5645, DOI 10.1074/jbc.M806780200; Lewarchik CM, 2008, J BIOL CHEM, V283, P28401, DOI 10.1074/jbc.M800516200; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Ostedgaard LS, 2000, P NATL ACAD SCI USA, V97, P5657, DOI 10.1073/pnas.100588797; Ostedgaard LS, 2001, J BIOL CHEM, V276, P7689, DOI 10.1074/jbc.R100001200; RICH DP, 1991, SCIENCE, V253, P205, DOI 10.1126/science.1712985; RIORDAN JR, 1989, SCIENCE, V245, P1066; Seibert FS, 1996, J BIOL CHEM, V271, P27493, DOI 10.1074/jbc.271.44.27493; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Vais H, 2004, AM J PHYSIOL-CELL PH, V287, pC737, DOI 10.1152/ajpcell.00504.2003; Wang GY, 2010, J BIOL CHEM, V285, P40438, DOI 10.1074/jbc.M110.161497; Wang GY, 2011, J BIOL CHEM, V286, P2171, DOI 10.1074/jbc.M110.145540; Wang W, 2005, J BIOL CHEM, V280, P23622, DOI 10.1074/jbc.M503118200; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; Wang W, 2010, P NATL ACAD SCI USA, V107, P3888, DOI 10.1073/pnas.0913001107; Wilkinson DJ, 1997, AM J PHYSIOL-LUNG C, V273, pL127, DOI 10.1152/ajplung.1997.273.1.L127; Winter MC, 1997, NATURE, V389, P294, DOI 10.1038/38514; Xie JX, 2002, J BIOL CHEM, V277, P23019, DOI 10.1074/jbc.M201661200; Zhang LA, 2011, BBA-BIOMEMBRANES, V1808, P399, DOI 10.1016/j.bbamem.2010.08.012; Zhang L, 2009, J STRUCT BIOL, V167, P242, DOI 10.1016/j.jsb.2009.06.004	33	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40484	40492		10.1074/jbc.M112.360214	http://dx.doi.org/10.1074/jbc.M112.360214			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23060444	Green Published, hybrid			2022-12-28	WOS:000311448800039
J	Marin, M; Thallmair, V; Ott, T				Marin, Macarena; Thallmair, Veronika; Ott, Thomas			The Intrinsically Disordered N-terminal Region of AtREM1.3 Remorin Protein Mediates Protein-Protein Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE ANALYSES; NATIVELY UNFOLDED PROTEINS; VIRUS-X MOVEMENT; IMPORTIN-ALPHA; MEMBRANE RAFTS; BINDING-SITES; I-TASSER; ARABIDOPSIS; PREDICTION; DOMAIN	The longstanding structure-function paradigm, which states that a protein only serves a biological function in a structured state, had to be substantially revised with the description of intrinsic disorder in proteins. Intrinsically disordered regions that undergo a stimulus-dependent disorder-to-order transition are common to a large number of signaling proteins. However, little is known about the functionality of intrinsically disordered regions in plant proteins. Here we investigated intrinsic disorder in a plant-specific remorin protein that has been described as a signaling component in plant-microbe interactions. Using bioinformatic, biochemical, and biophysical approaches, we characterized the highly abundant remorin AtREM1.3, showing that its N-terminal region is intrinsically disordered. Although only the AtREM1.3 C-terminal domain is essential for stable homo-oligomerization, the N-terminal region facilitates this interaction. Furthermore, we confirmed the stable interaction between AtREM1.3 and four isoforms of the importin alpha protein family in a yeast two-hybrid system and by an in planta bimolecular fluorescent complementation assay. Phosphorylation of Ser-66 in the intrinsically disordered N-terminal region decreases the interaction strength with the importin alpha proteins. Hence, the N-terminal region may constitute a regulatory domain, stabilizing these interactions.	[Marin, Macarena; Thallmair, Veronika; Ott, Thomas] Univ Munich, Inst Genet, D-82152 Martinsried, Germany	University of Munich	Marin, M (corresponding author), Univ Munich, Inst Genet, Grosshaderner Str 2-4, D-82152 Martinsried, Germany.	macarena.marin@bio.lmu.de; Thomas.Ott@biologie.uni-muenchen.de	Ott, Thomas/G-7056-2011; Marin, Macarena/H-8742-2013; Ott, Thomas/H-8192-2013	Marin, Macarena/0000-0002-6966-2446; Ott, Thomas/0000-0002-4494-9811	Collaborative Research Center (Sonder-forschungsbereich) [SFB924]; Emmy Noether Program [OT423/2-1]; Deutsche Forschungsgemeinschaft	Collaborative Research Center (Sonder-forschungsbereich)(German Research Foundation (DFG)); Emmy Noether Program(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Collaborative Research Center (Sonder-forschungsbereich) SFB924 and Emmy Noether Program Grant OT423/2-1 funded by the Deutsche Forschungsgemeinschaft.	Askjaer P, 2002, MOL BIOL CELL, V13, P4355, DOI 10.1091/mbc.E02-06-0346; Bariola PA, 2004, PLANT MOL BIOL, V55, P579, DOI 10.1007/s11103-004-1520-4; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Bhattacharjee S, 2008, PLANT CELL, V20, P2661, DOI 10.1105/tpc.108.060467; Bradford JR, 2005, BIOINFORMATICS, V21, P1487, DOI 10.1093/bioinformatics/bti242; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Bustos DM, 2012, MOL BIOSYST, V8, P178, DOI 10.1039/c1mb05216k; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Diaz-Moreno I, 2009, NAT STRUCT MOL BIOL, V16, P238, DOI 10.1038/nsmb.1558; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Falk S, 2010, J BIOL CHEM, V285, P5954, DOI 10.1074/jbc.M109.084996; FARMER EE, 1989, P NATL ACAD SCI USA, V86, P1539, DOI 10.1073/pnas.86.5.1539; Fu XD, 2002, PLANT CELL, V14, P3191, DOI 10.1105/tpc.006197; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Hussain A, 2005, PLANT J, V44, P88, DOI 10.1111/j.1365-313X.2005.02512.x; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jarsch IK, 2011, MOL PLANT MICROBE IN, V24, P7, DOI 10.1094/MPMI-07-10-0166; Kjaersgaard T, 2011, J BIOL CHEM, V286, P35418, DOI 10.1074/jbc.M111.247221; Kovacs D, 2008, PLANT PHYSIOL, V147, P381, DOI 10.1104/pp.108.118208; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lefebvre B, 2010, P NATL ACAD SCI USA, V107, P2343, DOI 10.1073/pnas.0913320107; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Liang XY, 2008, ACCOUNTS CHEM RES, V41, P991, DOI 10.1021/ar700148u; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; LOEB JDJ, 1995, P NATL ACAD SCI USA, V92, P7647, DOI 10.1073/pnas.92.17.7647; Marin M, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00086; Merkle T, 2011, PLANT CELL REP, V30, P153, DOI 10.1007/s00299-010-0928-3; MILLER JH, 1974, EXPT MOL GENETICS, P352; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Morbitzer R, 2011, NUCLEIC ACIDS RES, V39, P5790, DOI 10.1093/nar/gkr151; Mouillon JM, 2006, PLANT PHYSIOL, V141, P638, DOI 10.1104/pp.106.079848; Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Palma K, 2005, CURR BIOL, V15, P1129, DOI 10.1016/j.cub.2005.05.022; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Perraki A, 2012, PLANT PHYSIOL, V160, P624, DOI 10.1104/pp.112.200519; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; R Core Team, 2012, R LANG ENV STAT COMP; Raffaele S, 2007, PLANT PHYSIOL, V145, P593, DOI 10.1104/pp.107.108639; Raffaele S, 2009, PLANT CELL, V21, P1541, DOI 10.1105/tpc.108.064279; Reymond P, 1996, PLANT CELL, V8, P2265, DOI 10.1105/tpc.8.12.2265; REYMOND P, 1995, P NATL ACAD SCI USA, V92, P4145, DOI 10.1073/pnas.92.10.4145; Romero, 1997, GENOME INFORM SER WO, V8, P110; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Sun XL, 2010, J BIOL CHEM, V285, P11557, DOI 10.1074/jbc.M109.027011; Toth K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030817; Uversky VN, 2008, CURR ALZHEIMER RES, V5, P260, DOI 10.2174/156720508784533312; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Vacic V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-211; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; YANO R, 1994, P NATL ACAD SCI USA, V91, P6880, DOI 10.1073/pnas.91.15.6880; Yoon MK, 2006, PROTEINS, V65, P856, DOI 10.1002/prot.21089; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	61	44	44	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.414292	http://dx.doi.org/10.1074/jbc.M112.414292			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23027878	Green Published, hybrid			2022-12-28	WOS:000311233800065
J	Pedersen, HL; Fangel, JU; McCleary, B; Ruzanski, C; Rydahl, MG; Ralet, MC; Farkas, V; von Schantz, L; Marcus, SE; Andersen, MCF; Field, R; Ohlin, M; Knox, JP; Clausen, MH; Willats, WGT				Pedersen, Henriette L.; Fangel, Jonatan U.; McCleary, Barry; Ruzanski, Christian; Rydahl, Maja G.; Ralet, Marie-Christine; Farkas, Vladimir; von Schantz, Laura; Marcus, Susan E.; Andersen, Mathias C. F.; Field, Rob; Ohlin, Mats; Knox, J. Paul; Clausen, Mads H.; Willats, William G. T.			Versatile High Resolution Oligosaccharide Microarrays for Plant Glycobiology and Cell Wall Research	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; MONOCLONAL-ANTIBODY; PROTEIN; SPECIFICITY; POLYSACCHARIDES; METABOLISM; EXPRESSION; DIVERSITY; POLYMERS; LOCATION	Microarrays are powerful tools for high throughput analysis, and hundreds or thousands of molecular interactions can be assessed simultaneously using very small amounts of analytes. Nucleotide microarrays are well established in plant research, but carbohydrate microarrays are much less established, and one reason for this is a lack of suitable glycans with which to populate arrays. Polysaccharide microarrays are relatively easy to produce because of the ease of immobilizing large polymers noncovalently onto a variety of microarray surfaces, but they lack analytical resolution because polysaccharides often contain multiple distinct carbohydrate substructures. Microarrays of defined oligosaccharides potentially overcome this problem but are harder to produce because oligosaccharides usually require coupling prior to immobilization. We have assembled a library of well characterized plant oligosaccharides produced either by partial hydrolysis from polysaccharides or by de novo chemical synthesis. Once coupled to protein, these neoglycoconjugates are versatile reagents that can be printed as microarrays onto a variety of slide types and membranes. We show that these microarrays are suitable for the high throughput characterization of the recognition capabilities of monoclonal antibodies, carbohydrate-binding modules, and other oligosaccharide-binding proteins of biological significance and also that they have potential for the characterization of carbohydrate-active enzymes.	[Pedersen, Henriette L.; Fangel, Jonatan U.; Rydahl, Maja G.; Willats, William G. T.] Univ Copenhagen, Dept Plant Biol & Biotechnol, DK-1871 Frederiksberg, Denmark; [McCleary, Barry] Megazyme Int Ireland Ltd, Bray, County Wicklow, Ireland; [Ruzanski, Christian; Field, Rob] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; [Ralet, Marie-Christine] INRA, F-44316 Nantes 03, France; [Farkas, Vladimir] Slovak Acad Sci, Ctr Glycobiol, Inst Chem, SK-84538 Bratislava, Slovakia; [von Schantz, Laura; Ohlin, Mats] Lund Univ, Dept Immunotechnol, S-22184 Lund, Sweden; [Marcus, Susan E.; Knox, J. Paul] Univ Leeds, Fac Biol Sci, Ctr Plant Sci, Leeds LS2 9JT, W Yorkshire, England; [Andersen, Mathias C. F.; Clausen, Mads H.] Tech Univ Denmark, Ctr Nanomed & Theranost, DK-2800 Kongens Lyngby, Denmark; [Andersen, Mathias C. F.; Clausen, Mads H.] Tech Univ Denmark, Dept Chem, DK-2800 Kongens Lyngby, Denmark	University of Copenhagen; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; INRAE; Slovak Academy of Sciences; Lund University; University of Leeds; Technical University of Denmark; Technical University of Denmark	Willats, WGT (corresponding author), Univ Copenhagen, Dept Plant Biol & Biotechnol, DK-1871 Frederiksberg, Denmark.	willats@life.ku.dk	Clausen, Mads H/A-9656-2015; Ohlin, Mats/A-7307-2010; Rydahl, Maja G/F-7458-2014; Knox, Paul/H-4577-2012	Clausen, Mads H/0000-0001-9649-1729; Ohlin, Mats/0000-0002-5105-1938; Rydahl, Maja G/0000-0002-9388-0873; Knox, Paul/0000-0002-9231-6891; Field, Rob/0000-0001-8574-0275; Willats, William/0000-0003-2064-4025; Farkas, Vladimir/0000-0002-8219-4288; Ralet, Marie-Christine/0000-0002-0292-5272	Danish Research Council; Scientific Grant Agency (VEGA) (Slovakia) [2/0011/09]; Danish Research Council for Strategic Research; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0618] Funding Source: researchfish; BBSRC [BBS/E/J/000C0618] Funding Source: UKRI	Danish Research Council(Det Frie Forskningsrad (DFF)); Scientific Grant Agency (VEGA) (Slovakia)(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)); Danish Research Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Danish Research Council grants (to W. G. T. W.) and in part by Grant 2/0011/09 from the Scientific Grant Agency (VEGA) (Slovakia) (to V. F.). This work was also supported by the Danish Research Council for Strategic Research (to M. C. F. A., M. H. C., and W. G. T. W.).	Abou Hachem M, 2000, BIOCHEM J, V345, P53, DOI 10.1042/0264-6021:3450053; Albersheim P, 2011, PLANT CELL WALLS: FROM CHEMISTRY TO BIOLOGY, P1; Bacic A., 1988, BIOCH PLANTS, P52; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Clausen MH, 2004, PLANTA, V219, P1036, DOI 10.1007/s00425-004-1309-3; Clausen MH, 2003, CHEM-EUR J, V9, P3821, DOI 10.1002/chem.200204636; De Lorenzo G, 2002, CURR OPIN PLANT BIOL, V5, P295, DOI 10.1016/S1369-5266(02)00271-6; Ekins R, 1999, TRENDS BIOTECHNOL, V17, P217, DOI 10.1016/S0167-7799(99)01329-3; Feizi T, 2004, NAT REV MOL CELL BIO, V5, P582, DOI 10.1038/nrm1428; Feizi T, 2003, CURR OPIN STRUC BIOL, V13, P637, DOI 10.1016/j.sbi.2003.09.002; Feizi T, 2000, GLYCOCONJUGATE J, V17, P553, DOI 10.1023/A:1011022509500; Fry SC, 2004, NEW PHYTOL, V161, P641, DOI 10.1111/j.1469-8137.2004.00980.x; Fukui S, 2002, NAT BIOTECHNOL, V20, P1011, DOI 10.1038/nbt735; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Gunnarsson LC, 2007, BIOCHEM J, V406, P209, DOI 10.1042/BJ20070128; Gunnarsson LC, 2006, GLYCOBIOLOGY, V16, P1171, DOI 10.1093/glycob/cwl038; Gunnarsson LC, 2004, PROTEIN ENG DES SEL, V17, P213, DOI 10.1093/protein/gzh026; Johansson R, 2006, J MOL RECOGNIT, V19, P275, DOI 10.1002/jmr.794; Jones L, 1997, PLANT PHYSIOL, V113, P1405, DOI 10.1104/pp.113.4.1405; Klopffleisch K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.66; Knox JP, 2008, CURR OPIN PLANT BIOL, V11, P308, DOI 10.1016/j.pbi.2008.03.001; Knox JP, 1997, INT REV CYTOL, V171, P79; Kosik O, 2010, GLYCOCONJUGATE J, V27, P79, DOI 10.1007/s10719-009-9271-8; Lee KJD, 2011, MOL PLANT, V4, P212, DOI 10.1093/mp/ssq075; Liu Y, 2009, BIOL CHEM, V390, P647, DOI 10.1515/BC.2009.071; Marcus SE, 2010, PLANT J, V64, P191, DOI 10.1111/j.1365-313X.2010.04319.x; Marcus SE, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-60; McCartney L, 2005, J HISTOCHEM CYTOCHEM, V53, P543, DOI 10.1369/jhc.4B6578.2005; McWilliam I, 2011, METHODS MOL BIOL, V785, P345, DOI 10.1007/978-1-61779-286-1_23; MEIKLE PJ, 1991, PLANTA, V185, P1, DOI 10.1007/BF00194507; MEIKLE PJ, 1994, PLANT J, V5, P1, DOI 10.1046/j.1365-313X.1994.5010001.x; Moller I, 2008, GLYCOCONJUGATE J, V25, P37, DOI 10.1007/s10719-007-9059-7; Palma AS, 2010, METHOD ENZYMOL, V478, P265, DOI 10.1016/S0076-6879(10)78013-7; Park S, 2008, CHEM COMMUN, P4389, DOI 10.1039/b806699j; Pattathil S, 2010, PLANT PHYSIOL, V153, P514, DOI 10.1104/pp.109.151985; Pauly M, 2010, CURR OPIN PLANT BIOL, V13, P305, DOI 10.1016/j.pbi.2009.12.009; Pettolino FA, 2001, PLANTA, V214, P235, DOI 10.1007/s004250100606; Ralet MC, 2005, PHYTOCHEMISTRY, V66, P2800, DOI 10.1016/j.phytochem.2005.09.039; ROY R, 1984, CAN J BIOCHEM CELL B, V62, P270, DOI 10.1139/o84-037; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shipp M, 2008, GLYCOCONJUGATE J, V25, P49, DOI 10.1007/s10719-007-9060-1; Smith DF, 2010, METHOD ENZYMOL, V480, P417, DOI 10.1016/S0076-6879(10)80033-3; Sorensen I, 2011, METHODS MOL BIOL, V715, P115, DOI 10.1007/978-1-61779-008-9_8; Sorensen I, 2008, PLANT SIGNAL BEHAV, V3, P743, DOI 10.4161/psb.3.9.6633; Van den Ende W, 2004, TRENDS PLANT SCI, V9, P523, DOI 10.1016/j.tplants.2004.09.008; Verhertbruggen Y, 2009, PLANT J, V59, P413, DOI 10.1111/j.1365-313X.2009.03876.x; von Schantz L, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-92; Wang DN, 2002, NAT BIOTECHNOL, V20, P275, DOI 10.1038/nbt0302-275; Willats WGT, 2006, TRENDS FOOD SCI TECH, V17, P97, DOI 10.1016/j.tifs.2005.10.008; Willats WGT, 2001, PLANT MOL BIOL, V47, P9, DOI 10.1023/A:1010662911148; Willats WGT, 1998, CARBOHYD RES, V308, P149, DOI 10.1016/S0008-6215(98)00070-6; Willats WGT, 2002, PROTEOMICS, V2, P1666, DOI 10.1002/1615-9861(200212)2:12<1666::AID-PROT1666>3.0.CO;2-E; Yates EA, 1996, GLYCOBIOLOGY, V6, P131, DOI 10.1093/glycob/6.2.131; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301	55	174	174	2	83	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.396598	http://dx.doi.org/10.1074/jbc.M112.396598			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	22988248	Green Published, hybrid			2022-12-28	WOS:000311233800015
J	Wang, C; Sun, BG; Zhou, YG; Grubb, A; Gan, L				Wang, Chao; Sun, Binggui; Zhou, Yungui; Grubb, Anders; Gan, Li			Cathepsin B Degrades Amyloid-beta in Mice Expressing Wild-type Human Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL CYSTEINE PROTEINASES; ALZHEIMERS-DISEASE; CYSTATIN-C; A-BETA; TRANSGENIC MICE; MOUSE MODEL; INACTIVATION; DEGRADATION; INHIBITORS; DEFICITS	Accumulation of amyloid-beta (A beta), believed to be a key trigger of Alzheimer disease (AD), could result from impaired clearance mechanisms. Previously, we showed that the cysteine protease cathepsin B (CatB) degrades A beta, most likely by C-terminal truncation, in mice expressing human amyloid precursor protein with familial AD-linked mutations (hAPP(FAD)). In addition, the A beta-degrading activity of CatB is inhibited by its endogenous inhibitor, cystatin C (CysC). Reducing CysC expression markedly lowers A beta levels by enhancing CatB-mediated A beta degradation in hAPP(FAD) mice. However, because a vast majority of AD patients do not carry familial mutations, we investigated how the CysC-CatB axis affects A beta levels in mice expressing wild-type hAPP (hAPP(WT)). Enhancing CatB activity by CysC deletion significantly lowered total A beta and A beta 42 levels in hAPP(WT) mice, whereas CatB deletion increased A beta levels. To determine whether neuron-derived CatB degrades A beta in vivo, we generated transgenic mice overexpressing CatB under the control of a neuron-specific enolase promoter. Enhancing neuronal CatB activity in hAPP(WT) mice significantly lowered A beta 42 levels. The processing of hAPP(WT) was unaffected by increasing or ablating CatB activity. Thus, the CysC-CatB axis affects degradation of A beta 42 derived from hAPP lacking familial mutations. These findings support the notion that enhancing CatB activity could lower A beta, especially A beta 42, in AD patients with or without familial mutations.	[Wang, Chao; Sun, Binggui; Zhou, Yungui; Gan, Li] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Wang, Chao; Sun, Binggui; Gan, Li] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Grubb, Anders] Univ Lund Hosp, Dept Clin Chem, S-22185 Lund, Sweden	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Lund University; Skane University Hospital	Gan, L (corresponding author), Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA.	lgan@gladstone.ucsf.edu	Wang, Chao/A-4626-2016; Sun, Binggui/J-9028-2016	Wang, Chao/0000-0003-0357-4096; Sun, Binggui/0000-0002-0386-6569; Grubb, Anders/0000-0002-0125-3662	National Institutes of Health [R01 AG030207-01A2]; National Center for Research Resources [CO6 RRO18928]; California Health Services; Swedish Research Council Grant [05196]; S. D. Bechtel, Jr. Foundation; NATIONAL INSTITUTE ON AGING [R01AG030207, R01AG036884] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); California Health Services; Swedish Research Council Grant(Swedish Research Council); S. D. Bechtel, Jr. Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AG030207-01A2 (to L. G.) and Grant CO6 RRO18928 from the National Center for Research Resources (a facilities grant to the J. David Gladstone Institutes). This work was also supported by the California Health Services (to L. G.), Swedish Research Council Grant 05196 (to A. G.), the S. D. Bechtel, Jr. Foundation, and Alden W. and Helen T. Clausen.	Authier F, 1999, J BIOL CHEM, V274, P33723, DOI 10.1074/jbc.274.47.33723; BANATI RB, 1993, GLIA, V7, P183, DOI 10.1002/glia.440070208; Butler D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020501; Cataldo AM, 1997, J NEUROSCI, V17, P6142; Cimerman N, 1999, J ENZYM INHIB, V14, P167, DOI 10.3109/14756369909036552; Deng A, 2001, AM J PATHOL, V159, P1061, DOI 10.1016/S0002-9440(10)61781-6; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Golde TE, 2000, BBA-MOL BASIS DIS, V1502, P172, DOI 10.1016/S0925-4439(00)00043-0; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hook VYH, 2009, BIOCHEM BIOPH RES CO, V386, P284, DOI 10.1016/j.bbrc.2009.05.131; Huh CG, 1999, J CLIN PATHOL-MOL PA, V52, P332, DOI 10.1136/mp.52.6.332; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; Miners JS, 2011, J NEUROPATH EXP NEUR, V70, P944, DOI 10.1097/NEN.0b013e3182345e46; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; TAGAWA K, 1992, ANN NY ACAD SCI, V674, P129, DOI 10.1111/j.1749-6632.1992.tb27482.x; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; TSUJINAKA T, 1995, BIOCHEM BIOPH RES CO, V208, P353, DOI 10.1006/bbrc.1995.1345; Turk B, 2002, CURR PHARM DESIGN, V8, P1623, DOI 10.2174/1381612023394124; TURK B, 1995, BIOL CHEM H-S, V376, P225, DOI 10.1515/bchm3.1995.376.4.225; Viswanathan K., 2012, ACS MED CHE IN PRESS; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Yang CN, 2011, NEUROBIOL DIS, V42, P221, DOI 10.1016/j.nbd.2011.01.005; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341	32	71	73	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.371641	http://dx.doi.org/10.1074/jbc.M112.371641			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23024364	Green Published, hybrid			2022-12-28	WOS:000311233800051
J	Hibbert, RG; Sixma, TK				Hibbert, Richard G.; Sixma, Titia K.			Intrinsic Flexibility of Ubiquitin on Proliferating Cell Nuclear Antigen (PCNA) in Translesion Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-ETA; FANCONI-ANEMIA PATHWAY; MONOUBIQUITINATED PCNA; BINDING DOMAINS; E2; DIUBIQUITIN; COMPLEX; DAMAGE; SUMO	Ubiquitin conjugation provides a crucial signaling role in hundreds of cellular pathways; however, a structural understanding of ubiquitinated substrates is lacking. One important substrate is monoubiquitinated PCNA (PCNA-Ub), which signals for recruitment of damage-tolerant polymerases in the translesion synthesis (TLS) pathway of DNA damage avoidance. We use a novel and efficient enzymatic method to produce PCNA-Ub at high yield with a native isopeptide bond and study its Usp1/UAF1-dependent deconjugation. In solution we find that the ubiquitin moiety is flexible relative to the PCNA, with its hydrophobic patch mostly accessible for recruitment of TLS polymerases, which promotes the interaction with polymerase eta. The studies are a prototype for the nature of the ubiquitin modification.	[Hibbert, Richard G.] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Hibbert, RG (corresponding author), Netherlands Canc Inst, Div Biochem, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.hibbert@nki.nl; t.sixma@nki.nl		Sixma, Titia K/0000-0001-6180-0632	European Union RUBICON Network of Excellence; European Research Council advanced grant	European Union RUBICON Network of Excellence; European Research Council advanced grant(European Research Council (ERC))	This work was supported by the European Union RUBICON Network of Excellence and an European Research Council advanced grant (to T. K. S.).	Acharya N, 2010, P NATL ACAD SCI USA, V107, P10401, DOI 10.1073/pnas.1005492107; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bienko M, 2010, MOL CELL, V37, P396, DOI 10.1016/j.molcel.2009.12.039; Bomar MG, 2007, EMBO REP, V8, P247, DOI 10.1038/sj.embor.7400901; Brzovic PS, 2006, CELL CYCLE, V5, P2867, DOI 10.4161/cc.5.24.3592; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Chen JJ, 2010, NAT CHEM BIOL, V6, P270, DOI [10.1038/NCHEMBIO.316, 10.1038/nchembio.316]; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; COOK WJ, 1992, J BIOL CHEM, V267, P16467; Eger S, 2011, CHEMBIOCHEM, V12, P2807, DOI 10.1002/cbic.201100444; El Oualid F, 2010, ANGEW CHEM INT EDIT, V49, P10149, DOI 10.1002/anie.201005995; Faesen AC, 2011, CHEM BIOL, V18, P1550, DOI 10.1016/j.chembiol.2011.10.017; Freudenthal BD, 2010, NAT STRUCT MOL BIOL, V17, P479, DOI 10.1038/nsmb.1776; Garg P, 2005, P NATL ACAD SCI USA, V102, P18361, DOI 10.1073/pnas.0505949102; Haracska L, 2006, P NATL ACAD SCI USA, V103, P6477, DOI 10.1073/pnas.0510924103; Hibbert RG, 2011, P NATL ACAD SCI USA, V108, P5590, DOI 10.1073/pnas.1017516108; Hibbert RG, 2009, DNA REPAIR, V8, P525, DOI 10.1016/j.dnarep.2009.01.014; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Konarev P., 2012, J APPL CRYSTALLOGR, V39, P277; Kontopidis G, 2005, P NATL ACAD SCI USA, V102, P1871, DOI 10.1073/pnas.0406540102; Nishi H, 2011, STRUCTURE, V19, P1807, DOI 10.1016/j.str.2011.09.021; Parker JL, 2007, NUCLEIC ACIDS RES, V35, P881, DOI 10.1093/nar/gkl1102; Plosky BS, 2006, EMBO J, V25, P2847, DOI 10.1038/sj.emboj.7601178; Rudd PM, 1997, CRIT REV BIOCHEM MOL, V32, P1, DOI 10.3109/10409239709085144; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Serniwka SA, 2009, BIOCHEMISTRY-US, V48, P12169, DOI 10.1021/bi901686j; Simpson LJ, 2006, EMBO REP, V7, P927, DOI 10.1038/sj.embor.7400777; Terai K, 2010, MOL CELL, V37, P143, DOI 10.1016/j.molcel.2009.12.018; Tsutakawa SE, 2011, P NATL ACAD SCI USA, V108, P17672, DOI 10.1073/pnas.1110480108; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Yang KL, 2011, GENE DEV, V25, P1847, DOI 10.1101/gad.17020911; Zhang SF, 2008, CELL CYCLE, V7, P3399, DOI 10.4161/cc.7.21.6949; ZIMM BH, 1948, J CHEM PHYS, V16, P1093, DOI 10.1063/1.1746738	36	34	34	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39216	39223		10.1074/jbc.M112.389890	http://dx.doi.org/10.1074/jbc.M112.389890			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22989887	Green Published, hybrid			2022-12-28	WOS:000310982800076
J	Gurriaran-Rodriguez, U; Santos-Zas, I; Al-Massadi, O; Mosteiro, CS; Beiroa, D; Nogueiras, R; Crujeiras, AB; Seoane, LM; Senaris, J; Garcia-Caballero, T; Gallego, R; Casanueva, FF; Pazos, Y; Camina, JP				Gurriaran-Rodriguez, Uxia; Santos-Zas, Icia; Al-Massadi, Omar; Mosteiro, Carlos S.; Beiroa, Daniel; Nogueiras, Ruben; Crujeiras, Ana B.; Seoane, Luisa M.; Senaris, Jose; Garcia-Caballero, Tomas; Gallego, Rosalia; Casanueva, Felipe F.; Pazos, Yolanda; Camina, Jesus P.			The Obestatin/GPR39 System Is Up-regulated by Muscle Injury and Functions as an Autocrine Regenerative System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC-CANCER CELLS; SKELETAL-MUSCLE; GROWTH-FACTOR; SATELLITE CELLS; GENE-EXPRESSION; STEM-CELLS; IN-VITRO; DIFFERENTIATION; RECEPTOR; ACTIVATION	The maintenance and repair of skeletal muscle are attributable to an elaborate interaction between extrinsic and intrinsic regulatory signals that regulate the myogenic process. In the present work, we showed that obestatin, a 23-amino acid peptide encoded by the ghrelin gene, and the GPR39 receptor are expressed in rat skeletal muscle and are up-regulated upon experimental injury. To define their roles in muscle regeneration, L6E9 cells were used to perform in vitro assays. For the in vivo assays, skeletal muscle tissue was obtained from male rats and maintained under continuous subcutaneous infusion of obestatin. In differentiating L6E9 cells, preproghrelin expression and correspondingly obestatin increased during myogenesis being sustained throughout terminal differentiation. Autocrine action was demonstrated by neutralization of the endogenous obestatin secreted by differentiating L6E9 cells using a specific anti-obestatin antibody. Knockdown experiments by preproghrelin siRNA confirmed the contribution of obestatin to the myogenic program. Furthermore, GPR39 siRNA reduced obestatin action and myogenic differentiation. Exogenous obestatin stimulation was also shown to regulate myoblast migration and proliferation. Furthermore, the addition of obestatin to the differentiation medium increased myogenic differentiation of L6E9 cells. The relevance of the actions of obestatin was confirmed in vivo by the up-regulation of Pax-7, MyoD, Myf5, Myf6, myogenin, and myosin heavy chain (MHC) in obestatin-infused rats when compared with saline-infused rats. These data elucidate a novel mechanism whereby the obestatin/GPR39 system is coordinately regulated as part of the myogenic program and operates as an autocrine signal regulating skeletal myogenesis.	[Gurriaran-Rodriguez, Uxia; Santos-Zas, Icia; Al-Massadi, Omar; Mosteiro, Carlos S.; Crujeiras, Ana B.; Seoane, Luisa M.; Casanueva, Felipe F.; Pazos, Yolanda; Camina, Jesus P.] CHUS, Inst Invest Sanitaria Santiago IDIS, Area Endocrinol Mol & Celular, Serv Gallego Salud SERGAS, Santiago De Compostela 15706, Spain; [Senaris, Jose] CHUS, Serv Gallego Salud SERGAS, Serv Cirugia Ortoped & Traumatol, Santiago De Compostela 15706, Spain; [Gurriaran-Rodriguez, Uxia; Santos-Zas, Icia; Al-Massadi, Omar; Mosteiro, Carlos S.; Beiroa, Daniel; Nogueiras, Ruben; Crujeiras, Ana B.; Seoane, Luisa M.; Casanueva, Felipe F.; Pazos, Yolanda; Camina, Jesus P.] Hosp Clin Univ Santiago de Compostela Choupana, Ctr Invest Biomed Red CIBER Fisiopatol Obesidad &, Santiago De Compostela 15706, Spain; [Beiroa, Daniel; Nogueiras, Ruben] Univ Santiago de Compostela, Dept Fisiol, Santiago De Compostela 15704, Spain; [Garcia-Caballero, Tomas; Gallego, Rosalia] Univ Santiago de Compostela, Dept Ciencias Morfol, Santiago De Compostela 15704, Spain; [Casanueva, Felipe F.] Univ Santiago de Compostela, Dept Med, Santiago De Compostela 15704, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Camina, JP (corresponding author), Hosp Clin Univ Santiago, SERGAS, Area Endocrinol Mol & Celular, IDIS,Lab Endocrinol Celular Lab 4, Choupana S-N, Santiago De Compostela 15706, Spain.	jesus.perez@usc.es	Nogueiras, Ruben/AAS-9427-2021; Beiroa, Daniel/AAB-8662-2020; seoane, luisa M/E-6570-2013; Garcia-Caballero, Tomas/H-7213-2015; Al-Massadi, Omar/C-1526-2017; Zas, Icia Santos/ABI-7849-2020; Crujeiras, Ana/ABA-8866-2021	Nogueiras, Ruben/0000-0002-9976-9930; Beiroa, Daniel/0000-0003-1862-1668; Al-Massadi, Omar/0000-0003-0645-6159; Zas, Icia Santos/0000-0002-0310-9074; Crujeiras, Ana/0000-0003-4392-0301; Gurriaran, Uxia/0000-0002-5375-0142; Garcia-Caballero, Tomas/0000-0002-7938-1437; Rosalia, Gallego/0000-0002-6015-4680	Instituto de Salud Carlos III (ISCIII; Ministerio de Economia y Competitividad, Spain) [PS09/02202]; Ministerio de Economia y Competitividad [SAF2010-20451]; Xunta de Galicia [INCITE09918374PR]; Fundacion Mutua Madrilena; Xunta de Galicia through an Isabel Barreto research-staff contract; ISCIII; SERGAS through a Miguel Servet research-staff stabilization contract	Instituto de Salud Carlos III (ISCIII; Ministerio de Economia y Competitividad, Spain); Ministerio de Economia y Competitividad(Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Xunta de Galicia through an Isabel Barreto research-staff contract; ISCIII(Instituto de Salud Carlos III); SERGAS through a Miguel Servet research-staff stabilization contract	This work was supported in part by grants from Instituto de Salud Carlos III (ISCIII; Ministerio de Economia y Competitividad, Spain; Grant PS09/02202), Ministerio de Economia y Competitividad (Grant SAF2010-20451), Xunta de Galicia (Grant INCITE09918374PR), and Fundacion Mutua Madrilena.; Supported by the Xunta de Galicia through an Isabel Barreto research-staff contract.; Supported by the ISCIII and SERGAS through a Miguel Servet research-staff stabilization contract.	Abou-Khalil R, 2009, CELL STEM CELL, V5, P298, DOI 10.1016/j.stem.2009.06.001; Alvarez CJP, 2009, ENDOCR-RELAT CANCER, V16, P599, DOI 10.1677/ERC-08-0192; Bentzinger CF, 2012, COLD SPRING HARB PER, V4; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Bryan BA, 2008, MOL BIOL CELL, V19, P994, DOI 10.1091/mbc.E07-09-0856; CANTINI M, 1995, BIOCHEM BIOPH RES CO, V216, P49, DOI 10.1006/bbrc.1995.2590; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chartrel N, 2007, SCIENCE, V315, DOI 10.1126/science.1135047; Clemmons DR, 2009, TRENDS ENDOCRIN MET, V20, P349, DOI 10.1016/j.tem.2009.04.002; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; DIMARIO J, 1989, SCIENCE, V244, P688, DOI 10.1126/science.2717945; Ek ETH, 2006, TRENDS MOL MED, V12, P497, DOI 10.1016/j.molmed.2006.08.009; Filigheddu N, 2007, MOL BIOL CELL, V18, P986, DOI 10.1091/mbc.E06-05-0402; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Germani A, 2003, AM J PATHOL, V163, P1417, DOI 10.1016/S0002-9440(10)63499-2; Girgenrath M, 2006, EMBO J, V25, P5826, DOI 10.1038/sj.emboj.7601441; Goetsch KP, 2011, ANAL BIOCHEM, V411, P158, DOI 10.1016/j.ab.2010.12.012; Golding JP, 2007, EXP CELL RES, V313, P341, DOI 10.1016/j.yexcr.2006.10.019; Granata R, 2008, DIABETES, V57, P967, DOI 10.2337/db07-1104; Gurriaran-Rodriguez U, 2011, J CELL MOL MED, V15, P1927, DOI 10.1111/j.1582-4934.2010.01192.x; Gurriaran-Rodriguez U, 2011, J ENDOCRINOL, V210, pR1, DOI 10.1530/JOE-11-0233; Holst B, 2007, ENDOCRINOLOGY, V148, P13, DOI 10.1210/en.2006-0933; Horsley V, 2001, J CELL BIOL, V153, P329, DOI 10.1083/jcb.153.2.329; Hu P, 2008, DEV CELL, V15, P534, DOI 10.1016/j.devcel.2008.08.018; IRINTCHEV A, 1994, DEV DYNAM, V199, P326, DOI 10.1002/aja.1001990407; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Leloup L, 2007, INT J BIOCHEM CELL B, V39, P1177, DOI 10.1016/j.biocel.2007.03.003; Machida S, 2004, P NUTR SOC, V63, P337, DOI 10.1079/PNS2004354; Matheny RW, 2010, ENDOCRINOLOGY, V151, P865, DOI 10.1210/en.2009-1217; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Mourkioti F, 2005, TRENDS IMMUNOL, V26, P535, DOI 10.1016/j.it.2005.08.002; Mousavi K, 2006, J NEUROSCI, V26, P5739, DOI 10.1523/JNEUROSCI.5398-05.2006; NADALGINARD B, 1978, CELL, V15, P855, DOI 10.1016/0092-8674(78)90270-2; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Park KW, 2008, CELL METAB, V8, P454, DOI 10.1016/j.cmet.2008.11.001; Patel-Hett S, 2011, INT J DEV BIOL, V55, P353, DOI 10.1387/ijdb.103213sp; Pazos Y, 2007, GROWTH FACTORS, V25, P373, DOI 10.1080/08977190801889313; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Ratajczak MZ, 2003, STEM CELLS, V21, P363, DOI 10.1634/stemcells.21-3-363; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; ROSEN GD, 1992, CELL, V69, P1107, DOI 10.1016/0092-8674(92)90633-N; SEJERSEN T, 1986, P NATL ACAD SCI USA, V83, P6844, DOI 10.1073/pnas.83.18.6844; Serra C, 2007, MOL CELL, V28, P200, DOI 10.1016/j.molcel.2007.08.021; Shefer G, 2004, J CELL SCI, V117, P5393, DOI 10.1242/jcs.01419; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127; Toschi A, 2011, MOL ENDOCRINOL, V25, P1661, DOI 10.1210/me.2011-1049; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Wu MZ, 2011, J CELL PHYSIOL, V226, P29, DOI 10.1002/jcp.22353; Zeng L, 2010, J BIOL CHEM, V285, P36060, DOI 10.1074/jbc.M110.160879; Zhang JV, 2008, MOL ENDOCRINOL, V22, P1464, DOI 10.1210/me.2007-0569; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255; Zizzari P, 2007, ENDOCRINOLOGY, V148, P1648, DOI 10.1210/en.2006-1231	58	27	31	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45					38379	38389		10.1074/jbc.M112.374926	http://dx.doi.org/10.1074/jbc.M112.374926			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22992743	Green Published, hybrid			2022-12-28	WOS:000310642200070
J	Lang, BS; Gorren, ACF; Oberdorfer, G; Wenzl, MV; Furdui, CM; Poole, LB; Mayer, B; Gruber, K				Lang, Barbara S.; Gorren, Antonius C. F.; Oberdorfer, Gustav; Wenzl, M. Verena; Furdui, Cristina M.; Poole, Leslie B.; Mayer, Bernd; Gruber, Karl			Vascular Bioactivation of Nitroglycerin by Aldehyde Dehydrogenase-2 REACTION INTERMEDIATES REVEALED BY CRYSTALLOGRAPHY AND MASS SPECTROMETRY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ORGANIC NITRATES; SUBSTRATE-SPECIFICITY; COENZYME BINDING; NO DONORS; MITOCHONDRIAL; TOLERANCE; MECHANISM; SITE; IDENTIFICATION	Aldehyde dehydrogenase-2 (ALDH2) catalyzes the bioactivation of nitroglycerin (glyceryl trinitrate, GTN) in blood vessels, resulting in vasodilation by nitric oxide (NO) or a related species. Because the mechanism of this reaction is still unclear we determined the three-dimensional structures of wild-type (WT) ALDH2 and of a triple mutant of the protein that exhibits low denitration activity (E268Q/C301S/C303S) in complex with GTN. The structure of the triple mutant showed that GTN binds to the active site via polar contacts to the oxyanion hole and to residues 268 and 301 as well as by van der Waals interactions to hydrophobic residues of the catalytic pocket. The structure of the GTN-soaked wild-type protein revealed a thionitrate adduct to Cys-302 as the first reaction intermediate, which was also found by mass spectrometry (MS) experiments. In addition, the MS data identified sulfinic acid as the irreversibly inactivated enzyme species. Assuming that the structures of the triple mutant and wild-type ALDH2 reflect binding of GTN to the catalytic site and the first reaction step, respectively, superposition of the two structures indicates that denitration of GTN is initiated by nucleophilic attack of Cys-302 at one of the terminal nitrate groups, resulting in formation of the observed thionitrate intermediate and release of 1,2-glyceryl dinitrate. Our results shed light on the molecular mechanism of the GTN denitration reaction and provide useful information on the structural requirements for high affinity binding of organic nitrates to the catalytic site of ALDH2.	[Lang, Barbara S.; Gorren, Antonius C. F.; Wenzl, M. Verena; Mayer, Bernd] Graz Univ, Dept Pharmacol & Toxicol, A-8010 Graz, Austria; [Oberdorfer, Gustav; Gruber, Karl] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Furdui, Cristina M.] Wake Forest Sch Med, Dept Internal Med, Winston Salem, NC 27157 USA; [Poole, Leslie B.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	University of Graz; University of Graz; Wake Forest University; Wake Forest University	Mayer, B (corresponding author), Graz Univ, Dept Pharmacol & Toxicol, Univ Pl 2, A-8010 Graz, Austria.	mayer@uni-graz.at; karl.gruber@uni-graz.at	Gruber, Karl/GPP-6706-2022	Gruber, Karl/0000-0002-3485-9740; Oberdorfer, Gustav/0000-0002-6144-9114; Mayer, Bernd/0000-0002-2921-3494; Gorren, Antonius Cornelis Franciscus/0000-0003-3476-6162; Poole, Leslie/0000-0003-0334-7328; Furdui, Cristina M./0000-0003-3771-7999	National Institutes of Health [R01 GM050389]; Austrian Science Fund (FWF) [P20669, P21693, P19858, W901]; Austrian Science Fund (FWF) [W 901, P 21693] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM050389 (to L. B. P.) and the Austrian Science Fund (FWF) through Project Grants P20669 and P21693 (to B. M.) and P19858 (to K. G.) and through the Ph.D. program "Molecular Enzymology" W901 (to B. M. and K. G.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AHLNER J, 1991, PHARMACOL REV, V43, P351; Beretta M, 2008, J BIOL CHEM, V283, P17873, DOI [10.1074/jbc.M801182200, 10.1074/jbc.M804001200]; Beretta M, 2012, CIRC RES, V110, P385, DOI 10.1161/CIRCRESAHA.111.245837; Beretta M, 2010, J BIOL CHEM, V285, P943, DOI 10.1074/jbc.M109.014548; BRIEN JF, 1986, J PHARMACOL EXP THER, V237, P608; Chegaev K, 2009, J MED CHEM, V52, P4020, DOI 10.1021/jm9002236; Chen ZQ, 2006, TRENDS CARDIOVAS MED, V16, P259, DOI 10.1016/j.tcm.2006.05.001; Chen ZQ, 2002, P NATL ACAD SCI USA, V99, P8306, DOI 10.1073/pnas.122225199; Cobessi D, 1999, J MOL BIOL, V290, P161, DOI 10.1006/jmbi.1999.2853; D'Ambrosio K, 2006, BIOCHEMISTRY-US, V45, P2978, DOI 10.1021/bi0515117; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESPENBETOV AA, 1984, ACTA CRYSTALLOGR C, V40, P2096, DOI 10.1107/S0108270184010775; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FELDMAN RI, 1972, J BIOL CHEM, V247, P267; FELDMAN RI, 1972, J BIOL CHEM, V247, P260; Fung HL, 2004, ANNU REV PHARMACOL, V44, P67, DOI 10.1146/annurev.pharmtox.44.101802.121646; GOEDDE HW, 1992, HUM GENET, V88, P344; Gonzalez-Segura L, 2009, J MOL BIOL, V385, P542, DOI 10.1016/j.jmb.2008.10.082; Goto K, 2000, TETRAHEDRON LETT, V41, P8479, DOI 10.1016/S0040-4039(00)01487-8; Gruez A, 2004, J MOL BIOL, V343, P29, DOI 10.1016/j.jmb.2004.08.030; Hammen PK, 2002, BIOCHEMISTRY-US, V41, P7156, DOI 10.1021/bi012197t; Hurley TD, 2001, CHEM-BIOL INTERACT, V130, P3, DOI 10.1016/S0009-2797(00)00217-9; Inagaki E, 2006, J MOL BIOL, V362, P490, DOI 10.1016/j.jmb.2006.07.048; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keung WM, 1997, P NATL ACAD SCI USA, V94, P1675, DOI 10.1073/pnas.94.5.1675; Klyosov AA, 1996, BIOCHEMISTRY-US, V35, P4445, DOI 10.1021/bi9521093; Koenig A, 2007, BIOORG MED CHEM LETT, V17, P5881, DOI 10.1016/j.bmcl.2007.08.046; Kollau A, 2005, BIOCHEM J, V385, P769, DOI 10.1042/BJ20041354; Larson HN, 2007, J BIOL CHEM, V282, P12940, DOI 10.1074/jbc.M607959200; Larson HN, 2005, J BIOL CHEM, V280, P30550, DOI 10.1074/jbc.M502345200; Li ZL, 2005, ANAL BIOCHEM, V343, P35, DOI 10.1016/j.ab.2005.04.021; Liu ZJ, 1997, NAT STRUCT BIOL, V4, P317, DOI 10.1038/nsb0497-317; Lorentzen E, 2004, J MOL BIOL, V341, P815, DOI 10.1016/j.jmb.2004.05.032; Lowe ED, 2008, J MED CHEM, V51, P4482, DOI 10.1021/jm800488j; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697, 10.1517/17425255.4.6.697 ]; Marsh N, 2000, CLIN EXP PHARMACOL P, V27, P313, DOI 10.1046/j.1440-1681.2000.03240.x; Mayer B, 2008, BRIT J PHARMACOL, V155, P170, DOI 10.1038/bjp.2008.263; McCarthy AA, 2009, J SYNCHROTRON RADIAT, V16, P803, DOI 10.1107/S0909049509035377; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MUKERJEE N, 1992, ARCH BIOCHEM BIOPHYS, V299, P23, DOI 10.1016/0003-9861(92)90239-S; Munoz-Clares RA, 2011, CHEM-BIOL INTERACT, V191, P137, DOI 10.1016/j.cbi.2010.12.024; Munoz-Clares RA, 2010, ARCH BIOCHEM BIOPHYS, V493, P71, DOI 10.1016/j.abb.2009.09.006; Munzel T, 2005, CIRC RES, V97, P618, DOI 10.1161/01.RES.0000184694.03262.6d; Muto M, 2000, GUT, V47, P256, DOI 10.1136/gut.47.2.256; Ni L, 1999, PROTEIN SCI, V8, P2784; Perez-Miller S, 2010, NAT STRUCT MOL BIOL, V17, P159, DOI 10.1038/nsmb.1737; Perez-Miller SJ, 2003, BIOCHEMISTRY-US, V42, P7100, DOI 10.1021/bi034182w; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; RACKER E, 1949, J BIOL CHEM, V177, P883; Sage PR, 2000, CIRCULATION, V102, P2810; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; Terwilliger TC, 2007, ACTA CRYSTALLOGR D, V63, P101, DOI 10.1107/S0907444906046233; Terwilliger TC, 2006, ACTA CRYSTALLOGR D, V62, P915, DOI 10.1107/S0907444906017161; Tsybovsky Y, 2007, BIOCHEMISTRY-US, V46, P2917, DOI 10.1021/bi0619573; TU GC, 1988, J BIOL CHEM, V263, P1218; TZENG TB, 1992, MED HYPOTHESES, V37, P58, DOI 10.1016/0306-9877(92)90015-5; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Wenzel P, 2007, BRIT J PHARMACOL, V150, P526, DOI 10.1038/sj.bjp.0707116; Wenzl MV, 2011, MOL PHARMACOL, V80, P258, DOI 10.1124/mol.111.071704; Wenzl MV, 2009, J BIOL CHEM, V284, P19878, DOI 10.1074/jbc.M109.005652; Wessler C, 2003, EUR J MED CHEM, V38, P581, DOI 10.1016/S0223-5234(03)00079-5; Yang J, 2007, BIOCHEMISTRY-US, V46, P709, DOI 10.1021/bi061546m; Yokoyama A, 1999, ALCOHOL CLIN EXP RES, V23, P1705, DOI 10.1097/00000374-199911000-00001; Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x; ZHENG CF, 1993, ALCOHOL CLIN EXP RES, V17, P828, DOI 10.1111/j.1530-0277.1993.tb00849.x	68	23	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.371716	http://dx.doi.org/10.1074/jbc.M112.371716			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22988236	hybrid, Green Published			2022-12-28	WOS:000310642200046
J	Nardozzi, JD; Wang, XW; Mbantenkhu, M; Wilkens, S; Chen, XJ				Nardozzi, Jonathan D.; Wang, Xiaowen; Mbantenkhu, MacMillan; Wilkens, Stephan; Chen, Xin Jie			A Properly Configured Ring Structure Is Critical for the Function of the Mitochondrial DNA Recombination Protein, Mgm101	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; RAD52 PROTEIN; HOMOLOGOUS RECOMBINATION; REPLICATION; MAINTENANCE; GENOME; REPAIR; DOMAIN; SEQUENCES	Mgm101 is a Rad52-type recombination protein of bacteriophage origin required for the repair and maintenance of mitochondrial DNA (mtDNA). It forms large oligomeric rings of similar to 14-fold symmetry that catalyze the annealing of single-stranded DNAs in vitro. In this study, we investigated the structural elements that contribute to this distinctive higher order structural organization and examined its functional implications. A pair of vicinal cysteines, Cys-216 and Cys-217, was found to be essential for mtDNA maintenance. Mutations to the polar serine, the negatively charged aspartic and glutamic acids, and the hydrophobic amino acid alanine all destabilize mtDNA in vivo. The alanine mutants have an increased propensity of forming macroscopic filaments. In contrast, mutations to aspartic acid drastically destabilize the protein and result in unstructured aggregates with severely reduced DNA binding activity. Interestingly, the serine mutants partially disassemble the Mgm101 rings into smaller oligomers. In the case of the C216S mutant, a moderate increase in DNA binding activity was observed. By using small angle x-ray scattering analysis, we found that Mgm101 forms rings of similar to 200 angstrom diameter in solution, consistent with the structure previously established by transmission electron microscopy. We also found that the C216A/C217A double mutant tends to form broken rings, which likely provide free ends for seeding the growth of the super-stable but functionally defective filaments. Taken together, our data underscore the importance of a delicately maintained ring structure critical for Mgm101 activity. We discuss a potential role of Cys-216 and Cys-217 in regulating Mgm101 function and the repair of damaged mtDNA under stress conditions.	[Nardozzi, Jonathan D.; Wang, Xiaowen; Mbantenkhu, MacMillan; Wilkens, Stephan; Chen, Xin Jie] State Univ New York Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Chen, XJ (corresponding author), State Univ New York Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	chenx@upstate.edu		Nardozzi, Jonathan/0000-0002-6655-4765	National Institutes of Health [R01AG023731, R01GM058600]; National Science Foundation; NIGMS, National Institutes of Health; NCRR, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AG023731 and R01GM058600 (to X. J. C. and S. W.).; We thank the Cornell High Energy Synchrotron Source (CHESS) and the Macromolecular Diffraction at CHESS (MacCHESS) facility for beam time; Richard Gillilan for advice in SAXS data collection and analysis; Stewart Loh for the use of FPLC, and Jeung-Hoi (Jenny) Ha for help in the analysis of DNA binding data. CHESS is supported by the National Science Foundation and NIGMS, National Institutes of Health, and the MacCHESS resource is supported by NCRR, National Institutes of Health.	Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; CHEN XJ, 1993, NUCLEIC ACIDS RES, V21, P3473, DOI 10.1093/nar/21.15.3473; ClarkWalker GD, 1996, MOL GEN GENET, V252, P746, DOI 10.1007/s004380050285; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; GAILLARD C, 1980, NATURE, V283, P218, DOI 10.1038/283218a0; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Itoh K, 2011, MITOCHONDRION, V11, P575, DOI 10.1016/j.mito.2011.03.002; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-8; Janicka S., 2012, PLANT J IN PRESS; Kagawa W, 2002, MOL CELL, V10, P359, DOI 10.1016/S1097-2765(02)00587-7; Kalifa L, 2012, GENETICS, V190, P951, DOI 10.1534/genetics.111.138214; Kaufman BA, 2000, P NATL ACAD SCI USA, V97, P7772, DOI 10.1073/pnas.140063197; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Lim SI, 2008, J MOL BIOL, V384, P1098, DOI 10.1016/j.jmb.2008.10.047; LING F, 1995, EMBO J, V14, P4090, DOI 10.1002/j.1460-2075.1995.tb00081.x; Ling F, 2000, NUCLEIC ACIDS RES, V28, P4956, DOI 10.1093/nar/28.24.4956; Lopes A, 2010, NUCLEIC ACIDS RES, V38, P3952, DOI 10.1093/nar/gkq096; Mbantenkhu M, 2011, J BIOL CHEM, V286, P42360, DOI 10.1074/jbc.M111.307512; Meeusen S, 1999, J CELL BIOL, V145, P291, DOI 10.1083/jcb.145.2.291; Nagahara N, 2009, CURR MED CHEM, V16, P4419, DOI 10.2174/092986709789712880; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Nimonkar AV, 2009, P NATL ACAD SCI USA, V106, P3077, DOI 10.1073/pnas.0813247106; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Passy SI, 1999, P NATL ACAD SCI USA, V96, P4279, DOI 10.1073/pnas.96.8.4279; Petoukhov MV, 2007, CURR OPIN STRUC BIOL, V17, P562, DOI 10.1016/j.sbi.2007.06.009; Ploquin M, 2008, CURR BIOL, V18, P1142, DOI 10.1016/j.cub.2008.06.071; Poteete AR, 2008, MOL MICROBIOL, V68, P66, DOI 10.1111/j.1365-2958.2008.06133.x; POTEETE AR, 1983, J MOL BIOL, V171, P401, DOI 10.1016/0022-2836(83)90037-2; Rothenberg E, 2008, P NATL ACAD SCI USA, V105, P20274, DOI 10.1073/pnas.0810317106; Samach A, 2011, PLANT CELL, V23, P4266, DOI 10.1105/tpc.111.091744; Shi I, 2009, J BIOL CHEM, V284, P33275, DOI 10.1074/jbc.M109.057752; Shibata T, 2007, MITOCHONDRION, V7, P17, DOI 10.1016/j.mito.2006.11.024; Singleton MR, 2002, P NATL ACAD SCI USA, V99, P13492, DOI 10.1073/pnas.212449899; Stasiak AZ, 2000, CURR BIOL, V10, P337, DOI 10.1016/S0960-9822(00)00385-7; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; VANDYCK E, 1992, EMBO J, V11, P3421, DOI 10.1002/j.1460-2075.1992.tb05421.x; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; ZINN AR, 1988, P NATL ACAD SCI USA, V85, P2686, DOI 10.1073/pnas.85.8.2686; Zuo XM, 2007, FEMS YEAST RES, V7, P131, DOI 10.1111/j.1567-1364.2006.00141.x; Zuo XM, 2002, GENETICS, V160, P1389	44	9	9	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37259	37268		10.1074/jbc.M112.389965	http://dx.doi.org/10.1074/jbc.M112.389965			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22948312	Green Published, hybrid			2022-12-28	WOS:000310588500058
J	Shimshoni, JA; Roberts, AG; Scian, M; Topletz, AR; Blankert, SA; Halpert, JR; Nelson, WL; Isoherranen, N				Shimshoni, Jakob A.; Roberts, Arthur G.; Scian, Michele; Topletz, Ariel R.; Blankert, Sean A.; Halpert, James R.; Nelson, Wendel L.; Isoherranen, Nina			Stereoselective Formation and Metabolism of 4-Hydroxy-Retinoic Acid Enantiomers by Cytochrome P450 Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORCE-FIELD PARAMETERS; RETINOIC ACID; BIOLOGICAL-ACTIVITY; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURES; SUBSTRATE; CYP26A1; BINDING; LIGAND; IDENTIFICATION	All-trans-retinoic acid (atRA), the major active metabolite of vitamin A, plays a role in many biological processes, including maintenance of epithelia, immunity, and fertility and regulation of apoptosis and cell differentiation. atRA is metabolized mainly by CYP26A1, but other P450 enzymes such as CYP2C8 and CYP3As also contribute to atRA 4-hydroxylation. Although the primary metabolite of atRA, 4-OH-RA, possesses a chiral center, the stereochemical course of atRA 4-hydroxylation has not been studied previously. (4S)- and (4R)-OH-RA enantiomers were synthesized and separated by chiral column HPLC. CYP26A1 was found to form predominantly (4S)- OH-RA. This stereoselectivity was rationalized via docking of atRA in the active site of a CYP26A1 homology model. The docked structure showed a well defined niche for atRA within the active site and a specific orientation of the beta-ionone ring above the plane of the heme consistent with stereoselective abstraction of the hydrogen atom from the pro-(S)-position. In contrast to CYP26A1, CYP3A4 formed the 4-OH-RA enantiomers in a 1:1 ratio and CYP3A5 preferentially formed (4R)-OH-RA. Interestingly,CYP3A7 and CYP2C8 preferentially formed (4S)- OH-RA from atRA. Both (4S)- and (4R)-OH-RA were substrates of CYP26A1 but (4S)- OH-RA was cleared 3-fold faster than (4R)-OH-RA. In addition, 4-oxo-RA was formed from (4R)-OH-RA but not from (4S)-OH-RA by CYP26A1. Overall, these findings show that (4S)-OH-RA is preferred over (4R)- OH-RA by the enzymes regulating atRA homeostasis. The stereoselectivity observed in CYP26A1 function will aid in better understanding of the active site features of the enzyme and the disposition of biologically active retinoids.	[Shimshoni, Jakob A.; Topletz, Ariel R.; Isoherranen, Nina] Univ Washington, Sch Pharm, Dept Pharmaceut, Seattle, WA 98195 USA; [Scian, Michele; Nelson, Wendel L.] Univ Washington, Sch Pharm, Dept Med Chem, Seattle, WA 98195 USA; [Roberts, Arthur G.; Halpert, James R.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92093 USA; [Roberts, Arthur G.; Blankert, Sean A.] Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; University System of Georgia; University of Georgia	Isoherranen, N (corresponding author), Univ Washington, Sch Pharm, Dept Pharmaceut, Box 357610, Seattle, WA 98195 USA.	ni2@u.washington.edu			National Institutes of Health [R01-GM081569, R01-GM081569-S1, GM054995-16]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081569, R37GM054995, R01GM054995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM081569, R01-GM081569-S1, and GM054995-16.	Achkar CC, 1996, P NATL ACAD SCI USA, V93, P4879, DOI 10.1073/pnas.93.10.4879; Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Arnold SLM, 2012, J LIPID RES, V53, P587, DOI 10.1194/jlr.D019745; Autenrieth F, 2004, J COMPUT CHEM, V25, P1613, DOI 10.1002/jcc.20079; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; CAI GL, 1993, J AM CHEM SOC, V115, P7192, DOI 10.1021/ja00069a016; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; COREY EJ, 1987, J AM CHEM SOC, V109, P5551, DOI 10.1021/ja00252a056; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Montellano PRO, 2010, CHEM REV, V110, P932, DOI 10.1021/cr9002193; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; ECKHOFF C, 1990, J LIPID RES, V31, P1445; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; FIORELLA PD, 1991, J BIOL CHEM, V266, P16572; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gomaa MS, 2006, J ENZYM INHIB MED CH, V21, P361, DOI 10.1080/14756360600742014; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; Idres N, 2002, J BIOL CHEM, V277, P31491, DOI 10.1074/jbc.M205016200; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; Karlsson M, 2008, J CHEM THEORY COMPUT, V4, P1021, DOI 10.1021/ct800033x; KATSUTA Y, 1994, J ORG CHEM, V59, P6917, DOI 10.1021/jo00102a014; Kuhnel K, 2008, BIOCHEMISTRY-US, V47, P6552, DOI 10.1021/bi800328s; Langton S, 2008, DEV BIOL, V315, P331, DOI 10.1016/j.ydbio.2007.12.021; Lutz JD, 2009, BIOCHEM PHARMACOL, V77, P258, DOI 10.1016/j.bcp.2008.10.012; Manolescu DC, 2010, J NUTR, V140, P311, DOI 10.3945/jn.109.115147; Marill J, 2000, MOL PHARMACOL, V58, P1341, DOI 10.1124/mol.58.6.1341; McSorley LC, 2000, BIOCHEM PHARMACOL, V60, P517, DOI 10.1016/S0006-2952(00)00356-7; Moise AR, 2008, J AM CHEM SOC, V130, P1154, DOI 10.1021/ja710487q; Nadin L, 1999, BIOCHEM PHARMACOL, V58, P1201, DOI 10.1016/S0006-2952(99)00192-6; Niederreither K, 2002, NAT GENET, V31, P84, DOI 10.1038/ng876; Obach RS, 2002, DRUG METAB DISPOS, V30, P831, DOI 10.1124/dmd.30.7.831; Oda A, 2005, J COMPUT CHEM, V26, P818, DOI 10.1002/jcc.20221; Oostenbrink C, 2005, EUR BIOPHYS J BIOPHY, V34, P273, DOI 10.1007/s00249-004-0448-6; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Ren JH, 2008, MOL SIMULAT, V34, P337, DOI 10.1080/08927020801930562; REYNOLDS NJ, 1993, J PHARMACOL EXP THER, V266, P1636; Samokyszyn VM, 2000, J BIOL CHEM, V275, P6908, DOI 10.1074/jbc.275.10.6908; Schoch GA, 2008, J BIOL CHEM, V283, P17227, DOI 10.1074/jbc.M802180200; Sevrioukova IF, 2012, J BIOL CHEM, V287, P3510, DOI 10.1074/jbc.M111.317081; Sevrioukova IF, 2010, P NATL ACAD SCI USA, V107, P18422, DOI 10.1073/pnas.1010693107; Sonneveld E, 1999, DEV BIOL, V213, P390, DOI 10.1006/dbio.1999.9381; Takakuwa T, 1985, ANAL SCI, V1, P215, DOI DOI 10.2116/ANALSCI.1.215; Thatcher JE, 2011, MOL PHARMACOL, V80, P228, DOI 10.1124/mol.111.072413; Thatcher JE, 2010, BIOCHEM PHARMACOL, V80, P903, DOI 10.1016/j.bcp.2010.05.023; Topletz AR, 2012, BIOCHEM PHARMACOL, V83, P149, DOI 10.1016/j.bcp.2011.10.007; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; vanderLeede BM, 1997, J BIOL CHEM, V272, P17921, DOI 10.1074/jbc.272.29.17921; White JA, 1997, J BIOL CHEM, V272, P18538, DOI 10.1074/jbc.272.30.18538; White JA, 2000, P NATL ACAD SCI USA, V97, P6403, DOI 10.1073/pnas.120161397; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200	55	25	25	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42223	42232		10.1074/jbc.M112.404475	http://dx.doi.org/10.1074/jbc.M112.404475			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23071109	Green Published, hybrid			2022-12-28	WOS:000312103000058
J	Zhang, BT; Carrie, C; Ivanova, A; Narsai, R; Murcha, MW; Duncan, O; Wang, Y; Law, SR; Albrecht, V; Pogson, B; Giraud, E; Van Aken, O; Whelan, J				Zhang, Botao; Carrie, Chris; Ivanova, Aneta; Narsai, Reena; Murcha, Monika W.; Duncan, Owen; Wang, Yan; Law, Simon R.; Albrecht, Veronica; Pogson, Barry; Giraud, Estelle; Van Aken, Olivier; Whelan, James			LETM Proteins Play a Role in the Accumulation of Mitochondrially Encoded Proteins in Arabidopsis thaliana and AtLETM2 Displays Parent of Origin Effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WOLF-HIRSCHHORN-SYNDROME; EMBRYO SAC DEVELOPMENT; ALTERNATIVE OXIDASE; CARRIER PROTEINS; GENE; EXPRESSION; GENOME; BIOGENESIS; RNA; TRANSCRIPTION	The Arabidopsis thaliana genome contains two genes with homology to the mitochondrial protein LETM1 (leucine zipper-EF-hand-containing transmembrane protein). Inactivation of both genes, Atletm1 and Atletm2, together is lethal. Plants that are hemizygous for AtLETM2 and homozygous for Atletm1 (letm1(-/-) LETM2(+/-)) displayed a mild retarded growth phenotype during early seedling growth. It was shown that accumulation of mitochondrial proteins was reduced in hemizygous (letm1(-/-) LETM2(+/-)) plants. Examination of respiratory chain proteins by Western blotting, blue native PAGE, and enzymatic activity assays revealed that the steady state level of ATP synthase was reduced in abundance, whereas the steady state levels of other respiratory chain proteins remained unchanged. The absence of a functional maternal AtLETM2 allele in an Atletm1 mutant background resulted in early seed abortion. Reciprocal crosses revealed that maternally, but not paternally, derived AtLETM2 was absolutely required for seed development. This requirement for a functional maternal allele of AtLETM2 was confirmed using direct sequencing of reciprocal crosses of Col-0 and Ler accessions. Furthermore, AtLETM2 promoter beta-glucuronidase constructs displayed exclusive maternal expression patterns.	[Zhang, Botao; Carrie, Chris; Ivanova, Aneta; Narsai, Reena; Murcha, Monika W.; Duncan, Owen; Wang, Yan; Law, Simon R.; Giraud, Estelle; Van Aken, Olivier; Whelan, James] Univ Western Australia, Australian Res Council Ctr Excellence Plant Energ, Crawley, WA 6009, Australia; [Narsai, Reena] Univ Western Australia, Ctr Computat Syst Biol, Crawley, WA 6009, Australia; [Albrecht, Veronica; Pogson, Barry] Australian Natl Univ, Australian Res Council Ctr Excellence Plant Energ, Res Sch Biol, Acton, ACT 2601, Australia	University of Western Australia; University of Western Australia; Australian National University	Whelan, J (corresponding author), Univ Western Australia, Australian Res Council Ctr Excellence Plant Energ, Bayliss Bldg M316,35 Stirling Highway, Crawley, WA 6009, Australia.	jim.whelan@uwa.edu.au	Murcha, Monika W/C-3834-2011; Pogson, Barry J/C-9953-2009; Carrie, Chris/A-2638-2010; Murcha, Monika W/H-5495-2014; Van Aken, Olivier/H-5999-2014; Van Aken, Olivier/A-2607-2010; Zhang, Botao/H-7712-2016; Van Aken, Olivier/B-4633-2019; Whelan, James/F-6402-2011	Pogson, Barry J/0000-0003-1869-2423; Carrie, Chris/0000-0002-4240-4674; Murcha, Monika W/0000-0002-3689-6158; Van Aken, Olivier/0000-0003-4024-968X; Zhang, Botao/0000-0003-3691-7876; Van Aken, Olivier/0000-0003-4024-968X; Whelan, James/0000-0001-5754-025X; Law, Simon/0000-0003-0389-6650; WANG, YAN/0000-0003-1600-2863; Duncan, Owen/0000-0001-6999-1509	Chinese Scholarship Council Scholarship; Australian Research Council Centre of Excellence Program [CEO561495]	Chinese Scholarship Council Scholarship; Australian Research Council Centre of Excellence Program(Australian Research Council)	This work was supported by a Chinese Scholarship Council Scholarship (to B. Z.) and the Australian Research Council Centre of Excellence Program CEO561495.	ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BATHGATE B, 1989, EUR J BIOCHEM, V183, P303, DOI 10.1111/j.1432-1033.1989.tb14929.x; Bauerschmitt H, 2010, MOL BIOL CELL, V21, P1937, DOI 10.1091/mbc.E10-02-0101; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley KE, 2010, GENETICS, V185, P961, DOI 10.1534/genetics.110.115360; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Boisnard-Lorig C, 2001, PLANT CELL, V13, P495, DOI 10.1105/tpc.13.3.495; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; Carrie C, 2008, FEBS LETT, V582, P3073, DOI 10.1016/j.febslet.2008.07.061; Carrie C, 2010, J BIOL CHEM, V285, P36138, DOI 10.1074/jbc.M110.121202; Carrie C, 2009, PLANT J, V57, P1128, DOI 10.1111/j.1365-313X.2008.03745.x; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Christensen CA, 1997, SEX PLANT REPROD, V10, P49, DOI 10.1007/s004970050067; Considine MJ, 2001, PLANT PHYSIOL, V126, P1619, DOI 10.1104/pp.126.4.1619; Cooper H.M., 2009, CURR PROTOC NEUROSCI, DOI [10.1002/0471142301.ns0505s48, DOI 10.1002/0471142301.NS0505S48]; Daley DO, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-110; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Dutilleul C, 2003, PLANT CELL, V15, P1212, DOI 10.1105/tpc.009464; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Endele S, 1999, GENOMICS, V60, P218, DOI 10.1006/geno.1999.5881; Eubel H, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-11; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Frazier AE, 2006, J CELL BIOL, V172, P553, DOI 10.1083/jcb.200505060; Fujii S, 2011, NEW PHYTOL, V191, P37, DOI 10.1111/j.1469-8137.2011.03746.x; Geisler DA, 2012, PLANT CELL, V24, P2792, DOI 10.1105/tpc.112.099424; Giege P, 2005, PLANT CELL, V17, P1497, DOI 10.1105/tpc.104.030254; Giraud E, 2012, PLANT CELL ENVIRON, V35, P271, DOI 10.1111/j.1365-3040.2011.02293.x; Giraud E, 2009, PLANT PHYSIOL, V150, P1286, DOI 10.1104/pp.109.139782; Gleason C, 2011, P NATL ACAD SCI USA, V108, P10768, DOI 10.1073/pnas.1016060108; Gray MW, 2001, GENOME BIOL, V2; Gray MW, 2004, ANNU REV GENET, V38, P477, DOI 10.1146/annurev.genet.37.110801.142526; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Grini PE, 2002, GENETICS, V162, P1911; Haag JR, 2011, NAT REV MOL CELL BIO, V12, P483, DOI 10.1038/nrm3152; HAIG D, 1989, AM NAT, V134, P147, DOI 10.1086/284971; Heazlewood JL, 2003, FEBS LETT, V540, P201, DOI 10.1016/S0014-5793(03)00264-3; Herrmann JM, 2012, BIOCH BIOPH IN PRESS; Ikeda Y, 2012, PLANT CELL PHYSIOL, V53, P809, DOI 10.1093/pcp/pcs049; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Karpova OV, 2002, PLANT CELL, V14, P3271, DOI 10.1105/tpc.005603; Klodmann J, 2011, PLANT PHYSIOL, V157, P587, DOI 10.1104/pp.111.182352; Kuhn K, 2011, PLANT J, V67, P1067, DOI 10.1111/j.1365-313X.2011.04658.x; Kuhn K, 2009, PLANT CELL, V21, P2762, DOI 10.1105/tpc.109.068536; LAMATTINA L, 1993, EUR J BIOCHEM, V217, P831, DOI 10.1111/j.1432-1033.1993.tb18311.x; Law SR, 2012, PLANT PHYSIOL, V158, P1610, DOI 10.1104/pp.111.192351; Lister R, 2007, PLANT CELL, V19, P3739, DOI 10.1105/tpc.107.050534; Luo M, 2005, P NATL ACAD SCI USA, V102, P17531, DOI 10.1073/pnas.0508418102; Matsushima R, 2011, PLANT CELL, V23, P1608, DOI 10.1105/tpc.111.084012; Meyer EH, 2007, PLANT MOL BIOL, V64, P319, DOI 10.1007/s11103-007-9156-9; Millar AH, 2011, ANNU REV PLANT BIOL, V62, P79, DOI 10.1146/annurev-arplant-042110-103857; Murcha MW, 2005, J BIOL CHEM, V280, P16476, DOI 10.1074/jbc.M413299200; Murcha MW, 2004, J MOL BIOL, V344, P443, DOI 10.1016/j.jmb.2004.09.045; Nowikovsky K, 2004, J BIOL CHEM, V279, P30307, DOI 10.1074/jbc.M403607200; Ott M, 2010, BBA-MOL CELL RES, V1803, P767, DOI 10.1016/j.bbamcr.2009.11.010; Rak M, 2009, BBA-MOL CELL RES, V1793, P108, DOI 10.1016/j.bbamcr.2008.07.001; Rode C, 2011, J PROTEOMICS, V74, P2214, DOI 10.1016/j.jprot.2011.06.017; Schlickum S, 2004, GENOMICS, V83, P254, DOI 10.1016/j.ygeno.2003.08.013; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Van Aken O, 2009, MOL PLANT, V2, P1310, DOI 10.1093/mp/ssp053; WEBB MC, 1994, SEX PLANT REPROD, V7, P153, DOI 10.1007/BF00228488; WEBB MC, 1990, SEX PLANT REPROD, V3, P244, DOI 10.1007/BF00202882; WHELAN J, 1995, PLANT PHYSIOL, V107, P1469, DOI 10.1104/pp.107.4.1469	66	44	45	3	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41757	41773		10.1074/jbc.M112.383836	http://dx.doi.org/10.1074/jbc.M112.383836			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23043101	Green Published, hybrid			2022-12-28	WOS:000312103000018
J	Schmid, J; Dussmann, H; Boukes, GJ; Flanagan, L; Lindner, AU; O'Connor, CL; Rehm, M; Prehn, JHM; Huber, HJ				Schmid, Jasmin; Dussmann, Heiko; Boukes, Gerhardt J.; Flanagan, Lorna; Lindner, Andreas U.; O'Connor, Carla L.; Rehm, Markus; Prehn, Jochen H. M.; Huber, Heinrich J.			Systems Analysis of Cancer Cell Heterogeneity in Caspase-dependent Apoptosis Subsequent to Mitochondrial Outer Membrane Permeabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED-INHIBITOR; CYTOCHROME-C; COLORECTAL-CANCER; PROTEASOME INHIBITORS; ACTIVATION; PROTEINS; EXECUTION; RELEASE; MODEL; EXPRESSION	Deregulation of apoptosis is a hallmark of carcinogenesis. We here combine live cell imaging and systems modeling to investigate caspase-dependent apoptosis execution subsequent to mitochondrial outer membrane permeabilization ( MOMP) in several cancer cell lines. We demonstrate that, although most cell lines that underwent MOMP also showed robust and fast activation of executioner caspases and apoptosis, the colorectal cancer cell lines LoVo and HCT-116 Smac(-/-), similar to X-linked inhibitor of apoptosis protein (XIAP)-overexpressing HeLa (HeLa XIAP(Adv)) cells, only showed delayed and often no caspase activation, suggesting apoptosis impairment subsequent to MOMP. Employing APOPTO-CELL, a recently established model of apoptosis subsequent to MOMP, this impairment could be understood by studying the systemic interaction of five proteins that are present in the apoptosis pathway subsequent to MOMP. Using APOPTO-CELL as a tool to study detailed molecular mechanisms during apoptosis execution in individual cell lines, we demonstrate that caspase-9 was the most important regulator in DLD-1, HCT-116, and HeLa cells and identified additional cell line-specific co-regulators. Developing and applying a computational workflow for parameter screening, systems modeling identified that apoptosis execution kinetics are more robust against changes in reaction kinetics in HCT-116 and HeLa than in DLD-1 cells. Our systems modeling study is the first to draw attention to the variability in cell specific protein levels and reaction rates and to the emergent effects of such variability on the efficiency of apoptosis execution and on apoptosis impairment subsequent to MOMP.	[Schmid, Jasmin; Dussmann, Heiko; Boukes, Gerhardt J.; Flanagan, Lorna; Lindner, Andreas U.; O'Connor, Carla L.; Rehm, Markus; Prehn, Jochen H. M.; Huber, Heinrich J.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Ctr Syst Med, Dublin 2, Ireland	Royal College of Surgeons - Ireland	Huber, HJ (corresponding author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Ctr Syst Med, 123 St Stephens Green, Dublin 2, Ireland.	heinhuber@rcsi.ie	Prehn, Jochen HM/A-3928-2010; Rehm, Markus/C-3398-2012; Schmid, Jasmin/C-3393-2012	Prehn, Jochen HM/0000-0003-3479-7794; Rehm, Markus/0000-0001-6149-9261; Schmid, Jasmin/0000-0001-5384-2242; Flanagan, Lorna/0000-0001-5616-1055; Dussmann, Heiko/0000-0002-3582-8057; Lindner, Andreas/0000-0003-1590-3547	Science Foundation Ireland [08/IN.1/B1949, 07/RFP/BICF601]; Irish Health Research Board APOCO-LON Grant [TRA/2007/26]; European Union Framework Programme 7 (APO-SYS); European Union Marie Curie action project Oxysense [PIAP-GA-2009-230641]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Health Research Board APOCO-LON Grant; European Union Framework Programme 7 (APO-SYS); European Union Marie Curie action project Oxysense	This research was supported by Science Foundation Ireland Grant 08/IN.1/B1949 (to J. H. M. P. and H. J. H.), Science Foundation Ireland Grant 07/RFP/BICF601 (to M. R.), Irish Health Research Board APOCO-LON Grant TRA/2007/26 (to J. H. M. P.), the European Union Framework Programme 7 (APO-SYS), and the European Union Marie Curie action project Oxysense PIAP-GA-2009-230641 (to J. H. M. P.).	Adams J, 1999, CANCER RES, V59, P2615; Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Bialik S, 2010, TRENDS BIOCHEM SCI, V35, P556, DOI 10.1016/j.tibs.2010.04.008; Bratton SB, 2002, CELL DEATH DIFFER, V9, P881, DOI 10.1038/sj.cdd.4401069; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Eissing T, 2004, J BIOL CHEM, V279, P36892, DOI 10.1074/jbc.M404893200; FIDLER IJ, 1985, SEMIN ONCOL, V12, P207; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hector S, 2012, BRIT J CANCER, V106, P1499, DOI 10.1038/bjc.2012.133; Hector S, 2012, GUT, V61, P725, DOI 10.1136/gutjnl-2011-300433; Hector S, 2009, BBA-REV CANCER, V1795, P117, DOI 10.1016/j.bbcan.2008.12.002; Hua F, 2005, J IMMUNOL, V175, P985, DOI 10.4049/jimmunol.175.2.985; Huber HJ, 2007, BIOINFORMATICS, V23, P648, DOI 10.1093/bioinformatics/btl684; Huber HJ, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.2; Huber HJ, 2011, BBA-MOL CELL RES, V1813, P608, DOI 10.1016/j.bbamcr.2010.10.004; Huber HJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-9; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kappelhoff JC, 2009, PROTEIN J, V28, P96, DOI 10.1007/s10930-009-9168-1; Lavrik IN, 2007, J BIOL CHEM, V282, P13664, DOI 10.1074/jbc.M700434200; Legewie S, 2006, PLOS COMPUT BIOL, V2, P1061, DOI 10.1371/journal.pcbi.0020120; Martins LM, 2003, J BIOL CHEM, V278, P49417, DOI 10.1074/jbc.M308659200; O'Connor CL, 2008, BBA-MOL CELL RES, V1783, P1903, DOI 10.1016/j.bbamcr.2008.05.025; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Peterson QP, 2009, J MED CHEM, V52, P5721, DOI 10.1021/jm900722z; Peterson QP, 2009, J MOL BIOL, V388, P144, DOI 10.1016/j.jmb.2009.03.003; Rehm M, 2003, J CELL BIOL, V162, P1031, DOI 10.1083/jcb.200303123; Rehm M, 2002, J BIOL CHEM, V277, P24506, DOI 10.1074/jbc.M110789200; Rehm M, 2009, CELL DEATH DIFFER, V16, P613, DOI 10.1038/cdd.2008.187; Rehm M, 2006, EMBO J, V25, P4338, DOI 10.1038/sj.emboj.7601295; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tamm I, 2004, HEMATOL J, V5, P489, DOI 10.1038/sj.thj.6200549; Teicher BA, 1999, CLIN CANCER RES, V5, P2638; Twiddy D, 2004, J BIOL CHEM, V279, P19665, DOI 10.1074/jbc.M311388200; Tyas L, 2000, EMBO REP, V1, P266, DOI 10.1093/embo-reports/kvd050; Varekova RS, 2011, J CHEM INF MODEL, V51, P1795, DOI 10.1021/ci200133w; Waterhouse NJ, 2001, J CELL BIOL, V153, P319, DOI 10.1083/jcb.153.2.319; Wolan DW, 2009, SCIENCE, V326, P853, DOI 10.1126/science.1177585; Xiang GA, 2009, J SURG ONCOL, V100, P708, DOI 10.1002/jso.21408; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zlobec I, 2006, CANCER-AM CANCER SOC, V106, P284, DOI 10.1002/cncr.21600	52	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41546	41559		10.1074/jbc.M112.411827	http://dx.doi.org/10.1074/jbc.M112.411827			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23038270	Green Published, hybrid			2022-12-28	WOS:000311887600064
J	Chintala, H; Liu, HB; Parmar, R; Kamalska, M; Kim, YJ; Lovett, D; Grant, MB; Chaqour, B				Chintala, Hembindu; Liu, Haibo; Parmar, Rahul; Kamalska, Monika; Kim, Yoon Ji; Lovett, David; Grant, Maria B.; Chaqour, Brahim			Connective Tissue Growth Factor Regulates Retinal Neovascularization through p53 Protein-dependent Transactivation of the Matrix Metalloproteinase (MMP)-2 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATIVE DIABETIC-RETINOPATHY; VASCULAR ENDOTHELIAL-CELLS; ANGIOGENESIS IN-VIVO; MATRIX-METALLOPROTEINASE-2 MMP-2; EXTRACELLULAR-MATRIX; FACTOR CYR61; ISCHEMIA; MICE; CCN; PREMATURITY	Pathological angiogenesis in the retina is driven by dysregulation of hypoxia-driven stimuli that coordinate physiological vessel growth. How the various components of the neovascularization signaling network are integrated to yield pathological changes has not been defined. Connective tissue growth factor (CTGF/CCN2) is an inducible matricellular protein that plays a major role in fibroproliferative disorders. Here, we show that CTGF/CCN2 was dynamically expressed in the developing murine retinal vasculature and was abnormally increased and localized within neovascular tufts in the mouse eye with oxygen-induced retinopathy. Consistent with its propitious vascular localization, ectopic expression of the CTGF/CCN2 gene further accelerated neovascularization, whereas lentivirus-mediated loss-of-function or -expression of CTGF/CCN2 harnessed ischemia-induced neovessel outgrowth in oxygen-induced retinopathy mice. The neovascular effects of CTGF/CCN2 were mediated, at least in part, through increased expression and activity of matrix metalloproteinase (MMP)-2, which drives vascular remodeling through degradation of matrix and non matrix proteins, migration and invasion of endothelial cells, and formation of new vascular patterns. In cultured cells, CTGF/CCN2 activated the MMP-2 promoter through increased expression and tethering of the p53 transcription factor to a highly conserved p53-binding sequence within the MMP-2 promoter. Concordantly, the neovascular effects of CTGF/CCN2 were suppressed by p53 inhibition that culminated in reduced enrichment of the MMP-2 promoter with p53 and decreased MMP-2 gene expression. Our data identified new gene targets and downstream effectors of CTGF/CCN2 and provided the rational basis for targeting the p53 pathway to curtail the effects of CTGF/CCN2 on neovessel formation associated with ischemic retinopathy.	[Chintala, Hembindu; Liu, Haibo; Parmar, Rahul; Kamalska, Monika; Kim, Yoon Ji; Chaqour, Brahim] Suny Downstate Med Ctr, Dept Cell Biol, SUNY Eye Inst, Brooklyn, NY 11203 USA; [Chaqour, Brahim] Suny Downstate Med Ctr, Dept Ophthalmol, Brooklyn, NY 11203 USA; [Lovett, David] Univ Calif San Francisco, San Francisco Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Grant, Maria B.] Univ Florida, Dept Pharmacol, Gainesville, FL 32610 USA; [Grant, Maria B.] Univ Florida, Dept Therapeut, Gainesville, FL 32610 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Chaqour, B (corresponding author), Suny Downstate Med Ctr, Dept Cell Biol, SUNY Eye Inst, 450 Clarkson Ave,Box 5, Brooklyn, NY 11203 USA.	bchaqour@downstate.edu	Chaqour, Brahim/AEH-1314-2022	Chaqour, Brahim/0000-0002-8516-4324	National Institutes of Health [EY022091-01, EY019387-01A1]; NEI [DK39776]; NATIONAL EYE INSTITUTE [R01EY022091, R21EY019387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039776, R56DK039776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants EY022091-01 and EY019387-01A1 (to B. C.) and DK39776 (to D. L.) from NEI.	Abreu JG, 2002, GENE, V287, P39, DOI 10.1016/S0378-1119(01)00827-7; Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Apte RS, 2010, ADV EXP MED BIOL, V664, P15, DOI 10.1007/978-1-4419-1399-9_2; Arnott JA, 2011, CRIT REV EUKAR GENE, V21, P43, DOI 10.1615/CritRevEukarGeneExpr.v21.i1.40; Babic AM, 1999, MOL CELL BIOL, V19, P2958; Barnett JM, 2007, INVEST OPHTH VIS SCI, V48, P907, DOI 10.1167/iovs.06-0082; Bergers G, 2000, CURR OPIN GENET DEV, V10, P120, DOI 10.1016/S0959-437X(99)00043-X; Bergman MR, 2003, BIOCHEM J, V369, P485, DOI 10.1042/BJ20020707; Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; Calzi SL, 2010, MICROVASC RES, V79, P207, DOI 10.1016/j.mvr.2010.02.011; Chang KH, 2007, P NATL ACAD SCI USA, V104, P10595, DOI 10.1073/pnas.0702072104; Chaqour B, 2006, J BIOL CHEM, V281, P20608, DOI 10.1074/jbc.M600214200; Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200; Chen CC, 2010, J CELL COMMUN SIGNAL, V4, P63, DOI 10.1007/s12079-009-0080-4; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chintalapudi MR, 2008, CARCINOGENESIS, V29, P696, DOI 10.1093/carcin/bgn019; Crean JK, 2006, FASEB J, V20, P1712, DOI 10.1096/fj.05-5010fje; Dean RA, 2007, MOL CELL BIOL, V27, P8454, DOI 10.1128/MCB.00821-07; Di Giovanni S, 2012, CELL TISSUE RES, V349, P87, DOI 10.1007/s00441-011-1292-5; Doherty HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012909; Fleck BW, 2008, EARLY HUM DEV, V84, P83, DOI 10.1016/j.earlhumdev.2007.11.008; Gauthier R, 2005, INVEST OPHTH VIS SCI, V46, P3383, DOI 10.1167/iovs.05-0362; Grotendorst GR, 2005, FASEB J, V19, P729, DOI 10.1096/fj.04-3217com; Hall-Glenn F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030562; Hanna M, 2009, J BIOL CHEM, V284, P23125, DOI 10.1074/jbc.M109.019059; HARENDZA S, 1995, J BIOL CHEM, V270, P18786, DOI 10.1074/jbc.270.32.18786; Hasan A, 2011, J BIOL CHEM, V286, P9542, DOI 10.1074/jbc.M110.198689; He SK, 2008, INVEST OPHTH VIS SCI, V49, P4078, DOI 10.1167/iovs.07-1302; Hinton DR, 2004, DIABETES CARE, V27, P758, DOI 10.2337/diacare.27.3.758; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Ishida S, 2003, NAT MED, V9, P781, DOI 10.1038/nm877; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Kalka C, 2000, HERZ, V25, P611, DOI 10.1007/PL00001974; Katsube K, 2009, DEV GROWTH DIFFER, V51, P55, DOI 10.1111/j.1440-169X.2009.01077.x; Kireeva ML, 1997, EXP CELL RES, V233, P63, DOI 10.1006/excr.1997.3548; Kociok N, 2006, INVEST OPHTH VIS SCI, V47, P5057, DOI 10.1167/iovs.06-0407; Kordower JH, 1999, EXP NEUROL, V160, P1, DOI 10.1006/exnr.1999.7178; Kowluru RA, 2009, FREE RADICAL BIO MED, V46, P1677, DOI 10.1016/j.freeradbiomed.2009.03.024; Kubota Satoshi, 2007, Angiogenesis, V10, P1, DOI 10.1007/s10456-006-9058-5; Kuiper EJ, 2008, J HISTOCHEM CYTOCHEM, V56, P785, DOI 10.1369/jhc.2008.950980; Kuiper EJ, 2007, J HISTOCHEM CYTOCHEM, V55, P1139, DOI 10.1369/jhc.7A7258.2007; Kuiper EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002675; Kunz M, 2003, J BIOL CHEM, V278, P45651, DOI 10.1074/jbc.M301373200; Leask A, 2009, J CELL COMMUN SIGNAL, V3, P89, DOI 10.1007/s12079-009-0037-7; Lee JG, 2005, P NATL ACAD SCI USA, V102, P16345, DOI 10.1073/pnas.0508085102; Lee T, 2003, J VASC SURG, V38, P147, DOI 10.1016/S0741-5214(02)75468-2; Liu HB, 2008, ENDOCRINOLOGY, V149, P1666, DOI 10.1210/en.2007-1415; McVicar CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011870; Mohammad G, 2010, LAB INVEST, V90, P1365, DOI 10.1038/labinvest.2010.89; Pi LY, 2011, INVEST OPHTH VIS SCI, V52, P8701, DOI 10.1167/iovs.11-7870; Quinn GE, 2010, CHINESE MED J-PEKING, V123, P2929, DOI 10.3760/cma.j.issn.0366-6999.2010.20.033; Sakimoto S, 2012, DEVELOPMENT, V139, P1327, DOI 10.1242/dev.072330; Samarin J, 2010, J BIOL CHEM, V285, P4328, DOI 10.1074/jbc.M109.049650; Sapieha P, 2010, J CLIN INVEST, V120, P3022, DOI 10.1172/JCI42142; Scott A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011863; Shimo T, 1999, J BIOCHEM-TOKYO, V126, P137, DOI 10.1093/oxfordjournals.jbchem.a022414; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Suofu Y, 2012, NEUROSCIENCE, V212, P180, DOI 10.1016/j.neuroscience.2012.03.036; Suzuma K, 2000, J BIOL CHEM, V275, P40725, DOI 10.1074/jbc.M006509200; Tronc F, 2000, ARTERIOSCL THROM VAS, V20, pE120, DOI 10.1161/01.ATV.20.12.e120; Twigg SM, 2001, ENDOCRINOLOGY, V142, P1760, DOI 10.1210/endo.142.5.8141; Vinores SA, 2007, J NEUROIMMUNOL, V182, P73, DOI 10.1016/j.jneuroim.2006.09.015; Watson MG, 2012, J R SOC INTERFACE, V9, P2351, DOI 10.1098/rsif.2012.0067; Weidemann A, 2010, GLIA, V58, P1177, DOI 10.1002/glia.20997; Wunderlich K, 2000, GRAEF ARCH CLIN EXP, V238, P910, DOI 10.1007/s004170000199; Yoon PO, 2010, J MOL CELL CARDIOL, V49, P294, DOI 10.1016/j.yjmcc.2010.04.010; Yu J, 1999, P NATL ACAD SCI USA, V96, P14517, DOI 10.1073/pnas.96.25.14517	69	39	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40570	40585		10.1074/jbc.M112.386565	http://dx.doi.org/10.1074/jbc.M112.386565			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23048035	Green Published, hybrid			2022-12-28	WOS:000311448800047
J	Rosenhouse-Dantsker, A; Noskov, S; Han, HZ; Adney, SK; Tang, QY; Rodriguez-Menchaca, AA; Kowalsky, GB; Petrou, VI; Osborn, CV; Logothetis, DE; Levitan, I				Rosenhouse-Dantsker, Avia; Noskov, Sergei; Han, Huazhi; Adney, Scott K.; Tang, Qiong-Yao; Rodriguez-Menchaca, Aldo A.; Kowalsky, Gregory B.; Petrou, Vasileios I.; Osborn, Catherine V.; Logothetis, Diomedes E.; Levitan, Irena			Distant Cytosolic Residues Mediate a Two-way Molecular Switch That Controls the Modulation of Inwardly Rectifying Potassium (Kir) Channels by Cholesterol and Phosphatidylinositol 4,5-Bisphosphate (PI(4,5)P-2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED ANION CURRENT; MEMBRANE CHOLESTEROL; K+ CHANNELS; CRYSTAL-STRUCTURE; SENSITIVITY; ACTIVATION; HYPERCHOLESTEROLEMIA; PIP2; IDENTIFICATION; DYNAMICS	Inwardly rectifying potassium (Kir) channels play an important role in setting the resting membrane potential and modulating membrane excitability. An emerging feature of several Kir channels is that they are regulated by cholesterol. However, the mechanism by which cholesterol affects channel function is unclear. Here we show that mutations of two distant Kir2.1 cytosolic residues, Leu-222 and Asn-251, form a two-way molecular switch that controls channel modulation by cholesterol and affects critical hydrogen bonding. Notably, these two residues are linked by a residue chain that continues from Asn-251 to connect adjacent subunits. Furthermore, our data indicate that the same switch also regulates the sensitivity of the channels to phosphatidylinositol 4,5-bisphosphate, a phosphoinositide that is required for activation of Kir channels. Thus, although cholesterol and phosphatidylinositol 4,5-bisphosphate do not interact with the same region of Kir2.1, these different modulators induce a common gating pathway of the channel.	[Rosenhouse-Dantsker, Avia; Han, Huazhi; Kowalsky, Gregory B.; Osborn, Catherine V.; Levitan, Irena] Univ Illinois, Dept Med, Pulm Sect, Chicago, IL 60612 USA; [Noskov, Sergei] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Noskov, Sergei] Univ Calgary, Inst Biocomplex & Informat, Calgary, AB T2N 1N4, Canada; [Adney, Scott K.; Tang, Qiong-Yao; Rodriguez-Menchaca, Aldo A.; Petrou, Vasileios I.; Logothetis, Diomedes E.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23298 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Calgary; University of Calgary; Virginia Commonwealth University	Rosenhouse-Dantsker, A (corresponding author), Univ Illinois, Dept Med, Pulm Sect, Chicago, IL 60612 USA.	dantsker@uic.edu	Rodríguez-Menchaca, Aldo A./AAD-4603-2019; Petrou, Vasileios/U-5296-2017; Han, Huazhi/B-2261-2015; Noskov, Sergei/B-3654-2010	Rodríguez-Menchaca, Aldo A./0000-0001-7501-8836; Petrou, Vasileios/0000-0002-3194-9863; Noskov, Sergei/0000-0001-7769-335X; Adney, Scott/0000-0001-8743-5944	National Institutes of Health [HL-073965, HL-083298, HL-059949]; American Heart Association [11SDG5190025]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083298, R01HL073965, R01HL059949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-073965, HL-083298 (to I. L.), and HL-059949 (to D. E. L.). This work was also supported by American Heart Association Scientist Development Grant 11SDG5190025 (to A. R.-D.).	Ambudkar Indu S, 2004, Sci STKE, V2004, ppe32, DOI 10.1126/stke.2432004pe32; BOLOTINA V, 1989, PFLUG ARCH EUR J PHY, V415, P262, DOI 10.1007/BF00370875; Bowles DK, 2004, J APPL PHYSIOL, V96, P2240, DOI 10.1152/japplphysiol.01229.2003; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; D'Avanzo N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019393; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; Epshtein Y, 2009, P NATL ACAD SCI USA, V106, P8055, DOI 10.1073/pnas.0809847106; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; He C, 2002, J BIOL CHEM, V277, P6088, DOI 10.1074/jbc.M104851200; Heaps CL, 2005, AM J PHYSIOL-HEART C, V288, pH568, DOI 10.1152/ajpheart.00157.2004; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hilgemann Donald W., 1995, P307; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUTTER OF, 1960, NATURE, V188, P495, DOI 10.1038/188495a0; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Levitan I, 2000, J GEN PHYSIOL, V115, P405, DOI 10.1085/jgp.115.4.405; Levitan I, 2010, SUBCELL BIOCHEM, V51, P509, DOI 10.1007/978-90-481-8622-8_19; Levitan I, 2009, IUBMB LIFE, V61, P781, DOI 10.1002/iub.192; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Lundbaek JA, 1996, BIOCHEMISTRY-US, V35, P3825, DOI 10.1021/bi952250b; Lundbaek JA, 2004, J GEN PHYSIOL, V123, P599, DOI 10.1085/jgp.200308996; Martens JR, 2000, J BIOL CHEM, V275, P7443, DOI 10.1074/jbc.275.11.7443; Martens JR, 2001, J BIOL CHEM, V276, P8409, DOI 10.1074/jbc.M009948200; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Mirshahi T, 2006, BIOPHYS J, V90, P2776, DOI 10.1529/biophysj.105.069302; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Noskov SY, 2004, NATURE, V431, P830, DOI 10.1038/nature02943; OLESEN SP, 1988, NATURE, V331, P168, DOI 10.1038/331168a0; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Romanenko VG, 2004, BIOPHYS J, V87, P3850, DOI 10.1529/biophysj.104.043273; Romanenko VG, 2004, J GEN PHYSIOL, V123, P77, DOI 10.1085/jgp.200308882; Romanenko VG, 2002, BIOPHYS J, V83, P3211, DOI 10.1016/S0006-3495(02)75323-X; Rosenhouse-Dantsker A, 2008, NAT CHEM BIOL, V4, P624, DOI 10.1038/nchembio.112; Rosenhouse-Dantsker A, 2007, PFLUG ARCH EUR J PHY, V455, P45, DOI 10.1007/s00424-007-0291-6; Rosenhouse-Dantsker A, 2012, COMPR PHYSIOL, V2, P31, DOI 10.1002/cphy.c110001; Rosenhouse-Dantsker A, 2011, BIOPHYS J, V100, P381, DOI 10.1016/j.bpj.2010.11.086; Rosenhouse-Dantsker A, 2010, CHANNELS, V4, P63, DOI 10.4161/chan.4.1.10366; Rosenhouse-Dantsker A, 2006, BIOPHYS J, V91, P2860, DOI 10.1529/biophysj.105.080242; Sanguinetti M. C., 2010, CARDIAC ELECTROPHYSI, P105; Santiago J, 2001, J BIOL CHEM, V276, P46523, DOI 10.1074/jbc.M104563200; Singh DK, 2011, BBA-BIOMEMBRANES, V1808, P2527, DOI 10.1016/j.bbamem.2011.07.006; Singh DK, 2009, J BIOL CHEM, V284, P30727, DOI 10.1074/jbc.M109.011221; Soom M, 2001, FEBS LETT, V490, P49, DOI 10.1016/S0014-5793(01)02136-6; Tai KH, 2009, BIOCHEMISTRY-US, V48, P8758, DOI 10.1021/bi9007808; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Tikku S, 2007, AM J PHYSIOL-CELL PH, V293, pC440, DOI 10.1152/ajpcell.00492.2006; Toselli M, 2005, BIOPHYS J, V89, P2443, DOI 10.1529/biophysj.105.065623; WU CC, 1995, J MOL CELL CARDIOL, V27, P1263, DOI 10.1016/S0022-2828(05)82388-0; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Yokogawa M, 2011, J BIOL CHEM, V286, P2215, DOI 10.1074/jbc.M110.160754; Zaritsky JJ, 2000, CIRC RES, V87, P160, DOI 10.1161/01.RES.87.2.160; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	59	19	19	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40266	40278		10.1074/jbc.M111.336339	http://dx.doi.org/10.1074/jbc.M111.336339			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	22995912	Green Published, hybrid			2022-12-28	WOS:000311448800019
J	Connolly, S; Kingsbury, T				Connolly, Sean; Kingsbury, Tami			Regulatory Subunit Myristoylation Antagonizes Calcineurin Phosphatase Activation in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CALCIUM SENSOR; PROTEIN N-MYRISTOYLTRANSFERASE; MYRISTIC ACID AUXOTROPHY; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; TARGET; BINDING; STRESS; NFAT	The Ca2+/calmodulin-stimulated protein phosphatase calcineurin is a critical component of Ca2+ signaling cascades in eukaryotic cells. Myristoylation of the regulatory subunit of calcineurin (CNB) is conserved from yeast to humans. Here, we show that CNB myristoylation antagonizes phosphatase activation in yeast. Disruption of CNB myristoylation by mutation of the myristoylated glycine triggered constitutive expression of a calcineurin-dependent reporter gene and enhanced calcineurin-dependent phenotypes. Basal phosphatase activity was also increased in nmt1-181 yeast with reduced N-myristoyltransferase activity. Our findings are the first demonstration of a functional role for CNB myristoylation and reveal the importance of Nmt1 in modulating cellular calcineurin activation.	[Connolly, Sean; Kingsbury, Tami] Univ Maryland, Ctr Stem Cell Biol & Regenerat Med, Marlene & Stewart Greenbaum Canc Ctr, Dept Physiol,Program Oncol,Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Kingsbury, T (corresponding author), Univ Maryland, Ctr Stem Cell Biol & Regenerat Med, Marlene & Stewart Greenbaum Canc Ctr, Dept Physiol,Program Oncol,Sch Med, 20 S Penn St, Baltimore, MD 21201 USA.	tking001@umaryland.edu			National Institutes of Health from the NCI [R021 NS058464, 3P30CA134274]; NATIONAL CANCER INSTITUTE [P30CA134274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS058464] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R021 NS058464 (to T. K.) and Subaward 3P30CA134274 from the NCI.	AITKEN A, 1982, FEBS LETT, V150, P314, DOI 10.1016/0014-5793(82)80759-X; Ames JB, 2012, BBA-GEN SUBJECTS, V1820, P1205, DOI 10.1016/j.bbagen.2011.10.003; AMES JB, 1995, J BIOL CHEM, V270, P4526, DOI 10.1074/jbc.270.9.4526; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Boulware MJ, 2008, CURR BIOL, V18, pR769, DOI 10.1016/j.cub.2008.07.018; Boutin JA, 1997, CELL SIGNAL, V9, P15, DOI 10.1016/S0898-6568(96)00100-3; Buchholz M, 2007, CELL CYCLE, V6, P16, DOI 10.4161/cc.6.1.3650; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; CYERT MS, 1992, MOL CELL BIOL, V12, P3460, DOI 10.1128/MCB.12.8.3460; CYERT MS, 1991, P NATL ACAD SCI USA, V88, P7376, DOI 10.1073/pnas.88.16.7376; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; DURONIO RJ, 1989, SCIENCE, V243, P796, DOI 10.1126/science.2644694; DURONIO RJ, 1991, J CELL BIOL, V113, P1313, DOI 10.1083/jcb.113.6.1313; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Feng B, 2001, BIOCHEMISTRY-US, V40, P8808, DOI 10.1021/bi0025161; GEISER JR, 1991, CELL, V65, P949, DOI 10.1016/0092-8674(91)90547-C; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hayashi N, 2010, P JPN ACAD B-PHYS, V86, P494, DOI 10.2183/pjab.86.494; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Ivings L, 2002, BIOCHEM J, V363, P599, DOI 10.1042/0264-6021:3630599; Jeromin A, 2004, J BIOL CHEM, V279, P27158, DOI 10.1074/jbc.M312172200; JOHNSON DR, 1993, J BIOL CHEM, V268, P483; Kennedy MT, 1996, J BIOL CHEM, V271, P26517, DOI 10.1074/jbc.271.43.26517; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Lee SC, 2007, MOL MICROBIOL, V63, P1039, DOI 10.1111/j.1365-2958.2006.05575.x; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Li XA, 2011, CELL STEM CELL, V8, P46, DOI 10.1016/j.stem.2010.11.027; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu JO, 2003, BIOCHEM BIOPH RES CO, V311, P1103, DOI 10.1016/j.bbrc.2003.10.020; Martin DDO, 2011, BIOCHIMIE, V93, P18, DOI 10.1016/j.biochi.2010.10.018; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; Medyouf H, 2008, CELL CYCLE, V7, P297, DOI 10.4161/cc.7.3.5357; Muller MR, 2009, P NATL ACAD SCI USA, V106, P7034, DOI 10.1073/pnas.0813296106; Mukherjee A, 2011, CURR OPIN CELL BIOL, V23, P223, DOI 10.1016/j.ceb.2010.12.006; Musson REA, 2011, CURR MED CHEM, V18, P301; NAKAMURA T, 1993, EMBO J, V12, P4063, DOI 10.1002/j.1460-2075.1993.tb06090.x; Parekh AB, 2011, TRENDS BIOCHEM SCI, V36, P78, DOI 10.1016/j.tibs.2010.07.013; Peshenko IV, 2012, J BIOL CHEM, V287, P13972, DOI 10.1074/jbc.M112.341883; Peshenko IV, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00019; POLITINO M, 1987, J BIOL CHEM, V262, P10109; Raju RVS, 2000, MOL CELL BIOCHEM, V204, P135, DOI 10.1023/A:1007012622030; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Roy J, 2007, MOL CELL, V25, P889, DOI 10.1016/j.molcel.2007.02.014; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Vega RB, 2003, J BIOL CHEM, V278, P36981, DOI 10.1074/jbc.R300023200; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006; ZHU DH, 1995, J BIOL CHEM, V270, P24831, DOI 10.1074/jbc.270.42.24831	51	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.366617	http://dx.doi.org/10.1074/jbc.M112.366617			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23027860	Green Published, hybrid			2022-12-28	WOS:000311233800008
J	Rao, MD; Liu, HC; Yang, M; Zhao, CC; He, ZG				Rao, Muding; Liu, Huicong; Yang, Min; Zhao, Chunchao; He, Zheng-Guo			A Copper-responsive Global Repressor Regulates Expression of Diverse Membrane-associated Transporters and Bacterial Drug Resistance in Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID METABOLISM; ESCHERICHIA-COLI; GNTR FAMILY; MULTIDRUG-RESISTANCE; TRANSCRIPTION FACTOR; EFFLUX PUMP; MOLECULAR-MECHANISMS; NEGATIVE REGULATOR; TUBERCULOSIS; SMEGMATIS	Sequencing of entire bacterial genomes has led to the identification of many membrane-associated transporters, including several multidrug resistance transport proteins, in recent years. However, the regulators and signaling pathways involved in the expression of these genes remain largely unknown. In this study, we have identified Ms2173, a GntR/FadR family transcription factor, as a novel global regulator in Mycobacterium smegmatis. Ms2173 was found to specifically recognize a 15-bp palindromic motif and to broadly regulate expression of 292 genes, including 37 genes that encode membrane-associated transport proteins. Copper ions induced Ms2173 to form inactive proteins lacking DNA-binding activity. Ms2173 was shown to function as a repressor of its target genes. Interestingly, we found that the function of Ms2173 was linked to mycobacterial drug resistance. Compared with the substantially enhanced drug resistance in the Ms2173-deleted mutant strain, the strains overexpressing Ms2173 were more sensitive to anti-tuberculosis drugs than the wild-type strain. Additionally, copper ions could partially counteract the in vivo function of Ms2173. We have thus characterized the first mycobacterial GntR/Fad-like transcription factor that functions as a copper ion-responsive global repressor that we have renamed GfcR. These findings further enhance our understanding of membrane-associated transporter regulation and drug resistance in mycobacteria.	[Rao, Muding; Liu, Huicong; Yang, Min; Zhao, Chunchao; He, Zheng-Guo] Huazhong Agr Univ, Coll Life Sci & Technol, Natl Key Lab Agr Microbiol, Ctr Prote Res, Wuhan 430070, Peoples R China	Huazhong Agricultural University	He, ZG (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Natl Key Lab Agr Microbiol, Ctr Prote Res, Wuhan 430070, Peoples R China.	he.zhengguo@hotmail.com	He, Zheng-Guo/P-3647-2014	Yang, Min/0000-0003-2924-5717; Rao, Muding/0000-0001-9399-2333	National Natural Science Foundation of China [31025002, 30930003]; Fundamental Research Funds for the Central Universities [2011PY140]; Creative Research Groups of Hubei; Hubei Chutian Scholar Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Creative Research Groups of Hubei; Hubei Chutian Scholar Program	This work was supported by National Natural Science Foundation of China Grants 31025002 and 30930003, by Fundamental Research Funds for the Central Universities Grant 2011PY140, by the Creative Research Groups of Hubei, and by the Hubei Chutian Scholar Program (to H. Z. G.).	Agranoff D, 2004, FRONT BIOSCI-LANDMRK, V9, P2996, DOI 10.2741/1454; Aguilera L, 2008, J BACTERIOL, V190, P2997, DOI [10.1128/JB.02013-07, 10.1128/JB.00815-08]; AHMED M, 1994, J BIOL CHEM, V269, P28506; Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Alekshun MN, 1999, J BACTERIOL, V181, P4669, DOI 10.1128/JB.181.15.4669-4672.1999; Alland D, 2000, J BACTERIOL, V182, P1802, DOI 10.1128/JB.182.7.1802-1811.2000; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Casali N, 2006, J BACTERIOL, V188, P441, DOI 10.1128/JB.188.2.441-449.2006; Colangeli R, 2005, MOL MICROBIOL, V55, P1829, DOI 10.1111/j.1365-2958.2005.04510.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davies J., 1997, ANTIBIOTIC RESISTANC; De Rossi E, 2006, FEMS MICROBIOL REV, V30, P36, DOI 10.1111/j.1574-6976.2005.00000.x; DIRUSSO CC, 1992, J BIOL CHEM, V267, P8685; Festa RA, 2011, MOL MICROBIOL, V79, P133, DOI 10.1111/j.1365-2958.2010.07431.x; Franco IS, 2006, J BACTERIOL, V188, P3024, DOI 10.1128/JB.188.8.3024-3036.2006; Gaballa A, 2003, MICROBIOL-SGM, V149, P3413, DOI 10.1099/mic.0.26225-0; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; Grkovic S, 1998, J BIOL CHEM, V273, P18665, DOI 10.1074/jbc.273.29.18665; HAYDON DJ, 1991, FEMS MICROBIOL LETT, V79, P291, DOI 10.1016/0378-1097(91)90101-F; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Lee MH, 2003, J BACTERIOL, V185, P4315, DOI 10.1128/JB.185.15.4315-4325.2003; Li XZ, 2009, DRUGS, V69, P1555, DOI 10.2165/11317030-000000000-00000; Li XZ, 2004, ANTIMICROB AGENTS CH, V48, P2415, DOI 10.1128/AAC.48.7.2415-2423.2004; Li YQ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-242; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; LOMOVSKAYA O, 1995, J BACTERIOL, V177, P2328, DOI 10.1128/jb.177.9.2328-2334.1995; Louw GE, 2009, ANTIMICROB AGENTS CH, V53, P3181, DOI 10.1128/AAC.01577-08; Lubelski J, 2007, MICROBIOL MOL BIOL R, V71, P463, DOI 10.1128/MMBR.00001-07; Paulsen IT, 2001, J MOL MICROB BIOTECH, V3, P145; Rigali S, 2002, J BIOL CHEM, V277, P12507, DOI 10.1074/jbc.M110968200; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Spagnolo L, 2004, J BIOL CHEM, V279, P33447, DOI 10.1074/jbc.M404699200; Stoyanov JV, 2001, MOL MICROBIOL, V39, P502, DOI 10.1046/j.1365-2958.2001.02264.x; Strausak D, 1997, J BIOL CHEM, V272, P8932; Tojo S, 2011, J BACTERIOL, V193, P2388, DOI 10.1128/JB.00016-11; van Aalten DMF, 2000, EMBO J, V19, P5167, DOI 10.1093/emboj/19.19.5167; van Aalten DMF, 2001, EMBO J, V20, P2041, DOI 10.1093/emboj/20.8.2041; Vindal V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-289; Vindal V, 2007, TUBERCULOSIS, V87, P242, DOI 10.1016/j.tube.2006.11.002; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Wang Y, 2011, J BIOL CHEM, V286, P31159, DOI 10.1074/jbc.M111.241802; World Health Organization, 2010, GLOB TUB CONTR WHO R; Xu YB, 2001, J BIOL CHEM, V276, P17373, DOI 10.1074/jbc.M100195200; Yang M, 2012, NUCLEIC ACIDS RES, V40, P1009, DOI 10.1093/nar/gkr830; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010672; Zheng MY, 2009, ACTA CRYSTALLOGR D, V65, P356, DOI 10.1107/S0907444909004727	51	18	20	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.383604	http://dx.doi.org/10.1074/jbc.M112.383604			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23014988	Green Published, hybrid			2022-12-28	WOS:000311233800041
J	Aynaud, MM; Suspene, R; Vidalain, PO; Mussil, B; Guetard, D; Tangy, F; Wain-Hobson, S; Vartanian, JP				Aynaud, Marie-Ming; Suspene, Rodolphe; Vidalain, Pierre-Olivier; Mussil, Bianka; Guetard, Denise; Tangy, Frederic; Wain-Hobson, Simon; Vartanian, Jean-Pierre			Human Tribbles 3 Protects Nuclear DNA from Cytidine Deamination by APOBEC3A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-B-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; SOMATIC HYPERMUTATION; HUMAN HEPATOCYTES; EDITING ENZYMES; VIF PROTEIN; CELL-DEATH; HIV-1 DNA; IN-VIVO; EXPRESSION	The human polydeoxynucleotide cytidine deaminases APOBEC3A, APOBEC3C, and APOBEC3H are capable of mutating viral DNA in the nucleus, whereas APOBEC3A alone efficiently edits nuclear DNA. Deamination is rapidly followed by excision of uracil residues and can lead to double-stranded breaks. It is not known to which protein networks these DNA mutators belong. Using a yeast two-hybrid screen, we identified the human homolog of Drosophila Tribbles 3, TRIB3, as an interactor for APOBEC3A and APOBEC3C. The interaction was confirmed by co-affinity purification. Co-transfection of APOBEC3A with a TRIB3 expression vector reduced nuclear DNA editing whereas siRNA knockdown of TRIB3 increased the levels of nuclear DNA editing, indicating that TRIB3 functioned as a repressor of A3A. It also repressed A3A-associated gamma H2AX positive double-stranded breaks. The interaction results in degradation of A3A in a proteasome-independent manner. TRIB3 has been linked to cancer and via its own interactors and links the A3A DNA mutators to the Rb-BRCA1-ATM network. TRIB3 emerges as an important guardian of genome integrity.	[Aynaud, Marie-Ming; Suspene, Rodolphe; Mussil, Bianka; Guetard, Denise; Wain-Hobson, Simon; Vartanian, Jean-Pierre] Inst Pasteur, CNRS URA3015, Mol Retrovirol Unit, F-75724 Paris 15, France; [Vidalain, Pierre-Olivier; Tangy, Frederic] Inst Pasteur, CNRS URA3015, Viral Genom & Vaccinat Unit, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Wain-Hobson, S (corresponding author), Inst Pasteur, CNRS URA3015, Mol Retrovirol Unit, 28 Rue Dr Roux, F-75724 Paris 15, France.	simon.wain-hobson@pasteur.fr	Vidalain, Pierre-Olivier/F-9778-2019	Vidalain, Pierre-Olivier/0000-0003-3082-7407; Vartanian, Jean-Pierre/0000-0001-8079-8814	Institut Pasteur; CNRS; la Ligue pour la Recherche contre le Cancer; l'Association pour la Recherche contre le Cancer	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); la Ligue pour la Recherche contre le Cancer; l'Association pour la Recherche contre le Cancer	This work was supported by grants from Institut Pasteur and the CNRS. The Molecular Retrovirology Unit is equipe labellise par la Ligue pour la Recherche contre le Cancer.; Supported by a graduate fellowship from la Ligue pour la Recherche contre le Cancer.; Supported by a postdoctoral fellowship from l'Association pour la Recherche contre le Cancer.	Berger G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002221; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Bross L, 2002, J EXP MED, V195, P1187, DOI 10.1084/jem.20011749; Bulliard Y, 2011, J VIROL, V85, P1765, DOI 10.1128/JVI.01651-10; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Chinnadurai G, 2006, BBA-REV CANCER, V1765, P67, DOI 10.1016/j.bbcan.2005.09.002; Conticello SG, 2008, MOL CELL, V31, P474, DOI 10.1016/j.molcel.2008.07.009; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Hasham MG, 2010, NAT IMMUNOL, V11, P820, DOI 10.1038/ni.1909; Hegedus Z, 2007, CELL SIGNAL, V19, P238, DOI 10.1016/j.cellsig.2006.06.010; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Humphrey RK, 2010, J BIOL CHEM, V285, P22426, DOI 10.1074/jbc.M110.123786; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Johnson JA, 2012, DIABETOLOGIA, V55, P1607, DOI 10.1007/s00125-012-2525-1; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Komori J, 2008, HEPATOLOGY, V47, P888, DOI 10.1002/hep.22125; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; Kou T, 2007, INT J CANCER, V120, P469, DOI 10.1002/ijc.22292; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Mayumi-Matsuda K, 1999, BIOCHEM BIOPH RES CO, V258, P260, DOI 10.1006/bbrc.1999.0576; Mendoza JA, 2006, J VIROL, V80, P12420, DOI 10.1128/JVI.02576-05; Noguchi C, 2005, HEPATOLOGY, V41, P626, DOI 10.1002/hep.20580; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Refsland EW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002800; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Renehan AG, 2012, DIABETOLOGIA, V55, P1619, DOI 10.1007/s00125-012-2526-0; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rosler C, 2005, HEPATOLOGY, V42, P301, DOI 10.1002/hep.20801; Sakai S, 2010, BIOL PHARM BULL, V33, P1112, DOI 10.1248/bpb.33.1112; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Smith SM, 2011, J IMMUNOL, V186, P2462, DOI 10.4049/jimmunol.1000864; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Suspene R, 2005, J GEN VIROL, V86, P125, DOI 10.1099/vir.0.80426-0; Suspene R, 2011, J VIROL, V85, P7594, DOI 10.1128/JVI.00290-11; Suspene R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; Takai A, 2009, ONCOGENE, V28, P469, DOI 10.1038/onc.2008.415; Tsuge M, 2010, VIRUS RES, V149, P211, DOI 10.1016/j.virusres.2010.01.019; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Vartanian JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000928; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; WANG ZG, 1988, J BACTERIOL, V170, P1082, DOI 10.1128/jb.170.3.1082-1091.1988; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Xu JM, 2007, BBA-GEN SUBJECTS, V1770, P273, DOI 10.1016/j.bbagen.2006.09.025; Wasef SZY, 2006, AM J PHYSIOL-ENDOC M, V291, pE1274, DOI 10.1052/ajpendo.00117.2006; YAMANAKA S, 1995, P NATL ACAD SCI USA, V92, P8483, DOI 10.1073/pnas.92.18.8483; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	61	51	60	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39182	39192		10.1074/jbc.M112.372722	http://dx.doi.org/10.1074/jbc.M112.372722			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22977230	hybrid, Green Published			2022-12-28	WOS:000310982800073
J	Socodato, R; Santiago, FN; Portugal, CC; Domingues, AF; Santiago, AR; Relvas, JB; Ambrosio, AF; Paes-de-Carvalho, R				Socodato, Renato; Santiago, Felipe N.; Portugal, Camila C.; Domingues, Ana F.; Santiago, Ana R.; Relvas, Joao B.; Ambrosio, Antonio F.; Paes-de-Carvalho, Roberto			Calcium-permeable alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptors Trigger Neuronal Nitric-oxide Synthase Activation to Promote Nerve Cell Death in an Src Kinase-dependent Fashion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-PERMEABLE AMPA RECEPTORS; EMBRYO RETINA CELLS; CREB PHOSPHORYLATION; CYCLIC-GMP; IN-VITRO; EXPRESSION; GLUTAMATE; PROLIFERATION; SYNTHETASE; NMDA	In the retina information decoding is dependent on excitatory neurotransmission and is critically modulated by AMPA glutamate receptors. The Src-tyrosine kinase has been implicated in modulating neurotransmission in CNS. Thus, our main goal was to correlate AMPA-mediated excitatory neurotransmission with the modulation of Src activity in retinal neurons. Cultured retinal cells were used to access the effects of AMPA stimulation on nitric oxide (NO) production and Src phosphorylation. 4-Amino-5-methylamino-2',7'-difluorofluoresceindiacetatefluorescence mainly determined NO production, and immunocytochemistry and Western blotting evaluated Src activation. AMPA receptors activation rapidly up-regulated Src phosphorylation at tyrosine 416 (stimulatory site) and down-regulated phosphotyrosine 527 (inhibitory site) in retinal cells, an effect mainly mediated by calcium-permeable AMPA receptors. Interestingly, experiments confirmed that neuronal NOS was activated in response to calcium-permeable AMPA receptor stimulation. Moreover, data suggest NO pathway as a key regulatory signaling in AMPA-induced Src activation in neurons but not in glial cells. The NO donor SNAP (S-nitroso-N-acetyl-DL-penicillamine) and a soluble guanylyl cyclase agonist (YC-1) mimicked AMPA effect in Src Tyr-416 phosphorylation, reinforcing that Src activation is indeed modulated by the NO pathway. Gain and loss-of-function data demonstrated that ERK is a downstream target of AMPA-induced Src activation and NO signaling. Furthermore, AMPA stimulated NO production in organotypic retinal cultures and increased Src activity in the in vivo retina. Additionally, AMPA-induced apoptotic retinal cell death was regulated by both NOS and Src activity. Because Src activity is pivotal in several CNS regions, the data presented herein highlight that Src modulation is a critical step in excitatory retinal cell death.	[Paes-de-Carvalho, Roberto] Univ Fed Fluminense, Inst Biol, Dept Neurobiol, Programa Neurociencias, BR-24020971 Niteroi, RJ, Brazil; [Socodato, Renato; Portugal, Camila C.; Santiago, Ana R.; Ambrosio, Antonio F.] Univ Coimbra, Fac Med, Inst Biolmed Invest Luz & Imagem, Ctr Ophthalmol & Vis Sci, P-3004548 Coimbra, Portugal; [Domingues, Ana F.; Relvas, Joao B.] Inst Mol & Cellular Biol, P-4150180 Oporto, Portugal	Universidade Federal Fluminense; Universidade de Coimbra; Universidade do Porto	Paes-de-Carvalho, R (corresponding author), Univ Fed Fluminense, Inst Biol, Dept Neurobiol, Programa Neurociencias, Caixa Postal 100180, BR-24020971 Niteroi, RJ, Brazil.	robpaes@vm.uff.br	Portugal, Camila C/A-6267-2013; Paes-de-Carvalho, Roberto/F-8788-2018; Ambrósio, António F/I-3722-2012; Santiago, Ana Raquel/I-6566-2013; Relvas, Joao B/A-1142-2008; Socodato, Renato/A-7237-2013	Portugal, Camila C/0000-0002-1093-6545; Paes-de-Carvalho, Roberto/0000-0002-4081-7547; Ambrósio, António F/0000-0002-0477-1641; Santiago, Ana Raquel/0000-0002-7541-7041; Relvas, Joao B/0000-0001-7636-0924; Socodato, Renato/0000-0002-6882-5020; Domingues, Ana Filipa/0000-0003-3062-9144	CNPq; CAPES; FAPERJ; PRONEX/FAPERJ; CAPES/FCT fellowships [4349/10-9, 4349/10-5]; FCT, Portugal [PEst-C/SAU/UI3282/2011]; FEDER-COMPETE-POFC [PEst-C/SAU/UI3282/2011]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); PRONEX/FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES/FCT fellowships; FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER-COMPETE-POFC	This work was supported by grants from CNPq, CAPES, FAPERJ, PRONEX/FAPERJ, CAPES/FCT fellowships (processes 4349/10-9 and 4349/10-5) and by PEst-C/SAU/UI3282/2011 (FCT, Portugal, and FEDER-COMPETE-POFC).	Allcorn S, 1996, EUR J NEUROSCI, V8, P2499, DOI 10.1111/j.1460-9568.1996.tb01544.x; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Catsicas M, 2001, J NEUROBIOL, V49, P200, DOI 10.1002/neu.1075; Cossenza M, 2000, J NEUROCHEM, V74, P1885, DOI 10.1046/j.1471-4159.2000.0741885.x; Cristovao AJ, 2002, INT J DEV NEUROSCI, V20, P1, DOI 10.1016/S0736-5748(02)00006-0; Socodato RED, 2009, J NEUROCHEM, V108, P417, DOI 10.1111/j.1471-4159.2008.05778.x; Diamond JS, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00027; Fischer AJ, 1999, J COMP NEUROL, V405, P1, DOI 10.1002/(SICI)1096-9861(19990301)405:1<1::AID-CNE1>3.0.CO;2-U; Frade JG, 2009, HIPPOCAMPUS, V19, P603, DOI 10.1002/hipo.20536; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; Khanna S, 2007, J BIOL CHEM, V282, P23482, DOI 10.1074/jbc.M611269200; Kitazawa H, 1998, J NEUROPHYSIOL, V79, P137, DOI 10.1152/jn.1998.79.1.137; Kwak S, 2006, CURR OPIN NEUROBIOL, V16, P281, DOI 10.1016/j.conb.2006.05.004; Leung EL, 2010, MOL CANCER RES, V8, P578, DOI 10.1158/1541-7786.MCR-09-0178; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Magalhaes CR, 2006, INT J DEV NEUROSCI, V24, P53, DOI 10.1016/j.ijdevneu.2005.10.004; Mejia-Garcia TA, 2007, J NEUROCHEM, V100, P382, DOI 10.1111/j.1471-4159.2006.04244.x; Mishra OP, 2009, NEUROSCI LETT, V460, P61, DOI 10.1016/j.neulet.2009.05.041; MONCADA S, 1991, PHARMACOL REV, V43, P109; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; Narisawa-Saito M, 1999, NEUROSCIENCE, V88, P1009, DOI 10.1016/S0306-4522(98)00496-5; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Pena-Altamira E, 2010, CURR PHARM DESIGN, V16, P440, DOI 10.2174/138161210790232211; Portugal CC, 2012, J BIOL CHEM, V287, P3860, DOI 10.1074/jbc.M111.260166; Rahman MA, 2010, J BIOL CHEM, V285, P3806, DOI 10.1074/jbc.M109.059782; Rameau GA, 2007, J NEUROSCI, V27, P3445, DOI 10.1523/JNEUROSCI.4799-06.2007; Rangaswami H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001423; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; SCHLAEPFER DD, 1994, NATURE, V372, P786; Socodato R, 2011, J NEUROCHEM, V116, P227, DOI 10.1111/j.1471-4159.2010.07096.x; SORGE LK, 1984, CELL, V36, P249, DOI 10.1016/0092-8674(84)90218-6; TSUBOKAWA H, 1995, J NEUROPHYSIOL, V74, P218, DOI 10.1152/jn.1995.74.1.218; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; ZHANG J, 1994, SCIENCE, V263, P687, DOI 10.1126/science.8080500	38	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38680	38694		10.1074/jbc.M112.353961	http://dx.doi.org/10.1074/jbc.M112.353961			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22992730	hybrid, Green Published			2022-12-28	WOS:000310982800027
J	Zhu-Mauldin, X; Marsh, SA; Zou, LY; Marchase, RB; Chatham, JC				Zhu-Mauldin, Xiaoyuan; Marsh, Susan A.; Zou, Luyun; Marchase, Richard B.; Chatham, John C.			Modification of STIM1 by O-linked N-Acetylglucosamine (O-GlcNAc) Attenuates Store-operated Calcium Entry in Neonatal Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; CA2+ ENTRY; SKELETAL-MUSCLE; CARDIAC-HYPERTROPHY; CHANNEL FUNCTION; CRAC CHANNEL; HEXOSAMINE BIOSYNTHESIS; PLASMA-MEMBRANE; ION SELECTIVITY; ORAI CHANNELS	Store-operated calcium entry (SOCE) is a major Ca2+ signaling pathway responsible for regulating numerous transcriptional events. In cardiomyocytes SOCE has been shown to play an important role in regulating hypertrophic signaling pathways, including nuclear translocation of NFAT. Acute activation of pathways leading to O-GlcNAc synthesis have been shown to impair SOCE-mediated transcription and in diabetes, where O-GlcNAc levels are chronically elevated, cardiac hypertrophic signaling is also impaired. Therefore the goal of this study was to determine whether changes in cardiomyocyte O-GlcNAc levels impaired the function of STIM1, a widely recognized mediator of SOCE. We demonstrated that acute activation of SOCE in neonatal cardiomyocytes resulted in STIM1 puncta formation, which was inhibited in a dose-dependent manner by increasing O-GlcNAc synthesis with glucosamine or inhibiting O-GlcNAcase with thiamet-G. Glucosamine and thiamet-G also inhibited SOCE and were associated with increased O-GlcNAc modification of STIM1. These results suggest that activation of cardiomyocyte O-GlcNAcylation attenuates SOCE via STIM1 O-GlcNAcylation and that this may represent a new mechanism by which increased O-GlcNAc levels regulate Ca2+-mediated events in cardiomyocytes. Further, since SOCE is a fundamental mechanism underlying Ca2+ signaling in most cells and tissues, it is possible that STIM1 represents a nexus linking protein O-GlcNAcylation with Ca2+-mediated transcription.	[Zou, Luyun; Chatham, John C.] Univ Alabama Birmingham, Div Mol & Cellular Pathol, Dept Pathol, Birmingham, AL 35294 USA; [Zhu-Mauldin, Xiaoyuan; Marchase, Richard B.; Chatham, John C.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Marsh, Susan A.] Washington State Univ, Program Nutr & Exercise Physiol, Coll Pharm, Spokane, WA 99210 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Washington State University	Chatham, JC (corresponding author), Univ Alabama Birmingham, Div Mol & Cellular Pathol, Dept Pathol, 1670 Univ Blvd,Volker Hall G038, Birmingham, AL 35294 USA.	jchatham@uab.edu	Marsh, Sue/J-3711-2014	Marsh, Sue/0000-0002-7530-0417	NHLBI, National Institutes of Health [HL104549, HL101192, HL110366]; Washington State University of Office Research; Alabama Drug Discovery Alliance through the UAB CCTS [RR025777]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025777] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL110366, R15HL104549, R01HL101192] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Washington State University of Office Research; Alabama Drug Discovery Alliance through the UAB CCTS; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in whole or in part, by the NHLBI, National Institutes of Health Grants HL104549 (to S. A. M.), HL101192 and HL110366 (to J. C. C.); the Washington State University of Office Research (to S. A. M.), and the Alabama Drug Discovery Alliance through the UAB CCTS RR025777 (to J. C. C. and R. B. M.).	Baba Y, 2009, IMMUNOL REV, V231, P174, DOI 10.1111/j.1600-065X.2009.00813.x; Bannister RA, 2008, BIOPHYS J, V94, P2631, DOI 10.1529/biophysj.107.116467; Bannister RA, 2009, CHANNELS, V3, P268, DOI 10.4161/chan.3.4.9342; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Boglarka L, 2010, AM J PHYSIOL-HEART C, V299, pH1715, DOI 10.1152/ajpheart.00337.2010; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Champattanachai V, 2008, AM J PHYSIOL-CELL PH, V294, pC1509, DOI 10.1152/ajpcell.00456.2007; Cheng KT, 2011, ADV EXP MED BIOL, V704, P435, DOI 10.1007/978-94-007-0265-3_24; Cherednichenko G, 2004, P NATL ACAD SCI USA, V101, P15793, DOI 10.1073/pnas.0403485101; Darbha S, 1996, CELL CALCIUM, V20, P361, DOI 10.1016/S0143-4160(96)90042-1; Deng XX, 2009, J BIOL CHEM, V284, P22501, DOI 10.1074/jbc.R109.018655; Dirksen RT, 2009, J PHYSIOL-LONDON, V587, P3139, DOI 10.1113/jphysiol.2009.172148; Facundo HT, 2012, AM J PHYSIOL-HEART C, V302, pH2122, DOI 10.1152/ajpheart.00775.2011; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2010, CLIN IMMUNOL, V135, P169, DOI 10.1016/j.clim.2010.01.011; Fulop N, 2007, AM J PHYSIOL-HEART C, V292, pH2227, DOI 10.1152/ajpheart.01091.2006; Fulop N, 2007, AM J PHYSIOL-CELL PH, V292, pC1370, DOI 10.1152/ajpcell.00422.2006; Grimaldi M, 2003, J NEUROSCI, V23, P4737; Gruszczynska-Biegala J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019285; Hewavitharana T, 2007, CELL CALCIUM, V42, P173, DOI 10.1016/j.ceca.2007.03.009; Hulot JS, 2011, CIRCULATION, V124, P796, DOI 10.1161/CIRCULATIONAHA.111.031229; Hunton DL, 2004, AM J PHYSIOL-HEART C, V286, pH1124, DOI 10.1152/ajpheart.00162.2003; Hunton DL, 2002, J BIOL CHEM, V277, P14266, DOI 10.1074/jbc.M107167200; Jardin I, 2011, BLOOD CELL MOL DIS, V46, P252, DOI 10.1016/j.bcmd.2010.12.008; Lee KP, 2010, FEBS LETT, V584, P2022, DOI 10.1016/j.febslet.2009.11.078; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liao Y, 2008, P NATL ACAD SCI USA, V105, P2895, DOI 10.1073/pnas.0712288105; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu J, 2006, J MOL CELL CARDIOL, V40, P303, DOI 10.1016/j.yjmcc.2005.11.003; Liu J, 2007, AM J PHYSIOL-HEART C, V293, pH1391, DOI 10.1152/ajpheart.00285.2007; Luo X, 2012, J MOL CELL CARDIOL, V52, P136, DOI 10.1016/j.yjmcc.2011.11.003; Lyfenko AD, 2008, J PHYSIOL-LONDON, V586, P4815, DOI 10.1113/jphysiol.2008.160481; Ma HT, 2008, J IMMUNOL, V180, P2233, DOI 10.4049/jimmunol.180.4.2233; Marsh SA, 2011, AMINO ACIDS, V40, P819, DOI 10.1007/s00726-010-0699-8; McNally BA, 2012, NATURE, V482, P241, DOI 10.1038/nature10752; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; Nagy T, 2006, AM J PHYSIOL-CELL PH, V290, pC57, DOI 10.1152/ajpcell.00263.2005; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Ohba T, 2009, BIOCHEM BIOPH RES CO, V389, P172, DOI 10.1016/j.bbrc.2009.08.117; Pang Y, 2004, DIABETES, V53, P1074, DOI 10.2337/diabetes.53.4.1074; Pang Y, 2002, DIABETES, V51, P3461, DOI 10.2337/diabetes.51.12.3461; Quintana A, 2011, EMBO J, V30, P3895, DOI 10.1038/emboj.2011.289; Rivera AA, 1995, AM J PHYSIOL-CELL PH, V269, pC1482, DOI 10.1152/ajpcell.1995.269.6.C1482; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rosenberg P, 2011, CIRCULATION, V124, P766, DOI 10.1161/CIRCULATIONAHA.111.045179; Salido GM, 2011, ADV EXP MED BIOL, V704, P413, DOI 10.1007/978-94-007-0265-3_23; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Stiber JA, 2011, CELL CALCIUM, V49, P341, DOI 10.1016/j.ceca.2010.11.012; Tamarina NA, 2008, CELL CALCIUM, V44, P533, DOI 10.1016/j.ceca.2008.03.007; Trepakova ES, 2001, J BIOL CHEM, V276, P7782, DOI 10.1074/jbc.M010104200; Uehara A, 2002, CELL CALCIUM, V31, P89, DOI 10.1054/ceca.2001.0257; Vaca L, 2010, CELL CALCIUM, V47, P199, DOI 10.1016/j.ceca.2010.01.002; Valverde CA, 2010, CARDIOVASC RES, V85, P671, DOI 10.1093/cvr/cvp371; Varnai P, 2009, TRENDS PHARMACOL SCI, V30, P118, DOI 10.1016/j.tips.2008.11.005; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Voelkers M, 2010, J MOL CELL CARDIOL, V48, P1329, DOI 10.1016/j.yjmcc.2010.01.020; Walsh CM, 2010, BIOCHEM J, V430, P453, DOI 10.1042/BJ20100650; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Wang YJ, 2009, P NATL ACAD SCI USA, V106, P7391, DOI 10.1073/pnas.0900293106; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103	65	68	70	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39094	39106		10.1074/jbc.M112.383778	http://dx.doi.org/10.1074/jbc.M112.383778			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22992728	hybrid, Green Published			2022-12-28	WOS:000310982800065
J	Ulrich, JD; Kim, MS; Houlihan, PR; Shutov, LP; Mohapatra, DP; Strack, S; Usachev, YM				Ulrich, Jason D.; Kim, Man-Su; Houlihan, Patrick R.; Shutov, Leonid P.; Mohapatra, Durga P.; Strack, Stefan; Usachev, Yuriy M.			Distinct Activation Properties of the Nuclear Factor of Activated T-cells (NFAT) Isoforms NFATc3 and NFATc4 in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; TRANSCRIPTION FACTOR NFAT; CALCINEURIN BINDING-SITE; GENE-EXPRESSION; DEPENDENT TRANSCRIPTION; CREB PHOSPHORYLATION; HIPPOCAMPAL-NEURONS; ALZHEIMERS-DISEASE; NEURAL DEVELOPMENT; CARDIAC MYOCYTES	The Ca2+/calcineurin-dependent transcription factor NFAT (nuclear factor of activated T-cells) is implicated in regulating dendritic and axonal development, synaptogenesis, and neuronal survival. Despite the increasing appreciation for the importance of NFAT-dependent transcription in the nervous system, the regulation and function of specific NFAT isoforms in neurons are poorly understood. Here, we compare the activation of NFATc3 and NFATc4 in hippocampal and dorsal root ganglion neurons following electrically evoked elevations of intracellular Ca2+ concentration ([Ca2+](i)). We find that NFATc3 undergoes rapid dephosphorylation and nuclear translocation that are essentially complete within 20 min, although NFATc4 remains phosphorylated and localized to the cytosol, only exhibiting nuclear localization following prolonged (1-3 h) depolarization. Knocking down NFATc3, but not NFATc4, strongly diminished NFAT-mediated transcription induced by mild depolarization in neurons. By analyzing NFATc3/NFATc4 chimeras, we find that the region containing the serine-rich region-1 (SRR1) mildly affects initial NFAT translocation, although the region containing the serine-proline repeats is critical for determining the magnitude of NFAT activation and nuclear localization upon depolarization. Knockdown of glycogen synthase kinase 3 beta (GSK3 beta) significantly increased the depolarization-induced nuclear localization of NFATc4. In contrast, inhibition of p38 or mammalian target of rapamycin (mTOR) kinases had no significant effect on nuclear import of NFATc4. Thus, electrically evoked [Ca2+](i) elevation in neurons rapidly and strongly activates NFATc3, whereas activation of NFATc4 requires a coincident increase in [Ca2+](i) and suppression of GSK3 beta, with differences in the serine-proline-containing region giving rise to these distinct activation properties of NFATc3 and NFATc4.	[Ulrich, Jason D.; Kim, Man-Su; Houlihan, Patrick R.; Shutov, Leonid P.; Mohapatra, Durga P.; Strack, Stefan; Usachev, Yuriy M.] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA; [Kim, Man-Su] Inje Univ, Coll Pharm, Gimhae, South Korea	University of Iowa; Inje University	Usachev, YM (corresponding author), Univ Iowa, Dept Pharmacol, Carver Coll Med, 2-250 BSB,51 Newton Rd, Iowa City, IA 52242 USA.	yuriy-usachev@uiowa.edu	Mohapatra, Durga/M-2133-2017	Mohapatra, Durga/0000-0001-5016-1281; Strack, Stefan/0000-0002-6175-7280; Usachev, Yuriy/0000-0002-6948-4627	National Institutes of Health [NS054614, NS072432, NS043254, NS056244, NS069898]; NRSA [F31 MH081420]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH081420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069898, R01NS072432, R01NS056244, R56NS056244, R01NS054614, R01NS043254] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS054614 and NS072432 (to Y.M.U.), NS043254 and NS056244 (to S. S.), NS069898 (to D. P. M.), and F31 MH081420 from NRSA (to J.D.U.).	Abbott KL, 1998, MOL BIOL CELL, V9, P2905, DOI 10.1091/mbc.9.10.2905; Abdul HM, 2009, J NEUROSCI, V29, P12957, DOI 10.1523/JNEUROSCI.1064-09.2009; Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Benedito AB, 2005, J BIOL CHEM, V280, P2818, DOI 10.1074/jbc.M408741200; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bushdid PB, 2003, CIRC RES, V92, P1305, DOI 10.1161/01.RES.0000077045.84609.9F; Calabria E, 2009, P NATL ACAD SCI USA, V106, P13335, DOI 10.1073/pnas.0812911106; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chow CW, 1997, SCIENCE, V278, P1638, DOI 10.1126/science.278.5343.1638; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; del Arco PG, 2000, J BIOL CHEM, V275, P13872, DOI 10.1074/jbc.275.18.13872; Dolmetsch Ricardo, 2003, Sci STKE, V2003, pPE4; Gomez-Sintes R, 2010, J CLIN INVEST, V120, P2432, DOI 10.1172/JCI37873; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Groth RD, 2008, EUR J NEUROSCI, V27, P31, DOI 10.1111/j.1460-9568.2007.05980.x; Groth RD, 2007, J NEUROCHEM, V102, P1162, DOI 10.1111/j.1471-4159.2007.04632.x; Groth RD, 2003, J NEUROSCI, V23, P8125; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Horsley V, 2002, J CELL BIOL, V156, P771, DOI 10.1083/jcb.200111073; Hudry E, 2012, J NEUROSCI, V32, P3176, DOI 10.1523/JNEUROSCI.6439-11.2012; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Ichida M, 2001, J BIOL CHEM, V276, P3524, DOI 10.1074/jbc.M004275200; Jackson JG, 2007, MOL PHARMACOL, V72, P303, DOI 10.1124/mol.107.035048; Jayanthi S, 2005, P NATL ACAD SCI USA, V102, P868, DOI 10.1073/pnas.0404990102; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kim MS, 2009, J NEUROSCI, V29, P12101, DOI 10.1523/JNEUROSCI.3384-09.2009; Layne JJ, 2008, AM J PHYSIOL-CELL PH, V295, pC611, DOI 10.1152/ajpcell.00435.2007; Li HM, 2004, J MOL BIOL, V342, P1659, DOI 10.1016/j.jmb.2004.07.068; Liu J, 1999, J IMMUNOL, V162, P4755; Liu ZH, 2011, NAT IMMUNOL, V12, P1063, DOI 10.1038/ni.2113; Luoma JI, 2008, J NEUROSCI, V28, P3159, DOI 10.1523/JNEUROSCI.5227-07.2008; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Martinez-Martinez S, 2006, J BIOL CHEM, V281, P6227, DOI 10.1074/jbc.M513885200; Martinez-Martinez S, 2004, CURR MED CHEM, V11, P997, DOI 10.2174/0929867043455576; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Muller MR, 2009, P NATL ACAD SCI USA, V106, P7034, DOI 10.1073/pnas.0813296106; Nguyen T, 2008, INT J DEV NEUROSCI, V26, P141, DOI 10.1016/j.ijdevneu.2007.10.004; Nguyen T, 2009, J BIOL CHEM, V284, P18816, DOI 10.1074/jbc.M109.015719; Nieves-Cintron M, 2007, J BIOL CHEM, V282, P3231, DOI 10.1074/jbc.M608822200; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Okamura H, 2004, MOL CELL BIOL, V24, P4184, DOI 10.1128/MCB.24.10.4184-4195.2004; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Park S, 2000, P NATL ACAD SCI USA, V97, P7130, DOI 10.1073/pnas.97.13.7130; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; PITTMAN RN, 1993, J NEUROSCI, V13, P3669; Rinne A, 2010, AM J PHYSIOL-HEART C, V298, pH2001, DOI 10.1152/ajpheart.01072.2009; Rossow CF, 2004, CIRC RES, V94, P1340, DOI 10.1161/01.RES.0000128406.08418.34; Santana LF, 2008, CIRC RES, V103, P681, DOI 10.1161/CIRCRESAHA.108.185090; Schwartz N, 2009, NEURON, V62, P655, DOI 10.1016/j.neuron.2009.05.007; Sharma S, 2011, P NATL ACAD SCI USA, V108, P11381, DOI 10.1073/pnas.1019711108; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Shen TS, 2006, MOL BIOL CELL, V17, P1570, DOI 10.1091/mbc.E05-08-0780; Sheridan CM, 2002, J BIOL CHEM, V277, P48664, DOI 10.1074/jbc.M207029200; Soutar MPM, 2010, J NEUROCHEM, V115, P974, DOI 10.1111/j.1471-4159.2010.06988.x; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; Usachev YM, 1999, J PHYSIOL-LONDON, V519, P115, DOI 10.1111/j.1469-7793.1999.0115o.x; Vashishta A, 2009, J NEUROSCI, V29, P15331, DOI 10.1523/JNEUROSCI.4873-09.2009; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006; Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010; Yang TTC, 2008, MOL CELL BIOL, V28, P3489, DOI 10.1128/MCB.01847-07; Yang TTC, 2002, MOL CELL BIOL, V22, P3892, DOI 10.1128/MCB.22.11.3892-3904.2002; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011; Zhou WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043262; Zhu JY, 1999, NATURE, V398, P256, DOI 10.1038/18473; Zhu JY, 1998, CELL, V93, P851, DOI 10.1016/S0092-8674(00)81445-2	81	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.365197	http://dx.doi.org/10.1074/jbc.M112.365197			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22977251	Green Published, hybrid			2022-12-28	WOS:000310642200002
J	Lin, AHM; Lee, BH; Nichols, BL; Quezada-Calvillo, R; Rose, DR; Naim, HY; Hamaker, BR				Lin, Amy Hui-Mei; Lee, Byung-Hoo; Nichols, Buford L.; Quezada-Calvillo, Roberto; Rose, David R.; Naim, Hassan Y.; Hamaker, Bruce R.			Starch Source Influences Dietary Glucose Generation at the Mucosal alpha-Glucosidase Level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL MALTASE-GLUCOAMYLASE; SUBSTRATE BRAKE; CHAIN-LENGTH; DIGESTION; INHIBITION	The quality of starch digestion, related to the rate and extent of release of dietary glucose, is associated with glycemia-related problems such as diabetes and other metabolic syndrome conditions. Here, we found that the rate of glucose generation from starch is unexpectedly associated with mucosal alpha-glucosidases and not just alpha-amylase. This understanding could lead to a new approach to regulate the glycemic response and glucose-related physiologic responses in the human body. There are six digestive enzymes for starch: salivary and pancreatic alpha-amylases and four mucosal alpha-glucosidases, including N- and C-terminal subunits of both maltase-glucoamylase and sucrase-isomaltase. Only the mucosal alpha-glucosidases provide the final hydrolytic activities to produce substantial free glucose. We report here the unique and shared roles of the individual alpha-glucosidases for alpha-glucans persisting after starch is extensively hydrolyzed by alpha-amylase (to produce alpha-limit dextrins (alpha-LDx)). All four alpha-glucosidases share digestion of linear regions of alpha-LDx, and three can hydrolyze branched fractions. The alpha-LDx, which were derived from different maize cultivars, were not all equally digested, revealing that the starch source influences glucose generation at the mucosal alpha-glucosidase level. We further discovered a fraction of alpha-LDx that was resistant to the extensive digestion by the mucosal alpha-glucosidases. Our study further challenges the conventional view that alpha-amylase is the only rate-determining enzyme involved in starch digestion and better defines the roles of individual and collective mucosal alpha-glucosidases. Strategies to control the rate of glucogenesis at the mucosal level could lead to regulation of the glycemic response and improved glucose management in the human body.	[Lin, Amy Hui-Mei; Lee, Byung-Hoo; Hamaker, Bruce R.] Purdue Univ, Whistler Ctr Carbohydrate Res, W Lafayette, IN 47907 USA; [Lin, Amy Hui-Mei; Lee, Byung-Hoo; Hamaker, Bruce R.] Purdue Univ, Dept Food Sci, W Lafayette, IN 47907 USA; [Nichols, Buford L.; Quezada-Calvillo, Roberto] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Nichols, Buford L.; Quezada-Calvillo, Roberto] Baylor Univ, USDA ARS, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Rose, David R.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Naim, Hassan Y.] Univ Vet Med Hannover, Inst Physiol Chem, D-30559 Hannover, Germany	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Baylor College of Medicine; Baylor University; United States Department of Agriculture (USDA); University of Waterloo; University of Veterinary Medicine Hannover, Foundation	Lin, AHM (corresponding author), Purdue Univ, Whistler Ctr Carbohydrate Res, 745 Agr Mall Dr, W Lafayette, IN 47907 USA.	amylin@purdue.edu; hamakerb@purdue.edu	Yoo, Sang-Ho/AAI-4446-2020		Whistler Center for Carbohydrate Research; United States Department of Agriculture/Agricultural Research Service (USDA/ARS) [6250-51000-052]; Heart and Stroke Foundation of Ontario [NA-6305]; Canadian Institutes of Health Research [MOP 111237]; National Institutes of Health [DK58338]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R13DK058338] Funding Source: NIH RePORTER	Whistler Center for Carbohydrate Research; United States Department of Agriculture/Agricultural Research Service (USDA/ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Whistler Center for Carbohydrate Research and in part by United States Department of Agriculture/Agricultural Research Service (USDA/ARS) Grant 6250-51000-052, Heart and Stroke Foundation of Ontario Grant NA-6305, and Canadian Institutes of Health Research Grant MOP 111237. Part of this work was carried by at the Texas Medical Center Digestive Diseases Center (supported by National Institutes of Health Grant DK58338).	Ao ZH, 2007, J AGR FOOD CHEM, V55, P4540, DOI 10.1021/jf063123x; ENGLYST HN, 1992, EUR J CLIN NUTR, V46, pS33; Eskandari R, 2011, CHEM-EUR J, V17, P14817, DOI 10.1002/chem.201102109; FUWA H, 1987, STARCH-STARKE, V39, P295, DOI 10.1002/star.19870390902; Hizukuri S., 1996, CARBOHYDRATES FOOD, P347; Lee BH, 2012, J BIOL CHEM, V287, P31929, DOI 10.1074/jbc.M112.351858; Lin AHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035473; Nelson N, 1944, J BIOL CHEM, V153, P375; Quezada-Calvillo R, 2008, J NUTR, V138, P685, DOI 10.1093/jn/138.4.685; Quezada-Calvillo R, 2007, J PEDIATR GASTR NUTR, V45, P32, DOI 10.1097/MPG.0b013e31804216fc; ROBYT J, 1963, ARCH BIOCHEM BIOPHYS, V100, P451, DOI 10.1016/0003-9861(63)90112-7; SIDDONS RC, 1970, BIOCHEM J, V116, P71, DOI 10.1042/bj1160071; Sim L, 2008, J MOL BIOL, V375, P782, DOI 10.1016/j.jmb.2007.10.069; Sim L, 2010, J BIOL CHEM, V285, P17763, DOI 10.1074/jbc.M109.078980; Sim L, 2010, BIOCHEMISTRY-US, V49, P443, DOI 10.1021/bi9016457; TRINDER P, 1969, J CLIN PATHOL, V22, P246, DOI 10.1136/jcp.22.2.246-b; YUAN RC, 1993, CEREAL CHEM, V70, P81	17	38	39	0	49	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36917	36921		10.1074/jbc.M112.378331	http://dx.doi.org/10.1074/jbc.M112.378331			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22988246	Green Published, hybrid			2022-12-28	WOS:000310588500028
J	Juliana, C; Fernandes-Alnemri, T; Kang, S; Farias, A; Qin, FS; Alnemri, ES				Juliana, Christine; Fernandes-Alnemri, Teresa; Kang, Seokwon; Farias, Andrew; Qin, Fengsong; Alnemri, Emad S.			Non-transcriptional Priming and Deubiquitination Regulate NLRP3 Inflammasome Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; PYROPTOSOME; INHIBITORS	The NLRP3 inflammasome is a key component of the innate immune response to pathogenic infection and tissue damage. It is also involved in the pathogenesis of a number of human diseases, including gouty arthritis, silicosis, atherosclerosis, and type 2 diabetes. The assembly of the NLRP3 inflammasome requires a priming signal derived from pattern recognition or cytokine receptors, followed by a second signal derived from extracellular ATP, pore-forming toxins, or crystalline materials. How these two signals activate the NLRP3 inflammasome is not yet clear. Here, we show that in mouse macrophages, signaling by the pattern recognition receptor TLR4 through MyD88 can rapidly and non-transcriptionally prime NLRP3 by stimulating its deubiquitination. This process is dependent on mitochondrial reactive oxygen species production and can be inhibited by antioxidants. We further show that signaling by ATP can also induce deubiquitination of NLRP3 by a mechanism that is not sensitive to antioxidants. Pharmacological inhibition of NLRP3 deubiquitination completely blocked NLRP3 activation in both mouse and human cells, indicating that deubiquitination of NLRP3 is required for its activation. Our findings suggest that NLRP3 is activated by a two-step deubiquitination mechanism initiated by Toll-like receptor signaling and mitochondrial reactive oxygen species and further potentiated by ATP, which could explain how NLRP3 is activated by diverse danger signals.	[Alnemri, Emad S.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Alnemri, ES (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.	Emad.Alnemri@Jefferson.edu		Juliana, Christine/0000-0002-4314-1407	National Institutes of Health [AG14357, AR055398]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG14357 and AR055398 (to E. S. A.).	Aksentijevich I, 2007, ARTHRITIS RHEUM-US, V56, P1273, DOI 10.1002/art.22491; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	16	482	505	4	85	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36617	36622		10.1074/jbc.M112.407130	http://dx.doi.org/10.1074/jbc.M112.407130			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22948162	Green Published, hybrid			2022-12-28	WOS:000310364000081
J	Schaap, IAT; Eghiaian, F; des Georges, A; Veigel, C				Schaap, Iwan A. T.; Eghiaian, Frederic; des Georges, Amedee; Veigel, Claudia			Effect of Envelope Proteins on the Mechanical Properties of Influenza Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; A VIRUS; ELECTRON-MICROSCOPY; CELL-MEMBRANES; ELASTIC PROPERTIES; VIRAL CAPSIDS; LOW PH; HEMAGGLUTININ; NEURAMINIDASE; PARTICLES	The envelope of the influenza virus undergoes extensive structural change during the viral life cycle. However, it is unknown how lipid and protein components of the viral envelope contribute to its mechanical properties. Using atomic force microscopy, here we show that the lipid envelope of spherical influenza virions is similar to 10 times softer (similar to 0.05 nanonewton nm(-1)) than a viral protein-capsid coat and sustains deformations of one-third of the virion's diameter. Compared with phosphatidylcholine liposomes, it is twice as stiff, due to membrane-attached protein components. We found that virus indentation resulted in a biphasic force-indentation response. We propose that the first phase, including a stepwise reduction in stiffness at similar to 10-nm indentation and similar to 100 piconewtons of force, is due to mobilization of membrane proteins by the indenting atomic force microscope tip, consistent with the glycoprotein ectodomains protruding similar to 13 nm from the bilayer surface. This phase was obliterated for bromelain-treated virions with the ectodomains removed. Following pH 5 treatment, virions were as soft as pure liposomes, consistent with reinforcing proteins detaching from the lipid bilayer. We propose that the soft, pH-dependent mechanical properties of the envelope are critical for the pH-regulated life cycle and support the persistence of the virus inside and outside the host.	[Schaap, Iwan A. T.; Eghiaian, Frederic; Veigel, Claudia] Natl Inst Med Res, London NW7 1AA, England; [des Georges, Amedee] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC National Institute for Medical Research; MRC Laboratory Molecular Biology	Veigel, C (corresponding author), Univ Munich, Dept Cellular Physiol, Schillerstr 44, D-80336 Munich, Germany.	claudia.veigel@med.uni-muenchen.de	Schaap, Iwan A. T./L-3177-2013; Georges, Amédée des/C-3588-2014	Schaap, Iwan A. T./0000-0001-6665-5104; Georges, Amédée des/0000-0002-9704-3781	Medical Research Council; Royal Society; Deutsche Forschungsgemeinschaft [SFB 863]; Centre of Nanosciences, Ludwig-Maximilians Universitat Munchen, Germany; Marie Curie intra-European fellowship	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Centre of Nanosciences, Ludwig-Maximilians Universitat Munchen, Germany; Marie Curie intra-European fellowship(European Commission)	This work was supported by the Medical Research Council, the Royal Society, Deutsche Forschungsgemeinschaft Grant SFB 863, and the Centre of Nanosciences, Ludwig-Maximilians Universitat Munchen, Germany.; Supported by a Marie Curie intra-European fellowship.	Ahmed R, 2007, NAT IMMUNOL, V8, P1188, DOI 10.1038/ni1530; Area E, 2004, P NATL ACAD SCI USA, V101, P308, DOI 10.1073/pnas.0307127101; Biswas S, 2008, J GEN PHYSIOL, V131, P503, DOI 10.1085/jgp.200709932; BLOOM M, 1991, Q REV BIOPHYS, V24, P293, DOI 10.1017/S0033583500003735; BRAND CM, 1972, NATURE-NEW BIOL, V238, P145, DOI 10.1038/newbio238145a0; Burleigh LM, 2005, J VIROL, V79, P1262, DOI 10.1128/JVI.79.2.1262-1270.2005; Burnham NA, 2003, NANOTECHNOLOGY, V14, P1, DOI 10.1088/0957-4484/14/1/301; Calder LJ, 2010, P NATL ACAD SCI USA, V107, P10685, DOI 10.1073/pnas.1002123107; Carrasco C, 2006, P NATL ACAD SCI USA, V103, P13706, DOI 10.1073/pnas.0601881103; Chen BJ, 2008, J VIROL, V82, P10059, DOI 10.1128/JVI.01184-08; Chen BJ, 2007, J VIROL, V81, P7111, DOI 10.1128/JVI.00361-07; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; Coskun U, 2011, STRUCTURE, V19, P1543, DOI 10.1016/j.str.2011.10.010; de Pablo PJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.098101; Delorme N, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.030901; Dimova R, 2000, BIOPHYS J, V79, P340, DOI 10.1016/S0006-3495(00)76296-5; Dublineau A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028043; Giocondi MC, 2010, J GEN VIROL, V91, P329, DOI 10.1099/vir.0.015156-0; Greatorex JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027932; Harris A, 2006, P NATL ACAD SCI USA, V103, P19123, DOI 10.1073/pnas.0607614103; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Ivanovska IL, 2004, P NATL ACAD SCI USA, V101, P7600, DOI 10.1073/pnas.0308198101; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Knipe DM, 2007, FIELDS VIROLOGY; Kol N, 2007, BIOPHYS J, V92, P1777, DOI 10.1529/biophysj.106.093914; Kol N, 2006, BIOPHYS J, V91, P767, DOI 10.1529/biophysj.105.079657; Laney DE, 1997, BIOPHYS J, V72, P806, DOI 10.1016/S0006-3495(97)78714-9; Li S, 2011, BIOPHYS J, V100, P637, DOI 10.1016/j.bpj.2010.12.3701; Lipowski R., 2004, STRUCTURE DYNAMICS M; Michel JP, 2006, P NATL ACAD SCI USA, V103, P6184, DOI 10.1073/pnas.0601744103; Mui B, 2003, METHOD ENZYMOL, V367, P3; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; Polozov IV, 2008, NAT CHEM BIOL, V4, P248, DOI 10.1038/nchembio.77; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; Roos WH, 2007, CELL MOL LIFE SCI, V64, P1484, DOI 10.1007/s00018-007-6451-1; Roos WH, 2009, P NATL ACAD SCI USA, V106, P9673, DOI 10.1073/pnas.0901514106; Rossman JS, 2011, VIROLOGY, V411, P229, DOI 10.1016/j.virol.2010.12.003; RUIGROK RWH, 1989, VIROLOGY, V173, P311, DOI 10.1016/0042-6822(89)90248-1; RUIGROK RWH, 1986, EMBO J, V5, P41, DOI 10.1002/j.1460-2075.1986.tb04175.x; Schaap IAT, 2006, BIOPHYS J, V91, P1521, DOI 10.1529/biophysj.105.077826; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; Schmitz S, 2010, J BIOL CHEM, V285, P36577, DOI 10.1074/jbc.M110.142638; Shvartsman DE, 2003, J CELL BIOL, V163, P879, DOI 10.1083/jcb.200308142; SKEHEL JJ, 1971, VIROLOGY, V44, P396, DOI 10.1016/0042-6822(71)90270-4; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Sun XJ, 2003, J VIROL, V77, P12543, DOI 10.1128/JVI.77.23.12543-12551.2003; Takeda M, 2003, P NATL ACAD SCI USA, V100, P14610, DOI 10.1073/pnas.2235620100; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wood JP, 2010, ENVIRON SCI TECHNOL, V44, P7515, DOI 10.1021/es1016153; Yamaguchi M, 2008, J STRUCT BIOL, V162, P271, DOI 10.1016/j.jsb.2008.01.009	54	48	49	0	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41078	41088		10.1074/jbc.M112.412726	http://dx.doi.org/10.1074/jbc.M112.412726			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23048030	Green Published, hybrid			2022-12-28	WOS:000311887600025
J	Schafer, C; Rymarczyk, G; Ding, L; Kirber, MT; Bolotina, VM				Schaefer, Claudia; Rymarczyk, Grzegorz; Ding, Lai; Kirber, Michael T.; Bolotina, Victoria M.			Role of Molecular Determinants of Store-operated Ca2+ Entry (Orai1, Phospholipase A2 Group 6, and STIM1) in Focal Adhesion Formation and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MONOCYTE CHEMOTAXIS; PROTEIN-KINASE-A; CALCIUM INFLUX; SMOOTH-MUSCLE; I-CRAC; CHANNELS; ACTIN; DYNAMICS; CALPAIN; FORCE	Store-operated Ca2+ entry and its major determinants are known to be important for cell migration, but the mechanism of their involvement in this complex process is unknown. This study presents a detailed characterization of distinct roles of Orai1, STIM1, and PLA2g6 in focal adhesion (FA) formation and migration. Using HEK293 cells, we discovered that although molecular knockdown of Orai1, STIM1, or PLA2g6 resulted in a similar reduction in migration velocity, there were profound differences in their effects on number, localization, and lifetime of FAs. Knockdown of STIM1 caused an increase in lifetime and number of FAs, their redistribution toward lamellae region, and an increase in cell tail length. In contrast, the number of FAs in Orai1- or PLA2g6-deficient cells was significantly reduced, and FAs accumulated closer to the leading edge. Assembly rate and Vinculin phosphorylation of FAs was similarly reduced in Orai1, PLA2g6, or STIM1-deficient cells. Although Orai1 and PLA2g6 accumulated and co-localized at the leading edge, STIM1 distribution was more complex. We found STIM1 protrusions in lamellipodia, which co-localized with FAs, whereas major accumulation could be seen in central and retracting parts of the cell. Interestingly, knockdown of Orai1 and PLA2g6 produced similar and non-additive effect on migration, whereas knockdown of STIM1 simultaneously with either Orai1 or PLA2g6 produced additional inhibition. Together these data suggest that although Orai1, PLA2g6, and STIM1 play major roles in formation of new FAs at the leading edge, STIM1 may also be involved in Orai1- and PLA2g6-independent disassembly of FAs in the back of cells.	[Schaefer, Claudia; Rymarczyk, Grzegorz; Bolotina, Victoria M.] Boston Univ, Sch Med, Dept Med, Ion Channel & Calcium Signaling Unit, Boston, MA 02118 USA; [Ding, Lai] Harvard Univ, Sch Med, Harvard NeuroDiscovery Ctr, Opt Imaging Core, Boston, MA 02115 USA; [Kirber, Michael T.] Boston Univ, Sch Med, Dept Med, Cellular Imaging Core, Boston, MA 02118 USA	Boston University; Harvard University; Harvard Medical School; Boston University	Bolotina, VM (corresponding author), Boston Univ, Sch Med, Dept Med, Ion Channel & Calcium Signaling Unit, 650 Albany St,X-704, Boston, MA 02118 USA.	bolotina@bu.edu		Kirber, Michael/0000-0001-9009-5776; Bolotina, Victoria/0000-0001-5862-181X	National Institutes of Health [RO1 HL71793, RO1 HL54150]; Department of Medicine; Cellular Imaging Core; Evans Center for Interdisciplinary Biomedical Research (Affinity Research Collaborative program on Calcium Homeostasis in Health and Disease) at the Boston University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054150, R01HL071793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Medicine; Cellular Imaging Core; Evans Center for Interdisciplinary Biomedical Research (Affinity Research Collaborative program on Calcium Homeostasis in Health and Disease) at the Boston University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL71793 and RO1 HL54150. This work was also supported by the Department of Medicine, the Cellular Imaging Core, and the Evans Center for Interdisciplinary Biomedical Research (Affinity Research Collaborative program on Calcium Homeostasis in Health and Disease) at the Boston University School of Medicine.	Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bhatt A, 2002, J CELL SCI, V115, P3415; Bisaillon JM, 2010, AM J PHYSIOL-CELL PH, V298, pC993, DOI 10.1152/ajpcell.00325.2009; Bolotina V. M., 2012, STORE OPERATED CALCI, P115; Bolotina VM, 2008, J PHYSIOL-LONDON, V586, P3035, DOI 10.1113/jphysiol.2008.154997; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Carnevale KA, 2001, J IMMUNOL, V167, P3414, DOI 10.4049/jimmunol.167.6.3414; Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746; Chen JP, 2010, CELL CALCIUM, V47, P425, DOI 10.1016/j.ceca.2010.03.003; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Clapham DE, 2009, CELL, V136, P814, DOI 10.1016/j.cell.2009.02.022; Clark K, 2008, EUR J CELL BIOL, V87, P631, DOI 10.1016/j.ejcb.2008.01.009; Collins SR, 2009, DEV CELL, V16, P160, DOI 10.1016/j.devcel.2009.01.018; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Fabian A, 2008, PFLUG ARCH EUR J PHY, V457, P475, DOI 10.1007/s00424-008-0515-4; Fahmer M, 2009, IMMUNOL REV, V231, P99, DOI 10.1111/j.1600-065X.2009.00815.x; Feske S, 2009, IMMUNOL REV, V231, P189, DOI 10.1111/j.1600-065X.2009.00818.x; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Gwozdz T, 2008, AM J PHYSIOL-CELL PH, V295, pC1133, DOI 10.1152/ajpcell.00306.2008; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Howe AK, 2005, P NATL ACAD SCI USA, V102, P14320, DOI 10.1073/pnas.0507072102; Howe AK, 2011, CURR OPIN CELL BIOL, V23, P554, DOI 10.1016/j.ceb.2011.05.006; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Lewis RS, 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A003970; Li J, 2011, CIRC RES, V108, P1190, DOI 10.1161/CIRCRESAHA.111.243352; Logue JS, 2011, J BIOL CHEM, V286, P22113, DOI 10.1074/jbc.M111.232660; Mishra RS, 2008, J EXP MED, V205, P347, DOI 10.1084/jem.20071243; Mohl C, 2012, J CELL SCI, V125, P155, DOI 10.1242/jcs.090746; Mohl CC, 2009, CELL MOTIL CYTOSKEL, V66, P350, DOI 10.1002/cm.20375; NOEGEL A, 1987, FEBS LETT, V221, P391, DOI 10.1016/0014-5793(87)80962-6; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Putney JW, 2009, IMMUNOL REV, V231, P10, DOI 10.1111/j.1600-065X.2009.00810.x; Rao JN, 2010, AM J PHYSIOL-CELL PH, V299, pC579, DOI 10.1152/ajpcell.00066.2010; Schafer C, 2010, CELL ADHES MIGR, V4, P215, DOI 10.4161/cam.4.2.10745; Schafer C, 2009, EXP CELL RES, V315, P1212, DOI 10.1016/j.yexcr.2008.11.008; Schaff UY, 2010, BLOOD, V115, P657, DOI 10.1182/blood-2009-05-224659; Small J.V., 2004, ENCY BIOL CHEM, V1st, P356, DOI [10.1016/B0-12-443710-9/00097-1, DOI 10.1016/B0-12-443710-9/00097-1]; Small JV, 2010, TRENDS CELL BIOL, V20, P628, DOI 10.1016/j.tcb.2010.08.006; SMALL JV, 1981, J CELL BIOL, V91, P695, DOI 10.1083/jcb.91.3.695; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Smani T, 2003, J BIOL CHEM, V278, P11909, DOI 10.1074/jbc.M210878200; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Tian DQ, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001200; Urban E, 2010, NAT CELL BIOL, V12, P429, DOI 10.1038/ncb2044; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wei CL, 2010, CAN J PHYSIOL PHARM, V88, P105, DOI 10.1139/Y09-118; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zamir E, 1999, J CELL SCI, V112, P1655	59	27	27	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40745	40757		10.1074/jbc.M112.407155	http://dx.doi.org/10.1074/jbc.M112.407155			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23043102	Green Published, hybrid			2022-12-28	WOS:000311448800063
J	Furutani, Y; Kawasaki, M; Matsuno, H; Mitsui, S; Mori, K; Yoshihara, Y				Furutani, Yutaka; Kawasaki, Miwa; Matsuno, Hitomi; Mitsui, Sachiko; Mori, Kensaku; Yoshihara, Yoshihiro			Vitronectin Induces Phosphorylation of Ezrin/Radixin/Moesin Actin-binding Proteins through Binding to Its Novel Neuronal Receptor Telencephalin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; EXTRACELLULAR-MATRIX; HIPPOCAMPAL-NEURONS; ADHESION MOLECULE; SPINE MATURATION; INTEGRINS; BRAIN; LOCALIZATION; GLYCOPROTEIN; CYTOSKELETON	Vitronectin (VN) is an extracellular matrix protein abundantly present in blood and a wide variety of tissues and plays important roles in a number of biological phenomena mainly through its binding to alpha V integrins. However, its definite function in the brain remains largely unknown. Here we report the identification of telencephalin (TLCN/ICAM-5) as a novel VN receptor on neuronal dendrites. VN strongly binds to TLCN, a unique neuronal member of the ICAM family, which is specifically expressed on dendrites of spiny neurons in the mammalian telencephalon. VN-coated microbeads induce the formation of phagocytic cup-like plasma membrane protrusions on dendrites of cultured hippocampal neurons and trigger the activation of TLCN-dependent intracellular signaling cascade including the phosphorylation of ezrin/radixin/moesin actin-binding proteins and recruitment of F-actin and phosphatidylinositol 4,5-bisphosphate for morphological transformation of the dendritic protrusions. These results suggest that the extracellular matrix molecule VN and its neuronal receptor TLCN play a pivotal role in the phosphorylation of ezrin/radixin/moesin proteins and the formation of phagocytic cup-like structures on neuronal dendrites.	[Furutani, Yutaka; Kawasaki, Miwa; Matsuno, Hitomi; Mitsui, Sachiko; Yoshihara, Yoshihiro] RIKEN Brain Sci Inst, Lab Neurobiol Synapse, Wako, Saitama 3510198, Japan; [Furutani, Yutaka; Yoshihara, Yoshihiro] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Osaka 5600082, Japan; [Mori, Kensaku] Univ Tokyo, Grad Sch Med, Dept Physiol, Tokyo 1130033, Japan	RIKEN; Japan Science & Technology Agency (JST); University of Tokyo	Yoshihara, Y (corresponding author), RIKEN Brain Sci Inst, Lab Neurobiol Synapse, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	yoshihara@brain.riken.jp	Yoshihara, Yoshihiro/N-6481-2015; Furutani, Yutaka/C-3652-2017	Yoshihara, Yoshihiro/0000-0002-0319-7166; Furutani, Yutaka/0000-0002-2945-0166; Mori, Kensaku/0000-0001-7853-9370	Japan Society for the Promotion of Science KAKENHI [22700354, 24500392]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan KAKENHI [23123525]; MEXT KAKENHI [20022046]; Japan Science and Technology Agency Core Research for Evolutional Science and Technology grant; Takeda Science Foundation	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency Core Research for Evolutional Science and Technology grant; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants 22700354 and 24500392, Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan KAKENHI Grant 23123525 (to Y.F.), MEXT KAKENHI Grant 20022046 (to Y.Y.), a Japan Science and Technology Agency Core Research for Evolutional Science and Technology grant (to Y.Y.), and a grant from Takeda Science Foundation (to Y.Y.).	Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Benson DL, 1998, J NEUROSCI RES, V52, P43, DOI 10.1002/(SICI)1097-4547(19980401)52:1<43::AID-JNR5>3.3.CO;2-A; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; Cingolani LA, 2008, NEURON, V58, P749, DOI 10.1016/j.neuron.2008.04.011; Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898; Esselens C, 2004, J CELL BIOL, V166, P1041, DOI 10.1083/jcb.200406060; Furutani Y, 2007, J NEUROSCI, V27, P8866, DOI 10.1523/JNEUROSCI.1047-07.2007; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Matsuno H, 2006, J NEUROSCI, V26, P1776, DOI 10.1523/JNEUROSCI.2651-05.2006; Mitsui S, 2005, J NEUROSCI, V25, P1122, DOI 10.1523/JNEUROSCI.3853-04.2005; Mitsui S, 2007, CEREB CORTEX, V17, P522, DOI 10.1093/cercor/bhj177; Mizuno T, 1997, J BIOL CHEM, V272, P1156, DOI 10.1074/jbc.272.2.1156; MORI K, 1987, P NATL ACAD SCI USA, V84, P3921, DOI 10.1073/pnas.84.11.3921; Nakamura K, 2001, EUR J NEUROSCI, V13, P179, DOI 10.1046/j.0953-816X.2000.01366.x; Niquet J, 1996, GLIA, V16, P359, DOI 10.1002/(SICI)1098-1136(199604)16:4<359::AID-GLIA8>3.0.CO;2-V; Nyman-Huttunen H, 2006, J CELL SCI, V119, P3057, DOI 10.1242/jcs.03045; PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cellbio.7.1.275; Raemaekers T, 2012, EMBO J, V31, P3252, DOI 10.1038/emboj.2012.182; Sakurai E, 1998, NEUROREPORT, V9, P881, DOI 10.1097/00001756-199803300-00022; SEIFFERT D, 1995, DEV DYNAM, V203, P71, DOI 10.1002/aja.1002030108; Shi Y, 2006, J NEUROSCI, V26, P1813, DOI 10.1523/JNEUROSCI.4091-05.2006; Tada T, 2007, CURR BIOL, V17, P1752, DOI 10.1016/j.cub.2007.09.039; Tian L, 1997, J IMMUNOL, V158, P928; Vasilyev DV, 2004, J PHYSIOL-LONDON, V560, P659, DOI 10.1113/jphysiol.2004.069104; Vasilyev DV, 2003, J PHYSIOL-LONDON, V547, P859, DOI 10.1113/jphysiol.2002.036889; Wang QW, 2008, NEUROBIOL AGING, V29, P1485, DOI 10.1016/j.neurobiolaging.2007.03.018; YOSHIHARA Y, 1994, NEURON, V12, P541, DOI 10.1016/0896-6273(94)90211-9; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013; Zheng XX, 1995, P NATL ACAD SCI USA, V92, P12426, DOI 10.1073/pnas.92.26.12426	30	9	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39041	39049		10.1074/jbc.M112.383851	http://dx.doi.org/10.1074/jbc.M112.383851			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23019340	hybrid, Green Published			2022-12-28	WOS:000310982800060
J	Haynes, LM; Bouchard, BA; Tracy, PB; Mann, KG				Haynes, Laura M.; Bouchard, Beth A.; Tracy, Paula B.; Mann, Kenneth G.			Prothrombin Activation by Platelet-associated Prothrombinase Proceeds through the Prethrombin-2 Pathway via a Concerted Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; COAGULATION FACTOR-V; FACTOR-XA; FUNCTIONAL-CHARACTERIZATION; CATALYZED ACTIVATION; ANTITHROMBIN-III; MEMBRANE-PROTEIN; GLYCOPROTEIN-VI; FLOW CONDITIONS; KINETIC-MODEL	The protease alpha-thrombin is a key enzyme of the coagulation process as it is at the cross-roads of both the pro- and anticoagulant pathways. The main source of alpha-thrombin in vivo is the activation of prothrombin by the prothrombinase complex assembled on either an activated cell membrane or cell fragment, the most relevant of which is the activated platelet surface. When prothrombinase is assembled on synthetic phospholipid vesicles, prothrombin activation proceeds with an initial cleavage at Arg-320 yielding the catalytically active, yet effectively anticoagulant intermediate meizothrombin, which is released from the enzyme complex similar to 30-40% of the time. Prothrombinase assembled on the surface of activated platelets has been shown to proceed through the inactive intermediate prethrombin-2 via an initial cleavage at Arg-271 followed by cleavage at Arg-320. The current work tests whether or not platelet-associated prothrombinase proceeds via a concerted mechanism through a study of prothrombinase assembly and function on collagen-adhered, thrombin-activated, washed human platelets in a flow chamber. Prothrombinase assembly was demonstrated through visualization of bound factor Xa by confocal microscopy using a fluorophore-labeled anti-factor Xa antibody, which demonstrated the presence of distinct platelet subpopulations capable of binding factor Xa. When prothrombin activation was monitored at a typical venous shear rate over preassembled platelet-associated prothrombinase neither potential intermediate, meizothrombin or prethrombin-2, was observed in the effluent. Collectively, these findings suggest that platelet-associated prothrombinase activates prothrombin via an efficient concerted mechanism in which neither intermediate is released.	[Haynes, Laura M.; Bouchard, Beth A.; Tracy, Paula B.; Mann, Kenneth G.] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA	University of Vermont	Mann, KG (corresponding author), Univ Vermont, Coll Med, Dept Biochem, 208 S Pk Dr, Colchester, VT 05446 USA.	Kenneth.Mann@uvm.edu		Bouchard, Beth/0000-0002-0399-566X	National Institutes of Health [P01HL46703]; Hemostatis and Thrombosis Training Grant from NHLBI, National Institutes of Health [5T32HL007594]; NHLBI, National Institutes of Health [K02HL091111]; University of Vermont College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007594, P01HL046703, K02HL091111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hemostatis and Thrombosis Training Grant from NHLBI, National Institutes of Health; NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Vermont College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by P01HL46703 from the National Institutes of Health (Project 1 to K. G. M.) and (Project 3 to P. B. T.) Supported by a Hemostatis and Thrombosis Training Grant 5T32HL007594 from NHLBI, National Institutes of Health. Supported by K02HL091111 from NHLBI, National Institutes of Health and the University of Vermont College of Medicine.	Alberio L, 2000, BLOOD, V95, P1694, DOI 10.1182/blood.V95.5.1694.005k24_1694_1702; BAJAJ SP, 1973, J BIOL CHEM, V248, P7729; Batar P, 2001, J LAB CLIN MED, V138, P393, DOI 10.1067/mlc.2001.120049; BEUMER S, 1995, BLOOD, V86, P3452, DOI 10.1182/blood.V86.9.3452.bloodjournal8693452; Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; Billy D, 1997, BLOOD COAGUL FIBRIN, V8, P168, DOI 10.1097/00001721-199704000-00003; Boskovic DS, 2001, J BIOL CHEM, V276, P28686, DOI 10.1074/jbc.M101813200; Bouchard BA, 1997, J BIOL CHEM, V272, P9244; Brass LF, 2003, CHEST, V124, p18S, DOI 10.1378/chest.124.3_suppl.18S; Brooks EG, 2009, BLOOD, V114, P1276, DOI 10.1182/blood-2009-03-209981; BUTENAS S, 1992, BIOCHEMISTRY-US, V31, P5399, DOI 10.1021/bi00138a023; Butenas S, 1997, THROMB HAEMOSTASIS, V78, P1193; CAMIRE RM, 1995, J BIOL CHEM, V270, P20794, DOI 10.1074/jbc.270.35.20794; Cote HCF, 1997, J BIOL CHEM, V272, P6194, DOI 10.1074/jbc.272.10.6194; DOWNING MR, 1975, J BIOL CHEM, V250, P8897; Fager A. M., 2009, J THROMB HAEMOST, V7, p198a; Fager AM, 2010, ARTERIOSCL THROM VAS, V30, P2400, DOI 10.1161/ATVBAHA.110.216531; FUSTER V, 1990, CIRCULATION, V82, P47; GRIFFITH MJ, 1985, J BIOL CHEM, V260, P2218; Hathcock JJ, 2006, ARTERIOSCL THROM VAS, V26, P1729, DOI 10.1161/01.ATV.0000229658.76797.30; Haynes LM, 2012, J BIOL CHEM, V287, P5225, DOI 10.1074/jbc.M111.302075; Haynes LM, 2011, BIOPHYS J, V100, P765, DOI 10.1016/j.bpj.2010.12.3720; HELDEBRANT CM, 1973, J BIOL CHEM, V248, P7149; HIGGINS DL, 1983, J BIOL CHEM, V258, P6503; KALB E, 1992, BIOCHIM BIOPHYS ACTA, V1103, P307, DOI 10.1016/0005-2736(92)90101-Q; KATZMANN JA, 1981, P NATL ACAD SCI-BIOL, V78, P162, DOI 10.1073/pnas.78.1.162; Kempton CL, 2005, ARTERIOSCL THROM VAS, V25, P861, DOI 10.1161/01.ATV.0000155987.26583.9b; Kim PY, 2007, J BIOL CHEM, V282, P32568, DOI 10.1074/jbc.M701781200; Kim PY, 2012, BIOPHYS CHEM, V160, P75, DOI 10.1016/j.bpc.2011.09.004; KRISHNASWAMY S, 1986, J BIOL CHEM, V261, P8977; Lee CJ, 2011, J THROMB HAEMOST, V9, P2123, DOI 10.1111/j.1538-7836.2011.04463.x; Lee CJ, 2010, BIOPHYS CHEM, V149, P28, DOI 10.1016/j.bpc.2010.03.011; Lundblad R L, 1976, Methods Enzymol, V45, P156; MANN KG, 1990, BLOOD, V76, P1; MILETICH JP, 1977, P NATL ACAD SCI USA, V74, P4033, DOI 10.1073/pnas.74.9.4033; MONKOVIC DD, 1990, J BIOL CHEM, V265, P17132; MONKOVIC DD, 1990, BIOCHEMISTRY-US, V29, P1118, DOI 10.1021/bi00457a004; Moroi M, 1996, BLOOD, V88, P2081, DOI 10.1182/blood.V88.6.2081.bloodjournal8862081; MOROI M, 1989, J CLIN INVEST, V84, P1440, DOI 10.1172/JCI114318; MUSTARD JF, 1972, BRIT J HAEMATOL, V22, P193, DOI 10.1111/j.1365-2141.1972.tb08800.x; NESHEIM ME, 1993, THROMB HAEMOSTASIS, V70, P80; Panteleev MA, 2005, J THROMB HAEMOST, V3, P2545, DOI 10.1111/j.1538-7836.2005.01616.x; Petrovan RJ, 1998, BIOCHEMISTRY-US, V37, P1185, DOI 10.1021/bi971948h; RUGGERI ZM, 1982, P NATL ACAD SCI-BIOL, V79, P6038, DOI 10.1073/pnas.79.19.6038; SANTORO SA, 1986, CELL, V46, P913, DOI 10.1016/0092-8674(86)90073-5; SCHOEN P, 1990, THROMB HAEMOSTASIS, V64, P542; Shen Y, 2000, BLOOD, V95, P903, DOI 10.1182/blood.V95.3.903.003k37_903_910; TAMM LK, 1985, BIOPHYS J, V47, P105, DOI 10.1016/S0006-3495(85)83882-0; Topalov NN, 2012, BRIT J HAEMATOL, V157, P105, DOI 10.1111/j.1365-2141.2011.09021.x; TRACY PB, 1981, J BIOL CHEM, V256, P743; TRACY PB, 1983, P NATL ACAD SCI-BIOL, V80, P2380, DOI 10.1073/pnas.80.8.2380; TRACY PB, 1982, BLOOD, V60, P59; TRACY PB, 1985, J BIOL CHEM, V260, P2119; TRACY PB, 1979, J BIOL CHEM, V254, P354; Wood JP, 2011, BLOOD, V117, P1710, DOI 10.1182/blood-2010-09-311035	56	44	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38647	38655		10.1074/jbc.M112.407791	http://dx.doi.org/10.1074/jbc.M112.407791			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22989889	Green Published, hybrid			2022-12-28	WOS:000310982800024
J	Kim, YH; Kwon, HJ; Kim, DS				Kim, Yeon Hyang; Kwon, Hyung-Joo; Kim, Doo-Sik			Matrix Metalloproteinase 9 (MMP-9)-dependent Processing of beta ig-h3 Protein Regulates Cell Migration, Invasion, and Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; BRONCHIAL EPITHELIAL-CELLS; MATRIX METALLOPROTEINASES; BETAIG-H3 GENE; IN-VITRO; EXTRACELLULAR-MATRIX; SIGNALING PATHWAY; DOWN-REGULATION; EXPRESSION; IDENTIFICATION	Cell migration is critically involved in inflammation, cancer, and development. In this study, transforming growth factor-beta-induced protein (beta ig-h3) was identified as a substrate of matrix metalloproteinase-9 (MMP-9) by site-directed mutagenesis. beta ig-h3 has two cleavage sites with the consensus sequence Pro-Xaa-Xaa-Hy-(Ser/Thr) (Hy is a hydrophobic amino acid) (PGSFT beginning at amino acid 135 and PPMGT beginning at amino acid 501). Using recombinant human beta ig-h3 and MMP-9, beta ig-h3 from beta ig-h3-transfected HEK293F cells, and MMP-9 from MMP-9-transfected HEK293F cells, human macrophages, and neutrophils, we found that MMP-9 proteolytically cleaves beta ig-h3. Cleavage leads to the loss of its adhesive property and its release from extracellular matrix proteins, collagen IV, and fibronectin. Spheroids formed by increased cell-cell interactions were observed in beta ig-h3-transfected HEK293F cells but not in vehicle-transfected HEK293F cells. In human glioma U87MG cells, MMP-9 constitutive overexpression resulted in endogenous beta ig-h3 cleavage. beta ig-h3 cleavage by MMP-9 led to increased cell invasion, and beta ig-h3 knockdown also resulted in increased cell invasion. The beta ig-h3 fragment cleaved by MMP-9 could bind to the surface of macrophages, and it may play a role as a peptide chemoattractant by inducing macrophage migration via focal adhesion kinase/Src-mediated signal activation. Thus, intact beta ig-h3 is responsible for cell migration inhibition, cell-cell contact, and cell-extracellular matrix interaction. Experimental evidence indicates that MMP-9-cleaved beta ig-h3 plays a role in MMP-9-mediated tumor cell and macrophage migration.	[Kim, Yeon Hyang; Kim, Doo-Sik] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea; [Kwon, Hyung-Joo] Hallym Univ, Coll Med, Dept Microbiol, Gangwon Do 200702, South Korea	Yonsei University; Hallym University	Kim, YH (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea.	yeonhkim@yonsei.ac.kr; dskim@yonsei.ac.kr			National Research Foundation of Korea; Ministry of Education, Science, and Technology [2009-0081760]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Future-based Technology Development Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology Grant 2009-0081760.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Andersen RB, 2004, BIOCHEMISTRY-US, V43, P16374, DOI 10.1021/bi048589s; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Aumailley M, 1998, J MOL MED-JMM, V76, P253, DOI 10.1007/s001090050215; Becker J, 2006, CANCER RES, V66, P5314, DOI 10.1158/0008-5472.CAN-05-3049; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Calaf GM, 2008, INT J MOL MED, V21, P561; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Doliana R, 2000, FEBS LETT, V484, P164, DOI 10.1016/S0014-5793(00)02140-2; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879; Esteve PO, 2002, J BIOL CHEM, V277, P35150, DOI 10.1074/jbc.M108600200; Fiore E, 2002, ONCOGENE, V21, P5213, DOI 10.1038/sj.onc.1205684; Gingis-Velitski S, 2011, CANCER RES, V71, P6986, DOI 10.1158/0008-5472.CAN-11-0629; Handsley MM, 2005, INT J CANCER, V115, P849, DOI 10.1002/ijc.20945; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; Imai K, 1997, BIOCHEM J, V322, P809, DOI 10.1042/bj3220809; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim JE, 2002, J BIOL CHEM, V277, P46159, DOI 10.1074/jbc.M207055200; Kim YH, 2010, NITRIC OXIDE-BIOL CH, V23, P112, DOI 10.1016/j.niox.2010.04.009; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Krekoski CA, 2002, J NEUROSCI, V22, P10408; Kridel SJ, 2001, J BIOL CHEM, V276, P20572, DOI 10.1074/jbc.M100900200; MASURE S, 1991, EUR J BIOCHEM, V198, P391, DOI 10.1111/j.1432-1033.1991.tb16027.x; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; Nabokikh A, 2007, EXP CLIN ENDOCR DIAB, V115, P674, DOI 10.1055/s-2007-984477; Nagase H, 1997, BIOL CHEM, V378, P151; Nygardas PT, 2002, CLIN EXP IMMUNOL, V128, P245, DOI 10.1046/j.1365-2249.2002.01855.x; Oh JE, 2005, J BIOL CHEM, V280, P21629, DOI 10.1074/jbc.m412293200; Ohno S, 1999, BBA-MOL CELL RES, V1451, P196, DOI 10.1016/S0167-4889(99)00093-2; OPDENAKKER G, 1991, FEBS LETT, V284, P73, DOI 10.1016/0014-5793(91)80765-U; Park MJ, 2002, CANCER RES, V62, P6318; Pilcher BK, 1997, J CELL BIOL, V137, P1445, DOI 10.1083/jcb.137.6.1445; Powell WC, 1999, CURR BIOL, V9, P1441, DOI 10.1016/S0960-9822(00)80113-X; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; RIES C, 1995, BIOL CHEM H-S, V376, P345; Sawey ET, 2007, P NATL ACAD SCI USA, V104, P19327, DOI 10.1073/pnas.0705953104; Seiki M, 2002, CURR OPIN CELL BIOL, V14, P624, DOI 10.1016/S0955-0674(02)00363-0; Sellebjerg F, 2003, BRAIN RES BULL, V61, P347, DOI 10.1016/S0361-9230(03)00097-2; Shao GZ, 2006, CANCER RES, V66, P4566, DOI 10.1158/0008-5472.CAN-05-2130; SKONIER J, 1994, DNA CELL BIOL, V13, P571, DOI 10.1089/dna.1994.13.571; SKONIER J, 1992, DNA CELL BIOL, V11, P511, DOI 10.1089/dna.1992.11.511; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; WEBER KT, 1995, HERZ, V20, P81; WELGUS HG, 1990, J CLIN INVEST, V86, P1496, DOI 10.1172/JCI114867; Wen GY, 2011, CANCER LETT, V308, P23, DOI 10.1016/j.canlet.2011.04.010; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; Zhang Y, 2009, CANCER RES, V69, P37, DOI 10.1158/0008-5472.CAN-08-1648; Zhao YL, 2004, RADIAT RES, V162, P655, DOI 10.1667/RR3270; Zhao YL, 2002, ONCOGENE, V21, P7471, DOI 10.1038/sj.onc.1205891	53	47	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38957	38969		10.1074/jbc.M112.357863	http://dx.doi.org/10.1074/jbc.M112.357863			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23019342	hybrid, Green Published			2022-12-28	WOS:000310982800052
J	Mori, K; Hamanaka, H; Oshima, Y; Araki, Y; Ishikawa, F; Nose, K; Shibanuma, M				Mori, Kazunori; Hamanaka, Hiroyuki; Oshima, Yukiko; Araki, Yuri; Ishikawa, Fumihiro; Nose, Kiyoshi; Shibanuma, Motoko			A HIC-5-and KLF4-dependent Mechanism Transactivates p21(Cip1) in Response to Anchorage Loss	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL EPITHELIAL-CELLS; CYCLE PROGRESSION; FOCAL ADHESIONS; LIM PROTEIN; GENE; KINASE; EXPRESSION; MATRIX; ACTIVATION; WAF1/CIP1	Anchorage loss elicits a set of responses in cells, such as transcriptional changes, in order to prevent inappropriate cell growth in ectopic environments. However, the mechanisms underlying these responses are poorly understood. In this study, we investigated the transcriptional up-regulation of cyclin-dependent kinase inhibitor p21(Cip1) during anchorage loss, which is important for cell cycle arrest of nonadherent cells in the G1 phase. Up-regulation was mediated by an upstream element, designated as the detachment-responsive element (DRE), that contained Kruppel-like factor 4 (KLF4) and runt-related transcription factor 1 (RUNX1) recognition sites; both of these together were necessary for transactivation, as individually they were insufficient. RNAi experiments revealed that KLF4 and a multidomain adaptor protein, hydrogen peroxide-inducible clone 5 (HIC-5), were critically involved in DRE transactivation. The role of HIC-5 in this mechanism was to tether KLF4 to DNA sites in response to cellular detachment. In addition, further analysis suggested that oligomerization and subsequent nuclear matrix localization of HIC-5, which was accelerated spontaneously in cells during anchorage loss, was assumed to potentiate the scaffolding function of HIC-5 in the nucleus and consequently regulate p21(Cip1) transcription in a manner responding to anchorage loss. At the RUNX1 site, a LIM-only protein, CRP2, imposed negative regulation on transcription, which appeared to be removed by anchorage loss and contributed to increased transcriptional activity of DRE together with regulation at the KLF4 sites. In conclusion, this study revealed a novel transcriptional mechanism that regulated gene expression in a detachment-dependent manner, thereby contributing to anchorage-dependent cell growth.	[Shibanuma, Motoko] Showa Univ, Sch Pharm, Dept Mol Biol, Div Canc Cell Biol,Shinagawa Ku, Tokyo 1428555, Japan	Showa University	Shibanuma, M (corresponding author), Showa Univ, Sch Pharm, Dept Mol Biol, Div Canc Cell Biol,Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	smotoko@pharm.showa-u.ac.jp		Mori, Kazunori/0000-0001-7121-9956	High-Technology Research Center from the Ministry for Education, Culture, Sports, Science, and Technology (MEXT) of Japan [22790327]; Private University High Technology Research Center from Project MEXT	High-Technology Research Center from the Ministry for Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Private University High Technology Research Center from Project MEXT	This work was supported in part by Grant-in-aid for Young Scientists (B) 22790327, the High-Technology Research Center Project from the Ministry for Education, Culture, Sports, Science, and Technology (MEXT) of Japan, and a Private University High Technology Research Center Project matching fund subsidy from MEXT.	Assoian RK, 1997, J CELL BIOL, V136, P1, DOI 10.1083/jcb.136.1.1; Chew YC, 2011, J BIOL CHEM, V286, P28772, DOI 10.1074/jbc.M110.205245; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Egawa K, 1998, BIOL PHARM BULL, V21, P899; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fang F, 1996, SCIENCE, V271, P499, DOI 10.1126/science.271.5248.499; Giancotti FG, 1997, CURR OPIN CELL BIOL, V9, P691, DOI 10.1016/S0955-0674(97)80123-8; HE DC, 1990, J CELL BIOL, V110, P569, DOI 10.1083/jcb.110.3.569; Ishikawa F, 2010, ONCOGENE, V29, P909, DOI 10.1038/onc.2009.387; Ishikawa F, 2009, J BIOCHEM, V146, P123, DOI 10.1093/jb/mvp052; Kanome T, 2007, ONCOGENE, V26, P5991, DOI 10.1038/sj.onc.1210423; Kim-Kaneyama J, 2005, J CELL SCI, V118, P937, DOI 10.1242/jcs.01683; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kumar CC, 1998, ONCOGENE, V17, P1365, DOI 10.1038/sj.onc.1202172; Liu Z, 2006, ONCOGENE, V25, P7680, DOI 10.1038/sj.onc.1209753; Matsuya M, 1998, J BIOL CHEM, V273, P1003, DOI 10.1074/jbc.273.2.1003; Mori K, 2006, J BIOL CHEM, V281, P22048, DOI 10.1074/jbc.M513111200; Mori K, 2009, MOL BIOL CELL, V20, P218, DOI 10.1091/mbc.E08-04-0428; Nakano K, 1997, J BIOL CHEM, V272, P22199, DOI 10.1074/jbc.272.35.22199; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Nishiya N, 2001, MOL CELL BIOL, V21, P5332, DOI 10.1128/MCB.21.16.5332-5345.2001; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Schwartz MA, 1997, J CELL BIOL, V139, P575, DOI 10.1083/jcb.139.3.575; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shibanuma M, 2004, J CELL BIOCHEM, V91, P633, DOI 10.1002/jcb.10754; Shibanuma M, 2003, MOL BIOL CELL, V14, P1158, DOI 10.1091/mbc.02-06-0099; Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; WEINBERG WC, 1994, CANCER RES, V54, P5584; Wu RC, 1997, J BIOL CHEM, V272, P29091, DOI 10.1074/jbc.272.46.29091; Yan SR, 2005, ONCOGENE, V24, P6482, DOI 10.1038/sj.onc.1208810	33	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38854	38865		10.1074/jbc.M112.377721	http://dx.doi.org/10.1074/jbc.M112.377721			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23007394	Green Published, hybrid			2022-12-28	WOS:000310982800042
J	Sunamura, E; Konno, H; Imashimizu, M; Mochimaru, M; Hisabori, T				Sunamura, Ei-Ichiro; Konno, Hiroki; Imashimizu, Mari; Mochimaru, Mari; Hisabori, Toru			A Conformational Change of the gamma Subunit Indirectly Regulates the Activity of Cyanobacterial F-1-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLAST ATP SYNTHASE; COUPLING FACTOR-I; ESCHERICHIA-COLI F-1-ATPASE; EPSILON-SUBUNIT; ADENOSINE-TRIPHOSPHATASE; NUCLEOTIDE-BINDING; ALPHA(3)BETA(3)GAMMA COMPLEX; PHOTOSYNTHETIC F-1-ATPASE; INVERSE REGULATION; CATALYTIC-ACTIVITY	The central shaft of the catalytic core of ATP synthase, the gamma subunit consists of a coiled-coil structure of N- and C-terminal alpha-helices, and a globular domain. The gamma subunit of cyanobacterial and chloroplast ATP synthase has a unique 30 - 40-amino acid insertion within the globular domain. We recently prepared the insertion-removed alpha(3)beta(3)gamma complex of cyanobacterial ATP synthase (Sunamura, E., Konno, H., Imashimizu-Kobayashi, M., and Hisabori, T. (2010) Plant Cell Physiol. 51, 855865). Although the insertion is thought to be located in the periphery of the complex and far from catalytic sites, the mutant complex shows a remarkable increase in ATP hydrolysis activity due to a reduced tendency to lapse into ADP inhibition. We postulated that removal of the insertion affects the activity via a conformational change of two central alpha-helices in gamma. To examine this hypothesis, we prepared a mutant complex that can lock the relative position of two central alpha-helices to each other by way of a disulfide bond formation. The mutant obtained showed a significant change in ATP hydrolysis activity caused by this restriction. The highly active locked complex was insensitive to N-dimethyldodecylamine-N-oxide, suggesting that the complex is resistant to ADP inhibition. In addition, the lock affected is an element of inhibition. In contrast, the change in activity caused by removal of the gamma insertion was independent from the conformational restriction of the central axis component. These results imply that the global conformational change of the gamma subunit indirectly regulates complex activity by changing both ADP inhibition and is an element of inhibition.	[Sunamura, Ei-Ichiro; Konno, Hiroki; Imashimizu, Mari; Mochimaru, Mari; Hisabori, Toru] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Konno, Hiroki] Kanazawa Univ, BioAFM Frontier Res Ctr, Imaging Res Div, Kanazawa, Ishikawa 9201192, Japan; [Mochimaru, Mari] Komazawa Univ, Dept Nat Sci, Tokyo 1548525, Japan; [Hisabori, Toru] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol, Tokyo 1020075, Japan	Tokyo Institute of Technology; Kanazawa University; Japan Science & Technology Agency (JST)	Hisabori, T (corresponding author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Nagatsuta 4259-R1-8, Yokohama, Kanagawa 2268503, Japan.	thisabor@res.titech.ac.jp	Hisabori, Toru/E-5205-2014	Hisabori, Toru/0000-0003-2046-0277	Core Research of Evolutional Science and Technology program (CREST) from the Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science [22651048]	Core Research of Evolutional Science and Technology program (CREST) from the Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the Core Research of Evolutional Science and Technology program (CREST) from the Japan Science and Technology Agency (JST) and Grant-in-aid for Scientific Research 22651048 (to T. H.) from the Japan Society for the Promotion of Science.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Bald D, 1998, J BIOL CHEM, V273, P865, DOI 10.1074/jbc.273.2.865; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; DUNHAM KR, 1981, J BIOL CHEM, V256, P212; DUNN SD, 1990, BIOCHEMISTRY-US, V29, P4335, DOI 10.1021/bi00470a011; Feniouk BA, 2007, J BIOL CHEM, V282, P764, DOI 10.1074/jbc.M606321200; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Greene MD, 2003, J BIOL CHEM, V278, P51594, DOI 10.1074/jbc.M309948200; GRESSER MJ, 1982, J BIOL CHEM, V257, P2030; Haruyama Takamitsu, 2010, Biophysics (Nagoya-shi), V6, P59, DOI 10.2142/biophysics.6.59; He F, 2007, BIOCHEMISTRY-US, V46, P2411, DOI 10.1021/bi062295k; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; Hisabori T, 2003, FEBS LETT, V545, P71, DOI 10.1016/S0014-5793(03)00395-8; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Imashimizu M, 2011, J BIOL CHEM, V286, P26595, DOI 10.1074/jbc.M111.234138; JOSHI AK, 1989, J BIOL CHEM, V264, P2126; Kagawa Y, 1996, J BIOENERG BIOMEMBR, V28, P421, DOI 10.1007/BF02113984; Kato-Yamada Y, 2000, J BIOL CHEM, V275, P35746, DOI 10.1074/jbc.M006575200; Keis S, 2006, J BACTERIOL, V188, P3796, DOI 10.1128/JB.00040-06; Kim Y, 2011, J BIOL CHEM, V286, P9071, DOI 10.1074/jbc.M110.200584; Konno H, 2000, BIOCHEM J, V352, P783, DOI 10.1042/0264-6021:3520783; Konno H, 2006, EMBO J, V25, P4596, DOI 10.1038/sj.emboj.7601348; Konno H, 2011, J BIOL CHEM, V286, P13423, DOI 10.1074/jbc.M110.155986; MATSUI T, 1995, BBA-BIOENERGETICS, V1231, P139, DOI 10.1016/0005-2728(95)00070-Y; Matsui T, 1997, J BIOL CHEM, V272, P8215, DOI 10.1074/jbc.272.13.8215; MIKI J, 1988, FEBS LETT, V232, P221, DOI 10.1016/0014-5793(88)80421-6; MILLS JD, 1980, FEBS LETT, V112, P173, DOI 10.1016/0014-5793(80)80173-6; MINKOV IB, 1979, BIOCHEM BIOPH RES CO, V89, P1300, DOI 10.1016/0006-291X(79)92150-8; Mitome N, 2004, P NATL ACAD SCI USA, V101, P12159, DOI 10.1073/pnas.0403545101; Mnatsakanyan N, 2009, J BIOL CHEM, V284, P11336, DOI 10.1074/jbc.M900374200; NALIN CM, 1984, J BIOL CHEM, V259, P7275; Nichols NN, 1997, J BACTERIOL, V179, P5056, DOI 10.1128/jb.179.16.5056-5061.1997; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; RICHTER ML, 1984, J BIOL CHEM, V259, P7371; Richter ML, 2004, PHOTOSYNTH RES, V79, P319, DOI 10.1023/B:PRES.0000017157.08098.36; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; Saita E, 2010, J BIOL CHEM, V285, P11411, DOI 10.1074/jbc.M109.099143; Samra HS, 2008, J BIOENERG BIOMEMBR, V40, P69, DOI 10.1007/s10863-008-9131-4; Samra HS, 2006, J BIOL CHEM, V281, P31041, DOI 10.1074/jbc.M603315200; Sekiya M, 2010, J BIOL CHEM, V285, P42058, DOI 10.1074/jbc.M110.176701; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Sunamura EI, 2010, PLANT CELL PHYSIOL, V51, P855, DOI 10.1093/pcp/pcq061; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; Ueoka-Nakanishi H, 2004, J BIOL CHEM, V279, P16272, DOI 10.1074/jbc.M400607200; Usukura E, 2012, J BIOL CHEM, V287, P1884, DOI 10.1074/jbc.M111.305938; VASILYEVA EA, 1982, BIOCHEM J, V202, P9, DOI 10.1042/bj2020009; Weber J, 1999, J BIOL CHEM, V274, P19124, DOI 10.1074/jbc.274.27.19124; WERNER S, 1990, FEBS LETT, V261, P204, DOI 10.1016/0014-5793(90)80671-5; YOSHIDA M, 1979, J BIOL CHEM, V254, P9525; YOSHIDA M, 1983, J BIOL CHEM, V258, P4407; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	53	10	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38695	38704		10.1074/jbc.M112.395053	http://dx.doi.org/10.1074/jbc.M112.395053			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23012354	Green Published, hybrid			2022-12-28	WOS:000310982800028
J	Xiong, XW; Tao, RY; DePinho, RA; Dong, XC				Xiong, Xiwen; Tao, Rongya; DePinho, Ronald A.; Dong, X. Charlie			The Autophagy-related Gene 14 (Atg14) Is Regulated by Forkhead Box O Transcription Factors and Circadian Rhythms and Plays a Critical Role in Hepatic Autophagy and Lipid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOLOGICAL HYPERTROPHY; OXIDATIVE STRESS; HEART; FOXO; DEGRADATION; ACTIVATION; CATABOLISM; PATHWAYS	Autophagy plays a critical role in cell survival from prolonged starvation and recycling of aggregated proteins and damaged organelles. One of the essential genes involved in the autophagic initiation is autophagy-related 14 (Atg14), also called Barkor for Beclin 1-associated autophagy-related key regulator. Although its crucial role in the autophagic process has been reported, the gene regulation of Atg14 and its metabolic functions remain unclear. In this work we have identified that the Atg14 gene is regulated by forkhead box O (FoxO) transcription factors and circadian rhythms in the mouse liver. Luciferase reporter analyses and chromatin immunoprecipitation assays have revealed well conserved cis-elements for FoxOs and Clock/Bmal1 in the proximal promoter of the Atg14 gene. To examine the functions of hepatic Atg14, we have performed the gene knockdown and overexpression in the mouse livers. Remarkably, knockdown of Atg14 leads to elevated levels of triglycerides in the liver and serum as well. Conversely, overexpression of Atg14 improves hypertriglyceridemia in both high fat diet-treated wild-type mice and FoxO1/3/4 liver-specific knock-out mice. In summary, our data suggest that Atg14 is a new target gene of FoxOs and the core clock machinery, and this gene plays an important role in hepatic lipid metabolism.	[Xiong, Xiwen; Tao, Rongya; Dong, X. Charlie] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [DePinho, Ronald A.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	Indiana University System; Indiana University Bloomington; University of Texas System; UTMD Anderson Cancer Center	Dong, XC (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr,MS1021D, Indianapolis, IN 46202 USA.	xcdong@iupui.edu	Xiong, Xiwen/GSN-0686-2022; tao, rongya/B-8042-2014	tao, rongya/0000-0002-3316-5587; DePinho, Ronald/0000-0002-5625-577X	National Institutes of Health [R00DK077505, R01DK091592]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091592, R00DK077505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R00DK077505 and R01DK091592 (NIDDK; to X. C. D.).	Chaanine AH, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.5; Chiacchiera F, 2009, CELL DEATH DIFFER, V16, P1203, DOI 10.1038/cdd.2009.36; Comb WC, 2011, ONCOGENE, V30, P1727, DOI 10.1038/onc.2010.553; Ding WX, 2011, AUTOPHAGY, V7, P248, DOI 10.4161/auto.7.2.14347; Ding WX, 2010, GASTROENTEROLOGY, V139, P1740, DOI 10.1053/j.gastro.2010.07.041; Ding WX, 2009, METHOD ENZYMOL, V453, P397, DOI 10.1016/S0076-6879(08)04020-2; Fan W, 2011, P NATL ACAD SCI USA, V108, P7769, DOI 10.1073/pnas.1016472108; Han J, 2012, AUTOPHAGY, V8, P812, DOI 10.4161/auto.19471; Hariharan N, 2010, CIRC RES, V107, P1470, DOI 10.1161/CIRCRESAHA.110.227371; Hou TY, 2009, J BIOL CHEM, V284, P31735, DOI 10.1074/jbc.M109.013961; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Jaber N, 2012, P NATL ACAD SCI USA, V109, P2003, DOI 10.1073/pnas.1112848109; Komatsu M., 2012, PHARM RES IN PRESS; Kong DK, 2010, MOL BIOL CELL, V21, P1335, DOI 10.1091/mbc.E09-09-0818; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; Liu HY, 2009, J BIOL CHEM, V284, P31484, DOI 10.1074/jbc.M109.033936; Ma D, 2011, EMBO J, V30, P4642, DOI 10.1038/emboj.2011.322; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Polager S, 2008, ONCOGENE, V27, P4860, DOI 10.1038/onc.2008.117; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Sadagurski M, 2011, J CLIN INVEST, V121, P4070, DOI 10.1172/JCI46305; Sanchez AMJ, 2012, J CELL BIOCHEM, V113, P695, DOI 10.1002/jcb.23399; Schips TG, 2011, CARDIOVASC RES, V91, P587, DOI 10.1093/cvr/cvr144; Sengupta A, 2011, J BIOL CHEM, V286, P7468, DOI 10.1074/jbc.M110.179242; Sengupta A, 2009, J BIOL CHEM, V284, P28319, DOI 10.1074/jbc.M109.024406; Singh R, 2012, INT J CELL BIOL, DOI DOI 10.1155/2012/282041; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sinha RA, 2012, J CLIN INVEST, V122, P2428, DOI 10.1172/JCI60580; Skop V, 2012, PHYSIOL RES, V61, P287, DOI 10.33549/physiolres.932285; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Tao RY, 2011, J BIOL CHEM, V286, P14681, DOI 10.1074/jbc.M110.201061; van der Vos KE, 2012, NAT CELL BIOL, V14, P829, DOI 10.1038/ncb2536; Velikkakath AKG, 2012, MOL BIOL CELL, V23, P896, DOI 10.1091/mbc.E11-09-0785; Vidal RL, 2012, HUM MOL GENET, V21, P2245, DOI 10.1093/hmg/dds040; Wang XJ, 2011, CARDIOVASC RES, V91, P561, DOI 10.1093/cvr/cvr196; Weidberg H, 2009, DEV CELL, V16, P628, DOI 10.1016/j.devcel.2009.05.001; Xu P, 2011, GENE DEV, V25, P310, DOI 10.1101/gad.1984311; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yang PG, 2011, AUTOPHAGY, V7, P159, DOI 10.4161/auto.7.2.14223; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	48	137	144	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39107	39114		10.1074/jbc.M112.412569	http://dx.doi.org/10.1074/jbc.M112.412569			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22992773	Green Published, hybrid			2022-12-28	WOS:000310982800066
J	Linke, C; Siemens, N; Oehmcke, S; Radjainia, M; Law, RHP; Whisstock, JC; Baker, EN; Kreikemeyer, B				Linke, Christian; Siemens, Nikolai; Oehmcke, Sonja; Radjainia, Mazdak; Law, Ruby H. P.; Whisstock, James C.; Baker, Edward N.; Kreikemeyer, Bernd			The Extracellular Protein Factor Epf from Streptococcus pyogenes Is a Cell Surface Adhesin That Binds to Cells through an N-terminal Domain Containing a Carbohydrate-binding Module	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; GROUP-A STREPTOCOCCI; VIRULENCE FACTOR EXPRESSION; PATHOGENICITY REGION; SECONDARY-STRUCTURE; CRYSTAL-STRUCTURE; EPITHELIAL-CELLS; LIGAND-BINDING; FIBRONECTIN; PLASMINOGEN	Streptococcus pyogenes is an exclusively human pathogen. Streptococcal attachment to and entry into epithelial cells is a prerequisite for a successful infection of the human host and requires adhesins. Here, we demonstrate that the multidomain protein Epf from S. pyogenes serotype M49 is a streptococcal adhesin. An epf-deficient mutant showed significantly decreased adhesion to and internalization into human keratinocytes. Cell adhesion is mediated by the N-terminal domain of Epf (EpfN) and increased by the human plasma protein plasminogen. The crystal structure of EpfN, solved at 1.6 angstrom resolution, shows that it consists of two subdomains: a carbohydrate-binding module and a fibronectin type III domain. Both fold types commonly participate in ligand receptor and protein-protein interactions. EpfN is followed by 18 repeats of a domain classified as DUF1542 (domain of unknown function 1542) and a C-terminal cell wall sorting signal. The DUF1542 repeats are not involved in adhesion, but biophysical studies show they are predominantly alpha-helical and form a fiber-like stalk of tandem DUF1542 domains. Epf thus conforms with the widespread family of adhesins known as MSCRAMMs (microbial surface components recognizing adhesive matrix molecules), in which a cell wall-attached stalk enables long range interactions via its adhesive N-terminal domain.	[Linke, Christian; Radjainia, Mazdak; Baker, Edward N.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1142, New Zealand; [Linke, Christian; Radjainia, Mazdak; Baker, Edward N.] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand; [Siemens, Nikolai; Oehmcke, Sonja; Kreikemeyer, Bernd] Rostock Univ Hosp, Inst Med Microbiol Virol & Hyg, D-18057 Rostock, Germany; [Law, Ruby H. P.; Whisstock, James C.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	University of Auckland; University of Auckland; University of Rostock; Monash University	Baker, EN (corresponding author), Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1142, New Zealand.	ted.baker@auckland.ac.nz; bernd.kreikemeyer@med.uni-rostock.de	Linke-Winnebeck, Christian/P-1585-2019; Linke-Winnebeck, Christian/F-4091-2010	Linke-Winnebeck, Christian/0000-0002-2306-247X; Linke-Winnebeck, Christian/0000-0002-2306-247X; Siemens, Nikolai/0000-0003-0657-3822; Kreikemeyer, Bernd/0000-0001-9527-5098; Baker, Edward/0000-0003-2456-7661; Whisstock, James/0000-0003-4200-5611; law, ruby/0000-0001-5432-5781	Medical Faculty of the University of Rostock; German Federal Ministry of Education and Research (BMBF); Health Research Council of New Zealand; Tertiary Education Commission of New Zealand; Maurice Wilkins Centre for Molecular Biodiscovery; National Health and Medical Research Council of Australia; New Zealand International Doctoral Research Scholarship (Education New Zealand); Australian Research Council Federation Fellowship; National Health and Medical Research Council of Australia Principal Research Fellowship	Medical Faculty of the University of Rostock; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Health Research Council of New Zealand(Health Research Council of New Zealand); Tertiary Education Commission of New Zealand; Maurice Wilkins Centre for Molecular Biodiscovery; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); New Zealand International Doctoral Research Scholarship (Education New Zealand); Australian Research Council Federation Fellowship(Australian Research Council); National Health and Medical Research Council of Australia Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Medical Faculty of the University of Rostock in the framework of the FORUN program, the German Federal Ministry of Education and Research (BMBF) in the framework of the ERANet "Patho-GenoMics" I and II program, the Health Research Council of New Zealand, the Tertiary Education Commission of New Zealand through funding of the Maurice Wilkins Centre for Molecular Biodiscovery and the National Health and Medical Research Council of Australia. Access to the Australian Synchrotron was supported by the New Zealand Synchrotron Group Ltd.; Supported by a New Zealand International Doctoral Research Scholarship (Education New Zealand).; Supported by an Australian Research Council Federation Fellowship and an honorary National Health and Medical Research Council of Australia Principal Research Fellowship.	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Arnon TI, 2008, J MOL BIOL, V381, P1012, DOI 10.1016/j.jmb.2008.06.082; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Boraston AB, 2003, J MOL BIOL, V327, P659, DOI 10.1016/S0022-2836(03)00152-9; Boraston AB, 2002, J MOL BIOL, V319, P1143, DOI 10.1016/S0022-2836(02)00374-1; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Courtney HS, 2002, ANN MED, V34, P77, DOI 10.1080/07853890252953464; Cue D, 1998, INFECT IMMUN, V66, P4593, DOI 10.1128/IAI.66.10.4593-4601.1998; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; DeLano W.L, PYMOL MOL GRAPHICS S; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gullfot F, 2010, PROTEINS, V78, P785, DOI 10.1002/prot.22642; Himanen JP, 2009, EMBO REP, V10, P722, DOI 10.1038/embor.2009.91; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Joh D, 1999, MATRIX BIOL, V18, P211, DOI 10.1016/S0945-053X(99)00025-6; Kang HJ, 2012, CURR OPIN STRUC BIOL, V22, P200, DOI 10.1016/j.sbi.2012.01.009; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kreikemeyer B, 2004, INT J MED MICROBIOL, V294, P177, DOI 10.1016/j.ijmm.2004.06.017; Kreikemeyer B, 2004, J BIOL CHEM, V279, P15850, DOI 10.1074/jbc.M313613200; Kreikemeyer B, 2007, INFECT IMMUN, V75, P5698, DOI 10.1128/IAI.00175-07; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwinn LA, 2007, J BACTERIOL, V189, P1322, DOI 10.1128/JB.01256-06; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LAPENTA D, 1994, P NATL ACAD SCI USA, V91, P12115, DOI 10.1073/pnas.91.25.12115; Linke C, 2012, ACTA CRYSTALLOGR F, V68, P793, DOI 10.1107/S1744309112020313; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLellan JS, 2008, NATURE, V455, P979, DOI 10.1038/nature07358; Osterlund A, 1997, ACTA OTO-LARYNGOL, V117, P883, DOI 10.3109/00016489709114219; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; PATTI JM, 1992, J BIOL CHEM, V267, P4766; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Podbielski A, 2001, LANCET, V358, P3, DOI 10.1016/S0140-6736(00)05296-X; Sanderson-Smith ML, 2008, FASEB J, V22, P2715, DOI 10.1096/fj.07-105643; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Siemens N, 2012, J BACTERIOL, V194, P3618, DOI 10.1128/JB.00227-12; Siemens N, 2011, J BIOL CHEM, V286, P21612, DOI 10.1074/jbc.M110.202671; Simpson PJ, 2002, BIOCHEMISTRY-US, V41, P5712, DOI 10.1021/bi012093i; SMITH HE, 1993, INFECT IMMUN, V61, P3318, DOI 10.1128/IAI.61.8.3318-3326.1993; Unneberg P, 2001, PROTEINS, V42, P460, DOI 10.1002/1097-0134(20010301)42:4<460::AID-PROT50>3.0.CO;2-U; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vengadesan K, 2011, PROTEIN SCI, V20, P759, DOI 10.1002/pro.613; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006	53	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.376434	http://dx.doi.org/10.1074/jbc.M112.376434			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22977243	Green Published, hybrid			2022-12-28	WOS:000310642200051
J	Shen, Y; Li, NL; Wang, J; Liu, BM; Lester, S; Li, K				Shen, Yang; Li, Nan L.; Wang, Jie; Liu, Baoming; Lester, Sandra; Li, Kui			TRIM56 Is an Essential Component of the TLR3 Antiviral Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR; NF-KAPPA-B; INTERFERON REGULATORY FACTOR-3; HEPATITIS-C VIRUS; IFN-BETA PRODUCTION; FAMILY PROTEINS; ADAPTER; MOTIF; ACTIVATION; LIGASE	Members of the tripartite motif (TRIM) proteins are being recognized as important regulators of host innate immunity. However, specific TRIMs that contribute to TLR3-mediated antiviral defense have not been identified. We show here that TRIM56 is a positive regulator of TLR3 signaling. Overexpression of TRIM56 substantially potentiated extracellular dsRNA-induced expression of interferon (IFN)-beta and interferon-stimulated genes (ISGs), while knockdown of TRIM56 greatly impaired activation of IRF3, induction of IFN-beta and ISGs, and establishment of an antiviral state by TLR3 ligand and severely compromised TLR3-mediated chemokine induction following infection by hepatitis C virus. The ability to promote TLR3 signaling was independent of the E3 ubiquitin ligase activity of TRIM56. Rather, it correlated with a physical interaction between TRIM56 and TRIF. Deletion of the C-terminal portion of TRIM56 abrogated the TRIM56-TRIF interaction as well as the augmentation of TLR3-mediated IFN response. Together, our data demonstrate TRIM56 is an essential component of the TLR3 antiviral signaling pathway and reveal a novel role for TRIM56 in innate antiviral immunity.	[Shen, Yang; Li, Nan L.; Wang, Jie; Liu, Baoming; Lester, Sandra; Li, Kui] Univ Tennessee, Dept Microbiol Immunol & Biochem, Hlth Sci Ctr, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Li, K (corresponding author), Univ Tennessee, Dept Microbiol Immunol & Biochem, Hlth Sci Ctr, 858 Madison Ave, Memphis, TN 38163 USA.	kli1@uthsc.edu			National Institutes of Health [AI069285, AI078906]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI078906, R01AI069285, R56AI069285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported, in whole or in part, by National Institutes of Health Grant AI069285 (to K. L.).; Supported by an National Institutes of Health T32 Training Grant (AI078906).	Arimoto K, 2010, P NATL ACAD SCI USA, V107, P15856, DOI 10.1073/pnas.1004621107; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Chen ZH, 2007, VIROLOGY, V366, P277, DOI 10.1016/j.virol.2007.04.023; Chen ZH, 2007, J VIROL, V81, P964, DOI 10.1128/JVI.02076-06; Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394; Elco CP, 2005, J VIROL, V79, P3920, DOI 10.1128/JVI.79.7.3920-3929.2005; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Keskinen P, 1999, VIROLOGY, V263, P364, DOI 10.1006/viro.1999.9983; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Li K, 2012, HEPATOLOGY, V55, P666, DOI 10.1002/hep.24763; Liang QM, 2011, J IMMUNOL, V187, P4754, DOI 10.4049/jimmunol.1101704; Mcnab FW, 2011, CURR OPIN IMMUNOL, V23, P46, DOI 10.1016/j.coi.2010.10.021; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Munir M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3118jc2; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Short KM, 2006, J BIOL CHEM, V281, P8970, DOI 10.1074/jbc.M512755200; Tighe A, 2008, J CELL BIOL, V181, P893, DOI 10.1083/jcb.200712028; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang J, 2011, J VIROL, V85, P3733, DOI 10.1128/JVI.02546-10; Wang N, 2010, J BIOL CHEM, V285, P6080, DOI 10.1074/jbc.M109.054486; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Zha FK, 2006, J IMMUNOL, V176, P1072, DOI 10.4049/jimmunol.176.2.1072; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Zhao W, 2012, J IMMUNOL, V188, P5311, DOI 10.4049/jimmunol.1103506	43	52	56	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36404	36413		10.1074/jbc.M112.397075	http://dx.doi.org/10.1074/jbc.M112.397075			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22948160	hybrid, Green Published			2022-12-28	WOS:000310364000060
J	Graziano, V; Mcgrath, WJ; Suomalainen, M; Greber, UF; Freimuth, P; Blainey, PC; Luo, GB; Xie, XS; Mangel, WF				Graziano, Vito; Mcgrath, William J.; Suomalainen, Maarit; Greber, Urs F.; Freimuth, Paul; Blainey, Paul C.; Luo, Guobin; Xie, X. Sunney; Mangel, Walter F.			Regulation of a Viral Proteinase by a Peptide and DNA in One-dimensional Space I. BINDING TO DNA AND TO HEXON OF THE PRECURSOR TO PROTEIN VI, pVI, OF HUMAN ADENOVIRUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYOELECTRON MICROSCOPY STRUCTURE; RESOLUTION; ENTRY; LOCALIZATION; DISRUPTION; TRANSPORT; COFACTORS; TERMINUS; RECEPTOR; COMPLEX	The precursor to adenovirus protein VI, pVI, is a multifunctional protein with different roles early and late in virus infection. Here, we focus on two roles late in infection, binding of pVI to DNA and to the major capsid protein hexon. pVI bound to DNA as a monomer independent of DNA sequence with an apparent equilibrium dissociation constant, K-d(app), of 46 nM. Bound to double-stranded DNA, one molecule of pVI occluded 8 bp. Upon the binding of pVI to DNA, three sodium ions were displaced from the DNA. A Delta G(0)(0) of -4.54 kcal/mol for the nonelectrostatic free energy of binding indicated that a substantial component of the binding free energy resulted from nonspecific interactions between pVI and DNA. The proteolytically processed, mature form of pVI, protein VI, also bound to DNA; its K-d(app) was much higher, 307 nM. The binding assays were performed in 1 mM MgCl2 because in the absence of magnesium, the binding to pVI or protein VI to DNA was too tight to determine a K-d(app). Three molecules of pVI bound to one molecule of the hexon trimer with an equilibrium dissociation constant K-d(app) of 1.1 nM.	[Graziano, Vito; Mcgrath, William J.; Freimuth, Paul; Mangel, Walter F.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Suomalainen, Maarit; Greber, Urs F.] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Blainey, Paul C.; Luo, Guobin; Xie, X. Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; University of Zurich; Harvard University	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu; mangel@bnl.gov	Greber, Urs F/G-9458-2015	Greber, Urs F/0000-0003-2278-120X; McGrath, William/0000-0002-9375-624X; Blainey, Paul/0000-0002-4889-8783	National Institutes of Health; National Science Foundation; National Institutes of Health [R01AI41599]; Swiss National Science Foundation [31003A_125477/1]; Kanton Zurich; Brookhaven National Laboratory; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041599, R21AI113565] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kanton Zurich; Brookhaven National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by the National Institutes of Health Director's Pioneer Award and the National Science Foundation (to X. S. X.) and National Institutes of Health R01AI41599 Grant (to W. F. M.). This work was also supported by the Swiss National Science Foundation (Grant 31003A_125477/1) and the Kanton Zurich (to U. F. G.) and by a Laboratory Directed Research and Development grant from Brookhaven National Laboratory (to P. C. F.).	AKUSJARVI G, 1984, J BIOL CHEM, V259, P3976; Bajpayee NS, 2005, BIOCHEMISTRY-US, V44, P8721, DOI 10.1021/bi0502240; Baniecki ML, 2001, BIOCHEMISTRY-US, V40, P12349, DOI 10.1021/bi0109008; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Blainey PC, 2013, J BIOL CHEM, V288, P2092, DOI 10.1074/jbc.M112.407460; Burckhardt CJ, 2011, CELL HOST MICROBE, V10, P105, DOI 10.1016/j.chom.2011.07.006; Ding JZ, 1996, EMBO J, V15, P1778, DOI 10.1002/j.1460-2075.1996.tb00526.x; Freimuth P, 2008, CURR TOP MICROBIOL, V323, P67; Gastaldelli M, 2008, TRAFFIC, V9, P2265, DOI 10.1111/j.1600-0854.2008.00835.x; Graziano V, 2013, J BIOL CHEM, V288, P2068, DOI 10.1074/jbc.M112.407312; GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z; Gupta S, 2004, MOL CELL PROTEOMICS, V3, P950, DOI 10.1074/mcp.M400037-MCP200; Honkavuori KS, 2004, J GEN VIROL, V85, P3367, DOI 10.1099/vir.0.80203-0; Liu HR, 2010, SCIENCE, V329, P1038, DOI 10.1126/science.1187433; MANGEL WF, 1993, NATURE, V361, P274, DOI 10.1038/361274a0; Mangel WF, 1996, J BIOL CHEM, V271, P536, DOI 10.1074/jbc.271.1.536; MATTHEWS DA, 1995, J GEN VIROL, V76, P1959, DOI 10.1099/0022-1317-76-8-1959; MATTHEWS DA, 1994, J GEN VIROL, V75, P3365, DOI 10.1099/0022-1317-75-12-3365; McGrath WJ, 1996, VIROLOGY, V217, P131, DOI 10.1006/viro.1996.0100; McGrath WJ, 2003, BBA-PROTEINS PROTEOM, V1648, P1, DOI 10.1016/S1570-9639(03)00024-4; McGrath WJ, 2001, BIOCHEMISTRY-US, V40, P13237, DOI 10.1021/bi0111653; Meier O, 2002, J CELL BIOL, V158, P1119, DOI 10.1083/jcb.200112067; Moyer CL, 2011, J VIROL, V85, P2631, DOI 10.1128/JVI.02321-10; Philipson L, 1995, Curr Top Microbiol Immunol, V199 ( Pt 1), P1; Puntener D, 2011, J VIROL, V85, P481, DOI 10.1128/JVI.01571-10; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Russell WC, 2009, J GEN VIROL, V90, P1, DOI 10.1099/vir.0.003087-0; RUSSELL WC, 1982, J GEN VIROL, V63, P69, DOI 10.1099/0022-1317-63-1-69; Rux John J, 2007, Methods Mol Med, V131, P231; Saban SD, 2006, J VIROL, V80, P12049, DOI 10.1128/JVI.01652-06; San Martin C, 2008, J MOL BIOL, V383, P923, DOI 10.1016/j.jmb.2008.08.054; Silvestry M, 2009, J VIROL, V83, P7375, DOI 10.1128/JVI.00331-09; STEWART PL, 1993, EMBO J, V12, P2589, DOI 10.1002/j.1460-2075.1993.tb05919.x; Strunze S, 2011, CELL HOST MICROBE, V10, P210, DOI 10.1016/j.chom.2011.08.010; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; VANOOSTRUM J, 1985, J VIROL, V56, P439, DOI 10.1128/JVI.56.2.439-448.1985; Wang KN, 1998, J VIROL, V72, P3455, DOI 10.1128/JVI.72.4.3455-3458.1998; WEBSTER A, 1993, CELL, V72, P97, DOI 10.1016/0092-8674(93)90053-S; Wiethoff CM, 2005, J VIROL, V79, P1992, DOI 10.1128/JVI.79.4.1992-2000.2005; Wodrich H, 2003, EMBO J, V22, P6245, DOI 10.1093/emboj/cdg614; Wodrich H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000808	42	12	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					2059	2067		10.1074/jbc.M112.377150	http://dx.doi.org/10.1074/jbc.M112.377150			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23043136	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000313751400057
J	Kim, M; Kim, S; Lim, JH; Lee, C; Choi, HC; Woo, CH				Kim, Miso; Kim, Suji; Lim, Jae Hyang; Lee, ChuHee; Choi, Hyoung Chul; Woo, Chang-Hoon			Laminar Flow Activation of ERK5 Protein in Vascular Endothelium Leads to Atheroprotective Effect via NF-E2-related Factor 2 (Nrf2) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE-5; NITRIC-OXIDE SYNTHASE; SHEAR-STRESS; ANTIOXIDANT RESPONSE; GENE-EXPRESSION; CELLS; ATHEROSCLEROSIS; PHOSPHORYLATION; TRANSCRIPTION; INDUCTION	Atherosclerosis is often observed in areas where disturbed flow is formed, whereas atheroprotective region is found in areas where steady laminar flow is developed. It has been reported that some genes activated by blood flow play important roles in vascular function and pathogenesis of atherosclerosis. Extracellular signal-regulated kinase 5 (ERK5) has been reported to regulate endothelial integrity and protect from vascular dysfunction and disease under laminar flow. Kruppel-like factor 2 (KLF2) and NF-E2-related factor 2 (Nrf2) are major transcriptional factors that contribute to anti-atherogenic responses under laminar flow. Implication of ERK5 in laminar flow-mediated regulation of KLF2-dependent gene has been established, whereas the role of ERK5 in laminar flow-mediated activation of Nrf2 pathway has not been addressed yet. In this study, we found that the blockage of ERK5 either by genetic depletion with siRNA or by biochemical inactivation with a specific chemical compound inhibited laminar flow-induced up-regulation of Nrf2-dependent gene expressions, whereas activation of ERK5 increased transcriptional activity and nuclear translocation of Nrf2, which suggests that ERK5 mediates laminar flow-induced up-regulation of Nrf2-dependent gene expression. Further functional studies showed that ERK5 provides protection against oxidative stress-induced cytotoxicity dependent on Nrf2. Molecular interaction between ERK5 and Nrf2 was further induced by laminar flow. Finally, flow-dependent nuclear localization of Nrf2 was inhibited by BIX02189, a specific inhibitor of MEK5, in aorta of mice in vivo. Collectively, these data demonstrate that laminar flow-induced activation of ERK5-Nrf2 signal pathway plays a critical role for anti-inflammatory and anti-apoptotic mechanism in endothelial cells.	[Kim, Miso; Kim, Suji; Choi, Hyoung Chul; Woo, Chang-Hoon] Yeungnam Univ, Coll Med, Dept Pharmacol, Taegu 705717, South Korea; [Lee, ChuHee] Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Taegu 705717, South Korea; [Kim, Miso; Kim, Suji; Choi, Hyoung Chul; Woo, Chang-Hoon] Yeungnam Univ, Coll Med, Aging Associated Vasc Dis Res Ctr, Taegu 705717, South Korea; [Lim, Jae Hyang] Ewha Womans Univ, Sch Med, Dept Microbiol, Seoul 158710, South Korea	Yeungnam University; Yeungnam University; Yeungnam University; Ewha Womans University	Woo, CH (corresponding author), Yeungnam Univ, Coll Med, Dept Pharmacol, 317-1 Daemyung Dong, Taegu 705717, South Korea.	changhoon_woo@yu.ac.kr		Lim, Jae Hyang/0000-0003-0972-9271	Basic Science Research Program through the National Research Foundation of Korea (NRF); Korea government [2011-0006184, 2011-0026075]; Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A111345]	Basic Science Research Program through the National Research Foundation of Korea (NRF); Korea government(Korean Government); Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Korea government (Grants 2011-0006184 and 2011-0026075) and a grant from the Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (Grant A111345).	Akaike M, 2004, MOL CELL BIOL, V24, P8691, DOI 10.1128/MCB.24.19.8691-8704.2004; Ali F, 2009, J BIOL CHEM, V284, P18882, DOI 10.1074/jbc.M109.009886; Buschbeck M, 2005, J BIOL CHEM, V280, P2659, DOI 10.1074/jbc.M412599200; Cao Y, 2012, J BIOL CHEM, V287, P3029; Chen XL, 2003, J BIOL CHEM, V278, P703, DOI 10.1074/jbc.M203161200; Clark PR, 2011, MICROCIRCULATION, V18, P102, DOI 10.1111/j.1549-8719.2010.00071.x; Dai GH, 2004, P NATL ACAD SCI USA, V101, P14871, DOI 10.1073/pnas.0406073101; Dai G, 2007, CIRC RES, V101, P723, DOI 10.1161/CIRCRESAHA.107.152942; Dekker RJ, 2006, BLOOD, V107, P4354, DOI 10.1182/blood-2005-08-3465; Fleming I, 1998, CIRC RES, V82, P686, DOI 10.1161/01.RES.82.6.686; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Hayashi M, 2004, J CLIN INVEST, V113, P1138, DOI 10.1172/JCI200419890; Hosoya T, 2005, J BIOL CHEM, V280, P27244, DOI 10.1074/jbc.M502551200; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Lee HH, 2010, ARCH BIOCHEM BIOPHYS, V501, P142, DOI 10.1016/j.abb.2010.06.011; Lim JH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1776; Maher J, 2010, TOXICOL APPL PHARM, V244, P4, DOI 10.1016/j.taap.2010.01.011; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Nigro P, 2010, BLOOD, V116, P1971, DOI 10.1182/blood-2010-02-269134; Ohnesorge N, 2010, J BIOL CHEM, V285, P26199, DOI 10.1074/jbc.M110.103127; Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Pi XC, 2004, CIRC RES, V94, P362, DOI 10.1161/01.RES.0000112406.27800.6F; Shen GX, 2004, J BIOL CHEM, V279, P23052, DOI 10.1074/jbc.M401368200; Sun Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006588; Takabe W, 2011, ANTIOXID REDOX SIGN, V15, P1379, DOI 10.1089/ars.2010.3645; Wang X, 2006, CELL SIGNAL, V18, P753, DOI 10.1016/j.cellsig.2005.11.003; Warabi E, 2004, FREE RADICAL BIO MED, V37, P682, DOI 10.1016/j.freeradbiomed.2004.05.020; Warabi E, 2007, FREE RADICAL BIO MED, V42, P260, DOI 10.1016/j.freeradbiomed.2006.10.043; Woo CH, 2008, CIRC RES, V102, P538, DOI 10.1161/CIRCRESAHA.107.156877; Woo CH, 2006, J BIOL CHEM, V281, P32164, DOI 10.1074/jbc.M602369200; Yan C, 2001, J BIOL CHEM, V276, P10870, DOI 10.1074/jbc.M009286200; Yan Lijun, 2003, BMC Dev Biol, V3, P11, DOI 10.1186/1471-213X-3-11; Young A, 2009, ARTERIOSCL THROM VAS, V29, P1902, DOI 10.1161/ATVBAHA.109.193540; Zakkar M, 2009, ARTERIOSCL THROM VAS, V29, P1851, DOI 10.1161/ATVBAHA.109.193375	36	51	54	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40722	40731		10.1074/jbc.M112.381509	http://dx.doi.org/10.1074/jbc.M112.381509			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23043106	Green Published, hybrid			2022-12-28	WOS:000311448800061
J	Fujii, N; Sakaue, H; Sasaki, H; Fujii, N				Fujii, Norihiko; Sakaue, Hiroaki; Sasaki, Hiroshi; Fujii, Noriko			A Rapid, Comprehensive Liquid Chromatography-Mass Spectrometry (LC-MS)-based Survey of the Asp Isomers in Crystallins from Human Cataract Lenses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ASPARTIC ACID; ALPHA-A-CRYSTALLIN; IMMUNOHISTOCHEMICAL LOCALIZATION; SIMULTANEOUS STEREOINVERSION; CONTAINING PROTEINS; BACKBONE CLEAVAGE; B-CRYSTALLIN; DEAMIDATION; AGE; RACEMIZATION	Cataracts are caused by clouding of the eye lens and may lead to partial or total loss of vision. The mechanism of cataract development, however, is not well understood. It is thought that abnormal aggregates of lens proteins form with age, causing loss of lens clarity and development of the cataract. Lens proteins are composed of soluble alpha-, beta-, and gamma-crystallins, and as long lived proteins, they undergo post-translational modifications including isomerization, deamidation, and oxidation, which induce insolubilization, aggregation, and loss of function that may lead to cataracts. Therefore, analysis of post-translational modifications of individual amino acid residues in proteins is important. However, detection of the optical isomers of amino acids formed in these proteins is difficult because optical resolution is only achieved using complex methodology. In this study, we describe a new method for the analysis of isomerization of individual Asp residues in proteins using LC-MS and the corresponding synthetic peptides containing the Asp isomers. This makes it possible to analyze isomers of Asp residues in proteins precisely and quickly. We demonstrate that Asp-58, -76, -84, and -151 of alpha A-crystallin and Asp-62 and -96 of alpha B-crystallin are highly converted to L beta-, D beta-, and D alpha-isomers. The amount of isomerization of Asp is greater in the insoluble fraction at all Asp sites in lens proteins, therefore indicating that isomerization of these Asp residues affects the higher order structure of the proteins and contributes to the increase in aggregation, insolubilization, and disruption of function of proteins in the lens, leading to the cataract.	[Fujii, Norihiko; Fujii, Noriko] Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 5900494, Japan; [Sakaue, Hiroaki; Fujii, Noriko] Kyoto Univ, Dept Chem, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan; [Sasaki, Hiroshi] Kanazawa Med Univ, Uchinada, Ishikawa 9200293, Japan	Kyoto University; Kyoto University; Kanazawa Medical University	Fujii, N (corresponding author), Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 5900494, Japan.	nfujii@rri.kyoto-u.ac.jp	Sakaue, Hiroaki/AAT-7104-2021	Sakaue, Hiroaki/0000-0002-1977-0318	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	AMICHE M, 1989, MOL PHARMACOL, V35, P774; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; BROCCARDO M, 1981, BRIT J PHARMACOL, V73, P625, DOI 10.1111/j.1476-5381.1981.tb16797.x; CARPINO LA, 1972, J ORG CHEM, V37, P3404, DOI 10.1021/jo00795a005; Cloos PAC, 2000, BIOCHEM J, V345, P473, DOI 10.1042/0264-6021:3450473; COSTE J, 1990, TETRAHEDRON LETT, V31, P205, DOI 10.1016/S0040-4039(00)94371-5; Foulon CF, 2000, CANCER RES, V60, P4453; Fujii N, 2007, AMINO ACIDS, V32, P87, DOI 10.1007/s00726-006-0303-4; FUJII N, 1994, J BIOCHEM-TOKYO, V116, P663, DOI 10.1093/oxfordjournals.jbchem.a124577; Fujii N, 2002, BIOCHEM BIOPH RES CO, V294, P1047, DOI 10.1016/S0006-291X(02)00597-1; FUJII N, 1994, BBA-PROTEIN STRUCT M, V1204, P157, DOI 10.1016/0167-4838(94)90003-5; Fujii N, 2011, BIOCHEMISTRY-US, V50, P8628, DOI 10.1021/bi200983g; Fujii N, 2010, AMINO ACIDS, V39, P1393, DOI 10.1007/s00726-010-0597-0; Furuchi T, 2005, BIOL PHARM BULL, V28, P1566, DOI 10.1248/bpb.28.1566; GEIGER T, 1987, J BIOL CHEM, V262, P785; Hains PG, 2010, INVEST OPHTH VIS SCI, V51, P3107, DOI 10.1167/iovs.09-4308; Hanson SRA, 2000, EXP EYE RES, V71, P195, DOI 10.1006/exer.2000.0868; HASHIMOTO A, 1993, J NEUROCHEM, V60, P783, DOI 10.1111/j.1471-4159.1993.tb03219.x; HELFMAN PM, 1976, NATURE, V262, P279; Hooi MYS, 2012, INVEST OPHTH VIS SCI, V53, P3554, DOI 10.1167/iovs.11-9085; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Kaji Y, 2009, BRIT J OPHTHALMOL, V93, P977, DOI 10.1136/bjo.2008.144212; Kaji Y, 2009, BRIT J OPHTHALMOL, V93, P974, DOI 10.1136/bjo.2007.135889; Kaji Y, 2007, INVEST OPHTH VIS SCI, V48, P3923, DOI 10.1167/iovs.06-1284; KAMATANI Y, 1990, FEBS LETT, V276, P95, DOI 10.1016/0014-5793(90)80516-L; Kantorow M, 1998, INT J BIOL MACROMOL, V22, P307, DOI 10.1016/S0141-8130(98)00028-2; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Lampi KJ, 2006, BIOCHEMISTRY-US, V45, P3146, DOI 10.1021/bi052051k; Lampi KJ, 2001, EXP EYE RES, V72, P279, DOI 10.1006/exer.2000.0950; Li XJ, 2010, ANAL CHEM, V82, P3606, DOI 10.1021/ac9028467; Lund AL, 1996, EXP EYE RES, V63, P661, DOI 10.1006/exer.1996.0160; Masuda W, 2002, ARCH ORAL BIOL, V47, P757, DOI 10.1016/S0003-9969(02)00064-X; Mori Y, 2011, J CHROMATOGR B, V879, P3303, DOI 10.1016/j.jchromb.2011.05.010; Ohtani S, 1998, GROWTH DEVELOP AGING, V62, P141; PERRY RE, 1987, EXP EYE RES, V44, P269, DOI 10.1016/S0014-4835(87)80011-8; Ritz-Timme S, 2003, INT J LEGAL MED, V117, P96, DOI 10.1007/s00414-002-0355-2; ROHER AE, 1993, J BIOL CHEM, V268, P3072; Santhoshkumar P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019291; Shimizu K, 2012, MOL VIS, V18, P1823; SPECTOR A, 1978, P NATL ACAD SCI USA, V75, P3244, DOI 10.1073/pnas.75.7.3244; Takemoto L, 1995, EXP EYE RES, V61, P743, DOI 10.1016/S0014-4835(05)80025-9; Takemoto L, 1996, EXP EYE RES, V63, P585, DOI 10.1006/exer.1996.0149; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; Yamazaki Y, 2010, ANAL CHEM, V82, P6384, DOI 10.1021/ac100310x; Zhang ZL, 2003, EXP EYE RES, V77, P259, DOI 10.1016/S0014-4835(03)00159-3	46	65	67	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.399972	http://dx.doi.org/10.1074/jbc.M112.399972			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23007399	Green Published, hybrid			2022-12-28	WOS:000311233800066
J	Lee, KM; Park, Y; Bari, W; Yoon, MY; Go, J; Kim, SC; Lee, HI; Yoon, SS				Lee, Kang-Mu; Park, Yongjin; Bari, Wasimul; Yoon, Mi Young; Go, Junhyeok; Kim, Sang Cheol; Lee, Hyung-il; Yoon, Sang Sun			Activation of Cholera Toxin Production by Anaerobic Respiration of Trimethylamine N-oxide in Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRULENCE GENE-EXPRESSION; ARGININE TRANSLOCATION SYSTEM; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; EL-TOR; SHEWANELLA-ONEIDENSIS; SECRETORY PATHWAY; PROTEIN SECRETION; BIOFILM FORMATION; II SECRETION	Vibrio cholerae is a Gram-negative bacterium that causes cholera. Although the pathogenesis caused by this deadly pathogen takes place in the intestine, commonly thought to be anaerobic, anaerobiosis-induced virulence regulations are not fully elucidated. Anerobic growth of the V. cholerae strain, N16961, was promoted when trimethylamine N-oxide (TMAO) was used as an alternative electron acceptor. Strikingly, cholera toxin (CT) production was markedly induced during anaerobic TMAO respiration. N16961 mutants unable to metabolize TMAO were incapable of producing CT, suggesting a mechanistic link between anaerobic TMAO respiration and CT production. TMAO reductase is transported to the periplasm via the twin arginine transport (TAT) system. A similar defect in both anaerobic TMAO respiration and CT production was also observed in a N16961 TAT mutant. In contrast, the abilities to grow on TMAO and to produce CT were not affected in a mutant of the general secretion pathway. This suggests that V. cholerae may utilize the TAT system to secrete CT during TMAO respiration. During anaerobic growth with TMAO, N16961 cells exhibit green fluorescence when stained with 2',7'-dichlorofluorescein diacetate, a specific dye for reactive oxygen species (ROS). Furthermore, CT production was decreased in the presence of an ROS scavenger suggesting a positive role of ROS in regulating CT production. When TMAO was co-administered to infant mice infected with N16961, the mice exhibited more severe pathogenic symptoms. Together, our results reveal a novel anaerobic growth condition that stimulates V. cholerae to produce its major virulence factor.	[Lee, Kang-Mu; Park, Yongjin; Bari, Wasimul; Yoon, Mi Young; Go, Junhyeok; Yoon, Sang Sun] Yonsei Univ, Coll Med, Dept Microbiol & Immunol, Brain Korea Project Med Sci 21, Seoul 120752, South Korea; [Yoon, Sang Sun] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul 120752, South Korea; [Yoon, Sang Sun] Yonsei Univ, Coll Med, Res Inst Bacterial Resistance, Seoul 120752, South Korea; [Kim, Sang Cheol] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul 120752, South Korea; [Lee, Hyung-il] Univ Ulsan, Dept Chem, Ulsan 680749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; University of Ulsan	Yoon, SS (corresponding author), Yonsei Univ, Coll Med, Dept Microbiol & Immunol, Brain Korea Project Med Sci 21, 250 Seongsanno, Seoul 120752, South Korea.	sangsun_yoon@yuhs.ac		LEE, Kang-Mu/0000-0001-7414-5921; Yoon, Sang Sun/0000-0003-2979-365X	National Research Foundation of Korea (NRF); Korean Government (MEST) [2009-0087951, 2011-0016210]; Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs [A110096]; Yonsei University College of Medicine Research [6-2011-0101]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs; Yonsei University College of Medicine Research	This work was supported by grants from the National Research Foundation of Korea (NRF), funded by Korean Government (MEST) Grants 2009-0087951 and 2011-0016210. This work was also supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Grant A110096 and Yonsei University College of Medicine Research Grant 6-2011-0101.	Al-Sheboul S, 2011, ANAEROBE, V17, P501, DOI 10.1016/j.anaerobe.2011.06.008; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BARRETT EL, 1985, ANNU REV MICROBIOL, V39, P131, DOI 10.1146/annurev.mi.39.100185.001023; Bordi C, 2004, J BACTERIOL, V186, P4502, DOI 10.1128/JB.186.14.4502-4509.2004; Braun M, 2005, J BACTERIOL, V187, P5996, DOI 10.1128/JB.187.17.5996-6004.2005; Chandel NS, 2000, J IMMUNOL, V165, P1013, DOI 10.4049/jimmunol.165.2.1013; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Desvaux M, 2004, TRENDS MICROBIOL, V12, P306, DOI 10.1016/j.tim.2004.05.002; DIRITA VJ, 1992, MOL MICROBIOL, V6, P451, DOI 10.1111/j.1365-2958.1992.tb01489.x; Dos Santos JP, 1998, J MOL BIOL, V284, P421, DOI 10.1006/jmbi.1998.2155; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; GARDEL CL, 1994, METHOD ENZYMOL, V235, P517; Gon S, 2001, J BIOL CHEM, V276, P11545, DOI 10.1074/jbc.M008875200; Hase CC, 1998, P NATL ACAD SCI USA, V95, P730, DOI 10.1073/pnas.95.2.730; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Ilbert M, 2003, J BIOL CHEM, V278, P28787, DOI 10.1074/jbc.M302730200; Iredell Jonathan R., 1994, Trends in Microbiology, V2, P187, DOI 10.1016/0966-842X(94)90109-I; IWANAGA M, 1985, J CLIN MICROBIOL, V22, P405, DOI 10.1128/JCM.22.3.405-408.1985; IWANAGA M, 1986, MICROBIOL IMMUNOL, V30, P1075, DOI 10.1111/j.1348-0421.1986.tb03037.x; Johnson TL, 2006, FEMS MICROBIOL LETT, V255, P175, DOI 10.1111/j.1574-6968.2006.00102.x; Klose KE, 2001, INT J MED MICROBIOL, V291, P81, DOI 10.1078/1438-4221-00104; KONISHI K, 1981, MICROBIOL IMMUNOL, V25, P1221, DOI 10.1111/j.1348-0421.1981.tb00132.x; Kovacikova G, 2010, J BACTERIOL, V192, P4181, DOI 10.1128/JB.00193-10; Lang DH, 1998, BIOCHEM PHARMACOL, V56, P1005, DOI 10.1016/S0006-2952(98)00218-4; Layer G, 2002, J BIOL CHEM, V277, P34136, DOI 10.1074/jbc.M205247200; Lee KM, 2012, INFECT IMMUN, V80, P1639, DOI 10.1128/IAI.06161-11; Lee KM, 2011, INFECT IMMUN, V79, P2792, DOI 10.1128/IAI.01361-10; Lee PA, 2006, ANNU REV MICROBIOL, V60, P373, DOI 10.1146/annurev.micro.60.080805.142212; Liu Z, 2011, P NATL ACAD SCI USA, V108, P810, DOI 10.1073/pnas.1014640108; Marrero K, 2009, RES MICROBIOL, V160, P48, DOI 10.1016/j.resmic.2008.10.005; Martinez I, 2005, J AGR FOOD CHEM, V53, P6889, DOI 10.1021/jf0507902; Matson JS, 2007, INFECT IMMUN, V75, P5542, DOI 10.1128/IAI.01094-07; McCrindle SL, 2005, ADV MICROB PHYSIOL, V50, P147, DOI 10.1016/S0065-2911(05)50004-3; MEJEAN V, 1994, MOL MICROBIOL, V11, P1169, DOI 10.1111/j.1365-2958.1994.tb00393.x; MICHALSKI J, 1993, INFECT IMMUN, V61, P4462, DOI 10.1128/IAI.61.10.4462-4468.1993; Miyata ST, 2011, INFECT IMMUN, V79, P2941, DOI 10.1128/IAI.01266-10; NICHOLLS KM, 1976, J APPL BACTERIOL, V41, P265, DOI 10.1111/j.1365-2672.1976.tb00629.x; Nobechi K, 1925, J BACTERIOL, V10, P197, DOI 10.1128/JB.10.3.197-215.1925; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Pommier J, 1998, J BIOL CHEM, V273, P16615, DOI 10.1074/jbc.273.26.16615; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Pun SB, 2011, EMERG INFECT DIS, V17, P2178, DOI [10.3201/eid1711.110981, 10.3201/eid1707.110059]; Sanchez J, 2004, J BACTERIOL, V186, P1355, DOI 10.1128/JB.186.5.1355-1361.2004; Sandkvist M, 1997, J BACTERIOL, V179, P6994, DOI 10.1128/jb.179.22.6994-7003.1997; Sandkvist M, 2000, INT J MED MICROBIOL, V290, P345, DOI 10.1016/S1438-4221(00)80038-7; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; SPANGLER BD, 1992, MICROBIOL REV, V56, P622, DOI 10.1128/MMBR.56.4.622-647.1992; Taylor CT, 2007, J MOL MED, V85, P1295, DOI 10.1007/s00109-007-0277-z; Valeru SP, 2009, INFECT IMMUN, V77, P935, DOI 10.1128/IAI.00929-08; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Yoon MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016105; Yoon SS, 2006, J CLIN INVEST, V116, P436, DOI 10.1172/JCI24684; Zhang LJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-114	54	41	41	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.394932	http://dx.doi.org/10.1074/jbc.M112.394932			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23019319	Green Published, hybrid			2022-12-28	WOS:000311233800043
J	Liu, G; Tian, H; Huang, YQ; Hu, J; Ji, YX; Li, SQ; Feng, YQ; Guo, L; Zhu, YG				Liu, Gai; Tian, Han; Huang, Yun-Qing; Hu, Jun; Ji, Yan-Xiao; Li, Shao-Qing; Feng, Yu-Qi; Guo, Lin; Zhu, Ying-Guo			Alterations of Mitochondrial Protein Assembly and Jasmonic Acid Biosynthesis Pathway in Honglian (HL)-type Cytoplasmic Male Sterility Rice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALE GAMETOPHYTE DEVELOPMENT; PROGRAMMED CELL-DEATH; PLANT-MITOCHONDRIA; RESPIRATORY-CHAIN; SEX DETERMINATION; OXIDATIVE STRESS; INNER MEMBRANE; T-CYTOPLASM; CMS LINE; MAIZE	It has been suggested that the mitochondrial chimeric gene orfH79 is the cause for abortion of microspores in Honglian cytoplasmic male sterile rice, yet little is known regarding its mechanism of action. In this study, we used a mass spectrometry-based quantitative proteomics strategy to compare the mitochondrial proteome between the sterile line Yuetai A and its fertile near-isogenic line Yuetai B. We discovered a reduced quantity of specific proteins in mitochondrial complexes in Yuetai A compared with Yuetai B, indicating a defect in mitochondrial complex assembly in the sterile line. Western blotting showed that ORFH79 protein and ATP1 protein, an F-1 sector component of complex V, are both associated with large protein complexes of similar size. Respiratory complex activity assays and transmission electron microscopy revealed functional and morphological defects in the mitochondria of Yuetai A when compared with Yuetai B. In addition, we identified one sex determination TASSELSEED2-like protein increased in Yuetai A, leading to the discovery of an aberrant variation of the jasmonic acid pathway during the development of microspores.	[Tian, Han; Guo, Lin] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Liu, Gai; Hu, Jun; Ji, Yan-Xiao; Li, Shao-Qing; Zhu, Ying-Guo] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China; [Tian, Han; Feng, Yu-Qi; Guo, Lin] Wuhan Univ, Key Lab Analyt Chem Biol & Med, Minist Educ, Dept Chem, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Guo, L (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	guol@whu.edu.cn; zhuyg@public.wh.hb.cn	Feng, Yu-Qi/H-1479-2011	Feng, Yu-Qi/0000-0003-1107-5385	National Basic Research Program of China [2007CB109005, 2013CB911102]; National Natural Science Foundation of China [31071391, 91019013, 91017013, 31070327, 30921001]; National High-Tech Research and Development Project Grant [2009AA101101]; 111 Project of China [B06018]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Project Grant(National High Technology Research and Development Program of China); 111 Project of China(Ministry of Education, China - 111 Project)	This work was supported in part by the National Basic Research Program of China Grants 2007CB109005 and 2013CB911102, National Natural Science Foundation of China Grants 31071391, 91019013, 91017013, 31070327, and 30921001, the National High-Tech Research and Development Project Grant 2009AA101101, and the 111 Project of China Grant B06018.	Acosta IF, 2009, SCIENCE, V323, P262, DOI 10.1126/science.1164645; Balk J, 2001, PLANT CELL, V13, P1803, DOI 10.1105/tpc.13.8.1803; Budar F., 2007, PLANT MITOCHONDRIA, P278; Chen ML, 2011, J CHROMATOGR B, V879, P938, DOI 10.1016/j.jchromb.2011.03.003; Chen X, 2011, J CHROMATOGR B, V879, P25, DOI 10.1016/j.jchromb.2010.11.004; DELONG A, 1993, CELL, V74, P757, DOI 10.1016/0092-8674(93)90522-R; DEWEY RE, 1987, P NATL ACAD SCI USA, V84, P5374, DOI 10.1073/pnas.84.15.5374; Duroc Y, 2009, PLANT MOL BIOL, V70, P123, DOI 10.1007/s11103-009-9461-6; Eubel H, 2003, PLANT PHYSIOL, V133, P274, DOI 10.1104/pp.103.024620; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; Havey MJ, 2004, MOLECULAR BIOLOGY AND BIOTECHNOLOGY OF PLANT ORGANELLES: CHLOROPLASTS AND MITOCHONDRIA, P623, DOI 10.1007/978-1-4020-3166-3_23; Heazlewood JL, 2003, PLANT PHYSIOL, V132, P230, DOI 10.1104/pp.102.018986; Huang S, 2009, PLANT PHYSIOL, V149, P719, DOI 10.1104/pp.108.131300; Jansch L, 1996, PLANT J, V9, P357, DOI 10.1046/j.1365-313X.1996.09030357.x; Lenaz G, 2009, INT J BIOCHEM CELL B, V41, P1750, DOI 10.1016/j.biocel.2009.04.003; LEVINGS CS, 1992, PLANT MOL BIOL, V19, P135, DOI 10.1007/BF00015611; Li SQ, 2007, J INTEGR PLANT BIOL, V49, P791, DOI 10.1111/j.1744-7909.2007.00513.x; Li SQ, 2004, FUNCT PLANT BIOL, V31, P369, DOI 10.1071/FP03224; Li X. M., 2000, HEREDITY, V22, P201; Mackenzie S, 1999, PLANT CELL, V11, P571, DOI 10.1105/tpc.11.4.571; Mannella CA, 2006, BBA-MOL CELL RES, V1763, P542, DOI 10.1016/j.bbamcr.2006.04.006; Mihr C, 2001, J PLANT PHYSIOL, V158, P787, DOI 10.1078/0176-1617-00292; Moller IM, 2007, ANNU REV PLANT BIOL, V58, P459, DOI 10.1146/annurev.arplant.58.032806.103946; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Peng XJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-125; RHOADS DM, 1995, J BIOENERG BIOMEMBR, V27, P437, DOI 10.1007/BF02110006; Sabar M, 2005, PLANT J, V44, P893, DOI 10.1111/j.1365-313X.2005.02577.x; Sabar M, 2003, EMBO REP, V4, P381, DOI 10.1038/sj.embor.embor800; Schaller F, 2001, J EXP BOT, V52, P11, DOI 10.1093/jexbot/52.354.11; Sosso D, 2012, PLANT CELL, V24, P676, DOI 10.1105/tpc.111.091074; Wan CX, 2007, PLANT CELL REP, V26, P373, DOI 10.1007/s00299-006-0234-2; Wang ZH, 2006, PLANT CELL, V18, P676, DOI 10.1105/tpc.105.038240; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; WISE RP, 1987, PLANT MOL BIOL, V9, P121, DOI 10.1007/BF00015644; Wittig I, 2008, BBA-BIOENERGETICS, V1777, P592, DOI 10.1016/j.bbabio.2008.04.027; Wu XQ, 2007, FEBS J, V274, P1172, DOI 10.1111/j.1742-4658.2007.05642.x; Yi P, 2002, CHINESE SCI BULL, V47, P744, DOI 10.1360/02tb9168; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013	38	29	36	1	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.382549	http://dx.doi.org/10.1074/jbc.M112.382549			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23027867	Green Published, hybrid			2022-12-28	WOS:000311233800072
J	Shi, GX; Cai, WK; Andres, DA				Shi, Geng-Xian; Cai, Weikang; Andres, Douglas A.			Rit-mediated Stress Resistance Involves a p38-Mitogen- and Stress-activated Protein Kinase 1 (MSK1)-dependent cAMP Response Element-binding Protein (CREB) Activation Cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; P38 MAPK; DEPENDENT TRANSCRIPTION; GENE-TRANSCRIPTION; CELL-DEATH; PHOSPHORYLATION; PATHWAY; SURVIVAL; FAMILY; CONTRIBUTES	The cAMP response element (CRE)-binding protein (CREB) is a key regulatory factor of gene transcription, and plays an essential role in development of the central nervous system and for neuroprotection. Multiple signaling pathways have been shown to contribute to the regulation of CREB-dependent transcription, including both ERK and p38 mitogen-activated protein (MAP) kinases cascades. Recent studies have identified the Ras-related small G-protein, Rit, as a central regulator of a p38-MK2-HSP27 signaling cascade that functions as a critical survival mechanism for cells adapting to stress. Here, we examine the contribution of Rit-p38 signaling to the control of stress-dependent gene transcription. Using a pheochromocytoma cell model, we find that a novel Rit-p38-MSK1/2 pathway plays a critical role in stress-mediated CREB activation. RNAi-mediated Rit silencing, or inhibition of p38 or MSK1/2 kinases, was found to disrupt stress-mediated CREB-dependent transcription, resulting in increased cell death. Furthermore, ectopic expression of active Rit stimulates CREB-Ser133 phosphorylation, induces expression of the anti-apoptotic Bcl-2 and Bcl(XL) proteins, and promotes cell survival. These data indicate that the Rit-p38-MSK1/2 signaling pathway may have an important role in the stress-dependent regulation of CREB-dependent gene expression.	[Shi, Geng-Xian; Cai, Weikang; Andres, Douglas A.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky	Shi, GX (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, BBSRB Rm B136,741 S Limestone St, Lexington, KY 40536 USA.	gshi2@uky.edu; dandres@uky.edu	Cai, Weikang/K-2394-2019; Shi, Geng-Xian/AAK-6061-2021	Cai, Weikang/0000-0001-5638-0805	United States Public Health Service Grant from the National Institute of Neurological Disorders and Stroke [NS045103]; National Institutes of Health Grant from the National Institute of General Medical Sciences [P20GM103486]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS045103, R01NS045103] Funding Source: NIH RePORTER	United States Public Health Service Grant from the National Institute of Neurological Disorders and Stroke; National Institutes of Health Grant from the National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the United States Public Health Service Grant NS045103 (to D. A. A.) from the National Institute of Neurological Disorders and Stroke and in part by National Institutes of Health Grant P20GM103486 from the National Institute of General Medical Sciences.	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Andres DA, 2008, J NEUROCHEM, V107, P1436, DOI 10.1111/j.1471-4159.2008.05708.x; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Benito E, 2011, J NEUROSCI, V31, P18237, DOI 10.1523/JNEUROSCI.4554-11.2011; Benito E, 2010, TRENDS NEUROSCI, V33, P230, DOI 10.1016/j.tins.2010.02.001; Bonfanti L, 1996, J NEUROSCI, V16, P4186; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Cai WK, 2011, MOL BIOL CELL, V22, P3231, DOI 10.1091/mbc.E11-05-0400; Caivano M, 2000, J IMMUNOL, V164, P3018, DOI 10.4049/jimmunol.164.6.3018; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Grewal SS, 2000, J BIOL CHEM, V275, P34433, DOI 10.1074/jbc.M004728200; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Lein PJ, 2007, J NEUROSCI, V27, P4725, DOI 10.1523/JNEUROSCI.5633-06.2007; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; Merz K, 2011, EUR J NEUROSCI, V33, P1078, DOI 10.1111/j.1460-9568.2011.07606.x; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Rane MJ, 2003, J BIOL CHEM, V278, P27828, DOI 10.1074/jbc.M303417200; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Ronkina N, 2011, NUCLEIC ACIDS RES, V39, P2503, DOI 10.1093/nar/gkq1178; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Shi GX, 2006, MOL CELL BIOL, V26, P9136, DOI 10.1128/MCB.00332-06; Shi GX, 2011, MOL CELL BIOL, V31, P1938, DOI 10.1128/MCB.01380-10; Shi GX, 2010, MOL BIOL CELL, V21, P1597, DOI 10.1091/mbc.E09-12-1033; Shi GX, 2005, MOL CELL BIOL, V25, P830, DOI 10.1128/MCB.25.2.830-846.2005; Spencer ML, 2002, J BIOL CHEM, V277, P20160, DOI 10.1074/jbc.M201092200; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Walton M, 1999, J NEUROCHEM, V73, P1836; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386	48	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.384248	http://dx.doi.org/10.1074/jbc.M112.384248			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23038261	Green Published, hybrid			2022-12-28	WOS:000311233800054
J	Yu, SN; Maillard, RA; Gribenko, AV; Lee, JC				Yu, Shaoning; Maillard, Rodrigo A.; Gribenko, Alexey V.; Lee, J. Ching			The N-terminal Capping Propensities of the D-helix Modulate the Allosteric Activation of the Escherichia coli cAMP Receptor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAP-DNA COMPLEX; SINGLE-SITE MUTATIONS; CYCLIC-AMP; HINGE REORIENTATION; ANGSTROM RESOLUTION; GLOBULAR-PROTEINS; LIGAND-BINDING; AMINO-ACID; M-VALUES; NUCLEOTIDE	Transduction of biological signals at the molecular level involves the activation and/or inhibition of allosteric proteins. In the transcription factor cAMP receptor protein (CRP) from Escherichia coli, the allosteric activation, or apo-holo transition, involves rigid body motions of domains and structural rearrangements within the hinge region connecting the cAMP- and DNA-binding domains. During this apo-holo transition, residue 138 is converted as part of the elongated D-helix to the position of the N-terminal capping residue of a shorter D-helix. The goal of the current study is to elucidate the role of residue 138 in modulating the allostery between cAMP and DNA binding. By systematically mutating residue 138, we found that mutants with higher N-terminal capping propensities lead to increased cooperativity of cAMP binding and a concomitant increase in affinity for lac-DNA. Furthermore, mutants with higher N-terminal capping propensity correlate with properties characteristic of holo-CRP, particularly, increase in protein structural dynamics. Overall, our results provide a quantitative characterization of the role of residue 138 in the isomerization equilibrium between the apo and holo forms of CRP, and in turn the thermodynamic underpin to the molecular model of allostery revealed by the high resolution structural studies.	[Yu, Shaoning; Maillard, Rodrigo A.; Gribenko, Alexey V.; Lee, J. Ching] Univ Texas Med Branch Galveston, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Lee, JC (corresponding author), Univ Texas Med Branch Galveston, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	jclee@utmb.edu		Gribenko, Alexey/0000-0002-4285-4608	National Institutes of Health [GM-77551]; Robert A. Welch Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077551] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-77551. This work was also supported by the Robert A. Welch Foundation.	Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; Auton M, 2004, BIOCHEMISTRY-US, V43, P1329, DOI 10.1021/bi035908r; Auton M, 2005, P NATL ACAD SCI USA, V102, P15065, DOI 10.1073/pnas.0507053102; Auton M, 2007, P NATL ACAD SCI USA, V104, P15317, DOI 10.1073/pnas.0706251104; Barksdale A D, 1982, Methods Biochem Anal, V28, P1, DOI 10.1002/9780470110485.ch1; Baskakov IV, 1998, BIOCHEMISTRY-US, V37, P18010, DOI 10.1021/bi981849j; Chen SF, 2001, J MOL BIOL, V314, P75, DOI 10.1006/jmbi.2001.5090; Cheng XD, 1998, J BIOL CHEM, V273, P705, DOI 10.1074/jbc.273.2.705; Cheng XD, 1998, BIOCHEMISTRY-US, V37, P51, DOI 10.1021/bi9719455; CHENG XD, 1995, BIOCHEMISTRY-US, V34, P10816, DOI 10.1021/bi00034a014; CHENG XD, 1994, J BIOL CHEM, V269, P30781; DONG AC, 1994, METHOD ENZYMOL, V232, P139; Dong AC, 2002, BIOCHEMISTRY-US, V41, P6660, DOI 10.1021/bi020036z; EILEN E, 1977, J MOL BIOL, V114, P47, DOI 10.1016/0022-2836(77)90282-0; Gekko K, 2004, BIOCHEMISTRY-US, V43, P3844, DOI 10.1021/bi036271e; HEYDUK E, 1992, BIOCHEMISTRY-US, V31, P3682, DOI 10.1021/bi00129a017; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; HEYDUK T, 1989, BIOCHEMISTRY-US, V28, P6914, DOI 10.1021/bi00443a021; KIM J, 1992, P NATL ACAD SCI USA, V89, P9700, DOI 10.1073/pnas.89.20.9700; Kumar S, 1998, PROTEINS, V31, P460, DOI 10.1002/(SICI)1097-0134(19980601)31:4<460::AID-PROT12>3.0.CO;2-D; Lin SH, 2002, BIOCHEMISTRY-US, V41, P14935, DOI 10.1021/bi026756n; Lin SH, 2002, BIOCHEMISTRY-US, V41, P11857, DOI 10.1021/bi026099z; Lin SH, 2002, BIOCHEMISTRY-US, V41, P2946, DOI 10.1021/bi0119215; MCKAY DB, 1982, J BIOL CHEM, V257, P9518; O'Brien EP, 2009, BIOCHEMISTRY-US, V48, P3743, DOI 10.1021/bi8021119; Parkinson G, 1996, J MOL BIOL, V260, P395, DOI 10.1006/jmbi.1996.0409; Passner JM, 1997, P NATL ACAD SCI USA, V94, P2843, DOI 10.1073/pnas.94.7.2843; Passner JM, 2000, J MOL BIOL, V304, P847, DOI 10.1006/jmbi.2000.4231; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; Rohl CA, 1996, PROTEIN SCI, V5, P2623, DOI 10.1002/pro.5560051225; RYU S, 1993, P NATL ACAD SCI USA, V90, P75, DOI 10.1073/pnas.90.1.75; Sharma H, 2009, P NATL ACAD SCI USA, V106, P16604, DOI 10.1073/pnas.0908380106; SIXL F, 1990, BIOCHEM J, V266, P545, DOI 10.1042/bj2660545; SUSI H, 1986, METHOD ENZYMOL, V130, P290; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; WU CW, 1974, BIOCHEMISTRY-US, V13, P2573, DOI 10.1021/bi00709a016; Yu SN, 2004, BIOCHEMISTRY-US, V43, P4662, DOI 10.1021/bi0362166	38	8	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.404806	http://dx.doi.org/10.1074/jbc.M112.404806			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23035121	Green Published, hybrid			2022-12-28	WOS:000311233800012
J	Mikami, T; Koyama, S; Yabuta, Y; Kitagawa, H				Mikami, Tadahisa; Koyama, Shinji; Yabuta, Yumi; Kitagawa, Hiroshi			Chondroitin Sulfate Is a Crucial Determinant for Skeletal Muscle Development/Regeneration and Improvement of Muscular Dystrophies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION; DIFFERENTIATION; MDX; 4-O-SULFOTRANSFERASE-1; PROTEOGLYCANS; REGENERATION; MECHANISMS; EXPRESSION; PATHWAYS; LINKAGE	Skeletal muscle formation and regeneration require myoblast fusion to form multinucleated myotubes or myofibers, yet their molecular regulation remains incompletely understood. We show here that the levels of extra- and/or pericellular chondroitin sulfate (CS) chains in differentiating C2C12 myoblast culture are dramatically diminished at the stage of extensive syncytial myotube formation. Forced down-regulation of CS, but not of hyaluronan, levels enhanced myogenic differentiation in vitro. This characteristic CS reduction seems to occur through a cellautonomous mechanism that involves HYAL1, a known catabolic enzyme for hyaluronan and CS. In vivo injection of a bacterial CS-degrading enzyme boosted myofiber regeneration in a mouse cardiotoxin-induced injury model and ameliorated dystrophic pathology in mdx muscles. Our data suggest that the control of CS abundance is a promising new therapeutic approach for the treatment of skeletal muscle injury and progressive muscular dystrophies.	[Mikami, Tadahisa; Koyama, Shinji; Yabuta, Yumi; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan	Kobe Pharmaceutical University	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan.	kitagawa@kobepharma-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079	Japan Private School Promotion Foundation; Scientific Research on Innovative Areas [23110003]; Ministry of Education, Culture, Sports, Science and Technology, Japan;  [24590132]	Japan Private School Promotion Foundation; Scientific Research on Innovative Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported in part by the Scientific Promotion Fund from the Japan Private School Promotion Foundation, Grant-in-aid for Scientific Research (C) 24590132 (to T. M.), Scientific Research on Innovative Areas 23110003 (to H. K.), and Supported Program for the Strategic Research Foundation at Private Universities (2012-2016) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Carrino DA, 1999, POULTRY SCI, V78, P769, DOI 10.1093/ps/78.5.769; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; COULTON GR, 1988, NEUROPATH APPL NEURO, V14, P53, DOI 10.1111/j.1365-2990.1988.tb00866.x; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; Doherty KR, 2008, J BIOL CHEM, V283, P20252, DOI 10.1074/jbc.M802306200; Goetsch SC, 2003, PHYSIOL GENOMICS, V14, P261, DOI 10.1152/physiolgenomics.00056.2003; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Gushulak L, 2012, J BIOL CHEM, V287, P16689, DOI 10.1074/jbc.M112.350447; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Izumikawa T, 2011, BIOCHEM J, V434, P321, DOI 10.1042/BJ20101456; Izumikawa T, 2010, J BIOL CHEM, V285, P12190, DOI 10.1074/jbc.M110.100941; Kaneiwa T, 2010, GLYCOBIOLOGY, V20, P300, DOI 10.1093/glycob/cwp174; Kim MH, 2011, HUM MOL GENET, V20, P1324, DOI 10.1093/hmg/ddr015; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Koike T, 2012, BIOCHEM BIOPH RES CO, V420, P523, DOI 10.1016/j.bbrc.2012.03.024; Martin DC, 2008, HUM MOL GENET, V17, P1904, DOI 10.1093/hmg/ddn088; MCARDLE A, 1994, MUSCLE NERVE, V17, P1378, DOI 10.1002/mus.880171206; Mikami T, 2009, J BIOL CHEM, V284, P4494, DOI 10.1074/jbc.M809227200; Miyata S, 2012, NAT NEUROSCI, V15, P414, DOI 10.1038/nn.3023; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Mizumoto S, 2009, BIOCHEM J, V419, P387, DOI 10.1042/BJ20081639; Nadanaka S, 2011, J BIOL CHEM, V286, P4199, DOI 10.1074/jbc.M110.155093; Pavlath GK, 2010, EXP CELL RES, V316, P3067, DOI 10.1016/j.yexcr.2010.05.025; Rochlin K, 2010, DEV BIOL, V341, P66, DOI 10.1016/j.ydbio.2009.10.024; Roffe S, 2010, EXP CELL RES, V316, P1061, DOI 10.1016/j.yexcr.2010.01.003; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sunadome K, 2011, DEV CELL, V20, P192, DOI 10.1016/j.devcel.2010.12.005; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Uyama T., 2007, COMPR GLYCOSCI, V3, P79; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Wilson EM, 2007, J BIOL CHEM, V282, P5106, DOI 10.1074/jbc.C600315200; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yamada S, 2002, J BIOL CHEM, V277, P31877, DOI 10.1074/jbc.M205078200; Zanou N, 2012, J BIOL CHEM, V287, P14524, DOI 10.1074/jbc.M112.341784	44	26	27	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38531	38542		10.1074/jbc.M111.336925	http://dx.doi.org/10.1074/jbc.M111.336925			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23007393	Green Published, hybrid			2022-12-28	WOS:000310982800013
J	Morrison, K; Witte, K; Mayers, JR; Schuh, AL; Audhya, A				Morrison, Kylee; Witte, Kristen; Mayers, Jonathan R.; Schuh, Amber L.; Audhya, Anjon			Roles of Acidic Phospholipids and Nucleotides in Regulating Membrane Binding and Activity of a Calcium-independent Phospholipase A(2) Isoform	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFANTILE NEUROAXONAL DYSTROPHY; ENDOPLASMIC-RETICULUM STRESS; CELL-DEATH; IPLA(2)BETA; APOPTOSIS; ENZYMES; MITOCHONDRIAL; TRAFFICKING; DEFICIENCY; SECRETION	Phospholipase A(2) activity plays key roles in generating lipid second messengers and regulates membrane topology through the generation of asymmetric lysophospholipids. In particular, the Group VIA phospholipase A(2) (GVIA-iPLA(2)) subfamily of enzymes functions independently of calcium within the cytoplasm of cells and has been implicated in numerous cellular processes, including proliferation, apoptosis, and membrane transport steps. However, mechanisms underlying the spatial and temporal regulation of these enzymes have remained mostly unexplored. Here, we examine the subset of Caenorhabditis elegans lipases that harbor a consensus motif common to members of the GVIA-iPLA(2) subfamily. Based on sequence homology, we identify IPLA-1 as the closest C. elegans homolog of human GVIA-iPLA(2) enzymes and use a combination of liposome interaction studies to demonstrate a role for acidic phospholipids in regulating GVIA-iPLA(2) function. Our studies indicate that IPLA-1 binds directly to multiple acidic phospholipids, including phosphatidylserine, phosphatidylglycerol, cardiolipin, phosphatidic acid, and phosphorylated derivatives of phosphatidylinositol. Moreover, the presence of these acidic lipids dramatically elevates the specific activity of IPLA-1 in vitro. We also found that the addition of ATP and ADP promote oligomerization of IPLA-1, which probably underlies the stimulatory effect of nucleotides on its activity. We propose that membrane composition and the presence of nucleotides play key roles in recruiting and modulating GVIA-iPLA(2) activity in cells.	[Morrison, Kylee; Witte, Kristen; Mayers, Jonathan R.; Schuh, Amber L.; Audhya, Anjon] Univ Wisconsin Madison, Sch Med, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Audhya, A (corresponding author), Univ Wisconsin Madison, Sch Med, Dept Biomol Chem, 440 Henry Mall, Madison, WI 53706 USA.	audhya@wisc.edu			National Institutes of Health [1R01GM088151]; March of Dimes [5-FY09-525]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01GM088151 (to A. A.). This work was also supported by March of Dimes Basil O'Connor Award 5-FY09-525 (to A. A.).	ACKERMANN EJ, 1994, J BIOL CHEM, V269, P9227; Atsumi G, 2000, J BIOL CHEM, V275, P18248, DOI 10.1074/jbc.M000271200; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; Bao SZ, 2004, DIABETES, V53, pS186, DOI 10.2337/diabetes.53.2007.S186; Beck G, 2011, J NEUROSCI, V31, P11411, DOI 10.1523/JNEUROSCI.0345-11.2011; Ben-Tekaya H, 2010, MOL BIOL CELL, V21, P4130, DOI 10.1091/mbc.E10-01-0022; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Carrilho I, 2008, EUR J PAEDIATR NEURO, V12, P491, DOI 10.1016/j.ejpn.2008.01.005; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Fyfe I, 2011, J BIOL CHEM, V286, P34262, DOI 10.1074/jbc.M111.266411; Gadd ME, 2006, J BIOL CHEM, V281, P6931, DOI 10.1074/jbc.M510845200; Gordon N, 2002, DEV MED CHILD NEUROL, V44, P849; Gregory A, 2008, NEUROLOGY, V71, P1402, DOI 10.1212/01.wnl.0000327094.67726.28; Gregory A, 2009, J MED GENET, V46, P73, DOI 10.1136/jmg.2008.061929; Hsu YH, 2009, J BIOL CHEM, V284, P23652, DOI 10.1074/jbc.M109.021857; Inoue T, 2004, P NATL ACAD SCI USA, V101, P13233, DOI 10.1073/pnas.0405507101; KEMPNER ES, 1988, ADV ENZYMOL RAMB, V61, P107; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Lei X, 2010, DIABETES OBES METAB, V12, P93, DOI 10.1111/j.1463-1326.2010.01270.x; Lei XY, 2007, BIOCHEMISTRY-US, V46, P10170, DOI 10.1021/bi700017z; Lei XY, 2010, BIOCHIMIE, V92, P627, DOI 10.1016/j.biochi.2010.01.005; Lio YC, 1998, BBA-LIPID LIPID MET, V1392, P320, DOI 10.1016/S0005-2760(98)00049-6; Lucas KK, 2005, PROSTAG OTH LIPID M, V77, P235, DOI 10.1016/j.prostaglandins.2005.02.004; Ma ZM, 2001, PROG NUCLEIC ACID RE, V67, P1, DOI 10.1016/S0079-6603(01)67023-5; Malik I, 2008, AM J PATHOL, V172, P406, DOI 10.2353/ajpath.2008.070823; Mayers JR, 2011, J BIOL CHEM, V286, P9636, DOI 10.1074/jbc.M110.185363; Michel F, 2001, EMBO J, V20, P6180, DOI 10.1093/emboj/20.22.6180; Morgan NV, 2006, NAT GENET, V38, P752, DOI 10.1038/ng1826; Mosior M, 1998, J BIOL CHEM, V273, P2184, DOI 10.1074/jbc.273.4.2184; Oestvang J, 2006, BBA-MOL CELL BIOL L, V1761, P1309, DOI 10.1016/j.bbalip.2006.06.003; PIETRO ES, 2009, PLOS BIOL, V0007; PIOMELLI D, 1994, CRIT REV NEUROBIOL, V8, P65; Ramanadham S, 2004, DIABETES, V53, pS179, DOI 10.2337/diabetes.53.2007.S179; Ramanadham S, 2004, BIOCHEMISTRY-US, V43, P918, DOI 10.1021/bi035536m; Ramanadham S, 2003, BIOCHEMISTRY-US, V42, P13929, DOI 10.1021/bi034843p; Rivera R, 2008, REV PHYSIOL BIOCH P, V160, P25, DOI 10.1007/112_0507; Schmidt JA, 2010, TRAFFIC, V11, P1530, DOI 10.1111/j.1600-0854.2010.01115.x; Seeds MC, 1999, CLIN REV ALLERG IMMU, V17, P5, DOI 10.1007/BF02737594; Shinzawa K, 2003, J CELL BIOL, V163, P1219, DOI 10.1083/jcb.200306159; Shinzawa K, 2008, J NEUROSCI, V28, P2212, DOI 10.1523/JNEUROSCI.4354-07.2008; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Six DA, 2003, J BIOL CHEM, V278, P23842, DOI 10.1074/jbc.M301386200; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; Winstead MV, 2000, BBA-MOL CELL BIOL L, V1488, P28, DOI 10.1016/S1388-1981(00)00107-4; Witte K, 2011, NAT CELL BIOL, V13, P550, DOI 10.1038/ncb2225	48	12	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38824	38834		10.1074/jbc.M112.391508	http://dx.doi.org/10.1074/jbc.M112.391508			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23007400	Green Published, hybrid			2022-12-28	WOS:000310982800039
J	Miyazaki, T; Iwasawa, M; Nakashima, T; Mori, S; Shigemoto, K; Nakamura, H; Katagiri, H; Takayanagi, H; Tanaka, S				Miyazaki, Tsuyoshi; Iwasawa, Mitsuyasu; Nakashima, Tomoki; Mori, Shuuichi; Shigemoto, Kazuhiro; Nakamura, Hiroaki; Katagiri, Hideki; Takayanagi, Hiroshi; Tanaka, Sakae			Intracellular and Extracellular ATP Coordinately Regulate the Inverse Correlation between Osteoclast Survival and Bone Resorption	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL TRANSCRIPTION FACTOR; DNA GENE-EXPRESSION; COPY NUMBER; CELL-PROLIFERATION; SKELETAL-MUSCLE; APOPTOSIS; ACTIVATION; RECEPTOR; RELEASE; MTDNA	Osteoclasts, highly differentiated bone-resorbing cells of hematopoietic origin, have two conflicting tendencies: a lower capacity to survive and a higher capacity to execute energy-consuming activities such as bone resorption. Here, we report that when compared with their precursors, mature mitochondria-rich osteoclasts have lower levels of intracellular ATP, which is associated with receptor activator of nuclear factor kappa-B ligand (RANKL)-induced Bcl-xL down-regulation. Severe ATP depletion, caused by disrupting mitochondrial transcription factor A (Tfam) gene, leads to increased bone-resorbing activity despite accelerated apoptosis. Although AMP-activated protein kinase (AMPK) activation by ATP depletion is not involved in the regulation of osteoclast function, the release of ATP from intracellular stores negatively regulates bone-resorbing activity through an autocrine/paracrine feedback loop by altering cytoskeletal structures. Furthermore, osteoclasts derived from aged mice exhibit reduced mitochondrial DNA(mtDNA) and intracellular ATP levels with increased bone-resorbing activity, implicating the possible involvement of age-related mitochondrial dysfunction in osteoporosis. Thus, our study provides evidence for a mechanism underlying the control of cellular functions by reciprocal changes in intracellular and extracellular ATP, which regulate the negative correlation between osteoclast survival and bone resorption.	[Miyazaki, Tsuyoshi; Mori, Shuuichi; Shigemoto, Kazuhiro] Tokyo Metropolitan Geriatr Hosp, Dept Geriatr Med, Itabashi Ku, Tokyo 1730015, Japan; [Miyazaki, Tsuyoshi] Tokyo Metropolitan Geriatr Hosp, Dept Orthopaed Surg, Itabashi Ku, Tokyo 1730015, Japan; [Iwasawa, Mitsuyasu; Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1130033, Japan; [Nakashima, Tomoki; Takayanagi, Hiroshi] Tokyo Med & Dent Univ, Grad Sch, Dept Cell Signaling, Bunkyo Ku, Tokyo 1138549, Japan; [Nakamura, Hiroaki] Matsumoto Dent Univ, Dept Histol & Cell Biol, Nagano 3990781, Japan; [Katagiri, Hideki] Tohoku Univ, Grad Sch Med, Ctr Metab Dis, Dept Metab Dis,Aoba Ku, Sendai, Miyagi 9808575, Japan	University of Tokyo; Tokyo Medical & Dental University (TMDU); Matsumoto Dental University; Tohoku University	Miyazaki, T (corresponding author), Tokyo Metropolitan Geriatr Hosp, Dept Geriatr Med, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.	miyazak14@tmig.or.jp	Tanaka, Sakae/Y-3061-2019	Tanaka, Sakae/0000-0001-9210-9414; Miyazaki, Tsuyoshi/0000-0003-0715-9017	Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [22591698] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was in part supported by grants-in-aid for scientific research from the Japan Society for the Promotion of Science.	Akiyama T, 2005, BIOL PROCED ONLINE, V7, P48, DOI 10.1251/bpo105; Akiyama T, 2003, EMBO J, V22, P6653, DOI 10.1093/emboj/cdg635; Alavian KN, 2011, NAT CELL BIOL, V13, P1224, DOI 10.1038/ncb2330; Auger R, 2005, J BIOL CHEM, V280, P28142, DOI 10.1074/jbc.M501290200; Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Bodin P, 2001, NEUROCHEM RES, V26, P959, DOI 10.1023/A:1012388618693; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Burnstock G, 2002, ARTERIOSCL THROM VAS, V22, P364, DOI 10.1161/hq0302.105360; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen YB, 2011, J CELL BIOL, V195, P263, DOI 10.1083/jcb.201108059; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Clarke BL, 2002, CALCIFIED TISSUE INT, V70, P137, DOI 10.1007/s00223-001-1072-4; CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G; Duong L, 2000, MATRIX BIOL, V19, P97, DOI 10.1016/S0945-053X(00)00051-2; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Fatayerji D, 1999, J BONE MINER RES, V14, P1203, DOI 10.1359/jbmr.1999.14.7.1203; Feldenberg LR, 1999, AM J PHYSIOL-RENAL, V276, pF837, DOI 10.1152/ajprenal.1999.276.6.F837; Fields RD, 2011, SEMIN CELL DEV BIOL, V22, P214, DOI 10.1016/j.semcdb.2011.02.009; Gallagher JC, 1998, J BONE MINER RES, V13, P475, DOI 10.1359/jbmr.1998.13.3.475; Gaspari M, 2004, BBA-BIOENERGETICS, V1659, P148, DOI 10.1016/j.bbabio.2004.10.003; Genetos DC, 2005, J BONE MINER RES, V20, P41, DOI 10.1359/jbmr.041009; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Halloran BP, 2002, J BONE MINER RES, V17, P1044, DOI 10.1359/jbmr.2002.17.6.1044; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hazama R, 2009, GENES CELLS, V14, P871, DOI 10.1111/j.1365-2443.2009.01317.x; Huang Y, 2007, GLIA, V55, P46, DOI 10.1002/glia.20435; Hwang SM, 2009, J DENT RES, V88, P927, DOI 10.1177/0022034509342227; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Iwasawa M, 2009, J CLIN INVEST, V119, P3149, DOI 10.1172/JCI39819; Izyumov DS, 2004, BBA-BIOENERGETICS, V1658, P141, DOI 10.1016/j.bbabio.2004.05.007; Jeng JY, 2008, J CELL BIOCHEM, V103, P347, DOI 10.1002/jcb.21625; Katz S, 2011, ARCH BIOCHEM BIOPHYS, V513, P144, DOI 10.1016/j.abb.2011.06.013; Ke HZ, 2003, MOL ENDOCRINOL, V17, P1356, DOI 10.1210/me.2003-0021; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467; Li JL, 2005, J BIOL CHEM, V280, P42952, DOI 10.1074/jbc.M506415200; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; MARTIN SJ, 1995, J BIOL CHEM, V270, P6425, DOI 10.1074/jbc.270.12.6425; Matsumoto T, 2011, ARTHRITIS RHEUM-US, V63, P3908, DOI 10.1002/art.30646; MILLER DS, 1986, J BIOL CHEM, V261, P13911; Miyazaki T, 2003, J CELL BIOL, V160, P709, DOI 10.1083/jcb.200209098; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; Morelli A, 2003, MOL BIOL CELL, V14, P2655, DOI 10.1091/mbc.02-04-0061; Nagase Y, 2009, J BIOL CHEM, V284, P36659, DOI 10.1074/jbc.M109.016915; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x; Orriss IR, 2009, J CELL PHYSIOL, V220, P155, DOI 10.1002/jcp.21745; Oshima Y, 2008, J BIOL CHEM, V283, P26499, DOI 10.1074/jbc.M800933200; Panupinthu N, 2008, J CELL BIOL, V181, P859, DOI 10.1083/jcb.200708037; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Pellegatti P, 2011, FASEB J, V25, P1264, DOI 10.1096/fj.10-169854; Praetorius HA, 2009, PURINERG SIGNAL, V5, P433, DOI 10.1007/s11302-009-9146-2; Sawada Y, 2002, J CELL BIOL, V156, P609, DOI 10.1083/jcb.200110068; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tanaka S, 2006, ANN NY ACAD SCI, V1068, P180, DOI 10.1196/annals.1346.020; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Wang JM, 2001, P NATL ACAD SCI USA, V98, P4038, DOI 10.1073/pnas.061038798; Winkeler CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042005; WISHART JM, 1995, CLIN ENDOCRINOL, V42, P141, DOI 10.1111/j.1365-2265.1995.tb01854.x; Yi CH, 2011, CELL, V146, P607, DOI 10.1016/j.cell.2011.06.050	66	79	84	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.385369	http://dx.doi.org/10.1074/jbc.M112.385369			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22988253	Green Published, hybrid			2022-12-28	WOS:000310642200019
J	Sun, C; Tian, L; Nie, J; Zhang, H; Han, X; Shi, YG				Sun, Chao; Tian, Liang; Nie, Jia; Zhang, Hai; Han, Xiao; Shi, Yuguang			Inactivation of MARK4, an AMP-activated Protein Kinase (AMPK)-related Kinase, Leads to Insulin Hypersensitivity and Resistance to Diet-induced Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; STIMULATED PHOSPHORYLATION; HEPATIC STEATOSIS; METABOLIC-RATE; KNOCKOUT MICE; CELL POLARITY; IN-VIVO; LKB1; FAMILY; DYSFUNCTION	MARK4, also known as Par-1d/MarkL1, is a member of the AMP-activated protein kinase (AMPK)-related family of kinases, which are implicated in the regulation of dynamic biological functions, including glucose and energy homeostasis. However, the physiological function of MARK4 in mammals remains elusive. Here, we investigated a role for MARK4 in regulating energy homeostasis by generating mice with targeted inactivation of the mark4 gene. We show that MARK4 deficiency in mice caused hyperphagia, hyperactivity, and hypermetabolism, leading to protection from diet-induced obesity and its related metabolic complications through up-regulation of brown fat activity. Consequently, MARK4 deficiency mitigated insulin resistance associated with diet-induced obesity by dramatically enhancing insulin-stimulated AKT phosphorylation in major metabolic tissues. Ablation of MARK4 also significantly improved glucose homeostasis by up-regulating the activity and expression of AMPK kinase in key metabolic tissues. Taken together, these data identify a key role of MARK4 in energy metabolism, implicating the kinase as a novel drug target for the treatment of obesity and type 2 diabetes.	[Sun, Chao; Tian, Liang] NW A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Peoples R China; [Sun, Chao; Tian, Liang; Nie, Jia; Zhang, Hai; Shi, Yuguang] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Nie, Jia; Han, Xiao] Nanjing Med Univ, Key Lab Human Funct Genom Jiangsu Prov, Nanjing 210029, Jiangsu, Peoples R China	Northwest A&F University - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Nanjing Medical University	Shi, YG (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr,H166, Hershey, PA 17033 USA.	yus11@psu.edu	nie, jia/AAE-8355-2019	nie, jia/0000-0001-9085-7224	National Institutes of Health [DK076685]; China Scholarship Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK076685, R01DK076685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK076685 (to Y. S.). This work was also supported by a scholarship from the China Scholarship Council (to L. T.).	Bessone S, 1999, DEV BIOL, V214, P87, DOI 10.1006/dbio.1999.9379; Chen MB, 2005, J CLIN ENDOCR METAB, V90, P3665, DOI 10.1210/jc.2004-1980; DREWES G, 1995, J BIOL CHEM, V270, P7679, DOI 10.1074/jbc.270.13.7679; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Fu A, 2009, CELL METAB, V10, P285, DOI 10.1016/j.cmet.2009.08.008; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Gomes JE, 2002, CURR BIOL, V12, pR444, DOI 10.1016/S0960-9822(02)00939-9; Gosmanov AR, 2004, AM J PHYSIOL-ENDOC M, V287, pE8, DOI 10.1152/ajpendo.00485.2003; Granot Z, 2009, CELL METAB, V10, P296, DOI 10.1016/j.cmet.2009.08.010; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hardie DG, 2007, CELL METAB, V6, P339, DOI 10.1016/j.cmet.2007.10.001; Hojlund K, 2004, AM J PHYSIOL-ENDOC M, V286, pE239, DOI 10.1152/ajpendo.00326.2003; Hurov JB, 2001, MOL CELL BIOL, V21, P3206, DOI 10.1128/MCB.21.9.3206-3219.2001; Hurov J, 2007, CELL CYCLE, V6, P1966, DOI 10.4161/cc.6.16.4576; Hurov JB, 2007, P NATL ACAD SCI USA, V104, P5680, DOI 10.1073/pnas.0701179104; Ikeda Y, 2009, J BIOL CHEM, V284, P35839, DOI 10.1074/jbc.M109.057273; Jansen M, 2009, PHYSIOL REV, V89, P777, DOI 10.1152/physrev.00026.2008; Jessen N, 2010, BBA-MOL BASIS DIS, V1802, P593, DOI 10.1016/j.bbadis.2010.04.008; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Karlsson HKR, 2005, DIABETES, V54, P1692, DOI 10.2337/diabetes.54.6.1692; Kato T, 2001, NEOPLASIA, V3, P4, DOI 10.1038/sj.neo.7900132; Kobayashi T, 2004, HYPERTENSION, V44, P956, DOI 10.1161/01.HYP.0000147559.10261.a7; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; Lennerz JK, 2010, MOL CELL BIOL, V30, P5043, DOI 10.1128/MCB.01472-09; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Matenia D, 2009, TRENDS BIOCHEM SCI, V34, P332, DOI 10.1016/j.tibs.2009.03.008; Ohashi K, 2010, J BIOL CHEM, V285, P22291, DOI 10.1074/jbc.M110.123794; PARSA I, 1988, CANCER RES, V48, P2265; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Segu L, 2008, NEUROBIOL AGING, V29, P231, DOI 10.1016/j.neurobiolaging.2006.10.014; SEIDELL JC, 1992, INT J OBESITY, V16, P667; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Sun G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1261, DOI 10.1152/ajpendo.00100.2010; Thomson DM, 2010, J APPL PHYSIOL, V108, P1775, DOI 10.1152/japplphysiol.01293.2009; Tsang A, 2005, DIABETES, V54, P2360, DOI 10.2337/diabetes.54.8.2360; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	40	50	54	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.388934	http://dx.doi.org/10.1074/jbc.M112.388934			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22992738	hybrid, Green Published			2022-12-28	WOS:000310642200063
J	Aulds, J; Wierzbicki, S; McNairn, A; Schmitt, ME				Aulds, Jason; Wierzbicki, Sara; McNairn, Adrian; Schmitt, Mark E.			Global Identification of New Substrates for the Yeast Endoribonuclease, RNase Mitochondrial RNA Processing (MRP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARTILAGE-HAIR HYPOPLASIA; UNIQUE PROTEIN-COMPONENT; CELL-CYCLE PROGRESSION; SACCHAROMYCES-CEREVISIAE; BINDING PROTEIN; RIBOSOMAL-RNA; U2 SNRNA; REVEALS; MUTATIONS; ACE2P	RNase mitochondrial RNA processing (MRP) is an essential, evolutionarily conserved endoribonuclease composed of 10 different protein subunits and a single RNA. RNase MRP has established roles in multiple pathways including ribosome biogenesis, cell cycle regulation, and mitochondrial DNA replication. Although each of these functions is important to cell growth, additional functions may exist given the essential nature of the complex. To identify novel RNase MRP substrates, we utilized RNA immunoprecipitation and microarray chip analysis to identify RNA that physically associates with RNase MRP. We identified several new potential substrates for RNase MRP including a cell cycle-regulated transcript, CTS1; the yeast homolog of the mammalian p27(Kip1), SIC1; and the U2 RNA component of the spliceosome. In addition, we found RNase MRP to be involved in the regulation of the Ty1 transposon RNA. These results reinforce and broaden the role of RNase MRP in cell cycle regulation and help to identify new roles of this endoribonuclease.	[Aulds, Jason; Wierzbicki, Sara; McNairn, Adrian; Schmitt, Mark E.] State Univ New York Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [McNairn, Adrian] Cornell Univ, Dept Biomed Sci, Coll Vet Med, Ithaca, NY 14853 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Cornell University	Schmitt, ME (corresponding author), State Univ New York Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	schmittm@upstate.edu	McNairn, Adrian/AAZ-9221-2021	McNairn, Adrian/0000-0003-4727-3770	National Institutes of Health Grant, NIGMS [GM063798]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063798] Funding Source: NIH RePORTER	National Institutes of Health Grant, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM063798 from the NIGMS.	Aye M, 2004, GENETICS, V168, P1159, DOI 10.1534/genetics.104.028126; Barberis M, 2005, BIOCHEM J, V387, P639, DOI 10.1042/BJ20041299; Behm-Ansmant I, 2003, RNA, V9, P1371, DOI 10.1261/rna.5520403; BROWN JW, 1990, CELL, V62, P407, DOI 10.1016/0092-8674(90)90003-W; Cai T, 1999, MOL CELL BIOL, V19, P7857; Cai T, 2002, GENETICS, V161, P1029; CHANG DD, 1987, EMBO J, V6, P409, DOI 10.1002/j.1460-2075.1987.tb04770.x; CHAPMAN KB, 1991, CELL, V65, P483, DOI 10.1016/0092-8674(91)90466-C; Doolin MT, 2001, MOL MICROBIOL, V40, P422, DOI 10.1046/j.1365-2958.2001.02388.x; Esakova O, 2011, RNA, V17, P356, DOI 10.1261/rna.2393711; Gill T, 2006, J CELL BIOL, V173, P35, DOI 10.1083/jcb.200512025; Gill T, 2004, MOL CELL BIOL, V24, P945, DOI 10.1128/MCB.24.3.945-953.2004; Houser-Scott F, 2002, P NATL ACAD SCI USA, V99, P2684, DOI 10.1073/pnas.052586299; Jaag HM, 2011, J VIROL, V85, P243, DOI 10.1128/JVI.01749-10; Jain R, 2011, METHODS MOL BIOL, V703, P247, DOI 10.1007/978-1-59745-248-9_17; KARWAN R, 1991, GENE DEV, V5, P1264, DOI 10.1101/gad.5.7.1264; Larsen LSZ, 2008, J VIROL, V82, P2501, DOI 10.1128/JVI.01814-07; Larsen LSZ, 2007, J VIROL, V81, P6957, DOI 10.1128/JVI.02207-06; LI K, 1994, J CELL BIOL, V124, P871, DOI 10.1083/jcb.124.6.871; Lu QS, 2010, RNA, V16, P529, DOI 10.1261/rna.1893710; Lygerou Z, 1996, SCIENCE, V272, P268, DOI 10.1126/science.272.5259.268; Ma XJ, 2003, EMBO J, V22, P1889, DOI 10.1093/emboj/cdg191; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; O'Conallain C, 1999, MOL GEN GENET, V262, P275, DOI 10.1007/s004380051084; Ridanpaa M, 2001, CELL, V104, P195, DOI 10.1016/S0092-8674(01)00205-7; Roth JF, 2000, YEAST, V16, P785, DOI 10.1002/1097-0061(20000630)16:9<785::AID-YEA550>3.0.CO;2-L; Salinas K, 2005, J BIOL CHEM, V280, P11352, DOI 10.1074/jbc.M409568200; Sambrook J., 2001, MOL CLONING LAB MANU; SCHMITT ME, 1994, GENE DEV, V8, P2617, DOI 10.1101/gad.8.21.2617; SCHMITT ME, 1993, MOL CELL BIOL, V13, P7935, DOI 10.1128/MCB.13.12.7935; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Shadel GS, 2000, GENE, V245, P175, DOI 10.1016/S0378-1119(00)00013-5; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; Stevens SW, 2002, MOL CELL, V9, P31, DOI 10.1016/S1097-2765(02)00436-7; Taskinen M, 2008, AM J MED GENET A, V146A, P2370, DOI 10.1002/ajmg.a.32478; Thiel CT, 2011, BEST PRACT RES CL EN, V25, P131, DOI 10.1016/j.beem.2010.08.004; Thiel CT, 2005, AM J HUM GENET, V77, P795, DOI 10.1086/497708; Ufano S, 2004, J CELL SCI, V117, P545, DOI 10.1242/jcs.00880; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106	41	9	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37089	37097		10.1074/jbc.M112.389023	http://dx.doi.org/10.1074/jbc.M112.389023			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22977255	hybrid, Green Published			2022-12-28	WOS:000310588500043
J	Balasuriya, D; Stewart, AP; Crottes, D; Borgese, F; Soriani, O; Edwardson, JM				Balasuriya, Dilshan; Stewart, Andrew P.; Crottes, David; Borgese, Franck; Soriani, Olivier; Edwardson, J. Michael			The Sigma-1 Receptor Binds to the Nav1.5 Voltage-gated Na+ Channel with 4-Fold Symmetry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; METHYL-D-ASPARTATE; CANCER CELL-LINES; POTASSIUM CHANNELS; LIPID RAFTS; CORTICAL-NEURONS; SODIUM-CHANNELS; IN-VITRO; MODULATION; EXPRESSION	The sigma-1 receptor (Sig1R) is up-regulated in many human tumors and plays a role in the control of cancer cell proliferation and invasiveness. At the molecular level, the Sig1R modulates the activity of various ion channels, apparently through a direct interaction. We have previously shown using atomic force microscopy imaging that the Sig1R binds to the trimeric acid-sensing ion channel 1A with 3-fold symmetry. Here, we investigated the interaction between the Sig1R and the Nav1.5 voltage-gated Na+ channel, which has also been implicated in promoting the invasiveness of cancer cells. We show that the Sig1R and Nav1.5 can be co-isolated from co-transfected cells, consistent with an intimate association between the two proteins. Atomic force microscopy imaging of the co-isolated proteins revealed complexes in which Nav1.5 was decorated by Sig1Rs. Frequency distributions of angles between pairs of bound Sig1Rs had two peaks, at similar to 90 degrees and similar to 180 degrees, and the 90 degrees peak was about twice the size of the 180 peak. These results demonstrate that the Sig1R binds to Nav1.5 with 4-fold symmetry. Hence, each set of six transmembrane regions in Nav1.5 likely constitutes a Sig1R binding site, suggesting that the Sig1R interacts with the transmembrane regions of its partners. Interestingly, two known Sig1R ligands, haloperidol and (+)-pentazocine, disrupted the Nav1.5/Sig1R interaction both in vitro and in living cells. Finally, we show that endogenously expressed Sig1R and Nav1.5 also functionally interact.	[Balasuriya, Dilshan; Stewart, Andrew P.; Edwardson, J. Michael] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Crottes, David; Borgese, Franck; Soriani, Olivier] Univ Nice Sophia Antipolis, Inst Biol Valrose, CNRS UMR 7277, Fac Sci,INSERM UNS U1091, F-06108 Nice 2, France	University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Edwardson, JM (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	jme1000@cam.ac.uk		soriani, olivier/0000-0001-9485-3992; BORGESE, Franck/0000-0001-7718-2111	Jean Shanks Foundation; University of Cambridge; Centre National de la Recherche Scientifique (CNRS); Region Provence Alpes Cote d'Azur Fellowship; University of Nice Sophia Antipolis; CNRS; Association Ti'Toine Normandie; Wellcome Trust	Jean Shanks Foundation; University of Cambridge(University of Cambridge); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Region Provence Alpes Cote d'Azur Fellowship(Region Provence-Alpes-Cote d'Azur); University of Nice Sophia Antipolis; CNRS(Centre National de la Recherche Scientifique (CNRS)); Association Ti'Toine Normandie; Wellcome Trust(Wellcome Trust)	This work was supported by the Jean Shanks Foundation and the James Baird Fund of the University of Cambridge (to A. P. S.), a Centre National de la Recherche Scientifique (CNRS) and Region Provence Alpes Cote d'Azur Fellowship (to D. C.), the University of Nice Sophia Antipolis, the CNRS, and the Association Ti'Toine Normandie (to O. S.), and the Wellcome Trust (to J. M. E.).	Albagli-Curiel O, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-85; Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Aydar E, 2006, CANCER LETT, V242, P245, DOI 10.1016/j.canlet.2005.11.011; Brisson L, 2011, ONCOGENE, V30, P2070, DOI 10.1038/onc.2010.574; Carnally SM, 2008, BIOCHEM BIOPH RES CO, V372, P752, DOI 10.1016/j.bbrc.2008.05.100; Carnally SM, 2010, BIOPHYS J, V98, P1182, DOI 10.1016/j.bpj.2009.12.4293; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chioni AM, 2009, INT J BIOCHEM CELL B, V41, P1216, DOI 10.1016/j.biocel.2008.11.001; Crottes D, 2011, J BIOL CHEM, V286, P27947, DOI 10.1074/jbc.M111.226738; Eshcol JO, 2008, AM J PHYSIOL-CELL PH, V295, pC732, DOI 10.1152/ajpcell.00514.2007; Fontanilla D, 2009, SCIENCE, V323, P934, DOI 10.1126/science.1166127; Gillet L, 2009, J BIOL CHEM, V284, P8671, DOI 10.1074/jbc.M806891200; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; HAYASHI T, 1995, J PHARMACOL EXP THER, V275, P207; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Herrera Y, 2008, J PHARMACOL EXP THER, V327, P491, DOI 10.1124/jpet.108.143974; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Johannessen M, 2011, AM J PHYSIOL-CELL PH, V300, pC328, DOI 10.1152/ajpcell.00383.2010; Johannessen M, 2009, AM J PHYSIOL-CELL PH, V296, pC1049, DOI 10.1152/ajpcell.00431.2008; KENNEDY C, 1990, NEUROSCIENCE, V35, P725, DOI 10.1016/0306-4522(90)90343-3; Kinoshita M, 2012, BRAIN RES, V1452, P1, DOI 10.1016/j.brainres.2012.02.070; Kume T, 2002, EUR J PHARMACOL, V455, P91, DOI 10.1016/S0014-2999(02)02582-7; Lupardus PJ, 2000, J PHYSIOL-LONDON, V526, P527, DOI 10.1111/j.1469-7793.2000.00527.x; LYSKO PG, 1992, STROKE, V23, P414, DOI 10.1161/01.STR.23.3.414; Monnet FP, 2005, BIOL CELL, V97, P873; Monnet FP, 2003, J PHARMACOL EXP THER, V307, P705, DOI 10.1124/jpet.103.053447; MONNET FP, 1990, EUR J PHARMACOL, V179, P441, DOI 10.1016/0014-2999(90)90186-A; Neaves KJ, 2009, NUCLEIC ACIDS RES, V37, P2053, DOI 10.1093/nar/gkp042; Pal A, 2007, MOL PHARMACOL, V72, P921, DOI 10.1124/mol.107.038307; Pal A, 2008, J BIOL CHEM, V283, P19646, DOI 10.1074/jbc.M802192200; Palmer CP, 2007, CANCER RES, V67, P11166, DOI 10.1158/0008-5472.CAN-07-1771; Renaudo A, 2007, J BIOL CHEM, V282, P2259, DOI 10.1074/jbc.M607915200; Roger S, 2003, BBA-BIOMEMBRANES, V1616, P107, DOI 10.1016/j.bbamem.2003.07.001; Schneider SW, 1998, PFLUG ARCH EUR J PHY, V435, P362, DOI 10.1007/s004240050524; SCOTT DW, 1979, BIOMETRIKA, V66, P605, DOI 10.1093/biomet/66.3.605; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Spruce BA, 2004, CANCER RES, V64, P4875, DOI 10.1158/0008-5472.CAN-03-3180; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Wilke RA, 1999, J BIOL CHEM, V274, P18387, DOI 10.1074/jbc.274.26.18387; Wong W, 2004, J BIOL CHEM, V279, P444, DOI 10.1074/jbc.M304675200; Zhang HL, 2005, J PHARMACOL EXP THER, V313, P1387, DOI 10.1124/jpet.105.084152; Zhang HL, 2002, J NEUROPHYSIOL, V87, P2867, DOI 10.1152/jn.2002.87.6.2867	43	54	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37021	37029		10.1074/jbc.M112.382077	http://dx.doi.org/10.1074/jbc.M112.382077			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22952230	Green Published, hybrid			2022-12-28	WOS:000310588500037
J	Castilho, A; Neumann, L; Daskalova, S; Mason, HS; Steinkellner, H; Altmann, F; Strasser, R				Castilho, Alexandra; Neumann, Laura; Daskalova, Sasha; Mason, Hugh S.; Steinkellner, Herta; Altmann, Friedrich; Strasser, Richard			Engineering of Sialylated Mucin-type O-Glycosylation in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; HAMSTER OVARY CELLS; N-GLYCOSYLATION; NICOTIANA-BENTHAMIANA; ENHANCED SIALYLATION; BIOLOGICAL-ACTIVITY; IN-VITRO; EXPRESSION; BIOSYNTHESIS; CARBOHYDRATE	Proper N- and O-glycosylation of recombinant proteins is important for their biological function. Although the N-glycan processing pathway of different expression hosts has been successfully modified in the past, comparatively little attention has been paid to the generation of customized O-linked glycans. Plants are attractive hosts for engineering of O-glycosylation steps, as they contain no endogenous glycosyltransferases that perform mammalian-type Ser/Thr glycosylation and could interfere with the production of defined O-glycans. Here, we produced mucin-type O-GalNAc and core 1 O-linked glycan structures on recombinant human erythropoietin fused to an IgG heavy chain fragment (EPO-Fc) by transient expression in Nicotiana benthamiana plants. Furthermore, for the generation of sialylated core 1 structures constructs encoding human polypeptide: N-acetylgalactosaminyltransferase 2, Drosophila melanogaster core 1 beta 1,3-galactosyltransferase, human alpha 2,3-sialyltransferase, and Mus musculus alpha 2,6-sialyltransferase were transiently co-expressed in N. benthamiana together with EPO-Fc and the machinery for sialylation of N-glycans. The formation of significant amounts of mono-and disialylated O-linked glycans was confirmed by liquid chromatography-electrospray ionization-mass spectrometry. Analysis of the three EPO glycopeptides carrying N-glycans revealed the presence of biantennary structures with terminal sialic acid residues. Our data demonstrate that N. benthamiana plants are amenable to engineering of the O-glycosylation pathway and can produce well defined human-type O- and N-linked glycans on recombinant therapeutics.	[Castilho, Alexandra; Steinkellner, Herta; Strasser, Richard] Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, A-1190 Vienna, Austria; [Neumann, Laura; Altmann, Friedrich] Univ Nat Resources & Life Sci, Dept Chem, A-1190 Vienna, Austria; [Daskalova, Sasha; Mason, Hugh S.] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA; [Daskalova, Sasha; Mason, Hugh S.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Strasser, R (corresponding author), Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Muthgasse 18, A-1190 Vienna, Austria.	richard.strasser@boku.ac.at	Strasser, Richard/AAD-2916-2020; Steinkellner, Herta/N-4267-2016; Castilho, Alexandra/AAC-8927-2020	Steinkellner, Herta/0000-0003-4823-1505; Castilho, Alexandra/0000-0003-4114-7861; Altmann, Friedrich/0000-0002-0112-7877; Strasser, Richard/0000-0001-8764-6530	Federal Ministry of Transport, Innovation, and Technology (bmvit); Austrian Science Fund (FWF) TRP [242-B20]; PhD program "BioToP-Biomolecular Technology of Proteins" from the Austrian Science Fund (FWF) Project [W1224-B09]; Austrian Research Promotion Agency (FFG) Laura Bassi Centres of Expertise project [822757]; Austrian Science Fund (FWF) [TRP 242, L 575] Funding Source: researchfish	Federal Ministry of Transport, Innovation, and Technology (bmvit); Austrian Science Fund (FWF) TRP(Austrian Science Fund (FWF)); PhD program "BioToP-Biomolecular Technology of Proteins" from the Austrian Science Fund (FWF) Project(Austrian Science Fund (FWF)); Austrian Research Promotion Agency (FFG) Laura Bassi Centres of Expertise project; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by a grant (to R. S.) from the Federal Ministry of Transport, Innovation, and Technology (bmvit) and Austrian Science Fund (FWF) TRP 242-B20 (to R. S.), by the PhD program "BioToP-Biomolecular Technology of Proteins" from the Austrian Science Fund (FWF) Project W1224-B09 (to L. N.), and by a grant from the Austrian Research Promotion Agency (FFG) Laura Bassi Centres of Expertise project 822757 (to H. S.).	Amano K, 2008, P NATL ACAD SCI USA, V105, P3232, DOI 10.1073/pnas.0710412105; Badirou I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037508; Bork K, 2007, FEBS LETT, V581, P4195, DOI 10.1016/j.febslet.2007.07.060; Castilho A, 2008, PLANT PHYSIOL, V147, P331, DOI 10.1104/pp.108.117572; Castilho A, 2011, GLYCOBIOLOGY, V21, P813, DOI 10.1093/glycob/cwr009; Castilho A, 2010, J BIOL CHEM, V285, P15923, DOI 10.1074/jbc.M109.088401; Chung SM, 2005, TRENDS PLANT SCI, V10, P357, DOI 10.1016/j.tplants.2005.06.001; Daskalova SM, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-62; DELORME E, 1992, BIOCHEMISTRY-US, V31, P9871, DOI 10.1021/bi00156a003; DUBE S, 1988, J BIOL CHEM, V263, P17516; Egrie JC, 2003, EXP HEMATOL, V31, P290, DOI 10.1016/S0301-472X(03)00006-7; Elliott S, 2004, EXP HEMATOL, V32, P1146, DOI 10.1016/j.exphem.2004.08.004; FUKUDA MN, 1989, BLOOD, V73, P84; Ghaderi D, 2012, BIOTECHNOL GENET ENG, V28, P147, DOI 10.5661/bger-28-147; Hamilton SR, 2006, SCIENCE, V313, P1441, DOI 10.1126/science.1130256; Harrison RL, 2006, ADV VIRUS RES, V68, P159, DOI 10.1016/S0065-3527(06)68005-6; HOKKE CH, 1995, EUR J BIOCHEM, V228, P981, DOI 10.1111/j.1432-1033.1995.tb20350.x; Jacobs PP, 2009, NAT PROTOC, V4, P58, DOI 10.1038/nprot.2008.213; Jefferis R, 2012, ARCH BIOCHEM BIOPHYS, V526, P159, DOI 10.1016/j.abb.2012.03.021; Ju TZ, 2011, ANGEW CHEM INT EDIT, V50, P1770, DOI 10.1002/anie.201002313; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Karnoup AS, 2005, GLYCOBIOLOGY, V15, P965, DOI 10.1093/glycob/cwi077; KODAMA S, 1993, EUR J BIOCHEM, V211, P903, DOI 10.1111/j.1432-1033.1993.tb17624.x; Kolarich D, 2012, NAT PROTOC, V7, P1285, DOI 10.1038/nprot.2012.062; Leonard R, 2005, J BIOL CHEM, V280, P7932, DOI 10.1074/jbc.M410407200; Loos A, 2012, ARCH BIOCHEM BIOPHYS, V526, P167, DOI 10.1016/j.abb.2012.05.011; Marillonnet S, 2005, NAT BIOTECHNOL, V23, P718, DOI 10.1038/nbt1094; Mattu TS, 1998, J BIOL CHEM, V273, P2260, DOI 10.1074/jbc.273.4.2260; Maxmen A, 2012, NATURE, V485, P160, DOI 10.1038/485160a; Moriguchi R, 2011, BIOSCI BIOTECH BIOCH, V75, P994, DOI 10.1271/bbb.100884; Nagels B, 2012, J BIOTECHNOL, V160, P242, DOI 10.1016/j.jbiotec.2012.03.003; Pinkhasov J, 2011, PLANT BIOTECHNOL J, V9, P991, DOI 10.1111/j.1467-7652.2011.00614.x; SASAKI H, 1987, J BIOL CHEM, V262, P12059; Son YD, 2011, GLYCOBIOLOGY, V21, P1019, DOI 10.1093/glycob/cwr034; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Strasser R, 2007, PLANT PHYSIOL, V145, P5, DOI 10.1104/pp.107.101162; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Taschwer M, 2012, J BIOTECHNOL, V157, P295, DOI 10.1016/j.jbiotec.2011.11.014; TSUDA E, 1990, EUR J BIOCHEM, V188, P405, DOI 10.1111/j.1432-1033.1990.tb15417.x; VANDIJK W, 1983, BIOCHEM J, V214, P1003, DOI 10.1042/bj2141003; Velasquez SM, 2011, SCIENCE, V332, P1401, DOI 10.1126/science.1206657; WASLEY LC, 1991, BLOOD, V77, P2624; Weise A, 2007, PLANT BIOTECHNOL J, V5, P389, DOI 10.1111/j.1467-7652.2007.00248.x; Yang Z, 2012, PLANT PHYSIOL, V160, P450, DOI 10.1104/pp.112.198200; Yang Z, 2012, J BIOL CHEM, V287, P11911, DOI 10.1074/jbc.M111.312918; Zeleny R, 2006, PLANTA, V224, P222, DOI 10.1007/s00425-005-0206-8; Zimran A, 2011, BLOOD, V118, P5767, DOI 10.1182/blood-2011-07-366955	50	64	69	3	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36518	36526		10.1074/jbc.M112.402685	http://dx.doi.org/10.1074/jbc.M112.402685			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22948156	Green Published, hybrid			2022-12-28	WOS:000310364000071
J	Van Etten, J; Schagat, TL; Hrit, J; Weidmann, CA; Brumbaugh, J; Coon, JJ; Goldstrohm, AC				Van Etten, Jamie; Schagat, Trista L.; Hrit, Joel; Weidmann, Chase A.; Brumbaugh, Justin; Coon, Joshua J.; Goldstrohm, Aaron C.			Human Pumilio Proteins Recruit Multiple Deadenylases to Efficiently Repress Messenger RNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERMLINE STEM-CELLS; PUF FAMILY; CCR4-NOT COMPLEX; BINDING PROTEINS; PUM2 GENES; DROSOPHILA; TRANSLATION; NANOS; YEAST; EXPRESSION	PUF proteins are a conserved family of eukaryotic RNA-binding proteins that regulate specific mRNAs: they control many processes including stem cell proliferation, fertility, and memory formation. PUFs repress protein expression from their target mRNAs but the mechanism by which they do so remains unclear, especially for humans. Humans possess two PUF proteins, PUM1 and PUM2, which exhibit similar RNA binding specificities. Here we report new insights into their regulatory activities and mechanisms of action. We developed functional assays to measure sequence-specific repression by PUM1 and PUM2. Both robustly inhibit translation and promote mRNA degradation. Purified PUM complexes were found to contain subunits of the CCR4-NOT (CNOT) complex, which contains multiple enzymes that catalyze mRNA deadenylation. PUMs interact with the CNOT deadenylase subunits in vitro. We used three approaches to determine the importance of deadenylases for PUM repression. First, dominant-negative mutants of CNOT7 and CNOT8 reduced PUM repression. Second, RNA interference depletion of the deadenylases alleviated PUM repression. Third, the poly(A) tail was necessary for maximal PUM repression. These findings demonstrate a conserved mechanism of PUF-mediated repression via direct recruitment of the CCR4-POP2-NOT deadenylase leading to translational inhibition and mRNA degradation. A second, deadenylation independent mechanism was revealed by the finding that PUMs repress an mRNA that lacks a poly(A) tail. Thus, human PUMs are repressors capable of deadenylation-dependent and -independent modes of repression.	[Van Etten, Jamie; Schagat, Trista L.; Hrit, Joel; Weidmann, Chase A.; Goldstrohm, Aaron C.] Univ Michigan, Dept Biol Chem, Sch Med, Ann Arbor, MI 48109 USA; [Schagat, Trista L.] Promega Corp, Madison, WI 53711 USA; [Brumbaugh, Justin; Coon, Joshua J.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Brumbaugh, Justin; Coon, Joshua J.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	University of Michigan System; University of Michigan; Promega Corporation; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Goldstrohm, AC (corresponding author), 1150 W Med Ctr Dr,5301 MSRBIII,SPC 5606, Ann Arbor, MI 48109 USA.	acgold@umich.edu		Brumbaugh, Justin/0000-0002-9605-2010; Hrit, Joel/0000-0002-4497-956X; Weidmann, Chase/0000-0002-2941-0500	University of Michigan, Center for Genetics in Health and Medicine, Genomics and Genetics; Promega; Michigan Predoctoral Training Program in Genetics through National Institutes of Health National Research Service Award [5T32GM007544-33]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007544] Funding Source: NIH RePORTER	University of Michigan, Center for Genetics in Health and Medicine, Genomics and Genetics; Promega; Michigan Predoctoral Training Program in Genetics through National Institutes of Health National Research Service Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a grant from the University of Michigan, Center for Genetics in Health and Medicine, Genomics and Genetics, and a grant from Promega. T. L. S, spouse of A. C. G., is an employee of Promega Corporation.; Supported by the Michigan Predoctoral Training Program in Genetics through National Institutes of Health National Research Service Award 5T32GM007544-33.	AHRINGER J, 1992, EMBO J, V11, P2303, DOI 10.1002/j.1460-2075.1992.tb05289.x; AHRINGER J, 1991, NATURE, V349, P346, DOI 10.1038/349346a0; Albert TK, 2000, NUCLEIC ACIDS RES, V28, P809, DOI 10.1093/nar/28.3.809; Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; BARKER DD, 1992, GENE DEV, V6, P2312, DOI 10.1101/gad.6.12a.2312; Bianchin C, 2005, RNA, V11, P487, DOI 10.1261/rna.7135305; Cao QP, 2002, EMBO J, V21, P3852, DOI 10.1093/emboj/cdf353; Cao QP, 2010, RNA, V16, P221, DOI 10.1261/rna.1884610; Chagnovich D, 2001, P NATL ACAD SCI USA, V98, P11359, DOI 10.1073/pnas.201284398; Chekulaeva M, 2011, NAT STRUCT MOL BIOL, V18, P1218, DOI 10.1038/nsmb.2166; Chen CYA, 2009, NAT STRUCT MOL BIOL, V16, P1160, DOI 10.1038/nsmb.1709; Chen D, 2012, CURR BIOL, V22, P420, DOI 10.1016/j.cub.2012.01.039; Cheong CG, 2006, P NATL ACAD SCI USA, V103, P13635, DOI 10.1073/pnas.0606294103; Chritton JJ, 2010, RNA, V16, P1217, DOI 10.1261/rna.2070110; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; Cooke A, 2010, J BIOL CHEM, V285, P28506, DOI 10.1074/jbc.M110.150763; Crittenden SL, 2002, NATURE, V417, P660, DOI 10.1038/nature754; Dong SY, 2011, J BIOL CHEM, V286, P26732, DOI 10.1074/jbc.M111.244889; DRAPER MP, 1995, MOL CELL BIOL, V15, P3487; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Dupressoir A, 2001, BMC Genomics, V2, P9, DOI 10.1186/1471-2164-2-9; Edwards TA, 2001, CELL, V105, P281, DOI 10.1016/S0092-8674(01)00318-X; Friend K, 2012, NAT STRUCT MOL BIOL, V19, P176, DOI 10.1038/nsmb.2214; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Gamberi C, 2002, DEVELOPMENT, V129, P2699; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Goldstrohm A. C., 2012, MOL CELL BI IN PRESS; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Goldstrohm AC, 2007, J BIOL CHEM, V282, P109, DOI 10.1074/jbc.M609413200; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; Goldstrohm AC, 2008, METHOD ENZYMOL, V448, P77, DOI 10.1016/S0076-6879(08)02605-0; Hook BA, 2007, J BIOL CHEM, V282, P15430, DOI 10.1074/jbc.M611253200; Houshmandi SS, 2005, RNA, V11, P1655, DOI 10.1261/rna.2168505; Jackson JS, 2004, RNA, V10, P1625, DOI 10.1261/rna.7270204; Jenkins HT, 2009, J STRUCT BIOL, V167, P271, DOI 10.1016/j.jsb.2009.06.007; Kadyrova LY, 2007, DEVELOPMENT, V134, P1519, DOI 10.1242/dev.002212; Kaye JA, 2009, NEURON, V61, P57, DOI 10.1016/j.neuron.2008.11.012; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Lau NC, 2009, BIOCHEM J, V422, P443, DOI 10.1042/BJ20090500; Lee MV, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.48; Lee MH, 2007, PLOS GENET, V3, P2540, DOI 10.1371/journal.pgen.0030233; LEHMANN R, 1987, NATURE, V329, P167, DOI 10.1038/329167a0; Lin HF, 1997, DEVELOPMENT, V124, P2463; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; McAlister GC, 2008, J PROTEOME RES, V7, P3127, DOI 10.1021/pr800264t; McAlister GC, 2010, ANAL CHEM, V82, P316, DOI 10.1021/ac902005s; Mee CJ, 2004, J NEUROSCI, V24, P8695, DOI 10.1523/JNEUROSCI.2282-04.2004; Menon KP, 2004, NEURON, V44, P663, DOI 10.1016/j.neuron.2004.10.028; Miles WO, 2012, GENE DEV, V26, P356, DOI 10.1101/gad.182568.111; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Morita M, 2007, MOL CELL BIOL, V27, P4980, DOI 10.1128/MCB.02304-06; Morris AR, 2008, MOL CELL BIOL, V28, P4093, DOI 10.1128/MCB.00155-08; Nakahata S, 2003, MECH DEVELOP, V120, P865, DOI 10.1016/S0925-4773(03)00160-6; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Parisi M, 1999, GENETICS, V153, P235; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Phanstiel DH, 2011, NAT METHODS, V8, P821, DOI [10.1038/NMETH.1699, 10.1038/nmeth.1699]; Piao XH, 2010, MOL CELL BIOL, V30, P1486, DOI 10.1128/MCB.01481-09; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Quenault T, 2011, TRENDS CELL BIOL, V21, P104, DOI 10.1016/j.tcb.2010.09.013; Rouhana L, 2005, RNA, V11, P1117, DOI 10.1261/rna.2630205; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schweers BA, 2002, GENETICS, V161, P1177; Spassov DS, 2003, IUBMB LIFE, V55, P359, DOI 10.1080/15216540310001603093; Spassov DS, 2003, BLOOD CELL MOL DIS, V30, P55, DOI 10.1016/S1079-9796(03)00003-2; Spassov DS, 2002, GENE, V299, P195, DOI 10.1016/S0378-1119(02)01060-0; Suh N, 2009, GENETICS, V181, P1249, DOI 10.1534/genetics.108.099440; Temme C, 2004, EMBO J, V23, P2862, DOI 10.1038/sj.emboj.7600273; Temme C, 2010, RNA, V16, P1356, DOI 10.1261/rna.2145110; Vessey JP, 2006, J NEUROSCI, V26, P6496, DOI 10.1523/JNEUROSCI.0649-06.2006; Viswanathan P, 2004, J BIOL CHEM, V279, P23988, DOI 10.1074/jbc.M402803200; Wagner E, 2007, MOL CELL BIOL, V27, P1686, DOI 10.1128/MCB.01483-06; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wang XQ, 2001, MOL CELL, V7, P855, DOI 10.1016/S1097-2765(01)00229-5; Wang Y, 2009, NAT METHODS, V6, P825, DOI [10.1038/nmeth.1379, 10.1038/NMETH.1379]; Weidmann CA, 2012, MOL CELL BIOL, V32, P527, DOI 10.1128/MCB.06052-11; Wenger CD, 2011, PROTEOMICS, V11, P1064, DOI 10.1002/pmic.201000616; WHARTON RP, 1991, CELL, V67, P955, DOI 10.1016/0092-8674(91)90368-9; Wharton RP, 1998, MOL CELL, V1, P863, DOI 10.1016/S1097-2765(00)80085-4; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wreden C, 1997, DEVELOPMENT, V124, P3015; Xu EY, 2007, MOL REPROD DEV, V74, P912, DOI 10.1002/mrd.20687; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Zamore PD, 1997, RNA, V3, P1421; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297; Zheng DH, 2008, J CELL BIOL, V182, P89, DOI 10.1083/jcb.200801196	88	119	120	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36370	36383		10.1074/jbc.M112.373522	http://dx.doi.org/10.1074/jbc.M112.373522			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22955276	Green Published, hybrid			2022-12-28	WOS:000310364000057
J	Jeppsson, F; Eketjall, S; Janson, J; Karlstrom, S; Gustavsson, S; Olsson, LL; Radesater, AC; Ploeger, B; Cebers, G; Kolmodin, K; Swahn, BM; von Berg, S; Bueters, T; Falting, J				Jeppsson, Fredrik; Eketjall, Susanna; Janson, Juliette; Karlstrom, Sofia; Gustavsson, Susanne; Olsson, Lise-Lotte; Radesater, Ann-Cathrine; Ploeger, Bart; Cebers, Gvido; Kolmodin, Karin; Swahn, Britt-Marie; von Berg, Stefan; Bueters, Tjerk; Falting, Johanna			Discovery of AZD3839, a Potent and Selective BACE1 Inhibitor Clinical Candidate for the Treatment of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE INHIBITORS; BETA-SECRETASE; IN-VIVO; CEREBROSPINAL-FLUID; LEAD GENERATION; A-BETA; BRAIN; MODEL; REDUCTION	beta-Site amyloid precursor protein cleaving enzyme1 (BACE1) is one of the key enzymes involved in the processing of the amyloid precursor protein (APP) and formation of amyloid beta peptide (A beta species. Because cerebral deposition of A beta species might be critical for the pathogenesis of Alzheimer disease, BACE1 has emerged as a key target for the treatment of this disease. Here, we report the discovery and comprehensive preclinical characterization of AZD3839, a potent and selective inhibitor of human BACE1. AZD3839 was identified using fragment-based screening and structure-based design. In a concentration-dependent manner, AZD3839 inhibited BACE1 activity in a biochemical fluorescence resonance energy transfer (FRET) assay, A beta and sAPP beta release from modified and wild-type human SH-SY5Y cells and mouse N2A cells as well as from mouse and guinea pig primary cortical neurons. Selectivity against BACE2 and cathepsin D was 14 and >1000-fold, respectively. AZD3839 exhibited dose-and time-dependent lowering of plasma, brain, and cerebrospinal fluid A beta levels in mouse, guinea pig, and non-human primate. Pharmacokinetic/pharmacodynamic analyses of mouse and guinea pig data showed a good correlation between the potency of AZD3839 in primary cortical neurons and in vivo brain effects. These results suggest that AZD3839 effectively reduces the levels of A beta in brain, CSF, and plasma in several preclinical species. It might, therefore, have disease-modifying potential in the treatment of Alzheimer disease and related dementias. Based on the overall pharmacological profile and its drug like properties, AZD3839 has been progressed into Phase 1 clinical trials in man.	[Jeppsson, Fredrik; Eketjall, Susanna; Janson, Juliette; Karlstrom, Sofia; Gustavsson, Susanne; Radesater, Ann-Cathrine; Ploeger, Bart; Kolmodin, Karin; Swahn, Britt-Marie; von Berg, Stefan; Bueters, Tjerk; Falting, Johanna] Innovat Med AstraZeneca, CNS & Pain, S-15185 Sodertalje, Sweden; [Jeppsson, Fredrik] Karolinska Inst, Dept Med Biochem & Biophys, Div Translat Med & Chem Biol, Sci Life Lab, S-17165 Solna, Sweden; [Eketjall, Susanna] AstraZeneca Translat Sci Ctr, Sci Life Lab, S-17165 Solna, Sweden; [Olsson, Lise-Lotte] AstraZeneca, Discovery Sci, S-43153 Molndal, Sweden; [Cebers, Gvido] AstraZeneca Neurosci, Cambridge, MA 02139 USA	AstraZeneca; Karolinska Institutet; AstraZeneca; AstraZeneca; AstraZeneca	Falting, J (corresponding author), AstraZeneca R&D, Innovat Med, CNS & Pain, Sodertalje, Sweden.	Johanna.Falting@astrazeneca.com			AstraZeneca	AstraZeneca(AstraZeneca)	This work was supported by AstraZeneca.	Albert J., 2007, [No title captured], Patent No. [WO 2007058601A1, 2007058601, WO 2007058601 A1 20070524]; Anderson JJ, 2005, BIOCHEM PHARMACOL, V69, P689, DOI 10.1016/j.bcp.2004.11.015; Arnold J., 2007, PCT International Application, Patent No. [WO2007149033, 2007149033]; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Bateman RJ, 2009, ANN NEUROL, V66, P48, DOI 10.1002/ana.21623; Beckett LA, 2010, ALZHEIMERS DEMENT, V6, P257, DOI 10.1016/j.jalz.2010.03.002; Borgegard T., 2012, ALZHEIMERS DIS RES J, V3, P29; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bricogne G., 2010, AUTOBUSTER; Chang WP, 2011, FASEB J, V25, P775, DOI 10.1096/fj.10-167213; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Cumming JN, 2012, BIOORG MED CHEM LETT, V22, P2444, DOI 10.1016/j.bmcl.2012.02.013; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Das R, 2011, B MATH BIOL, V73, P230, DOI 10.1007/s11538-010-9540-5; DAYNEKA NL, 1993, J PHARMACOKINET BIOP, V21, P457, DOI 10.1007/BF01061691; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; DELANO WL, 2002, PYMOL MOL GRAPHIS SY; Di L, 2011, DRUG METAB DISPOS, V39, P1270, DOI 10.1124/dmd.111.038778; Edwards PD, 2007, J MED CHEM, V50, P5912, DOI 10.1021/jm070829p; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evin G, 2010, INT J BIOCHEM CELL B, V42, P1923, DOI 10.1016/j.biocel.2010.08.017; Friden M, 2009, DRUG METAB DISPOS, V37, P1226, DOI 10.1124/dmd.108.026377; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Geschwindner S, 2007, J MED CHEM, V50, P5903, DOI 10.1021/jm070825k; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Holenz J., 2010, PCT International Application, Patent No. [WO 010056196, 010056196]; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Ito K, 2011, J PHARM SCI-US, V100, P3939, DOI 10.1002/jps.22487; Janson J., 2012, PAGE POPULATION PKPD, P21; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Lanz TA, 2006, J PHARMACOL EXP THER, V319, P924, DOI 10.1124/jpet.106.110700; Lanz TA, 2010, J PHARMACOL EXP THER, V334, P269, DOI 10.1124/jpet.110.167379; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Leslie A. G. W., 1992, CRYSTALLOGRAPHY, V26, P27; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Lu YS, 2012, J PHARMACOL EXP THER, V342, P366, DOI 10.1124/jpet.112.192625; Lu YS, 2011, J PHARMACOL EXP THER, V339, P922, DOI 10.1124/jpet.111.186791; Malamas MS, 2010, BIOORG MED CHEM LETT, V20, P6597, DOI 10.1016/j.bmcl.2010.09.029; May PC, 2011, J NEUROSCI, V31, P16507, DOI 10.1523/JNEUROSCI.3647-11.2011; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Patel S, 2004, J MOL BIOL, V343, P407, DOI 10.1016/j.jmb.2004.08.018; Post TM, 2008, J PHARMACOKINET PHAR, V35, P185, DOI 10.1007/s10928-007-9081-1; Probst G, 2012, EXPERT OPIN THER PAT, V22, P511, DOI 10.1517/13543776.2012.681302; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rajendran L, 2008, SCIENCE, V320, P520, DOI 10.1126/science.1156609; Sankaranarayanan S, 2009, J PHARMACOL EXP THER, V328, P131, DOI 10.1124/jpet.108.143628; Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Stachel SJ, 2006, J MED CHEM, V49, P6147, DOI 10.1021/jm060884i; Stachel SJ, 2009, DRUG DEVELOP RES, V70, P101, DOI 10.1002/ddr.20289; Stanton MG, 2007, J MED CHEM, V50, P3431, DOI 10.1021/jm070272d; Swahn BM, 2012, J MED CHEM, V55, P9346, DOI 10.1021/jm3009025; Swahn BM, 2012, BIOORG MED CHEM LETT, V22, P1854, DOI 10.1016/j.bmcl.2012.01.079; Syvanen S, 2009, DRUG METAB DISPOS, V37, P635, DOI 10.1124/dmd.108.024745; Tai LM, 2012, J PHARMACOKINET PHAR, V39, P227, DOI 10.1007/s10928-012-9246-4; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Visser S. A. G., 2012, ANN M POP APPR GROUP, P21; Xu YC, 2012, ACTA CRYSTALLOGR D, V68, P13, DOI 10.1107/S0907444911047251; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; YOUNKIN SG, 1995, ANN NEUROL, V37, P287, DOI 10.1002/ana.410370303; Zhong ZY, 2007, ARCH GEN PSYCHIAT, V64, P718, DOI 10.1001/archpsyc.64.6.718	69	93	105	0	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41245	41257		10.1074/jbc.M112.409110	http://dx.doi.org/10.1074/jbc.M112.409110			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23048024	hybrid, Green Published			2022-12-28	WOS:000311887600039
J	Martin, LS; Cerda, F; Jimenez, V; Fuentealba, J; Munoz, B; Aguayo, LG; Guzman, L				San Martin, Loreto; Cerda, Fabian; Jimenez, Veronica; Fuentealba, Jorge; Munoz, Braulio; Aguayo, Luis G.; Guzman, Leonardo			Inhibition of the Ethanol-induced Potentiation of alpha 1 Glycine Receptor by a Small Peptide That Interferes with G beta gamma Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; MOUSE SPINAL NEURONS; SYNAPTIC-TRANSMISSION; MOLECULAR-DYNAMICS; SYNTHETIC PEPTIDES; HEART-FAILURE; ION-CHANNEL; SUBUNITS; MODULATION; RAT	Previous studies indicate that ethanol can modulate glycine receptors (GlyR), in part, through G beta gamma interaction with basic residues in the intracellular loop. In this study, we show that a seven-amino acid peptide (RQH(C7)), which has the primary structure of a motif in the large intracellular loop of GlyR (GlyR-IL), was able to inhibit the ethanol-elicited potentiation of this channel from 47 +/- 2 to 16 +/- 4%, without interfering with the effect of G beta gamma on GIRK (G protein activated inwardly rectifying potassium channel) activation. RQH(C7) displayed a concentration-dependent effect on ethanol action in evoked and synaptic currents. A fragment of GlyR-IL without the basic amino acids did not interact with G beta gamma or inhibit ethanol potentiation of GlyR. In silico analysis using docking and molecular dynamics allowed to identify a region of similar to 350 angstrom(2) involving aspartic acids 186, 228, and 246 in G beta gamma where we propose that RQH(C7) binds and exerts its blocking action on the effect of ethanol in GlyR.	[San Martin, Loreto; Cerda, Fabian; Fuentealba, Jorge; Munoz, Braulio; Aguayo, Luis G.; Guzman, Leonardo] Univ Concepcion, Fac Biol Sci, Dept Physiol, Concepcion 403901, Chile; [Jimenez, Veronica] Univ Concepcion, Fac Chem Sci, Dept Organ Chem, Concepcion 403901, Chile	Universidad de Concepcion; Universidad de Concepcion	Guzman, L (corresponding author), Univ Concepcion, Fac Biol Sci, Dept Physiol, Casilla 160-C, Concepcion 403901, Chile.	joseguzman@udec.cl	Munoz, Braulio/F-2493-2018; Jiménez, Verónica A/B-8789-2017; Guzman, Jose/AAM-7649-2020	Munoz, Braulio/0000-0003-4442-975X; Guzman, Jose/0000-0001-9596-5494	Fondecyt [11080145]; National Institutes of Health [R01AA 15150]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Fondecyt Grant 11080145 and National Institutes of Health Grant R01AA 15150.	Aguayo LG, 1996, J PHARMACOL EXP THER, V279, P1116; Aguayo LG, 2004, BRAIN RES REV, V47, P33, DOI 10.1016/j.brainresrev.2004.06.007; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Camacho CJ, 2005, BIOINFORMATICS, V21, P2534, DOI 10.1093/bioinformatics/bti322; CHEN JQ, 1995, SCIENCE, V268, P1166, DOI 10.1126/science.7761832; Davis TL, 2005, BIOCHEMISTRY-US, V44, P10593, DOI 10.1021/bi050655i; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Goubaeva F, 2003, J BIOL CHEM, V278, P19634, DOI 10.1074/jbc.M300052200; Gu YP, 1998, J PHYSIOL-LONDON, V506, P331, DOI 10.1111/j.1469-7793.1998.331bw.x; Guzman L, 2009, J PHARMACOL EXP THER, V331, P933, DOI 10.1124/jpet.109.160440; Harding VB, 2001, P NATL ACAD SCI USA, V98, P5809, DOI 10.1073/pnas.091102398; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kamal FA, 2011, J MOL CELL CARDIOL, V51, P462, DOI 10.1016/j.yjmcc.2011.01.006; Kirui JK, 2010, J PHARMACOL EXP THER, V333, P393, DOI 10.1124/jpet.109.164814; KONIG B, 1994, BBA-MOL CELL RES, V1223, P261, DOI 10.1016/0167-4889(94)90235-6; Krapivinsky G, 1998, J BIOL CHEM, V273, P16946, DOI 10.1074/jbc.273.27.16946; Kubota M, 2008, J PEPT SCI, V14, P998, DOI 10.1002/psc.1034; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Mahon MJ, 2006, MOL ENDOCRINOL, V20, P136, DOI 10.1210/me.2005-0169; Mathews JL, 2008, J NEUROSCI, V28, P12183, DOI 10.1523/JNEUROSCI.2326-08.2008; Melzer N, 2010, J BIOL CHEM, V285, P3730, DOI 10.1074/jbc.M109.030460; Millar RP, 2010, MOL ENDOCRINOL, V24, P261, DOI 10.1210/me.2009-0473; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Min BI, 1996, BRAIN RES, V734, P72; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Molander A, 2005, ALCOHOL CLIN EXP RES, V29, P38, DOI 10.1097/01.ALC.0000150009.78622.E0; Molander A, 2007, ALCOHOL ALCOHOLISM, V42, P11, DOI 10.1093/alcalc/ag1085; MUNCH G, 1991, EUR J BIOCHEM, V198, P357, DOI 10.1111/j.1432-1033.1991.tb16023.x; OKAMOTO T, 1991, CELL, V67, P723, DOI 10.1016/0092-8674(91)90067-9; OKAMOTO T, 1992, J BIOL CHEM, V267, P8342; Peoples RW, 1996, ANNU REV PHARMACOL, V36, P185, DOI 10.1146/annurev.pa.36.040196.001153; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sadtler S, 2003, J BIOL CHEM, V278, P16782, DOI 10.1074/jbc.M213077200; Sankaran B, 1998, J BIOL CHEM, V273, P7148, DOI 10.1074/jbc.273.12.7148; Shpakov A O, 2010, Ross Fiziol Zh Im I M Sechenova, V96, P1062; Shpakov AO, 2011, J AMINO ACIDS; Singer JH, 1998, J NEUROPHYSIOL, V80, P2608, DOI 10.1152/jn.1998.80.5.2608; Smrcka AV, 2002, METHOD ENZYMOL, V344, P557; SONG Y, 1990, NATURE, V348, P242, DOI 10.1038/348242a0; Stern CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018114; Tang XY, 2011, J BIOL CHEM, V286, P13244, DOI 10.1074/jbc.M110.206615; VAELLO ML, 1994, J BIOL CHEM, V269, P2002; van Zundert B, 2005, BRAIN RES, V1050, P40, DOI 10.1016/j.brainres.2005.05.014; van Zundert B, 2002, J NEUROPHYSIOL, V87, P640, DOI 10.1152/jn.00455.2001; WADE SM, 1994, MOL PHARMACOL, V45, P1191; Yevenes GE, 2003, NAT NEUROSCI, V6, P819, DOI 10.1038/nn1095; Yevenes GE, 2008, P NATL ACAD SCI USA, V105, P20523, DOI 10.1073/pnas.0806257105; Yevenes GE, 2006, J BIOL CHEM, V281, P39300, DOI 10.1074/jbc.M608272200; Yuan CJ, 2007, J BIOL CHEM, V282, P19938, DOI 10.1074/jbc.M700396200	52	8	8	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40713	40721		10.1074/jbc.M112.393603	http://dx.doi.org/10.1074/jbc.M112.393603			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23035114	hybrid, Green Published			2022-12-28	WOS:000311448800060
J	Haining, EJ; Yang, J; Bailey, RL; Khan, K; Collier, R; Tsai, S; Watson, SP; Frampton, J; Garcia, P; Tomlinson, MG				Haining, Elizabeth J.; Yang, Jing; Bailey, Rebecca L.; Khan, Kabir; Collier, Richard; Tsai, Schickwann; Watson, Steve P.; Frampton, Jon; Garcia, Paloma; Tomlinson, Michael G.			The TspanC8 Subgroup of Tetraspanins Interacts with A Disintegrin and Metalloprotease 10 (ADAM10) and Regulates Its Maturation and Cell Surface Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL EXUDATIVE VITREORETINOPATHY; GROWTH-FACTOR; ENDOPLASMIC-RETICULUM; PLATELET TETRASPANIN; ADHERENT LEUKOCYTES; MEMBRANE-PROTEINS; IN-VIVO; ALPHA; CD151; ERYTHROPOIESIS	A disintegrin and metalloprotease 10 (ADAM10) is a ubiquitous transmembrane metalloprotease that cleaves the extracellular regions from over 40 different transmembrane target proteins, including Notch and amyloid precursor protein. ADAM10 is essential for embryonic development and is also important in inflammation, cancer, and Alzheimer disease. However, ADAM10 regulation remains poorly understood. ADAM10 is compartmentalized into membrane microdomains formed by tetraspanins, which are a superfamily of 33 transmembrane proteins in humans that regulate clustering and trafficking of certain other transmembrane "partner" proteins. This is achieved by specific tetraspanin-partner interactions, but it is not clear which tetraspanins specifically interact with ADAM10. The aims of this study were to identify which tetraspanins interact with ADAM10 and how they regulate this metalloprotease. Co-immunoprecipitation identified specific ADAM10 interactions with Tspan5, Tspan10, Tspan14, Tspan15, Tspan17, and Tspan33/Penumbra. These are members of the largely unstudied TspanC8 subgroup of tetraspanins, all six of which promoted ADAM10 maturation. Different cell types express distinct repertoires of TspanC8 tetraspanins. Human umbilical vein endothelial cells express relatively high levels of Tspan14, the knockdown of which reduced ADAM10 surface expression and activity. Mouse erythrocytes express predominantly Tspan33, and ADAM10 expression was substantially reduced in the absence of this tetraspanin. In contrast, ADAM10 expression was normal on Tspan33-deficient mouse platelets in which Tspan14 is the major TspanC8 tetraspanin. These results define TspanC8 tetraspanins as essential regulators of ADAM10 maturation and trafficking to the cell surface. This finding has therapeutic implications because focusing on specific TspanC8-ADAM10 complexes may allow cell type- and/or substrate-specific ADAM10 targeting.	[Haining, Elizabeth J.; Yang, Jing; Bailey, Rebecca L.; Khan, Kabir; Collier, Richard; Tomlinson, Michael G.] Univ Birmingham, Sch Biosci, Coll Life & Environm Sci, Birmingham B15 2TT, W Midlands, England; [Watson, Steve P.] Univ Birmingham, Sch Clin & Expt Med, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Frampton, Jon; Garcia, Paloma] Univ Birmingham, Sch Immun & Infect, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Tsai, Schickwann] Univ Utah, Dept Med, Div Hematol, Salt Lake City, UT 84132 USA	University of Birmingham; University of Birmingham; University of Birmingham; Utah System of Higher Education; University of Utah	Tomlinson, MG (corresponding author), Univ Birmingham, Sch Biosci, Coll Life & Environm Sci, Birmingham B15 2TT, W Midlands, England.	m.g.tomlinson@bham.ac.uk	Garcia, Paloma/AFO-2595-2022; Watson, Stephen P/Q-6292-2016; Khan, Kabir/U-8350-2018	Watson, Stephen P/0000-0002-7846-7423; Khan, Kabir/0000-0001-8453-3485; Tomlinson, Michael/0000-0002-1189-0091; Garcia, Paloma/0000-0001-5582-8575	two Biotechnology and Biological Sciences Research Council studentships; British Heart Foundation (BHF) chair; Science City Research Alliance fellowship; BHF Senior Research Fellowship [FS/08/062/25797]; British Heart Foundation [FS/08/062/25797] Funding Source: researchfish; Medical Research Council [G9818340B] Funding Source: researchfish	two Biotechnology and Biological Sciences Research Council studentships(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation (BHF) chair(British Heart Foundation); Science City Research Alliance fellowship; BHF Senior Research Fellowship; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by two Biotechnology and Biological Sciences Research Council studentships (to E. J. H. and R. L. B.), a British Heart Foundation (BHF) chair (to S. P. W.), a Science City Research Alliance fellowship (to P. G.), and BHF Senior Research Fellowship FS/08/062/25797 (to M. G. T.).	Arduise C, 2008, J IMMUNOL, V181, P7002, DOI 10.4049/jimmunol.181.10.7002; Barreiro O, 2008, J CELL BIOL, V183, P527, DOI 10.1083/jcb.200805076; Bender M, 2010, BLOOD, V116, P3347, DOI 10.1182/blood-2010-06-289108; Charrin S, 2003, EUR J IMMUNOL, V33, P2479, DOI 10.1002/eji.200323884; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Donners MPC, 2010, ARTERIOSCL THROM VAS, V30, P2188, DOI 10.1161/ATVBAHA.110.213124; Doyle EL, 2011, BLOOD, V118, P4265, DOI 10.1182/blood-2010-11-321489; Dreymueller D, 2012, EUR J CELL BIOL, V91, P472, DOI 10.1016/j.ejcb.2011.09.003; Dumon S, 2006, EXP HEMATOL, V34, P654, DOI 10.1016/j.exphem.2006.01.014; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; Gardiner EE, 2007, J THROMB HAEMOST, V5, P1530, DOI 10.1111/j.1538-7836.2007.02590.x; Glomski K, 2011, BLOOD, V118, P1163, DOI 10.1182/blood-2011-04-348557; Goschnick MW, 2006, BLOOD, V108, P1911, DOI 10.1182/blood-2006-02-004267; Haining EJ, 2011, BIOCHEM SOC T, V39, P518, DOI 10.1042/BST0390518; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Heikens MJ, 2007, BLOOD, V109, P3244, DOI 10.1182/blood-2006-09-046672; Hundhausen C, 2007, J IMMUNOL, V178, P8064, DOI 10.4049/jimmunol.178.12.8064; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lewandrowski U, 2009, BLOOD, V114, pE10, DOI 10.1182/blood-2009-02-203828; MACIAG T, 1979, P NATL ACAD SCI USA, V76, P5674, DOI 10.1073/pnas.76.11.5674; Marcello E, 2010, J BIOL CHEM, V285, P10376, DOI 10.1074/jbc.M109.055947; McCarty OJT, 2006, J THROMB HAEMOST, V4, P1367, DOI 10.1111/j.1538-7836.2006.01966.x; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Nikopoulos K, 2010, AM J HUM GENET, V86, P240, DOI 10.1016/j.ajhg.2009.12.016; Orlowski E, 2009, J THROMB HAEMOST, V7, P2074, DOI 10.1111/j.1538-7836.2009.03612.x; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Poulter JA, 2010, AM J HUM GENET, V86, P248, DOI 10.1016/j.ajhg.2010.01.012; Protty MB, 2009, BIOCHEM J, V417, P391, DOI 10.1042/BJ20081126; Prox J, 2012, CELL MOL LIFE SCI, V69, P2919, DOI 10.1007/s00018-012-0960-2; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Schulz B, 2008, CIRC RES, V102, P1192, DOI 10.1161/CIRCRESAHA.107.169805; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sincock PM, 1997, J HISTOCHEM CYTOCHEM, V45, P515, DOI 10.1177/002215549704500404; Takeda Y, 2008, J BIOL CHEM, V283, P26089, DOI 10.1074/jbc.M801902200; Takeda Y, 2007, BLOOD, V109, P1524, DOI 10.1182/blood-2006-08-041970; Tomlinson MG, 2009, J THROMB HAEMOST, V7, P2070, DOI 10.1111/j.1538-7836.2009.03613.x; Tomlinson M G, 2001, BMC Immunol, V2, P4, DOI 10.1186/1471-2172-2-4; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Zelm MC, 2010, J CLIN INVEST, V120, P1265, DOI 10.1172/JCI39748; Vegiopoulos A, 2006, BLOOD, V107, P4703, DOI 10.1182/blood-2005-07-2968; Xu DS, 2009, FASEB J, V23, P3674, DOI 10.1096/fj.09-133462; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Zhang C, 2010, DEV DYNAM, V239, P2594, DOI 10.1002/dvdy.22391	45	109	118	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.416503	http://dx.doi.org/10.1074/jbc.M112.416503			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23035126	hybrid, Green Published			2022-12-28	WOS:000311233800044
J	Ramachandran, PL; Craig, TA; Atanasova, EA; Cui, GF; Owen, BA; Bergen, HR; Mer, G; Kumar, R				Ramachandran, Pradeep L.; Craig, Theodore A.; Atanasova, Elena A.; Cui, Gaofeng; Owen, Barbara A.; Bergen, H. Robert, III; Mer, Georges; Kumar, Rajiv			The Potassium Channel Interacting Protein 3 (DREAM/KChIP3) Heterodimerizes with and Regulates Calmodulin Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REPRESSOR; DNA-BINDING; DREAM; CALSENILIN; CALCINEURIN; CALSENILIN/DREAM/KCHIP3; MODULATION; FRAGMENT; SUBUNIT; MICE	Downstream regulatory element antagonistic modulator (DREAM/KChIP3), a neuronal EF-hand protein, modulates pain, potassium channel activity, and binds presenilin 1. Using affinity capture of neuronal proteins by immobilized DREAM/KChIP3 in the presence and absence of calcium (Ca2+) followed by mass spectroscopic identification of interacting proteins, we demonstrate that in the presence of Ca2+, DREAM/KChIP3 interacts with the EF-hand protein, calmodulin (CaM). The interaction of DREAM/KChIP3 with CaM does not occur in the absence of Ca2+. In the absence of Ca2+, DREAM/KChIP3 binds the EF-hand protein, calcineurin subunit-B. Ca2+-bound DREAM/KChIP3 binds CaM with a dissociation constant of similar to 3 mu M as assessed by changes in DREAM/KChIP3 intrinsic protein fluorescence in the presence of CaM. Two-dimensional H-1,N-15 heteronuclear single quantum coherence spectra reveal changes in chemical shifts and line broadening upon the addition of CaM to N-15 DREAM/KChIP3. The amino-terminal portion of DREAM/KChIP3 is required for its binding to CaM because a construct of DREAM/KChIP3 lacking the first 94 amino-terminal residues fails to bind CaM as assessed by fluorescence spectroscopy. The addition of Ca2+-bound DREAM/KChIP3 increases the activation of calcineurin (CN) by calcium CaM. A DREAM/KChIP3 mutant incapable of binding Ca2+ also stimulates calmodulin-dependent CN activity. The shortened form of DREAM/KChIP3 lacking the NH2-terminal amino acids fails to activate CN in the presence of calcium CaM. Our data demonstrate the interaction of DREAM/KChIP3 with the important EF-hand protein, CaM, and show that the interaction alters CN activity.	[Ramachandran, Pradeep L.; Craig, Theodore A.; Kumar, Rajiv] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA; [Ramachandran, Pradeep L.; Craig, Theodore A.; Kumar, Rajiv] Mayo Clin, Dept Med, Rochester, MN 55905 USA; [Atanasova, Elena A.; Cui, Gaofeng; Owen, Barbara A.; Bergen, H. Robert, III; Mer, Georges; Kumar, Rajiv] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Owen, Barbara A.] Mayo Clin, Div Surg Res, Rochester, MN 55905 USA; [Bergen, H. Robert, III] Mayo Clin, Prote Res Ctr, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Kumar, R (corresponding author), Mayo Clin, Div Nephrol & Hypertens, MS 1-120,200 1st St SW, Rochester, MN 55905 USA.	rkumar@mayo.edu	Mer, Georges/AAT-4946-2021; Cui, Gaofeng/A-1107-2013	Mer, Georges/0000-0002-1900-1578; Cui, Gaofeng/0000-0001-5267-9033; Kumar, Rajiv/0000-0003-3497-3057	National Institutes of Health [AR-058003, AR-60869]; Marion and Ralph Falk Medical Trust; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR060869, R21AR058003] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marion and Ralph Falk Medical Trust; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR-058003 and AR-60869. This work was also supported by a grant from the Marion and Ralph Falk Medical Trust.	Alexander JC, 2009, LEARN MEMORY, V16, P167, DOI 10.1101/lm.1261709; Ames JB, 2012, FRONT MOL NEUROSCI, V5, DOI [10.3389/fnmol.2012.00010, 10.1016/j.bbagen.2011.10.003]; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Cheng HYM, 2002, CELL, V108, P31, DOI 10.1016/S0092-8674(01)00629-8; Choi EK, 2001, J BIOL CHEM, V276, P19197, DOI 10.1074/jbc.M008597200; Craig TA, 2002, J BIOL CHEM, V277, P10955, DOI 10.1074/jbc.M109660200; Frost RJA, 2010, CELL METAB, V12, P205, DOI 10.1016/j.cmet.2010.08.007; Hammond PI, 2003, MOL BRAIN RES, V111, P104, DOI 10.1016/S0169-328X(02)00693-9; Hara MR, 2007, ANNU REV PHARMACOL, V47, P117, DOI 10.1146/annurev.pharmtox.47.120505.105311; Juranic N, 2007, PROTEIN SCI, V16, P1329, DOI 10.1110/ps.062689807; Kakihana K, 2012, BONE MARROW TRANSPL, V47, P593, DOI 10.1038/bmt.2011.120; Kretsinger RH, 2012, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2012.00041; Ledo F, 2000, MOL CELL BIOL, V20, P9120, DOI 10.1128/MCB.20.24.9120-9126.2000; Leissring MA, 2000, P NATL ACAD SCI USA, V97, P8590, DOI 10.1073/pnas.97.15.8590; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Lilliehook C, 2003, J NEUROSCI, V23, P9097; Lilliehook C, 2002, MOL CELL NEUROSCI, V19, P552, DOI 10.1006/mcne.2001.1096; Mellstrom B, 2001, SEMIN CELL DEV BIOL, V12, P59, DOI 10.1006/scdb.2000.0218; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Osawa M, 2001, J BIOL CHEM, V276, P41005, DOI 10.1074/jbc.M105842200; Owen BAL, 2005, NAT STRUCT MOL BIOL, V12, P663, DOI 10.1038/nsmb965; Owen BAL, 2002, J BIOL CHEM, V277, P7086, DOI 10.1074/jbc.M111450200; Rivas M, 2004, J BIOL CHEM, V279, P33114, DOI 10.1074/jbc.M403526200; Rivas M, 2011, SCI CHINA LIFE SCI, V54, P786, DOI 10.1007/s11427-011-4196-4; Rivas M, 2011, ANTIOXID REDOX SIGN, V14, P1237, DOI 10.1089/ars.2010.3385; Sato Y, 2007, ANESTH ANALG, V105, P1489, DOI 10.1213/01.ane.0000286173.60987.72; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; STEMMER PM, 1994, BIOCHEMISTRY-US, V33, P6859, DOI 10.1021/bi00188a015; Thomsen MB, 2009, CIRC RES, V104, P1382, DOI 10.1161/CIRCRESAHA.109.196972; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Zhang Y, 2010, J NEUROSCI, V30, P7575, DOI 10.1523/JNEUROSCI.1312-10.2010	35	12	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.398495	http://dx.doi.org/10.1074/jbc.M112.398495			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23019329	Green Published, hybrid			2022-12-28	WOS:000311233800016
J	Zhu, L; Wang, LD; Luo, XL; Zhang, YX; Ding, QR; Jiang, XM; Wang, X; Pan, Y; Chen, Y				Zhu, Lu; Wang, Lingdi; Luo, Xiaolin; Zhang, Yongxian; Ding, Qiurong; Jiang, Xiaomeng; Wang, Xiao; Pan, Yi; Chen, Yan			Tollip, an Intracellular Trafficking Protein, Is a Novel Modulator of the Transforming Growth Factor-beta Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IL-1 RECEPTOR; KAPPA-B; TGF; UBIQUITIN; INTERLEUKIN-1; SMAD7; ACTIVATION; COMPLEX; DOMAIN; LIPOPOLYSACCHARIDE	Upon activation, TGF-beta type I receptor (T beta RI) undergoes active ubiquitination via recruitment of E3 ligases to the receptor complex by Smad7. However, how ubiquitination of T beta RI is coupled to intracellular trafficking, and protein degradation remains unclear. We report here that Tollip, an adaptor protein that contains both ubiquitin-associated domains and endosome-targeting domain, plays an important role in modulating trafficking and degradation of T beta RI. Tollip was previously demonstrated to possess a functional role in modulating the signaling of interleukin-1 and Toll-like receptors. We identify here that Tollip interacts with Smad7, a major modulatory protein involved in the negative regulation of TGF-beta signaling. Overexpression of Tollip antagonizes TGF-beta-stimulated transcriptional response, Smad2 phosphorylation, and epithelial-mesenchymal transition. Tollip also interacts with ubiquitinated T beta RI, and such interaction requires ubiquitin-associated domains of Tollip. The interaction and intracellular colocalization of Tollip with T beta RI is enhanced by Smad7. Overexpression of Tollip accelerates protein degradation of activated T beta RI. In addition, Tollip alters subcellular compartmentalization and endosomal trafficking of activated T beta RI. Collectively, our studies reveal that Tollip cooperates with Smad7 to modulate intracellular trafficking and degradation of ubiquitinated T beta RI, whereby negatively regulates TGF-beta signaling pathway.	[Zhu, Lu; Wang, Lingdi; Luo, Xiaolin; Zhang, Yongxian; Ding, Qiurong; Jiang, Xiaomeng; Wang, Xiao; Pan, Yi; Chen, Yan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab,Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chen, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab,Grad Sch, 294 Taiyuan Rd, Shanghai 200031, Peoples R China.	ychen3@sibs.ac.cn	Luo, Xiaolin/D-7159-2014; Zhu, Lu/N-1073-2017	Luo, Xiaolin/0000-0003-3215-8112; Zhu, Lu/0000-0003-2716-4649	National Natural Science Foundation of China [30830037, 81021002, 81130077, 30971660]; Ministry of Science and Technology of China [2012CB524900, 2010CB529506]; Chinese Academy of Sciences [KSCX2-EW-R-08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by research grants from National Natural Science Foundation of China (30830037, 81021002, and 81130077 (to Y. C.) and 30971660 (to Y. P.)), Ministry of Science and Technology of China (2012CB524900 (to Y. C.) and 2010CB529506 (to Y. P. and Z. W.)), and Chinese Academy of Sciences (KSCX2-EW-R-08 (to Y. C.)).	Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brissoni B, 2006, CURR BIOL, V16, P2265, DOI 10.1016/j.cub.2006.09.062; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Chen XW, 2006, J BIOL CHEM, V281, P38609, DOI 10.1074/jbc.M512847200; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Didierlaurent A, 2006, MOL CELL BIOL, V26, P735, DOI 10.1128/MCB.26.3.735-742.2006; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Fan JM, 2001, AM J KIDNEY DIS, V37, P820, DOI 10.1016/S0272-6386(01)80132-3; Feng L, 2007, P NATL ACAD SCI USA, V104, P14348, DOI 10.1073/pnas.0701298104; Harada J, 2003, J BIOL CHEM, V278, P38998, DOI 10.1074/jbc.M307112200; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Ishida Y, 2006, J IMMUNOL, V176, P5598, DOI 10.4049/jimmunol.176.9.5598; Katoh Y, 2004, J BIOL CHEM, V279, P24435, DOI 10.1074/jbc.M400059200; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Li T, 2004, MOL IMMUNOL, V41, P85, DOI 10.1016/j.molimm.2004.03.009; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Nagarajan RP, 2000, BIOCHEM J, V348, P591, DOI 10.1042/0264-6021:3480591; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Shephard P, 2004, AM J PATHOL, V164, P2055, DOI 10.1016/S0002-9440(10)63764-9; Shi WB, 2004, J CELL BIOL, V164, P291, DOI 10.1083/jcb.200307151; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Wrana JL, 2000, CYTOKINE GROWTH F R, V11, P5, DOI 10.1016/S1359-6101(99)00024-6; Xie XY, 2011, CELL METAB, V14, P378, DOI 10.1016/j.cmet.2011.06.015; Yamakami M, 2003, J BIOL CHEM, V278, P52865, DOI 10.1074/jbc.M306740200; Yan XH, 2009, J BIOL CHEM, V284, P30097, DOI 10.1074/jbc.M109.049304; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200; Zhang Y, 2010, ONCOGENE, V29, P5404, DOI 10.1038/onc.2010.270	33	57	62	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.388009	http://dx.doi.org/10.1074/jbc.M112.388009			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23027871	Green Published, hybrid			2022-12-28	WOS:000311233800035
J	Farizano, JV; Pescaretti, MD; Lopez, FE; Hsu, FF; Delgado, MA				Farizano, Juan V.; de las Mercedes Pescaretti, Maria; Lopez, Fabian E.; Hsu, Fong-Fu; Delgado, Monica A.			The PmrAB System-inducing Conditions Control Both Lipid A Remodeling and O-antigen Length Distribution, Influencing the Salmonella Typhimurium-Host Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; 2-COMPONENT REGULATORY SYSTEMS; POLYMYXIN-RESISTANT MUTANTS; ESCHERICHIA-COLI; CHAIN-LENGTH; SIGNAL-TRANSDUCTION; PHOSPHOETHANOLAMINE MODIFICATION; ANTIMICROBIAL PEPTIDES; BACTERIAL-RESISTANCE; RESPONSE REGULATOR	The Salmonella enterica serovar Typhimurium lipopolysaccharide consisting of covalently linked lipid A, non-repeating core oligosaccharide, and the O-antigen polysaccharide is the most exposed component of the cell envelope. Previous studies demonstrated that all of these regions act against the host immunity barrier. The aim of this study was to define the role and interaction of PmrAB-dependent gene products required for the lipopolysaccharide component synthesis or modification mainly during the Salmonella infection. The PmrAB two-component system activation promotes a remodeling of lipid A and the core region by addition of 4-aminoarabinose and/or phosphoethanolamine. These PmrA-dependent activities are produced by activation of ugd, pbgPE, pmrC, cpta, and pmrG transcription. In addition, under PmrA regulator activation, the expression of wzz(fepE) and wzz(st) genes is induced, and their products are required to determine the O-antigen chain length. Here we report for the first time that Wzz(st) protein is necessary to maintain the balance of 4-aminoarabinose and phosphoethanolamine lipid A modifications. Moreover, we demonstrate that the interaction of the PmrA-dependent pbgE(2) and pbgE(3) gene products is important for the formation of the short O-antigen region. Our results establish that PmrAB is the global regulatory system that controls lipopolysaccharide modification, leading to a coordinate regulation of 4-aminoarabinose incorporation and O-antigen chain length to respond against the host defense mechanisms.	[Farizano, Juan V.; de las Mercedes Pescaretti, Maria; Lopez, Fabian E.; Delgado, Monica A.] Univ Nacl Tucuman, Consejo Nacl Invest Cient & Tecn, Inst Super Invest Biol, RA-4000 San Miguel De Tucuman, Tucuman, Argentina; [Farizano, Juan V.; de las Mercedes Pescaretti, Maria; Lopez, Fabian E.; Delgado, Monica A.] Inst Quim Biol Dr Bernabe Bloj, RA-4000 San Miguel De Tucuman, Tucuman, Argentina; [Hsu, Fong-Fu] Washington Univ, Sch Med, Dept Internal Med, Div Endocrinol Diabet & Metab, St Louis, MO 63110 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Tucuman; Washington University (WUSTL)	Delgado, MA (corresponding author), Univ Nacl Tucuman, Consejo Nacl Invest Cient & Tecn, Inst Super Invest Biol, Chacabuco 461, RA-4000 San Miguel De Tucuman, Tucuman, Argentina.	monicad@fbqf.unt.edu.ar	Delgado, Monica Alejandra/H-2740-2019	Delgado, Monica Alejandra/0000-0002-4283-6979; Farizano, Juan Vicente/0000-0003-0180-4927; Hsu, Fong-Fu/0000-0001-5368-0183; Pescaretti, Maria de las Mercedes/0000-0002-9299-2080	National Institutes of Health [P41-RR00954, P60-DK20579, P30-DK56341]; Consejo Nacional de Investigaciones Cient~ficas y Tecnicas (CONICET) [PIP 2518]; Universidad Nacional de Tucuman [CIUNT 26/D439]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, P60DK020579, P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Investigaciones Cient~ficas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional de Tucuman; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P41-RR00954, P60-DK20579, and P30-DK56341 (to the mass spectrometry facility of Washington University). This work was also supported by Consejo Nacional de Investigaciones Cient~ficas y Tecnicas (CONICET) Grant PIP 2518 and Universidad Nacional de Tucuman Grant CIUNT 26/D439.	Bennett HPJ, 2005, J BACTERIOL, V187, P77, DOI 10.1128/JB.187.1.77-84.2005; Bishop RE, 2004, J ENDOTOXIN RES, V10, P107, DOI 10.1179/096805104225004004; BRADE H, 1999, ENDOTOXIN HLTH DIS, P31; Breazeale SD, 2003, J BIOL CHEM, V278, P24731, DOI 10.1074/jbc.M304043200; Burns SM, 1998, INFECT IMMUN, V66, P4244; Chamnongpol S, 2000, J MOL BIOL, V300, P291, DOI 10.1006/jmbi.2000.3848; DASGUPTA T, 1994, INFECT IMMUN, V62, P809, DOI 10.1128/IAI.62.3.809-817.1994; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis R., 1980, ADV BACTERIAL GENETI; Pescaretti MD, 2011, MICROBIOL-SGM, V157, P2515, DOI 10.1099/mic.0.050088-0; Delgado MA, 2006, MOL MICROBIOL, V60, P39, DOI 10.1111/j.1365-2958.2006.05069.x; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Francez-Charlot A, 2003, MOL MICROBIOL, V49, P823, DOI 10.1046/j.1365-2958.2003.03601.x; Franco AV, 1998, J BACTERIOL, V180, P2670, DOI 10.1128/JB.180.10.2670-2675.1998; GOTTESMAN S, 1991, MOL MICROBIOL, V5, P1599, DOI 10.1111/j.1365-2958.1991.tb01906.x; Groisman EA, 1997, J BACTERIOL, V179, P7040, DOI 10.1128/jb.179.22.7040-7045.1997; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; HARSHEY RM, 1994, P NATL ACAD SCI USA, V91, P8631, DOI 10.1073/pnas.91.18.8631; HELANDER IM, 1994, MOL MICROBIOL, V11, P481, DOI 10.1111/j.1365-2958.1994.tb00329.x; Holzer SU, 2009, INFECT IMMUN, V77, P5458, DOI 10.1128/IAI.00871-09; Joiner K A, 1985, Curr Top Microbiol Immunol, V121, P99; JOINER KA, 1982, J EXP MED, V155, P797, DOI 10.1084/jem.155.3.797; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kato A, 2004, GENE DEV, V18, P2302, DOI 10.1101/gad.1230804; Kawasaki K, 2005, J ENDOTOXIN RES, V11, P57, DOI 10.1179/096805105225006696; Kawasaki K, 2004, J ENDOTOXIN RES, V10, P439, DOI 10.1179/096805104225006264; Kox LFF, 2000, EMBO J, V19, P1861, DOI 10.1093/emboj/19.8.1861; Lee H, 2004, J BACTERIOL, V186, P4124, DOI 10.1128/JB.186.13.4124-4133.2004; MAROLDA CL, 1990, J BACTERIOL, V172, P3590, DOI 10.1128/jb.172.7.3590-3599.1990; Miller J.H., 1972, EXPT MOL GENETICS; MORONA R, 1995, J BACTERIOL, V177, P1059, DOI 10.1128/jb.177.4.1059-1068.1995; Mouslim C, 2004, MOL MICROBIOL, V54, P386, DOI 10.1111/j.1365-2958.2004.04293.x; Mouslim C, 2003, J BIOL CHEM, V278, P50588, DOI 10.1074/jbc.M309433200; Mouslim C, 2003, MOL MICROBIOL, V47, P335, DOI 10.1046/j.1365-2958.2003.03318.x; Murray GL, 2005, MICROBES INFECT, V7, P1296, DOI 10.1016/j.micinf.2005.04.015; Murray GL, 2003, MOL MICROBIOL, V47, P1395, DOI 10.1046/j.1365-2958.2003.03383.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nishino K, 2006, MOL MICROBIOL, V61, P645, DOI 10.1111/j.1365-2958.2006.05273.x; RAETZ CRH, 1993, J BACTERIOL, V175, P5745, DOI 10.1128/JB.175.18.5745-5753.1993; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; ROLAND KL, 1993, J BACTERIOL, V175, P4154, DOI 10.1128/JB.175.13.4154-4164.1993; Sambrook J., 2002, MOL CLONING LAB MANU; SANDERSON KE, 1995, MICROBIOL REV, V59, P241, DOI 10.1128/MMBR.59.2.241-303.1995; Shi YX, 2004, MOL MICROBIOL, V53, P229, DOI 10.1111/j.1365-2958.2004.04107.x; Skurnik M, 2003, CARBOHYD RES, V338, P2521, DOI 10.1016/S0008-6215(03)00305-7; SNAVELY MD, 1991, J BIOL CHEM, V266, P824; Soncini FC, 1996, J BACTERIOL, V178, P6796, DOI 10.1128/jb.178.23.6796-6801.1996; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; Steinberg DA, 1997, ANTIMICROB AGENTS CH, V41, P1738, DOI 10.1128/AAC.41.8.1738; Tamayo R, 2005, J BACTERIOL, V187, P3391, DOI 10.1128/JB.187.10.3391-3399.2005; Trent MS, 2001, J BIOL CHEM, V276, P43122, DOI 10.1074/jbc.M106961200; Whitfield C, 1997, MOL MICROBIOL, V23, P629, DOI 10.1046/j.1365-2958.1997.2571614.x; Wosten MMSM, 2000, CELL, V103, P113, DOI 10.1016/S0092-8674(00)00092-1; Wosten MMSM, 1999, J BIOL CHEM, V274, P27185, DOI 10.1074/jbc.274.38.27185; Zhou ZM, 2001, J BIOL CHEM, V276, P43111, DOI 10.1074/jbc.M106960200; Zhou ZM, 1999, J BIOL CHEM, V274, P18503, DOI 10.1074/jbc.274.26.18503; Zhou ZM, 2000, J BIOL CHEM, V275, P13542, DOI 10.1074/jbc.275.18.13542	60	23	24	5	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38778	38789		10.1074/jbc.M112.397414	http://dx.doi.org/10.1074/jbc.M112.397414			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23019341	Green Published, hybrid			2022-12-28	WOS:000310982800035
J	Kotapati, S; Maddukuri, L; Wickramaratne, S; Seneviratne, U; Goggin, M; Pence, MG; Villalta, P; Guengerich, FP; Marnett, L; Tretyakova, N				Kotapati, Srikanth; Maddukuri, Leena; Wickramaratne, Susith; Seneviratne, Uthpala; Goggin, Melissa; Pence, Matthew G.; Villalta, Peter; Guengerich, F. Peter; Marnett, Lawrence; Tretyakova, Natalia			Translesion Synthesis across 1,N-6-(2-Hydroxy-3-hydroxymethylpropan-1,3-diyl)-2 '-deoxyadenosine (1,N-6-gamma-HMHP-dA) Adducts by Human and Archebacterial DNA Polymerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXOCYCLIC DEOXYADENOSINE ADDUCTS; IN-VITRO BYPASS; LESION-BYPASS; Y-FAMILY; 1,2,3,4-DIEPOXYBUTANE SYNTHESIS; CROSS-LINKS; BUTADIENE; O-6-METHYLGUANINE; N-2-ETHYLGUANINE; 1,3-BUTADIENE	The 1,N-6-(2-Hydroxy-3-hydroxymethylpropan-1,3-diyl)-2'-deoxyadenosine (1,N-6-gamma-HMHP-dA) adducts are formed upon bifunctional alkylation of adenine nucleobases in DNA by 1,2,3,4-diepoxybutane, the putative ultimate carcinogenic metabolite of 1,3-butadiene. The presence of a substituted 1,N-6-propano group on 1,N-6-gamma-HMHP-dA is expected to block the Watson-Crick base pairing of the adducted adenine with thymine, potentially contributing to mutagenesis. In this study, the enzymology of replication past site-specific 1,N-6-gamma-HMHP-dA lesions in the presence of human DNA polymerases (hpols) beta, eta, kappa, and iota and archebacterial polymerase Dpo4 was investigated. Run-on gel analysis with all four dNTPs revealed that hpol eta, kappa, and Dpo4 were able to copy the modified template. In contrast, hpol iota inserted a single base opposite 1,N-6-gamma-HMHP-dA but was unable to extend beyond the damaged site, and a complete replication block was observed with hpol beta. Single nucleotide incorporation experiments indicated that although hpol eta, kappa, and Dpo4 incorporated the correct nucleotide (dTMP) opposite the lesion, dGMP and dAMP were inserted with a comparable frequency. HPLC-ESI-MS/MS analysis of primer extension products confirmed the ability of bypass polymerases to insert dTMP, dAMP, or dGMP opposite 1,N-6-gamma-HMHP-dA and detected large amounts of -1 and -2 deletion products. Taken together, these results indicate that hpol eta and kappa enzymes bypass 1,N-6-gamma-HMHP-dA lesions in an error-prone fashion, potentially contributing to A-->T and A-->C transversions and frameshift mutations observed in cells following treatment with 1,2,3,4-diepoxybutane.	[Maddukuri, Leena; Pence, Matthew G.; Guengerich, F. Peter; Marnett, Lawrence] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Maddukuri, Leena; Pence, Matthew G.; Guengerich, F. Peter; Marnett, Lawrence] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Kotapati, Srikanth; Goggin, Melissa; Tretyakova, Natalia] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA; [Wickramaratne, Susith] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Kotapati, Srikanth; Wickramaratne, Susith; Seneviratne, Uthpala; Goggin, Melissa; Villalta, Peter; Tretyakova, Natalia] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA	Vanderbilt University; Vanderbilt University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Marnett, L (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 221 Kirkland Hall, Nashville, TN 37232 USA.	larry.marnett@vanderbilt.edu; trety001@umn.edu	Villalta, Peter W/J-4091-2019; Pence, Matthew/J-1379-2012	Pence, Matthew/0000-0003-2271-789X; Villalta, Peter/0000-0002-0067-3083; Kotapati, Srikanth/0000-0003-2302-5350	National Institutes of Health [CA-100670, ES-010375]; National Institutes of Health from the NCI [~ CA-77598]; NATIONAL CANCER INSTITUTE [P30CA077598, R37CA087819, R01CA100670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010375] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-100670 and ES-010375.; We thank Dr. Michael Stone (Vanderbilt University) for providing recombinant Dpo4 polymerase for these experiments. We are also thankful to Dr. Sarah Shuck (Vanderbilt University) for help with experimental protocols and PAGE experimental setup. HPLC-MS/MS analyses were performed in the Analytical Biochemistry Facility of the Masonic Cancer Center, which is supported in part by National Institutes of Health Grant CA-77598 from the NCI.	Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Burgers PMJ, 2001, J BIOL CHEM, V276, P43487, DOI 10.1074/jbc.R100056200; Carmical JR, 2000, J BIOL CHEM, V275, P19482, DOI 10.1074/jbc.M002037200; Carmical JR, 2000, ENVIRON MOL MUTAGEN, V35, P48, DOI 10.1002/(SICI)1098-2280(2000)35:1<48::AID-EM7>3.3.CO;2-3; Carmical JR, 2000, CHEM RES TOXICOL, V13, P18, DOI 10.1021/tx9901332; Choi JY, 2006, CHEM RES TOXICOL, V19, P879, DOI 10.1021/tx060051v; Choi JY, 2005, J MOL BIOL, V352, P72, DOI 10.1016/j.jmb.2005.06.079; Christov PP, 2009, CHEM RES TOXICOL, V22, P1086, DOI 10.1021/tx900047c; COCHRANE JE, 1994, CARCINOGENESIS, V15, P719, DOI 10.1093/carcin/15.4.719; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; Eoff RL, 2007, J BIOL CHEM, V282, P1456, DOI 10.1074/jbc.M609661200; Eoff RL, 2009, BIOCHEMISTRY-US, V48, P7079, DOI 10.1021/bi9003588; Fiala KA, 2007, J MOL BIOL, V365, P590, DOI 10.1016/j.jmb.2006.10.008; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Goggin M, 2011, CHEM RES TOXICOL, V24, P809, DOI 10.1021/tx200009b; Goggin M, 2010, CHEM RES TOXICOL, V23, P808, DOI 10.1021/tx900439w; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Kanuri M, 2002, CHEM RES TOXICOL, V15, P1572, DOI 10.1021/tx025591g; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Levine RL, 2001, J BIOL CHEM, V276, P18717, DOI 10.1074/jbc.M102158200; Maddukuri L, 2010, BIOCHEMISTRY-US, V49, P8415, DOI 10.1021/bi1009024; Michaelson-Richie ED, 2010, J PROTEOME RES, V9, P4356, DOI 10.1021/pr1000835; Nair Deepak T, 2006, Nat Struct Mol Biol, V13, P619, DOI 10.1038/nsmb1118; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Pence MG, 2010, J BIOL CHEM, V285, P40666, DOI 10.1074/jbc.M110.183665; Pence MG, 2011, DNA REPAIR, V10, P56, DOI 10.1016/j.dnarep.2010.09.007; Pence MG, 2009, J BIOL CHEM, V284, P1732, DOI 10.1074/jbc.M807296200; Perrino FW, 2003, CHEM RES TOXICOL, V16, P1616, DOI 10.1021/tx034164f; Plosky BS, 2004, CURR OPIN GENET DEV, V14, P113, DOI 10.1016/j.gde.2004.02.002; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Prakash S, 2002, GENE DEV, V16, P1872, DOI 10.1101/gad.1009802; Recio L, 2001, CHEM-BIOL INTERACT, V135, P325, DOI 10.1016/S0009-2797(01)00220-4; Seneviratne U, 2010, CHEM RES TOXICOL, V23, P1556, DOI 10.1021/tx100146v; Seneviratne U, 2010, CHEM RES TOXICOL, V23, P118, DOI 10.1021/tx900312e; Steen AM, 1997, MUTAGENESIS, V12, P61, DOI 10.1093/mutage/12.2.61; Swenberg JA, 2011, CHEM-BIOL INTERACT, V192, P150, DOI 10.1016/j.cbi.2010.10.010; Tissier A, 2000, GENE DEV, V14, P1642; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Woodgate R, 1999, GENE DEV, V13, P2191, DOI 10.1101/gad.13.17.2191; Yang W, 2005, FEBS LETT, V579, P868, DOI 10.1016/j.febslet.2004.11.047; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zhang YB, 2000, MOL CELL BIOL, V20, P7099, DOI 10.1128/MCB.20.19.7099-7108.2000	45	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38800	38811		10.1074/jbc.M112.396788	http://dx.doi.org/10.1074/jbc.M112.396788			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22977231	Green Published, hybrid			2022-12-28	WOS:000310982800037
J	Navaratnarajah, CK; Negi, S; Braun, W; Cattaneo, R				Navaratnarajah, Chanakha K.; Negi, Surendra; Braun, Werner; Cattaneo, Roberto			Membrane Fusion Triggering THREE MODULES WITH DIFFERENT STRUCTURE AND FUNCTION IN THE UPPER HALF OF THE MEASLES VIRUS ATTACHMENT PROTEIN STALK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEASLES-VIRUS HEMAGGLUTININ; PARAMYXOVIRUS FUSION; ATTACHMENT PROTEIN; CELL-FUSION; FUNCTIONAL INTERACTION; 4-HELIX BUNDLE; F-PROTEIN; RECEPTOR; STALK; REGION	The measles virus (MV) fusion apparatus consists of a fusion protein and an attachment protein named hemagglutinin (H). After receptor-binding through its cuboidal head, the H-protein transmits the fusion-triggering signal through its stalk to the fusion protein. However, the structural basis of signal transmission is unclear because only structures of H-heads without their stalk have been solved. On the other hand, the entire ectodomain structure of the hemagglutinin-neuraminidase protein of another Paramyxovirus revealed a four-helix bundle stalk. To probe the structure of the 95-residue MV H-stalk we individually substituted head-proximal residues (positions 103-153) with cysteine, and biochemically and functionally characterized the resultant proteins. Our results indicate that most residues in the central segment (positions 103-117) can be cross-linked by engineered disulfide bonds, and thus may be engaged in a tetrameric structure. While covalent tetramerization disrupts fusion triggering function, disulfide bond reduction restores it in most positions except Asp-113. The next stalk segment (residues 123-138) also has high propensity to form covalent tetramers, but since these cross-links have little or no effect on function, it can conduct the fusion-triggering signal while remaining in a stabilized tetrameric configuration. This segment may act as a spacer, maintaining H-heads at an optimal height. Finally, the head-proximal segment (residues 139-154) has very limited propensity to trap tetramers, suggesting bifurcation into two flexible linkers clamped by inter-subunit covalent links formed by natural Cys-139 and Cys-154. We discuss the modular structure of the MV H-stalk in the context of membrane fusion triggering and cell entry by Paramyxoviruses.	[Navaratnarajah, Chanakha K.; Cattaneo, Roberto] Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA; [Navaratnarajah, Chanakha K.; Cattaneo, Roberto] Mayo Grad Sch, Rochester, MN 55905 USA; [Negi, Surendra; Braun, Werner] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Negi, Surendra; Braun, Werner] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA	Mayo Clinic; Mayo Clinic; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Cattaneo, R (corresponding author), Mayo Clin, Dept Mol Med, 200 1st St SW, Rochester, MN 55905 USA.	cattaneo.roberto@mayo.edu	Braun, Werner/A-6642-2012; Navaratnarajah, Chanakha/AAB-6171-2019	Navaratnarajah, Chanakha/0000-0002-4513-8412	National Institutes of Health Grant [R01 CA090636]; NATIONAL CANCER INSTITUTE [R01CA090636] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA090636 (to R. C.).	Ader N, 2012, J BIOL CHEM, V287, P16324, DOI 10.1074/jbc.M112.342493; ALKHATIB G, 1986, VIROLOGY, V150, P479, DOI 10.1016/0042-6822(86)90312-0; [Anonymous], 2011, NATURE, V473, P434; Apte-Sengupta S, 2012, J BIOL CHEM, V287, P33026, DOI 10.1074/jbc.M112.373308; Bose S, 2012, P NATL ACAD SCI USA, V109, pE2625, DOI 10.1073/pnas.1213813109; Bose S, 2011, J VIROL, V85, P12855, DOI 10.1128/JVI.06350-11; Brindley MA, 2010, J VIROL, V84, P12174, DOI 10.1128/JVI.01222-10; Cathomen T, 1995, VIROLOGY, V214, P628, DOI 10.1006/viro.1995.0075; Cathomen T, 1998, J VIROL, V72, P1224, DOI 10.1128/JVI.72.2.1224-1234.1998; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Chang A, 2012, VIRUSES-BASEL, V4, P613, DOI 10.3390/v4040613; DENG RT, 1995, VIROLOGY, V209, P457, DOI 10.1006/viro.1995.1278; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Griffin DE., 2007, FIELDS VIROLOGY, P1551; Hashiguchi T, 2007, P NATL ACAD SCI USA, V104, P19535, DOI 10.1073/pnas.0707830104; Hashiguchi T, 2011, NAT STRUCT MOL BIOL, V18, P135, DOI 10.1038/nsmb.1969; Iorio RM, 2009, FUTURE VIROL, V4, P335, DOI 10.2217/FVL.09.17; Lamb R.A., 2007, FIELDS VIROLOGY, VFifth, P1305; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee B, 2011, TRENDS MICROBIOL, V19, P389, DOI 10.1016/j.tim.2011.03.005; Lee JK, 2008, J BIOL CHEM, V283, P16561, DOI 10.1074/jbc.M801018200; Liljeroos L, 2011, P NATL ACAD SCI USA, V108, P18085, DOI 10.1073/pnas.1105770108; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Mirza AM, 2011, J BIOL CHEM, V286, P17851, DOI 10.1074/jbc.M111.233965; Moss WJ, 2009, CURR TOP MICROBIOL, V330, P173; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Navaratnarajah CK, 2008, J BIOL CHEM, V283, P11763, DOI 10.1074/jbc.M800896200; Navaratnarajah CK, 2012, CURR OPIN VIROL, V2, P43, DOI 10.1016/j.coviro.2011.12.002; Navaratnarajah CK, 2011, NAT STRUCT MOL BIOL, V18, P128, DOI 10.1038/nsmb.1967; NORRBY E, 1971, VIROLOGY, V44, P599, DOI 10.1016/0042-6822(71)90374-6; Paal T, 2009, J VIROL, V83, P10480, DOI 10.1128/JVI.01195-09; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Plemper RK, 2000, J VIROL, V74, P6485, DOI 10.1128/JVI.74.14.6485-6493.2000; Plemper RK, 2001, J BIOL CHEM, V276, P44239, DOI 10.1074/jbc.M105967200; Porotto M, 2012, J VIROL, V86, P5730, DOI 10.1128/JVI.06793-11; RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x; RICHARDSON CD, 1983, VIROLOGY, V131, P518, DOI 10.1016/0042-6822(83)90517-2; Santiago C, 2010, NAT STRUCT MOL BIOL, V17, P124, DOI 10.1038/nsmb.1726; Tanabayashi K, 1996, J VIROL, V70, P6112, DOI 10.1128/JVI.70.9.6112-6118.1996; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; TSURUDOME M, 1995, VIROLOGY, V213, P190, DOI 10.1006/viro.1995.1559; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322; Yuan P, 2011, P NATL ACAD SCI USA, V108, P14920, DOI 10.1073/pnas.1111691108; Zokarkar A, 2012, J VIROL, V86, P2600, DOI 10.1128/JVI.06546-11	44	41	44	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38543	38551		10.1074/jbc.M112.410563	http://dx.doi.org/10.1074/jbc.M112.410563			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23007387	Green Published, hybrid			2022-12-28	WOS:000310982800014
J	Fernandez-Pevida, A; Rodriguez-Galan, O; Diaz-Quintana, A; Kressler, D; de la Cruz, J				Fernandez-Pevida, Antonio; Rodriguez-Galan, Olga; Diaz-Quintana, Antonio; Kressler, Dieter; de la Cruz, Jesus			Yeast Ribosomal Protein L40 Assembles Late into Precursor 60 S Ribosomes and Is Required for Their Cytoplasmic Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPORT; ELONGATION-FACTOR 2; EUKARYOTIC 80S RIBOSOME; SACCHAROMYCES-CEREVISIAE; NUCLEAR EXPORT; INITIATION-FACTOR; CRYSTAL-STRUCTURE; SUBUNIT BIOGENESIS; UBIQUITIN FUSION; ADAPTER PROTEIN	Most ribosomal proteins play important roles in ribosome biogenesis and function. Here, we have examined the contribution of the essential ribosomal protein L40 in these processes in the yeast Saccharomyces cerevisiae. Deletion of either the RPL40A or RPL40B gene and in vivo depletion of L40 impair 60 S ribosomal subunit biogenesis. Polysome profile analyses reveal the accumulation of half-mers and a moderate reduction in free 60 S ribosomal subunits. Pulse-chase, Northern blotting, and primer extension analyses in the L40-depleted strain clearly indicate that L40 is not strictly required for the precursor rRNA (pre-rRNA) processing reactions but contributes to optimal 27 SB pre-rRNA maturation. Moreover, depletion of L40 hinders the nucleo-cytoplasmic export of pre-60 S ribosomal particles. Importantly, all these defects most likely appear as the direct consequence of impaired Nmd3 and Rlp24 release from cytoplasmic pre-60 S ribosomal subunits and their inefficient recycling back into the nucle(ol)us. In agreement, we show that hemagglutinin epitope-tagged L40A assembles in the cytoplasm into almost mature pre-60 S ribosomal particles. Finally, we have identified that the hemagglutinin epitope-tagged L40A confers resistance to sordarin, a translation inhibitor that impairs the function of eukaryotic elongation factor 2, whereas the rpl40a and rpl40b null mutants are hypersensitive to this antibiotic. We conclude that L40 is assembled at a very late stage into pre-60 S ribosomal subunits and that its incorporation into 60 S ribosomal subunits is a prerequisite for subunit joining and may ensure proper functioning of the translocation process.	[de la Cruz, Jesus] Univ Seville, Fac Biol, Dept Genet, E-41012 Seville, Spain; [Diaz-Quintana, Antonio] Univ Seville, Consejo Super Invest Cient, Inst Bioquim Vegetal & Fotosintesis, E-41092 Seville, Spain; [Kressler, Dieter] Univ Fribourg, Biochem Unit, Dept Biol, CH-1700 Fribourg, Switzerland	University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF); University of Fribourg	de la Cruz, J (corresponding author), Univ Seville, Fac Biol, Dept Genet, Avda Reina Mercedes 6, E-41012 Seville, Spain.	jdlcd@us.es	Rodríguez-Galán, Olga/K-5580-2015; DE LA CRUZ, JESUS/A-7309-2013; Kressler, Dieter/C-2218-2012; IBIS, GENICA/O-1906-2015; Díaz-Quintana, Antonio/A-1946-2011	Rodríguez-Galán, Olga/0000-0002-3137-8554; DE LA CRUZ, JESUS/0000-0001-5870-659X; Díaz-Quintana, Antonio/0000-0001-8973-8009; Kressler, Dieter/0000-0003-4855-3563	Spanish Ministry of Science and Innovation; European Regional Development Grant [BFU2010-15690]; Andalusian Government Grant [CVI-271, P08-CVI-03508]; Swiss National Science Foundation [PP00P3_123341]; University of Seville	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Grant; Andalusian Government Grant; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Seville	This work was supported in part by Spanish Ministry of Science and Innovation and European Regional Development Grant BFU2010-15690, Andalusian Government Grant CVI-271, P08-CVI-03508 (to J. d. l. C.), and Swiss National Science Foundation Grant PP00P3_123341 (to D. K.).; Recipient of a fellowship from the University of Seville.	Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19754, DOI 10.1073/pnas.1010005107; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Babiano R, 2012, MOL CELL BIOL, V32, P3228, DOI 10.1128/MCB.00539-12; Babiano R, 2010, NUCLEIC ACIDS RES, V38, P5177, DOI 10.1093/nar/gkq260; Ballesta JPG, 1999, FEMS MICROBIOL REV, V23, P537, DOI 10.1111/j.1574-6976.1999.tb00412.x; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BARONASLOWELL DM, 1990, MOL CELL BIOL, V10, P5235, DOI 10.1128/MCB.10.10.5235; Becam AM, 2001, MOL GENET GENOMICS, V266, P454, DOI 10.1007/s004380100548; Belk JP, 1999, RNA, V5, P1055, DOI 10.1017/S1355838299990027; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Botet J, 2008, ANTIMICROB AGENTS CH, V52, P1623, DOI 10.1128/AAC.01603-07; Bradatsch B, 2007, MOL CELL, V27, P767, DOI 10.1016/j.molcel.2007.06.034; Briones C, 2000, NUCLEIC ACIDS RES, V28, P4497, DOI 10.1093/nar/28.22.4497; Briones E, 1998, J BIOL CHEM, V273, P31956, DOI 10.1074/jbc.273.48.31956; Bussiere C, 2012, J CELL BIOL, V197, P747, DOI 10.1083/jcb.201112131; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Capa L, 1998, ANTIMICROB AGENTS CH, V42, P2694, DOI 10.1128/AAC.42.10.2694; CHAN YL, 1995, BIOCHEM BIOPH RES CO, V215, P682, DOI 10.1006/bbrc.1995.2518; Chandramouli P, 2008, STRUCTURE, V16, P535, DOI 10.1016/j.str.2008.01.007; Dalley JA, 2008, MOL BIOL CELL, V19, P2876, DOI 10.1091/mbc.E07-10-1074; Dez C, 2004, MOL CELL BIOL, V24, P6324, DOI 10.1128/MCB.24.14.6324-6337.2004; Dinman JD, 2009, J BIOL CHEM, V284, P11761, DOI 10.1074/jbc.R800074200; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Dresios J, 2000, BIOCHEMISTRY-US, V39, P7236, DOI 10.1021/bi9925266; Dresios J, 2003, J BIOL CHEM, V278, P3314, DOI 10.1074/jbc.M207533200; EICHLER DC, 1994, PROG NUCLEIC ACID RE, V49, P197; Eisinger DP, 1997, MOL CELL BIOL, V17, P5136, DOI 10.1128/MCB.17.9.5136; Emery B, 2004, MOL MICROBIOL, V52, P141, DOI 10.1111/j.1365-2958.2003.03973.x; Fatica A, 2002, MOL CELL, V9, P341, DOI 10.1016/S1097-2765(02)00458-6; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Fewell SW, 1999, MOL CELL BIOL, V19, P826; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; Frey S, 2001, J BIOL CHEM, V276, P15905, DOI 10.1074/jbc.M009430200; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Gadal O, 2001, EMBO J, V20, P3695, DOI 10.1093/emboj/20.14.3695; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Gartmann M, 2010, J BIOL CHEM, V285, P14848, DOI 10.1074/jbc.C109.096057; Gerbi SA, 2004, MOL BIOL INTELL UNIT, P170; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Gomez-Lorenzo MG, 1998, J BIOL CHEM, V273, P25041, DOI 10.1074/jbc.273.39.25041; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Hackmann A, 2011, EMBO REP, V12, P1024, DOI 10.1038/embor.2011.155; Harnpicharnchai P, 2001, MOL CELL, V8, P505, DOI 10.1016/S1097-2765(01)00344-6; Hedges J, 2005, EMBO J, V24, P567, DOI 10.1038/sj.emboj.7600547; Hedges J, 2006, J BIOL CHEM, V281, P36579, DOI 10.1074/jbc.M606798200; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; Ho JHN, 2000, RNA, V6, P1625, DOI 10.1017/S1355838200001291; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Horiguchi G, 2011, PLANT J, V65, P724, DOI 10.1111/j.1365-313X.2010.04457.x; Hung NJ, 2008, MOL BIOL CELL, V19, P735, DOI 10.1091/mbc.E07-09-0968; Hurt E, 1999, J CELL BIOL, V144, P389, DOI 10.1083/jcb.144.3.389; Garcia-Gomez JJ, 2011, MOL CELL BIOL, V31, P4156, DOI 10.1128/MCB.05436-11; Justice MC, 1999, J BIOL CHEM, V274, P4869, DOI 10.1074/jbc.274.8.4869; Justice MC, 1998, J BIOL CHEM, V273, P3148, DOI 10.1074/jbc.273.6.3148; Kaiser C., 1994, METHODS YEAST GENETI; Kallstrom G, 2003, MOL CELL BIOL, V23, P4344, DOI 10.1128/MCB.23.12.4344-4355.2003; Kapasi P, 2007, MOL CELL, V25, P113, DOI 10.1016/j.molcel.2006.11.028; Kemmler S, 2009, J CELL BIOL, V186, P863, DOI 10.1083/jcb.200904111; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Kressler D, 1998, MOL CELL BIOL, V18, P1855, DOI 10.1128/MCB.18.4.1855; Kressler D, 1997, MOL CELL BIOL, V17, P7283, DOI 10.1128/MCB.17.12.7283; Kressler D, 2008, J CELL BIOL, V181, P935, DOI 10.1083/jcb.200801181; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; KRUISWIJK T, 1978, BIOCHIM BIOPHYS ACTA, V517, P378, DOI 10.1016/0005-2787(78)90204-6; Lacombe T, 2009, MOL MICROBIOL, V72, P69, DOI 10.1111/j.1365-2958.2009.06622.x; LASTICK SM, 1980, EUR J BIOCHEM, V113, P175; Lebreton A, 2006, J CELL BIOL, V173, P349, DOI 10.1083/jcb.200510080; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Lo KY, 2010, MOL CELL, V39, P196, DOI 10.1016/j.molcel.2010.06.018; Lo KY, 2009, J CELL BIOL, V186, P849, DOI 10.1083/jcb.200904110; Mager WH, 1997, NUCLEIC ACIDS RES, V25, P4872, DOI 10.1093/nar/25.24.4872; Martin-Marcos P, 2007, MOL CELL BIOL, V27, P5968, DOI 10.1128/MCB.00019-07; McCoy LS, 2011, WIRES RNA, V2, P209, DOI 10.1002/wrna.60; McIntosh KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023579; MELESE T, 1995, CURR OPIN CELL BIOL, V7, P319, DOI 10.1016/0955-0674(95)80085-9; Menne TF, 2007, NAT GENET, V39, P486, DOI 10.1038/ng1994; Meskauskas A, 2001, RNA, V7, P1084, DOI 10.1017/S1355838201001480; Meskauskas A, 2008, NUCLEIC ACIDS RES, V36, P1826, DOI 10.1093/nar/gkn034; Meskauskas A, 2007, MOL CELL, V25, P877, DOI 10.1016/j.molcel.2007.02.015; Nakao A, 2004, NUCLEIC ACIDS RES, V32, pD168, DOI 10.1093/nar/gkh004; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Nomura M, 2004, MOL BIOL INTELL UNIT, P128; Oeffinger M, 2010, J CELL BIOL, V189, P1071, DOI 10.1083/jcb.201006033; OZKAYNAK E, 1987, EMBO J, V6, P1429, DOI 10.1002/j.1460-2075.1987.tb02384.x; Panse VG, 2010, TRENDS BIOCHEM SCI, V35, P260, DOI 10.1016/j.tibs.2010.01.001; Pertschy B, 2007, MOL CELL BIOL, V27, P6581, DOI 10.1128/MCB.00668-07; PETITJEAN A, 1995, MOL CELL BIOL, V15, P5071; Petrov Alexey, 2004, RNA Biol, V1, P59; Petrov AN, 2008, NUCLEIC ACIDS RES, V36, P6187, DOI 10.1093/nar/gkn643; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poll G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008249; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Rhodin MHJ, 2011, MOL GENET GENOMICS, V285, P505, DOI 10.1007/s00438-011-0623-2; Rodriguez-Mateos M, 2009, NUCLEIC ACIDS RES, V37, P7519, DOI 10.1093/nar/gkp806; Rodriguez-Mateos M, 2009, NUCLEIC ACIDS RES, V37, P3514, DOI 10.1093/nar/gkp209; Rosado IV, 2004, RNA, V10, P1073, DOI 10.1261/rna.7340404; Rosado IV, 2007, MOL CELL BIOL, V27, P1207, DOI 10.1128/MCB.01523-06; Rosado IV, 2007, NUCLEIC ACIDS RES, V35, P4203, DOI 10.1093/nar/gkm388; Sahasranaman A, 2011, EMBO J, V30, P4020, DOI 10.1038/emboj.2011.338; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos C, 2004, ANTIMICROB AGENTS CH, V48, P2930, DOI 10.1128/AAC.48.8.2930-2936.2004; SANTOS C, 1994, J BIOL CHEM, V269, P15689; Saveanu C, 2003, MOL CELL BIOL, V23, P4449, DOI 10.1128/MCB.23.13.4449-4460.2003; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Senger B, 2001, MOL CELL, V8, P1363, DOI 10.1016/S1097-2765(01)00403-8; Sengupta J, 2010, J CELL BIOL, V189, P1079, DOI 10.1083/jcb.201001124; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Stage-Zimmermann T, 2000, MOL BIOL CELL, V11, P3777, DOI 10.1091/mbc.11.11.3777; Steffen KK, 2012, GENETICS, V191, P107, DOI 10.1534/genetics.111.136549; Strunk BS, 2009, RNA, V15, P2083, DOI 10.1261/rna.1792109; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; Ulbrich C, 2009, CELL, V138, P911, DOI 10.1016/j.cell.2009.06.045; Valasek L, 2003, GENE DEV, V17, P786, DOI 10.1101/gad.1065403; Valerio-Santiago M, 2011, J CELL BIOL, V192, P599, DOI 10.1083/jcb.201007044; Venema J, 1998, METH MOL B, V77, P257; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Verschoor A, 1998, NUCLEIC ACIDS RES, V26, P655, DOI 10.1093/nar/26.2.655; Vilardell J, 1997, MOL CELL BIOL, V17, P1959, DOI 10.1128/MCB.17.4.1959; VILELLA MD, 1991, EUR J BIOCHEM, V196, P407, DOI 10.1111/j.1432-1033.1991.tb15831.x; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Wehner KA, 2002, MOL CELL, V9, P329, DOI 10.1016/S1097-2765(02)00438-0; West M, 2005, MOL CELL BIOL, V25, P3802, DOI 10.1128/MCB.25.9.3802-3813.2005; Wilson DN, 2005, CRIT REV BIOCHEM MOL, V40, P243, DOI 10.1080/10409230500256523; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WOOL IG, 1979, ANNU REV BIOCHEM, V48, P719, DOI 10.1146/annurev.bi.48.070179.003443; Wu B, 2008, PROTEIN SCI, V17, P589, DOI 10.1110/ps.073273008; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359; Yao W, 2007, MOL CELL, V26, P51, DOI 10.1016/j.molcel.2007.02.018; Yao YH, 2010, RNA, V16, P1007, DOI 10.1261/rna.2012310; Yonath A, 2005, ANNU REV BIOCHEM, V74, P649, DOI 10.1146/annurev.biochem.74.082803.133130; Zanelli CF, 2006, BIOCHEM BIOPH RES CO, V348, P1358, DOI 10.1016/j.bbrc.2006.07.195; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307	148	36	36	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.400564	http://dx.doi.org/10.1074/jbc.M112.400564			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22995916	Green Published, hybrid			2022-12-28	WOS:000310642200071
J	Suchanowska, A; Kaczmarek, R; Duk, M; Lukasiewicz, J; Smolarek, D; Majorczyk, E; Jaskiewicz, E; Laskowska, A; Wasniowska, K; Grodecka, M; Lisowska, E; Czerwinski, M				Suchanowska, Anna; Kaczmarek, Radoslaw; Duk, Maria; Lukasiewicz, Jolanta; Smolarek, Dorota; Majorczyk, Edyta; Jaskiewicz, Ewa; Laskowska, Anna; Wasniowska, Kazimiera; Grodecka, Magdalena; Lisowska, Elwira; Czerwinski, Marcin			A Single Point Mutation in the Gene Encoding Gb3/CD77 Synthase Causes a Rare Inherited Polyagglutination Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-GALACTOSYL ANTIBODIES; EMBRYONAL CARCINOMA-CELLS; P-PHENOTYPE; NOR PHENOTYPE; ANTI-NOR; EXPRESSION; GLYCOSYLTRANSFERASES; IDENTIFICATION; ERYTHROCYTES; INDIVIDUALS	Rare polyagglutinable NOR erythrocytes contain three unique globoside (Gb4Cer) derivatives, NOR1, NORint, and NOR2, in which Gal(alpha 1-4), GalNAc(beta 1-3)Gal(alpha 1-4), and Gal(alpha 1-4)GalNAc(beta 1-3)Gal(alpha 1-4), respectively, are linked to the terminal GalNAc residue of Gb4Cer. NOR1 and NOR2, which both terminate with a Gal(alpha 1-4)GalNAc- sequence, react with anti-NOR antibodies commonly present in human sera. While searching for an enzyme responsible for the biosynthesis of Gal(alpha 1-4)GalNAc, we identified a mutation in the A4GALT gene encoding Gb3/CD77 synthase (alpha 1,4-galactosyltransferase). Fourteen NOR-positive donors were heterozygous for the C>G mutation at position 631 of the open reading frame of the A4GALT gene, whereas 495 NOR-negative donors were homozygous for C at this position. The enzyme encoded by the mutated gene contains glutamic acid instead of glutamine at position 211 (substitution Q211E). To determine whether this mutation could change the enzyme specificity, we transfected a teratocarcinoma cell line (2102Ep) with vectors encoding the consensus Gb3/CD77 synthase and Gb3/CD77 synthase with Glu at position 211. The cellular glycolipids produced by these cells were analyzed by flow cytometry, high-performance thin-layer chromatography, enzymatic degradation, and MALDI-TOF mass spectrometry. Cells transfected with either vector expressed the P1 blood group antigen, which was absent from untransfected cells. Cells transfected with the vector encoding the Gb3/CD77 synthase with Glu at position 211 expressed both P1 and NOR antigens. Collectively, these results suggest that the C631G mutation alters the acceptor specificity of Gb3/CD77 synthase, rendering it able to catalyze synthesis of the Gal(alpha 1-4)Gal and Gal(alpha 1-4)GalNAc moieties.	[Czerwinski, Marcin] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Dept Immunochem, Lab Glycoconjugate Immunochem, PL-53114 Wroclaw, Poland; [Lukasiewicz, Jolanta] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Lab Microbial Immunochem & Vaccines, PL-53114 Wroclaw, Poland; [Majorczyk, Edyta] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Lab Immunogenet & Tissue Immunol, PL-53114 Wroclaw, Poland; [Laskowska, Anna] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Lab Glycobiol & Cell Interact, PL-53114 Wroclaw, Poland; [Majorczyk, Edyta; Wasniowska, Kazimiera; Czerwinski, Marcin] Opole Univ Technol, Fac Phys Educ & Physiotherapy, Inst Physiotherapy, PL-45758 Opole, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Opole University of Technology	Czerwinski, M (corresponding author), Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Dept Immunochem, Lab Glycoconjugate Immunochem, PL-53114 Wroclaw, Poland.	czerwins@iitd.pan.wroc.pl	Majorczyk, Edyta/P-3066-2019	Majorczyk, Edyta/0000-0001-7248-9544; Wasniowska, Kazimiera/0000-0001-7629-2589; Kaczmarek, Radoslaw/0000-0001-8084-1958; Czerwinski, Marcin/0000-0003-2859-3699; Lukasiewicz, Jolanta/0000-0001-8081-7261	National Science Center of Poland [N N302 662940, N N401 631640]	National Science Center of Poland(National Science Centre, Poland)	This work was supported by National Science Center of Poland Grants N N302 662940 (to M. C.) and N N401 631640 (to A. S.).	Andrews PW, 1996, INT J CANCER, V66, P806, DOI 10.1002/(SICI)1097-0215(19960611)66:6<806::AID-IJC17>3.0.CO;2-0; CHEN C, 1989, BIOCHEMISTRY-US, V28, P2229, DOI 10.1021/bi00431a039; Czerwinski M, 2007, BIOCHEM BIOPH RES CO, V356, P816, DOI 10.1016/j.bbrc.2007.03.054; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Duk M, 2005, GLYCOBIOLOGY, V15, P109, DOI 10.1093/oxfordjournals.glycob.a034964; Duk M, 2003, GLYCOBIOLOGY, V13, P279, DOI 10.1093/glycob/cwg036; DUK M, 1994, ANAL BIOCHEM, V221, P266, DOI 10.1006/abio.1994.1410; Duk M, 2001, J BIOL CHEM, V276, P40574, DOI 10.1074/jbc.M102711200; Duk M, 2007, GLYCOBIOLOGY, V17, P304, DOI 10.1093/glycob/cwl071; Duk M, 2006, TRANSFUSION, V46, P1264, DOI 10.1111/j.1537-2995.2006.00882.x; Furukawa K, 2000, J BIOL CHEM, V275, P37752, DOI 10.1074/jbc.C000625200; HARRIS PA, 1982, VOX SANG, V42, P134, DOI 10.1111/j.1423-0410.1982.tb01083.x; Hassinen A, 2011, J BIOL CHEM, V286, P38329, DOI 10.1074/jbc.M111.277681; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Hellberg A, 2004, BRIT J HAEMATOL, V125, P528, DOI 10.1111/j.1365-2141.2004.04930.x; Hellberg A, 2008, TRANSFUSION, V48, P479, DOI 10.1111/j.1537-2995.2007.01552.x; Iwamura K, 2003, J BIOL CHEM, V278, P44429, DOI 10.1074/jbc.M301609200; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Kusnierz-Alejska G, 1999, TRANSFUSION, V39, P32, DOI 10.1046/j.1537-2995.1999.39199116892.x; Liew CG, 2007, STEM CELLS, V25, P1521, DOI 10.1634/stemcells.2006-0634; Lingwood CA, 2010, CHEM PHYS LIPIDS, V163, P27, DOI 10.1016/j.chemphyslip.2009.09.001; NAIKI M, 1975, BIOCHEMISTRY-US, V14, P4831, DOI 10.1021/bi00693a009; Ramakrishnan B, 2002, J BIOL CHEM, V277, P20833, DOI 10.1074/jbc.M111183200; Ramakrishnan B, 2007, J MOL BIOL, V365, P570, DOI 10.1016/j.jmb.2006.10.034; Sheeley DM, 1998, ANAL CHEM, V70, P3053, DOI 10.1021/ac9713058; SPITALNIK PF, 1995, TRANSFUS MED REV, V9, P110, DOI 10.1016/S0887-7963(05)80050-1; Steffensen R, 2000, J BIOL CHEM, V275, P16723, DOI 10.1074/jbc.M000728200; Storry J R, 2009, Immunohematology, V25, P48; Takematsu H, 2011, J BIOL CHEM, V286, P27214, DOI 10.1074/jbc.M111.234526; Thuresson B, 2011, BLOOD, V117, P678, DOI 10.1182/blood-2010-08-301333; Varki A., 1999, ESSENTIALS GLYCOBIOL, P6; WENK J, 1994, INT J CANCER, V58, P108, DOI 10.1002/ijc.2910580118; Yazer MH, 2006, TRANSFUS MED REV, V20, P207, DOI 10.1016/j.tmrv.2006.03.002	33	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.408286	http://dx.doi.org/10.1074/jbc.M112.408286			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22965229	Green Published, hybrid			2022-12-28	WOS:000310642200055
J	Lee, CL; Lam, EYF; Lam, KKW; Koistinen, H; Seppala, M; Ng, EHY; Yeung, WSB; Chiu, PCN				Lee, Cheuk-Lun; Lam, Eve Y. F.; Lam, Kevin K. W.; Koistinen, Hannu; Seppala, Markku; Ng, Ernest H. Y.; Yeung, William S. B.; Chiu, Philip C. N.			Glycodelin-A Stimulates Interleukin-6 Secretion by Human Monocytes and Macrophages through L-selectin and the Extracellular Signal-regulated Kinase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZONA PELLUCIDA BINDING; NATURAL-KILLER-CELLS; PLACENTAL PROTEIN-14; GENE-EXPRESSION; DENDRITIC CELLS; ENDOMETRIAL PROTEIN; ADHESION MOLECULES; CUMULUS-OOPHORUS; AMNIOTIC-FLUID; IMMUNE CELL	Macrophages represent the second major type of decidual leukocytes at the fetomaternal interface. Changes in macrophage number and activity are associated with fetal loss and pregnancy complications. Glycodelin-A (GdA) is an abundant glycoprotein in the first-trimester decidua. It is involved in fetomaternal defense and early placental development through its regulatory activities in various immune cells. The N-glycosylation of GdA mediates the binding and therefore the activities of the molecule. In this study, we studied the biological activities of GdA in the functions of human monocytes/macrophages. GdA was purified from amniotic fluid by affinity chromatography. GdA treatment did not affect the viability, cell death, or phagocytic activity of the monocytes/macrophages. GdA, but not recombinant glycodelin without glycosylation, induced IL-6 production as demonstrated by cytokine array, intracellular staining, and ELISA. GdA also induced phosphorylation of ERK in monocytes/macrophages. The involvement of ERKs in IL-6 induction was confirmed using pharmacological inhibitors. Co-immunoprecipitation showed that L-selectin on the monocytes/macrophages was the binding protein of GdA. Treatment with anti-L-selectin antibody reduced GdA binding and GdA-induced IL-6 production. GdA-treated macrophages suppressed IFN-gamma expression by co-cultured T-helper cells in an IL-6-dependent manner. These results show that GdA interacts with L-selectin to induce IL-6 production in monocytes/macrophages by activating the ERK signaling pathway. In turn, the increased IL-6 production suppresses IFN-gamma expression in T-helper cells, which may play an important role in inducing a Th-2-polarized cytokine environment that flavors the immunotolerance of the fetoplacental unit.	[Lee, Cheuk-Lun; Lam, Eve Y. F.; Lam, Kevin K. W.; Ng, Ernest H. Y.; Yeung, William S. B.; Chiu, Philip C. N.] Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Lee, Cheuk-Lun; Yeung, William S. B.; Chiu, Philip C. N.] Univ Hong Kong, Ctr Reprod Dev & Growth, Hong Kong, Hong Kong, Peoples R China; [Koistinen, Hannu; Seppala, Markku] Univ Helsinki, Cent Hosp, Dept Clin Chem, Helsinki 00014, Finland; [Koistinen, Hannu; Seppala, Markku] Univ Helsinki, FIN-00014 Helsinki, Finland	University of Hong Kong; University of Hong Kong; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Chiu, PCN (corresponding author), Univ Hong Kong, Dept Obstet & Gynaecol, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	pchiucn@hku.hk	Chiu, Chi Ngong/C-4245-2009; Seppala, Markku/AAT-6618-2021; Lee, Cheuk Lun/AGX-5720-2022; Koistinen, Hannu/AGU-1279-2022	Chiu, Chi Ngong/0000-0001-6217-1970; Koistinen, Hannu/0000-0003-0926-3109; Lee, Cheuk Lun/0000-0003-1553-3478; Ng, Ernest/0000-0002-7688-4557	University of Hong Kong [201007176033]; Hong Kong Research Grant Council [HKU774212]; Helsinki University; Academy of Finland	University of Hong Kong(University of Hong Kong); Hong Kong Research Grant Council(Hong Kong Research Grants Council); Helsinki University; Academy of Finland(Academy of Finland)	This work was supported in part by University of Hong Kong Grant 201007176033, Hong Kong Research Grant Council Grant HKU774212, the Helsinki University Central Hospital Research Fund, and the Academy of Finland.	Alok A, 2009, INT J BIOCHEM CELL B, V41, P1138, DOI 10.1016/j.biocel.2008.10.009; Breckpot K, 2004, HUM GENE THER, V15, P562, DOI 10.1089/104303404323142015; Brenner B, 1996, P NATL ACAD SCI USA, V93, P15376, DOI 10.1073/pnas.93.26.15376; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Chiu PCN, 2007, J BIOL CHEM, V282, P5378, DOI 10.1074/jbc.M607482200; Chiu PCN, 2007, J CELL SCI, V120, P33, DOI 10.1242/jcs.03258; Chiu PCN, 2010, HUM REPROD, V25, P2721, DOI 10.1093/humrep/deq243; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Crockett-Torabi E, 1998, J LEUKOCYTE BIOL, V63, P1; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Dimitriadis E, 2005, HUM REPROD UPDATE, V11, P613, DOI 10.1093/humupd/dmi023; Dominguez F, 2008, MOL HUM REPROD, V14, P423, DOI 10.1093/molehr/gan032; DUCLOS AJ, 1995, AM J REPROD IMMUNOL, V33, P354, DOI 10.1111/j.1600-0897.1995.tb00904.x; Grailer JJ, 2009, J DERMATOL SCI, V56, P141, DOI 10.1016/j.jdermsci.2009.10.001; Hashimoto S, 1999, BLOOD, V94, P837, DOI 10.1182/blood.V94.3.837.413k02_837_844; Haugen TS, 1999, RESPIRATION, V66, P528, DOI 10.1159/000029430; Houser BL, 2011, J IMMUNOL, V186, P2633, DOI 10.4049/jimmunol.1003153; Jauniaux E, 1996, MOL HUM REPROD, V2, P239, DOI 10.1093/molehr/2.4.239; Juliano RL, 2002, ANNU REV PHARMACOL, V42, P283, DOI 10.1146/annurev.pharmtox.42.090401.151133; Kim JH, 2009, OSTEOARTHR CARTILAGE, V17, P1662, DOI 10.1016/j.joca.2009.06.004; Kohro Takahide, 2004, J Atheroscler Thromb, V11, P88; Laird SM, 2003, HUM REPROD UPDATE, V9, P163, DOI 10.1093/humupd/dmg013; LAIRD SM, 1994, HUM REPROD, V9, P1339, DOI 10.1093/oxfordjournals.humrep.a138706; Lam KKW, 2011, J BIOL CHEM, V286, P37118, DOI 10.1074/jbc.M111.233841; Lam KKW, 2009, HUM REPROD, V24, P2093, DOI 10.1093/humrep/dep205; LAUDANNA C, 1994, J BIOL CHEM, V269, P4021; Lee CL, 2011, J REPROD IMMUNOL, V90, P29, DOI 10.1016/j.jri.2011.04.007; Lee CL, 2011, HUM REPROD, V26, P517, DOI 10.1093/humrep/deq381; Lee CL, 2011, DIABETES, V60, P909, DOI 10.2337/db10-1186; Lee CL, 2010, FERTIL STERIL, V94, P769, DOI 10.1016/j.fertnstert.2009.10.009; Lee CL, 2009, J BIOL CHEM, V284, P15084, DOI 10.1074/jbc.M807960200; Lehtonen A, 2007, J LEUKOCYTE BIOL, V82, P710, DOI 10.1189/jlb.0307194; Li CL, 2009, P NATL ACAD SCI USA, V106, P5767, DOI 10.1073/pnas.0901173106; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Link A, 1997, CLIN HEMORHEOL MICRO, V17, P175; MACKENNA A, 1993, FERTIL STERIL, V59, P577; Martinez E, 1996, BONE MARROW TRANSPL, V18, P1; Meisser A, 1999, MOL HUM REPROD, V5, P1055, DOI 10.1093/molehr/5.11.1055; Mishan-Eisenberg G, 2004, J IMMUNOL, V173, P5524, DOI 10.4049/jimmunol.173.9.5524; Mor Gil, 2003, Reprod Biol Endocrinol, V1, P119, DOI 10.1186/1477-7827-1-119; Mukhopadhyay D, 2001, J BIOL CHEM, V276, P28268, DOI 10.1074/jbc.M010487200; Murphy SP, 2009, BIOL REPROD, V80, P848, DOI 10.1095/biolreprod.108.073353; NISHINO E, 1990, J CLIN ENDOCR METAB, V71, P436, DOI 10.1210/jcem-71-2-436; Olsnes C, 2011, SCAND J IMMUNOL, V74, P114, DOI 10.1111/j.1365-3083.2011.02555.x; Patel KD, 2002, SEMIN IMMUNOL, V14, P73, DOI 10.1006/smim.2001.0344; Piccinni MP, 2007, GYNECOL OBSTET INVES, V64, P144, DOI 10.1159/000101738; Po JL, 1995, BIOCHEM BIOPH RES CO, V217, P1145, DOI 10.1006/bbrc.1995.2888; Poornima BL, 2007, FEBS LETT, V581, P4366, DOI 10.1016/j.febslet.2007.07.078; PRIETO J, 1994, CELL IMMUNOL, V156, P191, DOI 10.1006/cimm.1994.1164; Rachmilewitz J, 2003, J BIOL CHEM, V278, P14059, DOI 10.1074/jbc.M211716200; Renaud SJ, 2008, IMMUNOL INVEST, V37, P535, DOI 10.1080/08820130802191375; RIITTINEN L, 1989, CLIN CHIM ACTA, V184, P19, DOI 10.1016/0009-8981(89)90253-2; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Scholz C, 2008, AM J REPROD IMMUNOL, V60, P501, DOI 10.1111/j.1600-0897.2008.00647.x; Seppala M, 2007, HUM REPROD UPDATE, V13, P275, DOI 10.1093/humupd/dmm004; Seppala M, 2002, ENDOCR REV, V23, P401, DOI 10.1210/er.2001-0026; SILVER RM, 1993, AM J OBSTET GYNECOL, V169, P1101, DOI 10.1016/0002-9378(93)90263-I; Smith SD, 2009, AM J PATHOL, V174, P1959, DOI 10.2353/ajpath.2009.080995; Smolen JE, 2000, J BIOL CHEM, V275, P15876, DOI 10.1074/jbc.M906232199; So KH, 2012, REPROD BIOMED ONLINE, V24, P639, DOI 10.1016/j.rbmo.2012.03.004; Tee MK, 2008, J LEUKOCYTE BIOL, V83, P843, DOI 10.1189/jlb.0406291; TSENG SS, 1977, J ORG CHEM, V42, P3645, DOI 10.1021/jo00443a002; ULEVITCH RJ, 1993, ADV IMMUNOL, V53, P267, DOI 10.1016/S0065-2776(08)60502-7; Varki A., 2009, ESSENTIALS GLYCOBIOL; Vellenga E, 1999, BRIT J PHARMACOL, V127, P441, DOI 10.1038/sj.bjp.0702577; Vigne JL, 2001, J BIOL CHEM, V276, P17101, DOI 10.1074/jbc.M010451200; WADDELL TK, 1995, J BIOL CHEM, V270, P15403, DOI 10.1074/jbc.270.25.15403; Yaniv E, 2003, CELL IMMUNOL, V222, P156, DOI 10.1016/S0008-8749(03)00129-1; Yeung WSB, 2009, J REPROD IMMUNOL, V83, P26, DOI 10.1016/j.jri.2009.04.012; Zhao S, 2008, PLACENTA, V29, P1024, DOI 10.1016/j.placenta.2008.09.011	71	24	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36999	37009		10.1074/jbc.M112.385336	http://dx.doi.org/10.1074/jbc.M112.385336			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22977256	hybrid, Green Published			2022-12-28	WOS:000310588500035
J	Rezende, LF; Santos, GJ; Carneiro, EM; Boschero, AC				Rezende, Luiz F.; Santos, Gustavo J.; Carneiro, Everardo M.; Boschero, Antonio C.			Ciliary Neurotrophic Factor Protects Mice Against Streptozotocin-induced Type 1 Diabetes through SOCS3 THE ROLE OF STAT1/STAT3 RATIO IN beta-CELL DEATH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT PANCREATIC-ISLETS; CYTOKINE SIGNALING-3; INSULIN-RESISTANCE; BODY-WEIGHT; STAT1 GENE; SUPPRESSOR; CNTF; EXPRESSION; APOPTOSIS; PATHWAY	Type 1 diabetes is characterized by a loss of islet beta-cells. Ciliary neurotrophic factor (CNTF) protects pancreatic islets against cytokine-induced apoptosis. For this reason, we assessed whether CNTF protects mice against streptozotocin-induced diabetes (a model of type 1 diabetes) and the mechanism for this protection. WT and SOCS3 knockdown C57BL6 mice were treated for 5 days with citrate buffer or 0.1 mg/kg CNTF before receiving 80 mg/kg streptozotocin. Glycemia in non-fasted mice was measured weekly from days 0-28 after streptozotocin administration. Diabetes was defined as a blood glucose > 11.2 mmol/liter. Wild-type (WT) and SOCS3 knockdown MIN6 cells were cultured with CNTF, IL1 beta, or both. CNTF reduced diabetes incidence and islet apoptosis in WT but not in SOCS3kd mice. Likewise, CNTF inhibited apoptosis in WT but not in SOCS3kd MIN6 cells. CNTF increased STAT3 phosphorylation in WT and SOCS3kd mice and MIN6 cells but reduced STAT1 phosphorylation only in WT mice, in contrast to streptozotocin and IL1 beta. Moreover, CNTF reduced NF kappa B activation and required down-regulation of inducible NO synthase expression to exert its protective effects. In conclusion, CNTF protects mice against streptozotocin-induced diabetes by increasing pancreatic islet survival, and this protection depends on SOCS3. In addition, SOCS3 expression and beta-cell fate are dependent on STAT1/STAT3 ratio.	[Rezende, Luiz F.; Santos, Gustavo J.; Carneiro, Everardo M.; Boschero, Antonio C.] State Univ Campinas UNICAMP, Dept Struct & Funct Biol, Inst Biol, BR-13083865 Campinas, SP, Brazil	Universidade Estadual de Campinas	Rezende, LF (corresponding author), State Univ Campinas UNICAMP, Dept Struct & Funct Biol, Inst Biol, POB 6109, BR-13083865 Campinas, SP, Brazil.	luizbio@gmail.com	Carneiro, Everardo/D-4758-2012; Santos, Gustavo/L-6419-2013; Boschero, Antonio/O-7525-2014	Santos, Gustavo/0000-0001-9135-7184; Boschero, Antonio/0000-0003-3829-8570	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Instituto Nacional de Obesidade e Diabetes	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Obesidade e Diabetes	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, and Instituto Nacional de Obesidade e Diabetes.	Ahima RS, 2006, NAT MED, V12, P511, DOI 10.1038/nm0506-511; Bluher S, 2004, DIABETES, V53, P2787, DOI 10.2337/diabetes.53.11.2787; Borjesson A, 2011, IMMUNOL LETT, V136, P74, DOI 10.1016/j.imlet.2010.12.007; Cardozo AK, 2001, J BIOL CHEM, V276, P48879, DOI 10.1074/jbc.M108658200; Chandra J, 2001, DIABETES, V50, pS44, DOI 10.2337/diabetes.50.2007.S44; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Del Prato S, 2004, DIABETES OBES METAB, V6, P319; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Ettinger MP, 2003, JAMA-J AM MED ASSOC, V289, P1826, DOI 10.1001/jama.289.14.1826; Fasler-Kan E, 2010, BRAIN RES, V1354, P15, DOI 10.1016/j.brainres.2010.07.077; Flodstrom M, 1999, DIABETES, V48, P706, DOI 10.2337/diabetes.48.4.706; Gysemans CA, 2005, DIABETES, V54, P2396, DOI 10.2337/diabetes.54.8.2396; Hong F, 2002, J CLIN INVEST, V110, P1503, DOI 10.1172/JCI200215841; Jiang JJ, 2003, J GENE MED, V5, P977, DOI 10.1002/jgm.433; Karlsen AE, 2004, DIABETOLOGIA, V47, P1998, DOI 10.1007/s00125-004-1568-3; Karlsen AE, 2001, P NATL ACAD SCI USA, V98, P12191, DOI 10.1073/pnas.211445998; Kim JY, 2010, CELL SIGNAL, V22, P1669, DOI 10.1016/j.cellsig.2010.06.007; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Laubner K, 2005, DIABETES, V54, P3410, DOI 10.2337/diabetes.54.12.3410; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lindberg K, 2005, J MOL ENDOCRINOL, V35, P231, DOI 10.1677/jme.1.01840; Liu QS, 2007, BASIC CLIN PHARMACOL, V101, P78, DOI 10.1111/j.1742-7843.2007.00092.x; Mandrup-Poulsen T, 2003, ANN NY ACAD SCI, V1005, P32, DOI 10.1196/annals.1288.005; Matthews VB, 2008, J MOL MED-JMM, V86, P353, DOI 10.1007/s00109-007-0286-y; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Moore F, 2011, J BIOL CHEM, V286, P929, DOI 10.1074/jbc.M110.162131; Mori H, 2007, BIOCHEM BIOPH RES CO, V359, P952, DOI 10.1016/j.bbrc.2007.05.198; Nakata M, 2007, BIOCHEM BIOPH RES CO, V353, P1046, DOI 10.1016/j.bbrc.2006.12.134; Norkina O, 2008, ALCOHOL CLIN EXP RES, V32, P1565, DOI 10.1111/j.1530-0277.2008.00726.x; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; Rajan P, 1996, J NEUROSCI RES, V43, P403, DOI 10.1002/(SICI)1097-4547(19960215)43:4<403::AID-JNR2>3.0.CO;2-J; Rezende ACS, 2008, BRAZ J MED BIOL RES, V41, P1024, DOI 10.1590/S0100-879X2008005000052; Rezende LF, 2012, DIABETOLOGIA, V55, P1495, DOI 10.1007/s00125-012-2493-5; Rezende LF, 2007, J ENDOCRINOL, V195, P157, DOI 10.1677/JOE-07-0016; Rezende LF, 2009, CYTOKINE, V46, P65, DOI 10.1016/j.cyto.2008.12.014; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Rink JS, 2012, SURGERY, V151, P330, DOI 10.1016/j.surg.2011.07.011; Ronn SG, 2008, DIABETOLOGIA, V51, P1873, DOI 10.1007/s00125-008-1090-0; Santos GJ, 2011, CELL SIGNAL, V23, P1669, DOI 10.1016/j.cellsig.2011.06.001; Sleeman M W, 2000, Pharm Acta Helv, V74, P265, DOI 10.1016/S0031-6865(99)00050-3; Sleeman MW, 2003, P NATL ACAD SCI USA, V100, P14297, DOI 10.1073/pnas.2335926100; Steinberg GR, 2009, DIABETES, V58, P829, DOI 10.2337/db08-0659; Stephanou A, 2005, GROWTH FACTORS, V23, P177, DOI 10.1080/08977190500178745; STOCKLI KA, 1991, J CELL BIOL, V115, P447, DOI 10.1083/jcb.115.2.447; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Wadt KAW, 1998, DIABETES, V47, P1602, DOI 10.2337/diabetes.47.10.1602; Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383; WINTER CG, 1995, P NATL ACAD SCI USA, V92, P5865, DOI 10.1073/pnas.92.13.5865; Wormald S, 2004, J BIOL CHEM, V279, P821, DOI 10.1074/jbc.R300030200; Yasuda H, 2009, DIABETES RES CLIN PR, V83, P200, DOI 10.1016/j.diabres.2008.11.029	51	13	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41628	41639		10.1074/jbc.M112.358788	http://dx.doi.org/10.1074/jbc.M112.358788			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23038263	Green Published, hybrid			2022-12-28	WOS:000312103000007
J	Blumenthal, R; Durell, S; Viard, M				Blumenthal, Robert; Durell, Stewart; Viard, Mathias			HIV Entry and Envelope Glycoprotein-mediated Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; VIRAL MEMBRANE-FUSION; GP41 CYTOPLASMIC TAIL; INFLUENZA HEMAGGLUTININ; CELL-FUSION; T-CELLS; GP120 CORE; CONFORMATIONAL-CHANGES; TYPE-1 VIRIONS; PORE FORMATION	HIV entry involves binding of the trimeric viral envelope glycoprotein (Env) gp120/gp41 to cell surface receptors, which triggers conformational changes in Env that drive the membrane fusion reaction. The conformational landscape that the lipids and Env navigate en route to fusion has been examined by biophysical measurements on the microscale, whereas electron tomography, x-rays, and NMR have provided insights into the process on the nanoscale and atomic scale. However, the coupling between the lipid and protein pathways that give rise to fusion has not been resolved. Here, we discuss the known and unknown about the overall HIV Env-mediated fusion process.	[Blumenthal, Robert; Viard, Mathias] NCI, Nanobiol Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Durell, Stewart] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Viard, Mathias] SAIC Frederick Inc, Basic Sci Program, CCRNP, Frederick Natl Lab, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Blumenthal, R (corresponding author), NCI, Nanobiol Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA.	blumenthalr@mail.nih.gov			National Institutes of Health from NCI [HHSN261200800001E]; National Institutes of Health Intramural Research Program of NCI, Center for Cancer Research, Frederick National Lab; National Institutes of Health Intramural AIDS Targeted Antiviral Program (IATAP); NIAID Intramural Biodefense Research Program; NATIONAL CANCER INSTITUTE [ZIABC008303] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health Intramural Research Program of NCI, Center for Cancer Research, Frederick National Lab; National Institutes of Health Intramural AIDS Targeted Antiviral Program (IATAP)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID Intramural Biodefense Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This was supported, in whole or in part, by National Institutes of Health Contract HHSN261200800001E from NCI; the National Institutes of Health Intramural Research Program of NCI, Center for Cancer Research, Frederick National Lab; and grants from the National Institutes of Health Intramural AIDS Targeted Antiviral Program (IATAP) and the NIAID Intramural Biodefense Research Program. This is the first article in the Thematic Minireview Series on Understanding Human Immunodeficiency Virus-Host Interactions at the Biochemical Level.	Ashkenazi A, 2011, FASEB J, V25, P2156, DOI 10.1096/fj.10-175752; Bar S, 2004, J VIROL, V78, P811, DOI 10.1128/JVI.78.2.811-820.2004; Barrero-Villar M, 2009, J CELL SCI, V122, P103, DOI 10.1242/jcs.035873; Berger EA, 1997, AIDS, V11, pS3; Blumenthal R, 2003, CHEM REV, V103, P53, DOI 10.1021/cr000036+; Blumenthal R, 2002, CHEM PHYS LIPIDS, V116, P39, DOI 10.1016/S0009-3084(02)00019-1; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Cavrois M, 2004, VIROLOGY, V328, P36, DOI 10.1016/j.virol.2004.07.015; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; Chien MP, 2008, FASEB J, V22, P1179, DOI 10.1096/fj.07-9576com; CLAVEL F, 1994, J VIROL, V68, P1179, DOI 10.1128/JVI.68.2.1179-1185.1994; Daecke J, 2005, J VIROL, V79, P1581, DOI 10.1128/JVI.79.3.1581-1594.2005; Dale BM, 2011, CELL HOST MICROBE, V10, P551, DOI 10.1016/j.chom.2011.10.015; Dimitrov AS, 2007, BIOCHEMISTRY-US, V46, P1398, DOI 10.1021/bi062245f; Dimitrov AS, 2005, BIOCHEMISTRY-US, V44, P12471, DOI 10.1021/bi051092d; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Dobrowsky TM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000855; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Esser MT, 2001, J VIROL, V75, P6173, DOI 10.1128/JVI.75.13.6173-6182.2001; Felts RL, 2010, P NATL ACAD SCI USA, V107, P13336, DOI 10.1073/pnas.1003040107; Finnegan CM, 2007, J VIROL, V81, P5294, DOI 10.1128/JVI.02553-06; Finnegan CM, 2006, ANTIVIR RES, V69, P116, DOI 10.1016/j.antiviral.2005.11.002; Finnegan CM, 2004, P NATL ACAD SCI USA, V101, P15452, DOI 10.1073/pnas.0402874101; Finnegan CM, 2002, J VIROL, V76, P12123, DOI 10.1128/JVI.76.23.12123-12134.2002; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Garcia-Exposito L, 2011, MOL BIOL CELL, V22, P1148, DOI 10.1091/mbc.E10-08-0722; Garg H, 2007, J BIOL CHEM, V282, P16899, DOI 10.1074/jbc.M701701200; Garg H, 2011, CURR TOP MED CHEM, V11, P2947, DOI 10.2174/156802611798808479; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gordon-Alonso M, 2012, MOL BIOL CELL, V23, P2253, DOI 10.1091/mbc.E11-12-1003; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; Harmon B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000956; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; HUANG MJ, 1995, J VIROL, V69, P6810, DOI 10.1128/JVI.69.11.6810-6818.1995; Iyengar S, 1998, J VIROL, V72, P5251, DOI 10.1128/JVI.72.6.5251-5255.1998; Jacobs A, 2007, J BIOL CHEM, V282, P32406, DOI 10.1074/jbc.M705577200; Jimenez-Baranda S, 2007, NAT CELL BIOL, V9, P838, DOI 10.1038/ncb1610; Jones PLS, 1998, J BIOL CHEM, V273, P404, DOI 10.1074/jbc.273.1.404; Karatekin E, 2003, BIOPHYS J, V84, P1734, DOI 10.1016/S0006-3495(03)74981-9; KEMBLE GW, 1994, CELL, V76, P383, DOI 10.1016/0092-8674(94)90344-1; Klasse PJ, 2007, VIROLOGY, V369, P245, DOI 10.1016/j.virol.2007.06.044; Kliger Y, 2001, J BIOL CHEM, V276, P1391, DOI 10.1074/jbc.M004113200; Kozlov MM, 1998, BIOPHYS J, V75, P1384, DOI 10.1016/S0006-3495(98)74056-1; Kozlov MM, 2002, TRAFFIC, V3, P256, DOI 10.1034/j.1600-0854.2002.030403.x; Kozlovsky Y, 2002, BIOPHYS J, V82, P882, DOI 10.1016/S0006-3495(02)75450-7; Kuzmin PI, 2001, P NATL ACAD SCI USA, V98, P7235, DOI 10.1073/pnas.121191898; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Lai AL, 2012, J MOL BIOL, V418, P3, DOI 10.1016/j.jmb.2012.02.010; Lai WH, 2011, AIDS RES HUM RETROV, V27, P1013, DOI [10.1089/AID.2010.0259, 10.1089/aid.2010.0259]; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Lorizate M, 2009, J BIOL CHEM, V284, P22238, DOI 10.1074/jbc.M109.029256; LOWY RJ, 1995, EXP CELL RES, V216, P411, DOI 10.1006/excr.1995.1052; LOWY RJ, 1990, P NATL ACAD SCI USA, V87, P1850, DOI 10.1073/pnas.87.5.1850; Magnus C, 2009, J VIROL, V83, P1523, DOI 10.1128/JVI.01764-08; Markosyan RM, 2003, MOL BIOL CELL, V14, P926, DOI 10.1091/mbc.E02-09-0573; Markosyan RM, 2005, MOL BIOL CELL, V16, P5502, DOI 10.1091/mbc.E05-06-0496; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Melikyan GB, 1997, J CELL BIOL, V136, P995, DOI 10.1083/jcb.136.5.995; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Munoz-Barroso I, 1998, J CELL BIOL, V140, P315, DOI 10.1083/jcb.140.2.315; Munoz-Barroso I, 1999, J VIROL, V73, P6089; Pace MJ, 2011, J VIROL, V85, P644, DOI 10.1128/JVI.01851-10; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Raviv Y, 2002, VIROLOGY, V293, P243, DOI 10.1006/viro.2001.1237; Rawat SS, 2004, J VIROL, V78, P7360, DOI 10.1128/JVI.78.14.7360-7368.2004; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Richard JP, 2011, BIOCHEM J, V440, P185, DOI 10.1042/BJ20111243; Schaeffer E, 2004, J VIROL, V78, P1375, DOI 10.1128/JVI.78.3.1375-1383.2004; Sougrat R, 2007, PLOS PATHOG, V3, P571, DOI 10.1371/journal.ppat.0030063; Takenawa T, 2010, P JPN ACAD B-PHYS, V86, P509, DOI 10.2183/pjab.86.509; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; Trubey CM, 2003, J VIROL, V77, P12699, DOI 10.1128/JVI.77.23.12699-12709.2003; Ugolini S, 1999, TRENDS MICROBIOL, V7, P144, DOI 10.1016/S0966-842X(99)01474-2; Viard M, 2002, J VIROL, V76, P11584, DOI 10.1128/JVI.76.22.11584-11595.2002; Viard M, 2008, BIOCHEMISTRY-US, V47, P1977, DOI 10.1021/bi701920f; Vieira CR, 2010, CHEM BIOL, V17, P766, DOI 10.1016/j.chembiol.2010.05.023; Vorster PJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182238; WALKER BD, 1987, P NATL ACAD SCI USA, V84, P8120, DOI 10.1073/pnas.84.22.8120; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; White TA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001249; WILLEY RL, 1988, P NATL ACAD SCI USA, V85, P9580, DOI 10.1073/pnas.85.24.9580; Wyss S, 2005, J VIROL, V79, P12231, DOI 10.1128/JVI.79.19.12231-12241.2005; Yang L, 2002, SCIENCE, V297, P1877, DOI 10.1126/science.1074354; Yang XZ, 2005, J VIROL, V79, P12132, DOI 10.1128/JVI.79.19.12132-12147.2005; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Yu DY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000633; ZIMMERBERG J, 1994, J CELL BIOL, V127, P1885, DOI 10.1083/jcb.127.6.1885	100	150	152	0	66	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					40841	40849		10.1074/jbc.R112.406272	http://dx.doi.org/10.1074/jbc.R112.406272			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23043104	Green Published, hybrid			2022-12-28	WOS:000311887600002
J	Gil, JE; Kim, E; Kim, IS; Ku, B; Park, WS; Oh, BH; Ryu, SH; Cho, W; Heo, WD				Gil, Jung-Eun; Kim, Eui; Kim, Il-Shin; Ku, Bonsu; Park, Wei Sun; Oh, Byung-Ha; Ryu, Sung Ho; Cho, Wonhwa; Heo, Won Do			Phosphoinositides Differentially Regulate Protrudin Localization through the FYVE Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-PHOSPHATE; MEMBRANE TRAFFICKING; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; EARLY ENDOSOME; LIVING CELLS; PROTEIN; BINDING; 4,5-BISPHOSPHATE; RECOGNITION	Protrudin is a FYVE (Fab 1, YOTB, Vac 1, and EEA1) domain-containing protein involved in transport of neuronal cargoes and implicated in the onset of hereditary spastic paraplegia. Our image-based screening of the lipid binding domain library revealed novel plasma membrane localization of the FYVE domain of protrudin unlike canonical FYVE domains that are localized to early endosomes. The membrane binding study by surface plasmon resonance analysis showed that this FYVE domain preferentially binds phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2), phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P-2), and phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P-3) unlike canonical FYVE domains that specifically bind phosphatidylinositol 3-phosphate (PtdIns(3) P). Furthermore, we found that these phosphoinositides (PtdInsP) differentially regulate shuttling of protrudin between endosomes and plasma membrane via its FYVE domain. Protrudin mutants with reduced PtdInsP-binding affinity failed to promote neurite outgrowth in primary cultured hippocampal neurons. These results suggest that novel PtdInsP selectivity of the protrudin-FYVE domain is critical for its cellular localization and its role in neurite outgrowth.	[Gil, Jung-Eun; Ku, Bonsu; Park, Wei Sun; Oh, Byung-Ha; Heo, Won Do] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Heo, Won Do] Korea Adv Inst Sci & Technol, KAIST Inst BioCentury KIB, Taejon 305701, South Korea; [Heo, Won Do] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol WCU, Taejon 305701, South Korea; [Kim, Il-Shin; Ryu, Sung Ho] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, Kyungbook, South Korea; [Kim, Eui; Cho, Wonhwa] Pohang Univ Sci & Technol, Div Integrat Biosci & Bioengn, Pohang 790784, Kyungbook, South Korea; [Cho, Wonhwa] Univ Illinois, Dept Chem, Chicago, IL 60607 USA	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cho, W (corresponding author), Univ Illinois, Dept Chem MC 111, 845 W Taylor St, Chicago, IL 60607 USA.	wcho@uic.edu; wdheo@kaist.ac.kr	Heo, Won-Do/C-1696-2011; Oh, Byung-Ha/C-2061-2011	Ryu, Sung Ho/0000-0003-0913-3048; Ku, Bonsu/0000-0003-1784-8975	Ministry of Health & Welfare, Republic of Korea [A101204]	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea Grant A101204.	Ananthanarayanan B, 2003, J BIOL CHEM, V278, P46886, DOI 10.1074/jbc.M307853200; Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946; Blatner NR, 2007, EMBO J, V26, P3709, DOI 10.1038/sj.emboj.7601800; Blatner NR, 2004, J BIOL CHEM, V279, P53818, DOI 10.1074/jbc.M408408200; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; Corvera S, 1999, CURR OPIN CELL BIOL, V11, P460, DOI 10.1016/S0955-0674(99)80066-0; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DINITTO JP, 2003, SCI STKE, pRE16, DOI DOI 10.1126/STKE.2132003RE16; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Estrada L, 2001, HUM MOL GENET, V10, P485, DOI 10.1093/hmg/10.5.485; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gaullier JM, 2000, J BIOL CHEM, V275, P24595, DOI 10.1074/jbc.M906554199; Gillooly DJ, 2001, BIOCHEM J, V355, P249, DOI 10.1042/0264-6021:3550249; Heo WD, 2003, CELL, V113, P315; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Komatsu T, 2010, NAT METHODS, V7, P206, DOI [10.1038/nmeth.1428, 10.1038/NMETH.1428]; Kutateladze T, 2001, SCIENCE, V291, P1793, DOI 10.1126/science.291.5509.1793; Kutateladze TG, 2006, BBA-MOL CELL BIOL L, V1761, P868, DOI 10.1016/j.bbalip.2006.03.011; Lawe DC, 2000, J BIOL CHEM, V275, P3699, DOI 10.1074/jbc.275.5.3699; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Manna D, 2007, J BIOL CHEM, V282, P32093, DOI 10.1074/jbc.M703517200; Mannan AU, 2006, AM J HUM GENET, V79, P351, DOI 10.1086/504927; Mao YX, 2000, CELL, V100, P447, DOI 10.1016/S0092-8674(00)80680-7; Maroun CR, 2003, MOL BIOL CELL, V14, P1691, DOI 10.1091/mbc.E02-06-0352; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; Matsuzaki F, 2011, MOL BIOL CELL, V22, P4602, DOI 10.1091/mbc.E11-01-0068; Misra S, 2001, CELL, V107, P559, DOI 10.1016/S0092-8674(01)00594-3; Misra S, 1999, CELL, V97, P657, DOI 10.1016/S0092-8674(00)80776-X; Miura S, 2000, MOL CELL BIOL, V20, P9346, DOI 10.1128/MCB.20.24.9346-9355.2000; Murray JT, 2002, TRAFFIC, V3, P416, DOI 10.1034/j.1600-0854.2002.30605.x; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Pantakani DVK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029584; Park WS, 2008, MOL CELL, V30, P381, DOI 10.1016/j.molcel.2008.04.008; Patki V, 1998, NATURE, V394, P433, DOI 10.1038/28771; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Quinn KV, 2008, J PHYSIOL-LONDON, V586, P2855, DOI 10.1113/jphysiol.2008.153791; Ridley SH, 2001, J CELL SCI, V114, P3991; Saita S, 2009, J BIOL CHEM, V284, P13766, DOI 10.1074/jbc.M807938200; Seet LF, 2001, J BIOL CHEM, V276, P42445, DOI 10.1074/jbc.M105917200; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; TOKER A, 1995, J BIOL CHEM, V270, P29525, DOI 10.1074/jbc.270.49.29525; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yu M, 2006, J IMMUNOL, V176, P2421, DOI 10.4049/jimmunol.176.4.2421	52	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41268	41276		10.1074/jbc.M112.419127	http://dx.doi.org/10.1074/jbc.M112.419127			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23043110	hybrid, Green Published			2022-12-28	WOS:000311887600041
J	Hargreaves, VV; Putnam, CD; Kolodner, RD				Hargreaves, Victoria V.; Putnam, Christopher D.; Kolodner, Richard D.			Engineered Disulfide-forming Amino Acid Substitutions Interfere with a Conformational Change in the Mismatch Recognition Complex Msh2-Msh6 Required for Mismatch Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE MSH2-MSH6; ESCHERICHIA-COLI MUTS; DNA MISMATCH; COLORECTAL-CANCER; MISPAIR-BINDING; ATP HYDROLYSIS; TRANSLOCATION MECHANISM; BIOCHEMICAL-ANALYSIS; CRYSTAL-STRUCTURES; PROTEIN MUTS	ATP binding causes the mispair-bound Msh2-Msh6 mismatch recognition complex to slide along the DNA away from the mismatch, and ATP is required for the mispair-dependent interaction between Msh2-Msh6 and Mlh1-Pms1. It has been inferred from these observations that ATP induces conformational changes in Msh2-Msh6; however, the nature of these conformational changes and their requirement in mismatch repair are poorly understood. Here we show that ATP induces a conformational change within the C-terminal region of Msh6 that protects the trypsin cleavage site after Msh6 residue Arg(1124). An engineered disulfide bond within this region prevented the ATP-driven conformational change and resulted in an Msh2-Msh6 complex that bound mispaired bases but could not form sliding clamps or bind Mlh1-Pms1. The engineered disulfide bond also reduced mismatch repair efficiency in vivo, indicating that this ATP-driven conformational change plays a role in mismatch repair.	[Kolodner, Richard D.] Moores Univ Calif San Diego, Ctr Canc, Ludwig Inst Canc Res, Dept Med, La Jolla, CA 92093 USA; Moores Univ Calif San Diego, Ctr Canc, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Inst Genom Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Kolodner, RD (corresponding author), Moores Univ Calif San Diego, Ctr Canc, Ludwig Inst Canc Res, Dept Med, La Jolla, CA 92093 USA.	rkolodner@ucsd.edu	Classen, Scott/AAY-8176-2020	Putnam, Christopher/0000-0002-6145-1265	National Institutes of Health [GM50006, CA092584]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM50006 and CA092584.	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Alani E, 2003, J BIOL CHEM, V278, P16088, DOI 10.1074/jbc.M213193200; Alani E, 1997, MOL CELL BIOL, V17, P2436, DOI 10.1128/MCB.17.5.2436; Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; Amin NS, 2001, MOL CELL BIOL, V21, P5142, DOI 10.1128/MCB.21.15.5142-5155.2001; Antony E, 2003, BIOCHEMISTRY-US, V42, P7682, DOI 10.1021/bi034602h; Biswas I, 2001, J MOL BIOL, V305, P805, DOI 10.1006/jmbi.2000.4367; Blackwell LJ, 2001, J BIOL CHEM, V276, P33233, DOI 10.1074/jbc.M105076200; Blackwell LJ, 1998, J BIOL CHEM, V273, P32055, DOI 10.1074/jbc.273.48.32055; Bruns CM, 1999, J MOL BIOL, V288, P427, DOI 10.1006/jmbi.1999.2697; Das Gupta R, 2000, NAT GENET, V24, P53, DOI 10.1038/71684; DeLano W.L, PYMOL MOL GRAPHICS S; Flores-Rozas H, 1998, P NATL ACAD SCI USA, V95, P12404, DOI 10.1073/pnas.95.21.12404; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; Gupta S, 2012, NAT STRUCT MOL BIOL, V19, P72, DOI 10.1038/nsmb.2175; HABER LT, 1991, EMBO J, V10, P2707, DOI 10.1002/j.1460-2075.1991.tb07815.x; Hall MC, 1999, J BIOL CHEM, V274, P1306, DOI 10.1074/jbc.274.3.1306; Hargreaves VV, 2010, J BIOL CHEM, V285, P9301, DOI 10.1074/jbc.M109.096388; Heinen CD, 2011, J BIOL CHEM, V286, P40287, DOI 10.1074/jbc.M111.297523; Hess MT, 2002, J BIOL CHEM, V277, P25545, DOI 10.1074/jbc.M202282200; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2000, STRUCTURE, V8, pR237, DOI 10.1016/S0969-2126(00)00545-1; Huang ME, 2005, MOL CELL, V17, P709, DOI 10.1016/j.molcel.2005.02.008; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, CELL, V126, P239, DOI 10.1016/j.cell.2006.07.003; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lamers MH, 2004, J BIOL CHEM, V279, P43879, DOI 10.1074/jbc.M406380200; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Lopez-Mirabal HR, 2008, BBA-MOL CELL RES, V1783, P629, DOI 10.1016/j.bbamcr.2007.10.013; Lundgren Deborah H, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1303s28; Lynch HT, 1999, J MED GENET, V36, P801; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Marsischky GT, 1999, J BIOL CHEM, V274, P26668, DOI 10.1074/jbc.274.38.26668; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; Marti TM, 2002, J CELL PHYSIOL, V191, P28, DOI 10.1002/jcp.10077; Mazur DJ, 2006, MOL CELL, V22, P39, DOI 10.1016/j.molcel.2006.02.010; Mendillo ML, 2007, J BIOL CHEM, V282, P16345, DOI 10.1074/jbc.M700858200; Mendillo ML, 2010, J BIOL CHEM, V285, P13170, DOI 10.1074/jbc.M110.108894; Mendillo ML, 2009, P NATL ACAD SCI USA, V106, P22223, DOI 10.1073/pnas.0912250106; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Natrajan G, 2003, NUCLEIC ACIDS RES, V31, P4814, DOI 10.1093/nar/gkg677; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Peltomaki P, 2003, J CLIN ONCOL, V21, P1174, DOI 10.1200/JCO.2003.04.060; Qiu RY, 2012, EMBO J, V31, P2528, DOI 10.1038/emboj.2012.95; Raschle M, 1999, J BIOL CHEM, V274, P32368, DOI 10.1074/jbc.274.45.32368; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Selmane T, 2003, J MOL BIOL, V334, P949, DOI 10.1016/j.jmb.2003.10.010; Shell SS, 2007, P NATL ACAD SCI USA, V104, P10956, DOI 10.1073/pnas.0704148104; Studamire B, 1998, MOL CELL BIOL, V18, P7590, DOI 10.1128/MCB.18.12.7590; SU SS, 1986, P NATL ACAD SCI USA, V83, P5057, DOI 10.1073/pnas.83.14.5057; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; WELSH KM, 1987, J BIOL CHEM, V262, P15624; Wheeler JMD, 2000, GUT, V47, P148, DOI 10.1136/gut.47.1.148; Wilson T, 1999, J BIOL CHEM, V274, P21659, DOI 10.1074/jbc.274.31.21659; Winkler I, 2011, J BIOL CHEM, V286, P17326, DOI 10.1074/jbc.M110.187641	60	11	11	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41232	41244		10.1074/jbc.M112.402495	http://dx.doi.org/10.1074/jbc.M112.402495			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23045530	hybrid, Green Published			2022-12-28	WOS:000311887600038
J	Hollands, A; Gonzalez, D; Leire, E; Donald, C; Gallo, RL; Sanderson-Smith, M; Dorrestein, PC; Nizet, V				Hollands, Andrew; Gonzalez, David; Leire, Emma; Donald, Cortny; Gallo, Richard L.; Sanderson-Smith, Martina; Dorrestein, Pieter C.; Nizet, Victor			A Bacterial Pathogen Co-opts Host Plasmin to Resist Killing by Cathelicidin Antimicrobial Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; EXPRESSION; VIRULENCE; PROTECTS; STAPHYLOKINASE; INHIBITOR; INDUCTION; SKIN	The bacterial pathogen Group A Streptococcus (GAS) colonizes epithelial and mucosal surfaces and can cause a broad spectrum of human disease. Through the secreted plasminogen activator streptokinase (Ska), GAS activates human plasminogen into plasmin and binds it to the bacterial surface. The resulting surface plasmin protease activity has been proposed to play a role in disrupting tissue barriers, promoting invasive spread of the bacterium. We investigated whether this surface protease activity could aid the immune evasion role through degradation of the key innate antimicrobial peptide LL-37, the human cathelicidin. Cleavage products of plasmin-degraded LL-37 were analyzed by matrix-assisted laser desorption ionization mass spectrometry. Ska-deficient GAS strains were generated by targeted allelic exchange mutagenesis and confirmed to lack surface plasmin activity after growth in human plasma or media supplemented with plasminogen and fibrinogen. Loss of surface plasmin activity left GAS unable to efficiently degrade LL-37 and increased bacterial susceptibility to killing by the antimicrobial peptide. When mice infected with GAS were simultaneously treated with the plasmin inhibitor aprotinin, a significant reduction in the size of necrotic skin lesions was observed. Together these data reveal a novel immune evasion strategy of the human pathogen: co-opting the activity of a host protease to evade peptide-based innate host defenses.	[Nizet, Victor] Univ Calif San Diego, Div Pediat Pharmacol & Drug Discovery, Dept Pediat, La Jolla, CA 92093 USA; [Dorrestein, Pieter C.; Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Gallo, Richard L.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Donald, Cortny; Sanderson-Smith, Martina] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia; [Donald, Cortny; Sanderson-Smith, Martina] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Wollongong; University of Wollongong	Nizet, V (corresponding author), Univ Calif San Diego, Div Pediat Pharmacol & Drug Discovery, Dept Pediat, 9500 Gilman Dr,Mail Code 0687, La Jolla, CA 92093 USA.	vnizet@ucsd.edu	Nizet, Victor/AAF-3190-2019; Sanderson-Smith, Martina L/H-9614-2013; Gallo, Richard L/A-8931-2009; Dorrestein, Pieter/ABF-2930-2020; Sanderson-Smith, Martina/O-9387-2019; Leire, Emma/B-8026-2016	Sanderson-Smith, Martina L/0000-0002-6366-4993; Gallo, Richard L/0000-0002-1401-7861; Leire, Emma/0000-0001-9161-0442; Nizet, Victor/0000-0003-3847-0422	National Institutes of Health [AI077780, AI052453, AR052728]; National Health and Medical Research Council of Australia (NHMRC) [635218]; NHMRC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077780, R01AI052453, R37AI052453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI077780 (to V.N.), AI052453 (to R. L. G. and V.N.), and AR052728 (to R. L. G. and V.N.). This work was also supported by National Health and Medical Research Council of Australia (NHMRC) Grant 635218 (to M. S.).; The recipient of a Career development fellowship from the NHMRC.	Bergman P, 2006, INFECT IMMUN, V74, P6982, DOI 10.1128/IAI.01043-06; Braff MH, 2007, J INFECT DIS, V195, P1365, DOI 10.1086/513277; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Cole JN, 2010, MBIO, V1, DOI 10.1128/mBio.00191-10; Collen D, 1999, THROMB HAEMOSTASIS, V82, P259; Dorschner RA, 2001, J INVEST DERMATOL, V117, P91, DOI 10.1046/j.1523-1747.2001.01340.x; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Gryllos I, 2008, P NATL ACAD SCI USA, V105, P16755, DOI 10.1073/pnas.0803815105; Hollands A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004102; Jin T, 2004, J IMMUNOL, V172, P1169, DOI 10.4049/jimmunol.172.2.1169; Lauth X, 2009, J INNATE IMMUN, V1, P202, DOI 10.1159/000203645; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Lottenberg Richard, 1994, Trends in Microbiology, V2, P20, DOI 10.1016/0966-842X(94)90340-9; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Parry MAA, 2000, TRENDS BIOCHEM SCI, V25, P53, DOI 10.1016/S0968-0004(99)01521-2; Pence MA, 2010, J INNATE IMMUN, V2, P587, DOI 10.1159/000317672; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; Sanderson-Smith ML, 2008, FASEB J, V22, P2715, DOI 10.1096/fj.07-105643; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Sun HM, 2012, P NATL ACAD SCI USA, V109, P3469, DOI 10.1073/pnas.1201031109; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006; Yamasaki K, 2006, FASEB J, V20, P2068, DOI 10.1096/fj.06-6075com; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147	28	32	33	1	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					40891	40897		10.1074/jbc.M112.404582	http://dx.doi.org/10.1074/jbc.M112.404582			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23038245	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000311887600008
J	Krishnan, L; Engelman, A				Krishnan, Lavanya; Engelman, Alan			Retroviral Integrase Proteins and HIV-1 DNA Integration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SMALL-MOLECULE INHIBITORS; STRAND-TRANSFER; VIRAL-DNA; IN-VITRO; HUMAN GENOME; ACTIVE-SITE; PREINTEGRATION COMPLEXES; NUCLEOPROTEIN COMPLEXES; FUNCTIONAL DOMAINS; CHROMATIN-BINDING	Retroviral integrases catalyze two reactions, 3'-processing of viral DNA ends, followed by integration of the processed ends into chromosomal DNA. X-ray crystal structures of integrase-DNA complexes from prototype foamy virus, a member of the Spumavirus genus of Retroviridae, have revealed the structural basis of integration and how clinically relevant integrase strand transfer inhibitors work. Underscoring the translational potential of targeting virus-host interactions, small molecules that bind at the host factor lens epithelium-derived growth factor/p75-binding site on HIV-1 integrase promote dimerization and inhibit integrase-viral DNA assembly and catalysis. Here, we review recent advances in our knowledge of HIV-1 DNA integration, as well as future research directions.	[Engelman, Alan] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Engelman, A (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02215 USA.	alan_engelman@dfci.harvard.edu			National Institutes of Health [AI039394, AI070042]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI039394, R01AI070042, R01AI039394] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI039394 and AI070042. This is the third article in the Thematic Minireview Series on Understanding Human Immunodeficiency Virus-Host Interactions at the Biochemical Level.	Bao KK, 2003, J BIOL CHEM, V278, P1323, DOI 10.1074/jbc.C200550200; Bera S, 2009, J MOL BIOL, V389, P183, DOI 10.1016/j.jmb.2009.04.007; Bojja RS, 2011, J BIOL CHEM, V286, P17047, DOI 10.1074/jbc.M110.212571; BOWERMAN B, 1989, GENE DEV, V3, P469, DOI 10.1101/gad.3.4.469; Brown HEV, 1999, J VIROL, V73, P9011, DOI 10.1128/JVI.73.11.9011-9020.1999; BROWN PO, 1989, P NATL ACAD SCI USA, V86, P2525, DOI 10.1073/pnas.86.8.2525; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; BUSHMAN FD, 1991, P NATL ACAD SCI USA, V88, P1339, DOI 10.1073/pnas.88.4.1339; Busschots K, 2005, J BIOL CHEM, V280, P17841, DOI 10.1074/jbc.M411681200; Carteau S, 1999, J VIROL, V73, P6670, DOI 10.1128/JVI.73.8.6670-6679.1999; Chaconas G, 1999, BIOCHEM CELL BIOL, V77, P487, DOI 10.1139/bcb-77-6-487; Chen HM, 1999, J BIOL CHEM, V274, P17358, DOI 10.1074/jbc.274.24.17358; CHEN JW, 1992, CELL, V69, P647, DOI 10.1016/0092-8674(92)90228-5; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Christ F, 2012, ANTIMICROB AGENTS CH, V56, P4365, DOI 10.1128/AAC.00717-12; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Cooper DA, 2008, NEW ENGL J MED, V359, P355, DOI 10.1056/NEJMoa0708978; CRAIGIE R, 1991, NUCLEIC ACIDS RES, V19, P2729, DOI 10.1093/nar/19.10.2729; De Rijck J, 2010, NUCLEIC ACIDS RES, V38, P6135, DOI 10.1093/nar/gkq410; Delelis O, 2008, J BIOL CHEM, V283, P27838, DOI 10.1074/jbc.M803257200; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; ENGELMAN A, 1993, EMBO J, V12, P3269, DOI 10.1002/j.1460-2075.1993.tb05996.x; ENGELMAN A, 1992, J VIROL, V66, P6361, DOI 10.1128/JVI.66.11.6361-6369.1992; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Engelman A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000046; Farnet CM, 1996, P NATL ACAD SCI USA, V93, P9742, DOI 10.1073/pnas.93.18.9742; Fassati A, 2001, J VIROL, V75, P3626, DOI 10.1128/JVI.75.8.3626-3635.2001; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; Fenwick CW, 2011, ANTIVIR THER, V16, pA9; FUJIWARA T, 1988, CELL, V54, P497, DOI 10.1016/0092-8674(88)90071-2; Grobler JA, 2009, ANTIVIR THER, V14, pA27; Grobler JA, 2002, P NATL ACAD SCI USA, V99, P6661, DOI 10.1073/pnas.092056199; Guiot E, 2006, J BIOL CHEM, V281, P22707, DOI 10.1074/jbc.M602198200; Hare S, 2012, EMBO J, V31, P3020, DOI 10.1038/emboj.2012.118; Hare S, 2011, MOL PHARMACOL, V80, P565, DOI 10.1124/mol.111.073189; Hare S, 2010, P NATL ACAD SCI USA, V107, P20057, DOI 10.1073/pnas.1010246107; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000515; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000259; Hazuda DJ, 1997, J VIROL, V71, P7005, DOI 10.1128/JVI.71.9.7005-7011.1997; HAZUDA DJ, 1994, NUCLEIC ACIDS RES, V22, P1121, DOI 10.1093/nar/22.6.1121; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Hightower KE, 2011, ANTIMICROB AGENTS CH, V55, P4552, DOI 10.1128/AAC.00157-11; Jonsson CB, 1996, J VIROL, V70, P4585, DOI 10.1128/JVI.70.7.4585-4597.1996; Kessl JJ, 2012, J BIOL CHEM, V287, P16801, DOI 10.1074/jbc.M112.354373; Kessl JJ, 2011, NUCLEIC ACIDS RES, V39, P9009, DOI 10.1093/nar/gkr581; Kotova S, 2010, J MOL BIOL, V399, P491, DOI 10.1016/j.jmb.2010.04.026; Krishnan L, 2010, P NATL ACAD SCI USA, V107, P15910, DOI 10.1073/pnas.1002346107; KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Li M, 2005, J BIOL CHEM, V280, P29334, DOI 10.1074/jbc.M505367200; Li XA, 2011, VIROLOGY, V411, P194, DOI 10.1016/j.virol.2010.12.008; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Llano M, 2006, J MOL BIOL, V360, P760, DOI 10.1016/j.jmb.2006.04.073; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; Masuda T, 1998, J VIROL, V72, P8396, DOI 10.1128/JVI.72.10.8396-8402.1998; Michel F, 2009, EMBO J, V28, P980, DOI 10.1038/emboj.2009.41; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; MIZUUCHI K, 1991, CELL, V66, P129, DOI 10.1016/0092-8674(91)90145-O; MIZUUCHI K, 1992, J BIOL CHEM, V267, P21273; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Nowotny M, 2009, EMBO REP, V10, P144, DOI 10.1038/embor.2008.256; Oh J, 2006, J VIROL, V80, P451, DOI 10.1128/JVI.80.1.451-459.2006; Oh J, 2006, J VIROL, V80, P10281, DOI 10.1128/JVI.00361-06; PAHL A, 1995, J BIOL CHEM, V270, P2957, DOI 10.1074/jbc.270.7.2957; Pandey KK, 2007, J VIROL, V81, P3969, DOI 10.1128/JVI.02322-06; Pandey KK, 2011, BIOCHEMISTRY-US, V50, P9788, DOI 10.1021/bi201247f; Poeschla EM, 2008, CELL MOL LIFE SCI, V65, P1403, DOI 10.1007/s00018-008-7540-5; Pradeepa MM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002717; Quashie PK, 2012, J VIROL, V86, P2696, DOI 10.1128/JVI.06591-11; Raghavendra NK, 2007, VIROLOGY, V360, P1, DOI 10.1016/j.virol.2006.12.022; RICHET E, 1986, CELL, V46, P1011, DOI 10.1016/0092-8674(86)90700-2; ROTH MJ, 1989, CELL, V58, P47, DOI 10.1016/0092-8674(89)90401-7; Savilahti H, 1996, CELL, V85, P271, DOI 10.1016/S0092-8674(00)81103-4; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; SHERMAN PA, 1990, P NATL ACAD SCI USA, V87, P5119, DOI 10.1073/pnas.87.13.5119; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Shun MC, 2008, J VIROL, V82, P11555, DOI 10.1128/JVI.01561-08; Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z; Swanson PC, 2001, MOL CELL BIOL, V21, P449, DOI 10.1128/MCB.21.2.449-458.2001; Tsiang M, 2012, J BIOL CHEM, V287, P21189, DOI 10.1074/jbc.M112.347534; Turlure F, 2006, NUCLEIC ACIDS RES, V34, P1653, DOI 10.1093/nar/gkl052; Turlure F, 2004, FRONT BIOSCI-LANDMRK, V9, P3187, DOI 10.2741/1472; Valkov E, 2009, NUCLEIC ACIDS RES, V37, P243, DOI 10.1093/nar/gkn938; Van Maele B, 2006, TRENDS BIOCHEM SCI, V31, P98, DOI 10.1016/j.tibs.2005.12.002; Vandekerckhove L, 2006, J VIROL, V80, P1886, DOI 10.1128/JVI.80.4.1886-1896.2006; VANGENT DC, 1993, EMBO J, V12, P3261, DOI 10.1002/j.1460-2075.1993.tb05995.x; VANGENT DC, 1991, NUCLEIC ACIDS RES, V19, P3821, DOI 10.1093/nar/19.14.3821; VINK C, 1994, NUCLEIC ACIDS RES, V22, P2176, DOI 10.1093/nar/22.11.2176; Wei SQ, 1997, EMBO J, V16, P7511, DOI 10.1093/emboj/16.24.7511; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Yu SF, 1996, SCIENCE, V271, P1579, DOI 10.1126/science.271.5255.1579; Yuan YW, 2011, P NATL ACAD SCI USA, V108, P7884, DOI 10.1073/pnas.1104208108	100	73	73	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					40858	40866		10.1074/jbc.R112.397760	http://dx.doi.org/10.1074/jbc.R112.397760			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23043109	Green Published, hybrid			2022-12-28	WOS:000311887600004
J	Lien, CF; Mohanta, SK; Frontczak-Baniewicz, M; Swinny, JD; Zablocka, B; Gorecki, DC				Lien, Chun Fu; Mohanta, Sarajo Kumar; Frontczak-Baniewicz, Malgorzata; Swinny, Jerome D.; Zablocka, Barbara; Gorecki, Dariusz C.			Absence of Glial alpha-Dystrobrevin Causes Abnormalities of the Blood-Brain Barrier and Progressive Brain Edema	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSTROPHIC MDX MICE; CELLS IN-VITRO; ENDOTHELIAL-CELLS; SYNTROPHIN-BINDING; POTASSIUM CHANNEL; BETA-DYSTROBREVIN; EXPRESSION; PROTEIN; MOUSE; WATER	The blood-brain barrier (BBB) plays a key role in maintaining brain functionality. Although mammalian BBB is formed by endothelial cells, its function requires interactions between endotheliocytes and glia. To understand the molecular mechanisms involved in these interactions is currently a major challenge. We show here that alpha-dystrobrevin (alpha-DB), a protein contributing to dystrophin-associated protein scaffolds in astrocytic endfeet, is essential for the formation and functioning of BBB. The absence of alpha-DB in null brains resulted in abnormal brain capillary permeability, progressively escalating brain edema, and damage of the neurovascular unit. Analyses in situ and in two-dimensional and three-dimensional in vitro models of BBB containing alpha-DB-null astrocytes demonstrated these abnormalities to be associated with loss of aquaporin-4 water and Kir4.1 potassium channels from glial endfeet, formation of intracellular vacuoles in alpha-DB-null astrocytes, and defects of the astrocyte-endothelial interactions. These caused deregulation of tight junction proteins in the endothelia. Importantly, alpha-DB but not dystrophins showed continuous expression throughout development in BBB models. Thus, alpha-DB emerges as a central organizer of dystrophin-associated protein in glial endfeet and a rare example of a glial protein with a role in maintaining BBB function. Its abnormalities might therefore lead to BBB dysfunction.	[Lien, Chun Fu; Mohanta, Sarajo Kumar; Swinny, Jerome D.; Gorecki, Dariusz C.] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England; [Zablocka, Barbara] Mossakowski Med Res Ctr, Mol Biol Unit, PL-02106 Warsaw, Poland	University of Portsmouth; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences	Gorecki, DC (corresponding author), Univ Portsmouth, Sch Pharm & Biomed Sci, St Michaels Bldg,White Swan Rd, Portsmouth PO1 2DT, Hants, England.	darek.gorecki@port.ac.uk	Mohanta, Sarajo/L-1355-2019; Mohanta, Sarajo K/J-5441-2015	Mohanta, Sarajo/0000-0001-6144-4092; Mohanta, Sarajo K/0000-0001-6144-4092; Zablocka, Barbara/0000-0003-3116-7295; Gorecki, Dariusz/0000-0003-3584-1654; Swinny, Jerome/0000-0002-8194-5481	European Union (EU)	European Union (EU)(CGIAREuropean Commission)	This work was supported in part by European Union (EU) Interreg AdMiN and TC2N grants (to D. C. G.).	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Al Ahmad A, 2011, J CEREBR BLOOD F MET, V31, P693, DOI 10.1038/jcbfm.2010.148; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Amiry-Moghaddam M, 2004, NEUROSCIENCE, V129, P999, DOI 10.1016/j.neuroscience.2004.08.049; Banerjee S, 2007, ANNU REV NEUROSCI, V30, P235, DOI 10.1146/annurev.neuro.30.051606.094345; Blake DJ, 1998, P NATL ACAD SCI USA, V95, P241, DOI 10.1073/pnas.95.1.241; Bloch Orin, 2007, Neurosurg Focus, V22, pE3; Bohm SV, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-85; Bragg AD, 2006, GLIA, V53, P879, DOI 10.1002/glia.20347; Bragg AD, 2010, NEUROREPORT, V21, P695, DOI 10.1097/WNR.0b013e32833b0a3b; Brown RC, 2007, BRAIN RES, V1130, P17, DOI 10.1016/j.brainres.2006.10.083; Chow J, 2001, DEV BRAIN RES, V130, P123, DOI 10.1016/S0165-3806(01)00220-6; Connors NC, 2004, J BIOL CHEM, V279, P28387, DOI 10.1074/jbc.M402604200; Crocker SJ, 2008, GLIA, V56, P1187, DOI 10.1002/glia.20689; del Zoppo GJ, 2006, ARTERIOSCL THROM VAS, V26, P1966, DOI 10.1161/01.ATV.0000232525.65682.a2; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034; Grabner R, 2009, J EXP MED, V206, P233, DOI 10.1084/jem.20080752; Guadagno E, 2004, GLIA, V47, P138, DOI 10.1002/glia.20039; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; Haj-Yasein NN, 2011, P NATL ACAD SCI USA, V108, P17815, DOI 10.1073/pnas.1110655108; Hartmann C, 2007, EXP CELL RES, V313, P1318, DOI 10.1016/j.yexcr.2007.01.024; Haseloff RF, 2005, CELL MOL NEUROBIOL, V25, P25, DOI 10.1007/s10571-004-1375-x; Hazai D, 2008, BRAIN RES, V1201, P52, DOI 10.1016/j.brainres.2008.01.046; Imamura M, 1998, P NATL ACAD SCI USA, V95, P6139, DOI 10.1073/pnas.95.11.6139; Liebner S, 2005, BLOOD BRAIN BARRIER, P1; Lien CF, 2004, GENE EXPR PATTERNS, V4, P583, DOI 10.1016/j.modgep.2004.01.015; Lien CF, 2007, CELL TISSUE RES, V327, P67, DOI 10.1007/s00441-006-0241-1; Lien CF, 2012, BIOMACROMOLECULES, V13, P1067, DOI 10.1021/bm201790s; Marriott DR, 1995, NEURAL CELL CULTURE, P85; Mathiisen TM, 2010, GLIA, V58, P1094, DOI 10.1002/glia.20990; Ment LR, 1997, IN VITRO CELL DEV-AN, V33, P684; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198; Newey SE, 2000, CURR BIOL, V10, P1295, DOI 10.1016/S0960-9822(00)00760-0; Newey SE, 2001, J BIOL CHEM, V276, P6645, DOI 10.1074/jbc.M008305200; Nico B, 2005, CURR NEUROVASC RES, V2, P47, DOI 10.2174/1567202052773481; Nico B, 2004, NEUROSCIENCE, V125, P921, DOI 10.1016/j.neuroscience.2004.02.008; Nico B, 2003, GLIA, V42, P235, DOI 10.1002/glia.10216; Noel G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017559; Peters MF, 1997, J BIOL CHEM, V272, P31561, DOI 10.1074/jbc.272.50.31561; Rees MLJ, 2007, NEUROMUSCULAR DISORD, V17, P123, DOI 10.1016/j.nmd.2006.11.003; Reichenbach A, 2007, GRAEF ARCH CLIN EXP, V245, P627, DOI 10.1007/s00417-006-0516-y; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Saura J, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-26; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Sorbo JG, 2008, BIOCHEMISTRY-US, V47, P2631, DOI 10.1021/bi702146k; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Vajda Z, 2002, P NATL ACAD SCI USA, V99, P13131, DOI 10.1073/pnas.192457099; Wilcock DM, 2009, NEUROSCIENCE, V159, P1055, DOI 10.1016/j.neuroscience.2009.01.023; Wolburg H, 2011, INT REV CEL MOL BIO, V287, P1, DOI 10.1016/B978-0-12-386043-9.00001-3; Yoder EJ, 2002, GLIA, V38, P137, DOI 10.1002/glia.10016; Zea-Aragon Z, 2004, J NEUROSCI METH, V138, P89, DOI 10.1016/j.jneumeth.2004.03.018; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	56	48	52	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41374	41385		10.1074/jbc.M112.400044	http://dx.doi.org/10.1074/jbc.M112.400044			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23043099	Green Published, hybrid			2022-12-28	WOS:000311887600050
J	Okajima, K; Kashojiya, S; Tokutomi, S				Okajima, Koji; Kashojiya, Sachiko; Tokutomi, Satoru			Photosensitivity of Kinase Activation by Blue Light Involves the Lifetime of a Cysteinyl-Flavin Adduct Intermediate, S390, in the Photoreaction Cycle of the LOV2 Domain in Phototropin, a Plant Blue Light Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL-CHANGES; ARABIDOPSIS NPH1; BINDING DOMAINS; VOLTAGE DOMAINS; PHOTORECEPTOR; PROTEIN; OXYGEN; AUTOPHOSPHORYLATION; PHOSPHORYLATION; SUBSTRATE	Phototropin (phot) is a light-regulated protein kinase that mediates a variety of photoresponses in plants, such as phototropism, chloroplast positioning, and stomata opening. Arabidopsis has two homologues, phot1 and phot2, that share physiological functions depending on light intensity. A phot molecule has two photoreceptive light oxygen voltage-sensing domains, LOV1 and LOV2, and a Ser/Thr kinase domain. The LOV domains undergo a photocycle upon blue light (BL) stimulation, including transient adduct formation between the chromophore and a conserved cysteine (S390 intermediate) that leads to activation of the kinase. To uncover the mechanism underlying the photoactivation of the kinase, we have introduced a kinase assay system composed of a phot1 LOV2-linkerkinase polypeptide as a light-regulated kinase and its N-terminal polypeptide as an artificial substrate (Okajima, K., Matsuoka, D., and Tokutomi, S. (2011) LOV2-linker-kinase phosphorylates LOV1-containing N-terminal polypeptide substrate via photoreaction of LOV2 in Arabidopsis phototropin1. FEBS Lett. 585, 3391-3395). In the present study, we extended the assay system to phot2 and compared the photochemistry and kinase activation by BL between phot1 and phot2 to gain insight into the molecular basis for the different photosensitivities of phot1 and phot2. Photosensitivity of kinase activation by BL and the lifetime of S390 of phot1 were 10 times higher and longer, respectively, than those of phot2. This correlation was confirmed by an amino acid substitution experiment with phot1 to shorten the lifetime of S390. The present results demonstrated that the photosensitivity of kinase activation in phot involves the lifetime of S390 in LOV2, suggesting that the lifetime is one of the key factors for the different photosensitivities observed for phot1 and phot2.	[Okajima, Koji; Kashojiya, Sachiko; Tokutomi, Satoru] Osaka Prefecture Univ, Dept Biol Sci, Grad Sch Sci, Naka Ku, Sakai, Osaka 5998531, Japan	Osaka Metropolitan University	Tokutomi, S (corresponding author), Osaka Prefecture Univ, Dept Biol Sci, Grad Sch Sci, Naka Ku, Gakuen Cho 1-1, Sakai, Osaka 5998531, Japan.	toxan@b.s.osakafu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [17084008, 22120005, 23657105]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research on Priority Areas 17084008 (to S. T.), Grant-in-Aid for Scientific Research on Innovative Areas 22120005 (to S. T.), and Grant-in-Aid for Exploratory Research 23657105 (to S. T.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Alexandre MTA, 2009, BIOPHYS J, V97, P227, DOI 10.1016/j.bpj.2009.01.066; Briggs WR, 2001, ANTIOXID REDOX SIGN, V3, P775, DOI 10.1089/15230860152664975; Cho HY, 2007, PLANT PHYSIOL, V143, P517, DOI 10.1104/pp.106.089839; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Christie JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001076; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; de Carbonnel M, 2010, PLANT PHYSIOL, V152, P1391, DOI 10.1104/pp.109.150441; Demarsy E, 2012, EMBO J, V31, P3457, DOI 10.1038/emboj.2012.186; Eitoku T, 2005, J AM CHEM SOC, V127, P13238, DOI 10.1021/ja052523i; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Harper SM, 2004, J AM CHEM SOC, V126, P3390, DOI 10.1021/ja038224f; Inoue S, 2008, P NATL ACAD SCI USA, V105, P5626, DOI 10.1073/pnas.0709189105; Inoue S, 2011, PLANT PHYSIOL, V156, P117, DOI 10.1104/pp.111.175943; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kagawa T, 2004, PLANT CELL PHYSIOL, V45, P416, DOI 10.1093/pcp/pch045; Kaiserli E, 2009, PLANT CELL, V21, P3226, DOI 10.1105/tpc.109.067876; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; Kong SG, 2007, PLANT J, V51, P862, DOI 10.1111/j.1365-313X.2007.03187.x; Koyama T, 2009, BIOCHEMISTRY-US, V48, P7621, DOI 10.1021/bi9009192; Kozuka T, 2011, PLANT CELL, V23, P3684, DOI 10.1105/tpc.111.085852; Lariguet P, 2006, P NATL ACAD SCI USA, V103, P10134, DOI 10.1073/pnas.0603799103; Liu HT, 2011, TRENDS PLANT SCI, V16, P684, DOI 10.1016/j.tplants.2011.09.002; Losi A, 2004, BIOPHYS J, V86, P1051, DOI 10.1016/S0006-3495(04)74180-6; Matsuoka D, 2005, P NATL ACAD SCI USA, V102, P13337, DOI 10.1073/pnas.0506402102; Matsuoka D, 2007, PHOTOCHEM PHOTOBIOL, V83, P470, DOI 10.1562/2006-03-29-RA-097.x; Motchoulski A, 1999, SCIENCE, V286, P961, DOI 10.1126/science.286.5441.961; Nakasako M, 2004, BIOCHEMISTRY-US, V43, P14881, DOI 10.1021/bi0485530; Okajima K, 2011, FEBS LETT, V585, P3391, DOI 10.1016/j.febslet.2011.10.003; Pfeifer A, 2010, BIOCHEMISTRY-US, V49, P1024, DOI 10.1021/bi9016044; Sakai T, 2000, PLANT CELL, V12, P225, DOI 10.1105/tpc.12.2.225; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Salomon M, 2003, BIOCHEMISTRY-US, V42, P4217, DOI 10.1021/bi027324f; Salomon M, 1996, PLANTA, V199, P336, DOI 10.1007/BF00195724; Suetsugu N, 2005, PLANT PHYSIOL, V139, P151, DOI 10.1104/pp.105.067371; Sullivan S, 2008, MOL PLANT, V1, P178, DOI 10.1093/mp/ssm017; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Takayama Y, 2011, BIOCHEMISTRY-US, V50, P1174, DOI 10.1021/bi101689b; Zikihara K, 2006, BIOCHEMISTRY-US, V45, P10828, DOI 10.1021/bi0607857	44	34	35	0	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					40972	40981		10.1074/jbc.M112.406512	http://dx.doi.org/10.1074/jbc.M112.406512			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23066024	Green Published, hybrid			2022-12-28	WOS:000311887600015
J	Dutertre, S; Becker, CM; Betz, H				Dutertre, Sebastien; Becker, Cord-Michael; Betz, Heinrich			Inhibitory Glycine Receptors: An Update	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GATED ION-CHANNEL; RAT SPINAL-CORD; DORSAL HORN NEURONS; BETA-SUBUNIT; LIGAND-BINDING; CHROMOSOMAL LOCALIZATION; GABA(A) RECEPTOR; ALPHA-1 SUBUNIT; MOLECULAR DETERMINANTS; FUNCTIONAL EXPRESSION	Strychnine-sensitive glycine receptors (GlyRs) mediate synaptic inhibition in the spinal cord, brainstem, and other regions of the mammalian central nervous system. In this minireview, we summarize our current view of the structure, ligand-binding sites, and chloride channel of these receptors and discuss recently emerging functions of distinct GlyR isoforms. GlyRs not only regulate the excitability of motor and afferent sensory neurons, including pain fibers, but also are involved in the processing of visual and auditory signals. Hence, GlyRs constitute promising targets for the development of therapeutically useful compounds.	[Betz, Heinrich] Max Planck Inst Med Res, D-69120 Heidelberg, Germany; [Dutertre, Sebastien] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Becker, Cord-Michael] Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany; [Betz, Heinrich] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany	Max Planck Society; University of Queensland; University of Erlangen Nuremberg; Max Planck Society	Betz, H (corresponding author), Max Planck Inst Med Res, Jahnstr 29, D-69120 Heidelberg, Germany.	heinrich.betz@mpimf-heidelberg.mpg.de		Dutertre, Sebastien/0000-0002-2945-1484				Al-Owain M, 2012, CLIN GENET, V81, P479, DOI 10.1111/j.1399-0004.2011.01661.x; BECKER CM, 1988, EMBO J, V7, P3717, DOI 10.1002/j.1460-2075.1988.tb03255.x; Becker K, 2012, J BIOL CHEM, V287, P31185, DOI 10.1074/jbc.M112.375691; Betz H, 2006, J NEUROCHEM, V97, P1600, DOI 10.1111/j.1471-4159.2006.03908.x; Blednov YA, 2012, J PHARMACOL EXP THER, V340, P317, DOI 10.1124/jpet.111.185124; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; BORMANN J, 1993, EMBO J, V12, P3729, DOI 10.1002/j.1460-2075.1993.tb06050.x; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; Breitinger U, 2004, J BIOL CHEM, V279, P1627, DOI 10.1074/jbc.M303811200; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; BUCKWALTER MS, 1994, HUM MOL GENET, V3, P2025, DOI 10.1093/hmg/3.11.2025; Burzomato V, 2003, RECEPTOR CHANNEL, V9, P353, DOI 10.3109/714041016; Chung SK, 2010, J NEUROSCI, V30, P9612, DOI 10.1523/JNEUROSCI.1763-10.2010; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Davies JS, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00008; del Pino I, 2011, BIOCHEM BIOPH RES CO, V412, P435, DOI 10.1016/j.bbrc.2011.07.110; Dibas MI, 2002, J BIOL CHEM, V277, P9112, DOI 10.1074/jbc.M111356200; Dlugaiczyk J, 2008, HISTOCHEM CELL BIOL, V129, P513, DOI 10.1007/s00418-008-0387-x; Dutertre S, 2012, J NEUROCHEM, V122, P38, DOI 10.1111/j.1471-4159.2012.07755.x; GRAHAM D, 1983, EUR J BIOCHEM, V131, P519, DOI 10.1111/j.1432-1033.1983.tb07292.x; GRENNINGLOH G, 1990, NEURON, V4, P963, DOI 10.1016/0896-6273(90)90149-A; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; GRENNINGLOH G, 1990, EMBO J, V9, P771, DOI 10.1002/j.1460-2075.1990.tb08172.x; Griffon N, 1999, EMBO J, V18, P4711, DOI 10.1093/emboj/18.17.4711; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Gunthorpe MJ, 2001, J BIOL CHEM, V276, P10977, DOI 10.1074/jbc.M009575200; Haeger S, 2010, NAT STRUCT MOL BIOL, V17, P90, DOI 10.1038/nsmb.1721; Harvey RJ, 2000, EUR J NEUROSCI, V12, P994, DOI 10.1046/j.1460-9568.2000.00993.x; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hirzel K, 2006, NEURON, V52, P679, DOI 10.1016/j.neuron.2006.09.035; HOCH W, 1989, NEURON, V3, P339, DOI 10.1016/0896-6273(89)90258-4; Hutchinson M, 2008, NEUROLOGY, V71, P1291, DOI 10.1212/01.wnl.0000327606.50322.f0; Jenkins A, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0002.2001; Kallenborn-Gerhardt W, 2012, BEHAV BRAIN RES, V226, P106, DOI 10.1016/j.bbr.2011.09.002; Keramidas A, 2002, J GEN PHYSIOL, V119, P393, DOI 10.1085/jgp.20028552; KINGSMORE SF, 1994, NAT GENET, V7, P136, DOI 10.1038/ng0694-136; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; Kubota H, 2010, BIOCHEM BIOPH RES CO, V393, P587, DOI 10.1016/j.bbrc.2010.02.019; KUHSE J, 1990, J BIOL CHEM, V265, P22317; LANGOSCH D, 1994, EMBO J, V13, P4223, DOI 10.1002/j.1460-2075.1994.tb06742.x; LANGOSCH D, 1988, P NATL ACAD SCI USA, V85, P7394, DOI 10.1073/pnas.85.19.7394; Laube B, 2002, TRENDS PHARMACOL SCI, V23, P519, DOI 10.1016/S0165-6147(02)02138-7; Lee DJS, 2003, NEUROSCI LETT, V351, P196, DOI 10.1016/j.neulet.2003.08.005; Legendre P, 2001, CELL MOL LIFE SCI, V58, P760, DOI 10.1007/PL00000899; Lewis TM, 1998, J PHYSIOL-LONDON, V507, P25, DOI 10.1111/j.1469-7793.1998.025bu.x; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Liu J, 2010, NAT NEUROSCI, V13, P1225, DOI 10.1038/nn.2633; Lu H, 2002, J BIOL CHEM, V277, P41369, DOI 10.1074/jbc.M206768200; Lynagh T, 2011, J BIOL CHEM, V286, P43913, DOI 10.1074/jbc.M111.262634; LYNCH JW, 1995, J BIOL CHEM, V270, P13799, DOI 10.1074/jbc.270.23.13799; Lynch JW, 2001, J NEUROSCI, V21, P2589, DOI 10.1523/JNEUROSCI.21-08-02589.2001; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Maas C, 2006, J CELL BIOL, V172, P441, DOI 10.1083/jcb.200506066; Maksay G, 2009, J NEUROCHEM, V109, P1725, DOI 10.1111/j.1471-4159.2009.06083.x; MALOSIO ML, 1991, EMBO J, V10, P2401, DOI 10.1002/j.1460-2075.1991.tb07779.x; MATZENBACH B, 1994, J BIOL CHEM, V269, P2607; Meier JC, 2005, NAT NEUROSCI, V8, P736, DOI 10.1038/nn1467; Melzer N, 2010, J BIOL CHEM, V285, P3730, DOI 10.1074/jbc.M109.030460; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Miller PS, 2008, NAT STRUCT MOL BIOL, V15, P1084, DOI 10.1038/nsmb.1492; Miller PS, 2005, J BIOL CHEM, V280, P37877, DOI 10.1074/jbc.M508303200; Miller PS, 2004, BRIT J PHARMACOL, V143, P19, DOI 10.1038/sj.bjp.0705875; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; MULHARDT C, 1994, NEURON, V13, P1003, DOI 10.1016/0896-6273(94)90265-8; Nevin ST, 2003, J BIOL CHEM, V278, P28985, DOI 10.1074/jbc.M300097200; Nikolic Z, 1998, J BIOL CHEM, V273, P19708, DOI 10.1074/jbc.273.31.19708; Nobles RD, 2012, J NEUROSCI, V32, P3321, DOI 10.1523/JNEUROSCI.5341-11.2012; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Oertel J, 2007, J BIOL CHEM, V282, P2798, DOI 10.1074/jbc.M608941200; Perkins DI, 2010, PHARMACOL THERAPEUT, V127, P53, DOI 10.1016/j.pharmthera.2010.03.003; PFEIFFER F, 1982, J BIOL CHEM, V257, P9389; Pless SA, 2011, J BIOL CHEM, V286, P35129, DOI 10.1074/jbc.M111.269027; PRIBILLA I, 1992, EMBO J, V11, P4305, DOI 10.1002/j.1460-2075.1992.tb05529.x; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; RAJENDRA S, 1994, J BIOL CHEM, V269, P18739; RAJENDRA S, 1995, NEURON, V14, P169, DOI 10.1016/0896-6273(95)90251-1; REICHLING DB, 1994, J PHYSIOL-LONDON, V476, P411, DOI 10.1113/jphysiol.1994.sp020142; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; RYAN SG, 1994, NAT GENET, V7, P131, DOI 10.1038/ng0694-131; SAUL B, 1994, FEBS LETT, V350, P71, DOI 10.1016/0014-5793(94)00736-5; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; Singer JH, 1998, J NEUROPHYSIOL, V80, P2608, DOI 10.1152/jn.1998.80.5.2608; TAKAHASHI T, 1992, NEURON, V9, P1155, DOI 10.1016/0896-6273(92)90073-M; Turecek R, 2002, P NATL ACAD SCI USA, V99, P13884, DOI 10.1073/pnas.212419699; Villmann C, 2009, J NEUROSCI, V29, P2440, DOI 10.1523/JNEUROSCI.4400-08.2009; Wassle H, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.006.2009; Weiss J, 2008, MOL CELL NEUROSCI, V37, P40, DOI 10.1016/j.mcn.2007.08.012; Weltzien F, 2012, J COMP NEUROL, V520, P3962, DOI 10.1002/cne.23139; WHITE WF, 1982, NATURE, V298, P655, DOI 10.1038/298655a0; Xiong W, 2012, J EXP MED, V209, P1121, DOI 10.1084/jem.20120242; Xiong W, 2012, J NEUROSCI, V32, P5200, DOI 10.1523/JNEUROSCI.6347-11.2012; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195; Yang Z, 2007, J NEUROCHEM, V103, P580, DOI 10.1111/j.1471-4159.2007.04850.x; Yang Z, 2012, BIOCHEMISTRY-US, V51, P5229, DOI 10.1021/bi300063m; Yevenes GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023886; YOUNG AB, 1973, P NATL ACAD SCI USA, V70, P2832, DOI 10.1073/pnas.70.10.2832; Young-Pearse TL, 2006, MOL CELL BIOL, V26, P5728, DOI 10.1128/MCB.00237-06	100	118	122	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40216	40223		10.1074/jbc.R112.408229	http://dx.doi.org/10.1074/jbc.R112.408229			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23038260	Green Published, hybrid			2022-12-28	WOS:000311448800013
J	Kim, HJ; Jeong, MY; Na, U; Winge, DR				Kim, Hyung J.; Jeong, Mi-Young; Na, Un; Winge, Dennis R.			Flavinylation and Assembly of Succinate Dehydrogenase Are Dependent on the C-terminal Tail of the Flavoprotein Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; COMPLEX-II; UBIQUINONE OXIDOREDUCTASE; COVALENT ATTACHMENT; MITOCHONDRIA; GENE; YEAST; FAD; MUTATION; PARAGANGLIOMA	The enzymatic function of succinate dehydrogenase (SDH) is dependent on covalent attachment of FAD on the similar to 70-kDa flavoprotein subunit Sdh1. We show presently that flavinylation of the Sdh1 subunit of succinate dehydrogenase is dependent on a set of two spatially close C-terminal arginine residues that are distant from the FAD binding site. Mutation of Arg(582) in yeast Sdh1 precludes flavinylation as well as assembly of the tetrameric enzyme complex. Mutation of Arg(638) compromises SDH function only when present in combination with a Cys(630) substitution. Mutations of either Arg(582) or Arg(638)/Cys(630) do not markedly destabilize the Sdh1 polypeptide; however, the steady-state level of Sdh5 is markedly attenuated in the Sdh1 mutant cells. With each mutant Sdh1, second-site Sdh1 suppressor mutations were recovered in Sdh1 permitting flavinylation, stabilization of Sdh5 and SDH tetramer assembly. SDH assembly appears to require FAD binding but not necessarily covalent FAD attachment. The Arg residues may be important not only for Sdh5 association but also in the recruitment and/or guidance of FAD and or succinate to the substrate site for the flavinylation reaction. The impaired assembly of SDH with the C-terminal Sdh1 mutants suggests that FAD binding is important to stabilize the Sdh1 conformation enabling association with Sdh2 and the membrane anchor subunits.	[Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA; Univ Utah, Hlth Sci Ctr, Dept Biochem, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Winge, DR (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA.	dennis.winge@hsc.utah.edu			NIEHS, National Institutes of Health [ES03817]; Huntsman Cancer Institute [P30 CA042014]; National Institutes of Health [R24DK092784-01]; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK092784, T32DK007115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003817, R37ES003817] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Huntsman Cancer Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Grant ES03817 from the NIEHS, National Institutes of Health (to D. R. W.), funding from the Huntsman Cancer Institute (P30 CA042014), and support from the National Institutes of Health (R24DK092784-01).	Bafunno V, 2004, J BIOL CHEM, V279, P95, DOI 10.1074/jbc.M308230200; Birch-Machin MA, 2000, ANN NEUROL, V48, P330, DOI 10.1002/1531-8249(200009)48:3<330::AID-ANA7>3.0.CO;2-A; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Fraaije MW, 2000, J BIOL CHEM, V275, P38654, DOI 10.1074/jbc.M004753200; Giancaspero TA, 2008, FEBS J, V275, P1103, DOI 10.1111/j.1742-4658.2008.06270.x; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; HAGERHALL C, 1995, BBA-BIOENERGETICS, V1229, P356, DOI 10.1016/0005-2728(95)00023-C; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Heuts DPHM, 2009, FEBS J, V276, P3405, DOI 10.1111/j.1742-4658.2009.07053.x; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maklashina E, 2010, BBA-BIOENERGETICS, V1797, P747, DOI 10.1016/j.bbabio.2010.01.019; Mcneil MB, 2012, J BIOL CHEM, V287, P18418, DOI 10.1074/jbc.M111.293803; Oyedotun KS, 2001, J BIOL CHEM, V276, P16936, DOI 10.1074/jbc.M100184200; Robinson KM, 1996, J BIOL CHEM, V271, P4055; Robinson KM, 1995, METHOD ENZYMOL, V260, P34, DOI 10.1016/0076-6879(95)60128-7; ROBINSON KM, 1994, EUR J BIOCHEM, V222, P983, DOI 10.1111/j.1432-1033.1994.tb18949.x; Rutter J, 2010, MITOCHONDRION, V10, P393, DOI 10.1016/j.mito.2010.03.001; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Sitkin Y, 2007, BBA-BIOENERGETICS, V1767, P143, DOI 10.1016/j.bbabio.2006.11.017; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Tomasiak TM, 2008, J BIOL CHEM, V283, P15460, DOI 10.1074/jbc.M801372200; Tzagoloff A, 1996, J BIOL CHEM, V271, P7392, DOI 10.1074/jbc.271.13.7392; WU M, 1995, MOL CELL BIOL, V15, P264, DOI 10.1128/MCB.15.1.264	27	31	31	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40670	40679		10.1074/jbc.M112.405704	http://dx.doi.org/10.1074/jbc.M112.405704			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23043141	hybrid, Green Published			2022-12-28	WOS:000311448800056
J	Kulczyk, AW; Akabayov, B; Lee, SJ; Bostina, M; Berkowitz, SA; Richardson, CC				Kulczyk, Arkadiusz W.; Akabayov, Barak; Lee, Seung-Joo; Bostina, Mihnea; Berkowitz, Steven A.; Richardson, Charles C.			An Interaction between DNA Polymerase and Helicase Is Essential for the High Processivity of the Bacteriophage T7 Replisome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN BINDS DNA; CRYSTAL-STRUCTURE; REPLICATION FORK; GENE-4 PROTEIN; PRIMASE; COMPLEX; MECHANISM; DOMAIN; HYDROLYSIS	Synthesis of the leading DNA strand requires the coordinated activity of DNA polymerase and DNA helicase, whereas synthesis of the lagging strand involves interactions of these proteins with DNA primase. We present the first structural model of a bacteriophage T7 DNA helicase-DNA polymerase complex using a combination of small angle x-ray scattering, single-molecule, and biochemical methods. We propose that the protein-protein interface stabilizing the leading strand synthesis involves two distinct interactions: a stable binding of the helicase to the palm domain of the polymerase and an electrostatic binding of the carboxyl-terminal tail of the helicase to a basic patch on the polymerase. DNA primase facilitates binding of DNA helicase to ssDNA and contributes to formation of the DNA helicase-DNA polymerase complex by stabilizing DNA helicase.	[Kulczyk, Arkadiusz W.; Akabayov, Barak; Lee, Seung-Joo; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Bostina, Mihnea] McGill Univ, Facil Electron Microscopy Res, Montreal, PQ H3A 2B2, Canada; [Berkowitz, Steven A.] Biogen Idec Inc, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; McGill University; Biogen	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	ccr@hms.harvard.edu	Akabayov, Barak/Y-5786-2019	Akabayov, Barak/0000-0002-3882-2742; Bostina, Mihnea/0000-0003-3621-3772	National Institutes of Health [GM-54397]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-54397 (to C. C. R.).	Ahnert P, 2000, EMBO J, V19, P3418, DOI 10.1093/emboj/19.13.3418; Akabayov B, 2010, P NATL ACAD SCI USA, V107, P15033, DOI 10.1073/pnas.1010141107; Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; BERNSTEIN JA, 1988, P NATL ACAD SCI USA, V85, P396, DOI 10.1073/pnas.85.2.396; Bird LE, 2000, BIOCHEMISTRY-US, V39, P171, DOI 10.1021/bi9918801; Chen JZ, 2007, J STRUCT BIOL, V157, P168, DOI 10.1016/j.jsb.2006.06.001; Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; HUBER HE, 1987, J BIOL CHEM, V262, P16224; Johnson DE, 2007, P NATL ACAD SCI USA, V104, P5312, DOI 10.1073/pnas.0701062104; Kato M, 2004, J BIOL CHEM, V279, P30554, DOI 10.1074/jbc.M403485200; Kim DE, 2002, J MOL BIOL, V321, P807, DOI 10.1016/S0022-2836(02)00733-7; Kinebuchi T, 2004, MOL CELL, V14, P363, DOI 10.1016/S1097-2765(04)00218-7; Komori K, 2000, J BIOL CHEM, V275, P33791, DOI 10.1074/jbc.M004556200; Kulczyk A. W., 2010, J VIS EXP, V23, P37; Kulczyk AW, 2012, P NATL ACAD SCI USA, V109, P9408, DOI 10.1073/pnas.1207033109; Lasker K, 2010, PROTEINS, V78, P3205, DOI 10.1002/prot.22845; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Lipfert J, 2007, J MOL BIOL, V365, P1393, DOI 10.1016/j.jmb.2006.10.022; Loparo JJ, 2011, P NATL ACAD SCI USA, V108, P3584, DOI 10.1073/pnas.1018824108; MATSON SW, 1983, J BIOL CHEM, V258, P4017; Notarnicola SM, 1997, J BIOL CHEM, V272, P18425, DOI 10.1074/jbc.272.29.18425; NOTARNICOLA SM, 1993, J BIOL CHEM, V268, P27198; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Okorokov AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008586; Passy SI, 1999, P NATL ACAD SCI USA, V96, P10684, DOI 10.1073/pnas.96.19.10684; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; ROMANO LJ, 1979, J BIOL CHEM, V254, P483; Satapathy AK, 2011, J BIOL CHEM, V286, P34468, DOI 10.1074/jbc.M111.283796; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shin DS, 2003, EMBO J, V22, P4566, DOI 10.1093/emboj/cdg429; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TABOR S, 1987, J BIOL CHEM, V262, P16212; Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8; Yang SX, 2001, J MOL BIOL, V314, P1077, DOI 10.1006/jmbi.2000.5213; Yu X, 1997, NAT STRUCT BIOL, V4, P101, DOI 10.1038/nsb0297-101; Zhang HD, 2011, P NATL ACAD SCI USA, V108, P9372, DOI 10.1073/pnas.1106678108	45	21	22	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39050	39060		10.1074/jbc.M112.410647	http://dx.doi.org/10.1074/jbc.M112.410647			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22977246	Green Published, hybrid			2022-12-28	WOS:000310982800061
J	Geng, YP; Verhamme, IM; Messer, A; Sun, MF; Smith, SB; Bajaj, SP; Gailani, D				Geng, Yipeng; Verhamme, Ingrid M.; Messer, Amanda; Sun, Mao-fu; Smith, Stephen B.; Bajaj, S. Paul; Gailani, David			A Sequential Mechanism for Exosite-mediated Factor IX Activation by Factor XIa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-COAGULATION FACTOR; SUBSTRATE-BINDING SITE; MACROMOLECULAR SUBSTRATE; EXTRINSIC PATHWAY; APPLE DOMAINS; TISSUE FACTOR; LIGHT-CHAINS; HEAVY-CHAIN; FACTOR-X; IDENTIFICATION	During blood coagulation, the protease factor XIa (fXIa) activates factor IX (fIX). We describe a new mechanism for this process. FIX is cleaved initially after Arg(145) to form fIX alpha, and then after Arg(180) to form the protease fIXa beta. FIX alpha is released from fXIa, and must rebind for cleavage after Arg(180) to occur. Catalytic efficiency of cleavage after Arg(180) is 7-fold greater than for cleavage after Arg(145), limiting fIX alpha accumulation. FXIa contains four apple domains (A1-A4) and a catalytic domain. Exosite(s) on fXIa are required for fIX binding, however, there is lack of consensus on their location(s), with sites on the A2, A3, and catalytic domains described. Replacing the A3 domain with the prekallikrein A3 domain increases K-m for fIX cleavage after Arg(145) and Arg(180) 25- and >= 90-fold, respectively, and markedly decreases k(cat) for cleavage after Arg(180). Similar results were obtained with the isolated fXIa catalytic domain, or fXIa in the absence of Ca2+. Forms of fXIa lacking the A3 domain exhibit 15-fold lower catalytic efficiency for cleavage after Arg(180) than for cleavage after Arg(145), resulting in fIX alpha accumulation. Replacing the A2 domain does not affect fIX activation. The results demonstrate that fXIa activates fIX by an exosite- and Ca2+-mediated release-rebind mechanism in which efficiency of the second cleavage is enhanced by conformational changes resulting from the first cleavage. Initial binding of fIX and fIX alpha requires an exosite on the fXIa A3 domain, but not the A2 or catalytic domain.	[Geng, Yipeng; Verhamme, Ingrid M.; Sun, Mao-fu; Smith, Stephen B.; Gailani, David] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Messer, Amanda; Bajaj, S. Paul] Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90095 USA	Vanderbilt University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Gailani, D (corresponding author), 777 Preston Res Bldg,2220 Pierce Ave, Nashville, TN USA.	dave.gailani@vanderbilt.edu			National Institutes of Health from the NHLBI [HL58837, HL81326, HL080018, HL36365]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058837, R56HL036365, R55HL036365, R01HL081326, R01HL036365, R01HL080018] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL58837 and HL81326 (to D. G.), HL080018 (to I. M. V.), and HL36365 (to S. P. B.) from the NHLBI.	Aktimur A, 2003, J BIOL CHEM, V278, P7981, DOI 10.1074/jbc.M212748200; BAGLIA FA, 1991, J BIOL CHEM, V266, P24190; BAGLIA FA, 1989, BLOOD, V74, P244; Baugh RJ, 2000, J BIOL CHEM, V275, P28826, DOI 10.1074/jbc.M005266200; Betz A, 1998, J BIOL CHEM, V273, P10709, DOI 10.1074/jbc.273.17.10709; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; BOUMA BN, 1977, J BIOL CHEM, V252, P6432; CARLISLE TL, 1990, J BIOL CHEM, V265, P22044; Cheng Q, 2003, J THROMB HAEMOST, V1, P2340, DOI 10.1046/j.1538-7836.2003.00418.x; Colman R. W., 2006, HEMOSTASIS THROMBOSI, P131; FUJIKAWA K, 1986, BIOCHEMISTRY-US, V25, P2417, DOI 10.1021/bi00357a018; FURIE B, 2009, HEMATOLOGY BASIC PRI, P1819; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kravtsov DV, 2009, BLOOD, V114, P452, DOI 10.1182/blood-2009-02-203604; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; LAWSON JH, 1991, J BIOL CHEM, V266, P11317; LINDQUIST PA, 1978, J BIOL CHEM, V253, P1902; Marcinkiewicz MM, 2012, J BIOL CHEM, V287, P6187, DOI 10.1074/jbc.M111.291989; MCMULLEN BA, 1991, BIOCHEMISTRY-US, V30, P2056, DOI 10.1021/bi00222a008; NEMERSON Y, 1992, SEMIN HEMATOL, V29, P170; Ogawa T, 2005, J BIOL CHEM, V280, P23523, DOI 10.1074/jbc.M500894200; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; Orcutt SJ, 2002, J BIOL CHEM, V277, P46191, DOI 10.1074/jbc.M208677200; Page MJ, 2005, J THROMB HAEMOST, V3, P2401, DOI 10.1111/j.1538-7836.2005.01456.x; Papagrigoriou E, 2006, NAT STRUCT MOL BIOL, V13, P557, DOI 10.1038/nsmb1095; Ponczek MB, 2008, J THROMB HAEMOST, V6, P1876, DOI 10.1111/j.1538-7836.2008.03143.x; Roth D. A., 2009, HEMATOLOGY BASIC PRI, P1899; Schmidt AE, 2008, BLOOD, V112, P708; SINHA D, 1987, BIOCHEMISTRY-US, V26, P3768, DOI 10.1021/bi00387a005; Sinha D, 2007, BIOCHEMISTRY-US, V46, P9830, DOI 10.1021/bi062296c; Smith SB, 2008, J BIOL CHEM, V283, P6696, DOI 10.1074/jbc.M707234200; Smith SB, 2008, EXPERT REV HEMATOL, V1, P87, DOI 10.1586/17474086.1.1.87; Su YC, 2011, J BIOL CHEM, V286, P31904, DOI 10.1074/jbc.M111.257527; Sun MF, 1999, J BIOL CHEM, V274, P36373, DOI 10.1074/jbc.274.51.36373; Sun YH, 1996, J BIOL CHEM, V271, P29023, DOI 10.1074/jbc.271.46.29023; Wolberg AS, 1997, BIOCHEMISTRY-US, V36, P4074, DOI 10.1021/bi962274y; Wu WM, 2008, J BIOL CHEM, V283, P18655, DOI 10.1074/jbc.M802275200; ZUR M, 1980, J BIOL CHEM, V255, P5703	38	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.376343	http://dx.doi.org/10.1074/jbc.M112.376343			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22961984	Green Published, hybrid			2022-12-28	WOS:000310642200053
J	Hammond, VJ; Morgan, AH; Lauder, S; Thomas, CP; Brown, S; Freeman, BA; Lloyd, CM; Davies, J; Bush, A; Levonen, AL; Kansanen, E; Villacorta, L; Chen, YE; Porter, N; Garcia-Diaz, YM; Schopfer, FJ; O'Donnell, VB				Hammond, Victoria J.; Morgan, Alwena H.; Lauder, Sarah; Thomas, Christopher P.; Brown, Sarah; Freeman, Bruce A.; Lloyd, Clare M.; Davies, Jane; Bush, Andrew; Levonen, Anna-Liisa; Kansanen, Emilia; Villacorta, Luis; Chen, Y. Eugene; Porter, Ned; Garcia-Diaz, Yoel M.; Schopfer, Francisco J.; O'Donnell, Valerie B.			Novel Keto-phospholipids Are Generated by Monocytes and Macrophages, Detected in Cystic Fibrosis, and Activate Peroxisome Proliferator-activated Receptor-gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; ESTERIFIED EICOSANOIDS; INFLAMMATORY RESPONSE; EPITHELIAL-CELLS; HUMAN PLATELETS; HUMAN-BLOOD; ACID; 12/15-LIPOXYGENASE; 15-LIPOXYGENASE; LIGANDS	12/15-Lipoxygenases (LOXs) in monocytes and macrophages generate novel phospholipid-esterified eicosanoids. Here, we report the generation of two additional families of related lipids comprising 15-ketoeicosatetraenoic acid (KETE) attached to four phosphatidylethanolamines (PEs). The lipids are generated basally by 15-LOX in IL-4-stimulated monocytes, are elevated on calcium mobilization, and are detected at increased levels in bronchoalveolar lavage fluid from cystic fibrosis patients (3.6 ng/ml of lavage). Murine peritoneal macrophages generate 12-KETE-PEs, which are absent in 12/15-LOX-deficient mice. Inhibition of 15-prostaglandin dehydrogenase prevents their formation from exogenous 15-hydroxyeicosatetraenoic acid-PE in human monocytes. Both human and murine cells also generated analogous hydroperoxyeicosatetraenoic acid-PEs. The electrophilic reactivity of KETE-PEs is shown by their Michael addition to glutathione and cysteine. Lastly, both 15-hydroxyeicosatetraenoic acid-PE and 15-KETE-PE activated peroxisome proliferator-activated receptor-gamma reporter activity in macrophages in a dose-dependent manner. In summary, we demonstrate novel peroxisome proliferator-activated receptor-gamma-activating oxidized phospholipids generated enzymatically by LOX and 15-prostaglandin dehydrogenase in primary monocytic cells and in a human Th2-related lung disease. The lipids are a new family of bioactive mediators from the 12/15-LOX pathway that may contribute to its known anti-inflammatory actions in vivo.	[Hammond, Victoria J.; Morgan, Alwena H.; Lauder, Sarah; Thomas, Christopher P.; O'Donnell, Valerie B.] Cardiff Univ, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Freeman, Bruce A.; Schopfer, Francisco J.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Brown, Sarah; Lloyd, Clare M.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Brown, Sarah; Davies, Jane; Bush, Andrew] Univ London Imperial Coll Sci Technol & Med, Dept Paediat Resp Med, London SW3 6NP, England; [Brown, Sarah; Davies, Jane; Bush, Andrew] Royal Brompton Hosp, London SW3 6NP, England; [Levonen, Anna-Liisa; Kansanen, Emilia] Univ Eastern Finland, Dept Biotechnol & Mol Med, AI Virtanen Inst, FIN-70211 Kuopio, Finland; [Villacorta, Luis; Chen, Y. Eugene] Univ Michigan, Med Ctr, Ctr Cardiovasc, Dept Internal Med, Ann Arbor, MI 48109 USA; [Porter, Ned; Garcia-Diaz, Yoel M.] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA	Cardiff University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Imperial College London; Imperial College London; Royal Brompton Hospital; University of Eastern Finland; University of Michigan System; University of Michigan; Vanderbilt University	O'Donnell, VB (corresponding author), Cardiff Univ, Sch Med, Heath Pk Campus, Cardiff CF14 4XN, S Glam, Wales.	o-donnellvb@cardiff.ac.uk	Thomas, Christopher P/R-5243-2016; Schopfer, Francisco/AAW-6505-2021; Schopfer, Francisco Jose/AAE-8125-2020; Villacorta, Luis/E-8937-2011	Thomas, Christopher P/0000-0001-5840-8613; Schopfer, Francisco Jose/0000-0001-9526-695X; Villacorta, Luis/0000-0001-7824-7028; Davies, Jane/0000-0003-3506-1199; Levonen, Anna-Liisa/0000-0002-6575-2137; Kansanen, Emilia/0000-0001-6029-8097; Lloyd, Clare/0000-0001-8977-6726; /0000-0003-4089-8460	National Institutes of Health [HL068878, HL89544, R01-HL058115, R01-HL64937, P30-DK072506, P01-HL103455, R01-AT006822-01]; Wellcome Trust; European Union Marie Curie fellowship; American Heart Association Grant [10SDG4150085]; American Diabetes Association; Academy of Finland; Sigrid Juselius Foundation; American Diabetes Association Junior Faculty Award [7-08-JF 52]; Complexa, Inc.; Nitromega, Inc.; National Center for Complementary & Integrative Health [R01AT006822] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089544, P01HL103455, R01HL068878, R01HL105114, R01HL058115, R01HL064937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); European Union Marie Curie fellowship(European Commission); American Heart Association Grant(American Heart Association); American Diabetes Association(American Diabetes Association); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); American Diabetes Association Junior Faculty Award(American Diabetes Association); Complexa, Inc.; Nitromega, Inc.; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL068878 and HL89544 (to Y. E. C. and L. V.); R01-HL058115, R01-HL64937, P30-DK072506, and P01-HL103455 (to B.A.F.); and R01-AT006822-01 (to F. J. S.). This work was also supported by the Wellcome Trust (to V. B. O., C. M. L, N. P., Y. G. D., and V. H.), a European Union Marie Curie fellowship (to C. P. T.), American Heart Association Grant 10SDG4150085 (to L. V.), the American Diabetes Association (to F. J. S.), the Academy of Finland and the Sigrid Juselius Foundation (to A. L. L. and E. K.), and American Diabetes Association Junior Faculty Award 7-08-JF 52 (to F. J. S.). B.A.F. acknowledges financial interest in Complexa, Inc. and Nitromega, Inc.	AKIYAMA Y, 1983, J CLIN INVEST, V72, P1093, DOI 10.1172/JCI111034; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Bazan HEP, 2005, EXP EYE RES, V80, P453, DOI 10.1016/j.exer.2004.12.023; Bowers RC, 2000, J BIOL CHEM, V275, P29931, DOI 10.1074/jbc.C000502200; Bruscia EM, 2009, AM J RESP CELL MOL, V40, P295, DOI 10.1165/rcmb.2008-0170OC; Clark SR, 2011, BLOOD, V117, P2033, DOI 10.1182/blood-2010-04-278887; Davies SS, 2001, J BIOL CHEM, V276, P16015, DOI 10.1074/jbc.M100878200; Dioszeghy V, 2008, J IMMUNOL, V181, P6514, DOI 10.4049/jimmunol.181.9.6514; Groeger AL, 2010, NAT CHEM BIOL, V6, P433, DOI 10.1038/nchembio.367; Gronert K, 2005, PROSTAG LEUKOTR ESS, V73, P221, DOI 10.1016/j.plefa.2005.05.009; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; Gulliksson M, 2007, BBA-MOL CELL BIOL L, V1771, P1156, DOI 10.1016/j.bbalip.2007.06.001; Harkewicz R, 2007, J BIOL CHEM, V282, P2899, DOI 10.1074/jbc.M610067200; Harmon GS, 2010, NAT MED, V16, P313, DOI 10.1038/nm.2101; Hartl D, 2006, J ALLERGY CLIN IMMUN, V117, P204, DOI 10.1016/j.jaci.2005.09.023; Hong JT, 2002, J TOXICOL ENV HEAL A, V65, P407, DOI 10.1080/15287390252808073; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Ide T, 2003, THROMB RES, V110, P311, DOI 10.1016/S0049-3848(03)00418-3; Kenchegowda S, 2011, INVEST OPHTH VIS SCI, V52, P2240, DOI 10.1167/iovs.10-6199; Kim EJ, 2003, J PHARMACOL EXP THER, V307, P505, DOI 10.1124/jpet.103.053876; Kuhn H, 1999, FEBS LETT, V449, P7, DOI 10.1016/S0014-5793(99)00396-8; Lee SH, 2007, CHEM RES TOXICOL, V20, P1665, DOI 10.1021/tx700130p; LEVY BD, 1993, J CLIN INVEST, V92, P1572, DOI 10.1172/JCI116738; Liu H, 1999, AM J PHYSIOL-LUNG C, V276, pL28, DOI 10.1152/ajplung.1999.276.1.L28; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Maskrey BH, 2007, J BIOL CHEM, V282, P20151, DOI 10.1074/jbc.M611776200; Morgan AH, 2010, NAT PROTOC, V5, P1919, DOI 10.1038/nprot.2010.162; Morgan AH, 2009, J BIOL CHEM, V284, P21185, DOI 10.1074/jbc.M109.021634; Morgan LT, 2010, BIOCHEM J, V431, P141, DOI 10.1042/BJ20100415; Murphy RC, 2002, PROSTAG OTH LIPID M, V68-9, P471, DOI 10.1016/S0090-6980(02)00049-7; Nagy L, 2012, PHYSIOL REV, V92, P739, DOI 10.1152/physrev.00004.2011; Necela BM, 2008, IMMUNOLOGY, V125, P344, DOI 10.1111/j.1365-2567.2008.02849.x; O'Flaherty JT, 2005, BBA-MOL CELL BIOL L, V1736, P228, DOI 10.1016/j.bbalip.2005.08.009; Oskolkova OV, 2010, J IMMUNOL, V185, P7706, DOI 10.4049/jimmunol.0903594; POWELL WS, 1992, J BIOL CHEM, V267, P19233; Tan HL, 2011, AM J RESP CRIT CARE, V184, P252, DOI 10.1164/rccm.201102-0236OC; Thomas CP, 2010, J BIOL CHEM, V285, P6891, DOI 10.1074/jbc.M109.078428; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Uderhardt S, 2012, IMMUNITY, V36, P834, DOI 10.1016/j.immuni.2012.03.010; Wei C, 2009, MOL PHARMACOL, V76, P516, DOI 10.1124/mol.109.057489; Zhang JF, 2010, CIRC RES, V107, P540, DOI 10.1161/CIRCRESAHA.110.218404; Zhao JM, 2011, P NATL ACAD SCI USA, V108, P14246, DOI 10.1073/pnas.1018075108	42	48	48	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41651	41666		10.1074/jbc.M112.405407	http://dx.doi.org/10.1074/jbc.M112.405407			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23060450	Green Published, hybrid			2022-12-28	WOS:000312103000009
J	Collier, DM; Peterson, ZJ; Blokhin, IO; Benson, CJ; Snyder, PM				Collier, Daniel M.; Peterson, Zerubbabel J.; Blokhin, Ilya O.; Benson, Christopher J.; Snyder, Peter M.			Identification of Extracellular Domain Residues Required for Epithelial Na+ Channel Activation by Acidic pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNELS; SELF-INHIBITION	A growing body of evidence suggests that the extracellular domain of the epithelial Na+ channel (ENaC) functions as a sensor that fine tunes channel activity in response to changes in the extracellular environment. We previously found that acidic pH increases the activity of human ENaC, which results from a decrease in Na+ self-inhibition. In the current work, we identified extracellular domain residues responsible for this regulation. We found that rat ENaC is less sensitive to pH than human ENaC, an effect mediated in part by the gamma subunit. We identified a group of seven residues in the extracellular domain of gamma ENaC (Asp-164, Gln-165, Asp-166, Glu-292, Asp-335, His-439, and Glu-455) that, when individually mutated to Ala, decreased proton activation of ENaC. gamma(E455) is conserved in beta ENaC (Glu-446); mutation of this residue to neutral amino acids (Ala, Cys) reduced ENaC stimulation by acidic pH, whereas reintroduction of a negative charge (by MTSES modification of Cys) restored pH regulation. Combination of the seven gamma ENaC mutations with beta(E446A) generated a channel that was not activated by acidic pH, but inhibition by alkaline pH was intact. Moreover, these mutations reduced the effect of pH on Na+ self-inhibition. Together, the data identify eight extracellular domain residues in human beta- and gamma ENaC that are required for regulation by acidic pH.	[Collier, Daniel M.; Peterson, Zerubbabel J.; Blokhin, Ilya O.; Benson, Christopher J.; Snyder, Peter M.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Collier, Daniel M.; Peterson, Zerubbabel J.; Blokhin, Ilya O.; Snyder, Peter M.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Snyder, PM (corresponding author), Univ Iowa, Carver Coll Med, Dept Internal Med, 371 EMRB, Iowa City, IA 52242 USA.	peter-snyder@uiowa.edu	Collier, Daniel/GVU-0199-2022	Benson, Christopher/0000-0001-6600-8193	National Institutes of Health [2T32HL007121-36, DK25295, HL072256]; American Heart Association Predoctoral Fellowship [10PRE2610282]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by National Institutes of Health Grant 2T32HL007121-36. Also supported by American Heart Association Predoctoral Fellowship 10PRE2610282.; Supported by National Institutes of Health Grant DK25295.; Supported by National Institutes of Health Grant HL072256. To whom correspondence should be addressed: 371 EMRB, University of Iowa, Iowa City, IA 52242. E-mail: peter-snyder@uiowa.edu.	Boase NA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1284; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Collier DM, 2011, J BIOL CHEM, V286, P6027, DOI 10.1074/jbc.M110.198127; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; KAVANAUGH JS, 1992, BIOCHEMISTRY-US, V31, P4111, DOI 10.1021/bi00131a030; Kimura T, 2011, P NATL ACAD SCI USA, V108, P3216, DOI 10.1073/pnas.1010334108; Kusama N, 2010, J BIOL CHEM, V285, P17425, DOI 10.1074/jbc.M109.091561; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; Rose B. D., 1984, CLIN PHYSL ACID BASE, P274; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329	25	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					40907	40914		10.1074/jbc.M112.417519	http://dx.doi.org/10.1074/jbc.M112.417519			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23060445	Green Published, hybrid			2022-12-28	WOS:000311887600010
J	Bradley, JM; Marritt, SJ; Kihlken, MA; Haynes, K; Hemmings, AM; Berks, BC; Cheesman, MR; Butt, JN				Bradley, Justin M.; Marritt, Sophie J.; Kihlken, Margaret A.; Haynes, Kate; Hemmings, Andrew M.; Berks, Ben C.; Cheesman, Myles R.; Butt, Julea N.			Redox and Chemical Activities of the Hemes in the Sulfur Oxidation Pathway Enzyme SoxAX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC CIRCULAR-DICHROISM; GRAM-NEGATIVE BACTERIA; PROTEIN ACTIVE-SITES; PARACOCCUS-PANTOTROPHUS; RHODOVULUM-SULFIDOPHILUM; RHODOBACTER-CAPSULATUS; STARKEYA-NOVELLA; CYSTEINE RESIDUE; CYTOCHROME; SPECTROSCOPY	SoxAX enzymes couple disulfide bond formation to the reduction of cytochrome c in the first step of the phylogenetically widespread Sox microbial sulfur oxidation pathway. Rhodovulum sulfidophilum SoxAX contains three hemes. An electrochemical cell compatible with magnetic circular dichroism at near infrared wavelengths has been developed to resolve redox and chemical properties of the SoxAX hemes. In combination with potentiometric titrations monitored by electronic absorbance and EPR, this method defines midpoint potentials (Em) at pH 7.0 of approximately +210, -340, and -400 mV for the His/Met, His/Cys(-), and active site His/CysS(-)-ligated heme, respectively. Exposing SoxAX to S2O42-, a substrate analog with E-m similar to-450 mV, but not Eu(II) complexed with diethylene triamine pentaacetic acid (Em similar to-1140 mV), allows cyanide to displace the cysteine persulfide (CysS(-)) ligand to the active site heme. This provides the first evidence for the dissociation of CysS(-) that has been proposed as a key event in SoxAX catalysis.	[Bradley, Justin M.; Marritt, Sophie J.; Haynes, Kate; Hemmings, Andrew M.; Cheesman, Myles R.; Butt, Julea N.] Univ E Anglia, Sch Chem, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England; [Bradley, Justin M.; Marritt, Sophie J.; Haynes, Kate; Hemmings, Andrew M.; Cheesman, Myles R.; Butt, Julea N.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Kihlken, Margaret A.; Berks, Ben C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of East Anglia; University of East Anglia; University of Oxford	Butt, JN (corresponding author), Univ E Anglia, Sch Chem, Ctr Mol & Struct Biochem, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	j.butt@uea.ac.uk	Butt, Julea/E-2133-2011; HEMMINGS, ANDREW MICHAEL/E-5517-2011	Butt, Julea/0000-0002-9624-5226; HEMMINGS, ANDREW MICHAEL/0000-0003-3053-3134; Berks, Ben/0000-0001-9685-4067	Biotechnology and Biosciences Research Council [B15211, C007808, B18695, G024758, G009228]; University of East Anglia; Biotechnology and Biological Sciences Research Council [B18695, BB/C007808/1] Funding Source: researchfish	Biotechnology and Biosciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of East Anglia; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Biotechnology and Biosciences Research Council (Grants B15211, C007808, B18695, G024758, and G009228) and the University of East Anglia.	Anderson LJ, 2001, BIOCHEMISTRY-US, V40, P11294, DOI 10.1021/bi002706b; Appia-Ayme C, 2001, J BACTERIOL, V183, P6107, DOI 10.1128/JB.183.20.6107-6118.2001; Astuti Y, 2004, J AM CHEM SOC, V126, P8001, DOI 10.1021/ja0496470; Bamford VA, 2002, EMBO J, V21, P5599, DOI 10.1093/emboj/cdf566; Bordo' D, 2001, BIOL CHEM, V382, P1245, DOI 10.1515/BC.2001.155; CHEESMAN MR, 1991, ADV INORG CHEM, V36, P201, DOI 10.1016/S0898-8838(08)60040-9; Cheesman MR, 2001, BIOCHEMISTRY-US, V40, P10562, DOI 10.1021/bi0100081; Dambe T, 2005, J STRUCT BIOL, V152, P229, DOI 10.1016/j.jsb.2005.09.002; Dhawan IK, 1999, BIOCHEMISTRY-US, V38, P12805, DOI 10.1021/bi991303c; Du J, 2011, COORDIN CHEM REV, V255, P700, DOI 10.1016/j.ccr.2011.01.029; Friedrich CG, 2005, CURR OPIN MICROBIOL, V8, P253, DOI 10.1016/j.mib.2005.04.005; Frigaard NU, 2009, ADV MICROB PHYSIOL, V54, P103, DOI 10.1016/S0065-2911(08)00002-7; GADSBY PMA, 1990, J AM CHEM SOC, V112, P5003, DOI 10.1021/ja00169a002; Gliubich F, 1996, J BIOL CHEM, V271, P21054, DOI 10.1074/jbc.271.35.21054; Kappler U, 2004, J BIOL CHEM, V279, P6252, DOI 10.1074/jbc.M310644200; Kappler U, 2002, FEBS LETT, V529, P208, DOI 10.1016/S0014-5793(02)03344-6; Kappler U, 2008, J BIOL CHEM, V283, P22206, DOI 10.1074/jbc.M800315200; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kemp GL, 2009, BIOCHEM SOC T, V37, P368, DOI 10.1042/BST0370368; Kilmartin JR, 2011, J BIOL CHEM, V286, P24872, DOI 10.1074/jbc.M110.212183; Male L, 2008, THEOR CHEM ACC, V119, P107, DOI 10.1007/s00214-006-0233-y; Marritt SJ, 2008, J AM CHEM SOC, V130, P8588, DOI 10.1021/ja802641a; Marritt SJ, 2006, ANAL BIOCHEM, V359, P79, DOI 10.1016/j.ab.2006.08.017; MCKNIGHT J, 1993, EUR J BIOCHEM, V213, P683, DOI 10.1111/j.1432-1033.1993.tb17808.x; Mishra P, 2007, CELL, V131, P80, DOI 10.1016/j.cell.2007.07.037; Ogawa T, 2008, J BACTERIOL, V190, P6097, DOI 10.1128/JB.00634-08; Ostergaard H, 2001, EMBO J, V20, P5853, DOI 10.1093/emboj/20.21.5853; Perera R, 2003, P NATL ACAD SCI USA, V100, P3641, DOI 10.1073/pnas.0737142100; Quentmeier A, 2001, FEBS LETT, V503, P168, DOI 10.1016/S0014-5793(01)02727-2; Reijerse EJ, 2007, BIOCHEMISTRY-US, V46, P7804, DOI 10.1021/bi7003526; Sauve V, 2007, J BIOL CHEM, V282, P23194, DOI 10.1074/jbc.M701602200; Shaw AL, 1999, MICROBIOL-UK, V145, P1409, DOI 10.1099/13500872-145-6-1409; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Sono M, 2005, ARCH BIOCHEM BIOPHYS, V436, P40, DOI 10.1016/j.abb.2004.12.026; Vincent KA, 2003, CHEM COMMUN, P2590, DOI 10.1039/b308188e; Walker FA, 1999, COORDIN CHEM REV, V185-6, P471, DOI 10.1016/S0010-8545(99)00029-6; WEAVER PF, 1975, ARCH MICROBIOL, V105, P207, DOI 10.1007/BF00447139; Yoshioka S, 2001, EUR J BIOCHEM, V268, P252, DOI 10.1046/j.1432-1033.2001.01872.x	38	10	11	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40350	40359		10.1074/jbc.M112.396192	http://dx.doi.org/10.1074/jbc.M112.396192			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23060437	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000311448800026
J	Choi, JC; Wu, W; Muchir, A; Iwata, S; Homma, S; Worman, HJ				Choi, Jason C.; Wu, Wei; Muchir, Antoine; Iwata, Shinichi; Homma, Shunichi; Worman, Howard J.			Dual Specificity Phosphatase 4 Mediates Cardiomyopathy Caused by Lamin A/C (LMNA) Gene Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE PHOSPHATASE-1; HEART-FAILURE; DILATED CARDIOMYOPATHY; MUSCULAR-DYSTROPHY; NUCLEAR-ENVELOPE; INSULIN-RESISTANCE; PREMATURE DEATH; HYPERTROPHY; STRESS; METABOLISM	Mutations in the lamin A/C gene (LMNA) cause a diverse spectrum of diseases, the most common of which is dilated cardiomyopathy often with skeletal muscular dystrophy. Lamin A and C are fundamental components of the nuclear lamina, a dynamic meshwork of intermediate filaments lining the nuclear envelope inner membrane. Prevailing evidence suggests that the nuclear envelope functions as a signaling node and that abnormality in the nuclear lamina leads to dysregulated signaling pathways that underlie disease pathogenesis. We previously showed that activated ERK1/2 in hearts of a mouse model of LMNA cardiomyopathy (Lmna(H222P/H222P) mice) contributes to disease, but the complete molecular pathogenesis remains poorly understood. Here we uncover a pathogenic role of dual specificity phosphatase 4 (Dusp4), which is transcriptionally induced by ERK1/2. Dusp4 is highly expressed in the hearts of LmnaH222P/H222P mice, and transgenic mice with cardiac-selective overexpression of Dusp4 display heart dysfunction similar to LMNA cardiomyopathy. In both primary tissue and cell culture models, overexpression of Dusp4 positively regulates AKT-mTOR signaling, resulting in impaired autophagy. These findings identify a pathogenic role of Dusp4 in LMNA cardiomyopathy.	[Choi, Jason C.; Wu, Wei; Muchir, Antoine; Iwata, Shinichi; Homma, Shunichi; Worman, Howard J.] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Choi, Jason C.; Wu, Wei; Muchir, Antoine; Worman, Howard J.] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA	Columbia University; Columbia University	Worman, HJ (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Med, 630W 168th St,P&S 10-508, New York, NY 10032 USA.	hjw14@columbia.edu		Muchir, Antoine/0000-0002-4780-9275	National Institutes of Health [R01AR048997, F32-HL094037]; Muscular Dystrophy Association [MDA172222]; NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL094037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048997] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AR048997. This work was also supported by Muscular Dystrophy Association Grant MDA172222 ( to H. J. W.). The authors have reported a direct financial conflict of interest: H. J. W. and A. M. are inventors on a pending patent application (PCT/US09/42614) on methods for treating and/or preventing cardiomyopathies by ERK and JNK inhibition filed by the trustees of Columbia University. H. J. W. and J. C. C. are inventors on a provisional patent application on the use of rapamycin and rapamycin analogs for the treatment of dilated cardiomyopathies filed by the trustees of Columbia University.; Supported by a Ruth L. Kirschstein National Research Service Award Individual Fellowship through NHLBI, National Institutes of Health Grant F32-HL094037.	Arimura T, 2005, HUM MOL GENET, V14, P155, DOI 10.1093/hmg/ddi017; Baba HA, 2003, CARDIOVASC RES, V59, P390, DOI 10.1016/S0008-6363(03)00393-6; Bertrand AT, 2012, HUM MOL GENET, V21, P1037, DOI 10.1093/hmg/ddr534; BING RJ, 1954, AM J MED, V16, P504, DOI 10.1016/0002-9343(54)90365-4; Blanchet E, 2011, NAT CELL BIOL, V13, P1146, DOI 10.1038/ncb2309; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Brooks WW, 2010, GENOMICS, V95, P84, DOI 10.1016/j.ygeno.2009.12.002; Choi JC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003875; Communal C, 2002, J CARD FAIL, V8, P86, DOI 10.1054/jcaf.2002.32755; Cutler DA, 2002, BIOCHEM BIOPH RES CO, V291, P522, DOI 10.1006/bbrc.2002.6466; Dauer WT, 2009, DEV CELL, V17, P626, DOI 10.1016/j.devcel.2009.10.016; Galindo Cristi L., 2009, BMC Physiology, V9, P23, DOI 10.1186/1472-6793-9-23; Haq S, 2001, CIRCULATION, V103, P670; Hernandez L, 2010, DEV CELL, V19, P413, DOI 10.1016/j.devcel.2010.08.013; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Karoor V, 2004, J MOL CELL CARDIOL, V36, P305, DOI 10.1016/j.yjmcc.2003.11.006; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kubben N, 2011, NUCLEUS-PHILA, V2, P195, DOI 10.4161/nucl.2.3.15731; LIN F, 1993, J BIOL CHEM, V268, P16321; Luckey SW, 2009, J MOL CELL CARDIOL, V46, P739, DOI 10.1016/j.yjmcc.2009.02.010; Gonzalez JM, 2008, J CELL BIOL, V183, P653, DOI 10.1083/jcb.200805049; Marin TM, 2011, J CLIN INVEST, V121, P1026, DOI 10.1172/JCI44972; Mauro C, 2011, NAT CELL BIOL, V13, P1272, DOI 10.1038/ncb2324; MCMAHON DK, 1994, AM J PHYSIOL, V266, pC1795, DOI 10.1152/ajpcell.1994.266.6.C1795; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042; Muchir A, 2012, CARDIOVASC RES, V93, P311, DOI 10.1093/cvr/cvr301; Muchir A, 2009, HUM MOL GENET, V18, P241, DOI 10.1093/hmg/ddn343; OPIE LH, 1968, AM HEART J, V76, P685, DOI 10.1016/0002-8703(68)90168-3; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Princen F, 2009, MOL CELL BIOL, V29, P378, DOI 10.1128/MCB.01661-08; Purcell NH, 2007, P NATL ACAD SCI USA, V104, P14074, DOI 10.1073/pnas.0610906104; Ramos FJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003802; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Sakabe NJ, 2012, HUM MOL GENET, V21, P2194, DOI 10.1093/hmg/dds034; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Semple D, 2011, J AM SOC NEPHROL, V22, P207, DOI 10.1681/ASN.2009090900; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Son NH, 2007, J CLIN INVEST, V117, P2791, DOI 10.1172/JCI30335; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Takeishi Y, 2002, CARDIOVASC RES, V53, P131, DOI 10.1016/S0008-6363(01)00438-2; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wu W, 2011, CIRCULATION, V123, P53, DOI 10.1161/CIRCULATIONAHA.110.970673; Zebedin E, 2007, AM J PHYSIOL-HEART C, V292, pH439, DOI 10.1152/ajpheart.00119.2006	47	39	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40513	40524		10.1074/jbc.M112.404541	http://dx.doi.org/10.1074/jbc.M112.404541			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23048029	Green Published, hybrid			2022-12-28	WOS:000311448800042
J	Crooks, DR; Jeong, SY; Tong, WH; Ghosh, MC; Olivierre, H; Haller, RG; Rouault, TA				Crooks, Daniel R.; Jeong, Suh Young; Tong, Wing-Hang; Ghosh, Manik C.; Olivierre, Hayden; Haller, Ronald G.; Rouault, Tracey A.			Tissue Specificity of a Human Mitochondrial Disease DIFFERENTIATION-ENHANCED MIS-SPLICING OF THE Fe-S SCAFFOLD GENE ISCU RENDERS PATIENT CELLS MORE SENSITIVE TO OXIDATIVE STRESS IN ISCU MYOPATHY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFUR CLUSTER BIOGENESIS; SUCCINATE-DEHYDROGENASE; LACTIC-ACIDOSIS; PAROXYSMAL MYOGLOBINURIA; ACONITASE DEFICIENCY; HEREDITARY MYOPATHY; IRON HOMEOSTASIS; MAMMALIAN-CELLS; INTRON MUTATION; SKELETAL-MUSCLE	Iron-sulfur (Fe-S) cluster cofactors are formed on the scaffold protein ISCU. ISCU myopathy is a disease caused by an intronic mutation that leads to abnormally spliced ISCU mRNA. We found that two predominant mis-spliced ISCU mRNAs produce a truncated and short-lived ISCU protein product in multiple patient cell types. Expression of the muscle-specific transcription factor MyoD further diminished normal splicing of ISCU mRNA in patient myoblasts, demonstrating that the process of muscle differentiation enhances the loss of normal ISCU mRNA splicing. ISCU protein was nearly undetectable in patient skeletal muscle, but was higher in patient myoblasts, fibroblasts, and lymphoblasts. We next treated patient cells with pro-oxidants to mimic the oxidative stress associated with muscle activity. Brief hydrogen peroxide treatment or incubation in an enriched oxygen atmosphere led to a marked further reduction of ISCU protein levels, which could be prevented by pretreatment with the antioxidant ascorbate. Thus, we conclude that skeletal muscle differentiation of patient cells causes a higher degree of abnormal ISCU splicing and that oxidative stress resulting from skeletal muscle work destabilizes the small amounts of normal ISCU protein generated in patient skeletal muscles.	[Crooks, Daniel R.] Georgetown Univ, Dept Biochem Mol & Cellular Biol, Med Ctr, Washington, DC 20057 USA; [Crooks, Daniel R.; Jeong, Suh Young; Tong, Wing-Hang; Ghosh, Manik C.; Olivierre, Hayden; Rouault, Tracey A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Mol Med, NIH, Bethesda, MD 20892 USA; [Haller, Ronald G.] Texas Hlth Presbyterian Hosp, Neuromuscular Ctr, Inst Exercise & Environm Med, Dallas, TX 75231 USA; [Haller, Ronald G.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Haller, Ronald G.] N Texas VA Med Ctr, Div Neurol, Dallas, TX 75216 USA	Georgetown University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Rouault, TA (corresponding author), Bldg 18T,Rm 101,9000 Rockville Pike, Bethesda, MD 20892 USA.	rouault@helix.nih.gov		Jeong, Suh Young/0000-0002-6376-7001	National Institutes of Health through the NICHD Intramural Research Program; NIAMS [R01 AR050597]; Veterans Affairs Merit Review; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008814] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008814] Funding Source: NIH RePORTER	National Institutes of Health through the NICHD Intramural Research Program; NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs Merit Review(US Department of Veterans Affairs); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the National Institutes of Health through the NICHD Intramural Research Program (to T. A. R.) and NIAMS Grant R01 AR050597 (to R. G. H.). This work was also supported by a Veterans Affairs Merit Review (to R. G. H.).	ALESSIO HM, 1988, AM J PHYSIOL, V255, pC874, DOI 10.1152/ajpcell.1988.255.6.C874; Bach M, 2007, FEBS J, V274, P783, DOI 10.1111/j.1742-4658.2006.05623.x; Bitoun JP, 2008, BIOMETALS, V21, P693, DOI 10.1007/s10534-008-9154-7; Crooks DR, 2007, J NEUROSCI RES, V85, P1797, DOI 10.1002/jnr.21321; Crooks DR, 2010, BLOOD, V115, P860, DOI 10.1182/blood-2009-09-243105; DRUGGE U, 1995, J MED GENET, V32, P344, DOI 10.1136/jmg.32.5.344; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; Guillon B, 2009, FEBS J, V276, P1036, DOI 10.1111/j.1742-4658.2008.06847.x; HALBERT CL, 1991, J VIROL, V65, P473, DOI 10.1128/JVI.65.1.473-478.1991; HALL RE, 1993, J CLIN INVEST, V92, P2660, DOI 10.1172/JCI116882; HALLER RG, 1991, J CLIN INVEST, V88, P1197, DOI 10.1172/JCI115422; Holloszy JO, 1996, ANNU REV NUTR, V16, P121, DOI 10.1146/annurev.nu.16.070196.001005; Jang SJ, 2010, MOL MICROBIOL, V78, P1448, DOI 10.1111/j.1365-2958.2010.07418.x; Jeong SY, 2003, J BIOL CHEM, V278, P27144, DOI 10.1074/jbc.M301988200; Kavazis AN, 2009, FREE RADICAL BIO MED, V46, P842, DOI 10.1016/j.freeradbiomed.2009.01.002; Kirkinezos IG, 2001, SEMIN CELL DEV BIOL, V12, P449, DOI 10.1006/scdb.2001.0282; Kollberg G, 2011, NEUROMUSCULAR DISORD, V21, P115, DOI 10.1016/j.nmd.2010.11.010; Kollberg G, 2009, BRAIN, V132, P2170, DOI 10.1093/brain/awp152; Land T, 1998, MOL CELL, V2, P807, DOI 10.1016/S1097-2765(00)80295-6; LARSSON LE, 1964, J NEUROL NEUROSUR PS, V27, P361, DOI 10.1136/jnnp.27.5.361; Li KY, 2008, HUM MOL GENET, V17, P2265, DOI 10.1093/hmg/ddn127; LINDERHOLM H, 1969, ACTA MED SCAND, V185, P153; LINDERHOLM H, 1990, J INTERN MED, V228, P43, DOI 10.1111/j.1365-2796.1990.tb00191.x; Liu XF, 2008, J VIROL, V82, P11568, DOI 10.1128/JVI.01318-08; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lochmuller H, 1999, EXP CELL RES, V248, P186, DOI 10.1006/excr.1999.4407; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; Martelli A, 2012, DIS MODEL MECH, V5, P165, DOI 10.1242/dmm.008706; MEYDANI M, 1993, AM J PHYSIOL, V264, pR992, DOI 10.1152/ajpregu.1993.264.5.R992; MEYDANI M, 1992, ANN NY ACAD SCI, V669, P363; Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nordin A, 2012, HUM MUTAT, V33, P467, DOI 10.1002/humu.22002; Nordin A, 2011, HUM GENET, V129, P371, DOI 10.1007/s00439-010-0931-3; Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057; Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019; Sanaker PS, 2010, BBA-MOL BASIS DIS, V1802, P539, DOI 10.1016/j.bbadis.2010.02.010; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; SEN CK, 1995, J APPL PHYSIOL, V79, P675, DOI 10.1152/jappl.1995.79.3.675; Shi YB, 2009, HUM MOL GENET, V18, P3014, DOI 10.1093/hmg/ddp239; Shoubridge E A, 1996, Methods Enzymol, V264, P465, DOI 10.1016/S0076-6879(96)64042-7; Song JY, 2012, P NATL ACAD SCI USA, V109, P10370, DOI 10.1073/pnas.1206945109; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Uhrigshardt H, 2010, HUM MOL GENET, V19, P3816, DOI 10.1093/hmg/ddq301; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906	48	29	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40119	40130		10.1074/jbc.M112.418889	http://dx.doi.org/10.1074/jbc.M112.418889			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23035118	hybrid, Green Published			2022-12-28	WOS:000311448800003
J	Didovyk, A; Verdine, GL				Didovyk, Andriy; Verdine, Gregory L.			Structural Origins of DNA Target Selection and Nucleobase Extrusion by a DNA Cytosine Methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEIC-ACID STRUCTURES; HHAI METHYLTRANSFERASE; SOFTWARE; MECHANISM; VISUALIZATION; METHYLATION; SYSTEM; IDENTIFICATION; RECOGNITION; CATALYSIS	Epigenetic methylation of cytosine residues in DNA is an essential element of genome maintenance and function in organisms ranging from bacteria to humans. DNA 5-cytosine methyltransferase enzymes (DCMTases) catalyze cytosine methylation via reaction intermediates in which the DNA is drastically remodeled, with the target cytosine residue extruded from the DNA helix and plunged into the active site pocket of the enzyme. We have determined a crystal structure of M.HaeIII DCMTase in complex with its DNA substrate at a previously unobserved state, prior to extrusion of the target cytosine and frameshifting of the DNA recognition sequence. The structure reveals that M.HaeIII selects the target cytosine and destabilizes its base-pairing through a precise, focused, and coordinated assault on the duplex DNA, which isolates the target cytosine from its nearest neighbors and thereby facilitates its extrusion from DNA.	[Verdine, Gregory L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Didovyk, Andriy; Verdine, Gregory L.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Dana Farber Canc Inst, Program Canc Chem Biol, Boston, MA 02115 USA; [Verdine, Gregory L.] Dana Farber Canc Inst, Chem Biol Initiat, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Verdine, GL (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, 12 Oxford St, Cambridge, MA 02138 USA.	gregory_verdine@harvard.edu			National Institutes of Health Grant [GM044853]; National Center for Research Resources at the National Institutes of Health [RR-15301]; National Institutes of Health from the NCI [Y1-CO-1020]; National Institutes of Health from the NIGMS [Y1-GM-1104]; United States Department of Energy (U.S. DOE) [DE-AC02-06CH11357]; U.S. DOE, Basic Energy Sciences, Office of Science [W-31-109-ENG-38]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044853] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy (U.S. DOE)(United States Department of Energy (DOE)); U.S. DOE, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM044853 (to G. L. V.). This work is based upon research conducted at the Advanced Photon Source on the NE-CAT and GM/CA-CAT beamlines. NE-CAT is supported by award RR-15301 from the National Center for Research Resources at the National Institutes of Health. GM/CA-CAT was supported, in whole or in part, by National Institutes of Health Grants Y1-CO-1020 from the NCI and Y1-GM-1104 from the NIGMS. Use of the Advanced Photon Source was supported by the United States Department of Energy (U.S. DOE) under Contract DE-AC02-06CH11357 and by the U.S. DOE, Basic Energy Sciences, Office of Science, under Contract W-31-109-ENG-38.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN L, 1991, BIOCHEMISTRY-US, V30, P11018, DOI 10.1021/bi00110a002; CHEN L, 1993, J AM CHEM SOC, V115, P5318, DOI 10.1021/ja00065a063; Echols N, 2003, NUCLEIC ACIDS RES, V31, P478, DOI 10.1093/nar/gkg104; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Estabrook RA, 2009, J BIOL CHEM, V284, P22690, DOI 10.1074/jbc.M109.015966; Gerasimaite R, 2011, NUCLEIC ACIDS RES, V39, P3771, DOI 10.1093/nar/gkq1329; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klimasauskas S, 1998, EMBO J, V17, P317, DOI 10.1093/emboj/17.1.317; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Matje DM, 2011, BIOCHEMISTRY-US, V50, P1465, DOI 10.1021/bi101446g; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; OSTERMAN DG, 1988, BIOCHEMISTRY-US, V27, P5204, DOI 10.1021/bi00414a039; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papworth C, 1996, STRATEGIES, V9, P4; Qi Y, 2009, NATURE, V462, P762, DOI 10.1038/nature08561; Radlinska M, 2005, PROTEINS, V58, P263, DOI 10.1002/prot.20297; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Verdine GL, 2003, ANNU REV BIOCHEM, V72, P337, DOI 10.1146/annurev.biochem.72.121801.161447; WU JC, 1987, J BIOL CHEM, V262, P4778; Zangi R, 2010, J MOL BIOL, V400, P632, DOI 10.1016/j.jmb.2010.05.021; Zhang XD, 2006, P NATL ACAD SCI USA, V103, P6148, DOI 10.1073/pnas.0601587103	31	1	2	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40099	40105		10.1074/jbc.M112.413054	http://dx.doi.org/10.1074/jbc.M112.413054			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23012373	Green Published, hybrid			2022-12-28	WOS:000311448800001
J	Hill, KE; Wu, S; Motley, AK; Stevenson, TD; Winfrey, VP; Capecchi, MR; Atkins, JF; Burk, RF				Hill, Kristina E.; Wu, Sen; Motley, Amy K.; Stevenson, Teri D.; Winfrey, Virginia P.; Capecchi, Mario R.; Atkins, John F.; Burk, Raymond F.			Production of Selenoprotein P (Sepp1) by Hepatocytes Is Central to Selenium Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-E RECEPTOR-2; WHOLE-BODY SELENIUM; MOUSE-BRAIN; SELENOCYSTEINE; RAT; LIVER; GENE; MICE; EXCRETION; DELETION	Sepp1 is a widely expressed extracellular protein that in humans and mice contains 10 selenocysteine residues in its primary structure. Extra-hepatic tissues take up plasma Sepp1 for its selenium via apolipoprotein E receptor-2 (apoER2)-mediated endocytosis. The role of Sepp1 in the transport of selenium from liver, a rich source of the element, to peripheral tissues was studied using mice with selective deletion of Sepp1 in hepatocytes (Sepp1(c/c)/ alb-cre(+/-) mice). Deletion of Sepp1 in hepatocytes lowered plasma Sepp1 concentration to 10% of that in Sepp1(c/c) mice (controls) and increased urinary selenium excretion, decreasing whole-body and tissue selenium concentrations. Under selenium-deficient conditions, Sepp1(c/c)/alb-cre(+/-) mice accumulated selenium in the liver at the expense of extra-hepatic tissues, severely worsening clinical manifestations of dietary selenium deficiency. These findings are consistent with there being competition for metabolically available hepatocyte selenium between the synthesis of selenoproteins and the synthesis of selenium excretory metabolites. In addition, selenium deficiency down-regulated the mRNA of the most abundant hepatic selenoprotein, glutathione peroxidase-1 (Gpx1), to 15% of the selenium-replete value, while reducing Sepp1 mRNA, the most abundant hepatic selenoprotein mRNA, only to 61%. This strongly suggests that Sepp1 synthesis is favored in the liver over Gpx1 synthesis when selenium supply is limited, directing hepatocyte selenium to peripheral tissues in selenium deficiency. We conclude that production of Sepp1 by hepatocytes is central to selenium homeostasis in the organism because it promotes retention of selenium in the body and effects selenium distribution from the liver to extra-hepatic tissues, especially under selenium-deficient conditions.	[Hill, Kristina E.; Motley, Amy K.; Stevenson, Teri D.; Winfrey, Virginia P.; Burk, Raymond F.] Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37232 USA; [Wu, Sen; Capecchi, Mario R.; Atkins, John F.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Atkins, John F.] Univ Coll, BioSci Inst, Cork, Ireland	Vanderbilt University; Utah System of Higher Education; University of Utah; University College Cork	Burk, RF (corresponding author), Vanderbilt Univ Sch Med, 1030C Med Res Bldg 4, Nashville, TN 37232 USA.	raymond.burk@vanderbilt.edu		Atkins, John/0000-0001-7933-0165	National Institutes of Health [R37 ES002497, 5P30 DK058404, 5P30 ES000267]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267, R37ES002497] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 ES002497, 5P30 DK058404, and 5P30 ES000267.	Beffert U, 2006, CURR BIOL, V16, P2446, DOI 10.1016/j.cub.2006.10.029; Budiman ME, 2009, MOL CELL, V35, P479, DOI 10.1016/j.molcel.2009.06.026; Burk RF, 2006, BBA-GEN SUBJECTS, V1760, P1789, DOI 10.1016/j.bbagen.2006.08.010; Burk RF, 2009, BBA-GEN SUBJECTS, V1790, P1441, DOI 10.1016/j.bbagen.2009.03.026; BURK RF, 1973, P SOC EXP BIOL MED, V142, P214, DOI 10.3181/00379727-142-36991; Carlson BA, 2004, J BIOL CHEM, V279, P8011, DOI 10.1074/jbc.M310470200; Chiu-Ugalde J, 2010, BIOCHEM J, V431, P103, DOI 10.1042/BJ20100779; ESAKI N, 1982, J BIOL CHEM, V257, P4386; Guimaraes MJ, 1996, P NATL ACAD SCI USA, V93, P15086, DOI 10.1073/pnas.93.26.15086; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Hill KE, 2004, J NUTR, V134, P157, DOI 10.1093/jn/134.1.157; Hill KE, 2007, J BIOL CHEM, V282, P10972, DOI 10.1074/jbc.M700436200; Ho YS, 1997, J BIOL CHEM, V272, P16644, DOI 10.1074/jbc.272.26.16644; Hoffmann PR, 2007, NUCLEIC ACIDS RES, V35, P3963, DOI 10.1093/nar/gkm355; KATO T, 1992, AM J PHYSIOL, V262, pG854, DOI 10.1152/ajpgi.1992.262.5.G854; Kobayashi Y, 2002, P NATL ACAD SCI USA, V99, P15932, DOI 10.1073/pnas.252610699; KOH TS, 1983, J ASSOC OFF ANA CHEM, V66, P918; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kurokawa S, 2012, J BIOL CHEM, V287, P28717, DOI 10.1074/jbc.M112.383521; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; Ma SG, 2002, J BIOL CHEM, V277, P12749, DOI 10.1074/jbc.M111462200; MCCONNELL KP, 1952, J BIOL CHEM, V195, P277; Nakayama A, 2007, J NUTR, V137, P690, DOI 10.1093/jn/137.3.690; Okuno T, 2006, BIOL TRACE ELEM RES, V109, P155, DOI 10.1385/BTER:109:2:155; Olson GE, 2008, J BIOL CHEM, V283, P6854, DOI 10.1074/jbc.M709945200; Olson GE, 2007, J BIOL CHEM, V282, P12290, DOI 10.1074/jbc.M611403200; Olson GE, 2010, AM J PHYSIOL-RENAL, V298, pF1244, DOI 10.1152/ajprenal.00662.2009; Olson GE, 2005, BIOL REPROD, V73, P201, DOI 10.1095/biolreprod.105.040360; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Schweizer U, 2005, BIOCHEM J, V386, P221, DOI 10.1042/BJ20041973; SHEEHAN TMT, 1990, CLIN CHEM, V36, P2124; Shiobara Y, 1999, ANALYST, V124, P1237, DOI 10.1039/a902922b; Sunde RA, 2011, ADV NUTR, V2, P138, DOI 10.3945/an.110.000240; Sunde RA, 2009, BIOSCIENCE REP, V29, P329, DOI 10.1042/BSR20080146; Valentine WM, 2008, J NEUROPATH EXP NEUR, V67, P68, DOI 10.1097/NEN.0b013e318160f347; WALLACE E, 1983, GAMETE RES, V7, P377, DOI 10.1002/mrd.1120070409; Wu S, 2008, NAT PROTOC, V3, P1056, DOI 10.1038/nprot.2008.70; YANG JG, 1989, J NUTR, V119, P1010, DOI 10.1093/jn/119.7.1010; Yang XG, 2000, BBA-GEN SUBJECTS, V1474, P390, DOI 10.1016/S0304-4165(00)00035-0; Zhang Y, 2008, J BIOL CHEM, V283, P2427, DOI 10.1074/jbc.M707951200	40	100	104	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40414	40424		10.1074/jbc.M112.421404	http://dx.doi.org/10.1074/jbc.M112.421404			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23038251	Green Published, hybrid			2022-12-28	WOS:000311448800032
J	Jagtap, PKA; Soni, V; Vithani, N; Jhingan, GD; Bais, VS; Nandicoori, VK; Prakash, B				Jagtap, Pravin Kumar Ankush; Soni, Vijay; Vithani, Neha; Jhingan, Gagan Deep; Bais, Vaibhav Singh; Nandicoori, Vinay Kumar; Prakash, Balaji			Substrate-bound Crystal Structures Reveal Features Unique to Mycobacterium tuberculosis N-Acetyl-glucosamine 1-Phosphate Uridyltransferase and a Catalytic Mechanism for Acetyl Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; N-ACETYLGLUCOSAMINE-1-PHOSPHATE URIDYLTRANSFERASE; GLUCOSAMINE-1-PHOSPHATE ACETYLTRANSFERASE; ACTIVE-SITE; UDP-GALNAC; GLMU; ACETYLGLUCOSAMINE; PYROPHOSPHORYLASE; VALIDATION; EXPRESSION	N-Acetyl-glucosamine-1-phosphateuridyltransferase(GlmU), a bifunctional enzyme involved in bacterial cell wall synthesis is exclusive to prokaryotes. GlmU, now recognized as a promising target to develop new antibacterial drugs, catalyzes two key reactions: acetyl transfer and uridyl transfer at two independent domains. Hitherto, we identified GlmU from Mycobacterium tuberculosis (GlmU(Mtb)) to be unique in possessing a 30-residue extension at the C terminus. Here, we present the crystal structures of GlmU(Mtb) in complex with substrates/products bound at the acetyltransferase active site. Analysis of these and mutational data, allow us to infer a catalytic mechanism operative in GlmU(Mtb). In this S(N)2 reaction, His-374 and Asn-397 act as catalytic residues by enhancing the nucleophilicity of the attacking amino group of glucosamine 1-phosphate. Ser-416 and Trp-460 provide important interactions for substrate binding. A short helix at the C-terminal extension uniquely found in mycobacterial GlmU provides the highly conserved Trp-460 for substrate binding. Importantly, the structures reveal an uncommon mode of acetyl-CoA binding in GlmU(Mtb); we term this the U conformation, which is distinct from the L conformation seen in the available non-mycobacterial GlmU structures. Residues, likely determining U/L conformation, were identified, and their importance was evaluated. In addition, we identified that the primary site for PknB-mediated phosphorylation is Thr-418, near the acetyltransferase active site. Down-regulation of acetyltransferase activity upon Thr-418 phosphorylation is rationalized by the structures presented here. Overall, this work provides an insight into substrate recognition, catalytic mechanism for acetyl transfer, and features unique to GlmU(Mtb), which may be exploited for the development of inhibitors specific to GlmU.	[Soni, Vijay; Jhingan, Gagan Deep; Nandicoori, Vinay Kumar] Natl Inst Immunol, New Delhi 110067, India; [Jagtap, Pravin Kumar Ankush; Vithani, Neha; Bais, Vaibhav Singh; Prakash, Balaji] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Nandicoori, VK (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	vinaykn@nii.ac.in; bprakash@iitk.ac.in	Jagtap, Pravin Kumar Ankush/AAB-8149-2020; Vithani, Neha/AEA-8375-2022	Jagtap, Pravin Kumar Ankush/0000-0002-9457-4130; SONI, VIJAY/0000-0002-3395-7429; Nandicoori, Vinay/0000-0002-5682-4178	Department of Biotechnology, India [PR13047/MED]; National Bioscience Award; Council of Scientific and Industrial Research; Department of Biotechnology; Indian Council of Medical Research; Department of Science and Technology (India)	Department of Biotechnology, India(Department of Biotechnology (DBT) India); National Bioscience Award; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology; Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Department of Science and Technology (India)(Department of Science & Technology (India))	Supported by intramural and extramural funding provided by the Department of Biotechnology (PR13047/MED), India, and the National Bioscience Award.; Supported by the Council of Scientific and Industrial Research, the Department of Biotechnology, the Indian Council of Medical Research, the Department of Science and Technology (India), and the National Bioscience Award.	ANDERSON MS, 1987, J BIOL CHEM, V262, P5159; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Buurman ET, 2011, J BIOL CHEM, V286, P40734, DOI 10.1074/jbc.M111.274068; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khan S, 2010, J BIOL CHEM, V285, P37860, DOI 10.1074/jbc.M110.143131; Kostrewa D, 2001, EMBO J, V20, P4391, DOI 10.1093/emboj/20.16.4391; MENGINLECREULX D, 1994, J BACTERIOL, V176, P5788, DOI 10.1128/JB.176.18.5788-5795.1994; Mio T, 1998, J BIOL CHEM, V273, P14392, DOI 10.1074/jbc.273.23.14392; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICKLAUS MC, 1995, BIOORGAN MED CHEM, V3, P411, DOI 10.1016/0968-0896(95)00031-B; Olsen LR, 2007, PROTEIN SCI, V16, P1230, DOI 10.1110/ps.072779707; Olsen LR, 2001, BIOCHEMISTRY-US, V40, P1913, DOI 10.1021/bi002503n; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Parikh A, 2009, J MOL BIOL, V386, P451, DOI 10.1016/j.jmb.2008.12.031; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sulzenbacher G, 2001, J BIOL CHEM, V276, P11844, DOI 10.1074/jbc.M011225200; Verma SK, 2009, ACTA CRYSTALLOGR F, V65, P435, DOI 10.1107/S1744309109010252; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang-Gillam A, 1998, J BIOL CHEM, V273, P27055, DOI 10.1074/jbc.273.42.27055; Wang-Gillam A, 2000, J BIOL CHEM, V275, P1433, DOI 10.1074/jbc.275.2.1433; Zhang WL, 2008, INT J BIOCHEM CELL B, V40, P2560, DOI 10.1016/j.biocel.2008.05.003; Zhang Z, 2009, ACTA CRYSTALLOGR D, V65, P275, DOI 10.1107/S0907444909001036; Zhou Y, 2012, GLYCOCONJUGATE J, V29, P297, DOI 10.1007/s10719-012-9402-5	24	19	19	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.390765	http://dx.doi.org/10.1074/jbc.M112.390765			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	22969087	Green Published, hybrid			2022-12-28	WOS:000311233800024
J	King, BS; Cooper, KL; Liu, KJ; Hudson, LG				King, Brenee S.; Cooper, Karen L.; Liu, Ke Jian; Hudson, Laurie G.			Poly(ADP-ribose) Contributes to an Association between Poly(ADP-ribose) Polymerase-1 and Xeroderma Pigmentosum Complementation Group A in Nucleotide Excision Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; BINDING-PROTEINS; MACRO DOMAIN; XPA PROTEIN; PARP-1; IDENTIFICATION; RECRUITMENT; INHIBITORS; MOTIFS; FAMILY	Exposure to ultraviolet radiation (UVR) promotes the formation of UVR-induced, DNA helix distorting photolesions such as (6-4) pyrimidine-pyrimidone photoproducts and cyclobutane pyrimidine dimers. Effective repair of such lesions by the nucleotide excision repair (NER) pathway is required to prevent DNA mutations and chromosome aberrations. Poly(ADP-ribose) polymerase-1 (PARP-1) is a zinc finger protein with well documented involvement in base excision repair. PARP-1 is activated in response to DNA damage and catalyzes the formation of poly(ADP-ribose) subunits that assist in the assembly of DNA repair proteins at sites of damage. In this study, we present evidence for PARP-1 contributions to NER, extending the knowledge of PARP-1 function in DNA repair beyond the established role in base excision repair. Silencing the PARP-1 protein or inhibiting PARP activity leads to retention of UVR-induced photolesions. PARP activation following UVR exposure promotes association between PARP-1 and XPA, a central protein in NER. Administration of PARP inhibitors confirms that poly(ADP-ribose) facilitates PARP-1 association with XPA in whole cell extracts, in isolated chromatin complexes, and in vitro. Furthermore, inhibition of PARP activity decreases UVR-stimulated XPA chromatin association, illustrating that these relationships occur in a meaningful context for NER. These results provide a mechanistic link for PARP activity in the repair of UVR-induced photoproducts.	[King, Brenee S.; Cooper, Karen L.; Liu, Ke Jian; Hudson, Laurie G.] Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA	University of New Mexico	Hudson, LG (corresponding author), Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, MSC09 5360,1 Univ New Mexico, Albuquerque, NM 87131 USA.	LHudson@salud.unm.edu	King, Brenee/L-1197-2013; King, Brenee/C-8100-2013	King, Brenee/0000-0002-3313-799X; 	National Institutes of Health [RO1ES015826, F31ES019823]; University of New Mexico Initiative [R25GM060201]; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015826, R01ES021100, F31ES019823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of New Mexico Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1ES015826 (to L. G. H. and K. J. L.) and F31ES019823 (to B. S. K.).; This work was also supported by University of New Mexico Initiative to Maximize Student Diversity Grant R25GM060201.	ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; Bartels CL, 2007, BIOCHEM BIOPH RES CO, V356, P219, DOI 10.1016/j.bbrc.2007.02.125; Burkle A, 2001, BIOESSAYS, V23, P795, DOI 10.1002/bies.1115; Camenisch U, 2008, ADV EXP MED BIOL, V637, P28; Ding W, 2009, J BIOL CHEM, V284, P6809, DOI 10.1074/jbc.M805566200; Fahrer J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm944; Flohr C, 2003, NUCLEIC ACIDS RES, V31, P5332, DOI 10.1093/nar/gkg715; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Ghodgaonkar MM, 2008, DNA REPAIR, V7, P617, DOI 10.1016/j.dnarep.2008.01.001; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Han WD, 2011, MUTAT RES-REV MUTAT, V727, P86, DOI 10.1016/j.mrrev.2011.03.001; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hunter JE, 2012, ONCOGENE, V31, P251, DOI 10.1038/onc.2011.229; Kang HC, 2011, P NATL ACAD SCI USA, V108, P14103, DOI 10.1073/pnas.1108799108; Kang TH, 2011, NUCLEIC ACIDS RES, V39, P3176, DOI 10.1093/nar/gkq1318; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Kimbung S, 2012, CANCER LETT, V319, P232, DOI 10.1016/j.canlet.2012.01.015; Koberle B, 2006, DNA REPAIR, V5, P641, DOI 10.1016/j.dnarep.2005.12.001; Li GY, 2010, P NATL ACAD SCI USA, V107, P9129, DOI 10.1073/pnas.1000556107; Malanga M, 1998, J BIOL CHEM, V273, P11839, DOI 10.1074/jbc.273.19.11839; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; Missura M, 2001, EMBO J, V20, P3554, DOI 10.1093/emboj/20.13.3554; Moroni F, 2001, CELL DEATH DIFFER, V8, P921, DOI 10.1038/sj.cdd.4400884; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Narayanan DL, 2010, INT J DERMATOL, V49, P978, DOI 10.1111/j.1365-4632.2010.04474.x; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Park CJ, 2006, FEBS J, V273, P1600, DOI 10.1111/j.1742-4658.2006.05189.x; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Plummer R, 2008, CLIN CANCER RES, V14, P7917, DOI 10.1158/1078-0432.CCR-08-1223; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; Qin XJ, 2008, TOXICOL APPL PHARM, V232, P41, DOI 10.1016/j.taap.2008.05.019; Schmitz AAP, 1998, BIOCHEMISTRY-US, V37, P9520, DOI 10.1021/bi973063b; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Schwerdtle T, 2010, CHEM RES TOXICOL, V23, P432, DOI 10.1021/tx900444w; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; SUTO MJ, 1991, ANTI-CANCER DRUG DES, V6, P107; Woodhouse BC, 2008, DNA REPAIR, V7, P1077, DOI 10.1016/j.dnarep.2008.03.009; Zhou XX, 2011, J BIOL CHEM, V286, P22855, DOI 10.1074/jbc.M111.232926	43	55	58	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.393504	http://dx.doi.org/10.1074/jbc.M112.393504			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23038248	hybrid, Green Published			2022-12-28	WOS:000311233800050
J	Lohman, AW; Weaver, JL; Billaud, M; Sandilos, JK; Griffiths, R; Straub, AC; Penuela, S; Leitinger, N; Laird, DW; Bayliss, DA; Isakson, BE				Lohman, Alexander W.; Weaver, Janelle L.; Billaud, Marie; Sandilos, Joanna K.; Griffiths, Rachael; Straub, Adam C.; Penuela, Silvia; Leitinger, Norbert; Laird, Dale W.; Bayliss, Douglas A.; Isakson, Brant E.			S-Nitrosylation Inhibits Pannexin 1 Channel Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-ACTIVATION; ATP RELEASE; NITRIC-OXIDE; HEMICHANNELS; EXPRESSION; ERYTHROCYTES; PERMEABILITY; STRESS; FAMILY	S-Nitrosylation is a post-translational modification on cysteine(s) that can regulate protein function, and pannexin 1 (Panx1) channels are present in the vasculature, a tissue rich in nitric oxide (NO) species. Therefore, we investigated whether Panx1 can be S-nitrosylated and whether this modification can affect channel activity. Using the biotin switch assay, we found that application of the NO donor S-nitrosoglutathione (GSNO) or diethylammonium (Z)-1-1(N, N-diethylamino) diazen-1-ium-1,2-diolate (DEA NONOate) to human embryonic kidney (HEK) 293T cells expressing wild type (WT) Panx1 and mouse aortic endothelial cells induced Panx1 S-nitrosylation. Functionally, GSNO and DEA NONOate attenuated Panx1 currents; consistent with a role for S-nitrosylation, current inhibition was reversed by the reducing agent dithiothreitol and unaffected by 1H-[1,2,4] oxadiazolo[4,3-a] quinoxalin-1-one, a blocker of guanylate cyclase activity. In addition, ATP release was significantly inhibited by treatment with both NO donors. To identify which cysteine residue(s) was S-nitrosylated, we made single cysteine-to-alanine substitutions in Panx1 (Panx1(C40A), Panx1(C346A), and Panx1(C426A)). Mutation of these single cysteines did not prevent Panx1 S-nitrosylation; however, mutation of either Cys-40 or Cys-346 prevented Panx1 current inhibition and ATP release by GSNO. This observation suggested that multiple cysteines may be S-nitrosylated to regulate Panx1 channel function. Indeed, we found that mutation of both Cys-40 and Cys-346 (Panx1(C40A/C346A)) prevented Panx1 S-nitrosylation by GSNO as well as the GSNO-mediated inhibition of Panx1 current and ATP release. Taken together, these results indicate that S-nitrosylation of Panx1 at Cys-40 and Cys-346 inhibits Panx1 channel currents and ATP release.	[Isakson, Brant E.] Univ Virginia, Sch Med, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Lohman, Alexander W.; Billaud, Marie; Isakson, Brant E.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Weaver, Janelle L.; Sandilos, Joanna K.; Griffiths, Rachael; Leitinger, Norbert; Bayliss, Douglas A.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Penuela, Silvia; Laird, Dale W.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada	University of Virginia; University of Virginia; University of Virginia; Western University (University of Western Ontario)	Isakson, BE (corresponding author), Univ Virginia, Sch Med, Robert M Berne Cardiovasc Res Ctr, POB 801394, Charlottesville, VA 22908 USA.	brant@virginia.edu	Laird, Dale W/AAL-2407-2020; Penuela, Silvia/A-6961-2010; Billaud, Marie/N-7609-2017; Laird, Dale w/E-4176-2015	Laird, Dale W/0000-0002-4568-3285; Penuela, Silvia/0000-0003-4829-5517; Billaud, Marie/0000-0002-7591-0362; Straub, Adam/0000-0003-0542-9466; Weaver, Janelle/0000-0001-8677-8312	National Institutes of Health [HL088554, HL107963, HL112904-1, NS033583]; American Heart Association postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL107963, K99HL112904, R01HL088554, R00HL112904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267, T32GM008136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033583, R29NS033583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association postdoctoral fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL088554 (to B. E. I.), HL107963 (to B. E. I.), HL112904-1 (to A. C. S.), and NS033583 (to D. A. B.). This work was also supported by an American Heart Association postdoctoral fellowship (to M. B.) and an American Heart Association predoctoral fellowship (to A. W. L.).	Ambrosi C, 2010, J BIOL CHEM, V285, P24420, DOI 10.1074/jbc.M110.115444; Asada K, 2009, J BIOL CHEM, V284, P6014, DOI 10.1074/jbc.M807158200; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Billaud M, 2011, CIRC RES, V109, P80, DOI 10.1161/CIRCRESAHA.110.237594; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Bunse S, 2011, J MEMBRANE BIOL, V244, P21, DOI 10.1007/s00232-011-9393-3; Bunse S, 2010, J BIOL CHEM, V285, P38444, DOI 10.1074/jbc.M110.101014; Burnstock G, 2002, ARTERIOSCL THROM VAS, V22, P364, DOI 10.1161/hq0302.105360; Burnstock Geoffrey, 2011, World J Gastrointest Pathophysiol, V2, P31, DOI 10.4291/wjgp.v2.i2.31; Burnstock G, 2011, CELL MOL LIFE SCI, V68, P1369, DOI 10.1007/s00018-010-0614-1; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Dando R, 2009, J PHYSIOL-LONDON, V587, P5899, DOI 10.1113/jphysiol.2009.180083; Ellsworth ML, 2009, PHYSIOLOGY, V24, P107, DOI 10.1152/physiol.00038.2008; Godecke S, 2012, AM J PHYSIOL-CELL PH, V302, pC915, DOI 10.1152/ajpcell.00283.2010; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Iwabuchi S, 2011, NEUROCHEM INT, V58, P376, DOI 10.1016/j.neuint.2010.12.013; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Li S, 2011, ENDOCRINOLOGY, V152, P2342, DOI 10.1210/en.2010-1216; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Lohman AW, 2012, J VASC RES, V49, P405, DOI 10.1159/000338758; Lohman AW, 2012, CARDIOVASC RES, V95, P269, DOI 10.1093/cvr/cvs187; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Ransford GA, 2009, AM J RESP CELL MOL, V41, P525, DOI 10.1165/rcmb.2008-0367OC; Ray A, 2006, CEREBELLUM, V5, P189, DOI 10.1080/14734220500530082; Reigada D, 2008, NEUROSCIENCE, V157, P396, DOI 10.1016/j.neuroscience.2008.08.036; Retamal MA, 2006, P NATL ACAD SCI USA, V103, P4475, DOI 10.1073/pnas.0511118103; Rumjahn SM, 2009, BRIT J CANCER, V100, P1465, DOI 10.1038/sj.bjc.6604998; Sandilos JK, 2012, J BIOL CHEM, V287, P11303, DOI 10.1074/jbc.M111.323378; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Schwartz D, 2009, MOL CELL PROTEOMICS, V8, P365, DOI 10.1074/mcp.M800332-MCP200; Seminario-Vidal L, 2011, J BIOL CHEM, V286, P26277, DOI 10.1074/jbc.M111.260562; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Sridharan M, 2010, AM J PHYSIOL-HEART C, V299, pH1146, DOI 10.1152/ajpheart.00301.2010; Straub AC, 2011, ARTERIOSCL THROM VAS, V31, P399, DOI 10.1161/ATVBAHA.110.215939; Sun JH, 2001, P NATL ACAD SCI USA, V98, P11158, DOI 10.1073/pnas.201289098; Swayne LA, 2010, J BIOL CHEM, V285, P24977, DOI 10.1074/jbc.M110.130054; Wang JJ, 2010, J GEN PHYSIOL, V136, P515, DOI 10.1085/jgp.201010440; Weilinger NL, 2012, J NEUROSCI, V32, P12579, DOI 10.1523/JNEUROSCI.1267-12.2012; Woehrle T, 2010, J LEUKOCYTE BIOL, V88, P1181, DOI 10.1189/jlb.0410211; Woehrle T, 2010, BLOOD, V116, P3475, DOI 10.1182/blood-2010-04-277707; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Zhang L, 2008, J NEUROSCI RES, V86, P2281, DOI 10.1002/jnr.21675	43	79	80	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.397976	http://dx.doi.org/10.1074/jbc.M112.397976			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23033481	Green Published, hybrid			2022-12-28	WOS:000311233800030
J	Potet, F; Lorinc, AN; Chaigne, S; Hopkins, CR; Venkataraman, R; Stepanovic, SZ; Lewis, LM; Days, E; Sidorov, VY; Engers, DW; Zou, BY; Afshartous, D; George, AL; Campbell, CM; Balser, JR; Li, M; Baudenbacher, FJ; Lindsley, CW; Weaver, CD; Kupershmidt, S				Potet, Franck; Lorinc, Amanda N.; Chaigne, Sebastien; Hopkins, Corey R.; Venkataraman, Raghav; Stepanovic, Svetlana Z.; Lewis, L. Michelle; Days, Emily; Sidorov, Veniamin Y.; Engers, Darren W.; Zou, Beiyan; Afshartous, David; George, Alfred L., Jr.; Campbell, Courtney M.; Balser, Jeffrey R.; Li, Min; Baudenbacher, Franz J.; Lindsley, Craig W.; Weaver, C. David; Kupershmidt, Sabina			Identification and Characterization of a Compound That Protects Cardiac Tissue from Human Ether-a-go-go-related Gene (hERG)-related Drug-induced Arrhythmias	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPEN-CHANNEL BLOCK; HERG POTASSIUM CHANNEL; MOLECULAR DETERMINANTS; K+ CHANNELS; QT SYNDROME; XENOPUS-OOCYTES; AFFINITY; BINDING; PROLONGATION; RECTIFIER	The human Ether-a-go-go-related gene (hERG)-encoded K+ current, I-Kr is essential for cardiac repolarization but is also a source of cardiotoxicity because unintended hERG inhibition by diverse pharmaceuticals can cause arrhythmias and sudden cardiac death. We hypothesized that a small molecule that diminishes IKr block by a known hERG antagonist would constitute a first step toward preventing hERG-related arrhythmias and facilitating drug discovery. Using a high-throughput assay, we screened a library of compounds for agents that increase the IC70 of dofetilide, a well characterized hERG blocker. One compound, VU0405601, with the desired activity was further characterized. In isolated, Langendorff-perfused rabbit hearts, optical mapping revealed that dofetilide-induced arrhythmias were reduced after pretreatment with VU0405601. Patch clamp analysis in stable hERG-HEK cells showed effects on current amplitude, inactivation, and deactivation. VU0405601 increased the IC50 of dofetilide from 38.7 to 76.3 nM. VU0405601 mitigates the effects of hERG blockers from the extracellular aspect primarily by reducing inactivation, whereas most clinically relevant hERG inhibitors act at an inner pore site. Structure-activity relationships surrounding VU0405601 identified a 3-pyridiyl and a naphthyridine ring system as key structural components important for preventing hERG inhibition by multiple inhibitors. These findings indicate that small molecules can be designed to reduce the sensitivity of hERG to inhibitors.	[Kupershmidt, Sabina] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Div Res, Nashville, TN 37232 USA; [Hopkins, Corey R.; Engers, Darren W.; Lindsley, Craig W.] Vanderbilt Univ, Ctr Neurosci Drug Discovery, Nashville, TN 37232 USA; [Venkataraman, Raghav; Sidorov, Veniamin Y.; Baudenbacher, Franz J.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37232 USA; [Lewis, L. Michelle; Days, Emily; Weaver, C. David] Vanderbilt Univ, Inst Biol Chem, Nashville, TN 37232 USA; [Afshartous, David] Vanderbilt Univ, Dept Biostat, Nashville, TN 37232 USA; [George, Alfred L., Jr.; Campbell, Courtney M.; Kupershmidt, Sabina] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [George, Alfred L., Jr.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Zou, Beiyan; Li, Min] Johns Hopkins Univ, Sch Med, Johns Hopkins Ion Channel Ctr, Baltimore, MD 21205 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Johns Hopkins University	Kupershmidt, S (corresponding author), Vanderbilt Univ, Sch Med, Dept Anesthesiol, Div Res, P-445 MRBIV Langford,13th Floor, Nashville, TN 37232 USA.	sabina.kupershmidt@vanderbilt.edu	Kupershmidt, Sabina/AAO-5464-2021; Chaigne, Sebastien/AFN-4672-2022	Kupershmidt, Sabina/0000-0002-8119-2723; Campbell, Courtney/0000-0002-0803-0429	National Institutes of Health [1RO1HL090790, RO3MH084820, 1 U54 MH074427, U54MH084659]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL107066, R01HL090790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084659, R03MH084820, U54MH074427] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants 1RO1HL090790 and RO3MH084820 (to S.K.), 1 U54 MH074427 (to C.D.W.), and U54MH084659 (to C.W.L.).; Supported in part by a Scientist Development Grant from the American Heart Association.	Aiba T, 2005, J AM COLL CARDIOL, V45, P300, DOI 10.1016/j.jacc.2004.09.069; BASSANI JWM, 1995, BIOPHYS J, V68, P1453, DOI 10.1016/S0006-3495(95)80318-8; Brugada R, 2005, CAN MED ASSOC J, V173, P1349, DOI 10.1503/cmaj.050596; Brugada R, 2004, CIRCULATION, V109, P30, DOI 10.1161/01.CIR.0000109482.92774.3A; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; De Cicco M, 1999, CRIT CARE MED, V27, P332, DOI 10.1097/00003246-199902000-00040; Drolet B, 1999, J CARDIOVASC ELECTR, V10, P1597, DOI 10.1111/j.1540-8167.1999.tb00224.x; Fernandez D, 2004, J BIOL CHEM, V279, P10120, DOI 10.1074/jbc.M310683200; Ficker E, 1998, CIRC RES, V82, P386, DOI 10.1161/01.RES.82.3.386; Gussak I, 2000, CARDIOLOGY, V94, P99, DOI 10.1159/000047299; Hancox JC, 2008, PHARMACOL THERAPEUT, V119, P118, DOI 10.1016/j.pharmthera.2008.05.009; Hedley PL, 2009, HUM MUTAT, V30, P1486, DOI 10.1002/humu.21106; Hondeghem LM, 2003, J CARDIOVASC ELECTR, V14, P287, DOI 10.1046/j.1540-8167.2003.02466.x; Hondeghem LM, 2001, CIRCULATION, V103, P2004; JURKIEWICZ NK, 1993, CIRC RES, V72, P75, DOI 10.1161/01.RES.72.1.75; Kamiya K, 2006, MOL PHARMACOL, V69, P1709, DOI 10.1124/mol.105.020990; Kamiya K, 2001, MOL PHARMACOL, V60, P244, DOI 10.1124/mol.60.2.244; Kannankeril P, 2010, PHARMACOL REV, V62, P760, DOI 10.1124/pr.110.003723; Kiehn J, 1996, CIRCULATION, V94, P2572, DOI 10.1161/01.CIR.94.10.2572; Lees-Miller JP, 2000, MOL PHARMACOL, V57, P367; McPate MJ, 2008, BRIT J PHARMACOL, V155, P957, DOI 10.1038/bjp.2008.325; Milberg P, 2002, J PHARMACOL EXP THER, V303, P218, DOI 10.1124/jpet.102.037911; Milnes JT, 2003, BRIT J PHARMACOL, V139, P887, DOI 10.1038/sj.bjp.0705335; Mitcheson JS, 2000, J GEN PHYSIOL, V115, P229, DOI 10.1085/jgp.115.3.229; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Mitcheson JS, 2003, CURR OPIN DRUG DISC, V6, P667; Nattel S, 2008, PROG BIOPHYS MOL BIO, V98, P328, DOI 10.1016/j.pbiomolbio.2008.10.009; Perrin MJ, 2008, MOL PHARMACOL, V74, P1443, DOI 10.1124/mol.108.049056; Perry M, 2006, MOL PHARMACOL, V69, P509, DOI 10.1124/mol.105.016741; Potet F, 2001, J PHARMACOL EXP THER, V299, P1007; Ridley JM, 2006, J MOL CELL CARDIOL, V40, P107, DOI 10.1016/j.yjmcc.2005.09.017; Ridley JM, 2004, J MOL CELL CARDIOL, V36, P701, DOI 10.1016/j.yjmcc.2004.02.009; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Sanchez-Chapula JA, 2004, N-S ARCH PHARMACOL, V370, P484, DOI 10.1007/s00210-004-0995-5; Sanchez-Chapula JA, 2003, MOL PHARMACOL, V63, P1051, DOI 10.1124/mol.63.5.1051; Sanchez-Chapula JA, 2002, J BIOL CHEM, V277, P23587, DOI 10.1074/jbc.M200448200; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Schmalhofer WA, 2010, ASSAY DRUG DEV TECHN, V8, P714, DOI 10.1089/adt.2010.0351; Shah RR, 2007, DRUG SAFETY, V30, P1093, DOI 10.2165/00002018-200730120-00003; Snyders DJ, 1996, MOL PHARMACOL, V49, P949; Spector PS, 1996, CIRC RES, V78, P499, DOI 10.1161/01.RES.78.3.499; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Tseng GN, 2007, BIOPHYS J, V92, P3524, DOI 10.1529/biophysj.106.097360; Volberg WA, 2002, J PHARMACOL EXP THER, V302, P320, DOI 10.1124/jpet.302.1.320; Weaver CD, 2004, J BIOMOL SCREEN, V9, P671, DOI 10.1177/1087057104268749; Woosley RL, 1996, ANNU REV PHARMACOL, V36, P233, DOI 10.1146/annurev.pa.36.040196.001313; Wynia-Smith SL, 2008, J GEN PHYSIOL, V132, P507, DOI 10.1085/jgp.200810083; Yang T, 2001, J CARDIOVASC PHARM, V38, P737, DOI 10.1097/00005344-200111000-00010; Zhang M, 2003, BIOPHYS J, V84, P3022, DOI 10.1016/S0006-3495(03)70028-9; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3; Zou AR, 1998, J PHYSIOL-LONDON, V509, P129, DOI 10.1111/j.1469-7793.1998.129bo.x; Zou BY, 2010, ASSAY DRUG DEV TECHN, V8, P743, DOI 10.1089/adt.2010.0339	52	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.380162	http://dx.doi.org/10.1074/jbc.M112.380162			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23033485	hybrid, Green Published			2022-12-28	WOS:000311233800031
J	Taniguchi, M; Kitatani, K; Kondo, T; Hashimoto-Nishimura, M; Asano, S; Hayashi, A; Mitsutake, S; Igarashi, Y; Umehara, H; Takeya, H; Kigawa, J; Okazaki, T				Taniguchi, Makoto; Kitatani, Kazuyuki; Kondo, Tadakazu; Hashimoto-Nishimura, Mayumi; Asano, Satoshi; Hayashi, Akira; Mitsutake, Susumu; Igarashi, Yasuyuki; Umehara, Hisanori; Takeya, Hiroyuki; Kigawa, Junzo; Okazaki, Toshiro			Regulation of Autophagy and Its Associated Cell Death by "Sphingolipid Rheostat" RECIPROCAL ROLE OF CERAMIDE AND SPHINGOSINE 1-PHOSPHATE IN THE MAMMALIAN TARGET OF RAPAMYCIN PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTOR; INDUCED APOPTOSIS; ER STRESS; PROTEIN PHOSPHATASE-2A; CERAMIDE ACCUMULATION; S1P(3) RECEPTOR; LEUKEMIA-CELLS; HL-60 CELLS; KINASE-B; SPHINGOSINE-1-PHOSPHATE	The role of "sphingolipid rheostat" by ceramide and sphingosine 1-phosphate (S1P) in the regulation of autophagy remains unclear. In human leukemia HL-60 cells, amino acid deprivation (AA(-)) caused autophagy with an increase in acid sphingomy-leinase (SMase) activity and ceramide, which serves as an autophagy inducing lipid. Knockdown of acid SMase significantly suppressed the autophagy induction. S1P treatment counteracted autophagy induction by AA(-) or C-2-ceramide. AA(-) treatment promoted mammalian target of rapamycin (mTOR) dephosphorylation/inactivation, inducing autophagy. S1P treatment suppressed mTOR inactivation and autophagy induction by AA(-). S1P exerts biological actions via cell surface receptors, and S1P(3) among five S1P receptors was predominantly expressed in HL-60 cells. We evaluated the involvement of S1P(3) in suppressing autophagy induction. S1P treatment of CHO cells had no effects on mTOR inactivation and autophagy induction by AA(-) or C-2-ceramide. Whereas S1P treatment of S1P(3) overexpressing CHO cells resulted in activation of the mTOR pathway, preventing cells from undergoing autophagy induced by AA(-) or C-2-ceramide. These results indicate that S1P-S1P(3) plays a role in counteracting ceramide signals that mediate mTOR-controlled autophagy. In addition, we evaluated the involvement of ceramide-activated protein phosphatases (CAPPs) in ceramide-dependent inactivation of the mTOR pathway. Inhibition of CAPP by okadaic acid in AA(-)- or C-2-ceramide-treated cells suppressed dephosphorylation/inactivation of mTOR, autophagy induction, and autophagy-associated cell death, indicating a novel role of ceramide-CAPPs in autophagy induction. Moreover, S1P(3) engagement by S1P counteracted cell death. Taken together, these results indicated that sphingolipid rheostat in ceramide-CAPPs and S1P-S1P(3) signaling modulates autophagy and its associated cell death through regulation of the mTOR pathway.	[Taniguchi, Makoto; Kitatani, Kazuyuki; Hashimoto-Nishimura, Mayumi; Asano, Satoshi; Okazaki, Toshiro] Tottori Univ, Div Clin Lab Med, Fac Med, Yonago, Tottori 6838503, Japan; [Hashimoto-Nishimura, Mayumi; Asano, Satoshi; Kigawa, Junzo] Tottori Univ, Tottori Univ Hosp, Ctr Canc, Yonago, Tottori 6838503, Japan; [Hayashi, Akira; Takeya, Hiroyuki] Tottori Univ, Div Pathol Biochem, Dept Biomed Sci, Fac Med, Yonago, Tottori 6838503, Japan; [Hayashi, Akira; Umehara, Hisanori; Okazaki, Toshiro] Kanazawa Med Univ, Dept Hematol & Immunol, Uchinada, Ishikawa 9200293, Japan; [Kondo, Tadakazu] Kyoto Univ, Dept Hematol & Oncol, Grad Sch Med, Kyoto 6068507, Japan; [Kitatani, Kazuyuki] Tohoku Univ, Dept Biobank, Tohoku Med Megabank Org, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Taniguchi, Makoto] Kanazawa Med Univ, Dept Life Sci, Med Res Inst, Uchinada, Ishikawa 9200293, Japan; [Mitsutake, Susumu; Igarashi, Yasuyuki] Hokkaido Univ, Lab Biomembrane & Biofunct Chem, Fac Adv Life Sci, Kita Ku, Sapporo, Hokkaido 0010021, Japan	Tottori University; Tottori University; Tottori University; Kanazawa Medical University; Kyoto University; Tohoku University; Kanazawa Medical University; Hokkaido University	Okazaki, T (corresponding author), Kanazawa Med Univ, Dept Med, Div Hematol Immunol, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan.	toshiroo@kanazawa-med.ac.jp	Asano, Satoshi/AAQ-3817-2020; Kitatani, Kazuyuki/H-7100-2019; Mitsutake, Susumu/A-4082-2012; Taniguchi, Makoto/L-5757-2019	Kitatani, Kazuyuki/0000-0002-8516-6135; Taniguchi, Makoto/0000-0001-5920-8285; Asano, Satoshi/0000-0003-1537-4307	Sapporo Biocluster "Bio-S," the Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science and Technology (Japan); Japan Society for the Promotion of Science [21890144]; Sumitomo Foundation; Japanese Ministry of Education, Culture, Sports, Science and Technology [22249041]; Uehara Memorial Foundation; Vehicle Racing Commemorative Foundation; Kanazawa Medical University Research Foundation	Sapporo Biocluster "Bio-S," the Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science and Technology (Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sumitomo Foundation; Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Vehicle Racing Commemorative Foundation; Kanazawa Medical University Research Foundation	This work was supported in part by grants from the Sapporo Biocluster "Bio-S," the Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science and Technology (Japan), the Japan Society for the Promotion of Science (Grant-in-Aid for Young Scientists 21890144) (to K. K.), the Sumitomo Foundation (to K. K.), the Japanese Ministry of Education, Culture, Sports, Science and Technology 22249041 (to H. U.), the Uehara Memorial Foundation (to H. U.), the Vehicle Racing Commemorative Foundation (to H. U.), and the Kanazawa Medical University Research Foundation (to H. U).	Akao Y, 2002, BIOCHEM BIOPH RES CO, V294, P363, DOI 10.1016/S0006-291X(02)00462-X; An SZ, 1997, FEBS LETT, V417, P279, DOI 10.1016/S0014-5793(97)01301-X; Banno Y, 2001, J BIOL CHEM, V276, P35622, DOI 10.1074/jbc.M105673200; Bektas M, 2005, ONCOGENE, V24, P178, DOI 10.1038/sj.onc.1208019; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Blazquez C, 2008, CANCER RES, V68, P1945, DOI 10.1158/0008-5472.CAN-07-5176; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Chalfant CE, 2001, J BIOL CHEM, V276, P44848, DOI 10.1074/jbc.M106291200; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Chang CL, 2009, AM J PHYSIOL-CELL PH, V297, pC451, DOI 10.1152/ajpcell.00586.2008; Deng QL, 2007, MOL PHARMACOL, V71, P724, DOI 10.1124/mol.106.029223; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; El-Naggar S, 2009, MOL CELL BIOL, V29, P5710, DOI 10.1128/MCB.00197-09; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; Ghosh N, 2007, ENDOCRINOLOGY, V148, P1359, DOI 10.1210/en.2006-0750; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hla T, 2001, SCIENCE, V294, P1875, DOI 10.1126/science.1065323; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Im DS, 2000, J BIOL CHEM, V275, P14281, DOI 10.1074/jbc.275.19.14281; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kluk MJ, 2001, CIRC RES, V89, P496, DOI 10.1161/hh1801.096338; Kohno T, 2003, J BIOCHEM, V134, P667, DOI 10.1093/jb/mvg191; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Kondo T, 2000, J BIOL CHEM, V275, P8872, DOI 10.1074/jbc.275.12.8872; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Krymskaya VP, 2011, FASEB J, V25, P1922, DOI 10.1096/fj.10-175018; Krymskaya VP, 2009, CELL CYCLE, V8, P403, DOI 10.4161/cc.8.3.7555; Lavieu G, 2006, J BIOL CHEM, V281, P8518, DOI 10.1074/jbc.M506182200; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lepine S, 2011, CELL DEATH DIFFER, V18, P350, DOI 10.1038/cdd.2010.104; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; Maeurer C, 2009, CELL SIGNAL, V21, P293, DOI 10.1016/j.cellsig.2008.10.016; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Merrill AH, 1997, TOXICOL APPL PHARM, V142, P208, DOI 10.1006/taap.1996.8029; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Okajima F, 1996, FEBS LETT, V379, P260, DOI 10.1016/0014-5793(95)01526-4; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; Park MA, 2008, CANCER BIOL THER, V7, P1648, DOI 10.4161/cbt.7.10.6623; Pattingre S, 2009, J BIOL CHEM, V284, P2719, DOI 10.1074/jbc.M805920200; Pettus BJ, 2005, MOL PHARMACOL, V68, P330, DOI 10.1124/mol.104.008722; Potteck H, 2010, CELL PHYSIOL BIOCHEM, V26, P67, DOI 10.1159/000315107; Pyne S, 2002, BBA-MOL CELL BIOL L, V1582, P121, DOI 10.1016/S1388-1981(02)00146-4; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Sato K, 1998, BIOCHEM BIOPH RES CO, V253, P253, DOI 10.1006/bbrc.1998.9745; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Spassieva SD, 2009, BIOCHEM J, V424, P273, DOI 10.1042/BJ20090699; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Spiegel S, 2002, LEUKEMIA, V16, P1596, DOI 10.1038/sj.leu.2402611; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; STRUM JC, 1994, J BIOL CHEM, V269, P15493; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Van Brocklyn JR, 2000, BLOOD, V95, P2624; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamazaki Y, 2000, BIOCHEM BIOPH RES CO, V268, P583, DOI 10.1006/bbrc.2000.2162; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	66	103	107	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.416552	http://dx.doi.org/10.1074/jbc.M112.416552			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23035115	hybrid, Green Published			2022-12-28	WOS:000311233800058
J	Bugaj, V; Sansom, SC; Wen, DH; Hatcher, LI; Stockand, JD; Mironova, E				Bugaj, Vladislav; Sansom, Steven C.; Wen, Donghai; Hatcher, Lori I.; Stockand, James D.; Mironova, Elena			Flow-sensitive K+-coupled ATP Secretion Modulates Activity of the Epithelial Na+ Channel in the Distal Nephron	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLECTING DUCT; CONNEXIN HEMICHANNELS; CONNECTING TUBULE; SODIUM-CHANNEL; ENAC ACTIVITY; RENAL NA+; HYPERTENSION; EXCRETION; MEMBRANE; CELLS	The epithelial Na+ channel (ENaC) in the aldosterone-sensitive distal nephron (ASDN) is under tonic inhibition by a local purinergic signaling system responding to changes in dietary sodium intake. Normal BKCa channel function is required for flow-sensitive ATP secretion in the ASDN. We tested here whether ATP secreted through connexin channels in a coupled manner with K+ efflux through BKCa channels is required for inhibitory purinergic regulation of ENaC in response to increases in sodium intake. Inhibition of connexin channels relieves purinergic inhibition of ENaC. Deletion of the BK-beta 4 regulatory subunit, which is required for normal BKCa channel function and flow-sensitive ATP secretion in the ASDN, suppresses increases in urinary ATP in response to increases in sodium intake. As a consequence, ENaC activity, particularly in the presence of high sodium intake, is inappropriately elevated in BK-beta 4 nul lmice. ENaC in BK-beta 4 null mice, however, responds normally to exogenous ATP, indicating that increases in activity do not result from end-organ resistance but rather from lowered urinary ATP. Consistent with this, disruption of purinergic regulation increases ENaC activity in wild type but not BK-beta 4 null mice. Consequently, sodium excretion is impaired in BK-beta 4 null mice. These results demonstrate that the ATP secreted in the ASDN in a BKCa channel-dependent manner is physiologically available for purinergic inhibition of ENaC in response to changes in sodium homeostasis. Impaired sodium excretion resulting form loss of normal purinergic regulation of ENaC in BK-beta 4 null mice likely contributes to their elevated blood pressure.	[Bugaj, Vladislav; Stockand, James D.; Mironova, Elena] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Sansom, Steven C.; Wen, Donghai; Hatcher, Lori I.] Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE 68198 USA	University of Texas System; University of Texas Health San Antonio; University of Nebraska System; University of Nebraska Medical Center	Stockand, JD (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA.	stockand@uthscsa.edu		Stockand, James/0000-0002-3817-4319	National Institutes of Health [R01 DK059594, R01 DK71014]; American Heart Association Fellowship [10POST3200019]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059594, R01DK071014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Fellowship(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK059594 (to J. D. S.) and R01 DK71014 (to S. C. S.). This work was also supported by American Heart Association Fellowship 10POST3200019 (to V. B.).	Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; Bonny O, 2000, KIDNEY INT, V57, P1313, DOI 10.1046/j.1523-1755.2000.00968.x; De Vuyst E, 2007, MOL BIOL CELL, V18, P34, DOI 10.1091/mbc.E06-03-0182; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Grimm PR, 2009, P NATL ACAD SCI USA, V106, P11800, DOI 10.1073/pnas.0904635106; Holtzclaw JD, 2011, CURR OPIN NEPHROL HY, V20, P512, DOI 10.1097/MNH.0b013e3283488889; Holtzclaw JD, 2011, AM J PHYSIOL-RENAL, V300, pF1319, DOI 10.1152/ajprenal.00112.2011; Holtzclaw JD, 2010, J AM SOC NEPHROL, V21, P634, DOI 10.1681/ASN.2009080817; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Liu W, 2007, AM J PHYSIOL-RENAL, V293, pF227, DOI 10.1152/ajprenal.00057.2007; McCulloch F, 2005, AM J PHYSIOL-RENAL, V289, pF1304, DOI 10.1152/ajprenal.00203.2005; Mironova E, 2011, J BIOL CHEM, V286, P1054, DOI 10.1074/jbc.M110.176552; Pluznick JL, 2005, AM J PHYSIOL-RENAL, V288, pF846, DOI 10.1152/ajprenal.00340.2004; Pochynyuk O, 2008, AM J PHYSIOL-RENAL, V294, pF38, DOI 10.1152/ajprenal.00403.2007; Pochynyuk O, 2007, J GEN PHYSIOL, V130, P399, DOI 10.1085/jgp.200709800; Pochynyuk O, 2010, FASEB J, V24, P2056, DOI 10.1096/fj.09-151506; Pochynyuk O, 2008, J BIOL CHEM, V283, P36599, DOI 10.1074/jbc.M807129200; Rieg T, 2007, KIDNEY INT, V72, P566, DOI 10.1038/sj.ki.5002369; Rieg T, 2007, FASEB J, V21, P3717, DOI 10.1096/fj.07-8807com; Rieg T, 2011, AM J PHYSIOL-REG I, V301, pR510, DOI 10.1152/ajpregu.00148.2011; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Sipos A, 2009, J AM SOC NEPHROL, V20, P1724, DOI 10.1681/ASN.2008101099; Stockand JD, 2010, J AM SOC NEPHROL, V21, P1903, DOI 10.1681/ASN.2010040377; Taniguchi J, 1998, J MEMBRANE BIOL, V164, P35, DOI 10.1007/s002329900391; Toney GM, 2012, CURR OPIN NEPHROL HY, V21, P52, DOI 10.1097/MNH.0b013e32834db4a0; Vallon V, 2009, J AM SOC NEPHROL, V20, P721, DOI 10.1681/ASN.2008040415	27	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38552	38558		10.1074/jbc.M112.408476	http://dx.doi.org/10.1074/jbc.M112.408476			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23002235	Green Published, hybrid			2022-12-28	WOS:000310982800015
J	Cannino, G; El-Khoury, R; Pirinen, M; Hutz, B; Rustin, P; Jacobs, HT; Dufour, E				Cannino, Giuseppe; El-Khoury, Riyad; Pirinen, Marja; Hutz, Bettina; Rustin, Pierre; Jacobs, Howard T.; Dufour, Eric			Glucose Modulates Respiratory Complex I Activity in Response to Acute Mitochondrial Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; ELECTRON-TRANSPORT; OXIDATIVE-PHOSPHORYLATION; TCA CYCLE; NDI1 GENE; SUCCINATE; CHAIN; MECHANISMS; EXPRESSION; DISORDERS	Proper coordination between glycolysis and respiration is essential, yet the regulatory mechanisms involved in sensing respiratory chain defects and modifying mitochondrial functions accordingly are unclear. To investigate the nature of this regulation, we introduced respiratory bypass enzymes into cultured human (HEK293T) cells and studied mitochondrial responses to respiratory chain inhibition. In the absence of respiratory chain inhibitors, the expression of alternative respiratory enzymes did not detectably alter cell physiology or mitochondrial function. However, in permeabilized cells NDI1 (alternative NADH dehydrogenase) bypassed complex I inhibition, whereas alternative oxidase (AOX) bypassed complex III or IV inhibition. In contrast, in intact cells the effects of the AOX bypass were suppressed by growth on glucose, whereas those produced by NDI1 were unaffected. Moreover, NDI1 abolished the glucose suppression of AOX-driven respiration, implicating complex I as the target of this regulation. Rapid Complex I down-regulation was partly released upon prolonged respiratory inhibition, suggesting that it provides an "emergency shutdown" system to regulate metabolism in response to dysfunctions of the oxidative phosphorylation. This system was independent of HIF1, mitochondrial superoxide, or ATP synthase regulation. Our findings reveal a novel pathway for adaptation to mitochondrial dysfunction and could provide new opportunities for combatting diseases.	[Cannino, Giuseppe; Pirinen, Marja; Hutz, Bettina; Jacobs, Howard T.; Dufour, Eric] Univ Tampere, Tampere Univ Hosp, Inst Biomed Technol, Tampere 33014, Finland; [Cannino, Giuseppe; Pirinen, Marja; Hutz, Bettina; Jacobs, Howard T.; Dufour, Eric] Univ Tampere, Tampere Univ Hosp, Ctr Lab Med, Tampere 33014, Finland; [El-Khoury, Riyad; Rustin, Pierre] INSERM, U676, F-75019 Paris, France; [El-Khoury, Riyad; Rustin, Pierre] Univ Paris 07, Fac Med Denis Diderot, F-75019 Paris, France	Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Dufour, E (corresponding author), FI 33014 Univ Tampere, Inst Biomed Technol, Tampere 33100, Finland.	eric.dufour@uta.fi	Cannino, Giuseppe/AAS-7269-2021; Dufour, Eric/AAF-6210-2020; Jacobs, Howard T/G-2434-2011	Dufour, Eric/0000-0001-6690-5329; Jacobs, Howard/0000-0003-1895-6003	Leducq Foundation; ERC; Academy of Finland; Juselius Foundation; Tampere University Hospital Medical Research Fund; Pirkanmaa Hospital District	Leducq Foundation(Leducq Foundation); ERC(European Research Council (ERC)European Commission); Academy of Finland(Academy of Finland); Juselius Foundation; Tampere University Hospital Medical Research Fund; Pirkanmaa Hospital District	Supported by the Leducq Foundation.; Supported by ERC, Academy of Finland, Juselius Foundation, and the Tampere University Hospital Medical Research Fund.; Supported by the Academy of Finland and Pirkanmaa Hospital District.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Appleby RD, 1999, EUR J BIOCHEM, V262, P108, DOI 10.1046/j.1432-1327.1999.00350.x; Briere JJ, 2005, HUM MOL GENET, V14, P3263, DOI 10.1093/hmg/ddi359; Cannino G, 2009, MITOCHONDRION, V9, P471, DOI 10.1016/j.mito.2009.08.007; CHRETIEN D, 1994, CLIN CHIM ACTA, V228, P53, DOI 10.1016/0009-8981(94)90056-6; Dassa EP, 2009, EMBO MOL MED, V1, P30, DOI 10.1002/emmm.200900001; Diaz-Ruiz R, 2008, J BIOL CHEM, V283, P26948, DOI 10.1074/jbc.M800408200; DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Ejiri S, 2002, BIOSCI BIOTECH BIOCH, V66, P1, DOI 10.1271/bbb.66.1; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Hakkaart GAJ, 2006, EMBO REP, V7, P341, DOI 10.1038/sj.embor.7400601; Huang JY, 2010, BBA-PROTEINS PROTEOM, V1804, P1645, DOI 10.1016/j.bbapap.2009.12.021; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lee YJ, 2011, J BIOL CHEM, V286, P20267, DOI 10.1074/jbc.M110.209379; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Livnat-Levanon N, 2011, BBA-GENE REGUL MECH, V1809, P80, DOI 10.1016/j.bbagrm.2010.07.005; LOSCHEN G, 1971, FEBS LETT, V18, P261, DOI 10.1016/0014-5793(71)80459-3; Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429; Marella M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001433; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Matrai J, 2010, MOL THER, V18, P477, DOI 10.1038/mt.2009.319; Matsukawa K, 2009, FEBS LETT, V583, P148, DOI 10.1016/j.febslet.2008.11.040; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Pellinen R, 2004, INT J ONCOL, V25, P1753; Rodriguez-Enriquez S, 2001, EUR J BIOCHEM, V268, P2512, DOI 10.1046/j.1432-1327.2001.02140.x; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Scott I, 2012, BIOCHEM J, V443, P655, DOI 10.1042/BJ20120118; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Seo BB, 1999, BBA-BIOENERGETICS, V1412, P56, DOI 10.1016/S0005-2728(99)00051-1; Spector David L., 1998; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Tanaka-Esposito C, 2012, TRANSL RES, V160, P207, DOI 10.1016/j.trsl.2012.01.024; Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; WARBURG O, 1967, H-S Z PHYSIOL CHEM, V348, P1686, DOI 10.1515/bchm2.1967.348.1.1686; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wong A, 2002, BIOCHEM BIOPH RES CO, V298, P750, DOI 10.1016/S0006-291X(02)02546-9; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd	42	30	30	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38729	38740		10.1074/jbc.M112.386060	http://dx.doi.org/10.1074/jbc.M112.386060			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23007390	Green Published, hybrid			2022-12-28	WOS:000310982800031
J	Chan, CS; Ming-Lum, A; Golds, GB; Lee, SJ; Anderson, RJ; Mui, ALF				Chan, Catherine S.; Ming-Lum, Andrew; Golds, Gary B.; Lee, Shaina J.; Anderson, Raymond J.; Mui, Alice L. -F.			Interleukin-10 Inhibits Lipopolysaccharide-induced Tumor Necrosis Factor-alpha Translation through a SHIP1-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION-FACTOR 4E; MESSENGER-RNA TRANSLATION; CAP-BINDING PROTEIN; AU-RICH-ELEMENT; TNF-ALPHA; ANTIINFLAMMATORY RESPONSE; POSTTRANSCRIPTIONAL REGULATION; SIGNALING PATHWAY; CANCER-THERAPY; MACROPHAGES	Production of the proinflammatory cytokine TNF alpha by activated macrophages is an important component of host defense. However, TNF alpha production must be tightly controlled to avoid pathological consequences. The anti-inflammatory cytokine IL-10 inhibits TNF alpha mRNA expression through activation of the STAT3 transcription factor pathway and subsequent expression of STAT3-dependent gene products. We hypothesized that IL-10 must also have more rapid mechanisms of action and show that IL-10 rapidly shifts existing TNF alpha mRNA from polyribosome-associated polysomes to monosomes. This translation suppression requires the presence of SHIP1 (SH2 domain-containing inositol 5'-phosphatase 1) and involves inhibition of Mnk1 (MAPK signal-integrating kinase 1). Furthermore, activating SHIP1 using a small-molecule agonist mimics the inhibitory effect of IL-10 on Mnk1 phosphorylation and TNF alpha translation. Our data support the existence of an alternative STAT3-independent pathway through SHIP1 for IL-10 to regulate TNF alpha translation during the anti-inflammatory response.	[Chan, Catherine S.; Ming-Lum, Andrew; Golds, Gary B.; Lee, Shaina J.; Mui, Alice L. -F.] Vancouver Coastal Hlth Res Inst, Immun & Infect Res Ctr, Vancouver, BC V6H 3Z6, Canada; [Chan, Catherine S.; Golds, Gary B.; Lee, Shaina J.; Mui, Alice L. -F.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1Z3, Canada; [Chan, Catherine S.; Ming-Lum, Andrew; Golds, Gary B.; Lee, Shaina J.; Mui, Alice L. -F.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Anderson, Raymond J.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Anderson, Raymond J.] Univ British Columbia, Dept Oceanog, Vancouver, BC V6T 1Z1, Canada	Vancouver Coastal Health Research Institute; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Mui, ALF (corresponding author), Jack Bell Res Ctr, 2660 Oak St, Vancouver, BC V6H 3Z6, Canada.	alice.mui@ubc.ca			Canadian Institutes of Health Research [MOP-84539]; Canadian Cancer Society Research Institute Grant [017289]; CIHR Doctoral Research; Michael Smith Foundation for Health Research (MSFHR); CIHR	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute Grant; CIHR Doctoral Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by Research Grant MOP-84539 from the Canadian Institutes of Health Research (to A. L.-F. M.), and Canadian Cancer Society Research Institute Grant 017289 (to R. J. A.). A. M.-L. held CIHR Doctoral Research, and Michael Smith Foundation for Health Research (MSFHR) awards. The CIHR Transplantation Training Program provided graduate scholarships (to A. M. L., G. B. G., and C. S. C.).	Anderson P, 2007, MOL CELL, V25, P796, DOI 10.1016/j.molcel.2007.03.005; Andersson K, 2006, CYTOKINE, V33, P52, DOI 10.1016/j.cyto.2005.11.017; Beisang D, 2012, WIRES RNA, V3, P719, DOI 10.1002/wrna.1125; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Buxade M, 2008, FRONT BIOSCI-LANDMRK, V13, P5359, DOI 10.2741/3086; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; Denys A, 2002, J IMMUNOL, V168, P4837, DOI 10.4049/jimmunol.168.10.4837; El Kasmi KC, 2007, J IMMUNOL, V179, P7215, DOI 10.4049/jimmunol.179.11.7215; El Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880; FLYNN A, 1995, J BIOL CHEM, V270, P21684, DOI 10.1074/jbc.270.37.21684; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Glocker E. O., 2012, ANN NY ACAD SCI, V1246, P102; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; Hay N, 2010, P NATL ACAD SCI USA, V107, P13975, DOI 10.1073/pnas.1008908107; Hou JQ, 2012, ONCOTARGET, V3, P118; Hutchins AP, 2012, BLOOD, V119, pE110, DOI 10.1182/blood-2011-09-381483; JOSHI B, 1995, J BIOL CHEM, V270, P14597, DOI 10.1074/jbc.270.24.14597; Kerr WG, 2011, ANN NY ACAD SCI, V1217, P1, DOI 10.1111/j.1749-6632.2010.05869.x; Kontoyiannis D, 2001, EMBO J, V20, P3760, DOI 10.1093/emboj/20.14.3760; KRUYS V, 1992, P NATL ACAD SCI USA, V89, P673, DOI 10.1073/pnas.89.2.673; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kuwata H, 2003, BLOOD, V102, P4123, DOI 10.1182/blood-2003-04-1228; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Monick MM, 2001, J IMMUNOL, V166, P4713, DOI 10.4049/jimmunol.166.7.4713; Mukhopadhyay D, 2003, MOL CELL, V11, P113, DOI 10.1016/S1097-2765(03)00012-1; Murray PJ, 2006, BIOCHEM SOC T, V34, P1028, DOI 10.1042/BST0341028; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; Ong CJ, 2007, BLOOD, V110, P1942, DOI 10.1182/blood-2007-03-079699; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Polunovsky Vitaly A, 2006, RNA Biol, V3, P10; Qi MY, 2012, MOL CELL BIOL, V32, P913, DOI 10.1128/MCB.05340-11; Ronkina N, 2010, BIOCHEM PHARMACOL, V80, P1915, DOI 10.1016/j.bcp.2010.06.021; Rowlett RM, 2008, AM J PHYSIOL-GASTR L, V295, pG421, DOI 10.1152/ajpgi.00508.2007; Rowlett RM, 2008, AM J PHYSIOL-GASTR L, V294, pG452, DOI 10.1152/ajpgi.00077.2007; Schaljo B, 2009, J IMMUNOL, V183, P1197, DOI 10.4049/jimmunol.0803883; Scheper GC, 2002, EUR J BIOCHEM, V269, P5350, DOI 10.1046/j.1432-1033.2002.03291.x; Sly LM, 2007, FRONT BIOSCI-LANDMRK, V12, P2836, DOI 10.2741/2276; Spencer SD, 1998, J EXP MED, V187, P571, DOI 10.1084/jem.187.4.571; Stamou P, 2010, CURR DIR AUTOIMMUN, V11, P61, DOI 10.1159/000289197; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Wan YZ, 2009, J BIOL CHEM, V284, P10367, DOI 10.1074/jbc.M807822200; Yanagiya A, 2012, MOL CELL, V46, P847, DOI 10.1016/j.molcel.2012.04.004	46	31	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.348599	http://dx.doi.org/10.1074/jbc.M112.348599			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22955274	Green Published, hybrid			2022-12-28	WOS:000310642200036
J	Du, YT; Zhang, HH; Lu, J; Holmgren, A				Du, Yatao; Zhang, Huihui; Lu, Jun; Holmgren, Arne			Glutathione and Glutaredoxin Act as a Backup of Human Thioredoxin Reductase 1 to Reduce Thioredoxin 1 Preventing Cell Death by Aurothioglucose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN THIOREDOXIN; CANCER-THERAPY; IN-VIVO; PROTEIN OXIDATION; DNA-REPLICATION; REDOX STATE; SYSTEM; EBSELEN; DITHIOTHREITOL; IDENTIFICATION	Thioredoxin reductase 1 (TrxR1) in cytosol is the only known reductant of oxidized thioredoxin 1 (Trx1) in vivo so far. We and others found that aurothioglucose (ATG), a well known active-site inhibitor of TrxR1, inhibited TrxR1 activity in HeLa cell cytosol but had no effect on the viability of the cells. Using a redox Western blot analysis, no change was observed in redox state of Trx1, which was mainly fully reduced with five sulfhydryl groups. In contrast, auranofin killed cells and oxidized Trx1, also targeting mitochondrial TrxR2 and Trx2. Combining ATG with ebselen gave a strong synergistic effect, leading to Trx1 oxidation, reactive oxygen species accumulation, and cell death. We hypothesized that there should exist a backup system to reduce Trx1 when only TrxR1 activity was lost. Our results showed that physiological concentrations of glutathione, NADPH, and glutathione reductase reduced Trx1 in vitro and that the reaction was strongly stimulated by glutaredoxin1. Simultaneous depletion of TrxR activity by ATG and glutathione by buthionine sulfoximine led to overoxidation of Trx1 and loss of HeLa cell viability. In conclusion, the glutaredoxin system and glutathione have a backup role to keep Trx1 reduced in cells with loss of TrxR1 activity. Monitoring the redox state of Trx1 shows that cell death occurs when Trx1 is oxidized, followed by general protein oxidation catalyzed by the disulfide form of thioredoxin.	[Du, Yatao; Zhang, Huihui; Lu, Jun; Holmgren, Arne] Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, S-17177 Stockholm, Sweden	Karolinska Institutet	Holmgren, A (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, S-17177 Stockholm, Sweden.	Arne.Holmgren@ki.se	Lu, Jun/E-9701-2017; Zhang, Hui/HHN-8494-2022; zhang, hui/GXH-6098-2022	Lu, Jun/0000-0002-1699-8835; Du, Yatao/0000-0002-6881-0080	Swedish Research Council Medicine; Swedish Cancer Society; K.A. Wallenberg Foundation	Swedish Research Council Medicine(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society); K.A. Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the Swedish Research Council Medicine, the Swedish Cancer Society, and the K.A. Wallenberg Foundation.	Ahsan MK, 2009, ANTIOXID REDOX SIGN, V11, P2741, DOI [10.1089/ars.2009.2683, 10.1089/ARS.2009.2683]; Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Becker K, 2000, EUR J BIOCHEM, V267, P6118, DOI 10.1046/j.1432-1327.2000.01703.x; Berg D, 2004, CELL TISSUE RES, V318, P201, DOI 10.1007/s00441-004-0976-5; Bersani NA, 2002, METHOD ENZYMOL, V347, P317; Bindoli A, 2009, COORDIN CHEM REV, V253, P1692, DOI 10.1016/j.ccr.2009.02.026; Butterfield DA, 1998, ANN NY ACAD SCI, V854, P448, DOI 10.1111/j.1749-6632.1998.tb09924.x; Drechsel DA, 2010, J BIOL CHEM, V285, P27850, DOI 10.1074/jbc.M110.101196; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Fang Jianguo, 2005, Toxicol Appl Pharmacol, V207, P103, DOI 10.1016/j.taap.2005.02.022; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Greetham D., 2012, ANTIOXID REDOX SIGNA; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; HOLMGREN A, 1977, J BIOL CHEM, V252, P4600; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Kondo N, 2006, ANTIOXID REDOX SIGN, V8, P1881, DOI 10.1089/ars.2006.8.1881; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lu J, 2006, CANCER RES, V66, P4410, DOI 10.1158/0008-5472.CAN-05-3310; Lu J, 2009, J BIOL CHEM, V284, P723, DOI 10.1074/jbc.R800045200; Lu J, 2007, P NATL ACAD SCI USA, V104, P12288, DOI 10.1073/pnas.0701549104; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; Myers JM, 2009, FREE RADICAL BIO MED, V47, P1477, DOI 10.1016/j.freeradbiomed.2009.08.015; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Pourahmad J, 2001, FREE RADICAL BIO MED, V30, P89, DOI 10.1016/S0891-5849(00)00450-0; Prigge JR, 2012, FREE RADICAL BIO MED, V52, P803, DOI 10.1016/j.freeradbiomed.2011.11.025; Rengby O, 2004, APPL ENVIRON MICROB, V70, P5159, DOI 10.1128/AEM.70.9.5159-5167.2004; Rollins MF, 2010, J CELL SCI, V123, P2402, DOI 10.1242/jcs.068106; ROTHWARF DM, 1992, P NATL ACAD SCI USA, V89, P7944, DOI 10.1073/pnas.89.17.7944; Sallmyr A, 2008, CANCER LETT, V270, P1, DOI 10.1016/j.canlet.2008.03.036; Sasada T, 1999, FREE RADICAL BIO MED, V27, P504, DOI 10.1016/S0891-5849(99)00101-X; SIES H, 1993, FREE RADICAL BIO MED, V14, P313, DOI 10.1016/0891-5849(93)90028-S; Smith AD, 1999, J NUTR, V129, P194, DOI 10.1093/jn/129.1.194; Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191; Stadtman ER, 1998, DRUG METAB REV, V30, P225, DOI 10.3109/03602539808996310; TAKAHASHI N, 1990, ANAL BIOCHEM, V188, P359, DOI 10.1016/0003-2697(90)90621-F; Tan SX, 2010, J BIOL CHEM, V285, P6118, DOI 10.1074/jbc.M109.062844; Tonissen KF, 2009, MOL NUTR FOOD RES, V53, P87, DOI 10.1002/mnfr.200700492; Traber KE, 1999, INT IMMUNOL, V11, P143, DOI 10.1093/intimm/11.2.143; Trotter EW, 2003, EMBO REP, V4, P184, DOI 10.1038/sj.embor.embor729; Urig S, 2006, SEMIN CANCER BIOL, V16, P452, DOI 10.1016/j.semcancer.2006.09.004; Wang XF, 2007, TOXICOL APPL PHARM, V218, P88, DOI 10.1016/j.taap.2006.10.029; Watson WH, 2008, BIOCHEM BIOPH RES CO, V368, P832, DOI 10.1016/j.bbrc.2008.02.006; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; Yang CF, 2000, ARCH BIOCHEM BIOPHYS, V374, P142, DOI 10.1006/abbi.1999.1574; Yla-Herttuala S, 1999, ANN NY ACAD SCI, V874, P134, DOI 10.1111/j.1749-6632.1999.tb09231.x; Yoo MH, 2006, J BIOL CHEM, V281, P13005, DOI 10.1074/jbc.C600012200; Yoo MH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001112; Zhao R, 2002, J BIOL CHEM, V277, P39456, DOI 10.1074/jbc.M206452200; Zhao R, 2002, P NATL ACAD SCI USA, V99, P8579, DOI 10.1073/pnas.122061399	55	159	163	2	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.392225	http://dx.doi.org/10.1074/jbc.M112.392225			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22977247	Green Published, hybrid			2022-12-28	WOS:000310642200054
J	Grishin, AM; Ajamian, E; Zhang, LH; Rouiller, I; Bostina, M; Cygler, M				Grishin, Andrey M.; Ajamian, Eunice; Zhang, Linhua; Rouiller, Isabelle; Bostina, Mihnea; Cygler, Miroslaw			Protein-Protein Interactions in the beta-Oxidation Part of the Phenylacetate Utilization Pathway CRYSTAL STRUCTURE OF THE PaaF-PaaG HYDRATASE-ISOMERASE COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA(3)-DELTA(2)-ENOYL-COA ISOMERASE; ANGSTROM RESOLUTION; AEROBIC METABOLISM; COA HYDRATASE; ACID; BINDING; COENZYME; MECHANISM; THIOLASE; REVEALS	Microbial anaerobic and so-called hybrid pathways for degradation of aromatic compounds contain beta-oxidation-like steps. These reactions convert the product of the opening of the aromatic ring to common metabolites. The hybrid phenylacetate degradation pathway is encoded in Escherichia coli by the paa operon containing genes for 10 enzymes. Previously, we have analyzed protein-protein interactions among the enzymes catalyzing the initial oxidation steps in the paa pathway (Grishin, A. M., Ajamian, E., Tao, L., Zhang, L., Menard, R., and Cygler, M. (2011) J. Biol. Chem. 286, 10735-10743). Here we report characterization of interactions between the remaining enzymes of this pathway and show another stable complex, PaaFG, an enoyl-CoA hydratase and enoyl-Coa isomerase, both belonging to the crotonase superfamily. These steps are biochemically similar to the well studied fatty acid beta-oxidation, which can be catalyzed by individual monofunctional enzymes, multifunctional enzymes comprising several domains, or enzymatic complexes such as the bacterial fatty acid beta-oxidation complex. We have determined the structure of the PaaFG complex and determined that although individually PaaF and PaaG are similar to enzymes from the fatty acid beta-oxidation pathway, the structure of the complex is dissimilar from bacterial fatty acid beta-oxidation complexes. The PaaFG complex has a four-layered structure composed of homotrimeric discs of PaaF and PaaG. The active sites of PaaF and PaaG are adapted to accept the intermediary components of the Paa pathway, different from those of the fatty acid beta-oxidation. The association of PaaF and PaaG into a stable complex might serve to speed up the steps of the pathway following the conversion of phenylacetyl-CoA to a toxic and unstable epoxide-CoA by PaaABCE monooxygenase.	[Cygler, Miroslaw] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Ajamian, Eunice; Zhang, Linhua; Cygler, Miroslaw] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Rouiller, Isabelle] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; [Bostina, Mihnea] McGill Univ, Facil Electron Microscopy Res, Montreal, PQ H3A 2B2, Canada	University of Saskatchewan; McGill University; McGill University; McGill University	Cygler, M (corresponding author), Univ Saskatchewan, Dept Biochem, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	miroslaw.cygler@usask.ca	Rouiller, Isabelle/AAE-9637-2019; rouiller, isabelle/K-7679-2012	rouiller, isabelle/0000-0002-1288-8575; Bostina, Mihnea/0000-0003-3621-3772	Canadian Institutes of Health Research [MOP-48370]; Canada Research Chair Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair Program(Canada Research Chairs)	This research was supported by Canadian Institutes of Health Research Grant MOP-48370 and the Canada Research Chair Program (to M. C.). X-ray diffraction data for this study were measured at the Canadian Macromolecular Crystallography Facility at the Canadian Light Source, which is supported by the Canadian Foundation for Innovation, the Natural Sciences and Engineering Research Council of Canada, and Canadian Institutes of Health Research.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barycki JJ, 1999, BIOCHEMISTRY-US, V38, P5786, DOI 10.1021/bi9829027; Cao B, 2009, APPL MICROBIOL BIOT, V85, P207, DOI 10.1007/s00253-009-2192-4; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Egland PG, 1997, P NATL ACAD SCI USA, V94, P6484, DOI 10.1073/pnas.94.12.6484; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel CK, 1998, J MOL BIOL, V275, P847, DOI 10.1006/jmbi.1997.1491; Engel CK, 1996, EMBO J, V15, P5135, DOI 10.1002/j.1460-2075.1996.tb00897.x; Ferrandez A, 1998, J BIOL CHEM, V273, P25974, DOI 10.1074/jbc.273.40.25974; Fould B, 2010, BIOCHEMISTRY-US, V49, P8608, DOI 10.1021/bi100742w; Fuchs G, 2008, ANN NY ACAD SCI, V1125, P82, DOI 10.1196/annals.1419.010; Gibson J, 2002, ANNU REV MICROBIOL, V56, P345, DOI 10.1146/annurev.micro.56.012302.160749; Grishin AM, 2011, J BIOL CHEM, V286, P10735, DOI 10.1074/jbc.M110.194423; Haapalainen AM, 2007, BIOCHEMISTRY-US, V46, P4305, DOI 10.1021/bi6026192; Hamed RB, 2008, CELL MOL LIFE SCI, V65, P2507, DOI 10.1007/s00018-008-8082-6; Hofstein HA, 1999, BIOCHEMISTRY-US, V38, P9508, DOI 10.1021/bi990506y; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Ishikawa M, 2004, EMBO J, V23, P2745, DOI 10.1038/sj.emboj.7600298; Jancarik J, 2004, ACTA CRYSTALLOGR D, V60, P1670, DOI 10.1107/S0907444904010972; Kasaragod P, 2010, J BIOL CHEM, V285, P24089, DOI 10.1074/jbc.M110.117606; Kichise T, 2009, PROTEINS, V76, P779, DOI 10.1002/prot.22455; Kiema TR, 1999, BIOCHEMISTRY-US, V38, P2991, DOI 10.1021/bi981646v; Kim JJP, 2002, CURR OPIN STRUC BIOL, V12, P721, DOI 10.1016/S0959-440X(02)00390-1; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mathieu M, 1997, J MOL BIOL, V273, P714, DOI 10.1006/jmbi.1997.1331; Modis Y, 1998, STRUCTURE, V6, P957, DOI 10.1016/S0969-2126(98)00098-7; Mohamed ME, 2000, J BACTERIOL, V182, P286, DOI 10.1128/JB.182.2.286-294.2000; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Mursula AM, 2004, FEBS LETT, V557, P81, DOI 10.1016/S0014-5793(03)01450-9; Mursula AM, 2001, J MOL BIOL, V309, P845, DOI 10.1006/jmbi.2001.4671; Nogales J, 2007, MICROBIOL-SGM, V153, P357, DOI 10.1099/mic.0.2006/002444-0; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Partanen ST, 2004, J MOL BIOL, V342, P1197, DOI 10.1016/j.jmb.2004.07.039; Rather LJ, 2010, J BIOL CHEM, V285, P20615, DOI 10.1074/jbc.M110.124156; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107; Teufel R, 2012, NATURE, V483, P359, DOI 10.1038/nature10862; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	39	9	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.388231	http://dx.doi.org/10.1074/jbc.M112.388231			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22961985	Green Published, hybrid			2022-12-28	WOS:000310642200033
J	Peng, ZM; Liao, ZP; Dziegielewska, B; Matsumoto, Y; Thomas, S; Wan, YH; Yang, A; Tomkinson, AE				Peng, Zhimin; Liao, Zhongping; Dziegielewska, Barbara; Matsumoto, Yoshi; Thomas, Stefani; Wan, Yunhu; Yang, Austin; Tomkinson, Alan E.			Phosphorylation of Serine 51 Regulates the Interaction of Human DNA Ligase I with Replication Factor C and Its Participation in DNA Replication and Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; CLAMP LOADER; DAMAGE; SITE; PHOSPHOPROTEOME; IDENTIFICATION; QUANTITATION; EUKARYOTES; SENESCENCE; MECHANISM	Human DNA ligase I (hLigI) joins Okazaki fragments during DNA replication and completes excision repair via interactions with proliferating cell nuclear antigen and replication factor C (RFC). Unlike proliferating cell nuclear antigen, the interaction with RFC is regulated by hLigI phosphorylation. To identity of the site(s) involved in this regulation, we analyzed phosphorylated hLigI purified from insect cells by mass spectrometry. These results suggested that serine 51 phosphorylation negatively regulates the interaction with RFC. Therefore, we constructed versions of hLigI in which serine 51 was replaced with either alanine (hLigI51A) to prevent phosphorylation or aspartic acid (hLigI51D) to mimic phosphorylation. hLigI51D but not hLigI51A was defective in binding to purified RFC and in associating with RFC in cell extracts. Although DNA synthesis and proliferation of hLigI-deficient cells expressing either hLig51A or hLig51 was reduced compared with cells expressing wild-type hLigI, cellular senescence was only observed in the cells expressing hLigI51D. Notably, these cells had increased levels of spontaneous DNA damage and phosphorylated CHK2. In addition, although expression of hLigI51A complemented the sensitivity of hLigI-deficient cells to a poly (ADP-ribose polymerase (PARP) inhibitor, expression of hLig151D did not, presumably because these cells are more dependent upon PARP-dependent repair pathways to repair the damage resulting from the abnormal DNA replication. Finally, neither expression of hLigI51D nor hLigI51A fully complemented the sensitivity of hLigI-deficient cells to DNA alkylation. Thus, phosphorylation of serine 51 on hLigI plays a critical role in regulating the interaction between hLigI and RFC, which is required for efficient DNA replication and repair.	[Peng, Zhimin; Matsumoto, Yoshi; Tomkinson, Alan E.] Univ New Mexico, Univ New Mexico Canc Ctr, Albuquerque, NM 87131 USA; [Liao, Zhongping; Thomas, Stefani; Wan, Yunhu; Yang, Austin] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Dziegielewska, Barbara] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Radiat Oncol Res Lab,Dept Radiat Oncol, Baltimore, MD 21201 USA; [Peng, Zhimin; Matsumoto, Yoshi; Tomkinson, Alan E.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA	University of New Mexico; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of New Mexico	Tomkinson, AE (corresponding author), Univ New Mexico 1, Dept Internal Med, 915 Camino Salud NE, Albuquerque, NM 87131 USA.	atomkinson@salud.unm.edu	Dziegielewska, Barbara/J-5538-2019; peng, zhimin/B-4536-2010; Thomas, Stefani/AAF-4212-2021; Classen, Scott/AAY-8176-2020	Thomas, Stefani/0000-0003-1679-5453; 	National Institutes of Health [R01 GM 57479, P01 CA 92584, R01 AG25323]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM 57479 and P01 CA 92584 (to A. E. T.) and R01 AG25323 (to A. Y.).	Arakawa H, 2012, NUCLEIC ACIDS RES, V40, P2599, DOI 10.1093/nar/gkr1024; Balakrishnan L, 2011, J BIOL CHEM, V286, P6865, DOI 10.1074/jbc.R110.209502; BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; Bentley DJ, 1996, NAT GENET, V13, P489, DOI 10.1038/ng0896-489; Bentley DJ, 2002, J CELL SCI, V115, P1551; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen RQ, 2009, CANCER RES, V69, P2663, DOI 10.1158/0008-5472.CAN-08-3222; Christensen GL, 2010, MOL CELL PROTEOMICS, V9, P1540, DOI 10.1074/mcp.M900550-MCP200; Cripps D, 2006, J BIOL CHEM, V281, P10825, DOI 10.1074/jbc.M512786200; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fazlieva R, 2009, NUCLEIC ACIDS RES, V37, P2854, DOI 10.1093/nar/gkp155; Ferrari G, 2003, J BIOL CHEM, V278, P37761, DOI 10.1074/jbc.M304462200; Harrison C, 2002, CANCER RES, V62, P4065; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Iliuk AB, 2010, MOL CELL PROTEOMICS, V9, P2162, DOI 10.1074/mcp.M110.000091; Krude T, 1999, EXP CELL RES, V247, P148, DOI 10.1006/excr.1998.4342; LASKO DD, 1990, J BIOL CHEM, V265, P12618; LEHMANN AR, 1988, CANCER RES, V48, P6343; Levin DS, 2000, CURR BIOL, V10, P919, DOI 10.1016/S0960-9822(00)00619-9; Levin DS, 2004, J BIOL CHEM, V279, P55196, DOI 10.1074/jbc.M409250200; Levin DS, 1997, P NATL ACAD SCI USA, V94, P12863, DOI 10.1073/pnas.94.24.12863; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Montecucco A, 1998, EMBO J, V17, P3786, DOI 10.1093/emboj/17.13.3786; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Porcedda P, 2008, CYTOM PART A, V73A, P508, DOI 10.1002/cyto.a.20566; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Rossi R, 1999, EMBO J, V18, P5745, DOI 10.1093/emboj/18.20.5745; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Song W, 2007, J BIOL CHEM, V282, P22721, DOI 10.1074/jbc.M703774200; Soza S, 2009, MOL CELL BIOL, V29, P2032, DOI 10.1128/MCB.01730-08; Stein J. L., 1989, CELL SYNCHRONIZATION, P133; Vijayakumar S, 2009, MOL CELL BIOL, V29, P2042, DOI 10.1128/MCB.01732-08; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Wahl GM, 2001, NAT CELL BIOL, V3, pE277, DOI 10.1038/ncb1201-e277; WANG YCJ, 1994, J BIOL CHEM, V269, P31923; Wang YT, 2010, J PROTEOME RES, V9, P5582, DOI 10.1021/pr100394u	37	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36711	36719		10.1074/jbc.M112.383570	http://dx.doi.org/10.1074/jbc.M112.383570			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22952233	hybrid, Green Published			2022-12-28	WOS:000310588500009
J	Deng, YJ; Gam, J; French, JB; Zhao, H; An, S; Benkovic, SJ				Deng, Yijun; Gam, Jongsik; French, Jarrod B.; Zhao, Hong; An, Songon; Benkovic, Stephen J.			Mapping Protein-Protein Proximity in the Purinosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIENZYME COMPLEX; PURINE BIOSYNTHESIS; PURIFICATION; PATHWAY; CELLS	The enzymes in the human de novo purine synthesis pathway were found to form a cellular complex, the purinosome, upon culturing cells in purine-depleted medium (An, S., Kumar R., Sheets, E. D., and Benkovic, S. J. (2008) Science 320, 103-106). Purinosome formation and dissociation were found to be modulated by several factors, including the microtubule network and cell signaling involving protein phosphorylation. To determine whether the pathway enzymes are in physical contact, we probed for the protein-protein interactions (PPIs) within the purinosome with a novel application of the Tango PPI reporter system (Barnea, G., Strapps, W., Herrada, G., Berman, Y., Ong, J., Kloss, B., Axel, R., and Lee, K. J. (2008) Proc. Natl. Acad. Sci. U.S.A. 105, 64-69). We found PPIs among all six enzymes within the pathway and evidence for a core involving the first three enzymes. We also captured purinosomes under both purine-rich and purine-depleted conditions. The results provide additional insights into the transient nature and topography of the purinosome.	[Deng, Yijun; French, Jarrod B.; Zhao, Hong; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Gam, Jongsik] Korea Res Inst Biosci & Biotechnol, Taejon 306809, South Korea; [An, Songon] Univ Maryland, Dept Chem & Biochem, Baltimore, MD 21250 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Korea Research Institute of Bioscience & Biotechnology (KRIBB); University System of Maryland; University of Maryland Baltimore	Benkovic, SJ (corresponding author), Penn State Univ, Dept Chem, 414 Wartik Lab, University Pk, PA 16802 USA.	sjb1@psu.edu	ZHAO, HONG/C-6464-2013; French, Jarrod/K-6669-2014	French, Jarrod/0000-0002-6762-1309; An, Songon/0000-0003-2189-7374	National Institutes of Health [3 R01 GM024129-31S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 3 R01 GM024129-31S1.	An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; An S, 2010, P NATL ACAD SCI USA, V107, P12872, DOI 10.1073/pnas.1008451107; An S, 2010, J BIOL CHEM, V285, P11093, DOI 10.1074/jbc.M110.101139; Baresova V, 2012, HUM MOL GENET, V21, P1534, DOI 10.1093/hmg/ddr591; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Brodsky G, 1997, HUM MOL GENET, V6, P2043, DOI 10.1093/hmg/6.12.2043; CAPERELLI CA, 1980, J BIOL CHEM, V255, P1885; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Lievens S, 2009, TRENDS BIOCHEM SCI, V34, P579, DOI 10.1016/j.tibs.2009.06.009; ROWE PB, 1978, J BIOL CHEM, V253, P7711; Verrier F, 2011, NAT CHEM BIOL, V7, P909, DOI [10.1038/NCHEMBIO.690, 10.1038/nchembio.690]; Wilkins MR, 2008, TRENDS BIOCHEM SCI, V33, P195, DOI 10.1016/j.tibs.2008.03.001; Zhang Y, 2008, CELL MOL LIFE SCI, V65, P3699, DOI 10.1007/s00018-008-8295-8	13	45	45	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36201	36207		10.1074/jbc.M112.407056	http://dx.doi.org/10.1074/jbc.M112.407056			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22955281	Green Published, hybrid			2022-12-28	WOS:000310364000041
J	Chan, LJ; Rosengren, KJ; Layfield, SL; Bathgate, RAD; Separovic, F; Samuel, CS; Hossain, MA; Wade, JD				Chan, Linda J.; Rosengren, K. Johan; Layfield, Sharon L.; Bathgate, Ross A. D.; Separovic, Frances; Samuel, Chrishan S.; Hossain, Mohammed A.; Wade, John D.			Identification of Key Residues Essential for the Structural Fold and Receptor Selectivity within the A-chain of Human Gene-2 (H2) Relaxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY PEPTIDE RECEPTORS; SOLID-PHASE SYNTHESIS; BINDING SITE; IN-VIVO; INSULIN-RECEPTOR; ACTIVATION; HORMONE; LIGAND; COLLAGEN; LGR7	Human gene-2 (H2) relaxin is currently in Phase III clinical trials for the treatment of acute heart failure. It is a 53-amino acid insulin-like peptide comprising two chains and three disulfide bonds. It interacts with two of the relaxin family peptide (RXFP) receptors. Although its cognate receptor is RXFP1, it is also able to cross-react with RXFP2, the native receptor for a related peptide, insulin-like peptide 3. In order to understand the basis of this cross-reactivity, it is important to elucidate both binding and activation mechanisms of this peptide. The primary binding mechanism of this hormone has been extensively studied and well defined. H2 relaxin binds to the leucine-rich repeats of RXFP1 and RXFP2 using B-chain-specific residues. However, little is known about the secondary interaction that involves the A-chain of H2 relaxin and transmembrane exoloops of the receptors. We demonstrate here through extensive mutation of the A-chain that the secondary interaction between H2 relaxin and RXFP1 is not driven by any single amino acid, although residues Tyr-3, Leu-20, and Phe-23 appear to contribute. Interestingly, these same three residues are important drivers of the affinity and activity of H2 relaxin for RXFP2 with additional minor contributions from Lys-9, His-12, Lys-17, Arg-18, and Arg-22. Our results provide new insights into the mechanism of secondary activation interaction of RXFP1 and RXFP2 by H2 relaxin, leading to a potent and RXFP1-selective analog, H2:A(4-24)(F23A), which was tested in vitro and in vivo and found to significantly inhibit collagen deposition similar to native H2 relaxin.	[Chan, Linda J.; Layfield, Sharon L.; Bathgate, Ross A. D.; Samuel, Chrishan S.; Hossain, Mohammed A.; Wade, John D.] Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic 3010, Australia; [Chan, Linda J.; Separovic, Frances; Hossain, Mohammed A.; Wade, John D.] Univ Melbourne, Sch Chem, Melbourne, Vic 3010, Australia; [Bathgate, Ross A. D.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Rosengren, K. Johan] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Samuel, Chrishan S.] Monash Univ, Dept Pharmacol, Clayton, Vic 3145, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne; University of Queensland; Monash University	Samuel, CS (corresponding author), Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic 3010, Australia.	chrishan.samuel@florey.edu.au; akhter.hossain@florey.edu.au; john.wade@florey.edu.au	Bathgate, Ross/ABE-6471-2020; Separovic, Frances/D-9698-2011; Rosengren, K. Johan/P-4450-2016	Bathgate, Ross/0000-0001-6301-861X; Separovic, Frances/0000-0002-6484-2763; Rosengren, K. Johan/0000-0002-5007-8434; Hossain, Mohammed/0000-0002-9961-0006; Wade, John/0000-0002-1352-6568	National Health and Medical Research Council (NHMRC) (Australia) [508995, 1023078]; Victorian Government; Reid Trust; Florey Foundation	National Health and Medical Research Council (NHMRC) (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government; Reid Trust; Florey Foundation	This research was funded by National Health and Medical Research Council (NHMRC) (Australia) Project Grants 508995 and 1023078 (to J. D. W., M. A. H., and R. A. D. B.). Studies at the Florey Neuroscience Institutes were supported by the Victorian Government's Operational Infrastructure Support Program.; Recipient of Reid Trust and Florey Foundation Fellowships.	Bathgate RA, 2006, PHARMACOL REV, V58, P7, DOI 10.1124/pr.58.1.9; Bathgate RAD, 2006, BIOCHEMISTRY-US, V45, P1043, DOI 10.1021/bi052233e; Bathgate Ross A D, 2012, Front Endocrinol (Lausanne), V3, P11, DOI 10.3389/fendo.2012.00011; Brooks WW, 2009, COMPARATIVE MED, V59, P339; BRYANTGREENWOOD GD, 1994, ENDOCR REV, V15, P5, DOI 10.1210/er.15.1.5; Bullesbach EE, 2000, J BIOL CHEM, V275, P35276, DOI 10.1074/jbc.M005728200; Bullesbach EE, 2005, J BIOL CHEM, V280, P14051, DOI 10.1074/jbc.M500030200; Bullesbach EE, 2005, J BIOL CHEM, V280, P14586, DOI 10.1074/jbc.M414443200; Chan LJ, 2011, PROTEIN PEPTIDE LETT, V18, P220; CHEN WB, 1995, ANAL BIOCHEM, V226, P349, DOI 10.1006/abio.1995.1235; Du XJ, 2010, NAT REV CARDIOL, V7, P48, DOI 10.1038/nrcardio.2009.198; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hartley BJ, 2009, ANN NY ACAD SCI, V1160, P67, DOI 10.1111/j.1749-6632.2009.03949.x; Haugaard-Kedstrom LM, 2011, J AM CHEM SOC, V133, P4965, DOI 10.1021/ja110567j; Heeg MHJ, 2005, KIDNEY INT, V68, P96, DOI 10.1111/j.1523-1755.2005.00384.x; Hewitson TD, 2010, ENDOCRINOLOGY, V151, P4938, DOI 10.1210/en.2010-0286; Hossain MA, 2008, CHEMBIOCHEM, V9, P1816, DOI 10.1002/cbic.200800113; Hossain MA, 2008, J BIOL CHEM, V283, P17287, DOI 10.1074/jbc.M801911200; Hossain MA, 2006, INT J PEPT RES THER, V12, P211, DOI 10.1007/s10989-006-9020-9; Hossain MA, 2012, PEPTIDES, V35, P102, DOI 10.1016/j.peptides.2012.02.021; Hossain MA, 2011, J BIOL CHEM, V286, P37555, DOI 10.1074/jbc.M111.282194; Hossain MA, 2010, CURR PROTEIN PEPT SC, V11, P719; Hossain MA, 2011, BIOCHEMISTRY-US, V50, P1368, DOI 10.1021/bi1013968; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Huang K, 2007, J BIOL CHEM, V282, P35337, DOI 10.1074/jbc.M705996200; Keller R., 2004, COMPUTER AIDED RESON, V1; Kong RCK, 2010, MOL CELL ENDOCRINOL, V320, P1, DOI 10.1016/j.mce.2010.02.003; Kumagai J, 2002, J BIOL CHEM, V277, P31283, DOI 10.1074/jbc.C200398200; Liu CL, 2005, MOL PHARMACOL, V67, P231, DOI 10.1124/mol.104.006700; Liu CL, 2003, J BIOL CHEM, V278, P50754, DOI 10.1074/jbc.M308995200; Park JI, 2008, J BIOL CHEM, V283, P32099, DOI 10.1074/jbc.M806817200; Rosengren KJ, 2006, J BIOL CHEM, V281, P28287, DOI 10.1074/jbc.M603829200; Rosengren KJ, 2009, ANN NY ACAD SCI, V1160, P20, DOI 10.1111/j.1749-6632.2009.03833.x; Samuel CS, 2011, LAB INVEST, V91, P675, DOI 10.1038/labinvest.2010.198; Samuel Chrishan S., 2009, V466, P223, DOI 10.1007/978-1-59745-352-3_16; Samuel CS, 2004, ENDOCRINOLOGY, V145, P4125, DOI 10.1210/en.2004-0209; Samuel CS, 2002, FASEB J, V16, P121, DOI 10.1096/fj.02-0449fje; Scott DJ, 2007, MOL ENDOCRINOL, V21, P1699, DOI 10.1210/me.2007-0097; Scott DJ, 2009, ANN NY ACAD SCI, V1160, P74, DOI 10.1111/j.1749-6632.2009.03950.x; Scott DJ, 2006, J BIOL CHEM, V281, P34942, DOI 10.1074/jbc.M602728200; Shabanpoor F, 2008, BIOCONJUGATE CHEM, V19, P1456, DOI 10.1021/bc800127p; Shabanpoor F, 2012, BIOCHEM BIOPH RES CO, V420, P253, DOI 10.1016/j.bbrc.2012.02.141; Sudo S, 2003, J BIOL CHEM, V278, P7855, DOI 10.1074/jbc.M212457200; Teerlink JR, 2009, LANCET, V373, P1429, DOI 10.1016/S0140-6736(09)60622-X; UNEMORI EN, 1990, J BIOL CHEM, V265, P10681; Whittaker J, 2012, P NATL ACAD SCI USA, V109, P11166, DOI 10.1073/pnas.1205681109; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WUTHRICH K, 1983, BIOPOLYMERS, V22, P131, DOI 10.1002/bip.360220121; Zhang S, 2008, INT J PEPT RES THER, V14, P301, DOI 10.1007/s10989-008-9148-x	49	18	24	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41152	41164		10.1074/jbc.M112.409284	http://dx.doi.org/10.1074/jbc.M112.409284			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23024363	Green Published, hybrid			2022-12-28	WOS:000311887600031
J	Kir, S; Zhang, Y; Gerard, RD; Kliewer, SA; Mangelsdorf, DJ				Kir, Serkan; Zhang, Yuan; Gerard, Robert D.; Kliewer, Steven A.; Mangelsdorf, David J.			Nuclear Receptors HNF4 alpha and LRH-1 Cooperate in Regulating Cyp7a1 in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILE-ACID BIOSYNTHESIS; CHOLESTEROL 7-ALPHA-HYDROXYLASE GENE; NEGATIVE FEEDBACK-REGULATION; HETERODIMER PARTNER; LIPID HOMEOSTASIS; FACTOR 4-ALPHA; X-RECEPTOR; SHP; TRANSCRIPTION; LIVER	Fibroblast growth factor 19 (FGF19) is a postprandial enterokine induced by the nuclear bile acid receptor, FXR, in ileum. FGF19 inhibits bile acid synthesis in liver through transcriptional repression of cholesterol 7 alpha-hydroxylase (CYP7A1) via a mechanism involving the nuclear receptor SHP. Here, in a series of loss-of-function studies, we show that the nuclear receptors HNF4 alpha and LRH-1 have dual roles in regulating Cyp7a1 in vivo. First, they cooperate in maintaining basal Cyp7a1 expression. Second, they enable SHP binding to the Cyp7a1 promoter and facilitate FGF19-mediated repression of bile acid synthesis. HNF4 alpha and LRH-1 promote active transcription histone marks on the Cyp7a1 promoter that are reversed by FGF19 in a SHP-dependent manner. These findings demonstrate that both HNF4 alpha and LRH-1 are important regulators of Cyp7a1 transcription in vivo.	[Kir, Serkan; Zhang, Yuan; Kliewer, Steven A.; Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Gerard, Robert D.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Gerard, Robert D.; Kliewer, Steven A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kliewer, SA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	steven.kliewer@utsouthwestern.edu; davo.mango@utsouthwestern.edu		Mangelsdorf, David/0000-0002-4355-0796	Howard Hughes Medical Institute; National Institutes of Health [DK67158, DK62434]; Robert A. Welch Foundation [I-1275, I-1588]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067158, U19DK062434] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the Howard Hughes Medical Institute (to D. J. M.), the National Institutes of Health (Grants DK67158 and DK62434, to S. A. K. and D. J. M.), and the Robert A. Welch Foundation (I-1275, to D. J. M. and I-1588, to S. A. K.).	Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; De Fabiani E, 2001, J BIOL CHEM, V276, P30708, DOI 10.1074/jbc.M103270200; del Castillo-Olivares A, 2000, NUCLEIC ACIDS RES, V28, P3587; del Castillo-Olivares A, 2001, NUCLEIC ACIDS RES, V29, P4035, DOI 10.1093/nar/29.19.4035; Fang SS, 2007, MOL CELL BIOL, V27, P1407, DOI 10.1128/MCB.00944-06; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inoue Y, 2006, J LIPID RES, V47, P215, DOI 10.1194/jlr.M500430-JLR200; Kemper JK, 2004, MOL CELL BIOL, V24, P7707, DOI 10.1128/MCB.24.17.7707-7719.2004; Kerr TA, 2002, DEV CELL, V2, P713, DOI 10.1016/S1534-5807(02)00154-5; Kim I, 2007, J LIPID RES, V48, P2664, DOI 10.1194/jlr.M700330-JLR200; Kir S, 2011, COLD SH Q B, V76, P139, DOI 10.1101/sqb.2011.76.010710; Lee FY, 2006, TRENDS BIOCHEM SCI, V31, P572, DOI 10.1016/j.tibs.2006.08.002; Lee JM, 2011, NATURE, V474, P506, DOI 10.1038/nature10111; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Lee YK, 2008, MOL ENDOCRINOL, V22, P1345, DOI 10.1210/me.2007-0565; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Mataki C, 2007, MOL CELL BIOL, V27, P8330, DOI 10.1128/MCB.00852-07; Miao J, 2009, GENE DEV, V23, P986, DOI 10.1101/gad.1773909; Nitta M, 1999, P NATL ACAD SCI USA, V96, P6660, DOI 10.1073/pnas.96.12.6660; Potthoff MJ, 2011, CELL METAB, V13, P729, DOI 10.1016/j.cmet.2011.03.019; Russell DW, 2009, J LIPID RES, V50, pS120, DOI 10.1194/jlr.R800026-JLR200; Sanyal S, 2007, P NATL ACAD SCI USA, V104, P15665, DOI 10.1073/pnas.0706736104; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Stroup D, 2000, J LIPID RES, V41, P1; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9	29	93	100	5	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41334	41341		10.1074/jbc.M112.421834	http://dx.doi.org/10.1074/jbc.M112.421834			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23038264	hybrid, Green Published			2022-12-28	WOS:000311887600047
J	Kim, SK; Jung, I; Lee, H; Kang, K; Kim, M; Jeong, K; Kwon, CS; Han, YM; Kim, YS; Kim, D; Lee, D				Kim, Seung-Kyoon; Jung, Inkyung; Lee, Hosuk; Kang, Keunsoo; Kim, Mirang; Jeong, Kwiwan; Kwon, Chang Seob; Han, Yong-Mahn; Kim, Yong Sung; Kim, Dongsup; Lee, Daeyoup			Human Histone H3K79 Methyltransferase DOT1L Methyltransferase Binds Actively Transcribing RNA Polymerase II to Regulate Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ELONGATION; H3 METHYLATION; H2B MONOUBIQUITINATION; TERMINAL DOMAIN; UBIQUITINATION; YEAST; RECRUITMENT; NUCLEOSOME; KINASE; SET2	Histone-modifying enzymes play a pivotal role in gene expression and repression. In human, DOT1L (Dot1-like) is the only known histone H3 lysine 79 methyltransferase. hDOT1L is associated with transcriptional activation, but the general mechanism connecting hDOT1L to active transcription remains largely unknown. Here, we report that hDOT1L interacts with the phosphorylated C-terminal domain of actively transcribing RNA polymerase II (RNAPII) through a region conserved uniquely in multicellular DOT1 proteins. Genome-wide profiling analyses indicate that the occupancy of hDOT1L largely overlaps with that of RNAPII at actively transcribed genes, especially surrounding transcriptional start sites, in embryonic carcinoma NCCIT cells. We also find that C-terminal domain binding or H3K79 methylations by hDOT1L is important for the expression of target genes such as NANOG and OCT4 and a marker for pluripotency in NCCIT cells. Our results indicate that a functional interaction between hDOT1L and RNAPII targets hDOT1L and subsequent H3K79 methylations to actively transcribed genes.	[Kim, Seung-Kyoon; Lee, Hosuk; Kang, Keunsoo; Jeong, Kwiwan; Han, Yong-Mahn; Lee, Daeyoup] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Jung, Inkyung; Kim, Dongsup] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Kwon, Chang Seob] Korea Adv Inst Sci & Technol, Korea Sci Acad, Dept Biol & Chem, Pusan 614822, South Korea; [Kim, Mirang; Kim, Yong Sung] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Taejon 305806, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Lee, D (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, 291 Daehak Ro, Taejon 305701, South Korea.	daeyoup@kaist.ac.kr	Han, Yong-Mahn/C-1652-2011; Jung, Inkyung/CAJ-5773-2022; Kim, Dongsup/C-1612-2011; Lee, Daeyoup/C-1653-2011; Lee, Hosuk/AAE-9102-2022	Lee, Daeyoup/0000-0003-2006-1823; Kim, Seung-Kyoon/0000-0001-9776-4047; Jung, Inkyung/0000-0002-5885-2754	Epigenomic Research Program for Human Stem Cells Grant [2007-2004134]; Stem Cell Research Program Grant [2012M 3A9B 4027953]; Ministry of Education, Science & Technology (South Korea); KRIBB/KRCF Research Initiative Program (NAP), Rural Development Administration (South Korea)	Epigenomic Research Program for Human Stem Cells Grant; Stem Cell Research Program Grant; Ministry of Education, Science & Technology (South Korea); KRIBB/KRCF Research Initiative Program (NAP), Rural Development Administration (South Korea)	This work was supported by Epigenomic Research Program for Human Stem Cells Grant 2007-2004134, Stem Cell Research Program Grant 2012M 3A9B 4027953, and grants from the Ministry of Education, Science & Technology (South Korea) and the KRIBB/KRCF Research Initiative Program (NAP), Rural Development Administration (South Korea).	Barry ER, 2009, STEM CELLS, V27, P1538, DOI 10.1002/stem.86; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bitoun E, 2007, HUM MOL GENET, V16, P92, DOI 10.1093/hmg/ddl444; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; DAMJANOV I, 1993, EUR UROL, V23, P2; DAMJANOV I, 1993, LAB INVEST, V68, P220; de la Mata M, 2006, NAT STRUCT MOL BIOL, V13, P973, DOI 10.1038/nsmb1155; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Giannattasio M, 2005, J BIOL CHEM, V280, P9879, DOI 10.1074/jbc.M414453200; Hiromi N., 2009, COMP FUNCT GENOM, V2009, P8; Ho CK, 1999, MOL CELL, V3, P405, DOI 10.1016/S1097-2765(00)80468-2; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Jung I, 2012, GENOME RES, V22, P1026, DOI 10.1101/gr.120634.111; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Mohan M, 2010, GENE DEV, V24, P574, DOI 10.1101/gad.1898410; Mueller D, 2007, BLOOD, V110, P4445, DOI 10.1182/blood-2007-05-090514; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Oh S, 2010, BIOCHEM BIOPH RES CO, V399, P512, DOI 10.1016/j.bbrc.2010.07.100; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Phatnani HP, 2004, BIOCHEMISTRY-US, V43, P15702, DOI 10.1021/bi048364h; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; San-Segundo PA, 2000, MOL BIOL CELL, V11, P3601, DOI 10.1091/mbc.11.10.3601; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schulze JM, 2009, MOL CELL, V35, P626, DOI 10.1016/j.molcel.2009.07.017; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Shanower GA, 2005, GENETICS, V169, P173, DOI 10.1534/genetics.104.033191; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Spencer VA, 2003, METHODS, V31, P67, DOI 10.1016/S1046-2023(03)00089-6; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Suganuma T, 2002, P NATL ACAD SCI USA, V99, P13073, DOI 10.1073/pnas.192586699; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; TESHIMA T, 1988, INT J RADIAT ONCOL, V14, P281, DOI 10.1016/0360-3016(88)90433-6; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Wysocki R, 2005, MOL CELL BIOL, V25, P8430, DOI 10.1128/MCB.25.19.8430-8443.2005; Zhang KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001210; Zhang WZ, 2004, BIOCHEM J, V377, P641, DOI 10.1042/BJ20030839; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou K, 2009, P NATL ACAD SCI USA, V106, P6956, DOI 10.1073/pnas.0806302106	59	52	55	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.384057	http://dx.doi.org/10.1074/jbc.M112.384057			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23012353	hybrid, Green Published			2022-12-28	WOS:000311233800039
J	Zhao, YZ; Malinin, NL; Meller, J; Ma, Y; West, XZ; Bledzka, K; Qin, J; Podrez, EA; Byzova, TV				Zhao, Yongzhong; Malinin, Nikolay L.; Meller, Julia; Ma, Yi; West, Xiaoxia Z.; Bledzka, Kamila; Qin, Jun; Podrez, Eugene A.; Byzova, Tatiana V.			Regulation of Cell Adhesion and Migration by Kindlin-3 Cleavage by Calpain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED PROTEOLYSIS; LEUKOCYTE ADHESION; KINASE FAK; ACTIVATION; INTEGRINS; DYNAMICS; REVEALS; TALIN	Integrin activation on hematopoietic cells is essential for platelet aggregation, leukocyte adhesion, and transmigration through endothelium and extracellular matrix into inflamed tissues. To migrate through matrix, leukocyte integrin adhesion complexes undergo dynamic changes. Here we show that Kindlin-3, a main activator and binding partner of integrins in hematopoietic cells, can be cleaved by calpain in an activation-dependent manner. This calpain-mediated cleavage occurs in platelets and leukocytes as well as in endothelial cells. We determined the calpain I cleavage site in Kindlin-3 at tyrosine 373 in the N-terminal part of Kindlin-3 pleckstrin homology domain. Expression of the calpain-resistant Y373N mutant of Kindlin-3 promotes stronger cell adhesion to extracellular matrix under flow as well as to activated endothelium. In contrast, Y373N mutation in Kindlin-3 hinders cell migration. Mechanistically, calpain-resistant Y373N mutant of Kindlin-3 exhibited an activation-independent association with beta integrin cytoplasm domain. Thus, cleavage of Kindlin-3 by calpain controls the dynamics of integrin-Kindlin-3 interaction and as a result, integrin-dependent adhesion and migration of hematopoietic cells. This represents a novel mechanism regulating reversibility of integrin adhesion complexes in leukocytes, which, in turn, is critical for their successful transmigration through the extracellular matrix.	[Byzova, Tatiana V.] Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Byzova, TV (corresponding author), Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, 9500 Euclid Ave,NB-50, Cleveland, OH 44195 USA.	byzovat@ccf.org	Malinin, Nikolay/Z-5308-2019	Malinin, Nikolay/0000-0002-2654-1783; Byzova, Tatiana/0000-0002-2615-875X; Qin, Jun/0000-0002-2647-9270	National Institutes of Health [HL073311, HL071625, HL077213, 2P01HL073311-06]; American Heart Association [10SDG4300062]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077213, R01HL071625, P01HL073311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL073311 (to T. V. B.), HL071625 (to T. V. B.), HL077213 (to E. A. P.), and 2P01HL073311-06 (to T. V. B. and E. A. P.).; Supported by American Heart Association Grant 10SDG4300062.	Azam M, 2001, MOL CELL BIOL, V21, P2213, DOI 10.1128/MCB.21.6.2213-2220.2001; Bialkowska K, 2010, J BIOL CHEM, V285, P18640, DOI 10.1074/jbc.M109.085746; Byzova TV, 2000, EXP CELL RES, V254, P299, DOI 10.1006/excr.1999.4765; Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cortesio CL, 2011, J BIOL CHEM, V286, P9998, DOI 10.1074/jbc.M110.187294; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DU XP, 1995, J BIOL CHEM, V270, P26146, DOI 10.1074/jbc.270.44.26146; duVerle DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019035; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; Hyduk SJ, 2011, J IMMUNOL, V187, P4360, DOI 10.4049/jimmunol.1003725; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kliche S, 2012, BLOOD, V119, P777, DOI 10.1182/blood-2011-06-362269; Kuchay SM, 2012, J THROMB HAEMOST, V10, P1120, DOI 10.1111/j.1538-7836.2012.04715.x; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Liu ZX, 2011, MOL BIOSYST, V7, P2737, DOI 10.1039/c1mb05217a; Ma Y, 2010, BLOOD, V116, P1932, DOI 10.1182/blood-2010-02-268508; Malinin NL, 2010, BLOOD, V115, P4011, DOI 10.1182/blood-2009-10-239269; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Pellat-Deceunynck C, 1999, CLIN CANCER RES, V5, P705; SAMBROOK J, 2001, MOL CLONING LAB MANU; Sieg DJ, 1999, J CELL SCI, V112, P2677; Svensson L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015090; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931	28	27	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.380469	http://dx.doi.org/10.1074/jbc.M112.380469			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23012377	Green Published, hybrid			2022-12-28	WOS:000311233800068
J	Ohashi, T; Fujiyama, K; Takegawa, K				Ohashi, Takao; Fujiyama, Kazuhito; Takegawa, Kaoru			Identification of Novel alpha 1,3-Galactosyltransferase and Elimination of alpha-Galactose-containing Glycans by Disruption of Multiple alpha-Galactosyltransferase Genes in Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED OLIGOSACCHARIDES; FISSION-YEAST; SACCHAROMYCES-CEREVISIAE; GOLGI-APPARATUS; NONSEXUAL FLOCCULATION; HETEROLOGOUS PROTEINS; ENDOPLASMIC-RETICULUM; GLYCOSYLATION MUTANT; TRANSPORT; ALPHA-1,6-MANNOSYLTRANSFERASE	The oligosaccharides from fission yeast Schizosaccharomyces pombe contain large amounts of D-galactose (Gal) in addition to D-mannose (Man), in contrast to the budding yeast Saccharomyces cerevisiae. Detailed structural analysis has revealed that the Gal residues are attached to the N- and O-linked oligosaccharides via alpha 1,2- or alpha 1,3-linkages. Previously we constructed and characterized a septuple alpha-galactosyltransferase disruptant (7GalT Delta) anticipating a complete lack of alpha-Gal residues. However, the 7GalT Delta strain still contained oligosaccharides consisting of alpha 1,3-linked Gal residues, indicating the presence of at least one more additional unidentified alpha 1,3-galactosyltransferase. In this study we searched for unidentified putative glycosyltransferases in the S. pombe genome sequence and identified three novel genes, named otg1(+)-otg3(+) (alpha one, three-galactosyltransferase), that belong to glycosyltransferase gene family 8 in the Carbohydrate Active EnZymes (CAZY) database. Gal-recognizing lectin blotting and HPLC analyses of pyridylaminated oligosaccharides after deletion of these three additional genes from 7GalT Delta strain demonstrated that the resultant disruptant missing 10 alpha-galactosyltransferase genes, 10GalT Delta, exhibited a complete loss of galactosylation. In an in vitro galactosylation assay, the otg2(+) gene product had Gal transfer activity toward a pyridylaminated Man(9)GlcNAc(2) oligosaccharide and pyridylaminated Man alpha 1,2-Man alpha 1,2-Man oligosaccharide. In addition, the otg3(+) gene product exhibited Gal transfer activity toward the pyridylaminated Man9GlcNAc2 oligosaccharide. Generation of an alpha 1,3-linkage was confirmed by HPLC analysis, alpha-galactosidase digestion analysis, H-1 NMR spectroscopy, and LC-MS/MS analysis. These results indicate that Otg2p and Otg3p are involved in alpha 1,3-galactosylation of S. pombe oligosaccharides.	[Ohashi, Takao; Takegawa, Kaoru] Kyushu Univ, Dept Biosci & Biotechnol, Higashi Ku, Fukuoka 8128581, Japan; [Ohashi, Takao] Asahi Glass Co Ltd, Res Ctr, ASPEX Div, Kanagawa Ku, Yokohama, Kanagawa 2218755, Japan; [Ohashi, Takao; Fujiyama, Kazuhito] Osaka Univ, Int Ctr Biotechnol, Suita, Osaka 5650871, Japan	Kyushu University; AGC Inc; Osaka University	Takegawa, K (corresponding author), Kyushu Univ, Dept Biosci & Biotechnol, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	takegawa@agr.kyushu-u.ac.jp			Project for Development of a Technological Infrastructure for Industrial Bioprocesses on R&D of New Industrial Science and Technology Frontiers by the Ministry of Economy, Trade, and Industry (METI) of Japan; Noda Institute for Scientific Research	Project for Development of a Technological Infrastructure for Industrial Bioprocesses on R&D of New Industrial Science and Technology Frontiers by the Ministry of Economy, Trade, and Industry (METI) of Japan; Noda Institute for Scientific Research(Noda Institute for Scientific Research)	This work was supported in part by the Project for Development of a Technological Infrastructure for Industrial Bioprocesses on R&D of New Industrial Science and Technology Frontiers by the Ministry of Economy, Trade, and Industry (METI) of Japan, entrusted by the New Energy and Industrial Technology Development Organization (NEDO) (to T. O. and K. T.), and a grant from the Noda Institute for Scientific Research (to T. O.).	Alfa C, 2003, EXPT FISSION YEAST L; Andreishcheva EN, 2004, J BIOL CHEM, V279, P35644, DOI 10.1074/jbc.M403574200; BALLOU CE, 1994, P NATL ACAD SCI USA, V91, P9327, DOI 10.1073/pnas.91.20.9327; BALLOU L, 1995, P NATL ACAD SCI USA, V92, P2790, DOI 10.1073/pnas.92.7.2790; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CHAPPELL TG, 1989, J CELL BIOL, V109, P2693, DOI 10.1083/jcb.109.6.2693; CHAPPELL TG, 1994, MOL BIOL CELL, V5, P519, DOI 10.1091/mbc.5.5.519; Chayakulkeeree M, 2006, INFECT DIS CLIN N AM, V20, P507, DOI 10.1016/j.idc.2006.07.001; De Pourcq K, 2010, APPL MICROBIOL BIOT, V87, P1617, DOI 10.1007/s00253-010-2721-1; Dean N, 1997, J BIOL CHEM, V272, P31908, DOI 10.1074/jbc.272.50.31908; DEAN N, 1995, P NATL ACAD SCI USA, V92, P1287, DOI 10.1073/pnas.92.5.1287; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Elliott CE, 2007, MOL PLANT PATHOL, V8, P791, DOI [10.1111/j.1364-3703.2007.00433.x, 10.1111/J.1364-3703.2007.00433.X]; Gemmill TR, 1998, GLYCOBIOLOGY, V8, P1087, DOI 10.1093/glycob/8.11.1087; Gemmill TR, 1996, J BIOL CHEM, V271, P25945, DOI 10.1074/jbc.271.42.25945; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Gemmill TR, 1999, GLYCOBIOLOGY, V9, P507, DOI 10.1093/glycob/9.5.507; Giga-Hama Y, 2007, BIOTECHNOL APPL BIOC, V46, P147, DOI 10.1042/BA20060106; GRIMM C, 1988, MOL GEN GENET, V215, P81, DOI 10.1007/BF00331307; Hamilton SR, 2006, SCIENCE, V313, P1441, DOI 10.1126/science.1130256; HASE S, 1994, METHOD ENZYMOL, V230, P225; HASE S, 1978, BIOCHEM BIOPH RES CO, V85, P257, DOI 10.1016/S0006-291X(78)80037-0; Idiris A, 2006, YEAST, V23, P83, DOI 10.1002/yea.1342; Idiris A, 2010, APPL MICROBIOL BIOT, V86, P403, DOI 10.1007/s00253-010-2447-0; Ikeda Y, 2009, FEMS YEAST RES, V9, P115, DOI 10.1111/j.1567-1364.2008.00458.x; Kajiura H, 2012, J BIOSCI BIOENG, V113, P48, DOI 10.1016/j.jbiosc.2011.09.011; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Macher BA, 2008, BBA-GEN SUBJECTS, V1780, P75, DOI 10.1016/j.bbagen.2007.11.003; Matsuzawa T, 2011, MOL MICROBIOL, V82, P1531, DOI 10.1111/j.1365-2958.2011.07908.x; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morita T, 2004, YEAST, V21, P613, DOI 10.1002/yea.1104; Nakamura T, 2001, MOL BIOL CELL, V12, P3955, DOI 10.1091/mbc.12.12.3955; Nordbring-Hertz B., 2004, Mycologist, V18, P125, DOI 10.1017/S0269915X04003052; Ohashi T, 2011, GLYCOBIOLOGY, V21, P340, DOI 10.1093/glycob/cwq167; Ohashi T, 2010, J BIOTECHNOL, V150, P348, DOI 10.1016/j.jbiotec.2010.09.942; Ohashi T, 2010, APPL MICROBIOL BIOT, V86, P263, DOI 10.1007/s00253-009-2297-9; Ohashi T, 2009, BIOSCI BIOTECH BIOCH, V73, P407, DOI 10.1271/bbb.80712; Okamoto M, 2008, EUKARYOT CELL, V7, P310, DOI 10.1128/EC.00333-07; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; Suzuki S, 2010, MICROBIOL-SGM, V156, P708, DOI 10.1099/mic.0.035279-0; Tabuchi M, 1997, BIOCHEM BIOPH RES CO, V232, P121, DOI 10.1006/bbrc.1997.6239; Takegawa K, 1996, BIOSCI BIOTECH BIOCH, V60, P1156; Takegawa K, 2009, BIOTECHNOL APPL BIOC, V53, P227, DOI 10.1042/BA20090048; Tanaka N, 1999, J BACTERIOL, V181, P1356, DOI 10.1128/JB.181.4.1356-1359.1999; Tanaka N, 2001, YEAST, V18, P745, DOI 10.1002/yea.725; Tanaka N, 2001, YEAST, V18, P903, DOI 10.1002/yea.740; Todorow Z, 2000, P NATL ACAD SCI USA, V97, P13643, DOI 10.1073/pnas.250472397; Yoko-O T, 1998, EUR J BIOCHEM, V257, P630, DOI 10.1046/j.1432-1327.1998.2570630.x; Yoko-o T, 2003, GLYCOBIOLOGY, V13, P581, DOI 10.1093/glycob/cwg063; Yoko-o T, 2001, FEBS LETT, V489, P75, DOI 10.1016/S0014-5793(01)02082-8; Zhu BG, 2007, BIOTECHNIQUES, V43, P356, DOI 10.2144/000112536; Ziegler FD, 1999, GLYCOBIOLOGY, V9, P497, DOI 10.1093/glycob/9.5.497	52	12	12	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38866	38875		10.1074/jbc.M112.347351	http://dx.doi.org/10.1074/jbc.M112.347351			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22988247	Green Published, hybrid			2022-12-28	WOS:000310982800043
J	Lin, DH; Malpede, BM; Batchelor, JD; Tolia, NH				Lin, Daniel H.; Malpede, Brian M.; Batchelor, Joseph D.; Tolia, Niraj H.			Crystal and Solution Structures of Plasmodium falciparum Erythrocyte-binding Antigen 140 Reveal Determinants of Receptor Specificity during Erythrocyte Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALARIA PARASITES; GLYCOPHORIN-C; LIGAND; SCATTERING; RECOGNITION; PROTEINS; FAMILY; BAEBL	Erythrocyte-binding antigen 140 (PfEBA-140) is a critical Plasmodium falciparum erythrocyte invasion ligand that engages glycophorin C on host erythrocytes during malaria infection. The minimal receptor-binding region of PfEBA-140 contains two conserved Duffy binding-like (DBL) domains, a fold unique to Plasmodium species. Here, we present the crystal structure of the receptor-binding region of PfEBA-140 at 2.4 angstrom resolution. The two-domain binding region is present as a monomer in the asymmetric unit, and the structure reveals novel features in PfEBA-140 that are likely determinants of receptor specificity. Analysis by small-angle x-ray scattering demonstrated that the minimal binding region is monomeric in solution, consistent with the crystal structure. Erythrocyte binding assays showed that the full-length binding region containing the tandem DBL domains is required for erythrocyte engagement, suggesting that both domains contain critical receptor contact sites. The electrostatic surface of PfEBA-140 elucidates a basic patch that constitutes a putative high-affinity binding interface spanning both DBL domains. Mutation of residues within this interface results in severely diminished erythrocyte binding. This study provides insight into the structural basis and mechanism of PfEBA-140 receptor engagement and forms a basis for future studies of this critical interaction. In addition, the solution and crystal structures allow the first identification of likely determinants of erythrocyte receptor specificity for P. falciparum invasion ligands. A complete understanding of the PfEBA-140 erythrocyte invasion pathway will aid in the design of invasion inhibitory therapeutics and vaccines.	[Lin, Daniel H.; Malpede, Brian M.; Batchelor, Joseph D.; Tolia, Niraj H.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Tolia, NH (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	tolia@wustl.edu	Tolia, Niraj H/D-2332-2014	Tolia, Niraj H/0000-0002-2689-1337	National Institutes of Health Grant [AI 080792]; Edward Mallinckrodt, Jr. Foundation; National Science Foundation Graduate Research Fellowship [DGE-1143954]; Office of Science, Office of Basic Energy Sciences of the United States Department of Energy [DE-AC02-05CH11231]; Department of Energy IDAT Grant [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080792, R56AI080792] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Mallinckrodt, Jr. Foundation; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Office of Science, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); Department of Energy IDAT Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI 080792. This work was also supported by the Edward Mallinckrodt, Jr. Foundation (to N. H. T.) and National Science Foundation Graduate Research Fellowship DGE-1143954 (to B. M. M.).; We thank N. Salinas and W. Beatty for assistance with experiments, D. Sibley for constructive comments on the manuscript, and J. Nix (Molecular Biology Consortium Beamline 4.2.2, Advanced Light Source) for help with data collection. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences of the United States Department of Energy under Contract DE-AC02-05CH11231. We thank G. Hura, K. Dyer, and the Structurally Integrated Biology for Life Sciences Team at the Advanced Light Source for assistance in SAXS data collection (funded by Department of Energy IDAT Grant DE-AC02-05CH11231).	ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Batchelor JD, 2011, NAT STRUCT MOL BIOL, V18, P908, DOI 10.1038/nsmb.2088; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ford L, 2007, AM J TROP MED HYG, V77, P977, DOI 10.4269/ajtmh.2007.77.977; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gilberger TW, 2003, J BIOL CHEM, V278, P14480, DOI 10.1074/jbc.M211446200; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Lobo CA, 2004, INFECT IMMUN, V72, P5886, DOI 10.1128/IAI.72.10.5886-5891.2004; Lobo CA, 2003, BLOOD, V101, P4628, DOI 10.1182/blood-2002-10-3076; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lopaticki S, 2011, INFECT IMMUN, V79, P1107, DOI 10.1128/IAI.01021-10; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Mayer DCG, 2009, P NATL ACAD SCI USA, V106, P5348, DOI 10.1073/pnas.0900878106; Mayer DCG, 2006, P NATL ACAD SCI USA, V103, P2358, DOI 10.1073/pnas.0510648103; ORLANDI PA, 1992, J CELL BIOL, V116, P901, DOI 10.1083/jcb.116.4.901; Singh SK, 2006, NATURE, V439, P741, DOI 10.1038/nature04443; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033	23	44	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36830	36836		10.1074/jbc.M112.409276	http://dx.doi.org/10.1074/jbc.M112.409276			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22989878	hybrid, Green Published			2022-12-28	WOS:000310588500019
J	Sassa, A; Beard, WA; Prasad, R; Wilson, SH				Sassa, Akira; Beard, William A.; Prasad, Rajendra; Wilson, Samuel H.			DNA Sequence Context Effects on the Glycosylase Activity of Human 8-Oxoguanine DNA Glycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; THYMINE GLYCOL RESIDUE; DUAL-REACTION MODE; POLYMERASE-BETA; SACCHAROMYCES-CEREVISIAE; MUTATIONAL HOTSPOT; TANDEM MUTATIONS; AP-ENDONUCLEASE; BOVINE TESTIS; HUMAN-CELLS	Human 8-oxoguanine DNA glycosylase (OGG1) is a key enzyme involved in removing 7,8-dihydro-8-oxoguanine (8-oxoG), a highly mutagenic DNA lesion generated by oxidative stress. The removal of 8-oxoG by OGG1 is affected by the local DNA sequence, and this feature most likely contributes to observed mutational hot spots in genomic DNA. To elucidate the influence of local DNA sequence on 8-oxoG excision activity of OGG1, we conducted steady-state, pre-steady-state, and single turnover kinetic evaluation of OGG1 in alternate DNA sequence contexts. The sequence context effect was studied for a mutational hot spot at a CpG dinucleotide. Altering either the global DNA sequence or the 5'-flanking unmodified base pair failed to influence the excision of 8-oxoG. Methylation of the cytosine 5' to 8-oxoG also did not affect 8-oxoG excision. In contrast, a 5'-neighboring mismatch strongly decreased the rate of 8-oxoG base removal. Substituting the 5'-C in the CpG dinucleotide with T, A, or tetrahydrofuran (i.e. T:G, A:G, and tetrahydrofuran: G mispairs) resulted in a 10-, 13-, and 4-fold decrease in the rate constant for 8-oxoG excision, respectively. A greater loss in activity was observed when T:C or A:C was positioned 5' of 8-oxoG (59- and 108-fold, respectively). These results indicate that neighboring structural abnormalities 5' to 8-oxoG deter its repair thereby enhancing its mutagenic potential.	[Sassa, Akira; Beard, William A.; Prasad, Rajendra; Wilson, Samuel H.] NIEHS, NIH, Struct Biol Lab, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Beard, WA (corresponding author), 111 TW Alexander Dr,POB 12233,MD F3-01, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293; Sassa, Akira/0000-0003-2454-0223	National Institutes of Health Research Project in the Intramural Research Program, NIEHS [Z01-ES050158]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050158] Funding Source: NIH RePORTER	National Institutes of Health Research Project in the Intramural Research Program, NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Research Project Grant Z01-ES050158 in the Intramural Research Program, NIEHS.	Acosta-Silva C, 2010, J PHYS CHEM B, V114, P10217, DOI 10.1021/jp103850h; Agar NS, 2004, P NATL ACAD SCI USA, V101, P4954, DOI 10.1073/pnas.0401141101; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Beard WA, 2004, J BIOL CHEM, V279, P31921, DOI 10.1074/jbc.M404016200; Beard WA, 1995, METHOD ENZYMOL, V262, P98; Berg BJV, 2001, J BIOL CHEM, V276, P3408, DOI 10.1074/jbc.M002884200; BIRD AP, 1995, TRENDS GENET, V11, P94, DOI 10.1016/S0168-9525(00)89009-5; Boiteux S, 2000, ARCH BIOCHEM BIOPHYS, V377, P1, DOI 10.1006/abbi.2000.1773; Brown KL, 2008, J AM CHEM SOC, V130, P11701, DOI 10.1021/ja8016544; Brown KL, 2009, BIOCHEMISTRY-US, V48, P9722, DOI 10.1021/bi900695e; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Cao HC, 2007, NUCLEIC ACIDS RES, V35, P4833, DOI 10.1093/nar/gkm497; Chen X, 2006, METHOD ENZYMOL, V409, P39, DOI 10.1016/S0076-6879(05)09003-8; Cistulli C, 2004, DNA REPAIR, V3, P581, DOI 10.1016/j.dnarep.2003.09.012; Colussi C, 2002, CURR BIOL, V12, P912, DOI 10.1016/S0960-9822(02)00863-1; Dalhus B, 2011, STRUCTURE, V19, P117, DOI 10.1016/j.str.2010.09.023; EHRLICH M, 1986, BIOSCIENCE REP, V6, P387, DOI 10.1007/BF01116426; Fromme JC, 2003, J BIOL CHEM, V278, P51543, DOI 10.1074/jbc.M307768200; Hatahet Z, 1998, P NATL ACAD SCI USA, V95, P8556, DOI 10.1073/pnas.95.15.8556; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; Hussain SP, 2000, P NATL ACAD SCI USA, V97, P12770, DOI 10.1073/pnas.220416097; JARUGA P, 1994, FEBS LETT, V341, P59, DOI 10.1016/0014-5793(94)80240-8; Jiang Y, 2009, CHEM RES TOXICOL, V22, P574, DOI 10.1021/tx8003449; Kalam MA, 2005, CHEM RES TOXICOL, V18, P1187, DOI 10.1021/tx050119r; KAO JY, 1993, J BIOL CHEM, V268, P17787; Kirpota OO, 2011, NUCLEIC ACIDS RES, V39, P4836, DOI 10.1093/nar/gkq1333; Kohno T, 1998, ONCOGENE, V16, P3219, DOI 10.1038/sj.onc.1201872; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Kung HC, 1997, J BIOL CHEM, V272, P9227; Kuznetsov NA, 2005, NUCLEIC ACIDS RES, V33, P3919, DOI 10.1093/nar/gki694; Larson ED, 2003, DNA REPAIR, V2, P1199, DOI 10.1016/S1568-7864(03)00140-X; Lee DH, 2002, NUCLEIC ACIDS RES, V30, P3566, DOI 10.1093/nar/gkf478; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Marsin S, 2003, J BIOL CHEM, V278, P44068, DOI 10.1074/jbc.M306160200; McKibbin PL, 2012, J AM CHEM SOC, V134, P1653, DOI 10.1021/ja208510m; Miller JH, 2005, RADIAT RES, V164, P582, DOI 10.1667/RR3381.1; Minowa O, 2000, P NATL ACAD SCI USA, V97, P4156, DOI 10.1073/pnas.050404497; MODRICH P, 1987, ANNU REV BIOCHEM, V56, P435, DOI 10.1146/annurev.biochem.56.1.435; Morland I, 2005, DNA REPAIR, V4, P381, DOI 10.1016/j.dnarep.2004.11.002; Nilsen H, 2001, CARCINOGENESIS, V22, P987, DOI 10.1093/carcin/22.7.987; Nishioka K, 1999, MOL BIOL CELL, V10, P1637, DOI 10.1091/mbc.10.5.1637; Noren Hooten N, 2011, J BIOL CHEM, V286, P44679, DOI 10.1074/jbc.M111.255869; OLINSKI R, 1992, FEBS LETT, V309, P193, DOI 10.1016/0014-5793(92)81093-2; Oliva MR, 1997, MOL CARCINOGEN, V18, P232, DOI 10.1002/(SICI)1098-2744(199704)18:4<232::AID-MC7>3.0.CO;2-F; PATEL DJ, 1984, FED PROC, V43, P2663; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; Prasad R, 1996, J BIOL CHEM, V271, P16000, DOI 10.1074/jbc.271.27.16000; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; Reardon JT, 1997, P NATL ACAD SCI USA, V94, P9463, DOI 10.1073/pnas.94.17.9463; Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429; Sakumi K, 2003, CANCER RES, V63, P902; SCHMUTTE C, 1995, CANCER RES, V55, P3742; Scott AD, 1999, YEAST, V15, P205, DOI 10.1002/(SICI)1097-0061(199902)15:3<205::AID-YEA361>3.0.CO;2-1; SHEN JC, 1994, NUCLEIC ACIDS RES, V22, P972, DOI 10.1093/nar/22.6.972; SHEN JC, 1992, CELL, V71, P1073, DOI 10.1016/S0092-8674(05)80057-1; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; SINGHAL RK, 1995, J BIOL CHEM, V270, P949, DOI 10.1074/jbc.270.2.949; SOWERS LC, 1987, BIOCHEM BIOPH RES CO, V148, P790, DOI 10.1016/0006-291X(87)90945-4; Sunaga N, 2001, CARCINOGENESIS, V22, P1355, DOI 10.1093/carcin/22.9.1355; Sung RJ, 2012, J BIOL CHEM, V287, P18044, DOI 10.1074/jbc.M111.313635; Takao M, 1998, NUCLEIC ACIDS RES, V26, P2917, DOI 10.1093/nar/26.12.2917; TORNALETTI S, 1995, ONCOGENE, V10, P1493; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; VANYUSHIN BF, 1970, NATURE, V225, P948, DOI 10.1038/225948a0; Xie YL, 2004, CANCER RES, V64, P3096, DOI 10.1158/0008-5472.CAN-03-3834; Yamane A, 2003, CARCINOGENESIS, V24, P1031, DOI 10.1093/carcin/bgg056; Yuan BF, 2010, CHEM RES TOXICOL, V23, P11, DOI 10.1021/tx9004264; Zawia NH, 2009, FREE RADICAL BIO MED, V46, P1241, DOI 10.1016/j.freeradbiomed.2009.02.006; Zharkov DO, 2000, J BIOL CHEM, V275, P28607, DOI 10.1074/jbc.M002441200	69	35	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36702	36710		10.1074/jbc.M112.397786	http://dx.doi.org/10.1074/jbc.M112.397786			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22989888	Green Published, hybrid			2022-12-28	WOS:000310588500008
J	Tataroglu, O; Lauinger, L; Sancar, G; Jakob, K; Brunner, M; Diernfellner, ACR				Tataroglu, Oezguer; Lauinger, Linda; Sancar, Gencer; Jakob, Katharina; Brunner, Michael; Diernfellner, Axel C. R.			Glycogen Synthase Kinase Is a Regulator of the Circadian Clock of Neurospora crassa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WHITE-COLLAR COMPLEX; TRANSCRIPTION FACTOR; FREQUENCY DETERMINES; PROTEIN STABILITY; FEEDBACK LOOPS; PHOSPHORYLATION; REVEALS; PERIOD; LIGHT; DEGRADATION	Timekeeping by circadian clocks relies upon precise adjustment of expression levels of clock proteins. Here we identify glycogen synthase kinase (GSK) as a novel and critical component of the circadian clock of Neurospora crassa that regulates the abundance of its core transcription factor white collar complex (WCC) on a post-transcriptional level. We show that GSK specifically binds and phosphorylates both subunits of the WCC. Reduced expression of GSK promotes an increased accumulation of WC-1, the limiting factor of the WCC, causing an acceleration of the circadian clock and a shorter free-running period.	[Tataroglu, Oezguer; Lauinger, Linda; Sancar, Gencer; Jakob, Katharina; Brunner, Michael; Diernfellner, Axel C. R.] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Diernfellner, ACR (corresponding author), Heidelberg Univ, Biochem Ctr, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	axel.diernfellner@bzh.uni-heidelberg.de	Tataroglu, Ozgur/AAR-9351-2020	Tataroglu, Ozgur/0000-0001-9118-2054; Brunner, Michael/0000-0001-9798-3047	PhD fellowship of CellNetworks; Deutsche Forschungsgemeinschaft	PhD fellowship of CellNetworks; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by a PhD fellowship of CellNetworks (to O. T.) and by grants of the Deutsche Forschungsgemeinschaft.	Baker CL, 2009, MOL CELL, V34, P354, DOI 10.1016/j.molcel.2009.04.023; Belden WJ, 2007, GENE DEV, V21, P1494, DOI 10.1101/gad.1551707; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Diernfellner ACR, 2011, FEBS LETT, V585, P1461, DOI 10.1016/j.febslet.2011.03.049; Diernfellner ACR, 2005, GENE DEV, V19, P1968, DOI 10.1101/gad.345905; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; Gorl M, 2001, EMBO J, V20, P7074, DOI 10.1093/emboj/20.24.7074; Guo JH, 2009, CELL, V138, P1236, DOI 10.1016/j.cell.2009.06.043; He Q, 2003, EMBO J, V22, P4421, DOI 10.1093/emboj/cdg425; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; He QY, 2005, J BIOL CHEM, V280, P17526, DOI 10.1074/jbc.M414010200; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Hirota T, 2008, P NATL ACAD SCI USA, V105, P20746, DOI 10.1073/pnas.0811410106; Iitaka C, 2005, J BIOL CHEM, V280, P29397, DOI 10.1074/jbc.M503526200; JOHNSSON A, 1979, PHARMAKOPSYCH NEURO, V12, P423, DOI 10.1055/s-0028-1094638; Jolma IW, 2006, J BIOL RHYTHM, V21, P327, DOI 10.1177/0748730406292453; Ko HW, 2010, J NEUROSCI, V30, P12664, DOI 10.1523/JNEUROSCI.1586-10.2010; Kurabayashi N, 2010, MOL CELL BIOL, V30, P1757, DOI 10.1128/MCB.01047-09; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Liu Y, 2000, P NATL ACAD SCI USA, V97, P234, DOI 10.1073/pnas.97.1.234; Malzahn E, 2010, CELL, V142, P762, DOI 10.1016/j.cell.2010.08.010; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Mehra A, 2009, TRENDS BIOCHEM SCI, V34, P483, DOI 10.1016/j.tibs.2009.06.006; Merrow M, 2007, COLD SPRING HARB SYM, V72, P279, DOI 10.1101/sqb.2007.72.032; O'Brien WT, 2009, BIOCHEM SOC T, V37, P1133, DOI 10.1042/BST0371133; Peschel N, 2011, FEBS LETT, V585, P1435, DOI 10.1016/j.febslet.2011.02.028; Querfurth C, 2011, MOL CELL, V43, P713, DOI 10.1016/j.molcel.2011.06.033; Reischl S, 2011, FEBS LETT, V585, P1393, DOI 10.1016/j.febslet.2011.02.038; Sahar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008561; Sancar G, 2011, MOL CELL, V44, P687, DOI 10.1016/j.molcel.2011.10.019; Sancar G, 2009, FEBS LETT, V583, P1833, DOI 10.1016/j.febslet.2009.04.042; Schafmeier T, 2006, GENE DEV, V20, P297, DOI 10.1101/gad.360906; Schafmeier T, 2005, CELL, V122, P235, DOI 10.1016/j.cell.2005.05.032; Schafmeier T, 2011, FEBS LETT, V585, P1467, DOI 10.1016/j.febslet.2011.03.050; Schafmeier T, 2008, GENE DEV, V22, P3397, DOI 10.1101/gad.507408; Smith KM, 2010, EUKARYOT CELL, V9, P1549, DOI 10.1128/EC.00154-10; Spengler ML, 2009, CELL CYCLE, V8, P4138, DOI 10.4161/cc.8.24.10273; Talora C, 1999, EMBO J, V18, P4961, DOI 10.1093/emboj/18.18.4961; Tang CT, 2009, P NATL ACAD SCI USA, V106, P10722, DOI 10.1073/pnas.0904898106; Tataroglu O, 2010, EMBO REP, V11, P927, DOI 10.1038/embor.2010.174	41	14	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36936	36943		10.1074/jbc.M112.396622	http://dx.doi.org/10.1074/jbc.M112.396622			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22955278	hybrid, Green Published			2022-12-28	WOS:000310588500030
J	Horowitz, S; Trievel, RC				Horowitz, Scott; Trievel, Raymond C.			Carbon-Oxygen Hydrogen Bonding in Biological Structure and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CENTER-DOT-O; SERINE-PROTEASE CATALYSIS; C-H; CRYSTAL-STRUCTURE; X-RAY; ANGSTROM RESOLUTION; WATER-MOLECULES; POLYGLYCINE 2; SOLID-STATE; PROTEINS	Carbon-oxygen (CH center dot center dot center dot O) hydrogen bonding represents an unusual category of molecular interactions first documented in biological structures over 4 decades ago. Although CH center dot center dot center dot O hydrogen bonding has remained generally underappreciated in the biochemical literature, studies over the last 15 years have begun to yield direct evidence of these interactions in biological systems. In this minireview, we provide a historical context of biological CH center dot center dot center dot O hydrogen bonding and summarize some major advancements from experimental studies over the past several years that have elucidated the importance, prevalence, and functions of these interactions. In particular, we examine the impact of CH center dot center dot center dot center dot O bonds on protein and nucleic acid structure, molecular recognition, and enzyme catalysis and conclude by exploring overarching themes and unresolved questions regarding unconventional interactions in biomolecular structure.	[Horowitz, Scott] Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA; [Trievel, Raymond C.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Trievel, RC (corresponding author), Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA.	rtrievel@umich.edu		Horowitz, Scott/0000-0002-1148-0105	University of Michigan Rackham predoctoral fellowship; National Science Foundation Grant [CHE-1213484]	University of Michigan Rackham predoctoral fellowship(University of Michigan System); National Science Foundation Grant(National Science Foundation (NSF))	Supported by a University of Michigan Rackham predoctoral fellowship.; Supported by National Science Foundation Grant CHE-1213484. To whom correspondence should be addressed. E-mail:rtrievel@umich.edu.	Addlagatta A, 2001, ACTA CRYSTALLOGR D, V57, P649, DOI 10.1107/S0907444901003468; Arbely E, 2004, J AM CHEM SOC, V126, P5362, DOI 10.1021/ja049826h; Ash EL, 2000, P NATL ACAD SCI USA, V97, P10371, DOI 10.1073/pnas.97.19.10371; Bach RD, 2002, J PHYS CHEM B, V106, P4325, DOI 10.1021/jp020029k; Bartlett GJ, 2010, NAT CHEM BIOL, V6, P615, DOI [10.1038/NCHEMBIO.406, 10.1038/nchembio.406]; BENEVIDES JM, 1988, BIOCHEMISTRY-US, V27, P3868, DOI 10.1021/bi00410a051; Berger I, 1997, CHEM-EUR J, V3, P1400, DOI 10.1002/chem.19970030905; Berger I, 1996, P NATL ACAD SCI USA, V93, P12116, DOI 10.1073/pnas.93.22.12116; Blakeley MP, 2008, CURR OPIN STRUC BIOL, V18, P593, DOI 10.1016/j.sbi.2008.06.009; Bon C, 1999, ACTA CRYSTALLOGR D, V55, P978, DOI 10.1107/S0907444998018514; Bond CS, 1999, STRUCTURE, V7, P81, DOI 10.1016/S0969-2126(99)80011-2; Brandl M, 1999, THEOR CHEM ACC, V101, P103, DOI 10.1007/s002140050415; Cannizzaro CE, 2002, J AM CHEM SOC, V124, P7163, DOI 10.1021/ja012417q; Castellano RK, 2002, CHEM-EUR J, V8, P118; Castellano RK, 2004, CURR ORG CHEM, V8, P845, DOI 10.2174/1385272043370384; Chen JCH, 2012, P NATL ACAD SCI USA, V109, P15301, DOI 10.1073/pnas.1208341109; Cordier F, 2003, J AM CHEM SOC, V125, P15750, DOI 10.1021/ja038616m; Couture JF, 2006, J BIOL CHEM, V281, P19280, DOI 10.1074/jbc.M602257200; Couture JF, 2008, P NATL ACAD SCI USA, V105, P20659, DOI 10.1073/pnas.0806712105; Das R, 2010, NAT METHODS, V7, P291, DOI [10.1038/nmeth.1433, 10.1038/NMETH.1433]; Del Rizzo PA, 2010, J BIOL CHEM, V285, P31849, DOI 10.1074/jbc.M110.114587; Deng JP, 2001, P NATL ACAD SCI USA, V98, P13665, DOI 10.1073/pnas.241374798; DEREWENDA ZS, 1995, J MOL BIOL, V252, P248, DOI 10.1006/jmbi.1995.0492; DEREWENDA ZS, 1994, J MOL BIOL, V241, P83, DOI 10.1006/jmbi.1994.1475; Desiraju G.R., 1999, WEAK HYDROGEN BOND S; Desiraju GR, 1996, ACCOUNTS CHEM RES, V29, P441, DOI 10.1021/ar950135n; Duszczyk MM, 2011, RNA, V17, P1973, DOI 10.1261/rna.2747411; Esposito L, 2000, J MOL BIOL, V297, P713, DOI 10.1006/jmbi.2000.3597; Fuhrmann CN, 2006, J AM CHEM SOC, V128, P9086, DOI 10.1021/ja057721o; GEHRING K, 1993, NATURE, V363, P561, DOI 10.1038/363561a0; Ghosh A, 1999, J MOL BIOL, V294, P1149, DOI 10.1006/jmbi.1999.3323; Gilli G., 2009, OUTLINE COMPREHENSIV; Gu YL, 1999, J AM CHEM SOC, V121, P9411, DOI 10.1021/ja991795g; Horowitz S, 2011, J BIOL CHEM, V286, P18658, DOI 10.1074/jbc.M111.232876; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Iwase S, 2011, NAT STRUCT MOL BIOL, V18, P769, DOI 10.1038/nsmb.2062; Jiang L, 2002, J BIOL CHEM, V277, P37732, DOI 10.1074/jbc.M204514200; Joh NH, 2008, NATURE, V453, P1266, DOI 10.1038/nature06977; KANG CH, 1994, P NATL ACAD SCI USA, V91, P11636, DOI 10.1073/pnas.91.24.11636; Klaholz BP, 2002, STRUCTURE, V10, P1197, DOI 10.1016/S0969-2126(02)00828-6; Kovalevsky AY, 2008, BIOCHEMISTRY-US, V47, P7595, DOI 10.1021/bi8005434; KRIMM S, 1968, BIOPOLYMERS, V6, P401, DOI 10.1002/bip.1968.360060311; KRIMM S, 1967, SCIENCE, V158, P530, DOI 10.1126/science.158.3800.530-c; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Lee KM, 2003, J AM CHEM SOC, V125, P12358, DOI 10.1021/ja036719z; Leroy JL, 2001, MAGN RESON CHEM, V39, pS171, DOI 10.1002/mrc.935; Liu H, 2002, J MOL BIOL, V322, P955, DOI 10.1016/S0022-2836(02)00876-8; Mandel-Gutfreund Y, 1998, J MOL BIOL, V277, P1129, DOI 10.1006/jmbi.1998.1660; Musah RA, 1997, J AM CHEM SOC, V119, P9083, DOI 10.1021/ja9716766; Quinn JR, 2007, J AM CHEM SOC, V129, P934, DOI 10.1021/ja066341f; RAMACHANDRAN GN, 1968, BIOPOLYMERS, V6, P1649, DOI 10.1002/bip.1968.360061109; RAMACHANDRAN GN, 1966, BIOCHIM BIOPHYS ACTA, V112, P168, DOI 10.1016/S0926-6585(96)90019-9; Sandalova T, 1999, ACTA CRYSTALLOGR D, V55, P610, DOI 10.1107/S090744499801381X; Scheiner S, 2000, J MOL STRUC-THEOCHEM, V500, P441, DOI 10.1016/S0166-1280(00)00375-4; Scheiner S, 2011, PHYS CHEM CHEM PHYS, V13, P13860, DOI 10.1039/c1cp20427k; Scheiner S, 2009, J PHYS CHEM B, V113, P10421, DOI 10.1021/jp9035138; Schmiedekamp A, 2009, J INORG BIOCHEM, V103, P1054, DOI 10.1016/j.jinorgbio.2009.04.017; Senes A, 2001, P NATL ACAD SCI USA, V98, P9056, DOI 10.1073/pnas.161280798; Sengoku T, 2011, GENE DEV, V25, P2266, DOI 10.1101/gad.172296.111; Shefter E., 1964, J AM CHEM SOC, V86, P1871; Sheppard D, 2010, J AM CHEM SOC, V132, P7709, DOI 10.1021/ja101691s; Shi ZS, 2002, BIOPHYS CHEM, V101, P267, DOI 10.1016/S0301-4622(02)00171-0; Steiner T, 2002, ANGEW CHEM INT EDIT, V41, P48, DOI 10.1002/1521-3773(20020104)41:1<48::AID-ANIE48>3.0.CO;2-U; Steiner T, 1998, CHEM COMMUN, P891, DOI 10.1039/a708099i; Strop P, 2000, BIOCHEMISTRY-US, V39, P1251, DOI 10.1021/bi992257j; Sukumar N, 2010, P NATL ACAD SCI USA, V107, P6817, DOI 10.1073/pnas.0912672107; SUSSMAN JL, 1972, J MOL BIOL, V66, P403, DOI 10.1016/0022-2836(72)90423-8; Wahl MC, 1997, TRENDS BIOCHEM SCI, V22, P97, DOI 10.1016/S0968-0004(97)01004-9; Westler WM, 2011, J AM CHEM SOC, V133, P1310, DOI 10.1021/ja1049059; Yohannan S, 2004, J AM CHEM SOC, V126, P2284, DOI 10.1021/ja0317574; Yokoyama T, 2012, J STRUCT BIOL, V177, P283, DOI 10.1016/j.jsb.2011.12.022; Zhou PP, 2009, J PHYS CHEM A, V113, P10306, DOI 10.1021/jp9035452	72	204	205	1	91	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41576	41582		10.1074/jbc.R112.418574	http://dx.doi.org/10.1074/jbc.R112.418574			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23048026	hybrid, Green Published			2022-12-28	WOS:000312103000002
J	Sukharnikov, LO; Alahuhta, M; Brunecky, R; Upadhyay, A; Himmel, ME; Lunin, VV; Zhulin, IB				Sukharnikov, Leonid O.; Alahuhta, Markus; Brunecky, Roman; Upadhyay, Amit; Himmel, Michael E.; Lunin, Vladimir V.; Zhulin, Igor B.			Sequence, Structure, and Evolution of Cellulases in Glycoside Hydrolase Family 48	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOSTRIDIUM-THERMOCELLUM; CRYSTAL-STRUCTURE; PROTEIN; ALIGNMENT; GENE; CELLOBIOHYDROLASE; EXPRESSION; CONVERSION; DISCOVERY; INSIGHTS	Currently, the cost of cellulase enzymes remains a key economic impediment to commercialization of biofuels (1). Enzymes from glycoside hydrolase family 48 (GH48) are a critical component of numerous natural lignocellulose-degrading systems. Although computational mining of large genomic data sets is a promising new approach for identifying novel cellulolytic activities, current computational methods are unable to distinguish between cellulases and enzymes with different substrate specificities that belong to the same protein family. We show that by using a robust computational approach supported by experimental studies, cellulases and non-cellulases can be effectively identified within a given protein family. Phylogenetic analysis of GH48 showed non-monophyletic distribution, an indication of horizontal gene transfer. Enzymatic function of GH48 proteins coded by horizontally transferred genes was verified experimentally, which confirmed that these proteins are cellulases. Computational and structural studies of GH48 enzymes identified structural elements that define cellulases and can be used to computationally distinguish them from noncellulases. We propose that the structural element that can be used for in silico discrimination between cellulases and noncellulases belonging to GH48 is an omega-loop located on the surface of the molecule and characterized by highly conserved rare amino acids. These markers were used to screen metagenomics data for "true" cellulases.	[Sukharnikov, Leonid O.; Alahuhta, Markus; Brunecky, Roman; Upadhyay, Amit; Himmel, Michael E.; Lunin, Vladimir V.; Zhulin, Igor B.] Univ Tennessee, Oak Ridge Natl Lab, BioEnergy Sci Ctr, Oak Ridge, TN 37831 USA; [Sukharnikov, Leonid O.; Upadhyay, Amit; Zhulin, Igor B.] Univ Tennessee, Oak Ridge Natl Lab, Joint Inst Computat Sci, Oak Ridge, TN 37831 USA; [Alahuhta, Markus; Brunecky, Roman; Himmel, Michael E.; Lunin, Vladimir V.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC); University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Lunin, VV (corresponding author), Univ Tennessee, Oak Ridge Natl Lab, BioEnergy Sci Ctr, Oak Ridge, TN 37831 USA.	vladimir.lunin@nrel.gov; joulineib@ornl.gov	Zhulin, Igor/T-3509-2019; Upadhyay, Amit/R-5056-2019; Zhulin, Igor B/A-2308-2012; Alahuhta, Markus/E-9344-2012	Zhulin, Igor/0000-0002-6708-5323; Upadhyay, Amit/0000-0002-0952-4164; Zhulin, Igor B/0000-0002-6708-5323; Alahuhta, Markus/0000-0001-9375-778X; Brunecky, Roman/0000-0002-8352-4234	Department of Energy Office of Science, Office of Biological and Environmental Research, through the BioEnergy Science Center, a Department of Energy Bioenergy Research Center	Department of Energy Office of Science, Office of Biological and Environmental Research, through the BioEnergy Science Center, a Department of Energy Bioenergy Research Center(United States Department of Energy (DOE))	This work was supported by the Department of Energy Office of Science, Office of Biological and Environmental Research, through the BioEnergy Science Center, a Department of Energy Bioenergy Research Center.	Aden A, 2009, CELLULOSE, V16, P535, DOI 10.1007/s10570-009-9327-8; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berger E, 2007, FEMS MICROBIOL LETT, V268, P194, DOI 10.1111/j.1574-6968.2006.00583.x; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bevillard E, 2004, J BACTERIOL, V186, P136, DOI 10.1128/JB.186.1.136-145.2004; Brulc JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025329; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowan D, 2005, TRENDS BIOTECHNOL, V23, P321, DOI 10.1016/j.tibtech.2005.04.001; Dam P, 2011, NUCLEIC ACIDS RES, V39, P3240, DOI 10.1093/nar/gkq1281; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; FETROW JS, 1995, FASEB J, V9, P708, DOI 10.1096/fasebj.9.9.7601335; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fujita K, 2006, BIOCHEM BIOPH RES CO, V345, P502, DOI 10.1016/j.bbrc.2006.04.126; Gold ND, 2007, J BACTERIOL, V189, P6787, DOI 10.1128/JB.00882-07; Guimaraes BG, 2002, J MOL BIOL, V320, P587, DOI 10.1016/S0022-2836(02)00497-7; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gutierrez-Preciado A, 2009, MICROBIOL MOL BIOL R, V73, P36, DOI 10.1128/MMBR.00026-08; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Huws SA, 2010, FEMS MICROBIOL ECOL, V73, P396, DOI 10.1111/j.1574-6941.2010.00892.x; Irwin DC, 2000, EUR J BIOCHEM, V267, P4988, DOI 10.1046/j.1432-1327.2000.01546.x; Izquierdo JA, 2010, APPL ENVIRON MICROB, V76, P3545, DOI 10.1128/AEM.02689-09; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Liu CC, 1998, GENE, V211, P39, DOI 10.1016/S0378-1119(98)00081-X; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Medie FM, 2012, NAT REV MICROBIOL, V10, P227, DOI 10.1038/nrmicro2729; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Olson DG, 2010, P NATL ACAD SCI USA, V107, P17727, DOI 10.1073/pnas.1003584107; Parsiegla G, 2000, BIOCHEMISTRY-US, V39, P11238, DOI 10.1021/bi001139p; Parsiegla G, 1998, EMBO J, V17, P5551, DOI 10.1093/emboj/17.19.5551; Pignatelli M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019984; Ramirez-Ramirez N, 2008, INT J MOL SCI, V9, P247, DOI 10.3390/ijms9030247; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Sessitsch A, 2012, MOL PLANT MICROBE IN, V25, P28, DOI 10.1094/MPMI-08-11-0204; SHEN H, 1995, BIOCHEM J, V311, P67, DOI 10.1042/bj3110067; Sluiter A, 2006, NRELTP51042618; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; Sukharnikov LO, 2011, TRENDS BIOTECHNOL, V29, P473, DOI 10.1016/j.tibtech.2011.04.008; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vazana Y, 2010, APPL ENVIRON MICROB, V76, P3236, DOI 10.1128/AEM.00009-10; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wisniewski-Dye F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002430	50	27	30	2	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41068	41077		10.1074/jbc.M112.405720	http://dx.doi.org/10.1074/jbc.M112.405720			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23055526	Green Published, hybrid			2022-12-28	WOS:000311887600024
J	Diamantopoulou, Z; Kitsou, P; Menashi, S; Courty, J; Katsoris, P				Diamantopoulou, Zoi; Kitsou, Paraskevi; Menashi, Suzanne; Courty, Jose; Katsoris, Panagiotis			Loss of Receptor Protein Tyrosine Phosphatase beta/zeta (RPTP beta/zeta) Promotes Prostate Cancer Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFIN REGULATORY PEPTIDE; MOLECULE HB-GAM; EPITHELIAL-MESENCHYMAL TRANSITIONS; GROWTH-FACTOR PLEIOTROPHIN; CELLULAR-DISTRIBUTION; TUMOR PROGRESSION; ZETA/RPTP-BETA; MESSENGER-RNA; N-SYNDECAN; E-CADHERIN	Pleiotrophin is a growth factor that induces carcinogenesis. Despite the fact that many published reports focused on the role of pleiotrophin and its receptors, receptor protein tyrosine phosphatase (RPTP beta/zeta), and syndecan-3 during tumor development, no information is available regarding their function in tumor metastasis. To investigate the mechanism through which pleiotrophin regulates tumor metastasis, we used two different prostate carcinoma cell lines, DU145 and PC3, in which the expression of RPTP beta/zeta or syndecan-3 was down-regulated by the RNAi technology. The loss of RPTP beta/zeta expression initiated epithelial-to-mesenchymal transition (EMT) and increased the ability of the cells to migrate and invade. Importantly, the loss of RPTP beta/zeta expression increased metastasis in nude mice in an experimental metastasis assay. We also demonstrate that RPTP beta/zeta counterbalanced the pleiotrophin-mediated syndecan-3 pathway. While the inhibition of syndecan-3 expression inhibited the pleiotrophin-mediated cell migration and attachment through the Src and Fak pathway, the inhibition of RPTP beta/zeta expression increased pleiotrophin-mediated migration and attachment through an interaction with Src and the subsequent activation of a signal transduction pathway involving Fak, Pten, and Erk1/2. Taken together, these results suggest that the loss of RPTP beta/zeta may contribute to the metastasis of prostate cancer cells by inducing EMT and promoting pleiotrophin activity through the syndecan-3 pathway.	[Diamantopoulou, Zoi; Kitsou, Paraskevi; Katsoris, Panagiotis] Univ Patras, Dept Biol, Div Genet Cell & Dev Biol, GR-26500 Patras, Greece; [Menashi, Suzanne; Courty, Jose] Univ Paris Est, CNRS, Lab Rech Croissance Cellulaire Reparat & Regenera, F-94010 Creteil, France	University of Patras; Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Katsoris, P (corresponding author), Univ Patras, Dept Biol, Div Genet Cell & Dev Biol, GR-26500 Patras, Greece.	katsopan@upatras.gr	Courty, Jose/Q-3702-2018		ELKE; University of Patras; ANR [ANR-06-RIB016-02]; INCA [PL06-093]; Centre National de la Recherche Scientifique	ELKE; University of Patras; ANR(French National Research Agency (ANR)); INCA(Institut National du Cancer (INCA) France); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was partially supported through grants from ELKE, University of Patras (Karatheodoris), ANR (ANR-06-RIB016-02), INCA (PL06-093), and the Centre National de la Recherche Scientifique.	Chang YC, 2007, P NATL ACAD SCI USA, V104, P10888, DOI 10.1073/pnas.0704366104; CHAUHAN AK, 1993, P NATL ACAD SCI USA, V90, P679, DOI 10.1073/pnas.90.2.679; Choudhuri R, 1997, CANCER RES, V57, P1814; COURTY J, 1991, BIOCHEM BIOPH RES CO, V180, P145, DOI 10.1016/S0006-291X(05)81267-7; DELBE J, 1995, J CELL PHYSIOL, V164, P47, DOI 10.1002/jcp.1041640107; Diamantopoulou Z, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-224; FANG WJ, 1992, J BIOL CHEM, V267, P25889; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Gopalkrishnan RV, 2001, J CELL PHYSIOL, V189, P245, DOI 10.1002/jcp.10023; Grzelinski M, 2009, NEOPLASIA, V11, P145, DOI 10.1593/neo.81040; Gu DY, 2007, FEBS LETT, V581, P382, DOI 10.1016/j.febslet.2006.12.043; Hatziapostolou M, 2005, PROSTATE, V65, P151, DOI 10.1002/pros.20270; Hazan RB, 1996, CELL ADHES COMMUN, V4, P399, DOI 10.3109/15419069709004457; Heroult M, 2004, ONCOGENE, V23, P1745, DOI 10.1038/sj.onc.1206879; Jager R, 1997, INT J CANCER, V73, P537; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kawachi H, 2001, P NATL ACAD SCI USA, V98, P6593, DOI 10.1073/pnas.041608698; Klomp HJ, 2002, CLIN CANCER RES, V8, P823; LAAROUBI K, 1994, GROWTH FACTORS, V10, P89, DOI 10.3109/08977199409010982; Lei Z, 2004, NEUROL MED-CHIR, V44, P637, DOI 10.2176/nmc.44.637; LEVY JB, 1993, J BIOL CHEM, V268, P10573; Li JL, 2007, J BIOL CHEM, V282, P34984, DOI 10.1074/jbc.M703513200; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Lu KV, 2005, J BIOL CHEM, V280, P26953, DOI 10.1074/jbc.M502614200; Maeda N, 1996, J BIOL CHEM, V271, P21446, DOI 10.1074/jbc.271.35.21446; Maeda N, 1998, J CELL BIOL, V142, P203, DOI 10.1083/jcb.142.1.203; MAILLEUX P, 1992, NEUROSCI LETT, V142, P31, DOI 10.1016/0304-3940(92)90613-C; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Mentlein R, 2002, J NEUROCHEM, V83, P747, DOI 10.1046/j.1471-4159.2002.01179.x; MILNER PG, 1989, BIOCHEM BIOPH RES CO, V165, P1096, DOI 10.1016/0006-291X(89)92715-0; Muller S, 2003, ONCOGENE, V22, P6661, DOI 10.1038/sj.onc.1206763; Papadimitriou E, 2000, BIOCHEM BIOPH RES CO, V274, P242, DOI 10.1006/bbrc.2000.3126; Pariser H, 2005, P NATL ACAD SCI USA, V102, P12407, DOI 10.1073/pnas.0505901102; Pariser H, 2005, BIOCHEM BIOPH RES CO, V335, P232, DOI 10.1016/j.bbrc.2005.07.060; Pariser H, 2005, BIOCHEM BIOPH RES CO, V332, P664, DOI 10.1016/j.bbrc.2005.05.007; Park TJ, 2008, MOL CARCINOGEN, V47, P784, DOI 10.1002/mc.20438; Perez-Pinera P, 2006, P NATL ACAD SCI USA, V103, P17795, DOI 10.1073/pnas.0607299103; RAULO E, 1994, J BIOL CHEM, V269, P12999; RAUVALA H, 1989, EMBO J, V8, P2933, DOI 10.1002/j.1460-2075.1989.tb08443.x; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Suzuki H, 1998, CANCER RES, V58, P204; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Toba Y, 2002, EUR J NEUROSCI, V15, P1461, DOI 10.1046/j.1460-9568.2002.01983.x; Ulbricht U, 2003, J NEUROPATH EXP NEUR, V62, P1265, DOI 10.1093/jnen/62.12.1265; Ulbricht U, 2006, J NEUROCHEM, V98, P1497, DOI 10.1111/j.1471-4159.2006.04022.x; UMBAS R, 1994, CANCER RES, V54, P3929; UMBAS R, 1992, CANCER RES, V52, P5104; Vacherot F, 1999, PROSTATE, V38, P126, DOI 10.1002/(SICI)1097-0045(19990201)38:2<126::AID-PROS6>3.0.CO;2-C; VANDERWINDEN JM, 1992, ANAT EMBRYOL, V186, P387; Wu H, 2005, J CUTAN PATHOL, V32, P125, DOI 10.1111/j.0303-6987.2005.00282.x; Yamakawa T, 1999, CANCER LETT, V135, P91; Zhang N, 2006, BIOCHEM BIOPH RES CO, V343, P653, DOI 10.1016/j.bbrc.2006.03.006; Zhang N, 1999, P NATL ACAD SCI USA, V96, P6734, DOI 10.1073/pnas.96.12.6734	56	31	32	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40339	40349		10.1074/jbc.M112.405852	http://dx.doi.org/10.1074/jbc.M112.405852			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23060448	Green Published, hybrid			2022-12-28	WOS:000311448800025
J	Eliasen, R; Daly, NL; Wulff, BS; Andresen, TL; Conde-Frieboes, KW; Craik, DJ				Eliasen, Rasmus; Daly, Norelle L.; Wulff, Birgitte S.; Andresen, Thomas L.; Conde-Frieboes, Kilian W.; Craik, David J.			Design, Synthesis, Structural and Functional Characterization of Novel Melanocortin Agonists Based on the Cyclotide Kalata B1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; ALPHA-MELANOTROPIN; PLANT CYCLOTIDES; KNOTTED PROTEINS; RECEPTOR MC4-R; HIGHLY POTENT; PEPTIDES; IDENTIFICATION; EXPRESSION; SCAFFOLD	Obesity is an increasingly important global health problem that lacks current treatment options. The melanocortin receptor 4 (MC4R) is a target for obesity therapies because its activation triggers appetite suppression and increases energy expenditure. Cyclotides have been suggested as scaffolds for the insertion and stabilization of pharmaceutically active peptides. In this study, we explored the development of appetite-reducing peptides by synthesizing MC4R agonists based on the insertion of the His-Phe-Arg-Trp sequence into the cyclotide kalata B1. The ability of the analogues to fold similarly to kalata B1 but display MC4R activity were investigated. Four peptides were synthesized using t-butoxycarbonyl peptide chemistry with a C-terminal thioester to facilitate backbone cyclization. The structures of the peptides were found to be similar to kalata B1, evaluated by H alpha NMR chemical shifts. KB1(GHFRWG;23-28) had a K-i of 29 nM at the MC4R and was 107 or 314 times more selective over this receptor than MC1R or MC5R, respectively, and had no detectable binding to MC3R. The peptide had higher affinity for the MC4R than the endogenous agonist, alpha-melanocyte stimulation hormone, but it was less potent at the MC4R, with an EC50 of 580 nM for activation of the MC4R. In conclusion, we synthesized melanocortin analogues of kalata B1 that preserve the structural scaffold and display receptor binding and functional activity. KB1(GHFRWG;23-28) is potent and selective for the MC4R. This compound validates the use of cyclotides as scaffolds and has the potential to be a new lead for the treatment of obesity.	[Daly, Norelle L.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Eliasen, Rasmus; Wulff, Birgitte S.; Conde-Frieboes, Kilian W.] Novo Nordisk AS, DK-2760 Malov, Denmark; [Daly, Norelle L.] James Cook Univ, Sch Pharm & Mol Sci, Queensland Trop Hlth Alliance, Cairns, Qld 4870, Australia; [Daly, Norelle L.] James Cook Univ, Ctr Biodiscovery & Mol Dev Therapeut, Cairns, Qld 4870, Australia; [Eliasen, Rasmus; Andresen, Thomas L.] Tech Univ Denmark, Ctr Nanomed & Theranost, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark	University of Queensland; Novo Nordisk; James Cook University; James Cook University; Technical University of Denmark	Craik, DJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	d.craik@imb.uq.edu.au	Andresen, Thomas L/B-5324-2012; Daly, Norelle L/D-4302-2013; Craik, David/B-1695-2010; Eliasen, Rasmus/H-7707-2012	Daly, Norelle L/0000-0002-4697-6602; Craik, David/0000-0003-0007-6796; Eliasen, Rasmus/0000-0003-3137-8324; Andresen, Thomas Lars/0000-0002-1048-127X; Conde-Frieboes, Kilian/0000-0001-5303-4448	Australian Research Council [DP0984390]; National Health and Medical Research Council [APP1026501]; Danish Agency for Science Technology and Innovation; Novo Nordisk R&D Science Talent Attraction and Recruitment (STAR) program	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Danish Agency for Science Technology and Innovation; Novo Nordisk R&D Science Talent Attraction and Recruitment (STAR) program	This work was supported by Australian Research Council Grant DP0984390 and the National Health and Medical Research Council Grant APP1026501 (to University of Queensland) and by the Industrial Ph.D. Program by the Danish Agency for Science Technology and Innovation and the Novo Nordisk R&D Science Talent Attraction and Recruitment (STAR) program (to Novo Nordisk).	Barry DG, 2003, BIOCHEMISTRY-US, V42, P6688, DOI 10.1021/bi027323n; CASTRUCCI AMD, 1984, COMP BIOCHEM PHYS B, V78, P519, DOI 10.1016/0305-0491(84)90090-7; Chan LY, 2011, BLOOD, V118, P6709, DOI 10.1182/blood-2011-06-359141; Chen AS, 2000, TRANSGENIC RES, V9, P145, DOI 10.1023/A:1008983615045; Chen WB, 1997, CELL, V91, P789, DOI 10.1016/S0092-8674(00)80467-5; CHHAJLANI V, 1993, BIOCHEM BIOPH RES CO, V195, P866, DOI 10.1006/bbrc.1993.2125; CHHAJLANI V, 1992, FEBS LETT, V309, P417, DOI 10.1016/0014-5793(92)80820-7; Claeson P, 1998, J NAT PROD, V61, P77, DOI 10.1021/np970342r; Clark RJ, 2006, BIOCHEM J, V394, P85, DOI 10.1042/BJ20051691; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Conde-Frieboes K, 2012, J MED CHEM, V55, P1969, DOI 10.1021/jm201489a; Craik DJ, 2010, CELL MOL LIFE SCI, V67, P9, DOI 10.1007/s00018-009-0159-3; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Daly NL, 1999, BIOCHEMISTRY-US, V38, P10606, DOI 10.1021/bi990605b; Daly NL, 2009, ADV DRUG DELIVER REV, V61, P918, DOI 10.1016/j.addr.2009.05.003; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; DeLano W.L, PYMOL MOL GRAPHICS S; Emmerson PJ, 2007, CURR TOP MED CHEM, V7, P1121; FATHI Z, 1995, NEUROCHEM RES, V20, P107, DOI 10.1007/BF00995160; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; FUJINARI EM, 1992, J CHROMATOGR, V592, P209, DOI 10.1016/0021-9673(92)85087-A; GANTZ I, 1993, J BIOL CHEM, V268, P15174; GANTZ I, 1993, J BIOL CHEM, V268, P8246; Goransson U, 1999, J NAT PROD, V62, P283, DOI 10.1021/np9803878; GRAN L, 1973, LLOYDIA, V36, P174; Gruber CW, 2008, PLANT CELL, V20, P2471, DOI 10.1105/tpc.108.062331; Gunasekera S, 2008, J MED CHEM, V51, P7697, DOI 10.1021/jm800704e; GUSTAFSON KR, 1994, J AM CHEM SOC, V116, P9337, DOI 10.1021/ja00099a064; Haskell-Luevano C, 2001, J MED CHEM, V44, P2247, DOI 10.1021/jm010061n; He SW, 2010, BIOORG MED CHEM LETT, V20, P6524, DOI 10.1016/j.bmcl.2010.09.049; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; HRUBY VJ, 1987, J MED CHEM, V30, P2126, DOI 10.1021/jm00394a033; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Jagadish K, 2010, BIOPOLYMERS, V94, P611, DOI 10.1002/bip.21433; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lindholm P, 2002, MOL CANCER THER, V1, P365; Millard EL, 2009, J BIOL CHEM, V284, P4944, DOI 10.1074/jbc.M804950200; Miller WC, 1997, INT J OBESITY, V21, P941, DOI 10.1038/sj.ijo.0800499; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Reiss S, 2006, PLATELETS, V17, P153, DOI 10.1080/09537100500436663; ROSELLIREHFUSS L, 1993, P NATL ACAD SCI USA, V90, P8856, DOI 10.1073/pnas.90.19.8856; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; SAETHER O, 1995, BIOCHEMISTRY-US, V34, P4147, DOI 10.1021/bi00013a002; SAWYER TK, 1980, P NATL ACAD SCI-BIOL, V77, P5754, DOI 10.1073/pnas.77.10.5754; Schoepke T., 1993, SCI PHARM, V61, P145; Skjeldal L, 2002, ARCH BIOCHEM BIOPHYS, V399, P142, DOI 10.1006/abbi.2002.2769; Starowicz K, 2004, NEUROSCI LETT, V358, P79, DOI 10.1016/j.neulet.2003.12.096; Stevens J, 2001, OBES RES, V9, P696, DOI 10.1038/oby.2001.94; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Thongyoo P, 2008, ORG BIOMOL CHEM, V6, P1462, DOI 10.1039/b801667d; Wang CKL, 2008, NUCLEIC ACIDS RES, V36, pD206, DOI 10.1093/nar/gkm953; Wannamethee SG, 1998, J HUM HYPERTENS, V12, P735, DOI 10.1038/sj.jhh.1000714; Werle M, 2006, J DRUG TARGET, V14, P137, DOI 10.1080/10611860600648254; Wilczynski A, 2004, J MED CHEM, V47, P2194, DOI 10.1021/jm0303608; WITHERUP KM, 1994, J NAT PRODUCTS, V57, P1619, DOI 10.1021/np50114a002; Wolf HK, 1997, J HUM HYPERTENS, V11, P733, DOI 10.1038/sj.jhh.1000531; Wong CTT, 2012, ANGEW CHEM INT EDIT, V51, P5620, DOI 10.1002/anie.201200984; Wright SM, 2011, NAT REV ENDOCRINOL, V7, P69, DOI 10.1038/nrendo.2010.231	62	78	78	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40493	40501		10.1074/jbc.M112.395442	http://dx.doi.org/10.1074/jbc.M112.395442			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23012369	hybrid, Green Published			2022-12-28	WOS:000311448800040
J	Lanaspa, MA; Sanchez-Lozada, LG; Choi, YJ; Cicerchi, C; Kanbay, M; Roncal-Jimenez, CA; Ishimoto, T; Li, NX; Marek, G; Duranay, M; Schreiner, G; Rodriguez-Iturbe, B; Nakagawa, T; Kang, DH; Sautin, YY; Johnson, RJ				Lanaspa, Miguel A.; Sanchez-Lozada, Laura G.; Choi, Yea-Jin; Cicerchi, Christina; Kanbay, Mehmet; Roncal-Jimenez, Carlos A.; Ishimoto, Takuji; Li, Nanxing; Marek, George; Duranay, Murat; Schreiner, George; Rodriguez-Iturbe, Bernardo; Nakagawa, Takahiko; Kang, Duk-Hee; Sautin, Yuri Y.; Johnson, Richard J.			Uric Acid Induces Hepatic Steatosis by Generation of Mitochondrial Oxidative Stress POTENTIAL ROLE IN FRUCTOSE-DEPENDENT AND -INDEPENDENT FATTY LIVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-PRESSURE; RISK-FACTOR; CELL-PROLIFERATION; DIETARY FRUCTOSE; FILTRATION-RATE; DISEASE; HYPERURICEMIA; ASSOCIATION; ALLOPURINOL; HOMEOSTASIS	Metabolic syndrome represents a collection of abnormalities that includes fatty liver, and it currently affects one-third of the United States population and has become a major health concern worldwide. Fructose intake, primarily from added sugars in soft drinks, can induce fatty liver in animals and is epidemiologically associated with nonalcoholic fatty liver disease in humans. Fructose is considered lipogenic due to its ability to generate triglycerides as a direct consequence of the metabolism of the fructose molecule. Here, we show that fructose also stimulates triglyceride synthesis via a purine-degrading pathway that is triggered from the rapid phosphorylation of fructose by fructokinase. Generated AMP enters into the purine degradation pathway through the activation of AMP deaminase resulting in uric acid production and the generation of mitochondrial oxidants. Mitochondrial oxidative stress results in the inhibition of aconitase in the Krebs cycle, resulting in the accumulation of citrate and the stimulation of ATP citrate lyase and fatty-acid synthase leading to de novo lipogeneis. These studies provide new insights into the pathogenesis of hepatic fat accumulation under normal and diseased states.	[Cicerchi, Christina; Roncal-Jimenez, Carlos A.; Ishimoto, Takuji; Li, Nanxing; Nakagawa, Takahiko; Johnson, Richard J.] Univ Colorado, Dept Med, Div Renal Dis & Hypertens, Denver, CO 80045 USA; [Sanchez-Lozada, Laura G.] Inst Nacl Cardiol Ignacio Chavez, Dept Med, Lab Renal Physiopathol & Nephrol, Mexico City 14339, DF, Mexico; [Choi, Yea-Jin; Kang, Duk-Hee] Ewha Womans Univ, Sch Med, Dept Internal Med, Div Nephrol,Ehwa Med Res Ctr, Seoul 120750, South Korea; [Kanbay, Mehmet; Duranay, Murat] Kayseri Training & Res Hosp, Div Nephrol, Dept Med, TR-38039 Kayseri, Turkey; [Marek, George; Sautin, Yuri Y.] Univ Florida, Dept Med, Div Nephrol Hypertens & Transplantat, Gainesville, FL 32611 USA; [Schreiner, George] Cardero Therapeut Inc, Menlo Pk, CA 94085 USA; [Rodriguez-Iturbe, Bernardo] Inst Venezolano Invest Cient Zulia, Maracaibo 4001 A, Venezuela; [Rodriguez-Iturbe, Bernardo] Univ Hosp, Maracaibo 4001 A, Venezuela; [Rodriguez-Iturbe, Bernardo] Univ Zulia, Maracaibo 4001 A, Venezuela	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Institute of Cardiology - Mexico; Ewha Womans University; Kayseri Training & Research Hospital; State University System of Florida; University of Florida		Miguel.lanaspagarcia@ucdenver.edu	1, 1/L-6277-2019; Ishimoto, Takuji/M-4873-2014; Sanchez-Lozada, Laura/AAS-2104-2021; Lanaspa, Miguel/AAO-4971-2020	Ishimoto, Takuji/0000-0002-9861-5331; Sanchez-Lozada, Laura-Gabriela/0000-0003-0348-9617; Sautin, Yuri/0000-0003-3618-5134	National Institutes of Health [HL-68607, RC4 DK090869-01]; Amway; Cardero; Danone; Questcor; University of Colorado; Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea Grant [A101742]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amway; Cardero; Danone(Danone Nutricia); Questcor; University of Colorado; Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-68607 and RC4 DK090869-01 (to R. J. J.). This work was also supported by Amway, Cardero, Danone, and Questcor (to R. J. J.) and by startup funds from the University of Colorado (to R. J. J.) and Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea Grant A101742 (to D.-H. K.). M. A. L., T. I., and R. J. J. are listed as inventors on a patent application from the University of Colorado related to developing isoform-specific fructokinase inhibitors in the treatment of disorders associated with obesity and insulin resistance. T. N. and R. J. J. are listed as inventors on several patent applications related to lowering uric acid as a means to prevent or treat metabolic syndrome. Dr. Johnson also has a patent with the University of Washington and Merck for the use of allopurinol to treat hypertension. Dr. Johnson also discloses that he has consulted for Ardea, Astellas, Danone, and Novartis, that he is on the scientific board of Amway. R. J. J. and T. N. have patent applications related to lowering uric acid as a means to prevent fatty liver and metabolic syndrome. R. J. J., T. I., and M. L. also have patent applications related to blocking fructose metabolism as a means for preventing or treating metabolic syndrome. Dr. Johnson has also consulted for Novartis, Danone, Ardea, Mitsubishi Tanabe, and Astellas. Dr. Johnson also has two lay books on sugar, including the Sugar Fix (Rodale, 2008) and the Fat Switch (Mercola.com, 2012).	Abdelmalek MF, 2012, HEPATOLOGY, V56, P952, DOI 10.1002/hep.25741; Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535; Abdelmalek MF, 2007, HEPATOLOGY, V46, p293A; Ackerman Z, 2005, HYPERTENSION, V45, P1012, DOI 10.1161/01.HYP.0000164570.20420.67; Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Argalious MY, 2012, BRIT J ANAESTH, V109, P161, DOI 10.1093/bja/aes143; Baldini PM, 2004, CELL DEATH DIFFER, V11, pS210, DOI 10.1038/sj.cdd.4401520; Baldwin W, 2011, DIABETES, V60, P1258, DOI 10.2337/db10-0916; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; CHANEY AL, 1962, CLIN CHEM, V8, P130; Choi JWJ, 2008, ARTHRIT RHEUM-ARTHR, V59, P109, DOI 10.1002/art.23245; Cirillo P, 2009, J AM SOC NEPHROL, V20, P545, DOI 10.1681/ASN.2008060576; Corry DB, 2008, J HYPERTENS, V26, P269, DOI 10.1097/HJH.0b013e3282f240bf; Cox CL, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-68; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Feig DI, 2008, JAMA-J AM MED ASSOC, V300, P924, DOI 10.1001/jama.300.8.924; HAUSLADEN A, 1994, J BIOL CHEM, V269, P29405; Havel PJ, 2005, NUTR REV, V63, P133, DOI [10.1301/nr.2005.may.133-157, 10.1111/j.1753-4887.2005.tb00132.x]; Johnson RJ, 2009, ENDOCR REV, V30, P96, DOI 10.1210/er.2008-0033; Kanbay M, 2007, INT UROL NEPHROL, V39, P1227, DOI 10.1007/s11255-007-9253-3; Kanbay M, 2011, CLIN J AM SOC NEPHRO, V6, P1887, DOI 10.2215/CJN.11451210; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Kuo CF, 2010, SCAND J RHEUMATOL, V39, P466, DOI 10.3109/03009741003742797; Lee JW, 2010, GUT LIVER, V4, P378, DOI 10.5009/gnl.2010.4.3.378; Lee K, 2009, DIABETES METAB, V35, P447, DOI 10.1016/j.diabet.2009.04.011; Li YM, 2009, J HEPATOL, V50, P1029, DOI 10.1016/j.jhep.2008.11.021; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Lonardo A, 2002, DIGEST LIVER DIS, V34, P204, DOI 10.1016/S1590-8658(02)80194-3; Masuo K, 2003, HYPERTENSION, V42, P474, DOI 10.1161/01.HYP.0000091371.53502.D3; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; Nikkila E A, 1969, Adv Lipid Res, V7, P63; NIKKILA EA, 1972, ACTA MED SCAND, P221; ODIEVRE M, 1978, AM J DIS CHILD, V132, P605, DOI 10.1001/archpedi.1978.02120310069014; Ogino K, 2010, CIRC-HEART FAIL, V3, P73, DOI 10.1161/CIRCHEARTFAILURE.109.868604; Ouyang X, 2008, J HEPATOL, V48, P993, DOI 10.1016/j.jhep.2008.02.011; PERHEENT.J, 1967, LANCET, V2, P528; Petta S, 2011, ALIMENT PHARM THER, V34, P757, DOI 10.1111/j.1365-2036.2011.04788.x; REISER S, 1989, AM J CLIN NUTR, V49, P832, DOI 10.1093/ajcn/49.5.832; Roncal-Jimenez CA, 2011, METABOLISM, V60, P1259, DOI 10.1016/j.metabol.2011.01.008; Ryu S, 2011, METABOLISM, V60, P860, DOI 10.1016/j.metabol.2010.08.005; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Sirota J. C., 2012, METABOLISM, P7; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Van den Berghe G, 1986, Prog Biochem Pharmacol, V21, P1; VANDENBERGHE G, 1977, BIOCHEM J, V162, P601, DOI 10.1042/bj1620601; Xu CF, 2010, HEPATOLOGY, V52, P1865, DOI 10.1002/hep.23798; Xu CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011578; Xu P, 2000, J BIOL CHEM, V275, P5918, DOI 10.1074/jbc.275.8.5918; Yamada T, 2010, ACTA GASTRO-ENT BELG, V73, P12; Yu MA, 2010, J HYPERTENS, V28, P1234, DOI 10.1097/HJH.0b013e328337da1d	53	410	426	5	59	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40732	40744		10.1074/jbc.M112.399899	http://dx.doi.org/10.1074/jbc.M112.399899			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23035112	Green Published, hybrid			2022-12-28	WOS:000311448800062
J	Ruiz, S; Panopoulos, AD; Montserrat, N; Multon, MC; Daury, A; Rocher, C; Spanakis, E; Batchelder, EM; Orsini, C; Deleuze, JF; Belmonte, JCI				Ruiz, Sergio; Panopoulos, Athanasia D.; Montserrat, Nuria; Multon, Marie-Christine; Daury, Aurelie; Rocher, Corinne; Spanakis, Emmanuel; Batchelder, Erika M.; Orsini, Cecile; Deleuze, Jean-Francois; Izpisua Belmonte, Juan Carlos			Generation of a Drug-inducible Reporter System to Study Cell Reprogramming in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; HUMAN SOMATIC-CELLS; MICRORNAS; MOUSE; FIBROBLASTS; MICE; TRANSITION; STATE; OCT4; MYC	Reprogramming of somatic cells into induced pluripotent stem cells is achieved by the expression of defined transcription factors. In the last few years, reprogramming strategies on the basis of doxycycline-inducible lentiviruses in mouse cells became highly powerful for screening purposes when the expression of a GFP gene, driven by the reactivation of endogenous stem cell specific promoters, was used as a reprogramming reporter signal. However, similar reporter systems in human cells have not been generated. Here, we describe the derivation of drug-inducible human fibroblast-like cell lines that express different subsets of reprogramming factors containing a GFP gene under the expression of the endogenous OCT4 promoter. These cell lines can be used to screen functional substitutes for reprogramming factors or modifiers of reprogramming efficiency. As a proof of principle of this system, we performed a screening of a library of pluripotent-enriched microRNAs and identified hsa-miR-519a as a novel inducer of reprogramming efficiency.	[Ruiz, Sergio; Panopoulos, Athanasia D.; Batchelder, Erika M.; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Montserrat, Nuria; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain; [Multon, Marie-Christine; Daury, Aurelie; Rocher, Corinne; Spanakis, Emmanuel; Orsini, Cecile; Deleuze, Jean-Francois] Sanofi R&D, Ctr Rech Vitry Alfortville, Regenerat Med & Cell Therapy Platform, F-94403 Vitry Sur Seine, France	Salk Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; Sanofi-Aventis; Sanofi France	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Ruiz, Sergio/G-1561-2016; Montserrat, Nuria/F-3136-2016; Spanakis, Emmanuel/AAD-9014-2021	Ruiz, Sergio/0000-0002-0177-6965; Montserrat, Nuria/0000-0002-1603-1755; Panopoulos, Athanasia/0000-0002-9610-2604; Spanakis, Emmanuel/0000-0002-5107-8444	National Institutes of Health Grant [HL107442]; MINECO (Ministerio de Economia y Competitividad); Fundacion Cellex; Sanofi; Leona M. and Harry B. Helmsley Charitable Trust; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107442] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MINECO (Ministerio de Economia y Competitividad); Fundacion Cellex(Foundation CELLEX); Sanofi; Leona M. and Harry B. Helmsley Charitable Trust; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by grants from National Institutes of Health Grant HL107442, MINECO (Ministerio de Economia y Competitividad), Fundacion Cellex, Sanofi, The Leona M. and Harry B. Helmsley Charitable Trust, and the G. Harold and Leila Y. Mathers Charitable Foundation.	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Chen HF, 2011, STEM CELL REV REP, V7, P722, DOI 10.1007/s12015-011-9233-y; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Lin CH, 2009, EMBO J, V28, P3157, DOI 10.1038/emboj.2009.254; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Mallanna SK, 2010, DEV BIOL, V344, P16, DOI 10.1016/j.ydbio.2010.05.014; Markoulaki S, 2009, NAT BIOTECHNOL, V27, P169, DOI 10.1038/nbt.1520; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Redmer T, 2011, EMBO REP, V12, P720, DOI 10.1038/embor.2011.88; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yang CS, 2011, RNA, V17, P1451, DOI 10.1261/rna.2664111; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	37	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40767	40778		10.1074/jbc.M112.384024	http://dx.doi.org/10.1074/jbc.M112.384024			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23019325	Green Published, hybrid			2022-12-28	WOS:000311448800065
J	Doherty, MT; Kang, YS; Lee, C; Stumph, WE				Doherty, Matthew T.; Kang, Yoon Soon; Lee, Cheryn; Stumph, William E.			Architectural Arrangement of the Small Nuclear RNA (snRNA)-activating Protein Complex 190 Subunit (SNAP190) on U1 snRNA Gene Promoter DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL-SEQUENCE-ELEMENT; MYB-DOMAIN PROTEIN; TRANSCRIPTION FACTOR; BINDING DOMAIN; CRYSTAL-STRUCTURE; POLYMERASE-II; RECOGNITION; IDENTIFICATION; MODEL; TBP	Myb repeats similar to 52 amino acid residues in length were first characterized in the oncogenic Myb transcription factor, which contains three tandem Myb repeats in its DNA-binding domain. Proteins of this family normally contain either one, two, or three tandem Myb repeats that are involved in protein-DNA interactions. The small nuclear RNA (snRNA)-activating protein complex (SNAPc) is a heterotrimeric transcription factor that is required for expression of small nuclear RNA genes. This complex binds to an essential promoter element, the proximal sequence element, centered similar to 50 base pairs upstream of the transcription start site of snRNA genes. SNAP190, the largest subunit of SNAPc, uncharacteristically contains 4.5 tandem Myb repeats. Little is known about the arrangement of the Myb repeats in the SNAPc-DNA complex, and it has not been clear whether all 4.5 Myb repeats contact the DNA. By using a site-specific protein-DNA photo-cross-linking assay, we have now mapped specific nucleotides where each of the Myb repeats of Drosophila melanogaster SNAP190 interacts with a U1 snRNA gene proximal sequence element. The results reveal the topological arrangement of the 4.5 SNAP190 Myb repeats relative to the DNA and to each other when SNAP190 is bound to a U1 promoter as a subunit of SNAPc.	[Kang, Yoon Soon; Lee, Cheryn; Stumph, William E.] San Diego State Univ, Dept Chem & Biochem, San Diego, CA 92182 USA; [Doherty, Matthew T.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; San Diego State Univ, Inst Mol Biol, San Diego, CA 92182 USA	California State University System; San Diego State University; California State University System; San Diego State University; California State University System; San Diego State University	Stumph, WE (corresponding author), San Diego State Univ, Dept Chem & Biochem, 5500 Campanile Dr, San Diego, CA 92182 USA.	wstumph@sciences.sdsu.edu			National Science Foundation [MCB-0641350, MCB-1157549]; California Metabolic Research Foundation	National Science Foundation(National Science Foundation (NSF)); California Metabolic Research Foundation	This work was supported by National Science Foundation Grants MCB-0641350 and MCB-1157549 and in part by the California Metabolic Research Foundation.	Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Bilaud T, 1996, NUCLEIC ACIDS RES, V24, P1294, DOI 10.1093/nar/24.7.1294; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Crimmins D. L., 1996, CURR PROTOC PROTEIN, V4, P111411; Das A, 2005, MOL CELL BIOL, V25, P7314, DOI 10.1128/MCB.25.16.7314-7322.2005; Das A, 2003, P NATL ACAD SCI USA, V100, P80, DOI 10.1073/pnas.262609399; Egloff S, 2008, BIOCHEM SOC T, V36, P590, DOI 10.1042/BST0360590; GROTEWOLD E, 1991, P NATL ACAD SCI USA, V88, P4587, DOI 10.1073/pnas.88.11.4587; Hardin SB, 2000, NUCLEIC ACIDS RES, V28, P2771, DOI 10.1093/nar/28.14.2771; HENRY RW, 1995, NATURE, V374, P653, DOI 10.1038/374653a0; Hernandez G, 2007, NUCLEIC ACIDS RES, V35, P21, DOI 10.1093/nar/gkl982; Hernandez N, 2001, J BIOL CHEM, V276, P26733, DOI 10.1074/jbc.R100032200; Hung KH, 2011, CRIT REV BIOCHEM MOL, V46, P11, DOI 10.3109/10409238.2010.518136; Hung KH, 2009, J BIOL CHEM, V284, P22568, DOI 10.1074/jbc.M109.027961; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim MK, 2010, MOL CELL BIOL, V30, P2411, DOI 10.1128/MCB.01508-09; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; Konig P, 1998, NUCLEIC ACIDS RES, V26, P1731, DOI 10.1093/nar/26.7.1731; Lai HT, 2008, FEBS LETT, V582, P3734, DOI 10.1016/j.febslet.2008.09.059; Li C, 2004, MOL CELL BIOL, V24, P1897, DOI 10.1128/MCB.24.5.1897-1906.2004; Ma BC, 2002, MOL CELL BIOL, V22, P8067, DOI 10.1128/MCB.22.22.8067-8078.2002; MURPHY S, 1992, MOL CELL BIOL, V12, P3247, DOI 10.1128/MCB.12.7.3247; OGATA K, 1995, NAT STRUCT BIOL, V2, P309, DOI 10.1038/nsb0495-309; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; SADOWSKI CL, 1993, GENE DEV, V7, P1535, DOI 10.1101/gad.7.8.1535; SAKURA H, 1989, P NATL ACAD SCI USA, V86, P5758, DOI 10.1073/pnas.86.15.5758; Schimanski B, 2005, MOL CELL BIOL, V25, P7303, DOI 10.1128/MCB.25.16.7303-7313.2005; Su Y, 1997, EUR J BIOCHEM, V248, P231, DOI 10.1111/j.1432-1033.1997.t01-1-00231.x; Tahirov TH, 2002, CELL, V108, P57, DOI 10.1016/S0092-8674(01)00636-5; TANIKAWA J, 1993, P NATL ACAD SCI USA, V90, P9320, DOI 10.1073/pnas.90.20.9320; WALDSCHMIDT R, 1991, EMBO J, V10, P2595, DOI 10.1002/j.1460-2075.1991.tb07801.x; WANANDI I, 1993, J BIOL CHEM, V268, P6629; Wang Y, 1998, MOL CELL BIOL, V18, P1570, DOI 10.1128/MCB.18.3.1570; Wong MW, 1998, MOL CELL BIOL, V18, P368, DOI 10.1128/MCB.18.1.368; YOON JB, 1995, MOL CELL BIOL, V15, P2019; Yu EY, 2000, J BIOL CHEM, V275, P24208, DOI 10.1074/jbc.M003250200	38	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.407775	http://dx.doi.org/10.1074/jbc.M112.407775			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23038247	Green Published, hybrid			2022-12-28	WOS:000311233800009
J	Glaser, S; van Dooren, GG; Agrawal, S; Brooks, CF; McFadden, GI; Striepen, B; Higgins, MK				Glaser, Stephanie; van Dooren, Giel G.; Agrawal, Swati; Brooks, Carrie F.; McFadden, Geoffrey I.; Striepen, Boris; Higgins, Matthew K.			Tic22 Is an Essential Chaperone Required for Protein Import into the Apicoplast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER ENVELOPE MEMBRANE; PLASMODIUM-FALCIPARUM; TOXOPLASMA-GONDII; CRYSTAL-STRUCTURE; INTERMEMBRANE SPACE; CHLOROPLASTS; IDENTIFICATION; MACHINERIES; COMPONENTS; SUBSTRATE	Most plastids proteins are post-translationally imported into organelles through multisubunit translocons. The TIC and TOC complexes perform this role in the two membranes of the plant chloroplast and in the inner two membranes of the apicoplasts of the apicomplexan parasites, Toxoplasma gondii and Plasmodium falciparum. Tic22 is a ubiquitous intermembrane translocon component that interacts with translocating proteins. Here, we demonstrate that T. gondii Tic22 is an apicoplast-localized protein, essential for parasite survival and protein import into the apicoplast stroma. The structure of Tic22 from P. falciparum reveals a fold conserved from cyanobacteria to plants, which displays a non-polar groove on each side of the molecule. We show that these grooves allow Tic22 to act as a chaperone. General chaperones are common components of protein translocation systems where they maintain cargo proteins in an unfolded conformation during transit. Such a chaperone had not been identified in the intermembrane space of plastids and we propose that Tic22 fulfills this role.	[van Dooren, Giel G.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Glaser, Stephanie] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Agrawal, Swati; Striepen, Boris] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Brooks, Carrie F.; Striepen, Boris] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [McFadden, Geoffrey I.] Univ Melbourne, Sch Bot, Plant Cell Biol Res Ctr, Parkville, Vic 3010, Australia; [Higgins, Matthew K.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Australian National University; University of Cambridge; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Melbourne; University of Oxford	van Dooren, GG (corresponding author), Australian Natl Univ, Res Sch Biol, GPO Box 4, Canberra, ACT 0200, Australia.	giel.vandooren@anu.edu.au; striepen@uga.edu; matthew.higgins@bioch.ox.ac.uk	van Dooren, Giel G/A-8896-2012; McFadden, Geoffrey McFadden I/F-7667-2014	van Dooren, Giel G/0000-0003-2455-9821; McFadden, Geoffrey McFadden I/0000-0002-5351-1627; Striepen, Boris/0000-0002-7426-432X; Agrawal, Swati/0000-0001-6295-6954; Higgins, Matthew/0000-0002-2870-1955	Australian Research Council Discovery grant; National Health and Medical Research Council Program Grant; Medical Research Council grant; National Institutes of Health [AI 64671]; Medical Research Council; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064671] Funding Source: NIH RePORTER; MRC [G0901062] Funding Source: UKRI; Medical Research Council [G0901062] Funding Source: researchfish	Australian Research Council Discovery grant(Australian Research Council); National Health and Medical Research Council Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by an Australian Research Council Discovery grant (to G. v. D.), a National Health and Medical Research Council Program Grant (to G. I. M.), a Medical Research Council grant (to M. K. H.), and a grant from the National Institutes of Health (AI 64671) (to B. S.).; Supported by a Medical Research Council Studentship.; Supported by a predoctoral fellowship from the American Heart Association. Present address: Dept. of Microbiology and Immunology, University of Michigan, Ann Arbor, MI 48105.	Agrawal S, 2009, J BIOL CHEM, V284, P33683, DOI 10.1074/jbc.M109.044024; Becker T, 2004, MOL BIOL CELL, V15, P5130, DOI 10.1091/mbc.E04-05-0405; Brooks CF, 2010, CELL HOST MICROBE, V7, P62, DOI 10.1016/j.chom.2009.12.002; Brydges SD, 2000, MOL BIOCHEM PARASIT, V111, P51, DOI 10.1016/S0166-6851(00)00296-6; Bullmann L, 2010, J BIOL CHEM, V285, P6848, DOI 10.1074/jbc.M109.074807; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chou ML, 2006, J CELL BIOL, V175, P893, DOI 10.1083/jcb.200609172; Danese PN, 1998, ANNU REV GENET, V32, P59, DOI 10.1146/annurev.genet.32.1.59; del Valle LJ, 2002, BBA-PROTEINS PROTEOM, V1601, P100, DOI 10.1016/S1570-9639(02)00429-6; Glaser S, 2012, ACTA CRYSTALLOGR F, V68, P351, DOI 10.1107/S1744309112004952; Kalanon M, 2009, EUKARYOT CELL, V8, P1146, DOI 10.1128/EC.00061-09; Kikuchi S, 2009, PLANT CELL, V21, P1781, DOI 10.1105/tpc.108.063552; Kouranov A, 1998, J CELL BIOL, V143, P991, DOI 10.1083/jcb.143.4.991; Kouranov A, 1997, J CELL BIOL, V139, P1677, DOI 10.1083/jcb.139.7.1677; Kovacs-Bogdan E, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-133; Kovacs-Bogdan E, 2010, BBA-MOL CELL RES, V1803, P740, DOI 10.1016/j.bbamcr.2010.01.015; McFadden GI, 2004, CURR BIOL, V14, pR514, DOI 10.1016/j.cub.2004.06.041; Panse VG, 2000, J BIOL CHEM, V275, P18698, DOI 10.1074/jbc.275.25.18698; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Scheibel T, 1998, P NATL ACAD SCI USA, V95, P1495, DOI 10.1073/pnas.95.4.1495; Schleiff E, 2003, P NATL ACAD SCI USA, V100, P4604, DOI 10.1073/pnas.0730860100; SCHNELL DJ, 1993, J CELL BIOL, V120, P103, DOI 10.1083/jcb.120.1.103; Scott SV, 1996, J CELL BIOL, V132, P63, DOI 10.1083/jcb.132.1.63; Sheluho D, 2001, J BIOL CHEM, V276, P39945, DOI 10.1074/jbc.M107252200; Soll J, 2004, NAT REV MOL CELL BIO, V5, P198, DOI 10.1038/nrm1333; Tripp J, 2012, J BIOL CHEM, V287, P24164, DOI 10.1074/jbc.M112.341644; van Dooren GG, 2002, J BIOL CHEM, V277, P23612, DOI 10.1074/jbc.M201748200; van Dooren GG, 2008, P NATL ACAD SCI USA, V105, P13574, DOI 10.1073/pnas.0803862105; van Dooren GG, 2009, CURR BIOL, V19, P267, DOI 10.1016/j.cub.2008.12.048; Vojta L, 2007, FEBS J, V274, P5043, DOI 10.1111/j.1742-4658.2007.06023.x; Walton TA, 2004, MOL CELL, V15, P367, DOI 10.1016/j.molcel.2004.07.023; Webb CT, 2006, MOL CELL, V21, P123, DOI 10.1016/j.molcel.2005.11.010; Xu XH, 2007, J MOL BIOL, V373, P367, DOI 10.1016/j.jmb.2007.07.069; Xu ZH, 2000, NAT STRUCT BIOL, V7, P1172, DOI 10.1038/82040	34	50	50	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.405100	http://dx.doi.org/10.1074/jbc.M112.405100			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23027875	hybrid, Green Published			2022-12-28	WOS:000311233800022
J	Wu, Y; Feng, ZJ; Gao, SB; Matkar, S; Xu, B; Duan, HB; Lin, X; Li, SH; Hua, XX; Jin, GH				Wu, Yuan; Feng, Zi-Jie; Gao, Shu-Bin; Matkar, Smita; Xu, Bin; Duan, Hong-Bin; Lin, Xiao; Li, Shan-Hua; Hua, Xianxin; Jin, Guang-Hui			Interplay between Menin and K-Ras in Regulating Lung Adenocarcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; HISTONE METHYLATION; HUMAN CANCER; GENE; GROWTH; EXPRESSION; PROTEIN; IDENTIFICATION; SUPPRESSION; MUTATIONS	MEN1, which encodes the nuclear protein menin, acts as a tumor suppressor in lung cancer and is often inactivated in human primary lung adenocarcinoma. Here, we show that the inactivation of MEN1 is associated with increased DNA methylation at the MEN1 promoter by K-Ras. On one hand, the activated K-Ras up-regulates the expression of DNA methyltransferases and enhances the binding of DNA methyltransferase 1 to the MEN1 promoter, leading to increased DNA methylation at the MEN1 gene in lung cancer cells; on the other hand, menin reduces the level of active Ras-GTP at least partly by preventing GRB2 and SOS1 from binding to Ras, without affecting the expression of GRB2 and SOS1. In human lung adenocarcinoma samples, we further demonstrate that reduced menin expression is associated with the enhanced expression of Ras (p < 0.05). Finally, excision of the Men1 gene markedly accelerates the K-Ras(G12D)-induced tumor formation in the Men1(f/f); K-Ras(G12D/+); Cre ER mouse model. Together, these findings uncover a previously unknown link between activated K-Ras and menin, an important interplay governing tumor activation and suppression in the development of lung cancer.	[Wu, Yuan; Feng, Zi-Jie; Gao, Shu-Bin; Xu, Bin; Lin, Xiao; Li, Shan-Hua; Hua, Xianxin; Jin, Guang-Hui] Xiamen Univ, Dept Basic Med Sci, Coll Med, Zhongshan Hosp, Xiamen 361005, Fujian, Peoples R China; [Duan, Hong-Bin] Xiamen Univ, Dept Thorac Surg, Zhongshan Hosp, Xiamen 361005, Fujian, Peoples R China; [Wu, Yuan] Hubei Canc Hosp, Dept Radiotherapy, Wuhan 430079, Hubei, Peoples R China; [Matkar, Smita; Hua, Xianxin] Univ Penn, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	Xiamen University; Xiamen University; University of Pennsylvania; Pennsylvania Medicine	Hua, XX (corresponding author), Xiamen Univ, Dept Basic Med Sci, Coll Med, Zhongshan Hosp, Xiamen 361005, Fujian, Peoples R China.	huax@mail.med.upenn.edu; ghjin@xmu.edu.cn		Feng, Zijie/0000-0002-5633-3686	Natural Science Foundation of China [81071926, 81272719, 81101763, 81101924]; Natural Science Foundation of Fujian Province [2011J06016]; Natural Science Foundation of Xiamen [3502Z20104001]; Fundamental Research Grant for the central universities, Xiamen University [2010121106]; National Institutes of Health [R01 DK085121]; Lung Cancer Research Foundation Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085121] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Natural Science Foundation of Xiamen; Fundamental Research Grant for the central universities, Xiamen University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lung Cancer Research Foundation Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Natural Science Foundation of China Grants 81071926 and 81272719 (to G. H. J.), 81101763 (to S. B. G.), and 81101924 (to S. L.); Natural Science Foundation of Fujian Province Grant 2011J06016 (to G. H. J.); Natural Science Foundation of Xiamen Grant 3502Z20104001 (to G. H. J.); Fundamental Research Grant 2010121106 for the central universities, Xiamen University (to G. H. J.). This work was also supported by National Institutes of Health Grant R01 DK085121 (to X. H.) and a Lung Cancer Research Foundation Grant (to X. H.).	ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; BOS JL, 1989, CANCER RES, V49, P4682; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Debelenko LV, 1997, HUM MOL GENET, V6, P2285, DOI 10.1093/hmg/6.13.2285; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; Feng ZJ, 2010, ONCOGENE, V29, P5416, DOI 10.1038/onc.2010.282; Gao SB, 2008, ANN ENDOCRINOL-PARIS, V69, P426, DOI 10.1016/j.ando.2008.06.001; Gao SB, 2009, ONCOGENE, V28, P4095, DOI 10.1038/onc.2009.273; GUAN KL, 1994, GENE DEV, V8, P2939, DOI 10.1101/gad.8.24.2939; Henckel A, 2009, HUM MOL GENET, V18, P3375, DOI 10.1093/hmg/ddp277; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; HIRAI H, 1995, MOL CELL BIOL, V15, P2672; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jin SH, 2003, CANCER RES, V63, P4204; Jin SH, 2010, J CLIN INVEST, V120, P593, DOI 10.1172/JCI38030; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Karnik SK, 2007, SCIENCE, V318, P806, DOI 10.1126/science.1146812; Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102; Kim YS, 1999, ONCOGENE, V18, P5936, DOI 10.1038/sj.onc.1203005; Kwon O, 2010, CARCINOGENESIS, V31, P1194, DOI 10.1093/carcin/bgq071; Lin RK, 2007, LUNG CANCER, V55, P205, DOI 10.1016/j.lungcan.2006.10.022; Lin RK, 2010, J CLIN INVEST, V120, P521, DOI 10.1172/JCI40706; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; MITSUDOMI T, 1991, ONCOGENE, V6, P1353; Pei XH, 2007, CANCER RES, V67, P3162, DOI 10.1158/0008-5472.CAN-06-4517; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Risch A, 2008, INT J CANCER, V123, P1, DOI 10.1002/ijc.23605; RODENHUIS S, 1992, CANCER RES, V52, pS2665; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; Schnepp RW, 2006, CANCER RES, V66, P5707, DOI 10.1158/0008-5472.CAN-05-4518; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; SIMON MA, 1993, CELL, V73, P169, DOI 10.1016/0092-8674(93)90169-Q; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Thiel AT, 2010, CANCER CELL, V17, P148, DOI 10.1016/j.ccr.2009.12.034; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wang Y, 2011, CANCER RES, V71, P371, DOI 10.1158/0008-5472.CAN-10-3221; Xu B, 2011, J BIOL CHEM, V286, P13937, DOI 10.1074/jbc.M110.197830; Yaguchi H, 2004, MOL CELL BIOL, V24, P6569, DOI 10.1128/mcb.24.15.6569-6580.2004; Yang YM, 2010, J TAIWAN INST CHEM E, V41, P1, DOI 10.1016/j.jtice.2009.11.002; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025	45	30	34	3	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.382416	http://dx.doi.org/10.1074/jbc.M112.382416			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23027861	Green Published, hybrid			2022-12-28	WOS:000311233800067
J	Kugler, J; Schmelz, S; Gentzsch, J; Haid, S; Pollmann, E; van den Heuvel, J; Franke, R; Pietschmann, T; Heinz, DW; Collins, J				Kuegler, Jonas; Schmelz, Stefan; Gentzsch, Juliane; Haid, Sibylle; Pollmann, Erik; van den Heuvel, Joop; Franke, Raimo; Pietschmann, Thomas; Heinz, Dirk W.; Collins, John			High Affinity Peptide Inhibitors of the Hepatitis C Virus NS3-4A Protease Refractory to Common Resistant Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-PENETRATING PEPTIDES; NS4A COFACTOR PEPTIDE; DRUG-RESISTANCE; PLUS RIBAVIRIN; IN-VITRO; REPLICATION; INFECTION; TRANSDUCTION; DOMAIN; SOFTWARE	Hepatitis C virus (HCV) NS3-4A protease is essential for viral replication. All current small molecular weight drugs against NS3-4A are substrate peptidomimetics that have a similar binding and resistance profile. We developed inhibitory peptides (IPs) capping the active site and binding via a novel "tyrosine" finger at an alternative NS3-4A site that is of particular interest for further HCV drug development. The peptides are not cleaved due to a combination of geometrical constraints and impairment of the oxyanion hole function. Selection and optimization through combinatorial phagemid display, protein crystallography, and further modifications resulted in a 32-amino acid peptide with a K-i of 0.53 nM. Inhibition of viral replication in cell culture was demonstrated by fusion to a cell-penetrating peptide. Negligible susceptibility to known (A156V and R155K) resistance mutations of the NS3-4A protease was observed. This work shows for the first time that antiviral peptides can target an intracellular site and reveals a novel druggable site on the HCV protease.	[Kuegler, Jonas; Pollmann, Erik; Collins, John] Helmholtz Ctr Infect Res HZI, Res Grp Directed Evolut, D-38124 Braunschweig, Germany; [Schmelz, Stefan; van den Heuvel, Joop; Heinz, Dirk W.] Helmholtz Ctr Infect Res HZI, Dept Mol Struct Biol, D-38124 Braunschweig, Germany; [Franke, Raimo] Helmholtz Ctr Infect Res HZI, Dept Biol Chem, D-38124 Braunschweig, Germany; [Gentzsch, Juliane; Haid, Sibylle; Pietschmann, Thomas] Ctr Expt & Clin Infect Res, TWINCORE, Dept Expt Virol, D-30625 Hannover, Germany; [Collins, John] Tech Univ Carolo Wilhelmina Braunschweig, Fac Life Sci, D-38100 Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Braunschweig University of Technology	Collins, J (corresponding author), HZI, Helmholtz Ctr Infect Res, Res Grp Directed Evolut, Inhoffenstr 7, D-38124 Braunschweig, Germany.	jco@helmholtz-hzi.de	Pietschmann, Thomas/E-9241-2015	Pietschmann, Thomas/0000-0001-5138-6239; Collins, John/0000-0001-8009-4753; Franke, Raimo/0000-0002-5407-5521				Bartenschlager R, 2004, ADV VIRUS RES, V63, P71, DOI 10.1016/S0065-3527(04)63002-8; Bartenschlager R, 2000, BEST PRACT RES CL GA, V14, P241, DOI 10.1053/bega.1999.0073; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Collins J, 2001, J Biotechnol, V74, P317; de Bruijne J, 2009, VOX SANG, V97, P1, DOI 10.1111/j.1423-0410.2009.01187.x; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dimasi N, 1998, PROTEIN ENG, V11, P1257, DOI 10.1093/protein/11.12.1257; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gaudieri S, 2009, HEPATOLOGY, V49, P1069, DOI 10.1002/hep.22773; Gentile I, 2010, EXPERT OPIN INV DRUG, V19, P151, DOI 10.1517/13543780903501505; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; He Y, 2008, ANTIMICROB AGENTS CH, V52, P1101, DOI 10.1128/AAC.01149-07; Ingallinella P, 1998, BIOCHEMISTRY-US, V37, P8906, DOI 10.1021/bi980314n; Jensen DM, 2011, NEW ENGL J MED, V364, P1272, DOI 10.1056/NEJMe1100829; Johnson RM, 2011, METHODS MOL BIOL, V683, P535, DOI 10.1007/978-1-60761-919-2_38; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Landro JA, 1997, BIOCHEMISTRY-US, V36, P9340, DOI 10.1021/bi963054n; LIN C, 1995, J VIROL, V69, P4373, DOI 10.1128/JVI.69.7.4373-4380.1995; Lohmann V, 2003, J VIROL, V77, P3007, DOI 10.1128/JVI.77.5.3007-3019.2003; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Misialek S, 2009, ANAL BIOCHEM, V394, P138, DOI 10.1016/j.ab.2009.07.007; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Njoroge FG, 2008, ACCOUNTS CHEM RES, V41, P50, DOI 10.1021/ar700109k; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel LN, 2007, PHARM RES, V24, P1977, DOI 10.1007/s11095-007-9303-7; Romano KP, 2010, P NATL ACAD SCI USA, V107, P20986, DOI 10.1073/pnas.1006370107; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Sato AK, 2006, CURR OPIN BIOTECH, V17, P638, DOI 10.1016/j.copbio.2006.10.002; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Steinkuhler C, 1998, BIOCHEMISTRY-US, V37, P8899, DOI 10.1021/bi980313v; Taliani M, 1996, ANAL BIOCHEM, V240, P60, DOI 10.1006/abio.1996.0331; Tilstra J, 2007, BIOCHEM SOC T, V35, P811, DOI 10.1042/BST0350811; Tomei L, 1996, J GEN VIROL, V77, P1065, DOI 10.1099/0022-1317-77-5-1065; Urbani A, 1997, J BIOL CHEM, V272, P9204; van den Berg A, 2011, CURR OPIN BIOTECH, V22, P888, DOI 10.1016/j.copbio.2011.03.008; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Zahnd C, 2004, J BIOL CHEM, V279, P18870, DOI 10.1074/jbc.M309169200	47	13	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39224	39232		10.1074/jbc.M112.393843	http://dx.doi.org/10.1074/jbc.M112.393843			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22965230	Green Published, hybrid			2022-12-28	WOS:000310982800077
J	Ares, GR; Ortiz, PA				Ares, Gustavo R.; Ortiz, Pablo A.			Dynamin2, Clathrin, and Lipid Rafts Mediate Endocytosis of the Apical Na/K/2Cl Cotransporter NKCC2 in Thick Ascending Limbs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL NA+-K+-2CL(-) COTRANSPORTER; COATED VESICLE FORMATION; UT-A1 UREA TRANSPORTER; NA+/H+ EXCHANGER NHE3; SALT-SENSITIVE RATS; NA-K-2CL COTRANSPORTER; CHOLESTEROL DEPLETION; CONSTITUTIVE ENDOCYTOSIS; DEPENDENT ENDOCYTOSIS; SURFACE EXPRESSION	Steady- state surface levels of the apical Na/K/2Cl cotransporter NKCC2 regulate NaCl reabsorption by epithelial cells of the renal thick ascending limb (THAL). We reported that constitutive endocytosis of NKCC2 controls NaCl absorption in native THALs; however, the pathways involved in NKCC2 endocytosis are unknown. We hypothesized that NKCC2 endocytosis at the apical surface depends on dynamin-2 and clathrin. Measurements of steady-state surface NKCC2 and the rate of NKCC2 endocytosis in freshly isolated rat THALs showed that inhibition of endogenous dynamin-2 with dynasore blunted NKCC2 endocytosis by 56 +/- 11% and increased steady-state surface NKCC2 by 67 +/- 27% (p < 0.05). Expression of the dominant negative Dyn2K44A in THALs slowed the rate of NKCC2 endocytosis by 38 +/- 8% and increased steady-state surface NKCC2 by 37 +/- 8%, without changing total NKCC2 expression. Inhibition of clathrin-mediated endocytosis with chlorpromazine blunted NKCC2 endocytosis by 54 +/- 6%, while preventing clathrin from interacting with synaptojanin also blunted NKCC2 endocytosis by 52 +/- 5%. Disruption of lipid rafts blunted NKCC2 endocytosis by 39 +/- 4% and silencing caveolin-1 by 29 +/- 4%. Simultaneous inhibition of clathrin- and lipid raft-mediated endocytosis completely blocked NKCC2 internalization. We concluded that dynamin-2, clathrin, and lipid rafts mediate NKCC2 endocytosis and maintain steady-state apical surface NKCC2 in native THALs. These are the first data identifying the endocytic pathway for apical NKCC2 endocytosis.	[Ares, Gustavo R.; Ortiz, Pablo A.] Henry Ford Hosp, Dept Internal Med, Hypertens & Vasc Res Div, Detroit, MI 48202 USA; [Ortiz, Pablo A.] Wayne State Univ, Dept Physiol, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; Wayne State University	Ortiz, PA (corresponding author), Henry Ford Hosp, Dept Internal Med, Hypertens & Vasc Res Div, 2799 W Grand Blvd, Detroit, MI 48202 USA.	portiz1@hfhs.org		Ortiz, Pablo/0000-0002-7512-7255	National Institutes of Health [R0-1 HL080409]; American Heart Association [0715579Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080409] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R0-1 HL080409 (to P. A. O.).; Supported in part by a Predoctoral Fellowship Grant 0715579Z from the American Heart Association.	Ares GR, 2008, AM J PHYSIOL-RENAL, V295, pF877, DOI 10.1152/ajprenal.00449.2007; Ares GR, 2010, AM J PHYSIOL-RENAL, V299, pF1193, DOI 10.1152/ajprenal.00307.2010; Aviv A, 2004, HYPERTENSION, V43, P707, DOI 10.1161/01.HYP.0000120155.48024.6f; Benziane B, 2007, J BIOL CHEM, V282, P33817, DOI 10.1074/jbc.M700195200; Bosch B, 2008, ANTIVIR RES, V80, P185, DOI 10.1016/j.antiviral.2008.06.004; Bullis BL, 2002, EUR J BIOCHEM, V269, P4887, DOI 10.1046/j.1432-1033.2002.03202.x; Caceres PS, 2009, J BIOL CHEM, V284, P24965, DOI 10.1074/jbc.M109.037135; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Cao H, 2007, J CELL SCI, V120, P4167, DOI 10.1242/jcs.010686; Cao H, 2010, MOL CELL BIOL, V30, P781, DOI 10.1128/MCB.00330-09; Chan SA, 2003, J PHYSIOL-LONDON, V553, P707, DOI 10.1113/jphysiol.2003.053918; Chen JJ, 2007, ARTERIOSCL THROM VAS, V27, P2005, DOI 10.1161/ATVBAHA.107.145961; Cheng ZJ, 2010, J BIOL CHEM, V285, P15119, DOI 10.1074/jbc.M109.069427; Chow CW, 1999, J BIOL CHEM, V274, P37551, DOI 10.1074/jbc.274.53.37551; Chun TY, 2008, HYPERTENSION, V52, P241, DOI 10.1161/HYPERTENSIONAHA.108.109801; Collazo R, 2000, J BIOL CHEM, V275, P31601, DOI 10.1074/jbc.M000600200; COOK TA, 1994, P NATL ACAD SCI USA, V91, P644, DOI 10.1073/pnas.91.2.644; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Ecelbarger CA, 1996, AM J PHYSIOL-RENAL, V271, pF619, DOI 10.1152/ajprenal.1996.271.3.F619; Feng XY, 2009, AM J PHYSIOL-RENAL, V296, pF1514, DOI 10.1152/ajprenal.00068.2009; Fulop T, 2008, ARCH BIOCHEM BIOPHYS, V477, P146, DOI 10.1016/j.abb.2008.04.039; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gundelfinger ED, 2003, NAT REV MOL CELL BIO, V4, P127, DOI 10.1038/nrm1016; Hansen GH, 2000, J BIOL CHEM, V275, P5136, DOI 10.1074/jbc.275.7.5136; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Hoagland KM, 2004, HYPERTENSION, V43, P860, DOI 10.1161/01.HYP.0000120123.44945.47; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Hryciw DH, 2004, J BIOL CHEM, V279, P54996, DOI 10.1074/jbc.M411491200; Huang HD, 2010, AM J PHYSIOL-RENAL, V299, pF1389, DOI 10.1152/ajprenal.00718.2009; Inoue M, 2004, J BIOL CHEM, V279, P49160, DOI 10.1074/jbc.M408942200; Karpushev AV, 2008, BIOCHEM BIOPH RES CO, V377, P521, DOI 10.1016/j.bbrc.2008.10.014; KIRCHNER KA, 1990, J AM SOC NEPHROL, V1, P180; KIRCHNER KA, 1992, AM J PHYSIOL, V262, pR263, DOI 10.1152/ajpregu.1992.262.2.R263; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Le PU, 2002, J BIOL CHEM, V277, P3371, DOI 10.1074/jbc.M111240200; Li XH, 2001, J PHYSIOL-LONDON, V537, P537, DOI 10.1111/j.1469-7793.2001.00537.x; Lukacs GL, 1997, BIOCHEM J, V328, P353; Lundmark R, 2004, J BIOL CHEM, V279, P42694, DOI 10.1074/jbc.M407430200; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; Nevins AK, 2006, J BIOL CHEM, V281, P18961, DOI 10.1074/jbc.M603604200; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Nielsen S, 1998, AM J PHYSIOL-RENAL, V275, pF885, DOI 10.1152/ajprenal.1998.275.6.F885; Obermuller N, 1996, J CLIN INVEST, V98, P635, DOI 10.1172/JCI118834; Okamoto PM, 1997, J BIOL CHEM, V272, P11629; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; Ortiz PA, 2006, AM J PHYSIOL-RENAL, V290, pF608, DOI 10.1152/ajprenal.00248.2005; Ortiz PA, 2003, HYPERTENSION, V42, P674, DOI 10.1161/01.HYP.0000085561.00001.81; Ortiz PA, 2003, KIDNEY INT, V63, P1141, DOI 10.1046/j.1523-1755.2003.00827.x; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Parpal S, 2001, J BIOL CHEM, V276, P9670, DOI 10.1074/jbc.M007454200; Pressler CA, 2006, J AM SOC NEPHROL, V17, P2136, DOI 10.1681/ASN.2005101071; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; Rangarajan ES, 2010, J BIOL CHEM, V285, P11983, DOI 10.1074/jbc.M109.092049; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; Sonalker PA, 2004, J PHARMACOL EXP THER, V311, P1052, DOI 10.1124/jpet.104.071209; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Starremans PGJF, 2003, J AM SOC NEPHROL, V14, P1419, DOI 10.1097/01.ASN.0000064948.39199.A0; Subramanya AR, 2009, J BIOL CHEM, V284, P18471, DOI 10.1074/jbc.M109.008185; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Sun TX, 2002, AM J PHYSIOL-RENAL, V282, pF998, DOI 10.1152/ajprenal.00257.2001; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Weder AB, 2009, HYPERTENSION, V53, P715, DOI 10.1161/HYPERTENSIONAHA.108.121665; Welker P, 2008, AM J PHYSIOL-RENAL, V295, pF789, DOI 10.1152/ajprenal.90227.2008; Weller SG, 2010, P NATL ACAD SCI USA, V107, P5863, DOI 10.1073/pnas.0915123107; Yu MJ, 2008, AM J PHYSIOL-CELL PH, V295, pC661, DOI 10.1152/ajpcell.90650.2007	78	38	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.386425	http://dx.doi.org/10.1074/jbc.M112.386425			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22977238	hybrid, Green Published			2022-12-28	WOS:000310642200020
J	Bosch, D; Saiardi, A				Bosch, Daniel; Saiardi, Adolfo			Arginine Transcriptional Response Does Not Require Inositol Phosphate Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPHOSPHATE KINASE-ACTIVITY; ACTIVATED PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; STRESS TOLERANCE; GENE-EXPRESSION; HUMAN HOMOLOG; IN-VITRO; MULTIKINASE; YEAST; METABOLISM	Inositol phosphates are key signaling molecules affecting a large variety of cellular processes. Inositol-polyphosphate multikinase (IPMK) is a central component of the inositol phosphate biosynthetic routes, playing essential roles during development. IPMK phosphorylates inositol 1,4,5-trisphosphate to inositol tetrakisphosphate and subsequently to inositol pentakisphosphate and has also been described to function as a lipid kinase. Recently, a catalytically inactive mammalian IPMK was reported to be involved in nutrient signaling by way of mammalian target of rapamycin and AMP-activated protein kinase. In yeast, the IPMK homologue, Arg82, is the sole inositol-trisphosphate kinase. Arg82 has been extensively studied as part of the transcriptional complex regulating nitrogen sensing, in particular arginine metabolism. Whether this role requires Arg82 catalytic activity has long been a matter of contention. In this study, we developed a novel method for the real time study of promoter strength in vivo and used it to demonstrate that catalytically inactive Arg82 fully restored the arginine-dependent transcriptional response. We also showed that expression in yeast of catalytically active, but structurally very different, mammalian or plant IPMK homologue failed to restore arginine regulation. Our work indicates that inositol phosphates do not regulate arginine-dependent gene expression.	[Saiardi, Adolfo] UCL, MRC LMCB, Cell Biol Unit, London WC1E 6BT, England; UCL, Dept Cell & Dev Biol, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Saiardi, A (corresponding author), UCL, MRC LMCB, Cell Biol Unit, Gower St, London WC1E 6BT, England.	dmcbado@ucl.ac.uk			Medical Research Council, Cell Biology Unit; MRC [MC_U122680443] Funding Source: UKRI; Medical Research Council [MC_U122680443] Funding Source: researchfish	Medical Research Council, Cell Biology Unit; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council funding of the Cell Biology Unit.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Alcazar-Roman AR, 2008, CHROMOSOMA, V117, P1, DOI 10.1007/s00412-007-0126-4; Bang S, 2012, P NATL ACAD SCI USA, V109, P616, DOI 10.1073/pnas.1119751109; BECHET J, 1970, EUR J BIOCHEM, V12, P31, DOI 10.1111/j.1432-1033.1970.tb00817.x; BERCY J, 1987, GENE, V55, P277, DOI 10.1016/0378-1119(87)90287-3; Blind RD, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003111; BORRELLI E, 1988, P NATL ACAD SCI USA, V85, P7572, DOI 10.1073/pnas.85.20.7572; Burton A, 2009, J CELL PHYSIOL, V220, P8, DOI 10.1002/jcp.21763; Caddick SEK, 2007, BIOCHEM J, V403, P381, DOI 10.1042/BJ20061772; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Chan TF, 2000, P NATL ACAD SCI USA, V97, P13227, DOI 10.1073/pnas.240444197; Chang SC, 2002, J BIOL CHEM, V277, P43836, DOI 10.1074/jbc.M206134200; DAVIS RH, 1986, MICROBIOL REV, V50, P280, DOI 10.1128/MMBR.50.3.280-313.1986; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; DUBOIS E, 1991, MOL CELL BIOL, V11, P2162, DOI 10.1128/MCB.11.4.2162; Dubois E, 2000, FEBS LETT, V486, P300, DOI 10.1016/S0014-5793(00)02318-8; DURR M, 1979, ARCH MICROBIOL, V121, P169, DOI 10.1007/BF00689982; El Alami M, 2003, MOL MICROBIOL, V49, P457, DOI 10.1046/j.1365-2958.2003.03562.x; El Bakkoury M, 2000, MOL MICROBIOL, V35, P15, DOI 10.1046/j.1365-2958.2000.01665.x; Frederick JP, 2005, P NATL ACAD SCI USA, V102, P8454, DOI 10.1073/pnas.0503706102; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Hsieh CH, 2006, NUCL MED BIOL, V33, P653, DOI 10.1016/j.nucmedbio.2006.04.001; Ikai N, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110007; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; JONSSON JJ, 1991, ANAL BIOCHEM, V199, P232, DOI 10.1016/0003-2697(91)90095-B; Kim S, 2011, CELL METAB, V13, P215, DOI 10.1016/j.cmet.2011.01.007; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Lonetti A, 2011, J BIOL CHEM, V286, P31966, DOI 10.1074/jbc.M111.266320; Maag D, 2011, P NATL ACAD SCI USA, V108, P1391, DOI 10.1073/pnas.1017831108; MESSENGUY F, 1993, MOL CELL BIOL, V13, P2586, DOI 10.1128/MCB.13.4.2586; Meyer R, 2012, BIOL CHEM, V393, P149, DOI 10.1515/hsz-2011-0209; MICHELL RH, 1981, PHILOS T R SOC B, V296, P123, DOI 10.1098/rstb.1981.0177; Monserrate JP, 2010, CURR OPIN CELL BIOL, V22, P365, DOI 10.1016/j.ceb.2010.03.006; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Nalaskowski MM, 2002, BIOCHEM J, V366, P549, DOI 10.1042/BJ20020327; Odom AR, 2000, SCIENCE, V287, P2026, DOI 10.1126/science.287.5460.2026; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Resnick A. C., 2009, WILEY ENCY CHEM BIOL, V2, P349, DOI [10.1002/9780470048672.wecb252, DOI 10.1002/9780470048672.WECB252]; Resnick AC, 2005, P NATL ACAD SCI USA, V102, P12783, DOI 10.1073/pnas.0506184102; Resnick AC, 2008, FRONT BIOSCI-LANDMRK, V13, P856, DOI 10.2741/2726; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2002, P NATL ACAD SCI USA, V99, P14206, DOI 10.1073/pnas.212527899; Saiardi Adolfo, 2012, Advances in Biological Regulation, V52, P351, DOI 10.1016/j.jbior.2012.03.002; Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018; Seeds AM, 2005, J BIOL CHEM, V280, P27654, DOI 10.1074/jbc.M505089200; Smith JJ, 2008, EUKARYOT CELL, V7, P471, DOI 10.1128/EC.00409-07; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Stevenson-Paulik J, 2002, J BIOL CHEM, V277, P42711, DOI 10.1074/jbc.M209112200; Suzuki M, 2007, GENE, V405, P55, DOI 10.1016/j.gene.2007.09.006; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Warringer J, 2003, P NATL ACAD SCI USA, V100, P15724, DOI 10.1073/pnas.2435976100; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; Watson PJ, 2012, NATURE, V481, P335, DOI 10.1038/nature10728; Wu RH, 2011, NAT METHODS, V8, P677, DOI [10.1038/nmeth.1636, 10.1038/NMETH.1636]; Xia HJ, 2003, PLANT CELL, V15, P449, DOI 10.1105/tpc.006676; Yaghoubi SS, 2006, NAT PROTOC, V1, P2137, DOI 10.1038/nprot.2006.334; Yang L, 2008, PLANT MOL BIOL, V66, P329, DOI 10.1007/s11103-007-9267-3; Zhu JQ, 2009, PHYSIOL PLANTARUM, V136, P407, DOI 10.1111/j.1399-3054.2009.01235.x	58	22	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.384255	http://dx.doi.org/10.1074/jbc.M112.384255			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22992733	Green Published, hybrid			2022-12-28	WOS:000310642200067
J	Greenfield, LK; Richards, MR; Vinogradov, E; Wakarchuk, WW; Lowary, TL; Whitfield, C				Greenfield, Laura K.; Richards, Michele R.; Vinogradov, Evgeny; Wakarchuk, Warren W.; Lowary, Todd L.; Whitfield, Chris			Domain Organization of the Polymerizing Mannosyltransferases Involved in Synthesis of the Escherichia coli O8 and O9a Lipopolysaccharide O-antigens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE PREDICTION; 2 ACTIVE-SITES; PASTEURELLA-MULTOCIDA; BIOCHEMICAL-CHARACTERIZATION; CRYSTAL-STRUCTURE; GENE-CLUSTER; SACCHAROMYCES-CEREVISIAE; KLEBSIELLA-PNEUMONIAE; POLYSACCHARIDE CHAIN; POLYACRYLAMIDE GELS	The Escherichia coli O9a and O8 polymannose O-polysaccharides (O-PSs) serve as model systems for the biosynthesis of bacterial polysaccharides by ATP-binding cassette transporter-dependent pathways. Both O-PSs contain a conserved primer-adaptor domain at the reducing terminus and a serotype-specific repeat unit domain. The repeat unit domain is polymerized by the serotype-specific WbdA mannosyltransferase. In serotype O9a, WbdA is a bifunctional alpha-(1 -> 2)-, alpha-(1 -> 3)-mannosyltransferase, and its counterpart in serotype O8 is trifunctional (alpha-(1 -> 2), alpha-(1 -> 3), and beta-(1 -> 2)). Little is known about the detailed structures or mechanisms of action of the WbdA polymerases, and here we establish that they are multidomain enzymes. WbdA(O9a) contains two separable and functionally active domains, whereas WbdA(O8) possesses three. In WbdC(O9a) and WbdB(O9a), substitution of the first Glu of the EX7E motif had detrimental effects on the enzyme activity, whereas substitution of the second had no significant effect on activity in vivo. Mutation of the Glu residues in the EX7E motif of the N-terminal WbdA(O9a) domain resulted in WbdA variants unable to synthesize O-PS. In contrast, mutation of the Glu residues in the motif of the C-terminal WbdA(O9a) domain generated an enzyme capable of synthesizing an altered O-PS repeat unit consisting of only alpha-(1 -> 2) linkages. In vitro assays with synthetic acceptors unequivocally confirmed that the N-terminal domain of WbdA(O9a) possesses alpha-(1 -> 2)-mannosyltransferase activity. Together, these studies form a framework for detailed structure-function studies on individual domains and a strategy applicable for dissection and analysis of other multidomain glycosyltransferases.	[Greenfield, Laura K.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Richards, Michele R.; Lowary, Todd L.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Richards, Michele R.; Lowary, Todd L.] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB T6G 2G2, Canada; [Vinogradov, Evgeny; Wakarchuk, Warren W.] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of Guelph; University of Alberta; University of Alberta; National Research Council Canada	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Sci Complex, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca	Wakarchuk, Warren/Q-9514-2017; Wakarchuk, Warren/AAO-2774-2020; Lowary, Todd L/F-9608-2019; Richards, Mickey/E-8140-2011	Wakarchuk, Warren/0000-0002-1539-1679; Wakarchuk, Warren/0000-0002-1539-1679; Lowary, Todd L/0000-0002-8331-8211; Richards, Mickey/0000-0002-1973-5678; Vinogradov, Evgeny/0000-0002-5364-1376	Natural Sciences and Engineering Research Council; Alberta Glycomics Centre; Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council; Alberta Innovates Health Solutions Ph.D. Studentship	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Glycomics Centre; Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council; Alberta Innovates Health Solutions Ph.D. Studentship	This work was supported in part by grants from the Natural Sciences and Engineering Research Council (to C. W. and T. L. L.) and by the Alberta Glycomics Centre (to T. L. L.); Recipient of an Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council.; Recipient of an Alberta Innovates Health Solutions Ph.D. Studentship.	Abdian PL, 2000, J BIOL CHEM, V275, P40568, DOI 10.1074/jbc.M007496200; Absmanner B, 2010, BIOCHEM J, V426, P205, DOI 10.1042/BJ20091121; ALEXANDER DC, 1994, J BACTERIOL, V176, P7079, DOI 10.1128/JB.176.22.7079-7084.1994; Batt SM, 2010, J BIOL CHEM, V285, P37741, DOI 10.1074/jbc.M110.165407; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; BREW K, 1968, P NATL ACAD SCI USA, V59, P491, DOI 10.1073/pnas.59.2.491; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chavaroche AAE, 2012, APPL MICROBIOL BIOT, V95, P1199, DOI 10.1007/s00253-011-3813-2; Chavaroche AAE, 2011, J BIOL CHEM, V286, P1777, DOI 10.1074/jbc.M110.136754; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Chua TK, 2008, PLANT CELL, V20, P1059, DOI 10.1105/tpc.107.051193; Cid E, 2000, J BIOL CHEM, V275, P33614, DOI 10.1074/jbc.M005358200; Cieslewicz M, 1997, MOL MICROBIOL, V26, P237, DOI 10.1046/j.1365-2958.1997.5651942.x; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Clarke BR, 2011, J BIOL CHEM, V286, P41391, DOI 10.1074/jbc.M111.295857; Clarke BR, 2009, J BIOL CHEM, V284, P30662, DOI 10.1074/jbc.M109.052878; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Cuthbertson L, 2010, MICROBIOL MOL BIOL R, V74, P341, DOI 10.1128/MMBR.00009-10; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Geremia RA, 1996, BIOCHEM J, V318, P133, DOI 10.1042/bj3180133; Glover KJ, 2005, P NATL ACAD SCI USA, V102, P14255, DOI 10.1073/pnas.0507311102; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Greenfield LK, 2012, J BIOL CHEM, V287, P35078, DOI 10.1074/jbc.M112.401000; Greenfield LK, 2012, CARBOHYD RES, V356, P12, DOI 10.1016/j.carres.2012.02.027; Griffiths G, 1998, J BIOL CHEM, V273, P11752, DOI 10.1074/jbc.273.19.11752; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hagelueken G., 2012, MOL MICROBI IN PRESS; Hashimoto K, 2010, J MOL BIOL, V399, P196, DOI 10.1016/j.jmb.2010.03.059; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Hodson N, 2000, J BIOL CHEM, V275, P27311; Hou DJ, 2008, CARBOHYD RES, V343, P1778, DOI 10.1016/j.carres.2008.02.025; JANN K, 1979, BIOCHEM BIOPH RES CO, V86, P1185, DOI 10.1016/0006-291X(79)90242-0; JANN K, 1982, EUR J BIOCHEM, V127, P157, DOI 10.1111/j.1432-1033.1982.tb06850.x; JANSSON PE, 1985, CARBOHYD RES, V145, P59, DOI 10.1016/S0008-6215(00)90412-9; Jansson PE, 2006, CARBOHYD RES, V341, P1003, DOI 10.1016/j.carres.2006.02.034; Jing W, 2000, GLYCOBIOLOGY, V10, P883, DOI 10.1093/glycob/10.9.883; Jing W, 2003, GLYCOBIOLOGY, V13, P661, DOI 10.1093/glycob/cwg085; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kampf M, 2009, J BIOL CHEM, V284, P11900, DOI 10.1074/jbc.M806416200; Kane TA, 2006, J BIOL CHEM, V281, P33192, DOI 10.1074/jbc.M606897200; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kido N, 1998, MOL MICROBIOL, V27, P1213, DOI 10.1046/j.1365-2958.1998.00765.x; KIDO N, 1995, J BACTERIOL, V177, P2178, DOI 10.1128/jb.177.8.2178-2187.1995; Kido N, 2000, J BACTERIOL, V182, P2567, DOI 10.1128/JB.182.9.2567-2573.2000; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Kostova Z, 2003, EUR J BIOCHEM, V270, P4507, DOI 10.1046/j.1432-1033.2003.03844.x; Kubler-Kielb J, 2012, CARBOHYD RES, V347, P186, DOI 10.1016/j.carres.2011.11.019; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SJ, 2011, PROTEINS, V79, P2321, DOI 10.1002/prot.23038; Liu CJ, 2007, CARBOHYD RES, V342, P2818, DOI 10.1016/j.carres.2007.08.020; Lundborg M, 2011, ANAL CHEM, V83, P1514, DOI 10.1021/ac1032534; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; MEIERDIETER U, 1990, J BIOL CHEM, V265, P13490; Miller J. H., 1972, EXPT MOL GENETICS, P432; ORSKOV I, 1977, BACTERIOL REV, V41, P667, DOI 10.1128/MMBR.41.3.667-710.1977; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; PAROLIS LAS, 1986, CARBOHYD RES, V155, P272, DOI 10.1016/S0008-6215(00)90158-7; Parsonage D, 2010, BIOCHEMISTRY-US, V49, P8398, DOI 10.1021/bi100698n; PREHM P, 1976, EUR J BIOCHEM, V67, P53, DOI 10.1111/j.1432-1033.1976.tb10631.x; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RESKE K, 1972, EUR J BIOCHEM, V31, P320, DOI 10.1111/j.1432-1033.1972.tb02536.x; RICK PD, 1994, J BACTERIOL, V176, P2877, DOI 10.1128/JB.176.10.2877-2884.1994; Ruane KM, 2008, PROTEINS, V73, P784, DOI 10.1002/prot.22171; SAEKI A, 1993, MICROBIOL IMMUNOL, V37, P601, DOI 10.1111/j.1348-0421.1993.tb01682.x; SCHANBAC.FL, 1970, J BIOL CHEM, V245, P5057; Shatzman A. R., 2001, CURRENT PROTOCOLS MO; Sobhany M, 2008, J BIOL CHEM, V283, P32328, DOI 10.1074/jbc.M804332200; Sobhany M, 2012, J BIOL CHEM, V287, P36022, DOI 10.1074/jbc.M112.375873; Sperandeo P, 2009, BBA-MOL CELL BIOL L, V1791, P594, DOI 10.1016/j.bbalip.2009.01.011; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; Sugiura N, 2010, J BIOL CHEM, V285, P1597, DOI 10.1074/jbc.M109.023002; Troutman JM, 2009, BIOCHEMISTRY-US, V48, P2807, DOI 10.1021/bi802284d; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vetting MW, 2008, J BIOL CHEM, V283, P15834, DOI 10.1074/jbc.M801017200; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; Woo EJ, 2010, J MOL BIOL, V404, P247, DOI 10.1016/j.jmb.2010.09.056; Xiang Y, 2010, J VIROL, V84, P12265, DOI 10.1128/JVI.01303-10; Zheng Y, 2011, J BIOL CHEM, V286, P36108, DOI 10.1074/jbc.M111.275974	87	30	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.412577	http://dx.doi.org/10.1074/jbc.M112.412577			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22989876	hybrid, Green Published			2022-12-28	WOS:000310642200047
J	Bauer, M; Chicca, A; Tamborrini, M; Eisen, D; Lerner, R; Lutz, B; Poetz, O; Pluschke, G; Gertsch, J				Bauer, Mark; Chicca, Andrea; Tamborrini, Marco; Eisen, David; Lerner, Raissa; Lutz, Beat; Poetz, Oliver; Pluschke, Gerd; Gertsch, Juerg			Identification and Quantification of a New Family of Peptide Endocannabinoids (Pepcans) Showing Negative Allosteric Modulation at CB1 Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECTROMETRY-BASED QUANTIFICATION; HEMOGLOBIN-DERIVED PEPTIDES; CANNABINOID CB1; ADENYLATE-CYCLASE; SIGNAL-TRANSDUCTION; MOUSE-BRAIN; INHIBITION; AGONIST; BINDING; PHARMACOLOGY	The alpha-hemoglobin-derived dodecapeptide RVD-hemopressin (RVDPVNFKLLSH) has been proposed to be an endogenous agonist for the cannabinoid receptor type 1 (CB1). To study this peptide, we have raised mAbs against its C-terminal part. Using an immunoaffinity mass spectrometry approach, a whole family of N-terminally extended peptides in addition to RVD-Hp alpha were identified in rodent brain extracts and human and mouse plasma. We designated these peptides Pepcan-12 (RVDPVNFKLLSH) to Pepcan-23 (SALSDLHAHKLRVDPVNFKLLSH), referring to peptide length. The most abundant Pepcans found in the brain were tested for CB1 receptor binding. In the classical radioligand displacement assay, Pepcan-12 was the most efficacious ligand but only partially displaced both [H-3] CP55,940 and [H-3] WIN55,212-2. The data were fitted with the allosteric ternary complex model, revealing a cooperativity factor value alpha < 1, thus indicating a negative allosteric modulation. Dissociation kinetic studies of [3H] CP55,940 in the absence and presence of Pepcan-12 confirmed these results by showing increased dissociation rate constants induced by Pepcan-12. A fluorescently labeled Pepcan-12 analog was synthesized to investigate the binding to CB1 receptors. Competition binding studies revealed K-t values of several Pepcans in the nanomolar range. Accordingly, using competitive ELISA, we found low nanomolar concentrations of Pepcans in human plasma and similar to 100 pmol/g in mouse brain. Surprisingly, Pepcan-12 exhibited potent negative allosteric modulation of the orthosteric agonist-induced cAMP accumulation, [S-35] GTP gamma S binding, and CB1 receptor internalization. Pepcans are the first endogenous allosteric modulators identified forCB(1) receptors. Given their abundance in the brain, Pepcans could play an important physiological role in modulating endocannabinoid signaling.	[Bauer, Mark; Chicca, Andrea; Gertsch, Juerg] Univ Bern, Inst Biochem & Mol Med, Natl Ctr Competence Res TransCure, CH-3012 Bern, Switzerland; [Bauer, Mark; Tamborrini, Marco; Pluschke, Gerd] Univ Basel, CH-4003 Basel, Switzerland; [Bauer, Mark; Tamborrini, Marco; Pluschke, Gerd] Swiss Trop & Publ Hlth Inst, CH-4002 Basel, Switzerland; [Eisen, David; Poetz, Oliver] Univ Tubingen, Nat & Med Sci Inst, D-72770 Reutlingen, Germany; [Lerner, Raissa; Lutz, Beat] Johannes Gutenberg Univ Mainz, Inst Physiol Chem, Univ Med Ctr, D-55128 Mainz, Germany	University of Bern; University of Basel; University of Basel; Swiss Tropical & Public Health Institute; Eberhard Karls University of Tubingen; Johannes Gutenberg University of Mainz	Gertsch, J (corresponding author), Univ Bern, Inst Biochem & Mol Med, Natl Ctr Competence Res TransCure, Buhlstr 28, CH-3012 Bern, Switzerland.	gertsch@ibmm.unibe.ch	Lutz, Beat/AFK-6229-2022; Lutz, Beat/AAG-4538-2022; Chicca, Andrea/AAP-7156-2020	Gertsch, Jurg/0000-0003-0978-1555; Chicca, Andrea/0000-0001-9593-636X	Swiss National Science Foundation [31003A_141174/1]; National Center of Competence in Research TransCure; University of Bern Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research TransCure; University of Bern Research Foundation	This work was supported by Swiss National Science Foundation Grant 31003A_141174/1 (to J. G.), the National Center of Competence in Research TransCure, and the University of Bern Research Foundation.	Abadji V, 1999, J NEUROCHEM, V72, P2032, DOI 10.1046/j.1471-4159.1999.0722032.x; Anderson NL, 2004, J PROTEOME RES, V3, P235, DOI 10.1021/pr034086h; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; Bazinet RP, 2005, NEUROCHEM RES, V30, P597, DOI 10.1007/s11064-005-2746-5; Bonhaus DW, 1998, J PHARMACOL EXP THER, V287, P884; Calandra B, 1999, EUR J PHARMACOL, V374, P445, DOI 10.1016/S0014-2999(99)00349-0; Che FY, 2005, MOL CELL PROTEOMICS, V4, P1391, DOI 10.1074/mcp.T500010-MCP200; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chicca A, 2012, BRIT J PHARMACOL, V167, P1596, DOI 10.1111/j.1476-5381.2012.02059.x; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; DeSilva B, 2003, PHARM RES-DORDR, V20, P1885, DOI 10.1023/B:PHAM.0000003390.51761.3d; Devlin MG, 2007, J PEPT SCI, V13, P856, DOI 10.1002/psc.912; Devlin MG, 2002, J NEUROCHEM, V80, P1095, DOI 10.1046/j.0022-3042.2002.00797.x; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Dodd GT, 2010, J NEUROSCI, V30, P7369, DOI 10.1523/JNEUROSCI.5455-09.2010; Dufield DR, 2012, METHODS, V56, P236, DOI 10.1016/j.ymeth.2011.08.012; Eglen RM, 2011, PHARMACEUTICALS, V4, P244, DOI 10.3390/ph4020244; Felder CC, 1998, J PHARMACOL EXP THER, V284, P291; FELDER CC, 1992, MOL PHARMACOL, V42, P838; Fowler CJ, 2008, CURR PHARM DESIGN, V14, P2254, DOI 10.2174/138161208785740126; Gelman JS, 2010, J NEUROCHEM, V113, P871, DOI 10.1111/j.1471-4159.2010.06653.x; Gertsch J, 2008, P NATL ACAD SCI USA, V105, P9099, DOI 10.1073/pnas.0803601105; Glass M, 1997, J NEUROSCI, V17, P5327, DOI 10.1523/jneurosci.17-14-05327.1997; Gomes I, 2010, AAPS J, V12, P658, DOI 10.1208/s12248-010-9217-x; Gomes I, 2009, FASEB J, V23, P3020, DOI 10.1096/fj.09-132142; Hanus LO, 2009, MED RES REV, V29, P213, DOI 10.1002/med.20135; Heimann AS, 2007, P NATL ACAD SCI USA, V104, P20588, DOI 10.1073/pnas.0706980105; Hoeppe S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002857; Horswill JG, 2007, BRIT J PHARMACOL, V152, P805, DOI 10.1038/sj.bjp.0707347; HOWLETT AC, 1988, MOL PHARMACOL, V33, P297; HOWLETT AC, 1984, MOL PHARMACOL, V26, P532; HOWLETT AC, 1986, MOL PHARMACOL, V29, P307; Howlett AC, 2000, CHEM PHYS LIPIDS, V108, P53, DOI 10.1016/S0009-3084(00)00187-0; Hsieh C, 1999, J NEUROCHEM, V73, P493, DOI 10.1046/j.1471-4159.1999.0730493.x; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Kleyer J, 2012, BIOCHEM PHARMACOL, V83, P1393, DOI 10.1016/j.bcp.2012.02.014; Kurzeder C, 2007, INT J MOL MED, V19, P325; Leach K, 2011, CURR PROTOC PHARM; Leonti M, 2010, BIOCHEM PHARMACOL, V79, P1815, DOI 10.1016/j.bcp.2010.02.015; Litschig S, 1999, MOL PHARMACOL, V55, P453; LUNELLI L, 1994, BIOPOLYMERS, V34, P747, DOI 10.1002/bip.360340607; Mackie K, 2006, ANNU REV PHARMACOL, V46, P101, DOI 10.1146/annurev.pharmtox.46.120604.141254; Maneuf YP, 1997, BRIT J PHARMACOL, V120, P1397, DOI 10.1038/sj.bjp.0701101; Maple L, 2004, J IMMUNOL METHODS, V295, P169, DOI 10.1016/j.jim.2004.09.012; Massa F, 2010, J NEUROSCI, V30, P6273, DOI 10.1523/JNEUROSCI.2648-09.2010; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; MRABET NT, 1986, J BIOL CHEM, V261, P1111; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Navarro HA, 2009, BRIT J PHARMACOL, V156, P1178, DOI 10.1111/j.1476-5381.2009.00124.x; Neubig RR, 2003, PHARMACOL REV, V55, P597, DOI 10.1124/pr.55.4.4; Nicol GR, 2008, MOL CELL PROTEOMICS, V7, P1974, DOI 10.1074/mcp.M700476-MCP200; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pertwee RG, 2005, HANDB EXP PHARMACOL, V168, P1; Piscitelli F, 2012, J MED CHEM, V55, P5627, DOI 10.1021/jm201485c; Poetz O, 2005, PROTEOMICS, V5, P2402, DOI 10.1002/pmic.200401299; Poetz O, 2009, PROTEOMICS, V9, P1518, DOI 10.1002/pmic.200800842; Price MR, 2005, MOL PHARMACOL, V68, P1484, DOI 10.1124/mol.105.016162; Raduner S, 2006, J BIOL CHEM, V281, P14192, DOI 10.1074/jbc.M601074200; Reggio PH, 2005, HANDB EXP PHARMACOL, V168, P247; Ross RA, 2007, TRENDS PHARMACOL SCI, V28, P567, DOI 10.1016/j.tips.2007.10.006; Scrima M, 2010, BIOCHEMISTRY-US, V49, P10449, DOI 10.1021/bi1011833; Skold K, 2007, PROTEOMICS, V7, P4445, DOI 10.1002/pmic.200700142; Tamborrini M, 2006, ANGEW CHEM INT EDIT, V45, P6581, DOI 10.1002/anie.200602048; Tamborrini M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-314; Urwyler S, 2001, MOL PHARMACOL, V60, P963, DOI 10.1124/mol.60.5.963; Watson C, 2005, MOL PHARMACOL, V67, P1268, DOI 10.1124/mol.104.008565; Whiteaker JR, 2007, ANAL BIOCHEM, V362, P44, DOI 10.1016/j.ab.2006.12.023; Whiteaker JR, 2010, MOL CELL PROTEOMICS, V9, P184, DOI 10.1074/mcp.M900254-MCP200; Zahn K, 2002, J PHARMACOL EXP THER, V301, P720, DOI 10.1124/jpet.301.2.720; Zhou HZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006087	73	124	128	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36944	36967		10.1074/jbc.M112.382481	http://dx.doi.org/10.1074/jbc.M112.382481			24	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22952224	hybrid, Green Published			2022-12-28	WOS:000310588500031
J	Horvath, SE; Bottinger, L; Vogtle, FN; Wiedemann, N; Meisinger, C; Becker, T; Daum, G				Horvath, Susanne E.; Boettinger, Lena; Voegtle, F. -Nora; Wiedemann, Nils; Meisinger, Chris; Becker, Thomas; Daum, Guenther			Processing and Topology of the Yeast Mitochondrial Phosphatidylserine Decarboxylase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHETIC LETHAL INTERACTION; SACCHAROMYCES-CEREVISIAE; PROTEIN-IMPORT; BIOCHEMICAL-CHARACTERIZATION; CARDIOLIPIN BIOSYNTHESIS; PREPROTEIN TRANSLOCASE; PHOSPHOLIPID-SYNTHESIS; DIFFERENT PATHWAYS; MEMBRANE-PROTEINS; NULL ALLELE	The inner mitochondrial membrane plays a crucial role in cellular lipid homeostasis through biosynthesis of the non-bilayer-forming lipids phosphatidylethanolamine and cardiolipin. In the yeast Saccharomyces cerevisiae, the majority of cellular phosphatidylethanolamine is synthesized by the mitochondrial phosphatidylserine decarboxylase 1 (Psd1). The biogenesis of Psd1 involves several processing steps. It was speculated that the Psd1 precursor is sorted into the inner membrane and is subsequently released into the intermembrane space by proteolytic removal of a hydrophobic sorting signal. However, components involved in the maturation of the Psd1 precursor have not been identified. We show that processing of Psd1 involves the action of the mitochondrial processing peptidase and Oct1 and an autocatalytic cleavage at a highly conserved LGST motif yielding the alpha- and beta-subunit of the enzyme. The Psd1 beta-subunit (Psd1 beta) forms the membrane anchor, which binds the intermembrane space-localized alpha-subunit (Psd1 alpha). Deletion of a transmembrane segment in the beta-subunit results in mislocalization of Psd1 and reduced enzymatic activity. Surprisingly, autocatalytic cleavage does not depend on proper localization to the inner mitochondrial membrane. In summary, membrane integration of Psd1 is crucial for its functionality and for maintenance of mitochondrial lipid homeostasis.	[Horvath, Susanne E.; Boettinger, Lena; Voegtle, F. -Nora; Wiedemann, Nils; Meisinger, Chris; Becker, Thomas] Univ Freiburg, ZMBZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Horvath, Susanne E.; Daum, Guenther] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria; [Boettinger, Lena] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; [Voegtle, F. -Nora; Wiedemann, Nils; Meisinger, Chris; Becker, Thomas] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Freiburg; Graz University of Technology; University of Freiburg; University of Freiburg	Becker, T (corresponding author), Univ Freiburg, ZMBZ, Inst Biochem & Mol Biol, Stefan Meier Str 17, D-79104 Freiburg, Germany.	thomas.becker@biochemie.uni-freiburg.de; guenther.daum@tugraz.at	Meisinger, Chris/J-1110-2014; Becker, Thomas/AAS-9404-2020; Vögtle, F.-Nora/T-4290-2017	Meisinger, Chris/0000-0002-8326-3548; Vögtle, F.-Nora/0000-0002-5062-3287; Wiedemann, Nils/0000-0001-8305-6728	Austrian Science Fund [21429]; DK Molecular Enzymology [W901-B05]; Deutsche Forschungsgemeinschaft, Sonderforschungs-bereich [746]; Excellence Initiative of the German Federal and State Governments [EXC 294 BIOSS]; Austrian Science Fund (FWF) [W 901, P 21429] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); DK Molecular Enzymology(Austrian Science Fund (FWF)); Deutsche Forschungsgemeinschaft, Sonderforschungs-bereich(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (project 21429 and DK Molecular Enzymology W901-B05 (to G. D.)), the Deutsche Forschungsgemeinschaft, Sonderforschungs-bereich 746, and the Excellence Initiative of the German Federal and State Governments (EXC 294 BIOSS).	Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660; Becker T, 2011, J CELL BIOL, V194, P387, DOI 10.1083/jcb.201102044; Birner R, 2003, MOL BIOL CELL, V14, P370, DOI 10.1091/mbc.E02-05-0263; Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; BROEKHUYSE RM, 1968, BIOCHIM BIOPHYS ACTA, V152, P307, DOI 10.1016/0005-2760(68)90038-6; Burgermeister M, 2004, BBA-MOL CELL BIOL L, V1686, P161, DOI 10.1016/j.bbalip.2004.09.007; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Choi JY, 2012, J BIOL CHEM, V287, P222, DOI 10.1074/jbc.M111.313676; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Dekker PJT, 1998, MOL CELL BIOL, V18, P6515, DOI 10.1128/MCB.18.11.6515; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; DOWHAN W, 1992, METHOD ENZYMOL, V209, P348; Dowhan W, 1997, METHOD ENZYMOL, V280, P81; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frazier AE, 2003, MOL CELL BIOL, V23, P7818, DOI 10.1128/MCB.23.21.7818-7828.2003; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Gallas MR, 2006, MOL BIOL CELL, V17, P4051, DOI 10.1091/mbc.E06-04-0366; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gohil VM, 2009, J CELL BIOL, V184, P468, DOI 10.1083/jcb.200901127; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Gulshan K, 2008, MOL CELL BIOL, V28, P5851, DOI 10.1128/MCB.00405-08; IGARASHI K, 1995, J BIOL CHEM, V270, P29075, DOI 10.1074/jbc.270.49.29075; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; KELLY BL, 1990, BIOCHIM BIOPHYS ACTA, V1046, P144, DOI 10.1016/0005-2760(90)90181-V; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kim KS, 1999, J BIOL CHEM, V274, P14857, DOI 10.1074/jbc.274.21.14857; Klingenberg M, 2009, BBA-BIOMEMBRANES, V1788, P2048, DOI 10.1016/j.bbamem.2009.06.007; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; KUCHLER K, 1986, J BACTERIOL, V165, P901, DOI 10.1128/jb.165.3.901-910.1986; Kuge O, 1996, BIOCHEM J, V319, P33, DOI 10.1042/bj3190033; Kuroda T, 2011, MOL MICROBIOL, V80, P248, DOI 10.1111/j.1365-2958.2011.07569.x; Kutik S, 2008, J CELL BIOL, V183, P1213, DOI 10.1083/jcb.200806048; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; LI QX, 1990, J BIOL CHEM, V265, P4111; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Mossmann D, 2012, BBA-GENE REGUL MECH, V1819, P1098, DOI 10.1016/j.bbagrm.2011.11.007; Nebauer R, 2007, FEBS J, V274, P6180, DOI 10.1111/j.1742-4658.2007.06138.x; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nguyen TT, 2012, TRAFFIC, V13, P880, DOI 10.1111/j.1600-0854.2012.01352.x; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Rajakumari S, 2010, MOL BIOL CELL, V21, P501, DOI 10.1091/mbc.E09-09-0775; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; Rontein D, 2003, PLANT PHYSIOL, V132, P1678, DOI 10.1104/pp.103.023242; Saba JD, 1997, J BIOL CHEM, V272, P26087, DOI 10.1074/jbc.272.42.26087; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schleiff E, 2011, NAT REV MOL CELL BIO, V12, P48, DOI 10.1038/nrm3027; Schuiki I, 2010, BBA-MOL CELL BIOL L, V1801, P480, DOI 10.1016/j.bbalip.2009.12.008; Schuiki I, 2009, IUBMB LIFE, V61, P151, DOI 10.1002/iub.159; SIMBENI R, 1993, BIOCHIM BIOPHYS ACTA, V1145, P1, DOI 10.1016/0005-2736(93)90374-9; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; Stojanovski D, 2007, METHOD CELL BIOL, V80, P783, DOI 10.1016/S0091-679X(06)80036-1; TAMAI KT, 1990, BIOCHIM BIOPHYS ACTA, V1046, P214, DOI 10.1016/0005-2760(90)90192-Z; Tamura Y, 2006, J CELL BIOL, V174, P631, DOI 10.1083/jcb.200603087; Thornton N, 2010, J MOL BIOL, V396, P540, DOI 10.1016/j.jmb.2009.12.026; TROTTER PJ, 1995, J BIOL CHEM, V270, P6071, DOI 10.1074/jbc.270.11.6071; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; Tuller G, 1998, FEBS LETT, V421, P15, DOI 10.1016/S0014-5793(97)01525-1; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Vogtle FN, 2011, MOL BIOL CELL, V22, P2135, DOI 10.1091/mbc.E11-02-0169; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; VOELKER DR, 1984, P NATL ACAD SCI-BIOL, V81, P2669, DOI 10.1073/pnas.81.9.2669; Voelker DR, 1997, BBA-LIPID LIPID MET, V1348, P236, DOI 10.1016/S0005-2760(97)00101-X; WITTE C, 1988, EMBO J, V7, P1439, DOI 10.1002/j.1460-2075.1988.tb02961.x; Yamamoto H, 2009, J BIOL CHEM, V284, P31635, DOI 10.1074/jbc.M109.041756; ZBOROWSKI J, 1983, FEBS LETT, V157, P179, DOI 10.1016/0014-5793(83)81141-7; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	83	49	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36744	36755		10.1074/jbc.M112.398107	http://dx.doi.org/10.1074/jbc.M112.398107			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22984266	hybrid, Green Published			2022-12-28	WOS:000310588500012
J	Harris, RS; Hultquist, JF; Evans, DT				Harris, Reuben S.; Hultquist, Judd F.; Evans, David T.			The Restriction Factors of Human Immunodeficiency Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HOST-CELL RESTRICTION; HIV-1 VPU PROTEIN; FACTOR SAMHD1; INHIBITS HIV-1; ENVELOPE GLYCOPROTEIN; HUMAN TRIM5-ALPHA; PARTICLE RELEASE; HUMAN APOBEC3G; GENE-PRODUCT; BETA-TRCP	Cellular proteins called "restriction factors" can serve as powerful blockades to HIV replication, but the virus possesses elaborate strategies to circumvent these barriers. First, we discuss general hallmarks of a restriction factor. Second, we review how the viral Vif protein protects the viral genome from lethal levels of cDNA deamination by promoting APOBEC3 protein degradation; how the viral Vpu, Env, and Nef proteins facilitate internalization and degradation of the virus-tethering protein BST-2/tetherin; and how the viral Vpx protein prevents the premature termination of reverse transcription by degrading the dNTPase SAMHD1. These HIV restriction and counter-restriction mechanisms suggest strategies for new therapeutic interventions.	[Harris, Reuben S.; Hultquist, Judd F.] Univ Minnesota, Inst Mol Virol, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Harris, Reuben S.; Hultquist, Judd F.] Univ Minnesota, Inst Mol Virol, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Evans, David T.] Harvard Univ, New England Primate Res Ctr, Sch Med, Dept Microbiol & Immunobiol, Southborough, MA 01772 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Harvard University	Harris, RS (corresponding author), Univ Minnesota, Inst Mol Virol, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	rsh@umn.edu		Hultquist, Judd/0000-0001-6424-4280	National Institutes of Health [R01 AI064046, P01 GM091743, R01 AI098485, R21 AI087498, P51 RR000168/OD011103]; University of Minnesota; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064046, R01AI098485, R37AI095098, R21AI087498, R01AI095098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM091743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota(University of Minnesota System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI064046 and P01 GM091743 (to R. S. H.) and R01 AI098485 and R21 AI087498 (to D. T. E.). This is the fifth article in the Thematic Minireview Series on Understanding Human Immunodeficiency Virus-Host Interactions at the Biochemical Level.; Supported by a University of Minnesota graduate student fellowship.; Supported in part by National Institutes of Health Grant P51 RR000168/OD011103.	Ahn J, 2012, J BIOL CHEM, V287, P12550, DOI 10.1074/jbc.M112.340711; AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; Albin JS, 2010, J VIROL, V84, P10209, DOI 10.1128/JVI.00632-10; Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; Bour S, 2003, VIROLOGY, V309, P85, DOI 10.1016/S0042-6822(02)00128-9; Bour S, 1996, J VIROL, V70, P820, DOI 10.1128/JVI.70.2.820-829.1996; Browne EP, 2009, VIROLOGY, V387, P313, DOI 10.1016/j.virol.2009.02.026; Caillet M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002347; Casey L, 2010, CYTOKINE, V51, P1, DOI 10.1016/j.cyto.2010.02.018; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Compton AA, 2012, CELL HOST MICROBE, V11, P91, DOI 10.1016/j.chom.2011.11.010; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Dube M, 2011, TRAFFIC, V12, P1714, DOI 10.1111/j.1600-0854.2011.01277.x; Dube M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000856; Fitzpatrick K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000701; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; GERAGHTY RJ, 1994, J MED PRIMATOL, V23, P146, DOI 10.1111/j.1600-0684.1994.tb00115.x; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Goujon C, 2008, J VIROL, V82, P12335, DOI 10.1128/JVI.01181-08; Gupta RK, 2009, P NATL ACAD SCI USA, V106, P20889, DOI 10.1073/pnas.0907075106; Gupta RK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000443; Gustin JK, 2012, J BIOL CHEM, V287, P14837, DOI 10.1074/jbc.M112.349928; GUYADER M, 1989, EMBO J, V8, P1169, DOI 10.1002/j.1460-2075.1989.tb03488.x; Hache G, 2009, J VIROL, V83, P5956, DOI 10.1128/JVI.00045-09; Hammonds J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000749; Harris R, 2008, NAT BIOTECHNOL, V26, P1089, DOI 10.1038/nbt1008-1089; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Hauser H, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-51; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Janini M, 2001, J VIROL, V75, P7973, DOI 10.1128/JVI.75.17.7973-7986.2001; Janvier K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001265; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; KAPPES JC, 1991, VIROLOGY, V184, P197, DOI 10.1016/0042-6822(91)90836-Z; Kaushik R, 2009, CELL HOST MICROBE, V6, P68, DOI 10.1016/j.chom.2009.05.022; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Kobayashi T, 2011, J VIROL, V85, P932, DOI 10.1128/JVI.01668-10; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Laguette N, 2012, CELL HOST MICROBE, V11, P205, DOI 10.1016/j.chom.2012.01.007; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Larue RS, 2010, J VIROL, V84, P8193, DOI 10.1128/JVI.00685-10; Lau D, 2011, J VIROL, V85, P9834, DOI 10.1128/JVI.02633-10; Le Tortorec A, 2009, J VIROL, V83, P11966, DOI 10.1128/JVI.01515-09; Li Y, 2006, J VIROL, V80, P6738, DOI 10.1128/JVI.00270-06; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Lopez LA, 2010, J VIROL, V84, P7243, DOI 10.1128/JVI.02636-09; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Manel N, 2011, CELL, V147, P271, DOI 10.1016/j.cell.2011.09.010; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Miyagij E, 2007, J VIROL, V81, P13346, DOI 10.1128/JVI.01361-07; Miyakawa K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000700; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; OhAinle M, 2008, CELL HOST MICROBE, V4, P249, DOI 10.1016/j.chom.2008.07.005; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Pillai SK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-26; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Rahm N, 2012, CURR OPIN HIV AIDS, V7, P180, DOI 10.1097/COH.0b013e32835048e1; Refsland EW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002800; Rong LW, 2009, J VIROL, V83, P7536, DOI 10.1128/JVI.00620-09; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Schmidt S, 2011, MBIO, V2, DOI 10.1128/mBio.00036-11; Schumacher AJ, 2008, J VIROL, V82, P2652, DOI 10.1128/JVI.02391-07; Serra-Moreno R, 2011, CELL HOST MICROBE, V9, P46, DOI 10.1016/j.chom.2010.12.005; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon JHM, 1998, NAT MED, V4, P1397, DOI 10.1038/3987; Skasko M, 2012, J BIOL CHEM, V287, P58, DOI 10.1074/jbc.M111.296772; STREBEL K, 1988, SCIENCE, V241, P1221, DOI 10.1126/science.3261888; STREBEL K, 1987, NATURE, V328, P728, DOI 10.1038/328728a0; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Tervo HM, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-9; Tokarev AA, 2011, J VIROL, V85, P51, DOI 10.1128/JVI.01795-10; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; VARTANIAN JP, 1991, J VIROL, V65, P1779, DOI 10.1128/JVI.65.4.1779-1788.1991; Varthakavi V, 2003, P NATL ACAD SCI USA, V100, P15154, DOI 10.1073/pnas.2433165100; Vorontsov II, 2011, J BIOL CHEM, V286, P33158, DOI 10.1074/jbc.M111.250456; Wang XJ, 2011, J VIROL, V85, P3142, DOI 10.1128/JVI.02049-10; Wei W, 2012, CELL MICROBIOL, V14, P1745, DOI 10.1111/j.1462-5822.2012.01835.x; Yap MW, 2005, CURR BIOL, V15, P73, DOI 10.1016/j.cub.2004.12.042; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; YU XF, 1991, J VIROL, V65, P5088, DOI 10.1128/JVI.65.9.5088-5091.1991; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037477; Zhang FW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002039; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang WY, 2012, NATURE, V481, P376, DOI 10.1038/nature10718; Zhou JM, 2012, BIOCHEMISTRY-US, V51, P1288, DOI 10.1021/bi2015986	100	189	195	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					40875	40883		10.1074/jbc.R112.416925	http://dx.doi.org/10.1074/jbc.R112.416925			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23043100	hybrid, Green Published			2022-12-28	WOS:000311887600006
J	Asthana, J; Kuchibhatla, A; Jana, SC; Ray, K; Panda, D				Asthana, Jayant; Kuchibhatla, Anuradha; Jana, Swadhin Chandra; Ray, Krishanu; Panda, Dulal			Dynein Light Chain 1 (LC8) Association Enhances Microtubule Stability and Promotes Microtubule Bundling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DYNEIN; FISSION YEAST; IN-VIVO; KINETIC STABILIZATION; DYNAMIC MICROTUBULES; MITOTIC SPINDLE; CROSS-LINKERS; MYOSIN-V; PROTEIN; DROSOPHILA	Dynein light chain 1 (LC8), a highly conserved protein, is known to bind to a variety of different polypeptides. It functions as a dimer, which is inactivated through phosphorylation at the Ser-88 residue. A loss of LC8 function causes apoptosis in Drosophila embryos, and its overexpression induces malignant transformation of breast cancer cells. Here we show that LC8 binds to tubulin, promotes microtubule assembly, and induces the bundling of reconstituted microtubules in vitro. Furthermore, LC8 decorates microtubules both in Drosophila embryos and in HeLa cells, increases the microtubule stability, and promotes microtubule bundling in these cells. Microtubule stability influences a number of different cellular functions including mitosis and cell differentiation. The LC8 overexpression reduces the susceptibility of microtubules to cold and nocodazole-induced depolymerization in tissue-cultured cells and increases microtubule acetylation, suggesting that LC8 stabilizes microtubules. We also show that LC8 knockdown or transfection with inhibitory peptides destabilizes microtubules and inhibits bipolar spindle assembly in HeLa cells. In addition, LC8 knockdown leads to the mitotic block in HeLa cells. Furthermore, molecular docking analysis using the crystal structures of tubulin and LC8 dimer indicated that the latter may bind at alpha-beta tubulin junction in a protofilament at sites distinct from the kinesin and dynein binding sites. Together, we provide the first evidence of a novel microtubule-associated protein-like function of LC8 that could explain its reported roles in cellular metastasis and differentiation.	[Asthana, Jayant; Kuchibhatla, Anuradha; Panda, Dulal] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India; [Jana, Swadhin Chandra; Ray, Krishanu] Tata Inst Fundamental Res, Bombay 400005, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Tata Institute of Fundamental Research (TIFR)	Panda, D (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	panda@iitb.ac.in	Asthana, Jayant/AFQ-7879-2022	Ray, Krishanu/0000-0001-6406-3199; Asthana, Dr. Jayant/0000-0002-8961-6308; Jana, Swadhin/0000-0002-8311-3849	Department of Atomic Energy (DAE) Science Research Council, Government of India; Tata Institute of Fundamental Research, DAE	Department of Atomic Energy (DAE) Science Research Council, Government of India; Tata Institute of Fundamental Research, DAE	This work was supported by a grant from the Department of Atomic Energy (DAE) Science Research Council, Government of India (to D. P.) and by intramural funds of the Tata Institute of Fundamental Research, DAE (to K. R.).	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Asakawa K, 2005, EMBO REP, V6, P1194, DOI 10.1038/sj.embor.7400540; Barbar E, 2001, BIOCHEMISTRY-US, V40, P1596, DOI 10.1021/bi002278+; Benashski SE, 1997, J BIOL CHEM, V272, P20929, DOI 10.1074/jbc.272.33.20929; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; COFFEY RL, 1995, J BIOL CHEM, V270, P1035, DOI 10.1074/jbc.270.3.1035; Cowan CM, 2010, ACTA NEUROPATHOL, V120, P593, DOI 10.1007/s00401-010-0716-8; Crepieux P, 1997, MOL CELL BIOL, V17, P7375, DOI 10.1128/MCB.17.12.7375; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Diaz-Rodriguez E, 2008, P NATL ACAD SCI USA, V105, P16719, DOI 10.1073/pnas.0803504105; Dick T, 1996, MOL CELL BIOL, V16, P1966; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; Ghosh-Roy A, 2004, MOL BIOL CELL, V15, P2470, DOI 10.1091/mbc.E03-11-0848; Glotzer M, 2009, CURR BIOL, V19, pR162, DOI 10.1016/j.cub.2008.12.028; Goldstone S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010634; Graf ER, 2011, J NEUROSCI, V31, P15026, DOI 10.1523/JNEUROSCI.2024-11.2011; Gupta K, 2002, BIOCHEMISTRY-US, V41, P13029, DOI 10.1021/bi025952r; HAMEL E, 1981, ARCH BIOCHEM BIOPHYS, V209, P29, DOI 10.1016/0003-9861(81)90253-8; Hekkelman ML, 2010, NUCLEIC ACIDS RES, V38, pW719, DOI 10.1093/nar/gkq453; Herzig RP, 2000, J CELL SCI, V113, P4263; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Jaffrey SR, 1996, SCIENCE, V274, P774, DOI 10.1126/science.274.5288.774; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kaverina I, 2011, SEMIN CELL DEV BIOL, V22, P968, DOI 10.1016/j.semcdb.2011.09.017; KING SM, 1995, J BIOL CHEM, V270, P11445, DOI 10.1074/jbc.270.19.11445; Li S, 2012, EMBO J, V31, P552, DOI 10.1038/emboj.2011.460; Lippens G, 2007, PRION, V1, P21, DOI 10.4161/pri.1.1.4055; Liu B, 2003, MOL MICROBIOL, V47, P291, DOI 10.1046/j.1365-2958.2003.03285.x; Loiodice I, 2005, MOL BIOL CELL, V16, P1756, DOI 10.1091/mbc.E04-10-0899; Makokha M, 2004, PROTEIN SCI, V13, P727, DOI 10.1110/ps.03462204; Makrides V, 2004, P NATL ACAD SCI USA, V101, P6746, DOI 10.1073/pnas.0400992101; Mayer C, 2006, CELL CYCLE, V5, P1456, DOI 10.4161/cc.5.13.2912; Mohan PMK, 2006, PROTEIN SCI, V15, P335, DOI 10.1110/ps.051854906; Mohan R, 2008, CANCER RES, V68, P6181, DOI 10.1158/0008-5472.CAN-08-0584; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Musch A, 2004, TRAFFIC, V5, P1, DOI 10.1046/j.1600-0854.2003.00149.x; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Navarro-Lerida I, 2004, PROTEOMICS, V4, P339, DOI 10.1002/pmic.200300528; Nicastro D, 2011, P NATL ACAD SCI USA, V108, pE845, DOI 10.1073/pnas.1106178108; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; PELLMAN D, 1995, J CELL BIOL, V130, P1373, DOI 10.1083/jcb.130.6.1373; Peterman EJG, 2009, CURR BIOL, V19, pR1089, DOI 10.1016/j.cub.2009.10.047; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Rathinasamy K, 2008, BIOCHEM PHARMACOL, V76, P1669, DOI 10.1016/j.bcp.2008.09.001; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Schnorrer F, 2000, NAT CELL BIOL, V2, P185, DOI 10.1038/35008601; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Song CY, 2008, J BIOL CHEM, V283, P4004, DOI 10.1074/jbc.M704512200; Vadlamudi RK, 2004, CANCER CELL, V5, P575, DOI 10.1016/j.ccr.2004.05.022; Vakser IA, 1999, P NATL ACAD SCI USA, V96, P8477, DOI 10.1073/pnas.96.15.8477; Varma D, 2010, P NATL ACAD SCI USA, V107, P3493, DOI 10.1073/pnas.0908959107; Verni F, 2004, CURR BIOL, V14, P1569, DOI 10.1016/j.cub.2004.08.054; Wagner W, 2006, BIOCHEMISTRY-US, V45, P11564, DOI 10.1021/bi061142u; Witte H, 2008, CURR OPIN NEUROBIOL, V18, P479, DOI 10.1016/j.conb.2008.09.019; Yang ZB, 2005, J BIOL CHEM, V280, P654, DOI 10.1074/jbc.M408486200; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947; Zhang D, 2007, REPRODUCTION, V133, P685, DOI 10.1530/rep.1.01167	67	20	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40793	40805		10.1074/jbc.M112.394353	http://dx.doi.org/10.1074/jbc.M112.394353			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23038268	Green Published, hybrid			2022-12-28	WOS:000311448800067
J	Dresner, E; Malishkevich, A; Arviv, C; Barak, SL; Alon, S; Ofir, R; Gothilf, Y; Gozes, I				Dresner, Efrat; Malishkevich, Anna; Arviv, Carmit; Barak, Shelly Leibman; Alon, Shahar; Ofir, Rivka; Gothilf, Yoav; Gozes, Illana			Novel Evolutionary-conserved Role for the Activity-dependent Neuroprotective Protein (ADNP) Family That Is Important for Erythropoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR COMPLEXES; ERYTHROID-DIFFERENTIATION; PRIMITIVE ERYTHROPOIESIS; OXIDATIVE STRESS; GLOBIN GENES; DANIO-RERIO; ZEBRAFISH; CELLS; CHROMATIN; EXPRESSION	Activity-dependent neuroprotective protein (ADNP) and its homologue ADNP2 belong to a homeodomain, the zinc finger-containing protein family. ADNP is essential for mouse embryonic brain formation. ADNP2 is associated with cell survival, but its role in embryogenesis has not been evaluated. Here, we describe the use of the zebrafish model to elucidate the developmental roles of ADNP and ADNP2. Although we expected brain defects, we were astonished to discover that the knockdown zebrafish embryos were actually lacking blood and suffered from defective hemoglobin production. Evolutionary conservation was established using mouse erythroleukemia (MEL) cells, a well studied erythropoiesis model, in which silencing of ADNP or ADNP2 produced similar results as in zebrafish. Exogenous RNA encoding ADNP/ADNP2 rescued the MEL cell undifferentiated state, demonstrating phenotype specificity. Brg1, an ADNP-interacting chromatin-remodeling protein involved in erythropoiesis through regulation of the globin locus, was shown here to interact also with ADNP2. Furthermore, chromatin immunoprecipitation revealed recruitment of ADNP, similar to Brg1, to the mouse beta-globin locus control region in MEL cells. This recruitment was apparently diminished upon dimethyl sulfoxide (DMSO)-induced erythrocyte differentiation compared with the nondifferentiated state. Importantly, exogenous RNA encoding ADNP/ADNP2 significantly increased beta-globin expression in MEL cells in the absence of any other differentiation factors. Taken together, our results reveal an ancestral role for the ADNP protein family in maturation and differentiation of the erythroid lineage, associated with direct regulation of beta-globin expression.	[Dresner, Efrat; Malishkevich, Anna; Arviv, Carmit; Ofir, Rivka; Gozes, Illana] Tel Aviv Univ, Lily & Avraham Gildor Chair Invest Growth Factors, Adams Super Ctr Brain Studies,Sackler Fac Med, Dept Human Mol Genet & Biochem,Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Barak, Shelly Leibman; Alon, Shahar; Gothilf, Yoav] Tel Aviv Univ, Dept Neurobiol, Sagol Sch Neurosci, Wise Fac Life Sci, IL-69978 Tel Aviv, Israel; [Ofir, Rivka] Ben Gurion Univ Negev, Dead Sea & Arava Sci Ctr, IL-86815 Beer Sheva, Hazeva Dn, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Ben Gurion University	Gozes, I (corresponding author), Tel Aviv Univ, Lily & Avraham Gildor Chair Invest Growth Factors, Adams Super Ctr Brain Studies,Sackler Fac Med, Dept Human Mol Genet & Biochem,Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel.	igozes@post.tau.ac.il		Gothilf, Yoav/0000-0002-6054-4128	stem cell scholarship; Lily and Avraham Gildor Chair for the Investigation of Growth Factors; Elton Laboratory for Molecular Neuroendocrinology; Adams Super Center for Brain Studies at Tel Aviv University; AMN Foundation, Israel; Montreal Circle of Canadian Friends of Tel Aviv University; Joseph and Grace Alter; Barbara and Donald Seal; Oberfeld Family; Adams Family; Tel Aviv University; Eva Selwyn and Allon Therapeutics Inc., Vancouver, Canada	stem cell scholarship; Lily and Avraham Gildor Chair for the Investigation of Growth Factors; Elton Laboratory for Molecular Neuroendocrinology; Adams Super Center for Brain Studies at Tel Aviv University; AMN Foundation, Israel; Montreal Circle of Canadian Friends of Tel Aviv University; Joseph and Grace Alter; Barbara and Donald Seal; Oberfeld Family; Adams Family; Tel Aviv University; Eva Selwyn and Allon Therapeutics Inc., Vancouver, Canada	This work was supported by a stem cell scholarship, the Lily and Avraham Gildor Chair for the Investigation of Growth Factors, the Elton Laboratory for Molecular Neuroendocrinology, the Adams Super Center for Brain Studies at Tel Aviv University, the AMN Foundation, Israel, Montreal Circle of Canadian Friends of Tel Aviv University, Joseph and Grace Alter, Barbara and Donald Seal, the Oberfeld Family, the Adams Family, Australian Friends of Tel Aviv University, and Eva Selwyn and Allon Therapeutics Inc., Vancouver, Canada. I. G. serves as a Director-Founding Scientist of Allon Therapeutics Inc. that funded, in part, the described research. A patent has been applied for ADNP-like influence in anemia.	Bassan M, 1999, J NEUROCHEM, V72, P1283, DOI 10.1046/j.1471-4159.1999.0721283.x; Basu P, 2005, BLOOD, V106, P2566, DOI 10.1182/blood-2005-02-0674; Bennett CM, 2001, BLOOD, V98, P643, DOI 10.1182/blood.V98.3.643; Brand M, 2004, NAT STRUCT MOL BIOL, V11, P73, DOI 10.1038/nsmb713; Brownlie A, 2003, DEV BIOL, V255, P48, DOI 10.1016/S0012-1606(02)00041-6; Brownlie A, 1998, NAT GENET, V20, P244, DOI 10.1038/3049; Bultman SJ, 2005, GENE DEV, V19, P2849, DOI 10.1101/gad.1364105; COPP AJ, 1995, TRENDS GENET, V11, P87, DOI 10.1016/S0168-9525(00)89008-3; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; Dresner E, 2011, EUR NEUROPSYCHOPHARM, V21, P355, DOI 10.1016/j.euroneuro.2010.06.004; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; Galloway JL, 2003, CURR TOP DEV BIOL, V53, P139, DOI 10.1016/S0070-2153(03)53004-6; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Griffin CT, 2008, DEVELOPMENT, V135, P493, DOI 10.1242/dev.010090; Hattangadi SM, 2010, BLOOD, V115, P4853, DOI 10.1182/blood-2009-07-235093; Huo XF, 2006, MOL CELL BIOCHEM, V292, P155, DOI 10.1007/s11010-006-9229-0; IUCHI I, 1983, J EXP ZOOL, V226, P409, DOI 10.1002/jez.1402260311; Juarez MA, 2005, J BIOL CHEM, V280, P41636, DOI 10.1074/jbc.M507998200; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kim SI, 2009, P NATL ACAD SCI USA, V106, P2259, DOI 10.1073/pnas.0806420106; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kushnir M, 2008, J NEUROCHEM, V105, P537, DOI 10.1111/j.1471-4159.2007.05173.x; Liao EC, 2002, DEVELOPMENT, V129, P649; Mandel S, 2008, J MOL NEUROSCI, V35, P127, DOI 10.1007/s12031-007-9013-y; Mandel S, 2007, J BIOL CHEM, V282, P34448, DOI 10.1074/jbc.M704756200; Mandel S, 2007, DEV BIOL, V303, P814, DOI 10.1016/j.ydbio.2006.11.039; McArthur M, 2001, J MOL BIOL, V313, P27, DOI 10.1006/jmbi.2001.4969; McGrath K, 2008, CURR TOP DEV BIOL, V82, P1, DOI 10.1016/S0070-2153(07)00001-4; Orkin SH, 1978, IN VITRO, V14, P146; Palevitch O, 2007, CELL TISSUE RES, V327, P313, DOI 10.1007/s00441-006-0279-0; Paw BH, 2001, BLOOD CELL MOL DIS, V27, P62, DOI 10.1006/bcmd.2000.0354; Pelster B, 1996, CIRC RES, V79, P358, DOI 10.1161/01.RES.79.2.358; Pinhasov A, 2003, DEV BRAIN RES, V144, P83, DOI 10.1016/S0165-3806(03)00162-7; Porter FD, 1997, DEVELOPMENT, V124, P2935; RIFKIND RA, 1978, IN VITRO CELL DEV B, V14, P155, DOI 10.1007/BF02618182; SABBAN EL, 1980, J CELL PHYSIOL, V104, P261, DOI 10.1002/jcp.1041040217; Songhet P, 2007, DEV DYNAM, V236, P633, DOI 10.1002/dvdy.21056; Steingart RA, 2006, MOL CELL ENDOCRINOL, V252, P148, DOI 10.1016/j.mce.2006.03.029; Su FY, 2007, ZEBRAFISH, V4, P187, DOI 10.1089/zeb.2007.0505; Toobiak S, 2011, INT J LAB HEMATOL, V33, P645, DOI 10.1111/j.1751-553X.2011.01338.x; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; UOSHIMA N, 1995, BRIT J HAEMATOL, V91, P30, DOI 10.1111/j.1365-2141.1995.tb05240.x; Vulih-Shultzman I, 2007, J PHARMACOL EXP THER, V323, P438, DOI 10.1124/jpet.107.129551; Xu ZX, 2006, BIOCHEM J, V399, P297, DOI 10.1042/BJ20060873; Zamostiano R, 2001, J BIOL CHEM, V276, P708, DOI 10.1074/jbc.M007416200; Ziv L, 2005, J NEUROENDOCRINOL, V17, P314, DOI 10.1111/j.1365-2826.2005.01315.x	48	36	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40173	40185		10.1074/jbc.M112.387027	http://dx.doi.org/10.1074/jbc.M112.387027			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23071114	Green Published, hybrid			2022-12-28	WOS:000311448800008
J	Meldrum, KK; Zhang, HJ; Hile, KL; Moldower, LL; Dong, ZZ; Meldrum, DR				Meldrum, Kirstan K.; Zhang, Hongji; Hile, Karen L.; Moldower, Lyle L.; Dong, Zizheng; Meldrum, Daniel R.			Profibrotic Effect of Interleukin-18 in HK-2 Cells Is Dependent on Stimulation of the Toll-like Receptor 4 (TLR4) Promoter and Increased TLR4 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; UNILATERAL URETERAL OBSTRUCTION; TUBULOINTERSTITIAL FIBROSIS; GENE-EXPRESSION; RENAL FIBROSIS; TISSUE FIBROSIS; IL-18; TRANSDIFFERENTIATION; FIBROBLASTS	IL-18 is an important mediator of obstruction-induced renal fibrosis and tubular epithelial cell injury independent of TGF-beta 1 activity. We sought to determine whether the profibrotic effect of IL-18 is mediated through Toll-like receptor 4 (TLR4). Male C57BL6 wild type and mice transgenic for human IL-18-binding protein were subjected to left unilateral ureteral obstruction versus sham operation. The kidneys were harvested 1 week postoperatively and analyzed for IL-18 production and TLR4 expression. In a separate arm, renal tubular epithelial cells (HK-2) were directly stimulated with IL-18 in the presence or absence of a TLR4 agonist, TLR4 antagonist, or TLR4 siRNA knockdown. Cell lysates were analyzed for TLR4, alpha-smooth muscle actin, and E-cadherin expression. TLR4 promotor activity, as well as AP-1 activation and the effect of AP-1 knockdown on TLR4 expression, was evaluated in HK-2 cells in response to IL-18 stimulation. The results demonstrate that IL-18 induces TLR4 expression during unilateral ureteral obstruction and induces TLR4 expression in HK-2 cells via AP-1 activation. Inhibition of TLR4 or knockdown of TLR4 gene expression in turn prevents IL-18-induced profibrotic changes in HK-2 cells. These results suggest that IL-18 induces profibrotic changes in tubular epithelial cells via increased TLR4 expression/signaling.	[Meldrum, Kirstan K.] Univ Florida, Dept Urol, Gainesville, FL 32610 USA; [Moldower, Lyle L.; Meldrum, Daniel R.] Univ Florida, Dept Surg, Gainesville, FL 32610 USA; [Meldrum, Kirstan K.; Zhang, Hongji; Hile, Karen L.] Indiana Univ, Dept Urol, Indianapolis, IN 46202 USA; [Dong, Zizheng] Indiana Univ, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Meldrum, KK (corresponding author), Univ Florida, Div Pediat Neurol, 1600 SW Archer Rd,M203F, Gainesville, FL 32610 USA.	Kirstan.Meldrum@urology.ufl.edu			National Institutes of Health [R01 DK 081695]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK 081695.	ALVAREZ RJ, 1992, KIDNEY INT, V41, P14, DOI 10.1038/ki.1992.3; Anders HJ, 2004, J AM SOC NEPHROL, V15, P854, DOI 10.1097/01.ASN.0000121781.89599.16; Bani-Hani AH, 2009, KIDNEY INT, V76, P500, DOI 10.1038/ki.2009.216; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Campbell MT, 2011, J SURG RES, V168, pE61, DOI 10.1016/j.jss.2009.09.053; Chowdhury P, 2006, CLIN EXP IMMUNOL, V145, P346, DOI 10.1111/j.1365-2249.2006.03116.x; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Dinarello CA, 2007, SEMIN NEPHROL, V27, P98, DOI 10.1016/j.semnephrol.2006.09.013; Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495; Fan JM, 1999, KIDNEY INT, V56, P1455, DOI 10.1046/j.1523-1755.1999.00656.x; Fantuzzi G, 2003, J LEUKOCYTE BIOL, V74, P889, DOI 10.1189/jlb.0503230; Faust J, 2002, ARTHRITIS RHEUM-US, V46, P3083, DOI 10.1002/art.10563; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Healy E, 1998, CURR OPIN NEPHROL HY, V7, P525, DOI 10.1097/00041552-199809000-00007; HUMES HD, 1992, EXP CELL RES, V201, P8, DOI 10.1016/0014-4827(92)90342-6; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Iwano M, 2004, CURR OPIN NEPHROL HY, V13, P279, DOI 10.1097/00041552-200405000-00003; Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233; Klahr S, 2001, Heart Dis, V3, P205, DOI 10.1097/00132580-200105000-00013; KUNCIO GS, 1991, KIDNEY INT, V39, P550, DOI 10.1038/ki.1991.63; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; Li YJ, 2003, J CLIN INVEST, V112, P503, DOI 10.1172/JCI200317913; Liang D, 2007, NEPHROLOGY, V12, P53, DOI 10.1111/j.1440-1797.2006.00737.x; Meldrum KK, 2002, AM J PHYSIOL-HEART C, V282, pH540, DOI 10.1152/ajpheart.00072.2001; Miyajima A, 2000, KIDNEY INT, V58, P2301, DOI 10.1046/j.1523-1755.2000.00414.x; Miyajima A, 2001, J UROLOGY, V165, P1714, DOI 10.1016/S0022-5347(05)66400-2; Nakahira M, 2002, J IMMUNOL, V168, P1146, DOI 10.4049/jimmunol.168.3.1146; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; POSTLETHWAITE AE, 1987, J EXP MED, V165, P251, DOI 10.1084/jem.165.1.251; Radstake TRDJ, 2004, ARTHRITIS RHEUM-US, V50, P3856, DOI 10.1002/art.20678; Rastaldi MP, 2006, J NEPHROL, V19, P407; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; ROBERTS AB, 1992, KIDNEY INT, V41, P557, DOI 10.1038/ki.1992.81; Roger T, 2005, BIOCHEM J, V387, P355, DOI 10.1042/BJ20041243; Samuelsson P, 2004, INFECT IMMUN, V72, P3179, DOI 10.1128/IAI.72.6.3179-3186.2004; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Strutz F, 1996, EXP NEPHROL, V4, P267; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; VanderBrink BA, 2011, J UROLOGY, V186, P1502, DOI 10.1016/j.juro.2011.05.046; Zeisberg M, 2001, AM J PATHOL, V159, P1313, DOI 10.1016/S0002-9440(10)62518-7; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhang HJ, 2011, AM J PHYSIOL-RENAL, V301, pF171, DOI 10.1152/ajprenal.00339.2010	43	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40391	40399		10.1074/jbc.M112.402420	http://dx.doi.org/10.1074/jbc.M112.402420			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23027874	hybrid, Green Published			2022-12-28	WOS:000311448800030
J	Wemhoner, K; Silbernagel, N; Marzian, S; Netter, MF; Rinne, S; Stansfeld, PJ; Decher, N				Wemhoener, Konstantin; Silbernagel, Nicole; Marzian, Stefanie; Netter, Michael F.; Rinne, Susanne; Stansfeld, Phillip J.; Decher, Niels			A Leucine Zipper Motif Essential for Gating of Hyperpolarization-activated Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-GATED CHANNELS; PACEMAKER CHANNELS; S4-S5 LINKER; K+ CHANNELS; C-TERMINUS; VOLTAGE; PROTEIN; DOMAIN; STOICHIOMETRY; TRAFFICKING	Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are pacemakers in cardiac myocytes and neurons. Although their membrane topology closely resembles that of voltage-gated K+ channels, the mechanism of their unique gating behavior in response to hyperpolarization is still poorly understood. We have identified a highly conserved leucine zipper motif in the S5 segment of HCN family members. In order to study the role of this motif for channel function, the leucine residues of the zipper were individually mutated to alanine, arginine, or glutamine residues. Leucine zipper mutants traffic to the plasma membrane, but the channels lose their sensitivity to open upon hyperpolarization. Thus, our data indicate that the leucine zipper is an important molecular determinant for hyperpolarization-activated channel gating. Residues of the leucine zipper interact with the adjacent S6 segment of the channel. This interaction is essential for voltage-dependent gating of the channel. The lower part of the leucine zipper, at the intracellular mouth of the channel, is important for stabilizing the closed state. Mutations at these sites increase current amplitudes or result in channels with deficient closing and increased min-Po. Our data are further supported by homology models of the open and closed state of the HCN2 channel pore. Thus, we conclude that the leucine zipper of HCN channels is a major determinant for hyperpolarization-activated channel gating.	[Wemhoener, Konstantin; Silbernagel, Nicole; Marzian, Stefanie; Netter, Michael F.; Rinne, Susanne; Decher, Niels] Univ Marburg, Inst Physiol, Vegetat Physiol Grp, D-35037 Marburg, Germany; [Stansfeld, Phillip J.] Univ Oxford, Dept Biochem, Struct Bioinformat & Computat Biochem Unit, Oxford OX1 3QU, England	Philipps University Marburg; University of Oxford	Decher, N (corresponding author), Univ Marburg, Inst Physiol, Vegetat Physiol Grp, Deutschhausstr 1-2, D-35037 Marburg, Germany.	decher@staff.uni-marburg.de	Stansfeld, Phill/C-6213-2011; Stansfeld, Phillip James/AAA-9228-2020; Decher, Niels/AAF-5002-2020	Stansfeld, Phill/0000-0001-8800-7669; Stansfeld, Phillip James/0000-0001-8800-7669; 	Deutsche Forschungsgemeinschaft [DE1482-2/1, DE1482-3/2]; BBSRC [BB/H000267/1, BB/I019855/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BEP17032, BB/I019855/1, BB/H000267/1, BBS/B/16011, B19456] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Deutsche Forschungsgemeinschaft Grants DE1482-2/1 and DE1482-3/2 (to N. D.).	Chen J, 2000, J BIOL CHEM, V275, P36465, DOI 10.1074/jbc.M007034200; Chen J, 2001, P NATL ACAD SCI USA, V98, P11277, DOI 10.1073/pnas.201250598; Chow SS, 2012, J BIOL CHEM, V287, P600, DOI 10.1074/jbc.M111.269563; Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105; Decher N, 2004, J BIOL CHEM, V279, P13859, DOI 10.1074/jbc.M313704200; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; Hulme JT, 2003, P NATL ACAD SCI USA, V100, P13093, DOI 10.1073/pnas.2135335100; Hulme JT, 2002, J BIOL CHEM, V277, P4079, DOI 10.1074/jbc.M109814200; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Mannikko R, 2002, NATURE, V419, P837, DOI 10.1038/nature01038; MCCORMACK K, 1991, P NATL ACAD SCI USA, V88, P2931, DOI 10.1073/pnas.88.7.2931; Proenza C, 2006, J GEN PHYSIOL, V127, P183, DOI 10.1085/jgp.200509389; Proenza C, 2002, J BIOL CHEM, V277, P5101, DOI 10.1074/jbc.M106974200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanguinetti MC, 1999, J PHYSIOL-LONDON, V514, P667, DOI 10.1111/j.1469-7793.1999.667ad.x; Santoro B, 1997, P NATL ACAD SCI USA, V94, P14815, DOI 10.1073/pnas.94.26.14815; Shin KS, 2004, NEURON, V41, P737, DOI 10.1016/S0896-6273(04)00083-2; Syme CA, 2003, J BIOL CHEM, V278, P8476, DOI 10.1074/jbc.M210072200; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201	26	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40150	40160		10.1074/jbc.M112.378513	http://dx.doi.org/10.1074/jbc.M112.378513			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23048023	Green Published, hybrid			2022-12-28	WOS:000311448800006
J	Burstel, I; Siebert, E; Winter, G; Hummel, P; Zebger, I; Friedrich, B; Lenz, O				Buerstel, Ingmar; Siebert, Elisabeth; Winter, Gordon; Hummel, Philipp; Zebger, Ingo; Friedrich, Baerbel; Lenz, Oliver			A Universal Scaffold for Synthesis of the Fe(CN)(2)(CO) Moiety of [NiFe] Hydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATURATION PROTEINS HYPC; ALCALIGENES-EUTROPHUS; ACTIVE-SITE; ESCHERICHIA-COLI; CATALYTIC CYCLE; CYANIDE; CN; FE; IDENTIFICATION; BIOSYNTHESIS	Hydrogen-cycling [NiFe] hydrogenases harbor a dinuclear catalytic center composed of nickel and iron ions, which are coordinated by four cysteine residues. Three unusual diatomic ligands in the form of two cyanides (CN-) and one carbon monoxide (CO) are bound to the iron and apparently account for the complexity of the cofactor assembly process, which involves the function of at least six auxiliary proteins, designated HypA, -B, -C, -D, -E, and -F. It has been demonstrated previously that the HypC, -D, -E, and -F proteins participate in cyanide synthesis and transfer. Here, we show by infrared spectroscopic analysis that the purified HypCD complexes from Ralstonia eutropha and Escherichia coli carry in addition to both cyanides the CO ligand. We present experimental evidence that in vivo the attachment of the CN- ligands is a prerequisite for subsequent CO binding. With the aid of genetic engineering and subsequent mutant analysis, the functional role of conserved cysteine residues in HypD from R. eutropha was investigated. Our results demonstrate that the HypCD complex serves as a scaffold for the assembly of the Fe(CN)(2)(CO) entity of [NiFe] hydrogenase.	[Siebert, Elisabeth; Hummel, Philipp; Zebger, Ingo] Tech Univ Berlin, Max Volmer Lab, D-10623 Berlin, Germany; [Buerstel, Ingmar; Winter, Gordon; Friedrich, Baerbel; Lenz, Oliver] Humboldt Univ, Inst Biol Mikrobiol, D-10115 Berlin, Germany	Technical University of Berlin; Humboldt University of Berlin	Zebger, I (corresponding author), Tech Univ Berlin, Max Volmer Lab, Str 17 Juni 135, D-10623 Berlin, Germany.	ingo.zebger@tu-berlin.de; oliver.lenz@cms.hu-berlin.de	Lenz, Oliver/C-1582-2019; Lenz, Oliver/N-5130-2019; Winter, Gordon/R-6185-2017	Lenz, Oliver/0000-0003-4550-5128; Lenz, Oliver/0000-0003-4550-5128; Winter, Gordon/0000-0001-8855-8057	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Cluster of Excellence "Unifying Concepts in Catalysis."	Blokesch M, 2004, EUR J BIOCHEM, V271, P3428, DOI 10.1111/j.1432-1033.2004.04280.x; Blokesch M, 2004, J MOL BIOL, V344, P155, DOI 10.1016/j.jmb.2004.09.040; Blokesch M, 2006, FEBS LETT, V580, P4065, DOI 10.1016/j.febslet.2006.06.045; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Burstel I, 2011, J BIOL CHEM, V286, P44937, DOI 10.1074/jbc.M111.309351; Chung KCC, 2011, FEBS LETT, V585, P291, DOI 10.1016/j.febslet.2010.12.024; De Lacey AL, 2007, CHEM REV, V107, P4304, DOI 10.1021/cr0501947; Dernedde J, 1996, EUR J BIOCHEM, V235, P351, DOI 10.1111/j.1432-1033.1996.00351.x; DERNEDDE J, 1993, ARCH MICROBIOL, V159, P545, DOI 10.1007/BF00249034; Forzi L, 2007, FEBS LETT, V581, P3317, DOI 10.1016/j.febslet.2007.06.028; Forzi L, 2007, BIOMETALS, V20, P565, DOI 10.1007/s10534-006-9048-5; FRIEDRICH B, 1981, J BACTERIOL, V145, P1144, DOI 10.1128/JB.145.3.1144-1149.1981; Gordon JC, 2010, ORGANOMETALLICS, V29, P4682, DOI 10.1021/om100436c; Jones AK, 2004, BIOCHEMISTRY-US, V43, P13467, DOI 10.1021/bi048837k; Kaluarachchi H, 2011, BIOCHEMISTRY-US, V50, P10761, DOI 10.1021/bi201590d; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lenz O, 2007, FEBS LETT, V581, P3322, DOI 10.1016/j.febslet.2007.06.027; Lenz O, 2010, CHEMPHYSCHEM, V11, P1107, DOI 10.1002/cphc.200901002; Ludwig M, 2009, J BIOL CHEM, V284, P2159, DOI 10.1074/jbc.M808488200; Magalon A, 2001, FEBS LETT, V499, P73, DOI 10.1016/S0014-5793(01)02525-X; Moreland AC, 2000, INORG CHEM, V39, P3029, DOI 10.1021/ic9912629; Nakamoto K., 2008, INFRARED RAMAN SPECT, P403; Pandelia ME, 2010, CHEMPHYSCHEM, V11, P1127, DOI 10.1002/cphc.200900950; Petkun S, 2011, STRUCTURE, V19, P1773, DOI 10.1016/j.str.2011.09.023; PRIEFERT H, 1991, J BACTERIOL, V173, P4056, DOI 10.1128/jb.173.13.4056-4071.1991; Rauchfuss TB, 2001, J AM CHEM SOC, V123, P6933, DOI 10.1021/ja015948n; Reissmann S, 2003, SCIENCE, V299, P1067, DOI 10.1126/science.1080972; Roseboom W, 2005, FEBS LETT, V579, P469, DOI 10.1016/j.febslet.2004.12.013; SCHINK B, 1979, BIOCHIM BIOPHYS ACTA, V567, P315, DOI 10.1016/0005-2744(79)90117-7; Schwartz E, 1998, J BACTERIOL, V180, P3197, DOI 10.1128/JB.180.12.3197-3204.1998; Schwartz E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P496, DOI 10.1007/0-387-30742-7_17; Schwarze A, 2010, APPL ENVIRON MICROB, V76, P2641, DOI 10.1128/AEM.02700-09; SRIVASTAVA S, 1982, ARCH MICROBIOL, V131, P203, DOI 10.1007/BF00405879; Tard C, 2009, CHEM REV, V109, P2245, DOI 10.1021/cr800542q; Thiemermann S, 1996, J BACTERIOL, V178, P2368, DOI 10.1128/jb.178.8.2368-2374.1996; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Watanabe S, 2007, MOL CELL, V27, P29, DOI 10.1016/j.molcel.2007.05.039; Wolf I, 1998, ARCH MICROBIOL, V170, P451, DOI 10.1007/s002030050666	38	41	41	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38845	38853		10.1074/jbc.M112.376947	http://dx.doi.org/10.1074/jbc.M112.376947			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23019332	Green Published, hybrid			2022-12-28	WOS:000310982800041
J	Renner, LD; Weibel, DB				Renner, Lars D.; Weibel, Douglas B.			MinD and MinE Interact with Anionic Phospholipids and Regulate Division Plane Formation in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUARTZ-CRYSTAL MICROBALANCE; CELL-DIVISION; MEMBRANE INTERACTION; IN-VITRO; TOPOLOGICAL REGULATION; SUPPORTED MEMBRANES; PROTEIN-PATTERNS; POLE OSCILLATION; RAPID POLE; LOCALIZATION	The Min proteins (MinC, MinD, and MinE) form a pole-to-pole oscillator that controls the spatial assembly of the division machinery in Escherichia coli cells. Previous studies identified that interactions of MinD with phospholipids positioned the Min machinery at the membrane. We extend these studies by measuring the affinity, kinetics, and ATPase activity of E. coli MinD, MinE, and MinDE binding to supported lipid bilayers containing varying compositions of anionic phospholipids. Using quartz crystal microbalance measurements, we found that the binding affinity (K-d) for the interaction of recombinant E. coli MinD and MinE with lipid bilayers increased with increasing concentration of the anionic phospholipids phosphatidylglycerol and cardiolipin. The K-d for MinD (1.8 mu M) in the presence of ATP was smaller than for MinE (12.1 mu M) binding to membranes consisting of 95:5 phosphatidylcholine/cardiolipin. The simultaneous binding of MinD and MinE to membranes revealed that increasing the concentration of anionic phospholipid stimulates the initial rate of adsorption (k(on)). The ATPase activity of MinD decreased in the presence of anionic phospholipids. These results indicate that anionic lipids, which are concentrated at the poles, increase the retention of MinD and MinE and explain its dwell time at this region of bacterial cells. These studies provide insight into interactions between MinD and MinE and between these proteins and membranes that are relevant to understanding the process of bacterial cell division, in which the interaction of proteins and membranes is essential.	[Renner, Lars D.; Weibel, Douglas B.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Weibel, Douglas B.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Weibel, DB (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	weibel@biochem.wisc.edu	Renner, Lars D/D-6291-2012; Renner, Lars David/AAQ-2732-2021	Renner, Lars D/0000-0003-0178-1788; 	Alfred P. Sloan Foundation; Kinship Foundation; Deutsche Forschungsgemeinschaft; National Science Foundation [DMR-0520527]	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Kinship Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF))	This work was supported by an Alfred P. Sloan Foundation fellowship (to D.B.W.), the Kinship Foundation Searle Scholarship (to D.B.W.), a Deutsche Forschungsgemeinschaft fellowship (to L.D.R.), and National Science Foundation Grant DMR-0520527.	Barak I, 2008, MOL MICROBIOL, V68, P1315, DOI 10.1111/j.1365-2958.2008.06236.x; Bramkamp M, 2009, CURR OPIN MICROBIOL, V12, P683, DOI 10.1016/j.mib.2009.10.002; Corbin BD, 2002, EMBO J, V21, P1998, DOI 10.1093/emboj/21.8.1998; Cronan JE, 2003, ANNU REV MICROBIOL, V57, P203, DOI 10.1146/annurev.micro.57.030502.090851; Cytrynbaum EN, 2007, BIOPHYS J, V93, P1134, DOI 10.1529/biophysj.106.097162; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; DEBOER PAJ, 1991, EMBO J, V10, P4371, DOI 10.1002/j.1460-2075.1991.tb05015.x; Fange D, 2006, PLOS COMPUT BIOL, V2, P637, DOI 10.1371/journal.pcbi.0020080; Hsieh CW, 2010, MOL MICROBIOL, V75, P499, DOI 10.1111/j.1365-2958.2009.07006.x; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Huang KC, 2004, PHYS BIOL, V1, P229, DOI 10.1088/1478-3967/1/4/005; Huang KC, 2003, P NATL ACAD SCI USA, V100, P12724, DOI 10.1073/pnas.2135445100; Huang KC, 2010, MOL MICROBIOL, V76, P822, DOI 10.1111/j.1365-2958.2010.07168.x; Israelachvili J, 2005, Q REV BIOPHYS, V38, P331, DOI 10.1017/S0033583506004203; Ivanov V, 2010, P NATL ACAD SCI USA, V107, P8071, DOI 10.1073/pnas.0911036107; Johnson JM, 2002, BIOPHYS J, V83, P3371, DOI 10.1016/S0006-3495(02)75337-X; Keller CA, 2000, PHYS REV LETT, V84, P5443, DOI 10.1103/PhysRevLett.84.5443; Keller CA, 1998, BIOPHYS J, V75, P1397, DOI 10.1016/S0006-3495(98)74057-3; Khalifat N, 2008, BIOPHYS J, V95, P4924, DOI 10.1529/biophysj.108.136077; Koppelman CM, 2001, J BACTERIOL, V183, P6144, DOI 10.1128/JB.183.20.6144-6147.2001; Kruse K, 2007, MOL MICROBIOL, V63, P1279, DOI 10.1111/j.1365-2958.2007.05607.x; Lackner LL, 2003, J BACTERIOL, V185, P735, DOI 10.1128/JB.185.3.735-749.2003; Li G, 2012, MOL MICROBIOL, V84, P276, DOI 10.1111/j.1365-2958.2012.08021.x; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Loose M, 2011, NAT STRUCT MOL BIOL, V18, P577, DOI 10.1038/nsmb.2037; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Mazor S, 2008, BBA-BIOMEMBRANES, V1778, P2505, DOI 10.1016/j.bbamem.2008.08.004; Mazor S, 2008, BBA-BIOMEMBRANES, V1778, P2496, DOI 10.1016/j.bbamem.2008.08.003; Mileykovskaya E, 2003, J BIOL CHEM, V278, P22193, DOI 10.1074/jbc.M302603200; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Park KT, 2011, CELL, V146, P396, DOI 10.1016/j.cell.2011.06.042; Ramirez-Arcos S, 2002, MOL MICROBIOL, V46, P493, DOI 10.1046/j.1365-2958.2002.03168.x; RAND RP, 1972, BIOCHIM BIOPHYS ACTA, V225, P484, DOI 10.1016/0005-2736(72)90152-6; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396; Romantsov T, 2007, MOL MICROBIOL, V64, P1455, DOI 10.1111/j.1365-2958.2007.05727.x; Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43; SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937; Schweizer J, 2012, P NATL ACAD SCI USA, V109, P15283, DOI 10.1073/pnas.1206953109; Shih YL, 2002, EMBO J, V21, P3347, DOI 10.1093/emboj/cdf323; Shih YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021425; Szeto TH, 2003, J BIOL CHEM, V278, P40050, DOI 10.1074/jbc.M306876200; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; Szeto TH, 2001, J BACTERIOL, V183, P6684, DOI 10.1128/JB.183.22.6684-6687.2001; Varma A, 2008, J BACTERIOL, V190, P2106, DOI 10.1128/JB.00720-07; Wu W, 2011, MOL MICROBIOL, V79, P1515, DOI 10.1111/j.1365-2958.2010.07536.x	49	60	63	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38835	38844		10.1074/jbc.M112.407817	http://dx.doi.org/10.1074/jbc.M112.407817			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23012351	hybrid, Green Published			2022-12-28	WOS:000310982800040
J	Wun, KS; Ross, F; Patel, O; Besra, GS; Porcelli, SA; Richardson, SK; Keshipeddy, S; Howell, AR; Godfrey, DI; Rossjohn, J				Wun, Kwok S.; Ross, Fiona; Patel, Onisha; Besra, Gurdyal S.; Porcelli, Steven A.; Richardson, Stewart K.; Keshipeddy, Santosh; Howell, Amy R.; Godfrey, Dale I.; Rossjohn, Jamie			Human and Mouse Type I Natural Killer T Cell Antigen Receptors Exhibit Different Fine Specificities for CD1d-Antigen Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVARIANT NKT CELLS; STRUCTURAL BASIS; CUTTING EDGE; RECOGNITION; GLYCOLIPIDS; CD1D; SELECTION; LYMPHOCYTES; KINETICS; AGONISTS	Human and mouse type I natural killer T (NKT) cells respond to a variety of CD1d-restricted glycolipid antigens (Ags), with their NKT cell antigen receptors ( NKT TCRs) exhibiting reciprocal cross-species reactivity that is underpinned by a conserved NKT TCR-CD1d-Ag docking mode. Within this common docking footprint, the NKT TCR recognizes, to varying degrees of affinity, a range of Ags. Presently, it is unclear whether the human NKTTCRs will mirror the generalities underpinning the fine specificity of the mouse NKT TCR-CD1d-Ag interaction. Here, we assessed human NKT TCR recognition against altered glycolipid ligands of alpha-galactosylceramide (alpha-GalCer) and have determined the structures of a human NKT TCR in complex with CD1d-4',4 ''-deoxy-alpha-GalCer and CD1d-alpha-GalCer with a shorter, di-unsaturated acyl chain (C20:2). Altered glycolipid ligands with acyl chain modifications did not affect the affinity of the human NKT TCR-CD1d-Ag interaction. Surprisingly, human NKT TCR recognition is more tolerant to modifications at the 4'-OH position in comparison with the 3'-OH position of alpha-GalCer, which contrasts the fine specificity of the mouse NKT TCR-CD1d-Ag recognition (4'-OH > 3'-OH). The fine specificity differences between human and mouse NKT TCRs was attributable to differing interactions between the respective complementarity-determining region 1 alpha loops and the Ag. Accordingly, germline encoded fine-specificity differences underpin human and mouse type I NKT TCR interactions, which is an important consideration for therapeutic development and NKT cell physiology.	[Ross, Fiona; Godfrey, Dale I.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Wun, Kwok S.; Patel, Onisha; Rossjohn, Jamie] Monash Univ, Australian Res Council ARC Ctr Excellence Struct, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic 3800, Australia; [Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Porcelli, Steven A.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Richardson, Stewart K.; Keshipeddy, Santosh; Howell, Amy R.] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA	University of Melbourne; Monash University; University of Birmingham; Yeshiva University; Albert Einstein College of Medicine; University of Connecticut	Godfrey, DI (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	godfrey@unimelb.edu.au; jamie.rossjohn@monash.edu	Rossjohn, Jamie/F-9032-2013	Rossjohn, Jamie/0000-0002-2020-7522; Howell, Amy/0000-0003-1958-6411; keshipeddy, santosh/0000-0002-9375-2230; Besra, Gurdyal/0000-0002-5605-0395; Patel, Onisha/0000-0001-6701-7139; Wun, Kwok/0000-0002-1908-4596; Godfrey, Dale/0000-0002-3009-5472	National Health and Medical Research Council of Australia (NHMRC); ARC; Cancer Council of Victoria; NIH [GM 087136]; ARC Future Fellowship; NHMRC Australia Fellowship; NHMRC Senior Principal Research Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087136] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1048717] Funding Source: National Science Foundation	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARC Future Fellowship(Australian Research Council); NHMRC Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This research was supported by the National Health and Medical Research Council of Australia (NHMRC), the ARC, the Cancer Council of Victoria and an NIH RO1 Grant GM 087136.; Supported by an ARC Future Fellowship.; Supported by an NHMRC Senior Principal Research Fellowship. To whom correspondence may be addressed. Tel.: 613-8344-5689; Fax:613-93471540; E-mail: godfrey@unimelb.edu.au.; Supported by an NHMRC Australia Fellowship. To whom correspondence may be addressed. Tel: 613-99029236; Fax: 613-99025000; E-mail: jamie.rossjohn@monash.edu.	Aspeslagh S, 2011, EMBO J, V30, P2294, DOI 10.1038/emboj.2011.145; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borg NA, 2007, ADV EXP MED BIOL, V598, P20; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; Brigl M, 2006, J IMMUNOL, V176, P3625, DOI 10.4049/jimmunol.176.6.3625; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Cerundolo V, 2010, CURR OPIN IMMUNOL, V22, P417, DOI 10.1016/j.coi.2010.04.003; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Florence WC, 2009, EMBO J, V28, P3579, DOI 10.1038/emboj.2009.286; Gadola SD, 2006, J EXP MED, V203, P699, DOI 10.1084/jem.20052369; Girardi E, 2012, NAT IMMUNOL, V13, P851, DOI 10.1038/ni.2371; Girardi E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001189; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; Godfrey DI, 2010, SEMIN IMMUNOL, V22, P61, DOI 10.1016/j.smim.2009.10.004; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Im JS, 2009, IMMUNITY, V30, P888, DOI 10.1016/j.immuni.2009.03.022; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kerzerho J, 2012, J IMMUNOL, V188, P2254, DOI 10.4049/jimmunol.1103049; Kinjo Y, 2005, J CLIN IMMUNOL, V25, P522, DOI 10.1007/s10875-005-8064-5; Kinjo Y, 2011, NAT IMMUNOL, V12, P966, DOI 10.1038/ni.2096; Kjer-Nielsen L, 2006, J EXP MED, V203, P661, DOI 10.1084/jem.20051777; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Li YL, 2010, J EXP MED, V207, P2383, DOI 10.1084/jem.20101335; Lopez-Sagaseta J, 2012, EMBO J, V31, P2047, DOI 10.1038/emboj.2012.54; Mallevaey T, 2011, IMMUNITY, V34, P315, DOI 10.1016/j.immuni.2011.01.013; Mallevaey T, 2009, IMMUNITY, V31, P60, DOI 10.1016/j.immuni.2009.05.010; Matulis G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000402; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Patel O, 2012, NAT IMMUNOL, V13, P857, DOI 10.1038/ni.2372; Patel O, 2011, P NATL ACAD SCI USA, V108, P19007, DOI 10.1073/pnas.1109066108; Patel O, 2011, J IMMUNOL, V187, P4705, DOI 10.4049/jimmunol.1100794; Pellicci DG, 2011, NAT IMMUNOL, V12, P827, DOI 10.1038/ni.2076; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Raju R, 2009, BIOORG MED CHEM LETT, V19, P4122, DOI 10.1016/j.bmcl.2009.06.005; Rhost S, 2012, SCAND J IMMUNOL, V76, P246, DOI 10.1111/j.1365-3083.2012.02750.x; Schiefner A, 2009, J MOL BIOL, V394, P71, DOI 10.1016/j.jmb.2009.08.061; Schumann J, 2006, J IMMUNOL, V176, P2064, DOI 10.4049/jimmunol.176.4.2064; Scott-Browne JP, 2007, NAT IMMUNOL, V8, P1105, DOI 10.1038/ni1510; Uldrich AP, 2011, NAT IMMUNOL, V12, P616, DOI 10.1038/ni.2051; Venkataswamy MM, 2010, SEMIN IMMUNOL, V22, P68, DOI 10.1016/j.smim.2009.10.003; Wei DG, 2006, J EXP MED, V203, P1197, DOI 10.1084/jem.20060418; Wun KS, 2008, J EXP MED, V205, P939, DOI 10.1084/jem.20072141; Wun KS, 2011, IMMUNITY, V34, P327, DOI 10.1016/j.immuni.2011.02.001; Yu ED, 2011, J IMMUNOL, V187, P2079, DOI 10.4049/jimmunol.1101636; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	49	29	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39139	39148		10.1074/jbc.M112.412320	http://dx.doi.org/10.1074/jbc.M112.412320			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22995911	Green Published, hybrid			2022-12-28	WOS:000310982800069
J	Chen, TD; Xue, LX; Niu, J; Ma, LW; Li, N; Cao, XX; Li, Q; Wang, M; Zhao, WT; Li, GD; Wang, JM; Tong, TJ				Chen, Tianda; Xue, Lixiang; Niu, Jing; Ma, Liwei; Li, Na; Cao, Xiaoxiao; Li, Qian; Wang, Meng; Zhao, Wenting; Li, Guodong; Wang, Jiamu; Tong, Tanjun			The Retinoblastoma Protein Selectively Represses E2F1 Targets via a TAAC DNA Element during Cellular Senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN FIBROBLASTS; TUMOR-SUPPRESSOR; HETEROCHROMATIN FORMATION; REPLICATIVE SENESCENCE; GENES; CYCLE; PROLIFERATION; ACTIVATION; P27(KIP1); MYB	The retinoblastoma (Rb) protein mediates heterochromatin formation at the promoters of E2 transcription factor 1 (E2F1) target genes, such as proliferating cell nuclear antigen and cyclin A2 (CCNA2), and represses these genes during cellular senescence. However, the selectivity of Rb recruitment is still not well understood. Here, we demonstrate that a senescence-associated gene is a direct target of E2F1 and is also repressed by heterochromatin in senescent cells. In contrast, ARF and p27(KIP1), which are also E2F1 targets, are not repressed by Rb and heterochromatin formation. By comparing the promoter sequences of these genes, we found a novel TAAC element that is present in the cellular senescence-inhibited gene, proliferating cell nuclear antigen, and CCNA2 promoters but absent from the ARF and p27KIP1 promoters. This TAAC element associates with Rb and is required for Rb recruitment. We further determined that TAAC element-mediated Rb association requires the E2F1 binding site, but not E2F1 protein. These results provide a novel molecular mechanism for the different expression patterns of E2F1 targets and afford new mechanistic insight regarding the selectivity of Rb-mediated heterochromatin formation and gene repression during cellular senescence.	[Chen, Tianda; Xue, Lixiang; Niu, Jing; Ma, Liwei; Li, Na; Cao, Xiaoxiao; Li, Qian; Wang, Meng; Zhao, Wenting; Li, Guodong; Wang, Jiamu; Tong, Tanjun] Peking Univ, Hlth Sci Ctr, Res Ctr Aging, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China	Peking University	Tong, TJ (corresponding author), Peking Univ, Hlth Sci Ctr, Res Ctr Aging, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China.	ttj@bjmu.edu.cn	Li, Na/AAV-8761-2020		National Basic Research Programs of China [2012CB911200, 2013CB530801]; National Natural Science Foundation of China [30973146, 31000609, 31071206]; Ministry of Education of the People's Republic of China [20090001120044]	National Basic Research Programs of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of the People's Republic of China(Ministry of Education, China)	This work was supported by National Basic Research Programs of China Grants 2012CB911200 and 2013CB530801; National Natural Science Foundation of China Grants 30973146, 31000609, and 31071206; and Ministry of Education of the People's Republic of China Grant 20090001120044.	Alexander K, 2001, MOL CELL BIOL, V21, P3616, DOI 10.1128/MCB.21.11.3616-3631.2001; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chaussepied M, 2004, MOL CELL, V16, P831, DOI 10.1016/j.molcel.2004.11.003; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Dahiya A, 2001, MOL CELL, V8, P557, DOI 10.1016/S1097-2765(01)00346-X; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; DIMRI GP, 1994, J BIOL CHEM, V269, P16180; Elliott MJ, 2001, CLIN CANCER RES, V7, P3590; Gaubatz S, 2000, MOL CELL, V6, P729, DOI 10.1016/S1097-2765(00)00071-X; Guo SZ, 2004, EXP CELL RES, V298, P465, DOI 10.1016/j.yexcr.2004.04.044; Haddad MM, 1999, EXP CELL RES, V253, P561, DOI 10.1006/excr.1999.4688; Humbert PO, 2000, GENE DEV, V14, P690; Iaquinta PJ, 2005, COLD SH Q B, V70, P309, DOI 10.1101/sqb.2005.70.050; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Joaquin M, 2002, ONCOGENE, V21, P7923, DOI 10.1038/sj.onc.1206001; Leone G, 1997, NATURE, V387, P422, DOI 10.1038/387422a0; Li QA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013732; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Litovchick L, 2011, GENE DEV, V25, P801, DOI 10.1101/gad.2034211; Ma LW, 2008, MOL CELL BIOL, V28, P6290, DOI 10.1128/MCB.00142-08; McConnell BB, 1998, CURR BIOL, V8, P351, DOI 10.1016/S0960-9822(98)70137-X; Mittnacht S, 1997, CURR BIOL, V7, P219, DOI 10.1016/S0960-9822(97)70094-0; MIZUGUCHI G, 1990, J BIOL CHEM, V265, P9280; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Peeper DS, 1997, NATURE, V386, P177, DOI 10.1038/386177a0; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; SAIKUMAR P, 1990, P NATL ACAD SCI USA, V87, P8452, DOI 10.1073/pnas.87.21.8452; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Tsai RYL, 2005, J CELL BIOL, V168, P179, DOI 10.1083/jcb.200409053; Wang CG, 2005, J BIOL CHEM, V280, P12339, DOI 10.1074/jbc.C400536200; Zhang HS, 1999, CELL, V97, P53, DOI 10.1016/S0092-8674(00)80714-X; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997; Zhu L, 2010, CELL RES, V20, P605, DOI 10.1038/cr.2010.71	37	20	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37540	37551		10.1074/jbc.M111.260679	http://dx.doi.org/10.1074/jbc.M111.260679			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22955272	hybrid, Green Published			2022-12-28	WOS:000310588500082
J	Cheng, X; Folco, EJ; Shimizu, K; Libby, P				Cheng, Xiang; Folco, Eduardo J.; Shimizu, Koichi; Libby, Peter			Adiponectin Induces Pro-inflammatory Programs in Human Macrophages and CD4(+) T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY-HEART-DISEASE; ADIPOSE-SPECIFIC PROTEIN; PLASMA ADIPONECTIN; TNF-ALPHA; ALTERNATIVE ACTIVATION; INSULIN-RESISTANCE; METABOLIC SYNDROME; IMMUNE-RESPONSES; EXPRESSION; HYPOADIPONECTINEMIA	Abundant experimental and clinical data support a modulatory role for adiponectin in inflammation, dysmetabolism, and disease. Because the activation of cells involved in innate and adaptive immunity contributes to the pathogenesis of diseases such as atherosclerosis and obesity, this study investigated the role of adiponectin in human macrophage polarization and T cell differentiation. Examination of the adiponectin-induced transcriptome in primary human macrophages revealed that adiponectin promotes neither classical (M1) nor alternative (M2) macrophage activation but elicits a pro-inflammatory response that resembles M1 more closely than M2. Addition of adiponectin to polyclonally activated CD4(+) T lymphocytes did not affect cell proliferation but induced mRNA expression and protein secretion of interferon (IFN)-gamma and interleukin (IL)-6. Adiponectin treatment of CD4(+) T cells increased phosphorylation of p38 mitogen-activated protein kinase (MAPK) and signal transducer and activation of transcription (STAT) 4 and augmented T-bet expression. Inhibition of p38 with SB203580 abrogated adiponectin-induced IFN-gamma production, indicating that adiponectin enhances T(H)1 differentiation through the activation of the p38-STAT4-T-bet axis. Collectively, our results demonstrate that adiponectin can induce pro-inflammatory functions in isolated macrophages and T cells, concurring with previous observations that adiponectin induces a limited program of inflammatory activation that likely desensitizes these cells to further pro-inflammatory stimuli.	[Libby, Peter] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Libby, P (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc Med, 77 Ave Louis Pasteur,NRB 741, Boston, MA 02115 USA.	plibby@rics.bwh.harvard.edu	Libby, Peter/AAY-6404-2021	Libby, Peter/0000-0002-1502-502X				Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Cui GL, 2009, J BIOL CHEM, V284, P28420, DOI 10.1074/jbc.M109.012674; Folco EJ, 2009, J BIOL CHEM, V284, P25569, DOI 10.1074/jbc.M109.019786; Goldstein BJ, 2009, NAT CLIN PRACT CARD, V6, P27, DOI 10.1038/ncpcardio1398; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Iwashima Y, 2004, HYPERTENSION, V43, P1318, DOI 10.1161/01.HYP.0000129281.03801.4b; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kato H, 2006, ARTERIOSCL THROM VAS, V26, P224, DOI 10.1161/01.ATV.0000194076.84568.81; Kazumi T, 2004, METABOLISM, V53, P589, DOI 10.1016/j.metabol.2003.12.008; Kumada M, 2004, CIRCULATION, V109, P2046, DOI 10.1161/01.CIR.0000127953.98131.ED; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Lawlor DA, 2005, J CLIN ENDOCR METAB, V90, P5677, DOI 10.1210/jc.2005-0825; Lee MH, 2008, BIOCHEMISTRY-US, V47, P11682, DOI 10.1021/bi801451f; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Lindsay RS, 2005, ARTERIOSCL THROM VAS, V25, pE15, DOI 10.1161/01.ATV.0000153090.21990.8c; Lovren F, 2010, AM J PHYSIOL-HEART C, V299, pH656, DOI 10.1152/ajpheart.00115.2010; Mandal P, 2011, J BIOL CHEM, V286, P13460, DOI 10.1074/jbc.M110.204644; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Matsubara M, 2002, J CLIN ENDOCR METAB, V87, P2764, DOI 10.1210/jc.87.6.2764; Nawrocki AR, 2010, ARTERIOSCL THROM VAS, V30, P1159, DOI 10.1161/ATVBAHA.109.195826; Nishihara T, 2006, GASTROENTEROLOGY, V131, P853, DOI 10.1053/j.gastro.2006.06.015; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Okamoto Y, 2006, CLIN SCI, V110, P267, DOI 10.1042/CS20050182; Okamoto Y, 2008, CIRC RES, V102, P218, DOI 10.1161/CIRCRESAHA.107.164988; Okamoto Y, 2009, TRANSPLANTATION, V88, P879, DOI 10.1097/TP.0b013e3181b6efbf; Otake H, 2008, AM J CARDIOL, V101, P1, DOI 10.1016/j.amjcard.2007.07.041; Ouchi N, 2003, HYPERTENSION, V42, P231, DOI 10.1161/01.HYP.0000083488.67550.B8; Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057; Palmer C, 2008, HEPATOLOGY, V48, P374, DOI 10.1002/hep.22387; Park PH, 2007, J BIOL CHEM, V282, P21695, DOI 10.1074/jbc.M701419200; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Sattar N, 2006, CIRCULATION, V114, P623, DOI 10.1161/CIRCULATIONAHA.106.618918; Schulte S, 2008, AM J PATHOL, V172, P1500, DOI 10.2353/ajpath.2008.070776; Schulze MB, 2004, DIABETES CARE, V27, P1680, DOI 10.2337/diacare.27.7.1680; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takahashi T, 2005, J INT MED RES, V33, P207, DOI 10.1177/147323000503300208; Thakur V, 2006, AM J PHYSIOL-GASTR L, V290, pG998, DOI 10.1152/ajpgi.00553.2005; Trujillo ME, 2005, J INTERN MED, V257, P167, DOI 10.1111/j.1365-2796.2004.01426.x; Tsatsanis C, 2005, BIOCHEM BIOPH RES CO, V335, P1254, DOI 10.1016/j.bbrc.2005.07.197; Uji Y, 2009, SURGERY, V145, P550, DOI 10.1016/j.surg.2009.01.010; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Wilk S, 2011, EUR J IMMUNOL, V41, P2323, DOI 10.1002/eji.201041349; Wulster-Radcliffe MC, 2004, BIOCHEM BIOPH RES CO, V316, P924, DOI 10.1016/j.bbrc.2004.02.130; Yamaguchi N, 2005, FEBS LETT, V579, P6821, DOI 10.1016/j.febslet.2005.11.019; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Zhu WD, 2008, CLIN SCI, V114, P361, DOI 10.1042/CS20070347	51	89	94	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36896	36904		10.1074/jbc.M112.409516	http://dx.doi.org/10.1074/jbc.M112.409516			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22948153	Green Published, hybrid			2022-12-28	WOS:000310588500026
J	Serneels, J; Tournu, H; Van Dijck, P				Serneels, Joke; Tournu, Helene; Van Dijck, Patrick			Tight Control of Trehalose Content Is Required for Efficient Heat-induced Cell Elongation in Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; PROTEIN-COUPLED RECEPTOR; DECREASES INFECTIVITY; ASPERGILLUS-FUMIGATUS; TRANSCRIPTION FACTOR; OSMOLYTE TREHALOSE; OXIDATIVE STRESS; HYPHA FORMATION; GENE; TREHALOSE-6-PHOSPHATE	The ability to form hyphae in the human pathogenic fungus Candida albicans is a prerequisite for virulence. It contributes to tissue infection, biofilm formation, as well as escape from phagocytes. Cell elongation triggered by human body temperature involves the essential heat shock protein Hsp90, which negatively governs a filamentation program dependent upon the Ras-protein kinase A (PKA) pathway. Tight regulation of Hsp90 function is required to ensure fast appropriate response and maintenance of a wide range of regulatory and signaling proteins. Client protein activation by Hsp90 relies on a conformational change of the chaperone, whose ATPase activity is competitively inhibited by geldanamycin. We demonstrate a novel regulatory mechanism of heat- and Hsp90-dependent induced morphogenesis, whereby the nonreducing disaccharide trehalose acts as a negative regulator of Hsp90 release. By means of a mutant strain deleted for Gpr1, the G protein-coupled receptor upstream of PKA, we demonstrate that elevated trehalose content in that strain, resulting from misregulation of enzymatic activities involved in trehalose metabolism, disrupts the filamentation program in response to heat. Addition of geldanamycin does not result in hyphal extensions at 30 C in the gpr1 Delta/gpr1 Delta mutant as it does in wild type cells. In addition, validamycin, a specific inhibitor of trehalase, the trehalose-degrading enzyme, inhibits cell elongation in response to heat and geldanamycin. These results place Gpr1 as a regulator of trehalose metabolism in C. albicans and illustrate that trehalose modulates Hsp90-dependent activation of client proteins and signaling pathways leading to filamentation in the human fungal pathogen.	[Van Dijck, Patrick] Katholieke Univ Leuven, VIB, Dept Mol Microbiol, B-3001 Heverlee, Belgium; Katholieke Univ Leuven, Mol Cell Biol Lab, B-3001 Heverlee, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven	Van Dijck, P (corresponding author), Katholieke Univ Leuven, VIB, Dept Mol Microbiol, Kasteelpk,Arenberg 31,Bus 2438, B-3001 Heverlee, Belgium.	patrick.vandijck@mmbio.vib-kuleuven.be			Flemish Science Foundation, FWO [G.0804.11, WO.026.11N]; research funds of KU Leuven [GOA/2007/08, CREA/11/012]	Flemish Science Foundation, FWO(FWO); research funds of KU Leuven	This work was funded by Flemish Science Foundation, FWO Grants G.0804.11 and WO.026.11N and by research funds of KU Leuven Grants GOA/2007/08 and CREA/11/012.	Al-Bader N, 2010, INFECT IMMUN, V78, P3007, DOI 10.1128/IAI.00813-09; Alvarez-Peral FJ, 2000, RES MICROBIOL, V151, P837, DOI 10.1016/S0923-2508(00)01150-5; ASANO N, 1987, J ANTIBIOT, V40, P526, DOI 10.7164/antibiotics.40.526; Bahn YS, 2003, MOL MICROBIOL, V50, P391, DOI 10.1046/j.1365-2958.2003.03692.x; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; BLAZQUEZ MA, 1993, FEBS LETT, V329, P51, DOI 10.1016/0014-5793(93)80191-V; Bockmuhl DP, 2001, MOL MICROBIOL, V42, P1243, DOI 10.1046/j.1365-2958.2001.02688.x; Cao F, 2006, MOL BIOL CELL, V17, P295, DOI 10.1091/mbc.E05-06-0502; Colombo S, 1998, EMBO J, V17, P3326, DOI 10.1093/emboj/17.12.3326; Conlin LK, 2007, MOL CELL BIOL, V27, P1505, DOI 10.1128/MCB.01158-06; Eck R, 1997, MICROBIOL-UK, V143, P3747, DOI 10.1099/00221287-143-12-3747; Elliott B, 1996, GENETICS, V144, P923; Fillinger S, 2001, MICROBIOL-SGM, V147, P1851, DOI 10.1099/00221287-147-7-1851; FONZI WA, 1993, GENETICS, V134, P717; Foster AJ, 2003, EMBO J, V22, P225, DOI 10.1093/emboj/cdg018; KAMEDA Y, 1986, J ANTIBIOT, V39, P1491, DOI 10.7164/antibiotics.39.1491; Kaushik JK, 2003, J BIOL CHEM, V278, P26458, DOI 10.1074/jbc.M300815200; Kraakman L, 1999, MOL MICROBIOL, V32, P1002, DOI 10.1046/j.1365-2958.1999.01413.x; Lemaire K, 2004, MOL CELL, V16, P293, DOI 10.1016/j.molcel.2004.10.004; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maidan MM, 2005, MOL BIOL CELL, V16, P1971, DOI 10.1091/mbc.E04-09-0780; Maidan MM, 2008, INFECT IMMUN, V76, P1686, DOI 10.1128/IAI.01497-07; Ngamskulrungroj P, 2009, INFECT IMMUN, V77, P4584, DOI 10.1128/IAI.00565-09; Nicholls S, 2009, MOL MICROBIOL, V74, P844, DOI 10.1111/j.1365-2958.2009.06883.x; Nwaka S, 1998, PROG NUCLEIC ACID RE, V58, P197; Pedreno Y, 2007, MICROBIOL-SGM, V153, P1372, DOI 10.1099/mic.0.2006/003921-0; Pernambuco MB, 1996, MICROBIOL-SGM, V142, P1775, DOI 10.1099/13500872-142-7-1775; Petzold EW, 2006, INFECT IMMUN, V74, P5877, DOI 10.1128/IAI.00624-06; PIPER PW, 1988, FEMS MICROBIOL LETT, V49, P245; Puttikamonkul S, 2010, MOL MICROBIOL, V77, P891, DOI 10.1111/j.1365-2958.2010.07254.x; Reinders A, 1997, MOL MICROBIOL, V24, P687, DOI 10.1046/j.1365-2958.1997.3861749.x; Rocha CRC, 2001, MOL BIOL CELL, V12, P3631, DOI 10.1091/mbc.12.11.3631; Rolland F, 2001, FEMS YEAST RES, V1, P33, DOI 10.1111/j.1567-1364.2001.tb00011.x; Sebollela A, 2004, INT J BIOCHEM CELL B, V36, P900, DOI 10.1016/j.biocel.2003.10.006; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Shapiro RS, 2012, CURR BIOL, V22, P461, DOI 10.1016/j.cub.2012.01.062; Shapiro RS, 2009, CURR BIOL, V19, P621, DOI 10.1016/j.cub.2009.03.017; Singer MA, 1998, MOL CELL, V1, P639, DOI 10.1016/S1097-2765(00)80064-7; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tapia H, 2010, MOL BIOL CELL, V21, P63, DOI 10.1091/mbc.E09-05-0376; THEVELEIN JM, 1984, MICROBIOL REV, V48, P42, DOI 10.1128/MMBR.48.1.42-59.1984; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Van Dijck P, 2002, INFECT IMMUN, V70, P1772, DOI 10.1128/IAI.70.4.1772-1782.2002; Whiteway M, 2007, ANNU REV MICROBIOL, V61, P529, DOI 10.1146/annurev.micro.61.080706.093341; Xu WJ, 2012, CURR BIOL, V22, pR225, DOI 10.1016/j.cub.2012.02.037; Zaragoza O, 1998, J BACTERIOL, V180, P3809, DOI 10.1128/JB.180.15.3809-3815.1998; Zaragoza O, 2003, INT MICROBIOL, V6, P121, DOI 10.1007/s10123-003-0119-y; Zaragoza O, 2002, MICROBIOL-SGM, V148, P1281, DOI 10.1099/00221287-148-5-1281	50	18	19	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36873	36882		10.1074/jbc.M112.402651	http://dx.doi.org/10.1074/jbc.M112.402651			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22952228	hybrid, Green Published			2022-12-28	WOS:000310588500024
J	Zaun, HC; Shrier, A; Orlowski, J				Zaun, Hans C.; Shrier, Alvin; Orlowski, John			N-Myristoylation and Ca2+ Binding of Calcineurin B Homologous Protein CHP3 Are Required to Enhance Na+/H+ Exchanger NHE1 Half-life and Activity at the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-BINDING PROTEIN; ESSENTIAL COFACTOR; ION TRANSLOCATION; PH REGULATION; CALCIUM; TESCALCIN; GENE; CELLS; DIFFERENTIATION; ACTIVATION	Calcineurin B homologous proteins (CHP) are N-myristoylated, EF-hand Ca2+-binding proteins that regulate multiple cellular processes, including intracellular pH homeostasis. Previous work has shown that the heart-enriched isoform, CHP3, regulates the plasmalemmal Na+/H+ exchanger NHE1 isoform by enhancing its rate of oligosaccharide maturation and exocytosis as well as its half-life and transport activity at the cell surface (Zaun, H. C., Shrier, A., and Orlowski, J. (2008) J. Biol. Chem. 283, 12456-12467). However, the molecular basis for this effect is not well understood. In this report, we investigated whether the N-myristoylation and Ca2+-binding domains of CHP3 are important elements for regulating NHE1. Mutation of residues essential for either N-myristoylation (G2A) or calcium binding (D123A) did not prevent the interaction of CHP3 with NHE1, although the D123A mutant no longer showed elevated binding to NHE1 in the presence of Ca2+ when assessed using in vitro binding assays. Disruption of either site also did not impair the ability of CHP3 to stimulate the biosynthetic processing and trafficking of NHE1 to the plasma membrane nor did it affect the H+ sensitivity of the exchanger. However, they did significantly reduce the cell surface half-life and near maximal transport velocity of NHE1 to a similar extent. Simultaneous mutation of both sites (G2A/D123A) gave results identical to the individual substitutions. This finding suggests that both domains in CHP3 are interdependent and may function cooperatively as a Ca2+ myristoyl switch mechanism to selectively stabilize the NHE1 center dot CHP3 complex at the cell surface in a conformation that promotes optimal transport activity.	[Zaun, Hans C.; Shrier, Alvin; Orlowski, John] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada	McGill University	Orlowski, J (corresponding author), McGill Univ, Dept Physiol, McIntyre Med Sci Bldg,3655 Promenade Sir William, Montreal, PQ H3G 1Y6, Canada.	john.orlowski@mcgill.ca		Orlowski, John/0000-0001-7371-175X	Canadian Institutes for Health Research [MOP 11221, MOP 86589]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grants MOP 11221 (to J. O.) and MOP 86589 (to A. S.) from the Canadian Institutes for Health Research.	Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; Ames JB, 2012, FRONT MOL NEUROSCI, V5, DOI [10.3389/fnmol.2012.00010, 10.1016/j.bbagen.2011.10.003]; Ames JB, 2002, ADV EXP MED BIOL, V514, P333; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Andrade J, 2004, BIOCHEM J, V384, P327, DOI 10.1042/BJ20040622; BERTRAND B, 1994, J BIOL CHEM, V269, P13703; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Di Sole F, 2012, AM J PHYSIOL-RENAL, V303, pF165, DOI 10.1152/ajprenal.00628.2011; DYCK JRB, 1995, J BIOL CHEM, V270, P10420, DOI 10.1074/jbc.270.18.10420; Gutierrez-Ford C, 2003, BIOCHEMISTRY-US, V42, P14553, DOI 10.1021/bi034870f; Inoue H, 2003, BIOL PHARM BULL, V26, P148, DOI 10.1248/bpb.26.148; Jin Q, 2007, IN VIVO, V21, P593; KAPUS A, 1994, J BIOL CHEM, V269, P23544; LADANT D, 1995, J BIOL CHEM, V270, P3179; LEBIVIC A, 1989, P NATL ACAD SCI USA, V86, P9313; Levay K, 2007, J CLIN INVEST, V117, P2672, DOI 10.1172/JCI27465; Li GD, 2008, J BIOL CHEM, V283, P32660, DOI 10.1074/jbc.M806684200; Li XJ, 2009, AM J PHYSIOL-HEART C, V296, pH159, DOI 10.1152/ajpheart.00375.2008; Lin X, 1999, J BIOL CHEM, V274, P36125, DOI 10.1074/jbc.274.51.36125; Mailander J, 2001, FEBS LETT, V507, P331, DOI 10.1016/S0014-5793(01)02986-6; Matsushita M, 2011, AM J PHYSIOL-CELL PH, V301, pC280, DOI 10.1152/ajpcell.00404.2010; Maurer-Stroh S, 2002, J MOL BIOL, V317, P541, DOI 10.1006/jmbi.2002.5426; Meima ME, 2007, CURR OPIN NEPHROL HY, V16, P365, DOI 10.1097/MNH.0b013e3281bd888d; Mishima M, 2007, J BIOL CHEM, V282, P2741, DOI 10.1074/jbc.M604092200; Niki I, 1996, J BIOCHEM, V120, P685; O'Callaghan DW, 2003, BIOCHEM SOC T, V31, P963; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; ORLOWSKI J, 1993, J BIOL CHEM, V268, P16369; Orlowski J, 2011, COMPR PHYSIOL, V1, P2083, DOI 10.1002/cphy.c110020; Pang TX, 2004, BIOCHEMISTRY-US, V43, P3628, DOI 10.1021/bi0360004; Pang TX, 2002, J BIOL CHEM, V277, P43771, DOI 10.1074/jbc.M208313200; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; Perera EM, 2001, ENDOCRINOLOGY, V142, P455, DOI 10.1210/en.142.1.455; Putney LK, 2003, J BIOL CHEM, V278, P44645, DOI 10.1074/jbc.M308099200; ROTIN D, 1989, AM J PHYSIOL, V257, pC1158, DOI 10.1152/ajpcell.1989.257.6.C1158; Schelling JR, 2008, AM J PHYSIOL-RENAL, V295, pF625, DOI 10.1152/ajprenal.90212.2008; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Tominaga T, 1998, MOL BIOL CELL, V9, P2287, DOI 10.1091/mbc.9.8.2287; WAKABAYASHI S, 1994, J BIOL CHEM, V269, P13710; Wu KL, 2003, AM J PHYSIOL-RENAL, V284, pF829, DOI 10.1152/ajprenal.00314.2002; Zaun HC, 2008, J BIOL CHEM, V283, P12456, DOI 10.1074/jbc.M800267200	44	20	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36883	36895		10.1074/jbc.M112.394700	http://dx.doi.org/10.1074/jbc.M112.394700			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22984264	Green Published, hybrid			2022-12-28	WOS:000310588500025
J	Reinke, LM; Xu, YL; Cheng, CH				Reinke, Lauren M.; Xu, Yilin; Cheng, Chonghui			Snail Represses the Splicing Regulator Epithelial Splicing Regulatory Protein 1 to Promote Epithelial-Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SNAIL; GENE; CELLS; SF2/ASF	Epithelial-mesenchymal transition (EMT), a tightly regulated process that is critical for development, is frequently re-activated during cancer metastasis and recurrence. We reported previously that CD44 isoform switching is critical for EMT and showed that the splicing factor ESRP1 inhibits CD44 isoform switching during EMT. However, the mechanism by which ESRP1 is regulated during EMT has not been fully understood. Here we show that the transcription repressor Snail binds to E-boxes in the ESRP1 promoter, causing repression of the ESRP1 gene. Biochemically, we define the mechanism by which ESRP1 regulates CD44 alternative splicing: ESRP1 binds to the intronic region flanking a CD44 variable exon and causes increased variable exon inclusion. We further show that ectopically expressing ESRP1 inhibits Snail-induced EMT, suggesting that down-regulation of ESRP1 is required for function by Snail in EMT. Together, these data reveal how the transcription factor Snail mediates EMT through regulation of a splicing factor.	[Reinke, Lauren M.; Xu, Yilin; Cheng, Chonghui] Northwestern Univ, Dept Med, Robert H Lurie Comprehens Canc Ctr, Div Hematol & Oncol,Feinberg Sch Med, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Cheng, CH (corresponding author), Northwestern Univ, Dept Med, Robert H Lurie Comprehens Canc Ctr, Div Hematol & Oncol,Feinberg Sch Med, 303 E Super St, Chicago, IL 60611 USA.	chengc@northwestern.edu			American Cancer Society; American Association for Cancer Research; Department of Defense Breast Cancer Research Program; Schweppe Foundation; Lynn Sage Foundation; National Institutes of Health Carcinogenesis Training Grant [T32-CA009560-21]; Malkin Scholar Award from the Robert H. Lurie Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [T32CA009560] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); American Association for Cancer Research; Department of Defense Breast Cancer Research Program(United States Department of Defense); Schweppe Foundation; Lynn Sage Foundation; National Institutes of Health Carcinogenesis Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Malkin Scholar Award from the Robert H. Lurie Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by grants from the American Cancer Society, American Association for Cancer Research, the Department of Defense Breast Cancer Research Program, the Schweppe Foundation, and the Lynn Sage Foundation (to C. C.).; Supported by a predoctoral fellowship from the National Institutes of Health Carcinogenesis Training Grant T32-CA009560-21 and a Malkin Scholar Award from the Robert H. Lurie Comprehensive Cancer Center.	Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; BRICKELL PM, 1983, NATURE, V306, P756, DOI 10.1038/306756a0; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Dittmar KA, 2012, MOL CELL BIOL, V32, P1468, DOI 10.1128/MCB.06536-11; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Galiana-Arnoux D, 2005, BIOCHEM BIOPH RES CO, V336, P667, DOI 10.1016/j.bbrc.2005.08.153; Ghigna C, 2005, MOL CELL, V20, P881, DOI 10.1016/j.molcel.2005.10.026; Horiguchi K, 2012, ONCOGENE, V31, P3190, DOI 10.1038/onc.2011.493; Jia R, 2009, J VIROL, V83, P167, DOI 10.1128/JVI.01719-08; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MAUHIN V, 1993, NUCLEIC ACIDS RES, V21, P3951, DOI 10.1093/nar/21.17.3951; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Nakayama H, 1998, DEV BIOL, V199, P150, DOI 10.1006/dbio.1998.8914; Paronetto MP, 2010, CANCER RES, V70, P229, DOI 10.1158/0008-5472.CAN-09-2788; Sharma S, 2009, BLOOD, V114, P4179, DOI 10.1182/blood-2009-03-206482; SHTIVELMAN E, 1986, CELL, V47, P277, DOI 10.1016/0092-8674(86)90450-2; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009	25	72	74	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36435	36442		10.1074/jbc.M112.397125	http://dx.doi.org/10.1074/jbc.M112.397125			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22961986	Green Published, hybrid			2022-12-28	WOS:000310364000063
J	Zentner, GE; Scacheri, PC				Zentner, Gabriel E.; Scacheri, Peter C.			The Chromatin Fingerprint of Gene Enhancer Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HUMAN GENOME; REGULATORY ELEMENTS; TRANSCRIPTION FACTORS; HISTONE MODIFICATION; EPIGENETIC SIGNATURES; FUNCTIONAL ELEMENTS; DNA METHYLATION; CO-OCCUPANCY; HUMAN-CELLS; IN-VIVO	Different cell types within a single organism are generally distinguished by strikingly different patterns of gene expression, which are dynamic throughout development and adult life. Distal enhancer elements are key drivers of spatiotemporal specificity in gene regulation. Often located tens of kilobases from their target promoters and functioning in an orientation-independent manner, the identification of bona fide enhancers has proved a formidable challenge. With the development of ChIP-seq, global cataloging of putative enhancers has become feasible. Here, we review the current understanding of the chromatin landscape at enhancers and how these chromatin features enable robust identification of tissue-specific enhancers.	[Zentner, Gabriel E.; Scacheri, Peter C.] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Scacheri, Peter C.] Case Western Reserve Univ, Ctr Comprehens Canc, Cleveland, OH 44106 USA; [Zentner, Gabriel E.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Case Western Reserve University; Case Western Reserve University; Fred Hutchinson Cancer Center	Scacheri, PC (corresponding author), Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.	pxs183@case.edu		Zentner, Gabriel/0000-0002-0801-7646	National Institutes of Health; National Human Genome Research Institute [5R01 HG004722]; cloned P300-binding sites from each tissue for in vivo from NICHD [R01 HD056369]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD056369] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA160356] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004722] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); cloned P300-binding sites from each tissue for in vivo from NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by National Institutes of Health and cloned P300-binding sites from each tissue for in vivo Grant R01 HD056369 from NICHD and Grant 5R01 HG004722 from the National Human Genome Research Institute (to P.C.S.). This the first article in the Thematic Minireview Series on Results from the ENCODE Project: Integrative Global Analyses of Regulatory Regions in the Human Genome.	Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; BANERJI J, 1983, CELL, V33, P729, DOI 10.1016/0092-8674(83)90015-6; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Bultman SJ, 2008, ONCOGENE, V27, P460, DOI 10.1038/sj.onc.1210664; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; De S, 2011, MOL CELL BIOL, V31, P1512, DOI 10.1128/MCB.00920-10; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Eeckhoute J, 2009, GENOME RES, V19, P372, DOI 10.1101/gr.084582.108; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; GILLIES SD, 1983, CELL, V33, P717, DOI 10.1016/0092-8674(83)90014-4; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Hoffman BG, 2010, GENOME RES, V20, P1037, DOI 10.1101/gr.104356.109; Hoivik EA, 2011, ENDOCRINOLOGY, V152, P2100, DOI 10.1210/en.2010-1305; Hu GQ, 2011, GENOME RES, V21, P1650, DOI 10.1101/gr.121145.111; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Jin FL, 2011, P NATL ACAD SCI USA, V108, P5290, DOI 10.1073/pnas.1017214108; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kim MS, 2011, HISTOPATHOLOGY, V58, P660, DOI 10.1111/j.1365-2559.2011.03819.x; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Li G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r22; Li ZY, 2011, NAT STRUCT MOL BIOL, V18, P742, DOI 10.1038/nsmb.2060; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin H, 2010, BRIT J DERMATOL, V163, P502, DOI 10.1111/j.1365-2133.2010.09851.x; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; McGaughey DM, 2008, GENOME RES, V18, P252, DOI 10.1101/gr.6929408; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Ni ZY, 2008, NAT IMMUNOL, V9, P785, DOI 10.1038/ni.1619; Noonan JP, 2010, ANNU REV GENOM HUM G, V11, P1, DOI 10.1146/annurev-genom-082509-141651; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pasini D, 2010, NUCLEIC ACIDS RES, V38, P4958, DOI 10.1093/nar/gkq244; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Rada-Iglesias A, 2011, GENOME MED, V3, DOI 10.1186/gm252; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ramos YFM, 2010, NUCLEIC ACIDS RES, V38, P5396, DOI 10.1093/nar/gkq184; Raney BJ, 2011, NUCLEIC ACIDS RES, V39, pD871, DOI 10.1093/nar/gkq1017; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; Rodriguez-Nieto S, 2011, HUM MUTAT, V32, pE1999, DOI 10.1002/humu.21415; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109; Schneppenheim R, 2010, AM J HUM GENET, V86, P279, DOI 10.1016/j.ajhg.2010.01.013; Schnetz MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001023; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Serandour AA, 2011, GENOME RES, V21, P555, DOI 10.1101/gr.111534.110; Sims RJ, 2009, NAT GENET, V41, P270, DOI 10.1038/ng0309-270; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Sun A, 2007, PROSTATE, V67, P203, DOI 10.1002/pros.20521; Taher L, 2011, GENOME RES, V21, P1139, DOI 10.1101/gr.119016.110; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Tiwari VK, 2008, GENOME RES, V18, P1171, DOI 10.1101/gr.073452.107; van Berkum NL, 2009, METHODS MOL BIOL, V567, P189, DOI 10.1007/978-1-60327-414-2_13; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wiench M, 2011, EMBO J, V30, P3028, DOI 10.1038/emboj.2011.210; Wu WS, 2011, GENOME RES, V21, P1659, DOI 10.1101/gr.125088.111; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Zaret KS, 2008, COLD SH Q B, V73, P119, DOI 10.1101/sqb.2008.73.040; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zentner GE, 2010, AM J MED GENET A, V152A, P674, DOI 10.1002/ajmg.a.33323; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, pD149, DOI 10.1093/nar/gkp968; Zlatanova J, 2008, STRUCTURE, V16, P166, DOI 10.1016/j.str.2007.12.008	100	60	60	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					30888	30896		10.1074/jbc.R111.296491	http://dx.doi.org/10.1074/jbc.R111.296491			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22952241	Green Published, hybrid			2022-12-28	WOS:000308791300002
J	Broustas, CG; Zhu, AP; Lieberman, HB				Broustas, Constantinos G.; Zhu, Aiping; Lieberman, Howard B.			Rad9 Protein Contributes to Prostate Tumor Progression by Promoting Cell Migration and Anoikis Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRINS; INVASION; CANCER; ACTIVATION; ADHESION; KINASE; GROWTH; HRAD9	Rad9 as part of the Rad9-Hus1-Rad1 complex is known to participate in cell cycle checkpoint activation and DNA repair. However, Rad9 can act as a sequence-specific transcription factor, modulating expression of a number of genes. Importantly, Rad9 is up-regulated in prostate cancer cell lines and clinical specimens. Its expression correlates positively with advanced stage tumors and its down-regulation reduces tumor burden in mice. We show here that transient down-regulation of Rad9 by RNA interference reduces DU145 and PC3 prostate cancer cell proliferation and survival in vitro. In addition, transient or stable down-regulation of Rad9 impairs migration and invasion of the cells. Moreover, stable reduction of Rad9 renders DU145 cell growth anchorage-dependent. It also decreases expression of integrin beta 1 protein and sensitizes DU145 and LNCaP cells to anoikis and impairs Akt activation. On the other hand, stable expression of Mrad9, the mouse homolog, in DU145/shRNA Rad9 cells restores migration, invasion, anchorage-independent growth, integrin beta 1 expression, and anoikis resistance with a concomitant elevation of Akt activation. We thus demonstrate for the first time that Rad9 contributes to prostate tumorigenesis by increasing not only tumor proliferation and survival but also tumor migration and invasion, anoikis resistance, and anchorage-independent growth.	[Broustas, Constantinos G.; Zhu, Aiping; Lieberman, Howard B.] Columbia Univ Coll Phys & Surg, Ctr Radiol Res, New York, NY 10032 USA; [Lieberman, Howard B.] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY 10032 USA	Columbia University; Columbia University	Lieberman, HB (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Radiol Res, 630 W 168th St, New York, NY 10032 USA.	HBL1@columbia.edu		Broustas, Constantinos/0000-0001-7169-807X	National Institutes of Health [R01CA130536, R01GM079107, P01CA49062]; NATIONAL CANCER INSTITUTE [R01CA130536, P01CA049062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA130536, R01GM079107, and P01CA49062 (to H. B. L).	Balakrishnan L, 2009, J BIOL CHEM, V284, P15158, DOI 10.1074/jbc.M109.000505; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Bretland AJ, 2001, CELL PROLIFERAT, V34, P199, DOI 10.1046/j.1365-2184.2001.00198.x; Broustas CG, 2012, J CELL BIOCHEM, V113, P742, DOI 10.1002/jcb.23424; Carretero M, 2008, J INVEST DERMATOL, V128, P223, DOI 10.1038/sj.jid.5701043; Cheng CK, 2005, CANCER RES, V65, P8646, DOI 10.1158/0008-5472.CAN-04-4243; CIFONE MA, 1980, P NATL ACAD SCI-BIOL, V77, P1039, DOI 10.1073/pnas.77.2.1039; Coene ED, 2011, J CELL BIOL, V192, P497, DOI 10.1083/jcb.201004136; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Goel HL, 2005, CANCER RES, V65, P6692, DOI 10.1158/0008-5472.CAN-04-4315; Guerra L, 2011, J CELL SCI, V124, P2735, DOI 10.1242/jcs.085845; Hirai I, 2002, J BIOL CHEM, V277, P25722, DOI 10.1074/jbc.M203079200; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Janik ME, 2010, BBA-GEN SUBJECTS, V1800, P545, DOI 10.1016/j.bbagen.2010.03.013; Komatsu K, 2000, NAT CELL BIOL, V2, P1, DOI 10.1038/71316; Lieberman HB, 2011, J MOL CELL BIOL, V3, P39, DOI 10.1093/jmcb/mjq039; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Muller C, 2005, CELL CYCLE, V4, P438, DOI 10.4161/cc.4.3.1565; Ono M, 2003, GLYCOCONJUGATE J, V20, P71, DOI 10.1023/B:GLYC.0000018019.22070.7d; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Rantala JK, 2011, NAT CELL BIOL, V13, P1315, DOI 10.1038/ncb2340; Retta SF, 2001, MOL BIOL CELL, V12, P3126, DOI 10.1091/mbc.12.10.3126; Rizki A, 2007, CANCER RES, V67, P11106, DOI 10.1158/0008-5472.CAN-07-2348; Sakamoto S, 2010, MOL ASPECTS MED, V31, P205, DOI 10.1016/j.mam.2010.02.001; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; St Onge RP, 2003, J BIOL CHEM, V278, P26620, DOI 10.1074/jbc.M303134200; Tell G, 2010, CELL MOL LIFE SCI, V67, P3589, DOI 10.1007/s00018-010-0486-4; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wang LY, 2007, J CELL BIOCHEM, V100, P230, DOI 10.1002/jcb.21071; Wang WS, 2004, P NATL ACAD SCI USA, V101, P16762, DOI 10.1073/pnas.0407686101; WITKOWSKI CM, 1993, J CANCER RES CLIN, V119, P637, DOI 10.1007/BF01215981; Yin YX, 2004, P NATL ACAD SCI USA, V101, P8864, DOI 10.1073/pnas.0403130101; Yu JT, 2001, MOL CELL BIOL, V21, P3325, DOI 10.1128/MCB.21.10.3325-3335.2001; Zeng ZZ, 2006, CANCER RES, V66, P8091, DOI 10.1158/0008-5472.CAN-05-4400; Zhao YY, 2008, FEBS J, V275, P1939, DOI 10.1111/j.1742-4658.2008.06346.x; Zheng L, 2011, NUCLEIC ACIDS RES, V39, P781, DOI 10.1093/nar/gkq884	39	28	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41324	41333		10.1074/jbc.M112.402784	http://dx.doi.org/10.1074/jbc.M112.402784			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23066031	Green Published, hybrid			2022-12-28	WOS:000311887600046
J	Chan, YC; Roy, S; Huang, Y; Khanna, S; Sen, CK				Chan, Yuk Cheung; Roy, Sashwati; Huang, Yue; Khanna, Savita; Sen, Chandan K.			The MicroRNA miR-199a-5p Down-regulation Switches on Wound Angiogenesis by Derepressing the v-ets Erythroblastosis Virus E26 Oncogene Homolog 1-Matrix Metalloproteinase-1 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; HUMAN HEPATOCELLULAR-CARCINOMA; ISCHEMIA-REPERFUSION INJURY; CANCER CELL-PROLIFERATION; ENDOTHELIAL-CELLS; TRANSCRIPTION FACTOR; MULTIDRUG-RESISTANCE; RESPONSE ELEMENT; RETINOIC ACID; EXPRESSION	miR-199a-5p plays a critical role in controlling cardiomyocyte survival. However, its significance in endothelial cell biology remains ambiguous. Here, we report the first evidence that miR-199a-5p negatively regulates angiogenic responses by directly targeting v-ets erythroblastosis virus E26 oncogene homolog 1 (Ets-1). Induction of miR-199a-5p in human dermal microvascular endothelial cells (HMECs) blocked angiogenic response in Matrigel (R) culture, whereas miR-199a-5p-deprived cells exhibited enhanced angiogenesis in vitro. Bioinformatics prediction and miR target reporter assay recognized Ets-1 as a novel direct target of miR-199a-5p. Delivery of miR-199a-5p blocked Ets-1 expression in HMECs, whereas knockdown endogenous miR-199a-5p induced Ets-1 expression. Matrix metalloproteinase 1 (MMP-1), one of the Ets-1 downstream mediators, was negatively regulated by miR-199a-5p. Overexpression of Ets-1 not only rescued miR-199a-5p-dependent anti-angiogenic effects but also reversed miR-199a-5p-induced loss of MMP-1 expression. Similarly, Ets-1 knockdown blunted angiogenic response and induction of MMP-1 in miR-199a-5p-deprived HMECs. Examination of cutaneous wound dermal tissue revealed a significant down-regulation of miR-199a-5p expression, which was associated with induction of Ets-1 and MMP-1. Mice carrying homozygous deletions in the Ets-1 gene exhibited blunted wound blood flow and reduced abundance of endothelial cells. Impaired wound angiogenesis was associated with compromised wound closure, insufficient granulation tissue formation, and blunted induction of MMP-1. Thus, down-regulation of miR-199a-5p is involved in the induction of wound angiogenesis through derepressing of the Ets-1-MMP1 pathway.	[Chan, Yuk Cheung; Roy, Sashwati; Huang, Yue; Khanna, Savita; Sen, Chandan K.] Ohio State Univ, Dept Surg, Davis Heart & Lung Res Inst, Med Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Sen, CK (corresponding author), Ohio State Univ, Dept Surg, Davis Heart & Lung Res Inst, Med Ctr, 473 W 12th Ave, Columbus, OH 43210 USA.	chandan.sen@osumc.edu	Sen, Chandan K/A-8762-2013; Roy, sashwati/E-3990-2011; Khanna, Savita/E-3378-2011		National Institutes of Health [GM 077185, GM069589, DK076566]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076566, R56DK076566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069589, R01GM077185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 077185 and GM069589 (to C. K. S.) and DK076566 (to S. R.).	Biswas S, 2010, P NATL ACAD SCI USA, V107, P6976, DOI 10.1073/pnas.1001653107; Bonta PI, 2010, CARDIOVASC RES, V87, P561, DOI 10.1093/cvr/cvq064; Botusan IR, 2008, P NATL ACAD SCI USA, V105, P19426, DOI 10.1073/pnas.0805230105; Chan YC, 2012, MICROCIRCULATION, V19, P215, DOI 10.1111/j.1549-8719.2011.00154.x; Chan YC, 2012, ARTERIOSCL THROM VAS, V32, P1372, DOI 10.1161/ATVBAHA.112.248583; Chan YC, 2011, J BIOL CHEM, V286, P2047, DOI 10.1074/jbc.M110.158790; Cheng WW, 2012, FEBS J, V279, P2047, DOI 10.1111/j.1742-4658.2012.08589.x; Cheung HH, 2011, ONCOGENE, V30, P3404, DOI 10.1038/onc.2011.60; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Elson DA, 2000, CANCER RES, V60, P6189; Gonsalves CS, 2010, J IMMUNOL, V184, P3878, DOI 10.4049/jimmunol.0902594; Haghikia A, 2011, EUR HEART J, V32, P1287, DOI 10.1093/eurheartj/ehq369; Hsu PWC, 2007, NUCLEIC ACIDS RES, V35, pD381, DOI 10.1093/nar/gkl1009; Ito M, 1998, BIOCHEM BIOPH RES CO, V246, P123, DOI 10.1006/bbrc.1998.8585; Jia XQ, 2012, CELL BIOCHEM BIOPHYS, V62, P237, DOI 10.1007/s12013-011-9263-8; Kang SG, 2012, CARCINOGENESIS, V33, P661, DOI 10.1093/carcin/bgr320; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Li XH, 2011, J CELL MOL MED, V15, P1887, DOI 10.1111/j.1582-4934.2010.01194.x; Liang LH, 2010, HEPATOLOGY, V52, P1731, DOI 10.1002/hep.23904; Lima MHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036974; Liu LH, 2011, BIOCHEM BIOPH RES CO, V416, P31, DOI 10.1016/j.bbrc.2011.10.117; Mattia G, 2011, PIGM CELL MELANOMA R, V24, P953, DOI 10.1111/j.1755-148X.2011.00881.x; McArthur K, 2011, DIABETES, V60, P1314, DOI 10.2337/db10-1557; Mizuno S, 2012, CHEST, V142, P663, DOI 10.1378/chest.11-2746; Moncini S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020038; Mudduluru G, 2011, ONCOGENE, V30, P2888, DOI 10.1038/onc.2011.13; Muramatsu F., 2012, ONCOGENE IN PRESS; Nagarajan P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004179; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Oikawa M, 2001, BIOCHEM BIOPH RES CO, V289, P39, DOI 10.1006/bbrc.2001.5927; Ojha N, 2008, AM J PHYSIOL-HEART C, V294, pH2435, DOI 10.1152/ajpheart.01190.2007; Park HA, 2011, STROKE, V42, P2308, DOI 10.1161/STROKEAHA.110.608547; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Rane S, 2010, CELL SIGNAL, V22, P1054, DOI 10.1016/j.cellsig.2010.02.008; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Raouf A, 2000, ONCOGENE, V19, P1969, DOI 10.1038/sj.onc.1203505; Roy S, 2006, MOL THER, V13, P211, DOI 10.1016/j.ymthe.2005.07.684; Saito A, 2007, ENDOCRINOLOGY, V148, P1412, DOI 10.1210/en.2006-0900; Salloum FN, 2010, J CARDIOVASC PHARM, V56, P581, DOI 10.1097/FJC.0b013e3181f581ba; Sen CK, 2002, J BIOL CHEM, V277, P33284, DOI 10.1074/jbc.M203391200; Shen QL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-227; Shilo S, 2008, ARTERIOSCL THROM VAS, V28, P471, DOI 10.1161/ATVBAHA.107.160655; Song XW, 2010, J CELL PHYSIOL, V225, P437, DOI 10.1002/jcp.22217; Squarize CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010643; Stevens LJ, 2012, MOL BIOL CELL, V23, P1068, DOI 10.1091/mbc.E11-09-0745; Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17; Tanaka K, 1998, J CELL PHYSIOL, V176, P235, DOI 10.1002/(SICI)1097-4652(199808)176:2<235::AID-JCP2>3.0.CO;2-P; Tsukigi M, 2012, CANCER LETT, V315, P189, DOI 10.1016/j.canlet.2011.10.008; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Urbich C, 2012, BLOOD, V119, P1607, DOI 10.1182/blood-2011-08-373886; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wang YF, 2009, J BIOL CHEM, V284, P23094, DOI 10.1074/jbc.M109.012617; WERNERT N, 1992, AM J PATHOL, V140, P119; Wilson LA, 2005, FASEB J, V19, P2085, DOI 10.1096/fj.05-4401fje; Wong V, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/969618; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Ye YM, 2011, PHYSIOL GENOMICS, V43, P534, DOI 10.1152/physiolgenomics.00130.2010; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435	58	57	60	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41032	41043		10.1074/jbc.M112.413294	http://dx.doi.org/10.1074/jbc.M112.413294			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23060436	Green Published, hybrid			2022-12-28	WOS:000311887600021
J	Nihei, Y; Ito, D; Suzuki, N				Nihei, Yoshihiro; Ito, Daisuke; Suzuki, Norihiro			Roles of Ataxin-2 in Pathological Cascades Mediated by TAR DNA-binding Protein 43 (TDP-43) and Fused in Sarcoma (FUS)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; INCLUSION-BODY FORMATION; STRESS GRANULES; PROCESSING BODIES; NUCLEAR IMPORT; P-BODIES; MUTATIONS; ALS; EXPANSIONS	The RNA-binding proteins TDP-43 and Fused in Sarcoma (FUS) play central roles in neurodegeneration associated with amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Both proteins are components of messenger ribonucleoprotein (mRNP) granules and show cytoplasmic mislocalization in affected tissues. Recently, ataxin-2 was identified as a potent modifier of TDP-43 toxicity in an RNA-dependent manner. This study investigated to clarify how ataxin-2 modifies the TDP-43 and FUS pathological pathway. The expression of cytoplasmic TDP-43, the 35-kDa C-terminal fragment (TDP-p35f), and mutant FUS recruited ataxin-2 to mRNP granules, whereas increased ataxin-2 inhibited the mRNP granule formation of the 35-kDa C-terminal fragment and mutant FUS. A subcellular compartment analysis showed that the overexpressed ataxin-2 increased the cytoplasmic concentrations of both proteins, whereas it decreased their nuclear distributions. These data indicate that increased ataxin-2 impairs the assembly of TDP-43 and FUS into mRNP granules, leading to an aberrant distribution of RNA-binding proteins. Consequently, these sequences may exacerbate the impairment of the RNA-quality control system mediated by amyotrophic lateral sclerosis/frontotemporal lobar degeneration-associated RNA-binding proteins, which forms the core of the degenerative cascade.	[Nihei, Yoshihiro; Ito, Daisuke; Suzuki, Norihiro] Keio Univ, Sch Med, Dept Neurol, Shinjuku Ku, Tokyo 1608582, Japan	Keio University	Ito, D (corresponding author), Keio Univ, Sch Med, Dept Neurol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	d-ito@jk9.so-net.ne.jp	Ito, Daisuke/GXF-1648-2022; Suzuki, Norihiro/J-5125-2013; Ito, Daisuke/M-3608-2013	Suzuki, Norihiro/0000-0002-0399-6590; Ito, Daisuke/0000-0002-4740-1675	Eisai Co. Ltd; Ministry of Education, Culture, Sports, Science and Technology of Japan [23591254]; ALS Foundation; Japan ALS Association	Eisai Co. Ltd(Eisai Co Ltd); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ALS Foundation; Japan ALS Association	This work was supported by Eisai Co. Ltd, by Ministry of Education, Culture, Sports, Science and Technology of Japan Grant 23591254, by the ALS Foundation, and by the Japan ALS Association.	Albrecht M, 2004, EUR J BIOCHEM, V271, P3155, DOI 10.1111/j.1432-1033.2004.04245.x; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Corrado L, 2011, HUM GENET, V130, P575, DOI 10.1007/s00439-011-1000-2; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Fujita K, 2008, ACTA NEUROPATHOL, V116, P439, DOI 10.1007/s00401-008-0415-x; Hart MP, 2012, J NEUROSCI, V32, P9133, DOI 10.1523/JNEUROSCI.0996-12.2012; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Ito D, 2004, MOL CELL BIOL, V24, P9456, DOI 10.1128/MCB.24.21.9456-9469.2004; Ito D, 2007, ANN NEUROL, V61, P237, DOI 10.1002/ana.21070; Ito D, 2011, NEUROLOGY, V77, P1636, DOI 10.1212/WNL.0b013e3182343365; Ito D, 2011, ANN NEUROL, V69, P152, DOI 10.1002/ana.22246; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lee T, 2011, NEUROLOGY, V76, P2062, DOI 10.1212/WNL.0b013e31821f4447; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimoto Y, 2010, J BIOL CHEM, V285, P608, DOI 10.1074/jbc.M109.022012; Nishimura AL, 2010, BRAIN, V133, P1763, DOI 10.1093/brain/awq111; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Orr HT, 2004, NATURE, V431, P747, DOI 10.1038/431747a; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Satterfield TF, 2006, HUM MOL GENET, V15, P2523, DOI 10.1093/hmg/ddl173; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Swisher KD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010006; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Todd PK, 2010, ANN NEUROL, V67, P291, DOI 10.1002/ana.21948; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Van Damme P, 2011, NEUROLOGY, V76, P2066, DOI 10.1212/WNL.0b013e31821f445b; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942	37	35	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41310	41323		10.1074/jbc.M112.398099	http://dx.doi.org/10.1074/jbc.M112.398099			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23048034	hybrid, Green Published			2022-12-28	WOS:000311887600045
J	Duan, D; Jia, ZM; Joshi, M; Brunton, J; Chan, M; Drew, D; Davis, D; Allingham, JS				Duan, Da; Jia, Zhimeng; Joshi, Monika; Brunton, Jacqueline; Chan, Michelle; Drew, Doran; Davis, Darlene; Allingham, John S.			Neck Rotation and Neck Mimic Docking in the Noncatalytic Kar3-associated Protein Vik1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE MOTOR PROTEIN; CRYSTAL-STRUCTURE; KINESIN MOTOR; DOMAIN; KAR3; SPINDLE; CIK1; MOTIF; NCD	It is widely accepted that movement of kinesin motor proteins is accomplished by coupling ATP binding, hydrolysis, and product release to conformational changes in the microtubule-binding and force-generating elements of their motor domain. Therefore, understanding how the Saccharomyces cerevisiae proteins Cik1 and Vik1 are able to function as direct participants in movement of Kar3Cik1 and Kar3Vik1 kinesin complexes presents an interesting challenge given that their motor homology domain (MHD) cannot bind ATP. Our crystal structures of the Vik1 ortholog from Candida glabrata may provide insight into this mechanism by showing that its neck and neck mimic-like element can adopt several different conformations reminiscent of those observed in catalytic kinesins. We found that when the neck is alpha-helical and interacting with the MHD core, the C terminus of CgVik1 docks onto the central beta-sheet similarly to the ATP-bound form of Ncd. Alternatively, when neck-core interactions are broken, the Cterminus is disordered. Mutations designed to impair neck rotation, or some of the neck-MHD interactions, decreased microtubule gliding velocity and steady state ATPase rate of CgKar3Vik1 complexes significantly. These results strongly suggest that neck rotation and neck mimic docking in Vik1 and Cik1 may be a structural mechanism for communication with Kar3.	[Duan, Da; Jia, Zhimeng; Joshi, Monika; Brunton, Jacqueline; Drew, Doran; Davis, Darlene; Allingham, John S.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Chan, Michelle] Univ British Columbia, Dept Cellular & Dev Biol, Vancouver, BC V6T 1Z3, Canada	Queens University - Canada; University of British Columbia	Allingham, JS (corresponding author), Queens Univ, Dept Biomed & Mol Sci, 18 Stuart St,Rm 652, Kingston, ON K7L 3N6, Canada.	allinghj@queensu.ca	Jia, Zhimeng/GRI-9437-2022; Allingham, John/AAW-9262-2020; Jia, Zhimeng/AAS-9450-2021	Jia, Zhimeng/0000-0001-8156-5553; Jia, Zhimeng/0000-0001-8156-5553	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada and Canadian Institutes of Health Research (to J. S. A.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allingham JS, 2007, CELL, V128, P1161, DOI 10.1016/j.cell.2006.12.046; Barrett JG, 2000, MOL BIOL CELL, V11, P2373, DOI 10.1091/mbc.11.7.2373; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Chen CJ, 2011, J BIOL CHEM, V286, P29261, DOI 10.1074/jbc.M111.255554; Deavours BE, 1998, CELL MOTIL CYTOSKEL, V40, P408, DOI 10.1002/(SICI)1097-0169(1998)40:4<408::AID-CM8>3.0.CO;2-6; DeLano W.L, PYMOL MOL GRAPHICS S; Duan D, 2012, PROTEINS, V80, P1016, DOI 10.1002/prot.24004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endow SA, 1998, SCIENCE, V281, P1200, DOI 10.1126/science.281.5380.1200; Endres NF, 2006, NATURE, V439, P875, DOI 10.1038/nature04320; Gladfelter A, 2009, NAT REV MICROBIOL, V7, P875, DOI 10.1038/nrmicro2249; Gulick AM, 1998, BIOCHEMISTRY-US, V37, P1769, DOI 10.1021/bi972504o; Heuston E, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-19; HUANG TG, 1994, J BIOL CHEM, V269, P16493; Hwang W, 2008, STRUCTURE, V16, P62, DOI 10.1016/j.str.2007.11.008; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khalil AS, 2008, P NATL ACAD SCI USA, V105, P19247, DOI 10.1073/pnas.0805147105; Kozielski F, 1999, STRUCTURE, V7, P1407, DOI 10.1016/S0969-2126(00)80030-1; Krishna MMG, 2005, P NATL ACAD SCI USA, V102, P1053, DOI 10.1073/pnas.0409114102; Lang C, 2010, MOL BIOL CELL, V21, P18, DOI 10.1091/mbc.E09-01-0063; MELUH PB, 1990, CELL, V60, P1029, DOI 10.1016/0092-8674(90)90351-E; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAGE BD, 1992, GENE DEV, V6, P1414, DOI 10.1101/gad.6.8.1414; PAGE BD, 1994, J CELL BIOL, V124, P507, DOI 10.1083/jcb.124.4.507; Rank KC, 2012, J CELL BIOL, V197, P957, DOI 10.1083/jcb.201201132; Reddy VS, 2004, PLANT CELL, V16, P185, DOI 10.1105/tpc.016600; Sablin EP, 1996, NATURE, V380, P555, DOI 10.1038/380555a0; Sablin EP, 1998, NATURE, V395, P813, DOI 10.1038/27463; Sack S, 1997, BIOCHEMISTRY-US, V36, P16155, DOI 10.1021/bi9722498; Saunders W, 1997, J CELL BIOL, V137, P417, DOI 10.1083/jcb.137.2.417; SAUNDERS WS, 1992, CELL, V70, P451, DOI 10.1016/0092-8674(92)90169-D; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Sherwood RK, 2008, EUKARYOT CELL, V7, P1460, DOI 10.1128/EC.00138-08; Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066; Szczesna E, 2012, FEBS LETT, V586, P854, DOI 10.1016/j.febslet.2012.02.011; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vinogradova MV, 2009, P NATL ACAD SCI USA, V106, P8175, DOI 10.1073/pnas.0811131106; Vinogradova MV, 2004, J BIOL CHEM, V279, P23504, DOI 10.1074/jbc.M400741200; Walter WJ, 2012, P NATL ACAD SCI USA, V109, P5289, DOI 10.1073/pnas.1116315109; Wendt TG, 2002, EMBO J, V21, P5969, DOI 10.1093/emboj/cdf622; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Yun M, 2003, EMBO J, V22, P5382, DOI 10.1093/emboj/cdg531	44	9	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40292	40301		10.1074/jbc.M112.416529	http://dx.doi.org/10.1074/jbc.M112.416529			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23043140	hybrid, Green Published			2022-12-28	WOS:000311448800021
J	Sigel, E; Steinmann, ME				Sigel, Erwin; Steinmann, Michael E.			Structure, Function, and Modulation of GABA(A) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BENZODIAZEPINE BINDING-SITE; GATED ION-CHANNEL; NICOTINIC ACETYLCHOLINE-RECEPTOR; AMINOBUTYRIC ACID(A) RECEPTORS; BOVINE CEREBRAL-CORTEX; A RECEPTORS; SUBUNIT COMPOSITION; INTERNATIONAL UNION; AGONIST BINDING; DELTA-SUBUNIT	The GABA(A) receptors are the major inhibitory neurotransmitter receptors in mammalian brain. Each isoform consists of five homologous or identical subunits surrounding a central chloride ion-selective channel gated by GABA. How many isoforms of the receptor exist is far from clear. GABA(A) receptors located in the postsynaptic membrane mediate neuronal inhibition that occurs in the millisecond time range; those located in the extrasynaptic membrane respond to ambient GABA and confer long-term inhibition. GABA(A) receptors are responsive to a wide variety of drugs, e.g. benzodiazepines, which are often used for their sedative/hypnotic and anxiolytic effects.	[Sigel, Erwin; Steinmann, Michael E.] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland	University of Bern	Sigel, E (corresponding author), Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland.	erwin.sigel@ibmm.unibe.ch	Sigel, Erwin/F-7736-2015		Swiss National Foundation [31003A_132806/1]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Foundation Grant 31003A_132806/1. This is the third article in the Thematic Minireview Series on Celebrating the Discovery of the Cysteine Loop Ligand-gated Ion Channel Superfamily.	Alam S, 2006, MOL IMMUNOL, V43, P1432, DOI 10.1016/j.molimm.2005.07.025; Barnard EA, 1998, PHARMACOL REV, V50, P291; Baumann SW, 2003, J NEUROSCI, V23, P11158; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baur R, 2006, FEBS LETT, V580, P1616, DOI 10.1016/j.febslet.2006.02.002; Baur R, 2008, J NEUROCHEM, V106, P2353, DOI 10.1111/j.1471-4159.2008.05574.x; Baur R, 2009, J NEUROCHEM, V111, P1172, DOI 10.1111/j.1471-4159.2009.06387.x; Beg AA, 2003, NAT NEUROSCI, V6, P1145, DOI 10.1038/nn1136; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Berezhnoy D, 2004, J BIOL CHEM, V279, P3160, DOI 10.1074/jbc.M311371200; Berezhnoy D, 2009, MOL PHARMACOL, V76, P440, DOI 10.1124/mol.109.054650; BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; Bjurstrom H, 2008, J NEUROIMMUNOL, V205, P44, DOI 10.1016/j.jneuroim.2008.08.017; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bollan KA, 2008, MOL CELL NEUROSCI, V37, P610, DOI 10.1016/j.mcn.2007.12.011; Borghese CM, 2006, J PHARMACOL EXP THER, V316, P1360, DOI 10.1124/jpet.105.092452; BORMANN J, 1985, P NATL ACAD SCI USA, V82, P2168, DOI 10.1073/pnas.82.7.2168; Breitinger HG, 2002, CHEMBIOCHEM, V3, P1043, DOI 10.1002/1439-7633(20021104)3:11<1042::AID-CBIC1042>3.0.CO;2-7; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Chang YC, 2002, NAT NEUROSCI, V5, P1163, DOI 10.1038/nn926; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; Collinson N, 2002, J NEUROSCI, V22, P5572; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Crestani F, 2001, MOL PHARMACOL, V59, P442, DOI 10.1124/mol.59.3.442; Crestani F, 2002, P NATL ACAD SCI USA, V99, P8980, DOI 10.1073/pnas.142288699; Daniel C, 2009, BIOCHEM SOC T, V37, P1399, DOI 10.1042/BST0371399; Darlison MG, 2005, CELL MOL NEUROBIOL, V25, P607, DOI 10.1007/s10571-005-4004-4; Davies PA, 2003, J BIOL CHEM, V278, P712, DOI 10.1074/jbc.M208814200; Ernst M, 2005, MOL PHARMACOL, V68, P1291, DOI 10.1124/mol.105.015982; Ernst M, 2003, NEUROSCIENCE, V119, P933, DOI 10.1016/S0306-4522(03)00288-4; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Foucaud B, 2001, TRENDS PHARMACOL SCI, V22, P170, DOI 10.1016/S0165-6147(00)01674-6; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jechlinger M, 1998, J NEUROSCI, V18, P2449; KAILA K, 1989, J PHYSIOL-LONDON, V416, P161, DOI 10.1113/jphysiol.1989.sp017755; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Kaur KH, 2009, J BIOL CHEM, V284, P7889, DOI 10.1074/jbc.M806484200; Khatri A, 2010, J PHYSIOL-LONDON, V588, P59, DOI 10.1113/jphysiol.2009.179705; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Li SX, 2011, NAT NEUROSCI, V14, P1253, DOI 10.1038/nn.2908; Lippa A, 2005, P NATL ACAD SCI USA, V102, P7380, DOI 10.1073/pnas.0502579102; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Macdonald RL, 2010, J PHYSIOL-LONDON, V588, P1861, DOI 10.1113/jphysiol.2010.186999; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Minier F, 2004, P NATL ACAD SCI USA, V101, P7769, DOI 10.1073/pnas.0400220101; Minuk GY, 2007, HEPATOLOGY, V45, P735, DOI 10.1002/hep.21562; Mizuta K, 2008, AM J PHYSIOL-LUNG C, V294, pL1206, DOI 10.1152/ajplung.00287.2007; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; PFEIFFER F, 1982, J BIOL CHEM, V257, P9389; Popik P, 2006, J PHARMACOL EXP THER, V319, P1244, DOI 10.1124/jpet.106.107201; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; Ramerstorfer J, 2011, J NEUROSCI, V31, P870, DOI 10.1523/JNEUROSCI.5012-10.2011; Richter L, 2012, NAT CHEM BIOL, V8, P455, DOI [10.1038/nchembio.917, 10.1038/NCHEMBIO.917]; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; Shu HJ, 2012, BRIT J PHARMACOL, V165, P2228, DOI 10.1111/j.1476-5381.2011.01690.x; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; SIEGHART W, 1980, NATURE, V286, P285, DOI 10.1038/286285a0; SIEGHART W, 1995, PHARMACOL REV, V47, P181; Sieghart W, 2012, J PHYSIOL-LONDON, V590, P2181, DOI 10.1113/jphysiol.2012.231100; SIGEL E, 1982, FEBS LETT, V147, P45, DOI 10.1016/0014-5793(82)81008-9; SIGEL E, 1984, J BIOL CHEM, V259, P7219; SIGEL E, 1983, J BIOL CHEM, V258, P6965; Sigel E, 1997, TRENDS PHARMACOL SCI, V18, P425, DOI 10.1016/S0165-6147(97)90675-1; SIGEL E, 1990, NEURON, V5, P703, DOI 10.1016/0896-6273(90)90224-4; Sigel E, 2011, P NATL ACAD SCI USA, V108, P18150, DOI 10.1073/pnas.1113444108; Sigel E, 2011, CURR TOP MED CHEM, V11, P241, DOI 10.2174/156802611794863562; Simon J, 2004, J BIOL CHEM, V279, P41422, DOI 10.1074/jbc.M401354200; Sinkkonen ST, 2000, J NEUROSCI, V20, P3588, DOI 10.1523/JNEUROSCI.20-10-03588.2000; Tan KR, 2009, J NEUROCHEM, V111, P1264, DOI 10.1111/j.1471-4159.2009.06419.x; Thompson AJ, 2006, CURR PHARM DESIGN, V12, P3615, DOI 10.2174/138161206778522029; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tretter V, 1997, J NEUROSCI, V17, P2728; TWYMAN RE, 1989, ANN NEUROL, V25, P213, DOI 10.1002/ana.410250302; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Venkatachalan SP, 2012, J BIOL CHEM, V287, P6714, DOI 10.1074/jbc.M111.316836; Wagner DA, 2001, J NEUROSCI, V21, P67, DOI 10.1523/JNEUROSCI.21-01-00067.2001; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Whiting PJ, 1995, INT REV NEUROBIOL, V38, P95, DOI 10.1016/S0074-7742(08)60525-5; Wright R, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/728395; Wu Cathy, 2004, Human Genomics, V1, P229; Wulff P, 2007, NAT NEUROSCI, V10, P923, DOI 10.1038/nn1927; XU M, 1993, J BIOL CHEM, V268, P21505; Zheleznova N., 2008, BRIT J PHARMACOL, V53, P1062	95	449	463	11	121	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40224	40231		10.1074/jbc.R112.386664	http://dx.doi.org/10.1074/jbc.R112.386664			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23038269	hybrid, Green Published			2022-12-28	WOS:000311448800014
J	Tosello-Trampont, AC; Landes, SG; Nguyen, V; Novobrantseva, TI; Hahn, YS				Tosello-Trampont, Annie-Carole; Landes, Susan G.; Nguyen, Virginia; Novobrantseva, Tatiana I.; Hahn, Young S.			Kuppfer Cells Trigger Nonalcoholic Steatohepatitis Development in Diet-induced Mouse Model through Tumor Necrosis Factor-alpha Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC HEPATITIS-C; FATTY LIVER-DISEASE; CHOLINE-DEFICIENT DIET; VIRUS-INFECTION; TNF-ALPHA; GENE-EXPRESSION; LIPID-METABOLISM; INFLAMMATION; STEATOSIS; FIBROSIS	Nonalcoholic steatohepatitis (NASH), characterized by lipid deposits within hepatocytes (steatosis), is associated with hepatic injury and inflammation and leads to the development of fibrosis, cirrhosis, and hepatocarcinoma. However, the pathogenic mechanism of NASH is not well understood. To determine the role of distinct innate myeloid subsets in the development of NASH, we examined the contribution of liver resident macrophages (i.e. Kupffer cells) and blood-derived monocytes in triggering liver inflammation and hepatic damage. Employing a murine model of NASH, we discovered a previously unappreciated role for TNF alpha and Kupffer cells in the initiation and progression of NASH. Sequential depletion of Kupffer cells reduced the incidence of liver injury, steatosis, and proinflammatory monocyte infiltration. Furthermore, our data show a differential contribution of Kupffer cells and blood monocytes during the development of NASH; Kupffer cells increased their production of TNF alpha, followed by infiltration of CD11b(int)Ly6C(hi) monocytes, 2 and 10 days, respectively, after starting the methionine/choline- deficient (MCD) diet. Importantly, targeted knockdown of TNF alpha expression in myeloid cells decreased the incidence of NASH development by decreasing steatosis, liver damage, monocyte infiltration, and the production of inflammatory chemokines. Our findings suggest that the increase of TNF alpha-producing Kupffer cells in the liver is crucial for the early phase of NASH development by promoting blood monocyte infiltration through the production of TNF alpha and MCP-1.	[Tosello-Trampont, Annie-Carole; Landes, Susan G.; Nguyen, Virginia; Hahn, Young S.] Univ Virginia, Beirne Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Hahn, Young S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Novobrantseva, Tatiana I.] Alnylam Pharmaceut, Cambridge, MA 02142 USA	University of Virginia; University of Virginia	Hahn, YS (corresponding author), POB 801386, Charlottesville, VA 22908 USA.	ysh5e@cms.mail.virginia.edu			National Institutes of Health [R01DK063222, U19AI083024]; NATIONAL CANCER INSTITUTE [P30CA044579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants R01DK063222 and U19AI083024 (to Y. S. H.)	Abiru S, 2006, LIVER INT, V26, P39, DOI 10.1111/j.1478-3231.2005.01191.x; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Bedossa P, 2007, HEPATOLOGY, V46, P380, DOI 10.1002/hep.21711; BEIER K, 1992, FEBS LETT, V310, P273, DOI 10.1016/0014-5793(92)81347-O; Boeker KHW, 2002, CLIN CHIM ACTA, V316, P71, DOI 10.1016/S0009-8981(01)00730-6; Castera L, 2005, AM J GASTROENTEROL, V100, P711, DOI 10.1111/j.1572-0241.2005.40898.x; Chen XP, 2009, CELL BIOCHEM FUNCT, V27, P407, DOI 10.1002/cbf.1596; Cheung O, 2010, CURR OPIN GASTROEN, V26, P202, DOI 10.1097/MOG.0b013e328337b0c4; Crespo J, 2001, HEPATOLOGY, V34, P1158, DOI 10.1053/jhep.2001.29628; Dela Pena A, 2005, GASTROENTEROLOGY, V129, P1663, DOI 10.1053/j.gastro.2005.09.004; Endo M, 2007, EXP BIOL MED, V232, P614; Galastri S, 2012, CLIN SCI, V123, P459, DOI 10.1042/CS20110515; Harvey CE, 2003, J LEUKOCYTE BIOL, V74, P360, DOI 10.1189/jlb.0303093; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001; Kassel KM, 2010, LAB INVEST, V90, P1794, DOI 10.1038/labinvest.2010.143; Kim MS, 2007, METABOLISM, V56, P267, DOI 10.1016/j.metabol.2006.10.007; Kitamura K, 2002, LAB INVEST, V82, P571, DOI 10.1038/labinvest.3780452; Koike K, 2005, J GASTROENTEROL, V40, P329, DOI 10.1007/s00535-005-1586-z; Larter CZ, 2008, J GASTROEN HEPATOL, V23, P1635, DOI 10.1111/j.1440-1746.2008.05543.x; Lassen MG, 2010, J IMMUNOL, V184, P2693, DOI 10.4049/jimmunol.0901362; Leuschner F, 2011, NAT BIOTECHNOL, V29, P1005, DOI 10.1038/nbt.1989; Li WJ, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-49; Mas E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007929; McCaughan GW, 2004, GUT, V53, P318, DOI 10.1136/gut.2003.026393; Miura K, 2012, AM J PHYSIOL-GASTR L, V302, pG1310, DOI 10.1152/ajpgi.00365.2011; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Muhlbauer M, 2003, GASTROENTEROLOGY, V125, P1085, DOI 10.1016/S0016-5085(03)01213-7; Napoli J, 1996, HEPATOLOGY, V24, P759; Nash PT, 2005, MED J AUSTRALIA, V183, P205, DOI 10.5694/j.1326-5377.2005.tb06998.x; Negro F, 2010, GUT, V59, P1279, DOI 10.1136/gut.2009.192732; Novobrantseva TI, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2011.3; Obstfeld AE, 2010, DIABETES, V59, P916, DOI 10.2337/db09-1403; Palmer C, 2010, GUT, V59, P397, DOI 10.1136/gut.2008.165316; Pandey AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009063; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Petrasek J, 2011, GASTROENTEROLOGY, V140, P697, DOI 10.1053/j.gastro.2010.08.020; Poniachik J, 2006, CYTOKINE, V33, P252, DOI 10.1016/j.cyto.2006.02.006; Romero AI, 2006, J INFECT DIS, V194, P895, DOI 10.1086/507307; Rull A, 2009, CYTOKINE, V48, P273, DOI 10.1016/j.cyto.2009.08.006; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Stienstra R, 2010, HEPATOLOGY, V51, P511, DOI 10.1002/hep.23337; Su GL, 2002, AM J PHYSIOL-GASTR L, V283, pG256, DOI 10.1152/ajpgi.00550.2001; Szabo G, 2012, J HEPATOL, V57, P642, DOI 10.1016/j.jhep.2012.03.035; TILG H, 1992, GASTROENTEROLOGY, V103, P264, DOI 10.1016/0016-5085(92)91122-K; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Tomita K, 2006, GUT, V55, P415, DOI 10.1136/gut.2005.071118; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Yamaguchi K, 2010, LAB INVEST, V90, P1169, DOI 10.1038/labinvest.2010.75; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yoshiji H, 2002, HEPATOLOGY, V36, P850, DOI 10.1053/jhep.2002.35625	51	280	298	1	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40161	40172		10.1074/jbc.M112.417014	http://dx.doi.org/10.1074/jbc.M112.417014			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23066023	hybrid, Green Published			2022-12-28	WOS:000311448800007
J	Yang, CX; Park, AC; Davis, NA; Russell, JD; Kim, B; Brand, DD; Lawrence, MJ; Ge, Y; Westphall, MS; Coon, JJ; Greenspan, DS				Yang, Chenxi; Park, Arick C.; Davis, Nicholas A.; Russell, Jason D.; Kim, Byoungjae; Brand, David D.; Lawrence, Matthew J.; Ge, Ying; Westphall, Michael S.; Coon, Joshua J.; Greenspan, Daniel S.			Comprehensive Mass Spectrometric Mapping of the Hydroxylated Amino Acid residues of the alpha 1(V) Collagen Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYANOGEN-BROMIDE PEPTIDES; BONE MORPHOGENETIC PROTEIN-1; BASEMENT-MEMBRANE COLLAGEN; EHLERS-DANLOS-SYNDROME; T-CELL RECOGNITION; V COLLAGEN; POSTTRANSLATIONAL MODIFICATIONS; 3-HYDROXYPROLINE RESIDUES; PROLYL 3-HYDROXYLASE; COVALENT STRUCTURE	Aberrant expression of the type V collagen alpha 1(V) chain can underlie the connective tissue disorder classic Ehlers-Danlos syndrome, and autoimmune responses against the alpha 1(V) chain are linked to lung transplant rejection and atherosclerosis. The alpha 1(V) collagenous COL1 domain is thought to contain greater numbers of post-translational modifications (PTMs) than do similar domains of other fibrillar collagen chains, PTMs consisting of hydroxylated prolines and lysines, the latter of which can be glycosylated. These types of PTMs can contribute to epitopes that underlie immune responses against collagens, and the high level of PTMs may contribute to the unique biological properties of the alpha 1(V) chain. Here we use high resolution mass spectrometry to map such PTMs in bovine placental alpha 1(V) and human recombinant pro-alpha 1(V) procollagen chains. Findings include the locations of those PTMs that vary and those PTMs that are invariant between these alpha 1(V) chains from widely divergent sources. Notably, an unexpectedly large number of hydroxyproline residues were mapped to the X-positions of Gly-X-Y triplets, contrary to expectations based on previous amino acid analyses of hydrolyzed alpha 1(V)chains from various tissues. We attribute this difference to the ability of tandem mass spectrometry coupled to nanoflow chromatographic separations to detect lower-level PTM combinations with superior sensitivity and specificity. The data are consistent with the presence of a relatively large number of 3-hydroxyproline sites with less than 100% occupancy, suggesting a previously unknown mechanism for the differential modification of alpha 1(V) chain and type V collagen properties.	[Yang, Chenxi; Russell, Jason D.; Coon, Joshua J.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Yang, Chenxi; Russell, Jason D.; Coon, Joshua J.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Park, Arick C.; Davis, Nicholas A.; Kim, Byoungjae; Lawrence, Matthew J.; Ge, Ying; Greenspan, Daniel S.] Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI 53706 USA; [Lawrence, Matthew J.; Ge, Ying] Univ Wisconsin, Human Prote Program, Madison, WI 53706 USA; [Westphall, Michael S.; Coon, Joshua J.] Univ Wisconsin, Genome Ctr, Madison, WI 53706 USA; [Brand, David D.] Univ Tennessee, Hlth Sci Ctr, Vet Affairs Med Ctr, Res Serv, Memphis, TN 38104 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Greenspan, DS (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, 600 Highland Ave, Madison, WI 53792 USA.	dsgreens@wisc.edu		Brand, David/0000-0002-9260-7963; Greenspan, Daniel/0000-0001-8096-7446; Park, Arick/0000-0001-5668-0701	National Institutes of Health [GM080148, AR047746, AI084853]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI084853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR047746, R01AR047746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692, R01GM080148] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM080148 (to J. J. C.) and AR047746 and AI084853 (to D. S. G.).	ABEDIN MZ, 1982, BIOSCIENCE REP, V2, P493, DOI 10.1007/BF01115247; ARBOGAST BW, 1976, J IMMUNOL, V117, P2181; Bann JG, 2000, J BIOL CHEM, V275, P24466, DOI 10.1074/jbc.M003336200; BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999; BIRK DE, 1990, J CELL SCI, V95, P649; Bobadilla JL, 2008, AM J RESP CRIT CARE, V177, P660, DOI 10.1164/rccm.200612-1901OC; BRAND DD, 1994, J IMMUNOL, V152, P3088; Breci LA, 2003, ANAL CHEM, V75, P1963, DOI 10.1021/ac026359i; Burlingham WJ, 2007, J CLIN INVEST, V117, P3498, DOI 10.1172/JCI28031; BUTLER WT, 1967, BIOCHEMISTRY-US, V6, P3771, DOI 10.1021/bi00864a022; Chanut-Delalande H, 2001, J BIOL CHEM, V276, P24352, DOI 10.1074/jbc.M101182200; CHUNG E, 1976, BIOCHEM BIOPH RES CO, V71, P1167, DOI 10.1016/0006-291X(76)90776-2; CLICK EM, 1970, BIOCHEMISTRY-US, V9, P4699; Corthay A, 1998, EUR J IMMUNOL, V28, P2580, DOI 10.1002/(SICI)1521-4141(199808)28:08<2580::AID-IMMU2580>3.0.CO;2-X; Dart ML, 2010, CIRC RES, V107, P1106, DOI 10.1161/CIRCRESAHA.110.221069; Delacoux F, 1998, J BIOL CHEM, V273, P15069, DOI 10.1074/jbc.273.24.15069; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Eyre DR, 2011, J BIOL CHEM, V286, P7732, DOI 10.1074/jbc.C110.195768; Fernandes RJ, 2011, J BIOL CHEM, V286, P30662, DOI 10.1074/jbc.M111.267906; Ficarro SB, 2009, ANAL CHEM, V81, P3440, DOI 10.1021/ac802720e; Fichard A, 1997, J BIOL CHEM, V272, P30083, DOI 10.1074/jbc.272.48.30083; FICHARD A, 1995, MATRIX BIOL, V14, P515, DOI 10.1016/S0945-053X(05)80001-0; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Good DM, 2007, MOL CELL PROTEOMICS, V6, P1942, DOI 10.1074/mcp.M700073-MCP200; Good DM, 2010, PROTEOMICS, V10, P164, DOI 10.1002/pmic.200900570; Good DM, 2009, J AM SOC MASS SPECTR, V20, P1435, DOI 10.1016/j.jasms.2009.03.006; Gopalakrishnan B, 2004, J BIOL CHEM, V279, P30904, DOI 10.1074/jbc.M402252200; Gorres KL, 2010, CRIT REV BIOCHEM MOL, V45, P106, DOI 10.3109/10409231003627991; GREENSPAN DS, 1991, J BIOL CHEM, V266, P24727; GRYDER RM, 1975, J BIOL CHEM, V250, P2470; Henkel W, 2007, J PROTEOME RES, V6, P4269, DOI 10.1021/pr070318r; Huang YY, 2004, J AM CHEM SOC, V126, P3034, DOI 10.1021/ja038041t; Imamura Y, 2000, J BIOL CHEM, V275, P8749, DOI 10.1074/jbc.275.12.8749; Imamura Y, 1998, J BIOL CHEM, V273, P27511, DOI 10.1074/jbc.273.42.27511; INOUYE K, 1982, ARCH BIOCHEM BIOPHYS, V219, P198, DOI 10.1016/0003-9861(82)90149-7; Iwata T, 2008, J IMMUNOL, V181, P5738, DOI 10.4049/jimmunol.181.8.5738; Jenkins CL, 2003, J AM CHEM SOC, V125, P6422, DOI 10.1021/ja034015j; KEFALIDES NA, 1975, J INVEST DERMATOL, V65, P85, DOI 10.1111/1523-1747.ep12598062; Kessler E, 2001, J BIOL CHEM, V276, P27051, DOI 10.1074/jbc.M102921200; KIVIRIKKO KI, 1993, ANN MED, V25, P113, DOI 10.3109/07853899309164153; Licklider LJ, 2002, ANAL CHEM, V74, P3076, DOI 10.1021/ac025529o; LOO JA, 1993, ANAL CHEM, V65, P425, DOI 10.1021/ac00052a020; Mares DC, 2000, AM J RESP CELL MOL, V23, P62, DOI 10.1165/ajrcmb.23.1.3924; McAlister GC, 2010, ANAL CHEM, V82, P316, DOI 10.1021/ac902005s; MICHAELSSON E, 1994, J EXP MED, V180, P745, DOI 10.1084/jem.180.2.745; MILLER EJ, 1973, BIOCHEMISTRY-US, V12, P3153, DOI 10.1021/bi00741a003; Mizuno K, 2008, FEBS J, V275, P5830, DOI 10.1111/j.1742-4658.2008.06704.x; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; MORRIS NP, 1987, J BIOL CHEM, V262, P11345; Myers LK, 2004, J IMMUNOL, V172, P2970, DOI 10.4049/jimmunol.172.5.2970; MYERS LK, 1995, IMMUNOLOGY, V84, P509; Olsen JV, 2009, MOL CELL PROTEOMICS, V8, P2759, DOI 10.1074/mcp.M900375-MCP200; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Pyott SM, 2011, HUM MOL GENET, V20, P1595, DOI 10.1093/hmg/ddr037; RHODES RK, 1979, J BIOL CHEM, V254, P2084; Richards AJ, 1998, J MED GENET, V35, P846, DOI 10.1136/jmg.35.10.846; RISTELI J, 1977, EUR J BIOCHEM, V73, P485, DOI 10.1111/j.1432-1033.1977.tb11341.x; Rodriguez J, 2008, J PROTEOME RES, V7, P300, DOI 10.1021/pr0705035; Roulet M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/376927; Savitski MM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003830; Schumacher MA, 2006, J BIOL CHEM, V281, P27566, DOI 10.1074/jbc.M602797200; SEYER JM, 1989, ARCH BIOCHEM BIOPHYS, V271, P120, DOI 10.1016/0003-9861(89)90262-2; SEYER JM, 1981, BIOCHEMISTRY-US, V20, P2621, DOI 10.1021/bi00512a040; Shah R, 2009, BRIT J CANCER, V100, P1687, DOI 10.1038/sj.bjc.6605042; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Sipila L, 2007, J BIOL CHEM, V282, P33381, DOI 10.1074/jbc.M704198200; Sumpter TL, 2004, AM J PHYSIOL-LUNG C, V286, pL1129, DOI 10.1152/ajplung.00330.2003; Swaney DL, 2010, J PROTEOME RES, V9, P1323, DOI 10.1021/pr900863u; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; TANG XJ, 1993, ANAL CHEM, V65, P2824, DOI 10.1021/ac00068a020; Tiainen P, 2008, J BIOL CHEM, V283, P19432, DOI 10.1074/jbc.M802973200; Toriello HV, 1996, NAT GENET, V13, P361, DOI 10.1038/ng0796-361; Unsold C, 2002, J BIOL CHEM, V277, P5596, DOI 10.1074/jbc.M110003200; Vaisar T, 1996, J MASS SPECTROM, V31, P1185, DOI 10.1002/(SICI)1096-9888(199610)31:10<1185::AID-JMS396>3.0.CO;2-Q; Van den Steen PE, 2004, BIOCHEMISTRY-US, V43, P10809, DOI 10.1021/bi0493665; Van Den Steen PE, 2002, FASEB J, V16, DOI 10.1096/fj.01-0688com; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; Wenger CD, 2011, PROTEOMICS, V11, P1064, DOI 10.1002/pmic.201000616; Wiesner J, 2008, PROTEOMICS, V8, P4466, DOI 10.1002/pmic.200800329; Wu JJ, 2009, J BIOL CHEM, V284, P5539, DOI 10.1074/jbc.M806369200; Zhang GF, 2009, FOOD HYDROCOLLOID, V23, P2001, DOI 10.1016/j.foodhyd.2009.03.010	81	37	38	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40598	40610		10.1074/jbc.M112.406850	http://dx.doi.org/10.1074/jbc.M112.406850			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23060441	Green Published, hybrid			2022-12-28	WOS:000311448800049
J	Darshi, M; Trinh, KN; Murphy, AN; Taylor, SS				Darshi, Manjula; Trinh, Kristina N.; Murphy, Anne N.; Taylor, Susan S.			Targeting and Import Mechanism of Coiled-coil Helix Coiled-coil Helix Domain-containing Protein 3 (ChChd3) into the Mitochondrial Intermembrane Space	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRISTAE MORPHOLOGY; N-MYRISTOYLATION; MEMBRANE; MITOFILIN; MIA40; BIOGENESIS; COMPLEX; KINASE; SAM50; IDENTIFICATION	Coiled-coil helix coiled-coil helix domain-containing protein 3 (ChChd3) is a mitochondrial inner membrane (IM) protein facing toward the intermembrane space (IMS). In the IMS, ChChd3 complexes with multiple proteins at the crista junctions and contact sites and plays a key role in maintaining crista integrity. ChChd3 is myristoylated at the N terminus and has a CHCH domain with twin CX9C motifs at its C terminus. The CHCH domain proteins are traditionally imported and trapped in the IMS by using a disulfide relay system mediated by Mia40 and Erv1. In this study, we systematically analyzed the role of the myristoylation and the CHCH domain in the import and mitochondrial localization of ChChd3. Based on our results, we predict that myristoylation promotes binding of ChChd3 to the outer membrane and that the CHCH domain translocates the protein across the outer membrane. By analysis of the CHCH domain cysteine mutants, we further show that they have distinct roles in binding to Mia40 in the IMS and proper folding of the protein. The transient disulfide-bonded intermediate with Mia40 is formed preferentially between the second cysteine in helix 1, Cys(193), and the active site cysteine in Mia40, Cys(55). Although each of the four cysteines is essential for folding of the protein and binding to mitofilin and Sam50, they are not involved in import. Together our results indicate that both the myristoylation and the CHCH domain are essential for the import and mitochondrial localization of ChChd3. Once imported, ChChd3 binds to Mia40 for further folding and assembly into macromolecular complexes.	[Darshi, Manjula; Taylor, Susan S.] UCSD, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Trinh, Kristina N.; Taylor, Susan S.] UCSD, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Murphy, Anne N.; Taylor, Susan S.] UCSD, Dept Pharmacol, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Taylor, SS (corresponding author), UCSD, Howard Hughes Med Inst, Leichtag 415, La Jolla, CA 92093 USA.	staylor@ucsd.edu	Murphy, Anne N/H-3217-2016	Murphy, Anne N/0000-0002-5222-9902	National Institutes of Health [P01 DK54441]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 DK54441 (to S. S. T.).	Alkhaja AK, 2012, MOL BIOL CELL, V23, P247, DOI 10.1091/mbc.E11-09-0774; An J, 2012, J BIOL CHEM, V287, P7411, DOI 10.1074/jbc.M111.277103; Banci L, 2008, J BIOL CHEM, V283, P7912, DOI 10.1074/jbc.M708016200; Banci L, 2009, FEBS LETT, V583, P1699, DOI 10.1016/j.febslet.2009.03.061; Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553; Colombo S, 2005, J CELL BIOL, V168, P735, DOI 10.1083/jcb.200407082; Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Head BP, 2011, MOL BIOL CELL, V22, P831, DOI 10.1091/mbc.E10-07-0600; Hofmann S, 2005, J MOL BIOL, V353, P517, DOI 10.1016/j.jmb.2005.08.064; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Kawano S, 2009, P NATL ACAD SCI USA, V106, P14403, DOI 10.1073/pnas.0901793106; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kloppel C, 2011, MOL BIOL CELL, V22, P3749, DOI 10.1091/mbc.E11-04-0293; Kovanich D, 2010, CHEMBIOCHEM, V11, P963, DOI 10.1002/cbic.201000058; Kozjak-Pavlovic V, 2007, EMBO REP, V8, P576, DOI 10.1038/sj.embor.7400982; LaPorte SL, 2005, P NATL ACAD SCI USA, V102, P1889, DOI 10.1073/pnas.0408890102; Means CK, 2011, P NATL ACAD SCI USA, V108, pE1227, DOI 10.1073/pnas.1107182108; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Milenkovic D, 2007, J BIOL CHEM, V282, P22472, DOI 10.1074/jbc.M703294200; Milenkovic D, 2009, MOL BIOL CELL, V20, P2530, DOI 10.1091/mbc.E08-11-1108; Ott C, 2012, MOL CELL BIOL, V32, P1173, DOI 10.1128/MCB.06388-11; Rabl R, 2009, J CELL BIOL, V185, P1047, DOI 10.1083/jcb.200811099; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Schauble S, 2007, J BIOL CHEM, V282, P14952, DOI 10.1074/jbc.M609221200; Sideris DP, 2009, J CELL BIOL, V187, P1007, DOI 10.1083/jcb.200905134; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; THELEN M, 1991, NATURE, V351, P320, DOI 10.1038/351320a0; Webb CT, 2006, MOL CELL, V21, P123, DOI 10.1016/j.molcel.2005.11.010; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; [No title captured]	32	52	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.387696	http://dx.doi.org/10.1074/jbc.M112.387696			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23019327	hybrid, Green Published			2022-12-28	WOS:000311233800020
J	Fu, CY; Su, YF; Lee, MH; Chang, GD; Tsai, HJ				Fu, Chuan-Yang; Su, Ying-Fang; Lee, Ming-Hsuan; Chang, Geen-Dong; Tsai, Huai-Jen			Zebrafish Dkk3a Protein Regulates the Activity of myf5 Promoter through Interaction with Membrane Receptor Integrin alpha 6b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DICKKOPF GENES; TYROSINE KINASE; SKELETAL-MUSCLE; MAP KINASE; REIC/DKK-3; CELLS; ACTIVATION; EXPRESSION; ADHESION; CANCER	Myogenic regulatory factor Myf5 plays important roles in muscle development. In zebrafish myf5, a microRNA (miR), termed miR-3906 or miR-In300, was reported to silence dick-kopf-3-related gene (dkk3r or dkk3a), resulting in repression of myf5 promoter activity. However, the membrane receptor that interacts with ligand Dkk3a to control myf5 expression through signal transduction remains unknown. To address this question, we applied immunoprecipitation and LC-MS/MS to screen putative membrane receptors of Dkk3a, and Integrin alpha 6b (Itg alpha 6b) was finally identified. To further confirm this, we used cell surface binding assays, which showed that Dkk3a and Itg alpha 6b were co-expressed at the cell membrane of HEK-293T cells. Cross-linking immunoprecipitation data also showed high affinity of Itg alpha 6b for Dkk3a. We further proved that the beta-propeller repeat domains of Itg alpha 6b are key segments bound by Dkk3a. Moreover, when dkk3a and itg alpha 6b mRNAs were co-injected into embryos, luciferase activity was up-regulated 4-fold greater than that of control embryos. In contrast, the luciferase activities of dkk3a knockdown embryos co-injected with itg alpha 6b mRNA and itg alpha 6b knockdown embryos co-injected with dkk3a mRNA were decreased in a manner similar to that in control embryos, respectively. Knockdown of itg alpha 6b resulted in abnormal somite shape, fewer somitic cells, weaker or absent myf5 expression, and reduced the protein level of phosphorylated p38a in somites. These defective phenotypes of trunk muscular development were similar to those of dkk3a knockdown embryos. We demonstrated that the secreted ligand Dkk3a binds to the membrane receptor Itg alpha 6b, which increases the protein level of phosphorylated p38a and activates myf5 promoter activity of zebrafish embryos during myogenesis.	[Fu, Chuan-Yang; Su, Ying-Fang; Lee, Ming-Hsuan; Tsai, Huai-Jen] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 106, Taiwan; [Chang, Geen-Dong] Natl Taiwan Univ, Inst Biochem Sci, Taipei 106, Taiwan	National Taiwan University; National Taiwan University	Tsai, HJ (corresponding author), Natl Taiwan Univ, Inst Mol & Cellular Biol, 1,Sect 4,Roosevelt Rd, Taipei 106, Taiwan.	hjtsai@ntu.edu.tw			National Science Council, Republic of China [100-2313-B-002-043-MY3]	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council, Republic of China Grant 100-2313-B-002-043-MY3. We are grateful to the staffs of TC5 Bio-Image Tools, Technology Commons, College of Life Science, NTU for help with the CLSM.	Abarzua F, 2005, CANCER RES, V65, P9617, DOI 10.1158/0008-5472.CAN-05-0829; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Bajanca F, 2004, DEV DYNAM, V231, P402, DOI 10.1002/dvdy.20136; Brott BK, 2002, MOL CELL BIOL, V22, P6100, DOI 10.1128/MCB.22.17.6100-6110.2002; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Caricasole A, 2003, J BIOL CHEM, V278, P37024, DOI 10.1074/jbc.M300191200; CHEN QM, 1994, J BIOL CHEM, V269, P26602; Chen YH, 2002, DIFFERENTIATION, V70, P447, DOI 10.1046/j.1432-0436.2002.700807.x; Chiang YH, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/780108; Chong SW, 2009, J FISH BIOL, V74, P1693, DOI 10.1111/j.1095-8649.2009.02174.x; CHUN JS, 1993, MOL BIOL CELL, V4, P271; CLARK EA, 1993, MOL CELL BIOL, V13, P1863, DOI 10.1128/MCB.13.3.1863; COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; El Nakamura R, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-52; Hoang BH, 2004, CANCER RES, V64, P2734, DOI 10.1158/0008-5472.CAN-03-1952; Hsu RJ, 2011, J BIOL CHEM, V286, P6855, DOI 10.1074/jbc.M110.161638; Hsu RJ, 2010, NUCLEIC ACIDS RES, V38, P4384, DOI 10.1093/nar/gkq148; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Kawano O, 2006, LUNG CANCER, V54, P209, DOI 10.1016/j.lungcan.2006.07.006; Kawasaki K, 2009, CANCER GENE THER, V16, P65, DOI 10.1038/cgt.2008.58; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Kuphal S, 2006, ONCOGENE, V25, P5027, DOI 10.1038/sj.onc.1209508; Kurose K, 2004, J UROLOGY, V171, P1314, DOI 10.1097/01.ju.0000101047.64379.d4; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Lee EJ, 2009, INT J CANCER, V124, P287, DOI 10.1002/ijc.23913; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; Li L, 2002, J BIOL CHEM, V277, P5977, DOI 10.1074/jbc.M111131200; Lodygin D, 2005, CANCER RES, V65, P4218, DOI 10.1158/0008-5472.CAN-04-4407; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mao BY, 2003, GENE, V302, P179, DOI 10.1016/S0378-1119(02)01106-X; MCNAMEE HP, 1993, J CELL BIOL, V121, P673, DOI 10.1083/jcb.121.3.673; Monaghan AP, 1999, MECH DEVELOP, V87, P45, DOI 10.1016/S0925-4773(99)00138-0; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Nozaki I, 2001, INT J ONCOL, V19, P117; Ochiai K, 2011, BIOCHEM BIOPH RES CO, V412, P391, DOI 10.1016/j.bbrc.2011.07.109; Otey CA, 1996, INT REV CYTOL, V167, P161, DOI 10.1016/S0074-7696(08)61347-9; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Segat D, 2002, J BIOL CHEM, V277, P31612, DOI 10.1074/jbc.M203471200; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Springer TA, 1997, P NATL ACAD SCI USA, V94, P65, DOI 10.1073/pnas.94.1.65; Tajbakhsh S, 2005, EXP CELL RES, V306, P364, DOI 10.1016/j.yexcr.2005.03.033; Tsuji T, 2001, BIOCHEM BIOPH RES CO, V289, P257, DOI 10.1006/bbrc.2001.5972; Untergasser G, 2011, GENE EXPR PATTERNS, V11, P491, DOI 10.1016/j.gep.2011.08.005; VUORI K, 1993, J BIOL CHEM, V268, P21459; Wilschut KJ, 2011, STEM CELL RES, V7, P112, DOI 10.1016/j.scr.2011.05.001; Wu W, 2000, CURR BIOL, V10, P1611, DOI 10.1016/S0960-9822(00)00868-X; ZHU XY, 1995, MOL BIOL CELL, V6, P273, DOI 10.1091/mbc.6.3.273	48	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.395012	http://dx.doi.org/10.1074/jbc.M112.395012			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23024366	Green Published, hybrid			2022-12-28	WOS:000311233800070
J	Mailloux, RJ; Fu, A; Robson-Doucette, C; Allister, EM; Wheeler, MB; Screaton, R; Harper, ME				Mailloux, Ryan J.; Fu, Accalia; Robson-Doucette, Christine; Allister, Emma M.; Wheeler, Michael B.; Screaton, Robert; Harper, Mary-Ellen			Glutathionylation State of Uncoupling Protein-2 and the Control of Glucose-stimulated Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; OXYGEN SPECIES PRODUCTION; S-GLUTATHIONYLATION; MITOCHONDRIAL-MEMBRANE; OXIDATIVE STRESS; MUSCLE-CELLS; PROTON LEAK; RELEASE; ISLETS; CONDUCTANCE	The role of reactive oxygen species (ROS) in glucose-stimulated insulin release remains controversial because ROS have been shown to both amplify and impede insulin release. In regard to preventing insulin release, ROS activates uncoupling protein-2 (UCP2), a mitochondrial inner membrane protein that negatively regulates glucose-stimulated insulin secretion (GSIS) by uncoupling oxidative phosphorylation. With our recent discovery that the UCP2-mediated proton leak is modulated by reversible glutathionylation, a process responsive to small changes in ROS levels, we resolved to determine whether glutathionylation is required for UCP2 regulation of GSIS. Using Min6 cells and pancreatic islets, we demonstrate that induction of glutathionylation not only deactivates UCP2-mediated proton leak but also enhances GSIS. Conversely, an increase in mitochondrial matrix ROS was found to deglutathionylate and activate UCP2 leak and impede GSIS. Glucose metabolism also decreased the total amount of cellular glutathionylated proteins and increased the cellular glutathione redox ratio (GSH/GSSG). Intriguingly, the provision of extracellular ROS (H2O2, 10 mu M) amplified GSIS and also activated UCP2. Collectively, our findings indicate that the glutathionylation status of UCP2 contributes to the regulation of GSIS, and different cellular sites and inducers of ROS can have opposing effects on GSIS, perhaps explaining some of the controversy surrounding the role of ROS in GSIS.	[Mailloux, Ryan J.; Harper, Mary-Ellen] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Fu, Accalia; Screaton, Robert] Childrens Hosp Eastern Ontario, Res Inst, Apoptosis Res Ctr, Ottawa, ON K1H 8L1, Canada; [Robson-Doucette, Christine; Allister, Emma M.; Wheeler, Michael B.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; University of Toronto	Harper, ME (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.	mharper@uottawa.ca		Doucette, Christine/0000-0002-5070-2639; Harper, Mary-Ellen/0000-0003-3864-5886; Wheeler, Michael B./0000-0002-7480-7267; Mailloux, Ryan/0000-0003-3986-9830; Fu, Accalia/0000-0002-1110-8039	Canadian Institutes of Health Research; Canadian Diabetes Association	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association	This work was supported in part by Canadian Institutes of Health Research Canadian Institutes of Health Research (to M. E. H.).; Supported by a postdoctoral fellowship provided by the Canadian Institutes of Health Research.; Supported by a doctoral training fellowship from the Canadian Diabetes Association.	Affourtit C, 2008, BBA-BIOENERGETICS, V1777, P973, DOI 10.1016/j.bbabio.2008.03.022; Affourtit C, 2008, BIOCHEM J, V409, P199, DOI 10.1042/BJ20070954; Affourtit C, 2011, FREE RADICAL BIO MED, V50, P609, DOI 10.1016/j.freeradbiomed.2010.12.020; AMMON HPT, 1980, DIABETES, V29, P830, DOI 10.2337/diabetes.29.10.830; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; BUS JS, 1984, ENVIRON HEALTH PERSP, V55, P37, DOI 10.2307/3429690; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Cooper AJL, 2011, EXPERT OPIN DRUG MET, V7, P891, DOI 10.1517/17425255.2011.577738; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gray JP, 2010, TOXICOL MECH METHOD, V20, P167, DOI 10.3109/15376511003695181; Heart E, 2012, TOXICOL APPL PHARM, V258, P216, DOI 10.1016/j.taap.2011.11.002; Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999; JANJIC D, 1992, EUR J BIOCHEM, V210, P297, DOI 10.1111/j.1432-1033.1992.tb17421.x; Kitiphongspattana K, 2007, AM J PHYSIOL-ENDOC M, V292, pE1543, DOI 10.1152/ajpendo.00620.2006; Kong D, 2010, CELL METAB, V12, P545, DOI 10.1016/j.cmet.2010.09.013; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Koshkin V, 2003, J BIOL CHEM, V278, P19709, DOI 10.1074/jbc.M209709200; Kushnareva YE, 2000, ARCH BIOCHEM BIOPHYS, V376, P377, DOI 10.1006/abbi.2000.1730; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Liedhegner EAS, 2012, ANTIOXID REDOX SIGN, V16, P543, DOI 10.1089/ars.2011.4119; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; MACDONALD MJ, 1991, BIOSCIENCE REP, V11, P165, DOI 10.1007/BF01182485; MACDONALD MJ, 1990, ARCH BIOCHEM BIOPHYS, V279, P104, DOI 10.1016/0003-9861(90)90468-E; MacLellan JD, 2005, DIABETES, V54, P2343, DOI 10.2337/diabetes.54.8.2343; Mailloux RJ, 2012, TRENDS ENDOCRIN MET, V23, P451, DOI 10.1016/j.tem.2012.04.004; Mailloux RJ, 2012, FASEB J, V26, P363, DOI 10.1096/fj.11-189639; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Mailloux RJ, 2011, J BIOL CHEM, V286, P21865, DOI 10.1074/jbc.M111.240242; Mailloux RJ, 2010, FASEB J, V24, P2495, DOI 10.1096/fj.09-151803; Malmgren S, 2009, J BIOL CHEM, V284, P32395, DOI 10.1074/jbc.M109.026708; MASON RP, 1990, ENVIRON HEALTH PERSP, V87, P237, DOI 10.2307/3431031; Mertz RJ, 1996, J BIOL CHEM, V271, P4838, DOI 10.1074/jbc.271.9.4838; Mieyal JJ, 2012, ANTIOXID REDOX SIGN, V16, P471, DOI 10.1089/ars.2011.4454; Park WH, 2007, J CELL BIOCHEM, V102, P98, DOI 10.1002/jcb.21280; Parker N, 2008, BIOCHEM J, V412, P131, DOI 10.1042/BJ20080006; Pi J, 2010, DIABETES OBES METAB, V12, P141, DOI 10.1111/j.1463-1326.2010.01269.x; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Porterfield DM, 2000, DIABETES, V49, P1511, DOI 10.2337/diabetes.49.9.1511; Rani S, 2010, CELL PHYSIOL BIOCHEM, V25, P667, DOI 10.1159/000315086; Rebelato E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024507; Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581; Robson-Doucette CA, 2011, DIABETES, V60, P2710, DOI 10.2337/db11-0132; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Spacek T, 2008, INT J BIOCHEM CELL B, V40, P1522, DOI 10.1016/j.biocel.2007.11.015; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010	48	53	54	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.393538	http://dx.doi.org/10.1074/jbc.M112.393538			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23035124	Green Published, hybrid			2022-12-28	WOS:000311233800037
J	Merceron, R; Foucault, M; Haser, R; Mattes, R; Watzlawick, H; Gouet, P				Merceron, Romain; Foucault, Marine; Haser, Richard; Mattes, Ralf; Watzlawick, Hildegard; Gouet, Patrice			The Molecular Mechanism of Thermostable alpha-Galactosidases AgaA and AgaB Explained by X-ray Crystallography and Mutational Studies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-STEAROTHERMOPHILUS NCIM-5146; 1.9 ANGSTROM STRUCTURE; CRYSTAL-STRUCTURE; COLD ADAPTATION; N-ACETYLGALACTOSAMINIDASE; PSYCHROPHILIC ENZYMES; SUBSTRATE-SPECIFICITY; GLYCOSYL HYDROLASES; CATALYTIC MECHANISM; GLYCOSIDASES	The alpha-galactosidase AgaA from the thermophilic microorganism Geobacillus stearothermophilus has great industrial potential because it is fully active at 338 K against raffinose and can increase the yield of manufactured sucrose. AgaB has lower affinity for its natural substrates but is a powerful tool for the enzymatic synthesis of disaccharides by transglycosylation. These two enzymes have 97% identity and belong to the glycoside hydrolase (GH) family GH36 for which few structures are available. To understand the structural basis underlying the differences between these two enzymes, we determined the crystal structures of AgaA and AgaB by molecular replacement at 3.2- and 1.8 angstrom-resolution, respectively. We also solved a 2.8-angstrom structure of the AgaA(A355E) mutant, which has enzymatic properties similar to those of AgaB. We observe that residue 355 is located 20 angstrom away from the active site and that the A355E substitution causes structural rearrangements resulting in a significant displacement of the invariant Trp(336) at catalytic subsite - 1. Hence, the active cleft of AgaA is narrowed in comparison with AgaB, and AgaA is more efficient than AgaB against its natural substrates. The structure of AgaA(A355E) complexed with 1-deoxygalactonojirimycin reveals an induced fit movement; there is a rupture of the electrostatic interaction between Glu(355) and Asn(335) and a return of Trp(336) to an optimal position for ligand stacking. The structures of two catalytic mutants of AgaA(A355E) complexed with raffinose and stachyose show that the binding interactions are stronger at subsite -1 to enable the binding of various alpha-galactosides.	[Mattes, Ralf; Watzlawick, Hildegard] Univ Stuttgart, Inst Ind Genet, D-70569 Stuttgart, Germany; [Merceron, Romain; Foucault, Marine; Haser, Richard; Gouet, Patrice] Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot, F-69367 Lyon 07, France	University of Stuttgart; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Watzlawick, H (corresponding author), Univ Stuttgart, Inst Ind Genet, Allmandring 31, D-70569 Stuttgart, Germany.	hildegard.watzlawick@iig.uni-stuttgart.de; p.gouet@ibcp.fr		gouet, patrice/0000-0001-9485-6157	European Community's Seventh Framework Program [283570]	European Community's Seventh Framework Program	This work was supported by the European Community's Seventh Framework Program (FP7/2007-2013) under Grant Agreement 283570 (BioStruct-X).	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Aittaleb M, 1997, PROTEIN ENG, V10, P475, DOI 10.1093/protein/10.5.475; BANNER DW, 1975, NATURE, V255, P609, DOI 10.1038/255609a0; Bruel L, 2011, J BIOL CHEM, V286, P40814, DOI 10.1074/jbc.M111.286039; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clark NE, 2009, J MOL BIOL, V393, P435, DOI 10.1016/j.jmb.2009.08.021; Clarke JH, 2000, APPL MICROBIOL BIOT, V53, P661, DOI 10.1007/s002530000344; Comfort DA, 2007, BIOCHEMISTRY-US, V46, P3319, DOI 10.1021/bi061521n; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DORN E, 1978, BIOCHEM J, V174, P85, DOI 10.1042/bj1740085; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feller G, 1997, CELL MOL LIFE SCI, V53, P830, DOI 10.1007/s000180050103; Feller G, 2003, NAT REV MICROBIOL, V1, P200, DOI 10.1038/nrmicro773; Fernandez-Leiro R, 2010, J BIOL CHEM, V285, P28020, DOI 10.1074/jbc.M110.144584; Foucault M, 2006, ACTA CRYSTALLOGR F, V62, P100, DOI [10.1107/S1744309105042582, 10.1107/S1744309105042562]; Fredslund F, 2011, J MOL BIOL, V412, P466, DOI 10.1016/j.jmb.2011.07.057; Fridjonsson O, 1999, FEMS MICROBIOL LETT, V176, P147, DOI 10.1016/S0378-1097(99)00231-1; Fridjonsson O, 2002, J BACTERIOL, V184, P3385, DOI 10.1128/JB.184.12.3385-3391.2002; Fujimoto Z, 2003, J BIOL CHEM, V278, P20313, DOI 10.1074/jbc.M302292200; Fujimoto Z, 2009, BIOSCI BIOTECH BIOCH, V73, P2360, DOI 10.1271/bbb.90604; GANTER C, 1988, J BIOTECHNOL, V8, P301, DOI 10.1016/0168-1656(88)90022-3; Garman SC, 2004, J MOL BIOL, V337, P319, DOI 10.1016/j.jmb.2004.01.035; Garman SC, 2002, STRUCTURE, V10, P425, DOI 10.1016/S0969-2126(02)00726-8; Golubev AM, 2004, J MOL BIOL, V339, P413, DOI 10.1016/j.jmb.2004.03.062; Gote MM, 2007, ENZYME MICROB TECH, V40, P1312, DOI 10.1016/j.enzmictec.2006.10.004; Gote MM, 2006, PROCESS BIOCHEM, V41, P1311, DOI 10.1016/j.procbio.2006.01.003; Guce AI, 2010, J BIOL CHEM, V285, P3625, DOI 10.1074/jbc.M109.060145; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LeBlanc Jean Guy, 2004, Genet Mol Res, V3, P432; Ly HD, 1999, ANNU REV BIOCHEM, V68, P487, DOI 10.1146/annurev.biochem.68.1.487; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Perugino G, 2004, TRENDS BIOTECHNOL, V22, P31, DOI 10.1016/j.tibtech.2003.10.008; Russell RJM, 1998, STRUCTURE, V6, P351, DOI 10.1016/S0969-2126(98)00037-9; Spangenberg P, 2000, CARBOHYD RES, V329, P65, DOI 10.1016/S0008-6215(00)00170-1; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	42	31	33	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.394114	http://dx.doi.org/10.1074/jbc.M112.394114			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23012371	hybrid, Green Published			2022-12-28	WOS:000311233800034
J	Tian, J; Lee, SO; Liang, L; Luo, J; Huang, CK; Li, L; Niu, YJ; Chang, C				Tian, Jing; Lee, Soo Ok; Liang, Liang; Luo, Jie; Huang, Chiung-Kuei; Li, Lei; Niu, Yuanjie; Chang, Chawnshang			Targeting the Unique Methylation Pattern of Androgen Receptor (AR) Promoter in Prostate Stem/Progenitor Cells with 5-Aza-2 '-deoxycytidine (5-AZA) Leads to Suppressed Prostate Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER STEM-CELLS; TUMOR-INITIATING CELLS; GENE-EXPRESSION; SELF-RENEWAL; MICE LACKING; PHASE-II; DIFFERENTIATION; IDENTIFICATION; LINES; POPULATION	Androgen receptor (AR) expression surveys found that normal prostate/prostate cancer (PCa) stem/progenitor cells, but not embryonic or mesenchymal stem cells, expressed little AR with high methylation in the AR promoter. Mechanism dissection revealed that the differential methylation pattern in the AR promoter could be due to differential expression of methyl-transferases and binding of methylation binding protein to the AR promoter region. The low expression of AR in normal prostate/PCa stem/progenitor cells was reversed after adding 5-aza-2'-deoxycytidine, a demethylating agent, which could then lead to decreased stemness and drive cells into a more differentiated status, suggesting that the methylation in the AR promoter of prostate stem/progenitor cells is critical not only in maintaining the stemness but also critical in protection of cells from differentiation. Furthermore, induced AR expression, via alteration of its methylation pattern, led to suppression of the self-renewal/proliferation of prostate stem/progenitor cells and PCa tumorigenesis in both in vitro assays and in vivo orthotopic xenografted mouse studies. Taken together, these data prove the unique methylation pattern of AR promoter in normal prostate/PCa stem/progenitor cells and the influence of AR on their renewal/proliferation and differentiation. Targeting PCa stem/progenitor cells with alteration of methylated AR promoter status might provide a new potential therapeutic approach to battle PCa because the PCa stem/progenitor cells have high tumorigenicity.	[Tian, Jing; Niu, Yuanjie] Tianjin Med Univ, Chawnshang Chang Sex Hormone Res Ctr, Tianjin Inst Urol, Tianjin 300211, Peoples R China; [Tian, Jing; Lee, Soo Ok; Liang, Liang; Luo, Jie; Huang, Chiung-Kuei; Li, Lei; Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Pathol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; [Tian, Jing; Lee, Soo Ok; Liang, Liang; Luo, Jie; Huang, Chiung-Kuei; Li, Lei; Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Urol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; [Tian, Jing; Lee, Soo Ok; Liang, Liang; Luo, Jie; Huang, Chiung-Kuei; Li, Lei; Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Radiat Oncol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; [Tian, Jing; Lee, Soo Ok; Liang, Liang; Luo, Jie; Huang, Chiung-Kuei; Li, Lei; Chang, Chawnshang] Univ Rochester, Med Ctr, Wilmot Canc Ctr, Rochester, NY 14642 USA; [Liang, Liang; Li, Lei] Xi An Jiao Tong Univ, Sex Hormone Res Ctr, Dept Urol, Affiliated Hosp 1, Xian 710061, Peoples R China; [Chang, Chawnshang] China Med Univ Hosp, Sex Hormone Res Ctr, Taichung 404, Taiwan	Tianjin Medical University; University of Rochester; University of Rochester; University of Rochester; University of Rochester; Xi'an Jiaotong University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Niu, YJ (corresponding author), Tianjin Med Univ, Chawnshang Chang Sex Hormone Res Ctr, Tianjin Inst Urol, Tianjin 300211, Peoples R China.	niuyuanjie@gmail.com; chang@urmc.rochester.edu	Luo, Jie/AAG-3091-2019	Chang, Chawnshang/0000-0001-8510-3516	National Institutes of Health [CA127300]; George Whipple Professorship Endowment; National Natural Science Foundation for Young Scholars of China [81202024, 518304]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH99-TD-B-111-004]; NATIONAL CANCER INSTITUTE [R01CA127300] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George Whipple Professorship Endowment; National Natural Science Foundation for Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Taiwan Department of Health Clinical Trial and Research Center of Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA127300. This work was also supported by the George Whipple Professorship Endowment, the National Natural Science Foundation for Young Scholars of China (Grant 81202024 and 973 Grant 518304), and Taiwan Department of Health Clinical Trial and Research Center of Excellence Grant DOH99-TD-B-111-004 (to China Medical University, Taichung, Taiwan).	Abdallah BM, 2004, J BONE MINER RES, V19, P841, DOI 10.1359/JBMR.040118; Ariff IM, 2012, J NEUROSCI RES, V90, P529, DOI 10.1002/jnr.22804; Blanco S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002403; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Chang CY, 2006, FERTIL STERIL, V85, P1195, DOI 10.1016/j.fertnstert.2005.11.031; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Collins AT, 2001, J CELL SCI, V114, P3865; COOKE PS, 1991, ENDOCRINOLOGY, V128, P2867, DOI 10.1210/endo-128-6-2867; Crawford PA, 1997, MOL CELL BIOL, V17, P3997, DOI 10.1128/MCB.17.7.3997; Crocoll A, 1998, MECH DEVELOP, V72, P175, DOI 10.1016/S0925-4773(98)00007-0; CUNHA GR, 1992, J ANDROL, V13, P465; Deonarain MP, 2009, MABS-AUSTIN, V1, P12, DOI 10.4161/mabs.1.1.7347; DIDUCH DR, 1993, J BONE JOINT SURG AM, V75A, P92, DOI 10.2106/00004623-199301000-00012; Dubrovska A, 2010, CLIN CANCER RES, V16, P5692, DOI 10.1158/1078-0432.CCR-10-1601; Duhagon MA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-324; Goldring MB, 2012, TRENDS MOL MED, V18, P109, DOI 10.1016/j.molmed.2011.11.005; Griend DJV, 2008, CANCER RES, V68, P9703, DOI 10.1158/0008-5472.CAN-08-3084; Guzman-Ramirez N, 2009, PROSTATE, V69, P1683, DOI 10.1002/pros.21018; Heer R, 2007, J CELL PHYSIOL, V212, P572, DOI 10.1002/jcp.21154; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Isaacs JT, 2008, PROSTATE, V68, P1025, DOI 10.1002/pros.20763; Jiang M, 2010, CELL DEATH DIFFER, V17, P469, DOI 10.1038/cdd.2009.148; Juffroy O, 2009, DIFFERENTIATION, V78, P223, DOI 10.1016/j.diff.2009.07.005; Jung CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027740; Kawasaki BT, 2009, PROSTATE, V69, P827, DOI 10.1002/pros.20931; Kinoshita H, 2000, CANCER RES, V60, P3623; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Kontic M, 2012, CLIN LUNG CANCER, V13, P297, DOI 10.1016/j.cllc.2011.11.003; Lee S. O., 2012, J MOL CELL IN PRESS; Li HW, 2011, J SURG ONCOL, V103, P558, DOI 10.1002/jso.21806; Lin JQ, 2011, PROSTATE, V71, P333, DOI 10.1002/pros.21247; Litvinov IV, 2003, J CLIN ENDOCR METAB, V88, P2972, DOI 10.1210/jc.2002-022038; Maitland NJ, 2008, J CLIN ONCOL, V26, P2862, DOI 10.1200/JCO.2007.15.1472; Martino DJ, 2011, EPIGENETICS-US, V6, P1085, DOI 10.4161/epi.6.9.16401; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Mimeault M, 2010, MOL CANCER THER, V9, P617, DOI 10.1158/1535-7163.MCT-09-1013; Mishra DK, 2010, MOL CANCER THER, V9, P33, DOI 10.1158/1535-7163.MCT-09-0486; Miyamoto H, 2007, J NATL CANCER I, V99, P558, DOI 10.1093/jnci/djk113; Mueller Maria-Theresa, 2010, Front Biosci (Elite Ed), V2, P602, DOI 10.2741/e117; Niakan KK, 2006, MOL GENET METAB, V88, P261, DOI 10.1016/j.ymgme.2005.12.010; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; Pulukuri SM, 2006, ONCOGENE, V25, P4559, DOI 10.1038/sj.onc.1209462; Rajasekhar VK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1159; Ramos KS, 2011, BIRTH DEFECTS RES A, V91, P693, DOI 10.1002/bdra.20786; Rasheed ZA, 2011, STEM CELLS, V29, P883, DOI 10.1002/stem.648; Sims-Mourtada J, 2007, ONCOGENE, V26, P5674, DOI 10.1038/sj.onc.1210356; Sonpavde G, 2007, CLIN GENITOURIN CANC, V5, P457, DOI 10.3816/CGC.2007.n.036; Tang DG, 2007, MOL CARCINOGEN, V46, P1, DOI 10.1002/mc.20255; Thibault A, 1998, TUMORI, V84, P87, DOI 10.1177/030089169808400120; TILLEY WD, 1990, CANCER RES, V50, P5382; Titus MA, 2005, CLIN CANCER RES, V11, P4653, DOI 10.1158/1078-0432.CCR-05-0525; Trowbridge JJ, 2012, NAT GENET, V44, P13, DOI 10.1038/ng.1043; Van Leenders GJLH, 2001, BJU INT, V88, P35, DOI 10.1046/j.1464-410X.2001.00117.x; VERHAGEN APM, 1992, CANCER RES, V52, P6182; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wilhelm-Benartzi CS, 2012, ENVIRON HEALTH PERSP, V120, P296, DOI 10.1289/ehp.1103927; Wrzeszczynski KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028503; Wu CT, 2007, P NATL ACAD SCI USA, V104, P12679, DOI 10.1073/pnas.0704940104; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Yang ZM, 2007, NAT MED, V13, P348, DOI 10.1038/nm1547; Yu SQ, 2011, PROSTATE, V71, P517, DOI 10.1002/pros.21264; Zhao H, 2005, CANCER-AM CANCER SOC, V104, P44, DOI 10.1002/cncr.21135	62	49	52	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.395574	http://dx.doi.org/10.1074/jbc.M112.395574			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23012352	Green Published, hybrid			2022-12-28	WOS:000311233800063
J	Xu, RY; Ori, A; Rudd, TR; Uniewicz, KA; Ahmed, YA; Guimond, SE; Skidmore, MA; Siligardi, G; Yates, EA; Fernig, DG				Xu, Ruoyan; Ori, Alessandro; Rudd, Timothy R.; Uniewicz, Katarzyna A.; Ahmed, Yassir A.; Guimond, Scott E.; Skidmore, Mark A.; Siligardi, Giuliano; Yates, Edwin A.; Fernig, David G.			Diversification of the Structural Determinants of Fibroblast Growth Factor-Heparin Interactions IMPLICATIONS FOR BINDING SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; DIFFERENTIAL SCANNING FLUOROMETRY; CIRCULAR-DICHROISM SPECTROSCOPY; CRYSTAL-STRUCTURE; SULFATE PROTEOGLYCANS; RECEPTOR SPECIFICITY; FACTOR FGF; NMR; OLIGOSACCHARIDES; AFFINITY	The functions of a large number (>435) of extracellular regulatory proteins are controlled by their interactions with heparan sulfate (HS). In the case of fibroblast growth factors (FGFs), HS binding determines their transport between cells and is required for the assembly of high affinity signaling complexes with their cognate FGF receptor. However, the specificity of the interaction of FGFs with HS is still debated. Here, we use a panel of FGFs (FGF-1, FGF-2, FGF-7, FGF-9, FGF-18, and FGF-21) spanning five FGF subfamilies to probe their specificities for HS at different levels as follows: binding parameters, identification of heparin-binding sites (HBSs) in the FGFs, changes in their secondary structure caused by heparin binding and structures in the sugar required for binding. For interaction with heparin, the FGFs exhibit K-D values varying between 38 nM (FGF-18) and 620 nM(FGF-9) and association rate constants spanning over 20-fold (FGF-1, 2,900,000 M-1 s(-1) and FGF-9, 130,000 M-1 s(-1)). The canonical HBS in FGF-1, FGF-2, FGF-7, FGF-9, and FGF-18 differs in its size, and these FGFs have a different complement of secondary HBS, ranging from none (FGF-9) to two (FGF-1). Differential scanning fluorimetry identified clear preferences in these FGFs for distinct structural features in the polysaccharide. These data suggest that the differences in heparin-binding sites in both the protein and the sugar are greatest between subfamilies and may be more restricted within a FGF subfamily in accord with the known conservation of function within FGF subfamilies.	[Skidmore, Mark A.; Yates, Edwin A.; Fernig, David G.] Univ Liverpool, Inst Integrat Biol, Dept Chem & Struct Biol, Liverpool L69 7ZB, Merseyside, England; [Ori, Alessandro] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Rudd, Timothy R.] Ist Chim & Biochim, I-20133 Milan, Italy; [Uniewicz, Katarzyna A.] PromoCell GmbH, D-69126 Heidelberg, Germany; [Skidmore, Mark A.] Keele Univ, Inst Sci & Technol Med, Keele ST5 5BG, Staffs, England; [Siligardi, Giuliano] Diamond Light Source Ltd, Didcot OX11 0DE, Oxon, England	University of Liverpool; European Molecular Biology Laboratory (EMBL); Keele University; Diamond Light Source	Yates, EA (corresponding author), Univ Liverpool, Dept Struct & Chem Biol, Biosci Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England.	eayates@liverpool.ac.uk; dgfernig@liverpool.ac.uk	Ori, Alessandro/B-7067-2011; Yates, Edwin A/I-4808-2013; Rudd, Tim/M-6129-2019; Ori, Alessandro/M-8586-2019; Siligardi, Giuliano/AAO-7024-2020; Fernig, David G/A-3590-2008	Ori, Alessandro/0000-0002-3046-0871; Rudd, Tim/0000-0003-4434-0333; Ori, Alessandro/0000-0002-3046-0871; Fernig, David G/0000-0003-4875-4293; Yates, Edwin/0000-0001-9365-5433; Guimond, Scott/0000-0002-5903-418X	Cancer and Polio Research Fund; North West Cancer Research Fund; Biotechnology and Biological Sciences Research Council; Alexander von Humboldt Foundation; Marie Curie Actions	Cancer and Polio Research Fund; North West Cancer Research Fund; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Marie Curie Actions(European Commission)	This work was supported in part by the Cancer and Polio Research Fund, the North West Cancer Research Fund, and Biotechnology and Biological Sciences Research Council.; Supported by postdoctoral fellowships from the Alexander von Humboldt Foundation and Marie Curie Actions.	BAIRD A, 1988, P NATL ACAD SCI USA, V85, P2324, DOI 10.1073/pnas.85.7.2324; Blaber M, 1996, BIOCHEMISTRY-US, V35, P2086, DOI 10.1021/bi9521755; Canales A, 2006, FEBS J, V273, P4716, DOI 10.1111/j.1742-4658.2006.05474.x; Chang Z, 2000, FASEB J, V14, P137, DOI 10.1096/fasebj.14.1.137; Delehedde M, 2002, BIOCHEM J, V366, P235, DOI 10.1042/BJ20011718; Delehedde M, 2002, J BIOL CHEM, V277, P12456, DOI 10.1074/jbc.M111345200; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; Duchesne L, 2006, J BIOL CHEM, V281, P27178, DOI 10.1074/jbc.M601248200; Duchesne L, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001361; ERIKSSON AE, 1991, P NATL ACAD SCI USA, V88, P3441, DOI 10.1073/pnas.88.8.3441; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; FERRO DR, 1986, J AM CHEM SOC, V108, P6773, DOI 10.1021/ja00281a052; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hadian K, 2011, J BIOL CHEM, V286, P26107, DOI 10.1074/jbc.M111.233163; Harmer NJ, 2004, BIOCHEMISTRY-US, V43, P629, DOI 10.1021/bi035320k; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; KE YQ, 1992, BIOCHIM BIOPHYS ACTA, V1131, P307, DOI 10.1016/0167-4781(92)90029-Y; Kinsella L, 1998, GLYCOCONJUGATE J, V15, P419, DOI 10.1023/A:1006986104865; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Landriscina M, 2001, J BIOL CHEM, V276, P25549, DOI 10.1074/jbc.M102925200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Lin XH, 1999, DEVELOPMENT, V126, P3715; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Lozano RM, 2000, BIOCHEMISTRY-US, V39, P4982, DOI 10.1021/bi992544n; Makarenkova HP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000304; Moy FJ, 1996, BIOCHEMISTRY-US, V35, P13552, DOI 10.1021/bi961260p; Murphy KJ, 2004, J BIOL CHEM, V279, P27239, DOI 10.1074/jbc.M401774200; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Olsen SK, 2006, GENE DEV, V20, P185, DOI 10.1101/gad.1365406; Ori A, 2008, FRONT BIOSCI-LANDMRK, V13, P4309, DOI 10.2741/3007; Ori A, 2009, MOL CELL PROTEOMICS, V8, P2256, DOI 10.1074/mcp.M900031-MCP200; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Plotnikov AN, 2001, J BIOL CHEM, V276, P4322, DOI 10.1074/jbc.M006502200; Powell AK, 2010, NAT PROTOC, V5, P821, DOI 10.1038/nprot.2010.17; Rahmoune H, 1998, J BIOL CHEM, V273, P7303, DOI 10.1074/jbc.273.13.7303; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Romero A, 1996, EUR J BIOCHEM, V241, P453, DOI 10.1111/j.1432-1033.1996.00453.x; Rudd TR, 2008, CARBOHYD RES, V343, P2184, DOI 10.1016/j.carres.2007.12.019; Rudd TR, 2007, GLYCOBIOLOGY, V17, P983, DOI 10.1093/glycob/cwm062; Rudd TR, 2010, ORG BIOMOL CHEM, V8, P5390, DOI 10.1039/c0ob00246a; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SENO M, 1990, EUR J BIOCHEM, V188, P239, DOI 10.1111/j.1432-1033.1990.tb15395.x; Sreerama N, 1999, PROTEIN SCI, V8, P370; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Thompson Sophie M, 2011, BMC Dev Biol, V11, P38, DOI 10.1186/1471-213X-11-38; Uniewicz KA, 2010, ANAL CHEM, V82, P3796, DOI 10.1021/ac100188x; Wang F, 1997, J BIOL CHEM, V272, P23887, DOI 10.1074/jbc.272.38.23887; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yates EA, 1996, CARBOHYD RES, V294, P15; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Ye S, 2001, BIOCHEMISTRY-US, V40, P14429, DOI 10.1021/bi011000u; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	57	56	58	0	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.398826	http://dx.doi.org/10.1074/jbc.M112.398826			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23019343	hybrid, Green Published			2022-12-28	WOS:000311233800073
J	Grzegorzewicz, AE; Kordulakova, J; Jones, V; Born, SEM; Belardinelli, JM; Vaquie, A; Gundi, VAKB; Madacki, J; Slama, N; Laval, F; Vaubourgeix, J; Crew, RM; Gicquel, B; Daffe, M; Morbidoni, HR; Brennan, PJ; Quemard, A; McNeil, MR; Jackson, M				Grzegorzewicz, Anna E.; Kordulakova, Jana; Jones, Victoria; Born, Sarah E. M.; Belardinelli, Juan M.; Vaquie, Adrien; Gundi, Vijay A. K. B.; Madacki, Jan; Slama, Nawel; Laval, Francoise; Vaubourgeix, Julien; Crew, Rebecca M.; Gicquel, Brigitte; Daffe, Mamadou; Morbidoni, Hector R.; Brennan, Patrick J.; Quemard, Annaik; McNeil, Michael R.; Jackson, Mary			A Common Mechanism of Inhibition of the Mycobacterium tuberculosis Mycolic Acid Biosynthetic Pathway by Isoxyl and Thiacetazone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG; CYCLOPROPANATION; DERIVATIVES; SYSTEM	Isoxyl (ISO) and thiacetazone (TAC), two prodrugs once used in the clinical treatment of tuberculosis, have long been thought to abolish Mycobacterium tuberculosis (M. tuberculosis) growth through the inhibition of mycolic acid biosynthesis, but their respective targets in this pathway have remained elusive. Here we show that treating M. tuberculosis with ISO or TAC results in both cases in the accumulation of 3-hydroxy C-18, C-20, and C-22 fatty acids, suggestive of an inhibition of the dehydratase step of the fatty-acid synthase type II elongation cycle. Consistently, overexpression of the essential hadABC genes encoding the (3R)-hydroxyacyl-acyl carrier protein dehydratases resulted in more than a 16- and 80-fold increase in the resistance of M. tuberculosis to ISO and TAC, respectively. A missense mutation in the hadA gene of spontaneous ISO- and TAC-resistant mutants was sufficient to confer upon M. tuberculosis high level resistance to both drugs. Other mutations found in hypersusceptible or resistant M. tuberculosis and Mycobacterium kansasii isolates mapped to hadC. Mutations affecting the non-essential mycolic acid methyltransferases MmaA4 and MmaA2 were also found in M. tuberculosis spontaneous ISO- and TAC-resistant mutants. That MmaA4, at least, participates in the activation of the two prodrugs as proposed earlier is not supported by our biochemical evidence. Instead and in light of the known interactions of both MmaA4 and MmaA2 with HadAB and HadBC, we propose that mutations affecting these enzymes may impact the binding of ISO and TAC to the dehydratases.	[Grzegorzewicz, Anna E.; Jones, Victoria; Born, Sarah E. M.; Vaquie, Adrien; Gundi, Vijay A. K. B.; Crew, Rebecca M.; Brennan, Patrick J.; McNeil, Michael R.; Jackson, Mary] Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA; [Kordulakova, Jana; Madacki, Jan] Comenius Univ, Fac Nat Sci, Dept Biochem, Bratislava 84215, Slovakia; [Belardinelli, Juan M.; Morbidoni, Hector R.] Univ Nacl Rosario, Fac Ciencias Med, Catedra Microbiol, Santa Fe, NM, Argentina; [Slama, Nawel; Laval, Francoise; Vaubourgeix, Julien; Daffe, Mamadou; Quemard, Annaik] CNRS, IPBS, Dept Mecanismes Mol Infect Mycobacteriennes, F-31077 Toulouse, France; [Slama, Nawel; Laval, Francoise; Vaubourgeix, Julien; Daffe, Mamadou; Quemard, Annaik] Univ Toulouse Paul Sabatier, F-31077 Toulouse, France; [Gicquel, Brigitte] Inst Pasteur, Unite Genet Mycobacterienne, F-75015 Paris, France	Colorado State University; Comenius University Bratislava; National University of Rosario; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	McNeil, MR (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA.	M.Mcneil@colostate.edu; Mary.Jackson@colostate.edu	Brennan, Patrick J/G-6896-2017; Kordulakova, Jana/I-3887-2014; LAUZERAL-VIZCAINO, Françoise/W-8898-2019; Jackson, Mary/D-5345-2017; Gundi, Vijay A.K.B./B-6121-2013; Belardinelli, Juan Manuel/N-7335-2019	Kordulakova, Jana/0000-0003-2834-0165; LAUZERAL-VIZCAINO, Françoise/0000-0002-9741-3252; Jackson, Mary/0000-0002-9212-0258; Belardinelli, Juan Manuel/0000-0003-1336-9141; Born, Sarah/0000-0001-5964-3121; Quemard, Annaik/0000-0002-5545-3424; Vaubourgeix, Julien/0000-0003-4872-0464; Madacki, Jan/0000-0001-6534-4240	National Institutes of Health from the NIAID [AI085992, AI063054]; Heiser Program for Research in Leprosy and Tuberculosis; Slovak Research and Development Agency [APVV-0441-10]; National University of Rosario; Proyectos de Investigacion Cientifica y Tecnologica from the Agencia Nacional de Promocion Cientifica y Tecnologica (National Agency for Promotion of Science and Technology), Argentina [38198]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI085992, R01AI063054] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Heiser Program for Research in Leprosy and Tuberculosis; Slovak Research and Development Agency(Slovak Research and Development Agency); National University of Rosario; Proyectos de Investigacion Cientifica y Tecnologica from the Agencia Nacional de Promocion Cientifica y Tecnologica (National Agency for Promotion of Science and Technology), Argentina; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI085992 and AI063054 from the NIAID. This work was also supported by the Heiser Program for Research in Leprosy and Tuberculosis (a fellowship to J. K.), Slovak Research and Development Agency Contract APVV-0441-10, and grants from the National University of Rosario and Proyectos de Investigacion Cientifica y Tecnologica Grant 38198 from the Agencia Nacional de Promocion Cientifica y Tecnologica (National Agency for Promotion of Science and Technology), Argentina.	Alahari A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001343; Alahari A, 2009, MOL MICROBIOL, V71, P1263, DOI 10.1111/j.1365-2958.2009.06604.x; Barkan D, 2012, INFECT IMMUN, V80, P1958, DOI 10.1128/IAI.00021-12; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Belardinelli J.M., 2012, MOL MICROBI IN PRESS; Brown JR, 2011, BIOORGAN MED CHEM, V19, P5585, DOI 10.1016/j.bmc.2011.07.034; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Cantaloube S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029564; Chesne-Seck ML, 2008, J BACTERIOL, V190, P1329, DOI 10.1128/JB.01465-07; Dover LG, 2007, ANTIMICROB AGENTS CH, V51, P1055, DOI 10.1128/AAC.01063-06; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Gumbo T, 2007, J INFECT DIS, V195, P194, DOI 10.1086/510247; Kordulakova J, 2007, ANTIMICROB AGENTS CH, V51, P3824, DOI 10.1128/AAC.00433-07; LAMBELIN G, 1970, ANTIBIOT CHEMOTHER, V16, P84; Marrakchi H, 2008, MYCOBACTERIAL CELL ENVELOPE, P41; Nishida CR, 2011, CHEM-BIOL INTERACT, V192, P21, DOI 10.1016/j.cbi.2010.09.015; Phetsuksiri B, 1999, ANTIMICROB AGENTS CH, V43, P1042, DOI 10.1128/AAC.43.5.1042; Phetsuksiri B, 2003, J BIOL CHEM, V278, P53123, DOI 10.1074/jbc.M311209200; Sacco E, 2007, P NATL ACAD SCI USA, V104, P14628, DOI 10.1073/pnas.0704132104; Titscher R, 1966, Prax Pneumol, V20, P202; URBANCIK B, 1970, ANTIBIOT CHEMOTHER, V16, P117; Veyron-Churlet R, 2005, J MOL BIOL, V353, P847, DOI 10.1016/j.jmb.2005.09.016; Veyron-Churlet R, 2004, MOL MICROBIOL, V54, P1161, DOI 10.1111/j.1365-2958.2004.04334.x; WINDER FG, 1971, J GEN MICROBIOL, V66, P379, DOI 10.1099/00221287-66-3-379	25	66	66	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38434	38441		10.1074/jbc.M112.400994	http://dx.doi.org/10.1074/jbc.M112.400994			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23002234	Green Published, hybrid			2022-12-28	WOS:000310982800003
J	Kudo, Y; Iizuka, S; Yoshida, M; Tsunematsu, T; Kondo, T; Subarnbhesaj, A; Deraz, EM; Siriwardena, SBSM; Tahara, H; Ishimaru, N; Ogawa, I; Takata, T				Kudo, Yasusei; Iizuka, Shinji; Yoshida, Maki; Tsunematsu, Takaaki; Kondo, Tomoyuki; Subarnbhesaj, Ajiravudh; Deraz, Elsayed M.; Siriwardena, Samadarani B. S. M.; Tahara, Hidetoshi; Ishimaru, Naozumi; Ogawa, Ikuko; Takata, Takashi			Matrix Metalloproteinase-13 (MMP-13) Directly and Indirectly Promotes Tumor Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SQUAMOUS-CELL CARCINOMAS; COLLAGENASE-3 EXPRESSION; CANCER; HEAD; METASTASIS; MYOFIBROBLASTS; FIBROBLASTS; TRANSITION; INHIBITORS; MIGRATION	Matrix metalloproteinases (MMPs) are extracellular zinc-dependent endopeptidases involved in the degradation and remodeling of extracellular matrix in physiological and pathological processes. MMPs also have a role in cell proliferation, migration, differentiation, angiogenesis, and apoptosis. We previously identified cancer invasion-related factors by comparing the gene expression profiles between parent and the highly invasive clone of cancer cells. Matrix metalloproteinase-13 (MMP-13) was identified as a common up-regulated gene by cancer invasion-related factors. Although MMP-13 slightly promoted tumor invasion, we found that MMP-13 was involved in tumor angiogenesis. Conditioned medium from MMP-13-overexpressing cells promoted capillary formation of immortalized human umbilical vein endothelial cells. Furthermore, treatment with recombinant MMP-13 protein enhanced capillary tube formation both in vitro and in vivo. MMP-13-promoted capillary tube formation was mediated by activation of focal adhesion kinase and ERK. Interestingly, MMP-13-promoted the secretion of VEGF-A from fibroblasts and endothelial cells. By immunohistochemical analysis, we found a possible correlation between MMP-13 expression and the number of blood vessels in human cancer cases. In summary, these findings suggest that MMP-13 may directly and indirectly promote tumor angiogenesis.	[Kudo, Yasusei; Kondo, Tomoyuki; Ishimaru, Naozumi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, Tokushima 7708504, Japan; [Kudo, Yasusei; Iizuka, Shinji; Yoshida, Maki; Tsunematsu, Takaaki; Subarnbhesaj, Ajiravudh; Deraz, Elsayed M.; Siriwardena, Samadarani B. S. M.; Takata, Takashi] Hiroshima Univ, Grad Sch Biomed Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima 7348553, Japan; [Tahara, Hidetoshi] Hiroshima Univ, Grad Sch Biomed Sci, Dept Cellular & Mol Biol, Hiroshima 7348553, Japan; [Ogawa, Ikuko] Hiroshima Univ Hosp, Ctr Oral Clin Examinat, Hiroshima 7348553, Japan	Tokushima University; Hiroshima University; Hiroshima University; Hiroshima University	Kudo, Y (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, 3-18-15 Kuramoto, Tokushima 7708504, Japan.	yasusei@tokushima-u.ac.jp; ttakata@hiroshima-u.ac.jp		Kudo, Yasusei/0000-0002-0392-7720	Ministry of Education, Science, and Culture of Japan; research fellowship for Young Scientists and the Excellent Young Researchers Overseas Visit Program from the Japan Society for the Promotion of Science; Kurozumi Memorial Foundation grant; Grants-in-Aid for Scientific Research [23300363] Funding Source: KAKEN	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); research fellowship for Young Scientists and the Excellent Young Researchers Overseas Visit Program from the Japan Society for the Promotion of Science; Kurozumi Memorial Foundation grant; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Science, and Culture of Japan (to Y. K. and T. Ta.), a research fellowship for Young Scientists and the Excellent Young Researchers Overseas Visit Program from the Japan Society for the Promotion of Science (to S. I. and T. Ts.), and a Kurozumi Memorial Foundation grant (to Y. K.).	Anno K, 2007, BIOCHEM BIOPH RES CO, V353, P926, DOI 10.1016/j.bbrc.2006.12.112; Ashworth JL, 1999, BIOCHEM J, V340, P171, DOI 10.1042/0264-6021:3400171; Baek Y.Y, 2011, EUR J PHARMACOL, V674, P629; Bauer KS, 2000, J PHARMACOL EXP THER, V292, P31; Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Bouck N, 1996, ADV CANCER RES, V69, P135, DOI 10.1016/S0065-230X(08)60862-3; Corte MD, 2005, INT J BIOL MARKER, V20, P242, DOI 10.1177/172460080502000407; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Culhaci N, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-42; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; del Casar Lizcano J M, 2003, Gastroenterol Hepatol, V26, P1; Deraz EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025438; Direkze NC, 2004, CANCER RES, V64, P8492, DOI 10.1158/0008-5472.CAN-04-1708; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; FIDLER IJ, 1990, CANCER RES, V50, P6130; FOLKMAN J, 2000, CANC MED, P132; FOX SB, 1995, J PATHOL, V177, P275, DOI 10.1002/path.1711770310; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; Fukumura D, 1998, CELL, V94, P715, DOI 10.1016/S0092-8674(00)81731-6; Gabarra-Niecko V, 2003, CANCER METAST REV, V22, P359, DOI 10.1023/A:1023725029589; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hattori N, 2009, AM J PATHOL, V175, P533, DOI 10.2353/ajpath.2009.081080; Howell GMS, 2005, HEAD NECK-J SCI SPEC, V27, P710, DOI 10.1002/hed.20222; ILLC D, 1995, NATURE, V377, P539; Johansson N, 1999, AM J PATHOL, V154, P469, DOI 10.1016/S0002-9440(10)65293-5; Johansson N, 1997, AM J PATHOL, V151, P499; Kosaki N, 2007, BIOCHEM BIOPH RES CO, V354, P846, DOI 10.1016/j.bbrc.2006.12.234; Krecicki T, 2003, EUR ARCH OTO-RHINO-L, V260, P494, DOI 10.1007/s00405-003-0610-2; Kudo Y, 2006, CANCER RES, V66, P6928, DOI 10.1158/0008-5472.CAN-05-4540; Lederle W, 2010, CARCINOGENESIS, V31, P1175, DOI 10.1093/carcin/bgp248; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Littlepage LE, 2010, CANCER RES, V70, P2224, DOI 10.1158/0008-5472.CAN-09-3515; Luukkaa M, 2006, HEAD NECK-J SCI SPEC, V28, P225, DOI 10.1002/hed.20322; Milner Jennifer M., 2005, Current Drug Targets - Inflammation and Allergy, V4, P363, DOI 10.2174/1568010054022141; Nielsen BS, 2001, CANCER RES, V61, P7091; Noma K, 2008, GASTROENTEROLOGY, V134, P1981, DOI 10.1053/j.gastro.2008.02.061; Pendas AM, 2000, CLIN CHIM ACTA, V291, P137, DOI 10.1016/S0009-8981(99)00225-9; Ribatti D, 2009, LEUKEMIA RES, V33, P638, DOI 10.1016/j.leukres.2008.11.019; Roeb E, 2004, INT J COLORECTAL DIS, V19, P518, DOI 10.1007/s00384-004-0592-6; SAPPINO AP, 1988, INT J CANCER, V41, P707, DOI 10.1002/ijc.2910410512; SCHOR SL, 1985, J CELL SCI, V73, P221; Tardif G, 2004, MOD RHEUMATOL, V14, P1489; Uitto VJ, 1998, AM J PATHOL, V152, P1489; Werner JA, 2002, CLIN EXP METASTAS, V19, P275, DOI 10.1023/A:1015531319087; Zhao X, 2011, ADV DRUG DELIVER REV, V63, P610, DOI 10.1016/j.addr.2010.11.001; Zijlstra A, 2004, J BIOL CHEM, V279, P27633, DOI 10.1074/jbc.M313617200	48	81	85	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38716	38728		10.1074/jbc.M112.373159	http://dx.doi.org/10.1074/jbc.M112.373159			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22992737	hybrid, Green Published			2022-12-28	WOS:000310982800030
J	McKoy, AF; Chen, J; Schupbach, T; Hecht, MH				McKoy, Angela Fortner; Chen, Jermont; Schupbach, Trudi; Hecht, Michael H.			A Novel Inhibitor of Amyloid beta (A beta) Peptide Aggregation FROM HIGH THROUGHPUT SCREENING TO EFFICACY IN AN ANIMAL MODEL OF ALZHEIMER DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GINKGO-BILOBA; DROSOPHILA MODEL; PROTEIN; OLIGOMERS; TOXICITY; ASSAY	Compelling evidence indicates that aggregation of the amyloid beta (A beta) peptide is a major underlying molecular culprit in Alzheimer disease. Specifically, soluble oligomers of the 42-residue peptide (A beta 42) lead to a series of events that cause cellular dysfunction and neuronal death. Therefore, inhibiting A beta 42 aggregation may be an effective strategy for the prevention and/or treatment of disease. We describe the implementation of a high throughput screen for inhibitors of A beta 42 aggregation on a collection of 65,000 small molecules. Among several novel inhibitors isolated by the screen, compound D737 was most effective in inhibiting A beta 42 aggregation and reducing A beta 42-induced toxicity in cell culture. The protective activity of D737 was most significant in reducing the toxicity of high molecular weight oligomers of A beta 42. The ability of D737 to prevent A beta 42 aggregation protects against cellular dysfunction and reduces the production/accumulation of reactive oxygen species. Most importantly, treatment with D737 increases the life span and locomotive ability of flies in a Drosophila melanogaster model of Alzheimer disease.	[McKoy, Angela Fortner; Chen, Jermont; Hecht, Michael H.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Schupbach, Trudi] Princeton Univ, Dept Mol Biol, Howard Hughes Med Inst, Princeton, NJ 08544 USA	Princeton University; Howard Hughes Medical Institute; Princeton University	Hecht, MH (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	hecht@princeton.edu		Hecht, Michael/0000-0002-5538-9813	National Institutes of Health [5R21AG028462]; NCI Initiative for Chemical Genetics, National Institutes of Health [N01-CO-12400]; Alzheimer Association [IIRG-08-89944]; Howard Hughes Medical Institute; NATIONAL INSTITUTE ON AGING [R21AG028462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Initiative for Chemical Genetics, National Institutes of Health; Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R21AG028462 (to M. H. H.) and the NCI Initiative for Chemical Genetics, National Institutes of Health, under Contract N01-CO-12400 and has been performed with the assistance of the Chemical Biology Platform of the Broad Institute of Harvard and MIT. This work was also supported by Award IIRG-08-89944 from the Alzheimer Association (to M. H. H.) and by the Howard Hughes Medical Institute (to T. S.).	Alexandrescu AT, 2005, PROTEIN SCI, V14, P1; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Clippingdale AB, 2001, J PEPT SCI, V7, P227; Crowther DC, 2006, METHOD ENZYMOL, V412, P234, DOI 10.1016/S0076-6879(06)12015-7; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Frydman-Marom A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016564; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703; Johansson AS, 2006, FEBS J, V273, P2618, DOI 10.1111/j.1742-4658.2006.05263.x; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim W, 2006, NY TIMES BK REV, P1; Lee S, 2007, PROTEIN SCI, V16, P723, DOI 10.1110/ps.062514807; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mazza M, 2006, EUR J NEUROL, V13, P981, DOI 10.1111/j.1468-1331.2006.01409.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Scherzer-Attali R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011101; Seiler KP, 2008, NUCLEIC ACIDS RES, V36, pD351, DOI 10.1093/nar/gkm843; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; Shaykhalishahi H, 2009, EUR J PHARMACOL, V622, P1, DOI 10.1016/j.ejphar.2009.07.017; Shi C, 2009, CHEM-BIOL INTERACT, V181, P115, DOI 10.1016/j.cbi.2009.05.010; Tiraboschi P, 2004, NEUROLOGY, V62, P1984, DOI 10.1212/01.WNL.0000129697.01779.0A; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Yao ZX, 2001, BRAIN RES, V889, P181, DOI 10.1016/S0006-8993(00)03131-0; Yazdanparast R, 2009, TOXICOL IN VITRO, V23, P1277, DOI 10.1016/j.tiv.2009.07.024	37	91	91	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38992	39000		10.1074/jbc.M112.348037	http://dx.doi.org/10.1074/jbc.M112.348037			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22992731	Green Published, hybrid			2022-12-28	WOS:000310982800055
J	Yang, FK; Yao, YX; Jiang, YP; Lu, L; Ma, YP; Dai, W				Yang, Feikun; Yao, Yixin; Jiang, Yongping; Lu, Luo; Ma, Yupo; Dai, Wei			Sumoylation Is Important for Stability, Subcellular Localization, and Transcriptional Activity of SALL4, an Essential Stem Cell Transcription Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; PROTEASE 2; SOX2; ONCOGENE; GENE; PHOSPHORYLATION; PLURIPOTENCY; MUTATIONS; REGULATOR; ROLES	SALL4 is a transcription factor that plays a key role in the maintenance and self-renewal of embryonic stem cells and hematopoietic stem cells. Given that little is known about regulation of SALL4, we studied biochemical modifications of SALL4B, a major splicing variant of SALL4, and elucidated their biological function. SALL4B was primarily modified by ubiquitination when it was expressed in both Sf9 and HEK293T cells. A significant fraction of SALL4B was further modified by sumoylation when it was expressed in HEK293T cells. Constitutive SUMO-modification of SALL4B was also detected in Tera-1, a cell line of the teratocarcinoma origin. SALL4B sumoylation was independent of ubiquitination and lysine residues 156, 316, 374, and 401 were essential for sumoylation. Chromatin fraction contained more SUMO-deficient SALL4B. Despite a shorter half-life than the wild-type counterpart, SUMO-deficient SALL4B interacted with OCT4 more efficiently than the wild-type SALL4B. RNAi-mediated silencing of SALL4 expression caused significant down-regulation of both OCT4 and SOX2, which was rescued by ectopic expression of SALL4B but not by SUMO-deficient mutant. Significantly, compared with the wild-type SALL4B, SUMO-deficient mutant exhibited compromised trans-activation or trans-repression activities in reporter gene assays. Combined, our studies reveal sumoylation as a novel form of post-translational modification for regulating the stability, subcellular localization, and transcriptional activity of SALL4.	[Yang, Feikun; Yao, Yixin; Dai, Wei] NYU, Langone Med Ctr, Dept Environm Med, Tuxedo Pk, NY 10987 USA; [Jiang, Yongping; Ma, Yupo; Dai, Wei] Chinese Acad Med Sci, Biopharmaceut Res Ctr, Suzhou 215021, Peoples R China; [Jiang, Yongping; Ma, Yupo; Dai, Wei] Peking Union Med Coll, Suzhou 215021, Peoples R China; [Lu, Luo] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Mol Med, Torrance, CA 90501 USA; [Ma, Yupo] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA	New York University; NYU Langone Medical Center; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Dai, W (corresponding author), NYU, Langone Med Ctr, Dept Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	wei.dai@nyumc.org		Dai, Wei/0000-0003-0169-8327; Yao, Yixin/0000-0003-1891-7186	US Public Service Awards [CA090658, ES019929]; NIEHS Center Grant [ES000260]; key State project of China on iPS and stem cell research [2011ZX09102-010-04]; NATIONAL CANCER INSTITUTE [R01CA090658] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020591, P30ES000260, R03ES019929] Funding Source: NIH RePORTER	US Public Service Awards; NIEHS Center Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); key State project of China on iPS and stem cell research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported, in whole or in part, by US Public Service Awards (to W. D.) (CA090658 and ES019929), NIEHS Center Grant ES000260, and a key State project of China on iPS and stem cell research (2011ZX09102-010-04).	Aguila JR, 2011, BLOOD, V118, P576, DOI 10.1182/blood-2011-01-333641; Baltus GA, 2009, STEM CELLS, V27, P2175, DOI 10.1002/stem.168; Borozdin W, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.019505; Brumbaugh J, 2012, P NATL ACAD SCI USA, V109, P7162, DOI 10.1073/pnas.1203874109; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Chiu SY, 2008, PLOS BIOL, V6, P2801, DOI 10.1371/journal.pbio.0060310; Cui W, 2006, MODERN PATHOL, V19, P1585, DOI 10.1038/modpathol.3800694; Hamard PJ, 2007, NUCLEIC ACIDS RES, V35, P1134, DOI 10.1093/nar/gkl1168; Hannoun Z, 2010, TOXICOLOGY, V278, P288, DOI 10.1016/j.tox.2010.07.013; Jeong CH, 2010, STEM CELLS, V28, P2141, DOI 10.1002/stem.540; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Kohlhase J, 2005, HUM MUTAT, V26, P176, DOI 10.1002/humu.20215; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Lu JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005577; Ma YP, 2006, BLOOD, V108, P2726, DOI 10.1182/blood-2006-02-001594; Mallanna SK, 2010, STEM CELLS, V28, P1715, DOI 10.1002/stem.494; Miertus J, 2006, HUM GENET, V119, P154, DOI 10.1007/s00439-005-0124-7; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Paradisi I, 2007, AM J MED GENET A, V143A, P326, DOI 10.1002/ajmg.a.31603; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Rao S, 2010, MOL CELL BIOL, V30, P5364, DOI 10.1128/MCB.00419-10; Rosonina E, 2012, GENE DEV, V26, P350, DOI 10.1101/gad.184689.111; Shuai X, 2009, CANCER GENET CYTOGEN, V194, P119, DOI 10.1016/j.cancergencyto.2009.06.006; Sterneckert J, 2012, STEM CELLS, V30, P15, DOI 10.1002/stem.765; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taylor KM, 2005, DEV CELL, V9, P593, DOI 10.1016/j.devcel.2005.09.016; Tsubooka N, 2009, GENES CELLS, V14, P683, DOI 10.1111/j.1365-2443.2009.01301.x; Tsuruzoe S, 2006, BIOCHEM BIOPH RES CO, V351, P920, DOI 10.1016/j.bbrc.2006.10.130; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang BB, 2010, INT J CARDIOL, V145, P224, DOI 10.1016/j.ijcard.2009.05.067; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yang FK, 2012, J BIOL CHEM, V287, P4875, DOI 10.1074/jbc.M111.318261; Yang JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010766; Yang JC, 2008, P NATL ACAD SCI USA, V105, P19756, DOI 10.1073/pnas.0809321105; Yang WH, 2009, MOL CELL BIOL, V29, P613, DOI 10.1128/MCB.00295-08; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhao HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027026	41	25	28	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38600	38608		10.1074/jbc.M112.391441	http://dx.doi.org/10.1074/jbc.M112.391441			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23012367	hybrid, Green Published			2022-12-28	WOS:000310982800020
J	Verbitskiy, D; Zehrmann, A; Hartel, B; Brennicke, A; Takenaka, M				Verbitskiy, Daniil; Zehrmann, Anja; Haertel, Barbara; Brennicke, Axel; Takenaka, Mizuki			Two Related RNA-editing Proteins Target the Same Sites in Mitochondria of Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; DYW PROTEIN; PPR PROTEIN; PLANT-MITOCHONDRIA; GENE; DOMAIN; GENOME; IDENTIFICATION; TRANSCRIPT; STABILIZES	The facilitators for specific cytosine-to-uridine RNA-editing events in plant mitochondria and plastids are pentatricopeptide repeat (PPR)-containing proteins with specific additional C-terminal domains. Here we report the related PPR proteins mitochondrial editing factor 8 (MEF8) and MEF8S with only five such repeats each to be both involved in RNA editing at the same two sites in mitochondria of Arabidopsis thaliana. Mutants of MEF8 show diminished editing in leaves but not in pollen, whereas mutants of the related protein MEF8S show reduced RNA editing in pollen but not in leaves. Overexpressed MEF8 or MEF8S both increase editing at the two target sites in a mef8 mutant. Double mutants of MEF8 and MEF8S are not viable although both identified target sites are in mRNAs for nonessential proteins. This suggests that MEF8 and MEF8S may have other essential functions beyond these two editing sites in complex I mRNAs.	[Verbitskiy, Daniil; Zehrmann, Anja; Haertel, Barbara; Brennicke, Axel; Takenaka, Mizuki] Univ Ulm, D-89069 Ulm, Germany	Ulm University	Takenaka, M (corresponding author), Univ Ulm, D-89069 Ulm, Germany.	mizuki.takenaka@uni-ulm.de	Takenaka, Mizuki/B-2636-2013; Takenaka, Mizuki/AAK-9884-2020	Takenaka, Mizuki/0000-0002-3242-5092; Takenaka, Mizuki/0000-0002-3242-5092	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (to M. T. and A. B.).	Beick S, 2008, MOL CELL BIOL, V28, P5337, DOI 10.1128/MCB.00563-08; Bentolila S, 2010, PLANT PHYSIOL, V154, P1966, DOI 10.1104/pp.110.165969; Berg M, 2005, PLANT J, V44, P866, DOI 10.1111/j.1365-313X.2005.02580.x; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bock R, 1996, EMBO J, V15, P5052, DOI 10.1002/j.1460-2075.1996.tb00885.x; Chateigner-Boutin AL, 2008, PLANT J, V56, P590, DOI 10.1111/j.1365-313X.2008.03634.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Doniwa Y, 2010, GENE, V454, P39, DOI 10.1016/j.gene.2010.01.008; Fujii S, 2011, NEW PHYTOL, V191, P37, DOI 10.1111/j.1469-8137.2011.03746.x; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Gobert A, 2010, NAT STRUCT MOL BIOL, V17, P740, DOI 10.1038/nsmb.1812; Grewe F, 2011, NUCLEIC ACIDS RES, V39, P2890, DOI 10.1093/nar/gkq1227; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Handa H, 2003, NUCLEIC ACIDS RES, V31, P5907, DOI 10.1093/nar/gkg795; Kagi C, 2010, P NATL ACAD SCI USA, V107, P22350, DOI 10.1073/pnas.1012795108; Khrouchtchova A, 2012, RNA, V18, P1197, DOI 10.1261/rna.032623.112; Kim SR, 2009, PLANT J, V59, P738, DOI 10.1111/j.1365-313X.2009.03909.x; Knoop V, 2010, FEBS LETT, V584, P4287, DOI 10.1016/j.febslet.2010.09.041; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Nakamura T, 2008, FEBS LETT, V582, P4163, DOI 10.1016/j.febslet.2008.11.017; Neuwirt J, 2005, RNA, V11, P1563, DOI 10.1261/rna.2740905; O'Toole N, 2008, MOL BIOL EVOL, V25, P1120, DOI 10.1093/molbev/msn057; Ohtani S, 2010, PLANT CELL PHYSIOL, V51, P1942, DOI 10.1093/pcp/pcq142; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Okuda K, 2006, J BIOL CHEM, V281, P37661, DOI 10.1074/jbc.M608184200; Okuda K, 2012, NUCLEIC ACIDS RES, V40, P5052, DOI 10.1093/nar/gks164; Okuda K, 2010, PLANT J, V61, P339, DOI 10.1111/j.1365-313X.2009.04059.x; Okuda K, 2009, PLANT CELL, V21, P146, DOI 10.1105/tpc.108.064667; Pfalz J, 2009, EMBO J, V28, P2042, DOI 10.1038/emboj.2009.121; Rivals E, 2006, PLANT PHYSIOL, V141, P825, DOI 10.1104/pp.106.077826; Robbins JC, 2009, RNA, V15, P1142, DOI 10.1261/rna.1533909; Rudinger M, 2008, MOL BIOL EVOL, V25, P1405, DOI 10.1093/molbev/msn084; Rudinger M, 2011, PLANT J, V67, P370, DOI 10.1111/j.1365-313X.2011.04600.x; Salone V, 2007, FEBS LETT, V581, P4132, DOI 10.1016/j.febslet.2007.07.075; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Shikanai T, 2006, CELL MOL LIFE SCI, V63, P698, DOI 10.1007/s00018-005-5449-9; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Takenaka M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn975; Takenaka M, 2008, MITOCHONDRION, V8, P35, DOI 10.1016/j.mito.2007.09.004; Takenaka M, 2007, METHOD ENZYMOL, V424, P439, DOI 10.1016/S0076-6879(07)24020-0; Takenaka M, 2012, NAT PROTOC, V7, P1931, DOI 10.1038/nprot.2012.117; Takenaka M, 2012, P NATL ACAD SCI USA, V109, P5104, DOI 10.1073/pnas.1202452109; Takenaka M, 2011, METHODS MOL BIOL, V718, P163, DOI 10.1007/978-1-61779-018-8_10; Takenaka M, 2011, METHODS MOL BIOL, V718, P151, DOI 10.1007/978-1-61779-018-8_9; Takenaka M, 2010, J BIOL CHEM, V285, P27122, DOI 10.1074/jbc.M110.128611; Takenaka M, 2010, PLANT PHYSIOL, V152, P939, DOI 10.1104/pp.109.151175; Tasaki E, 2010, PLANT J, V62, P560, DOI 10.1111/j.1365-313X.2010.04175.x; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; van der Merwe JA, 2006, FEBS LETT, V580, P268, DOI 10.1016/j.febslet.2005.12.011; Verbitskiy D, 2010, PLANT SIGNAL BEHAV, V5, P558, DOI 10.4161/psb.11095; Verbitskiy D, 2011, FEBS LETT, V585, P700, DOI 10.1016/j.febslet.2011.01.037; Verbitskiy D, 2010, PLANT J, V61, P446, DOI 10.1111/j.1365-313X.2009.04076.x; Yu QB, 2009, PLANT J, V59, P1011, DOI 10.1111/j.1365-313X.2009.03930.x; Zehrmann A, 2011, RNA BIOL, V8, P67, DOI 10.4161/rna.8.1.14298; Zehrmann A, 2010, FEBS LETT, V584, P4181, DOI 10.1016/j.febslet.2010.08.049; Zehrmann A, 2009, PLANT CELL, V21, P558, DOI 10.1105/tpc.108.064535; Zhou WB, 2009, PLANT J, V58, P82, DOI 10.1111/j.1365-313X.2008.03766.x	60	31	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.397992	http://dx.doi.org/10.1074/jbc.M112.397992			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22977245	hybrid, Green Published			2022-12-28	WOS:000310642200040
J	Xiao, SY; Charonko, JJ; Fu, XP; Salmanzadeh, A; Davalos, RV; Vlachos, PP; Finkielstein, CV; Capelluto, DGS				Xiao, Shuyan; Charonko, John J.; Fu, Xiangping; Salmanzadeh, Alireza; Davalos, Rafael V.; Vlachos, Pavlos P.; Finkielstein, Carla V.; Capelluto, Daniel G. S.			Structure, Sulfatide Binding Properties, and Inhibition of Platelet Aggregation by a Disabled-2 Protein-derived Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARAMAGNETIC RELAXATION ENHANCEMENT; SOLUTION NMR-SPECTROSCOPY; MEMBRANE-LIKE ENVIRONMENT; CRYSTAL-STRUCTURE; CELL-ADHESION; KAPPA-CASEIN; PTB DOMAINS; MYOSIN-VI; FIBRINOGEN; RECEPTOR	Disabled-2 (Dab2) targets membranes and triggers a wide range of biological events, including endocytosis and platelet aggregation. Dab2, through its phosphotyrosine-binding (PTB) domain, inhibits platelet aggregation by competing with fibrinogen for alpha(IIb)beta(3) integrin receptor binding. We have recently shown that the N-terminal region, including the PTB domain (N-PTB), drives Dab2 to the platelet membrane surface by binding to sulfatides through two sulfatide-binding motifs, modulating the extent of platelet aggregation. The three-dimensional structure of a Dab2-derived peptide encompassing the sulfatide-binding motifs has been determined in dodecylphosphocholine micelles using NMR spectroscopy. Dab2 sulfatide-binding motif contains two helices when embedded in micelles, reversibly binds to sulfatides with moderate affinity, lies parallel to the micelle surface, and when added to a platelet mixture, reduces the number and size of sulfatide-induced aggregates. Overall, our findings identify and structurally characterize a minimal region in Dab2 that modulates platelet homotypic interactions, all of which provide the foundation for rational design of a new generation of anti-aggregatory low-molecular mass molecules for therapeutic purposes.	[Xiao, Shuyan; Capelluto, Daniel G. S.] Virginia Tech, Dept Biol Sci, Wake Forest Sch Biomed Engn, Prot Signaling Domains Lab, Blacksburg, VA 24061 USA; [Charonko, John J.; Vlachos, Pavlos P.] Virginia Tech, Adv Expt Thermofluid Engn Res Lab, Wake Forest Sch Biomed Engn, Dept Mech Engn, Blacksburg, VA 24061 USA; [Fu, Xiangping; Finkielstein, Carla V.] Virginia Tech, Integrated Cellular Responses Lab, Wake Forest Sch Biomed Engn, Dept Biol Sci, Blacksburg, VA 24061 USA; [Salmanzadeh, Alireza; Davalos, Rafael V.] Virginia Tech, Bioelectromech Syst Lab, Wake Forest Sch Biomed Engn, Blacksburg, VA 24061 USA; [Salmanzadeh, Alireza; Davalos, Rafael V.] Virginia Tech, Dept Engn Sci & Mech, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Capelluto, DGS (corresponding author), Virginia Tech, Dept Biol Sci, Wake Forest Sch Biomed Engn, Prot Signaling Domains Lab, 1981 Kraft Dr,Rm 2007, Blacksburg, VA 24061 USA.	capellut@vt.edu	Charonko, John/D-6701-2013; Vlachos, Pavlos P/G-3779-2010	Charonko, John/0000-0002-0396-9672; Vlachos, Pavlos P/0000-0002-8040-9257; finkielstein, carla/0000-0002-8417-4643	American Heart Association [11BGIA6160000]	American Heart Association(American Heart Association)	This work was supported by American Heart Association Grant 11BGIA6160000 (to D. G. S. C.).	Ahn VE, 2003, P NATL ACAD SCI USA, V100, P38, DOI 10.1073/pnas.0136947100; Alajlouni R, 2011, BBA-BIOMEMBRANES, V1808, P2734, DOI 10.1016/j.bbamem.2011.07.029; ANDRIEUX A, 1989, J BIOL CHEM, V264, P9258; ARUFFO A, 1991, CELL, V67, P35, DOI 10.1016/0092-8674(91)90570-O; Basani RB, 2001, J BIOL CHEM, V276, P13975, DOI 10.1074/jbc.M011511200; Beswick V, 1998, EUR BIOPHYS J BIOPHY, V28, P48, DOI 10.1007/s002490050182; Boesze-Battaglia K, 1997, J EXP BIOL, V200, P2927; Cho SY, 2000, BIOCHEM J, V352, P645, DOI 10.1042/0264-6021:3520645; COX D, 1994, MED RES REV, V14, P195, DOI 10.1002/med.2610140203; DEJANA E, 1990, BLOOD, V75, P1509; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; Drahos KE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008007; Eckhardt M, 2008, MOL NEUROBIOL, V37, P93, DOI 10.1007/s12035-008-8022-3; FAUVEL J, 1986, BIOCHIM BIOPHYS ACTA, V856, P155, DOI 10.1016/0005-2736(86)90022-2; Gautier A, 2010, NAT STRUCT MOL BIOL, V17, P768, DOI 10.1038/nsmb.1807; Goddar T. D., 2008, SPARKY 3; Hasson T, 2003, J CELL SCI, V116, P3453, DOI 10.1242/jcs.00669; Hocevar BA, 2001, EMBO J, V20, P2789, DOI 10.1093/emboj/20.11.2789; Huang CL, 2006, J CELL SCI, V119, P4420, DOI 10.1242/jcs.03195; Huisman JG, 2000, BIOCHEMISTRY-US, V39, P10866, DOI 10.1021/bi0004504; JOLLES P, 1986, EUR J BIOCHEM, V158, P379, DOI 10.1111/j.1432-1033.1986.tb09764.x; Kim HJ, 2009, PROG NUCL MAG RES SP, V55, P335, DOI 10.1016/j.pnmrs.2009.07.002; LAUTERWEIN J, 1979, BIOCHIM BIOPHYS ACTA, V556, P244, DOI 10.1016/0005-2736(79)90046-4; LEONIL J, 1990, BIOCHEM J, V271, P247, DOI 10.1042/bj2710247; Lerch M, 2005, BIOCHEMISTRY-US, V44, P9255, DOI 10.1021/bi0501232; Liang BY, 2006, J AM CHEM SOC, V128, P4389, DOI 10.1021/ja0574825; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; Malinina L, 2004, NATURE, V430, P1048, DOI 10.1038/nature02856; Marrink SJ, 2000, J PHYS CHEM B, V104, P12165, DOI 10.1021/jp001898h; Merten M, 2001, CIRCULATION, V104, P2955, DOI 10.1161/hc4901.100383; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; MOK SC, 1994, GYNECOL ONCOL, V52, P247, DOI 10.1006/gyno.1994.1040; Moody DB, 2005, NAT REV IMMUNOL, V5, P387, DOI 10.1038/nri1605; Morris SM, 2002, TRAFFIC, V3, P331, DOI 10.1034/j.1600-0854.2002.30503.x; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Mozsolits H, 2001, BBA-BIOMEMBRANES, V1512, P64, DOI 10.1016/S0005-2736(01)00303-0; Muranyi A, 2000, BIOCHEMISTRY-US, V39, P15742, DOI 10.1021/bi0004450; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; PLOW EF, 1981, J BIOL CHEM, V256, P9477; ROBERTS DD, 1985, J BIOL CHEM, V260, P9405; ROBERTS DD, 1988, ARCH BIOCHEM BIOPHYS, V267, P405, DOI 10.1016/0003-9861(88)90046-X; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SEGREST JP, 1994, ADV PROTEIN CHEM, V45, P303; SHATTIL SJ, 1975, J CLIN INVEST, V55, P636, DOI 10.1172/JCI107971; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sheng ZJ, 2000, ONCOGENE, V19, P4847, DOI 10.1038/sj.onc.1203853; Snook CF, 2006, BBA-MOL CELL BIOL L, V1761, P927, DOI 10.1016/j.bbalip.2006.06.004; Song JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005756; Stolt PC, 2004, BIOCHEMISTRY-US, V43, P10979, DOI 10.1021/bi049092l; Stolt PC, 2003, STRUCTURE, V11, P569, DOI 10.1016/S0969-2126(03)00068-6; Tengel T, 2002, EUR J BIOCHEM, V269, P3659, DOI 10.1046/j.1432-1033.2002.03051.x; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Wang CH, 2006, J BIOL CHEM, V281, P656, DOI 10.1074/jbc.M507880200; Welsh JD, 2011, BRIT J HAEMATOL, V154, P122, DOI 10.1111/j.1365-2141.2011.08705.x; WILLIAMSON P, 1995, BIOCHEMISTRY-US, V34, P10448, DOI 10.1021/bi00033a017; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200; Zajonc DM, 2003, NAT IMMUNOL, V4, P808, DOI 10.1038/ni948; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625	60	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.385609	http://dx.doi.org/10.1074/jbc.M112.385609			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22977233	hybrid, Green Published			2022-12-28	WOS:000310642200009
J	Yadav, PK; Xie, P; Banerjee, R				Yadav, Pramod Kumar; Xie, Peter; Banerjee, Ruma			Allosteric Communication between the Pyridoxal 5 '-Phosphate (PLP) and Heme Sites in the H2S Generator Human Cystathionine beta-Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDOX REGULATION; LIGAND SWITCH; CBS DOMAINS; BINDING; MUTATIONS; PROTEIN; HOMOCYSTINURIA; ENZYME; FLUORESCENCE; SPECTROSCOPY	Human cystathionine beta-synthase (CBS) is a unique pyridoxal 5'-phosphate (PLP)-dependent enzyme that has a regulatory heme cofactor. Previous studies have demonstrated the importance of Arg-266, a residue at the heme pocket end of alpha-helix 8, for communication between the heme and PLP sites. In this study, we have examined the role of the conserved Thr-257 and Thr-260 residues, located at the other end of alpha-helix 8 on the heme electronic environment and on activity. The mutations at the two positions destabilize PLP binding, leading to lower PLP content and similar to 2-to similar to 500-fold lower activity compared with the wild-type enzyme. Activity is unresponsive to PLP supplementation, consistent with the pyridoxine-nonresponsive phenotype of the T257M mutation in a homocystinuric patient. The H2S-producing activities, also impacted by the mutations, show a different pattern of inhibition compared with the canonical transsulfuration reaction. Interestingly, the mutants exhibit contrasting sensitivities to the allosteric effector, S-adenosylmethionine (AdoMet); whereas T257M and T257I are inhibited, the other mutants are hyperactivated by AdoMet. All mutants showed an increased propensity of the ferrous heme to form an inactive species with a 424 nm Soret peak and exhibited significantly reduced enzyme activity in the ferrous and ferrous-CO states. Our results provide the first evidence for bidirectional transmission of information between the cofactor binding sites, suggest the additional involvement of this region in allosteric communication with the regulatory AdoMet-binding domain, and reveal the potential for independent modulation of the canonical transsulfuration versus H2S-generating reactions catalyzed by CBS.	[Yadav, Pramod Kumar; Xie, Peter; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Med Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Dept Biol Chem, Med Ctr, 3320B MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Yadav, Pramod K./A-6166-2010	Yadav, Pramod K./0000-0003-0026-1684	National Institutes of Health [HL58984]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL58984.	Banerjee R, 2003, BBA-PROTEINS PROTEOM, V1647, P30, DOI 10.1016/S1570-9639(03)00044-X; Cherney MM, 2007, BIOCHEMISTRY-US, V46, P13199, DOI 10.1021/bi701159y; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Evande R, 2004, ARCH BIOCHEM BIOPHYS, V427, P188, DOI 10.1016/j.abb.2004.04.027; FINKELSTEIN JD, 1975, BIOCHEM BIOPH RES CO, V66, P81, DOI 10.1016/S0006-291X(75)80297-X; Green EL, 2001, BIOCHEMISTRY-US, V40, P459, DOI 10.1021/bi0010874; Janosik M, 2001, AM J HUM GENET, V68, P1506, DOI 10.1086/320597; Kabil O, 2011, BIOCHEMISTRY-US, V50, P8261, DOI 10.1021/bi201270q; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kery V, 1999, BIOCHEMISTRY-US, V38, P2716, DOI 10.1021/bi981808n; KERY V, 1994, J BIOL CHEM, V269, P25283; Koutmos M, 2010, P NATL ACAD SCI USA, V107, P20958, DOI 10.1073/pnas.1011448107; Kraus JP, 1999, HUM MUTAT, V13, P362; MCCLURE GD, 1994, BIOCHEMISTRY-US, V33, P1674, DOI 10.1021/bi00173a009; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; Miles EW, 2004, J BIOL CHEM, V279, P29871, DOI 10.1074/jbc.R400005200; Ojha S, 2002, BIOCHEMISTRY-US, V41, P4649, DOI 10.1021/bi011827o; Ojha S, 2000, BIOCHEMISTRY-US, V39, P10542, DOI 10.1021/bi000831h; Pazicni S, 2005, BIOCHEMISTRY-US, V44, P16785, DOI 10.1021/bi051305z; Pazicni S, 2004, BIOCHEMISTRY-US, V43, P14684, DOI 10.1021/bi0488496; Puranik M, 2004, J BIOL CHEM, V279, P21096, DOI 10.1074/jbc.M400613200; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; SEBASTIO G, 1995, AM J HUM GENET, V56, P1324; Sen S, 2007, BIOCHEMISTRY-US, V46, P4110, DOI 10.1021/bi602617f; Shan XY, 1998, NAT GENET, V19, P91, DOI 10.1038/ng0598-91; Singh S, 2007, NAT PROD REP, V24, P631, DOI 10.1039/b604182p; Singh S, 2011, BBA-PROTEINS PROTEOM, V1814, P1518, DOI 10.1016/j.bbapap.2011.02.004; Singh S, 2009, J INORG BIOCHEM, V103, P689, DOI 10.1016/j.jinorgbio.2009.01.009; STRAMBINI GB, 1992, BIOCHEMISTRY-US, V31, P7527, DOI 10.1021/bi00148a013; Taoka S, 1999, BIOCHEMISTRY-US, V38, P2738, DOI 10.1021/bi9826052; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; Taoka S, 1999, BIOCHEMISTRY-US, V38, P13155, DOI 10.1021/bi990865t; Taoka S, 2002, BIOCHEMISTRY-US, V41, P10454, DOI 10.1021/bi026052d; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; Weeks CL, 2009, J AM CHEM SOC, V131, P12809, DOI 10.1021/ja904468w	35	24	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.414706	http://dx.doi.org/10.1074/jbc.M112.414706			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22977242	Green Published, hybrid			2022-12-28	WOS:000310642200003
J	Lisa, S; Domingo, B; Martinez, J; Gilch, S; Llopis, JF; Schatzl, HM; Gasset, M				Lisa, Silvia; Domingo, Beatriz; Martinez, Javier; Gilch, Sabine; Llopis, Juan F.; Schaetzl, Hermann M.; Gasset, Maria			RETRACTED: Failure of Prion Protein Oxidative Folding Guides the Formation of Toxic Transmembrane Forms (Retracted article. See vol. 292, pg. 20045, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							ENDOPLASMIC-RETICULUM; PATHOGENIC MUTATIONS; DISULFIDE BOND; CELL-LINE; WILD-TYPE; METHIONINE SULFOXIDES; MEMBRANE INSERTION; HYDROPHOBIC CORE; QUALITY-CONTROL; IN-VITRO	The mechanism by which pathogenic mutations in the globular domain of the cellular prion protein (PrPC) increase the likelihood of misfolding and predispose to diseases is not yet known. Differences in the evidences provided by structural and metabolic studies of these mutants suggest that in vivo folding could be playing an essential role in their pathogenesis. To address this role, here we use the single or combined M206S and M213S artificial mutants causing labile folds and express them in cells. We find that these mutants are highly toxic, fold as transmembrane PrP, and lack the intramolecular disulfide bond. When the mutations are placed in a chain with impeded transmembrane PrP formation, toxicity is rescued. These results suggest that oxidative folding impairment, as on aging, can be fundamental for the genesis of intracellular neurotoxic intermediates key in prion neurodegenerations.	[Lisa, Silvia; Martinez, Javier; Gasset, Maria] CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain; [Domingo, Beatriz; Llopis, Juan F.] Univ Castilla La Mancha, Ctr Reg Invest Biomed, Albacete 02006, Spain; [Domingo, Beatriz; Llopis, Juan F.] Univ Castilla La Mancha, Fac Med, Albacete 02006, Spain; [Gilch, Sabine; Schaetzl, Hermann M.] Univ Wyoming, Dept Vet Sci, Laramie, WY 82071 USA; [Gilch, Sabine; Schaetzl, Hermann M.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; University of Wyoming; University of Wyoming	Gasset, M (corresponding author), CSIC, Inst Quim Fis Rocasolano, Serrano 119, E-28006 Madrid, Spain.	mgasset@iqfr.csic.es	Romo, José A./J-3024-2012; Gasset, Maria/K-4339-2012; Llopis, Juan/I-2622-2012; Gasset, Maria/I-2050-2014	Romo, José A./0000-0003-2907-580X; Gasset, Maria/0000-0001-6436-4055; Llopis, Juan/0000-0002-9460-0642; Gasset, Maria/0000-0001-6436-4055; Schatzl, Hermann/0000-0003-4972-8740; Domingo, Beatriz/0000-0001-9430-4803	Spanish Ministerio de Economia y Competitividad Grant [BFU2009-07971]; Fundacion Cien-Fundacion Reina Sofia grant; Alberta Prions Research Institute grant; Formacion del Personal Investigador Ph.D. grants; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076853] Funding Source: NIH RePORTER	Spanish Ministerio de Economia y Competitividad Grant(Spanish Government); Fundacion Cien-Fundacion Reina Sofia grant; Alberta Prions Research Institute grant; Formacion del Personal Investigador Ph.D. grants; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Spanish Ministerio de Economia y Competitividad Grant BFU2009-07971 (to M. G.), a Fundacion Cien-Fundacion Reina Sofia grant (to M. G.), and an Alberta Prions Research Institute grant (to H. M. S.).; Supported by Formacion del Personal Investigador Ph.D. grants.	Adrover M, 2010, J BIOL CHEM, V285, P21004, DOI 10.1074/jbc.M110.111815; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Anelli T, 2003, EMBO J, V22, P5015, DOI 10.1093/emboj/cdg491; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Anelli T, 2007, EMBO J, V26, P4177, DOI 10.1038/sj.emboj.7601844; Apetri AC, 2004, J BIOL CHEM, V279, P18008, DOI 10.1074/jbc.M313581200; Ashok A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000479; Birkett CR, 2001, EMBO J, V20, P3351, DOI 10.1093/emboj/20.13.3351; Bosques CJ, 2003, P NATL ACAD SCI USA, V100, P7593, DOI 10.1073/pnas.1232504100; Calzolai L, 2000, P NATL ACAD SCI USA, V97, P8340, DOI 10.1073/pnas.97.15.8340; Campana V, 2006, J CELL SCI, V119, P433, DOI 10.1242/jcs.02768; Canello T, 2008, BIOCHEMISTRY-US, V47, P8866, DOI 10.1021/bi800801f; Canello T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000977; Capellari S, 1999, J BIOL CHEM, V274, P34846, DOI 10.1074/jbc.274.49.34846; Chakrabarti O, 2009, TRENDS BIOCHEM SCI, V34, P287, DOI 10.1016/j.tibs.2009.03.001; Colombo G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004296; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Emerman AB, 2010, MOL BIOL CELL, V21, P4325, DOI 10.1091/mbc.E10-09-0742; FRA AM, 1993, EMBO J, V12, P4755, DOI 10.1002/j.1460-2075.1993.tb06164.x; GASSET M, 1992, P NATL ACAD SCI USA, V89, P10940, DOI 10.1073/pnas.89.22.10940; Gregersen N, 2010, METHODS MOL BIOL, V648, P3, DOI 10.1007/978-1-60761-756-3_1; GUENZI S, 1994, EUR J IMMUNOL, V24, P2477, DOI 10.1002/eji.1830241033; Harris DA, 2003, BRIT MED BULL, V66, P71, DOI 10.1093/bmb/66.1.71; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hegde RS, 1999, NATURE, V402, P822, DOI 10.1038/45574; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; Ivanova L, 2001, J BIOL CHEM, V276, P42409, DOI 10.1074/jbc.M106928200; Juanes ME, 2009, J BIOL CHEM, V284, P2787, DOI 10.1074/jbc.M804051200; Kiachopoulos S, 2005, J BIOL CHEM, V280, P9320, DOI 10.1074/jbc.M412525200; Kim PS, 1998, ENDOCR REV, V19, P173, DOI 10.1210/er.19.2.173; Kim SJ, 2002, MOL BIOL CELL, V13, P3775, DOI 10.1091/mbc.E02-05-0293; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Lee S, 2003, NAT STRUCT BIOL, V10, P725, DOI 10.1038/nsb961; Liemann S, 1999, BIOCHEMISTRY-US, V38, P3258, DOI 10.1021/bi982714g; Lisa S, 2010, CELL MOL LIFE SCI, V67, P2825, DOI 10.1007/s00018-010-0363-1; Lorenz H, 2002, J BIOL CHEM, V277, P8508, DOI 10.1074/jbc.M110197200; Lucassen R, 2003, BIOCHEMISTRY-US, V42, P4127, DOI 10.1021/bi027218d; Maiti NR, 2001, J BIOL CHEM, V276, P2427, DOI 10.1074/jbc.M007862200; Makarava N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002419; Meli M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019093; Muramoto T, 1997, NAT MED, V3, P750, DOI 10.1038/nm0797-750; Nishimura T, 2008, BIOCHEM BIOPH RES CO, V377, P1047, DOI 10.1016/j.bbrc.2008.10.087; Nuss JE, 2008, BIOCHEM BIOPH RES CO, V365, P355, DOI 10.1016/j.bbrc.2007.10.194; Orsi A, 2007, PRION, V1, P236, DOI 10.4161/pri.1.4.5727; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; Rane NS, 2004, EMBO J, V23, P4550, DOI 10.1038/sj.emboj.7600462; Reddy MM, 1996, AM J PHYSIOL-CELL PH, V271, pC486, DOI 10.1152/ajpcell.1996.271.2.C486; Resenberger UK, 2011, TOP CURR CHEM, V305, P101, DOI 10.1007/128_2011_160; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Rosenmann H, 2001, J NEUROCHEM, V76, P1654, DOI 10.1046/j.1471-4159.2001.00195.x; Schiff E, 2008, TRAFFIC, V9, P1101, DOI 10.1111/j.1600-0854.2008.00746.x; Shin JY, 2009, MOL CELLS, V27, P673, DOI 10.1007/s10059-009-0089-9; Shin JI, 2008, BIOCHEM BIOPH RES CO, V377, P995, DOI 10.1016/j.bbrc.2008.10.095; SITIA R, 1990, CELL, V60, P781, DOI 10.1016/0092-8674(90)90092-S; Stewart RS, 2005, J BIOL CHEM, V280, P15855, DOI 10.1074/jbc.M412298200; Stewart RS, 2001, MOL BIOL CELL, V12, P881, DOI 10.1091/mbc.12.4.881; Tabrett CA, 2010, BIOCHEM J, V428, P169, DOI 10.1042/BJ20091635; TURK E, 1988, EUR J BIOCHEM, V176, P21, DOI 10.1111/j.1432-1033.1988.tb14246.x; van der Kamp MW, 2010, J MOL BIOL, V404, P732, DOI 10.1016/j.jmb.2010.09.060; Vetrugno V, 1999, NEUROSCI LETT, V270, P41, DOI 10.1016/S0304-3940(99)00460-7; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wang X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014602; Wang Y, 2008, BIOCHEM J, V409, P623, DOI 10.1042/BJ20071492; Watts JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000608; Yanai A, 1999, FEBS LETT, V460, P11, DOI 10.1016/S0014-5793(99)01316-2; Yin SM, 2007, P NATL ACAD SCI USA, V104, P7546, DOI 10.1073/pnas.0610827104; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	70	14	15	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36693	36701		10.1074/jbc.M112.398776	http://dx.doi.org/10.1074/jbc.M112.398776			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22955286	hybrid, Green Published			2022-12-28	WOS:000310588500007
J	Lodish, HF				Lodish, Harvey F.			Translational Control of Protein Synthesis: The Early Years	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE F2 RNA; HEMOGLOBIN-SYNTHESIS; MESSENGER-RNA; ERYTHROPOIETIN RECEPTOR; POTASSIUM-TRANSPORT; POLYPEPTIDE-CHAIN; MEMBRANE-PROTEINS; RIBONUCLEIC-ACID; MULTIPLE LEVELS; STEM-CELL	For the past fifty-five years, much of my research has focused on the function and biogenesis of red blood cells, including the cloning and study of many membrane proteins such as glucose and anion transporters and the erythropoietin receptor. We have also elucidated the mechanisms of membrane insertion, folding, and maturation of many plasma membrane and secreted proteins. Despite all of this work and more, I remain extremely proud of our very early work on the regulation of mRNA translation: work on bacteriophage f2 RNA in the 1960s and on translation of alpha- and beta-globin mRNAs in the early 1970s. Using techniques hopelessly antiquated by today's standards, we correctly elucidated many important aspects of translational control, and I thought readers would be interested in learning how we did these experiments.	[Lodish, Harvey F.] MIT, Whitehead Inst Biomed Res, Dept Biol, Cambridge, MA 02142 USA; [Lodish, Harvey F.] MIT, Whitehead Inst Biomed Res, Dept Bioengn, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute	Lodish, HF (corresponding author), MIT, Whitehead Inst Biomed Res, Dept Biol, Cambridge, MA 02142 USA.	lodish@wi.mit.edu						ALPER SL, 1987, KIDNEY INT, V32, pS117; ALPER SL, 1988, J BIOL CHEM, V263, P17092; BRAELL WA, 1982, CELL, V28, P23, DOI 10.1016/0092-8674(82)90371-3; CHANG H, 1976, P NATL ACAD SCI USA, V73, P3206, DOI 10.1073/pnas.73.9.3206; CHARRON MJ, 1989, P NATL ACAD SCI USA, V86, P2535, DOI 10.1073/pnas.86.8.2535; Constantinescu SN, 1999, TRENDS ENDOCRIN MET, V10, P18, DOI 10.1016/S1043-2760(98)00101-5; D'Andrea AD, 1990, CURR OPIN CELL BIOL, V2, P648, DOI 10.1016/0955-0674(90)90106-O; DANDREA AD, 1989, CELL, V57, P277, DOI 10.1016/0092-8674(89)90965-3; DJERASSI C, 1962, J AM CHEM SOC, V84, P1499, DOI 10.1021/ja00867a041; ECKEL RE, 1961, J CLIN INVEST, V40, P1035; ECKEL RE, 1966, AM J PHYSIOL, V210, P737, DOI 10.1152/ajplegacy.1966.210.4.737; Flygare J, 2011, BLOOD, V117, P3435, DOI 10.1182/blood-2010-07-295550; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; HOUSMAN D, 1970, NATURE, V227, P913, DOI 10.1038/227913a0; Hu WQ, 2011, GENE DEV, V25, P2573, DOI 10.1101/gad.178780.111; HUNT T, 1968, J MOL BIOL, V36, P31, DOI 10.1016/0022-2836(68)90217-9; HUNT T, 1969, J MOL BIOL, V43, P123, DOI 10.1016/0022-2836(69)90083-7; Hunt T., 1969, BIOCHEM J, V113, p5Pa; KATZ FN, 1977, P NATL ACAD SCI USA, V74, P3278, DOI 10.1073/pnas.74.8.3278; KNIPE DM, 1977, J VIROL, V21, P1121, DOI 10.1128/JVI.21.3.1121-1127.1977; KNIPE DM, 1977, J VIROL, V21, P1149, DOI 10.1128/JVI.21.3.1149-1158.1977; KNIPE DM, 1977, J VIROL, V21, P1128, DOI 10.1128/JVI.21.3.1128-1139.1977; KOPITO RR, 1985, NATURE, V316, P234, DOI 10.1038/316234a0; Lodish H, 2010, IUBMB LIFE, V62, P492, DOI 10.1002/iub.322; LODISH HF, 1969, NATURE, V224, P867, DOI 10.1038/224867a0; LODISH HF, 1971, J MOL BIOL, V56, P627, DOI 10.1016/0022-2836(71)90406-2; Lodish HF, 1995, COLD SPRING HARB SYM, V60, P93, DOI 10.1101/SQB.1995.060.01.012; LODISH HF, 1974, NATURE, V251, P385, DOI 10.1038/251385a0; LODISH HF, 1968, NATURE, V220, P345, DOI 10.1038/220345a0; LODISH HF, 1972, J BIOL CHEM, V247, P7822; LODISH HF, 1972, J BIOL CHEM, V247, P3622; LODISH HF, 1971, J BIOL CHEM, V246, P7131; LODISH HF, 1970, J MOL BIOL, V50, P689, DOI 10.1016/0022-2836(70)90093-8; LODISH HF, 1969, J MOL BIOL, V45, P9, DOI 10.1016/0022-2836(69)90206-X; LODISH HF, 1973, P NATL ACAD SCI USA, V70, P1526, DOI 10.1073/pnas.70.5.1526; LODISH HF, 1975, J CELL BIOL, V65, P51, DOI 10.1083/jcb.65.1.51; LODISH HF, 1988, HARVEY LECT, V82, P19; LODISH HF, 1969, COLD SPRING HARB SYM, V34, P655, DOI 10.1101/SQB.1969.034.01.076; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; NATHAN DG, 1971, P NATL ACAD SCI USA, V68, P2514, DOI 10.1073/pnas.68.10.2514; ROBERTSON HD, 1970, P NATL ACAD SCI USA, V67, P710, DOI 10.1073/pnas.67.2.710; ROTHMAN JE, 1978, CELL, V15, P1447, DOI 10.1016/0092-8674(78)90068-5; ROTHMAN JE, 1977, NATURE, V269, P775, DOI 10.1038/269775a0; Sankaran VG, 2012, GENE DEV, V26, P2075, DOI 10.1101/gad.197020.112; THORENS B, 1990, DIABETES CARE, V13, P209, DOI 10.2337/diacare.13.3.209; THORENS B, 1988, CELL, V55, P281, DOI 10.1016/0092-8674(88)90051-7; Zhang LB, 2011, GENE DEV, V25, P119, DOI 10.1101/gad.1998711	47	7	7	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36528	36535		10.1074/jbc.X112.420356	http://dx.doi.org/10.1074/jbc.X112.420356			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22988251	Green Published, hybrid			2022-12-28	WOS:000310364000073
J	Chittka, A; Nitarska, J; Grazini, U; Richardson, WD				Chittka, Alexandra; Nitarska, Justyna; Grazini, Ursula; Richardson, William D.			Transcription Factor Positive Regulatory Domain 4 (PRDM4) Recruits Protein Arginine Methyltransferase 5 (PRMT5) to Mediate Histone Arginine Methylation and Control Neural Stem Cell Proliferation and Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; GENE-EXPRESSION; NEUROGENESIS; CYCLE; FATE; REPRESSION; CHROMATIN; BLIMP1; SPECIFICATION; PROGRESSION	During development of the cerebral cortex, neural stem cells (NSCs) undergo a temporal switch from proliferative (symmetric) to neuron-generating (asymmetric) divisions. We investigated the role of Schwann cell factor 1 (SC1/PRDM4), a member of the PRDM family of transcription factors, in this critical transition. We discovered that SC1 recruits the chromatin modifier PRMT5, an arginine methyltransferase that catalyzes symmetric dimethylation of histone H4 arginine 3 (H4R3me2s) and that this modification is preferentially associated with undifferentiated cortical NSCs. Overexpressing SC1 in embryonic NSCs led to an increase in the number of Nestin-expressing precursors; mutational analysis of SC1 showed that this was dependent on recruitment of PRMT5. We found that SC1 protein levels are down-regulated at the onset of neurogenesis and that experimental knockdown of SC1 in primary NSCs triggers precocious neuronal differentiation. We propose that SC1 and PRMT5 are components of an epigenetic regulatory complex that maintains the "stem-like" cellular state of the NSC by preserving their proliferative capacity and modulating their cell cycle progression. Our findings provide evidence that histone arginine methylation regulates NSC differentiation.	[Chittka, Alexandra; Grazini, Ursula; Richardson, William D.] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [Chittka, Alexandra; Grazini, Ursula; Richardson, William D.] UCL, Res Dept Cell & Dev Biol, London WC1E 6BT, England; [Nitarska, Justyna] UCL, Med Res Council, Mol Cell Biol Lab, London WC1E 6BT, England	University of London; University College London; University of London; University College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; University College London	Chittka, A (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	a.chittka@ucl.ac.uk	Chittka, Alexandra/AAR-9370-2021; Richardson FMedSci FRS, William D/C-1762-2008	Chittka, Alexandra/0000-0002-3495-270X; Nitarska, Justyna/0000-0001-6992-6686; Richardson FMedSci FRS, William D/0000-0001-7261-2485	Wellcome Trust [WT076656MA]; United Kingdom Medical Research Council; BBSRC [BB/J006602/1] Funding Source: UKRI; MRC [G0800575] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J006602/1] Funding Source: researchfish; Medical Research Council [G0800575] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust Career Re-entry Fellowship WT076656MA (to A. C.) and by funds from the United Kingdom Medical Research Council (to W. D. R.).	Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Andreu-Perez P, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001936; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bikoff EK, 2009, CURR OPIN GENET DEV, V19, P379, DOI 10.1016/j.gde.2009.05.005; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chittka A, 2004, J CELL BIOL, V164, P985, DOI 10.1083/jcb.200301106; Chittka A, 1999, P NATL ACAD SCI USA, V96, P10705, DOI 10.1073/pnas.96.19.10705; Chittka A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013807; Cimato TR, 1997, J CELL BIOL, V138, P1089, DOI 10.1083/jcb.138.5.1089; Cimato TR, 2002, J NEUROSCI RES, V67, P435, DOI 10.1002/jnr.10123; Davis CA, 2006, MOL CELL BIOL, V26, P2626, DOI 10.1128/MCB.26.7.2626-2636.2006; Derunes C, 2005, BIOCHEM BIOPH RES CO, V333, P925, DOI 10.1016/j.bbrc.2005.05.190; Dirks PB, 2010, MOL ONCOL, V4, P420, DOI 10.1016/j.molonc.2010.08.001; Eom GH, 2009, BIOCHEM BIOPH RES CO, V388, P131, DOI 10.1016/j.bbrc.2009.07.134; Fumasoni I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-187; Guillemot F, 2007, PROG NEUROBIOL, V83, P37, DOI 10.1016/j.pneurobio.2007.02.009; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; Hayashi K, 2006, CELL CYCLE, V5, P615, DOI 10.4161/cc.5.6.2572; Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156; Hirabayashi Y, 2005, NEUROSCI RES, V51, P331, DOI 10.1016/j.neures.2005.01.004; Hsieh J, 2004, CURR OPIN GENET DEV, V14, P461, DOI 10.1016/j.gde.2004.07.006; Huang JH, 2011, J BIOL CHEM, V286, P44424, DOI 10.1074/jbc.M111.277046; Iacopetti P, 1999, P NATL ACAD SCI USA, V96, P4639, DOI 10.1073/pnas.96.8.4639; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; John SA, 2009, EXP CELL RES, V315, P1077, DOI 10.1016/j.yexcr.2008.11.015; Kendall SE, 2003, DEV BRAIN RES, V144, P151, DOI 10.1016/S0165-3806(03)00166-4; Kessaris N, 2004, DEVELOPMENT, V131, P1289, DOI 10.1242/dev.01027; Lukaszewicz A, 2005, NEURON, V47, P353, DOI 10.1016/j.neuron.2005.06.032; Matsumoto S, 2006, DEV BIOL, V289, P372, DOI 10.1016/j.ydbio.2005.10.044; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Nishioka K, 2003, METHODS, V31, P49, DOI 10.1016/S1046-2023(03)00087-2; Ohnuma S, 2001, CURR OPIN NEUROBIOL, V11, P66, DOI 10.1016/S0959-4388(00)00175-6; Ohnuma S, 2003, NEURON, V40, P199, DOI 10.1016/S0896-6273(03)00632-9; Okano H, 2009, CURR OPIN NEUROBIOL, V19, P112, DOI 10.1016/j.conb.2009.04.003; Pal S, 2007, J CELL PHYSIOL, V213, P306, DOI 10.1002/jcp.21180; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; Robertson EJ, 2007, DEVELOPMENT, V134, P4335, DOI 10.1242/dev.012047; Saitou M, 2009, CURR OPIN GENET DEV, V19, P386, DOI 10.1016/j.gde.2009.06.003; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Tedeschi A, 2009, EMBO REP, V10, P576, DOI 10.1038/embor.2009.89; Tio M, 2001, NATURE, V409, P1063, DOI 10.1038/35059124; Xu XJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-396; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568	50	59	60	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42995	43006		10.1074/jbc.M112.392746	http://dx.doi.org/10.1074/jbc.M112.392746			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23048031	hybrid, Green Published			2022-12-28	WOS:000312501600056
J	Vajjhala, PR; Mirams, RE; Hill, JM				Vajjhala, Parimala R.; Mirams, Ruth E.; Hill, Justine M.			Multiple Binding Sites on the Pyrin Domain of ASC Protein Allow Self-association and Interaction with NLRP3 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PATTERN-RECOGNITION RECEPTORS; NALP3 INFLAMMASOME; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; ONLY PROTEIN; ACTIVATION; DEATH; OLIGOMERIZATION; CASPASE-1	A key process underlying an innate immune response to pathogens or cellular stress is activation of members of the NOD-like receptor family, such as NLRP3, to assemble caspase-1- activating inflammasome complexes. Activated caspase-1 processes proinflammatory cytokines into active forms that mediate inflammation. Activation of the NLRP3 inflammasome is also associated with common diseases including cardiovascular disease, diabetes, chronic kidney disease, and Alzheimer disease. However, the molecular details of NLRP3 inflammasome assembly are not established. The adaptor protein ASC plays a key role in inflammasome assembly. It is composed of an N-terminal pyrin domain (PYD) and a C-terminal caspase recruitment domain, which are protein interaction domains of the death fold superfamily. ASC interacts with NLRP3 via a homotypic PYD interaction and recruits procaspase-1 via a homotypic caspase recruitment domain interaction. Here we demonstrate that ASC PYD contains two distinct binding sites important for self-association and interaction with NLRP3 and the modulatory protein POP1. Modeling of the homodimeric ASC PYD complex formed via an asymmetric interaction using both sites resembles a type I interaction found in other death fold domain complexes. This interaction mode also permits assembly of ASC PYDs into filaments. Furthermore, a type I binding mode is likely conserved in interactions with NLRP3 and POP1, because residues critical for interaction of ASC PYD are conserved in these PYDs. We also demonstrate that ASC PYD can simultaneously self-associate and interact with NLRP3, rationalizing the model whereby ASC self-association upon recruitment to NLRP3 promotes clustering and activation of procaspase-1.	[Vajjhala, Parimala R.; Mirams, Ruth E.; Hill, Justine M.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Hill, Justine M.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Hill, JM (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.	justine.hill1@gmail.com	Hill, Justine M/C-5781-2009	Mirams, Ruth/0000-0003-3391-8419	Australian National Health and Medical Research Council [511227]; R. D. Wright Biomedical Career Development Award [401748]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); R. D. Wright Biomedical Career Development Award	This work was supported by the Australian National Health and Medical Research Council under Project Grant 511227 and R. D. Wright Biomedical Career Development Award 401748 (to J. M. H.).	Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Bae JY, 2011, J BIOL CHEM, V286, P39528, DOI 10.1074/jbc.M111.278812; Bruey JM, 2004, J BIOL CHEM, V279, P51897, DOI 10.1074/jbc.M406741200; Cook GP, 2010, EUR J IMMUNOL, V40, P631, DOI 10.1002/eji.200940162; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; de Alba E, 2009, J BIOL CHEM, V284, P32932, DOI 10.1074/jbc.M109.024273; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dowds TA, 2003, BIOCHEM BIOPH RES CO, V302, P575, DOI 10.1016/S0006-291X(03)00221-3; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Ferrao R, 2012, CURR OPIN STRUC BIOL, V22, P241, DOI 10.1016/j.sbi.2012.02.006; George J, 2011, J BIOL CHEM, V286, P1341, DOI 10.1074/jbc.M110.159996; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hill Justine A., 2008, V426, P437, DOI 10.1007/978-1-60327-058-8_29; Hiller S, 2003, STRUCTURE, V11, P1199, DOI 10.1016/j.str.2003.08.009; Hoffman HM, 2011, J BIOL CHEM, V286, P10889, DOI 10.1074/jbc.R110.135491; Kersse K, 2011, TRENDS BIOCHEM SCI, V36, P541, DOI 10.1016/j.tibs.2011.06.006; Khare S, 2012, IMMUNITY, V36, P464, DOI 10.1016/j.immuni.2012.02.001; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leemans JC, 2011, IMMUNOL REV, V243, P152, DOI 10.1111/j.1600-065X.2011.01043.x; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Liepinsh E, 2003, J MOL BIOL, V332, P1155, DOI 10.1016/j.jmb.2003.07.007; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masters SL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001902; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Masumoto J, 2001, BIOCHEM BIOPH RES CO, V280, P652, DOI 10.1006/bbrc.2000.4190; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Moriya M, 2005, BIOCHEMISTRY-US, V44, P575, DOI 10.1021/bi048374i; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Natarajan A, 2006, J BIOL CHEM, V281, P31863, DOI 10.1074/jbc.M605458200; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pellecchia M, 1999, NAT STRUCT BIOL, V6, P336; Pinheiro AS, 2011, J MOL BIOL, V413, P790, DOI 10.1016/j.jmb.2011.09.024; Pinheiro AS, 2010, J BIOL CHEM, V285, P27402, DOI 10.1074/jbc.M110.113191; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Richards N, 2001, J BIOL CHEM, V276, P39320, DOI 10.1074/jbc.M104730200; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shiozaki EN, 2002, P NATL ACAD SCI USA, V99, P4197, DOI 10.1073/pnas.072544399; Srimathi T, 2008, J BIOL CHEM, V283, P15390, DOI 10.1074/jbc.M801589200; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Stehlik C, 2003, BIOCHEM J, V373, P101, DOI 10.1042/BJ20030304; Stehlik C, 2002, J EXP MED, V196, P1605, DOI 10.1084/jem.20021552; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734	63	110	119	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41732	41743		10.1074/jbc.M112.381228	http://dx.doi.org/10.1074/jbc.M112.381228			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23066025	Green Published, hybrid			2022-12-28	WOS:000312103000015
J	Mahankali, M; Henkels, KM; Alter, G; Gomez-Cambronero, J				Mahankali, Madhu; Henkels, Karen M.; Alter, Gerald; Gomez-Cambronero, Julian			Identification of the Catalytic Site of Phospholipase D2 (PLD2) Newly Described Guanine Nucleotide Exchange Factor Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAC2; CHEMOTAXIS; PROTEINS; GEF; PHOSPHORYLATION; STIMULATION; FIBROBLASTS; ACTIVATION; RECEPTOR; FAMILY	We have demonstrated that phospholipase D2 (PLD2) is a guanine nucleotide exchange factor (GEF) for Rac2 and determined the PLD2 domains and amino acid site(s) responsible for its GEF activity. Experiments using GST fusion proteins or GST-free counterparts, purified proteins revealed that the PX domain is sufficient to exert GEF activity similar to full-length PLD2. The PLD2-GEF catalytic site is formed by a hydrophobic pocket of residues Phe-107, Phe-129, Leu-166, and Leu-173, all of which are in the PX domain. A nearby Arg-172 is also important in the overall activity. PX mutants altering any of those five amino acids fail to have GEF activity but still bind to Rac2, while their lipase activity was mostly unaffected. In addition to the PX domain, a region in the pleckstrin homology domain (Ile-306-Ala-310) aids in the PX-mediated GEF activity by providing a docking site to hold Rac2 in place during catalysis. We conclude that PLD2 is a unique GEF, with the PX being the major catalytic domain for its GEF activity, whereas the pleckstrin homology domain assists in the PX-mediated activity. The physiological relevance of this novel GEF in cell biology is demonstrated here in chemotaxis and phagocytosis of leukocytes, as the specific PX and and PH mutants abolished cell function. Thus, this study reveals for the first time the catalytic site that forms the basis for the mechanism behind the GEF activity of PLD2.	[Mahankali, Madhu; Henkels, Karen M.; Alter, Gerald; Gomez-Cambronero, Julian] Wright State Univ, Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA	Wright State University Dayton	Gomez-Cambronero, J (corresponding author), Wright State Univ, Sch Med, Dept Biochem & Mol Biol, 3640 Colonel Glenn Hwy, Dayton, OH 45435 USA.	julian.cambronero@wright.edu		Gomez-Cambronero, Julian/0000-0002-7581-9227	National Institutes of Health Grant [HL056653]; Boonshoft School of Medicine Grant [229102]; State of Ohio Research Incentive Grant [668372]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL056653, R01HL056653] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boonshoft School of Medicine Grant; State of Ohio Research Incentive Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL056653 (to J. G.-C.). This work was also supported by Boonshoft School of Medicine Grant 229102 and State of Ohio Research Incentive Grant 668372 (to J. G.-C.).	Chae YC, 2008, MOL BIOL CELL, V19, P3111, DOI 10.1091/mbc.E07-04-0337; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Di Fulvio M, 2007, J MOL BIOL, V367, P814, DOI 10.1016/j.jmb.2007.01.021; Exton JH, 2002, FEBS LETT, V531, P58, DOI 10.1016/S0014-5793(02)03405-1; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Gomez-Cambronero J, 2011, CELL SIGNAL, V23, P1885, DOI 10.1016/j.cellsig.2011.06.017; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Houle MG, 1999, BBA-MOL CELL BIOL L, V1439, P135, DOI 10.1016/S1388-1981(99)00090-6; Jeon H, 2011, CELL SIGNAL, V23, P1320, DOI 10.1016/j.cellsig.2011.03.014; Kantonen S, 2011, MOL CELL BIOL, V31, P4524, DOI 10.1128/MCB.05684-11; Knapek K, 2010, MOL CELL BIOL, V30, P4492, DOI 10.1128/MCB.00229-10; Kwofie MA, 2008, J BIOL CHEM, V283, P3088, DOI 10.1074/jbc.M705170200; Liscovitch M, 2000, BIOCHEM J, V345, P401, DOI 10.1042/0264-6021:3450401; Lu ZM, 2000, MOL CELL BIOL, V20, P462, DOI 10.1128/MCB.20.2.462-467.2000; Mahankali M, 2011, P NATL ACAD SCI USA, V108, P19617, DOI 10.1073/pnas.1114692108; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Ming WY, 2007, MOL CELL BIOL, V27, P312, DOI 10.1128/MCB.00985-06; Morris AJ, 1997, BIOCHEM SOC T, V25, P1151, DOI 10.1042/bst0251151; Oshimoto H, 2003, ONCOL RES, V14, P31, DOI 10.3727/000000003108748586; Peng HJ, 2011, MOL CELL BIOL, V31, P2227, DOI 10.1128/MCB.01348-10; Peng HJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.206672; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Slaaby R, 1998, J BIOL CHEM, V273, P33722, DOI 10.1074/jbc.273.50.33722; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Xu LM, 2011, J BIOL CHEM, V286, P25477, DOI 10.1074/jbc.M111.249631; Zhang H, 2009, J IMMUNOL, V183, P2718, DOI 10.4049/jimmunol.0900849; Zhang YQ, 2009, BBA-MOL CELL BIOL L, V1791, P850, DOI 10.1016/j.bbalip.2009.05.013; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594	28	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41417	41431		10.1074/jbc.M112.383596	http://dx.doi.org/10.1074/jbc.M112.383596			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23035122	Green Published, hybrid			2022-12-28	WOS:000311887600054
J	Tachibanaki, S; Yonetsu, SI; Fukaya, S; Koshitani, Y; Kawamura, S				Tachibanaki, Shuji; Yonetsu, Shin-Ichi; Fukaya, Satoshi; Koshitani, Yuki; Kawamura, Satoru			Low Activation and Fast Inactivation of Transducin in Carp Cones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE ACCELERATING PROTEIN; VISUAL PIGMENT; RODS; PHOTOTRANSDUCTION; PHOSPHORYLATION; PHOTORECEPTORS; PHOTORESPONSES; AMPLIFICATION; METABOLISM; EXPRESSION	Cone photoreceptors show lower light sensitivity and briefer light responses than rod photoreceptors. The light detection signal in these cells is amplified through a phototransduction cascade. The first step of amplification in the cascade is the activation of a GTP-binding protein, transducin (Tr), by light-activated visual pigment (R*). We quantified transducin activation by measuring the binding of GTP gamma S in purified carp rod and cone membrane preparations with the use of a rapid quench apparatus and found that transducin activation by an R* molecule is similar to 5 times less efficient in cones than in rods. Transducin activation terminated in less than 1 s in cones, more quickly than in rods. The rate of GTP hydrolysis in Tr*, and thus the rate of Tr* inactivation, was similar to 25 times higher in cones than in rods. This faster inactivation of Tr* ensures briefer light responses in cones. The expression level of RGS9 was found to be similar to 20 times higher in cones than in rods, which explains higher GTP hydrolytic activity and, thus, faster Tr* inactivation in cones than in rods. Although carp rods and cones express rod-or cone-versions of visual pigment and transducin, these molecules themselves do not seem to induce the differences significantly in the transducin activation and Tr* inactivation in rods and cones. Instead, the differences seem to be brought about in a rod or cone cell-type specific manner.	[Tachibanaki, Shuji; Yonetsu, Shin-Ichi; Fukaya, Satoshi; Kawamura, Satoru] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Tachibanaki, Shuji; Koshitani, Yuki; Kawamura, Satoru] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Kawamura, S (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Yamada Oka 1-3, Suita, Osaka 5650871, Japan.	kawamura@fbs.osaka-u.ac.jp			Japan Society for the Promotion of Science [20370060, 23227002, 222770150, 24570085]; Human Frontier Science Program grant; Naito Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Human Frontier Science Program grant(Human Frontier Science Program); Naito Foundation(Naito Memorial Foundation)	This work was supported by Japan Society for the Promotion of Science Grants 20370060 and 23227002 (to S. K.) and 222770150 and 24570085 (to S. T.), by a Human Frontier Science Program grant (to S. K.), and by the Naito Foundation (to S. T.).	Ala-Laurila P, 2006, J GEN PHYSIOL, V128, P153, DOI 10.1085/jgp.200609557; Alves ID, 2005, BIOPHYS J, V88, P198, DOI 10.1529/biophj.104.046722; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Cowan CW, 1998, P NATL ACAD SCI USA, V95, P5351, DOI 10.1073/pnas.95.9.5351; Cowan CW, 2000, METHOD ENZYMOL, V315, P524; DETURCO EBR, 1991, J NEUROSCI, V11, P3667; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Golobokova EY, 2006, VISION RES, V46, P2287, DOI 10.1016/j.visres.2005.12.017; HAROSI FI, 1975, J GEN PHYSIOL, V66, P357, DOI 10.1085/jgp.66.3.357; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; Kawamura S, 2008, COMP BIOCHEM PHYS A, V150, P369, DOI 10.1016/j.cbpa.2008.04.600; Miyazono S, 2008, P NATL ACAD SCI USA, V105, P16051, DOI 10.1073/pnas.0806593105; Niu SL, 2004, J BIOL CHEM, V279, P31098, DOI 10.1074/jbc.M404376200; PEPPERBERG DR, 1992, VISUAL NEUROSCI, V8, P9, DOI 10.1017/S0952523800006441; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Rieke F, 2000, NEURON, V26, P181, DOI 10.1016/S0896-6273(00)81148-4; Shimauchi-Matsukawa Y, 2008, MOL VIS, V14, P358; Tachibanaki S, 1997, BIOCHEMISTRY-US, V36, P14173, DOI 10.1021/bi970932o; Tachibanaki S, 2005, P NATL ACAD SCI USA, V102, P9329, DOI 10.1073/pnas.0501875102; Tachibanaki S, 2001, P NATL ACAD SCI USA, V98, P14044, DOI 10.1073/pnas.241396898; Takemoto N, 2009, P NATL ACAD SCI USA, V106, P11788, DOI 10.1073/pnas.0812781106; Vogalis F, 2011, J PHYSIOL-LONDON, V589, P2321, DOI 10.1113/jphysiol.2010.204156; Zhang X, 2003, J NEUROSCI, V23, P1287, DOI 10.1523/JNEUROSCI.23-04-01287.2003	24	20	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41186	41194		10.1074/jbc.M112.403717	http://dx.doi.org/10.1074/jbc.M112.403717			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23045532	hybrid, Green Published			2022-12-28	WOS:000311887600034
J	van den Berg, B				van den Berg, Bert			Structural Basis for Outer Membrane Sugar Uptake in Pseudomonads	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE-FORMING PROTEIN; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; MALTOPORIN CHANNELS; LAMB; AERUGINOSA; PORINS; TRANSLOCATION; PURIFICATION; SELECTIVITY	Substrate-specific outer membrane channels of Gram-negative bacteria mediate uptake of many small molecules, including carbohydrates. The mechanism of sugar uptake by enterobacterial channels, such as Escherichia coli LamB (maltoporin), has been characterized in great detail. In pseudomonads and related organisms, sugar uptake is not mediated by LamB but by OprB channels. Beyond the notion that OprB channels seem to prefer monosaccharides as substrates, very little is known about OprB-mediated sugar uptake. Here I report the X-ray crystal structure of an OprB channel from Pseudomonas putida F1. The structure shows that OprB forms a monomeric, 16-stranded beta-barrel with a constriction formed by extracellular loops L2 and L3. The side chains of two highly conserved arginine residues (Arg(83) and Arg(110)) and a conserved glutamate (Glu(106)) line the channel constriction and interact with a bound glucose molecule. Liposome swelling uptake assays show a strong preference for monosaccharide transport over disaccharides. Moreover, substrates with a net negative charge are disfavored by the channel, probably due to the negatively charged character of the constriction. The architecture of the eyelet and the absence of a greasy slide provide an explanation for the observed specificity of OprB for monosaccharides rather than the oligosaccharides preferred by LamB and related enterobacterial channels.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	van den Berg, B (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	bert.vandenberg@umassmed.edu		van den Berg, Bert/0000-0003-1966-8804	National Institutes of Health [RO1 GM085785]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM085785.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Adewoye LO, 1998, J BIOENERG BIOMEMBR, V30, P257, DOI 10.1023/A:1020596820314; Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; BENZ R, 1992, BIOCHIM BIOPHYS ACTA, V1104, P299, DOI 10.1016/0005-2736(92)90044-M; BENZ R, 1986, J BACTERIOL, V165, P978, DOI 10.1128/jb.165.3.978-986.1986; Daddaoua A, 2009, J BIOL CHEM, V284, P21360, DOI 10.1074/jbc.M109.014555; DARGENT B, 1987, FEBS LETT, V220, P136, DOI 10.1016/0014-5793(87)80891-8; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dumas F, 2000, J BIOL CHEM, V275, P19747, DOI 10.1074/jbc.M000268200; Dutzler R, 1996, STRUCTURE, V4, P127, DOI 10.1016/S0969-2126(96)00016-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forst D, 1998, NAT STRUCT BIOL, V5, P37, DOI 10.1038/nsb0198-37; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HANCOCK REW, 1980, FEMS MICROBIOL LETT, V8, P105, DOI 10.1111/j.1574-6968.1980.tb05060.x; Hearn EM, 2009, NATURE, V458, P367, DOI 10.1038/nature07678; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Klebba PE, 1997, RES MICROBIOL, V148, P375, DOI 10.1016/S0923-2508(97)83868-5; KLEBBA PE, 1994, EMBO J, V13, P4670, DOI 10.1002/j.1460-2075.1994.tb06790.x; Moraes TF, 2007, NAT STRUCT MOL BIOL, V14, P85, DOI 10.1038/nsmb1189; NIKAIDO H, 1983, J BACTERIOL, V153, P232, DOI 10.1128/JB.153.1.232-240.1983; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phale PS, 1998, BIOCHEMISTRY-US, V37, P15663, DOI 10.1021/bi981215c; SARAVOLAC EG, 1991, J BACTERIOL, V173, P4970, DOI 10.1128/jb.173.16.4970-4976.1991; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; SCHULEIN K, 1990, MOL MICROBIOL, V4, P625, DOI 10.1111/j.1365-2958.1990.tb00631.x; Seshadri K, 1998, PROTEIN SCI, V7, P2026, DOI 10.1002/pro.5560070919; Shrivastava R, 2011, MICROBIOL-SGM, V157, P1531, DOI 10.1099/mic.0.047191-0; STANIER RY, 1966, J GEN MICROBIOL, V43, P159, DOI 10.1099/00221287-43-2-159; Tamber S, 2006, J BACTERIOL, V188, P45, DOI 10.1128/JB.188.1.45-54.2006; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; VanGelder P, 1996, J BACTERIOL, V178, P5320, DOI 10.1128/jb.178.17.5320-5322.1996; WYLIE JL, 1995, J BACTERIOL, V177, P3021, DOI 10.1128/jb.177.11.3021-3026.1995	37	34	34	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41044	41052		10.1074/jbc.M112.408518	http://dx.doi.org/10.1074/jbc.M112.408518			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23066028	Green Published, hybrid			2022-12-28	WOS:000311887600022
J	Chan, EYL; McQuibban, GA				Chan, Eliana Y. L.; McQuibban, G. Angus			Phosphatidylserine Decarboxylase 1 (Psd1) Promotes Mitochondrial Fusion by Regulating the Biophysical Properties of the Mitochondrial Membrane and Alternative Topogenesis of Mitochondrial Genome Maintenance Protein 1 (Mgm1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PHOSPHATIDYLETHANOLAMINE; CARDIOLIPIN; MORPHOLOGY; PROTEASE; LIPIDS; YEAST; COMPETENT; CURVATURE; PATHWAYS	Non-bilayer-forming lipids such as cardiolipin, phosphatidic acid, and phosphatidylethanolamine (PE) are proposed to generate negative membrane curvature, promoting membrane fusion. However, the mechanism by which lipids regulate mitochondrial fusion remains poorly understood. Here, we show that mitochondrial-localized Psd1, the key yeast enzyme that synthesizes PE, is required for proper mitochondrial morphology and fusion. Yeast cells lacking Psd1 exhibit fragmented and aggregated mitochondria with impaired mitochondrial fusion during mating. More importantly, we demonstrate that a reduction in PE reduces the rate of lipid mixing during fusion of liposomes with lipid compositions reflecting the mitochondrial membrane. This suggests that the mitochondrial fusion defect in the Delta psd1 strain could be due to the altered biophysical properties of the mitochondrial membrane, resulting in reduced fusion kinetics. The Delta psd1 strain also has impaired mitochondrial activity such as oxidative phosphorylation and reduced mitochondrial ATP levels which are due to a reduction in mitochondrial PE. The loss of Psd1 also impairs the biogenesis of s-Mgm1, a protein essential for mitochondrial fusion, further exacerbating the mitochondrial fusion defect of the Delta psd1 strain. Increasing s-Mgm1 levels in Delta psd1 cells markedly reduced mitochondrial aggregation. Our results demonstrate that mitochondrial PE regulates mitochondrial fusion by regulating the biophysical properties of the mitochondrial membrane and by enhancing the biogenesis of s-Mgm1. While several proteins are required to orchestrate the intricate process of membrane fusion, we propose that specific phospholipids of the mitochondrial membrane promote fusion by enhancing lipid mixing kinetics and by regulating the action of profusion proteins.	[Chan, Eliana Y. L.; McQuibban, G. Angus] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto	McQuibban, GA (corresponding author), 1 Kings Coll Circle,Med Sci Bldg,Rm 5342, Toronto, ON M5S 1A8, Canada.	angus.mcquibban@utoronto.ca			Canadian Institutes of Health Research; University of Toronto open fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Toronto open fellowship(University of Toronto)	This work was supported by an operating grant from the Canadian Institutes of Health Research.; Supported in part by a University of Toronto open fellowship.	Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; Burgermeister M, 2004, BBA-MOL CELL BIOL L, V1686, P161, DOI 10.1016/j.bbalip.2004.09.007; Chen HK, 2011, J BIOL CHEM, V286, P5215, DOI 10.1074/jbc.M110.151084; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Churchward MA, 2008, BIOPHYS J, V94, P3976, DOI 10.1529/biophysj.107.123984; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Epand RM, 1996, BIOPHYS J, V71, P1806, DOI 10.1016/S0006-3495(96)79381-5; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Fritz S, 2003, MOL BIOL CELL, V14, P2303, DOI 10.1091/mbc.E02-12-0831; Gregg C., 2009, JOVE-J VIS EXP, pe1417; Herlan M, 2004, J CELL BIOL, V165, P167, DOI 10.1083/jcb.200403022; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kuroda T, 2011, MOL MICROBIOL, V80, P248, DOI 10.1111/j.1365-2958.2011.07569.x; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; RAMSEY RB, 1976, BIOCHEM J, V158, P501, DOI 10.1042/bj1580501; Sakamoto T, 2012, J BIOL CHEM, V287, P4590, DOI 10.1074/jbc.M111.314823; Sesaki H, 2004, J BIOL CHEM, V279, P28298, DOI 10.1074/jbc.M401363200; Sesaki H, 2003, BIOCHEM BIOPH RES CO, V308, P276, DOI 10.1016/S0006-291X(03)01348-2; Sesaki H, 2003, MOL BIOL CELL, V14, P2342, DOI 10.1091/mbc.E02-12-0788; Siegel DP, 1997, BIOPHYS J, V73, P3089, DOI 10.1016/S0006-3495(97)78336-X; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Yang QL, 1997, BIOPHYS J, V73, P277, DOI 10.1016/S0006-3495(97)78068-8; Zick M, 2009, FEBS LETT, V583, P2237, DOI 10.1016/j.febslet.2009.05.053	33	63	64	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40131	40139		10.1074/jbc.M112.399428	http://dx.doi.org/10.1074/jbc.M112.399428			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23045528	hybrid, Green Published			2022-12-28	WOS:000311448800004
J	Fiori, MC; Figueroa, V; Zoghbi, ME; Saez, JC; Reuss, L; Altenberg, GA				Fiori, Mariana C.; Figueroa, Vania; Zoghbi, Maria E.; Saez, Juan C.; Reuss, Luis; Altenberg, Guillermo A.			Permeation of Calcium through Purified Connexin 26 Hemichannels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION CHANNELS; C-MEDIATED PHOSPHORYLATION; INOSITOL 1,4,5-TRISPHOSPHATE; ATP RELEASE; INNER-EAR; CA2+; PERMEABILITY; MECHANISM; DEAFNESS; MUTANT	Gap junction channels communicate the cytoplasms of two cells and are formed by head to head association of two hemichannels, one from each of the cells. Gap junction channels and hemichannels are permeable to ions and hydrophilic molecules of up to M-r 1,000, including second messengers and metabolites. Intercellular Ca2+ signaling can occur by movement of a number of second messengers, including Ca2+, through gap junction channels, or by a paracrine pathway that involves activation of purinergic receptors in neighboring cells following ATP release through hemichannels. Understanding Ca2+ permeation through Cx26 hemichannels is important to assess the role of gap junction channels and hemichannels in health and disease. In this context, it is possible that increased Ca2+ influx through hemichannels under ischemic conditions contributes to cell damage. Previous studies suggest Ca2+ permeation through hemichannels, based on indirect arguments. Here, we demonstrate for the first time hemichannel permeability to Ca2+ by measuring Ca2+ transport through purified Cx26 hemichannels reconstituted in liposomes. We trapped the low affinity Ca2+-sensitive fluorescent probe Fluo-5N into the liposomes and followed the increases in intraliposomal [Ca2+] in response to an imposed [Ca2+] gradient. We show that Ca2+ does move through Cx26 hemichannels and that the permeability of the hemichannels to Ca2+ is high, similar to that for Na+. We suggest that hemichannels can be a significant pathway for Ca2+ influx into cells under conditions such as ischemia.	[Fiori, Mariana C.; Zoghbi, Maria E.; Reuss, Luis; Altenberg, Guillermo A.] Texas Tech Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA; [Fiori, Mariana C.; Zoghbi, Maria E.; Reuss, Luis; Altenberg, Guillermo A.] Texas Tech Hlth Sci Ctr, Ctr Membrane Prot Res, Lubbock, TX 79430 USA; [Figueroa, Vania; Saez, Juan C.] Pontificia Univ Catolica Chile, Dept Fisiol, Santiago, Chile; [Figueroa, Vania; Saez, Juan C.] Ctr Interdisciplinario Neurociencias Valparaiso, Inst Nucleo Milenio, Valparaiso, Chile	Texas Tech University System; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University Health Science Center; Pontificia Universidad Catolica de Chile	Altenberg, GA (corresponding author), Texas Tech Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA.	g.altenberg@ttuhsc.edu		Zoghbi, Maria/0000-0002-4206-4673; Altenberg, Guillermo/0000-0002-8932-740X; Figueroa Ipinza, Vania A./0000-0002-2953-9507	National Institutes of Health [R01GM79629, 3R01GM079629-03S1]; Center of Membrane Protein Research; Programa MECE 2 Educacion Superior [UVA 0603]; Consejo Nacional de Investigacion Cientifica y Tecnologica [21090112, ACT71]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Membrane Protein Research; Programa MECE 2 Educacion Superior; Consejo Nacional de Investigacion Cientifica y Tecnologica; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM79629 and 3R01GM079629-03S1. This work was also supported by a grant from the Center of Membrane Protein Research, and Programa MECE 2 Educacion Superior, Projecto UVA 0603, and Consejo Nacional de Investigacion Cientifica y Tecnologica grants 21090112 and ACT71.	Ambrosi C, 2010, BIOPHYS J, V98, P1809, DOI 10.1016/j.bpj.2010.01.019; Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; Ayad WA, 2006, J BIOL CHEM, V281, P16727, DOI 10.1074/jbc.M600136200; Bao XY, 2004, J BIOL CHEM, V279, P20058, DOI 10.1074/jbc.M311137200; Bao XY, 2004, AM J PHYSIOL-CELL PH, V286, pC647, DOI 10.1152/ajpcell.00295.2003; Bargiotas P, 2009, CURR MOL MED, V9, P186, DOI 10.2174/156652409787581646; Beltramello M, 2005, NAT CELL BIOL, V7, P63, DOI 10.1038/ncb1205; Bevans CG, 1998, J BIOL CHEM, V273, P2808, DOI 10.1074/jbc.273.5.2808; BOITANO S, 1992, SCIENCE, V258, P292, DOI 10.1126/science.1411526; Chen YY, 2005, FASEB J, V19, P1516, DOI 10.1096/fj.04-3491fje; CHRIST GJ, 1992, AM J PHYSIOL, V263, pC373, DOI 10.1152/ajpcell.1992.263.2.C373; FINKBEINER S, 1992, NEURON, V8, P1101, DOI 10.1016/0896-6273(92)90131-V; Gassmann O, 2009, J STRUCT BIOL, V168, P168, DOI 10.1016/j.jsb.2009.02.004; Gomez-Hernandez JM, 2003, P NATL ACAD SCI USA, V100, P16030, DOI 10.1073/pnas.2530348100; Gossman DG, 2008, CELL COMMUN ADHES, V15, P305, DOI 10.1080/15419060802357217; Harris AL, 2001, METH MOL B, V154, P357; Harris Andrew L., 2009, P165, DOI 10.1007/978-1-59745-489-6_7; Isakson BE, 2007, CIRC RES, V100, P246, DOI 10.1161/01.RES.0000257744.23795.93; Kanaporis G, 2008, J GEN PHYSIOL, V131, P293, DOI 10.1085/jgp.200709934; Leybaert L, 1998, GLIA, V24, P398, DOI 10.1002/(SICI)1098-1136(199812)24:4<398::AID-GLIA5>3.0.CO;2-R; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Majumder P, 2010, PURINERG SIGNAL, V6, P167, DOI 10.1007/s11302-010-9192-9; Martinez AD, 2009, ANTIOXID REDOX SIGN, V11, P309, DOI 10.1089/ars.2008.2138; Mese G, 2007, J INVEST DERMATOL, V127, P2516, DOI 10.1038/sj.jid.5700770; Muller DJ, 2002, EMBO J, V21, P3598, DOI 10.1093/emboj/cdf365; Orellana JA, 2012, REV NEUROSCIENCE, V23, P163, DOI 10.1515/revneuro-2011-0065; Orellana JA, 2012, ADV EXP MED BIOL, V740, P777, DOI 10.1007/978-94-007-2888-2_34; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Oshima A, 2003, J BIOL CHEM, V278, P1807, DOI 10.1074/jbc.M207713200; SAEZ JC, 1989, P NATL ACAD SCI USA, V86, P2708, DOI 10.1073/pnas.86.8.2708; Sanchez HA, 2010, J GEN PHYSIOL, V136, P47, DOI 10.1085/jgp.201010433; Sanchez HA, 2009, AM J PHYSIOL-CELL PH, V297, pC665, DOI 10.1152/ajpcell.00200.2009; Schalper KA, 2010, AM J PHYSIOL-CELL PH, V299, pC1504, DOI 10.1152/ajpcell.00015.2010; Scheckenbach KEL, 2011, J VASC RES, V48, P91, DOI 10.1159/000316942; STAUFFER KA, 1995, J BIOL CHEM, V270, P6768; STAUFFER KA, 1991, J CELL BIOL, V115, P141, DOI 10.1083/jcb.115.1.141; Sun JJ, 2005, AM J PHYSIOL-CELL PH, V288, pC613, DOI 10.1152/ajpcell.00341.2004; Tao L, 2004, J BIOL CHEM, V279, P38544, DOI 10.1074/jbc.M405654200; Venance L, 1997, J NEUROSCI, V17, P1981; Weber PA, 2004, BIOPHYS J, V87, P958, DOI 10.1529/biophysj.103.036350; Zhao HB, 2005, P NATL ACAD SCI USA, V102, P18724, DOI 10.1073/pnas.0506481102	41	65	67	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40826	40834		10.1074/jbc.M112.383281	http://dx.doi.org/10.1074/jbc.M112.383281			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23048025	Green Published, hybrid			2022-12-28	WOS:000311448800070
J	Fujita, N; Gogate, SS; Chiba, K; Toyama, Y; Shapiro, IM; Risbud, MV				Fujita, Nobuyuki; Gogate, Shilpa S.; Chiba, Kazuhiro; Toyama, Yoshiaki; Shapiro, Irving M.; Risbud, Makarand V.			Prolyl Hydroxylase 3 (PHD3) Modulates Catabolic Effects of Tumor Necrosis Factor-alpha (TNF-alpha) on Cells of the Nucleus Pulposus through Co-activation of Nuclear Factor kappa B (NF-kappa B)/p65 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INTERVERTEBRAL DISC; HYPOXIA-RESPONSIVE ELEMENT; DEGENERATION; EXPRESSION; HIF-1; IDENTIFICATION; DEGRADATION; HIF-1-ALPHA; PROMOTES; PATHWAY	Recent studies suggest a differential role of prolyl hydroxylase (PHD) isoforms in controlling hypoxia-inducible factor (HIF)-alpha degradation and activity in nucleus pulposus (NP) cells. However, the regulation and function of PHDs under inflammatory conditions that characterize disc disease are not yet known. Here, we show that in NP cells, TNF-alpha and IL-1 beta induce PHD3 expression through NF-kappa B. Lentiviral delivery of Sh-p65 and Sh-IKK beta confirms that cytokine-mediated PHD3 expression is NF-kappa B-dependent. It is noteworthy that although both cytokines induce HIF activity, mechanistic studies using Sh-HIF-1 alpha and PHD3 promoter/enhancer constructs harboring well characterized hypoxia response element (HRE) show lack of HIF involvement in cytokine-mediated PHD3 expression. Loss-of-function studies clearly indicate that PHD3 serves as a co-activator of NF-kappa B signaling activity in NP cells; PHD3 interacts with, and co-localizes with, p65. We observed that when PHD3 is silenced, there is a significant decrease in TNF-alpha-induced expression of catabolic markers that include ADAMTS5, syndecan4, MMP13, and COX2, and at the same time, there is restoration of aggrecan and collagen type II expression. It is noteworthy that hydroxylase function of PHDs is not required for mediating cytokine-dependent gene expression. These findings show that by enhancing the activity of inflammatory cytokines, PHD3 may serve a critical role in degenerative disc disease.	[Fujita, Nobuyuki; Gogate, Shilpa S.; Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA; [Fujita, Nobuyuki; Gogate, Shilpa S.; Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Grad Program Cell & Dev Biol, Philadelphia, PA 19107 USA; [Fujita, Nobuyuki; Toyama, Yoshiaki] Keio Univ, Dept Orthopaed Surg, Sch Med, Tokyo 1088345, Japan; [Chiba, Kazuhiro] Kitasato Univ, Dept Orthopaed Surg, Kitasato Inst Hosp, Tokyo 1088641, Japan	Jefferson University; Jefferson University; Keio University; Kitasato University	Risbud, MV (corresponding author), Thomas Jefferson Univ, Dept Orthopaed Surg, 1015 Walnut St,Ste 501 Curtis Bldg, Philadelphia, PA 19107 USA.	makarand.risbud@jefferson.edu	Toyama, Yoshiaki/K-5743-2013; Fujita, Nobuyuki/L-4800-2013		National Institutes of Health [R01-AR050087, R01-AR055655]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050087, R01AR055655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AR050087 and R01-AR055655 (to M.V.R.).	Bartels EM, 1998, SPINE, V23, P1, DOI 10.1097/00007632-199801010-00001; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; Fu J, 2010, J BIOL CHEM, V285, P8927, DOI 10.1074/jbc.M109.078600; Fujita N, 2012, J BIOL CHEM, V287, P16975, DOI 10.1074/jbc.M111.334466; Fujita N, 2012, J BONE MINER RES, V27, P401, DOI 10.1002/jbmr.538; Gruber HE, 2005, SPINE, V30, P2593, DOI 10.1097/01.brs.0000187877.30149.83; HASSLER O, 1969, ACTA ORTHOP SCAND, V40, P765, DOI 10.3109/17453676908989540; Johansen JL, 2010, J NEUROCHEM, V115, P209, DOI 10.1111/j.1471-4159.2010.06917.x; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732; Lee JM, 2011, J ORTHOP RES, V29, P265, DOI 10.1002/jor.21210; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Marxsen JH, 2004, BIOCHEM J, V381, P761, DOI 10.1042/BJ20040620; Metzen E, 2005, BIOCHEM J, V387, P711, DOI 10.1042/BJ20041736; Nam SY, 2011, BRIT J CANCER, V104, P166, DOI 10.1038/sj.bjc.6606020; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; RUDERT M, 1993, ACTA ORTHOP SCAND, V64, P37, DOI 10.3109/17453679308994524; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Seguin CA, 2005, SPINE, V30, P1940, DOI 10.1097/01.brs.0000176188.40263.f9; Seguin CA, 2006, MATRIX BIOL, V25, P409, DOI 10.1016/j.matbio.2006.07.002; Shamji MF, 2010, ARTHRITIS RHEUM-US, V62, P1974, DOI 10.1002/art.27444; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Wang JR, 2011, J BIOL CHEM, V286, P39738, DOI 10.1074/jbc.M111.264549; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Weiler C, 2005, SPINE, V30, P44, DOI 10.1097/01.brs.0000149186.63457.20; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153; Yeramian A, 2011, LAB INVEST, V91, P859, DOI 10.1038/labinvest.2011.58	29	61	63	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.375964	http://dx.doi.org/10.1074/jbc.M112.375964			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	22948157	Green Published, hybrid			2022-12-28	WOS:000311233800062
J	Green, NM; Moody, KS; Debatis, M; Marshak-Rothstein, A				Green, Nathaniel M.; Moody, Krishna-Sulayman; Debatis, Michelle; Marshak-Rothstein, Ann			Activation of Autoreactive B Cells by Endogenous TLR7 and TLR3 RNA Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TOLL-LIKE RECEPTOR-3; SMALL NUCLEAR RNAS; INNATE IMMUNITY; SUBCELLULAR-LOCALIZATION; BINDING-SITES; MURINE MODEL; I INTERFERON; MOUSE MODEL; IFN	The key step in the activation of autoreactive B cells is the internalization of nucleic acid containing ligands and delivery of these ligands to the Toll-like Receptor (TLR) containing endolysosomal compartment. Ribonucleoproteins represent a large fraction of autoantigens in systemic autoimmune diseases. Here we demonstrate that many uridine-rich mammalian RNA sequences associated with common autoantigens effectively activate autoreactive B cells. Priming with type I IFN increased the magnitude of activation, and the range of which RNAs were stimulatory. A subset of RNAs that contain a high degree of self-complementarity also activated B cells through TLR3. For the RNA sequences that activated predominantly through TLR7, the activation is proportional to uridine-content, and more precisely defined by the frequency of specific uridine-containing motifs. These results identify parameters that define specific mammalian RNAs as ligands for TLRs.	[Green, Nathaniel M.; Moody, Krishna-Sulayman; Debatis, Michelle; Marshak-Rothstein, Ann] Univ Massachusetts, Sch Med, Dept Med, Div Rheumatol, Worcester, MA 01605 USA; [Green, Nathaniel M.; Moody, Krishna-Sulayman; Marshak-Rothstein, Ann] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA	University of Massachusetts System; University of Massachusetts Worcester; Boston University	Marshak-Rothstein, A (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Rheumatol, 364 Plantat St, Worcester, MA 01605 USA.	ann.rothstein@umassmed.edu			National Institutes of Health [AR05-256, AR035230]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035230, P01AR050256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR05-256 and AR035230.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Avalos AM, 2010, EUR J IMMUNOL, V40, P2692, DOI 10.1002/eji.200940184; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Braun D, 2002, INT IMMUNOL, V14, P411, DOI 10.1093/intimm/14.4.411; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; CHU WM, 1995, NUCLEIC ACIDS RES, V23, P1750, DOI 10.1093/nar/23.10.1750; Diebold SS, 2006, EUR J IMMUNOL, V36, P3256, DOI 10.1002/eji.200636617; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; EILAT D, 1991, J IMMUNOL, V147, P361; Farina GA, 2010, J INVEST DERMATOL, V130, P2583, DOI 10.1038/jid.2010.200; FENN BJ, 1990, ANAL BIOCHEM, V190, P78, DOI 10.1016/0003-2697(90)90136-W; Forsbach A, 2008, J IMMUNOL, V180, P3729, DOI 10.4049/jimmunol.180.6.3729; Forsbach A, 2007, OLIGONUCLEOTIDES, V17, P405, DOI 10.1089/oli.2007.0098; Gehrig S, 2012, J EXP MED, V209, P225, DOI 10.1084/jem.20111044; Gesteland RF., 1993, RNA WORLD NATURE MOD; Green NM, 2011, SEMIN IMMUNOL, V23, P106, DOI 10.1016/j.smim.2011.01.016; Green NM, 2009, J IMMUNOL, V183, P1569, DOI 10.4049/jimmunol.0803899; Hannum LG, 1996, J EXP MED, V184, P1269, DOI 10.1084/jem.184.4.1269; Harris ML, 2003, CURR OPIN RHEUMATOL, V15, P778, DOI 10.1097/00002281-200311000-00016; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hua J, 2006, ARTHRITIS RHEUM-US, V54, P1906, DOI 10.1002/art.21890; Jockel S, 2012, J EXP MED, V209, P235, DOI 10.1084/jem.20111075; Jurk M, 2011, NUCLEIC ACID THER, V21, P201, DOI 10.1089/nat.2011.0298; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lee PY, 2008, J EXP MED, V205, P2995, DOI 10.1084/jem.20080462; LERNER MR, 1979, P NATL ACAD SCI USA, V76, P5495, DOI 10.1073/pnas.76.11.5495; Leung AKL, 2011, NAT STRUCT MOL BIOL, V18, P237, DOI 10.1038/nsmb.1991; Levine SM, 2007, ARTHRITIS RHEUM, V56, P2729, DOI 10.1002/art.22790; Li TH, 1999, GENE, V239, P367, DOI 10.1016/S0378-1119(99)00384-4; LIU WM, 1995, NUCLEIC ACIDS RES, V23, P1758, DOI 10.1093/nar/23.10.1758; Loh C, 2011, EUR J IMMUNOL, V41, P527, DOI 10.1002/eji.201040983; Marshall-Clarke S, 2006, EUR J IMMUNOL, V36, P95, DOI 10.1002/eji.200535331; Marshall-Clarke S, 2007, J BIOL CHEM, V282, P24759, DOI 10.1074/jbc.M700188200; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Nandula SR, 2011, ORAL DIS, V17, P801, DOI 10.1111/j.1601-0825.2011.01839.x; Nishiya T, 2004, J BIOL CHEM, V279, P19008, DOI 10.1074/jbc.M311618200; Patole PS, 2007, J AUTOIMMUN, V29, P52, DOI 10.1016/j.jaut.2007.04.004; Radic M, 2004, J IMMUNOL, V172, P6692, DOI 10.4049/jimmunol.172.11.6692; Sadik CD, 2009, NUCLEIC ACIDS RES, V37, P5041, DOI 10.1093/nar/gkp525; Soejima M, 2011, ARTHRITIS RHEUM-US, V63, P479, DOI 10.1002/art.30113; Sweet RA, 2010, AUTOIMMUNITY, V43, P607, DOI 10.3109/08916930903567500; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tluk S, 2009, INT IMMUNOL, V21, P607, DOI 10.1093/intimm/dxp030; Tournadre A, 2012, ARTHRITIS RHEUM-US, V64, P533, DOI 10.1002/art.33350; Uccellini MB, 2008, J IMMUNOL, V181, P5875, DOI 10.4049/jimmunol.181.9.5875; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; Villarreal GM, 1997, LUPUS, V6, P425, DOI 10.1177/096120339700600503; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696; Yasuda K, 2007, J IMMUNOL, V178, P6876, DOI 10.4049/jimmunol.178.11.6876; Yasuda K, 2009, J IMMUNOL, V183, P3109, DOI 10.4049/jimmunol.0900399; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	56	45	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.383000	http://dx.doi.org/10.1074/jbc.M112.383000			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23019335	Green Published, hybrid			2022-12-28	WOS:000311233800047
J	Forouzan, D; Ammelburg, M; Hobel, CF; Stroh, LJ; Sessler, N; Martin, J; Lupas, AN				Forouzan, Dara; Ammelburg, Moritz; Hobel, Cedric F.; Stroeh, Luisa J.; Sessler, Nicole; Martin, Joerg; Lupas, Andrei N.			The Archaeal Proteasome Is Regulated by a Network of AAA ATPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HALOARCHAEON HALOFERAX-VOLCANII; 20S PROTEASOME; THERMOPLASMA-ACIDOPHILUM; MYCOBACTERIUM-TUBERCULOSIS; PROTEINS; PATHWAY; GATE; PARTICLE; TRANSLOCATION; DEGRADATION	The proteasome is the central machinery for targeted protein degradation in archaea, Actinobacteria, and eukaryotes. In its basic form, it consists of a regulatory ATPase complex and a proteolytic core particle. The interaction between the two is governed by an HbYX motif (where Hb is a hydrophobic residue, Y is tyrosine, and X is any amino acid) at the C terminus of the ATPase subunits, which stimulates gate opening of the proteasomal alpha-subunits. In archaea, the proteasome-interacting motif is not only found in canonical proteasome-activating nucleotidases of the PAN/ARC/Rpt group, which are absent in major archaeal lineages, but also in proteins of the CDC48/p97/VAT and AMA groups, suggesting a regulatory network of proteasomal ATPases. Indeed, Thermoplasma acidophilum, which lacks PAN, encodes one CDC48 protein that interacts with the 20S proteasome and activates the degradation of model substrates. In contrast, Methanosarcina mazei contains seven AAA proteins, five of which, both PAN proteins, two out of three CDC48 proteins, and the AMA protein, function as proteasomal gatekeepers. The prevalent presence of multiple, distinct proteasomal ATPases in archaea thus results in a network of regulatory ATPases that may widen the substrate spectrum of proteasomal protein degradation.	[Forouzan, Dara; Ammelburg, Moritz; Hobel, Cedric F.; Martin, Joerg; Lupas, Andrei N.] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany; [Stroeh, Luisa J.] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Sessler, Nicole] Univ Tubingen, Proteome Ctr, Interfac Inst Cell Biol, D-72076 Tubingen, Germany	Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Lupas, AN (corresponding author), Max Planck Inst Dev Biol, Dept Prot Evolut, Spemannstr 35, D-72076 Tubingen, Germany.	andrei.lupas@tuebingen.mpg.de	Ammelburg, Moritz/F-1401-2011	Ammelburg, Moritz/0000-0001-8282-6487	institutional funds of the Max Planck Society	institutional funds of the Max Planck Society	This work was supported by institutional funds of the Max Planck Society.	Ammelburg M, 2006, J STRUCT BIOL, V156, P2, DOI 10.1016/j.jsb.2006.05.002; Bajorek M, 2003, CURR BIOL, V13, P1140, DOI 10.1016/S0960-9822(03)00417-2; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Borchert N, 2010, GENOME RES, V20, P837, DOI 10.1101/gr.103119.109; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Djuranovic S, 2006, J STRUCT BIOL, V156, P130, DOI 10.1016/j.jsb.2006.03.010; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gerega A, 2005, J BIOL CHEM, V280, P42856, DOI 10.1074/jbc.M510592200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Humbard MA, 2010, NATURE, V463, P54, DOI 10.1038/nature08659; Imkamp F, 2010, EMBO REP, V11, P791, DOI 10.1038/embor.2010.119; Isakov E, 2011, J BIOL CHEM, V286, P30274, DOI 10.1074/jbc.M111.240309; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Kisselev AF, 1998, J BIOL CHEM, V273, P1982, DOI 10.1074/jbc.273.4.1982; Kusmierczyk AR, 2011, NAT STRUCT MOL BIOL, V18, P622, DOI 10.1038/nsmb.2027; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Madding LS, 2007, J BACTERIOL, V189, P583, DOI 10.1128/JB.01382-06; Makarova KS, 2010, NAT REV MICROBIOL, V8, P731, DOI 10.1038/nrmicro2406; Maupin-Furlow J, 2012, NAT REV MICROBIOL, V10, P100, DOI 10.1038/nrmicro2696; Medalia N, 2006, J STRUCT BIOL, V156, P84, DOI 10.1016/j.jsb.2006.03.015; Neuwald AF, 1999, GENOME RES, V9, P27; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pamnani V, 1997, FEBS LETT, V404, P263, DOI 10.1016/S0014-5793(97)00138-5; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Religa TL, 2010, SCIENCE, V328, P98, DOI 10.1126/science.1184991; Reuter CJ, 2004, J BACTERIOL, V186, P7763, DOI 10.1128/JB.186.22.7763-7772.2004; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Ruepp A, 1998, FEBS LETT, V425, P87, DOI 10.1016/S0014-5793(98)00205-1; Ruepp A, 2001, J STRUCT BIOL, V135, P126, DOI 10.1006/jsbi.2001.4402; SEEMULLER E, 1995, SCIENCE, V268, P579, DOI 10.1126/science.7725107; Seemuller E, 1996, NATURE, V382, P468, DOI 10.1038/382468a0; Serek-Heuberger J, 2009, BIOCHEM SOC T, V37, P118, DOI 10.1042/BST0370118; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW374, DOI 10.1093/nar/gkl195; Stadtmueller BM, 2010, J BIOL CHEM, V285, P13, DOI 10.1074/jbc.C109.070425; Striebel F, 2010, EMBO J, V29, P1262, DOI 10.1038/emboj.2010.23; Summer H, 2006, J STRUCT BIOL, V156, P120, DOI 10.1016/j.jsb.2006.01.010; Wang T, 2010, NAT STRUCT MOL BIOL, V17, P1352, DOI 10.1038/nsmb.1918; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Wolf S, 1998, J MOL BIOL, V277, P13, DOI 10.1006/jmbi.1997.1589; Yu YD, 2010, EMBO J, V29, P692, DOI 10.1038/emboj.2009.382; Zhang F, 2009, MOL CELL, V34, P485, DOI 10.1016/j.molcel.2009.04.022; Zhou GY, 2008, J BACTERIOL, V190, P8096, DOI 10.1128/JB.01180-08; Zwickl P, 1999, J BIOL CHEM, V274, P26008, DOI 10.1074/jbc.274.37.26008	54	34	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39254	39262		10.1074/jbc.M112.386458	http://dx.doi.org/10.1074/jbc.M112.386458			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22992741	hybrid, Green Published			2022-12-28	WOS:000310982800080
J	Lee, SJ; Zhu, B; Akabayov, B; Richardson, CC				Lee, Seung-Joo; Zhu, Bin; Akabayov, Barak; Richardson, Charles C.			Zinc-binding Domain of the Bacteriophage T7 DNA Primase Modulates Binding to the DNA Template	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA PRIMER SYNTHESIS; GENE 4 PROTEIN; HELICASE; RECOGNITION; SEQUENCE; RESIDUES; INITIATION; EVOLUTION; EXTENSION; INSIGHTS	The zinc-binding domain (ZBD) of prokaryotic DNA primases has been postulated to be crucial for recognition of specific sequences in the single-stranded DNA template. To determine the molecular basis for this role in recognition, we carried out homolog-scanning mutagenesis of the zinc-binding domain of DNA primase of bacteriophage T7 using a bacterial homolog from Geobacillus stearothermophilus. The ability of T7 DNA primase to catalyze template-directed oligoribonucleotide synthesis is eliminated by substitution of any five-amino acid residue-long segment within the ZBD. The most significant defect occurs upon substitution of a region (Pro-16 to Cys-20) spanning two cysteines that coordinate the zinc ion. The role of this region in primase function was further investigated by generating a protein library composed of multiple amino acid substitutions for Pro-16, Asp-18, and Asn-19 followed by genetic screening for functional proteins. Examination of proteins selected from the screening reveals no change in sequence-specific recognition. However, the more positively charged residues in the region facilitate DNA binding, leading to more efficient oligoribonucleotide synthesis on short templates. The results suggest that the zinc-binding mode alone is not responsible for sequence recognition, but rather its interaction with the RNA polymerase domain is critical for DNA binding and for sequence recognition. Consequently, any alteration in the ZBD that disturbs its conformation leads to loss of DNA-dependent oligoribonucleotide synthesis.	[Lee, Seung-Joo; Zhu, Bin; Akabayov, Barak; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave,C2-219, Boston, MA 02115 USA.	ccr@hms.harvard.edu	Akabayov, Barak/Y-5786-2019	Akabayov, Barak/0000-0002-3882-2742	National Institutes of Health [GM 54397]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 54397 (to C.C.R.).	Akabayov B, 2009, BIOCHEMISTRY-US, V48, P1763, DOI 10.1021/bi802123t; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205; BERNSTEIN JA, 1988, P NATL ACAD SCI USA, V85, P396, DOI 10.1073/pnas.85.2.396; Corn JE, 2005, MOL CELL, V20, P391, DOI 10.1016/j.molcel.2005.09.004; CUNNINGHAM BC, 1989, SCIENCE, V243, P1330, DOI 10.1126/science.2466339; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; Frick DN, 1999, J BIOL CHEM, V274, P35889, DOI 10.1074/jbc.274.50.35889; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; HINE AV, 1994, P NATL ACAD SCI USA, V91, P12327, DOI 10.1073/pnas.91.25.12327; ILYINA TV, 1992, J MOL EVOL, V34, P351, DOI 10.1007/BF00160243; Iyer LM, 2005, NUCLEIC ACIDS RES, V33, P3875, DOI 10.1093/nar/gki702; Kato M, 2004, J BIOL CHEM, V279, P30554, DOI 10.1074/jbc.M403485200; Kato M, 2003, MOL CELL, V11, P1349, DOI 10.1016/S1097-2765(03)00195-3; Koepsell SA, 2006, J BACTERIOL, V188, P4673, DOI 10.1128/JB.00316-06; Kusakabe T, 1999, P NATL ACAD SCI USA, V96, P4295, DOI 10.1073/pnas.96.8.4295; Kusakabe T, 1997, J BIOL CHEM, V272, P12446, DOI 10.1074/jbc.272.19.12446; Kusakabe T, 1996, J BIOL CHEM, V271, P19563, DOI 10.1074/jbc.271.32.19563; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lao-Sirieix SH, 2005, NAT STRUCT MOL BIOL, V12, P1137, DOI 10.1038/nsmb1013; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larson MA, 2008, NUCLEIC ACIDS RES, V36, P5260, DOI 10.1093/nar/gkn461; Larson MA, 2010, NUCLEIC ACIDS RES, V38, P7167, DOI 10.1093/nar/gkq588; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Lee SJ, 2010, NUCLEIC ACIDS RES, V38, P4372, DOI 10.1093/nar/gkq205; Lee SJ, 2005, J BIOL CHEM, V280, P26984, DOI 10.1074/jbc.M504817200; Lee SJ, 2001, J BIOL CHEM, V276, P49419, DOI 10.1074/jbc.M108443200; Lee SJ, 2002, P NATL ACAD SCI USA, V99, P12703, DOI 10.1073/pnas.202471499; MENDELMAN LV, 1994, EMBO J, V13, P3909, DOI 10.1002/j.1460-2075.1994.tb06702.x; MENDELMAN LV, 1991, J BIOL CHEM, V266, P23240; Pan H, 2000, STRUCTURE, V8, P231, DOI 10.1016/S0969-2126(00)00101-5; Qimron U, 2006, EMBO J, V25, P2199, DOI 10.1038/sj.emboj.7601112; Rosenberg AH, 1996, J BIOL CHEM, V271, P26819, DOI 10.1074/jbc.271.43.26819; TABOR S, 1981, P NATL ACAD SCI-BIOL, V78, P205, DOI 10.1073/pnas.78.1.205; Thirlway J, 2006, J BACTERIOL, V188, P1534, DOI 10.1128/JB.188.4.1534-1539.2006; Zhu B, 2009, J BIOL CHEM, V284, P23842, DOI 10.1074/jbc.M109.026104	35	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39030	39040		10.1074/jbc.M112.414151	http://dx.doi.org/10.1074/jbc.M112.414151			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23024359	Green Published, hybrid			2022-12-28	WOS:000310982800059
J	Chanda, D; Kim, YH; Kim, DK; Lee, MW; Lee, SY; Park, TS; Koo, SH; Lee, CH; Choi, HS				Chanda, Dipanjan; Kim, Yong-Hoon; Kim, Don-Kyu; Lee, Min-Woo; Lee, Su-Yeon; Park, Tae-Sik; Koo, Seung-Hoi; Lee, Chul-Ho; Choi, Hueng-Sik			Activation of Cannabinoid Receptor Type 1 (Cb1r) Disrupts Hepatic Insulin Receptor Signaling via Cyclic AMP-response Element-binding Protein H (Crebh)-mediated Induction of Lipin1 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDIC-ACID PHOSPHATASE; BOUND TRANSCRIPTION FACTOR; FATTY LIVER; RESISTANCE; DIACYLGLYCEROL; METABOLISM; CREBH; ENDOCANNABINOIDS; GLUCONEOGENESIS; EXPRESSION	Activation of hepatic cannabinoid 1 receptor (Cb1r) signaling has been implicated in the development of phenotypes associated with fatty liver, hypertriglyceridemia, and insulin resistance. In the current study, we have elucidated the critical role of endoplasmic reticulum-bound transcription factor cyclic AMP-response element-binding protein H (Crebh) in mediating activated Cb1r signaling in inducing phosphatidic acid phosphatase Lipin1 gene expression and subsequently deregulating hepatic insulin receptor signaling. Cb1r agonist (2-arachidonoylglycerol (2-AG)) treatment induced Lipin1 gene expression in a Crebh-dependent manner via recruiting CREBH to the endogenous Lipin1 gene promoter. Adenoviral overexpression of Crebh or 2-AG treatment in mice induced Lipin1 gene expression to increase the hepatic diacylglycerol (DAG) level and phosphorylation of protein kinase C epsilon (PKC epsilon). This in turn inhibited hepatic insulin receptor signaling. Knockdown of Crebh or Cb1r antagonism attenuated 2-AG-mediated induction of Lipin1 gene expression and decreased DAG production in mouse liver and subsequently restored insulin receptor signaling. Similarly, knockdown of Lipin1 attenuated the 2-AG-induced increase in the DAG level and PKC epsilon phosphorylation. Finally, shRNA-mediated knockdown of Crebh partially but significantly blunted Lipin1 expression and the DAG level in db/db mice. These results demonstrate a novel mechanism by which Cb1r signaling induces Lipin1 gene expression and increases DAG production by activating Crebh, thereby deregulating insulin receptor signaling pathway and lipid homeostasis.	[Kim, Yong-Hoon; Lee, Chul-Ho] Univ Sci & Technol, Korea Res Inst Biosci & Biotechnol, Anim Model Ctr, Taejon 305806, South Korea; [Chanda, Dipanjan; Kim, Don-Kyu; Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Natl Creat Res Initiat,Ctr Nucl Receptor Signals, Kwangju 500757, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Med, Res Inst Med Sci, Dept Biomed Sci, Kwangju 501746, South Korea; [Lee, Min-Woo; Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea; [Lee, Min-Woo; Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Suwon 440746, South Korea; [Lee, Su-Yeon; Park, Tae-Sik] Gachon Univ, Dept Life Sci, Songnam 461701, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chonnam National University; Chonnam National University; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Gachon University	Lee, CH (corresponding author), Univ Sci & Technol, Korea Res Inst Biosci & Biotechnol, Anim Model Ctr, Taejon 305806, South Korea.	chullee@kribb.re.kr; hsc@chonnam.ac.kr	Koo, Seung-Hoi/E-2763-2015; Chanda, Dipanjan/AAU-3996-2021	Koo, Seung-Hoi/0000-0001-8769-2879; Chanda, Dipanjan/0000-0003-0685-187X	Korea Research Foundation; Ministry of Education, Science and Technology [2010-0019512]; National Creative Research Initiatives; Korean Ministry of Education, Science and Technology [20110018305]; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program of Korea	Korea Research Foundation(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Creative Research Initiatives; Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Research Institute of Bioscience and Biotechnology Research Initiative Program of Korea	This work was supported by the Future-based Technology Development Program (BIO Fields) through the Korea Research Foundation funded by the Ministry of Education, Science and Technology (Grant 2010-0019512) (to H.-S. C), a National Creative Research Initiatives grant funded by the Korean Ministry of Education, Science and Technology (Grant 20110018305) (to H.-S. C), and the Korea Research Institute of Bioscience and Biotechnology Research Initiative Program of Korea (to C.-H. L.).	Brindley DN, 2009, BBA-MOL CELL BIOL L, V1791, P956, DOI 10.1016/j.bbalip.2009.02.007; Brose N, 2004, CURR OPIN NEUROBIOL, V14, P328, DOI 10.1016/j.conb.2004.05.006; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Chanda D, 2011, J BIOL CHEM, V286, P27971, DOI 10.1074/jbc.M111.224352; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; Danno H, 2010, BIOCHEM BIOPH RES CO, V391, P1222, DOI 10.1016/j.bbrc.2009.12.046; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; HEYDRICK SJ, 1991, DIABETES, V40, P1707, DOI 10.2337/diabetes.40.12.1707; Ishimoto K, 2009, J BIOL CHEM, V284, P22195, DOI 10.1074/jbc.M109.028753; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Kaiser JP, 2009, ARCH BIOCHEM BIOPHYS, V482, P104, DOI 10.1016/j.abb.2008.11.004; Kim DK, 2011, J BIOL CHEM, V286, P38035, DOI 10.1074/jbc.M111.250613; Kunos G, 2009, TRENDS PHARMACOL SCI, V30, P1, DOI 10.1016/j.tips.2008.10.001; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Luebke-Wheeler J, 2008, HEPATOLOGY, V48, P1242, DOI 10.1002/hep.22439; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Monteleone P, 2005, NEUROPSYCHOPHARMACOL, V30, P1216, DOI 10.1038/sj.npp.1300695; Nogueiras R, 2008, DIABETES, V57, P2977, DOI 10.2337/db08-0161; Reue K, 2009, CURR OPIN LIPIDOL, V20, P165, DOI 10.1097/MOL.0b013e32832adee5; Ryu D, 2009, CELL METAB, V9, P240, DOI 10.1016/j.cmet.2009.01.007; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Waggoner DW, 1999, BBA-MOL CELL BIOL L, V1439, P299, DOI 10.1016/S1388-1981(99)00102-X; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	29	29	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.377978	http://dx.doi.org/10.1074/jbc.M112.377978			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22989885	Green Published, hybrid			2022-12-28	WOS:000310642200038
J	Li, JG; Chen, CG; Huang, P; Wang, YJ; Liu-Chen, LY				Li, Jian-Guo; Chen, Chongguang; Huang, Peng; Wang, Yujun; Liu-Chen, Lee-Yuan			14-3-3 zeta Protein Regulates Anterograde Transport of the Human kappa-Opioid Receptor (hKOPR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION-DEPENDENT INTERACTION; ENDOPLASMIC-RETICULUM LOCALIZATION; CELL-SURFACE EXPRESSION; MEMBRANE-PROTEINS; U50,488H-INDUCED INTERNALIZATION; GABA(B) RECEPTORS; DOWN-REGULATION; K+ CHANNELS; TRAFFICKING; INTERACTS	By proteomic analysis, we found that 14-3-3 zeta was one of the proteins co-immunoprecipitated with human kappa-opioid receptor (hKOPR) from extracts of solubilized Neuro2A cells stably expressing FLAG-hKOPR (N2A-FLAG-hKOPR cells). 14-3-3 proteins are a family of conserved regulatory molecules in eukaryotic cells, where they participate in signal transduction, metabolism, and membrane protein transport. 14-3-3 zeta co-localized with the hKOPR in N2A cells. The hKOPR C-tail interacted with 14-3-3 zeta in rat brain extracts and bound directly to purified 14-3-3 zeta as demonstrated by pulldown techniques. 14-3-3 zeta siRNA decreased expression of the hKOPR in N2A-FLAG-hKOPR cells and cultured primary cortical neurons of E19 rats by similar to 25% as determined by immunoblotting, ligand binding, and flow cytometry. The effect of 14-3-3 zeta siRNA was reversed by overexpression of 14-3-3 zeta. Expression of the 14-3-3 scavenger protein pGpLI-R18 also decreased hKOPR expression. 14-3-3 zeta siRNA did not change expressions of the hDOPR and rMOPR in N2A cells. Pulse-chase study showed that 14-3-3 zeta siRNA decreased the amount of mature hKOPR but did not change the rate of maturation or stability of hKOPR protein. Mutations of R354A/S358A in the putative 14-3-3 interaction motif (354)RQSTS(358) in the hKOPR C-tail reduced interaction of the hKOPR with 14-3-3 zeta and abolished the effect of 14-3-3 zeta knockdown on hKOPR expression. Mutation of the endoplasmic reticulum retention motif (RVR)-R-359 adjacent to the 14-3-3 interaction motif in the hKOPR C-tail decreased interaction of coatomer protein I (COPI) with the hKOPR and abolished 14-3-3 zeta-mediated regulation of hKOPR expression. 14-3-3 zeta knockdown increased association of COPI with the hKOPR. These results suggest that 14-3-3 zeta promotes expression of the hKOPR by inhibiting COPI and RVR motif-mediated endoplasmic reticulum localization machinery.	[Liu-Chen, Lee-Yuan] Temple Univ, Sch Med, Ctr Subst Abuse Res, Philadelphia, PA 19140 USA; [Liu-Chen, Lee-Yuan] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Liu-Chen, LY (corresponding author), Temple Univ, Sch Med, Ctr Subst Abuse Res, 3500 N Broad St,MERB 851, Philadelphia, PA 19140 USA.	lliuche@temple.edu			National Institutes of Health [R01 DA17302, P30 DA13429]; National Institutes of Heath [P30CA016520, ES013508]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA013429, R01DA017302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Heath(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DA17302 and P30 DA13429 (to L.-Y. L.-C.).; The mass spectrometry analysis was provided by Proteomics Core Facility, The University of Pennsylvania (fee for service) was supported by National Institutes of Heath Grants P30CA016520 (to Abramson Cancer Center) and ES013508 (to the Center of Excellence in Environmental Toxicology). We thank Kelly DiMattio for editing the manuscript.	Arulpragasam A, 2012, BIOCHEM J, V441, P995, DOI 10.1042/BJ20111277; Baxter HC, 2002, NEUROSCIENCE, V109, P5, DOI 10.1016/S0306-4522(01)00492-4; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Bernier V, 2004, CURR OPIN PHARMACOL, V4, P528, DOI 10.1016/j.coph.2004.08.001; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Brock C, 2005, MOL BIOL CELL, V16, P5572, DOI 10.1091/mbc.E05-05-0400; Carlezon WA, 2009, PHARMACOL THERAPEUT, V123, P334, DOI 10.1016/j.pharmthera.2009.05.008; Chen CG, 2006, J BIOL CHEM, V281, P7983, DOI 10.1074/jbc.M509805200; Chen Y, 2009, FRONT BIOSCI-LANDMRK, V14, P634, DOI 10.2741/3269; Cohen BD, 2004, MOL CELL ENDOCRINOL, V220, P1, DOI 10.1016/j.mce.2004.04.012; Couve A, 2001, MOL CELL NEUROSCI, V17, P317, DOI 10.1006/mcne.2000.0938; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; Dong CM, 2010, J BIOL CHEM, V285, P20369, DOI 10.1074/jbc.M109.081521; Duvernay MT, 2011, J BIOL CHEM, V286, P14080, DOI 10.1074/jbc.M111.222323; Godde NJ, 2006, J CELL SCI, V119, P3296, DOI 10.1242/jcs.03065; Heusser K, 2006, J CELL SCI, V119, P4353, DOI 10.1242/jcs.03196; Huang P, 2004, J BIOL CHEM, V279, P25002, DOI 10.1074/jbc.M313366200; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Janovick JA, 2002, J CLIN ENDOCR METAB, V87, P3255, DOI 10.1210/jc.87.7.3255; Li JG, 2003, J PHARMACOL EXP THER, V305, P531, DOI 10.1124/jpet.102.045559; Li JG, 2002, J BIOL CHEM, V277, P27545, DOI 10.1074/jbc.M200058200; Li JG, 1999, J BIOL CHEM, V274, P12087, DOI 10.1074/jbc.274.17.12087; Li JG, 2008, MOL PHARMACOL, V73, P1319, DOI 10.1124/mol.107.042846; Li JG, 2007, BIOCHEMISTRY-US, V46, P10960, DOI 10.1021/bi700443j; Liu-Chen LY, 2004, LIFE SCI, V75, P511, DOI 10.1016/j.lfs.2003.10.041; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Mrowiec T, 2006, BIOL CHEM, V387, P1227, DOI 10.1515/BC.2006.152; Nakamura T, 2010, J BIOL CHEM, V285, P16145, DOI 10.1074/jbc.M109.081315; Nakao K, 2009, DRUG TODAY, V45, P323, DOI [10.1358/dot.2009.45.5.1377595, 10.1358/dot.2009.45.5.1362067]; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Okamoto Y, 2011, J BIOL CHEM, V286, P7171, DOI 10.1074/jbc.M110.199695; Pagano A, 2001, J NEUROSCI, V21, P1189; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Prezeau L, 1999, J BIOL CHEM, V274, P13462, DOI 10.1074/jbc.274.19.13462; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Shikano S, 2005, NAT CELL BIOL, V7, P985, DOI 10.1038/ncb1297; Shikano S, 2003, P NATL ACAD SCI USA, V100, P5783, DOI 10.1073/pnas.1031748100; Shikano S, 2006, TRENDS CELL BIOL, V16, P370, DOI 10.1016/j.tcb.2006.05.006; Smith AJ, 2011, PHYSIOLOGY, V26, P181, DOI 10.1152/physiol.00042.2010; Tazawa H, 2003, BBA-GEN SUBJECTS, V1620, P32, DOI 10.1016/S0304-4165(02)00503-2; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Yan WL, 2006, BIOCHEM PHARMACOL, V71, P624, DOI 10.1016/j.bcp.2005.11.027; Yuan HB, 2003, CURR BIOL, V13, P638, DOI 10.1016/S0960-9822(03)00208-2; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang XP, 2011, J BIOL CHEM, V286, P20525, DOI 10.1074/jbc.M111.222034; Zuzarte M, 2009, J PHYSIOL-LONDON, V587, P929, DOI 10.1113/jphysiol.2008.164756	48	11	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.359679	http://dx.doi.org/10.1074/jbc.M112.359679			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22989890	Green Published, hybrid			2022-12-28	WOS:000310642200017
J	Abutbul-Ionita, I; Rujiviphat, J; Nir, I; McQuibban, GA; Danino, D				Abutbul-Ionita, Inbal; Rujiviphat, Jarungjit; Nir, Iftach; McQuibban, G. Angus; Danino, Dganit			Membrane Tethering and Nucleotide-dependent Conformational Changes Drive Mitochondrial Genome Maintenance (Mgm1) Protein-mediated Membrane Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; DYNAMIN; GTP; CONSTRICTION; TUBULATION; FISSION; ENDOCYTOSIS; HYDROLYSIS; MECHANISM; STALK	Cellular membrane remodeling events such as mitochondrial dynamics, vesicle budding, and cell division rely on the large GTPases of the dynamin superfamily. Dynamins have long been characterized as fission molecules; however, how they mediate membrane fusion is largely unknown. Here we have characterized by cryo-electron microscopy and in vitro liposome fusion assays how the mitochondrial dynamin Mgm1 may mediate membrane fusion. Using cryo-EM, we first demonstrate that the Mgm1 complex is able to tether opposing membranes to a gap of similar to 15 nm, the size of mitochondrial cristae folds. We further show that the Mgm1 oligomer undergoes a dramatic GTP-dependent conformational change suggesting that s-Mgm1 interactions could overcome repelling forces at fusion sites and that ultrastructural changes could promote the fusion of opposing membranes. Together our findings provide mechanistic details of the two known in vivo functions of Mgm1, membrane fusion and cristae maintenance, and more generally shed light onto how dynamins may function as fusion proteins.	[Rujiviphat, Jarungjit; McQuibban, G. Angus] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Abutbul-Ionita, Inbal; Nir, Iftach; Danino, Dganit] Technion Israel Inst Technol, Dept Biotechnol & Food Engn Technion, IL-32000 Haifa, Israel; [Danino, Dganit] Technion Israel Inst Technol, Russell Berrie Nanotechnol Inst, IL-32000 Haifa, Israel	University of Toronto; Technion Israel Institute of Technology; Technion Israel Institute of Technology	McQuibban, GA (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada.	angus.mcquibban@utoronto.ca; dganitd@tx.technion.ac.il	Danino, Dganit/D-6832-2016	Danino, Dganit/0000-0002-9782-4940; Ionita, Inbal/0000-0001-7359-0142	Canadian Institutes of Health Research; Israel Science Foundation; Charles H. Revson Foundation [530/03]; Russell Berrie Nanotechnology Institute at the Technion	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Israel Science Foundation(Israel Science Foundation); Charles H. Revson Foundation; Russell Berrie Nanotechnology Institute at the Technion	Supported by an Operating Grant from the Canadian Institutes of Health Research. To whom correspondence may be addressed. E-mail: angus.mcquibban@utoronto.ca.; Supported by the Israel Science Foundation, the Charles H. Revson Foundation (Grant 530/03), and the Russell Berrie Nanotechnology Institute at the Technion. To whom correspondence may be addressed. E-mail: dganitd@tx.technion.ac.il.	Avinoam O, 2011, SCIENCE, V332, P589, DOI 10.1126/science.1202333; Ban T, 2010, HUM MOL GENET, V19, P2113, DOI 10.1093/hmg/ddq088; Bueler SA, 2008, BIOCHEMISTRY-US, V47, P11804, DOI 10.1021/bi801665x; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Danino D, 2001, CURR OPIN CELL BIOL, V13, P454, DOI 10.1016/S0955-0674(00)00236-2; Danino D, 2001, COLLOID SURFACE A, V183, P113, DOI 10.1016/S0927-7757(01)00543-X; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020; He B, 2010, MOL BIOL CELL, V21, P610, DOI 10.1091/mbc.E09-05-0440; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Lenz M, 2009, FEBS LETT, V583, P3839, DOI 10.1016/j.febslet.2009.11.012; Low HH, 2009, CELL, V139, P1342, DOI 10.1016/j.cell.2009.11.003; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Marsden HR, 2011, CHEM SOC REV, V40, P1572, DOI 10.1039/c0cs00115e; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Meglei G, 2009, BIOCHEMISTRY-US, V48, P1774, DOI 10.1021/bi801723d; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Rujiviphat J, 2009, J BIOL CHEM, V284, P28682, DOI 10.1074/jbc.M109.044933; Sever S, 2000, TRAFFIC, V1, P385, DOI 10.1034/j.1600-0854.2000.010503.x; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; von der Malsburg A, 2011, J BIOL CHEM, V286, P37858, DOI 10.1074/jbc.M111.249037; Weidberg H, 2011, DEV CELL, V20, P444, DOI 10.1016/j.devcel.2011.02.006; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922; Zick M, 2009, FEBS LETT, V583, P2237, DOI 10.1016/j.febslet.2009.05.053	32	18	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36634	36638		10.1074/jbc.C112.406769	http://dx.doi.org/10.1074/jbc.C112.406769			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22977249	hybrid, Green Published			2022-12-28	WOS:000310588500001
J	Krypotou, E; Kosti, V; Amillis, S; Myrianthopoulos, V; Mikros, E; Diallinas, G				Krypotou, Emilia; Kosti, Vasiliki; Amillis, Sotiris; Myrianthopoulos, Vassilios; Mikros, Emmanuel; Diallinas, George			Modeling, Substrate Docking, and Mutational Analysis Identify Residues Essential for the Function and Specificity of a Eukaryotic Purine-Cytosine NCS1 Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATING ACCESS MECHANISM; ASPERGILLUS-NIDULANS; SACCHAROMYCES-CEREVISIAE; MOLECULAR CHARACTERIZATION; MEMBRANE-TRANSPORT; CRYSTAL-STRUCTURE; NAT FAMILY; PERMEASE; PROTEIN; GENE	The recent elucidation of crystal structures of a bacterial member of the NCS1 family, the Mhp1 benzyl-hydantoin permease from Microbacterium liquefaciens, allowed us to construct and validate a three-dimensional model of the Aspergillus nidulans purine-cytosine/H+ FcyB symporter. The model consists of 12 transmembrane alpha-helical, segments (TMSs) and cytoplasmic N- and C-tails. Adistinct core of 10 TMSs is made of two intertwined inverted repeats (TMS1-5 and TMS6-10) that are followed by two additional TMSs. TMS1, TMS3, TMS6, and TMS8 form an open cavity that is predicted to host the substrate binding site. Based on primary sequence alignment, three-dimensional topology, and substrate docking, we identified five residues as potentially essential for substrate binding in FcyB; Ser-85 (TMS1), Trp-159, Asn-163 (TMS3), Trp-259 (TMS6), and Asn-354 (TMS8). To validate the role of these and other putatively critical residues, we performed a systematic functional analysis of relevant mutants. We show that the proposed substrate binding residues, plus Asn-350, Asn-351, and Pro-353 are irreplaceable for FcyB function. Among these residues, Ser-85, Asn-163, Asn-350, Asn-351, and Asn-354 are critical for determining the substrate binding affinity and/or the specificity of FcyB. Our results suggest that Ser-85, Asn-163, and Asn-354 directly interact with substrates, Trp-159 and Trp-259 stabilize binding through pi-pi stacking interactions, and Pro-353 affects the local architecture of substrate binding site, whereas Asn-350 and Asn-351 probably affect substrate binding indirectly. Our work is the first systematic approach to address structure-function-specificity relationships in a eukaryotic member of NCS1 family by combining genetic and computational approaches.	[Krypotou, Emilia; Kosti, Vasiliki; Amillis, Sotiris; Diallinas, George] Univ Athens, Fac Biol, Athens 15784, Greece; [Myrianthopoulos, Vassilios; Mikros, Emmanuel] Univ Athens, Sch Pharm, GR-15771 Athens, Greece	National & Kapodistrian University of Athens; National & Kapodistrian University of Athens	Diallinas, G (corresponding author), Univ Athens, Fac Biol, Athens 15784, Greece.	diallina@biol.uoa.gr	Mikros, Emmanuel/E-4223-2017; Myrianthopoulos, Vassilios/AGN-8510-2022; Diallinas, George/AAE-8457-2019	Mikros, Emmanuel/0000-0002-5984-5169; Myrianthopoulos, Vassilios/0000-0001-8359-9634; Diallinas, George/0000-0002-3426-726X; Krypotou, Aimilia/0000-0003-3258-9983	John S. Latsis Public Benefit Foundation; European Union (European Social Fund); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework-Research Funding Program: THALIS and Heracleitus II, Investing in knowledge society through the European Social Fund	John S. Latsis Public Benefit Foundation; European Union (European Social Fund)(European Social Fund (ESF)); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework-Research Funding Program: THALIS and Heracleitus II, Investing in knowledge society through the European Social Fund	This work was supported in part by the John S. Latsis Public Benefit Foundation.; Co-financed by the European Union (European Social Fund) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework-Research Funding Program: THALIS and Heracleitus II, Investing in knowledge society through the European Social Fund.	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Adelman JL, 2011, BIOPHYS J, V101, P2399, DOI 10.1016/j.bpj.2011.09.061; Amillis S, 2004, MOL MICROBIOL, V52, P205, DOI 10.1046/j.1365-2958.2003.03956.x; Amillis S, 2011, J MOL BIOL, V411, P567, DOI 10.1016/j.jmb.2011.06.024; Barrett MP, 2006, ADV PARASIT, V63, P125, DOI 10.1016/S0065-308X(06)63002-9; Bowers K.J., 2006, P 2006 ACM IEEE C SU, P43, DOI DOI 10.1109/SC.2006.54; Cecchetto G, 2004, J BIOL CHEM, V279, P3132, DOI 10.1074/jbc.M308826200; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; de Koning H, 2000, MOL MEMBR BIOL, V17, P75; de Koning HP, 2005, FEMS MICROBIOL REV, V29, P987, DOI 10.1016/j.femsre.2005.03.004; DIALLINAS G, 1995, J BIOL CHEM, V270, P8610; Diallinas G, 2008, CHANNELS, V2, P363, DOI 10.4161/chan.2.5.6902; Edgerton-Morgan H, 2012, J CELL BIOL, V198, P785, DOI 10.1083/jcb.201203115; Erpapazoglou Z, 2006, FUNGAL GENET BIOL, V43, P222, DOI 10.1016/j.fgb.2005.11.006; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Ferreira T, 1999, EUR J BIOCHEM, V263, P57, DOI 10.1046/j.1432-1327.1999.00454.x; Ferreira T, 1997, J BIOL CHEM, V272, P9697; Ferreira T, 1999, EUR J BIOCHEM, V260, P22, DOI 10.1046/j.1432-1327.1999.00140.x; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; GORFINKIEL L, 1993, J BIOL CHEM, V268, P23376; Goudela S, 2006, MOL MEMBR BIOL, V23, P291, DOI 10.1080/09687860600685109; Gournas C, 2008, MOL BIOSYST, V4, P404, DOI 10.1039/b719777b; Gournas C, 2010, MOL MICROBIOL, V75, P246, DOI 10.1111/j.1365-2958.2009.06997.x; Hamari Z, 2009, MOL MICROBIOL, V73, P43, DOI 10.1111/j.1365-2958.2009.06738.x; Harada N, 2000, ACTA HAEMATOL-BASEL, V103, P144, DOI 10.1159/000041037; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kose M, 2009, FUTURE MED CHEM, V1, P303, DOI [10.4155/fmc.09.29, 10.4155/FMC.09.29]; Kosti V, 2010, J MOL BIOL, V397, P1132, DOI 10.1016/j.jmb.2010.02.037; Koukaki M, 2003, J MICROBIOL METH, V55, P687, DOI 10.1016/S0167-7012(03)00208-2; KRAUPP M, 1995, GEN PHARMACOL-VASC S, V26, P1185, DOI 10.1016/0306-3623(95)00005-L; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Mourad GS, 2006, J EXP BOT, V57, P3563, DOI 10.1093/jxb/erl107; Mourad GS, 2012, FEBS LETT, V586, P1370, DOI 10.1016/j.febslet.2012.03.058; Pantazopoulou A, 2007, FEMS MICROBIOL REV, V31, P657, DOI 10.1111/j.1574-6976.2007.00083.x; Papageorgiou L, 2008, J MOL BIOL, V382, P1121, DOI 10.1016/j.jmb.2008.08.005; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schultes NP, 1996, PLANT CELL, V8, P463, DOI 10.1105/tpc.8.3.463; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Suzuki S, 2006, J BACTERIOL, V188, P3329, DOI 10.1128/JB.188.9.3329-3336.2006; Vlanti A, 2006, J MOL BIOL, V357, P808, DOI 10.1016/j.jmb.2005.12.070; Vlanti A, 2008, MOL MICROBIOL, V68, P959, DOI 10.1111/j.1365-2958.2008.06198.x; WEBER E, 1990, MOL MICROBIOL, V4, P585, DOI 10.1111/j.1365-2958.1990.tb00627.x; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Weyand S, 2011, J SYNCHROTRON RADIAT, V18, P20, DOI 10.1107/S0909049510032449; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Zrenner R, 2006, ANNU REV PLANT BIOL, V57, P805, DOI 10.1146/annurev.arplant.57.032905.105421	57	28	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36792	36803		10.1074/jbc.M112.400382	http://dx.doi.org/10.1074/jbc.M112.400382			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22969088	hybrid, Green Published			2022-12-28	WOS:000310588500016
J	Kowlessur, D; Tobacman, LS				Kowlessur, Devanand; Tobacman, Larry S.			Significance of Troponin Dynamics for Ca2+-mediated Regulation of Contraction and Inherited Cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; RABBIT SKELETAL-MUSCLE; HUMAN CARDIAC TROPONIN; THIN-FILAMENT REGULATION; HYDROGEN-EXCHANGE; HYPERTROPHIC CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; ELECTRON-MICROSCOPY; ACTIN-TROPOMYOSIN; UNIT INTERACTIONS	Ca2+ dissociation from troponin causes cessation of muscle contraction by incompletely understood structural mechanisms. To investigate this process, regulatory site Ca2+ binding in the NH2-lobe of subunit troponin C (TnC) was abolished by mutagenesis, and effects on cardiac troponin dynamics were mapped by hydrogen-deuterium exchange (HDX)-MS. The findings demonstrate the interrelationships among troponin's detailed dynamics, troponin's regulatory actions, and the pathogenesis of cardiomyopathy linked to troponin mutations. Ca2+ slowed HDX up to 2 orders of magnitude within the NH2-lobe and the NH2-lobe-associated TnI switch helix, implying that Ca2+ greatly stabilizes this troponin regulatory region. HDX of the TnI COOH terminus indicated that its known role in regulation involves a partially folded rather than unfolded structure in the absence of Ca2+ and actin. Ca2+-triggered stabilization extended beyond the known direct regulatory regions: to the start of the nearby TnI helix 1 and to the COOH terminus of the TnT-TnI coiled-coil. Ca2+ destabilized rather than stabilized specific TnI segments within the coiled-coil and destabilized a region not previously implicated in Ca2+-mediated regulation: the coiled-coil's NH2-terminal base plus the preceding TnI loop with which the base interacts. Cardiomyopathy-linked mutations clustered almost entirely within influentially dynamic regions of troponin, and many sites were Ca2+-sensitive. Overall, the findings demonstrate highly selective effects of regulatory site Ca2+, including opposite changes in protein dynamics at opposite ends of the troponin core domain. Ca2+ release triggers an intramolecular switching mechanism that propagates extensively within the extended troponin structure, suggests specific movements of the TnI inhibitory regions, and prominently involves troponin's dynamic features.	[Kowlessur, Devanand; Tobacman, Larry S.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Tobacman, Larry S.] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Tobacman, LS (corresponding author), 1853 W Polk St,MC 784, Chicago, IL 60612 USA.	LST@uic.edu			National Institutes of Health [HL063774, UL1TR000050]; CBC/UIC Proteomics and Informatics Facility; Searle Funds at the Chicago Community Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CBC/UIC Proteomics and Informatics Facility; Searle Funds at the Chicago Community Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL063774 and UL1TR000050. This work was also supported by the CBC/UIC Proteomics and Informatics Facility, established by a grant from the Searle Funds at the Chicago Community Trust to the Chicago Biomedical Consortium.	Arrington CB, 2000, METHOD ENZYMOL, V323, P104; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Baryshnikova OK, 2008, BIOCHEMISTRY-US, V47, P10950, DOI 10.1021/bi801165c; Baryshnikova OK, 2008, J MOL BIOL, V375, P735, DOI 10.1016/j.jmb.2007.10.062; Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; Biesiadecki BJ, 2007, CIRC RES, V100, P1486, DOI 10.1161/01.RES.0000267744.92677.7f; Blumenschein TMA, 2006, BIOPHYS J, V90, P2436, DOI 10.1529/biophysj.105.076216; BRITO RMM, 1991, BIOCHEMISTRY-US, V30, P10236, DOI 10.1021/bi00106a023; Burkart EM, 2003, J BIOL CHEM, V278, P11265, DOI 10.1074/jbc.M210712200; Butters CA, 1997, J BIOL CHEM, V272, P13196, DOI 10.1074/jbc.272.20.13196; Cammarato A, 2004, BIOPHYS J, V86, P1618, DOI 10.1016/S0006-3495(04)74229-0; Carballo S, 2009, CIRC RES, V105, P375, DOI 10.1161/CIRCRESAHA.109.196055; EBASHI S, 1969, Quarterly Reviews of Biophysics, V2, P351; Engel PL, 2007, J BIOL CHEM, V282, P183, DOI 10.1074/jbc.M512337200; Englander SW, 2000, ANNU REV BIOPH BIOM, V29, P213, DOI 10.1146/annurev.biophys.29.1.213; Galinska A, 2010, CIRC RES, V106, P705, DOI 10.1161/CIRCRESAHA.109.210047; Galinska-Rakoczy A, 2008, J MOL BIOL, V379, P929, DOI 10.1016/j.jmb.2008.04.062; Gillis TE, 2007, J PHYSIOL-LONDON, V580, P561, DOI 10.1113/jphysiol.2007.128975; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Heeley DH, 2002, P NATL ACAD SCI USA, V99, P16731, DOI 10.1073/pnas.252236399; Hinkle A, 2003, J BIOL CHEM, V278, P506, DOI 10.1074/jbc.M209194200; Hoffman RMB, 2006, J MOL BIOL, V361, P625, DOI 10.1016/j.jmb.2006.06.031; Homsher E, 2000, J PHYSIOL-LONDON, V524, P233, DOI 10.1111/j.1469-7793.2000.00233.x; Howarth JW, 2007, J MOL BIOL, V373, P706, DOI 10.1016/j.jmb.2007.08.035; Huyghues-Despointes BMP, 1999, NAT STRUCT BIOL, V6, P910; Huynh Q, 1996, BIOPHYS J, V70, P1447, DOI 10.1016/S0006-3495(96)79704-7; Jin JP, 2001, BIOCHEMISTRY-US, V40, P2623, DOI 10.1021/bi002423j; KIM KS, 1993, BIOCHEMISTRY-US, V32, P9600, DOI 10.1021/bi00088a012; Kimura A, 1997, NAT GENET, V16, P379, DOI 10.1038/ng0897-379; Knowles AC, 2012, J MOL BIOL, V421, P125, DOI 10.1016/j.jmb.2012.05.005; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Kowlessur D, 2010, J BIOL CHEM, V285, P38978, DOI 10.1074/jbc.M110.181305; Kowlessur D, 2010, J BIOL CHEM, V285, P2686, DOI 10.1074/jbc.M109.062349; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038259; Manning EP, 2012, J BIOL CHEM, V287, P14515, DOI 10.1074/jbc.M111.257436; Manning EP, 2011, BIOCHEMISTRY-US, V50, P7405, DOI 10.1021/bi200506k; Matsumoto F, 2009, BIOCHEM BIOPH RES CO, V382, P205, DOI 10.1016/j.bbrc.2009.03.009; Maytum R, 1999, BIOCHEMISTRY-US, V38, P1102, DOI 10.1021/bi981603e; Mogensen J, 2004, J AM COLL CARDIOL, V44, P2315, DOI 10.1016/j.jacc.2004.05.088; Mogensen J, 2004, J AM COLL CARDIOL, V44, P2033, DOI 10.1016/j.jacc.2004.08.027; Moreno-Gonzalez A, 2007, J PHYSIOL-LONDON, V579, P313, DOI 10.1113/jphysiol.2006.124164; Morimoto S, 2002, P NATL ACAD SCI USA, V99, P913, DOI 10.1073/pnas.022628899; Morris CA, 2003, J PHYSIOL-LONDON, V550, P205, DOI 10.1113/jphysiol.2003.040899; Morris CA, 2001, J BIOL CHEM, V276, P20245, DOI 10.1074/jbc.M007371200; MOSS RL, 1986, J GEN PHYSIOL, V87, P761, DOI 10.1085/jgp.87.5.761; Murakami K, 2005, J MOL BIOL, V352, P178, DOI 10.1016/j.jmb.2005.06.067; NOLAND TA, 1995, J BIOL CHEM, V270, P25445, DOI 10.1074/jbc.270.43.25445; Ohtsuki I, 2008, BIOCHEM BIOPH RES CO, V369, P62, DOI 10.1016/j.bbrc.2007.11.187; Palm T, 2001, BIOPHYS J, V81, P2827, DOI 10.1016/S0006-3495(01)75924-3; Pirani A, 2006, J MOL BIOL, V357, P707, DOI 10.1016/j.jmb.2005.12.050; Poole KJV, 2006, J STRUCT BIOL, V155, P273, DOI 10.1016/j.jsb.2006.02.020; POTTER JD, 1974, BIOCHEMISTRY-US, V13, P2697, DOI 10.1021/bi00710a007; Preston LC, 2007, BIOCHEM BIOPH RES CO, V360, P27, DOI 10.1016/j.bbrc.2007.05.221; PUTKEY JA, 1989, J BIOL CHEM, V264, P12370; Pyle WG, 2002, AM J PHYSIOL-HEART C, V283, pH1215, DOI 10.1152/ajpheart.00128.2002; Ramos CHI, 1999, J BIOL CHEM, V274, P18189, DOI 10.1074/jbc.274.26.18189; Rarick HM, 1997, J BIOL CHEM, V272, P26887, DOI 10.1074/jbc.272.43.26887; Regnier M, 2002, J PHYSIOL-LONDON, V540, P485, DOI 10.1113/jphysiol.2001.013179; Robinson P, 2002, J BIOL CHEM, V277, P40710, DOI 10.1074/jbc.M203446200; Sadayappan S, 2008, FASEB J, V22, P1246, DOI 10.1096/fj.07-9458com; Seidman CE, 2011, CIRC RES, V108, P743, DOI 10.1161/CIRCRESAHA.110.223834; Smith DL, 1998, BIOCHEMISTRY-MOSCOW+, V63, P285; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; Takahashi-Yanaga F, 2001, J MOL CELL CARDIOL, V33, P2095, DOI 10.1006/jmcc.2001.1473; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tardiff JC, 2011, CIRC RES, V108, P765, DOI 10.1161/CIRCRESAHA.110.224170; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; Tripet B, 1997, J MOL BIOL, V271, P728, DOI 10.1006/jmbi.1997.1200; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; Westfall MV, 2003, J BIOL CHEM, V278, P33694, DOI 10.1074/jbc.M305404200; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5; Zhou ZQ, 2012, J BIOL CHEM, V287, P7661, DOI 10.1074/jbc.M111.281600	75	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42299	42311		10.1074/jbc.M112.423459	http://dx.doi.org/10.1074/jbc.M112.423459			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23066014	hybrid, Green Published			2022-12-28	WOS:000312103000065
J	Maddukuri, L; Ketkar, A; Eddy, S; Zafar, MK; Griffin, WC; Eoff, RL				Maddukuri, Leena; Ketkar, Amit; Eddy, Sarah; Zafar, Maroof K.; Griffin, Wezley C.; Eoff, Robert L.			Enhancement of Human DNA Polymerase eta Activity and Fidelity Is Dependent Upon a Bipartite Interaction with the Werner Syndrome Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION FORK PROGRESSION; THYMINE-THYMINE DIMER; CONFORMATIONAL-CHANGES; TRANSLESION SYNTHESIS; KINETIC-ANALYSIS; DAMAGE RESPONSE; BINDING; MECHANISM; HELICASE; PCNA	We have investigated the interaction between human DNA polymerase eta (hpol eta) and the Werner syndrome protein (WRN). Functional assays revealed that the WRN exonuclease and RecQ C-terminal (RQC) domains are necessary for full stimulation of hpol eta-catalyzed formation of correct base pairs. We find that WRN does not stimulate hpol eta-catalyzed formation of mispairs. Moreover, the exonuclease activity of WRN prevents stable mispair formation by hpol eta. These results are consistent with a proofreading activity for WRN during single-nucleotide additions. ATP hydrolysis by WRN appears to attenuate stimulation of hpol eta. Pre-steady-state kinetic results show that k(pol) is increased 4-fold by WRN. Finally, pulldown assays reveal a bipartite physical interaction between hpol eta and WRN that is mediated by the exonuclease and RQC domains. Taken together, these results are consistent with alteration of the rate-limiting step in polymerase catalysis by direct protein-protein interactions between WRN and hpol eta. In summary, WRN improves the efficiency and fidelity of hpol eta to promote more effective replication of DNA.	[Maddukuri, Leena; Ketkar, Amit; Eddy, Sarah; Zafar, Maroof K.; Griffin, Wezley C.; Eoff, Robert L.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Eoff, RL (corresponding author), Biomed Res Ctr 1, Rm B421E,4301 W Markham St, Little Rock, AR 72205 USA.	RLEOFF@UAMS.EDU	Ketkar, Amit/H-8022-2019	ketkar, amit/0000-0002-6536-7415	National Institutes of Health [R00 GM084460]; National Center for Research Resources [UL1RR029884]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM084460] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R00 GM084460 (to R. L. E.) and Award Number UL1RR029884 from the National Center for Research Resources (to C. Lowery).	Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Ammazzalorso F, 2010, EMBO J, V29, P3156, DOI 10.1038/emboj.2010.205; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Beckman JW, 2008, J BIOL CHEM, V283, P36711, DOI 10.1074/jbc.M806785200; Betous R, 2009, MOL CARCINOGEN, V48, P369, DOI 10.1002/mc.20509; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bienko M, 2010, MOL CELL, V37, P396, DOI 10.1016/j.molcel.2009.12.039; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Bohr VA, 2000, EXP GERONTOL, V35, P695, DOI 10.1016/S0531-5565(00)00145-5; Chang DJ, 2009, NAT CHEM BIOL, V5, P82, DOI 10.1038/nchembio.139; Chen YW, 2008, P NATL ACAD SCI USA, V105, P16578, DOI 10.1073/pnas.0808589105; Choi JY, 2005, J MOL BIOL, V352, P72, DOI 10.1016/j.jmb.2005.06.079; Choudhary S, 2004, J BIOL CHEM, V279, P34603, DOI 10.1074/jbc.M401901200; Compton SA, 2008, J BIOL CHEM, V283, P24478, DOI 10.1074/jbc.M803370200; Cui S, 2004, NUCLEIC ACIDS RES, V32, P2158, DOI 10.1093/nar/gkh540; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Eoff RL, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/830473; Eoff RL, 2009, J BIOL CHEM, V284, P21090, DOI 10.1074/jbc.M109.009506; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; Fygenson DK, 1997, J BIOL CHEM, V272, P27931, DOI 10.1074/jbc.272.44.27931; Garg P, 2005, P NATL ACAD SCI USA, V102, P18361, DOI 10.1073/pnas.0505949102; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Guo CX, 2009, CELL MOL LIFE SCI, V66, P2363, DOI 10.1007/s00018-009-0024-4; Haracska L, 2002, MOL CELL BIOL, V22, P784, DOI 10.1128/MCB.22.3.784-791.2002; Haracska L, 2001, MOL CELL, V8, P407, DOI 10.1016/S1097-2765(01)00319-7; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Kamath-Loeb AS, 2007, P NATL ACAD SCI USA, V104, P10394, DOI 10.1073/pnas.0702513104; Kamath-Loeb AS, 2012, J BIOL CHEM, V287, P12480, DOI 10.1074/jbc.M111.332577; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kim SH, 2008, MOL CELL, V32, P757, DOI 10.1016/j.molcel.2008.11.016; Langston LD, 2009, CELL CYCLE, V8, P2686, DOI 10.4161/cc.8.17.9390; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; Machwe A, 2011, BIOCHEMISTRY-US, V50, P6774, DOI 10.1021/bi2001054; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Murfuni I, 2013, ONCOGENE, V32, P610, DOI 10.1038/onc.2012.80; Muzzolini L, 2007, PLOS BIOL, V5, P157, DOI 10.1371/journal.pbio.0050020; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; Orren DK, 1999, NUCLEIC ACIDS RES, V27, P3557, DOI 10.1093/nar/27.17.3557; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Perry JJP, 2006, NAT STRUCT MOL BIOL, V13, P414, DOI 10.1038/nsmb1088; Phillips LG, 2010, DNA REPAIR, V9, P1064, DOI 10.1016/j.dnarep.2010.07.006; Rey L, 2009, MOL CELL BIOL, V29, P3344, DOI 10.1128/MCB.00115-09; Rucker R, 2010, PROTEINS, V78, P671, DOI 10.1002/prot.22596; Sarkies P, 2012, NUCLEIC ACIDS RES, V40, P1485, DOI 10.1093/nar/gkr868; Sarkies P, 2010, MOL CELL, V40, P703, DOI 10.1016/j.molcel.2010.11.009; Sidorova JM, 2008, CELL CYCLE, V7, P796, DOI 10.4161/cc.7.6.5566; Silverstein TD, 2010, NATURE, V465, P1039, DOI 10.1038/nature09104; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Ummat A, 2012, J MOL BIOL, V415, P627, DOI 10.1016/j.jmb.2011.11.038; van der Kemp PA, 2009, NUCLEIC ACIDS RES, V37, P2549, DOI 10.1093/nar/gkp105; Vindigni A, 2009, HFSP J, V3, P153, DOI 10.2976/1.3079540; von Kobbe C, 2002, J BIOL CHEM, V277, P22035, DOI 10.1074/jbc.M200914200; Washington MT, 2003, MOL CELL BIOL, V23, P8316, DOI 10.1128/MCB.23.22.8316-8322.2003; Washington MT, 2000, P NATL ACAD SCI USA, V97, P3094, DOI 10.1073/pnas.050491997; Xing GX, 2009, MOL MICROBIOL, V71, P678, DOI 10.1111/j.1365-2958.2008.06553.x; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Yuasa MS, 2006, GENES CELLS, V11, P731, DOI 10.1111/j.1365-2443.2006.00974.x	60	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42312	42323		10.1074/jbc.M112.410332	http://dx.doi.org/10.1074/jbc.M112.410332			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23045531	hybrid, Green Published			2022-12-28	WOS:000312103000066
J	Neumayer, G; Helfricht, A; Shim, SY; Le, HT; Lundin, C; Belzil, C; Chansard, M; Yu, YP; Lees-Miller, SP; Gruss, OJ; van Attikum, H; Helleday, T; Nguyen, MD				Neumayer, Gernot; Helfricht, Angela; Shim, Su Yeon; Hoa Thi Le; Lundin, Cecilia; Belzil, Camille; Chansard, Mathieu; Yu, Yaping; Lees-Miller, Susan P.; Gruss, Oliver J.; van Attikum, Haico; Helleday, Thomas; Minh Dang Nguyen			Targeting Protein for Xenopus Kinesin-like Protein 2 (TPX2) Regulates gamma-Histone 2AX (gamma-H2AX) Levels upon Ionizing Radiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE CHECKPOINT; DOUBLE-STRAND BREAKS; DEPHOSPHORYLATES GAMMA-H2AX; CELL-CYCLE; THERAPEUTIC TARGET; CYTOPLASMIC DYNEIN; CATALYTIC SUBUNIT; IMPORTIN-ALPHA; KEY REGULATOR; CNS NEURONS	The microtubule-associated protein targeting protein for Xenopus kinesin-like protein 2 (TPX2) plays a key role in spindle assembly and is required for mitosis in human cells. In interphase, TPX2 is actively imported into the nucleus to prevent its premature activity in microtubule organization. To date, no function has been assigned to nuclear TPX2. We now report that TPX2 plays a role in the cellular response to DNA double strand breaks induced by ionizing radiation. Loss of TPX2 leads to inordinately strong and transient accumulation of ionizing radiation-dependent Ser-139-phosphorylated Histone 2AX (gamma-H2AX) at G(0) and G(1) phases of the cell cycle. This is accompanied by the formation of increased numbers of high intensity gamma-H2AX ionizing radiation-induced foci. Conversely, cells overexpressing TPX2 have reduced levels of gamma-H2AX after ionizing radiation. Consistent with a role for TPX2 in the DNA damage response, we found that the protein accumulates at DNA double strand breaks and associates with the mediator of DNA damage checkpoint 1 (MDC1) and the ataxia telangiectasia mutated (ATM) kinase, both key regulators of gamma-H2AX amplification. Pharmacologic inhibition or depletion of ATM or MDC1, but not of DNA-dependent protein kinase (DNA-PK), antagonizes the gamma-H2AX phenotype caused by TPX2 depletion. Importantly, the regulation of gamma-H2AX signals by TPX2 is not associated with apoptosis or the mitotic functions of TPX2. In sum, our study identifies a novel and the first nuclear function for TPX2 in the cellular responses to DNA damage.	[Neumayer, Gernot; Shim, Su Yeon; Hoa Thi Le; Belzil, Camille; Chansard, Mathieu; Minh Dang Nguyen] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada; [Neumayer, Gernot; Shim, Su Yeon; Hoa Thi Le; Belzil, Camille; Chansard, Mathieu; Minh Dang Nguyen] Univ Calgary, Hotchkiss Brain Inst, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; [Neumayer, Gernot; Shim, Su Yeon; Yu, Yaping; Lees-Miller, Susan P.; Minh Dang Nguyen] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Lundin, Cecilia; Helleday, Thomas] Karolinska Inst, Div Translat Med & Chem Biol, Dept Med Biochem & Biophys, Sci Life Lab, S-17121 Stockholm, Sweden; [Helfricht, Angela; van Attikum, Haico] Leiden Univ, Dept Toxicogenet, Med Ctr, NL-2333 ZC Leiden, Netherlands; [Gruss, Oliver J.] Univ Heidelberg ZMBH Alliance, ZMBH, Zentrum Mol Biol, Deutsch Krebsforschungszentrum DKFZ, D-69120 Heidelberg, Germany	University of Calgary; University of Calgary; University of Calgary; Karolinska Institutet; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Nguyen, MD (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	mdnguyen@ucalgary.ca	Helleday, Thomas/D-5224-2013; van Attikum, Haico/A-4596-2010	Helleday, Thomas/0000-0002-7384-092X; Lees-Miller, Susan/0000-0001-5809-2516; Van Attikum, Haico/0000-0001-8590-0240	Canadian Institute of Health Research (CIHR); Alberta Innovates - Health Solutions (AI-HS) cancer grant; Medical Research Council; Austrian Academy of Sciences; University of Calgary; Alberta Cancer Foundation; Netherlands Organisation for Scientific Research (VIDI grant); Human Frontier Science Program Organization (HFSPO) (HFSP Career Development Award grant); Leiden University Medical Center; Leids Universiteits Fonds/Gratama stichting	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates - Health Solutions (AI-HS) cancer grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Austrian Academy of Sciences; University of Calgary; Alberta Cancer Foundation; Netherlands Organisation for Scientific Research (VIDI grant); Human Frontier Science Program Organization (HFSPO) (HFSP Career Development Award grant); Leiden University Medical Center; Leids Universiteits Fonds/Gratama stichting	This work was supported in part by a Canadian Institute of Health Research (CIHR) operating grant, an Alberta Innovates - Health Solutions (AI-HS) cancer grant (to M. D. N.), and the Medical Research Council (to T. H.).; Recipient of a DOC-fellowship from the Austrian Academy of Sciences, an Achievers in Medical Sciences award from the University of Calgary, and a scholarship from the Alberta Cancer Foundation.; Recipient of grants from the Netherlands Organisation for Scientific Research (VIDI grant), Human Frontier Science Program Organization (HFSPO) (HFSP Career Development Award grant), the Leiden University Medical Center, and the Leids Universiteits Fonds/Gratama stichting.	Aguirre-Portoles C, 2012, CANCER RES, V72, P1518, DOI 10.1158/0008-5472.CAN-11-1971; Arbour N, 2008, J NEUROSCI, V28, P6068, DOI 10.1523/JNEUROSCI.4940-07.2008; Asteriti IA, 2010, BBA-REV CANCER, V1806, P230, DOI 10.1016/j.bbcan.2010.08.001; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Berger SM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq616; Boleti H, 1996, CELL, V84, P49, DOI 10.1016/S0092-8674(00)80992-7; Brooks PJ, 2002, MUTAT RES-FUND MOL M, V509, P93, DOI 10.1016/S0027-5107(02)00222-1; Cha H, 2010, CANCER RES, V70, P4112, DOI 10.1158/0008-5472.CAN-09-4244; Chang HP, 2012, ONCOL REP, V27, P1353, DOI 10.3892/or.2012.1668; Chowdhury D, 2008, MOL CELL, V31, P33, DOI 10.1016/j.molcel.2008.05.016; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; Douglas P, 2010, MOL CELL BIOL, V30, P1368, DOI 10.1128/MCB.00741-09; Durocher D, 2000, COLD SPRING HARB SYM, V65, P423, DOI 10.1101/sqb.2000.65.423; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Garrett S, 2002, CURR BIOL, V12, P2055, DOI 10.1016/S0960-9822(02)01277-0; Gietz R D, 2002, Methods Mol Biol, V185, P471; Gietz RD, 2007, NAT PROTOC, V2, P38, DOI 10.1038/nprot.2007.15; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Guo J, 2006, MOL BIOL CELL, V17, P680, DOI 10.1091/mbc.E05-04-0360; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Heidebrecht HJ, 1997, BLOOD, V90, P226; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Kagawa S, 2001, CLIN CANCER RES, V7, P1474; Kahana JA, 2001, SCIENCE, V291, P1718, DOI 10.1126/science.1059765; Karsenti E, 2005, MOL CELL, V19, P431, DOI 10.1016/j.molcel.2005.08.002; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Khanna KK, 2001, CELL DEATH DIFFER, V8, P1052, DOI 10.1038/sj.cdd.4400874; Kim JE, 2006, MOL CARCINOGEN, V45, P403, DOI 10.1002/mc.20221; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li B, 2010, BRAIN RES, V1352, P200, DOI 10.1016/j.brainres.2010.06.060; Liang Y, 2007, MOL BIOL CELL, V18, P2656, DOI 10.1091/mbc.E06-04-0345; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; MacPhail SH, 2003, RADIAT RES, V159, P759, DOI 10.1667/RR3003; Macurek L, 2010, ONCOGENE, V29, P2281, DOI 10.1038/onc.2009.501; Manda R, 1999, GENOMICS, V61, P5, DOI 10.1006/geno.1999.5939; Massip L, 2010, CELL CYCLE, V9, P2963, DOI 10.4161/cc.9.15.12412; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Maxwell CA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001199; McManus KJ, 2005, MOL BIOL CELL, V16, P5013, DOI 10.1091/mbc.E05-01-0065; Moon SH, 2010, J BIOL CHEM, V285, P12935, DOI 10.1074/jbc.M109.071696; Mori D, 2009, NAT CELL BIOL, V11, P1057, DOI 10.1038/ncb1919; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Nguyen MD, 2004, NAT CELL BIOL, V6, P595, DOI 10.1038/ncb1139; Peng YL, 2005, CANCER RES, V65, P1670, DOI 10.1158/0008-5472.CAN-04-3451; Pramparo T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001331; Ramakrishna M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009983; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Satow R, 2010, CLIN CANCER RES, V16, P2518, DOI 10.1158/1078-0432.CCR-09-2214; Schatz CA, 2003, EMBO J, V22, P2060, DOI 10.1093/emboj/cdg195; Shim SY, 2008, J BIOL CHEM, V283, P12232, DOI 10.1074/jbc.M710200200; Shim SY, 2008, J NEUROSCI, V28, P3604, DOI 10.1523/JNEUROSCI.5278-07.2008; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Sii-Felice K, 2008, CELL CYCLE, V7, P1911, DOI 10.4161/cc.7.13.6235; Sillars-Hardebol AH, 2012, GUT, V61, P1568, DOI 10.1136/gutjnl-2011-301153; Slee EA, 1996, BIOCHEM J, V315, P21, DOI 10.1042/bj3150021; Smeenk G, 2010, J CELL BIOL, V190, P741, DOI 10.1083/jcb.201001048; Stewart GS, 2009, CELL CYCLE, V8, P1532, DOI 10.4161/cc.8.10.8351; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stuck M, 2004, DNA REPAIR, V3, P953, DOI 10.1016/j.dnarep.2004.03.007; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Townsend K, 2009, J BIOL CHEM, V284, P33939, DOI 10.1074/jbc.M109.009191; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Vanneste D, 2009, CURR BIOL, V19, P1712, DOI 10.1016/j.cub.2009.09.019; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Warner SL, 2009, CLIN CANCER RES, V15, P6519, DOI 10.1158/1078-0432.CCR-09-0077; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371	84	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42206	42222		10.1074/jbc.M112.385674	http://dx.doi.org/10.1074/jbc.M112.385674			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23045526	Green Published, hybrid			2022-12-28	WOS:000312103000057
J	Streb, S; Eicke, S; Zeeman, SC				Streb, Sebastian; Eicke, Simona; Zeeman, Samuel C.			The Simultaneous Abolition of Three Starch Hydrolases Blocks Transient Starch Breakdown in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WATER DIKINASE; DEBRANCHING ENZYMES; TRANSITORY STARCH; CIRCADIAN CONTROL; ALPHA-AMYLASE; BETA-AMYLASES; R1 PROTEIN; DEGRADATION; METABOLISM; ISOAMYLASE	In this study, we investigated which enzymes are involved in debranching amylopectin during transient starch degradation. Previous studies identified two debranching enzymes, isoamylase 3 (ISA3) and limit dextrinase (LDA), involved in this process. However, plants lacking both enzymes still degrade substantial amounts of starch. Thus, other enzymes/mechanisms must contribute to starch breakdown. We show that the chloroplastic alpha-amylase 3 (AMY3) also participates in starch degradation and provide evidence that all three enzymes can act directly at the starch granule surface. The isa3 mutant has a starch excess phenotype, reflecting impaired starch breakdown. In contrast, removal of AMY3, LDA, or both enzymes together has no impact on starch degradation. However, removal of AMY3 or LDA in addition to ISA3 enhances the starch excess phenotype. In plants lacking all three enzymes, starch breakdown is effectively blocked, and starch accumulates to the highest levels observed so far. This provides indirect evidence that the hetero-multimeric debranching enzyme ISA1-ISA2 is not involved in starch breakdown. However, we illustrate that ISA1-ISA2 can hydrolyze small soluble branched glucans that accumulate when ISA3 and LDA are missing, albeit at a slow rate. Starch accumulation in the mutants correlates inversely with plant growth.	[Streb, Sebastian; Eicke, Simona; Zeeman, Samuel C.] ETH, Inst Agr Sci, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Streb, S (corresponding author), ETH, Inst Agr Sci, Univ Str 2, CH-8092 Zurich, Switzerland.	sstreb@ethz.ch		Zeeman, Samuel/0000-0002-2791-0915; Streb, Sebastian/0000-0002-9095-6596	Swiss National Science Foundation [31002AB_131074]; ETH Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich)	This work was supported by Swiss National Science Foundation Grant 31002AB_131074 (to S.Z.) and by ETH Zurich.	Asatsuma S, 2005, PLANT CELL PHYSIOL, V46, P858, DOI 10.1093/pcp/pci091; Baunsgaard L, 2005, PLANT J, V41, P595, DOI 10.1111/j.1365-313X.2004.02322.x; Blennow A, 2010, TRENDS PLANT SCI, V15, P236, DOI 10.1016/j.tplants.2010.01.009; Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3; Delatte T, 2006, J BIOL CHEM, V281, P12050, DOI 10.1074/jbc.M513661200; Delatte T, 2005, PLANT J, V41, P815, DOI 10.1111/j.1365-313X.2005.02348.x; Dinges JR, 2003, PLANT CELL, V15, P666, DOI 10.1105/tpc.007575; Edner C, 2007, PLANT PHYSIOL, V145, P17, DOI 10.1104/pp.107.104224; Egli B, 2010, PLANT PHYSIOL, V154, P1659, DOI 10.1104/pp.110.165027; FINCHER GB, 1989, ANNU REV PLANT PHYS, V40, P305, DOI 10.1146/annurev.pp.40.060189.001513; Fulton DC, 2008, PLANT CELL, V20, P1040, DOI 10.1105/tpc.107.056507; GIDLEY MJ, 1987, CARBOHYD RES, V161, P291, DOI 10.1016/S0008-6215(00)90086-7; Glaring MA, 2011, FEBS J, V278, P1175, DOI 10.1111/j.1742-4658.2011.08043.x; Graf A, 2010, P NATL ACAD SCI USA, V107, P9458, DOI 10.1073/pnas.0914299107; Hussain H, 2003, PLANT CELL, V15, P133, DOI 10.1105/tpc.006635; Kotting O, 2009, PLANT CELL, V21, P334, DOI 10.1105/tpc.108.064360; Kotting O, 2005, PLANT PHYSIOL, V137, P242, DOI 10.1104/pp.104.055954; Lorberth R, 1998, NAT BIOTECHNOL, V16, P473, DOI 10.1038/nbt0598-473; Lu Y, 2005, PLANT PHYSIOL, V138, P2280, DOI 10.1104/pp.105.061903; Machovic M, 2006, FEBS LETT, V580, P6349, DOI 10.1016/j.febslet.2006.10.041; Myers AM, 2000, PLANT PHYSIOL, V122, P989, DOI 10.1104/pp.122.4.989; Rasse DP, 2006, NEW PHYTOL, V172, P500, DOI 10.1111/j.1469-8137.2006.01848.x; Ritte G, 2002, P NATL ACAD SCI USA, V99, P7166, DOI 10.1073/pnas.062053099; Santelia D, 2011, PLANT CELL, V23, P4096, DOI 10.1105/tpc.111.092155; Smith AM, 2006, NAT PROTOC, V1, P1342, DOI 10.1038/nprot.2006.232; Stettler M, 2009, MOL PLANT, V2, P1233, DOI 10.1093/mp/ssp093; Stitt M, 2012, CURR OPIN PLANT BIOL, V15, P282, DOI 10.1016/j.pbi.2012.03.016; Streb S, 2008, PLANT CELL, V20, P3448, DOI 10.1105/tpc.108.063487; Takashima Y, 2007, BIOSCI BIOTECH BIOCH, V71, P2308, DOI 10.1271/bbb.70215; Vester-Christensen MB, 2010, J MOL BIOL, V403, P739, DOI 10.1016/j.jmb.2010.09.031; Wattebled F, 2005, PLANT PHYSIOL, V138, P184, DOI 10.1104/pp.105.059295; Wattebled F, 2008, PLANT PHYSIOL, V148, P1309, DOI 10.1104/pp.108.129379; Weise SE, 2006, PLANT PHYSIOL, V141, P879, DOI 10.1104/pp.106.081174; Wu CY, 2002, ARCH BIOCHEM BIOPHYS, V406, P21, DOI 10.1016/S0003-9861(02)00412-5; Yazdanbakhsh N, 2011, PLANT CELL ENVIRON, V34, P877, DOI 10.1111/j.1365-3040.2011.02286.x; Yu TS, 2005, J BIOL CHEM, V280, P9773, DOI 10.1074/jbc.M413638200; Yu TS, 2001, PLANT CELL, V13, P1907, DOI 10.1105/tpc.13.8.1907; Yun MS, 2011, PLANT CELL PHYSIOL, V52, P1068, DOI 10.1093/pcp/pcr058; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301; Zeeman SC, 1998, PLANT CELL, V10, P1699, DOI 10.1105/tpc.10.10.1699	40	43	45	0	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41745	41756		10.1074/jbc.M112.395244	http://dx.doi.org/10.1074/jbc.M112.395244			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23019330	Green Published, hybrid			2022-12-28	WOS:000312103000017
J	Zhang, YS; Eades, G; Yao, Y; Li, QL; Zhou, Q				Zhang, Yongshu; Eades, Gabriel; Yao, Yuan; Li, Qinglin; Zhou, Qun			Estrogen Receptor alpha Signaling Regulates Breast Tumor-initiating Cells by Down-regulating miR-140 Which Targets the Transcription Factor SOX2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER STEM-CELLS; IN-VITRO PROPAGATION; SELF-RENEWAL; MICRORNA EXPRESSION; CARCINOMA; CARCINOGENESIS; CHONDROCYTES; METASTASIS; RESISTANCE; SIGNATURES	Several reports have indicated that miR-140, a possible tumor suppressor microRNA (miR), is down-regulated in breast tumors compared with normal breast tissues. However, the role of miR-140 in breast tumorigenesis is unclear. We initiated studies that examined estrogen receptor alpha (ER alpha) signaling in the tissue-specific regulation of miR-140 in breast cancer. We found that estrogen stimulation of ER alpha-positive breast cancer cells resulted in decreased miR-140 expression. We performed promoter analyses and examined predicted ER alpha binding elements in the miR-140 promoter using luciferase constructs of a miR-140 promoter deletion series. Our studies revealed that ER alpha binds to one specific estrogen response element flanking the miR-140 promoter and consequently suppresses miR-140 transcription. We found that the stem cell self-renewal regulator SOX2 is a novel target of miR-140, and that this miR-140/SOX2 pathway critically regulates breast tumor-initiating cell survival, providing a new link between ER alpha signaling and breast cancer stem cell maintenance.	[Zhang, Yongshu; Eades, Gabriel; Yao, Yuan; Li, Qinglin; Zhou, Qun] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Zhou, Q (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	qzhou@som.umaryland.edu	Li, Qinglin/K-2570-2015	Li, Qinglin/0000-0002-4125-1944	NCI, National Institutes of Health; Maryland Stem Cell Fund; NIH [CA163820]; FAMRI; American Cancer Society; NATIONAL CANCER INSTITUTE [T32CA154274, R01CA163820, P30CA134274] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Maryland Stem Cell Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAMRI; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health, T32 Training Support (to G. E.) and by grants from the Maryland Stem Cell Fund, FAMRI, American Cancer Society, and the NIH (CA163820) (to Q. Z.).	Abukhdeir AM, 2006, BREAST CANCER RES TR, V99, P23, DOI 10.1007/s10549-006-9177-0; Adams BD, 2009, MOL ENDOCRINOL, V23, P1215, DOI 10.1210/me.2009-0062; Al-Ejeh F, 2011, CARCINOGENESIS, V32, P650, DOI 10.1093/carcin/bgr028; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bhat-Nakshatri P, 2009, NUCLEIC ACIDS RES, V37, P4850, DOI 10.1093/nar/gkp500; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Di Leva G, 2010, JNCI-J NATL CANCER I, V102, P706, DOI 10.1093/jnci/djq102; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Jones KL, 2004, ENDOCR-RELAT CANCER, V11, P391, DOI 10.1677/erc.1.00594; Jung JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028068; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Lengerke C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-42; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liu SL, 2005, BREAST CANCER RES, V7, P86, DOI 10.1186/bcr1021; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Miyaki S, 2010, GENE DEV, V24, P1173, DOI 10.1101/gad.1915510; Miyaki S, 2009, ARTHRITIS RHEUM-US, V60, P2723, DOI 10.1002/art.24745; Nicolas FE, 2011, RNA BIOL, V8, P607, DOI 10.4161/rna.8.4.15390; O'Brien CA, 2010, CLIN CANCER RES, V16, P3113, DOI 10.1158/1078-0432.CCR-09-2824; Pais H, 2010, RNA, V16, P489, DOI 10.1261/rna.1701210; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Sand M, 2012, BRIT J DERMATOL, V167, P847, DOI 10.1111/j.1365-2133.2012.11022.x; Song B, 2009, ONCOGENE, V28, P4065, DOI 10.1038/onc.2009.274; Stingl John, 2011, Hormones & Cancer, V2, P85, DOI 10.1007/s12672-010-0055-1; Tan XG, 2011, CLIN CANCER RES, V17, P6802, DOI 10.1158/1078-0432.CCR-11-0419; Tardif G, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-148; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Xiang R, 2011, BRIT J CANCER, V104, P1410, DOI 10.1038/bjc.2011.94; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yamagata K, 2009, MOL CELL, V36, P340, DOI 10.1016/j.molcel.2009.08.017; Yamashita S, 2012, J BIOL CHEM, V287, P22206, DOI 10.1074/jbc.M112.343194; Yang J, 2011, FEBS LETT, V585, P2992, DOI 10.1016/j.febslet.2011.08.013; Yao Y, 2010, CARCINOGENESIS, V31, P382, DOI 10.1093/carcin/bgp308	41	88	97	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41514	41522		10.1074/jbc.M112.404871	http://dx.doi.org/10.1074/jbc.M112.404871			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23060440	Green Published, hybrid			2022-12-28	WOS:000311887600061
J	Aikawa, Y; Hirakawa, H; Lee, S				Aikawa, Yoshikatsu; Hirakawa, Hideki; Lee, Sangho			Spatiotemporal Regulation of the Ubiquitinated Cargo-binding Activity of Rabex-5 in the Endocytic Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE FACTOR RABEX-5; STRUCTURAL BASIS; MEMBRANE-FUSION; RAB5; PROTEINS; DOMAINS; VPS9; TRAFFICKING; RECOGNITION; ACTIVATION	Ubiquitin (Ub)-dependent endocytosis of membrane proteins requires precise molecular recognition of ubiquitinated cargo by Ub-binding proteins (UBPs). Many UBPs are often themselves monoubiquitinated, a mechanism referred to as coupled monoubiquitination, which prevents them from binding in trans to the ubiquitinated cargo. However, the spatiotemporal regulatory mechanism underlying the interaction of UBPs with the ubiquitinated cargo, via their Ub-binding domains (UBDs) remains unclear. Previously, we reported the interaction of Rabex-5, a UBP and guanine nucleotide exchange factor (GEF) for Rab5, with ubiquitinated neural cell adhesion molecule L1, via its motif interacting with Ub (MIU) domain. This interaction is critical for the internalization and sorting of the ubiquitinated L1 into endosomal/lysosomal compartments. The present study demonstrated that the interaction of Rabex-5 with Rab5 depends specifically on interaction of the MIU domain with the ubiquitinated L1 to drive its internalization. Notably, impaired GEF mutants and the Rabex-5(E213A) mutant increased the flexibility of the hinge region in the HB-VPS9 tandem domain, which significantly affected their interactions with the ubiquitinated L1. In addition, GEF mutants increased the catalytic efficiency, which resulted in a reduced interaction with the ubiquitinated L1. Furthermore, the coupled monoubiquitination status of Rabex-5 was found to be significantly associated with interaction of Rabex-5 and the ubiquitinated L1. Collectively, our study reveals a novel mechanism, wherein the GEF activity of Rabex-5 acts as an intramolecular switch orchestrating ubiquitinated cargo-binding activity and coupled monoubiquitination to permit the spatiotemporal dynamic exchange of the ubiquitinated cargos.	[Aikawa, Yoshikatsu] Doshisha Univ, Grad Sch Brain Sci, Lab Neural Membrane Biol, Kyoto 6100394, Japan; [Hirakawa, Hideki] Kazusa DNA Res Inst, Kisarazu, Chiba 2920818, Japan; [Lee, Sangho] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea	Doshisha University; Kazusa DNA Research Institute; Sungkyunkwan University (SKKU)	Aikawa, Y (corresponding author), Doshisha Univ, Grad Sch Brain Sci, Lab Neural Membrane Biol, 1-3 Miyakodani, Kyoto 6100394, Japan.	yaikawa@mail.doshisha.ac.jp	Lee, Sangho/P-4204-2018	Lee, Sangho/0000-0003-3886-4579	Japan Society for the Promotion of Science [20790085]; Uehara Memorial Foundation; Doshisha University; Ministry of Education, Science, and Technology [2011-0023402]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Doshisha University; Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a Grant-in-aid for Young Scientists (B) (20790085) from the Japan Society for the Promotion of Science, the Uehara Memorial Foundation, an individual research allowance from Doshisha University (to Y. A.), and a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2011-0023402) (to S. L.).	Aikawa Y, 2012, J BIOL CHEM, V287, P32312, DOI 10.1074/jbc.M112.374322; Ali BR, 2005, BIOCHEM SOC T, V33, P652, DOI 10.1042/BST0330652; Archer FR, 1999, EUR J NEUROSCI, V11, P3565, DOI 10.1046/j.1460-9568.1999.00773.x; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; Chen H, 2003, P NATL ACAD SCI USA, V100, P14908, DOI 10.1073/pnas.2136625100; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Delprato A, 2007, NAT STRUCT MOL BIOL, V14, P406, DOI 10.1038/nsmb1232; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Donaldson KM, 2003, CURR BIOL, V13, P258, DOI 10.1016/S0960-9822(03)00043-5; Esters H, 2001, J MOL BIOL, V310, P141, DOI 10.1006/jmbi.2001.4735; Faesen AC, 2011, MOL CELL, V44, P147, DOI 10.1016/j.molcel.2011.06.034; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Han LM, 1997, P NATL ACAD SCI USA, V94, P4954, DOI 10.1073/pnas.94.10.4954; Harper JW, 2006, CELL, V124, P1133, DOI 10.1016/j.cell.2006.03.009; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kalesnikoff J, 2007, BLOOD, V109, P5308, DOI 10.1182/blood-2007-01-067363; Keren-Kaplan T, 2012, EMBO J, V31, P378, DOI 10.1038/emboj.2011.397; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Lee S, 2006, NAT STRUCT MOL BIOL, V13, P264, DOI 10.1038/nsmb1064; LI GP, 1994, J BIOL CHEM, V269, P14631; Lippe R, 2001, MOL BIOL CELL, V12, P2219, DOI 10.1091/mbc.12.7.2219; Mattera R, 2006, J BIOL CHEM, V281, P6874, DOI 10.1074/jbc.M509939200; Mattera R, 2008, EMBO J, V27, P2484, DOI 10.1038/emboj.2008.177; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Raiborg C, 2006, TRENDS BIOCHEM SCI, V31, P541, DOI 10.1016/j.tibs.2006.07.009; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Traub LM, 2007, J CELL SCI, V120, P543, DOI 10.1242/jcs.03385; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; WILLIAMS EJ, 1992, J CELL BIOL, V119, P883, DOI 10.1083/jcb.119.4.883; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484; Yan H, 2010, CURR BIOL, V20, P1378, DOI 10.1016/j.cub.2010.06.058; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhu HP, 2009, MOL BIOL CELL, V20, P4720, DOI 10.1091/mbc.E09-06-0453	42	3	3	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40586	40597		10.1074/jbc.M112.411793	http://dx.doi.org/10.1074/jbc.M112.411793			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23048039	Green Published, hybrid			2022-12-28	WOS:000311448800048
J	Karalewitz, APA; Fu, ZJ; Baldwin, MR; Kim, JJP; Barbieri, JT				Karalewitz, Andrew P. -A.; Fu, Zhuji; Baldwin, Michael R.; Kim, Jung-Ja P.; Barbieri, Joseph T.			Botulinum Neurotoxin Serotype C Associates with Dual Ganglioside Receptors to Facilitate Cell Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE EXOCYTOSIS; CLOSTRIDIAL-NEUROTOXINS; BINDING-SITES; PROTEIN-RECEPTOR; HEAVY-CHAIN; RECOGNITION; TETANUS; TOXIN; NEURONS; DOMAIN	Botulinum neurotoxins (BoNTs) cleave SNARE proteins in motor neurons that inhibits synaptic vesicle (SV) exocytosis, resulting in flaccid paralysis. There are seven BoNT serotypes (A-G). In current models, BoNTs initially bind gangliosides on resting neurons and upon SV exocytosis associate with the luminal domains of SV-associated proteins as a second receptor. The entry of BoNT/C is less clear. Characterizing the heavy chain receptor binding domain (HCR), BoNT/C was shown to utilize gangliosides as dual host receptors. Crystallographic and biochemical studies showed that the two ganglioside binding sites, termed GBP2 and Sia-1, were independent and utilized unique mechanisms to bind complex gangliosides. The GBP2 binding site recognized gangliosides that contained a sia5 sialic acid, whereas the Sia-1 binding site recognized gangliosides that contained a sia7 sialic acid and sugars within the backbone of the ganglioside. Utilizing gangliosides that uniquely recognized the GBP2 and Sia-1 binding sites, HCR/C entry into Neuro-2A cells required both functional ganglioside binding sites. HCR/C entered cells differently than the HCR of tetanus toxin, which also utilizes dual gangliosides as host receptors. A point-mutated HCR/C that lacked GBP2 binding potential retained the ability to bind and enter Neuro-2A cells. This showed that ganglioside binding at the Sia-1 site was accessible on the plasma membrane, suggesting that SV exocytosis may not be required to expose BoNT/C receptors. These studies highlight the utility of BoNT HCRs as probes to study the role of gangliosides in neurotransmission.	[Karalewitz, Andrew P. -A.; Barbieri, Joseph T.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Fu, Zhuji; Kim, Jung-Ja P.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Baldwin, Michael R.] Univ Missouri, Dept Microbiol & Mol Genet, Columbia, MO 65212 USA	Medical College of Wisconsin; Medical College of Wisconsin; University of Missouri System; University of Missouri Columbia	Barbieri, JT (corresponding author), Med Coll Wisconsin, Dept Microbiol & Mol Genet, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jtb01@mcw.edu			National Institutes of Health from the NIAID; Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research Program; National Institutes of Health Grant [1-R00-NS-061763]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS061763] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research Program; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health grants from the NIAID and the Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research Program (to J. J. K. and J. T. B).; Supported by National Institutes of Health Grant 1-R00-NS-061763.	Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Baldwin MR, 2007, BIOCHEMISTRY-US, V46, P3200, DOI 10.1021/bi602396x; Baldwin MR, 2007, NAT STRUCT MOL BIOL, V14, P9, DOI 10.1038/nsmb0107-9; Benson MA, 2011, J BIOL CHEM, V286, P34015, DOI 10.1074/jbc.M111.272054; Binz T, 2009, J NEUROCHEM, V109, P1584, DOI 10.1111/j.1471-4159.2009.06093.x; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chai Q, 2006, NATURE, V444, P1096, DOI 10.1038/nature05411; Chen C, 2008, BIOCHEMISTRY-US, V47, P7179, DOI 10.1021/bi800640y; Chen C, 2009, J BIOL CHEM, V284, P26569, DOI 10.1074/jbc.M109.027391; Chen S, 2008, J BIOL CHEM, V283, P21153, DOI 10.1074/jbc.M800611200; de Chaves EP, 2010, FEBS LETT, V584, P1748, DOI 10.1016/j.febslet.2009.12.010; Dittman J, 2009, ANNU REV CELL DEV BI, V25, P133, DOI 10.1146/annurev.cellbio.042308.113302; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2007, J CELL BIOL, V179, P1511, DOI 10.1083/jcb.200707184; Dong M, 2008, MOL BIOL CELL, V19, P5226, DOI 10.1091/mbc.E08-07-0765; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ewers H, 2010, NAT CELL BIOL, V12, P11, DOI 10.1038/ncb1999; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Fu ZJ, 2009, BIOCHEMISTRY-US, V48, P5631, DOI 10.1021/bi9002138; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Hua YF, 2011, NAT NEUROSCI, V14, P833, DOI 10.1038/nn.2838; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jin RS, 2006, NATURE, V444, P1092, DOI 10.1038/nature05387; Johannes L, 2010, CELL, V142, P507, DOI 10.1016/j.cell.2010.08.007; Karalewitz APA, 2010, BIOCHEMISTRY-US, V49, P8117, DOI 10.1021/bi100865f; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Kroken AR, 2011, J BIOL CHEM, V286, P26828, DOI 10.1074/jbc.M111.254086; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Montal M, 2010, ANNU REV BIOCHEM, V79, P591, DOI 10.1146/annurev.biochem.051908.125345; MONTECUCCO C, 1986, TRENDS BIOCHEM SCI, V11, P314, DOI 10.1016/0968-0004(86)90282-3; MORIISHI K, 1989, INFECT IMMUN, V57, P2886, DOI 10.1128/IAI.57.9.2886-2891.1989; Moriishi K, 1996, BBA-GENE STRUCT EXPR, V1307, P123, DOI 10.1016/0167-4781(96)00006-1; Neale EA, 1999, J CELL BIOL, V147, P1249, DOI 10.1083/jcb.147.6.1249; Nuemket N, 2011, BIOCHEM BIOPH RES CO, V411, P433, DOI 10.1016/j.bbrc.2011.06.173; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; Rummel A, 2009, J NEUROCHEM, V110, P1942, DOI 10.1111/j.1471-4159.2009.06298.x; Sato MH, 1997, BIOTECHNIQUES, V23, P254, DOI 10.2144/97232bm17; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Shapiro RE, 1997, J BIOL CHEM, V272, P30380, DOI 10.1074/jbc.272.48.30380; SIMPSON LL, 1981, PHARMACOL REV, V33, P155; Stenmark P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000129; Strotmeier J, 2011, MOL MICROBIOL, V81, P143, DOI 10.1111/j.1365-2958.2011.07682.x; Strotmeier J, 2010, BIOCHEM J, V431, P207, DOI 10.1042/BJ20101042; Tsukamoto K, 2005, J BIOL CHEM, V280, P35164, DOI 10.1074/jbc.M507596200; Tsukamoto K, 2008, MICROB PATHOGENESIS, V44, P484, DOI 10.1016/j.micpath.2007.12.003; Varki A., 2009, ESSENTIALS GLYCOBIOL; Webb RP, 2007, VACCINE, V25, P4273, DOI 10.1016/j.vaccine.2007.02.081; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Yeh FL, 2011, BIOCHEMISTRY-US, V50, P10419, DOI 10.1021/bi201490t; Yowler BC, 2004, GLYCOCONJUGATE J, V21, P287, DOI 10.1023/B:GLYC.0000046271.64647.fd	53	35	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40806	40816		10.1074/jbc.M112.404244	http://dx.doi.org/10.1074/jbc.M112.404244			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23027864	hybrid, Green Published			2022-12-28	WOS:000311448800068
J	Lummis, SCR				Lummis, Sarah C. R.			5-HT3 Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GATED ION-CHANNEL; LIGAND-BINDING SITE; SEROTONIN-RECEPTOR; 5-HYDROXYTRYPTAMINE(3A) RECEPTOR; NERVOUS-SYSTEM; MOLECULAR DETERMINANTS; 5-HT(3)AB RECEPTORS; SUBUNITS 5-HT3C; INDUCED EMESIS; GENE HTR3A	5-Hydroxytryptamine type 3 (5-HT3) receptors are cation-selective Cys loop receptors found in both the central and peripheral nervous systems. There are five 5-HT3 receptor subunits (A-E), and all functional receptors require at least one A subunit. Regions from noncontiguous parts of the subunit sequence contribute to the agonist-binding site, and the roles of a range of amino acid residues that form the binding pocket have been identified. Drugs that selectively antagonize 5-HT3 receptors (the "setrons") are the current gold standard for treatment of chemotherapy-induced and postoperative nausea and vomiting and have potential for the treatment of a range of other conditions.	Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Cambridge	Lummis, SCR (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	sl120@cam.ac.uk			Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust. This is the fifth article in the Thematic Minireview Series on Celebrating the Discovery of the Cysteine Loop Ligand-gated Ion Channel Superfamily.	AAPRO MS, 1991, DRUGS, V42, P551, DOI 10.2165/00003495-199142040-00002; Barnes NM, 2009, NEUROPHARMACOLOGY, V56, P273, DOI 10.1016/j.neuropharm.2008.08.003; Barrera NP, 2005, P NATL ACAD SCI USA, V102, P12595, DOI 10.1073/pnas.0503253102; Beene DL, 2002, BIOCHEMISTRY-US, V41, P10262, DOI 10.1021/bi020266d; BLANDINA P, 1989, J PHARMACOL EXP THER, V251, P803; Boess FG, 1997, NEUROPHARMACOLOGY, V36, P637, DOI 10.1016/S0028-3908(97)00044-0; BOESS FG, 1992, J NEUROCHEM, V59, P1692, DOI 10.1111/j.1471-4159.1992.tb11000.x; BRADLEY PB, 1986, NEUROPHARMACOLOGY, V25, P563, DOI 10.1016/0028-3908(86)90207-8; COSTALL B, 1986, NEUROPHARMACOLOGY, V25, P959, DOI 10.1016/0028-3908(86)90030-4; Das P, 2005, J PHARMACOL EXP THER, V314, P320, DOI 10.1124/jpet.104.080325; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; Davies PA, 2011, CURR OPIN PHARMACOL, V11, P75, DOI 10.1016/j.coph.2011.01.010; DERKACH V, 1989, NATURE, V339, P706, DOI 10.1038/339706a0; Dubin AE, 1999, J BIOL CHEM, V274, P30799, DOI 10.1074/jbc.274.43.30799; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; FOZARD JR, 1984, N-S ARCH PHARMACOL, V326, P36, DOI 10.1007/BF00518776; GADDUM JH, 1957, BRIT J PHARM CHEMOTH, V12, P323, DOI 10.1111/j.1476-5381.1957.tb00142.x; GADDUM JH, 1953, J PHYSIOL-LONDON, V119, P363, DOI 10.1113/jphysiol.1953.sp004851; Galligan JJ, 2002, NEUROGASTROENT MOTIL, V14, P611, DOI 10.1046/j.1365-2982.2002.00363.x; GILL CH, 1995, BRIT J PHARMACOL, V114, P1211, DOI 10.1111/j.1476-5381.1995.tb13335.x; GREEN T, 1995, J BIOL CHEM, V270, P6056, DOI 10.1074/jbc.270.11.6056; Gunthorpe MJ, 2001, J BIOL CHEM, V276, P10977, DOI 10.1074/jbc.M009575200; Holbrook JD, 2009, J NEUROCHEM, V108, P384, DOI 10.1111/j.1471-4159.2008.05775.x; Hope AG, 1999, MOL PHARMACOL, V55, P1037, DOI 10.1124/mol.55.6.1037; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; HOYER D, 1994, PHARMACOL REV, V46, P157; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Kapeller J, 2011, J COMP NEUROL, V519, P420, DOI 10.1002/cne.22525; Karnovsky AM, 2003, GENE, V319, P137, DOI 10.1016/S0378-1119(03)00803-5; KILPATRICK GJ, 1987, NATURE, V330, P746, DOI 10.1038/330746a0; LAPORTE AM, 1992, SYNAPSE, V10, P271, DOI 10.1002/syn.890100402; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Livesey MR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.219618; Livesey MR, 2008, J BIOL CHEM, V283, P19301, DOI 10.1074/jbc.M802406200; Lochner M, 2010, BIOPHYS J, V98, P1494, DOI 10.1016/j.bpj.2009.12.4313; Machu TK, 2011, PHARMACOL THERAPEUT, V130, P338, DOI 10.1016/j.pharmthera.2011.02.003; Maksay G, 2003, J RECEPT SIG TRANSD, V23, P255, DOI 10.1081/RRS-120025568; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; McKinnon NK, 2011, J GEN PHYSIOL, V138, P453, DOI 10.1085/jgp.201110686; MINER WD, 1986, BRIT J PHARMACOL, V88, P497, DOI 10.1111/j.1476-5381.1986.tb10228.x; Miquel MC, 2002, EUR J NEUROSCI, V15, P449, DOI 10.1046/j.0953-816x.2001.01872.x; Mochizuki S, 1999, EUR J PHARMACOL, V369, P125, DOI 10.1016/S0014-2999(99)00058-8; Monk SA, 2001, NEUROPHARMACOLOGY, V41, P1013, DOI 10.1016/S0028-3908(01)00153-8; Morales M, 2002, J NEUROSCI, V22, P6732; Morales M, 1996, BRAIN RES, V731, P199, DOI 10.1016/S0006-8993(96)00557-4; Morales M, 1996, MOL BRAIN RES, V36, P251, DOI 10.1016/0169-328X(96)88406-3; Morales R, 1998, J COMP NEUROL, V402, P385; Niesler B, 2003, GENE, V310, P101, DOI 10.1016/S0378-1119(03)00503-1; Niesler B, 2001, PHARMACOGENETICS, V11, P471, DOI 10.1097/00008571-200108000-00002; Niesler B, 2001, PHARMACOGENETICS, V11, P21, DOI 10.1097/00008571-200102000-00003; Niesler B, 2008, PHARMACOGENOMICS, V9, P501, DOI 10.2217/14622416.9.5.501; Niesler B, 2007, MOL PHARMACOL, V72, P8, DOI 10.1124/mol.106.032144; Niesler B, 2011, CURR OPIN PHARMACOL, V11, P81, DOI 10.1016/j.coph.2011.01.011; Panicker S, 2002, J NEUROSCI, V22, P1629, DOI 10.1523/JNEUROSCI.22-05-01629.2002; Price KL, 2008, BIOCHEMISTRY-US, V47, P6370, DOI 10.1021/bi800222n; Price KL, 2004, J BIOL CHEM, V279, P23294, DOI 10.1074/jbc.M314075200; RAPPORT MM, 1947, FED PROC, V6, P184; Reeves DC, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-27; Reeves DC, 2003, BIOPHYS J, V84, P2338, DOI 10.1016/S0006-3495(03)75039-5; Reeves DC, 2002, MOL MEMBR BIOL, V19, P11, DOI 10.1080/09687680110110048; Reeves DC, 2001, J BIOL CHEM, V276, P42035, DOI 10.1074/jbc.M106066200; RICHARDSON BP, 1985, NATURE, V316, P126, DOI 10.1038/316126a0; SILVA MRE, 1953, BRIT J PHARM CHEMOTH, V8, P378, DOI 10.1111/j.1476-5381.1953.tb01333.x; Spier AD, 2000, J BIOL CHEM, V275, P5620, DOI 10.1074/jbc.275.8.5620; Steward LJ, 2000, MOL PHARMACOL, V57, P1249; SUGITA S, 1992, NEURON, V8, P199, DOI 10.1016/0896-6273(92)90121-S; Sullivan NL, 2006, MOL MEMBR BIOL, V23, P442, DOI 10.1080/09687860600831539; Suryanarayanan A, 2005, BIOCHEMISTRY-US, V44, P9140, DOI 10.1021/bi050661e; TECOTT LH, 1993, P NATL ACAD SCI USA, V90, P1430, DOI 10.1073/pnas.90.4.1430; Thompson AJ, 2006, CURR PHARM DESIGN, V12, P3615, DOI 10.2174/138161206778522029; Thompson AJ, 2012, J PHARMACOL EXP THER, V341, P350, DOI 10.1124/jpet.111.190769; Thompson AJ, 2011, J PHYSIOL-LONDON, V589, P4243, DOI 10.1113/jphysiol.2011.208439; Thompson AJ, 2008, BIOPHYS J, V95, P5728, DOI 10.1529/biophysj.108.135624; Thompson AJ, 2003, BRIT J PHARMACOL, V140, P359, DOI 10.1038/sj.bjp.0705424; Thompson AJ, 2007, EXPERT OPIN THER TAR, V11, P527, DOI 10.1517/14728222.11.4.527; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Thompson AJ, 2006, J BIOL CHEM, V281, P16576, DOI 10.1074/jbc.M601265200; Trattnig SM, 2012, J BIOL CHEM, V287, P25241, DOI 10.1074/jbc.M112.360370; Tzvetkov MV, 2007, GENE, V386, P52, DOI 10.1016/j.gene.2006.08.002; Venkataraman P, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-16; Venkataraman P, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-15; Walstab J, 2010, PHARMACOL THERAPEUT, V128, P146, DOI 10.1016/j.pharmthera.2010.07.001; Yan D, 2005, MOL PHARMACOL, V68, P365, DOI 10.1124/mol.105.011957; Yan D, 1999, J BIOL CHEM, V274, P5537, DOI 10.1074/jbc.274.9.5537; YANG J, 1990, J GEN PHYSIOL, V96, P1177, DOI 10.1085/jgp.96.6.1177	85	94	98	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40239	40245		10.1074/jbc.R112.406496	http://dx.doi.org/10.1074/jbc.R112.406496			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23038271	Green Published, hybrid			2022-12-28	WOS:000311448800016
J	Shimizu, T; Takaya, N; Nakamura, A				Shimizu, Tetsu; Takaya, Naoki; Nakamura, Akira			An L-glucose Catabolic Pathway in Paracoccus Species 43P	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; BACILLUS-SUBTILIS; ACID CATABOLISM; D-SUGARS; IDENTIFICATION; METABOLISM; GLYCERALDEHYDE; DERIVATIVES; OXIDATION; BACTERIA	AnL-glucose-utilizing bacterium, Paracoccus sp. 43P, was isolated from soil by enrichment cultivation in a minimal medium containing L-glucose as the sole carbon source. In cell-free extracts from this bacterium, NAD(+)-dependent L-glucose dehydrogenase was detected as having sole activity toward L-glucose. This enzyme, LgdA, was purified, and the lgdA gene was found to be located in a cluster of putative inositol catabolic genes. LgdA showed similar dehydrogenase activity toward scyllo-and myo-inositols. L-Gluconate dehydrogenase activity was also detected in cell-free extracts, which represents the reaction product of LgdA activity toward L-glucose. Enzyme purification and gene cloning revealed that the corresponding gene resides in a nine-gene cluster, the lgn cluster, which may participate in aldonate incorporation and assimilation. Kinetic and reaction product analysis of each gene product in the cluster indicated that they sequentially metabolize L-gluconate to glycolytic intermediates, D-glyceraldehyde-3-phosphate, and pyruvate through reactions of C-5 epimerization by dehydrogenase/reductase, dehydration, phosphorylation, and aldolase reaction, using a pathway similar to L-galactonate catabolism in Escherichia coli. Gene disruption studies indicated that the identified genes are responsible for L-glucose catabolism.	[Shimizu, Tetsu; Takaya, Naoki; Nakamura, Akira] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	University of Tsukuba	Nakamura, A (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.	nakamura.akira.fm@u.tsukuba.ac.jp		Nakamura, Akira/0000-0001-7250-7175	Noda Institute for Scientific Research, Japan; Japan Society for Promotion of Science	Noda Institute for Scientific Research, Japan; Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by NISR Research Grant from the Noda Institute for Scientific Research, Japan, and grants-in-aid for scientific research (B) from Japan Society for Promotion of Science.	Anderson K, 2000, ANAL BIOCHEM, V287, P337, DOI 10.1006/abio.2000.4829; BABBITT PC, 1995, SCIENCE, V267, P1159, DOI 10.1126/science.7855594; Bausch C, 1998, J BACTERIOL, V180, P3704, DOI 10.1128/JB.180.14.3704-3710.1998; Breslow R, 2010, P NATL ACAD SCI USA, V107, P5723, DOI 10.1073/pnas.1001639107; COOPER RA, 1979, FEBS LETT, V103, P216, DOI 10.1016/0014-5793(79)81330-7; COOPER RA, 1980, FEBS LETT, V115, P63, DOI 10.1016/0014-5793(80)80727-7; De Groeve MRM, 2009, BIOTECHNOL LETT, V31, P1873, DOI 10.1007/s10529-009-0087-1; Hemker M, 2001, J BACTERIOL, V183, P4484, DOI 10.1128/JB.183.15.4484-4492.2001; Hilditch S, 2007, J BIOL CHEM, V282, P26195, DOI 10.1074/jbc.M704401200; HOWE AF, 1964, ANAL BIOCHEM, V9, P443, DOI 10.1016/0003-2697(64)90205-2; KALYANANDA MKGS, 1987, J BACTERIOL, V169, P2488, DOI 10.1128/jb.169.6.2488-2493.1987; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kuorelahti S, 2006, MOL MICROBIOL, V61, P1060, DOI 10.1111/j.1365-2958.2006.05294.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LIVESEY G, 1995, J NUTR, V125, P3020; Lobanok AG, 1998, WORLD J MICROB BIOT, V14, P259, DOI 10.1023/A:1008850601037; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moore S, 1940, J BIOL CHEM, V133, P293; Morinaga T, 2010, MICROBIOL-SGM, V156, P1538, DOI 10.1099/mic.0.037499-0; OCHMAN H, 1988, GENETICS, V120, P621; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; RAMALEY R, 1979, J BIOL CHEM, V254, P7684; Reed JL, 2006, P NATL ACAD SCI USA, V103, P17480, DOI 10.1073/pnas.0603364103; RUDNEY HARRY, 1940, SCIENCE, V92, P112, DOI 10.1126/science.92.2379.112; SASAJIMA KI, 1979, BIOCHIM BIOPHYS ACTA, V571, P120, DOI 10.1016/0005-2744(79)90232-8; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Sun HJ, 2009, ASTROBIOLOGY, V9, P443, DOI 10.1089/ast.2008.0315; WONG TY, 1994, APPL ENVIRON MICROB, V60, P2065, DOI 10.1128/AEM.60.6.2065-2068.1994; Yoshida KI, 2008, J BIOL CHEM, V283, P10415, DOI 10.1074/jbc.M708043200; Zhang LS, 2011, FUNGAL GENET BIOL, V48, P990, DOI 10.1016/j.fgb.2011.06.002	32	32	33	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40448	40456		10.1074/jbc.M112.403055	http://dx.doi.org/10.1074/jbc.M112.403055			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23038265	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000311448800036
J	Siow, DL; Wattenberg, BW				Siow, Deanna L.; Wattenberg, Binks W.			Mammalian ORMDL Proteins Mediate the Feedback Response in Ceramide Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE PALMITOYLTRANSFERASE ACTIVITY; SHORT-CHAIN CERAMIDE; SPHINGOLIPID BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; CULTURED NEURONS; HOMEOSTASIS; CELLS; LOCALIZATION; METABOLISM; MECHANISMS	The mammalian ORMDL proteins are orthologues of the yeast Orm proteins (Orm1/2), which are regulators of ceramide biosynthesis. In mammalian cells, ceramide is a proapoptotic signaling sphingolipid, but it is also an obligate precursor to essential higher order sphingolipids. Therefore levels of ceramide are expected to be tightly controlled. We tested the three ORMDL isoforms for their role in homeostatically regulating ceramide biosynthesis in mammalian cells. Treatment of cells with a short chain (C6) ceramide or sphingosine resulted in a dramatic inhibition of ceramide biosynthesis. This inhibition was almost completely eliminated by ORMDL knockdown. This establishes that the ORMDL proteins mediate the feedback regulation of ceramide biosynthesis in mammalian cells. The ORMDL proteins are functionally redundant. Knockdown of all three isoforms simultaneously was required to alleviate the sphingolipid-mediated inhibition of ceramide biosynthesis. The lipid sensed by the ORMDL-mediated feedback mechanism is medium or long chain ceramide or a higher order sphingolipid. Treatment of permeabilized cells with C6-ceramide resulted in ORMDL-mediated inhibition of the rate-limiting enzyme in sphingolipid biosynthesis, serine palmitoyltransferase. This indicates that C6-ceramide inhibition requires only membrane-bound elements and does not involve diffusible proteins or small molecules. We also tested the atypical sphingomyelin synthase isoform, SMSr, for its role in the regulation of ceramide biosynthesis. This unusual enzyme has been reported to regulate ceramide levels in the endoplasmic reticulum. We were unable to detect a role for SMSr in regulating ceramide biosynthesis. We suggest that the role of SMSr may be in the regulation of downstream metabolism of ceramide.	[Wattenberg, Binks W.] Univ Louisville, Sch Med, Dept Med, Louisville, KY 40202 USA; [Wattenberg, Binks W.] Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40202 USA; [Wattenberg, Binks W.] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40202 USA; [Siow, Deanna L.; Wattenberg, Binks W.] James Graham Brown Canc Ctr, Louisville, KY 40202 USA	University of Louisville; University of Louisville; University of Louisville	Wattenberg, BW (corresponding author), Univ Louisville, Sch Med, Dept Med, Clin & Translat Res Bldg,505 S Hancock St, Louisville, KY 40202 USA.	b0watt01@louisville.edu			University of Louisville-Clinical and Translational Research Program; University of Louisville Center for Environmental Genomics and Integrative Biology; Kentucky Lung Cancer Research Program; University of Louisville; James Graham Brown Research Fellowship	University of Louisville-Clinical and Translational Research Program; University of Louisville Center for Environmental Genomics and Integrative Biology; Kentucky Lung Cancer Research Program; University of Louisville; James Graham Brown Research Fellowship	This work was supported in part by the University of Louisville-Clinical and Translational Research Program, the University of Louisville Center for Environmental Genomics and Integrative Biology, and The Kentucky Lung Cancer Research Program, a Bridge Grant from the University of Louisville, and a James Graham Brown Research Fellowship (to D. L. S.).	Berdyshev EV, 2006, CELL SIGNAL, V18, P1779, DOI 10.1016/j.cellsig.2006.01.018; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Breslow DK, 2010, MOL CELL, V40, P267, DOI 10.1016/j.molcel.2010.10.005; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hirota T, 2008, J ALLERGY CLIN IMMUN, V121, P769, DOI 10.1016/j.jaci.2007.09.038; Hjelmqvist L, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-6-research0027; Jaffrezou JP, 1998, FASEB J, V12, P999, DOI 10.1096/fasebj.12.11.999; Liu M, 2012, J CELL SCI, V125, P2428, DOI 10.1242/jcs.100578; Mancinetti A, 2009, LIPIDS, V44, P1039, DOI 10.1007/s11745-009-3350-2; MANDON EC, 1991, EUR J BIOCHEM, V198, P667, DOI 10.1111/j.1432-1033.1991.tb16065.x; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; RIDGWAY ND, 1995, BBA-LIPID LIPID MET, V1256, P57, DOI 10.1016/0005-2760(95)00010-A; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Rutti MF, 2009, J LIPID RES, V50, P1237, DOI 10.1194/jlr.D900001-JLR200; Siow DL, 2010, J LIPID RES, V51, P2546, DOI 10.1194/jlr.M004374; Sun YD, 2012, MOL BIOL CELL, V23, P2388, DOI 10.1091/mbc.E12-03-0209; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Tamehiro N, 2009, J BIOL CHEM, V284, P24881, DOI 10.1074/jbc.M109.014365; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; VANECHTEN G, 1990, J BIOL CHEM, V265, P9333; WILLIAMS RD, 1984, ARCH BIOCHEM BIOPHYS, V228, P282, DOI 10.1016/0003-9861(84)90069-9; Yasuda S, 2003, J BIOL CHEM, V278, P4176, DOI 10.1074/jbc.M209602200	27	89	93	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40198	40204		10.1074/jbc.C112.404012	http://dx.doi.org/10.1074/jbc.C112.404012			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23066021	Green Published, hybrid			2022-12-28	WOS:000311448800010
J	Xue, HY; Slavov, D; Wischmeyer, PE				Xue, Hongyu; Slavov, Dobromir; Wischmeyer, Paul E.			Glutamine-mediated Dual Regulation of Heat Shock Transcription Factor-1 Activation and Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE SYNTHETASE GENE; SENSING RESPONSE PATHWAY; AMINO-ACID REGULATION; BINDING-PROTEIN-BETA; C/EBP-BETA; STRESS; HEAT-SHOCK-PROTEIN-70; PHOSPHORYLATION; MECHANISMS; RATS	Heat shock transcription factor-1 (HSF1) is the master regulator for cytoprotective heat shock protein (Hsp) expression. It is widely thought that HSF1 expression is non-inducible, and thus the key control point of Hsp expression is regulation of the transactivation activity of HSF1. How HSF1 expression is regulated remains unknown. Herein we demonstrate that glutamine (Gln), a preferred fuel substrate for the gut, enhanced Hsp expression both in rat colonic epithelium in vivo and in cultured non-transformed young adult mouse colonic epithelial cells. This was associated with up-regulation of the transactivation activity of HSF1 via increased HSF1 trimerization, nuclear localization, DNA binding, and relative abundance of activating phosphorylation at Ser-230 of HSF1. More intriguingly, Gln enhanced HSF1 protein and mRNA expression and Hsf1 gene promoter activity. Within the -281/-200 region of the Hsf1 promoter, deletion of the putative CCAAT enhancer-binding protein (C/EBP) binding site abolished the HSF1 response to Gln. C/EBP beta was further shown to bind to this 82-bp sequence both in vitro and in vivo. Gln availability strikingly altered the ratio of C/EBP beta inhibitory and active isoforms, i.e. liver-enriched inhibitory protein and liver-enriched activating protein. Liver-enriched inhibitory protein and liver-enriched activating protein were further shown to be an independent repressor and activator, respectively, for Hsf1 gene transcription, and the relative abundance of these two C/EBP beta isoforms was demonstrated to determine Hsf1 transcription. We show for the first time that Gln not only enhances the transactivation of HSF1 but also induces Hsf1 expression by activating its transcription in a C/EBP beta-dependent manner.	[Xue, Hongyu; Wischmeyer, Paul E.] Univ Colorado Denver, Dept Anesthesiol, Aurora, CO 80045 USA; [Slavov, Dobromir] Univ Colorado Denver, Dept Cardiol, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Xue, HY (corresponding author), Univ Colorado Denver, Dept Anesthesiol, Anschutz Med Campus,RC2,P15,Box 8602,12700 E 19th, Aurora, CO 80045 USA.	Hongyu.Xue@ucdenver.edu	Xue, Hongyu/E-4201-2013		National Institutes of Health [RO1 GM078312]; Department of Anesthesiology, University of Colorado; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Anesthesiology, University of Colorado; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM078312 (to P. E. W.). This work was also supported by a start-up grant from the Department of Anesthesiology, University of Colorado (to H. X.).	Anckar J, 2007, ADV EXP MED BIOL, V594, P78; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Banine F, 1998, BBA-GENE STRUCT EXPR, V1398, P1, DOI 10.1016/S0167-4781(98)00042-6; Barbosa-Tessmann IP, 2000, J BIOL CHEM, V275, P26976; BELLON G, 1995, BBA-MOL CELL RES, V1268, P311, DOI 10.1016/0167-4889(95)00093-8; Bruhat A, 2000, MOL CELL BIOL, V20, P7192, DOI 10.1128/MCB.20.19.7192-7204.2000; Bruhat A, 1997, J BIOL CHEM, V272, P17588, DOI 10.1074/jbc.272.28.17588; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; Chu BY, 1996, J BIOL CHEM, V271, P30847, DOI 10.1074/jbc.271.48.30847; Curi R, 2005, J CELL PHYSIOL, V204, P392, DOI 10.1002/jcp.20339; De Maio A, 1999, SHOCK, V11, P1, DOI 10.1097/00024382-199901000-00001; Ding XZ, 1996, MOL CELL BIOCHEM, V158, P189; Fafournoux P, 2000, BIOCHEM J, V351, P1, DOI 10.1042/0264-6021:3510001; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; GONG SS, 1991, MOL CELL BIOL, V11, P6059, DOI 10.1128/MCB.11.12.6059; GUERRINI L, 1993, MOL CELL BIOL, V13, P3202, DOI 10.1128/MCB.13.6.3202; Hegazi RA, 2011, CRIT CARE, V15, DOI 10.1186/cc10430; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Holmberg CI, 2001, EMBO J, V20, P3800, DOI 10.1093/emboj/20.14.3800; Jeppesen Palle Bekker, 2002, Curr Gastroenterol Rep, V4, P338, DOI 10.1007/s11894-002-0085-0; Kline MP, 1997, MOL CELL BIOL, V17, P2107, DOI 10.1128/MCB.17.4.2107; Knauf U, 1996, GENE DEV, V10, P2782, DOI 10.1101/gad.10.21.2782; LARSON JS, 1988, NATURE, V335, P372, DOI 10.1038/335372a0; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; Metzler B, 2003, AM J PATHOL, V162, P1669, DOI 10.1016/S0002-9440(10)64301-5; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Morrison AL, 2006, AM J PHYSIOL-CELL PH, V290, pC1625, DOI 10.1152/ajpcell.00635.2005; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; RAUGHT B, 1995, MOL ENDOCRINOL, V9, P1223, DOI 10.1210/me.9.9.1223; Ren HY, 2001, GASTROENTEROLOGY, V121, P631, DOI 10.1053/gast.2001.27028; Ritossa F, 1996, CELL STRESS CHAPERON, V1, P97, DOI 10.1379/1466-1268(1996)001<0097:DOTHSR>2.3.CO;2; Ropeleski MJ, 2005, GASTROENTEROLOGY, V129, P170, DOI 10.1053/j.gastro.2005.05.017; Shao JH, 2005, DIABETES, V54, P976, DOI 10.2337/diabetes.54.4.976; Singleton KD, 2007, AM J PHYSIOL-REG I, V292, pR1839, DOI 10.1152/ajpregu.00755.2006; Siu F, 2001, J BIOL CHEM, V276, P48100, DOI 10.1074/jbc.M109533200; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Sonna LA, 2010, CELL STRESS CHAPERON, V15, P55, DOI 10.1007/s12192-009-0121-1; SORGER PK, 1987, NATURE, V329, P81, DOI 10.1038/329081a0; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; STRAUS DS, 1994, J NUTR, V124, P1041, DOI 10.1093/jn/124.7.1041; Sundar SV, 2005, BIOCHEM BIOPH RES CO, V332, P688, DOI 10.1016/j.bbrc.2005.05.008; Thiaville MM, 2008, BIOCHEM J, V410, P473, DOI 10.1042/BJ20071252; Voellmy Richard, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P357; Vujanac M, 2005, TRAFFIC, V6, P214, DOI 10.1111/j.1600-0854.2005.00266.x; Weiss YG, 2002, J CLIN INVEST, V110, P801, DOI 10.1172/JCI200215888; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Wheelhouse NM, 1999, J ENDOCRINOL, V163, P353, DOI 10.1677/joe.0.1630353; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Wischmeyer P, 2011, CURR OPIN ANESTHESIO, V24, P381, DOI 10.1097/ACO.0b013e32834872b6; Wischmeyer PE, 2001, J APPL PHYSIOL, V90, P2403, DOI 10.1152/jappl.2001.90.6.2403; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Xue HY, 2008, J NUTR, V138, P740, DOI 10.1093/jn/138.4.740; Xue HY, 2007, CLIN CANCER RES, V13, P7146, DOI 10.1158/1078-0432.CCR-07-0823; Xue HY, 2011, JPEN-PARENTER ENTER, V35, P188, DOI 10.1177/0148607110381407; Yang JQ, 2008, ITESS: 2008 PROCEEDINGS OF INFORMATION TECHNOLOGY AND ENVIRONMENTAL SYSTEM SCIENCES, PT 1, P1, DOI 10.1109/CVPR.2008.4587647; Zhou JD, 2008, CHINESE MED J-PEKING, V121, P1269, DOI 10.1097/00029330-200807020-00004; Ziegler TR, 2005, INTENS CARE MED, V31, P1079, DOI 10.1007/s00134-005-2690-5; ZIMARINO V, 1987, NATURE, V327, P727, DOI 10.1038/327727a0	59	33	34	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40400	40413		10.1074/jbc.M112.410712	http://dx.doi.org/10.1074/jbc.M112.410712			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23055521	Green Published, hybrid			2022-12-28	WOS:000311448800031
J	Mayer, F; Leone, V; Langer, JD; Faraldo-Gomez, JD; Muller, V				Mayer, Florian; Leone, Vanessa; Langer, Julian D.; Faraldo-Gomez, Jose D.; Mueller, Volker			A c Subunit with Four Transmembrane Helices and One Ion (Na+)-binding Site in an Archaeal ATP Synthase IMPLICATIONS FOR c RING FUNCTION AND STRUCTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-TRANSLOCATING METHYLTRANSFERASE; PROTEIN SECONDARY STRUCTURE; ROTOR RING; V-TYPE; F-TYPE; METHANOPYRUS-KANDLERI; METHANOGENIC ARCHAEA; MOLECULAR-DYNAMICS; REACTIVE PROTEIN; A-TYPE	The ion-driven membrane rotors of ATP synthases consist of multiple copies of subunit c, forming a closed ring. Subunit c typically comprises two transmembrane helices, and the c ring features an ion-binding site in between each pair of adjacent subunits. Here, we use experimental and computational methods to study the structure and specificity of an archaeal c subunit more akin to those of V-type ATPases, namely that from Pyrococcus furiosus. The c subunit was purified by chloroform/methanol extraction and determined to be 15.8 kDa with four predicted transmembrane helices. However, labeling with DCCD as well as Na+-DCCD competition experiments revealed only one binding site for DCCD and Na+, indicating that the mature c subunit of this A(1)A(O) ATP synthase is indeed of the V-type. A structural model generated computationally revealed one Na+-binding site within each of the c subunits, mediated by a conserved glutamate side chain alongside other coordinating groups. An intriguing second glutamate located in-between adjacent c subunits was ruled out as a functional Na+-binding site. Molecular dynamics simulations indicate that the c ring of P. furiosus is highly Na+-specific under in vivo conditions, comparable with the Na+-dependent V1VO ATPase from Enterococcus hirae. Interestingly, the same holds true for the c ring from the methanogenic archaeon Methanobrevibacter ruminantium, whose c subunits also feature a V-type architecture but carry two Na+-binding sites instead. These findings are discussed in light of their physiological relevance and with respect to the mode of ion coupling in A(1)A(O) ATP synthases.	[Leone, Vanessa; Faraldo-Gomez, Jose D.] Max Planck Inst Biophys, Theoret Mol Biophys Grp, D-60438 Frankfurt, Germany; [Mueller, Volker] Goethe Univ Frankfurt, Inst Mol Biosci, D-60438 Frankfurt, Germany; [Langer, Julian D.] Max Planck Inst Biophys, Dept Mol Membrane Biol, D-60438 Frankfurt, Germany; [Faraldo-Gomez, Jose D.] Cluster Excellence Macromol Complexes, D-60438 Frankfurt, Germany	Max Planck Society; Goethe University Frankfurt; Max Planck Society	Faraldo-Gomez, JD (corresponding author), Max Planck Inst Biophys, Theoret Mol Biophys Grp, Max von Laue Str 3, D-60438 Frankfurt, Germany.	jose.faraldo@biophys.mpg.de; vmueller@bio.uni-frankfurt.de	Leone, Vanessa/AGZ-1133-2022; Mueller, Volker/ABE-4305-2021; Faraldo-Gomez, Jose/H-7127-2016	Leone, Vanessa/0000-0001-7017-4020; Mueller, Volker/0000-0001-7955-5508; Langer, Julian David/0000-0002-5190-577X	Deutsche Forschungsgemeinschaft [SFB807, EXC115]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grants SFB807 (to V. M.) and EXC115 (to J. D. F.-G.) from the Deutsche Forschungsgemeinschaft.	ALTENDORF K, 1977, FEBS LETT, V73, P271, DOI 10.1016/0014-5793(77)80997-6; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buschmann S, 2010, SCIENCE, V329, P327, DOI 10.1126/science.1187303; Cross RL, 2004, FEBS LETT, V576, P1, DOI 10.1016/j.febslet.2004.08.065; FILLINGAME RH, 1976, J BIOL CHEM, V251, P6630; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Fricke WF, 2006, J BACTERIOL, V188, P642, DOI 10.1128/JB.188.2.642-658.2006; Furutani Y, 2011, J AM CHEM SOC, V133, P2860, DOI 10.1021/ja1116414; Gottschalk G, 2001, BBA-BIOENERGETICS, V1505, P28, DOI 10.1016/S0005-2728(00)00274-7; Gruber G, 2001, J EXP BIOL, V204, P2597; Gruber G, 2008, BIOESSAYS, V30, P1096, DOI 10.1002/bies.20827; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; JETTEN MSM, 1991, FEMS MICROBIOL LETT, V84, P313, DOI 10.1111/j.1574-6968.1991.tb04616.x; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KLUGE C, 1993, J BIOL CHEM, V268, P14557; Krah A, 2010, BBA-BIOENERGETICS, V1797, P763, DOI 10.1016/j.bbabio.2010.04.014; Leone V, 2010, BIOPHYS J, V99, pL53, DOI 10.1016/j.bpj.2010.07.046; Lewalter K, 2006, BBA-BIOENERGETICS, V1757, P437, DOI 10.1016/j.bbabio.2006.04.027; Li WZ, 2002, BIOINFORMATICS, V18, P77, DOI 10.1093/bioinformatics/18.1.77; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Lolkema JS, 2003, FEBS LETT, V543, P47, DOI 10.1016/S0014-5793(03)00398-3; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MANDEL M, 1988, P NATL ACAD SCI USA, V85, P5521, DOI 10.1073/pnas.85.15.5521; McMillan DGG, 2011, J BIOL CHEM, V286, P39882, DOI 10.1074/jbc.M111.281675; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2009, J MOL BIOL, V391, P498, DOI 10.1016/j.jmb.2009.05.082; Melo F, 2007, PROTEIN SCI, V16, P2412, DOI 10.1110/ps.072895107; Mizutani K, 2011, P NATL ACAD SCI USA, V108, P13474, DOI 10.1073/pnas.1103287108; Muller V, 2005, J MOL MICROB BIOTECH, V10, P167, DOI 10.1159/000091563; Muller V, 2005, J BIOENERG BIOMEMBR, V37, P455, DOI 10.1007/s10863-005-9491-y; Muller V, 2004, J BIOENERG BIOMEMBR, V36, P115, DOI 10.1023/B:JOBB.0000019603.68282.04; Muller V, 2003, CELL MOL LIFE SCI, V60, P474, DOI 10.1007/s000180300040; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Murata T, 2001, BBA-BIOENERGETICS, V1505, P75, DOI 10.1016/S0005-2728(00)00278-4; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pisa KY, 2007, FEBS J, V274, P3928, DOI 10.1111/j.1742-4658.2007.05925.x; Poehlein A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033439; Pogoryelov D, 2010, NAT CHEM BIOL, V6, P891, DOI 10.1038/NCHEMBIO.457; Pogoryelov D, 2009, NAT STRUCT MOL BIOL, V16, P1068, DOI 10.1038/nsmb.1678; Robb FT, 2001, METHOD ENZYMOL, V330, P134; Ruppert C, 1999, J BIOL CHEM, V274, P25281, DOI 10.1074/jbc.274.36.25281; Ruppert C, 2001, FEMS MICROBIOL LETT, V195, P47, DOI 10.1016/S0378-1097(00)00544-9; Sapra R, 2003, P NATL ACAD SCI USA, V100, P7545, DOI 10.1073/pnas.1331436100; SCHAFER G, 1992, BIOCHIM BIOPHYS ACTA, V1101, P232, DOI 10.1016/0005-2728(92)90233-R; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schlegel K, 2012, P NATL ACAD SCI USA, V109, P947, DOI 10.1073/pnas.1115796109; Schut GJ, 2013, FEMS MICROBIOL REV, V37, P182, DOI 10.1111/j.1574-6976.2012.00346.x; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Slesarev AI, 2002, P NATL ACAD SCI USA, V99, P4644, DOI 10.1073/pnas.032671499; SPRUTH M, 1995, BBA-BIOENERGETICS, V1229, P96, DOI 10.1016/0005-2728(94)00192-8; Staritzbichler R, 2011, J CHEM THEORY COMPUT, V7, P1167, DOI 10.1021/ct100576m; Stetter KO, 2006, EXTREMOPHILES, V10, P357, DOI 10.1007/s00792-006-0012-7; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Vonck J, 2009, J BIOL CHEM, V284, P10110, DOI 10.1074/jbc.M808498200	61	21	21	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.411223	http://dx.doi.org/10.1074/jbc.M112.411223			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23007388	Green Published, hybrid			2022-12-28	WOS:000311233800005
J	Xu, M; Liu, K; Swaroop, M; Porter, FD; Sidhu, R; Finkes, S; Ory, DS; Marugan, JJ; Xiao, JB; Southall, N; Pavan, WJ; Davidson, C; Walkley, SU; Remaley, AT; Baxa, U; Sun, W; McKew, JC; Austin, CP; Zheng, W				Xu, Miao; Liu, Ke; Swaroop, Manju; Porter, Forbes D.; Sidhu, Rohini; Finkes, Sally; Ory, Daniel S.; Marugan, Juan J.; Xiao, Jingbo; Southall, Noel; Pavan, William J.; Davidson, Cristin; Walkley, Steven U.; Remaley, Alan T.; Baxa, Ulrich; Sun, Wei; McKew, John C.; Austin, Christopher P.; Zheng, Wei			delta-Tocopherol Reduces Lipid Accumulation in Niemann-Pick Type C1 and Wolman Cholesterol Storage Disorders	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TOCOPHEROL; VITAMIN-E; DISEASE; EXOCYTOSIS; PLASMA; SUPPLEMENTATION; TOCOTRIENOLS; FIBROBLASTS; METABOLISM; TISSUE	Niemann-Pick disease type C (NPC) and Wolman disease are two members of a family of storage disorders caused by mutations of genes encoding lysosomal proteins. Deficiency in function of either the NPC1 or NPC2 protein in NPC disease or lysosomal acid lipase in Wolman disease results in defective cellular cholesterol trafficking. Lysosomal accumulation of cholesterol and enlarged lysosomes are shared phenotypic characteristics of both NPC and Wolman cells. Utilizing a phenotypic screen of an approved drug collection, we found that delta-tocopherol effectively reduced lysosomal cholesterol accumulation, decreased lysosomal volume, increased cholesterol efflux, and alleviated pathological phenotypes in both NPC1 and Wolman fibroblasts. Reduction of these abnormalities may be mediated by a delta-tocopherol-induced intracellular Ca2+ response and subsequent enhancement of lysosomal exocytosis. Consistent with a general mechanism for reduction of lysosomal lipid accumulation, we also found that delta-tocopherol reduces pathological phenotypes in patient fibroblasts from other lysosomal storage diseases, including NPC2, Batten (ceroid lipofuscinosis, neuronal 2, CLN2), Fabry, Farber, Niemann-Pick disease type A, Sanfilippo type B (mucopolysaccharidosis type IIIB, MPSIIIB), and Tay-Sachs. Our data suggest that regulated exocytosis may represent a potential therapeutic target for reduction of lysosomal storage in this class of diseases.	[Xu, Miao; Liu, Ke; Swaroop, Manju; Marugan, Juan J.; Xiao, Jingbo; Southall, Noel; Sun, Wei; McKew, John C.; Austin, Christopher P.; Zheng, Wei] NIH, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [Porter, Forbes D.] Eunice Kennedy Shriver NICHD, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA; [Sidhu, Rohini; Finkes, Sally; Ory, Daniel S.] Washington Univ, Sch Med, Diabet Cardiovasc Dis Ctr, St Louis, MO 63110 USA; [Pavan, William J.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Davidson, Cristin; Walkley, Steven U.] Albert Einstein Coll Med, Rose F Kennedy Ctr, Sidney Weisner Lab Genet Neurol Dis, Bronx, NY 10461 USA; [Remaley, Alan T.] NHLBI, Lab Lipoprot Metab, NIH, Bethesda, MD 20892 USA; [Xu, Miao] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Hangzhou 310016, Zhejiang, Peoples R China; [Baxa, Ulrich] NCI, Electron Microscopy Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Zhejiang University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zheng, W (corresponding author), NIH, Natl Ctr Adv Translat Sci, 9800 Med Ctr Dr,MSC 3370, Bethesda, MD 20892 USA.	wzheng@mail.nih.gov	Davidson, Cristin/AAA-2733-2020; Davidson, Cristin/F-4889-2017; Sander-Effron, Samuel/AAX-2231-2020; Resource Center, NINDS Human Genetics/AGF-2474-2022; Sidhu, Rohini/G-3547-2012; Zheng, Wei/J-8889-2014; Zheng, Wei/GOE-5990-2022; Southall, Noel T/H-8991-2012; xu, miao/U-1176-2017	Davidson, Cristin/0000-0002-5508-8113; Davidson, Cristin/0000-0002-5508-8113; Sidhu, Rohini/0000-0003-1703-2167; Zheng, Wei/0000-0003-1034-0757; Southall, Noel T/0000-0003-4500-880X; Swaroop, Manju/0000-0002-0576-1664; Sun, Wei/0000-0002-1306-3946; Pavan, William/0000-0001-8281-5120; Baxa, Ulrich/0000-0002-7263-5078	National Institutes of Health Intramural Research Program of the National Center for Advancing Translational Sciences; Intramural Research Program of the National Human Genome Research Institute; Intramural Research Program of the Eunice Kennedy Shriver NICHD; NCI, National Institutes of Health [HHSN26120080001E]; Ara Parseghian Medical Research Foundation; National Institutes of Health [P60 DK020579]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008824, R01HD045561, P30HD071593] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000002] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020579, P30DK020579] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the National Center for Advancing Translational Sciences; Intramural Research Program of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural Research Program of the Eunice Kennedy Shriver NICHD; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ara Parseghian Medical Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the National Center for Advancing Translational Sciences, by the Intramural Research Program of the National Human Genome Research Institute, by the Intramural Research Program of the Eunice Kennedy Shriver NICHD, and by NCI, National Institutes of Health, Contract HHSN26120080001E. This work was also supported by a grant from the Ara Parseghian Medical Research Foundation.; We thank Support of Accelerated Research for Niemann-Pick Disease Type C (SOAR-NPC) for fostering a collaborative research environment and stimulating discussion. Mass spectrometry analysis was performed in the Washington University Metabolomics Facility, supported by National Institutes of Health Grant P60 DK020579. We thank Dr. Yiannis A. Ioannou (Mount Sinai School of Medicine) for technical assistance with the exocytosis assays and Ferri Soheilian and Christina Burks for assistance with electron microscopy.	Arantes RME, 2006, J NEUROSCI, V26, P4630, DOI 10.1523/JNEUROSCI.0009-06.2006; Atkinson J, 2010, MOL NUTR FOOD RES, V54, P641, DOI 10.1002/mnfr.200900439; Bascunan-Castillo Eric C., 2004, Journal of Applied Genetics, V45, P461; Baxter LL, 2012, NUTRIENTS, V4, P467, DOI 10.3390/nu4060467; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOUSTANY RMN, 1990, PEDIATR NEUROL, V6, P177, DOI 10.1016/0887-8994(90)90059-A; Chen FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015054; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Deffieu MS, 2011, P NATL ACAD SCI USA, V108, P18932, DOI 10.1073/pnas.1110439108; Du H, 2008, J LIPID RES, V49, P1646, DOI 10.1194/jlr.M700482-JLR200; Eggermont E, 2006, EUR J PEDIATR, V165, P429, DOI 10.1007/s00431-006-0084-5; Fielding CJ, 1997, J LIPID RES, V38, P1503; GIESELMANN V, 1995, BBA-MOL BASIS DIS, V1270, P103, DOI 10.1016/0925-4439(94)00075-2; Gohil K, 2010, MOL NUTR FOOD RES, V54, P693, DOI 10.1002/mnfr.200900575; Han XL, 2004, ANAL BIOCHEM, V330, P317, DOI 10.1016/j.ab.2004.04.004; Hemmerling J, 2010, MOL NUTR FOOD RES, V54, P652, DOI 10.1002/mnfr.200900462; Huang HY, 2003, J NUTR, V133, P3137, DOI 10.1093/jn/133.10.3137; Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Klein D, 2005, BIOCHEM BIOPH RES CO, V327, P663, DOI 10.1016/j.bbrc.2004.12.054; KRUTH HS, 1986, J BIOL CHEM, V261, P6769; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Manor D, 2007, VITAM HORM, V76, P45, DOI 10.1016/S0083-6729(07)76003-X; Martins RM, 2011, CELL MICROBIOL, V13, P943, DOI 10.1111/j.1462-5822.2011.01590.x; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Nagashima K, 2011, METHODS MOL BIOL, V697, P83, DOI 10.1007/978-1-60327-198-1_8; NORMAN AW, 1972, J BIOL CHEM, V247, P1918; Ory DS, 2004, TRENDS CARDIOVAS MED, V14, P66, DOI 10.1016/j.tcm.2003.12.003; Pani A, 2009, J ALZHEIMERS DIS, V18, P829, DOI 10.3233/JAD-2009-1193; Patterson M., 2001, METABOLIC MOL BASES, VII, P3611; Perez-Poyato MS, 2011, CURR PHARM BIOTECHNO, V12, P897, DOI 1389-2010/11 $58.00+.00; Pipalia NH, 2011, P NATL ACAD SCI USA, V108, P5620, DOI 10.1073/pnas.1014890108; Qureshi OS, 2007, J CELL SCI, V120, P3838, DOI 10.1242/jcs.010348; Ravaglia G, 2008, AM J CLIN NUTR, V87, P1306, DOI 10.1093/ajcn/87.5.1306; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Rosenbaum AI, 2009, BBA-MOL CELL BIOL L, V1791, P1155, DOI 10.1016/j.bbalip.2009.08.005; Royer MC, 2009, J BIOL CHEM, V284, P15826, DOI 10.1074/jbc.M808641200; Schultz ML, 2011, TRENDS NEUROSCI, V34, P401, DOI 10.1016/j.tins.2011.05.006; Schulze H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004804; Sen CK, 2006, LIFE SCI, V78, P2088, DOI 10.1016/j.lfs.2005.12.001; Sethi AA, 2008, J BIOL CHEM, V283, P32273, DOI 10.1074/jbc.M804461200; Sontag TJ, 2007, J LIPID RES, V48, P1090, DOI 10.1194/jlr.M600514-JLR200; Sontag TJ, 2002, J BIOL CHEM, V277, P25290, DOI 10.1074/jbc.M201466200; Tietge UJF, 2001, HUM GENE THER, V12, P279, DOI 10.1089/10430340150218413; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; WOLMAN M, 1995, CLIN PEDIATR, V34, P207, DOI 10.1177/000992289503400406; Yancey PG, 2003, ARTERIOSCL THROM VAS, V23, P712, DOI 10.1161/01.ATV.0000057572.97137.DD	49	87	95	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.357707	http://dx.doi.org/10.1074/jbc.M112.357707			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23035117	hybrid, Green Published			2022-12-28	WOS:000311233800007
J	Ghislat, G; Patron, M; Rizzuto, R; Knecht, E				Ghislat, Ghita; Patron, Maria; Rizzuto, Rosario; Knecht, Erwin			Withdrawal of Essential Amino Acids Increases Autophagy by a Pathway Involving Ca2+/Calmodulin-dependent Kinase Kinase-beta (CaMKK-beta)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HUMAN FIBROBLASTS; MAMMALIAN-CELLS; MTOR; PHOSPHORYLATION; CALCIUM; APOPTOSIS; ULK1; AMPK; MACROAUTOPHAGY	Autophagy is the main lysosomal catabolic process that becomes activated under stress conditions, such as amino acid starvation and cytosolic Ca2+ upload. However, the molecular details on how both conditions control autophagy are still not fully understood. Here we link essential amino acid starvation and Ca2+ in a signaling pathway to activate autophagy. We show that withdrawal of essential amino acids leads to an increase in cytosolic Ca2+, arising from both extracellular medium and intracellular stores, which induces the activation of adenosine monophosphate-activated protein kinase (AMPK) via Ca2+/calmodulin-dependent kinase kinase-beta (CaMKK-beta). Furthermore, we show that autophagy induced by amino acid starvation requires AMPK, as this induction is attenuated in its absence. Subsequently, AMPK activates UNC-51-like kinase (ULK1), a mammalian autophagy-initiating kinase, through phosphorylation at Ser-555 in a process that requires CaMKK-beta. Finally, the mammalian target of rapamycin complex C1 (mTORC1), a negative regulator of autophagy downstream of AMPK, is inhibited by amino acid starvation in a Ca2+-sensitive manner, and CaMKK-beta appears to be important for mTORC1 inactivation, especially in the absence of extracellular Ca2+. All these results highlight that amino acid starvation regulates autophagy in part through an increase in cellular Ca2+ that activates a CaMKK-beta-AMPK pathway and inhibits mTORC1, which results in ULK1 stimulation.	[Ghislat, Ghita; Knecht, Erwin] Ctr Invest Principe Felipe, Lab Biol Celular, Valencia 46012, Spain; [Ghislat, Ghita; Knecht, Erwin] CIBERER, Valencia 46012, Spain; [Patron, Maria; Rizzuto, Rosario] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy	Prince Felipe Research Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Padua	Knecht, E (corresponding author), Ctr Invest Principe Felipe, Lab Biol Celular, C Eduardo Primo Yufera 3, Valencia 46012, Spain.	knecht@cipf.es	Knecht, Erwin/K-2432-2014; Ghislat, Ghita/ABA-4769-2020; Knecht, Erwin/A-9366-2014	Knecht, Erwin/0000-0002-7208-3832; Rizzuto, Rosario/0000-0001-7044-5097	Ministerio de Educacion y Ciencia Grant [BFU2011-22630]; Fundacio Marato TV3 Grant [100130]	Ministerio de Educacion y Ciencia Grant(Spanish Government); Fundacio Marato TV3 Grant	This work was supported by Ministerio de Educacion y Ciencia Grant BFU2011-22630 and Fundacio Marato TV3 Grant 100130).	Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Esteban I, 2007, FEBS LETT, V581, P3415, DOI 10.1016/j.febslet.2007.06.043; Fuertes G, 2003, BIOCHEM J, V375, P75, DOI 10.1042/BJ20030282; Ghislat G, 2012, J CELL SCI, V125, P92, DOI 10.1242/jcs.086728; GORDON PB, 1993, J BIOL CHEM, V268, P26107; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kim E, 2009, NUTR RES PRACT, V3, P64, DOI 10.4162/nrp.2009.3.1.64; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Knecht E, 2009, CELL MOL LIFE SCI, V66, P2427, DOI 10.1007/s00018-009-0030-6; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Meijer Alfred J., 2008, V445, P89, DOI 10.1007/978-1-59745-157-4_5; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Niemann A, 2000, J HISTOCHEM CYTOCHEM, V48, P251, DOI 10.1177/002215540004800210; Ogier-Denis E, 2000, J BIOL CHEM, V275, P39090, DOI 10.1074/jbc.M006198200; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2003, J BIOL CHEM, V278, P16667, DOI 10.1074/jbc.M210998200; PerezTerzic CM, 1995, BIOCHEM J, V312, P955, DOI 10.1042/bj3120955; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Wang RC, 2010, FEBS LETT, V584, P1417, DOI 10.1016/j.febslet.2010.01.009; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Yan Y, 2009, BIOCHEM J, V417, P747, DOI 10.1042/BJ20081865	43	87	94	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38625	38636		10.1074/jbc.M112.365767	http://dx.doi.org/10.1074/jbc.M112.365767			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23027865	Green Published, hybrid			2022-12-28	WOS:000310982800022
J	Kang, H; Louie, J; Weisman, A; Sheu-Gruttadauria, J; Davis-Dusenbery, BN; Lagna, G; Hata, A				Kang, Hara; Louie, Justin; Weisman, Alexandra; Sheu-Gruttadauria, Jessica; Davis-Dusenbery, Brandi N.; Lagna, Giorgio; Hata, Akiko			Inhibition of MicroRNA-302 (miR-302) by Bone Morphogenetic Protein 4 (BMP4) Facilitates the BMP Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-CELL DIFFERENTIATION; PLURIPOTENT STEM-CELLS; CANCER-CELLS; BETA; EXPRESSION; TARGETS; FAMILY; IDENTIFICATION; MODULATION; MATURATION	The signaling pathway mediated by BMPs plays an essential role during development as well as the maintenance of homeostasis in adult. Aberrant activation or inactivation of BMP signaling can lead to developmental defects and various human disorders. To fine-tune its activity, BMP signaling is regulated both positively and negatively by extrinsic and intrinsic regulatory factors that modulate binding of ligand to the receptors, and the activity of receptors and their dedicated signal transducers, the Smad proteins. Upon BMP binding to the receptor complex, Smad proteins translocate to the nucleus and modulate gene expression transcriptionally by directly associating with the promoter region of target genes, or post-transcriptionally through modulation of microRNA (miRNA) synthesis. In this study, we demonstrate that BMP signaling down-regulates transcription of the miRNA-302 similar to 367 gene cluster. We show that the type II BMP receptor (BMPRII) is a novel target of miR-302. Upon overexpression, miR-302 targets a partially complementary sequence localized in the 3'-untranslated region (UTR) of BMPRII transcripts and leads to destabilization of the transcripts and down-regulation of BMP signaling. We propose that the negative regulatory loop of BMP4-miR-302-BMPRII is a potential mechanism for the maintenance and fine-tuning of the BMP signaling pathway in various systems.	[Louie, Justin; Sheu-Gruttadauria, Jessica; Lagna, Giorgio; Hata, Akiko] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Kang, Hara; Weisman, Alexandra; Davis-Dusenbery, Brandi N.; Lagna, Giorgio; Hata, Akiko] Tufts Univ, Sch Med, Mol Cardiol Res Inst, Tufts Med Ctr, Boston, MA 02111 USA; [Hata, Akiko] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA	University of California System; University of California San Francisco; Tufts Medical Center; Tufts University; Tufts University	Hata, A (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, 555 Mission Bay Blvd S,Rm 252T, San Francisco, CA 94158 USA.	akiko.hata@ucsf.edu	Davis-Dusenbery, Brandi/N-2798-2013	Davis-Dusenbery, Brandi/0000-0001-7811-8613	NHLBI, National Institutes of Health Grant [HL093154]; LeDucq Foundation; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108317, R01HL093154] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health Grant; LeDucq Foundation(Leducq Foundation); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by NHLBI, National Institutes of Health Grant HL093154, the LeDucq Foundation, and the American Heart Association (to A. H.).	Barroso-delJesus A, 2008, MOL CELL BIOL, V28, P6609, DOI 10.1128/MCB.00398-08; Barroso-delJesus A, 2011, FASEB J, V25, P1497, DOI 10.1096/fj.10-172221; Blahna MT, 2012, FEBS LETT, V586, P1906, DOI 10.1016/j.febslet.2012.01.041; Chan MC, 2010, EMBO J, V29, P559, DOI 10.1038/emboj.2009.370; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; Davis-Dusenbery BN, 2011, ARTERIOSCL THROM VAS, V31, P2370, DOI 10.1161/ATVBAHA.111.226670; Davis-Dusenbery BN, 2011, J BIOL CHEM, V286, P28097, DOI 10.1074/jbc.M111.236950; Davis-Dusenbery BN, 2010, J BIOCHEM, V148, P381, DOI 10.1093/jb/mvq096; Golestaneh AF, 2012, CELL BIOCHEM FUNCT, V30, P411, DOI 10.1002/cbf.2815; HOGAN BLM, 1994, DEVELOPMENT, P53; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Jesus ABD, 2009, CELL CYCLE, V8, P394; Kang H, 2012, J BIOL CHEM, V287, P3976, DOI 10.1074/jbc.M111.303156; Kim DW, 2003, MOL CELL BIOL, V23, P8704, DOI 10.1128/MCB.23.23.8704-8717.2003; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kuo CH, 2012, BIOCHEM BIOPH RES CO, V417, P11, DOI 10.1016/j.bbrc.2011.11.058; Lagna G, 2007, J BIOL CHEM, V282, P37244, DOI 10.1074/jbc.M708137200; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Lipchina I, 2012, CELL CYCLE, V11, P1517, DOI 10.4161/cc.19846; Lipchina I, 2011, GENE DEV, V25, P2173, DOI 10.1101/gad.17221311; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Murray MJ, 2011, AM J CLIN PATHOL, V135, P119, DOI 10.1309/AJCPOE11KEYZCJHT; Neuman NA, 2009, J BIOL CHEM, V284, P13202, DOI 10.1074/jbc.M900282200; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Palmer RD, 2010, CANCER RES, V70, P2911, DOI 10.1158/0008-5472.CAN-09-3301; Rosa A, 2011, EMBO J, V30, P237, DOI 10.1038/emboj.2010.319; Rosa A, 2009, DEV CELL, V16, P517, DOI 10.1016/j.devcel.2009.02.007; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Wilson KD, 2009, STEM CELLS DEV, V18, P749, DOI 10.1089/scd.2008.0247	33	46	49	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38656	38664		10.1074/jbc.M112.390898	http://dx.doi.org/10.1074/jbc.M112.390898			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22988237	Green Published, hybrid			2022-12-28	WOS:000310982800025
J	Makise, M; Mackay, DR; Elgort, S; Shankaran, SS; Adam, SA; Ullman, KS				Makise, Masaki; Mackay, Douglas R.; Elgort, Suzanne; Shankaran, Sunita S.; Adam, Stephen A.; Ullman, Katharine S.			The Nup153-Nup50 Protein Interface and Its Role in Nuclear Import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE-ASSOCIATED PROTEIN; NUCLEOPORIN NUP153; TF1 RETROTRANSPOSON; FISSION YEAST; LIVING CELLS; COMPLEX; TRANSPORT; ENVELOPE; BINDING; EXPORT	Interactions between Nup50 and soluble transport factors underlie the efficiency of certain nucleocytoplasmic transport pathways. The platform on which these interactions take place is important to building a complete understanding of nucleocytoplasmic trafficking. Nup153 is the nucleoporin that provides this scaffold for Nup50. Here, we have delineated requirements for the interaction between Nup153 and Nup50, revealing a dual interface. An interaction between Nup50 and a region in the unique N-terminal region of Nup153 is critical for the nuclear pore localization of Nup50. A second site of interaction is at the distal tail of Nup153 and is dependent on importin alpha. Both of these interactions involve the N-terminal domain of Nup50. The configuration of the Nup153-Nup50 partnership suggests that the Nup153 scaffold provides not just a means of pore targeting for Nup50 but also serves to provide a local environment that facilitates bringing Nup50 and importin alpha together, as well as other soluble factors involved in transport. Consistent with this, disruption of the Nup153-Nup50 interface decreases efficiency of nuclear import.	[Ullman, Katharine S.] Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Makise, Masaki] Sojo Univ, Fac Pharmaceut Sci, Kumamoto 8600082, Japan; [Adam, Stephen A.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Sojo University; Northwestern University; Feinberg School of Medicine	Ullman, KS (corresponding author), Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, 2000 Circle Hope Dr, Salt Lake City, UT 84112 USA.	katharine.ullman@hci.utah.edu		Ullman, Katharine/0000-0003-3693-2830; Adam, Stephen/0000-0003-3444-7655	National Institutes of Health Grant [R01 GM61275, P30 CA042014]; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061275] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24890288] Funding Source: KAKEN	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM61275 (to K. S. U.). Shared resources used in this work are supported in part by National Institutes of Health Grant P30 CA042014 awarded to the Huntsman Cancer Institute.	Al-Haboubi T, 2011, NUCLEUS-PHILA, V2, P500, DOI 10.4161/nucl.2.5.17913; Ball JR, 2005, CHROMOSOMA, V114, P319, DOI 10.1007/s00412-005-0019-3; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Chow KH, 2012, NUCLEUS-PHILA, V3, P349, DOI 10.4161/nucl.20822; Dimaano C, 2001, J BIOL CHEM, V276, P45349, DOI 10.1074/jbc.M102592200; Dultz E, 2008, J CELL BIOL, V180, P857, DOI 10.1083/jcb.200707026; Fan F, 1997, GENOMICS, V40, P444, DOI 10.1006/geno.1996.4557; Freedman ND, 2004, MOL BIOL CELL, V15, P2276, DOI 10.1091/mbc.E03-11-0839; Guan TL, 2000, MOL CELL BIOL, V20, P5619, DOI 10.1128/MCB.20.15.5619-5630.2000; Hase ME, 2003, MOL BIOL CELL, V14, P1923, DOI 10.1091/mbc.E02-09-0620; Kaiser C, 2008, RNA, V14, P2170, DOI 10.1261/rna.1171808; Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011; Kosako H, 2009, NAT STRUCT MOL BIOL, V16, P1026, DOI 10.1038/nsmb.1656; Lindsay ME, 2002, CELL, V110, P349, DOI 10.1016/S0092-8674(02)00836-X; Love DC, 1998, P NATL ACAD SCI USA, V95, P10608, DOI 10.1073/pnas.95.18.10608; Mackay DR, 2009, MOL BIOL CELL, V20, P1652, DOI 10.1091/mbc.E08-08-0883; Matsuura Y, 2005, EMBO J, V24, P3681, DOI 10.1038/sj.emboj.7600843; Moore MS, 2003, TRENDS CELL BIOL, V13, P61, DOI 10.1016/S0962-8924(02)00044-2; Moorhead Greg B. G., 2008, BMC Biochemistry, V9, P28, DOI 10.1186/1471-2091-9-28; Moroianu J, 1997, P NATL ACAD SCI USA, V94, P9699, DOI 10.1073/pnas.94.18.9699; Muller D, 2000, EMBO J, V19, P2168, DOI 10.1093/emboj/19.10.2168; Nakielny S, 1999, EMBO J, V18, P1982, DOI 10.1093/emboj/18.7.1982; Ogawa Y, 2012, TRAFFIC, V13, P934, DOI 10.1111/j.1600-0854.2012.01367.x; Ogawa Y, 2010, MOL BIOL CELL, V21, P630, DOI 10.1091/mbc.E09-05-0374; Pumroy RA, 2012, J BIOL CHEM, V287, P2022, DOI 10.1074/jbc.M111.315838; Pyhtila B, 2003, J BIOL CHEM, V278, P42699, DOI 10.1074/jbc.M307135200; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Sabri N, 2007, J CELL BIOL, V178, P557, DOI 10.1083/jcb.200612135; Shah S, 1998, J CELL BIOL, V141, P31, DOI 10.1083/jcb.141.1.31; Sistla S, 2007, MOL BIOL CELL, V18, P3692, DOI 10.1091/mbc.E06-12-1062; Smitherman M, 2000, MOL CELL BIOL, V20, P5631, DOI 10.1128/MCB.20.15.5631-5642.2000; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Vagnarelli P, 2011, DEV CELL, V21, P328, DOI 10.1016/j.devcel.2011.06.020; Varadarajan P, 2005, MOL BIOL CELL, V16, P1823, DOI 10.1091/mbc.E04-07-0583; Walther TC, 2001, EMBO J, V20, P5703, DOI 10.1093/emboj/20.20.5703; Zhou LX, 2010, FEBS LETT, V584, P3013, DOI 10.1016/j.febslet.2010.05.038	37	40	40	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38515	38522		10.1074/jbc.M112.378893	http://dx.doi.org/10.1074/jbc.M112.378893			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23007389	Green Published, hybrid			2022-12-28	WOS:000310982800011
J	Oishi, A; Makita, N; Sato, J; Iiri, T				Oishi, Atsuro; Makita, Noriko; Sato, Junichiro; Iiri, Taroh			Regulation of RhoA Signaling by the cAMP-dependent Phosphorylation of RhoGDI alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CONTRACTION; LIGHT-CHAIN PHOSPHATASE; PROTEIN-KINASE; SMALL GTPASE; ADP-RIBOSYLTRANSFERASE; DISSOCIATION INHIBITOR; CELL BIOLOGY; GENE-PRODUCT; CYCLIC-AMP; IN-VIVO	RhoA plays a pivotal role in regulating cell shape and movement. Protein kinase A (PKA) inhibits RhoA signaling and thereby induces a characteristic morphological change, cell rounding. This has been considered to result from cAMP-induced phosphorylation of RhoA at Ser-188, which induces a stable RhoA-GTP-RhoGDI alpha complex and sequesters RhoA to the cytosol. However, few groups have shown RhoA phosphorylation in intact cells. Here we show that phosphorylation of RhoGDI alpha but not RhoA plays an essential role in the PKA-induced inhibition of RhoA signaling and in the morphological changes using cardiac fibroblasts. The knockdown of RhoGDI alpha by siRNA blocks cAMP-induced cell rounding, which is recovered by RhoGDI alpha-WT expression but not when a RhoGDI alpha-S174A mutant is expressed. PKA phosphorylates RhoGDI alpha at Ser-174 and the phosphorylation of RhoGDI alpha is likely to induce the formation of a active RhoA-RhoGDI alpha complex. Our present results thus reveal a principal molecular mechanism underlying G(g)/cAMP-induced cross-talk with G(q)/G(13)/RhoA signaling.	[Oishi, Atsuro; Makita, Noriko; Sato, Junichiro; Iiri, Taroh] Univ Tokyo, Sch Med, Dept Endocrinol & Nephrol, Tokyo 1138655, Japan	University of Tokyo	Makita, N (corresponding author), Univ Tokyo, Sch Med, Dept Endocrinol & Nephrol, Tokyo 1138655, Japan.	norimaki-tky@umin.ac.jp; tiiri-tky@umin.ac.jp	Makita, Noriko/GQY-8175-2022	OISHI, Atsuro/0000-0003-1788-5485	Ministry of Education, Science, Sports, and Culture, Japan; Grants-in-Aid for Scientific Research [22591008] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture, Japan.	ADAMSON P, 1992, J CELL BIOL, V119, P617, DOI 10.1083/jcb.119.3.617; Bolz SS, 2003, CIRCULATION, V107, P3081, DOI 10.1161/01.CIR.0000074202.19612.8C; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Dong JM, 1998, J BIOL CHEM, V273, P22554, DOI 10.1074/jbc.273.35.22554; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Dransart E, 2005, TRAFFIC, V6, P957, DOI 10.1111/j.1600-0854.2005.00335.x; Ellerbroek SM, 2003, J BIOL CHEM, V278, P19023, DOI 10.1074/jbc.M213066200; Essler M, 2000, J IMMUNOL, V164, P6543, DOI 10.4049/jimmunol.164.12.6543; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Iiri T, 1997, P NATL ACAD SCI USA, V94, P5656, DOI 10.1073/pnas.94.11.5656; Iiri T, 1999, P NATL ACAD SCI USA, V96, P499, DOI 10.1073/pnas.96.2.499; IIRI T, 1994, NATURE, V371, P164, DOI 10.1038/371164a0; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Knezevic N, 2007, MOL CELL BIOL, V27, P6323, DOI 10.1128/MCB.00523-07; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; LANG P, 1993, BIOCHEM BIOPH RES CO, V196, P1522, DOI 10.1006/bbrc.1993.2424; Loirand G, 2010, NAT REV CARDIOL, V7, P637, DOI 10.1038/nrcardio.2010.136; Makita N, 2007, P NATL ACAD SCI USA, V104, P17424, DOI 10.1073/pnas.0708561104; Makita N, 2007, P NATL ACAD SCI USA, V104, P5443, DOI 10.1073/pnas.0701290104; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; MIURA Y, 1993, J BIOL CHEM, V268, P510; Miyoshi J, 2009, AFCS NATURE MOL PAGE, DOI [10.1038/mp.a0002062.01, DOI 10.1038/MP.A0002062.01]; Murthy KS, 2003, AM J PHYSIOL-GASTR L, V284, pG1006, DOI 10.1152/ajpgi.00465.2002; Narumiya S, 1996, J BIOCHEM-TOKYO, V120, P215; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; NEMOTO Y, 1992, J BIOL CHEM, V267, P20916; Nunes KP, 2010, CELL MOL LIFE SCI, V67, P3823, DOI 10.1007/s00018-010-0460-1; Puetz S, 2009, PHYSIOLOGY, V24, P342, DOI 10.1152/physiol.00023.2009; Qiao J, 2003, AM J PHYSIOL-LUNG C, V284, pL972, DOI 10.1152/ajplung.00429.2002; Qiao J, 2008, AM J PHYSIOL-CELL PH, V295, pC1161, DOI 10.1152/ajpcell.00139.2008; Ridley AJ, 2001, J CELL SCI, V114, P2713; Rolli-Derkinderen M, 2005, CIRC RES, V96, P1152, DOI 10.1161/01.RES.0000170084.88780.ea; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Sawada N, 2001, BIOCHEM BIOPH RES CO, V280, P798, DOI 10.1006/bbrc.2000.4194; SEKINE A, 1989, J BIOL CHEM, V264, P8602; Shichi D, 2010, J BIOL CHEM, V285, P33680, DOI 10.1074/jbc.M110.122390; Takahashi K, 2012, J BIOL CHEM, V287, P2099, DOI 10.1074/jbc.M111.268797; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Tamma G, 2003, J CELL SCI, V116, P1519, DOI 10.1242/jcs.00355; Tkachenko E, 2011, NAT CELL BIOL, V13, P660, DOI 10.1038/ncb2231; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	53	33	34	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38705	38715		10.1074/jbc.M112.401547	http://dx.doi.org/10.1074/jbc.M112.401547			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23012358	hybrid, Green Published			2022-12-28	WOS:000310982800029
J	Singh, AP; Arora, S; Bhardwaj, A; Srivastava, SK; Kadakia, MP; Wang, B; Grizzle, WE; Owen, LB; Singh, S				Singh, Ajay P.; Arora, Sumit; Bhardwaj, Arun; Srivastava, Sanjeev K.; Kadakia, Madhavi P.; Wang, Bin; Grizzle, William E.; Owen, Laurie B.; Singh, Seema			CXCL12/CXCR4 Protein Signaling Axis Induces Sonic Hedgehog Expression in Pancreatic Cancer Cells via Extracellular Regulated Kinase- and Akt Kinase-mediated Activation of Nuclear Factor kappa B IMPLICATIONS FOR BIDIRECTIONAL TUMOR-STROMAL INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTOR CXCR4; IN-VITRO; PROLIFERATION; SURVIVAL; PATHWAY; BIOLOGY; GROWTH; PROGRESSION; RESISTANCE; INITIATION	Recent evidence suggests a major role of tumor-stromal interactions in pancreatic cancer pathobiology. The chemokine CXCL12 (stromal cell-derived factor 1 (SDF-1)), abundantly produced by stromal cells, promotes progression, metastasis, and chemoresistance of pancreatic cancer cells. On the other hand, pancreatic tumor cell-derived sonic hedgehog (SHH) acts predominantly on stromal cells to induce desmoplasia and, thus, has a paracrine effect on tumorigenesis and therapeutic outcome. In this study, we examined the association between these two proteins of pathological significance in pancreatic cancer. Our data demonstrate that CXCL12 leads to a dose- and time-dependent up-regulation of SHH in pancreatic cancer cells. CXCL12-induced SHH up-regulation is specifically mediated through the receptor CXCR4 and is dependent on the activation of downstream Akt and ERK signaling pathways. Both Akt and ERK cooperatively promote nuclear accumulation of NF-kappa B by inducing the phosphorylation and destabilization of its inhibitory protein, I kappa B-alpha. Using dominant negative I kappa B-alpha, a SHH promoter (deletion mutant) reporter, and chromatin immunoprecipitation assays, we demonstrate that CXCL12 exposure enhances direct binding of NF-kappa B to the SHH promoter and that suppression of NF-kappa B activation abrogates CXCL12-induced SHH expression. Finally, our data demonstrate a strong correlative expression of CXCR4 and SHH in human pancreatic cancer tissues, whereas their expression is not observed in the normal pancreas. Altogether, our data reveal a novel mechanism underlying aberrant SHH expression in pancreatic cancer and identify a molecular link facilitating bidirectional tumor-stromal interactions.	[Singh, Ajay P.; Arora, Sumit; Bhardwaj, Arun; Srivastava, Sanjeev K.; Owen, Laurie B.; Singh, Seema] Univ S Alabama, Dept Oncol Sci, Mitchell Canc Inst, Mobile, AL 36688 USA; [Singh, Ajay P.] Univ S Alabama, Dept Biochem & Mol Biol, Coll Med, Mobile, AL 36688 USA; [Wang, Bin] Univ S Alabama, Dept Math & Stat, Mobile, AL 36688 USA; [Kadakia, Madhavi P.] Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; [Grizzle, William E.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	University of South Alabama; University of South Alabama; University of South Alabama; University System of Ohio; Wright State University Dayton; University of Alabama System; University of Alabama Birmingham	Singh, AP (corresponding author), Univ S Alabama, Dept Oncol Sci, Mitchell Canc Inst, 1660 Springhill Ave, Mobile, AL 36604 USA.	asingh@usouthal.edu; seemasingh@usouthal.edu	Singh, Ajay/AAF-4414-2020	Wang, Bin/0000-0002-3689-6932; Singh, Ajay/0000-0003-3492-6330	National Cancer Institute (NCI) [CA137513, CA167137, CA101955]; University of South Alabama Mitchell Cancer Institute (USAMCI); NATIONAL CANCER INSTITUTE [P50CA101955, P20CA101955, R03CA137513, R21CA167137] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of South Alabama Mitchell Cancer Institute (USAMCI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute (NCI) Grants CA137513, CA167137 (to A. P. S.), and NCI P50 SPORE CA101955 (to W. E. G.), and by internal funding support from University of South Alabama Mitchell Cancer Institute (USAMCI).	Agarwal U, 2010, CIRC RES, V107, P667, DOI 10.1161/CIRCRESAHA.110.223289; Arora S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021573; Bai D, 2009, INT J CANCER, V125, P2863, DOI 10.1002/ijc.24748; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Caserta TM, 2006, MOL CANCER RES, V4, P759, DOI 10.1158/1541-7786.MCR-05-0149; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Ding YZ, 2010, PANCREAS, V39, P283, DOI 10.1097/MPA.0b013e3181c15619; do Carmo A, 2010, CANCER BIOL THER, V9, P56, DOI 10.4161/cbt.9.1.10342; Duda DG, 2011, CLIN CANCER RES, V17, P2074, DOI 10.1158/1078-0432.CCR-10-2636; Erkan M., 2010, Experimental Oncology, V32, P128; Evangelista M, 2006, CLIN CANCER RES, V12, P5924, DOI 10.1158/1078-0432.CCR-06-1736; Feldmann G, 2008, MOL CANCER THER, V7, P2725, DOI 10.1158/1535-7163.MCT-08-0573; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Kasperczyk H, 2009, FASEB J, V23, P21, DOI 10.1096/fj.08-111096; Kelleher FC, 2011, CARCINOGENESIS, V32, P445, DOI 10.1093/carcin/bgq280; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Lu DY, 2009, EUR J PHARMACOL, V613, P146, DOI 10.1016/j.ejphar.2009.03.001; Marchesi F, 2004, CANCER RES, V64, P8420, DOI 10.1158/0008-5472.CAN-04-1343; Marechal R, 2009, BRIT J CANCER, V100, P1444, DOI 10.1038/sj.bjc.6605020; Matsuo Y, 2009, INT J CANCER, V124, P853, DOI 10.1002/ijc.24040; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Raffel C, 1997, CANCER RES, V57, P842; Shen XM, 2010, PANCREAS, V39, P81, DOI 10.1097/MPA.0b013e3181bb2ab7; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Singh S, 2010, BRIT J CANCER, V103, P1671, DOI 10.1038/sj.bjc.6605968; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Thomas RM, 2008, GUT, V57, P1555, DOI 10.1136/gut.2007.143941; Wang Z, 2008, BRIT J CANCER, V99, P1695, DOI 10.1038/sj.bjc.6604745; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	49	92	92	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39115	39124		10.1074/jbc.M112.409581	http://dx.doi.org/10.1074/jbc.M112.409581			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22995914	hybrid, Green Published			2022-12-28	WOS:000310982800067
J	Li, SY; Tietz, DR; Rutaganira, FU; Kells, PM; Anzai, Y; Kato, F; Pochapsky, TC; Sherman, DH; Podust, LM				Li, Shengying; Tietz, Drew R.; Rutaganira, Florentine U.; Kells, Petrea M.; Anzai, Yojiro; Kato, Fumio; Pochapsky, Thomas C.; Sherman, David H.; Podust, Larissa M.			Substrate Recognition by the Multifunctional Cytochrome P450 MycG in Mycinamicin Hydroxylation and Epoxidation Reactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHETIC GENE-CLUSTER; GIBBERELLA-FUJIKUROI ENCODES; MICROMONOSPORA-GRISEORUBIDA; MACROLIDE ANTIBIOTICS; FUSARIUM-VERTICILLIOIDES; ABSOLUTE-CONFIGURATION; AUREOTHIN BIOSYNTHESIS; CRYSTAL-STRUCTURE; ACTIVE-SITE; ENZYMES	The majority of characterized cytochrome P450 enzymes in actinomycete secondary metabolic pathways are strictly sub-strate-, regio-, and stereo-specific. Examples of multifunctional biosynthetic cytochromes P450 with broader substrate and regio-specificity are growing in number and are of particular interest for biosynthetic and chemoenzymatic applications. MycG is among the first P450 monooxygenases characterized that catalyzes both hydroxylation and epoxidation reactions in the final biosynthetic steps, leading to oxidative tailoring of the 16-membered ring macrolide antibiotic mycinamicin II in the actinomycete Micromonospora griseorubida. The ordering of steps to complete the biosynthetic process involves a complex substrate recognition pattern by the enzyme and interplay between three tailoring modifications as follows: glycosylation, methylation, and oxidation. To understand the catalytic properties of MycG, we structurally characterized the ligand-free enzyme and its complexes with three native metabolites. These include substrates mycinamicin IV and V and their biosynthetic precursor mycinamicin III, which carries the monomethoxy sugar javose instead of the dimethoxylated sugar mycinose. The two methoxy groups of mycinose serve as sensors that mediate initial recognition to discriminate between closely related substrates in the post-polyketide oxidative tailoring of mycinamicin metabolites. Because x-ray structures alone did not explain the mechanisms of macrolide hydroxylation and epoxidation, para-magnetic NMR relaxation measurements were conducted. Molecular modeling based on these data indicates that in solution substrate may penetrate the active site sufficiently to place the abstracted hydrogen atom of mycinamicin IV within 6 angstrom of the heme iron and similar to 4 angstrom of the oxygen of iron-ligated water.	[Podust, Larissa M.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94158 USA; [Li, Shengying; Sherman, David H.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Li, Shengying] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao 266101, Shandong, Peoples R China; [Tietz, Drew R.; Pochapsky, Thomas C.] Brandeis Univ, Dept Chem, Waltham, MA 02454 USA; [Tietz, Drew R.; Pochapsky, Thomas C.] Brandeis Univ, Rosenstiel Basic Med Sci Inst, Waltham, MA 02454 USA; [Rutaganira, Florentine U.; Kells, Petrea M.; Podust, Larissa M.] Univ Calif San Francisco, Ctr Discovery & Innovat Parasit Dis, San Francisco, CA 94158 USA; [Anzai, Yojiro; Kato, Fumio] Toho Univ, Fac Pharmaceut Sci, Chiba 2748510, Japan	University of California System; University of California San Francisco; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Brandeis University; Brandeis University; University of California System; University of California San Francisco; Toho University	Podust, LM (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94158 USA.	larissa.podust@ucsf.edu	Podust, Larissa/ABB-7940-2020	Podust, Larissa/0000-0002-8537-8760; Pochapsky, Thomas/0000-0001-8995-1088	National Institutes of Health [RO1 GM078553, GM44191, P41 RR001081]; Hans W. Vahlteich Professorship; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017269, P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044191, R01GM078553, R29GM044191, T32GM064337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hans W. Vahlteich Professorship; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM078553 (to D. H. S. and L. M. P.) and GM44191 (to T. C. P.). This work was also supported by the Hans W. Vahlteich Professorship (to D. H. S.).; We thank Potter Wickware for critical reading of the manuscript and the staff members James Holton, George Meigs, and Jane Tanamachi of beamline 8.3.1 at the Advanced Light Source, Lawrence Berkeley National Laboratory, for assistance with data collection. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231. Molecular graphics images were produced in part using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health Grant P41 RR001081).	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Anzai Y, 2003, FEMS MICROBIOL LETT, V218, P135, DOI 10.1111/j.1574-6968.2003.tb11509.x; Anzai Y, 2008, CHEM BIOL, V15, P950, DOI 10.1016/j.chembiol.2008.07.014; Anzai Y, 2012, ANTIMICROB AGENTS CH, V56, P3648, DOI 10.1128/AAC.06063-11; Asciutto EK, 2012, BIOCHEMISTRY-US, V51, P3383, DOI 10.1021/bi300007r; BLOEMBERGEN N, 1957, J CHEM PHYS, V27, P572, DOI 10.1063/1.1743771; Bojja RS, 2004, J AGR FOOD CHEM, V52, P2855, DOI 10.1021/jf035429z; Carlson JC, 2011, NAT CHEM, V3, P628, DOI [10.1038/NCHEM.1087, 10.1038/nchem.1087]; Carlson JC, 2010, CHEMBIOCHEM, V11, P564, DOI 10.1002/cbic.200900658; Carlson JC, 2009, J NAT PROD, V72, P2076, DOI 10.1021/np9005597; Case D. A., 2021, AMBER 2022; Chen MS, 2010, SCIENCE, V327, P566, DOI 10.1126/science.1183602; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cresnar B, 2011, BBA-PROTEINS PROTEOM, V1814, P29, DOI 10.1016/j.bbapap.2010.06.020; CuppVickery JR, 1996, NAT STRUCT BIOL, V3, P632, DOI 10.1038/nsb0796-632; CUPPVICKERY JR, 1995, NAT STRUCT BIOL, V2, P144, DOI 10.1038/nsb0295-144; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; He J, 2003, CHEM BIOL, V10, P1225, DOI 10.1016/j.chembiol.2003.11.009; Holton J, 2004, P NATL ACAD SCI USA, V101, P1537, DOI 10.1073/pnas.0306241101; INOUYE M, 1994, MOL GEN GENET, V245, P456, DOI 10.1007/BF00302258; Isin EM, 2008, ANAL BIOANAL CHEM, V392, P1019, DOI 10.1007/s00216-008-2244-0; Johnston JB, 2011, ARCH BIOCHEM BIOPHYS, V507, P86, DOI 10.1016/j.abb.2010.08.011; Kells PM, 2010, CHEM BIOL, V17, P841, DOI 10.1016/j.chembiol.2010.05.026; KINOSHITA K, 1992, J ANTIBIOT, V45, P1; KINOSHITA K, 1985, J ANTIBIOT, V38, P522, DOI 10.7164/antibiotics.38.522; KINOSHITA K, 1989, J ANTIBIOT, V42, P1869, DOI 10.7164/antibiotics.42.1869; KINOSHITA K, 1989, J ANTIBIOT, V42, P1003, DOI 10.7164/antibiotics.42.1003; Kudo F, 2010, CHEMBIOCHEM, V11, P1574, DOI 10.1002/cbic.201000214; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Li SY, 2007, J AM CHEM SOC, V129, P12940, DOI 10.1021/ja075842d; Li SY, 2009, P NATL ACAD SCI USA, V106, P18463, DOI 10.1073/pnas.0907203106; Li SY, 2009, J BIOL CHEM, V284, P5723, DOI 10.1074/jbc.M807592200; MODI S, 1995, BIOCHEMISTRY-US, V34, P8982, DOI 10.1021/bi00028a006; Muller M, 2006, CHEMBIOCHEM, V7, P37, DOI 10.1002/cbic.200500161; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagano S, 2003, J BIOL CHEM, V278, P44886, DOI 10.1074/jbc.M308115200; OMURA T, 1964, J BIOL CHEM, V239, P2379; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PHILSON SB, 1979, J BIOL CHEM, V254, P173; Podust LM, 2012, NAT PROD REP, V29, P1251, DOI 10.1039/c2np20020a; Proctor RH, 2006, J AGR FOOD CHEM, V54, P2424, DOI 10.1021/jf0527706; Rojas MC, 2001, P NATL ACAD SCI USA, V98, P5838, DOI 10.1073/pnas.091096298; SATOI S, 1980, J ANTIBIOT, V33, P364, DOI 10.7164/antibiotics.33.364; Savino C, 2009, J BIOL CHEM, V284, P29170, DOI 10.1074/jbc.M109.003590; Seo JA, 2001, FUNGAL GENET BIOL, V34, P155, DOI 10.1006/fgbi.2001.1299; Sherman DH, 2006, J BIOL CHEM, V281, P26289, DOI 10.1074/jbc.M605478200; SOLOMON I, 1955, PHYS REV, V99, P559, DOI 10.1103/PhysRev.99.559; SUZUKI H, 1990, J ANTIBIOT, V43, P1508, DOI 10.7164/antibiotics.43.1508; Takenaka S, 1998, FEMS MICROBIOL LETT, V167, P95, DOI 10.1111/j.1574-6968.1998.tb13213.x; Tokai T, 2007, BIOCHEM BIOPH RES CO, V353, P412, DOI 10.1016/j.bbrc.2006.12.033; Tsukada S, 2010, FEMS MICROBIOL LETT, V304, P148, DOI 10.1111/j.1574-6968.2010.01899.x; Tudzynski B, 2002, J BIOL CHEM, V277, P21246, DOI 10.1074/jbc.M201651200; Tudzynski B, 2001, APPL ENVIRON MICROB, V67, P3514, DOI 10.1128/AEM.67.8.3514-3522.2001; von Kries J. P., 2010, CURR PROTOC MICROBIO, V16; Wei JY, 2005, J AM CHEM SOC, V127, P6974, DOI 10.1021/ja051195j; Xu LH, 2010, J BIOL CHEM, V285, P16844, DOI 10.1074/jbc.M109.092460; Xu LH, 2009, J BACTERIOL, V191, P1211, DOI 10.1128/JB.01276-08; Yasutake Y, 2007, BIOCHEM BIOPH RES CO, V361, P876, DOI 10.1016/j.bbrc.2007.07.062; Zocher G, 2011, J AM CHEM SOC, V133, P2292, DOI 10.1021/ja110146z	60	43	44	2	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.410340	http://dx.doi.org/10.1074/jbc.M112.410340			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22952225	hybrid, Green Published			2022-12-28	WOS:000310642200024
J	Qin, SY; Hu, D; Matsumoto, K; Takeda, K; Matsumoto, N; Yamaguchi, Y; Yamamoto, K				Qin, Sheng-Ying; Hu, Dan; Matsumoto, Kana; Takeda, Koh; Matsumoto, Naoki; Yamaguchi, Yoshiki; Yamamoto, Kazuo			Malectin Forms a Complex with Ribophorin I for Enhanced Association with Misfolded Glycoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; N-GLYCOSYLATION; BINDING PROTEIN; QUALITY-CONTROL; MRH DOMAIN; HUMAN OS-9; OLIGOSACCHARYLTRANSFERASE; ALPHA-1-ANTITRYPSIN; DEGRADATION; EFFICIENT	Malectin is an endoplasmic reticulum-resident lectin, which recognizes di-glucosylated Glc(2)Man(9)GlcNAc(2) (G2M9) N-glycans on newly synthesized glycoproteins. Wepreviously demonstrated that malectin preferentially associates with misfolded glycoproteins and inhibits their secretion (Chen, Y., Hu, D., Yabe, R., Tateno, H., Qin, S. Y., Matsumoto, N., Hirabayashi, J., and Yamamoto, K. (2011) Mol. Biol. Cell 22, 3559-3570). The sugar binding activity of malectin is required for this process. However, because G2M9 N-glycans are generated at the very early stage of processing and are typically found on both misfolded glycoproteins and glycoproteins undergoing folding, other mechanisms must underlie the preference of malectin for misfolded glycoproteins. Here, we searched for proteins that were co-immunoprecipitated with malectin, and we found that malectin formed a stable complex with an endoplasmic reticulum-resident transmembrane protein, ribophorin I. Co-expression of malectin and ribophorin I significantly enhanced the association between malectin and a folding-defective alpha 1-antitrypsin variant (null Hong Kong) and reduced its secretion; however, secretion of wild-type alpha 1-antitrypsin was not affected. The enhanced association and reduced secretion were counteracted by siRNA-mediated down-regulation of ribophorin I. Also, a reporter assay revealed that ribophorin I preferentially interacted with misfolded ribonuclease A but not with the native form, suggesting that ribophorin I may function as a chaperone that recognizes misfolded proteins inside cells. These results provide the first evidence of the mechanism by which malectin preferentially associates with misfolded glycoproteins.	[Qin, Sheng-Ying; Hu, Dan; Takeda, Koh; Matsumoto, Naoki; Yamamoto, Kazuo] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan; [Matsumoto, Kana; Yamaguchi, Yoshiki] RIKEN, Adv Sci Inst, Struct Glycobiol Team, Wako, Saitama 3510198, Japan	University of Tokyo; RIKEN	Yamamoto, K (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan.	yamamoto@k.u-tokyo.ac.jp	Yamaguchi, Yoshiki/N-5246-2015	Yamaguchi, Yoshiki/0000-0003-0100-5439	Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology, Japan [21390173, 24390015]	Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency and Grants-in-aid for Scientific Research 21390173 and 24390015 (to K. Y.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200; Chen Y, 2011, MOL BIOL CELL, V22, P3559, DOI 10.1091/mbc.E11-03-0201; Galli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016304; Gauss R, 2011, MOL CELL, V42, P782, DOI 10.1016/j.molcel.2011.04.027; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; HILLSON DA, 1984, METHOD ENZYMOL, V107, P281; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Hu D, 2009, GLYCOBIOLOGY, V19, P1127, DOI 10.1093/glycob/cwp104; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; KELLEHER DJ, 1992, CELL, V69, P55, DOI 10.1016/0092-8674(92)90118-V; Mikami K, 2010, GLYCOBIOLOGY, V20, P310, DOI 10.1093/glycob/cwp175; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Muller LN, 2010, ORG BIOMOL CHEM, V8, P3294, DOI 10.1039/c004502k; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Oliver JD, 1999, MOL BIOL CELL, V10, P2573, DOI 10.1091/mbc.10.8.2573; Schallus T, 2008, MOL BIOL CELL, V19, P3404, DOI 10.1091/mbc.E08-04-0354; Schallus T, 2010, GLYCOBIOLOGY, V20, P1010, DOI 10.1093/glycob/cwq059; Serve O, 2010, J MOL BIOL, V396, P361, DOI 10.1016/j.jmb.2009.11.049; SOUSA MC, 1992, BIOCHEMISTRY-US, V31, P97, DOI 10.1021/bi00116a015; Wilson CM, 2005, J BIOL CHEM, V280, P4195, DOI 10.1074/jbc.M410329200; Wilson CM, 2008, P NATL ACAD SCI USA, V105, P9534, DOI 10.1073/pnas.0711846105; Wilson CM, 2007, J CELL SCI, V120, P648, DOI 10.1242/jcs.000729; Yamaguchi D, 2010, GLYCOBIOLOGY, V20, P348, DOI 10.1093/glycob/cwp182	24	45	45	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.394288	http://dx.doi.org/10.1074/jbc.M112.394288			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22988243	hybrid, Green Published			2022-12-28	WOS:000310642200042
J	Kurnellas, MP; Brownell, SE; Su, L; Malkovskiy, AV; Rajadas, J; Dolganov, G; Chopra, S; Schoolnik, GK; Sobel, RA; Webster, J; Ousman, SS; Becker, RA; Steinman, L; Rothbard, JB				Kurnellas, Michael P.; Brownell, Sara E.; Su, Leon; Malkovskiy, Andrey V.; Rajadas, Jayakumar; Dolganov, Gregory; Chopra, Sidharth; Schoolnik, Gary K.; Sobel, Raymond A.; Webster, Jonathan; Ousman, Shalina S.; Becker, Rachel A.; Steinman, Lawrence; Rothbard, Jonathan B.			Chaperone Activity of Small Heat Shock Proteins Underlies Therapeutic Efficacy in Experimental Autoimmune Encephalomyelitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-B-CRYSTALLIN; FUNCTIONAL ELEMENT; AGGREGATION; TRANSLOCATION; ACTIVATION; PREDICTION; APOPTOSIS; SEQUESTER; PEPTIDES; REVEALS	To determine whether the therapeutic activity of alpha B crystallin, small heat shock protein B5 (HspB5), was shared with other human sHsps, a set of seven human family members, a mutant of HspB5 G120 known to exhibit reduced chaperone activity, and a mycobacterial sHsp were expressed and purified from bacteria. Each of the recombinant proteins was shown to be a functional chaperone, capable of inhibiting aggregation of denatured insulin with varying efficiency. When injected into mice at the peak of disease, they were all effective in reducing the paralysis in experimental autoimmune encephalomyelitis. Additional structure activity correlations between chaperone activity and therapeutic function were established when linear regions within HspB5 were examined. A single region, corresponding to residues 73-92 of HspB5, forms amyloid fibrils, exhibited chaperone activity, and was an effective therapeutic for encephalomyelitis. The linkage of the three activities was further established by demonstrating individual substitutions of critical hydrophobic amino acids in the peptide resulted in the loss of all of the functions.	[Kurnellas, Michael P.; Brownell, Sara E.; Webster, Jonathan; Ousman, Shalina S.; Becker, Rachel A.; Steinman, Lawrence; Rothbard, Jonathan B.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Su, Leon; Rothbard, Jonathan B.] Stanford Univ, Sch Med, Div Rheumatol & Immunol, Dept Med, Stanford, CA 94305 USA; [Sobel, Raymond A.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Malkovskiy, Andrey V.; Rajadas, Jayakumar] Stanford Univ, Sch Med, Biomat & Adv Drug Delivery Lab, Stanford, CA 94305 USA; [Dolganov, Gregory; Chopra, Sidharth; Schoolnik, Gary K.] Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Dept Med, Stanford, CA 94305 USA; [Schoolnik, Gary K.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Steinman, L (corresponding author), Beckman B002,279 Campus Dr, Stanford, CA 94305 USA.	Steinman@stanford.edu	Rajadas, Jayakumar/AHC-0630-2022	Steinman, Lawrence/0000-0002-2437-2250; Sobel, Raymond/0000-0002-0477-9002; Chopra, Sidharth/0000-0001-8823-6074; Rajadas, Jayakumar/0000-0001-6520-3923	National Institutes of Health [R01NS55997, UO1 DK078123, 1R43 AI0949]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000949, T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK078123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055997] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS55997 (to L. S.), UO1 DK078123 (to J. B. R.), 1R43 AI0949 (to J. B. R. and L. S.), grants form the National MS Society (to J. B. R., M. K., and L. S.), and the Endriz Fund (to L. S.).	Arac A, 2011, P NATL ACAD SCI USA, V108, P13287, DOI 10.1073/pnas.1107368108; Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Balbirnie M, 2001, P NATL ACAD SCI USA, V98, P2375, DOI 10.1073/pnas.041617698; Bhattacharyya J, 2006, BIOCHEMISTRY-US, V45, P3069, DOI 10.1021/bi0518141; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Candido E Peter M, 2002, Prog Mol Subcell Biol, V28, P61; Cazalla D, 2005, PROTEIN EXPRES PURIF, V42, P54, DOI 10.1016/j.pep.2005.03.035; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Clark AR, 2011, J MOL BIOL, V408, P118, DOI 10.1016/j.jmb.2011.02.020; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; FARAHBAKHSH ZT, 1995, BIOCHEMISTRY-US, V34, P509, DOI 10.1021/bi00002a015; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Grant JL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004145; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Haslbeck M, 2004, EMBO J, V23, P638, DOI 10.1038/sj.emboj.7600080; Kamradt MC, 2005, J BIOL CHEM, V280, P11059, DOI 10.1074/jbc.M413382200; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; Kappe Guido, 2002, Prog Mol Subcell Biol, V28, P1; Kennaway CK, 2005, J BIOL CHEM, V280, P33419, DOI 10.1074/jbc.M504263200; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kim R, 1998, P NATL ACAD SCI USA, V95, P9129, DOI 10.1073/pnas.95.16.9129; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Liu S, 2007, BIOCHEM BIOPH RES CO, V354, P109, DOI 10.1016/j.bbrc.2006.12.152; Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Pangratz-Fuehrer S, 2011, EYE, V25, P809, DOI 10.1038/eye.2011.42; Pasta SY, 2004, MOL VIS, V10, P655; Perng MD, 2004, MOL BIOL CELL, V15, P2335, DOI 10.1091/mbc.E03-12-0893; Rothbard JB, 2012, J BIOL CHEM, V287, P9708, DOI 10.1074/jbc.M111.337691; Rothbard JB, 2011, J IMMUNOL, V186, P4263, DOI 10.4049/jimmunol.1003934; Santhoshkumar P, 2006, PROTEIN SCI, V15, P2488, DOI 10.1110/ps.062338206; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Shammas SL, 2011, BIOPHYS J, V101, P1681, DOI 10.1016/j.bpj.2011.07.056; Sharma KK, 2000, J BIOL CHEM, V275, P3767, DOI 10.1074/jbc.275.6.3767; Sharma KK, 1998, J BIOL CHEM, V273, P8965, DOI 10.1074/jbc.273.15.8965; Simon S, 2007, BIOCHEMISTRY-US, V46, P9605, DOI 10.1021/bi7003125; Steinman L, 2006, ANN NEUROL, V60, P12, DOI 10.1002/ana.20913; Sugiyama Y, 2000, J BIOL CHEM, V275, P1095, DOI 10.1074/jbc.275.2.1095; Tanaka N, 2008, BIOCHEMISTRY-US, V47, P2961, DOI 10.1021/bi701823g; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Velotta JB, 2011, ANN THORAC SURG, V91, P1907, DOI 10.1016/j.athoracsur.2011.02.072; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003	49	46	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36423	36434		10.1074/jbc.M112.371229	http://dx.doi.org/10.1074/jbc.M112.371229			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22955287	Green Published, hybrid			2022-12-28	WOS:000310364000062
J	Blainey, PC; Graziano, V; Perez-Berna, AJ; McGrath, WJ; Flint, SJ; Martin, CS; Xie, XS; Mangel, WF				Blainey, Paul C.; Graziano, Vito; Perez-Berna, Ana J.; McGrath, William J.; Flint, S. Jane; San Martin, Carmen; Xie, X. Sunney; Mangel, Walter F.			Regulation of a Viral Proteinase by a Peptide and DNA in One-dimensional Space IV. VIRAL PROTEINASE SLIDES ALONG DNA TO LOCATE AND PROCESS ITS SUBSTRATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ADENOVIRUS PROTEINASE; BINDING; PROTEASE; PERFORMANCE; ACTIVATION; DIFFUSION; COFACTORS; DYNAMICS; CONTACT; LINKING	Precursor proteins used in the assembly of adenovirus virions must be processed by the virally encoded adenovirus proteinase (AVP) before the virus particle becomes infectious. An activated adenovirus proteinase, the AVP-pVIc complex, was shown to slide along viral DNA with an extremely fast one-dimensional diffusion constant, 21.0 +/- 1.9 x 10(6) bp(2)/s. In principle, one-dimensional diffusion can provide a means for DNA-bound proteinases to locate and process DNA-bound substrates. Here, we show that this is correct. In vitro, AVP-pVIc complexes processed a purified virion precursor protein in a DNA-dependent reaction; in a quasi in vivo environment, heat-disrupted ts-1 virions, AVP-pVIc complexes processed five different precursor proteins in DNA-dependent reactions. Sliding of AVP-pVIc complexes along DNA illustrates a new biochemical mechanism by which a proteinase can locate its substrates, represents a new paradigm for virion maturation, and reveals a new way of exploiting the surface of DNA.	[Xie, X. Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Graziano, Vito; McGrath, William J.; Mangel, Walter F.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Perez-Berna, Ana J.; San Martin, Carmen] CSIC, CNB, Dept Macromol Struct, E-28049 Madrid, Spain; [Flint, S. Jane] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Harvard University; United States Department of Energy (DOE); Brookhaven National Laboratory; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Princeton University	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu; mangel@bnl.gov	San Martín, Carmen/A-4074-2010; Perez-Berna, Ana/G-2789-2016	San Martín, Carmen/0000-0001-9799-175X; McGrath, William/0000-0002-9375-624X; Perez-Berna, Ana/0000-0003-4145-532X; Blainey, Paul/0000-0002-4889-8783	National Institutes of Health [R01AI41599, GM037705]; National Institutes of Health; National Science Foundation; Ministerio de Ciencia e Innovacion of Spain [BFU2010-16382, FIS2010-10552-E]; Juan de la Cierva from the Ministerio de Ciencia e Innovacion of Spain; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041599, R21AI113565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037705] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Juan de la Cierva from the Ministerio de Ciencia e Innovacion of Spain; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI41599 (to W. F. M.) and GM037705 (to S. J. F.) and the National Institutes of Health Director's Pioneer Award and a National Science Foundation (to X. S. X.) This work was also supported by Grants BFU2010-16382 and FIS2010-10552-E from the Ministerio de Ciencia e Innovacion of Spain (to C. S. M.).; The recipient of a Juan de la Cierva postdoctoral contract from the Ministerio de Ciencia e Innovacion of Spain.	Bagchi B, 2008, J PHYS CHEM B, V112, P6282, DOI 10.1021/jp077568f; Bajpayee NS, 2005, BIOCHEMISTRY-US, V44, P8721, DOI 10.1021/bi0502240; Baniecki ML, 2001, BIOCHEMISTRY-US, V40, P12349, DOI 10.1021/bi0109008; Blainey PC, 2009, NAT STRUCT MOL BIOL, V16, P1224, DOI 10.1038/nsmb.1716; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Brown MT, 1996, FEBS LETT, V388, P233, DOI 10.1016/0014-5793(96)00569-8; Casjens S., 1997, STRUCTURAL BIOL VIRU, P3; CHATTERJEE PK, 1986, J MOL BIOL, V188, P23, DOI 10.1016/0022-2836(86)90477-8; Cooper M, 2004, J FLUORESC, V14, P145, DOI 10.1023/B:JOFL.0000016286.62641.59; Ding JZ, 1996, EMBO J, V15, P1778, DOI 10.1002/j.1460-2075.1996.tb00526.x; Doyle PS, 2000, PHYS REV LETT, V84, P4769, DOI 10.1103/PhysRevLett.84.4769; EARNSHAW WC, 1980, CELL, V21, P319, DOI 10.1016/0092-8674(80)90468-7; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Flint S.J., 2020, PRINCIPLES VIROLOGY, V2; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gowers DM, 2005, P NATL ACAD SCI USA, V102, P15883, DOI 10.1073/pnas.0505378102; Graziano V, 2013, J BIOL CHEM, V288, P2059, DOI 10.1074/jbc.M112.377150; Graziano V, 2013, J BIOL CHEM, V288, P2068, DOI 10.1074/jbc.M112.407312; Greber UF, 1998, REV MED VIROL, V8, P213; Gruber HJ, 2000, BIOCONJUGATE CHEM, V11, P696, DOI 10.1021/bc000015m; Gupta S, 2004, MOL CELL PROTEOMICS, V3, P950, DOI 10.1074/mcp.M400037-MCP200; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Harada Y, 1999, BIOPHYS J, V76, P709, DOI 10.1016/S0006-3495(99)77237-1; KABATA H, 1993, SCIENCE, V262, P1561, DOI 10.1126/science.8248804; Kim SJ, 2007, NAT METHODS, V4, P397, DOI 10.1038/NMETH1037; Kochaniak AB, 2009, J BIOL CHEM, V284, P17700, DOI 10.1074/jbc.M109.008706; Komazin-Meredith G, 2008, P NATL ACAD SCI USA, V105, P10721, DOI 10.1073/pnas.0802676105; Lehmberg E, 1999, J CHROMATOGR B, V732, P411, DOI 10.1016/S0378-4347(99)00316-3; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu HR, 2010, SCIENCE, V329, P1038, DOI 10.1126/science.1187433; MANGEL WF, 1993, NATURE, V361, P274, DOI 10.1038/361274a0; Mangel WF, 1996, J BIOL CHEM, V271, P536, DOI 10.1074/jbc.271.1.536; Mangenot S, 2003, BIOPHYS J, V85, P1817, DOI 10.1016/S0006-3495(03)74610-4; McGrath WJ, 2002, VIROLOGY, V296, P234, DOI 10.1006/viro.2002.1394; McGrath WJ, 2001, BIOCHEMISTRY-US, V40, P13237, DOI 10.1021/bi0111653; McGrath WJ, 2001, BIOCHEMISTRY-US, V40, P14468, DOI 10.1021/bi011562d; MURPHY LD, 1995, BIOPHYS CHEM, V57, P71, DOI 10.1016/0301-4622(95)00047-2; Perez-Berna AJ, 2009, J MOL BIOL, V392, P547, DOI 10.1016/j.jmb.2009.06.057; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Russell W C, 1967, J Gen Virol, V1, P509, DOI 10.1099/0022-1317-1-4-509; RUSSELL WC, 1982, J GEN VIROL, V63, P69, DOI 10.1099/0022-1317-63-1-69; Schroeder C. M., 2008, SINGLE MOL TECHNIQUE, P461; Thanbichler M, 2006, J STRUCT BIOL, V156, P292, DOI 10.1016/j.jsb.2006.05.007; van Oijen AM, 2003, SCIENCE, V301, P1235, DOI 10.1126/science.1084387; VANOOSTRUM J, 1985, J VIROL, V56, P439, DOI 10.1128/JVI.56.2.439-448.1985; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; WEBER J, 1976, J VIROL, V17, P462, DOI 10.1128/JVI.17.2.462-471.1976; WEBSTER A, 1994, J VIROL, V68, P7292, DOI 10.1128/JVI.68.11.7292-7300.1994; WEBSTER A, 1993, CELL, V72, P97, DOI 10.1016/0092-8674(93)90053-S; Zimmerman SB, 2006, J STRUCT BIOL, V156, P255, DOI 10.1016/j.jsb.2006.03.022	51	37	41	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					2092	2102		10.1074/jbc.M112.407460	http://dx.doi.org/10.1074/jbc.M112.407460			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23043138	Green Published, hybrid			2022-12-28	WOS:000313751400060
J	Grassian, AR; Lin, F; Barrett, R; Liu, Y; Jiang, W; Korpal, M; Astley, H; Gitterman, D; Henley, T; Howes, R; Levell, J; Korn, JM; Pagliarini, R				Grassian, Alexandra R.; Lin, Fallon; Barrett, Rosemary; Liu, Yue; Jiang, Wei; Korpal, Manav; Astley, Holly; Gitterman, Daniel; Henley, Thomas; Howes, Rob; Levell, Julian; Korn, Joshua M.; Pagliarini, Raymond			Isocitrate Dehydrogenase (IDH) Mutations Promote a Reversible ZEB1/MicroRNA (miR)-200-dependent Epithelial-Mesenchymal Transition (EMT)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; MIR-200 FAMILY; E-CADHERIN; ONCOMETABOLITE 2-HYDROXYGLUTARATE; REPRESSORS ZEB1; CANCER-CELLS; MUTANT IDH1; STEM-CELLS; GENE; EXPRESSION	Mutations in the genes encoding isocitrate dehydrogenase 1 and 2 (IDH1/2) occur in a variety of tumor types, resulting in production of the proposed oncometabolite, 2-hydroxyglutarate (2-HG). How mutant IDH and 2-HG alter signaling pathways to promote cancer, however, remains unclear. Additionally, there exist relatively few cell lines with IDH mutations. To examine the effect of endogenous IDH mutations and 2-HG, we created a panel of isogenic epithelial cell lines with either wild-type IDH1/2 or clinically relevant IDH1/2 mutations. Differences were noted in the ability of IDH mutations to cause robust 2-HG accumulation. IDH1/2 mutants that produce high levels of 2-HG cause an epithelial-mesenchymal transition (EMT)-like phenotype, characterized by changes in EMT-related gene expression and cellular morphology. 2-HG is sufficient to recapitulate aspects of this phenotype in the absence of an IDH mutation. In the cells types examined, mutant IDH-induced EMT is dependent on up-regulation of the transcription factor ZEB1 and down-regulation of the miR-200 family of microRNAs. Furthermore, sustained knockdown of IDH1 in IDH1 R132H mutant cells is sufficient to reverse many characteristics of EMT, demonstrating that continued expression of mutant IDH is required to maintain this phenotype. These results suggest mutant IDH proteins can reversibly deregulate discrete signaling pathways that contribute to tumorigenesis.	[Grassian, Alexandra R.; Lin, Fallon; Barrett, Rosemary; Liu, Yue; Jiang, Wei; Korpal, Manav; Levell, Julian; Korn, Joshua M.; Pagliarini, Raymond] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Astley, Holly; Gitterman, Daniel; Henley, Thomas; Howes, Rob] Horizon Discovery Ltd, Cambridge CB25 9TL, England	Novartis	Pagliarini, R (corresponding author), Novartis Inst Biomed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA.	raymond.pagliarini@novartis.com	Jiang, Wei/F-2521-2010		Novartis Institutes for Biomedical Research	Novartis Institutes for Biomedical Research	Recipients of presidential postdoctoral fellowships from Novartis Institutes for Biomedical Research.	Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Arai M, 2012, BRAIN TUMOR PATHOL, V29, P201, DOI 10.1007/s10014-012-0085-1; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Blick T, 2010, J MAMMARY GLAND BIOL, V15, P235, DOI 10.1007/s10911-010-9175-z; Borger DR, 2012, ONCOLOGIST, V17, P72, DOI 10.1634/theoncologist.2011-0386; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cairns RA, 2012, BLOOD, V119, P1901, DOI 10.1182/blood-2011-11-391748; Capper D, 2009, ACTA NEUROPATHOL, V118, P599, DOI 10.1007/s00401-009-0595-z; Chou WC, 2011, LEUKEMIA, V25, P246, DOI 10.1038/leu.2010.267; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Christoffersen NR, 2007, RNA, V13, P1172, DOI 10.1261/rna.586807; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Deneberg S, 2011, BLOOD, V118, P5573, DOI 10.1182/blood-2011-01-332353; Duncan C. G., 2012, GENOME RES IN PRESS; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Ghiam AF, 2012, ONCOGENE, V31, P3826, DOI 10.1038/onc.2011.546; Grassian AR, 2011, GENE DEV, V25, P1716, DOI 10.1101/gad.16771811; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Hayden JT, 2009, CELL CYCLE, V8, P1806, DOI 10.4161/cc.8.11.8594; Herranz H, 2010, GENE DEV, V24, P1339, DOI 10.1101/gad.1937010; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kang MR, 2009, INT J CANCER, V125, P353, DOI 10.1002/ijc.24379; Kohli M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh009; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kranendijk M, 2012, J INHERIT METAB DIS, V35, P571, DOI 10.1007/s10545-012-9462-5; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Lopez GY, 2010, BIOCHEM BIOPH RES CO, V398, P585, DOI 10.1016/j.bbrc.2010.06.125; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Oishi N, 2012, HEPATOLOGY, V56, P1792, DOI 10.1002/hep.25890; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Popovici-Muller J, 2012, ACS MED CHEM LETT, V3, P850, DOI 10.1021/ml300225h; Sasaki M, 2012, GENE DEV, V26, P2038, DOI 10.1101/gad.198200.112; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Sellner L, 2010, EUR J HAEMATOL, V85, P457, DOI 10.1111/j.1600-0609.2010.01505.x; Sequist LV, 2011, ANN ONCOL, V22, P2616, DOI 10.1093/annonc/mdr489; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Struys EA, 2005, AM J HUM GENET, V76, P358, DOI 10.1086/427890; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Wang P, 2013, ONCOGENE, V32, P3091, DOI 10.1038/onc.2012.315; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Wiederschain D, 2007, MOL CELL BIOL, V27, P4968, DOI 10.1128/MCB.02244-06; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yan ZY, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks395; Yen KE, 2012, ONCOLOGIST, V17, P5, DOI 10.1634/theoncologist.2011-0429; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	66	69	71	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42180	42194		10.1074/jbc.M112.417832	http://dx.doi.org/10.1074/jbc.M112.417832			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23038259	hybrid, Green Published			2022-12-28	WOS:000312103000055
J	Kowalski-Chauvel, A; Najib, S; Tikhonova, IG; Huc, L; Lopez, F; Martinez, LO; Cohen-Jonathan-Moyal, E; Ferrand, A; Seva, C				Kowalski-Chauvel, Aline; Najib, Souad; Tikhonova, Irina G.; Huc, Laurence; Lopez, Frederic; Martinez, Laurent O.; Cohen-Jonathan-Moyal, Elizabeth; Ferrand, Audrey; Seva, Catherine			Identification of the F-1-ATPase at the Cell Surface of Colonic Epithelial Cells ROLE IN MEDIATING CELL PROLIFERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINE-EXTENDED GASTRIN; ATP SYNTHASE; BIOLOGICAL-ACTIVITY; ENDOTHELIAL-CELLS; STIMULATES PROLIFERATION; COLORECTAL-CARCINOMA; ONCOGENIC RAS; GROWTH-FACTOR; TUMOR-CELLS; FERRIC IONS	F-1 domain of F1Fo-ATPase was initially believed to be strictly expressed in the mitochondrial membrane. Interestingly, recent reports have shown that the F-1 complex can serve as a cell surface receptor for apparently unrelated ligands. Here we show for the first time the presence of the F-1-ATPase at the cell surface of normal or cancerous colonic epithelial cells. Using surface plasmon resonance technology and mass spectrometry, we identified a peptide hormone product of the gastrin gene (glycine-extended gastrin (G-gly)) as a new ligand for the F-1-ATPase. By molecular modeling, we identified the motif in the peptide sequence (E(E/D)XY), that directly interacts with the F-1-ATPase and the amino acids in the F-1-ATPase that bind this motif. Replacement of the Glu-9 residue by an alanine in the E(E/D)XY motif resulted in a strong decrease of G-gly binding to the F-1-ATPase and the loss of its biological activity. In addition we demonstrated that F-1-ATPase mediates the growth effects of the peptide. Indeed, blocking F-1-ATPase activity decreases G-glyinduced cell growth. The mechanism likely involves ADP production by the membrane F-1-ATPase, which is induced by G-gly. These results suggest an important contribution of cell surface F-1-ATPase in the pro-proliferative action of this gastrointestinal peptide.	[Kowalski-Chauvel, Aline; Najib, Souad; Lopez, Frederic; Cohen-Jonathan-Moyal, Elizabeth; Ferrand, Audrey; Seva, Catherine] Univ Toulouse 3, Canc Res Ctr Toulouse, INSERM UMR 1037, F-31052 Toulouse, France; [Tikhonova, Irina G.] Queens Univ Belfast, Sch Pharm, Ctr Med Biol, Belfast BT9 7BL, Antrim, North Ireland; [Huc, Laurence] Univ Toulouse, Inst Natl Polytech, Ecole Natl Vet Toulouse, Inst Natl Rech Agron,TOXALIM Res Ctr Food Toxicol, F-31300 Toulouse, France; [Martinez, Laurent O.] Inst Malad Metab & Cardiovasc I2MC, INSERM UMR 1048, F-31432 Toulouse, France; [Cohen-Jonathan-Moyal, Elizabeth] Inst Claudius Regaud, F-31052 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Queens University Belfast; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Claudius Regaud	Seva, C (corresponding author), Inst Claudius Regaud, INSERM UMR CRCT 1037, 20-24 Rue Pont St Pierre, F-31052 Toulouse, France.	cathy.seva@inserm.fr	Huc, Laurence/J-1888-2014; FERRAND, Audrey/I-5623-2016; Martinez, Laurent O/B-8343-2015; Moyal, Elizabeth/A-9802-2015; SEVA, Catherine/O-9166-2014; Martinez, Laurent O./ABD-6880-2020; Kowalski-Chauvel, Aline/O-9212-2014	Huc, Laurence/0000-0002-0336-7559; FERRAND, Audrey/0000-0002-1057-8151; Martinez, Laurent O/0000-0002-0985-3152; Moyal, Elizabeth/0000-0002-6593-9276; SEVA, Catherine/0000-0002-4265-7372; Martinez, Laurent O./0000-0002-0985-3152; Najib, Souad/0000-0001-5509-1411	INSERM; French Association for Cancer Research [ARC-SFI-201112-03828]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Association for Cancer Research	This work was supported by INSERM, the French Association for Cancer Research (ARC-SFI-201112-03828).	Alard JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014654; Aly A, 2001, INT J CANCER, V94, P307, DOI 10.1002/ijc.1483; Arakaki N, 2003, MOL CANCER RES, V1, P931; Bertrand C, 2010, INT J CANCER, V126, P2847, DOI 10.1002/ijc.25001; Biason JV, 2011, J MOL BIOL, V406, P443, DOI 10.1016/j.jmb.2010.12.025; Cabezon E, 2000, J BIOL CHEM, V275, P25460, DOI 10.1074/jbc.M003859200; Chakladar A, 2005, BIOCHEM BIOPH RES CO, V336, P190, DOI 10.1016/j.bbrc.2005.08.061; Champagne E, 2006, CURR OPIN LIPIDOL, V17, P279, DOI 10.1097/01.mol.0000226120.27931.76; Chang HJ, 2007, CANCER SCI, V98, P1184, DOI 10.1111/j.1349-7006.2007.00527.x; Chi SL, 2006, CANCER RES, V66, P875, DOI 10.1158/0008-5472.CAN-05-2806; CICCOTOSTO GD, 1995, GASTROENTEROLOGY, V109, P1142, DOI 10.1016/0016-5085(95)90572-3; Clarke PA, 2006, CANCER RES, V66, P3504, DOI 10.1158/0008-5472.CAN-05-0280; Dardousis K, 2007, MOL THER, V15, P94, DOI 10.1038/sj.mt.6300003; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; Ferrand A, 2006, WORLD J GASTROENTERO, V12, P1859, DOI 10.3748/wjg.v12.i12.1859; Ferrand A, 2006, CANCER LETT, V238, P15, DOI 10.1016/j.canlet.2005.06.025; Ferrand A, 2010, AM J PHYSIOL-GASTR L, V299, pG220, DOI 10.1152/ajpgi.00046.2010; FINLEY GG, 1993, CANCER RES, V53, P2919; He H, 2005, AM J PHYSIOL-GASTR L, V289, pG478, DOI 10.1152/ajpgi.00034.2005; Hollande F, 1997, GASTROENTEROLOGY, V113, P1576, DOI 10.1053/gast.1997.v113.pm9352860; Houli N, 2006, REGUL PEPTIDES, V134, P9, DOI 10.1016/j.regpep.2005.10.001; Iwase K, 1997, GASTROENTEROLOGY, V113, P782, DOI 10.1016/S0016-5085(97)70172-0; Koh TJ, 2000, J CLIN INVEST, V106, P533, DOI 10.1172/JCI9476; Koh TJ, 1999, J CLIN INVEST, V103, P1119, DOI 10.1172/JCI4910; Koh TJ, 2004, CANCER RES, V64, P196, DOI 10.1158/0008-5472.CAN-03-2112; Lemarie A, 2011, CELL DEATH DIFFER, V18, P338, DOI 10.1038/cdd.2010.93; LUTTER R, 1993, J MOL BIOL, V229, P787, DOI 10.1006/jmbi.1993.1081; Martinez LO, 2003, NATURE, V421, P75, DOI 10.1038/nature01250; Moser TL, 2001, P NATL ACAD SCI USA, V98, P6656, DOI 10.1073/pnas.131067798; Moser TL, 1999, P NATL ACAD SCI USA, V96, P2811, DOI 10.1073/pnas.96.6.2811; Mowery YM, 2008, CANCER BIOL THER, V7, P1836, DOI 10.4161/cbt.7.11.7155; Nakata H, 1998, GASTROENTEROLOGY, V115, P1144, DOI 10.1016/S0016-5085(98)70085-X; NEMETH J, 1993, GUT, V34, P90, DOI 10.1136/gut.34.1.90; Ogunwobi OA, 2006, REGUL PEPTIDES, V134, P1, DOI 10.1016/j.regpep.2005.08.002; Ogunwobi OO, 2008, MOL CELL ENDOCRINOL, V296, P94, DOI 10.1016/j.mce.2008.08.004; Pannequin J, 2004, J ENDOCRINOL, V181, P315, DOI 10.1677/joe.0.1810315; Pannequin J, 2004, J BIOL CHEM, V279, P2453, DOI 10.1074/jbc.M309806200; Pannequin J, 2002, J BIOL CHEM, V277, P48602, DOI 10.1074/jbc.M208440200; Radojkovic C, 2009, ARTERIOSCL THROM VAS, V29, P1125, DOI 10.1161/ATVBAHA.109.187997; SEVA C, 1994, SCIENCE, V265, P410, DOI 10.1126/science.8023165; SOLEIMANI M, 1994, J BIOL CHEM, V269, P27973; Stepan VM, 1999, AM J PHYSIOL-REG I, V277, pR572, DOI 10.1152/ajpregu.1999.277.2.R572; Tomonaga T, 2004, CLIN CANCER RES, V10, P2007, DOI 10.1158/1078-0432.CCR-03-0321; VANSOLINGE WW, 1993, GASTROENTEROLOGY, V104, P1099, DOI 10.1016/0016-5085(93)90279-L; Wang JB, 2008, CANCER BIOL THER, V7, P1829, DOI 10.4161/cbt.7.11.6861; Watson SA, 1996, CANCER RES, V56, P880	46	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41458	41468		10.1074/jbc.M112.382465	http://dx.doi.org/10.1074/jbc.M112.382465			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23055519	hybrid, Green Published			2022-12-28	WOS:000311887600057
J	Mi, RJ; Song, LN; Wang, YC; Ding, XK; Zeng, JW; Lehoux, S; Aryal, RP; Wang, JM; Crew, VK; van Die, I; Chapman, AB; Cummings, RD; Ju, TZ				Mi, Rongjuan; Song, Lina; Wang, Yingchun; Ding, Xiaokun; Zeng, Junwei; Lehoux, Sylvain; Aryal, Rajindra P.; Wang, Jianmei; Crew, Vanja K.; van Die, Irma; Chapman, Arlene B.; Cummings, Richard D.; Ju, Tongzhong			Epigenetic Silencing of the Chaperone Cosmc in Human Leukocytes Expressing Tn Antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN O-GLYCOSYLATION; PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; IGA NEPHROPATHY; DNA METHYLATION; X-CHROMOSOME; GENE; BETA-1,3-GALACTOSYLTRANSFERASE; CANCER; DEFICIENCY; MUTATIONS	Cosmc is the specific molecular chaperone in the endoplasmic reticulum for T-synthase, a Golgi beta 3-galactosyltransferase that generates the core 1 O-glycan, Gal beta 1-3GalNAc alpha-Ser/Thr, in glycoproteins. Dysfunctional Cosmc results in the formation of inactive T-synthase and consequent expression of the Tn antigen (GalNAc alpha 1-Ser/Thr), which is associated with several human diseases. However, the molecular regulation of expression of Cosmc, which is encoded by a single gene on Xq24, is poorly understood. Here we show that epigenetic silencing of Cosmc through hypermethylation of its promoter leads to loss of Cosmc transcripts in Tn4 cells, an immortalized B cell line from a male patient with a Tn-syndrome-like phenotype. These cells lack T-synthase activity and express the Tn antigen. Treatment of cells with 5-aza-2'-deoxycytidine causes restoration of Cosmc transcripts, restores T-synthase activity, and reduces Tn antigen expression. Bisulfite sequencing shows that CG dinucleotides in the Cosmc core promoter are hypermethylated. Interestingly, several other X-linked genes associated with glycosylation are not silenced in Tn4 cells, and we observed no correlation of a particular DNA methyltransferase to aberrant methylation of Cosmc in these cells. Thus, hypermethylation of the Cosmc promoter in Tn4 cells is relatively specific. Epigenetic silencing of Cosmc provides another mechanism underlying the abnormal expression of the Tn antigen, which may be important in understanding aberrant Tn antigen expression in human diseases, including IgA nephropathy and cancer.	[Mi, Rongjuan; Song, Lina; Wang, Yingchun; Ding, Xiaokun; Zeng, Junwei; Lehoux, Sylvain; Aryal, Rajindra P.; Cummings, Richard D.; Ju, Tongzhong] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Chapman, Arlene B.] Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA; [Crew, Vanja K.] Natl Hlth Serv Blood & Transplant, Bristol Inst Transfus Sci, Bristol BS34 7QG, Avon, England; [van Die, Irma] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, NL-1081 BT Amsterdam, Netherlands	Emory University; Emory University; NHS Blood & Transplant (NHSBT); Vrije Universiteit Amsterdam	Ju, TZ (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE,Rm 4029, Atlanta, GA 30322 USA.	tju@emory.edu	Wang, Jianmei/HHZ-0585-2022; Mi, Rongjuan/O-2564-2013	Ju, Tongzhong/0000-0002-4429-1976; Aryal, Rajindra P/0000-0001-8718-636X	National Institutes of Health [R01DK80876]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK80876 (to T. J.).	Aller CT, 1996, AM J HEMATOL, V52, P29, DOI 10.1002/(SICI)1096-8652(199605)52:1<29::AID-AJH5>3.0.CO;2-8; Aryal RP, 2012, J BIOL CHEM, V287, P15317, DOI 10.1074/jbc.M111.312587; Aryal RP, 2010, J BIOL CHEM, V285, P2456, DOI 10.1074/jbc.M109.065169; Bogdanovic O, 2009, CHROMOSOMA, V118, P549, DOI 10.1007/s00412-009-0221-9; Brodsky RA, 2008, BLOOD REV, V22, P65, DOI 10.1016/j.blre.2007.10.002; Bronner C, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001764; Bui C, 2010, FASEB J, V24, P436, DOI 10.1096/fj.09-136291; Chachadi VB, 2011, INT J BIOCHEM CELL B, V43, P586, DOI 10.1016/j.biocel.2010.12.015; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Crew VK, 2008, BRIT J HAEMATOL, V142, P657, DOI 10.1111/j.1365-2141.2008.07215.x; Desai PR, 2000, TRANSFUS MED REV, V14, P312, DOI 10.1053/tmrv.2000.16229; Felner KM, 1998, BBA-MOL BASIS DIS, V1406, P115; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; Gao S, 2004, INT J CANCER, V109, P230, DOI 10.1002/ijc.11592; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Homeister JW, 2001, IMMUNITY, V15, P115, DOI 10.1016/S1074-7613(01)00166-2; Inoue T, 2011, ADV OTO-RHINO-LARYNG, V72, P71, DOI 10.1159/000324610; Inoue T, 2010, CLIN IMMUNOL, V136, P447, DOI 10.1016/j.clim.2010.05.009; Jin Bilian, 2011, Genes Cancer, V2, P607, DOI 10.1177/1947601910393957; Ju TZ, 2008, J CELL BIOL, V182, P531, DOI 10.1083/jcb.200711151; Ju TZ, 2008, CANCER RES, V68, P1636, DOI 10.1158/0008-5472.CAN-07-2345; Ju TZ, 2011, GLYCOBIOLOGY, V21, P352, DOI 10.1093/glycob/cwq168; Ju TZ, 2011, ANGEW CHEM INT EDIT, V50, P1770, DOI 10.1002/anie.201002313; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Kawamura YI, 2008, GASTROENTEROLOGY, V135, P142, DOI 10.1053/j.gastro.2008.03.031; MCEVER RP, 1995, J BIOL CHEM, V270, P11025, DOI 10.1074/jbc.270.19.11025; Miyamoto K, 2003, ONCOGENE, V22, P274, DOI 10.1038/sj.onc.1206146; Nai HS, 2012, COMB CHEM HIGH T SCR, V15, P216; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Patra SK, 2009, BIOCHEMISTRY-MOSCOW+, V74, P613, DOI 10.1134/S0006297909060042; Qin W, 2005, J INTERN MED, V258, P467, DOI 10.1111/j.1365-2796.2005.01558.x; Qin W, 2008, NEPHROL DIAL TRANSPL, V23, P1608, DOI 10.1093/ndt/gfm781; Qin Wei, 2011, Sichuan Da Xue Xue Bao Yi Xue Ban, V42, P762; ROXBY DJ, 1992, TRANSFUSION, V32, P834, DOI 10.1046/j.1537-2995.1992.32993110755.x; Schietinger A, 2006, SCIENCE, V314, P304, DOI 10.1126/science.1129200; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shenker N, 2012, BRIT J CANCER, V106, P248, DOI 10.1038/bjc.2011.550; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Suzuki H, 2008, J CLIN INVEST, V118, P629, DOI 10.1172/JCI33189; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; THURNHER M, 1993, J CLIN INVEST, V91, P2103, DOI 10.1172/JCI116434; WALLNER M, 1985, BLUT, V51, P355, DOI 10.1007/BF00320046; Wang YC, 2012, P NATL ACAD SCI USA, V109, P16143, DOI 10.1073/pnas.1208253109; Wang YC, 2010, P NATL ACAD SCI USA, V107, P9228, DOI 10.1073/pnas.0914004107; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112; Xie LS, 2010, CLIN INVEST MED, V33, pE5; Yamada K, 2010, NEPHROL DIAL TRANSPL, V25, P3890, DOI 10.1093/ndt/gfq325; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4; Yoo NJ, 2008, APMIS, V116, P154, DOI 10.1111/j.1600-0463.2008.00965.x	53	50	52	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41523	41533		10.1074/jbc.M112.371989	http://dx.doi.org/10.1074/jbc.M112.371989			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23035125	Green Published, hybrid			2022-12-28	WOS:000311887600062
J	Perche-Letuvee, P; Kathirvelu, V; Berggren, G; Clemancey, M; Latour, JM; Maurel, V; Douki, T; Armengaud, J; Mulliez, E; Fontecave, M; Garcia-Serres, R; Gambarelli, S; Atta, M				Perche-Letuvee, Phanelie; Kathirvelu, Velavan; Berggren, Gustav; Clemancey, Martin; Latour, Jean-Marc; Maurel, Vincent; Douki, Thierry; Armengaud, Jean; Mulliez, Etienne; Fontecave, Marc; Garcia-Serres, Ricardo; Gambarelli, Serge; Atta, Mohamed			4-Demethylwyosine Synthase from Pyrococcus abyssi Is a Radical-S-adenosyl-L-methionine Enzyme with an Additional [4Fe-4S](+2) Cluster That Interacts with the Pyruvate Co-substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4FE-4S CLUSTER; MODIFIED NUCLEOSIDES; INHIBITOR BINDING; BASE FORMATION; ADENOSYLMETHIONINE; RNA; SAM; BIOSYNTHESIS; COORDINATION; SPECTROSCOPY	Wybutosine and its derivatives are found in position 37 of tRNA encoding Phe in eukaryotes and archaea. They are believed to play a key role in the decoding function of the ribosome. The second step in the biosynthesis of wybutosine is catalyzed by TYW1 protein, which is a member of the well established class of metalloenzymes called "Radical-SAM." These enzymes use a [4Fe-4S] cluster, chelated by three cysteines in a CX3CX2C motif, and S-adenosyl-L-methionine (SAM) to generate a 5'-deoxyadenosyl radical that initiates various chemically challenging reactions. Sequence analysis of TYW1 proteins revealed, in the N-terminal half of the enzyme beside the Radical-SAM cysteine triad, an additional highly conserved cysteine motif. In this study we show by combining analytical and spectroscopic methods including UV-visible absorption, Mossbauer, EPR, and HYSCORE spectroscopies that these additional cysteines are involved in the coordination of a second [4Fe-4S] cluster displaying a free coordination site that interacts with pyruvate, the second substrate of the reaction. The presence of two distinct iron-sulfur clusters on TYW1 is reminiscent of MiaB, another tRNA-modifying metalloenzyme whose active form was shown to bind two iron-sulfur clusters. A possible role for the second [4Fe-4S] cluster in the enzyme activity is discussed.	[Kathirvelu, Velavan; Clemancey, Martin; Latour, Jean-Marc; Garcia-Serres, Ricardo] Univ Grenoble 1, Lab Chim & Biol Met,UMR 5249, Equipe Physicochim Met Biol,CEA Grenoble,CNRS, Inst Rech Technol & Sci Vivant,iRTSV LCBM Pmb,CEA, F-38054 Grenoble 09, France; [Perche-Letuvee, Phanelie; Kathirvelu, Velavan; Berggren, Gustav; Mulliez, Etienne; Fontecave, Marc; Atta, Mohamed] Univ Grenoble 1, Lab Chim & Biol Met, Equipe Biocatalyse,UMR 5249,CEA,CNRS,CEA Grenoble, Inst Rech Technol & Sci Vivant,iRTSV LCBM Biocat, F-38054 Grenoble 09, France; [Kathirvelu, Velavan; Maurel, Vincent; Gambarelli, Serge] Univ Grenoble 1, Lab Resonance Magnet, Inst Nanosci & Cryogenie, CEA,SCIB,UME E3, F-38054 Grenoble 09, France; [Douki, Thierry] Univ Grenoble 1, Lab Les Acides Nucl, Inst Nanosci & Cryogenie, CEA,SCIB,UME E3, F-38054 Grenoble 09, France; [Armengaud, Jean] IBEB, SBTN, LBSP, F-30207 Bagnols Sur Ceze, France; [Fontecave, Marc] Coll France, F-75231 Paris 05, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; PSL Research University Paris; College de France	Garcia-Serres, R (corresponding author), Univ Grenoble 1, Lab Chim & Biol Met,UMR 5249, Equipe Physicochim Met Biol,CEA Grenoble,CNRS, Inst Rech Technol & Sci Vivant,iRTSV LCBM Pmb,CEA, F-38054 Grenoble 09, France.	ricardo.garcia@cea.fr; serge.gambarelli@cea.fr; mohamed.atta@cea.fr	García-Serres, Ricardo/E-4344-2012; Kathirvelu, Velavan/ABD-4854-2021; Thierry, Douki/H-2108-2018; Berggren, Gustav/H-8659-2013	García-Serres, Ricardo/0000-0001-5203-0568; Kathirvelu, Velavan/0000-0003-0232-1425; Thierry, Douki/0000-0002-5022-071X; Berggren, Gustav/0000-0002-6717-6612; ARMENGAUD, Jean/0000-0003-1589-445X	GIS (Groupement d'interet scientifique)-CNRS; ANR Blanc Grant INSERAD; Region Rhone-Alpes Grants CIBLE; Stiftelsen Bengt Lundqvist minne; Swedish Research Council FORMAS; Royal Swedish Academy of Sciences	GIS (Groupement d'interet scientifique)-CNRS; ANR Blanc Grant INSERAD(French National Research Agency (ANR)); Region Rhone-Alpes Grants CIBLE(Region Auvergne-Rhone-Alpes); Stiftelsen Bengt Lundqvist minne; Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Royal Swedish Academy of Sciences	This work was supported by a GIS (Groupement d'interet scientifique)-CNRS fellowship PP-L, <SUP>1,2,3</SUP>ANR Blanc-2010 Grant INSERAD (to P. P.-L. and V. K.), and Region Rhone-Alpes Grants CIBLE 2007-2010, 2008-2011, and 2011-2014.; Supported by Stiftelsen Bengt Lundqvist minne, the Swedish Research Council FORMAS, and the Royal Swedish Academy of Sciences.	Agris PF, 1996, PROG NUCLEIC ACID RE, V53, P79, DOI 10.1016/S0079-6603(08)60143-9; Ahrens-Botzong A, 2011, ANGEW CHEM INT EDIT, V50, P11976, DOI 10.1002/anie.201104562; Atta M, 2009, DNA RNA MODIFICATION, P347; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Chan A, 2012, ANGEW CHEM INT EDIT, V51, P7711, DOI 10.1002/anie.201202261; Chandor A, 2007, CR CHIM, V10, P756, DOI 10.1016/j.crci.2007.02.019; Chen DW, 2003, J AM CHEM SOC, V125, P11788, DOI 10.1021/ja036120z; Cosper MM, 2002, J AM CHEM SOC, V124, P14006, DOI 10.1021/ja0283044; de Crecy-Lagard V, 2010, MOL BIOL EVOL, V27, P2062, DOI 10.1093/molbev/msq096; EMPTAGE MH, 1983, P NATL ACAD SCI-BIOL, V80, P4674, DOI 10.1073/pnas.80.15.4674; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Fluhe E, 2012, NAT CHEM BIOL, V8, P350, DOI [10.1038/NCHEMBIO.798, 10.1038/nchembio.798]; Fontecave M, 2004, TRENDS BIOCHEM SCI, V29, P243, DOI 10.1016/j.tibs.2004.03.007; Gambarelli S, 2005, CHEMBIOCHEM, V6, P1960, DOI 10.1002/cbic.200500182; GEHRKE CW, 1989, J CHROMATOGR, V471, P3, DOI 10.1016/S0021-9673(00)94152-9; Goto-Ito S, 2007, ACTA CRYSTALLOGR D, V63, P1059, DOI 10.1107/S0907444907040668; Grosjean H., 2009, DNA RNA MODIFICATION; Grove TL, 2010, BIOCHEMISTRY-US, V49, P3783, DOI 10.1021/bi9022126; KASAI H, 1976, BIOCHEMISTRY-US, V15, P898, DOI 10.1021/bi00649a027; Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102; Kirino Yohei, 2005, RNA Biol, V2, P41, DOI 10.4161/rna.2.2.1610; Lees NS, 2009, J AM CHEM SOC, V131, P9184, DOI 10.1021/ja903978u; LIMBACH PA, 1994, NUCLEIC ACIDS RES, V22, P2183, DOI 10.1093/nar/22.12.2183; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Seemann M, 2009, J AM CHEM SOC, V131, P13184, DOI 10.1021/ja9012408; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Suzuki Y, 2007, J MOL BIOL, V372, P1204, DOI 10.1016/j.jmb.2007.07.024; Tyryshkin AM, 1999, J AM CHEM SOC, V121, P3396, DOI 10.1021/ja982085y; Urbonavicius J., 2009, DNA RNA MODIFICATION, P423; Waas WF, 2005, J BIOL CHEM, V280, P37616, DOI 10.1074/jbc.M506939200; Young AP, 2011, BIOCHEMISTRY-US, V50, P10573, DOI 10.1021/bi2015053	31	40	42	2	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41174	41185		10.1074/jbc.M112.405019	http://dx.doi.org/10.1074/jbc.M112.405019			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23043105	Green Published, hybrid			2022-12-28	WOS:000311887600033
J	Chae, M; Han, GS; Carman, GM				Chae, Minjung; Han, Gil-Soo; Carman, George M.			The Saccharomyces cerevisiae Actin Patch Protein App1p Is a Phosphatidate Phosphatase Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIACYLGLYCEROL PYROPHOSPHATE PHOSPHATASE; CYTIDINE DIPHOSPHATE CHOLINE; PHOSPHOLIPASE-D ACTIVITY; PARTIAL-PURIFICATION; INTERACTION NETWORKS; SIGNALING FUNCTIONS; MEMBRANE-PROTEINS; ORTHOLOGUE PAH1P; INTERACTION MAP; LIPIN HOMOLOG	Phosphatidate phosphatase (PAP) catalyzes the dephosphorylation of phosphatidate to yield diacylglycerol. In the yeast Saccharomyces cerevisiae, PAP is encoded by PAH1, DPP1, and LPP1. The presence of PAP activity in the pah1 Delta dpp1 Delta lpp1 Delta triple mutant indicated another gene(s) encoding the enzyme. We purified PAP from the pah1 Delta dpp1 Delta lpp1 Delta triple mutant by salt extraction of mitochondria followed by chromatography with DE52, Affi-Gel Blue, phenyl-Sepharose, MonoQ, and Superdex 200. Liquid chromatography/tandem mass spectrometry analysis of a PAP-enriched sample revealed multiple putative phosphatases. By analysis of PAP activity in mutants lacking each of the proteins, we found that APP1, a gene whose molecular function has been unknown, confers similar to 30% PAP activity of wild type cells. The overexpression of APP1 in the pah1 Delta dpp1 Delta lpp1 Delta mutant exhibited a 10-fold increase in PAP activity. The PAP activity shown by App1p heterologously expressed in Escherichia coli confirmed that APP1 is the structural gene for the enzyme. Introduction of the app1 Delta mutation into the pah1 Delta dpp1 Delta lpp1 Delta triple mutant resulted in a complete loss of PAP activity, indicating that distinct PAP enzymes in S. cerevisiae are encoded by APP1, PAH1, DPP1, and LPP1. Lipid analysis of cells lacking the PAP genes, singly or in combination, showed that Pah1p is the only PAP involved in the synthesis of triacylglycerol as well as in the regulation of phospholipid synthesis. App1p, which shows interactions with endocytic proteins, may play a role in vesicular trafficking through its PAP activity.	[Carman, George M.] Rutgers State Univ, Dept Food Sci, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, Rutgers Ctr Lipid Res, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu			National Institutes of Health, United States Public Health Service [GM-28140]; National Institutes of Health [NS046593]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028140, R37GM028140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS046593] Funding Source: NIH RePORTER	National Institutes of Health, United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-28140 (to G. M. C.) from the United States Public Health Service.; Chris A. Marfo is acknowledged for the initial characterization of the anti-App1p antibodies. The mass spectrometry data were obtained from an Orbitrap instrument funded in part by National Institutes of Health Grant NS046593, for the support of the University of Medicine and Dentistry of New Jersey Neuroproteomics Core Facility.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; Asp L, 2009, MOL BIOL CELL, V20, P780, DOI 10.1091/mbc.E08-03-0256; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BELENDIUK G, 1978, J BIOL CHEM, V253, P4555; BISHOP WR, 1986, J BIOL CHEM, V261, P6993; Blackwood RA, 1997, AM J PHYSIOL-CELL PH, V272, pC1279, DOI 10.1152/ajpcell.1997.272.4.C1279; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bon E, 2000, YEAST, V16, P1229, DOI 10.1002/1097-0061(20000930)16:13<1229::AID-YEA618>3.0.CO;2-Q; BORKENHAGEN LF, 1957, J BIOL CHEM, V227, P951; Brachmann CB, 1998, YEAST, V14, P115; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729; Das A, 2006, MOL BIOCHEM PARASIT, V150, P201, DOI 10.1016/j.molbiopara.2006.08.002; DAVIDSON JB, 1971, BIOCHEM BIOPH RES CO, V42, P1191, DOI 10.1016/0006-291X(71)90032-5; Dillon DA, 1997, J BIOL CHEM, V272, P10361; Dillon DA, 1996, J BIOL CHEM, V271, P30548, DOI 10.1074/jbc.271.48.30548; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057; ESKO JD, 1980, J BIOL CHEM, V255, P4474; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Faulkner A, 1999, J BIOL CHEM, V274, P14831, DOI 10.1074/jbc.274.21.14831; Fazi B, 2002, J BIOL CHEM, V277, P5290, DOI 10.1074/jbc.M109848200; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; FISCHL AS, 1983, J BACTERIOL, V154, P304, DOI 10.1128/JB.154.1.304-311.1983; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Furneisen JM, 2000, BBA-MOL CELL BIOL L, V1484, P71, DOI 10.1016/S1388-1981(99)00202-4; Goni FM, 1999, PROG LIPID RES, V38, P1, DOI 10.1016/S0163-7827(98)00021-6; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2004, J BIOL CHEM, V279, P5338, DOI 10.1074/jbc.M311779200; Han GS, 2001, J BIOL CHEM, V276, P10126, DOI 10.1074/jbc.M011421200; Hanscho M, 2012, FEMS YEAST RES, V12, P796, DOI 10.1111/j.1567-1364.2012.00830.x; Havriluk T, 2008, ANAL BIOCHEM, V373, P392, DOI 10.1016/j.ab.2007.08.037; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; HOSAKA K, 1984, BIOCHIM BIOPHYS ACTA, V796, P110; HOSAKA K, 1984, BIOCHIM BIOPHYS ACTA, V796, P102; Howe AG, 2006, CAN J PHYSIOL PHARM, V84, P29, DOI 10.1139/Y05-138; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jain MR, 2012, J PROTEOME RES, V11, P1791, DOI 10.1021/pr201043u; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; KENNEDY EP, 1956, J BIOL CHEM, V222, P185; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; KIYASU JY, 1963, J BIOL CHEM, V238, P2293; KOTER M, 1978, BIOCHIM BIOPHYS ACTA, V514, P255, DOI 10.1016/0005-2736(78)90296-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; LEHEL C, 1995, J BIOL CHEM, V270, P19651, DOI 10.1074/jbc.270.33.19651; LIAO MJ, 1979, BIOCHIM BIOPHYS ACTA, V550, P157, DOI 10.1016/0005-2736(79)90204-9; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; LIN YP, 1989, J BIOL CHEM, V264, P8641; Madera M, 2004, NUCLEIC ACIDS RES, V32, pD235, DOI 10.1093/nar/gkh117; Maissel A, 2006, CELL SIGNAL, V18, P1127, DOI 10.1016/j.cellsig.2005.09.003; Michelot A, 2010, CURR BIOL, V20, P1890, DOI 10.1016/j.cub.2010.10.016; MORLOCK KR, 1991, J BIOL CHEM, V266, P3586; Morris AJ, 2007, BIOCHEM SOC SYMP, V74, P247, DOI 10.1042/BSS2007c20; Oshiro J, 2000, J BIOL CHEM, V275, P40887, DOI 10.1074/jbc.M008144200; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; PAULUS H, 1960, J BIOL CHEM, V235, P1303; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; Rose MD., 1990, METHODS YEAST GENETI; Roth MG, 2008, TRAFFIC, V9, P1233, DOI 10.1111/j.1600-0854.2008.00742.x; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Sambrook J., 1989, MOL CLONING LAB MANU; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Sciorra VA, 2002, BBA-MOL CELL BIOL L, V1582, P45, DOI 10.1016/S1388-1981(02)00136-1; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; SMITH SW, 1957, J BIOL CHEM, V228, P915; Stukey J, 1997, PROTEIN SCI, V6, P469; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Toke DA, 1999, BIOCHEMISTRY-US, V38, P14606, DOI 10.1021/bi991472x; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Tonikian R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000218; Waggoner DW, 1999, BBA-MOL CELL BIOL L, V1439, P299, DOI 10.1016/S1388-1981(99)00102-X; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587; Weinberg J, 2012, TRENDS CELL BIOL, V22, P1, DOI 10.1016/j.tcb.2011.09.001; WEISS SB, 1958, J BIOL CHEM, V231, P53; WEISS SB, 1960, J BIOL CHEM, V235, P40; Wu WI, 1996, J BIOL CHEM, V271, P1868, DOI 10.1074/jbc.271.4.1868; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	110	40	45	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40186	40196		10.1074/jbc.M112.421776	http://dx.doi.org/10.1074/jbc.M112.421776			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23071111	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000311448800009
J	Johar, K; Priya, A; Wong-Riley, MTT				Johar, Kaid; Priya, Anusha; Wong-Riley, Margaret T. T.			Regulation of Na+/K+-ATPase by Nuclear Respiratory Factor 1 IMPLICATION IN THE TIGHT COUPLING OF NEURONAL ACTIVITY, ENERGY GENERATION, AND ENERGY CONSUMPTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; GENE-EXPRESSION; NEUROCHEMICAL ORGANIZATION; TRANSCRIPTIONAL REGULATION; NA,K-ATPASE ALPHA-1; BETA-SUBUNITS; FACTOR-I; RAT; METABOLISM; ISOFORM	Energy generation and energy consumption are tightly coupled to neuronal activity at the cellular level. Na+/K+-ATPase, a major energy-consuming enzyme, is well expressed in neurons rich in cytochrome c oxidase, an important enzyme of the energy-generating machinery, and glutamatergic receptors that are mediators of neuronal activity. The present study sought to test our hypothesis that the coupling extends to the molecular level, whereby Na+/K+-ATPase subunits are regulated by the same transcription factor, nuclear respiratory factor 1 (NRF-1), found recently by our laboratory to regulate all cytochrome c oxidase subunit genes and some NMDA and AMPA receptor subunit genes. By means of multiple approaches, including in silico analysis, electrophoretic mobility shift and supershift assays, in vivo chromatin immunoprecipitation, promoter mutational analysis, and real-time quantitative PCR, NRF-1 was found to functionally bind to the promoters of Atp1a1 and Atp1b1 genes but not of the Atp1a3 gene in neurons. The transcripts of Atp1a1 and Atp1b1 subunit genes were up-regulated by KCl and down-regulated by tetrodotoxin. Atp1b1 is positively regulated by NRF-1, and silencing of NRF-1 with small interference RNA blocked the up-regulation of Atp1b1 induced by KCl, whereas overexpression of NRF-1 rescued these transcripts from being suppressed by tetrodotoxin. On the other hand, Atp1a1 is negatively regulated by NRF-1. The binding sites of NRF-1 on Atp1a1 and Atp1b1 are conserved among mice, rats, and humans. Thus, NRF-1 regulates key Na+/K+-ATPase subunits and plays an important role in mediating the tight coupling between energy consumption, energy generation, and neuronal activity at the molecular level.	[Johar, Kaid; Priya, Anusha; Wong-Riley, Margaret T. T.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Wong-Riley, MTT (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	mwr@mcw.edu	Johar, Kaid/AAC-9182-2021; Wong-Riley, Margaret/AGM-6202-2022; Johar, Kaid/F-5034-2013	Johar, Kaid/0000-0002-1703-6611	National Institutes of Health [R01EY018441, T32-EY14537]; NATIONAL EYE INSTITUTE [R01EY018441, T32EY014537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01EY018441 and Grant T32-EY14537.	ACKERMANN U, 1990, FEBS LETT, V269, P105, DOI 10.1016/0014-5793(90)81130-G; ASTRUP J, 1981, STROKE, V12, P726, DOI 10.1161/01.STR.12.6.726; Blanco G, 2005, SEMIN NEPHROL, V25, P292, DOI 10.1016/j.semnephrol.2005.03.004; Bottger P, 2011, J COMP NEUROL, V519, P376, DOI 10.1002/cne.22524; Dhar SS, 2008, J BIOL CHEM, V283, P3120, DOI 10.1074/jbc.M707587200; Dhar SS, 2011, BBA-MOL CELL RES, V1813, P403, DOI 10.1016/j.bbamcr.2010.12.013; Dhar SS, 2009, BBA-MOL CELL RES, V1793, P1604, DOI 10.1016/j.bbamcr.2009.07.001; Dhar SS, 2009, J NEUROCHEM, V108, P1595, DOI 10.1111/j.1471-4159.2009.05929.x; Dhar SS, 2009, J NEUROSCI, V29, P483, DOI 10.1523/JNEUROSCI.3704-08.2009; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; GEERING K, 1990, J MEMBRANE BIOL, V115, P109, DOI 10.1007/BF01869450; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; GICK GG, 1993, J MEMBRANE BIOL, V131, P229, DOI 10.1007/BF02260111; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Habiba A, 2000, BRAIN RES, V875, P1, DOI 10.1016/S0006-8993(00)02541-5; HEVNER RF, 1992, NEUROSCI LETT, V138, P188, DOI 10.1016/0304-3940(92)90502-X; Huo L, 2001, MOL CELL BIOL, V21, P644, DOI 10.1128/MCB.21.2.644-654.2001; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; KANO I, 1989, FEBS LETT, V250, P91, DOI 10.1016/0014-5793(89)80691-X; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Liang HL, 2006, NEUROREPORT, V17, P401, DOI 10.1097/01.wnr.0000204980.98876.11; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; MATA M, 1980, J NEUROCHEM, V34, P213, DOI 10.1111/j.1471-4159.1980.tb04643.x; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; Morth JP, 2009, PHILOS T R SOC B, V364, P217, DOI 10.1098/rstb.2008.0201; Muller-Ehmsen J, 2001, AM J PHYSIOL-CELL PH, V281, pC1355, DOI 10.1152/ajpcell.2001.281.4.C1355; MUNZER JS, 1994, J BIOL CHEM, V269, P16668; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; Ongwijitwat S, 2005, GENE, V360, P65, DOI 10.1016/j.gene.2005.06.015; Ongwijitwat S, 2004, GENE, V337, P163, DOI 10.1016/j.gene.2004.04.024; Ongwijitwat S, 2006, GENE, V374, P39, DOI 10.1016/j.gene.2006.01.009; ORLOWSKI J, 1988, J BIOL CHEM, V263, P17817; ORLOWSKI J, 1988, J BIOL CHEM, V263, P10436; Poulsen H, 2010, NATURE, V467, P99, DOI 10.1038/nature09309; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006; Shao Y, 2001, ARCH BIOCHEM BIOPHYS, V390, P78, DOI 10.1006/abbi.2001.2354; SHULL MM, 1990, GENOMICS, V6, P451, DOI 10.1016/0888-7543(90)90475-A; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; SUZUKIYAGAWA Y, 1992, MOL CELL BIOL, V12, P4046, DOI 10.1128/MCB.12.9.4046; SWEADNER KJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P185, DOI 10.1016/0304-4157(89)90019-1; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Weber B, 2008, CEREB CORTEX, V18, P2318, DOI 10.1093/cercor/bhm259; Wong-Riley M, 1998, NEUROSCIENCE, V83, P1025, DOI 10.1016/S0306-4522(97)00432-6; Wong-Riley M, 2010, EYE BRAIN, V2, P99; Wong-Riley MTT, 2012, ADV EXP MED BIOL, V748, P283, DOI 10.1007/978-1-4614-3573-0_12; Wong-Riley MTT, 1998, VISION RES, V38, P1455, DOI 10.1016/S0042-6989(98)00001-7; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; Yang SJ, 2006, NEUROSCIENCE, V141, P1181, DOI 10.1016/j.neuroscience.2006.04.063; Yu HY, 1996, BBA-GENE STRUCT EXPR, V1309, P239, DOI 10.1016/S0167-4781(96)00130-3; Zhang CY, 2000, EUR J NEUROSCI, V12, P1013, DOI 10.1046/j.1460-9568.2000.00997.x	56	20	20	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40381	40390		10.1074/jbc.M112.414573	http://dx.doi.org/10.1074/jbc.M112.414573			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23048038	Green Published, hybrid			2022-12-28	WOS:000311448800029
J	Li, JJ; Zhou, F; Zhan, DG; Gao, QQ; Cui, N; Li, JW; Iakhiaeva, E; Zwieb, C; Lin, BY; Wong, JM				Li, Jingjing; Zhou, Fan; Zhan, Deguo; Gao, Qinqin; Cui, Nan; Li, Jiwen; Iakhiaeva, Elena; Zwieb, Christian; Lin, Biaoyang; Wong, Jiemin			A Novel Histone H4 Arginine 3 Methylation-sensitive Histone H4 Binding Activity and Transcriptional Regulatory Function for Signal Recognition Particle Subunits SRP68 and SRP72	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR; DNA METHYLATION; GENE-EXPRESSION; PROTEIN; RNA; IDENTIFICATION; COMPLEX; H3R2; MUTAGENESIS; BIOGENESIS	Arginine methylation broadly occurs in the tails of core histones. However, the mechanisms by which histone arginine methylation regulates transcription remain poorly understood. In this study we attempted to identify nuclear proteins that specifically recognize methylated arginine 3 in the histone H4 (H4R3) tail using an unbiased proteomic approach. No major nuclear protein was observed to specifically bind to methylated H4R3 peptides. However, H4R3 methylation markedly inhibited the binding of two proteins to H4 tail peptide. These proteins were identified as the SRP68 and SRP72 heterodimers (SRP68/72), the components of the signal recognition particle (SRP). Only SRP68/72, but not the SRP complex, bound the H4 tail peptide. SRP68 and SRP72 bound the H4 tail in vitro and associated with chromatin in vivo. The chromatin association of SRP68 and SRP72 was regulated by PRMT5 and PRMT1. Both SRP68 and SRP72 activated transcription when tethered to a reporter via a heterologous DNA binding domain. Analysis of the genome-wide occupancy of SRP68 identified target genes regulated by SRP68. Taken together, these results demonstrate a role of H4R3 methylation in blocking the binding of effectors to chromatin and reveal a novel role for the SRP68/SRP72 heterodimer in the binding of chromatin and transcriptional regulation.	[Li, Jingjing; Zhan, Deguo; Gao, Qinqin; Cui, Nan; Li, Jiwen; Wong, Jiemin] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Li, Jingjing; Zhan, Deguo; Gao, Qinqin; Cui, Nan; Li, Jiwen; Wong, Jiemin] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Zhou, Fan; Lin, Biaoyang] Zhejiang Univ, Zhejiang California Int Nanosyst Inst ZCNI, Syst Biol Div, Hangzhou 310029, Zhejiang, Peoples R China; [Iakhiaeva, Elena; Zwieb, Christian] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	East China Normal University; East China Normal University; Zhejiang University; University of Texas System; University of Texas Health San Antonio	Wong, JM (corresponding author), E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.	jmweng@bio.ecnu.edu.cn	Lin, Biaoyang/AAA-1258-2020	Lin, Biaoyang/0000-0002-2189-0407; Wong, Jiemin/0000-0002-5311-842X	Ministry of Science and Technology of China [2010CB944903, 2009CB918402, 2009CB825601]; National Natural Science Foundation of China [90919025, 30871381]; Science Technology Commission of Shanghai Municipality [09DJ1400400, 11DZ2260300]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by Ministry of Science and Technology of China Grants 2010CB944903, 2009CB918402, and 2009CB825601, National Natural Science Foundation of China Grants 90919025 and 30871381, and Science Technology Commission of Shanghai Municipality Grants 09DJ1400400 and 11DZ2260300.	An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Chan DW, 2009, PROTEOMICS, V9, P2343, DOI 10.1002/pmic.200800600; Cote J, 2005, J BIOL CHEM, V280, P28476, DOI 10.1074/jbc.M414328200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Grosshans H, 2001, J CELL BIOL, V153, P745, DOI 10.1083/jcb.153.4.745; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Iakhiaeva E, 2006, PROTEIN SCI, V15, P1290, DOI 10.1110/ps.051861406; Iakhiaeva E, 2009, PROTEIN SCI, V18, P2183, DOI 10.1002/pro.232; Iberg AN, 2008, J BIOL CHEM, V283, P3006, DOI 10.1074/jbc.C700192200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Kirmizis A, 2007, NATURE, V449, P928, DOI 10.1038/nature06160; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; Leung E, 2010, BIOCHEM SOC T, V38, P1093, DOI 10.1042/BST0381093; Li J, 2012, J BIOL CHEM, V287, P10089, DOI 10.1074/jbc.M111.313965; Li XG, 2010, BLOOD, V115, P2028, DOI 10.1182/blood-2009-07-236059; Liu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030375; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Nye AC, 2002, MOL CELL BIOL, V22, P3437, DOI 10.1128/MCB.22.10.3437-3449.2002; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Politz JC, 2002, J CELL BIOL, V159, P411, DOI 10.1083/jcb.200208037; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; Rajakumara E, 2011, MOL CELL, V43, P275, DOI 10.1016/j.molcel.2011.07.006; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Stenoien DL, 2001, MOL CELL BIOL, V21, P4404, DOI 10.1128/MCB.21.13.4404-4412.2001; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wu JC, 2012, P NATL ACAD SCI USA, V109, P5675, DOI 10.1073/pnas.1114905109; Wu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034692; Wysocka J, 2006, FRONT BIOSCI-LANDMRK, V11, P344, DOI 10.2741/1802; Xu XJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-396; Yang YZ, 2010, MOL CELL, V40, P1016, DOI 10.1016/j.molcel.2010.11.024; Yap KL, 2011, BIOCHEMISTRY-US, V50, P1966, DOI 10.1021/bi101885m; Yap KL, 2010, CRIT REV BIOCHEM MOL, V45, P488, DOI 10.3109/10409238.2010.512001; Yin J, 2007, RNA BIOL, V4, P154, DOI 10.4161/rna.4.3.5428; Yuan P, 2009, GENE DEV, V23, P2507, DOI 10.1101/gad.1831909; Zhang DZ, 2005, MOL CELL BIOL, V25, P6404, DOI 10.1128/MCB.25.15.6404-6414.2005; Zhang JQ, 2011, CELL RES, V21, P1723, DOI 10.1038/cr.2011.176; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568	46	14	16	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40641	40651		10.1074/jbc.M112.414284	http://dx.doi.org/10.1074/jbc.M112.414284			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23048028	hybrid, Green Published			2022-12-28	WOS:000311448800053
J	Wildenhain, S; Ingenhag, D; Ruckert, C; Degistirici, O; Dugas, M; Meisel, R; Hauer, J; Borkhardt, A				Wildenhain, Sarah; Ingenhag, Deborah; Ruckert, Christian; Degistirici, Oezer; Dugas, Martin; Meisel, Roland; Hauer, Julia; Borkhardt, Arndt			Homeobox Protein HB9 Binds to the Prostaglandin E Receptor 2 Promoter and Inhibits Intracellular cAMP Mobilization in Leukemic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFANT LEUKEMIA; EXPRESSION; GENES; ETV6; EP2; DIFFERENTIATION; HLXB9; AML; T(7/12)(Q36,P13); T(7-12)(Q36-P13)	The transcription factor HB9, encoded by the homeobox gene B9 (HLXB9), is involved in the development of pancreatic betaand motor neuronal cells. In addition, HLXB9 is recurrently rearranged in young children with acute myeloid leukemia characterized by a chromosomal translocation t(7;12)-HLXB9/TEL and concomitant high expression of the unrearranged, wildtype HLXB9 allele. However, target genes of HB9 in hematopoietic cells are not known to date. In this study, we used ChIP-on-chip analysis together with expression profiling and identified PTGER2 (prostaglandin E receptor 2) as a target gene of HB9 in a hematopoietic cell line. The functional HB9 homeodomain as well as the HB9 binding domain within the PTGER2 promoter are essential for binding of HB9 to the PTGER2 promoter region and down-regulation of PTGER2 expression. Functionally, HB9 conducted down-regulation of PTGER2 results in a reduced content of intracellular cAMP mobilization and furthermore the decreased PTGER2 gene expression is valid in bone marrow cells from translocation t(7;12) positive patients. Among the primary and secondary target genes of HB9 in the myeloid cell line HL60, 78% of significantly regulated genes are down-regulated, indicating an overall repressive function of HB9. Differentially regulated genes were preferentially confined to pathways involved in cell-adhesion and cell-cell interactions, similar to the gene expression footprint of HLXB9-expressing cells from t(7;12) positive patients.	[Wildenhain, Sarah; Ingenhag, Deborah; Degistirici, Oezer; Meisel, Roland; Hauer, Julia; Borkhardt, Arndt] Univ Dusseldorf, Ctr Child & Adolescent Hlth, Dept Pediat Oncol Hematol & Clin Immunol, D-40225 Dusseldorf, Germany; [Ruckert, Christian; Dugas, Martin] Univ Munster, Inst Med Informat, D-48149 Munster, Germany	Heinrich Heine University Dusseldorf; University of Munster	Hauer, J (corresponding author), Univ Dusseldorf, Ctr Child & Adolescent Hlth, Dept Pediat Oncol Hematol & Clin Immunol, Moorenstr 5, D-40225 Dusseldorf, Germany.	Julia.Hauer@med.uni-duesseldorf.de	Dugas, Martin/F-5454-2011; Degistirici, Özer/ABC-3439-2021; Ruckert, Christian/A-8732-2013	Ruckert, Christian/0000-0001-9915-1287	Forschungskommission of the Heinrich Heine University of Dusseldorf	Forschungskommission of the Heinrich Heine University of Dusseldorf	This work was partially funded by the Forschungskommission of the Heinrich Heine University of Dusseldorf.	Beverloo HB, 2001, CANCER RES, V61, P5374; CURRARINO G, 1981, AM J ROENTGENOL, V137, P395, DOI 10.2214/ajr.137.2.395; DALTON WT, 1988, BLOOD, V71, P242; DEGUCHI Y, 1991, BLOOD, V78, P323; Denizot Y, 2005, INT J CANCER, V115, P499, DOI 10.1002/ijc.20877; DHOOGHE MC, 1993, LEUKEMIA, V7, P1777; Fedyk ER, 1996, MOL IMMUNOL, V33, P33, DOI 10.1016/0161-5890(95)00130-1; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Georges AB, 2010, FASEB J, V24, P346, DOI 10.1096/fj.09-142117; Hammerich-Hille S, 2010, J BIOL CHEM, V285, P3608, DOI 10.1074/jbc.M109.066431; Harrison KA, 1999, NAT GENET, V23, P71, DOI 10.1038/12674; HARRISON KA, 1994, J BIOL CHEM, V269, P19968; Hauer J, 2008, PEDIATR BLOOD CANCER, V50, P921, DOI 10.1002/pbc.21376; Hollington P, 2004, ANTICANCER RES, V24, P955; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kobayashi Y, 2005, J BIOL CHEM, V280, P24035, DOI 10.1074/jbc.M500926200; Kobayashi Y, 2005, J BIOL CHEM, V280, P11395, DOI 10.1074/jbc.M411189200; Kornblau SM, 2010, BLOOD, V116, P4251, DOI 10.1182/blood-2010-01-262071; Malissein E, 2006, LEUKEMIA RES, V30, P1309, DOI 10.1016/j.leukres.2005.12.017; Martin M, 2005, DEV BIOL, V284, P399, DOI 10.1016/j.ydbio.2005.05.035; Mielke C, 2000, GENE, V254, P1, DOI 10.1016/S0378-1119(00)00294-8; Nagel S, 2005, GENE CHROMOSOME CANC, V42, P170, DOI 10.1002/gcc.20113; Nakachi Y, 2008, BIOCHEM BIOPH RES CO, V372, P362, DOI 10.1016/j.bbrc.2008.05.037; Okuyama T, 2002, J LAB CLIN MED, V140, P92, DOI 10.1067/mlc.2002.125784; Paquette J, 2010, BIOINFORMATICS, V26, P285, DOI 10.1093/bioinformatics/btp656; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; SANTORO MG, 1977, CANCER RES, V37, P3774; Scacheri PC, 2006, PLOS GENET, V2, P406, DOI 10.1371/journal.pgen.0020051; Simmons HM, 2002, LEUKEMIA, V16, P2408, DOI 10.1038/sj.leu.2402773; Slater RM, 2001, LEUKEMIA, V15, P915, DOI 10.1038/sj.leu.2402121; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Sugino Y, 2007, ONCOGENE, V26, P7401, DOI 10.1038/sj.onc.1210550; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Tosi S, 2000, GENE CHROMOSOME CANC, V29, P325, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1039>3.0.CO;2-9; Tosi S, 2003, GENE CHROMOSOME CANC, V38, P191, DOI 10.1002/gcc.10258; von Bergh ARM, 2006, GENE CHROMOSOME CANC, V45, P731, DOI 10.1002/gcc.20335; Wang Y, 2005, COMPUT BIOL CHEM, V29, P37, DOI 10.1016/j.compbiolchem.2004.11.001; Wildenhain S, 2010, LEUKEMIA, V24, P1657, DOI 10.1038/leu.2010.146; Wilkens L, 2011, VIRCHOWS ARCH, V458, P697, DOI 10.1007/s00428-011-1070-5; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762; ZAPPAVIGNA V, 1994, GENE DEV, V8, P732, DOI 10.1101/gad.8.6.732	41	10	10	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40703	40712		10.1074/jbc.M111.308965	http://dx.doi.org/10.1074/jbc.M111.308965			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23048027	Green Published, hybrid			2022-12-28	WOS:000311448800059
J	Desmond, CR; Atwal, RS; Xia, JR; Truant, R				Desmond, Carly R.; Atwal, Randy Singh; Xia, Jianrun; Truant, Ray			Identification of a Karyopherin beta 1/beta 2 Proline-Tyrosine Nuclear Localization Signal in Huntingtin Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; MESSENGER-RNA EXPORT; IMPORTIN-ALPHA; DISEASE; TRANSPORT; FRAGMENTS; PROTEOLYSIS; TOXICITY; MULTIPLE; BRAINS	Among the known pathways of protein nuclear import, the karyopherin beta 2/transportin pathway is only the second to have a defined nuclear localization signal (NLS) consensus. Huntingtin, a 350-kDa protein, has defined roles in the nucleus, as well as a CRM1/exportin-dependent nuclear export signal; however, the NLS and exact pathway of import have remained elusive. Here, using a live cell assay and affinity chromatography, we show that huntingtin has a karyopherin beta 2-dependent prolinetyrosine (PY)-NLS in the amino terminus of the protein. This NLS comprises three consensus components: a basic charged sequence, a downstream conserved arginine, and a PY sequence. Unlike the classic PY-NLS, which has an unstructured intervening sequence between the consensus components, we show that a beta sheet structured region separating the consensus elements is critical for huntingtin NLS function. The huntingtin PY-NLS is also capable of import through the importin/karyopherin beta 1 pathway but was not functional in all cell types tested. We propose that this huntingtin PY-NLS may comprise a new class of multiple import factor-dependent NLSs with an internal structural component that may regulate NLS activity.	[Desmond, Carly R.; Xia, Jianrun; Truant, Ray] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Atwal, Randy Singh] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA 02114 USA	McMaster University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Truant, R (corresponding author), HSC 4N54,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	truantr@mcmaster.ca			Huntington Society of Canada; CHDI Inc.; Krembil Foundation; Canadian Institutes of Health Research Operating Grant [MOP-119391]	Huntington Society of Canada; CHDI Inc.; Krembil Foundation; Canadian Institutes of Health Research Operating Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by the Huntington Society of Canada, CHDI Inc., the Krembil Foundation, and the Canadian Institutes of Health Research Operating Grant MOP-119391 (to R.T.).	Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Cansizoglu AE, 2007, NAT STRUCT MOL BIOL, V14, P452, DOI 10.1038/nsmb1229; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; Dishinger JF, 2010, NAT CELL BIOL, V12, P703, DOI 10.1038/ncb2073; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Gu LL, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-17; HOOGEVEEN AT, 1993, HUM MOL GENET, V2, P2069, DOI 10.1093/hmg/2.12.2069; Kamei Y, 1999, J HISTOCHEM CYTOCHEM, V47, P363, DOI 10.1177/002215549904700310; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Malnou CE, 2007, J BIOL CHEM, V282, P31046, DOI 10.1074/jbc.M702833200; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Mende-Mueller LM, 2001, J NEUROSCI, V21, P1830, DOI 10.1523/JNEUROSCI.21-06-01830.2001; Nikolaev I, 2003, EUKARYOT CELL, V2, P209, DOI 10.1128/EC.2.2.209-221.2003; Petersen A, 2009, NEURODEGENER DIS, V6, P154, DOI 10.1159/000225377; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Sato M, 2011, J COMP NEUROL, V519, P1770, DOI 10.1002/cne.22600; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Sorg G, 1999, BIOTECHNIQUES, V26, P858, DOI 10.2144/99265bm12; Suel KE, 2008, PLOS BIOL, V6, P1253, DOI 10.1371/journal.pbio.0060137; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Truant R, 1999, MOL CELL BIOL, V19, P1210; Truant R, 2007, PROG NEUROBIOL, V83, P211, DOI 10.1016/j.pneurobio.2006.11.004; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Voss TC, 2005, BIOTECHNIQUES, V38, P413, DOI 10.2144/05383RV01; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Waldmann I, 2007, J BIOL CHEM, V282, P27685, DOI 10.1074/jbc.M703301200; Xia JR, 2003, HUM MOL GENET, V12, P1393, DOI 10.1093/hmg/ddg156; Zhang ZC, 2011, MOL BIOL CELL, V22, P4657, DOI 10.1091/mbc.E11-03-0222	35	30	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.412379	http://dx.doi.org/10.1074/jbc.M112.412379			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23012356	hybrid, Green Published			2022-12-28	WOS:000311233800032
J	Zhao, HL; Chen, XL; Xie, BB; Zhou, MY; Gao, X; Zhang, XY; Zhou, BC; Weiss, AS; Zhang, YZ				Zhao, Hui-Lin; Chen, Xiu-Lan; Xie, Bin-Bin; Zhou, Ming-Yang; Gao, Xiang; Zhang, Xi-Ying; Zhou, Bai-Cheng; Weiss, Anthony S.; Zhang, Yu-Zhong			Elastolytic Mechanism of a Novel M23 Metalloprotease Pseudoalterin from Deep-sea Pseudoalteromonas sp CF6-2 CLEAVING NOT ONLY GLYCYL BONDS IN THE HYDROPHOBIC REGIONS BUT ALSO PEPTIDE BONDS IN THE HYDROPHILIC REGIONS INVOLVED IN CROSS-LINKING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-LYTIC PROTEASE; PSEUDOMONAS-AERUGINOSA; ELASTIC FIBER; BACTERIOLYTIC ACTIVITY; EXTRACELLULAR-MATRIX; HUMAN TROPOELASTIN; ESCHERICHIA-COLI; ORGANIC NITROGEN; DESEASIN MCP-01; SORANGIUM SP	Elastin is a common insoluble protein that is abundant in marine vertebrates, and for this reason its degradation is important for the recycling of marine nitrogen. It is still unclear how marine elastin is degraded because of the limited study of marine elastases. Here, a novel protease belonging to the M23A subfamily, secreted by Pseudoalteromonas sp. CF6-2 from deep-sea sediment, was purified and characterized, and its elastolytic mechanism was studied. This protease, named pseudoalterin, has low identities ( < 40%) to the known M23 proteases. Pseudo-alterin has a narrow specificity but high activity toward elastin. Analysis of the cleavage sites of pseudoalterin on elastin showed that pseudoalterin cleaves the glycyl bonds in hydrophobic regions and the peptide bonds Ala-Ala, Ala-Lys, and Lys-Ala involved in cross-linking. Two peptic derivatives of desmosine, desmosine-Ala-Ala and desmosine-Ala-Ala-Ala, were detected in the elastin hydrolysate, indicating that pseudoalterin can dissociate cross-linked elastin. These results reveal a new elastolytic mechanism of the M23 protease pseudoalterin, which is different from the reported mechanism where the M23 proteases only cleave glycyl bonds in elastin. Genome analysis suggests that M23 proteases may be popular in deep-sea sediments, implying their important role in elastin degradation. An elastin degradation model of pseudoalterin was proposed, based on these results and scanning electron microscopic analysis of the degradation by pseudoalterin of bovine elastin and cross-linked recombinant tropoelastin. Our results shed light on the mechanism of elastin degradation in deep-sea sediment.	[Zhao, Hui-Lin; Chen, Xiu-Lan; Xie, Bin-Bin; Zhou, Ming-Yang; Gao, Xiang; Zhang, Xi-Ying; Zhou, Bai-Cheng; Zhang, Yu-Zhong] Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Weiss, Anthony S.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	Shandong University; University of Sydney	Zhang, YZ (corresponding author), Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhangyz@sdu.edu.cn	Weiss, Anthony S/F-8103-2010; Weiss, Anthony S/GYV-0157-2022	Weiss, Anthony S/0000-0002-8106-4836; 	National Natural Science Foundation of China [31025001, 31000034, 91228210, 31170055, 81271896, 41276149]; Hi-Tech Research and Development Program of China [2011AA090703, 2012AA092103]; COMRA Program [DY125-15-T-05, DY125-13-E-01]; Special Fund of China for Marine-scientific Research in the Public Interest Grant [201005032-6]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); COMRA Program; Special Fund of China for Marine-scientific Research in the Public Interest Grant	The work was supported by National Natural Science Foundation of China Grants 31025001, 31000034, 91228210, 31170055, 81271896, and 41276149, Hi-Tech Research and Development Program of China Grants 2011AA090703 and 2012AA092103, COMRA Program Grants DY125-15-T-05 and DY125-13-E-01, and Special Fund of China for Marine-scientific Research in the Public Interest Grant 201005032-6.	Ahmed K, 2003, J BIOSCI BIOENG, V95, P27, DOI 10.1263/jbb.95.27; Albarbarawi O, 2010, ANAL CHEM, V82, P3745, DOI 10.1021/ac100152f; Authier F, 2002, J BIOL CHEM, V277, P9437, DOI 10.1074/jbc.M110188200; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BRESSAN GM, 1983, J ULTRA MOL STRUCT R, V82, P335, DOI 10.1016/S0022-5320(83)80021-5; Chen XL, 2007, MICROBIOL-SGM, V153, P2116, DOI 10.1099/mic.0.2007/006056-0; Chen XL, 2009, APPL ENVIRON MICROB, V75, P1838, DOI 10.1128/AEM.02285-08; Chen Z, 2009, EXP DERMATOL, V18, P378, DOI 10.1111/j.1600-0625.2008.00799.x; Clarke AW, 2006, BIOCHEMISTRY-US, V45, P9989, DOI 10.1021/bi0610092; Czirok A, 2006, J CELL PHYSIOL, V207, P97, DOI 10.1002/jcp.20573; DATTA G, 1995, ARCH BIOCHEM BIOPHYS, V317, P365, DOI 10.1006/abbi.1995.1176; Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3; FEDER J, 1968, BIOCHEM BIOPH RES CO, V32, P326, DOI 10.1016/0006-291X(68)90389-6; He HL, 2004, FOOD CHEM, V84, P307, DOI 10.1016/S0308-8146(03)00242-5; Jorgensen BB, 2007, NAT REV MICROBIOL, V5, P770, DOI 10.1038/nrmicro1745; KESSLER E, 1993, J BIOL CHEM, V268, P7503; Kessler E, 1997, J BIOL CHEM, V272, P9884; Kessler E., 2004, HDB PROTEOLYTIC ENZY, P998; KESSLER E, 2004, HDB PROTEOLYTIC ENZY, P401; Kessler E., 2004, HDB PROTEOLYTIC ENZY, P1001; KEWLEY MA, 1977, J ANAT, V123, P129; Kozel BA, 2006, J CELL PHYSIOL, V207, P87, DOI 10.1002/jcp.20546; Kruger Nicholas J., 1996, P15, DOI 10.1007/978-1-60327-259-9_4; Li SL, 1998, J BIOCHEM-TOKYO, V124, P332, DOI 10.1093/oxfordjournals.jbchem.a022116; LOEWY AG, 1993, J BIOL CHEM, V268, P9071; MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M; Mithieux SM, 2009, BIOMATERIALS, V30, P431, DOI 10.1016/j.biomaterials.2008.10.018; Miyamoto K, 2002, BIOSCI BIOTECH BIOCH, V66, P416, DOI 10.1271/bbb.66.416; Moll A, 2010, MOL MICROBIOL, V77, P90, DOI 10.1111/j.1365-2958.2010.07224.x; Muiznieks LD, 2003, ARCH BIOCHEM BIOPHYS, V410, P317, DOI 10.1016/S0003-9861(02)00719-1; Nilsen T, 2003, APPL ENVIRON MICROB, V69, P2975, DOI 10.1128/AEM.69.5.2975-2984.2003; OZA NB, 1973, INT J PEPT PROT RES, V5, P365; Park P. W., 2004, HDB PROTEOLYTIC ENZY, P1004; PETERS JE, 1990, J BACTERIOL, V172, P2236, DOI 10.1128/jb.172.5.2236-2240.1990; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; ROSENBLOOM J, 1993, FASEB J, V7, P1208, DOI 10.1096/fasebj.7.13.8405806; Salvesen G, 1989, PROTEOLYTIC ENZYMES, P83; SCHINDLER CA, 1965, BIOCHIM BIOPHYS ACTA, V97, P242, DOI 10.1016/0304-4165(65)90088-7; Simmonds RS, 1995, MICROB ECOL HEALTH D, V8, P281, DOI 10.3109/08910609509140107; Tu Y, 2010, MATRIX BIOL, V29, P152, DOI 10.1016/j.matbio.2009.10.003; Tu YD, 2010, MICRON, V41, P268, DOI 10.1016/j.micron.2009.11.003; Uehara T, 2009, J BACTERIOL, V191, P5094, DOI 10.1128/JB.00505-09; USHIKI T, 1991, ARCH HISTOL CYTOL, V54, P427, DOI 10.1679/aohc.54.427; Ushiki T, 2002, ARCH HISTOL CYTOL, V65, P109, DOI 10.1679/aohc.65.109; Vessillier S, 2001, EUR J BIOCHEM, V268, P1049, DOI 10.1046/j.1432-1327.2001.01967.x; WHITAKER DR, 1965, CAN J BIOCHEM CELL B, V43, P1961, DOI 10.1139/o65-219; WHITAKER DR, 1965, CAN J BIOCHEM CELL B, V43, P1935, DOI 10.1139/o65-217; Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017; Worthington Biochemical Corporation, 1972, WORTH ENZ MAN, P43; Wu WJ, 1999, J BIOL CHEM, V274, P21719, DOI 10.1074/jbc.274.31.21719; Yeo GC, 2011, ADV COLLOID INTERFAC, V167, P94, DOI 10.1016/j.cis.2010.10.003; Zhao GY, 2008, J BIOL CHEM, V283, P36100, DOI 10.1074/jbc.M804438200; Zhou MY, 2009, MICROB ECOL, V58, P582, DOI 10.1007/s00248-009-9506-z; ZYSKIND JW, 1965, SCIENCE, V147, P1458, DOI 10.1126/science.147.3664.1458	54	26	28	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.405076	http://dx.doi.org/10.1074/jbc.M112.405076			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23012370	Green Published, hybrid			2022-12-28	WOS:000311233800040
J	Cassone, M; Gagne, AL; Spruce, LA; Seeholzer, SH; Sebert, ME				Cassone, Marco; Gagne, Alyssa L.; Spruce, Lynn A.; Seeholzer, Steven H.; Sebert, Michael E.			The HtrA Protease from Streptococcus pneumoniae Digests Both Denatured Proteins and the Competence-stimulating Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENETIC-TRANSFORMATION; ESCHERICHIA-COLI; STRUCTURAL BASIS; E-CADHERIN; DEGP; CHAPERONE; STRESS; SPECIFICITY; PHEROMONE; VIRULENCE	The HtrA protease of Streptococcus pneumoniae functions both in a general stress response role and as an error sensor that specifically represses genetic competence when the overall level of biosynthetic errors in cellular proteins is low. However, the mechanism through which HtrA inhibits development of competence has been unknown. We found that HtrA digested the pneumococcal competence-stimulating peptide (CSP) and constituted the primary extracytoplasmic CSP-degrading activity in cultures of S. pneumoniae. Mass spectrometry demonstrated that cleavage predominantly followed residue Phe-8 of the CSP-1 isoform of the peptide within its central hydrophobic patch, and in competition assays, both CSP-1 and CSP-2 interacted with HtrA with similar efficiencies. More generally, analysis of beta-casein digestion and of digestion within HtrA itself revealed a preference for substrates with non-polar residues at the P1 site. Consistent with a specificity for exposed hydrophobic residues, competition from native BSA only weakly inhibited digestion of CSP, but denaturation converted BSA into a strong competitive inhibitor of such proteolysis. Together these findings support a model in which digestion of CSP by HtrA is reduced in the presence of other unfolded proteins that serve as alternative targets for degradation. Such competition may provide a mechanism by which HtrA functions in a quality control capacity to monitor the frequency of biosynthetic errors that result in protein misfolding.	[Cassone, Marco; Gagne, Alyssa L.; Sebert, Michael E.] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; [Spruce, Lynn A.; Seeholzer, Steven H.] Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Sebert, Michael E.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Sebert, ME (corresponding author), Childrens Hosp Philadelphia, Div Infect Dis, 3615 Civ Ctr Blvd,Abramson Res Bldg,Rm 1202C, Philadelphia, PA 19104 USA.	sebert@email.chop.edu			National Institutes of Health [R01 AI075194]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI075194 (to M. E. S.).	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bartilson M, 2001, MOL MICROBIOL, V39, P126, DOI 10.1046/j.1365-2958.2001.02218.x; Baud C, 2011, MOL MICROBIOL, V80, P1625, DOI 10.1111/j.1365-2958.2011.07672.x; Boehm M, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-3; Chastanet A, 2001, J BACTERIOL, V183, P7295, DOI 10.1128/JB.183.24.7295-7307.2001; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Claverys JP, 2006, ANNU REV MICROBIOL, V60, P451, DOI 10.1146/annurev.micro.60.080805.142139; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Fan K, 2011, J STRUCT BIOL, V176, P16, DOI 10.1016/j.jsb.2011.06.009; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; HAVARSTEIN LS, 1995, P NATL ACAD SCI USA, V92, P11140, DOI 10.1073/pnas.92.24.11140; Hoy B, 2010, EMBO REP, V11, P798, DOI 10.1038/embor.2010.114; Huesgen PF, 2011, BIOCHEM J, V435, P733, DOI 10.1042/BJ20102131; Huston WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024547; Ibrahim YM, 2004, INFECT IMMUN, V72, P3584, DOI 10.1128/IAI.72.6.3584-3591.2004; Jiang JS, 2008, P NATL ACAD SCI USA, V105, P11939, DOI 10.1073/pnas.0805464105; Johnsborg O, 2006, J BACTERIOL, V188, P1744, DOI 10.1128/JB.188.5.1744-1749.2006; Johnsborg O, 2009, FEMS MICROBIOL REV, V33, P627, DOI 10.1111/j.1574-6976.2009.00167.x; Kim S, 2012, P NATL ACAD SCI USA, V109, P7263, DOI 10.1073/pnas.1204791109; Kim S, 2011, CELL, V145, P67, DOI 10.1016/j.cell.2011.02.024; Kolmar H, 1996, J BACTERIOL, V178, P5925, DOI 10.1128/jb.178.20.5925-5929.1996; Kowalko JE, 2008, INFECT IMMUN, V76, P3131, DOI 10.1128/IAI.01696-07; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; Lau PCY, 2002, J MICROBIOL METH, V49, P193, DOI 10.1016/S0167-7012(01)00369-4; Livney YD, 2004, J DAIRY SCI, V87, P3638, DOI 10.3168/jds.S0022-0302(04)73502-X; Malet H, 2012, NAT STRUCT MOL BIOL, V19, P152, DOI 10.1038/nsmb.2210; Meltzer M, 2008, ANGEW CHEM INT EDIT, V47, P1332, DOI 10.1002/anie.200703273; Merdanovic M, 2010, NAT STRUCT MOL BIOL, V17, P837, DOI 10.1038/nsmb.1839; Oggioni MR, 2006, MOL MICROBIOL, V61, P1196, DOI 10.1111/j.1365-2958.2006.05310.x; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Peterson SN, 2004, MOL MICROBIOL, V51, P1051, DOI 10.1046/j.1365-2958.2003.03907.x; PORTER RD, 1976, J VIROL, V19, P659, DOI 10.1128/JVI.19.2.659-667.1976; Prudhomme M, 2006, SCIENCE, V313, P89, DOI 10.1126/science.1127912; Sawa J, 2011, J BIOL CHEM, V286, P30680, DOI 10.1074/jbc.M111.243832; Sebert ME, 2005, J BACTERIOL, V187, P3969, DOI 10.1128/JB.187.12.3969-3979.2005; Sebert ME, 2002, INFECT IMMUN, V70, P4059, DOI 10.1128/IAI.70.8.4059-4067.2002; Shen QT, 2009, P NATL ACAD SCI USA, V106, P4858, DOI 10.1073/pnas.0811780106; SIBOLD C, 1994, MOL MICROBIOL, V12, P1013, DOI 10.1111/j.1365-2958.1994.tb01089.x; Skorko-Glonek J, 2003, BBA-PROTEINS PROTEOM, V1649, P171, DOI 10.1016/S1570-9639(03)00170-5; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Stevens KE, 2011, MBIO, V2, DOI 10.1128/mBio.00071-11; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Tsui HCT, 2011, MBIO, V2, DOI 10.1128/mBio.00202-11; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Whatmore AM, 1999, J BACTERIOL, V181, P3144, DOI 10.1128/JB.181.10.3144-3154.1999; Wrase R, 2011, P NATL ACAD SCI USA, V108, P10490, DOI 10.1073/pnas.1101084108	47	65	65	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38449	38459		10.1074/jbc.M112.391482	http://dx.doi.org/10.1074/jbc.M112.391482			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23012372	Green Published, hybrid			2022-12-28	WOS:000310982800005
J	Della-Maria, J; Hegde, ML; McNeill, DR; Matsumoto, Y; Tsai, MS; Ellenberger, T; Wilson, DM; Mitra, S; Tomkinson, AE				Della-Maria, Julie; Hegde, Muralidhar L.; McNeill, Daniel R.; Matsumoto, Yoshihiro; Tsai, Miaw-Sheue; Ellenberger, Tom; Wilson, David M., III; Mitra, Sankar; Tomkinson, Alan E.			The Interaction between Polynucleotide Kinase Phosphatase and the DNA Repair Protein XRCC1 Is Critical for Repair of DNA Alkylation Damage and Stable Association at DNA Damage Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; STRAND BREAK REPAIR; N-TERMINAL DOMAIN; LIGASE III-ALPHA; POLYMERASE-BETA; AP ENDONUCLEASE; HUMAN-CELLS; POLY(ADP-RIBOSE) POLYMERASE; BRCT DOMAIN; IN-VITRO	XRCC1 plays a key role in the repair of DNA base damage and single-strand breaks. Although it has no known enzymatic activity, XRCC1 interacts with multiple DNA repair proteins and is a subunit of distinct DNA repair protein complexes. Here we used the yeast two-hybrid genetic assay to identify mutant versions of XRCC1 that are selectively defective in interacting with a single protein partner. One XRCC1 mutant, A482T, that was defective in binding to polynucleotide kinase phosphatase (PNKP) not only retained the ability to interact with partner proteins that bind to different regions of XRCC1 but also with aprataxin and aprataxin-like factor whose binding sites overlap with that of PNKP. Disruption of the interaction between PNKP and XRCC1 did not impact their initial recruitment to localized DNA damage sites but dramatically reduced their retention there. Furthermore, the interaction between PNKP and the DNA ligase III alpha-XRCC1 complex significantly increased the efficiency of reconstituted repair reactions and was required for complementation of the DNA damage sensitivity to DNA alkylation agents of xrcc1 mutant cells. Together our results reveal novel roles for the interaction between PNKP and XRCC1 in the retention of XRCC1 at DNA damage sites and in DNA alkylation damage repair.	[Della-Maria, Julie] Univ Maryland, Sch Med, Radiat Oncol Res Lab, Dept Radiat Oncol, Baltimore, MD 21201 USA; [Della-Maria, Julie] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Hegde, Muralidhar L.; Mitra, Sankar] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [McNeill, Daniel R.; Wilson, David M., III] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; [Matsumoto, Yoshihiro; Tomkinson, Alan E.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Matsumoto, Yoshihiro; Tomkinson, Alan E.] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA; [Tsai, Miaw-Sheue] Univ Calif Berkeley, Ernest Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Ellenberger, Tom] Washington Univ, Sch Med, Div Oncol, Dept Med, St Louis, MO 63110 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Texas System; University of Texas Medical Branch Galveston; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of New Mexico; University of New Mexico; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Washington University (WUSTL)	Tomkinson, AE (corresponding author), 1 Univ New Mexico, Canc Res Facil, 915 Camino Salud, Albuquerque, NM 87131 USA.	atomkinson@salud.unm.edu	Wilson, David M/AAK-5409-2021; Classen, Scott/AAY-8176-2020	Wilson, David M/0000-0002-8945-0395; Hegde, Muralidhar/0000-0001-7333-8123; Matsumoto, Yoshihiro/0000-0001-6580-7188	National Institutes of Health [R01 ES 012512, R01 CA81063, R01 GM052504, P01 CA 92584]; Intramural Research Program of the NIA, National Institutes of Health; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA081063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES 012512 (to A. E. T.), R01 CA81063 (to S. M.), R01 GM052504 (to T. E.), and P01 CA 92584 (to A. E. T., S. M., and T. E.) and by the Intramural Research Program of the NIA, National Institutes of Health.	Ali AAE, 2009, NUCLEIC ACIDS RES, V37, P1701, DOI 10.1093/nar/gkn1086; Berquist BR, 2010, NUCLEIC ACIDS RES, V38, P5023, DOI 10.1093/nar/gkq193; Breslin C, 2009, MOL CELL BIOL, V29, P4653, DOI 10.1128/MCB.00677-09; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Caldecott KW, 1995, NUCLEIC ACIDS RES, V23, P4836, DOI 10.1093/nar/23.23.4836; Cuneo MJ, 2011, NUCLEIC ACIDS RES, V39, P7816, DOI 10.1093/nar/gkr419; Cuneo MJ, 2010, P NATL ACAD SCI USA, V107, P6805, DOI 10.1073/pnas.0914077107; Das A, 2006, DNA REPAIR, V5, P1439, DOI 10.1016/j.dnarep.2006.07.003; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; Della-Maria J, 2011, J BIOL CHEM, V286, P33845, DOI 10.1074/jbc.M111.274159; Dianova II, 2004, NUCLEIC ACIDS RES, V32, P2550, DOI 10.1093/nar/gkh567; Dulic A, 2001, BIOCHEMISTRY-US, V40, P5906, DOI 10.1021/bi002701e; Fan JS, 2004, NUCLEIC ACIDS RES, V32, P2193, DOI 10.1093/nar/gkh556; Gryk MR, 2002, STRUCTURE, V10, P1709, DOI 10.1016/S0969-2126(02)00908-5; Gueven N, 2004, HUM MOL GENET, V13, P1081, DOI 10.1093/hmg/ddh122; Hanssen-Bauer A, 2011, ENVIRON MOL MUTAGEN, V52, P623, DOI 10.1002/em.20663; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Hegde ML, 2008, J BIOL CHEM, V283, P27028, DOI 10.1074/jbc.M802712200; Hegde ML, 2012, J BIOL CHEM, V287, P34202, DOI 10.1074/jbc.M112.384032; Iles N, 2007, MOL CELL BIOL, V27, P3793, DOI 10.1128/MCB.02269-06; Kanno SI, 2007, EMBO J, V26, P2094, DOI 10.1038/sj.emboj.7601663; Krejci L, 2001, MOL CELL BIOL, V21, P966, DOI 10.1128/MCB.21.3.966-976.2001; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Lu ML, 2010, NUCLEIC ACIDS RES, V38, P510, DOI 10.1093/nar/gkp1023; Luo H, 2004, MOL CELL BIOL, V24, P8356, DOI 10.1128/MCB.24.19.8356-8365.2004; Mackey ZB, 1997, MOL CELL BIOL, V17, P989, DOI 10.1128/MCB.17.2.989; Marintchev A, 1999, NAT STRUCT BIOL, V6, P884; Marsin S, 2003, J BIOL CHEM, V278, P44068, DOI 10.1074/jbc.M306160200; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Muniandy PA, 2009, J BIOL CHEM, V284, P27908, DOI 10.1074/jbc.M109.029025; Nash RA, 1997, BIOCHEMISTRY-US, V36, P5207, DOI 10.1021/bi962281m; Okano S, 2003, MOL CELL BIOL, V23, P3974, DOI 10.1128/MCB.23.11.3974-3981.2003; Parsons JL, 2008, MOL CELL, V29, P477, DOI 10.1016/j.molcel.2007.12.027; Parsons JL, 2005, BIOCHEMISTRY-US, V44, P10613, DOI 10.1021/bi050085m; Rasouli-Nia A, 2004, P NATL ACAD SCI USA, V101, P6905, DOI 10.1073/pnas.0400099101; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Shen NR, 1998, NUCLEIC ACIDS RES, V26, P1032, DOI 10.1093/nar/26.4.1032; Taylor RM, 1998, CURR BIOL, V8, P877, DOI 10.1016/S0960-9822(07)00350-8; THOMPSON LH, 1982, P NATL ACAD SCI-BIOL, V79, P534, DOI 10.1073/pnas.79.2.534; THOMPSON LH, 1990, MOL CELL BIOL, V10, P6160, DOI 10.1128/MCB.10.12.6160; Vidal AE, 2001, EMBO J, V20, P6530, DOI 10.1093/emboj/20.22.6530; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Xia LQ, 2005, J MOL BIOL, V346, P1259, DOI 10.1016/j.jmb.2005.01.014; ZDZIENICKA MZ, 1992, MUTAGENESIS, V7, P265, DOI 10.1093/mutage/7.4.265	49	23	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39233	39244		10.1074/jbc.M112.369975	http://dx.doi.org/10.1074/jbc.M112.369975			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22992732	Green Published, hybrid			2022-12-28	WOS:000310982800078
J	Halff, EF; Diebolder, CA; Versteeg, M; Schouten, A; Brondijk, THC; Huizinga, EG				Halff, Els F.; Diebolder, Christoph A.; Versteeg, Marian; Schouten, Arie; Brondijk, T. Harma C.; Huizinga, Eric G.			Formation and Structure of a NAIP5-NLRC4 Inflammasome Induced by Direct Interactions with Conserved N- and C-terminal Regions of Flagellin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP BINDING; 3-DIMENSIONAL STRUCTURE; NUCLEOTIDE-BINDING; MAMMALIAN-CELLS; FAMILY MEMBER; APOPTOSOME; ACTIVATION; CASPASE-1; SECRETION; PURIFICATION	The NOD-like receptors NAIP5 and NLRC4 play an essential role in the innate immune response to the bacterial tail protein flagellin. Upon flagellin detection, NAIP5 and NLRC4 form a hetero-oligomeric inflammasome that induces caspase-1-dependent cell death. So far, both the mechanism of formation of the NAIP5-NLRC4 inflammasome and its structure are poorly understood. In this study we combine inflammasome reconstitution in HEK293 cells, purification of inflammasome components, and negative stain electron microscopy to address these issues. We find that a Salmonella typhimurium flagellin fragment comprising the D0 domain and the neighboring spoke region is able to co-precipitate NAIP5 and induce formation of the NAIP5-NLRC4 inflammasome. Comparison with smaller fragments indicates that flagellin recognition is mediated by its C-terminal residues as well as the spoke region. Were constitute the inflammasome from purified flagellin, NAIP5, and NLRC4, thus proving that no other cellular components are required for its formation. Electron micrographs of the purified inflammasome provide unprecedented insight into its architecture, revealing disk-like complexes consisting of 11 or 12 protomers in which NAIP5 and NLRC4 appear to occupy equivalent positions. On the basis of our data, we propose a model for inflammasome formation wherein direct interaction of flagellin with a single NAIP5 induces the recruitment and progressive incorporation of NLRC4, resulting in the formation of a hetero-oligomeric inflammasome.	[Halff, Els F.; Diebolder, Christoph A.; Versteeg, Marian; Schouten, Arie; Brondijk, T. Harma C.; Huizinga, Eric G.] Univ Utrecht, Dept Chem, Fac Sci, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Diebolder, Christoph A.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Sect Elect Microscopy, NL-2300 RC Leiden, Netherlands	Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Huizinga, EG (corresponding author), Univ Utrecht, Dept Chem, Fac Sci, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands.	e.g.huizinga@uu.nl	Brondijk, Harma/AAD-6485-2019; Halff, Els F/M-9110-2015	Brondijk, Harma/0000-0002-0234-673X; Halff, Els F/0000-0001-5814-0899; Diebolder, Christoph/0000-0001-7694-7362	Dutch Top Institute Pharma Project [D1-101]	Dutch Top Institute Pharma Project	This work was supported by the Dutch Top Institute Pharma Project D1-101.	Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Askari N, 2012, J BIOTECHNOL, V157, P75, DOI 10.1016/j.jbiotec.2011.10.007; Chaudhary D, 1998, J BIOL CHEM, V273, P17708, DOI 10.1074/jbc.273.28.17708; Chinnaiyan AM, 1997, NATURE, V388, P728, DOI 10.1038/41913; Damiano JS, 2004, BIOCHEM J, V381, P213, DOI 10.1042/BJ20031506; Damiano JS, 2001, GENOMICS, V75, P77, DOI 10.1006/geno.2001.6579; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Fernandez JJ, 2006, ULTRAMICROSCOPY, V106, P587, DOI 10.1016/j.ultramic.2006.02.004; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Geddes BJ, 2001, BIOCHEM BIOPH RES CO, V284, P77, DOI 10.1006/bbrc.2001.4928; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Hu YM, 1998, J BIOL CHEM, V273, P33489, DOI 10.1074/jbc.273.50.33489; IBRAHIM GF, 1985, J CLIN MICROBIOL, V22, P1040, DOI 10.1128/JCM.22.6.1040-1044.1985; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Lu CF, 2005, BIOCHEM BIOPH RES CO, V331, P1114, DOI 10.1016/j.bbrc.2005.04.027; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Mo JY, 2012, J BIOL CHEM, V287, P23057, DOI 10.1074/jbc.M112.344283; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Qi SQ, 2010, CELL, V141, P446, DOI 10.1016/j.cell.2010.03.017; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Samatey FA, 2001, NATURE, V410, P331, DOI 10.1038/35066504; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Tameling WIL, 2002, PLANT CELL, V14, P2929, DOI 10.1105/tpc.005793; Tameling WIL, 2006, PLANT PHYSIOL, V140, P1233, DOI 10.1104/pp.105.073510; Tsai A, 2006, NAT PROTOC, V1, P2820, DOI 10.1038/nprot.2006.371; VONDERVISZT F, 1991, J MOL BIOL, V221, P1461, DOI 10.1016/0022-2836(91)90946-4; Ye ZM, 2008, MOL CELL BIOL, V28, P1841, DOI 10.1128/MCB.01468-07; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830; Yu XC, 2006, J MOL BIOL, V355, P577, DOI 10.1016/j.jmb.2005.10.040; Yu XC, 2005, STRUCTURE, V13, P1725, DOI 10.1016/j.str.2005.09.006; Yuan SJ, 2011, STRUCTURE, V19, P1084, DOI 10.1016/j.str.2011.07.001; Yuan SJ, 2011, STRUCTURE, V19, P128, DOI 10.1016/j.str.2010.10.009; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Zurek B, 2012, INNATE IMMUN-LONDON, V18, P100, DOI 10.1177/1753425910394002	48	108	112	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38460	38472		10.1074/jbc.M112.393512	http://dx.doi.org/10.1074/jbc.M112.393512			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23012363	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000310982800006
J	Ramesh, B; Sendra, VG; Cirino, PC; Varadarajan, N				Ramesh, Balakrishnan; Sendra, Victor G.; Cirino, Patrick C.; Varadarajan, Navin			Single-cell Characterization of Autotransporter-mediated Escherichia coli Surface Display of Disulfide Bond-containing Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL AUTOTRANSPORTERS; CRYSTAL-STRUCTURE; SERINE-PROTEASE; CHAIN FV; SECRETION; DOMAIN; AUTODISPLAY; EXPRESSION; TOLERANCE; DISCOVERY	Autotransporters (ATs) are a family of bacterial proteins containing a C-terminal beta-barrel-forming domain that facilitates the translocation of N-terminal passenger domain whose functions range from adhesion to proteolysis. Genetic replacement of the native passenger domain with heterologous proteins is an attractive strategy not only for applications such as biocatalysis, live-cell vaccines, and protein engineering but also for gaining mechanistic insights toward understanding AT translocation. The ability of ATs to efficiently display functional recombinant proteins containing multiple disulfides has remained largely controversial. By employing high-throughput single-cell flow cytometry, we have systematically investigated the ability of the Escherichia coli AT Antigen 43 (Ag43) to display two different recombinant reporter proteins, a single-chain antibody (M18 scFv) that contains two disulfides and chymotrypsin that contains four disulfides, by varying the signal peptide and deleting the different domains of the native protein. Our results indicate that only the C-terminal beta-barrel and the threaded alpha-helix are essential for efficient surface display of functional recombinant proteins containing multiple disulfides. These results imply that there are no inherent constraints for functional translocation and display of disulfide bond-containing proteins mediated by the AT system and should open new avenues for protein display and engineering.	[Ramesh, Balakrishnan; Sendra, Victor G.; Cirino, Patrick C.; Varadarajan, Navin] Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77204 USA; [Varadarajan, Navin] Univ Houston, Dept Biomed Engn, Houston, TX 77204 USA	University of Houston System; University of Houston; University of Houston System; University of Houston	Varadarajan, N (corresponding author), Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77204 USA.	nvaradar@central.uh.edu	Cirino, Patrick/AAM-1203-2021	Varadarajan, Navin/0000-0001-7524-8228	Welch Foundation [E-1774]; University of Houston Startup funds; NATIONAL CANCER INSTITUTE [R01CA174385] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); University of Houston Startup funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Welch Foundation (Grant E-1774) and University of Houston Startup funds.	AUSUBEL FM, 1999, SHORT PROTOCOLS MOL, P10; Becker S, 2007, CHEMBIOCHEM, V8, P943, DOI 10.1002/cbic.200700020; Bernstein HD, 2007, TRENDS MICROBIOL, V15, P441, DOI 10.1016/j.tim.2007.09.007; Binder U, 2010, J MOL BIOL, V400, P783, DOI 10.1016/j.jmb.2010.05.049; Brandon LD, 2001, J BACTERIOL, V183, P951, DOI 10.1128/JB.183.3.951-958.2001; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; Dautin N, 2011, J BACTERIOL, V193, P3748, DOI 10.1128/JB.05070-11; Harvey BR, 2004, P NATL ACAD SCI USA, V101, P9193, DOI 10.1073/pnas.0400187101; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Ieva R, 2008, MOL MICROBIOL, V67, P188, DOI 10.1111/j.1365-2958.2007.06048.x; Jeong KJ, 2007, P NATL ACAD SCI USA, V104, P8247, DOI 10.1073/pnas.0702650104; Johnson TA, 2009, J MOL BIOL, V389, P559, DOI 10.1016/j.jmb.2009.04.041; Jong WSP, 2007, MOL MICROBIOL, V63, P1524, DOI 10.1111/j.1365-2958.2007.05605.x; Jose J, 1996, GENE, V178, P107, DOI 10.1016/0378-1119(96)00343-5; Jose J, 2005, BIOCHEM BIOPH RES CO, V333, P1218, DOI 10.1016/j.bbrc.2005.06.028; Jose J, 2007, MICROBIOL MOL BIOL R, V71, P600, DOI 10.1128/MMBR.00011-07; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Junker M, 2009, MOL MICROBIOL, V71, P1323, DOI 10.1111/j.1365-2958.2009.06607.x; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Leysath CE, 2009, J MOL BIOL, V387, P680, DOI 10.1016/j.jmb.2009.02.003; Leyton DL, 2012, NAT REV MICROBIOL, V10, P213, DOI 10.1038/nrmicro2733; Leyton DL, 2011, J BIOL CHEM, V286, P42283, DOI 10.1074/jbc.M111.306118; Leyton DL, 2010, FEMS MICROBIOL LETT, V311, P133, DOI 10.1111/j.1574-6968.2010.02081.x; Li CK, 2008, BIOTECHNOL BIOENG, V99, P485, DOI 10.1002/bit.21548; Luirink J, 2003, PROTEIN SECRETION PATHWAYS IN BACTERIA, P1; Marin E, 2010, J BACTERIOL, V192, P5588, DOI 10.1128/JB.00432-10; Nhan NT, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-22; Otto BR, 2005, J BIOL CHEM, V280, P17339, DOI 10.1074/jbc.M412885200; Pallen MJ, 2003, CURR OPIN MICROBIOL, V6, P519, DOI 10.1016/j.mib.2003.09.005; POHLNER J, 1987, NATURE, V325, P458, DOI 10.1038/325458a0; Pyo HM, 2009, VACCINE, V27, P2030, DOI 10.1016/j.vaccine.2009.01.130; Rutherford N, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-22; Rutherford N, 2006, J BACTERIOL, V188, P4111, DOI 10.1128/JB.01949-05; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Sauri A, 2009, MICROBIOL-SGM, V155, P3982, DOI 10.1099/mic.0.034991-0; Schultheiss E, 2008, APPL ENVIRON MICROB, V74, P4782, DOI 10.1128/AEM.01575-07; Shibasaki S, 2001, APPL MICROBIOL BIOT, V57, P528; Skillman KM, 2005, MOL MICROBIOL, V58, P945, DOI 10.1111/j.1365-2958.2005.04885.x; Szabady RL, 2005, P NATL ACAD SCI USA, V102, P221, DOI 10.1073/pnas.0406055102; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Valls M, 2000, NAT BIOTECHNOL, V18, P661, DOI 10.1038/76516; van den Berg B, 2010, J MOL BIOL, V396, P627, DOI 10.1016/j.jmb.2009.12.061; van der Woude MW, 2008, ANNU REV MICROBIOL, V62, P153, DOI 10.1146/annurev.micro.62.081307.162938; Varadarajan N, 2005, P NATL ACAD SCI USA, V102, P6855, DOI 10.1073/pnas.0500063102; Varadarajan N, 2008, NAT CHEM BIOL, V4, P290, DOI 10.1038/nchembio.80; Varadarajan N, 2009, NAT PROTOC, V4, P893, DOI 10.1038/nprot.2009.60; VASQUEZ JR, 1989, J CELL BIOCHEM, V39, P265, DOI 10.1002/jcb.240390306; Veiga E, 1999, MOL MICROBIOL, V33, P1232, DOI 10.1046/j.1365-2958.1999.01571.x; Veiga E, 2004, MOL MICROBIOL, V52, P1069, DOI 10.1111/j.1365-2958.2004.04014.x; VOORHOUT WF, 1986, J MICROSC-OXFORD, V141, P303, DOI 10.1111/j.1365-2818.1986.tb02724.x; Wargacki AJ, 2012, SCIENCE, V335, P308, DOI 10.1126/science.1214547; Wells TJ, 2007, FEMS MICROBIOL LETT, V274, P163, DOI 10.1111/j.1574-6968.2007.00833.x; Zeng LY, 2011, JOVE-J VIS EXP, DOI 10.3791/3363	53	17	19	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38580	38589		10.1074/jbc.M112.388199	http://dx.doi.org/10.1074/jbc.M112.388199			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	23019324	Green Published, hybrid			2022-12-28	WOS:000310982800018
J	Mccue, HV; Patel, P; Herbert, AP; Lian, LY; Burgoyne, RD; Haynes, LP				McCue, Hannah V.; Patel, Pryank; Herbert, Andrew P.; Lian, Lu-Yun; Burgoyne, Robert D.; Haynes, Lee P.			Solution NMR Structure of the Ca2+-bound N-terminal Domain of CaBP7 A REGULATOR OF GOLGI TRAFFICKING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CALCIUM SENSOR-1; SEQUENCE-INDEPENDENT RECOGNITION; CRYSTAL-STRUCTURE; BINDING PROTEINS; EF-HAND; PHOSPHATIDYLINOSITOL 4-KINASE-BETA; 3-DIMENSIONAL STRUCTURE; MOLECULAR-MECHANISM; CA(V)2.1 CHANNELS; CA(V)1.3 CHANNELS	Calcium-binding protein 7 (CaBP7) is a member of the calmodulin (CaM) superfamily that harbors two high affinity EF-hand motifs and a C-terminal transmembrane domain. CaBP7 has been previously shown to interact with and modulate phosphatidylinositol 4-kinase III-beta (PI4KIII beta) activity in in vitro assays and affects vesicle transport in neurons when overexpressed. Here we show that the N-terminal domain (NTD) of CaBP7 is sufficient to mediate the interaction of CaBP7 with PI4KIII beta. CaBP7 NTD encompasses the two high affinity Ca2+ binding sites, and structural characterization through multi-angle light scattering, circular dichroism, and NMR reveals unique properties for this domain. CaBP7 NTD binds specifically to Ca2+ but not Mg2+ and undergoes significant conformational changes in both secondary and tertiary structure upon Ca2+ binding. The Ca2+-bound form of CaBP7 NTD is monomeric and exhibits an open conformation similar to that of CaM. Ca2+-bound CaBP7 NTD has a solvent-exposed hydrophobic surface that is more expansive than observed in CaM or CaBP1. Within this hydrophobic pocket, there is a significant reduction in the number of methionine residues that are conserved in CaM and CaBP1 and shown to be important for target recognition. In CaBP7 NTD, these residues are replaced with isoleucine and leucine residues with branched side chains that are intrinsically more rigid than the flexible methionine side chain. We propose that these differences in surface hydrophobicity, charge, and methionine content may be important in determining highly specific interactions of CaBP7 with target proteins, such as PI4KIII beta.	[Lian, Lu-Yun] Univ Liverpool, Inst Integrat Biol, NMR Ctr Struct Biol, Liverpool L69 3BX, Merseyside, England; [McCue, Hannah V.; Patel, Pryank; Herbert, Andrew P.; Burgoyne, Robert D.; Haynes, Lee P.] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Physiol Lab, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool	Lian, LY (corresponding author), Univ Liverpool, Inst Integrat Biol, NMR Ctr Struct Biol, Liverpool L69 3BX, Merseyside, England.	lu-yun.lian@liverpool.ac.uk; leeh@liverpool.ac.uk	Herbert, Andrew P/C-4755-2008; Burgoyne, Robert D/P-6641-2019; Herbert, Andy P/F-6693-2010; Burgoyne, Robert/C-6706-2008	Herbert, Andrew P/0000-0002-4549-6965; Burgoyne, Robert D/0000-0002-9219-0387; Herbert, Andy P/0000-0002-4549-6965; Burgoyne, Robert/0000-0002-9219-0387; McCue, Hannah/0000-0001-5237-3261	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust prize Ph.D. studentship (to H. V. M.).	Ames JB, 2012, BBA-GEN SUBJECTS, V1820, P1205, DOI 10.1016/j.bbagen.2011.10.003; Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Aravind P, 2008, J MOL BIOL, V376, P1100, DOI 10.1016/j.jmb.2007.12.033; Asmara H, 2010, J PHARMACOL SCI, V112, P397, DOI 10.1254/jphs.09342FP; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Cardy TJA, 1998, BIOCHEM J, V334, P447, DOI 10.1042/bj3340447; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; Cui GY, 2007, J PHYSIOL-LONDON, V585, P791, DOI 10.1113/jphysiol.2007.142307; de Barry J, 2006, J BIOL CHEM, V281, P18098, DOI 10.1074/jbc.M509842200; DIETER P, 1985, PLANTA, V166, P216, DOI 10.1007/BF00397351; Feric M, 2011, AM J PHYSIOL-CELL PH, V300, pC755, DOI 10.1152/ajpcell.00360.2010; Few AP, 2005, J NEUROSCI, V25, P7071, DOI 10.1523/JNEUROSCI.0452-05.2005; Findeisen F, 2010, STRUCTURE, V18, P1617, DOI 10.1016/j.str.2010.09.012; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; GELLMAN SH, 1991, BIOCHEMISTRY-US, V30, P6633, DOI 10.1021/bi00241a001; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Haynes LP, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00009; Haynes LP, 2006, PROTEOMICS, V6, P1822, DOI 10.1002/pmic.200500489; Haynes LP, 2005, J BIOL CHEM, V280, P6047, DOI 10.1074/jbc.M413090200; Haynes LP, 2004, J BIOL CHEM, V279, P547, DOI 10.1074/jbc.M309617200; Hradsky J, 2011, J BIOL CHEM, V286, P36762, DOI 10.1074/jbc.M111.280339; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; Kasri NN, 2004, MOL PHARMACOL, V66, P276, DOI 10.1124/mol.66.2.276; Kim EY, 2008, STRUCTURE, V16, P1455, DOI 10.1016/j.str.2008.07.010; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lee A, 2002, NAT NEUROSCI, V5, P210, DOI 10.1038/nn805; Li CM, 2009, J BIOL CHEM, V284, P2472, DOI 10.1074/jbc.M806513200; Lim S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208868; Lim S, 2009, BIOCHEMISTRY-US, V48, P850, DOI 10.1021/bi801897p; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Liu ZH, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00038; Lusin JD, 2008, BIOCHEMISTRY-US, V47, P2252, DOI 10.1021/bi7017267; Mccue HV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017853; McCue HV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004085; McCue Hannah V, 2010, BMC Res Notes, V3, P118, DOI 10.1186/1756-0500-3-118; Mccue HV, 2009, BIOCHEM BIOPH RES CO, V380, P825, DOI 10.1016/j.bbrc.2009.01.177; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mikhaylova M, 2006, BBA-MOL CELL RES, V1763, P1229, DOI 10.1016/j.bbamcr.2006.08.047; Mikhaylova M, 2009, P NATL ACAD SCI USA, V106, P9093, DOI 10.1073/pnas.0903001106; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; PALMITER RD, 1974, BIOCHEMISTRY-US, V13, P3606, DOI 10.1021/bi00714a032; Park S, 2011, PROTEIN SCI, V20, P1356, DOI 10.1002/pro.662; ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schwenk J, 2008, J BIOL CHEM, V283, P18937, DOI 10.1074/jbc.M800976200; Seidenbecher CI, 1998, J BIOL CHEM, V273, P21324, DOI 10.1074/jbc.273.33.21324; Stephen R, 2006, J MOL BIOL, V359, P266, DOI 10.1016/j.jmb.2006.03.042; Strahl T, 2007, J BIOL CHEM, V282, P30949, DOI 10.1074/jbc.M705499200; Takeuchi T, 2008, FEBS LETT, V582, P591, DOI 10.1016/j.febslet.2008.01.026; Taverna E, 2002, J CELL SCI, V115, P3909, DOI 10.1242/jcs.00072; Tippens AL, 2007, J BIOL CHEM, V282, P8464, DOI 10.1074/jbc.M611384200; Vijay-Kumar S, 1999, NAT STRUCT BIOL, V6, P80; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WEISENBE.RC, 1970, BIOCHEMISTRY-US, V9, P4110, DOI 10.1021/bi00823a012; Wingard JN, 2005, J BIOL CHEM, V280, P37461, DOI 10.1074/jbc.M508541200; Wu YQ, 2001, MOL GENET METAB, V72, P343, DOI 10.1006/mgme.2001.3160; Yang J, 2002, P NATL ACAD SCI USA, V99, P7711, DOI 10.1073/pnas.102006299; Yang PS, 2006, J NEUROSCI, V26, P10677, DOI 10.1523/JNEUROSCI.3236-06.2006; ZHANG MJ, 1994, J BIOL CHEM, V269, P15546; Zhao XH, 2001, J BIOL CHEM, V276, P40183, DOI 10.1074/jbc.M104048200; Zheng Q, 2005, J NEUROCHEM, V92, P442, DOI 10.1111/j.1471-4159.2004.02897.x; Zhou H, 2005, J BIOL CHEM, V280, P29612, DOI 10.1074/jbc.M504167200; Zhou H, 2004, J NEUROSCI, V24, P4698, DOI 10.1523/JNEUROSCI.5523-03.2004; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	74	5	6	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.402289	http://dx.doi.org/10.1074/jbc.M112.402289			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22989873	Green Published, hybrid			2022-12-28	WOS:000310642200056
J	Sengupta, S; Tu, SW; Wedin, K; Earnest, S; Stippec, S; Luby-Phelps, K; Cobb, MH				Sengupta, Samarpita; Tu, Szu-Wei; Wedin, Kyle; Earnest, Svetlana; Stippec, Steve; Luby-Phelps, Katherine; Cobb, Melanie H.			Interactions with WNK (With No Lysine) Family Members Regulate Oxidative Stress Response 1 and Ion Co-transporter Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; KINASE-DEFECTIVE ISOFORM; NA+-CL-COTRANSPORTER; GENOME-WIDE ANALYSIS; ALANINE-RICH KINASE; PROTEIN-KINASE; MEDIATED ENDOCYTOSIS; ACTIVATES SGK1; BLOOD-PRESSURE; OSR1	Two of the four WNK (with no lysine (K)) protein kinases are associated with a heritable form of ion imbalance culminating in hypertension. WNK1 affects ion transport in part through activation of the closely related Ste20 family protein kinases oxidative stress-responsive 1 (OSR1) and STE20/SPS1-related proline-, alanine-rich kinase (SPAK). Once activated by WNK1, OSR1 and SPAK phosphorylate and stimulate the sodium, potassium, two chloride co-transporters, NKCC1 and NKCC2, and also affect other related ion co-transporters. We find that WNK1 and OSR1 co-localize on cytoplasmic puncta in HeLa and other cell types. We show that the C-terminal region of WNK1 including a coiled coil is sufficient to localize the fragment in a manner similar to the full-length protein, but some other fragments lacking this region are mislocalized. Photo-bleaching experiments indicate that both hypertonic and hypotonic conditions reduce the mobility of GFP-WNK1 in cells. The four WNK family members can phosphorylate the activation loop of OSR1 to increase its activity with similar kinetic constants. C-terminal fragments of WNK1 that contain three RFXV interaction motifs can bind OSR1, block activation of OSR1 by sorbitol, and prevent the OSR1-induced enhancement of ion co-transporter activity in cells, further supporting the conclusion that association with WNK1 is required for OSR1 activation and function at least in some contexts. C-terminal WNK1 fragments can be phosphorylated by OSR1, suggesting that OSR1 catalyzes feedback phosphorylation of WNK1.	[Luby-Phelps, Katherine] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Sengupta, Samarpita; Tu, Szu-Wei; Wedin, Kyle; Earnest, Svetlana; Stippec, Steve; Cobb, Melanie H.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Luby-Phelps, Katherine] Univ Texas SW Med Ctr Dallas, Live Cell Imaging Facil, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Luby-Phelps, K (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	Kate.Phelps@UTSouthwestern.edu; Melanie.Cobb@UTSouthwestern.edu		Luby-Phelps, Katherine/0000-0002-8378-1409; Cobb, Melanie/0000-0003-0833-5473	National Institutes of Health [GM53032]; National Cancer Institute Cancer Center Support Grant [1P30 CA142543-01]; Robert A. Welch Foundation [I1243]; NATIONAL CANCER INSTITUTE [P30CA142543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM53032 (to M. H. C.). This work was also supported by National Cancer Institute Cancer Center Support Grant 1P30 CA142543-01 and Robert A. Welch Foundation Grant I1243 (to M. H. C.).	Ahlstrom R, 2009, AM J PHYSIOL-RENAL, V297, pF685, DOI 10.1152/ajprenal.00358.2009; Anselmo AN, 2006, P NATL ACAD SCI USA, V103, P10883, DOI 10.1073/pnas.0604607103; Bergaya S, 2012, CURR OPIN NEPHROL HY, V21, P39, DOI 10.1097/MNH.0b013e32834d2fde; Cha SK, 2010, J BIOL CHEM, V285, P6604, DOI 10.1074/jbc.M109.056044; Chen W, 2004, J BIOL CHEM, V279, P11129, DOI 10.1074/jbc.M313562200; Cheng CJ, 2011, J AM SOC NEPHROL, V22, P460, DOI 10.1681/ASN.2010060681; Choe KP, 2007, AM J PHYSIOL-CELL PH, V293, pC915, DOI 10.1152/ajpcell.00126.2007; Coppola D, 2008, CANCER-AM CANCER SOC, V113, P2665, DOI 10.1002/cncr.23892; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Cruz-Rangel S, 2011, AM J PHYSIOL-CELL PH, V301, pC601, DOI 10.1152/ajpcell.00070.2011; Delaloy C, 2003, MOL CELL BIOL, V23, P9208, DOI 10.1128/MCB.23.24.9208-9221.2003; Delpire E, 2007, PHYSIOL GENOMICS, V28, P223, DOI 10.1152/physiolgenomics.00173.2006; Dorwart MR, 2007, J PHYSIOL-LONDON, V584, P333, DOI 10.1113/jphysiol.2007.135855; Filippi BM, 2011, EMBO J, V30, P1730, DOI 10.1038/emboj.2011.78; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Grimm PR, 2012, FASEB J, V26; Hannemann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017992; Hannemann A, 2009, J BIOL CHEM, V284, P35348, DOI 10.1074/jbc.M109.060004; He GC, 2007, J CLIN INVEST, V117, P1078, DOI 10.1172/JCI30087; Heroes E., 2012, FEBS J IN PRESS; Kahle KT, 2004, CURR OPIN NEPHROL HY, V13, P557, DOI 10.1097/00041552-200409000-00012; Kahle KT, 2003, NAT GENET, V35, P372, DOI 10.1038/ng1271; Lazrak A, 2006, P NATL ACAD SCI USA, V103, P1615, DOI 10.1073/pnas.0510609103; Lee BH, 2004, MOL CELL, V15, P741, DOI 10.1016/j.molcel.2004.07.018; Lenertz LY, 2005, J BIOL CHEM, V280, P26653, DOI 10.1074/jbc.M502598200; McCormick JA, 2011, CELL METAB, V14, P352, DOI 10.1016/j.cmet.2011.07.009; McCormick JA, 2011, PHYSIOL REV, V91, P177, DOI 10.1152/physrev.00017.2010; Min XS, 2004, STRUCTURE, V12, P1303, DOI 10.1016/j.str.2004.04.014; Moriguchi T, 2005, J BIOL CHEM, V280, P42685, DOI 10.1074/jbc.M510042200; Nakamichi N, 2002, BIOSCI BIOTECH BIOCH, V66, P2429, DOI 10.1271/bbb.66.2429; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Richardson C, 2011, J CELL SCI, V124, P789, DOI 10.1242/jcs.077230; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; RUIZPEREZ VL, 1995, CURR GENET, V28, P309, DOI 10.1007/BF00326428; San-Cristobal P, 2008, AM J PHYSIOL-RENAL, V295, pF1199, DOI 10.1152/ajprenal.90396.2008; Subramanya AR, 2006, KIDNEY INT, V70, P630, DOI 10.1038/sj.ki.5001634; Subramanya AR, 2006, AM J PHYSIOL-RENAL, V290, pF619, DOI 10.1152/ajprenal.00280.2005; Thastrup JO, 2012, BIOCHEM J, V441, P325, DOI 10.1042/BJ20111879; Tu SW, 2011, P NATL ACAD SCI USA, V108, P1385, DOI 10.1073/pnas.1018567108; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Vidal-Petiot E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037751; Villa F, 2007, EMBO REP, V8, P839, DOI 10.1038/sj.embor.7401048; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Wade JB, 2006, P NATL ACAD SCI USA, V103, P8558, DOI 10.1073/pnas.0603109103; Wang ZH, 2004, BIOCHEM BIOPH RES CO, V317, P939, DOI 10.1016/j.bbrc.2004.03.132; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wilson FH, 2003, P NATL ACAD SCI USA, V100, P680, DOI 10.1073/pnas.242735399; Xie J, 2006, PEDIATR NEPHROL, V21, P1231, DOI 10.1007/s00467-006-0106-6; Xu BE, 2005, J BIOL CHEM, V280, P34218, DOI 10.1074/jbc.M505735200; Xu BE, 2005, P NATL ACAD SCI USA, V102, P10315, DOI 10.1073/pnas.0504422102; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200; Xu BE, 2002, J BIOL CHEM, V277, P48456, DOI 10.1074/jbc.M207917200; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Xu BE, 1999, J BIOL CHEM, V274, P34029, DOI 10.1074/jbc.274.48.34029; Xu Q, 2002, NUCLEIC ACIDS RES, V30, P3754, DOI 10.1093/nar/gkf492; Yang CL, 2007, J CLIN INVEST, V117, P3403, DOI 10.1172/JCI32033; Yang CL, 2007, BIOCHEM BIOPH RES CO, V353, P535, DOI 10.1016/j.bbrc.2006.11.151; Yang CL, 2005, J CLIN INVEST, V115, P1379, DOI 10.1172/JCI200522452; Yang CL, 2003, J CLIN INVEST, V111, P1039, DOI 10.1172/JCI200317443; Zagorska A, 2007, J CELL BIOL, V176, P89, DOI 10.1083/jcb.200605093	64	14	15	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.398750	http://dx.doi.org/10.1074/jbc.M112.398750			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22989884	Green Published, hybrid			2022-12-28	WOS:000310642200023
J	Zhang, YL; Gan, ZJ; Huang, P; Zhou, LT; Mao, T; Shao, ML; Jiang, XM; Chen, Y; Ying, H; Cao, MN; Li, JY; Li, J; Zhang, WPJ; Yang, L; Liu, Y				Zhang, Yongliang; Gan, Zhenji; Huang, Ping; Zhou, Luting; Mao, Ting; Shao, Mengle; Jiang, Xiaomeng; Chen, Yan; Ying, Hao; Cao, Meina; Li, Jingya; Li, Jia; Zhang, Weiping J.; Yang, Liu; Liu, Yong			A Role for Protein Inhibitor of Activated STAT1 (PIAS1) in Lipogenic Regulation through SUMOylation-independent Suppression of Liver X Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE RECEPTOR; ORPHAN NUCLEAR RECEPTORS; FATTY-ACID SYNTHESIS; LXR-ALPHA; TRANSCRIPTIONAL REGULATION; MEDIATES TRANSREPRESSION; HEPATIC LIPOGENESIS; RESPONSE PATHWAY; GENE-ACTIVATION; PPAR-GAMMA	Liver X receptors (LXRs) are nuclear receptors that function to modulate lipid metabolism as well as immune and inflammatory responses. Upon activation by their ligands, LXRs up-regulate a spectrum of gene transcription programs involved in cholesterol and fatty acid homeostasis. However, the mechanisms by which LXR-mediated transcriptional activation is regulated remain incompletely understood. Here, we show that PIAS1, a member of the protein inhibitor of the activated STAT family of proteins with small ubiquitin-like modifier (SUMO) E3 ligase activity, acts to suppress LXR ligand-dependent transcriptional activation of the lipogenic program in hepatocytes. We found that liver mRNA expression levels of Pias1 and Pias3 were inversely associated with those of genes involved in lipogenesis in mouse models with diet-induced or genetic obesity. Overexpression of PIAS1 in primary hepatocytes resulted in a reduction of LXR ligand-induced fatty acid synthesis and suppression of the expression of lipogenic genes, including Srebp1c and Fas. Moreover, PIAS1 was able to interact with LXR beta and repress its transcriptional activity upon ligand stimulation, which did not require PIAS1-promoted SUMO modification of LXR beta. In addition, PIAS1 could also interact with PGC-1 beta and attenuate its association with LXR beta, blunting the ability of PGC-1 beta to co-activate LXR beta. Importantly, PIAS1 impaired LXR beta binding to its target DNA sequence. Taken together, our results suggest that PIAS1 may serve as a lipogenic regulator by negatively modulating LXRs in a SUMOylation-independent manner.	[Zhang, Yongliang; Gan, Zhenji; Huang, Ping; Mao, Ting; Shao, Mengle; Jiang, Xiaomeng; Chen, Yan; Ying, Hao; Yang, Liu; Liu, Yong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab,Grad Sch, Shanghai 200031, Peoples R China; [Zhou, Luting; Zhang, Weiping J.] Second Mil Med Univ, Ctr Obes & Diabet Res & Innovat, Dept Pathophysiol, Shanghai 200433, Peoples R China; [Cao, Meina; Li, Jingya; Li, Jia] Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Naval Medical University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Liu, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab,Grad Sch, 294 Taiyuan Rd, Shanghai 200031, Peoples R China.	liuy@sibs.ac.cn	Shao, Mengle/AAH-8392-2019; li, jia/GVT-7587-2022; Shao, Mengle/D-9951-2014; Li, Jia/F-9116-2011	Shao, Mengle/0000-0002-5488-9904; Shao, Mengle/0000-0002-5488-9904; LIU, YONG/0000-0001-7771-4181; Gan, Zhenji/0000-0001-5940-207X	Ministry of Science and Technology from the 973 Program [2012CB524900, 2011CB910900]; National Natural Science Foundation [81021002, 30988002, 30830033]; Chinese Academy of Sciences Knowledge Innovation Programs [KSCX2-EW-R-09, KSCX2-EW-Q-1-09]; Science and Technology Commission of Shanghai Municipality [10XD1406400]	Ministry of Science and Technology from the 973 Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences Knowledge Innovation Programs; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by Ministry of Science and Technology Grants 2012CB524900 and 2011CB910900 from the 973 Program, National Natural Science Foundation Grants 81021002, 30988002, and 30830033, Chinese Academy of Sciences Knowledge Innovation Programs KSCX2-EW-R-09 and KSCX2-EW-Q-1-09, and Science and Technology Commission of Shanghai Municipality Grant 10XD1406400 (to Y. L.).	Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794; APFEL R, 1994, MOL CELL BIOL, V14, P7025, DOI 10.1128/MCB.14.10.7025; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Glass CK, 2000, GENE DEV, V14, P121; Godbey WT, 1999, GENE THER, V6, P1380, DOI 10.1038/sj.gt.3300976; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Huang P, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-59; Jackson PK, 2001, GENE DEV, V15, P3053, DOI 10.1101/gad.955501; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jiang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006884; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Lee JH, 2009, MOL CELL, V35, P806, DOI 10.1016/j.molcel.2009.07.021; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Liu B, 2005, MOL CELL BIOL, V25, P1113, DOI 10.1128/MCB.25.3.1113-1123.2005; Lu TT, 2001, J BIOL CHEM, V276, P37735, DOI 10.1074/jbc.R100035200; Mao T, 2011, P NATL ACAD SCI USA, V108, P15852, DOI 10.1073/pnas.1107394108; MCGARRY JD, 1978, J BIOL CHEM, V253, P8294; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Qiu YF, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000514; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Rytinki MM, 2009, J BIOL CHEM, V284, P26184, DOI 10.1074/jbc.M109.038943; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Sharrocks AD, 2006, GENE DEV, V20, P754, DOI 10.1101/gad.1421006; Shuai K, 2006, CELL RES, V16, P196, DOI 10.1038/sj.cr.7310027; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Song YY, 2012, J HEPATOL, V56, P248, DOI 10.1016/j.jhep.2011.07.014; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Wu YF, 2002, J BIOL CHEM, V277, P8898, DOI 10.1074/jbc.M110761200; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883	48	14	14	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.403139	http://dx.doi.org/10.1074/jbc.M112.403139			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22969086	Green Published, hybrid			2022-12-28	WOS:000310642200032
J	Divakaruni, AS; Humphrey, DM; Brand, MD				Divakaruni, Ajit S.; Humphrey, Dickon M.; Brand, Martin D.			Fatty Acids Change the Conformation of Uncoupling Protein 1 (UCP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROWN-ADIPOSE-TISSUE; NUCLEOTIDE-BINDING; PROTON CONDUCTANCE; NONSHIVERING THERMOGENESIS; PURINE NUCLEOTIDES; MITOCHONDRIAL; MECHANISM; TRANSPORT; MEMBRANE; PROTEOLYSIS	UCP1 catalyzes proton leak across the mitochondrial inner membrane to disengage substrate oxidation from ATP production. It is well established that UCP1 is activated by fatty acids and inhibited by purine nucleotides, but precisely how this regulation occurs remains unsettled. Although fatty acids can competitively overcome nucleotide inhibition in functional assays, fatty acids have little effect on purine nucleotide binding. Here, we present the first demonstration that fatty acids induce a conformational change in UCP1. Palmitate dramatically changed the binding kinetics of 2'/3'-O-(N-methylanthraniloyl)-GDP, a fluorescently labeled nucleotide analog, for UCP1. Furthermore, palmitate accelerated the rate of enzymatic proteolysis of UCP1. The altered kinetics of both processes indicate that fatty acids change the conformation of UCP1, reconciling the apparent discrepancy between existing functional and ligand binding data. Our results provide a framework for how fatty acids and nucleotides compete to regulate the activity of UCP1.	[Divakaruni, Ajit S.; Humphrey, Dickon M.; Brand, Martin D.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England; [Divakaruni, Ajit S.; Brand, Martin D.] Buck Inst Res Aging, Novato, CA 94945 USA	Buck Institute for Research on Aging	Divakaruni, AS (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	adivakaruni@ucsd.edu	Brand, Martin D/A-9423-2012	Brand, Martin D/0000-0003-4418-6153	National Institutes of Health [P01 AG025901, PL1 AG032118]; Medical Research Council (United Kingdom); British Marshall scholarship; National Science Foundation graduate research fellowship; NATIONAL INSTITUTE ON AGING [P01AG025901, PL1AG032118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Marshall scholarship; National Science Foundation graduate research fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 AG025901 and PL1 AG032118 (to M. D. B.). This work was also supported by the Medical Research Council (United Kingdom) and a British Marshall scholarship and a National Science Foundation graduate research fellowship (to A. S. D.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams AE, 2008, BBA-BIOENERGETICS, V1777, P115, DOI 10.1016/j.bbabio.2007.10.003; Aksamitiene E, 2007, ELECTROPHORESIS, V28, P3163, DOI 10.1002/elps.200700002; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Blesneac I, 2012, BBA-BIOMEMBRANES, V1818, P798, DOI 10.1016/j.bbamem.2011.12.016; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brand M. D., 1995, BIOENERGETICS, V154, P62; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Breen EP, 2006, J BIOL CHEM, V281, P2114, DOI 10.1074/jbc.M511575200; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carroll AM, 2005, J BIOL CHEM, V280, P15534, DOI 10.1074/jbc.M413315200; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; ECKERSKORN C, 1987, FEBS LETT, V226, P166, DOI 10.1016/0014-5793(87)80572-0; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Esteves TC, 2006, BIOCHEM J, V395, P619, DOI 10.1042/BJ20052004; Garlid KD, 1998, FEBS LETT, V438, P10, DOI 10.1016/S0014-5793(98)01246-0; Gonzalez-Barroso MM, 1998, J BIOL CHEM, V273, P15528, DOI 10.1074/jbc.273.25.15528; GORNALL AG, 1949, J BIOL CHEM, V177, P751; HEATON GM, 1978, EUR J BIOCHEM, V82, P515, DOI 10.1111/j.1432-1033.1978.tb12045.x; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Huang SG, 2003, ARCH BIOCHEM BIOPHYS, V420, P40, DOI 10.1016/j.abb.2003.07.005; HUANG SG, 1995, BIOCHEMISTRY-US, V34, P349, DOI 10.1021/bi00001a043; Huang SG, 1996, BIOCHEMISTRY-US, V35, P7846, DOI 10.1021/bi960244p; Hughes DA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-4; Jastroch M, 2007, J COMP PHYSIOL B, V177, P743, DOI 10.1007/s00360-007-0171-6; Jekabsons MB, 2002, BIOCHEM J, V366, P565, DOI 10.1042/BJ20020469; JEZEK P, 1994, J BIOL CHEM, V269, P26184; Khailova LS, 2006, BBA-BIOENERGETICS, V1757, P1324, DOI 10.1016/j.bbabio.2006.04.024; KLINGENBERG M, 1988, BIOCHEMISTRY-US, V27, P781, DOI 10.1021/bi00402a044; KLINGENBERG M, 1985, EMBO J, V4, P3087, DOI 10.1002/j.1460-2075.1985.tb04049.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN CS, 1982, BIOCHEMISTRY-US, V21, P2950, DOI 10.1021/bi00541a023; LIN CS, 1980, FEBS LETT, V113, P299, DOI 10.1016/0014-5793(80)80613-2; MARTY I, 1992, BIOCHEMISTRY-US, V31, P4058, DOI 10.1021/bi00131a023; Parker N, 2008, BIOCHEM J, V412, P131, DOI 10.1042/BJ20080006; Parker N, 2009, J BIOENERG BIOMEMBR, V41, P335, DOI 10.1007/s10863-009-9232-8; REYNAFARJE B, 1985, ANAL BIOCHEM, V145, P406, DOI 10.1016/0003-2697(85)90381-1; RIAL E, 1983, EUR J BIOCHEM, V137, P197, DOI 10.1111/j.1432-1033.1983.tb07815.x; RICHIERI GV, 1993, BIOCHEMISTRY-US, V32, P7574, DOI 10.1021/bi00080a032; Saito S, 2008, GENE, V408, P37, DOI 10.1016/j.gene.2007.10.018; Shabalina IG, 2004, J BIOL CHEM, V279, P38236, DOI 10.1074/jbc.M402375200; Stuart JA, 2001, BIOCHEM J, V356, P779, DOI 10.1042/0264-6021:3560779; WINKLER E, 1994, J BIOL CHEM, V269, P2508	43	37	38	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36845	36853		10.1074/jbc.M112.381780	http://dx.doi.org/10.1074/jbc.M112.381780			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22952235	hybrid, Green Published			2022-12-28	WOS:000310588500021
J	Lin, S; Cronan, JE				Lin, Steven; Cronan, John E.			The BioC O-Methyltransferase Catalyzes Methyl Esterification of Malonyl-Acyl Carrier Protein, an Essential Step in Biotin Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSYL-L-METHIONINE; FATTY-ACID BIOSYNTHESIS; ESCHERICHIA-COLI; ACTIVE-SITE; PHOSPHOPANTETHEINYL TRANSFERASE; DEPENDENT ENZYMES; PATHWAY; TRANSACYLASE; INHIBITION; EXPRESSION	Recent work implicated the Escherichia coli BioC protein as the initiator of the synthetic pathway that forms the pimeloyl moiety of biotin (Lin, S., Hanson, R. E., and Cronan, J. E. (2010) Nat. Chem. Biol. 6, 682-688). BioC was believed to be an O-methyltransferase that methylated the free carboxyl of either malonyl-CoA or malonyl-acyl carrier protein based on the ability of O-methylated (but not unmethylated) precursors to bypass the BioC requirement for biotin synthesis both in vivo and in vitro. However, only indirect proof of the hypothesized enzymatic activity was obtained because the activities of the available BioC preparations were too low for direct enzymatic assay. Because E. coli BioC protein was extremely recalcitrant to purification in an active form, BioC homologues of other bacteria were tested. We report that the native form of Bacillus cereus ATCC10987 BioC functionally replaced E. coli BioC in vivo, and the protein could be expressed in soluble form and purified to homogeneity. In disagreement with prior scenarios that favored malonyl-CoA as the methyl acceptor, malonyl-acyl carrier protein was a far better acceptor of methyl groups from S-adenosyl-L-methionine than was malonyl-CoA. BioC was specific for the malonyl moiety and was inhibited by S-adenosyl-L-homocysteine and sinefungin. High level expression of B. cereus BioC in E. coli blocked cell growth and fatty acid synthesis.	[Cronan, John E.] Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, Urbana, IL 61801 USA; [Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, 601 S Goodwin Ave, Urbana, IL 61801 USA.	j-cronan@life.uiuc.edu	Cronan, John/V-6626-2019; Lin, Steven/ABD-7821-2021; Lin, Steven/G-6142-2019	Lin, Steven/0000-0002-7542-4663; Lin, Steven/0000-0002-7542-4663	National Institutes of Health [AI15650]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015650, R37AI015650] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI15650.	Attwood PV, 2002, ACCOUNTS CHEM RES, V35, P113, DOI 10.1021/ar000049+; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BORCHARDT RT, 1979, BIOCHEM BIOPH RES CO, V89, P919, DOI 10.1016/0006-291X(79)91866-7; Borgaro JG, 2011, BIOCHEMISTRY-US, V50, P10678, DOI 10.1021/bi201199x; Chapman-Smith A, 1999, TRENDS BIOCHEM SCI, V24, P359, DOI 10.1016/S0968-0004(99)01438-3; Choi-Rhee EJ, 2005, CHEM BIOL, V12, P589, DOI 10.1016/j.chembiol.2005.04.012; Cronan JE, 2006, PLASMID, V55, P152, DOI 10.1016/j.plasmid.2005.07.001; Cronan JE, 2009, METHOD ENZYMOL, V459, P395, DOI 10.1016/S0076-6879(09)04617-5; De Lay NR, 2008, GENETICS, V178, P1327, DOI 10.1534/genetics.107.081836; De Lay NR, 2007, J BIOL CHEM, V282, P20319, DOI 10.1074/jbc.M703789200; Farrar CE, 2010, BIOCHEMISTRY-US, V49, P9985, DOI 10.1021/bi101023c; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Halliday NM, 2010, ANAL BIOCHEM, V403, P20, DOI 10.1016/j.ab.2010.04.021; HARDER ME, 1974, J BIOL CHEM, V249, P7468; Heath RJ, 2002, NAT PROD REP, V19, P581, DOI 10.1039/b110221b; HOFFMAN JL, 1986, BIOCHEMISTRY-US, V25, P4444, DOI 10.1021/bi00363a041; IFUKU O, 1994, EUR J BIOCHEM, V220, P585, DOI 10.1111/j.1432-1033.1994.tb18659.x; KNOWLES JR, 1989, ANNU REV BIOCHEM, V58, P195, DOI 10.1146/annurev.bi.58.070189.001211; Lemoine Y, 1996, MOL MICROBIOL, V19, P645, DOI 10.1046/j.1365-2958.1996.t01-4-442924.x; LEVYSCHIL S, 1993, APPL MICROBIOL BIOT, V38, P755, DOI 10.1007/BF00167141; Lin S, 2011, MOL BIOSYST, V7, P1811, DOI 10.1039/c1mb05022b; Lin S, 2010, NAT CHEM BIOL, V6, P682, DOI [10.1038/nchembio.420, 10.1038/NCHEMBIO.420]; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Oefner C, 2006, ACTA CRYSTALLOGR D, V62, P613, DOI 10.1107/S0907444906009474; Park J, 1996, BIOORGAN MED CHEM, V4, P2179, DOI 10.1016/S0968-0896(96)00228-3; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Rasko DA, 2004, NUCLEIC ACIDS RES, V32, P977, DOI 10.1093/nar/gkh258; REICH NO, 1990, J BIOL CHEM, V265, P8966; RUCH FE, 1973, J BIOL CHEM, V248, P8086; Sanishvili R, 2003, J BIOL CHEM, V278, P26039, DOI 10.1074/jbc.M303867200; SANYAL I, 1994, J AM CHEM SOC, V116, P2637, DOI 10.1021/ja00085a061; Tomczyk NH, 2002, FEBS LETT, V513, P299, DOI 10.1016/S0014-5793(02)02342-6; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Yang G, 1997, BIOCHEMISTRY-US, V36, P4751, DOI 10.1021/bi9631677	34	41	58	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37010	37020		10.1074/jbc.M112.410290	http://dx.doi.org/10.1074/jbc.M112.410290			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22965231	Green Published, hybrid			2022-12-28	WOS:000310588500036
J	Neal, MD; Sodhi, CP; Jia, H; Dyer, M; Egan, CE; Yazji, I; Good, M; Afrazi, A; Marino, R; Slagle, D; Ma, CR; Branca, MF; Prindle, T; Grant, Z; Ozolek, J; Hackam, DJ				Neal, Matthew D.; Sodhi, Chhinder P.; Jia, Hongpeng; Dyer, Mitchell; Egan, Charlotte E.; Yazji, Ibrahim; Good, Misty; Afrazi, Amin; Marino, Ryan; Slagle, Dennis; Ma, Congrong; Branca, Maria F.; Prindle, Thomas, Jr.; Grant, Zachary; Ozolek, John; Hackam, David J.			Toll-like Receptor 4 Is Expressed on Intestinal Stem Cells and Regulates Their Proliferation and Apoptosis via the p53 Up-regulated Modulator of Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROTIZING ENTEROCOLITIS; IN-VIVO; STEM/PROGENITOR CELLS; WNT RECEPTORS; BETA-CATENIN; PUMA; TLR4; PATHOGENESIS; INJURY; COLON	Factors regulating the proliferation and apoptosis of intestinal stem cells (ISCs) remain incompletely understood. Because ISCs exist among microbial ligands, immune receptors such as toll-like receptor 4 (TLR4) could play a role. We now hypothesize that ISCs express TLR4 and that the activation of TLR4 directly on the intestinal stem cells regulates their ability to proliferate or to undergo apoptosis. Using flow cytometry and fluorescent in situ hybridization for the intestinal stem cell marker Lgr5, we demonstrate that TLR4 is expressed on the Lgr5-positive intestinal stem cells. TLR4 activation reduced proliferation and increased apoptosis in ISCs both in vivo and in ISC organoids, a finding not observed in mice lacking TLR4 in the Lgr5-positive ISCs, confirming the in vivo significance of this effect. To define molecular mechanisms involved, TLR4 inhibited ISC proliferation and increased apoptosis via the p53-up-regulated modulator of apoptosis (PUMA), as TLR4 did not affect crypt proliferation or apoptosis in organoids or mice lacking PUMA. In vivo effects of TLR4 on ISCs required TIR-domain-containing adapter-inducing interferon-beta (TRIF) but were independent of myeloid-differentiation primary response-gene 88 (MYD88) and TNF alpha. Physiological relevance was suggested, as TLR4 activation in necrotizing enterocolitis led to reduced proliferation and increased apoptosis of the intestinal crypts in a manner that could be reversed by inhibition of PUMA, both globally or restricted to the intestinal epithelium. These findings illustrate that TLR4 is expressed on ISCs where it regulates their proliferation and apoptosis through activation of PUMA and that TLR4 regulation of ISCs contributes to the pathogenesis of necrotizing enterocolitis.	[Neal, Matthew D.; Sodhi, Chhinder P.; Jia, Hongpeng; Dyer, Mitchell; Egan, Charlotte E.; Yazji, Ibrahim; Afrazi, Amin; Marino, Ryan; Ma, Congrong; Branca, Maria F.; Prindle, Thomas, Jr.; Grant, Zachary; Hackam, David J.] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Div Pediat Surg, Pittsburgh, PA 15224 USA; [Neal, Matthew D.; Sodhi, Chhinder P.; Jia, Hongpeng; Dyer, Mitchell; Egan, Charlotte E.; Yazji, Ibrahim; Afrazi, Amin; Marino, Ryan; Ma, Congrong; Branca, Maria F.; Prindle, Thomas, Jr.; Grant, Zachary; Hackam, David J.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15224 USA; [Good, Misty; Slagle, Dennis] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Div Newborn Med, Pittsburgh, PA 15224 USA; [Good, Misty; Slagle, Dennis] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15224 USA; [Ozolek, John] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Div Pathol, Pittsburgh, PA 15224 USA; [Ozolek, John] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hackam, DJ (corresponding author), UPMC, Childrens Hosp Pittsburgh, Div Pediat Surg, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	david.hackam@chp.edu	Neal, Matthew/GMW-5601-2022; Good, Misty/AAI-6192-2020; Marino, Ryan/AAM-8665-2020	Neal, Matthew/0000-0001-8931-6236; Good, Misty/0000-0002-0264-5721; Hackam, David/0000-0001-5195-8807	National Institutes of Health [R01GM078238, RO1DK08752, 5K12HD052892]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health Grant [F30DK085930]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052892] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083752, F30DK085930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078238, P50GM053789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM078238 and RO1DK08752 (to D. J. H.) and 5K12HD052892 (to M. G.) and by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health Grant F30DK085930 (to A. A.).	Abraham C, 2011, GASTROENTEROLOGY, V140, P1729, DOI 10.1053/j.gastro.2011.02.012; Afrazi A, 2012, J IMMUNOL, V188, P4543, DOI 10.4049/jimmunol.1103114; Afrazi A, 2011, PEDIATR RES, V69, P183, DOI 10.1203/PDR.0b013e3182093280; Aguilera C, 2011, NATURE, V469, P231, DOI 10.1038/nature09607; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Carmon KS, 2012, MOL CELL BIOL, V32, P2054, DOI 10.1128/MCB.00272-12; Chen CL, 2012, LAB INVEST, V92, P331, DOI 10.1038/labinvest.2011.167; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Dehmer JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027070; Dekaney CM, 2009, AM J PHYSIOL-GASTR L, V297, pG461, DOI 10.1152/ajpgi.90446.2008; Dirisina R, 2011, GASTROENTEROLOGY, V141, P1036, DOI 10.1053/j.gastro.2011.05.032; Garrison AP, 2009, J PEDIATR GASTR NUTR, V49, P2, DOI 10.1097/MPG.0b013e3181ad3021; Good M, 2012, P NATL ACAD SCI USA, V109, P11330, DOI 10.1073/pnas.1200856109; Gribar SC, 2009, J IMMUNOL, V182, P636, DOI 10.4049/jimmunol.182.1.636; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; Khailova L, 2010, AM J PHYSIOL-GASTR L, V299, pG1118, DOI 10.1152/ajpgi.00131.2010; Kim TH, 2012, P NATL ACAD SCI USA, V109, P3932, DOI 10.1073/pnas.1113890109; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Leaphart CL, 2007, J IMMUNOL, V179, P4808, DOI 10.4049/jimmunol.179.7.4808; Neal MD, 2006, J IMMUNOL, V176, P3070, DOI 10.4049/jimmunol.176.5.3070; Neal MD, 2011, J SURG RES, V167, P1, DOI 10.1016/j.jss.2010.04.037; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; POTTEN CS, 1995, GUT, V36, P864, DOI 10.1136/gut.36.6.864; Qiu W, 2008, CELL STEM CELL, V2, P576, DOI 10.1016/j.stem.2008.03.009; Qiu W, 2011, J CLIN INVEST, V121, P1722, DOI 10.1172/JCI42917; Qiu W, 2009, CANCER RES, V69, P4999, DOI 10.1158/0008-5472.CAN-09-0262; Qureshi FG, 2005, GASTROENTEROLOGY, V128, P1012, DOI 10.1053/j.gastro.2005.01.052; Ragab A, 2011, EMBO J, V30, P1123, DOI 10.1038/emboj.2011.4; Richardson WM, 2010, GASTROENTEROLOGY, V139, P904, DOI 10.1053/j.gastro.2010.05.038; Ruemmele FM, 2002, GUT, V51, P842, DOI 10.1136/gut.51.6.842; Sancho R, 2009, EMBO J, V28, P1843, DOI 10.1038/emboj.2009.153; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schepers AG, 2011, EMBO J, V30, P1104, DOI 10.1038/emboj.2011.26; Sodhi CP, 2010, GASTROENTEROLOGY, V138, P185, DOI 10.1053/j.gastro.2009.09.045; Suzuki A, 2010, LAB INVEST, V90, P1425, DOI 10.1038/labinvest.2010.150; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wu B, 2007, GUT, V56, P645, DOI 10.1136/gut.2006.101683; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yu TX, 2012, J BIOL CHEM, V287, P3760, DOI 10.1074/jbc.M111.316349; Zamora R, 2005, AM J PHYSIOL-GASTR L, V289, pG822, DOI 10.1152/ajpgi.00181.2005	47	138	147	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37296	37308		10.1074/jbc.M112.375881	http://dx.doi.org/10.1074/jbc.M112.375881			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22955282	hybrid, Green Published			2022-12-28	WOS:000310588500061
J	Por, ED; Bierbower, SM; Berg, KA; Gomez, R; Akopian, AN; Wetsel, WC; Jeske, NA				Por, Elaine D.; Bierbower, Sonya M.; Berg, Kelly A.; Gomez, Ruben; Akopian, Armen N.; Wetsel, William C.; Jeske, Nathaniel A.			beta-Arrestin-2 Desensitizes the Transient Receptor Potential Vanilloid 1 (TRPV1) Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CAPSAICIN-ACTIVATED CURRENTS; BETA-ARRESTIN RECRUITMENT; BONE CANCER PAIN; SENSORY NEURONS; BETA-2-ADRENERGIC RECEPTOR; PKA PHOSPHORYLATION; COUPLED RECEPTORS; ERK1/2 ACTIVATION; AGONIST AFFINITY	Transient receptor potential vanilloid 1 (TRPV1) is a nonselective cation channel activated by multiple stimuli and is implicated in a variety of pain disorders. Dynamic sensitization of TRPV1 activity by A-kinase anchoring protein 150 demonstrates a critical role for scaffolding proteins in nociception, yet few studies have investigated scaffolding proteins capable of mediating receptor desensitization. In this study, we identify beta-arrestin-2 as a scaffolding protein that regulates TRPV1 receptor activity. We report beta-arrestin-2 association with TRPV1 in multiple cell models. Moreover, siRNA-mediated knockdown of beta-arrestin-2 in primary cultures resulted in a significant increase in both initial and repeated responses to capsaicin. Electrophysiological analysis further revealed significant deficits in TRPV1 desensitization in primary cultures from beta-arrestin-2 knock-out mice compared with wild type. In addition, we found that beta-arrestin-2 scaffolding of phosphodiesterase PDE4D5 to the plasma membrane was required for TRPV1 desensitization. Importantly, inhibition of PDE4D5 activity reversed beta-arrestin-2 desensitization of TRPV1. Together, these results identify a new endogenous scaffolding mechanism that regulates TRPV1 ligand binding and activation.	[Gomez, Ruben; Jeske, Nathaniel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Oral & Maxillofacial Surg, San Antonio, TX 78229 USA; [Por, Elaine D.; Berg, Kelly A.; Jeske, Nathaniel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Bierbower, Sonya M.; Jeske, Nathaniel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Akopian, Armen N.] Univ Texas Hlth Sci Ctr San Antonio, Dept Endodont, San Antonio, TX 78229 USA; [Wetsel, William C.] Duke Univ, Dept Psychiat & Behav Sci Cell Biol & Neurobiol, Durham, NC 27710 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Duke University	Jeske, NA (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Oral & Maxillofacial Surg, MC 7908,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	jeske@UTHSCSA.edu		Por, Elaine/0000-0001-8025-5713	National Institutes of Health [T32 HL07446-29, R21 NS055835, F31 DE022517-01, RO1 NS061884]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F31DE022517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061884, R01NS055835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 HL07446-29 (to S. M. B.), R21 NS055835 (to K. A. B.), F31 DE022517-01 (to E. D. P), and RO1 NS061884 (to N. A. J.).	Baillie GS, 2007, BIOCHEM J, V404, P71, DOI 10.1042/BJ20070005; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Bohn LM, 2002, J NEUROSCI, V22, P10494; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; Dasgupta P, 2006, J CLIN INVEST, V116, P3083, DOI 10.1172/JCI28164C1; DeFea KA, 2011, CELL SIGNAL, V23, P621, DOI 10.1016/j.cellsig.2010.10.004; Docherty RJ, 1996, PFLUG ARCH EUR J PHY, V431, P828, DOI 10.1007/BF02332166; Ghilardi JR, 2005, J NEUROSCI, V25, P3126, DOI 10.1523/JNEUROSCI.3815-04.2005; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; Houslay MD, 2005, BIOCHEM SOC T, V33, P1333, DOI 10.1042/BST0331333; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Jala VR, 2005, J BIOL CHEM, V280, P4880, DOI 10.1074/jbc.M409821200; Jeske NA, 2008, PAIN, V138, P604, DOI 10.1016/j.pain.2008.02.022; Jeske NA, 2006, J BIOL CHEM, V281, P32879, DOI 10.1074/jbc.M603220200; Jeske NA, 2009, PAIN, V146, P301, DOI 10.1016/j.pain.2009.08.002; Jeske NA, 2009, J NEUROCHEM, V108, P591, DOI 10.1111/j.1471-4159.2008.05779.x; Jin SLC, 1998, J BIOL CHEM, V273, P19672, DOI 10.1074/jbc.273.31.19672; Jung JY, 2004, J BIOL CHEM, V279, P7048, DOI 10.1074/jbc.M311448200; Key TA, 2003, J BIOL CHEM, V278, P4041, DOI 10.1074/jbc.M204687200; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Li X, 2006, BIOCHEM J, V394, P427, DOI 10.1042/BJ20051560; Li X, 2009, J BIOL CHEM, V284, P16170, DOI 10.1074/jbc.M109.008078; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lin FT, 1998, J BIOL CHEM, V273, P31640, DOI 10.1074/jbc.273.48.31640; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; LOHSE MJ, 1992, J BIOL CHEM, V267, P8558; Luttrell LM, 1997, ADV SEC MESS PHOSPH, V31, P263; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Mandadi S, 2004, CELL CALCIUM, V35, P471, DOI 10.1016/j.ceca.2003.11.003; Mohapatra DP, 2005, J BIOL CHEM, V280, P13424, DOI 10.1074/jbc.M410917200; Mohapatra DP, 2003, J BIOL CHEM, V278, P50080, DOI 10.1074/jbc.M306619200; Mohapatra DP, 2003, MOL CELL NEUROSCI, V23, P314, DOI 10.1016/S1044-7431(03)00054-X; Mundell SJ, 2000, J BIOL CHEM, V275, P12900, DOI 10.1074/jbc.275.17.12900; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; Patwardhan AM, 2006, P NATL ACAD SCI USA, V103, P11393, DOI 10.1073/pnas.0603861103; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Schnizler K, 2008, J NEUROSCI, V28, P4904, DOI 10.1523/JNEUROSCI.0233-08.2008; Sevcik MA, 2005, PAIN, V115, P128, DOI 10.1016/j.pain.2005.02.022; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shukla AK, 2010, J BIOL CHEM, V285, P30115, DOI 10.1074/jbc.M110.141549; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Studer M, 2010, J PHYSIOL-LONDON, V588, P3743, DOI 10.1113/jphysiol.2010.190611; SZALLASI A, 1990, BRAIN RES, V524, P106, DOI 10.1016/0006-8993(90)90498-Z; SZALLASI A, 1990, LIFE SCI, V47, P1399, DOI 10.1016/0024-3205(90)90518-V; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tominaga M, 2005, PFLUG ARCH EUR J PHY, V451, P143, DOI 10.1007/s00424-005-1457-8; Tominaga Makoto, 2004, Novartis Found Symp, V261, P4; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Vogler O, 1999, J BIOL CHEM, V274, P12333, DOI 10.1074/jbc.274.18.12333; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Zhang XM, 2008, NEURON, V59, P450, DOI 10.1016/j.neuron.2008.05.015	60	34	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37552	37563		10.1074/jbc.M112.391847	http://dx.doi.org/10.1074/jbc.M112.391847			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22952227	Green Published, hybrid			2022-12-28	WOS:000310588500083
J	Payne, CM; Baban, J; Horn, SJ; Backe, PH; Arvai, AS; Dalhus, B; Bjoras, M; Eijsink, VGH; Sorlie, M; Beckham, GT; Vaaje-Kolstad, G				Payne, Christina M.; Baban, Jamil; Horn, Svein J.; Backe, Paul H.; Arvai, Andrew S.; Dalhus, Bjorn; Bjoras, Magnar; Eijsink, Vincent G. H.; Sorlie, Morten; Beckham, Gregg T.; Vaaje-Kolstad, Gustav			Hallmarks of Processivity in Glycoside Hydrolases from Crystallographic and Computational Studies of the Serratia marcescens Chitinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICHODERMA-REESEI CELLOBIOHYDROLASE; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; FAMILY-18 CHITINASE; BIOMASS RECALCITRANCE; CATALYTIC MECHANISM; AROMATIC RESIDUES; ACTIVE-SITE; DEGRADATION; RESOLUTION	Degradation of recalcitrant polysaccharides in nature is typically accomplished by mixtures of processive and nonprocessive glycoside hydrolases (GHs), which exhibit synergistic activity wherein nonprocessive enzymes provide new sites for productive attachment of processive enzymes. GH processivity is typically attributed to active site geometry, but previous work has demonstrated that processivity can be tuned by point mutations or removal of single loops. To gain additional insights into the differences between processive and nonprocessive enzymes that give rise to their synergistic activities, this study reports the crystal structure of the catalytic domain of the GH family 18 nonprocessive endochitinase, ChiC, from Serratia marcescens. This completes the structural characterization of the co-evolved chitinolytic enzymes from this bacterium and enables structural analysis of their complementary functions. The ChiC catalytic module reveals a shallow substrate-binding cleft that lacks aromatic residues vital for processivity, a calcium-binding site not previously seen in GH18 chitinases, and, importantly, a displaced catalytic acid (Glu-141), suggesting flexibility in the catalytic center. Molecular dynamics simulations of two processive chitinases (ChiA and ChiB), the ChiC catalytic module, and an endochitinase from Lactococcus lactis show that the nonprocessive enzymes have more flexible catalytic machineries and that their bound ligands are more solvated and flexible. These three features, which relate to the more dynamic on-off ligand binding processes associated with nonprocessive action, correlate to experimentally measured differences in processivity of the S. marcescens chitinases. These newly defined hallmarks thus appear to be key dynamic metrics in determining processivity in GH enzymes complementing structural insights.	[Beckham, Gregg T.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Payne, Christina M.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Baban, Jamil; Horn, Svein J.; Eijsink, Vincent G. H.; Sorlie, Morten; Vaaje-Kolstad, Gustav] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway; [Backe, Paul H.; Dalhus, Bjorn; Bjoras, Magnar] Natl Hosp Norway, Dept Microbiol, Oslo Univ Hosp, N-0424 Oslo, Norway; [Backe, Paul H.; Dalhus, Bjorn; Bjoras, Magnar] Natl Hosp Norway, Dept Med Biochem, Oslo Univ Hosp, N-0424 Oslo, Norway; [Arvai, Andrew S.] Scripps Res Inst, Dept Mol Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Beckham, Gregg T.] Colorado Sch Mines, Dept Chem Engn, Golden, CO 80401 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Norwegian University of Life Sciences; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; Scripps Research Institute; Colorado School of Mines	Beckham, GT (corresponding author), Natl Renewable Energy Lab, Natl Bioenergy Ctr, 15013 Denver W Pkwy,MS 3322, Golden, CO 80401 USA.	gregg.beckham@nrel.gov; gustko@umb.no	Horn, Svein Jarle/C-6258-2008; Payne, Christina M/C-7338-2011; Bjørås, Magnar/N-9286-2017; Dalhus, Bjørn/AAK-2895-2020; Payne, Christina/ABE-8330-2020	Horn, Svein Jarle/0000-0002-1590-9001; Payne, Christina M/0000-0001-5264-0964; Payne, Christina/0000-0001-5264-0964; Vaaje-Kolstad, Gustav/0000-0002-3077-8003	Norwegian Research Council [218425, 186946, 196885, 209335]; United States Department of Energy; South-Eastern Norway Regional Health Authority [2009100, 2011040]; United States Office of Energy Efficiency and Renewable Energy [DE-AC36-08GO28308]; Texas Advanced Computing Center Ranger cluster; National Institute for Computational Sciences Kraken cluster under the National Science Foundation XSEDE [MCB090159]	Norwegian Research Council(Research Council of NorwayEuropean Commission); United States Department of Energy(United States Department of Energy (DOE)); South-Eastern Norway Regional Health Authority; United States Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE)); Texas Advanced Computing Center Ranger cluster; National Institute for Computational Sciences Kraken cluster under the National Science Foundation XSEDE	Supported by the Norwegian Research Council (Grant 218425) and the United States Department of Energy Biomass Program.; Supported by the Norwegian Research Council (Grants 186946, 196885, and 209335).; Supported by the South-Eastern Norway Regional Health Authority (Grants 2009100 and 2011040 for establishing the Regional Core Facility for Structural Biology and Bioinformatics).; Computer time for this research was provided by the National Renewable Energy Laboratory Computational Sciences Center supported by the United States Office of Energy Efficiency and Renewable Energy under Contract Number DE-AC36-08GO28308 and by the Texas Advanced Computing Center Ranger cluster and the National Institute for Computational Sciences Kraken cluster under the National Science Foundation XSEDE Grant MCB090159. We are grateful to the beamline staff at the ESRF, Grenoble, France for providing assistance in using beamline ID14-2.	Aronson NN, 2006, BIOSCI BIOTECH BIOCH, V70, P243, DOI 10.1271/bbb.70.243; Aronson NN, 2003, BIOCHEM J, V376, P87, DOI 10.1042/bj20030273; Baban J, 2010, J PHYS CHEM B, V114, P6144, DOI 10.1021/jp909801x; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Bokma E, 2002, EUR J BIOCHEM, V269, P893, DOI 10.1046/j.0014-2956.2001.02721.x; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brameld KA, 1998, J AM CHEM SOC, V120, P3571, DOI 10.1021/ja972282h; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brurberg MB, 1996, MICROBIOL-SGM, V142, P1581, DOI 10.1099/13500872-142-7-1581; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 2000, BIOCHEM J, V348, P201, DOI 10.1042/0264-6021:3480201; Demain AL, 2005, MICROBIOL MOL BIOL R, V69, P124, DOI 10.1128/MMBR.69.1.124-154.2005; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Eijsink VGH, 2008, TRENDS BIOTECHNOL, V26, P228, DOI 10.1016/j.tibtech.2008.02.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Guimaraes BG, 2002, J MOL BIOL, V320, P587, DOI 10.1016/S0022-2836(02)00497-7; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2006, BIOCATAL BIOTRANSFOR, V24, P39, DOI 10.1080/10242420500518482; Horn SJ, 2006, FEBS J, V273, P491, DOI 10.1111/j.1742-4658.2005.05079.x; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Houston DR, 2004, J MED CHEM, V47, P5713, DOI 10.1021/jm049940a; Houston DR, 2002, BIOCHEM J, V368, P23, DOI 10.1042/BJ20021034; Houston DR, 2002, P NATL ACAD SCI USA, V99, P9127, DOI 10.1073/pnas.132060599; Hsieh YC, 2010, J BIOL CHEM, V285, P31603, DOI 10.1074/jbc.M110.149310; Hult EL, 2005, BIOCHEM J, V388, P851, DOI 10.1042/BJ20050090; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; Koivula A, 1998, FEBS LETT, V429, P341, DOI 10.1016/S0014-5793(98)00596-1; Medie FM, 2012, NAT REV MICROBIOL, V10, P227, DOI 10.1038/nrmicro2729; MEINKE A, 1995, J BIOL CHEM, V270, P4383, DOI 10.1074/jbc.270.9.4383; Murphy L, 2012, J BIOL CHEM, V287, P1252, DOI 10.1074/jbc.M111.276485; Nakamura T, 2007, ACTA CRYSTALLOGR F, V63, P7, DOI 10.1107/S1744309106051773; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Nimlos MR, 2012, J BIOL CHEM, V287, P20603, DOI 10.1074/jbc.M112.358184; Norberg AL, 2010, FEBS LETT, V584, P4581, DOI 10.1016/j.febslet.2010.10.017; Pages S, 2001, J BIOL CHEM, V276, P33652, DOI 10.1074/jbc.M105770200; Payne CM, 2011, J BIOL CHEM, V286, P41028, DOI 10.1074/jbc.M111.297713; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Proctor MR, 2005, P NATL ACAD SCI USA, V102, P2697, DOI 10.1073/pnas.0500051102; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; Sikorski P, 2006, BIOCHEMISTRY-US, V45, P9566, DOI 10.1021/bi060370l; Stern R, 2008, CHEM REV, V108, P5061, DOI 10.1021/cr078240l; Suzuki K, 1999, BIOCHEM J, V343, P587, DOI 10.1042/0264-6021:3430587; Synstad B, 2004, EUR J BIOCHEM, V271, P253, DOI 10.1046/j.1432-1033.2003.03923.x; Synstad B, 2008, BIOSCI BIOTECH BIOCH, V72, P715, DOI 10.1271/bbb.70594; Tews I, 1997, J AM CHEM SOC, V119, P7954, DOI 10.1021/ja970674i; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2004, J BIOL CHEM, V279, P3612, DOI 10.1074/jbc.M310057200; Vaaje-Kolstad G, 2004, BBA-PROTEINS PROTEOM, V1696, P103, DOI 10.1016/j.bbapap.2003.09.014; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; van Aalten DMF, 2001, P NATL ACAD SCI USA, V98, P8979, DOI 10.1073/pnas.151103798; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; VANSCHELTINGA ACT, 1994, STRUCTURE, V2, P1181, DOI 10.1016/S0969-2126(94)00120-0; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Vuong TV, 2009, APPL ENVIRON MICROB, V75, P6655, DOI 10.1128/AEM.01260-09; Watanabe T, 1997, J BACTERIOL, V179, P7111, DOI 10.1128/jb.179.22.7111-7117.1997; WATANABE T, 1994, J BACTERIOL, V176, P4465, DOI 10.1128/JB.176.15.4465-4472.1994; Watanabe T, 2003, BIOCHEM J, V376, P237, DOI 10.1042/BJ20030419; Zakariassen H, 2009, J BIOL CHEM, V284, P10610, DOI 10.1074/jbc.M900092200	68	76	76	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36322	36330		10.1074/jbc.M112.402149	http://dx.doi.org/10.1074/jbc.M112.402149			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22952223	hybrid, Green Published			2022-12-28	WOS:000310364000053
J	Euskirchen, G; Auerbach, RK; Snyder, M				Euskirchen, Ghia; Auerbach, Raymond K.; Snyder, Michael			SWI/SNF Chromatin-remodeling Factors: Multiscale Analyses and Diverse Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MALIGNANT RHABDOID TUMORS; DNA-BINDING PROPERTIES; CANCER CELL-LINES; FREQUENT MUTATIONS; ACTIVE CHROMATIN; GENE-EXPRESSION; COMPLEX; PROTEIN; ACTIVATION; INTEGRASE	Chromatin-remodeling enzymes play essential roles in many biological processes, including gene expression, DNA replication and repair, and cell division. Although one such complex, SWI/SNF, has been extensively studied, new discoveries are still being made. Here, we review SWI/SNF biochemistry; highlight recent genomic and proteomic advances; and address the role of SWI/SNF in human diseases, including cancer and viral infections. These studies have greatly increased our understanding of complex nuclear processes.	[Euskirchen, Ghia; Snyder, Michael] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Auerbach, Raymond K.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA	Stanford University; Yale University	Snyder, M (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	mpsnyder@stanford.edu		Snyder, Michael/0000-0003-0784-7987				Agbottah E, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-48; Ariumi Y, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-47; Bazett-Jones DP, 1999, MOL CELL BIOL, V19, P1470; Bourgo RJ, 2009, MOL BIOL CELL, V20, P3192, DOI 10.1091/mbc.E08-12-1224; Bowman GD, 2010, CURR OPIN STRUC BIOL, V20, P73, DOI 10.1016/j.sbi.2009.12.002; Brehm A, 2004, BIOESSAYS, V26, P133, DOI 10.1002/bies.10392; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; Cha S, 2011, INTERVIROLOGY, V54, P66, DOI 10.1159/000318871; Chai B, 2005, GENE DEV, V19, P1656, DOI 10.1101/gad.1273105; Cohen SM, 2010, NUCLEIC ACIDS RES, V38, P6906, DOI 10.1093/nar/gkq559; Cook PR, 2010, J MOL BIOL, V395, P1, DOI 10.1016/j.jmb.2009.10.031; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Cui KR, 2004, MOL CELL BIOL, V24, P4476, DOI 10.1128/MCB.24.10.4476-4486.2004; Das S, 2009, J BIOL CHEM, V284, P19903, DOI 10.1074/jbc.M808141200; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; De S, 2011, MOL CELL BIOL, V31, P1512, DOI 10.1128/MCB.00920-10; DeCristofaro MF, 2001, J CELL PHYSIOL, V186, P136; Dinant C, 2009, J CELL BIOL, V185, P21, DOI 10.1083/jcb.200811080; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Euskirchen GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002008; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; FOURY F, 1979, P NATL ACAD SCI USA, V76, P6529, DOI 10.1073/pnas.76.12.6529; Gadd S, 2010, LAB INVEST, V90, P724, DOI 10.1038/labinvest.2010.66; Gkikopoulos T, 2011, EMBO J, V30, P1919, DOI 10.1038/emboj.2011.112; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Guidi CJ, 2001, MOL CELL BIOL, V21, P3598, DOI 10.1128/MCB.21.10.3598-3603.2001; Gwack Y, 2003, MOL CELL BIOL, V23, P2055, DOI 10.1128/MCB.23.6.2055-2067.2003; HABER JE, 1977, GENETICS, V87, P33; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Jagani Z, 2010, NAT MED, V16, P1429, DOI 10.1038/nm.2251; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kaeser MD, 2008, J BIOL CHEM, V283, P32254, DOI 10.1074/jbc.M806061200; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; Kim SI, 2009, NUCLEIC ACIDS RES, V37, P6019, DOI 10.1093/nar/gkp677; Kim SI, 2009, P NATL ACAD SCI USA, V106, P2259, DOI 10.1073/pnas.0806420106; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Kwiatkowski B, 2004, J VIROL, V78, P6067, DOI 10.1128/JVI.78.11.6067-6072.2004; Lange M, 2008, GENE DEV, V22, P2370, DOI 10.1101/gad.471408; Lee D, 1999, NATURE, V399, P487, DOI 10.1038/20966; Lee D, 2002, J BIOL CHEM, V277, P48842, DOI 10.1074/jbc.M203583200; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Li XS, 2010, MOL CELL BIOL, V30, P1673, DOI 10.1128/MCB.00540-09; Liu G, 2011, ONCOGENE, V30, P3295, DOI 10.1038/onc.2011.81; Luijsterburg MS, 2010, J CELL BIOL, V189, P445, DOI 10.1083/jcb.200909175; Mahmoudi T, 2006, J BIOL CHEM, V281, P19960, DOI 10.1074/jbc.M603336200; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Monahan BJ, 2008, NAT STRUCT MOL BIOL, V15, P873, DOI 10.1038/nsmb.1452; Morozov A, 1998, P NATL ACAD SCI USA, V95, P1120, DOI 10.1073/pnas.95.3.1120; Morozov A, 2007, CLIN CANCER RES, V13, P4721, DOI 10.1158/1078-0432.CCR-07-0054; Musselman CA, 2011, NUCLEIC ACIDS RES, V39, P9061, DOI 10.1093/nar/gkr613; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nagaich AK, 2004, MOL CELL, V14, P163, DOI 10.1016/S1097-2765(04)00178-9; NEIGEBORN L, 1984, GENETICS, V108, P845; Ni ZY, 2008, NAT IMMUNOL, V9, P785, DOI 10.1038/ni.1619; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Reisman DN, 2003, CANCER RES, V63, P560; Reyes JC, 1997, J CELL BIOL, V137, P263, DOI 10.1083/jcb.137.2.263; Rino J, 2007, PLOS COMPUT BIOL, V3, P2019, DOI 10.1371/journal.pcbi.0030201; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; Ryme J, 2009, J CELL BIOCHEM, V108, P565, DOI 10.1002/jcb.22288; Sigauke E, 2006, MODERN PATHOL, V19, P717, DOI 10.1038/modpathol.3800581; Singh M, 2007, CHEMBIOCHEM, V8, P1308, DOI 10.1002/cbic.200600562; Singh M, 2006, BIOL CHEM, V387, P1469, DOI 10.1515/BC.2006.184; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Smith CL, 2003, NAT STRUCT BIOL, V10, P141, DOI 10.1038/nsb888; Sorin M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000463; Sudarsanam P, 2000, TRENDS GENET, V16, P345, DOI 10.1016/S0168-9525(00)02060-6; Treand C, 2006, EMBO J, V25, P1690, DOI 10.1038/sj.emboj.7601074; Turelli P, 2001, MOL CELL, V7, P1245, DOI 10.1016/S1097-2765(01)00255-6; Van Duyne R, 2011, J MOL BIOL, V411, P581, DOI 10.1016/j.jmb.2011.06.001; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Wang WD, 1998, P NATL ACAD SCI USA, V95, P492, DOI 10.1073/pnas.95.2.492; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Wu DY, 1996, J VIROL, V70, P6020, DOI 10.1128/JVI.70.9.6020-6028.1996; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Wu KL, 2004, J BIOL CHEM, V279, P495, DOI 10.1074/jbc.M310069200; Wu Yuntao, 2004, Retrovirology, V1, P13, DOI 10.1186/1742-4690-1-13; Xue YT, 2000, P NATL ACAD SCI USA, V97, P13015, DOI 10.1073/pnas.240208597; Yung E, 2004, J VIROL, V78, P2222, DOI 10.1128/JVI.78.5.2222-2231.2004; Zhang B, 2007, ONCOGENE, V26, P7153, DOI 10.1038/sj.onc.1210509; Zhang YL, 2006, MOL CELL, V24, P559, DOI 10.1016/j.molcel.2006.10.025; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	94	112	128	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					30897	30905		10.1074/jbc.R111.309302	http://dx.doi.org/10.1074/jbc.R111.309302			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22952240	Green Published, hybrid			2022-12-28	WOS:000308791300003
J	Chatterjee, M; Hedrich, CM; Rauen, T; Ioannidis, C; Terhorst, C; Tsokos, GC				Chatterjee, Madhumouli; Hedrich, Christian M.; Rauen, Thomas; Ioannidis, Christina; Terhorst, Cox; Tsokos, George C.			CD3-T Cell Receptor Co-stimulation through SLAMF3 and SLAMF6 Receptors Enhances ROR gamma t Recruitment to the IL17A Promoter in Human T Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; EFFECTOR FUNCTIONS; NFAT; TH17; DIFFERENTIATION; SAP; DISEASE; IL-17; ACTIVATION; MECHANISMS	Th17 lymphocytes play a key role during immune responses against bacteria and fungi and are involved in the pathophysiology of multiple autoimmune disorders. The co-stimulatory molecules SLAMF3 and SLAMF6 have been implicated in the formation of Th17 phenotypes and IL-17A expression. Increased surface expression of SLAMF3 and SLAMF6 has been linked with disease activity in systemic lupus erythematosus. Here we demonstrate that in human total T lymphocytes the canonical CD28 and the non-canonical SLAMF3/SLAMF6 co-stimulatory pathways cooperate in the recruitment of the transcription factor NFAT1 to the IL17A promoter. Furthermore, the dominance of the SLAMF3/SLAMF6 pathway in inducing IL-17A production can be attributed to an increased nuclear abundance and recruitment of ROR gamma t to the IL17A promoter. Thus, we have identified an additional mechanism that may be central for the specific control of IL17A gene regulation in systemic lupus erythematosus T lymphocytes.	[Chatterjee, Madhumouli; Hedrich, Christian M.; Rauen, Thomas; Ioannidis, Christina; Tsokos, George C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Rheumatol, Sch Med, Boston, MA 02215 USA; [Terhorst, Cox] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Div Immunol,Med Sch, Boston, MA 02215 USA; [Rauen, Thomas] Rheinisch Westfael Tech Hsch Aachen Univ, Dept Nephrol & Clin Immunol, D-52056 Aachen, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; RWTH Aachen University	Tsokos, GC (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Div Rheumatol, Sch Med, Boston, MA 02215 USA.	gtsokos@bidmc.harvard.edu	tsokos, george C/O-3360-2013; Szczesny, Bartosz/D-1026-2012; BANERJEE, DIBYENDU/C-6656-2012; Rauen, Thomas/GLR-8682-2022; Chatterjee, Arpita/GPS-9141-2022; Hedrich, Christian/AAD-6855-2019; Hedrich, Christian/AAW-3958-2020; Banerjee, Dibyendu/Y-4652-2019; Mandal, Santi M./AAF-7156-2020	tsokos, george C/0000-0001-9589-2360; Banerjee, Dibyendu/0000-0003-4244-9714; Hedrich, Christian/0000-0002-1295-6179; Hegde, Muralidhar/0000-0001-7333-8123; Gustafsson, Claes/0000-0003-3531-8468; Dixit, Pavana/0000-0003-0811-3942	National Institutes of Health [R01 AI49954, P01 AI065687]; Deutsche Forschungsgemeinschaft [RA1927-1/1]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI49954 and P01 AI065687. This work was also supported by Deutsche Forschungsgemeinschaft Grant RA1927-1/1 (to T. R.).	Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Calpe S, 2008, ADV IMMUNOL, V97, P177, DOI 10.1016/S0065-2776(08)00004-7; Chatterjee M, 2012, J IMMUNOL, V188, P1206, DOI 10.4049/jimmunol.1102773; Chatterjee M, 2011, AUTOIMMUNITY, V44, P211, DOI 10.3109/08916934.2010.530627; Cippa PE, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.38; Collins M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-223; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; Detre C, 2010, SEMIN IMMUNOPATHOL, V32, P157, DOI 10.1007/s00281-009-0193-0; Dong C, 2011, EXP MOL MED, V43, P1, DOI 10.3858/emm.2011.43.1.007; Garrett-Sinha LA, 2008, CURR OPIN RHEUMATOL, V20, P519, DOI 10.1097/BOR.0b013e328304b6b5; Graef IA, 2001, CURR OPIN GENET DEV, V11, P505, DOI 10.1016/S0959-437X(00)00225-2; Graham DB, 2006, J IMMUNOL, V176, P291, DOI 10.4049/jimmunol.176.1.291; Henning G, 2001, EUR J IMMUNOL, V31, P2741, DOI 10.1002/1521-4141(200109)31:9<2741::AID-IMMU2741>3.0.CO;2-6; Hermann-Kleiter N, 2010, BLOOD, V115, P2989, DOI 10.1182/blood-2009-10-233585; Howie D, 2002, BLOOD, V100, P2899, DOI 10.1182/blood-2002-02-0445; Howie D, 2005, J IMMUNOL, V174, P5931, DOI 10.4049/jimmunol.174.10.5931; Kayama H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000514; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; LUCAS PJ, 1995, J IMMUNOL, V154, P5757; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Rauen T, 2012, GENES IMMUN, V13, P346, DOI 10.1038/gene.2011.85; Rauen T, 2011, J BIOL CHEM, V286, P43437, DOI 10.1074/jbc.M111.299313; Rudensky AY, 2006, CELL, V126, P253, DOI 10.1016/j.cell.2006.07.005; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Sundrud MS, 2007, CURR OPIN IMMUNOL, V19, P287, DOI 10.1016/j.coi.2007.04.014; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Valdez PA, 2004, J BIOL CHEM, V279, P18662, DOI 10.1074/jbc.M312313200; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Veillette A, 2007, IMMUNITY, V27, P698, DOI 10.1016/j.immuni.2007.11.005; Wilke CM, 2011, TRENDS IMMUNOL, V32, P603, DOI 10.1016/j.it.2011.08.003; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016	36	84	88	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.415067	http://dx.doi.org/10.1074/jbc.M112.415067			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22130663	hybrid, Green Published			2022-12-28	WOS:000310642200050
J	Mandal, SM; Hegde, ML; Chatterjee, A; Hegde, PM; Szczesny, B; Banerjee, D; Boldogh, I; Gao, R; Falkenberg, M; Gustafsson, CM; Sarkar, PS; Hazra, TK				Mandal, Santi M.; Hegde, Muralidhar L.; Chatterjee, Arpita; Hegde, Pavana M.; Szczesny, Bartosz; Banerjee, Dibyendu; Boldogh, Istvan; Gao, Rui; Falkenberg, Maria; Gustafsson, Claes M.; Sarkar, Partha S.; Hazra, Tapas K.			Role of Human DNA Glycosylase Nei-like 2 (NEIL2) and Single Strand Break Repair Protein Polynucleotide Kinase 3 '-Phosphatase in Maintenance of Mitochondrial Genome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; MAMMALIAN-CELLS; OXIDATIVE DAMAGE; OXIDIZED BASES; TRANSCRIPTION FACTORS; IN-VITRO; KAPPA-B; NUCLEAR; IDENTIFICATION; GENE	The repair of reactive oxygen species-induced base lesions and single strand breaks (SSBs) in the nuclear genome via the base excision (BER) and SSB repair (SSBR) pathways, respectively, is well characterize, and important for maintaining genomic integrity. However, the role of mitochondrial (mt) BER and SSBR proteins in mt genome maintenance is not completely clear. Here we show the presence of the oxidized base-specific DNA glycosylase Nei-like 2 (NEIL2) and the DNA end-processing enzyme polynucleotide kinase 3'-phosphatase (PNKP) in purified human mitochondrial extracts (MEs). Confocal microscopy revealed co-localization of PNKP and NEIL2 with the mitochondrion-specific protein cytochrome c oxidase subunit 2 (MT-CO2). Further, chromatin immunoprecipitation analysis showed association of NEIL2 and PNKP with the mitochondrial genes MT-CO2 and MT-CO3 (cytochrome c oxidase subunit 3); importantly, both enzymes also associated with the mitochondrion-specific DNA polymerase gamma. In cell association of NEIL2 and PNKP with polymerase gamma was further confirmed by proximity ligation assays. PNKP-depleted ME showed a significant decrease in both BER and SSBR activities, and PNKP was found to be the major 3'-phosphatase in human ME. Furthermore, individual depletion of NEIL2 and PNKP in human HEK293 cells caused increased levels of oxidized bases and SSBs in the mt genome, respectively. Taken together, these studies demonstrate the critical role of NEIL2 and PNKP in maintenance of the mammalian mitochondrial genome.	[Hazra, Tapas K.] Univ Texas Med Branch, Div Pulm & Crit Care Med, Sealy Ctr Mol Med, Dept Internal Med, Galveston, TX 77555 USA; [Hegde, Muralidhar L.; Hegde, Pavana M.; Szczesny, Bartosz; Banerjee, Dibyendu; Hazra, Tapas K.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Gao, Rui; Sarkar, Partha S.] Univ Texas Med Branch, Dept Neurol & Neurosci & Cell Biol, Galveston, TX 77555 USA; [Falkenberg, Maria; Gustafsson, Claes M.] Univ Gothenburg, Inst Biomed, SE-40530 Gothenburg, Sweden	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Gothenburg	Hazra, TK (corresponding author), Univ Texas Med Branch, Div Pulm & Crit Care Med, Sealy Ctr Mol Med, Dept Internal Med, 6-136 Med Res Bldg,Route 1079, Galveston, TX 77555 USA.	tkhazra@utmb.edu	tsokos, george C/O-3360-2013; Szczesny, Bartosz/D-1026-2012; BANERJEE, DIBYENDU/C-6656-2012; Rauen, Thomas/GLR-8682-2022; Chatterjee, Arpita/GPS-9141-2022; Hedrich, Christian/AAD-6855-2019; Hedrich, Christian/AAW-3958-2020; Banerjee, Dibyendu/Y-4652-2019; Mandal, Santi M./AAF-7156-2020	tsokos, george C/0000-0001-9589-2360; Banerjee, Dibyendu/0000-0003-4244-9714; Hedrich, Christian/0000-0002-1295-6179; Hegde, Muralidhar/0000-0001-7333-8123; Gustafsson, Claes/0000-0003-3531-8468; Dixit, Pavana/0000-0003-0811-3942	National Institutes of Health from the USPHS [CA102271, ES017353, CA81063, ES018948]	National Institutes of Health from the USPHS	This work was supported, in whole or in part, by National Institutes of Health Grants CA102271 and ES017353 (to T. K. H.), CA81063 (to S. M. M.), and ES018948 (to I. B.) from the USPHS.	Banerjee D, 2011, J BIOL CHEM, V286, P6006, DOI 10.1074/jbc.M110.198796; BARRY MA, 1993, ARCH BIOCHEM BIOPHYS, V300, P440, DOI 10.1006/abbi.1993.1060; Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Bottero V, 2001, J BIOL CHEM, V276, P21317, DOI 10.1074/jbc.M005850200; BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3; Cadet JL, 1998, NEUROCHEM INT, V32, P117, DOI 10.1016/S0197-0186(97)00031-4; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Caldecott KW, 2001, BIOESSAYS, V23, P447, DOI 10.1002/bies.1063; Chattopadhyay R, 2006, NUCLEIC ACIDS RES, V34, P2067, DOI 10.1093/nar/gkl177; Copeland WC, 2010, METHODS, V51, P363, DOI 10.1016/j.ymeth.2010.07.008; Das A, 2006, DNA REPAIR, V5, P1439, DOI 10.1016/j.dnarep.2006.07.003; Das BB, 2010, P NATL ACAD SCI USA, V107, P19790, DOI 10.1073/pnas.1009814107; Das S, 2007, J BIOL CHEM, V282, P28474, DOI 10.1074/jbc.M704672200; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; de Souza-Pinto NC, 2008, DNA REPAIR, V7, P1098, DOI 10.1016/j.dnarep.2008.03.011; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; DODSON ML, 1994, J BIOL CHEM, V269, P32709; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; GILONI L, 1981, J BIOL CHEM, V256, P8608; Gordon DM, 2001, BIOCHEM J, V356, P207, DOI 10.1042/0264-6021:3560207; Hazra IK, 1998, NUCLEIC ACIDS RES, V26, P5116, DOI 10.1093/nar/26.22.5116; Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hegde ML, 2010, J BIOL CHEM, V285, P28812, DOI 10.1074/jbc.M110.126664; HENNER WD, 1983, J BIOL CHEM, V258, P5198; Hu JP, 2005, J BIOL CHEM, V280, P40544, DOI 10.1074/jbc.M508772200; Jilani A, 1999, J BIOL CHEM, V274, P24176, DOI 10.1074/jbc.274.34.24176; Johansson H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013678; Kaneko M, 1998, TOXICOL LETT, V99, P15, DOI 10.1016/S0378-4274(98)00132-5; Karimi-Busheri F, 1999, J BIOL CHEM, V274, P24187, DOI 10.1074/jbc.274.34.24187; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Kumar D, 2009, J BIOL CHEM, V284, P1853, DOI 10.1074/jbc.M806289200; Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244; Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Mitra S, 2002, FREE RADICAL BIO MED, V33, P15, DOI 10.1016/S0891-5849(02)00819-5; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Patrick ME, 2004, EMERG INFECT DIS, V10, P1; Pohjanpelto P, 1996, EMBO J, V15, P1193, DOI 10.1002/j.1460-2075.1996.tb00458.x; Psarra AMG, 2008, BBA-MOL CELL RES, V1783, P1, DOI 10.1016/j.bbamcr.2007.10.021; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Scovassi AI, 2004, FASEB J, V18, P1487, DOI 10.1096/fj.04-1841rev; Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stucki M, 1998, ONCOGENE, V17, P835, DOI 10.1038/sj.onc.1202001; Sykora P, 2011, P NATL ACAD SCI USA, V108, P7437, DOI 10.1073/pnas.1100084108; Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Taylor RM, 2000, NUCLEIC ACIDS RES, V28, P3558, DOI 10.1093/nar/28.18.3558; Wallace Douglas C, 2002, Methods Mol Biol, V197, P3, DOI 10.1385/1-59259-284-8:003; Wang HX, 2003, J BIOL CHEM, V278, P28686, DOI 10.1074/jbc.M302844200; Weinfeld M, 2011, TRENDS BIOCHEM SCI, V36, P262, DOI 10.1016/j.tibs.2011.01.006; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024	62	84	88	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2819	2829		10.1074/jbc.M111.272179	http://dx.doi.org/10.1074/jbc.M111.272179			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22130663	hybrid, Green Published			2022-12-28	WOS:000300292300053
